Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
AAAS		ENSG00000094914	"Aladin WD repeat nucleoporin"	Q9NRG9	12	53307456-53324864	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040086	Approved		Approved	"Nuclear membrane,Centrosome,Cytosol"				"Nuclear membrane"	"Centrosome, Cytosol"	"HPA040086: AB_10805602"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.44e-2)"	15.0	35.1	13.4	22.0	16.6	19.9	16.5	19.2	18.4	17.6	16.4	22.6	20.9	15.4	19.3	26.1	18.2	25.3	19.4	20.7	13.2	11.8	20.4	26.0	13.4	23.4	19.3	10.1	19.7	27.3	33.1	27.3	23.6	15.8	17.3	19.3	21.5	22.8	18.5	19.7	22.2	17.5	21.2	16.4	22.0	19.1	26.6	19.5	39.1	19.5	24.6	24.4	17.2	16.9	15.3	17.2	8.2	14.7	10.0	16.7	10.1	10.1	30.9	24.2	14.8	11.5	14.0	15.5	11.6	12.6	29.2	16.9	21.0	21.6	24.4	20.0	14.7	14.8	42.1	31.0	17.3	15.4	27.2	19.8	13.7	21.1	11.7	17.5	15.0	13.3	15.6	19.4	18.9	23.0	26.2	28.3	14.1	32.9	27.4	18.1	16.6	21.6	27.0	16.1	27.3	20.7	8.4	13.0	16.5	8.5	19.4	9.0	24.8	15.3	10.4	13.9	21.1	11.0	12.2	12.7	16.0	22.1	11.2	15.2	16.0	1.2	12.1	8.2	13.7	14.0	16.5	15.2	12.3	12.6	13.7	15.3	16.7	16.2	1.1	10.0	14.7	17.2	12.6	10.1	13.4	16.6	19.2	18.4	13.2	11.8	19.3	10.1	15.8	19.5
AARS	"AlaRS, CMT2N"	ENSG00000090861	"Alanyl-tRNA synthetase"	P49588	16	70252295-70289543	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034261, HPA040870, HPA044223"	Supported		Enhanced	Cytosol		700000	700000	Cytosol		"CAB034261: AB_1562673, HPA040870: AB_10794995, HPA044223: AB_2678862"	"unprognostic (1.98e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.83e-3)"	22.8	25.3	28.0	19.6	34.8	5.9	22.6	36.4	54.0	22.3	18.4	30.6	21.4	16.8	22.0	33.9	14.5	20.4	14.1	20.9	29.5	31.7	25.5	36.4	19.5	17.9	40.3	40.5	18.7	45.4	61.2	23.1	21.0	37.5	23.2	17.5	17.3	30.1	30.0	25.2	14.1	14.4	28.4	33.2	16.7	21.1	12.2	32.7	10.3	42.1	10.6	20.9	17.7	26.9	13.4	11.6	3.9	13.3	21.3	13.4	11.6	22.9	38.7	10.7	39.6	25.0	22.7	25.8	18.2	25.3	23.0	29.1	31.7	31.0	26.1	24.5	18.3	26.9	30.9	24.8	32.4	11.8	11.1	25.7	16.4	28.1	66.2	15.4	15.4	26.8	37.5	44.2	99.0	22.8	32.7	34.5	17.2	52.0	16.5	18.1	20.0	22.3	31.6	6.7	57.0	15.7	11.8	13.3	11.4	50.6	11.9	44.8	37.3	33.9	15.0	17.0	16.5	16.8	15.1	48.7	31.9	48.1	29.1	24.1	33.2	3.9	8.6	3.9	12.6	12.7	12.8	13.4	10.9	12.1	11.6	11.4	13.1	13.4	1.3	21.3	13.3	7.9	8.4	11.6	28.0	34.8	36.4	54.0	29.5	31.7	40.3	40.5	37.5	32.7
AARS2	"AARSL, bA444E17.1, KIAA1270"	ENSG00000124608	"Alanyl-tRNA synthetase 2, mitochondrial"	Q5JTZ9	6	44299654-44313326	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Premature ovarian failure, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035636, HPA061396"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA035636: AB_10670837, HPA061396: "	"unprognostic (1.56e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.83e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	8.6	10.7	15.9	16.2	11.8	11.4	9.9	23.5	19.8	11.4	14.5	11.4	13.0	15.3	14.1	10.4	17.2	13.4	15.9	10.4	13.2	8.9	10.3	12.6	10.9	13.4	12.4	14.3	17.1	13.8	16.2	14.2	10.1	11.1	13.2	9.8	11.2	14.4	14.6	10.2	16.8	18.3	12.1	8.8	14.1	12.3	12.9	14.1	14.7	12.3	10.4	13.4	10.2	13.9	7.1	3.2	3.7	3.4	3.7	5.5	2.8	10.4	7.9	10.3	19.0	6.1	5.7	13.7	8.7	4.5	9.2	8.9	8.5	5.7	11.5	13.9	3.7	7.9	11.4	12.4	3.6	8.1	18.3	13.4	7.7	10.0	4.0	12.4	11.9	4.8	7.9	7.4	7.9	7.8	15.8	11.3	4.9	11.7	10.4	10.7	7.7	7.7	12.4	6.3	7.9	4.8	9.5	24.6	8.9	7.5	8.4	11.6	7.8	16.2	6.6	10.0	10.0	6.1	10.8	6.7	6.2	11.9	5.6	11.0	17.1	3.7	2.4	0.0	3.4	3.3	5.5	3.6	4.8	4.4	2.6	7.1	4.7	4.3	0.7	3.7	3.4	3.2	3.0	2.8	15.9	11.8	23.5	19.8	13.2	8.9	12.4	14.3	11.1	14.1
AASS	"LKRSDH, LORSDH"	ENSG00000008311	"Aminoadipate-semialdehyde synthase"	Q9UDR5	7	122075647-122144280	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 26.1;NTERA-2: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.0;granulocytes: 3.5;T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020637, HPA020728, HPA020734"	Enhanced		Enhanced	Vesicles,Mitochondria		17000	17000	Mitochondria	Vesicles	"HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417"	"unprognostic (4.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.00e-2)"	"prognostic favourable (9.81e-4)"	"unprognostic (4.48e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.76e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-1)"	13.9	9.5	7.4	4.8	11.8	1.6	11.2	2.7	9.8	16.0	8.1	12.5	8.2	2.2	16.8	11.6	6.4	14.9	6.7	12.6	8.8	3.7	14.4	35.8	9.1	3.3	15.2	5.0	36.7	10.7	14.9	10.4	7.1	9.9	9.2	3.8	9.2	5.4	10.4	11.3	4.4	5.5	9.3	12.1	5.2	9.0	5.1	13.2	0.8	7.8	8.3	3.1	11.0	9.0	1.0	0.4	3.5	0.1	0.3	1.2	0.1	0.1	0.0	16.2	26.1	13.5	8.7	6.3	4.4	4.7	4.6	6.7	7.4	0.2	0.0	0.3	3.1	2.8	18.6	8.4	6.3	0.0	6.8	5.6	3.6	4.8	11.1	0.0	1.8	7.6	0.2	5.5	5.8	11.0	1.5	10.3	3.1	0.0	0.5	0.0	25.5	1.0	8.4	8.6	0.3	2.1	1.8	1.6	0.5	1.4	0.0	2.7	0.4	0.0	5.0	9.0	2.7	4.1	4.2	2.2	1.6	0.0	3.3	0.5	3.4	3.5	0.1	0.0	0.7	0.0	0.1	0.5	0.8	0.0	0.4	1.0	1.2	0.5	0.0	0.3	0.0	0.0	0.7	0.1	7.4	11.8	2.7	7.3	8.8	3.7	15.2	5.0	9.9	13.2
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138428	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 23.1;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 28.0;SK-BR-3: 13.1;T-47d: 6.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebral cortex: 1.6;hippocampal formation: 1.8"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoli, Cytosol"	"HPA078239: "	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	6.9	0.1	0.1	6.2	0.3	0.0	1.4	0.0	0.0	4.4	8.4	0.1	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.1	4.9	0.0	0.1	0.4	0.0	0.3	0.0	0.1	23.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.0	29.3	6.1	0.1	3.7	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.0	0.0	2.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	2.0	0.0	13.1	0.0	6.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.0	0.0
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;lung: 75.8"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 20.8;T-47d: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA007884: AB_1078077"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.30e-1)"	6.3	6.2	12.9	3.4	15.3	1.6	7.0	21.9	30.8	3.0	3.8	13.1	1.8	2.7	3.2	4.2	3.6	4.9	3.3	5.6	14.6	13.8	3.9	1.5	75.8	3.9	11.4	13.1	3.2	9.6	14.8	6.0	4.7	18.3	5.3	2.1	4.9	8.5	5.0	5.0	4.2	2.5	5.0	11.3	3.7	3.0	7.2	6.1	5.6	16.2	0.5	6.4	3.0	1.3	0.2	0.5	0.0	0.6	2.0	1.5	0.4	0.3	9.5	1.8	14.8	0.4	0.0	0.1	2.6	0.6	1.0	1.1	1.3	1.5	0.1	3.8	1.1	0.2	8.5	0.1	0.3	14.9	5.7	0.9	1.1	0.2	1.3	0.1	1.6	0.1	0.2	0.1	0.5	14.4	10.2	0.0	0.0	12.7	0.0	1.0	2.0	4.6	2.3	0.3	1.6	8.5	0.3	20.8	14.9	1.8	10.5	0.2	34.2	0.9	4.1	0.1	0.5	4.0	4.2	2.8	1.2	0.0	2.1	5.1	0.1	0.0	0.1	0.0	1.5	0.1	0.8	0.2	0.6	1.4	0.5	0.1	0.6	1.5	0.0	2.0	0.6	0.0	0.3	0.4	12.9	15.3	21.9	30.8	14.6	13.8	11.4	13.1	18.3	6.1
ABCA4	"ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1"	ENSG00000198691	"ATP binding cassette subfamily A member 4"	P78363	1	93992835-94121132	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"		"Age-related macular degeneration, Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 142.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.0;EFO-21: 11.2;HeLa: 3.5;SK-BR-3: 4.2"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.1"	"Region enriched"	"Detected in some"	13	"pons and medulla: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078826	Enhanced									"HPA078826: "	"unprognostic (1.25e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-2)"	"prognostic favourable (2.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.70e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.17e-9)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (2.72e-4)"	0.7	0.0	0.3	0.2	0.4	0.0	1.1	0.2	0.9	0.7	0.2	3.2	0.2	3.7	0.2	12.9	0.2	0.6	0.2	0.2	2.0	0.2	6.7	1.2	0.4	0.3	0.3	0.2	0.3	0.2	0.0	0.2	0.8	25.5	0.3	0.0	142.7	0.2	2.1	0.2	3.5	4.2	0.2	0.2	0.2	0.1	2.1	0.2	0.2	0.7	0.2	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	5.0	0.2	0.3	0.0	0.2	0.1	0.0	0.0	11.2	0.5	1.1	0.0	0.0	0.1	0.0	0.0	0.7	3.5	1.2	0.6	0.0	0.0	0.5	0.0	0.5	0.0	1.0	0.0	0.2	0.0	1.4	0.5	0.0	2.0	0.0	0.2	0.4	0.3	0.5	0.5	0.0	0.0	1.0	4.2	0.2	0.4	0.0	0.2	0.3	2.2	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.9	2.0	0.2	0.3	0.2	25.5	0.2
ABCA7	ABCX	ENSG00000064687	"ATP binding cassette subfamily A member 7"	Q8IZY2	19	1040101-1065572	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Phagocytosis, Transport"		"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 26.2;HMC-1: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041564	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"				"Golgi apparatus, Plasma membrane"	"Cell Junctions"	"HPA041564: "	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (7.26e-4)"	"prognostic favourable (1.12e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.68e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.08e-2)"	"unprognostic (3.66e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.85e-2)"	6.0	3.5	6.2	20.2	4.8	35.2	7.6	13.6	11.1	5.0	5.8	1.9	4.7	4.9	2.1	3.9	7.5	2.8	5.5	2.3	5.3	6.5	5.3	3.6	9.5	17.7	5.2	5.1	1.0	7.0	5.6	34.5	3.1	7.7	4.9	4.2	34.7	9.9	6.5	5.5	11.1	11.1	1.8	6.7	26.6	7.9	1.6	4.3	19.8	7.0	3.9	14.5	5.1	4.9	1.5	9.9	10.8	2.5	1.9	2.6	1.2	5.6	5.3	1.1	3.3	6.5	2.9	5.4	0.8	0.8	0.3	0.6	4.0	2.1	11.0	3.8	0.7	5.6	2.3	5.0	0.3	7.3	2.1	8.5	26.2	4.0	2.5	3.1	31.6	2.7	1.8	1.5	2.8	1.8	8.5	6.8	1.0	1.3	3.1	2.3	0.6	2.5	2.8	0.6	7.9	2.7	10.6	0.7	2.1	6.2	1.9	0.6	3.6	5.1	2.7	0.6	1.3	2.8	0.8	8.0	7.7	6.0	1.4	7.6	1.3	4.3	2.5	7.0	2.6	1.7	1.6	1.0	1.5	1.8	2.8	1.5	1.4	2.1	10.8	1.9	1.6	9.9	0.6	1.2	6.2	4.8	13.6	11.1	5.3	6.5	5.2	5.1	7.7	4.3
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503633-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 57.8;intestine: 49.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 29.4;HEK 293: 9.0;HEL: 16.3;Hep G2: 8.1;RPTEC TERT1: 11.3;SH-SY5Y: 36.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 19.2"	"Group enriched"	"Detected in many"	8	"NK-cells: 11.4;T-cells: 19.2"									"CAB001716, HPA002199"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"				"Nucleoplasm, Focal adhesion sites, Cytosol"		"CAB001716: , HPA002199: AB_1844428"	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favourable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favourable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	57.8	9.4	3.2	11.5	1.2	3.4	5.1	10.5	5.5	22.7	3.8	2.0	14.4	9.4	3.5	2.0	3.2	9.0	1.8	9.2	6.6	19.1	15.6	3.8	2.2	9.4	5.7	2.2	1.5	1.7	1.3	3.1	11.1	2.7	10.7	7.6	1.5	2.1	1.1	1.3	49.6	5.7	9.0	2.4	1.7	1.3	8.6	0.1	2.4	1.4	2.2	2.6	5.9	1.9	0.0	0.1	0.0	11.4	19.2	1.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	9.0	16.3	1.9	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	11.3	0.0	0.4	36.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.4	3.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.8	0.0	19.2	0.4	2.0	4.7	0.0	1.9	1.2	4.8	0.1	11.4	0.0	0.0	0.0	1.5	9.4	11.5	5.1	10.5	9.2	6.6	9.4	5.7	11.1	8.6
ABCB11	"ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP"	ENSG00000073734	"ATP binding cassette subfamily B member 11"	O95342	2	168922938-169031322	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 47.4"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.0;NB-4: 1.6;PC-3: 1.0;THP-1: 2.5;TIME: 1.8;U-2197: 2.8"	"Cancer enriched"	"Detected in single"	87	"liver cancer: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA019035	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA019035: AB_1844429"	"unprognostic (7.78e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-1)"	"unprognostic (5.26e-6)"	"unprognostic (7.12e-2)"	"unprognostic (1.82e-1)"		"unprognostic (1.94e-1)"	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	1.6	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401697-87480435	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 93.2"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 11.7;WM-115: 22.3"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory B-cell: 4.9;naive B-cell: 11.4"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"				"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: , HPA053288: "	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.5	4.1	0.2	4.3	0.2	0.2	0.3	0.1	1.1	0.2	0.6	0.4	0.0	0.0	0.1	0.2	0.6	0.1	0.3	4.0	0.3	0.2	0.4	93.2	0.1	4.1	0.3	0.2	0.3	0.1	0.0	0.5	0.0	0.3	0.3	0.4	0.8	0.4	0.1	2.9	0.6	1.2	1.6	0.5	5.2	0.2	0.5	0.4	0.1	0.4	4.2	3.2	0.6	0.5	11.4	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	11.7	0.0	0.5	2.2	0.2	0.5	0.0	0.2	1.6	0.1	0.0	0.0	0.0	2.7	0.2	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.1	1.4	11.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.1	1.1	0.3	0.2	0.3	0.2	0.3	0.4
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209766-219219017	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"		22000	22000	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: "	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavourable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavourable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.1	8.4	8.2	3.9	13.5	10.2	9.2	7.6	9.1	6.9	7.6	5.4	8.3	8.1	7.1	10.1	9.0	8.4	8.5	9.5	5.6	8.2	6.9	16.2	7.2	4.9	9.8	7.6	13.1	7.1	8.0	6.0	3.7	9.2	9.2	4.2	6.0	5.6	11.3	24.0	5.5	8.0	9.5	9.2	3.2	6.8	19.5	7.7	0.8	9.9	11.3	4.7	14.8	6.0	2.8	5.6	1.3	1.1	1.2	3.2	2.4	0.1	10.0	2.0	12.6	14.1	5.0	12.4	3.7	3.5	4.1	4.1	15.3	2.2	0.1	19.3	3.6	21.6	0.2	1.5	1.3	6.4	2.2	15.6	11.0	28.2	17.0	0.0	5.2	7.4	1.8	2.7	0.0	7.2	13.3	1.9	2.8	5.1	1.0	0.1	3.2	4.1	5.2	6.4	0.6	2.2	0.2	7.4	7.9	7.8	18.5	8.2	5.5	0.3	3.2	5.5	0.2	7.4	4.3	5.1	4.0	0.0	6.3	0.1	7.4	1.3	1.1	0.0	1.7	0.9	0.5	2.8	1.3	0.7	0.9	2.3	3.2	2.1	0.0	1.2	0.8	5.6	1.1	2.4	8.2	13.5	7.6	9.1	5.6	8.2	9.8	7.6	9.2	7.7
ABCB7	"ABC7, ASAT, Atm1p, EST140535"	ENSG00000131269	"ATP binding cassette subfamily B member 7"	O75027	X	75051554-75156732	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034982	Approved		Supported	Mitochondria				Mitochondria		"HPA034982: AB_10601010"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.55e-2)"	"prognostic favourable (5.31e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	15.1	18.0	12.3	14.7	14.3	13.0	14.6	26.0	16.2	11.6	15.2	12.0	13.7	19.0	14.7	13.6	14.7	11.7	10.0	21.4	11.7	7.1	15.6	22.4	12.2	15.9	13.0	8.5	16.4	12.4	14.7	22.6	11.5	14.0	10.6	15.4	9.5	12.9	15.5	34.6	15.3	15.9	14.9	12.2	13.9	14.8	5.4	16.2	19.7	12.4	19.3	16.0	13.9	13.3	19.4	19.3	7.0	18.7	12.2	21.5	12.4	11.4	11.2	11.5	14.5	7.6	18.9	5.5	8.1	9.1	7.4	12.7	13.9	17.0	18.0	15.6	6.6	12.0	22.2	10.3	12.6	19.3	18.4	12.1	22.5	10.3	6.3	19.6	10.5	13.4	9.8	10.0	13.1	16.0	13.1	23.3	8.0	6.9	14.8	14.4	19.5	15.7	15.0	22.1	21.0	9.6	11.4	13.8	9.1	19.1	17.5	10.9	7.8	13.8	8.3	7.6	14.8	15.8	7.8	7.6	19.3	16.3	7.4	23.6	8.0	5.9	18.7	7.0	11.5	17.7	12.3	18.1	12.8	12.4	19.3	19.4	21.5	16.0	2.2	12.2	13.4	11.9	17.4	12.4	12.3	14.3	26.0	16.2	11.7	7.1	13.0	8.5	14.0	16.2
ABCC6	"ARA, EST349056, MLP1, MRP6, PXE, URG7"	ENSG00000091262	"ATP binding cassette subfamily C member 6"	O95255	16	16148928-16223522	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.4"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 37.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 16.7"					"Cell type enriched"	"Detected in some"	5	"classical monocyte: 7.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038105			Supported	"Plasma membrane"				"Plasma membrane"		"HPA038105: "	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.09e-1)"	"prognostic favourable (3.82e-4)"	"unprognostic (6.54e-3)"	"unprognostic (3.64e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.41e-1)"	2.3	1.4	0.2	0.0	0.2	0.0	1.1	0.0	0.0	0.1	1.5			7.0	0.0	0.0	0.0	0.3	1.2	0.8	0.1	0.1	9.0	27.4	2.8	0.0	0.2		0.1	6.7	0.5	0.1	0.0		0.7	1.2		6.7	0.2	1.7	0.0	3.7	0.0	0.2	0.1	2.2	0.0			2.2		0.0	0.0	0.0	0.2	0.9	1.3	7.3	0.6	0.1	1.2	0.0	0.9	0.4	0.0	0.0	0.5	1.1	0.0	0.2	0.5	0.9	3.7	1.4	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.0	0.4	1.1	0.1	37.7	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.6	0.0	0.4	0.1	4.8	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	7.3	0.3	0.0	1.0	0.0	0.0	0.1	0.0	0.9	0.2	0.1	0.1	1.3	0.6	0.1	0.1	0.0	1.2										
ABCD1	"adrenoleukodystrophy, ALD, ALDP, AMN"	ENSG00000101986	"ATP binding cassette subfamily D member 1"	P33897	X	153724868-153744762	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 46.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 32.4;PC-3: 22.9;SK-BR-3: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.57e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (5.50e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.23e-2)"	13.8	20.3	2.1	6.0	2.7	5.0	8.9	1.1	2.5	6.2	15.9	2.7	12.7	12.5	21.4	9.7	4.7	6.1	8.8	10.4	2.0	2.0	7.0	14.3	7.5	10.1	3.0	1.9	6.0	11.7	2.2	6.5	23.1	2.0	7.1	2.3	9.3	6.1	7.3	14.7	3.0	46.2	8.3	2.7	9.1	4.6	24.0	1.7	12.1	3.8	6.5	4.9	7.8	9.8	1.9	4.8	4.1	5.4	1.4	7.7	3.4	5.8	1.8	1.2	5.1	3.5	1.5	15.8	2.8	3.1	1.9	3.4	1.1	3.2	1.5	32.4	3.9	0.7	0.7	0.6	0.2	5.2	0.9	4.6	18.2	15.0	4.6	2.8	10.4	2.9	0.8	2.2	0.2	3.0	2.6	5.7	2.7	2.0	1.9	2.7	1.5	22.9	3.4	2.9	2.5	1.4	0.6	1.3	5.3	7.4	22.7	11.6	1.7	4.8	3.5	2.6	3.5	6.6	3.1	5.7	2.4	3.7	3.2	9.7	3.6	0.7	4.8	4.1	1.6	5.4	7.7	1.9	1.9	2.3	4.8	1.5	2.1	1.5	3.1	1.4	4.7	3.0	0.6	3.4	2.1	2.7	1.1	2.1	2.0	2.0	3.0	1.9	2.0	1.7
ABCD3	"PMP70, PXMP1, ZWS2"	ENSG00000117528	"ATP binding cassette subfamily D member 3"	P28288	1	94418455-94518666	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032026, HPA032027, CAB032516, CAB075749"	Enhanced		Enhanced	Peroxisomes				Peroxisomes		"CAB032516: AB_2257637, CAB075749: , HPA032026: AB_2674117, HPA032027: AB_10602103"	"unprognostic (1.41e-2)"	"unprognostic (3.21e-1)"	"prognostic favourable (1.16e-5)"	"unprognostic (1.92e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.12e-2)"	"prognostic favourable (4.84e-5)"	"unprognostic (5.45e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	8.9	14.2	13.1	9.5	13.3	10.3	16.8	11.2	12.8	11.8	21.2	14.9	24.9	21.4	9.8	14.6	15.4	10.0	17.3	16.0	12.7	10.3	29.3	60.6	11.2	9.9	13.2	10.4	8.1	16.7	18.3	14.6	11.2	14.3	11.0	20.1	21.4	13.2	24.0	12.9	17.1	21.7	10.8	16.5	7.6	20.8	10.2	12.7	46.5	13.7	10.8	9.9	11.8	11.1	3.1	8.4	3.9	6.2	8.0	7.4	4.2	27.7	13.0	13.5	12.8	10.4	11.5	20.0	14.5	11.3	16.7	18.6	40.6	8.8	17.2	18.8	18.3	20.4	15.5	18.8	23.5	13.8	13.4	19.5	19.3	35.2	10.1	17.3	6.0	9.6	10.6	19.4	7.5	10.2	8.7	10.4	17.2	3.9	29.0	9.1	15.5	18.6	16.4	28.1	6.6	16.5	42.5	10.2	16.8	25.1	26.7	18.9	9.8	14.4	10.1	12.5	18.0	21.8	19.2	5.9	5.4	16.8	9.7	8.9	5.8	0.3	5.3	3.9	6.5	6.2	6.1	2.8	5.9	7.4	8.4	3.1	7.1	6.9	1.3	8.0	5.2	2.2	6.5	4.2	13.1	13.3	11.2	12.8	12.7	10.3	13.2	10.4	14.3	12.7
ABCD4	"EST352188, P70R, PMP69, PXMP1L"	ENSG00000119688	"ATP binding cassette subfamily D member 4"	O14678	14	74285423-74303056	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003396	Approved									"HPA003396: AB_1078078"	"unprognostic (3.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.21e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-3)"	"unprognostic (7.93e-3)"	17.1	13.0	17.2	13.6	21.9	11.8	15.1	23.4	21.3	13.3	16.7	22.7	15.1	23.4	18.3	17.0	13.6	23.8	21.4	16.6	15.7	15.7	18.6	22.2	16.3	16.4	20.9	11.7	22.2	17.1	12.4	19.7	19.9	17.7	13.4	11.5	15.7	12.7	15.7	11.3	11.7	22.8	14.7	21.7	17.8	13.1	15.7	17.9	13.3	20.0	8.6	13.5	16.4	14.7	3.1	6.7	9.6	2.5	4.0	7.6	2.7	2.7	3.2	8.2	6.3	6.8	4.5	10.0	4.2	5.7	5.9	6.3	6.5	13.9	4.6	7.8	6.1	9.1	6.1	5.6	3.2	3.9	3.8	2.3	4.3	5.1	2.4	2.8	4.7	10.8	2.5	4.1	2.8	9.8	4.2	2.0	4.7	4.6	7.8	5.7	3.0	6.0	9.5	11.6	6.4	9.1	8.7	3.9	7.5	5.5	5.7	5.9	12.5	1.7	10.0	3.8	7.6	3.2	2.5	4.6	4.4	3.3	5.4	4.3	4.6	9.6	2.5	2.7	5.0	1.9	3.1	2.9	4.4	5.7	3.9	3.1	2.5	3.5	1.7	4.0	1.5	6.7	7.6	2.7	17.2	21.9	23.4	21.3	15.7	15.7	20.9	11.7	17.7	17.9
ABCG5	STSL	ENSG00000138075	"ATP binding cassette subfamily G member 5"	Q9H222	2	43812472-43838865	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	85	"intestine: 54.3;liver: 40.9"	"Cell line enriched"	"Detected in single"	47	"Hep G2: 14.4"	"Cancer enriched"	"Detected in some"	23	"liver cancer: 11.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.71e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.01e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.97e-2)"	"prognostic favourable (2.60e-5)"	"unprognostic (4.59e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.52e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.08e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	19.5	0.0	0.0	27.6	0.1	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.1	40.9	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	54.3	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0
ABCG8	GBD4	ENSG00000143921	"ATP binding cassette subfamily G member 8"	Q9H221	2	43831942-43882987	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 62.4;liver: 64.4"	"Cell line enriched"	"Detected in single"	47	"Hep G2: 14.4"	"Cancer enriched"	"Detected in some"	30	"liver cancer: 21.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019556	Uncertain		Approved	Vesicles				Vesicles		"HPA019556: AB_1844444"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (4.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.86e-3)"	"unprognostic (5.03e-1)"		"unprognostic (1.50e-1)"	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.1	0.4	0.1	21.2	0.0	0.0	24.0	0.1	0.1	0.1	0.1	1.7	0.1	0.2	0.3	0.2	64.4	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	62.4	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.6	2.1	0.3	0.5	0.8	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	14.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	2.1	0.3	0.4	0.7	0.3	0.5	0.5	0.6	0.5	0.1	0.7	0.8	0.7	1.7	0.5	0.3	0.6	0.3	0.2	0.2	0.3	0.1	0.4	0.2	0.3	0.2	0.0	0.0	0.0
ABHD12	"ABHD12A, BEM46L2, C20orf22, dJ965G21.2, DKFZP434P106"	ENSG00000100997	"Abhydrolase domain containing 12"	Q8N2K0	20	25294743-25390983	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Cataract, Deafness, Disease mutation, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 71.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026866	Uncertain									"HPA026866: AB_1844446"	"prognostic unfavourable (3.81e-5)"	"prognostic favourable (1.30e-5)"	"unprognostic (1.32e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavourable (7.18e-4)"	"unprognostic (8.51e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.08e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.11e-3)"	11.3	13.4	27.4	10.0	32.1	9.8	10.4	22.3	39.8	11.1	15.6	30.8	14.1	20.7	9.1	58.9	20.4	11.3	14.0	12.2	41.5	25.9	18.9	13.1	14.0	10.3	31.5	21.0	13.8	65.6	16.0	14.4	25.6	26.9	15.6	15.2	11.5	13.8	17.4	4.0	16.2	21.1	9.9	43.3	7.8	22.1	7.6	19.0	10.2	36.8	7.9	16.0	15.7	10.9	3.9	14.6	12.6	14.2	11.1	11.5	6.0	14.8	34.1	8.8	11.0	18.1	10.8	21.7	21.4	17.9	16.8	19.4	19.9	22.8	4.7	12.1	16.8	24.2	11.1	12.7	14.4	4.8	8.9	7.5	9.3	27.6	14.4	7.2	16.1	13.4	8.3	20.7	9.8	7.7	5.5	71.3	15.9	30.7	11.0	7.7	6.7	21.6	8.4	22.6	44.5	11.3	30.9	11.3	9.4	18.0	44.5	31.7	15.1	12.4	9.6	21.3	14.4	12.9	12.3	8.4	7.7	7.5	14.8	8.6	13.7	9.8	14.2	12.6	8.0	12.2	6.4	3.1	8.8	11.5	14.6	3.9	7.5	7.4	1.8	11.1	13.1	13.1	7.9	6.0	27.4	32.1	22.3	39.8	41.5	25.9	31.5	21.0	26.9	19.0
ABHD5	"CGI-58, NCIE2"	ENSG00000011198	"Abhydrolase domain containing 5"	Q8WTS1	3	43690108-43734371	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Cataract, Deafness, Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 70.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 26.1;classical monocyte: 7.6;neutrophil: 21.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 26.1;monocytes: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020685, HPA035851, HPA035852"	Approved		Approved	Vesicles				Vesicles		"CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-1)"	"prognostic favourable (8.89e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.56e-2)"	"unprognostic (4.13e-3)"	"prognostic favourable (9.17e-5)"	"unprognostic (2.48e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.18e-2)"	26.5	10.5	5.2	7.4	12.2	32.2	70.3	8.5	10.3	7.6	10.2	10.5	5.9	7.4	4.6	4.0	22.7	3.7	10.4	9.8	7.4	4.5	10.1	18.4	14.1	8.7	18.5	4.6	4.2	12.8	9.1	8.6	20.2	14.9	5.8	6.7	4.4	21.1	7.4	10.4	24.8	15.1	8.1	19.0	7.0	8.9	8.1	12.5	3.3	13.2	9.9	6.7	11.2	16.0	1.7	3.6	26.1	7.6	0.9	2.4	2.5	8.3	2.9	3.5	3.7	14.9	5.7	7.3	34.2	13.6	9.4	7.1	4.6	2.9	7.0	4.7	10.7	2.8	5.5	8.3	9.6	25.3	5.4	17.8	11.4	3.1	7.4	4.0	5.8	6.3	28.9	15.8	13.5	15.7	10.6	5.3	20.9	4.5	2.9	2.8	9.5	9.6	1.2	10.2	4.0	12.2	16.7	4.4	5.9	15.0	8.1	3.5	8.7	3.5	8.7	8.3	6.6	15.4	14.8	4.8	13.3	3.3	8.9	7.4	6.4	26.1	7.6	4.4	1.2	3.7	1.0	1.7	0.9	1.4	3.6	1.2	0.8	1.3	21.0	0.9	2.7	0.9	2.4	2.5	5.2	12.2	8.5	10.3	7.4	4.5	18.5	4.6	14.9	12.5
ACACA	"ACAC, ACC, ACC1"	ENSG00000278540	"Acetyl-CoA carboxylase alpha"	Q13085	17	37084988-37406818	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Allosteric enzyme, Ligase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013715, HPA036650, HPA063018"	Approved		Supported	"Nucleoli fibrillar center,Actin filaments,Cytosol"				Cytosol	"Nucleoli fibrillar center, Actin filaments"	"CAB013715: , HPA036650: , HPA063018: "	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.24e-5)"	"unprognostic (8.81e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.89e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-2)"	10.7	4.8	5.6	2.5	7.7	3.0	18.5	6.0	11.5	5.3	4.2	6.9	12.7	3.8	4.5	11.7	9.2	3.8	3.6	2.3	4.9		3.0	5.8	7.3	3.5	6.3	4.6	4.3	2.3	13.6	7.9	2.6	6.1	12.2	5.1	4.8	4.6	14.4	11.3	5.4	2.5	7.8	4.2	2.3	3.9	5.5	5.7	2.0	4.2	4.5	5.0	4.3	4.6	4.4	3.2	1.3	4.1	2.0	3.9	2.0	14.6	3.0	17.9	18.8	25.0	24.7	6.2	6.6	9.3	6.8	12.4	11.9	2.5	2.0	5.4	10.5	15.2	3.3	22.3	10.7	5.8	9.8	11.7	7.7	12.1	4.0	6.3	2.4	19.9	13.0	18.1	13.5	12.0	27.9	1.4	1.0	12.4	6.7	9.7	13.6	9.7	10.3	11.3	2.7	16.2	16.7	20.3	8.0	11.8	5.5	5.2	11.1	7.2	10.6	5.8	9.3	8.1	1.6	3.9	4.7	18.3	5.3	5.3	8.0	1.1	2.8	0.3	2.3	4.1	2.1	2.7	2.5	2.7	3.2	4.4	3.9	2.7	1.3	2.0	2.7	2.4	3.2	2.0										
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724347-75787575	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7;skeletal muscle: 82.8"	"Cell line enhanced"	"Detected in all"		"Daudi: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		1200000	1200000	Mitochondria		"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favourable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favourable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	18.1	25.0	12.3	11.3	13.0	3.9	18.0	12.0	10.8	8.4	21.6	8.3	10.1	25.1	6.7	8.6	21.9	7.6	6.7	49.7	10.5	11.2	71.1	89.7	6.3	9.4	13.0	9.2	10.5	10.3	8.1	12.0	4.2	14.3	9.2	12.1	8.0	9.0	11.7	82.8	5.6	25.1	9.8	10.7	12.3	12.0	8.5	11.0	11.0	12.2	42.1	10.0	9.5	8.1	29.7	16.7	14.1	13.8	16.8	20.0	13.2	6.9	5.5	17.4	7.6	15.0	12.3	4.9	13.0	10.6	12.8	10.8	10.3	11.1	75.9	11.5	9.3	6.4	14.7	11.0	15.9	29.3	7.2	24.9	16.9	15.8	10.5	21.2	6.9	14.2	6.4	11.1	6.7	10.0	25.3	17.2	13.7	2.6	24.9	10.0	14.0	13.3	32.5	22.9	7.9	21.2	18.3	9.4	11.9	10.5	31.4	27.1	9.3	26.9	5.4	8.7	8.6	7.4	21.3	11.2	16.0	33.7	7.4	17.3	9.9	10.7	9.6	14.1	13.2	13.8	20.0	29.7	13.8	15.9	14.3	18.0	15.8	17.6	0.8	16.8	12.7	16.7	13.8	13.2	12.3	13.0	12.0	10.8	10.5	11.2	13.0	9.2	14.3	11.0
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725735-120740008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.4;skeletal muscle: 50.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Enhanced	Nucleoplasm,Mitochondria		15000	15000	Mitochondria	Nucleoplasm	"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favourable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favourable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favourable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (6.34e-5)"	19.5	14.5	5.7	10.0	5.2	5.3	18.0	2.3	4.6	2.9	26.2	4.7	4.5	35.8	2.8	5.3	5.0	2.9	9.1	32.6	3.7	3.3	13.2	58.4	5.6	7.8	5.0	4.1	2.3	14.4	3.0	2.4	4.3	3.8	4.1	9.0	5.6	8.9	4.6	50.7	3.4	35.3	6.5	3.8	8.6	9.5	10.7	5.4	4.0	8.1	16.8	4.3	5.0	3.2	6.8	11.4	7.2	14.0	15.3	14.7	10.0	2.0	7.2	0.4	6.3	8.6	3.4	7.3	3.0	3.0	3.9	2.9	5.6	5.1	0.2	7.8	2.5	3.3	4.3	1.3	0.5	10.5	5.3	5.2	2.2	12.0	6.2	0.4	23.7	10.3	2.0	1.7	0.1	4.0	4.2	0.0	1.7	4.2	7.2	12.0	1.3	3.0	5.4	2.7	1.4	7.3	11.6	0.7	4.0	6.2	0.0	9.9	5.0	8.2	4.4	0.1	3.1	3.0	0.6	10.1	5.7	2.5	6.7	4.4	2.6	7.2	13.0	6.4	12.4	14.0	8.8	5.9	11.3	13.0	11.4	6.8	14.7	13.2	1.3	15.3	8.7	9.5	11.9	10.0	5.7	5.2	2.3	4.6	3.7	3.3	5.0	4.1	3.8	5.4
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058311	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 28.9;liver: 114.2"	"Cell line enhanced"	"Detected in all"		"Hep G2: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041458	Enhanced		Supported	Mitochondria		63000	63000	Mitochondria		"HPA041458: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favourable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favourable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	4.6	9.4	6.7	2.4	9.0	1.4	8.3	10.3	8.3	3.9	5.3	5.5	6.4	16.8	4.1	3.3	4.4	4.1	3.1	13.7	8.5	4.8	28.9	114.2	4.3	2.7	5.1	8.2	5.0	5.3	8.0	4.9	1.9	7.5	7.9	5.8	4.9	5.6	6.0	12.7	4.7	5.5	5.2	4.8	2.7	4.8	2.9	5.4	3.6	4.3	7.9	3.9	5.0	4.1	6.3	6.8	13.5	5.0	9.0	11.7	6.0	9.5	6.8	5.1	9.3	7.0	8.7	4.5	5.9	12.0	5.9	6.0	6.0	3.1	10.0	4.1	5.0	4.0	7.9	4.1	9.9	6.5	8.2	5.2	2.1	34.6	4.9	7.3	5.0	6.4	4.2	3.7	3.4	5.7	5.0	7.4	7.4	4.4	7.0	6.1	3.1	4.3	8.3	10.7	3.1	8.5	10.6	1.0	5.9	9.1	2.7	9.3	8.3	3.6	6.0	3.2	2.9	7.4	7.1	8.3	9.4	5.3	5.0	7.0	2.4	13.5	5.0	12.3	10.0	5.0	11.7	5.9	9.4	8.6	6.8	6.3	8.9	9.9	3.2	9.0	3.0	4.1	7.6	6.0	6.7	9.0	10.3	8.3	8.5	4.8	5.1	8.2	7.5	5.4
ACADVL	"ACAD6, LCACD, VLCAD"	ENSG00000072778	"Acyl-CoA dehydrogenase very long chain"	P49748	17	7217125-7225273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019006, HPA020595"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		19000000	19000000	"Nucleoli, Mitochondria"	"Nucleoplasm, Cytosol"	"HPA019006: AB_1844478, HPA020595: AB_1844479"	"unprognostic (4.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favourable (6.87e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.84e-3)"	32.7	69.2	22.8	18.2	21.1	15.1	24.1	19.8	18.4	21.1	44.0	16.5	26.7	51.7	17.4	19.7	31.5	14.2	24.4	118.2	20.2	12.2	35.2	90.0	17.3	9.8	18.5	16.8	15.5	67.8	31.5	32.3	40.2	20.9	22.1	24.2	20.0	27.4	29.0	132.3	20.3	51.2	25.0	15.7	21.9	28.7	11.5	18.6	14.6	29.6	36.9	21.2	22.4	31.8	8.3	32.0	37.9	29.0	11.6	14.9	20.0	33.2	31.9	13.1	18.0	56.6	20.8	24.8	24.5	34.1	28.0	17.4	12.9	30.2	17.8	20.5	51.4	25.7	8.8	26.8	24.8	56.5	9.0	9.5	22.7	19.6	27.2	9.0	24.8	23.2	24.6	23.4	36.9	25.1	12.2	21.8	44.9	12.6	9.4	10.9	6.2	12.6	13.1	14.5	42.4	62.2	30.4	3.5	8.6	34.6	44.0	20.1	20.2	13.9	25.0	24.8	18.6	12.5	23.9	20.4	9.5	0.9	45.6	16.0	18.0	6.8	29.0	37.9	13.5	18.0	12.4	8.3	10.9	14.9	32.0	7.6	8.3	10.2	6.3	11.6	12.0	26.0	9.7	20.0	22.8	21.1	19.8	18.4	20.2	12.2	18.5	16.8	20.9	18.6
ACAT1	"ACAT, THIL"	ENSG00000075239	"Acetyl-CoA acetyltransferase 1"	P24752	11	108121516-108147776	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 267.1"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004428, HPA007569"	Enhanced		Enhanced	Mitochondria		870000	870000	Mitochondria		"HPA004428: AB_1078088, HPA007569: AB_1844482"	"unprognostic (3.70e-3)"	"unprognostic (2.23e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favourable (1.43e-5)"	"unprognostic (3.59e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.13e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.62e-3)"	18.8	28.5	8.9	6.9	9.5	5.4	16.9	5.6	11.6	8.5	16.8	8.5	9.4	15.5	8.8	8.9	8.8	7.6	5.1	53.8	7.4	7.4	88.8	267.1	7.3	6.0	9.9	9.9	10.3	27.3	14.3	6.3	3.8	22.4	7.6	13.1	10.6	27.1	15.9	65.0	8.2	10.9	16.4	8.1	7.7	13.9	14.2	7.2	1.7	10.1	32.1	5.2	12.3	6.9	18.8	20.2	2.3	14.7	7.7	20.7	11.6	15.8	13.0	10.3	29.6	33.3	29.5	5.7	15.2	16.3	16.5	19.3	35.8	16.4	8.8	26.2	17.0	16.8	29.8	14.4	18.0	17.5	24.4	25.3	14.8	32.5	23.0	23.9	15.0	26.7	16.0	14.4	27.0	17.5	35.1	13.1	26.3	9.1	14.1	22.3	10.1	29.1	19.7	20.3	85.2	22.6	10.4	16.5	19.6	24.8	32.2	16.6	27.5	19.6	19.5	17.8	10.4	16.2	18.3	4.4	12.9	16.5	7.9	47.9	12.6	0.8	9.8	2.3	15.6	14.7	17.7	18.8	17.6	17.5	20.2	10.2	15.5	14.3	1.0	7.7	14.4	7.0	20.7	11.6	8.9	9.5	5.6	11.6	7.4	7.4	9.9	9.9	22.4	7.2
ACO2	ACONM	ENSG00000100412	"Aconitase 2"	Q99798	22	41469125-41528989	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 121.0;skeletal muscle: 157.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001097	Enhanced	Approved	Approved	Mitochondria		4000000	4000000	Mitochondria		"HPA001097: AB_1078092"	"unprognostic (1.95e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.07e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.46e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.12e-2)"	22.8	18.5	41.4	11.1	38.2	9.8	12.2	21.0	43.5	12.2	25.4	27.7	12.3	45.1	9.5	9.9	17.5	15.7	11.1	121.0	33.8	24.2	37.9	22.2	10.0	11.1	27.6	32.7	8.6	17.2	48.5	7.6	9.1	24.9	12.5	20.0	14.7	20.1	15.2	157.9	9.8	46.6	12.5	28.6	10.0	21.0	9.6	23.1	9.5	16.0	42.7	12.0	12.3	8.8	22.9	28.1	7.3	36.6	15.8	16.4	19.4	16.1	18.8	18.9	39.0	32.6	21.3	26.5	14.9	18.8	25.1	23.5	27.7	21.1	37.1	24.4	22.1	37.1	35.1	27.2	13.2	24.5	25.0	18.0	26.3	29.4	28.5	47.9	27.6	37.8	21.9	26.0	27.7	24.8	23.2	40.5	19.7	30.3	24.4	16.2	12.9	37.7	33.2	13.0	51.4	32.3	32.1	13.6	11.6	36.6	43.3	27.6	25.1	25.6	17.6	21.4	24.0	19.5	16.3	24.1	29.9	25.9	34.6	20.9	23.1	4.5	21.1	7.3	14.7	31.3	14.0	22.9	12.5	15.8	28.1	20.2	14.2	14.6	5.3	15.8	36.6	11.2	16.4	19.4	41.4	38.2	21.0	43.5	33.8	24.2	27.6	32.7	24.9	23.1
ACOX1	PALMCOX	ENSG00000161533	"Acyl-CoA oxidase 1"	Q15067	17	75941507-75979363	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 95.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 34.6;RT4: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 22.9;neutrophil: 38.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021094, HPA021192, HPA021195, HPA028759"	Approved		Approved	Nucleoli,Peroxisomes		160000	160000	Peroxisomes	Nucleoli	"CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352"	"unprognostic (7.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.38e-2)"	"prognostic favourable (5.25e-7)"	"unprognostic (3.39e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.46e-2)"	21.8	12.9	8.8	8.3	10.2	4.2	13.6	6.4	9.8	6.4	26.5	8.2	9.6	31.0	6.6	6.7	19.5	6.0	12.3	16.0	8.3	7.9	20.8	95.6	9.2	7.5	8.2	8.3	7.6	28.7	9.8	8.9	13.6	7.8	9.5	14.3	11.3	9.5	9.1	18.3	13.4	53.1	7.9	6.7	7.2	13.6	6.2	6.3	7.1	9.1	11.4	10.6	10.6	7.9	1.6	3.3	38.6	5.8	2.1	2.7	2.2	5.3	7.6	2.5	3.8	13.0	5.5	34.6	3.9	3.9	4.7	5.4	5.3	8.8	3.1	4.2	6.6	3.2	10.5	4.1	7.4	2.8	3.1	4.0	4.3	17.3	7.1	3.4	2.6	9.1	3.2	5.3	3.5	11.7	4.0	3.0	5.2	15.7	7.4	2.5	1.8	6.5	4.1	7.6	3.6	8.0	46.6	3.0	4.5	11.1	17.5	3.7	10.7	3.8	7.8	6.5	4.8	5.3	3.7	5.0	3.4	1.2	3.8	3.1	3.8	22.9	5.8	1.6	2.1	4.5	2.7	1.6	2.0	2.7	3.3	1.6	2.4	2.3	38.6	2.1	2.8	2.9	2.6	2.2	8.8	10.2	6.4	9.8	8.3	7.9	8.2	8.3	7.8	6.3
ACOX2	"BRCACOX, BRCOX, THCCox"	ENSG00000168306	"Acyl-CoA oxidase 2"	Q99424	3	58505136-58537319	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 70.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 12.2;ASC TERT1: 20.2;fHDF/TERT166: 6.6;Hep G2: 7.8;HSkMC: 13.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA038280, HPA064845"	Enhanced		Approved	Vesicles,Cytosol		190000	190000	Vesicles	Cytosol	"HPA038280: AB_10672623, HPA064845: AB_2685368"	"unprognostic (6.62e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.63e-3)"	4.0	5.3	1.9	3.8	2.5	0.1	3.4	1.6	2.1	4.4	10.2	2.7	9.5	10.0	9.0	6.2	3.8	4.4	4.8	8.8	2.4	1.4	17.1	70.5	2.8	0.7	2.0	1.7	5.1	2.9	3.8	3.0	1.4	4.0	7.2	3.4	11.4	3.0	5.9	4.2	1.7	13.7	10.6	2.5	0.9	2.6	4.0	2.0	1.0	7.7	2.7	1.6	5.4	5.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.2	20.2	3.5	2.3	0.2	0.0	0.3	0.6	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	1.8	0.0	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.5	1.6	2.1	2.4	1.4	2.0	1.7	4.0	2.0
ACP2	LAP	ENSG00000134575	"Acid phosphatase 2, lysosomal"	P11117	11	47239302-47248906	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 30.3"	"Lineage enriched"	"Detected in all"	5	"monocytes: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	8100	8100				"unprognostic (5.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.86e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.57e-1)"	15.7	23.6	13.1	13.9	13.6	3.6	13.0	12.5	19.5	11.3	15.4	11.7	15.4	26.9	10.5	20.0	8.9	9.3	12.4	18.1	14.4	18.2	18.7	65.4	13.3	40.7	11.8	12.7	8.1	36.2	13.6	13.8	31.3	12.2	15.3	11.7	16.4	32.3	18.5	10.1	7.0	24.4	10.8	11.0	18.9	14.2	14.6	7.1	10.0	12.4	9.6	9.7	14.3	8.0	1.0	6.6	4.6	30.3	3.8	5.6	4.2	6.7	14.0	13.6	12.0	12.2	6.1	10.5	11.1	19.9	20.4	21.3	9.6	11.1	1.8	9.2	14.2	10.0	7.1	10.3	9.9	34.6	12.2	4.5	20.6	10.1	17.0	6.7	11.7	14.9	6.5	10.6	6.2	14.7	8.2	14.6	13.3	10.9	5.5	6.0	9.4	8.5	4.3	18.4	14.7	15.2	15.7	7.2	11.2	15.4	34.3	7.9	20.9	5.9	8.7	10.4	8.7	13.5	15.8	12.2	15.7	1.5	15.3	3.4	15.8	4.6	7.2	3.0	5.6	30.3	4.4	1.0	3.5	5.0	6.6	0.7	3.1	2.7	1.2	3.8	19.5	0.2	3.6	4.2	13.1	13.6	12.5	19.5	14.4	18.2	11.8	12.7	12.2	7.1
ACP4	ACPT	ENSG00000142513	"Acid phosphatase 4"	Q9BZG2	19	50790415-50795224	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skin 1: 4.2;testis: 4.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 4.3;Karpas-707: 2.8;U-266/84: 5.3"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (9.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.89e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.1	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.1		0.2	0.7	1.1	0.0	0.0		0.0	0.0		0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.0	0.0	4.0			0.0		0.0	0.0	0.0	0.9	0.3	0.0	0.5	0.3	0.8	0.0	0.5	0.2	0.9	1.6	0.0	0.0	1.0	0.5	0.0	0.0	0.0	2.1	0.2	0.8	0.1	0.0	0.5	0.0	0.0	0.0	1.5	4.3	0.1	1.3	0.6	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.0	0.8	0.6	1.3	0.5	1.5	0.9	0.4	0.6	0.0	1.5	0.4	0.6	0.3	0.3	0.7	0.1	1.0	0.0	0.7	0.6	0.8	0.3	0.7	5.3	0.6	0.7	0.9	0.3	0.0	0.1	0.0	0.2	0.5	0.8	0.8	0.6	0.5	0.0	0.9	0.8	0.5	0.0	0.3	0.2	0.3	0.1	0.0										
ACP5	"HPAP, TRAP"	ENSG00000102575	"Acid phosphatase 5, tartrate resistant"	P13686	19	11574660-11579008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 117.9;lung: 151.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.3;RPMI-8226: 13.6;SK-MEL-30: 40.4;U-138 MG: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 51.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002584, HPA057655, HPA059463"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	3700000	3700000	Cytosol		"CAB002584: AB_564039, HPA057655: , HPA059463: "	"unprognostic (4.27e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.93e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	117.9	2.8	0.9	21.1	1.1	1.4	7.7	0.7	1.0	11.9	10.2	1.2	2.1	7.7	7.7	6.5	12.1	3.5	9.1	6.8	0.9	0.4	28.0	16.3	151.9	30.8	1.0	1.0	13.2	8.7	0.2	1.6	9.2	1.2	6.4	8.7	19.1	8.6	2.8	3.0	10.4	15.6	3.3	1.9	20.7	15.0	3.5	0.7	9.2	2.2	8.2	18.4	11.4	10.1	51.4	13.9	16.8	9.4	2.6	16.0	8.1	3.2	0.4	0.0	0.0	0.2	0.0	14.3	0.4	9.6	0.0	0.0	0.0	0.1	0.4	0.6	2.8	0.1	0.0	1.4	0.0	3.6	0.3	0.1	0.0	1.7	0.5	0.0	0.2	0.0	1.1	0.1	0.0	0.0	10.0	0.0	0.0	0.7	0.3	0.5	0.3	0.2	0.1	0.7	13.6	0.0	0.1	0.2	0.3	0.0	0.0	40.4	0.0	0.1	0.3	38.0	0.4	0.7	0.1	0.2	1.8	0.2	7.8	0.0	1.2	0.0	9.4	16.8	4.1	9.1	2.1	51.4	6.4	4.7	1.7	23.5	8.3	4.7	2.6	2.6	8.7	13.9	16.0	8.1	0.9	1.1	0.7	1.0	0.9	0.4	1.0	1.0	1.2	0.7
ACSL4	"ACS4, FACL4, LACS4, MRX63, MRX68"	ENSG00000068366	"Acyl-CoA synthetase long chain family member 4"	O60488	X	109624244-109733403	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000286, HPA005552"	Supported		Approved	"Golgi apparatus,Mitochondria"		100000	100000	"Golgi apparatus"	Mitochondria	"HPA000286: , HPA005552: AB_1078774"	"unprognostic (9.13e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.29e-2)"	"prognostic favourable (5.73e-4)"	29.5	31.1	16.3	25.5	18.0	9.2	30.0	13.9	22.8	34.7	10.5	8.8	4.6	10.0	13.7	11.7	11.2	10.7	20.1	20.3	27.6	20.3	31.2	9.6	27.8	29.6	15.2	19.0	13.1	8.8	16.7	12.9	33.9	21.1	9.7	9.7	8.0	10.7	11.0	42.5	9.1	9.0	15.8	24.6	17.0	12.9	17.7	9.7	9.5	12.8	8.5	11.9	19.5	21.0	2.2	6.5	20.3	10.9	2.2	4.0	3.8	13.7	4.4	5.5	5.9	20.7	13.0	4.3	20.1	22.3	19.7	20.5	4.3	9.6	9.8	7.8	14.5	3.9	4.7	19.4	31.0	3.4	4.9	38.7	6.3	45.8	9.5	9.2	80.3	11.2	7.6	22.5	16.4	14.7	1.1	12.1	22.5	0.9	8.0	12.1	6.9	8.0	5.8	10.1	8.1	28.2	4.4	3.6	2.8	24.0	0.0	12.4	0.3	9.8	27.2	18.0	5.1	28.4	18.4	6.0	6.9	9.2	31.7	20.6	11.4	15.5	7.0	20.3	2.8	9.8	2.0	2.2	2.5	2.2	6.5	2.2	2.0	2.4	19.8	2.2	10.9	2.6	4.0	3.8	16.3	18.0	13.9	22.6	27.6	20.3	15.2	19.0	21.1	9.7
ACSL6	"ACS2, FACL6, KIAA0837, LACS2, LACS5"	ENSG00000164398	"Acyl-CoA synthetase long chain family member 6"	Q9UKU0	5	131949973-132012243	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0;ductus deferens: 30.1;seminal vesicle: 35.8;testis: 23.0"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 14.6;U-937: 8.5"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA040470	Enhanced									"HPA040470: AB_10794033"	"unprognostic (1.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.89e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.38e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.28e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.70e-1)"	0.6	4.8	16.5	1.5	15.7	21.3	0.7	22.8	34.0	0.5	0.7	5.3	30.1	5.4	0.5	1.0	0.9	0.7	0.9	2.0	12.4	9.7	2.3	2.6	0.8	2.5	9.6	12.1	0.5	1.9	13.0	2.7	1.1	12.1	0.8	0.8	3.3	0.8	35.8	3.6	0.6	3.3	0.5	4.2	1.2	1.2	23.0	4.7	0.0	0.9	0.0	1.5	0.7	0.3	0.1	0.0	0.6	0.1	1.2	4.2	1.1	0.0	0.0	0.2	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.1	1.6	0.2	0.0	0.0	0.9	0.1	0.0	2.2	0.0	0.2	2.1	0.0	0.1	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	1.4	0.9	0.1	0.1	0.0	0.0	0.0	0.0	14.6	0.7	0.2	0.2	1.1	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.5	0.0	0.3	8.5	0.5	0.6	0.1	0.1	1.5	0.0	3.5	0.1	2.1	4.2	0.0	0.1	3.9	1.8	0.2	1.2	0.0	0.0	0.1	1.1	16.5	15.7	22.8	18.8	12.4	9.7	9.6	12.1	12.1	4.7
ACTN2		ENSG00000077522	"Actinin alpha 2"	P35609	1	236686454-236764631	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 141.3;skeletal muscle: 320.9;tongue: 75.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.0;HSkMC: 11.9;hTEC/SVTERT24-B: 7.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 59.7"	"Low region specificity"	"Detected in all"			"HPA006035, HPA008315"	Enhanced		Uncertain	"Actin filaments"		69000000	69000000	"Actin filaments"		"HPA006035: AB_1078095, HPA008315: AB_1844543"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-11)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	3.5	0.6	1.6	0.6	10.7	0.6	0.7	0.3	2.5	0.6	0.6	5.1	0.0	0.6	0.7	4.4	3.7	0.7	0.7	141.3	2.5	1.4	0.6	0.6	0.9	0.6	4.7	1.4	0.7	0.7	0.6	0.1	0.6	2.7	2.8	0.6	0.0	4.9	0.6	320.9	0.6	0.7	1.5	3.9	0.6	0.7	0.9	4.3	0.0	3.5	75.4	4.8	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.7	11.9	0.0	7.5	0.0	0.3	0.6	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	10.7	0.3	2.5	2.5	1.4	4.7	1.4	2.7	4.3
ACVR1	"ACVR1A, ACVRLK2, ALK2, SKR1"	ENSG00000115170	"Activin A receptor type 1"	Q04771	2	157736444-157875862	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007505, HPA046514"	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA007505: AB_1844752, HPA046514: "	"unprognostic (6.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavourable (5.17e-4)"	18.9	9.2	18.0	10.0	12.7	1.6	38.7	15.3	12.2	25.2	14.4	7.4	8.4	8.9	24.8	26.8	11.0	16.6	20.5	18.8	18.7	8.6	21.7	18.9	22.5	15.1	10.4	7.9	18.5	12.3	11.3	17.0	14.2	12.3	16.8	10.5	14.3	18.1	13.6	15.6	12.8	11.5	29.2	12.3	9.2	11.8	8.8	10.9	7.5	34.0	14.6	6.9	16.1	32.5	1.4	2.4	3.8	2.6	1.9	10.0	1.6	2.1	4.2	4.9	6.4	25.0	26.1	6.9	15.1	25.2	12.1	13.0	3.3	4.7	0.0	7.0	16.4	5.9	3.5	8.2	13.1	14.5	3.0	8.6	2.5	4.8	19.8	0.6	10.2	32.6	15.6	24.9	31.8	13.2	3.1	2.4	15.3	3.7	0.1	0.2	7.4	7.7	1.4	6.6	1.8	15.8	7.9	4.4	5.4	5.8	3.3	20.7	1.7	2.3	19.0	18.5	6.1	9.1	5.7	1.6	1.2	0.1	19.0	0.5	19.9	3.8	2.6	0.2	1.1	1.7	1.2	1.4	7.8	2.5	1.8	0.8	3.1	1.5	0.8	1.9	2.3	2.4	10.0	1.6	18.0	12.7	15.3	12.2	18.7	8.6	10.4	7.9	12.3	10.9
ACVR1B	"ActRIB, ACVRLK4, ALK4, SKR2"	ENSG00000135503	"Activin A receptor type 1B"	P36896	12	51951667-51997078	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026126, HPA063761"	Approved		Approved	Cytosol				Cytosol		"CAB026126: , HPA063761: "	"unprognostic (8.66e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.79e-2)"	11.1	7.4	12.0	6.4	14.6	7.9	14.3	14.2	24.4	8.6	16.7	5.1	28.0	19.2	6.7	13.1	14.4	10.9	11.1	7.6	11.2	10.5	24.6	21.0	10.3	7.1	8.1	14.7	7.1	35.1	24.9	10.9	7.5	7.3	10.0	17.1	8.7	21.7	34.3	11.7	30.6	19.8	8.2	5.8	6.7	17.2	10.6	4.8	3.9	9.9	5.8	8.4	10.1	12.1	0.5	1.3	6.8	4.0	0.1	1.6	0.6	6.2	13.8	10.7	5.9	12.3	9.7	6.1	7.1	8.1	7.6	5.8	27.8	9.7	2.7	10.0	7.7	11.1	10.2	8.6	7.9	4.0	12.0	6.8	3.5	8.6	14.1	10.9	25.5	18.9	11.2	8.6	10.9	10.7	7.2	8.6	6.7	12.8	10.4	9.5	10.4	4.8	5.6	8.3	3.5	21.5	9.6	13.7	11.4	7.7	11.0	5.0	12.1	7.1	6.7	5.2	8.0	5.9	3.4	5.2	3.7	3.8	5.6	5.3	6.7	4.5	2.2	6.8	0.7	3.3	1.0	0.1	0.6	0.7	1.3	0.5	1.6	0.9	1.9	0.1	4.0	0.7	1.0	0.6	12.0	14.6	14.2	24.4	11.2	10.5	8.1	14.7	7.3	4.8
ACVR2B	ActR-IIB	ENSG00000114739	"Activin A receptor type 2B"	Q13705	3	38453851-38493142	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 16.6;NTERA-2: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007398, CAB025115, HPA040384"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies"	"CAB025115: , HPA007398: , HPA040384: "	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.75e-1)"	2.8	7.4	5.5	4.6	7.9	1.1	5.5	13.2	7.5	5.2	3.4	7.2	4.5	2.8	4.7	5.1	2.5	5.6	3.3	3.9	5.9	5.4	5.3	5.4	6.9	2.2	5.9	5.4	8.3	6.1	11.3	5.1	16.0	6.5	3.9	3.6	5.0	4.6	4.2	15.9	2.4	2.8	4.6	4.7	3.1	4.0	9.1	9.1	12.8	4.8	1.7	2.2	4.2	10.3	0.3	0.3	0.5	0.2	0.5	1.6	0.3	0.8	1.4	16.6	1.4	0.6	0.4	8.9	0.3	0.5	0.3	0.7	2.4	1.1	0.1	1.3	0.4	1.0	6.3	1.0	0.9	2.4	4.1	4.2	2.6	3.5	0.8	3.0	1.6	0.7	0.9	0.5	1.8	1.1	7.0	1.4	0.3	1.3	5.1	1.9	20.5	0.7	1.7	5.5	1.0	1.1	2.0	3.9	6.8	0.5	2.5	2.2	1.4	4.0	0.9	0.6	2.7	0.4	1.4	4.0	5.4	0.9	0.6	2.5	1.1	0.5	0.1	0.1	0.4	0.2	0.6	0.2	1.0	0.5	0.0	0.3	1.6	1.5	0.3	0.5	0.2	0.3	0.7	0.3	5.5	7.9	13.2	7.0	5.9	5.4	5.9	5.4	6.5	9.1
ACVRL1	"ACVRLK1, ALK1, HHT, HHT2, ORW2"	ENSG00000139567	"Activin A receptor like type 1"	P37023	12	51906908-51923361	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 55.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 18.1;ASC TERT1: 12.4;EFO-21: 16.0;HUVEC TERT2: 58.5;TIME: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 3.6;myeloid DC: 5.0"	"Group enriched"	"Detected in many"	12	"dendritic cells: 5.0;monocytes: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007041	Approved				"Intracellular and membrane"					"HPA007041: AB_1078097"	"unprognostic (2.50e-1)"	"unprognostic (4.83e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.60e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.98e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.10e-1)"	25.5	5.1	3.2	9.3	4.3	0.2	15.6	1.6	3.6	15.1	20.1	3.7	13.1	4.9	12.7	11.0	12.1	13.9	11.0	15.4	3.7	3.2	13.6	3.4	55.0	19.1	4.9	3.6	5.9	6.1	21.6	2.7	44.1	5.3	12.3	14.7	12.3	6.9	10.6	14.2	8.0	11.1	8.2	3.7	14.8	8.1	3.5	3.6	1.7	12.9	6.8	5.4	9.3	11.2	0.1	5.0	0.3	3.6	0.0	0.1	0.7	0.0	0.2	0.1	0.0	18.1	12.4	0.0	0.8	1.6	0.0	0.0	0.1	0.1	0.0	16.0	6.8	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	2.7	0.0	0.4	5.0	0.0	0.1	0.0	58.5	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	45.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	3.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.7	3.2	4.3	1.6	3.6	3.7	3.2	4.9	3.6	5.3	3.6
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983278-51989202	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 53.3;kidney: 91.6;liver: 77.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB003695, HPA036174, HPA036175"	Enhanced					28000000	28000000			"CAB003695: AB_425286, HPA036174: , HPA036175: "	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favourable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favourable (6.77e-4)"	4.4	8.5	2.5	3.9	3.0	1.5	4.4	1.5	3.3	3.2	24.9	4.1	9.8	34.5	1.9	7.9	3.8	3.0	8.4	4.1	2.3	1.8	91.6	77.8	3.5	6.3	2.8	2.9	2.1	9.0	6.2	1.9	4.3	2.9	3.7	6.2	6.6	9.4	9.2	7.6	2.6	53.3	2.1	3.5	3.4	4.9	1.5	1.7	0.6	5.9	6.7	4.1	3.3	2.5	5.0	12.1	3.8	10.0	12.1	6.4	4.5	3.9	8.0	3.9	10.9	9.0	12.2	12.9	4.2	7.9	9.3	5.1	12.5	20.9	2.5	3.6	7.3	4.9	4.0	25.7	3.7	7.0	5.1	9.0	4.6	38.5	16.7	6.0	5.8	14.0	21.3	8.2	22.2	3.5	13.5	8.0	9.1	11.2	0.0	11.0	5.7	13.6	3.1	3.3	22.6	24.4	15.1	5.5	5.0	5.3	17.6	9.3	14.2	7.9	1.7	6.7	6.4	8.3	5.0	21.0	4.9	3.8	7.9	12.6	8.1	3.8	10.0	0.2	6.4	9.0	3.6	5.0	2.0	2.8	12.1	4.0	3.3	4.0	0.0	12.1	3.4	1.9	2.7	4.5	2.5	3.0	1.5	3.3	2.3	1.8	2.8	2.9	2.9	1.7
ADA2	"ADGF, CECR1, IDGFL"	ENSG00000093072	"Adenosine deaminase 2"	Q9NZK5	22	17178790-17221989	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.0;EFO-21: 11.5;HUVEC TERT2: 12.4;Karpas-707: 22.1;MOLT-4: 20.5;U-266/70: 12.6;U-937: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA007888	Uncertain				"Secreted to blood"	50000000	50000000			"HPA007888: AB_1078495"	"unprognostic (1.03e-3)"	"unprognostic (2.00e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.01e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.80e-2)"	"prognostic favourable (9.26e-4)"	"prognostic favourable (8.91e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	24.7	6.6	6.9	15.3	7.5	8.7	6.3	9.7	9.2	7.8	9.8	17.3	3.9	7.0	9.6	7.0	6.9	18.2	12.4	15.9	6.4	8.8	15.2	8.5	28.6	24.3	9.2	5.8	8.9	6.7	0.6	13.7	8.4	14.5	7.4	12.3	15.3	6.9	6.3	2.5	2.5	12.6	7.9	18.2	45.0	7.2	9.7	5.3	63.0	7.5	2.9	22.6	18.0	4.1	6.1	29.8	2.6	46.4	9.5	7.9	28.3	0.0	0.0	3.4	0.0	0.0	0.6	0.1	1.2	0.1	0.0	0.0	0.0	13.0	2.9	11.5	3.6	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.2	0.1	6.2	0.0	0.1	0.0	12.4	0.1	22.1	0.5	0.0	20.5	1.5	10.2	0.0	0.4	0.0	3.2	0.0	3.9	5.8	0.1	0.0	0.1	0.0	0.0	5.8	1.4	0.0	0.1	0.1	0.0	12.6	1.1	0.7	0.1	20.7	0.1	2.6	44.1	2.4	7.9	46.4	6.3	6.1	6.4	7.9	29.8	5.0	7.6	7.8	2.1	9.5	35.2	14.7	3.6	28.3	6.9	7.5	9.7	9.2	6.4	8.8	9.2	5.8	14.5	5.3
ADAM10	"CD156c, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588807-58749978	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	8200000	8200000	"Plasma membrane"	"Nucleoplasm, Vesicles"	"CAB001709: , HPA050670: "	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-3)"	"unprognostic (7.48e-2)"	"prognostic unfavourable (8.46e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.60e-2)"	25.9	11.1	15.5	17.1	17.7	15.6	20.0	25.2	17.6	18.6	20.1	15.7	12.7	13.9	19.9	11.8	17.1	13.8	18.0	18.8	17.6	13.7	20.8	14.8	25.0	26.1	23.1	12.4	13.9	13.1	10.9	11.6	36.1	14.5	23.6	16.7	14.6	12.4	19.1	8.9	15.4	15.6	12.8	30.4	40.4	18.4	8.5	18.9	38.5	27.3	9.2	14.9	30.0	19.1	6.2	12.7	26.9	23.7	9.8	12.2	12.8	11.8	26.9	7.3	8.0	9.4	13.6	18.5	10.2	30.4	7.5	10.5	12.4	15.7	5.5	31.6	9.1	24.3	4.4	10.8	10.0	8.2	5.6	9.4	9.8	11.5	10.5	6.6	27.2	11.9	8.0	5.2	7.7	14.6	5.9	15.0	13.2	4.4	21.9	7.6	10.0	3.8	9.1	24.0	14.1	17.5	32.1	8.0	5.2	11.1	12.9	17.6	7.7	13.3	10.3	9.9	11.0	76.0	9.8	8.4	18.1	6.0	13.8	12.9	17.3	12.9	18.8	10.4	8.1	21.5	12.2	5.3	8.0	7.1	12.7	6.2	8.4	7.0	26.9	9.8	23.7	5.8	10.3	12.8	15.5	17.7	25.2	16.9	17.6	13.7	23.1	12.4	14.5	18.9
ADAM17	"CD156B, cSVP, TACE"	ENSG00000151694	"ADAM metallopeptidase domain 17"	P78536	2	9488486-9555792	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010738, CAB025906, HPA051575"	Approved		Supported	Cytosol	"Intracellular and membrane"	27000	27000	Cytosol		"CAB025906: , HPA010738: AB_1078100, HPA051575: "	"unprognostic (2.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.82e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavourable (4.23e-5)"	18.6	11.0	13.6	15.4	13.8	21.9	14.7	20.4	15.5	14.0	11.7	13.8	8.3	8.7	14.2	15.8	18.7	10.7	17.4	13.4	11.2	12.4	12.4	7.8	24.7	15.0	11.6	11.7	18.1	9.6	10.9	11.9	29.0	11.2	8.2	9.4	10.6	12.5	9.8	12.3	16.7	11.1	13.9	14.3	21.4	8.9	17.4	12.3	14.7	12.5	13.9	20.3	12.3	14.4	7.0	7.7	16.0	10.2	6.0	7.9	6.0	7.7	12.7	13.4	13.9	26.5	19.8	24.2	8.1	13.8	9.4	13.9	11.2	18.7	22.1	11.8	10.2	14.2	9.9	17.2	12.9	8.8	9.9	11.3	9.6	9.9	37.5	11.0	12.7	22.1	17.4	15.0	29.1	23.5	15.3	8.5	10.0	7.3	8.3	11.1	11.1	5.2	9.6	13.2	10.5	12.5	12.9	7.9	19.8	9.1	11.1	19.3	5.7	14.2	18.8	16.7	8.7	11.7	15.4	11.1	10.0	19.2	13.8	7.1	19.8	16.0	9.8	7.6	6.1	10.2	7.9	7.0	5.0	5.1	7.7	5.1	4.5	4.6	11.8	6.0	9.5	4.3	5.7	6.0	13.6	13.8	20.4	13.1	11.2	12.4	11.6	11.7	11.2	12.3
ADAMTS13	"C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP"	ENSG00000160323	"ADAM metallopeptidase with thrombospondin type 1 motif 13"	Q76LX8	9	133414358-133459402	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 53.7"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042014, HPA042844, HPA052077"	Approved		Approved	Vesicles	"Secreted to blood"	38000000	38000000	Vesicles		"HPA042014: , HPA042844: , HPA052077: "	"unprognostic (1.09e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.75e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.52e-5)"	"unprognostic (1.11e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.30e-3)"	1.4	1.0	3.1	1.4	3.7	0.5	1.4	6.6	4.2	1.4	1.4	1.4	1.4	4.1	1.6	4.0	1.4	2.1	1.5	1.7	3.4	2.2	1.8	53.7	4.8	1.4	2.1	1.4	2.3	1.8	2.2	4.2	1.7	1.6	1.6	1.1	1.6	2.5	2.0	2.6	2.9	4.4	1.4	2.0	1.4	5.5	3.8	1.4	1.4	1.7	1.4	1.4	1.7	1.4	0.3	0.0	2.3	0.0	0.0	0.5	0.1	0.0	1.4	3.4	4.7	2.7	2.5	1.2	1.1	0.9	0.5	0.7	0.5	3.7	0.4	1.5	0.8	0.6	0.3	0.6	0.1	2.0	3.1	0.4	1.4	0.7	2.0	0.1	1.1	6.6	1.7	0.5	1.3	0.3	0.1	1.4	0.5	5.6	0.1	1.5	3.6	2.0	0.4	0.4	1.6	1.5	1.4	2.2	6.9	2.4	1.3	1.8	5.9	0.6	0.8	2.5	1.4	1.6	0.0	2.5	0.6	0.5	2.1	0.4	2.8	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	3.7	6.6	4.2	3.4	2.2	2.1	1.4	1.6	1.4
ADAMTS2	"ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP"	ENSG00000087116	"ADAM metallopeptidase with thrombospondin type 1 motif 2"	O95450	5	179110851-179345430	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.7;ASC TERT1: 13.7;BJ: 12.1;fHDF/TERT166: 14.2;HHSteC: 44.5;HSkMC: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA028363, HPA028444"	Uncertain		Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"			"Plasma membrane"	Vesicles	"HPA028363: , HPA028444: AB_10601964"	"unprognostic (6.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.85e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (1.71e-8)"	"unprognostic (1.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.48e-2)"	24.2	4.3	0.9	5.8	0.7	0.7	29.1	0.9	2.3	16.3	10.1	0.4	3.9	2.7	12.0	9.5	6.0	7.2	9.5	10.1	0.7	1.2	4.2	7.4	13.1	25.9	1.0	1.3	6.3	2.7	1.0	8.7	15.1	2.4	6.0	2.6	3.8	2.5	3.8	3.8	4.6	4.6	13.8	0.7	16.5	4.2	4.3	0.5	0.8	3.2	5.9	1.2	8.8	14.7	1.4	1.3	2.1	0.3	0.8	0.6	0.1	0.0	0.0	0.0	0.3	13.7	13.7	0.0	12.1	2.0	4.6	4.9	0.0	0.0	0.0	0.1	14.2	0.0	0.7	0.0	2.0	0.0	0.6	0.0	0.0	0.9	44.5	0.0	0.0	35.5	0.0	1.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.5	0.0	0.0	0.1	0.0	3.9	0.0	7.7	1.2	10.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	1.5	0.3	0.4	0.6	0.2	0.3	0.6	0.5	0.4	1.3	1.4	0.5	0.5	2.1	0.8	0.1	0.8	0.5	0.1	0.9	0.7	0.9	2.3	0.7	1.2	1.0	1.3	2.4	0.5
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase, RNA specific"	P55265	1	154582062-154627999	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"CAB056157: , HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	36.1	33.1	30.3	36.6	44.4	43.1	29.7	41.4	50.8	30.7	28.2	33.3	19.9	31.4	38.0	26.5	27.7	32.9	28.9	24.0	25.7	38.1	31.5	36.0	34.7	41.3	27.3	32.6	39.2	29.5	46.2	38.4	33.9	39.8	28.8	31.1	32.2	36.7	30.2	14.0	27.0	40.6	36.3	24.4	47.7	29.1	21.9	26.9	57.6	32.8	16.7	41.9	29.7	27.6	7.8	6.1	25.1	8.6	6.4	9.7	5.6	26.1	30.3	26.0	32.0	26.3	27.3	31.0	18.0	36.3	60.5	52.6	26.1	25.8	47.2	29.2	28.8	25.5	33.2	34.3	30.8	45.8	16.7	24.6	21.5	14.8	28.7	34.7	27.3	26.5	25.1	31.0	31.8	31.0	23.2	36.3	21.1	32.0	41.9	17.9	43.0	22.9	40.1	21.4	37.9	20.8	29.2	25.9	30.9	31.2	50.4	37.0	33.9	42.7	28.2	21.8	21.4	17.9	20.9	43.1	47.1	50.7	21.1	22.9	24.5	6.9	6.6	12.0	9.4	8.3	8.8	7.8	9.4	9.7	6.1	6.2	8.8	8.6	25.1	6.4	8.6	5.5	7.1	5.6	30.3	44.4	41.4	50.8	25.7	38.1	27.3	32.6	39.8	26.9
ADCY1	"AC1, DFNB44"	ENSG00000164742	"Adenylate cyclase 1"	Q08828	7	45574140-45723116	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, cAMP biosynthesis"	"Calmodulin-binding, Lyase"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.0"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 15.0;SCLC-21H: 9.1;SH-SY5Y: 17.3;SK-MEL-30: 19.9;WM-115: 11.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018364, HPA068274"	Uncertain		Approved	Mitochondria				Mitochondria		"CAB018364: AB_2223098, HPA068274: "	"unprognostic (9.41e-3)"	"unprognostic (7.30e-4)"	"unprognostic (9.31e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.74e-6)"	"unprognostic (2.49e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.23e-1)"	2.8	2.8	11.5	0.7	11.7	0.4	6.8	22.7	29.0	7.8	0.9	2.0	0.0	0.7	2.7	1.1	1.2	2.4	1.2	4.0	11.6	4.0	1.8	9.6	1.0	0.8	5.8	13.4	1.2	3.6	1.0	1.5	0.9	6.2	4.1	1.0	5.0	0.8	2.1	9.2	0.6	0.7	1.6	2.2	1.0	1.8	3.9	1.2	0.0	3.0	0.2	0.8	1.0	1.5	0.5	0.4	0.6	0.1	0.0	0.2	0.0	0.5	3.8	1.4	2.2	2.8	0.0	2.7	0.1	0.0	0.5	0.2	0.4	0.0	0.0	0.2	0.1	1.2	2.5	0.1	0.0	6.9	1.8	0.0	0.0	0.3	0.0	0.1	0.0	3.4	1.9	0.3	15.0	0.1	0.2	4.6	0.2	4.6	0.0	0.0	5.6	0.0	0.0	0.0	7.5	0.0	3.7	9.1	17.3	1.4	0.0	19.9	1.3	2.3	0.0	0.4	2.9	0.3	2.3	0.0	0.0	0.0	0.0	0.0	11.3	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	11.5	11.7	22.7	29.0	11.6	4.0	5.8	13.4	6.2	1.2
ADCY10	"HCA2, RP1-313L4.2, SAC, SACI, Sacy"	ENSG00000143199	"Adenylate cyclase 10"	Q96PN6	1	167809388-167914215	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"liver: 14.9;testis: 38.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.6;T-47d: 4.9"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.7"	"Region enriched"	"Detected in single"	5	"cerebellum: 1.6"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015243, HPA017749"	Approved									"HPA015243: AB_1856540, HPA017749: AB_1856541"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.43e-2)"	"unprognostic (7.83e-5)"	"unprognostic (5.86e-7)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.59e-1)"	0.1	0.1	0.2	0.1	0.3	0.0	1.3	1.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.3	14.9	0.1	0.1	0.2	0.3	0.1	0.4	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	38.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.4	0.6	0.0	0.3	0.4	0.3	0.1	0.1	0.2	0.6	0.5	2.6	0.1	1.0	0.3	1.1	1.6	0.1	0.2	0.3	0.0	0.0	1.1	0.1	0.2	0.4	1.6	0.5	0.3	0.7	0.1	0.0	0.0	0.1	1.8	0.8	0.6	0.0	1.2	0.1	0.1	0.0	0.5	0.8	1.0	0.0	0.1	0.0	0.3	1.2	0.0	0.4	0.0	0.0	0.0	0.5	4.9	0.8	0.1	0.2	0.0	0.2	0.1	1.2	0.6	0.8	0.7	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.4	0.2	0.3	1.6	0.3	0.3	0.2	0.2	0.3	0.1	0.1
ADCY5	AC5	ENSG00000173175	"Adenylate cyclase 5"	O95622	3	123282296-123449758	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 69.9"	"Cell line enhanced"	"Detected in some"		"MCF7: 17.6;RPMI-8226: 3.1;RPTEC TERT1: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"basal ganglia: 347.3"	"Region enriched"	"Detected in all"	6	"basal ganglia: 205.1"	"HPA017730, HPA077682"	Uncertain		Enhanced	"Intermediate filaments"				"Intermediate filaments"		"HPA017730: AB_1844595, HPA077682: "	"unprognostic (3.55e-2)"	"unprognostic (1.01e-3)"	"unprognostic (7.61e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.64e-2)"	"prognostic favourable (7.46e-6)"	"unprognostic (1.81e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.97e-4)"	13.3	3.0	12.5	3.7	32.0	0.6	9.3	2.6	14.4	4.5	11.7	10.4	3.1	4.2	6.2	4.4	13.8	5.3	7.3	69.9	10.4	8.3	5.3	2.4	2.6	2.0	15.0	8.6	10.1	5.7	1.1	7.7	4.8	9.7	13.8	4.6	4.6	3.1	16.3	2.2	1.1	4.8	13.5	8.8	4.7	9.6	5.9	16.0	0.0	1.0	0.2	2.6	9.5	8.5	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.6	1.5	0.1	0.1	0.1	0.4	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.3	0.2	0.5	0.8	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	17.6	0.0	0.0	1.0	0.1	0.0	0.4	3.1	6.3	0.6	2.2	2.0	0.0	0.6	0.1	0.0	0.1	0.0	0.1	1.5	0.1	0.3	0.2	0.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	12.5	32.0	2.6	14.4	10.4	8.3	15.0	8.6	9.7	16.0
ADCY6	AC6	ENSG00000174233	"Adenylate cyclase 6"	O43306	12	48766194-48789037	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 30.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018365	Approved		Approved	"Golgi apparatus"				"Golgi apparatus"		"CAB018365: AB_2257941"	"unprognostic (1.18e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.68e-2)"	"prognostic unfavourable (8.23e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-3)"	"unprognostic (5.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.48e-2)"	25.9	9.6	14.1	12.4	7.5	0.8	19.7	15.0	17.0	9.8	15.2	5.5	16.2	12.3	13.2	12.8	6.2	9.5	17.6	37.5	9.9	8.3	11.3	5.6	8.5	4.7	5.6	11.0	14.6	17.4	15.8	9.1	9.5	8.9	11.1	12.6	11.8	19.9	12.0	7.3	10.2	13.9	9.1	4.7	2.9	13.5	4.0	5.5	0.6	11.1	6.8	3.8	7.8	14.9	1.8	0.4	1.4	0.4	0.5	0.4	0.5	5.9	11.5	13.3	8.3	14.0	7.0	14.4	7.3	7.4	8.9	6.2	20.4	20.0	0.0	16.8	6.3	4.8	3.8	4.9	3.2	0.0	5.9	5.4	15.7	3.7	8.0	0.0	4.5	8.9	6.0	7.4	2.7	8.1	0.7	2.0	6.5	10.3	0.0	0.2	4.5	5.4	1.9	5.1	3.2	10.0	18.5	2.0	8.2	7.5	30.1	6.5	23.5	1.4	9.2	8.4	6.0	4.4	3.2	3.1	1.5	0.2	7.6	0.0	3.8	1.4	0.4	0.4	0.3	0.2	0.2	1.1	0.3	0.2	0.3	1.8	0.4	0.3	0.9	0.5	0.4	0.4	0.2	0.5	14.1	7.5	15.0	17.0	9.9	8.3	5.6	11.0	8.9	5.5
ADGRE2	"CD312, EMR2"	ENSG00000127507	"Adhesion G protein-coupled receptor E2"	Q9UHX3	19	14732393-14778541	"CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Cell adhesion, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.7;lymphoid tissue: 38.9"	"Cell line enhanced"	"Detected in some"		"HEL: 10.1;HMC-1: 16.3;NB-4: 9.8;RPMI-8226: 7.2;U-937: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 19.6;eosinophil: 24.2;intermediate monocyte: 15.7;neutrophil: 19.1;non-classical monocyte: 28.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 24.2;monocytes: 28.7"									HPA055200			Uncertain	Vesicles,Cytosol				Vesicles	Cytosol	"HPA055200: "	"unprognostic (2.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (4.35e-6)"	"unprognostic (1.46e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.01e-1)"	6.3	3.1	1.7	22.9	1.9	7.2	4.4	1.0	1.3	14.9	8.1	2.5	0.9	2.4	12.0	1.0	1.9	2.3	3.3	7.3	2.0	1.8	3.4	4.3	15.6	37.4	2.2	0.0	5.3	3.5	0.7	1.6	10.9	2.4	3.8	2.5	3.2	2.4	3.9	3.5	3.0	3.0	2.0	3.1	38.9	2.0	2.2	1.4	2.8	3.4	5.2	2.8	7.5	2.1	0.1	3.1	24.2	28.7	1.2	0.0	1.8	0.2	1.0	0.1	0.2	0.1	0.3	1.1	0.8	1.1	0.0	0.0	0.2	0.2	0.2	0.1	0.6	1.7	0.3	0.1	0.0	0.2	0.2	10.1	3.2	0.2	0.5	3.7	16.3	0.8	1.4	3.6	0.6	0.1	2.3	0.4	1.2	0.5	1.3	9.8	0.4	0.2	0.1	1.4	7.2	0.0	0.3	0.1	0.2	2.1	1.7	0.4	0.3	4.7	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.2	1.0	12.9	0.5	19.6	4.4	24.2	0.0	15.7	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	19.1	1.2	28.7	0.6	0.0	1.8	1.7	1.9	1.0	1.3	2.0	1.8	2.2	0.0	2.4	1.4
ADGRG1	"GPR56, TM7LN4, TM7XN1"	ENSG00000205336	"Adhesion G protein-coupled receptor G1"	Q9Y653	16	57610652-57665580	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein, G-protein coupled receptor, Heparin-binding, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 41.6;RPTEC TERT1: 39.1;SK-BR-3: 53.9;SK-MEL-30: 55.6;TIME: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 48.1"	"Lineage enriched"	"Detected in many"	6	"T-cells: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046065	Uncertain				"Secreted to blood"	22000	22000			"HPA046065: "	"unprognostic (4.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavourable (2.53e-4)"	"unprognostic (4.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"prognostic favourable (5.52e-7)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.98e-1)"	18.9	5.6	39.3	5.1	32.3	6.5	19.7	9.1	70.9	15.2	14.2	28.2	14.6	10.3	10.0	34.5	16.8	20.3	26.7	8.7	33.4	15.9	82.1	1.9	15.4	2.2	24.2	22.8	3.1	25.2	13.5	6.7	38.1	27.2	13.0	13.4	6.3	34.3	24.7	5.7	32.6	7.7	7.8	32.0	4.9	18.1	22.1	28.9	12.1	81.4	8.7	7.2	17.8	14.2	0.1	0.1	1.0	0.2	8.7	48.1	8.4	7.7	8.5	2.5	0.1	0.0	0.0	24.9	1.4	0.8	2.5	0.5	6.4	41.6	0.0	20.8	1.3	28.5	0.0	19.3	1.0	0.3	0.0	0.8	10.4	7.3	0.0	0.0	0.4	0.5	27.9	4.5	1.9	20.6	0.0	0.3	0.5	9.6	20.5	0.1	0.3	8.3	0.7	0.2	5.7	39.1	24.6	7.2	0.2	0.4	53.9	55.6	23.9	0.1	44.6	4.7	7.7	0.3	17.3	0.0	0.3	0.1	38.6	0.1	11.3	0.6	0.2	0.0	48.1	0.1	0.5	0.1	3.3	18.3	0.0	0.0	1.7	14.1	1.0	8.7	0.1	0.1	0.0	8.4	39.3	32.3	9.1	35.0	33.4	15.9	24.2	22.8	27.2	28.9
ADGRG2	"EDDM6, GPR64, HE6, TM7LN2"	ENSG00000173698	"Adhesion G protein-coupled receptor G2"	Q8IZP9	X	18989309-19122637	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 202.4"	"Cell line enhanced"	"Detected in some"		"A549: 6.1;BEWO: 7.7;HeLa: 6.4;NTERA-2: 6.7;SH-SY5Y: 7.0;U-2197: 15.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001478, HPA050029"	Enhanced		Approved	"Plasma membrane,Cytosol"		7900000	7900000	"Plasma membrane, Cytosol"		"HPA001478: AB_1078923, HPA050029: AB_2680996"	"unprognostic (3.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-7)"	"unprognostic (6.37e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	4.4	0.3	0.4	0.9	0.2	0.2	2.8	0.1	0.2	0.8	1.0	0.1	6.6	0.2	0.5	202.4	0.9	6.9	1.4	1.8	0.6	0.6	0.7	0.9	1.7	3.1	0.2	0.2	0.9	0.9	24.8	1.9	0.6	0.3	3.2	0.2	1.6	9.6	0.8	0.6	0.3	1.4	0.6	0.2	1.2	3.5	4.7	0.2	2.7	1.8	0.6	1.9	1.1	1.5	0.1	0.2	0.9	0.6	0.0	0.2	0.0	0.2	6.1	0.0	0.0	0.1	0.9	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	6.4	0.2	0.9	0.0	0.0	0.1	0.1	0.0	1.2	0.0	0.0	0.2	0.0	1.0	0.0	2.3	6.7	2.0	0.0	0.1	4.4	0.0	1.2	2.3	7.0	1.5	0.1	0.0	0.1	0.1	0.1	0.2	0.4	15.3	2.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.9	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.7	0.0	0.6	0.1	0.0	0.0	0.4	0.2	0.1	0.2	0.6	0.6	0.2	0.2	0.3	0.2
ADGRG6	"FLJ14937, GPR126"	ENSG00000112414	"Adhesion G protein-coupled receptor G6"	Q86SQ4	6	142301854-142446266	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 51.9;placenta: 104.9"	"Cell line enhanced"	"Detected in many"		"A549: 25.2;Hep G2: 23.5;hTERT-HME1: 23.9;HUVEC TERT2: 46.1;MCF7: 43.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"myeloid DC: 3.5"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017346	Approved					70000000	70000000			"HPA017346: AB_1849260"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.00e-2)"	"unprognostic (8.64e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (2.78e-5)"	"unprognostic (4.46e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.59e-2)"	5.6	1.4	1.1	4.1	1.0	0.0	6.1	0.5	1.1	4.1	14.0	1.0	2.7	8.9	2.2	2.8	9.1	2.6	8.8	4.4	1.4	1.1	5.3	51.9	12.0	2.6	1.9	0.8	1.4	3.1	0.3	0.7	104.9	1.3	7.2	3.3	3.3	6.3	3.6	1.5	7.8	17.5	5.0	2.3	6.1	6.6	1.5	0.9	2.2	2.1	3.9	4.7	11.3	9.2	0.0	3.5	0.0	0.2	0.0	0.1	0.0	4.7	25.2	0.5	2.6	0.1	0.0	0.0	6.5	1.2	5.0	3.1	20.1	14.6	0.0	5.9	3.7	11.8	0.7	6.3	8.3	0.0	1.9	1.0	4.3	23.5	4.9	4.0	0.0	0.0	10.2	0.1	23.9	46.1	0.1	0.0	2.0	43.2	0.0	0.0	0.2	5.7	0.0	2.2	4.9	2.6	10.7	0.0	0.0	1.9	8.9	4.1	4.8	0.0	1.5	0.0	2.2	2.2	3.2	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	1.0	0.5	1.1	1.4	1.1	1.9	0.8	1.3	0.9
ADGRV1	"DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1"	ENSG00000164199	"Adhesion G protein-coupled receptor V1"	Q8WXG9	5	90529344-91164437	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Hydrolase, Receptor, Transducer"	"Deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 95.3;pituitary gland: 35.4"	"Cell line enhanced"	"Detected in many"		"AF22: 12.4;HAP1: 18.4;K-562: 7.4;NTERA-2: 9.6;SCLC-21H: 9.0;U-266/70: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067503	Approved		Approved	"Lipid droplets"				"Lipid droplets"		"HPA067503: "	"unprognostic (1.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.50e-3)"	"unprognostic (9.73e-7)"	"unprognostic (1.87e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.14e-2)"	0.5	95.3	21.9	0.6	19.8	0.8	2.2	13.9	14.7	0.7	1.0	3.1	1.2	0.7	0.6	0.9	1.0	0.6	6.3	0.6	26.5	1.5	10.6	19.4	5.5	0.5	1.1	7.0	0.6	1.3	1.1	35.4	2.4	4.9	1.1	1.0	4.9	0.7	2.4	0.6	1.5	0.7	0.6	0.4	0.7	1.0	1.1	5.3	0.0	4.2	0.0	0.7	5.4	0.4	4.1	2.2	8.4	1.7	1.7	3.4	0.4	0.4	1.6	12.4	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	1.3	0.1	0.2	0.3	0.0	0.1	18.4	0.1	0.0	0.7	3.4	3.1	1.5	1.1	0.0	0.2	0.1	0.0	3.8	0.0	0.1	0.0	7.4	2.0	0.0	1.5	0.1	0.1	9.6	3.3	0.0	0.3	1.6	0.0	0.4	9.0	2.2	2.7	1.8	0.1	4.7	0.0	0.6	0.3	1.5	0.4	0.8	10.8	3.0	0.4	0.6	0.1	0.0	4.9	1.7	4.8	2.0	1.3	3.2	2.5	2.2	2.6	0.9	4.1	3.4	1.8	8.4	1.7	1.0	2.2	2.7	0.4	21.9	19.8	13.9	14.7	26.5	1.5	1.1	7.0	4.9	5.3
ADIPOQ	"ACDC, ACRP30, adiponectin, AdipoQ, apM1, GBP28"	ENSG00000181092	"Adiponectin, C1Q and collagen domain containing"	Q15848	3	186842690-186858463	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hormone	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 176.7;breast: 79.4"	"Cell line enriched"	"Detected in single"	670	"ASC diff: 84.1"	"Group enriched"	"Detected in some"	8	"breast cancer: 6.5;pancreatic cancer: 1.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB046467, HPA051767"	Uncertain				"Secreted to blood"	1000000000	1000000000			"CAB046467: AB_1078104, HPA051767: "	"unprognostic (1.76e-2)"									"unprognostic (1.53e-1)"	"unprognostic (2.20e-2)"			"unprognostic (6.99e-3)"	"unprognostic (1.87e-1)"			176.7	1.9	0.0	16.7	0.0	0.1	79.4	0.0	0.1	0.1	23.2	0.0	0.4	0.1	0.1	1.3	0.3	0.1	13.2	5.8	0.0	0.0	0.5	0.1	0.1	6.1	0.0	0.0	0.2	1.3	0.1	0.0	0.1	0.0	0.4	1.4	0.0	14.7	0.6	2.0	1.5	2.1	0.4	0.0	0.1	0.6	0.1	0.0	0.0	0.7	9.5	0.3	1.0	0.9	0.8	0.6	2.4	0.4	0.7	0.5	0.1	0.0	0.0	0.0	0.0	84.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.6	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.8	0.3	0.5	1.9	0.7	0.4	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADSL		ENSG00000239900	"Adenylosuccinate lyase"	P30566	22	40346500-40390463	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Lyase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000525, CAB019285"	Enhanced		Enhanced	Cytosol		180000	180000	Cytosol		"CAB019285: , HPA000525: AB_1078106"	"unprognostic (2.80e-1)"	"unprognostic (2.12e-1)"	"prognostic favourable (2.38e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"prognostic unfavourable (5.81e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.44e-2)"	9.3	11.6	5.0	13.7	8.5	11.2	9.0	6.8	10.1	7.9	9.5	7.3	4.4	6.0	10.8	9.4	9.7	9.0	6.9	14.6	4.5	4.7	12.0	17.3	6.8	17.6	4.9	4.9	10.5	21.8	5.4	9.1	9.5	5.1	7.1	9.7	9.2	14.7	6.4	79.0	6.2	9.4	10.7	4.9	14.5	9.6	10.9	4.4	18.8	8.4	23.6	15.5	9.5	7.4	15.3	28.8	11.0	22.7	19.8	34.0	24.6	21.0	24.9	21.4	30.5	14.5	20.4	24.8	19.3	19.1	41.8	32.0	41.1	12.4	61.3	16.4	22.3	15.9	47.7	31.0	43.0	16.3	44.9	27.8	28.1	37.8	30.3	90.4	23.4	21.9	17.6	36.7	39.0	30.9	32.8	26.9	31.2	23.5	27.9	32.3	34.9	26.6	42.6	45.0	43.5	26.9	16.7	13.8	13.6	23.0	12.7	36.5	17.6	28.6	20.4	22.4	41.5	19.7	36.9	25.6	44.6	47.0	18.6	33.6	21.8	11.0	19.3	7.8	16.2	22.7	22.8	15.3	34.0	21.7	28.8	14.9	27.0	20.8	1.9	19.8	20.2	14.9	34.0	24.6	5.0	8.5	6.8	10.1	4.5	4.7	4.9	4.9	5.1	4.4
ADSSL1	FLJ38602	ENSG00000185100	"Adenylosuccinate synthase like 1"	Q8N142	14	104724186-104747325	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 200.5;tongue: 53.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 12.7;MCF7: 11.3;SiHa: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									220000	220000				"unprognostic (2.23e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavourable (4.99e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	2.5	1.1	0.8	0.5	1.8	0.4	0.9	0.3	1.2	0.8	0.7	3.4	0.3	0.8	0.9	3.5	3.9	1.5	2.2	27.8	1.2	1.5	2.9	7.2	0.7	0.5	3.3	0.4	0.8	1.7	1.9	2.2	1.6	2.0	1.9	0.6	4.6	3.2	1.1	200.5	1.3	0.8	1.0	2.1	0.5	1.2	3.4	2.0	0.0	1.7	53.2	2.8	6.1	3.8	0.0	0.4	1.2	2.1	0.0	0.5	0.0	0.1	2.6	2.0	5.8	1.4	0.9	0.6	0.7	1.1	0.2	0.6	0.2	2.0	0.0	12.7	0.6	1.0	0.2	0.4	0.5	0.8	0.4	0.0	6.2	0.9	1.5	0.0	5.0	2.8	1.9	0.0	2.1	0.4	2.3	0.1	1.0	11.3	0.0	0.6	1.7	1.1	0.1	0.3	0.7	0.4	1.4	1.7	3.5	19.0	0.8	2.5	5.9	1.6	0.6	0.1	0.5	1.3	0.0	3.7	2.7	0.0	1.8	0.8	1.2	0.0	0.1	1.2	0.5	2.1	0.0	0.0	0.1	0.4	0.4	0.0	0.4	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.8	1.8	0.3	1.2	1.2	1.5	3.3	0.4	2.0	2.0
AFG3L2	"SCA28, SPAX5"	ENSG00000141385	"AFG3 like matrix AAA peptidase subunit 2"	Q9Y4W6	18	12328944-12377314	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004479, HPA004480"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA004479: AB_1078109, HPA004480: AB_1078108"	"unprognostic (1.11e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (1.31e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-2)"	"prognostic favourable (6.05e-14)"	"unprognostic (5.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.22e-1)"	11.5	15.8	11.8	14.3	14.0	11.7	19.9	17.2	30.3	11.2	25.7	9.5	12.7	33.1	11.4	10.1	18.3	10.4	11.2	77.4	13.2	13.1	27.2	22.9	16.3	23.7	12.0	13.2	12.0	23.1	34.3	12.6	9.9	16.9	10.8	23.5	12.2	14.9	14.8	61.0	17.5	35.0	15.1	14.0	9.9	16.0	8.9	7.1	10.7	16.9	22.4	13.2	14.0	11.6	10.1	15.8	8.5	12.3	19.9	15.2	8.4	16.9	17.4	12.4	14.0	14.4	15.7	16.6	19.0	19.0	27.3	20.0	26.9	10.5	48.9	21.0	17.3	17.1	31.4	21.9	22.3	11.4	13.4	14.6	19.0	25.1	19.7	55.1	22.0	17.4	24.0	25.8	34.2	19.8	32.9	29.0	13.3	26.9	19.7	16.9	17.3	12.8	22.2	39.3	40.8	23.4	37.8	23.2	16.2	29.9	32.4	26.7	14.9	25.0	15.0	32.5	28.0	30.9	24.8	20.4	23.5	31.4	17.8	21.7	14.9	2.6	11.5	8.5	8.7	12.3	10.7	10.1	10.4	13.7	15.8	7.7	13.3	15.2	0.8	19.9	10.8	8.1	6.4	8.4	11.8	14.0	17.2	30.3	13.2	13.1	12.0	13.2	16.9	7.1
AGA	ASRG	ENSG00000038002	Aspartylglucosaminidase	P20933	4	177430770-177442503	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 31.5;Karpas-707: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031415, HPA031417"	Enhanced				"Intracellular and membrane"	28000000	28000000			"HPA031415: AB_10603578, HPA031417: AB_10670967"	"unprognostic (8.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (8.61e-4)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.49e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.47e-2)"	12.8	15.1	11.2	11.2	11.9	10.9	18.5	4.4	13.7	13.5	12.1	24.2	8.0	8.0	9.8	26.4	18.8	7.1	15.1	8.4	13.0	9.4	20.5	26.5	12.4	12.3	14.0	11.0	10.2	14.7	19.2	9.0	9.3	15.0	10.1	11.1	24.0	27.1	10.8	6.7	16.9	14.4	8.1	22.3	14.9	13.0	13.3	10.0	13.4	14.0	14.3	18.3	9.0	10.2	10.0	11.1	16.3	23.8	8.9	16.3	10.3	2.0	4.6	5.3	7.6	6.3	5.6	3.6	15.5	31.5	8.0	10.2	2.4	10.3	10.3	2.9	11.9	2.5	4.5	5.1	16.3	6.6	2.9	4.3	5.1	6.7	4.1	7.5	3.0	4.0	8.9	5.9	2.7	7.6	3.8	44.6	3.3	5.7	6.0	4.7	2.0	4.8	1.9	2.2	1.5	8.5	5.2	2.9	6.7	4.6	4.0	12.3	9.1	15.4	2.3	5.6	5.0	2.6	5.9	8.6	6.6	5.5	9.0	8.5	6.2	15.0	10.7	16.3	11.7	18.9	13.4	10.0	12.8	14.0	10.5	8.1	11.4	16.3	2.4	8.9	23.8	11.1	12.0	10.3	11.2	11.9	4.4	13.7	13.0	9.4	14.0	11.0	15.0	10.0
AGBL1	"CCP4, FLJ32310"	ENSG00000273540	"ATP/GTP binding protein like 1"	Q96MI9	15	86079973-87029052	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Corneal dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 16.7;tongue: 35.5"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;RH-30: 1.8;SCLC-21H: 2.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"																						"unprognostic (3.70e-2)"	"unprognostic (4.46e-2)"		"unprognostic (1.06e-1)"										0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.4	0.0	0.0	0.0	5.8	1.3	0.0	0.0	0.0	0.1		0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.0	0.0	1.3	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	35.5	1.0	0.0	0.0	0.5	0.3	1.3	0.3	0.3	0.2	0.0	0.0	0.1	2.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.0	0.1	0.1	1.8	0.1	0.0	0.2	2.8	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.7	0.3	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.5	0.1	0.1	1.3	0.3	0.0	0.3	0.1	0.0										
AGBL5	"CCP5, FLJ21839"	ENSG00000084693	"ATP/GTP binding protein like 5"	Q8NDL9	2	27042364-27070622	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"testis: 91.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030981	Uncertain		Supported	"Microtubules,Cytokinetic bridge,Cytosol"				"Cytokinetic bridge"	"Microtubules, Cytosol"	"HPA030981: AB_10611673"	"unprognostic (1.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.50e-2)"	3.8	8.1	3.9	3.5	4.8	3.8	4.2	3.1	6.6	5.0	6.8	6.6	11.7	2.8	5.4	9.3	6.3	7.2	6.6	4.1	3.4	3.9	8.2	3.0	3.6	3.2	3.5	3.4	5.9	5.9	11.2	6.2	6.3	5.4	6.8	3.8	7.7	8.2	5.9	2.6	6.8	3.9	8.6	3.4	4.6	5.4	91.6	3.5	8.4	9.9	4.9	4.4	7.8	3.5	5.7	5.4	7.1	2.3	11.2	6.3	4.6	22.8	14.8	24.3	16.2	5.2	10.5	27.2	4.7	10.2	13.6	14.1	12.8	17.5	12.7	14.8	8.1	10.5	19.4	21.2	15.1	10.6	28.8	18.6	18.5	27.6	10.6	8.9	6.3	10.9	16.1	11.9	9.8	14.2	15.9	10.4	13.1	9.0	26.0	13.5	17.2	10.2	26.9	27.5	19.9	13.9	5.8	16.3	23.3	9.2	7.3	15.1	10.9	6.9	6.7	12.7	17.5	6.1	10.0	20.7	10.8	26.0	14.1	10.3	11.3	7.1	2.3	5.7	4.5	1.3	3.4	5.7	5.7	6.3	5.4	3.0	5.1	2.8	1.4	11.2	0.9	3.0	3.6	4.6	3.9	4.8	3.1	6.6	3.4	3.9	3.5	3.4	5.4	3.5
AGK	"FLJ10842, MULK"	ENSG00000006530	"Acylglycerol kinase"	Q53H12	7	141551189-141655244	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Cardiomyopathy, Cataract, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 37.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020959, HPA053471"	Supported		Supported	Vesicles,Mitochondria	"Intracellular and membrane"			Mitochondria	Vesicles	"HPA020959: AB_1854206, HPA053471: "	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.47e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.90e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.18e-1)"	8.7	12.0	11.9	8.0	19.0	5.9	10.6	21.3	23.7	8.8	8.9	10.2	8.8	6.4	16.8	17.1	9.5	11.9	6.8	24.5	16.1	12.3	16.0	10.5	8.4	10.0	11.8	18.8	10.8	8.0	15.7	13.3	9.9	14.2	10.1	13.4	10.6	13.5	10.7	8.4	6.8	8.8	15.0	13.9	12.2	9.0	12.9	9.0	7.8	9.8	8.4	15.6	8.4	8.5	4.6	6.4	0.4	5.5	37.9	10.3	5.7	12.2	13.3	13.2	10.9	10.5	13.0	9.0	13.0	12.7	20.9	20.9	10.3	9.5	13.8	11.7	12.4	9.1	18.4	15.1	22.5	16.2	16.4	12.8	6.3	10.2	15.6	8.8	6.9	14.4	13.3	18.3	18.0	16.0	19.0	19.7	10.1	12.3	23.9	4.1	14.0	15.0	15.5	2.3	41.2	13.3	10.4	11.6	15.9	13.5	16.3	13.4	8.7	9.7	8.9	9.7	7.6	12.9	18.7	15.0	14.8	6.6	15.9	4.1	26.6	0.0	2.6	0.4	9.1	5.5	6.5	4.6	7.4	10.3	6.4	2.5	5.5	9.6	0.2	37.9	3.2	2.5	7.2	5.7	11.9	19.0	21.3	23.7	16.1	12.3	11.8	18.8	14.2	9.0
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850084-99924023	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 23.1;skeletal muscle: 85.6;tongue: 34.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		16000	16000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: "	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favourable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	5.0	4.5	2.5	4.7	3.6	2.0	4.2	5.4	6.1	3.4	4.5	2.1	5.4	3.3	4.8	4.2	9.1	4.1	2.6	8.2	2.2	2.3	5.8	23.1	4.2	5.3	2.4	4.2	3.8	3.6	8.7	4.7	4.8	2.9	5.5	4.2	3.9	5.1	8.7	85.6	3.7	4.0	5.4	2.8	4.8	4.4	2.9	1.2	7.1	4.3	34.4	3.4	6.7	3.6	3.0	2.3	3.5	1.6	6.1	4.3	2.1	11.8	3.5	4.2	6.9	7.0	6.6	14.2	3.8	5.6	3.3	5.9	13.3	4.0	15.6	7.3	6.4	6.7	24.6	7.4	6.3	8.3	7.8	9.1	12.2	7.4	4.6	8.0	5.5	8.1	4.8	4.6	3.9	5.2	14.9	1.1	3.4	3.7	9.4	2.5	6.7	4.6	0.0	1.4	0.8	10.1	16.1	10.5	7.3	10.9	10.5	5.8	7.5	5.4	5.3	4.0	5.8	5.4	3.7	4.5	3.5	18.1	7.1	2.1	2.1	0.1	1.3	3.5	4.3	1.6	4.1	3.0	3.2	2.9	2.3	2.9	3.2	3.2	1.5	6.1	0.9	2.1	3.3	2.1	2.5	3.6	5.4	6.1	2.2	2.3	2.4	4.2	2.9	1.2
AGPAT2	"BSCL, LPAAT-beta"	ENSG00000169692	"1-acylglycerol-3-phosphate O-acyltransferase 2"	O15120	9	136673143-136687423	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 71.5;liver: 63.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA019544	Uncertain		Approved	Centrosome				Centrosome		"HPA019544: AB_1844646"	"unprognostic (3.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.30e-3)"	"unprognostic (5.06e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.93e-1)"	71.5	5.3	2.3	8.1	2.2	8.4	35.2	2.0	3.0	7.4	20.2	2.2	5.9	31.3	4.7	7.1	11.7	4.1	15.8	12.4	2.8	2.4	10.9	63.1	12.1	11.1	2.5	2.8	5.3	47.7	2.5	6.2	4.9	2.6	5.5	3.3	8.9	12.9	6.2	9.5	7.0	33.6	4.0	1.9	6.8	11.0	5.2	1.9	5.1	13.4	7.0	8.8	6.6	4.9	7.0	20.3	33.2	28.4	2.1	2.5	9.8	14.6	20.6	2.4	11.4	17.7	5.5	10.4	9.7	7.7	6.7	5.1	23.3	29.0	4.8	21.9	5.5	39.7	3.4	6.0	0.7	50.0	15.8	7.1	8.5	5.1	12.2	7.5	17.5	5.3	8.4	5.7	3.0	3.4	8.6	0.8	2.8	26.4	0.5	23.3	6.2	37.5	10.9	8.8	26.6	7.8	9.3	5.5	8.8	12.6	13.3	15.9	8.4	29.5	6.8	8.9	9.1	2.8	6.2	1.2	0.1	3.1	0.1	16.1	8.8	6.0	28.4	33.2	2.2	25.3	2.1	4.1	1.9	2.5	14.9	7.0	1.6	1.8	19.1	2.1	22.2	20.3	2.3	9.8	2.3	2.2	2.0	3.0	2.8	2.4	2.5	2.8	2.6	1.9
AGPS	"ADAP-S, ADAS, ADHAPS, ADPS, ALDHPSY"	ENSG00000018510	"Alkylglycerone phosphate synthase"	O00116	2	177392644-177559299	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cataract, Disease mutation, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030209, HPA030210, HPA030211"	Supported		Enhanced	Peroxisomes	"Intracellular and membrane"	9300	9300	Peroxisomes		"HPA030209: AB_10600634, HPA030210: AB_10600202, HPA030211: AB_10602195"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (8.62e-6)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavourable (8.35e-4)"	"unprognostic (7.74e-2)"	"prognostic favourable (9.45e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.92e-2)"	22.9	17.7	13.5	21.2	14.9	28.3	17.1	14.9	13.4	16.0	23.5	17.2	14.1	14.1	22.4	10.5	18.4	12.5	16.0	23.9	14.2	13.5	20.8	21.2	15.2	14.7	17.4	11.8	16.4	21.2	37.0	11.7	14.7	15.0	14.7	24.0	8.0	18.2	10.8	23.2	9.6	17.6	21.3	31.8	17.1	14.5	19.1	13.7	29.5	14.2	14.4	14.5	16.9	20.7	3.4	7.6	11.2	6.8	5.6	6.4	3.0	17.7	11.4	8.1	8.3	10.4	11.4	19.3	13.9	6.9	11.9	11.8	21.2	12.4	20.0	30.4	14.4	19.4	21.8	14.2	15.6	26.4	7.4	27.8	19.8	24.9	10.6	30.1	29.6	9.9	9.0	19.1	15.2	23.8	19.0	12.5	14.3	0.0	24.3	10.2	13.8	18.9	19.5	24.2	12.1	20.3	21.3	10.0	12.1	26.4	2.3	16.4	0.1	12.5	24.4	10.7	36.7	10.9	24.3	16.2	28.0	10.0	9.8	13.5	4.1	3.8	6.1	11.2	4.3	6.7	6.4	3.4	5.5	5.3	7.6	2.1	5.3	3.1	1.3	5.6	6.8	0.7	6.2	3.0	13.5	14.9	14.9	13.4	14.2	13.5	17.4	11.8	15.0	13.7
AGXT	"AGT, AGT1, AGXT1, PH1, SPAT, SPT"	ENSG00000172482	"Alanine-glyoxylate aminotransferase"	P21549	2	240868479-240880502	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	172	"liver: 247.3"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 13.1"	"Cancer enriched"	"Detected in some"	425	"liver cancer: 253.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035370, HPA035371"	Enhanced		Supported	Vesicles		5200000	5200000	Vesicles		"HPA035370: AB_10673218, HPA035371: AB_2674593"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"prognostic favourable (5.92e-5)"	"unprognostic (8.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.57e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.37e-1)"		"unprognostic (3.26e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	247.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.2	0.0	0.0	0.0	0.1	0.0	0.8	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
AHCY	SAHH	ENSG00000101444	Adenosylhomocysteinase	P23526	20	34280268-34311802	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA041225, HPA044675"	Approved		Supported	Cytosol		3900000	3900000	Cytosol		"HPA041225: AB_2677371, HPA044675: AB_2679041"	"unprognostic (3.35e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-3)"	15.3	18.6	11.7	15.4	15.0	17.0	24.3	6.3	16.4	25.1	30.0	14.7	18.4	24.6	20.2	23.9	43.4	26.6	22.4	26.0	12.0	12.8	52.2	99.8	19.1	18.1	16.0	10.6	39.1	72.0	15.7	15.0	44.5	13.2	26.9	20.2	14.4	32.4	18.3	48.2	14.8	20.4	18.8	15.7	17.9	22.2	33.3	13.4	25.0	52.8	31.0	29.2	18.2	20.5	9.1	24.1	2.3	26.0	4.6	7.4	11.4	36.8	48.4	20.5	36.2	24.0	25.8	23.6	15.2	21.8	33.9	27.0	130.7	31.9	57.5	27.1	19.4	42.4	48.3	85.2	21.8	7.6	29.3	69.4	24.1	84.1	25.8	32.3	22.8	53.4	38.8	21.0	33.9	23.1	33.7	14.6	17.9	39.1	42.2	30.6	26.3	47.2	31.7	52.2	40.4	30.3	26.3	35.6	23.7	30.3	36.0	50.4	54.1	30.1	14.6	29.5	31.4	14.8	28.6	21.8	31.9	34.6	21.7	20.0	15.7	2.3	13.7	0.4	4.1	26.0	6.7	9.1	6.0	5.3	21.1	7.8	6.6	7.4	1.1	4.6	16.5	24.1	6.7	11.4	11.7	15.0	6.3	16.4	12.0	12.8	16.0	10.6	13.2	13.4
AICDA	"AID, ARP2, CDA2, HIGM2"	ENSG00000111732	"Activation induced cytidine deaminase"	Q9GZX7	12	8602166-8612871	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.6;lymphoid tissue: 22.3"	"Group enriched"	"Detected in some"	6	"Daudi: 48.4;U-698: 40.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.6"	"Group enriched"	"Detected in many"	6	"B-cells: 6.6;granulocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (2.71e-2)"	"unprognostic (1.39e-2)"		"unprognostic (7.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.96e-2)"		"unprognostic (4.04e-6)"	"unprognostic (8.82e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.65e-1)"	1.3	0.1	0.1	22.3	0.1	0.4	0.4	0.1	0.1	0.2	0.3	0.1	0.1	0.0	0.9	0.1	0.1	0.2	0.3	0.4	0.1	0.0	0.2	0.1	0.5	15.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	1.8	0.1	1.1	0.5	3.9	0.1	0.1	1.7	0.2	0.2	0.1	0.6	0.3	0.1	12.2	0.1	0.7	6.6	0.7	1.6	0.7	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	48.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.6	7.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	40.4	0.0	0.1	0.0	1.0	0.7	0.4	0.4	0.3	0.2	4.3	0.4	0.2	0.4	6.6	0.4	0.4	1.6	0.5	0.4	0.7	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
AK1		ENSG00000106992	"Adenylate kinase 1"	P00568	9	127866480-127877743	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 84.5;skeletal muscle: 279.0"	"Cell line enhanced"	"Detected in many"		"U-2197: 46.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006456, CAB009893"	Enhanced		Supported	Cytosol		32000000	32000000	Cytosol		"CAB009893: AB_2225151, HPA006456: AB_1078116"	"unprognostic (6.07e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"prognostic favourable (7.31e-4)"	"unprognostic (2.62e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.99e-3)"	7.7	9.2	19.6	3.7	18.8	6.5	3.9	9.8	17.3	10.5	8.6	18.1	12.2	5.2	3.4	17.3	9.0	84.5	12.0	60.4	17.6	18.5	6.3	10.7	18.7	2.2	16.4	15.3	12.3	4.6	5.6	7.1	2.9	17.5	5.2	10.8	7.0	13.4	15.7	279.0	3.4	2.6	6.3	11.5	5.6	5.8	9.8	11.1	0.0	10.5	61.5	4.0	4.4	4.4	1.2	3.4	2.8	0.4	1.4	1.5	1.2	15.2	6.6	8.4	11.5	20.5	41.8	7.7	10.6	10.7	18.9	11.5	4.8	9.7	0.4	11.6	21.8	22.0	0.0	11.8	7.6	2.4	7.3	2.2	18.9	8.4	11.5	0.0	0.3	31.7	23.0	14.0	10.2	25.2	8.9	0.6	21.4	14.5	0.0	0.3	3.0	20.4	0.4	8.5	3.3	12.6	1.1	13.7	8.5	28.0	16.1	8.1	12.9	9.1	20.8	13.2	5.4	46.5	10.1	1.0	0.1	0.0	16.6	0.0	9.2	0.9	0.4	0.4	1.5	0.3	1.1	0.3	0.6	1.1	0.1	1.2	0.3	1.1	2.8	1.4	0.4	3.4	0.3	1.2	19.6	18.8	9.8	17.3	17.6	18.5	16.4	15.3	17.5	11.1
AK2		ENSG00000004455	"Adenylate kinase 2"	P54819	1	33007940-33080996	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018479	Approved					5500000	5500000			"HPA018479: AB_1844676"	"prognostic favourable (4.37e-4)"	"unprognostic (3.25e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavourable (8.65e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavourable (9.32e-4)"	"unprognostic (7.86e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (6.40e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.56e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-3)"	24.9	27.1	16.0	27.6	20.3	18.3	24.2	19.1	17.6	21.4	31.3	24.6	22.4	36.6	20.6	22.8	31.6	17.6	25.0	33.9	15.1	14.5	51.2	46.5	17.9	18.2	23.1	9.9	24.3	23.2	27.2	16.2	18.6	19.7	22.4	31.8	20.4	31.4	21.5	73.8	20.6	37.1	18.7	25.9	24.7	24.0	29.3	25.0	40.2	37.4	34.4	28.7	26.7	23.3	31.7	51.9	50.9	41.2	27.4	24.4	43.1	44.8	20.0	18.9	21.9	13.1	16.4	19.2	25.4	19.6	38.2	40.2	38.3	40.8	83.7	30.1	18.8	32.6	43.8	43.1	41.2	36.5	32.0	55.4	38.4	29.1	30.6	98.6	31.4	16.2	32.6	32.7	66.1	26.1	58.8	31.5	22.6	22.6	37.3	54.5	26.4	30.7	43.5	32.1	55.1	37.6	27.1	27.8	16.3	29.0	32.2	80.9	26.2	70.1	19.0	23.2	28.0	35.6	47.4	32.9	43.0	78.0	31.5	93.3	26.7	11.0	41.2	50.9	22.0	37.4	23.0	31.7	20.6	20.6	51.9	27.7	21.2	19.8	11.3	27.4	31.5	39.1	24.4	43.1	16.0	20.3	19.1	17.6	15.1	14.5	23.1	9.9	19.7	25.0
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 127.0"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 11.8"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 1.2;gdT-cell: 1.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.2;T-cells: 1.1"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		1800000	1800000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: , HPA068265: "	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	127.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	1.1	0.1	0.0	1.5	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.5	0.3	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
AKT1	"AKT, PKB, PRKBA, RAC"	ENSG00000142208	"AKT serine/threonine kinase 1"	P31749	14	104769349-104795751	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 30.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 30.7"	"Low region specificity"	"Detected in all"							"HPA002891, CAB003765"	Supported		Supported	Nucleoplasm,Microtubules				Nucleoplasm	Microtubules	"CAB003765: AB_562035, HPA002891: AB_1078123"	"unprognostic (3.30e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"prognostic favourable (4.83e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.90e-2)"	"prognostic favourable (2.12e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	31.7	45.4	22.9	24.2	23.6	20.3	40.0	20.9	29.5	24.7	32.6	20.0	30.8	22.5	27.0	21.5	33.0	25.5	30.3	47.7	22.9	19.1	26.3	49.2	31.3	21.0	22.1	14.7	25.9	43.0	20.3	16.7	28.4	21.5	31.1	18.2	25.3	30.4	36.1	23.8	20.4	24.0	40.5	17.5	35.4	32.6	16.2	18.8	26.3	32.7	22.4	29.3	36.7	35.9	3.2	5.2	30.7	5.8	5.7	6.2	3.0	15.1	30.3	25.0	37.2	19.4	20.1	28.0	27.9	34.0	41.3	33.1	19.8	18.3	18.3	21.5	38.2	19.7	17.7	26.0	18.0	41.8	7.2	13.9	18.1	21.3	21.5	22.6	36.3	28.8	21.9	20.7	13.8	30.8	12.1	20.4	26.4	113.2	28.4	28.9	6.5	21.7	26.8	23.2	12.5	19.1	37.7	28.7	23.9	23.3	30.5	17.5	39.9	33.7	24.6	27.7	13.3	39.4	28.0	22.2	10.7	15.8	23.3	19.1	33.3	3.3	5.3	30.7	5.4	5.2	4.0	2.9	4.8	6.2	3.6	3.2	2.5	5.7	11.8	5.7	5.8	5.2	4.7	3.0	22.9	23.6	20.9	29.5	22.9	19.1	22.1	14.7	21.5	18.8
AKT2		ENSG00000105221	"AKT serine/threonine kinase 2"	P31751	19	40230317-40285536	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Diabetes mellitus, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004204, HPA064521"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles, Cytosol"		"CAB004204: AB_626659, HPA064521: "	"unprognostic (6.13e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (1.05e-6)"	"unprognostic (2.85e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (4.74e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.00e-1)"	31.1	20.3	15.4	17.6	15.2	21.3	18.2	46.3	18.2	23.3	18.2	23.4	21.2	12.3	22.8	28.0	22.1	22.7	14.0	23.1	15.4	10.0	23.0	62.5	14.6	17.8	17.9	13.3	27.8	24.5	21.1	24.0	17.5	14.7	19.7	12.3	26.8	18.5	24.3	48.5	18.3	17.1	20.0	16.8	18.7	15.5	21.3	15.7	26.6	52.6	29.5	23.6	19.6	19.9	6.3	8.8	7.7	4.4	3.2	4.9	2.4	22.4	55.4	21.1	21.7	26.3	32.2	11.7	15.0	22.2	31.1	27.8	24.3	20.9	22.9	13.4	33.1	9.8	23.4	31.3	20.1	21.9	26.7	15.0	35.1	15.3	16.5	17.2	18.1	29.7	18.8	21.1	20.1	6.7	19.3	24.0	17.3	18.7	27.3	8.4	11.4	14.9	18.2	11.5	16.5	24.2	36.8	29.1	17.8	15.4	26.4	12.5	20.8	22.2	6.7	19.0	18.8	17.0	23.5	22.4	19.2	18.8	18.6	20.4	15.5	7.6	4.4	3.6	4.5	2.0	4.5	3.9	3.6	3.0	3.0	6.3	3.5	4.9	7.7	3.2	2.6	8.8	2.7	2.4	15.4	15.2	46.3	18.2	15.4	10.0	17.9	13.3	14.7	15.7
AKT3	"PKBG, PRKBG, RAC-gamma"	ENSG00000117020	"AKT serine/threonine kinase 3"	Q9Y243	1	243488233-243851079	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013090, HPA026441"	Approved		Supported	Cytosol				Cytosol		"CAB013090: AB_2533692, HPA026441: AB_1844711"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (9.27e-4)"	15.4	17.0	16.0	7.8	15.2	2.2	11.0	39.9	33.4	16.9	16.1	12.4	17.4	4.1	19.7	12.3	10.0	11.8	12.1	9.8	15.5	13.6	12.8	4.0	11.3	7.9	14.2	15.8	29.8	4.4	15.1	14.6	17.0	18.4	19.4	6.6	8.9	4.1	23.9	4.8	4.7	8.1	20.4	12.1	9.9	8.7	10.4	14.8	2.9	17.7	5.0	6.2	17.2	18.6	1.9	0.8	1.2	0.9	3.8	3.6	0.6	23.5	2.4	14.9	0.0	11.0	12.6	7.9	13.3	12.2	8.6	7.6	0.1	9.7	0.0	0.0	16.8	0.3	8.2	5.3	11.4	5.9	6.4	0.3	0.0	0.0	5.7	0.1	2.6	6.5	0.0	10.7	9.7	17.6	0.0	0.1	3.9	0.0	5.0	1.1	6.3	3.7	2.7	9.1	0.1	2.9	0.8	19.1	25.3	0.1	0.0	23.8	0.0	8.0	13.8	15.3	11.8	0.1	11.0	1.3	0.4	2.8	11.2	1.2	12.8	1.2	0.9	0.5	2.3	0.3	3.6	1.0	2.2	2.5	0.8	1.9	1.9	1.7	0.2	3.8	0.7	0.6	0.7	0.6	16.0	15.2	39.9	22.9	15.5	13.6	14.2	15.8	18.4	14.8
ALAS2	ASB	ENSG00000158578	"5'-aminolevulinate synthase 2"	P22557	X	55009055-55031064	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 130.9;placenta: 53.5"	"Group enriched"	"Detected in some"	87	"HEL: 32.0;K-562: 35.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 2.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"								"Intracellular and membrane"						"unprognostic (7.82e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.68e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-1)"	1.7	0.4	0.8	0.4	0.8	130.9	0.5	0.2	0.5	0.3	0.4	0.5	0.0	0.4	0.3	0.3	2.3	1.0	0.5	2.9	0.7	0.7	1.6	2.4	17.3	0.3	1.3	0.7	6.1	2.3	0.3	1.0	53.5	2.3	2.6	0.3	1.0	0.5	0.3	3.7	0.4	0.4	1.1	0.9	22.3	0.3	0.5	0.0	0.4	3.2	0.0	0.3	7.0	6.5	0.3	2.0	0.3	0.1	0.0	0.3	10.7	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	32.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	2.0	0.0	10.7	0.8	0.8	0.2	0.5	0.7	0.7	1.3	0.7	2.3	0.0
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605929-95656706	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	"Kinase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 68.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Supported	Mitochondria		23000	23000	Mitochondria		"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favourable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	6.3	10.4	7.1	10.4	7.9	5.2	7.7	7.3	9.3	13.7	20.1	7.2	20.5	33.8	9.3	12.3	12.8	8.5	15.2	7.2	6.2	7.1	13.0	28.9	6.6	7.4	6.7	5.3	14.5	40.7	12.7	17.4	14.3	7.7	9.6	19.4	7.9	68.8	20.5	3.5	9.6	45.4	10.0	5.4	8.6	15.2	8.4	5.4	12.7	25.9	9.7	15.9	8.6	8.2	13.1	5.2	0.3	4.0	13.0	16.3	8.0	18.2	17.3	16.6	43.6	22.4	21.7	17.9	21.3	32.1	21.7	27.3	34.6	14.6	62.1	20.0	33.5	24.2	33.3	21.9	24.7	17.6	26.2	19.7	12.3	49.1	14.7	34.3	22.0	22.7	13.5	17.7	34.7	22.7	18.3	13.1	16.2	26.2	31.0	22.1	19.6	17.3	29.2	19.1	21.3	25.3	13.9	16.6	16.5	16.9	13.5	15.7	20.1	16.0	18.8	9.0	14.4	23.2	24.4	15.1	11.2	38.0	17.6	39.8	11.5	0.0	1.4	0.1	15.5	2.7	16.3	13.1	14.2	16.0	5.2	9.0	12.1	13.4	0.3	13.0	4.0	3.1	13.3	8.0	7.1	7.9	7.3	9.3	6.2	7.1	6.7	5.3	7.7	5.4
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 42.0;HaCaT: 52.3;HBEC3-KT: 129.5;U-2197: 74.4;U-87 MG: 59.2;WM-115: 61.1"	"Group enriched"	"Detected in many"	7	"melanoma: 16.8;prostate cancer: 80.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 1.0;eosinophil: 2.1;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: "	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	30.3	5.7	2.3	14.9	1.6	0.0	11.1	4.1	2.6	14.2	11.5	1.6	10.5	5.2	5.9	37.9	10.5	11.5	15.0	6.1	2.1	2.0	3.7	1.7	4.2	5.5	2.6	1.7	9.0	7.4	3.2	13.2	5.1	3.9	51.9	3.2	49.9	41.5	19.2	6.1	1.7	15.6	14.2	6.4	1.5	5.3	15.9	0.7	0.6	0.9	15.2	18.9	18.0	9.8	0.3	1.5	2.1	0.2	0.0	0.0	0.1	42.0	5.6	0.0	0.0	9.3	4.1	0.1	0.3	0.3	0.2	0.1	0.1	33.7	0.3	0.5	11.3	52.3	1.0	129.5	0.8	0.0	0.2	0.2	2.3	0.0	3.1	0.1	0.2	2.9	3.6	2.9	0.5	0.4	0.0	0.2	0.2	0.4	0.0	0.2	1.1	34.2	0.0	0.5	0.2	0.0	35.3	0.0	3.0	13.1	11.5	3.9	1.1	0.3	6.6	0.0	0.1	74.4	1.6	0.0	0.3	0.2	59.2	0.0	61.1	1.0	0.2	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	2.3	1.6	4.1	2.6	2.1	2.0	2.6	1.7	3.9	0.7
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19677598	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Approved									"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favourable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	22.3	66.4	8.5	9.0	24.6	2.8	10.0	8.8	12.8	13.7	15.9	17.5	7.5	15.6	13.5	19.2	39.6	10.7	26.4	12.5	9.5	6.5	52.5	88.6	17.7	4.3	11.1	10.3	13.5	24.4	10.1	14.9	3.1	14.4	20.7	11.1	16.2	26.0	10.0	18.5	57.1	26.6	10.5	10.2	8.0	18.3	9.8	15.4	4.5	27.3	27.9	22.5	9.8	17.0	3.9	14.3	11.6	14.2	8.6	6.4	5.7	6.7	42.3	4.2	10.6	20.2	17.1	2.9	2.0	5.2	4.0	4.6	13.2	11.0	2.1	4.9	8.4	15.1	16.6	20.3	2.9	9.4	7.2	1.0	22.3	32.3	3.8	5.0	0.5	9.4	28.9	3.8	2.3	8.0	0.2	0.1	10.1	9.1	0.1	6.2	10.1	23.2	4.9	12.1	6.4	4.7	21.4	8.2	5.8	18.5	7.1	5.9	12.4	4.6	9.5	2.6	4.7	6.8	6.3	2.9	7.2	3.0	12.6	0.0	8.4	0.0	14.2	11.6	4.2	12.6	6.4	3.9	4.3	3.7	14.3	3.0	4.9	3.4	0.7	8.6	13.7	0.2	5.8	5.7	8.5	24.6	8.8	12.8	9.5	6.5	11.1	10.3	14.4	15.4
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902781	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.7;liver: 92.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 33.9;SK-BR-3: 35.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401"	Enhanced					40000	40000			"CAB004645: AB_425775, HPA006401: AB_1844731"	"unprognostic (1.17e-1)"	"prognostic favourable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	22.9	4.1	14.4	2.0	18.0	4.6	6.6	3.1	16.8	3.8	2.4	8.6	18.9	1.3	2.5	5.2	11.4	2.7	3.0	12.6	8.6	7.1	73.7	92.6	2.4	1.7	15.9	11.2	2.9	2.2	9.4	2.4	8.3	8.5	12.1	1.6	9.7	2.4	12.1	25.6	8.0	1.3	3.3	2.7	2.1	3.4	1.4	6.6	2.8	3.0	8.9	2.9	8.3	3.6	1.5	7.2	2.6	5.6	0.3	1.4	2.2	5.0	7.9	4.0	11.9	17.0	2.5	9.8	4.8	3.0	5.0	4.0	5.7	3.8	3.4	6.5	6.2	13.5	6.8	14.4	1.8	1.9	6.0	1.9	1.8	33.9	5.3	1.6	6.1	6.6	8.1	2.8	2.7	5.6	7.5	2.5	3.4	12.9	1.6	8.2	1.9	4.0	10.5	3.3	3.9	5.2	12.8	7.9	3.0	8.5	35.0	6.3	15.9	2.6	4.6	4.3	5.7	5.2	1.7	2.7	6.5	0.9	1.5	13.2	5.7	0.0	4.1	2.6	1.1	5.6	0.9	1.5	0.7	1.4	7.2	1.1	0.3	0.9	0.6	0.3	3.1	2.4	1.0	2.2	14.4	18.0	3.1	16.8	8.6	7.1	15.9	11.2	8.5	6.6
ALDH5A1	"SSADH, SSDH"	ENSG00000112294	"Aldehyde dehydrogenase 5 family member A1"	P51649	6	24494852-24537207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 40.3;U-698: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029715, HPA029716"	Enhanced		Supported	Mitochondria		44000	44000	Mitochondria		"HPA029715: AB_10599994, HPA029716: AB_10601876"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"prognostic favourable (7.61e-6)"	"unprognostic (2.38e-2)"	"unprognostic (2.17e-2)"	"prognostic favourable (6.20e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-1)"	"prognostic favourable (3.68e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-2)"	5.8	4.8	23.7	8.3	27.4	3.1	4.1	13.5	21.5	4.1	6.0	9.5	1.2	7.7	3.9	3.1	5.6	13.5	4.4	9.8	17.3	21.0	18.4	62.6	5.0	8.9	16.0	14.7	5.8	6.6	11.4	4.5	2.2	13.0	6.2	5.7	4.1	3.9	4.3	31.1	6.9	5.4	2.8	10.9	4.8	5.2	3.7	8.8	21.4	12.1	4.9	8.8	6.3	5.5	3.9	3.8	0.4	0.2	1.6	6.8	1.2	3.2	2.9	2.1	3.1	0.0	0.0	3.5	0.3	0.6	0.8	0.5	11.5	0.8	40.3	6.1	0.3	0.0	3.4	0.4	0.5	4.1	5.6	6.3	1.9	13.1	0.5	9.7	0.8	0.3	1.6	0.1	0.0	0.0	3.1	0.0	0.6	7.5	11.8	5.8	0.8	1.5	13.6	0.6	0.3	2.4	6.4	3.6	3.2	3.8	0.4	3.9	5.7	5.3	0.0	0.4	2.0	0.1	2.0	5.7	8.5	50.3	0.0	3.1	0.4	0.4	0.1	0.2	1.7	0.0	3.3	3.7	2.4	2.8	0.2	3.9	6.8	5.7	0.4	1.6	0.2	3.8	1.6	1.2	23.7	27.4	13.5	21.5	17.3	21.0	16.0	14.7	13.0	8.8
ALDH6A1	MMSDH	ENSG00000119711	"Aldehyde dehydrogenase 6 family member A1"	Q02252	14	74056850-74084493	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 140.0;liver: 134.5"	"Cell line enhanced"	"Detected in all"		"T-47d: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 25.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029072, HPA029073, HPA029074, HPA029075"	Enhanced		Enhanced	Mitochondria		9100	9100	Mitochondria		"HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.11e-3)"	"prognostic favourable (4.22e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.13e-1)"	"prognostic favourable (2.00e-15)"	"unprognostic (4.59e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.12e-1)"	14.1	6.9	31.3	2.8	30.9	2.3	6.7	11.6	26.4	8.0	11.0	20.1	4.6	11.0	5.5	5.5	5.0	6.2	4.8	15.6	21.1	14.2	140.0	134.5	4.7	3.0	19.4	18.5	12.3	11.8	16.4	3.2	4.0	14.8	11.0	7.2	7.1	7.8	7.8	10.5	3.4	9.3	5.6	13.1	3.1	9.6	7.4	18.7	2.0	12.1	4.0	3.1	6.3	3.3	4.5	5.6	25.5	3.8	5.5	6.7	2.8	4.6	4.0	5.7	12.1	20.8	10.2	9.2	3.2	6.1	3.5	6.0	9.0	5.2	5.4	7.2	6.9	2.7	12.9	3.6	7.7	4.8	1.8	2.5	4.2	9.9	23.7	1.3	1.2	15.0	6.5	4.5	11.4	6.1	4.0	7.5	2.4	17.7	3.7	2.0	4.5	2.7	7.6	5.9	7.1	5.6	3.5	2.3	3.6	10.7	11.6	2.8	29.6	4.8	1.9	4.0	4.9	6.2	1.2	5.1	9.1	5.5	5.2	1.6	3.8	13.3	3.8	25.5	4.5	2.9	6.7	4.5	5.1	5.3	5.6	3.6	6.5	4.6	1.5	5.5	2.4	3.2	3.6	2.8	31.3	30.9	11.6	26.4	21.1	14.2	19.4	18.5	14.8	18.7
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023296	Enhanced		Supported	Mitochondria,Cytosol		140000	140000	Mitochondria	Cytosol	"HPA023296: AB_1844738"	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	14.8	9.8	27.8	46.0	23.2	13.8	35.5	17.8	22.0	20.7	26.8	27.6	14.3	0.0	18.2	13.9	11.1	8.6	60.2	19.1	0.0	10.4	2.8	14.7	23.4	11.3	0.0	0.0	16.9	14.2	16.1	11.6	16.5	0.0	0.0	18.2	9.7	0.6	0.0	18.8	8.3	8.9	31.6	0.0	19.7	11.3	9.5	11.3	0.0	9.8	10.3	17.7	0.6	20.0	6.0	18.6	6.9	12.2	0.0	0.0	0.0	3.2	0.0	9.6	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 1296.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA004177, CAB006252"	Enhanced		Supported	Cytosol		1200000000	1200000000	Cytosol		"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavourable (5.79e-5)"	"prognostic unfavourable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	27.9	30.9	34.7	24.2	42.3	36.0	25.3	31.2	59.7	21.0	32.8	16.3	25.9	29.4	21.9	33.9	73.5	22.1	24.4	109.3	31.6	33.4	28.2	11.1	17.9	34.0	35.0	49.6	23.4	19.4	51.0	25.2	19.9	38.0	23.6	23.5	24.6	37.9	36.9	1296.2	28.4	21.5	30.1	22.7	17.4	24.4	9.2	18.9	18.5	26.6	189.8	29.0	36.8	27.7	61.1	142.9	165.7	166.3	50.5	93.2	217.0	138.7	104.6	31.5	101.2	48.3	55.1	100.7	84.0	87.6	85.7	107.2	73.9	107.0	94.6	137.8	84.8	106.0	63.1	183.2	62.9	41.6	83.0	77.4	83.9	163.2	75.4	112.5	83.1	75.5	64.7	96.2	64.7	63.1	66.6	62.5	90.8	197.9	68.4	93.0	78.3	88.2	102.1	50.6	211.5	106.7	79.0	63.1	44.4	52.4	221.1	78.4	94.0	76.3	75.0	126.6	50.5	69.0	90.8	123.5	84.3	86.6	235.6	109.3	99.9	106.7	164.0	130.3	70.2	156.8	79.1	61.1	76.8	72.5	142.9	55.5	73.8	70.3	165.7	50.5	166.3	53.8	93.2	217.0	34.7	42.3	31.2	59.7	31.6	33.4	35.0	49.6	38.0	18.9
ALDOA		ENSG00000285043	"Aldolase, fructose-bisphosphate A"	P04075	16	30053090-30070420	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA004177	Uncertain		Supported	Cytosol		1200000000	1200000000	Cytosol		"HPA004177: AB_1078128"																		1.8	0.9	2.7	1.1	5.0	2.1	7.2	0.7	7.7	4.9	1.5	2.0	2.4	0.0	2.5	3.9	0.9	3.6	1.6	5.3	2.3		1.3	0.0	2.3	2.0	0.8	4.4	2.2	0.8	0.8	3.0	1.4	4.0	2.4	0.5	2.8	1.6	7.5	10.6	0.6	0.1	1.9	0.4	1.7	1.3	11.6	0.8	1.2	4.7	0.2	2.7	1.2	1.0	7.0	6.6	0.9	6.2	4.2	8.5	12.5	3.7	8.8	1.9	6.2	1.5	5.2	1.5	4.0	6.9	5.4	21.6	3.6	5.0	24.5	5.9	6.8	6.3	14.0	10.9	3.8	4.3	7.9	6.0	8.2	5.9	11.5	10.5	2.3	5.1	0.5	10.7	12.2	7.7	1.2	7.1	13.4	3.9	4.9	8.0	2.1	5.5	7.6	4.0	22.4	15.1	0.7	6.1	5.0	1.0	1.6	1.5	5.1	4.0	1.7	8.0	2.4	3.7	5.3	7.3	5.5	8.0	7.6	11.4	3.5	0.1	6.2	0.1	5.3	2.6	7.4	7.0	7.0	5.7	6.6	6.2	8.5	6.6	0.9	4.2	2.3	5.6	5.4	12.5										
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420578-101435823	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 804.1;kidney: 253.1;liver: 598.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.1;NB-4: 13.2;RPMI-8226: 15.2;SH-SY5Y: 13.2"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA002198, CAB020827"	Enhanced					930000000	930000000			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.2	0.1	334.5	0.2	0.2	145.9	0.2	0.6	0.1	0.1	5.7	0.1	0.1	0.1	253.1	598.8	0.1	0.1	0.1	0.1	0.1	18.3	0.0	0.4	0.1	0.4	0.1	0.0	0.2	0.2	0.1	0.1	0.1	804.1	0.1	0.1	0.2	1.5	0.3	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.3	0.0	2.9	1.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.4	0.0	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.2	13.2	0.2	0.0	0.2	3.1	15.2	0.0	0.0	2.5	13.2	1.5	0.0	0.0	0.0	0.1	0.7	0.0	0.7	5.3	0.2	0.4	0.2	1.6	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.4	0.1
ALG1	"CDG1K, HMAT1, HMT-1, Mat-1"	ENSG00000033011	"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase"	Q9BT22	16	5033960-5087379	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA060392	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA060392: "	"unprognostic (1.66e-2)"	"unprognostic (5.18e-1)"	"prognostic favourable (5.79e-4)"	"unprognostic (1.55e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (6.93e-4)"	"unprognostic (2.58e-3)"	"unprognostic (3.86e-2)"	11.0	22.2	8.7	10.8	12.8	6.6	12.8	9.3	18.8	13.7	16.4	14.9	10.1	14.7	12.1	17.0	11.7	12.4	14.3	8.1	8.8	10.4	18.9	31.6	9.9	12.7	10.5	6.5	10.1	27.9	21.5	13.6	10.7	14.6	10.8	17.2	15.5	20.6	12.0	7.3	9.1	12.8	12.1	9.4	16.2	16.5	19.4	11.4	16.0	15.0	8.7	14.5	12.1	8.7	20.7	24.3	7.8	23.3	20.9	26.5	31.7	6.4	17.6	4.4	8.3	17.0	10.1	8.2	14.5	20.4	19.0	19.0	14.5	23.9	13.7	12.5	18.5	17.4	12.1	14.3	12.9	11.2	13.8	7.7	14.6	29.9	13.9	13.4	13.5	12.3	10.9	14.9	9.4	11.3	9.6	18.0	14.1	17.5	8.6	16.5	16.8	10.1	16.0	6.1	38.2	11.8	7.0	7.5	7.6	15.5	24.3	8.3	15.8	11.0	10.8	8.8	8.2	45.0	12.1	13.1	15.8	9.3	7.3	14.4	12.5	3.3	23.3	7.8	26.5	21.6	23.1	19.8	22.9	25.4	24.3	20.7	21.0	23.7	1.5	20.9	21.2	21.2	21.6	31.7	8.7	12.8	9.3	18.8	8.8	10.4	10.5	6.5	14.6	11.4
ALG11	"CDG1P, KIAA0266"	ENSG00000253710	"ALG11, alpha-1,2-mannosyltransferase"	Q2TAA5	13	52012398-52029664	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047214	Approved									"HPA047214: AB_10961640"	"unprognostic (9.21e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.97e-3)"	"unprognostic (8.89e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.03e-2)"	"unprognostic (9.71e-3)"	14.7	16.9	11.9	9.6	16.2	14.2	13.8	11.8	17.7	13.9	11.9	12.6	15.9	9.8	15.2	13.0	12.6	12.9	11.3	12.2	13.4	9.5	17.3	20.9	11.5	9.3	13.5	11.5	13.1	15.6	18.4	18.4	19.5	15.7	13.5	13.9	11.4	17.6	13.7	13.0	13.7	15.6	14.2	16.6	11.6	13.1	12.2	12.3	13.8	19.6	7.0	10.3	14.7	11.2	10.4	14.4	14.6	14.1	8.7	13.3	6.4	4.9	6.9	12.1	12.1	10.9	10.7	10.6	13.3	11.2	10.2	8.9	9.4	12.1	9.8	3.6	11.4	10.5	12.5	8.8	13.9	11.6	9.4	23.5	7.5	8.5	10.5	19.7	23.6	9.8	13.2	9.4	11.2	9.1	13.4	9.6	12.4	4.5	9.6	7.3	12.5	5.8	12.4	8.7	6.0	10.1	9.8	5.1	9.4	10.2	9.4	8.3	11.5	11.5	13.0	9.4	7.7	9.7	9.6	5.4	7.6	13.0	6.2	7.4	15.5	14.6	7.4	9.8	11.3	6.0	11.2	8.0	10.2	10.5	8.3	10.4	13.1	13.3	4.1	8.7	14.1	14.4	9.8	6.4	11.9	16.2	11.8	17.7	13.4	9.5	13.5	11.5	15.7	12.3
ALG12	"CDG1G, ECM39"	ENSG00000182858	"ALG12, alpha-1,6-mannosyltransferase"	Q9BV10	22	49900229-49918458	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003076, HPA051665"	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA003076: , HPA051665: "	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.39e-3)"	"prognostic favourable (6.09e-4)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.21e-1)"	"prognostic favourable (3.60e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.89e-3)"	"unprognostic (6.32e-2)"	9.8	13.3	9.6	11.3	11.2	8.5	9.9	16.0	12.7	10.9	11.7	16.2	15.7	18.0	13.2	11.5	12.1	11.4	11.0	12.0	10.0	5.8	14.1	22.8	10.8	9.2	11.6	7.9	11.8	17.5	14.7	10.6	11.3	10.9	13.5	7.1	12.2	19.4	10.2	8.7	11.5	14.8	7.7	8.9	11.5	14.5	6.5	14.9	12.6	24.5	10.5	12.8	12.1	10.3	7.6	7.8	17.7	9.4	16.1	12.7	7.9	6.9	7.0	7.4	12.3	14.2	6.6	8.2	7.3	6.5	8.6	6.9	11.4	10.0	3.7	6.7	6.4	12.6	9.0	8.6	4.3	5.9	13.2	3.4	11.7	11.4	16.0	8.5	7.6	10.0	8.9	8.4	12.2	8.2	4.2	9.4	4.5	15.8	8.2	6.9	7.1	6.4	13.9	9.3	9.8	9.0	7.9	5.0	8.2	11.6	22.0	9.0	9.0	7.7	6.3	9.6	7.3	6.6	5.5	8.3	3.8	4.9	10.6	6.5	9.1	17.7	8.8	7.4	12.4	8.2	12.7	5.3	9.8	12.2	7.7	7.6	8.3	9.3	6.9	16.1	9.4	7.8	12.3	7.9	9.6	11.2	16.0	12.7	10.0	5.8	11.6	7.9	10.9	14.9
ALG13	"CDG1S, CXorf45, FLJ23018, GLT28D1, MDS031, TDRD13, YGL047W"	ENSG00000101901	"ALG13, UDP-N-acetylglucosaminyltransferase subunit"	Q9NP73	X	111665811-111760649	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Glycosyltransferase, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Congenital disorder of glycosylation, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA002853	Approved									"HPA002853: AB_1078131"	"unprognostic (4.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.97e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.62e-3)"	"prognostic unfavourable (1.10e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.45e-2)"	20.6	23.0	18.4	23.2	23.2	19.3	24.8	20.9	25.5	21.1	23.3	21.6	22.0	18.0	26.3	28.5	18.3	22.5	22.2	16.8	16.6	16.2	23.5	31.1	19.7	28.4	22.4	16.1	24.2	18.8	13.0	41.7	18.7	19.5	26.7	26.5	16.3	19.5	25.6	11.2	25.2	25.7	23.5	21.6	31.4	20.1	19.0	20.3	23.6	24.5	14.6	25.8	18.3	20.9	10.2	14.4	21.7	12.5	3.4	11.1	7.1	11.5	13.1	11.8	7.5	7.7	11.0	6.7	9.5	9.8	12.2	15.1	13.2	12.2	10.1	18.2	13.1	6.7	14.0	6.6	12.9	7.2	9.4	5.5	14.9	14.9	11.4	10.1	22.3	13.1	12.5	9.8	21.2	13.2	12.3	29.1	12.1	29.5	8.5	9.1	10.8	18.1	6.6	7.5	14.0	19.5	18.0	7.1	10.5	13.5	8.2	8.2	7.3	9.7	8.9	10.6	5.3	13.6	18.1	14.0	23.2	16.2	11.3	13.4	8.0	21.7	12.4	12.2	7.8	12.5	7.6	8.4	8.9	7.6	14.4	10.2	11.1	9.1	2.5	3.4	9.4	7.5	10.7	7.1	18.4	23.2	20.9	25.5	16.6	16.2	22.4	16.1	19.5	20.3
ALG2	"CDG1I, CDGIi, FLJ14511, hALPG2, NET38"	ENSG00000119523	"ALG2, alpha-1,3/1,6-mannosyltransferase"	Q9H553	9	99216426-99221956	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041512, HPA041601"	Approved		Enhanced	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"HPA041512: AB_10794380, HPA041601: AB_10794302"	"unprognostic (8.86e-3)"	"unprognostic (4.39e-1)"	"unprognostic (2.37e-1)"	"prognostic favourable (8.44e-5)"	"unprognostic (9.21e-3)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (1.06e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (2.28e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.81e-1)"	12.5	28.0	9.2	9.4	9.7	10.5	16.4	13.1	12.5	18.8	12.9	11.6	31.1	11.0	15.2	39.2	12.3	15.8	13.9	12.1	8.3	9.5	24.8	45.5	16.0	12.8	10.8	6.5	18.4	43.4	14.7	22.4	22.5	12.0	16.7	14.9	14.7	24.1	32.6	13.3	8.7	15.5	12.6	11.3	15.9	15.0	12.6	9.7	14.8	26.0	9.9	15.8	12.9	11.8	16.8	41.0	18.2	18.5	17.5	26.4	17.8	8.1	11.0	8.1	11.6	30.1	19.6	16.7	16.7	26.6	17.1	14.9	13.1	11.8	8.8	7.8	19.2	32.3	13.7	17.9	17.2	13.3	6.3	5.2	8.7	19.4	36.2	9.2	9.9	21.4	23.4	14.5	26.4	19.1	9.1	19.9	15.8	17.1	4.6	10.9	10.5	15.5	5.4	16.5	13.7	22.9	10.4	8.7	7.1	12.3	22.7	21.5	9.2	7.8	13.6	11.7	11.6	14.9	10.4	18.7	10.1	3.8	22.0	7.3	5.7	18.2	18.5	11.2	18.6	14.6	26.4	16.8	17.7	18.4	23.0	13.3	15.4	15.0	5.0	17.5	12.9	41.0	18.8	17.8	9.2	9.7	13.1	12.5	8.3	9.5	10.8	6.5	12.0	9.7
ALG3	"CDGS4, D16Ertd36e, Not56, NOT56L"	ENSG00000214160	"ALG3, alpha-1,3- mannosyltransferase"	Q92685	3	184242301-184249548	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045103	Approved									"HPA045103: AB_10960547"	"unprognostic (3.63e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.63e-1)"	"unprognostic (7.93e-3)"	"prognostic unfavourable (1.58e-5)"	"prognostic unfavourable (8.67e-5)"	"unprognostic (6.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.15e-2)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.02e-2)"	14.2	24.1	7.7	12.2	10.3	11.6	15.4	7.2	12.9	11.5	15.5	13.7	15.2	14.3	12.8	11.2	20.5	11.5	15.4	13.0	7.3	6.5	19.7	74.4	12.9	16.8	11.5	7.3	12.7	37.7	18.4	11.7	26.6	10.2	14.0	16.0	12.4	20.9	13.7	18.9	18.4	16.3	14.0	7.9	14.9	15.0	20.8	10.1	13.9	15.9	14.9	18.8	17.4	15.8	14.2	30.1	6.0	25.4	18.7	18.0	15.5	20.3	17.7	4.8	16.3	19.6	11.2	16.5	11.0	12.5	15.1	12.9	27.1	13.7	17.9	30.0	13.5	24.6	17.5	23.8	9.4	12.9	20.3	16.1	13.6	21.8	18.0	26.0	14.5	13.3	20.0	17.8	25.1	8.2	15.8	36.3	9.7	25.0	12.6	21.1	15.3	23.2	13.1	7.5	71.2	16.9	6.8	12.2	10.3	10.2	40.3	17.5	38.2	14.8	6.5	16.0	10.0	13.9	23.4	19.9	34.9	19.0	14.3	34.2	14.3	0.2	25.4	6.0	16.0	25.0	18.0	14.2	17.3	16.2	30.1	12.3	15.6	15.1	0.9	18.7	19.7	27.4	18.0	15.5	7.7	10.3	7.2	12.9	7.3	6.5	11.5	7.3	10.2	10.1
ALG6		ENSG00000088035	"ALG6, alpha-1,3-glucosyltransferase"	Q9Y672	1	63367590-63438562	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062536			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA062536: "	"unprognostic (1.21e-1)"	"unprognostic (5.60e-3)"	"prognostic favourable (4.86e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (9.46e-4)"	"unprognostic (2.07e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavourable (2.63e-6)"	"unprognostic (1.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.41e-1)"	9.7	13.7	9.3	13.5	13.5	8.8	11.6	12.2	12.6	9.9	11.8	10.1	9.0	12.1	11.0	14.3	16.7	9.6	9.1	9.9	11.2	7.1	10.3	14.6	10.0	13.4	8.2	11.1	10.8	11.5	10.6	10.0	14.1	11.6	8.9	14.0	10.2	12.9	11.9	8.0	13.7	13.5	7.5	10.5	14.5	10.0	6.9	8.7	25.9	9.7	8.5	21.7	10.0	11.6	7.5	7.9	24.2	7.4	7.4	10.6	5.6	5.3	4.8	8.5	7.8	10.2	8.8	11.2	6.3	2.2	3.3	3.8	5.6	5.4	13.9	15.2	5.2	10.3	12.4	10.1	6.0	15.6	9.8	10.7	5.5	4.6	5.0	12.7	9.3	7.3	6.1	8.1	3.0	12.5	11.3	11.2	7.7	7.0	12.2	10.7	26.0	7.2	12.5	12.0	16.4	9.5	7.4	7.9	4.3	16.8	17.5	16.5	9.7	7.2	6.8	5.5	5.5	11.6	8.1	9.5	13.3	11.5	5.3	12.7	18.4	24.2	7.4	13.6	8.8	6.6	10.6	7.5	7.2	8.5	7.9	5.6	8.7	9.1	4.3	7.4	6.4	6.5	9.4	5.6	9.3	13.5	12.2	12.6	11.2	7.1	8.2	11.1	11.6	8.7
ALG8	MGC2840	ENSG00000159063	"ALG8, alpha-1,3-glucosyltransferase"	Q9BVK2	11	78100936-78139660	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051898	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA051898: "	"unprognostic (1.37e-1)"	"unprognostic (9.24e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.38e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.37e-2)"	20.2	24.5	18.0	11.2	22.3	9.7	23.7	13.8	17.9	16.5	15.0	20.7	23.9	10.3	14.5	30.9	13.3	18.4	12.3	13.0	15.9	16.0	24.9	40.8	12.8	15.7	16.0	11.6	22.9	23.4	24.2	23.6	21.7	17.1	15.5	19.0	17.6	23.2	19.5	8.2	13.3	13.3	14.8	17.6	13.8	13.1	38.9	16.5	18.2	29.7	13.1	17.4	13.2	11.2	21.9	19.4	3.0	20.3	18.2	19.0	14.9	9.3	25.9	24.9	21.2	21.5	15.2	13.4	13.8	20.7	23.7	23.0	49.0	34.4	22.0	25.6	16.5	27.1	28.9	19.9	38.3	15.8	17.4	26.5	22.8	22.0	14.0	25.3	17.6	12.1	12.8	27.6	13.8	17.2	32.8	22.7	31.6	13.7	21.1	28.5	27.6	13.6	22.5	11.4	52.3	23.8	14.5	7.3	18.3	19.9	32.3	10.0	36.0	20.0	10.5	16.1	18.7	36.2	11.9	16.3	31.6	32.5	8.9	24.8	27.8	0.3	17.5	3.0	15.7	19.5	17.5	21.9	16.0	16.1	19.4	16.6	19.0	17.2	1.1	18.2	20.3	18.7	13.0	14.9	18.0	22.3	13.8	17.9	15.9	16.0	16.0	11.6	17.1	16.5
ALG9	DIBD1	ENSG00000086848	"ALG9, alpha-1,2-mannosyltransferase"	Q9H6U8	11	111782195-111871581	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA038575	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA038575: AB_10672718"	"unprognostic (1.48e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.34e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.07e-3)"	"unprognostic (5.11e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavourable (7.29e-5)"	"unprognostic (9.15e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.10e-2)"	19.9	13.5	11.8	11.4	17.9	9.0	16.8	19.3	19.3	16.9	13.7	15.6	15.7	16.2	19.1	15.7	13.8	12.5	14.0	14.3	11.6	13.7	13.7	17.7	12.3	13.5	12.2	11.2	19.2	29.9	21.0	16.5	20.3	14.6	14.7	14.9	17.5	34.3	20.1	11.7	17.3	13.2	15.8	13.2	13.0	14.1	25.0	9.8	15.3	17.4	10.9	15.2	13.8	14.2	7.8	9.5	7.0	7.9	7.1	12.2	6.5	9.7	9.8	19.3	18.9	12.0	11.5	14.7	12.7	10.3	10.5	11.4	16.8	16.6	15.7	18.1	14.2	18.3	10.1	15.3	14.9	12.1	7.9	11.9	5.8	12.3	14.0	13.4	8.3	10.0	10.4	11.0	10.9	10.1	11.9	24.6	17.2	7.2	13.4	11.9	6.4	10.9	12.3	17.2	30.6	11.6	8.7	9.5	16.3	11.2	17.1	6.8	18.5	5.5	9.9	22.2	15.6	10.7	13.6	8.0	6.0	14.8	9.2	16.7	15.0	6.7	5.8	7.0	8.5	7.9	9.4	7.8	8.0	8.8	9.5	6.6	12.2	7.3	2.3	7.1	6.9	9.4	7.7	6.5	11.8	17.9	19.3	19.3	11.6	13.7	12.2	11.2	14.6	9.8
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996065-7010736	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7"	"Group enriched"	"Detected in some"	5	"A-431: 17.1;HEL: 27.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 5.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Cytosol"		5800000	5800000	Cytosol	"Nuclear speckles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	0.3	0.6	0.3	1.5	0.4	2.0	0.3	0.3	1.0	28.6	0.4	0.3	0.3	0.7	3.4	0.5	28.4	0.4	1.6	0.8	0.3	0.1	0.3	0.3	0.5	1.9	0.5	0.3	0.4	0.8	0.0	0.3	0.7	0.4	0.3	0.0	0.4	8.1	0.3	0.5	12.8	0.8	0.3	0.3	1.5	0.3	0.6	0.3	0.3	0.8	22.7	9.5	1.2	42.7	1.1	1.3	4.8	0.9	0.7	0.8	14.3	17.1	2.9	1.3	1.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	2.5	0.6	0.8	0.6	0.0	2.2	0.0	0.1	0.0	1.8	2.2	27.4	3.8	1.8	0.1	0.2	4.5	0.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	0.2	0.3	0.6	0.9	0.6	0.9	0.5	0.4	0.0	2.2	0.1	0.6	0.5	0.5	0.2	1.0	0.7	3.2	1.5	0.8	1.4	0.7	0.5	0.2	0.5	0.8	2.0	0.7	1.8	0.9	1.7	0.7	0.5	0.5	1.1	0.5	0.8	0.7	0.7	0.2	0.4	4.8	0.7	0.4	1.3	0.3	14.3	0.3	0.4	0.3	0.6	0.3	0.1	0.5	0.3	0.4	0.3
ALOX15	15-LOX-1	ENSG00000161905	"Arachidonate 15-lipoxygenase"	P16050	17	4630902-4642294	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 27.9;blood: 89.8;lung: 24.4"	"Group enriched"	"Detected in some"	7	"HMC-1: 16.1;MCF7: 14.0;T-47d: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	183	"eosinophil: 89.8"	"Lineage enriched"	"Detected in single"	183	"granulocytes: 89.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004962, CAB004963, HPA013859"	Approved									"CAB004962: , CAB004963: , HPA013859: AB_1844758"	"unprognostic (5.31e-4)"	"unprognostic (1.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.36e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-1)"	27.9	0.1	0.2	4.5	1.1	0.2	4.2	0.2	0.3	0.5	2.8	0.2	0.2	1.9	0.2	8.1	0.4	14.4	1.5	2.7	0.3	0.4	0.2	1.7	24.4	1.7	0.5	0.2	3.0	0.2	0.0	6.3	1.5	0.4	0.3	0.9	0.2	1.0	0.2	0.2	2.2	3.7	0.5	0.7	1.1	1.0	1.4	0.4	2.0	0.2	0.2	0.4	1.9	0.2	0.0	0.4	89.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.0	0.0	0.3	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	89.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	1.1	0.2	0.3	0.3	0.4	0.5	0.2	0.4	0.4
ALOXE3	"E-LOX, eLOX3"	ENSG00000179148	"Arachidonate lipoxygenase 3"	Q9BYJ1	17	8095900-8119047	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skin 1: 30.2"	"Cell line enhanced"	"Detected in some"		"A-431: 6.5;HBEC3-KT: 10.6;hTCEpi: 7.8;hTERT-HME1: 14.8;T-47d: 4.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.9"	"Group enriched"	"Detected in many"	8	"basal ganglia: 1.1;cerebellum: 1.4;cerebral cortex: 2.3;pons and medulla: 1.1"	"Group enriched"	"Detected in some"	5	"gdT-cell: 1.0;naive CD4 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA023120, HPA078597"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA023120: AB_10959300, HPA078597: "	"unprognostic (2.40e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.87e-3)"	"unprognostic (2.09e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.06e-2)"		"unprognostic (3.56e-4)"	"unprognostic (3.60e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.66e-5)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	0.1	0.0	0.1	0.1	1.1	0.0	1.6	1.4	2.3	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	30.2	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	1.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	2.7	0.2	6.5	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.4	0.1	0.5	0.2	0.2	0.1	0.4	0.9	10.6	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.8	0.1	14.8	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.7	0.0	4.7	0.0	0.1	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	1.4	2.3	0.1	0.1	0.1	0.1	1.1	0.1
ALPK3	"KIAA1330, MAK, Midori"	ENSG00000136383	"Alpha kinase 3"	Q96L96	15	84816680-84873482	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 18.4;skeletal muscle: 47.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.2;HDLM-2: 6.9;HUVEC TERT2: 9.9;LHCN-M2: 13.6;NTERA-2: 8.3;RH-30: 24.4"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA026558	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA026558: AB_1844774"	"unprognostic (2.69e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.23e-1)"	"prognostic favourable (3.95e-7)"	"unprognostic (1.76e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.87e-2)"	3.7	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.5	1.4			0.0	0.1	1.7	0.8	0.2	0.3	18.4	0.0	0.6	1.6	1.3	1.0	0.0	0.1		0.0	2.1	8.8	6.9	0.6		0.4	0.0		0.4	0.2	47.6	0.0	0.2	0.8	0.0	0.0	1.2	0.0			0.6		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.1	0.1	0.1	0.2	0.0	9.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	6.9	1.1	1.1	0.2	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	9.9	0.0	0.0	13.6	0.5	0.0	0.1	8.3	0.0	0.0	24.4	0.1	0.0	2.5	0.0	0.1	0.0	1.3	0.0	0.0	6.0	0.2	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0										
ALPL	"HOPS, TNSALP"	ENSG00000162551	"Alkaline phosphatase, liver/bone/kidney"	P05186	1	21509372-21578412	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.3;liver: 52.7;lung: 45.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 52.2;hTEC/SVTERT24-B: 40.8;LHCN-M2: 29.7;SCLC-21H: 26.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	91	"neutrophil: 73.3"	"Lineage enriched"	"Detected in single"	127	"granulocytes: 73.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	7300000	7300000	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	15.9	22.7	4.5	17.6	6.0	2.6	10.6	2.2	7.8	2.2	2.1	4.1	0.7	1.9	3.7	1.1	2.0	5.7	2.8	10.9	5.7	4.2	29.7	52.7	45.1	28.1	5.3	4.8	1.2	4.3	2.4	4.1	2.2	7.7	2.6	1.3	18.3	3.1	6.6	0.9	1.8	2.7	2.5	3.8	19.6	1.8	2.9	2.7	0.5	3.7	1.7	3.9	7.1	8.4	0.5	0.0	73.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	1.9	3.3	0.1	0.7	0.2	0.4	0.2	0.0	0.6	2.2	0.0	0.0	8.9	0.0	0.1	0.0	0.6	0.0	1.1	1.0	0.5	0.0	0.2	52.2	0.0	40.8	0.1	0.0	0.0	0.0	29.7	0.0	0.0	0.0	11.9	0.0	0.0	1.1	0.0	0.0	0.0	26.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	73.3	0.0	0.0	0.0	0.0	0.0	4.5	6.0	2.2	7.8	5.7	4.2	5.3	4.8	7.7	2.7
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986178-34008108	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.0;liver: 63.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 58.5;U-266/84: 30.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 34.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"		65000	65000	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favourable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	2.8	8.3	5.2	2.7	8.2	0.9	2.8	4.7	7.8	4.4	14.1	4.3	6.5	6.2	4.0	3.6	8.2	2.3	11.0	3.5	4.5	6.8	68.0	63.6	3.3	2.0	4.5	4.5	2.9	5.1	5.4	4.3	3.2	7.0	13.9	15.5	5.5	25.4	5.4	6.0	2.6	7.4	3.7	3.8	2.9	15.9	2.1	2.1	3.8	3.3	3.4	3.3	5.7	4.5	7.8	10.2	11.2	14.2	9.9	10.0	6.8	4.0	6.5	3.7	4.7	2.6	4.0	6.3	5.4	4.0	2.5	1.9	21.1	4.9	1.3	2.9	7.6	1.9	0.9	3.9	2.6	4.0	3.4	3.1	4.7	6.1	1.8	1.9	1.0	6.1	1.9	3.2	1.2	2.8	1.1	4.8	7.3	2.9	1.5	2.4	3.3	10.6	1.9	6.1	2.0	11.1	20.3	2.0	2.8	8.9	6.4	5.4	4.9	1.9	5.0	8.3	1.8	2.0	4.3	58.5	30.5	2.3	2.3	3.9	6.1	0.3	7.1	10.2	10.0	8.8	8.4	7.8	8.7	7.8	10.2	7.0	8.1	6.1	11.2	9.9	14.2	5.3	8.9	6.8	5.2	8.2	4.7	7.8	4.5	6.8	4.5	4.5	7.0	2.1
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 27.1;ovary: 38.2;testis: 15.2"	"Group enriched"	"Detected in some"	18	"HEL: 27.6;K-562: 15.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"hippocampal formation: 14.3"	"HPA060228, HPA069636"			Approved	"Nucleoplasm,Vesicles,Centriolar satellite,Cytosol"				Vesicles	"Nucleoplasm, Centriolar satellite, Cytosol"	"HPA060228: , HPA069636: "	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.3	27.1	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.3	0.3	0.2	0.0	0.3	0.6	0.4	0.2	0.4	0.8	0.2	0.0	0.2	1.1	0.3	0.2	0.2	0.2	38.2	8.8	0.1	0.2	0.2	0.3	0.4	0.0	0.2	0.2	0.2	2.5	0.0	0.4	0.5	0.2	3.7	0.3	15.2	0.2	0.2	0.2	0.5	0.3	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	27.6	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2
AMPD1	"MAD, MADA"	ENSG00000116748	"Adenosine monophosphate deaminase 1"	P23109	1	114673090-114695618	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 212.4"	"Cell line enriched"	"Detected in single"	32	"U-266/70: 13.9"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	31	"memory B-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"B-cells: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA026478, HPA028080"	Enhanced				"Intracellular and membrane"					"HPA026478: AB_10599969, HPA028080: AB_10600776"	"unprognostic (1.98e-3)"	"unprognostic (1.43e-3)"	"unprognostic (8.75e-3)"	"unprognostic (8.03e-2)"		"unprognostic (1.95e-2)"		"unprognostic (5.61e-3)"	"unprognostic (8.21e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.36e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.02e-1)"	2.9	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.2	3.3	0.0	0.0	3.5	0.1	3.3	1.4	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.6	1.2	0.0	2.1	1.5	212.4	0.1	1.4	0.0	0.1	0.5	0.7	0.1	0.0	0.0	0.2	25.3	2.8	0.2	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
AMPD2	SPG63	ENSG00000116337	"Adenosine monophosphate deaminase 2"	Q01433	1	109616104-109632051	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 64.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.8;granulocytes: 29.7;monocytes: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027137, HPA045760, HPA050590"	Approved		Enhanced	Cytosol		380000	380000	Cytosol		"HPA027137: , HPA045760: , HPA050590: "	"unprognostic (2.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.78e-10)"	"unprognostic (9.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	8.1	22.7	20.2	21.7	41.3	64.4	4.9	16.3	26.8	9.5	10.1	9.5	6.3	17.1	9.0	6.0	5.9	11.8	13.2	5.2	21.7	19.4	7.8	13.0	8.2	10.7	14.2	14.2	16.3	9.4	13.0	37.1	10.8	18.3	9.7	5.7	15.7	9.1	12.2	2.1	10.0	11.6	9.1	8.5	15.9	8.3	5.3	12.2	10.3	6.4	3.0	7.5	8.2	8.1	2.8	8.8	29.7	24.5	3.0	4.3	5.4	10.9	12.8	18.8	15.8	16.4	16.4	7.1	15.6	32.0	16.0	15.8	9.7	4.7	5.4	12.0	29.3	8.6	9.8	14.5	9.9	8.8	13.3	28.6	16.8	10.8	15.4	12.1	30.8	18.3	7.7	21.2	16.5	13.8	8.8	14.8	11.4	17.0	17.9	29.0	12.1	13.6	12.8	7.2	8.4	14.7	6.7	14.6	15.3	10.7	13.0	12.7	7.3	11.3	13.2	19.8	23.0	24.2	16.1	29.6	14.3	7.8	29.5	18.9	20.6	0.5	9.2	11.2	3.4	19.6	4.3	2.8	3.3	3.4	8.8	1.7	3.8	2.8	29.7	3.0	24.5	1.4	2.6	5.4	20.2	41.3	16.3	26.8	21.7	19.4	14.2	14.2	18.3	12.2
AMPD3		ENSG00000133805	"Adenosine monophosphate deaminase 3"	Q01432	11	10308313-10507579	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.2;skeletal muscle: 61.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.3;CAPAN-2: 19.0;HMC-1: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038662, HPA047408"	Uncertain		Enhanced	"Nuclear membrane"				"Nuclear membrane"		"HPA038662: , HPA047408: "	"unprognostic (2.24e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.44e-2)"	"prognostic favourable (2.37e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.12e-2)"	2.9	13.7	5.3	13.8	14.0	39.2	2.3	2.3	7.8	3.3	3.4	19.6	0.7	4.7	3.1	4.2	5.2	8.0	4.6	2.1	7.4	7.1	4.2	1.5	4.5	12.7	15.2	5.7	2.3	2.5	24.9	14.5	3.7	11.2	5.5	4.9	4.3	4.7	2.8	61.0	10.8	5.0	3.1	12.8	8.3	4.6	1.4	12.6	14.8	2.7	7.6	14.2	6.1	5.1	7.6	3.9	17.0	6.0	3.3	5.3	2.3	7.4	1.1	0.3	0.1	4.0	2.9	0.4	6.8	24.3	1.7	1.7	3.7	19.0	2.7	0.6	3.1	4.7	0.1	6.4	5.0	6.7	0.2	6.7	0.9	0.5	1.3	9.1	20.2	10.6	10.0	3.3	4.3	0.7	10.1	2.9	5.5	0.2	5.3	11.9	0.9	6.7	2.0	8.8	9.8	0.3	6.3	2.8	1.5	1.5	0.2	0.4	0.2	3.1	1.8	7.7	0.1	5.3	0.2	2.7	1.5	2.9	8.9	9.1	0.2	6.6	6.0	17.0	2.3	3.8	5.3	7.6	3.3	2.5	3.9	5.8	3.7	2.5	8.3	3.3	1.6	2.5	1.9	2.3	5.3	14.0	2.3	7.8	7.4	7.1	15.2	5.7	11.2	12.6
AMT	"GCST, NKH"	ENSG00000145020	Aminomethyltransferase	P48728	3	49416775-49422753	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 10.2;Hep G2: 29.5;NTERA-2: 5.3;SH-SY5Y: 7.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005566	Supported		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA005566: AB_1844811"	"unprognostic (2.10e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.14e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.88e-1)"	"prognostic favourable (3.90e-8)"	"unprognostic (4.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.98e-3)"	4.7	10.9	6.6	8.0	8.8	6.0	6.6	16.7	10.4	8.4	10.0	7.4	21.3	10.9	9.2	11.1	3.4	9.7	13.0	16.6	7.4	2.0	21.4	41.2	5.6	2.3	7.6	8.3	14.5	18.5	16.3	10.4	2.5	10.7	9.1	10.1	12.2	9.8	20.0	3.8	5.4	11.0	7.1	5.8	7.9	8.1	2.6	7.4	1.7	8.7	0.4	1.8	6.2	8.1	0.7	5.4	4.7	3.2	8.9	1.6	2.3	0.1	0.5	0.7	0.1	0.4	0.0	10.2	0.0	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.2	0.2	0.1	0.4	0.1	0.2	0.1	0.0	0.3	29.5	1.1	0.0	0.1	0.3	0.7	0.0	0.4	0.1	0.0	0.0	0.1	0.2	0.2	0.2	5.3	0.1	0.0	0.1	0.2	0.7	0.2	0.0	7.8	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	3.2	4.7	0.0	1.9	0.1	0.6	0.0	0.0	5.4	0.7	1.6	1.5	0.3	8.9	0.7	0.5	0.0	2.3	6.6	8.8	16.7	10.4	7.4	2.0	7.6	8.3	10.7	7.4
ANK1	"ANK, SPH1"	ENSG00000029534	"Ankyrin 1"	P16157	8	41653220-41896762	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 166.5;tongue: 58.3"	"Group enriched"	"Detected in some"	4	"HEL: 37.1;K-562: 39.0;RH-30: 49.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 20.1"	"Group enriched"	"Detected in some"	8	"memory B-cell: 10.6;naive B-cell: 9.1;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	7	"B-cells: 10.6;dendritic cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004842, HPA056953"	Supported	Supported			"Intracellular and membrane"	33000000	33000000			"HPA004842: AB_1844827, HPA056953: "	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.76e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	1.2	0.3	0.6	0.7	0.6	14.8	0.3	20.1	3.8	0.2	0.2	0.0	0.0	0.4	0.2	2.7	1.8	0.2	0.3	18.0	0.6	1.2	0.3	0.2	0.4	0.9	4.0	0.4	0.2	0.3	4.3	0.3	0.8	8.3	0.9	0.2	0.5	2.9	0.3	166.5	0.2	0.3	0.2	1.0	0.7	1.1	0.3	0.0	0.0	1.0	58.3	3.8	0.3	0.4	10.6	3.5	1.0	0.2	0.1	0.9	0.7	0.0	5.0	0.1	0.0	0.0	0.9	0.0	1.4	10.0	0.4	0.2	0.0	0.0	2.3	0.4	1.0	0.8	0.2	0.1	0.2	0.9	0.0	37.1	0.2	0.0	0.0	0.1	0.1	1.3	0.2	0.1	0.0	0.0	39.0	0.8	0.6	0.1	0.0	0.4	0.5	0.0	0.2	49.4	0.2	0.2	0.1	0.7	0.4	0.0	0.7	0.0	0.6	0.9	0.2	0.1	0.2	8.5	0.0	0.0	0.0	1.4	0.9	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.5	10.6	0.3	0.5	0.1	9.1	0.0	0.0	0.5	0.1	0.0	3.5	0.9	0.7	0.6	0.6	20.1	3.8	0.6	1.2	4.0	0.4	8.3	0.0
ANK2	LQT4	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818109-113383740	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.5;heart muscle: 56.7;kidney: 59.8;skeletal muscle: 66.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.1;ASC TERT1: 22.5;RH-30: 30.8;SH-SY5Y: 15.5"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"				"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: , HPA035970: "	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavourable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	17.3	8.7	34.0	6.3	42.1	0.8	10.7	43.7	58.5	20.9	9.5	24.5	0.6	4.3	10.5	4.3	8.3	5.8	13.0	56.7	29.4	30.3	59.8	2.0	4.6	5.1	28.7	38.7	19.0	2.4	1.6	8.6	2.0	42.1	5.4	7.2	7.8	2.6	8.7	66.9	3.5	4.7	15.2	19.0	15.1	3.8	5.8	24.2	0.0	5.6	4.4	4.5	4.5	4.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	10.2	4.2	16.1	22.5	0.0	1.0	1.8	0.7	2.0	4.0	0.0	4.2	1.4	3.6	0.0	7.5	0.4	0.6	1.9	6.2	2.4	0.0	1.7	1.0	1.0	0.7	9.6	1.6	0.9	3.9	0.0	0.0	6.9	3.4	0.1	0.2	0.0	5.3	1.7	0.5	30.8	0.0	0.1	0.0	8.3	15.5	0.1	0.3	5.3	0.1	0.6	0.0	3.2	1.7	0.2	1.9	4.1	1.1	0.6	12.7	0.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	42.1	43.7	54.3	29.4	30.3	28.7	38.7	42.1	24.2
ANKH	"ANK, CCAL2, CMDJ, CPPDD, HANK, SLC62A1"	ENSG00000154122	"ANKH inorganic pyrophosphate transport regulator"	Q9HCJ1	5	14704800-14871785	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Phosphate transport, Transport"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068104			Approved	Cytosol				Cytosol		"HPA068104: "	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (5.62e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.76e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.66e-2)"	"unprognostic (6.46e-2)"	8.5	9.7	15.2	8.0	17.0	5.9	9.2	29.1	25.9	4.4	10.9	19.5	3.4	14.4	6.5	4.7	6.8	7.2	8.4	27.0	15.9	14.9	7.4	18.1	6.3	9.6	19.7	17.1	14.9	13.1	19.6	19.2	7.3	15.4	29.5	10.3	16.1	11.7	8.6	31.0	17.4	14.9	7.6	22.6	6.3	6.5	2.0	15.3	9.3	9.5	12.7	11.8	6.4	6.3	2.5	0.6	0.7	1.4	0.6	7.0	0.7	3.8	2.9	3.7	0.6	7.8	18.4	1.7	3.7	7.4	1.4	1.5	2.3	4.8	8.9	8.7	5.0	2.5	2.5	4.0	1.6	3.5	6.1	0.2	27.0	6.1	2.6	2.1	0.7	5.7	7.1	4.4	5.1	3.0	1.8	19.3	4.7	5.1	3.6	7.0	1.4	3.2	5.1	1.8	8.0	0.0	1.2	9.0	2.5	17.9	2.9	3.9	0.1	0.8	2.9	3.8	3.9	6.3	6.6	5.1	4.7	7.0	13.2	8.0	15.7	0.7	0.4	0.1	2.4	0.7	4.0	2.5	5.0	3.9	0.6	2.1	5.7	2.6	0.5	0.6	1.4	0.6	7.0	0.7	15.2	17.0	29.1	25.9	15.9	14.9	19.7	17.1	15.4	15.3
ANO10	"FLJ10375, MGC47890, SCAR10, TMEM16K"	ENSG00000160746	"Anoctamin 10"	Q9NW15	3	43354859-43691594	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016624, HPA051569"	Approved		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA016624: , HPA051569: "	"unprognostic (1.51e-3)"	"unprognostic (1.38e-2)"	"prognostic favourable (6.70e-4)"	"prognostic favourable (1.11e-4)"	"unprognostic (4.23e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (3.19e-4)"	"unprognostic (7.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (6.41e-6)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (5.71e-2)"	21.6	12.7	11.8	12.6	13.2	20.6	22.0	18.2	14.1	17.5	27.4	14.3	13.2	42.0	17.9	12.4	19.8	10.4	16.7	10.5	12.3	15.2	22.2	10.5	13.6	10.7	17.3	12.3	12.7	14.4	18.6	14.4	17.5	19.4	10.7	24.4	18.6	23.1	19.5	11.3	24.6	52.9	19.9	23.6	9.4	11.1	9.1	8.8	5.5	17.7	15.8	13.9	13.7	17.0	2.0	8.5	22.4	12.5	6.3	4.6	4.3	8.8	7.1	7.9	8.3	32.2	17.3	9.7	26.2	43.6	13.4	17.1	4.8	8.3	1.0	8.4	34.5	4.9	6.2	14.3	16.3	9.9	4.4	11.6	9.6	5.2	14.1	2.0	9.5	16.1	11.4	16.5	22.5	31.3	8.7	7.6	29.6	6.3	2.2	1.5	9.4	8.3	1.8	5.7	3.0	26.4	9.4	1.9	5.8	10.3	8.5	6.0	18.1	4.3	25.4	20.4	7.6	21.4	11.9	4.9	6.4	0.3	18.6	4.4	13.4	4.4	12.5	0.9	4.6	7.1	2.7	1.9	3.2	3.1	8.5	2.0	2.8	4.3	22.4	6.3	7.7	1.5	3.5	4.3	11.8	13.2	18.2	14.1	12.3	15.2	17.3	12.3	19.4	8.8
ANO3	"C11orf25, DYT23, GENX-3947, TMEM16C"	ENSG00000134343	"Anoctamin 3"	Q9BYT9	11	26309599-26663288	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"brain: 83.1;epididymis: 47.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.3;U-2 OS: 2.8;U-2197: 7.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"basal ganglia: 83.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 142.2"	"Region enriched"	"Detected in many"	5	"basal ganglia: 149.8"	HPA041629	Uncertain									"HPA041629: AB_10793969"	"unprognostic (7.01e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.94e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-4)"	"unprognostic (9.48e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.01e-1)"	2.8	1.2	6.4	0.5	83.1	0.4	0.6	0.2	13.3	1.1	0.6	0.1	0.0	0.6	0.6	47.3	0.5	0.7	2.0	0.5	7.0	0.6	1.4	1.4	0.8	0.5	1.1	5.4	0.5	0.7	0.5	0.3	0.5	5.9	0.5	0.6	0.0	0.6	0.6	0.4	0.5	0.5	0.7	0.5	0.8	0.5	1.9	9.0	0.0	1.4	0.0	0.5	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	2.1	2.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.5	0.4	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.8	7.5	0.0	0.7	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	83.1	0.2	13.3	7.0	0.6	1.1	5.4	5.9	9.0
ANO5	"GDD1, LGMD2L, TMEM16E"	ENSG00000171714	"Anoctamin 5"	Q75V66	11	22193176-22283357	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Limb-girdle muscular dystrophy, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.7;parathyroid gland: 26.9;skeletal muscle: 43.7"	"Cell line enhanced"	"Detected in some"		"A549: 6.5;HAP1: 7.1;HEK 293: 8.9;NTERA-2: 4.9;RPTEC TERT1: 4.4;U-266/84: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA058857	Uncertain									"HPA058857: "	"unprognostic (5.25e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.54e-4)"	"unprognostic (8.55e-2)"	"prognostic favourable (2.50e-7)"	"unprognostic (3.65e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.77e-4)"	"unprognostic (7.94e-2)"	1.0	3.8	3.9	0.9	3.8	0.3	0.9	0.9	7.9	1.7	2.6	1.1	1.0	2.9	1.5	1.6	2.4	1.1	1.6	37.7	4.5	4.2	3.1	2.3	1.4	0.6	3.4	6.3	1.0	3.3	26.9	5.0	0.4	3.5	3.8	2.9	2.7	3.4	3.7	43.7	0.5	3.1	4.1	1.9	1.0	3.0	2.3	1.7	0.0	3.9	14.2	0.6	3.2	1.9	0.0	0.9	0.0	1.5	0.0	0.1	0.1	0.0	6.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.4	4.3	0.0	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	4.4	0.1	3.9	3.6	0.0	0.0	0.0	3.3	2.5	0.0	0.0	2.9	0.0	0.0	2.8	5.2	0.0	4.0	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	3.8	0.9	7.9	4.5	4.2	3.4	6.3	3.5	1.7
ANO6	"DKFZp313M0720, TMEM16F"	ENSG00000177119	"Anoctamin 6"	Q4KMQ2	12	45215987-45440404	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Lipid transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038958	Approved		Approved	"Plasma membrane,Cytosol"		1500000	1500000	"Plasma membrane, Cytosol"		"HPA038958: AB_10672835"	"prognostic unfavourable (7.56e-5)"	"prognostic unfavourable (3.82e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.82e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.28e-1)"	40.7	15.3	6.4	17.3	7.0	3.8	42.8	2.5	7.3	22.2	29.7	6.1	34.8	16.5	33.2	16.0	21.2	18.5	20.2	20.7	6.7	5.4	21.6	25.4	25.6	11.7	7.6	4.2	27.4	12.7	20.1	7.1	23.3	8.8	21.6	6.9	14.2	16.8	39.3	40.3	10.0	41.3	42.8	14.6	12.5	13.5	10.4	5.8	21.6	11.2	14.7	9.6	37.6	38.1	2.1	7.1	4.4	9.3	3.1	4.0	5.0	13.8	15.9	8.9	12.1	41.1	21.4	34.2	19.5	24.5	13.4	12.5	23.9	20.9	7.2	18.2	30.4	18.4	8.1	10.8	15.7	10.5	5.8	8.3	6.5	20.1	13.1	12.9	6.7	17.8	10.8	11.3	16.6	17.7	6.3	11.7	14.3	3.6	13.7	4.1	10.0	6.0	7.9	11.6	7.9	12.4	22.0	4.0	13.9	20.3	12.7	9.3	14.9	20.3	24.1	14.4	9.2	14.5	9.8	6.2	7.1	8.7	12.9	41.3	11.5	4.4	7.7	1.9	3.3	9.3	3.4	2.1	3.2	2.8	7.1	1.7	2.9	2.0	0.9	3.1	8.6	3.6	4.0	5.0	6.4	7.0	2.5	7.3	6.7	5.4	7.6	4.2	8.8	5.8
ANXA5	"ANX5, ENX2"	ENSG00000164111	"Annexin A5"	P08758	4	121667955-121697113	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Blood coagulation, Hemostasis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003677, HPA035330"	Approved		Approved	"Nuclear membrane"		6100000	6100000	"Nuclear membrane"		"CAB003677: AB_425305, HPA035330: AB_2674574"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.70e-2)"	"prognostic favourable (3.64e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (3.01e-5)"	"prognostic unfavourable (1.64e-5)"	"unprognostic (7.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.54e-1)"	"prognostic unfavourable (9.29e-7)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavourable (1.26e-4)"	130.1	65.6	24.6	43.2	26.1	15.3	151.3	10.0	17.9	85.9	35.6	33.8	45.1	17.5	64.4	45.9	42.8	42.4	54.7	46.8	22.5	25.1	62.2	73.1	68.0	49.3	37.8	16.4	62.6	52.1	25.7	55.3	135.8	40.8	57.1	29.8	56.1	83.7	49.8	23.1	28.0	30.1	68.3	51.5	67.9	39.4	33.3	27.8	15.9	61.8	32.5	31.2	57.3	69.8	13.9	80.0	37.2	87.3	4.8	29.9	64.7	30.4	22.6	30.8	17.0	148.6	113.4	33.6	108.3	96.6	56.2	50.4	16.4	13.3	2.3	19.6	148.5	10.8	19.6	47.9	52.8	21.7	11.3	6.8	21.3	44.7	85.2	14.7	11.8	65.4	23.3	47.8	47.2	74.1	6.6	18.4	141.8	20.1	14.9	5.0	15.9	47.4	0.5	70.5	4.6	94.3	4.5	7.9	9.6	39.0	15.3	98.6	13.4	17.6	54.6	89.4	43.8	63.9	32.1	16.5	20.0	5.1	57.3	8.0	105.1	9.2	74.0	37.2	11.9	87.3	15.5	13.9	18.2	14.8	80.0	8.8	6.1	8.8	17.1	4.8	79.7	9.7	29.9	64.7	24.6	26.1	10.0	17.9	22.5	25.1	37.8	16.4	40.8	27.8
AP1S1	"AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2"	ENSG00000106367	"Adaptor related protein complex 1 sigma 1 subunit"	P61966	7	101154400-101161596	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Ichthyosis, Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060945	Supported		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA060945: "	"unprognostic (1.98e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-3)"	"unprognostic (8.70e-3)"	"unprognostic (7.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	7.6	9.7	30.6	7.9	41.1	3.0	10.8	7.9	45.8	6.8	16.5	6.4	4.6	23.3	6.6	10.6	10.9	8.9	9.3	4.2	22.9	14.6	16.6	15.5	6.7	6.9	12.3	25.3	7.9	8.0	6.3	10.5	10.2	10.1	10.9	14.2	4.6	10.4	6.1	3.5	12.3	18.0	7.9	8.7	7.7	13.2	6.9	9.3	4.7	9.3	7.4	8.5	8.7	6.1	4.4	8.2	2.1	5.5	1.9	5.9	4.2	26.2	21.3	14.3	27.1	10.6	17.5	31.1	17.6	11.9	12.0	12.8	11.4	33.5	5.9	30.8	19.2	13.0	8.2	27.1	10.7	13.3	13.3	4.0	13.4	14.2	13.1	10.7	19.9	19.5	20.7	11.8	5.1	17.7	12.8	23.7	29.6	65.4	8.9	23.1	22.9	43.0	5.6	6.5	12.3	28.8	22.4	11.3	37.0	10.0	26.6	32.1	11.7	10.0	18.3	17.3	30.2	6.5	12.1	5.3	11.2	11.3	44.0	11.9	34.8	0.8	5.5	0.5	4.2	4.9	3.7	4.4	5.9	4.7	7.4	3.8	3.5	3.2	2.1	1.9	2.8	8.2	5.5	4.2	30.6	41.1	7.9	35.1	22.9	14.6	12.3	25.3	10.1	9.3
APCS	"MGC88159, PTX2, SAP"	ENSG00000132703	"Amyloid P component, serum"	P02743	1	159587825-159588865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 316.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.3;RH-30: 4.2;SiHa: 2.1"	"Cancer enriched"	"Detected in some"	25	"liver cancer: 826.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB007817, HPA053294"	Supported				"Secreted to blood"	76000000000	76000000000			"CAB007817: AB_598185, HPA053294: "							"unprognostic (3.19e-3)"				"unprognostic (2.30e-2)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.7	316.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.8	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.7	4.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.7	0.2	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
APRT		ENSG00000198931	"Adenine phosphoribosyltransferase"	P07741	16	88809339-88811944	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026681	Approved		Supported	Nucleoplasm,Cytosol		1200000	1200000	"Nucleoplasm, Cytosol"		"HPA026681: AB_1844964"	"unprognostic (5.87e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.48e-2)"	22.9	37.1	10.9	33.6	13.2	32.9	31.6	10.1	15.3	22.7	31.1	10.7	33.6	27.1	19.9	28.3	50.7	21.0	30.4	22.5	9.1	8.2	27.7	60.4	30.6	94.2	14.8	10.7	17.9	58.2	19.4	15.6	19.3	11.0	25.1	15.1	13.9	48.2	37.4	26.2	49.8	24.3	18.4	12.1	30.4	27.5	16.0	12.2	37.9	29.5	49.7	35.8	18.5	32.8	65.4	92.1	24.2	70.2	58.2	83.7	104.7	25.4	37.4	7.3	33.0	9.0	17.9	39.1	19.3	17.2	22.8	8.9	38.5	30.9	23.7	37.8	10.9	27.3	12.0	31.7	4.6	16.7	71.6	20.2	17.7	40.2	28.6	13.8	16.5	19.1	34.3	18.1	23.0	28.4	42.4	17.8	11.5	93.8	39.0	40.8	28.2	49.0	42.0	11.4	56.1	25.1	17.3	36.5	22.4	36.8	21.5	20.8	71.0	27.5	18.3	20.6	18.0	16.6	18.9	35.0	29.3	65.2	30.3	36.8	18.1	8.5	70.2	24.2	63.0	57.7	83.7	63.2	81.9	67.5	71.6	65.4	75.9	64.3	4.3	58.2	37.1	92.1	66.1	104.7	10.9	13.2	10.1	15.3	9.1	8.2	14.8	10.7	11.0	12.2
APTX	"AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157"	ENSG00000137074	Aprataxin	Q7Z2E3	9	32972606-33025168	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064930	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA064930: "	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-2)"	"prognostic favourable (6.01e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.50e-2)"	12.9	20.3	17.5	11.2	18.4	19.9	16.5	15.1	21.7	12.0	15.2	19.3	9.3	11.7	14.7	12.9	19.1	14.7	8.0	11.9	13.3	13.9	17.9	23.4	12.6	11.8	16.4	16.5	11.8	14.3	15.8	14.3	12.1	20.2	12.1	18.1	14.6	12.5	11.9	14.1	20.6	13.8	14.6	15.7	11.7	12.5	18.2	14.5	8.8	10.5	12.6	16.1	13.4	12.1	17.1	18.4	16.1	20.8	26.4	19.4	15.0	21.2	16.1	12.3	10.6	12.5	11.0	16.2	14.2	14.8	17.4	19.2	21.4	7.5	16.6	8.6	11.9	11.3	20.0	19.1	21.6	22.4	8.2	9.8	23.1	21.8	14.6	15.8	9.4	14.7	23.4	19.9	25.9	16.6	14.8	16.5	16.2	9.1	14.2	23.2	18.7	17.3	12.8	8.5	11.8	14.3	12.9	8.5	7.2	13.0	11.7	9.5	13.3	6.5	10.2	9.7	12.9	16.7	14.6	7.2	11.8	16.6	14.4	12.9	7.7	9.1	17.7	14.9	13.4	16.3	17.6	17.0	15.2	15.5	18.4	17.1	18.0	14.6	16.1	26.4	20.8	17.9	19.4	15.0	17.5	18.4	15.1	21.7	13.3	13.9	16.4	16.5	20.2	14.5
AQP2		ENSG00000167580	"Aquaporin 2"	P41181	12	49950741-49958881	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Diabetes insipidus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"ductus deferens: 178.6;kidney: 96.5;seminal vesicle: 108.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.6;EFO-21: 7.7;HEL: 2.2;HMC-1: 4.7;REH: 1.2"	"Group enriched"	"Detected in some"	6	"renal cancer: 1.7;stomach cancer: 1.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"intermediate monocyte: 1.4;non-classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046834	Enhanced									"HPA046834: "	"unprognostic (2.10e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.60e-2)"			"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.38e-3)"	"unprognostic (5.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.11e-1)"		0.1	1.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	178.6	0.0	0.1	3.3	0.1	0.1	0.0	0.6	0.1	0.1	96.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.2	108.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
AQP5		ENSG00000161798	"Aquaporin 5"	P55064	12	49961870-49965681	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"salivary gland: 217.9;testis: 76.2"	"Group enriched"	"Detected in some"	9	"CAPAN-2: 11.2;REH: 12.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 87.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA065008	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"HPA065008: "	"unprognostic (4.67e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.92e-3)"	"prognostic favourable (1.75e-5)"	"unprognostic (4.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.88e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.69e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (9.11e-3)"	0.2	0.1	0.4	0.2	1.1	0.0	3.8	0.4	0.3	3.0	0.3	0.4	0.3	3.2	0.6	0.8	3.8	0.1	15.6	1.0	0.3	0.3	0.2	0.2	2.3	0.2	0.7	0.2	0.2	0.8	0.1	0.4	0.2	0.3	0.5	0.0	0.4	217.9	0.6	0.9	23.5	0.3	0.6	0.2	0.2	12.0	76.2	0.3	0.2	0.3	2.8	11.5	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.2	0.0	1.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.9	0.0	12.8	0.0	0.0	0.4	0.0	0.3	0.1	1.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.4	0.3	0.3	0.3	0.7	0.2	0.3	0.3
ARG1		ENSG00000118520	"Arginase 1"	P05089	6	131573144-131584332	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 284.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.6;HL-60: 3.9;RH-30: 1.6;SiHa: 1.8;U-698: 2.2"	"Cancer enriched"	"Detected in some"	45	"liver cancer: 167.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 24.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 24.4"	"Region enhanced"	"Detected in single"		"cerebellum: 2.7"	"Low region specificity"	"Detected in single"			"HPA003595, CAB009434, HPA024006, CAB056159"	Enhanced					15000000	15000000			"CAB009434: AB_2058955, CAB056159: , HPA003595: AB_1078190, HPA024006: AB_1844987"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.55e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.79e-2)"	1.0	0.0	0.1	0.1	0.1	34.3	0.6	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.3	0.1	3.0	0.2	0.0	0.1	284.1	5.1	0.8	0.2	0.1	0.4	0.2	0.0	0.1	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	14.6	0.1	0.1	0.1	3.5	0.0	0.3	0.1	0.5	0.3	1.7	0.3	0.3	0.7	0.1	0.1	24.4	0.4	0.0	4.7	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.6	0.0	3.9	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.5	0.1	0.3	0.1	0.0	0.0	1.6	0.4	0.0	0.3	0.2	0.1	1.8	0.4	0.2	0.1	0.5	0.0	0.0	0.2	0.3	0.1	1.0	0.1	2.2	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.1	24.4	0.0	0.4	0.1	4.7	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.1
ARSA		ENSG00000100299	"Arylsulfatase A"	P15289	22	50622754-50628173	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005554, CAB025183"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	4500000	4500000	"Golgi apparatus"	Cytosol	"CAB025183: , HPA005554: AB_1078220"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"prognostic favourable (2.96e-5)"	"unprognostic (4.66e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.73e-3)"	19.0	15.2	14.0	15.2	15.7	16.6	15.2	11.9	17.9	12.0	20.3	21.4	26.4	30.2	13.3	21.4	15.6	18.5	23.3	18.8	13.4	8.8	17.5	24.1	15.7	16.8	19.1	10.3	9.3	45.4	13.1	20.4	18.5	17.3	15.8	8.8	14.0	36.8	21.9	6.3	11.1	23.4	8.7	13.2	25.6	23.6	27.2	17.9	10.6	18.7	7.5	16.5	14.8	13.3	5.6	15.7	30.1	19.8	3.9	8.9	7.7	4.0	5.7	2.8	5.3	20.5	11.2	6.9	6.6	8.0	2.9	4.9	1.6	6.3	2.7	4.0	10.7	6.3	0.6	6.0	0.4	1.2	4.3	1.6	6.4	5.7	14.2	2.4	16.8	13.3	11.8	4.7	3.0	6.4	1.7	38.4	5.8	4.6	2.1	2.7	0.8	5.6	1.9	0.2	12.6	4.8	6.3	1.3	4.2	9.3	8.3	4.7	3.7	3.0	11.3	2.0	7.8	7.4	1.9	9.1	0.8	2.1	5.9	2.1	6.7	4.3	13.7	17.1	8.9	16.0	7.9	5.6	6.5	7.3	11.2	5.6	3.9	5.3	30.1	3.9	19.8	15.7	8.5	7.7	14.0	15.7	11.9	17.9	13.4	8.8	19.1	10.3	17.3	17.9
ARSB		ENSG00000113273	"Arylsulfatase B"	P15848	5	78777209-78986087	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 17.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.5;granulocytes: 17.2;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037770, HPA037771"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"		"HPA037770: AB_10671719, HPA037771: AB_10671720"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.57e-3)"	"unprognostic (9.88e-2)"	"unprognostic (6.54e-3)"	"prognostic unfavourable (3.42e-4)"	15.2	8.4	7.7	9.9	8.9	9.4	11.4	6.2	10.4	7.8	8.7	10.8	2.6	4.0	14.1	6.7	8.6	6.7	12.0	13.0	7.7	5.8	23.2	9.3	10.8	17.2	7.1	6.1	6.1	9.6	10.7	6.1	14.7	7.1	7.5	10.5	12.1	5.2	9.3	5.3	3.4	6.0	18.0	8.3	10.9	7.9	4.1	5.6	7.2	6.4	4.0	6.2	10.3	5.6	1.2	5.5	17.2	5.7	0.1	0.6	1.6	2.3	5.5	9.0	2.9	22.0	8.7	8.3	13.0	11.5	9.7	11.9	4.8	4.2	2.7	14.1	12.7	1.9	3.4	3.7	9.6	23.2	2.6	4.4	5.9	18.6	5.0	4.9	5.2	10.1	1.2	10.2	3.4	11.3	0.9	6.4	9.8	4.5	2.3	9.2	2.7	2.9	3.4	5.3	2.9	6.1	3.0	3.2	7.3	9.7	3.1	5.7	3.4	12.7	7.5	8.7	5.0	3.9	11.6	5.5	9.9	3.6	10.5	10.5	19.7	10.5	5.7	17.2	0.6	4.6	0.4	1.2	0.3	0.3	5.5	1.1	0.2	0.4	3.3	0.1	3.7	4.0	0.5	1.6	7.7	8.9	6.2	10.4	7.7	5.8	7.1	6.1	7.1	5.6
ARV1		ENSG00000173409	"ARV1 homolog, fatty acid homeostasis modulator"	Q9H2C2	1	230978981-231000595	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035709	Approved		Approved	Vesicles				Vesicles		"HPA035709: "	"unprognostic (2.32e-1)"	"unprognostic (4.69e-2)"	"prognostic favourable (1.33e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.95e-2)"	"unprognostic (5.66e-2)"	"prognostic favourable (3.27e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-2)"	"unprognostic (9.57e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.82e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-3)"	8.2	16.3	22.0	10.1	31.0	10.0	16.1	17.1	24.3	11.0	20.0	16.5	13.9	13.8	8.1	20.6	13.6	12.3	17.0	24.2	23.8	21.8	21.0	20.9	12.5	11.0	22.7	17.7	9.8	14.9	18.4	25.8	9.4	22.0	14.0	21.6	15.4	16.9	13.4	15.7	14.6	15.6	10.7	27.1	10.5	13.7	24.6	18.2	11.0	18.4	16.8	11.9	12.7	9.3	15.3	13.9	7.3	17.7	12.5	14.0	8.3	20.1	21.9	11.0	13.1	15.9	13.9	10.2	9.5	17.6	17.4	20.2	8.1	15.7	5.8	11.8	10.9	16.5	20.6	12.9	20.7	14.8	28.9	18.0	15.9	10.9	16.3	26.4	14.7	15.1	13.6	9.4	11.0	11.7	26.4	16.0	11.5	7.0	10.7	8.0	14.0	14.8	12.8	16.3	16.4	23.3	16.6	11.5	17.4	11.3	13.4	27.9	24.1	23.5	6.4	6.9	4.4	12.6	22.7	24.7	21.7	14.5	18.9	23.1	18.8	6.4	7.6	7.3	9.8	10.8	13.3	15.3	11.0	11.7	9.1	10.1	13.8	12.7	1.9	12.5	17.7	13.9	14.0	8.3	22.0	31.0	17.1	24.3	23.8	21.8	22.7	17.7	22.0	18.2
ASAH1	"AC, ACDase, ASAH, FLJ21558, PHP32"	ENSG00000104763	"N-acylsphingosine amidohydrolase 1"	Q13510	8	18055992-18084998	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease mutation, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 71.3;SK-MEL-30: 101.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 27.0;classical monocyte: 53.6;eosinophil: 36.5;intermediate monocyte: 77.9;myeloid DC: 20.8;neutrophil: 73.8;non-classical monocyte: 80.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 20.8;granulocytes: 73.8;monocytes: 80.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005468	Supported				"Intracellular and membrane"	410000	410000			"HPA005468: AB_1845062"	"unprognostic (1.99e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.15e-3)"	"unprognostic (9.23e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.03e-2)"	"prognostic favourable (3.08e-8)"	"unprognostic (1.95e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.36e-3)"	41.9	16.8	18.5	11.2	20.7	20.7	44.2	17.6	19.1	23.9	18.5	15.4	31.5	11.9	17.6	30.6	19.8	16.2	22.3	120.4	17.5	19.2	45.0	13.2	57.2	40.2	27.0	16.7	13.0	16.5	18.0	28.2	36.5	29.8	19.5	19.7	33.3	20.4	39.4	18.2	16.4	16.4	19.5	40.9	25.9	12.9	8.2	15.9	4.5	73.4	15.1	12.3	31.4	16.0	9.8	20.8	73.8	80.5	6.7	6.0	38.7	8.2	11.5	4.5	11.2	71.3	8.4	7.0	8.4	12.0	4.2	7.4	6.1	11.5	5.1	10.8	9.3	10.9	2.8	4.4	5.1	3.9	6.6	22.8	8.7	16.4	19.5	4.6	25.6	18.1	15.3	6.0	4.1	1.1	4.0	10.9	11.9	8.3	2.5	8.3	5.3	7.1	3.3	4.6	6.9	19.7	47.2	7.4	9.9	7.8	25.9	101.4	8.4	5.3	7.3	5.4	7.8	9.9	4.0	13.4	30.3	3.7	16.0	10.5	4.3	27.0	53.6	36.5	6.0	77.9	5.4	9.8	4.5	4.5	20.8	7.7	5.3	4.8	73.8	6.7	80.5	3.9	4.9	38.7	18.5	20.7	17.6	19.1	17.5	19.2	27.0	16.7	29.8	15.9
ASL		ENSG00000126522	"Argininosuccinate lyase"	P04424	7	66075798-66093558	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB003696, HPA016646"	Enhanced		Approved	Cytosol		10000000	10000000	Cytosol		"CAB003696: AB_425316, HPA016646: AB_1845096"	"unprognostic (2.95e-2)"	"prognostic unfavourable (4.05e-6)"	"unprognostic (4.83e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.40e-3)"	5.6	4.8	4.0	8.0	4.3	7.3	5.9	7.2	7.4	5.5	17.2	3.7	7.8	20.8	5.0	7.1	7.7	4.9	19.5	4.3	3.7	4.3	16.0	99.5	8.1	4.5	4.4	6.2	5.9	10.4	3.3	5.8	3.3	7.2	5.4	12.4	5.8	7.1	5.7	2.4	4.1	16.6	3.4	3.2	8.6	12.6	2.1	3.5	1.2	7.1	7.9	5.9	5.2	5.9	8.6	19.3	20.7	18.4	30.4	9.2	10.7	18.2	7.5	4.1	14.8	9.4	7.3	9.0	12.8	11.2	18.3	16.7	16.8	22.6	5.6	20.5	16.8	5.0	2.6	21.7	5.3	4.6	3.4	7.4	7.3	26.1	17.7	8.4	21.7	13.7	7.9	12.8	20.5	18.0	13.1	10.7	10.1	13.0	1.7	11.6	6.2	9.7	4.5	4.3	19.2	13.3	11.0	7.1	9.7	11.7	40.8	4.4	17.8	7.6	20.4	23.2	12.0	9.2	16.5	11.7	6.1	7.3	21.9	16.0	18.7	12.1	18.1	20.7	7.7	18.4	6.5	8.6	5.2	6.1	19.3	5.6	3.7	4.0	4.0	30.4	13.8	1.2	9.2	10.7	4.0	4.3	7.2	7.4	3.7	4.3	4.4	6.2	7.2	3.5
ASNS		ENSG00000070669	"Asparagine synthetase (glutamine-hydrolyzing)"	P08243	7	97852118-97872542	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"	Ligase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 68.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 8.6;T-cells: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004924, HPA029318, HPA064737"	Approved		Enhanced	Cytosol				Cytosol		"HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341"	"unprognostic (3.93e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.70e-2)"	"prognostic unfavourable (4.24e-4)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (8.79e-5)"	"prognostic unfavourable (9.42e-6)"	"unprognostic (2.28e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-3)"	"prognostic unfavourable (6.21e-7)"	"unprognostic (5.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.33e-1)"	6.5	7.5	15.9	10.9	21.4	7.6	9.9	31.7	32.3	5.7	10.1	9.4	5.6	6.5	10.0	19.9	10.2	6.9	6.8	9.2	24.5	20.4	6.5	5.9	9.6	16.0	16.3	13.4	19.2	68.0	16.7	16.7	3.2	35.9	9.2	12.7	4.4	49.9	9.3	3.5	13.6	7.8	11.3	20.6	11.0	20.8	16.9	9.2	3.6	16.7	8.2	15.0	9.6	6.6	8.6	1.4	1.5	1.2	2.2	13.2	3.2	18.8	7.2	7.3	59.3	5.8	8.2	17.9	13.9	8.9	6.7	19.9	9.3	7.6	14.8	7.0	28.3	8.6	18.9	22.0	15.9	18.5	14.0	4.7	3.6	6.9	53.7	30.2	13.3	16.1	74.0	8.7	53.8	5.4	26.5	52.6	10.4	39.9	0.8	8.0	10.0	19.7	2.3	1.3	38.8	4.3	3.7	31.9	24.0	3.6	19.3	75.0	8.2	21.2	1.4	3.3	21.8	8.7	6.5	62.4	31.1	56.4	41.2	13.8	31.7	1.5	0.3	0.5	3.8	1.2	4.9	8.6	7.4	3.4	1.4	6.2	10.2	5.5	1.5	2.2	0.8	0.1	13.2	3.2	15.9	21.4	31.7	32.3	24.5	20.4	16.3	13.4	35.9	9.2
ASPA	"ACY2, ASP"	ENSG00000108381	Aspartoacylase	P45381	17	3472374-3503419	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.3;kidney: 33.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.1;ASC TERT1: 6.3;CACO-2: 5.4;HSkMC: 11.4"	"Cancer enhanced"	"Detected in some"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022142, HPA022145"	Enhanced		Uncertain	Cytosol				Cytosol		"HPA022142: AB_1845102, HPA022145: AB_1845103"	"unprognostic (4.42e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.07e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.49e-1)"	10.9	4.1	14.5	1.8	37.6	1.7	3.3	3.0	19.4	6.2	3.6	35.2	3.1	9.7	4.1	5.5	4.5	5.0	3.3	2.2	21.9	11.0	33.2	12.6	3.2	1.3	50.2	11.3	2.9	1.0	0.9	0.9	3.1	18.9	4.0	4.6	2.6	1.9	4.8	9.3	4.6	13.3	2.9	22.4	4.6	3.9	5.6	51.3	0.0	1.8	1.1	0.8	4.5	3.5	1.7	1.2	3.6	0.7	1.6	1.3	0.2	0.4	0.2	0.9	0.7	8.1	6.3	0.5	0.4	0.3	0.3	0.3	5.4	0.3	1.1	0.3	1.0	0.5	0.5	0.3	0.4	2.8	0.3	0.5	0.9	0.4	0.9	0.7	0.8	11.4	0.6	0.7	0.2	0.1	0.6	1.9	0.4	0.4	0.3	0.9	0.8	0.5	0.4	0.5	0.9	0.4	1.6	0.7	0.5	1.6	0.6	1.2	0.6	0.3	0.6	1.0	0.7	0.7	0.4	1.2	0.6	0.7	0.4	0.6	0.8	3.4	0.7	0.8	1.2	0.6	1.0	1.1	1.0	0.9	0.5	1.7	1.2	1.3	3.6	1.6	0.7	1.2	0.5	0.2	14.5	37.6	3.0	19.4	21.9	11.0	50.2	11.3	18.9	51.3
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		900000	900000	"Endoplasmic reticulum"		"HPA055161: , HPA059303: "	"unprognostic (8.07e-2)"	"prognostic unfavourable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavourable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavourable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (4.24e-4)"	"unprognostic (2.74e-2)"	104.6	60.4	27.3	15.0	29.5	4.8	84.3	35.2	31.3	22.3	23.8	10.6	18.3	14.0	16.8	17.8	22.4	16.5	19.1	33.9	26.1	22.4	19.0	23.0	22.5	10.9	21.1	22.2	20.5	13.8	12.5	15.7	14.7	20.5	17.3	26.8	23.6	28.8	23.4	103.1	12.0	13.9	26.1	16.7	12.8	30.5	6.4	19.6	2.9	31.7	36.0	13.7	30.0	25.4	3.3	21.0	15.9	5.2	4.9	3.4	2.3	50.0	72.7	10.2	6.2	45.8	43.5	3.5	89.8	83.5	38.5	40.4	12.4	66.7	3.8	6.2	52.6	18.7	6.3	31.3	65.8	1.4	6.4	8.9	44.2	34.0	29.4	1.3	1.4	35.7	7.1	21.4	27.3	16.2	2.4	3.6	33.8	10.6	0.3	1.8	5.8	42.9	2.4	11.0	0.8	23.5	41.5	10.6	3.7	27.9	13.2	11.1	5.4	2.4	50.8	39.0	20.0	35.6	31.6	2.3	2.9	0.1	102.6	0.8	26.0	1.1	5.2	0.1	1.6	1.9	3.1	3.3	2.3	1.6	6.1	3.3	3.4	1.6	15.9	4.9	1.0	21.0	2.3	2.3	27.3	29.5	35.2	31.3	26.1	22.4	21.1	22.2	20.5	19.6
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444929-130501274	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 121.5;liver: 309.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 86.6;HaCaT: 82.0;hTCEpi: 79.7;RPMI-8226: 132.8;THP-1: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020896, HPA020934"	Enhanced		Approved	Nucleoplasm,Cytosol		4500000	4500000	Cytosol	Nucleoplasm	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	20.6	15.4	4.6	7.1	4.1	0.0	15.7	2.3	5.4	8.3	18.5	3.5	33.9	11.9	12.0	12.6	9.4	16.6	14.0	11.4	3.8	5.7	121.5	309.9	8.0	2.2	3.2	4.3	11.4	7.9	0.5	4.6	8.7	4.5	12.1	16.8	10.7	26.3	40.6	7.4	12.5	26.8	5.9	3.4	2.7	5.2	8.7	2.2	0.8	17.5	7.0	4.5	17.7	8.6	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.6	1.1	1.3	2.2	8.8	22.5	4.2	13.9	86.6	2.7	8.4	4.9	3.2	0.0	9.4	28.6	82.0	5.7	0.5	1.9	2.0	2.6	0.0	1.8	12.7	30.7	1.7	0.1	14.8	79.7	4.4	8.0	0.1	0.4	51.7	2.7	57.6	0.6	24.3	1.8	2.5	0.1	1.5	132.8	7.6	5.8	33.4	0.5	49.5	52.2	3.9	35.8	99.5	0.0	1.1	6.9	0.2	1.2	8.6	8.2	2.9	21.8	12.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	4.6	4.1	2.3	5.4	3.8	5.7	3.2	4.3	4.5	2.2
ATG16L1	"APG16L, ATG16A, ATG16L, FLJ10035, WDR30"	ENSG00000085978	"Autophagy related 16 like 1"	Q676U5	2	233210051-233295674	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012577, HPA063900"	Supported		Approved	Cytosol				Cytosol		"HPA012577: AB_1845155, HPA063900: "	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.49e-1)"	"prognostic unfavourable (1.48e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (3.93e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.08e-1)"	7.7	8.1	7.8	15.7	16.4	28.2	11.9	25.3	22.7	9.8	12.0	13.5	7.4	11.4	12.3	14.8	11.8	8.4	9.7	11.3	9.6	9.0	10.0	15.0	8.0	11.4	10.9	9.4	9.7	12.8	11.6	6.6	8.6	12.3	13.2	13.8	9.4	11.8	10.7	19.4	16.9	11.5	10.7	9.7	12.1	13.0	16.7	9.2	13.8	12.3	10.2	14.3	11.7	12.5	3.3	2.1	4.4	6.2	6.0	7.3	3.1	10.8	11.5	4.1	6.9	10.7	7.7	13.1	9.9	7.9	8.9	8.4	8.3	7.8	2.8	3.6	8.2	5.5	9.1	4.8	7.9	5.4	7.8	6.5	7.4	13.3	8.1	5.3	8.3	4.2	8.5	10.4	8.5	8.6	6.7	2.8	7.7	8.9	5.5	10.7	17.4	12.8	4.0	9.4	2.3	7.9	7.1	8.4	5.8	6.8	8.4	5.1	4.9	5.8	10.1	5.6	4.6	8.9	8.2	6.3	3.3	5.1	9.2	5.5	8.8	0.0	2.5	4.4	7.3	2.0	6.0	3.3	5.0	6.4	2.1	3.2	5.6	5.5	1.7	6.0	6.2	1.1	5.6	3.1	7.8	16.4	25.3	22.7	9.6	9.0	10.9	9.4	12.3	9.2
ATG5	"APG5, APG5L, ASP, hAPG5"	ENSG00000057663	"Autophagy related 5"	Q9H1Y0	6	106045423-106325791	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Host-virus interaction, Immunity"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034432, CAB037309, HPA042973"	Approved		Approved	Centrosome	"Intracellular and membrane"			Centrosome		"CAB034432: AB_2243288, CAB037309: AB_796188, HPA042973: AB_2678246"	"unprognostic (1.21e-3)"	"unprognostic (6.53e-3)"	"unprognostic (2.68e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.35e-3)"	"prognostic unfavourable (8.84e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (8.73e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.42e-2)"	18.0	28.5	16.1	15.6	17.2	9.4	21.4	16.0	21.4	23.0	20.9	10.5	14.1	16.9	21.5	23.2	16.7	20.6	12.8	14.0	15.1	15.4	20.5	23.6	15.4	18.1	14.7	15.8	21.0	16.7	12.8	23.3	26.9	17.0	22.9	20.6	11.0	16.5	21.7	20.4	10.9	28.6	19.7	14.9	20.3	16.4	13.0	10.2	23.3	24.9	14.7	18.0	20.7	21.0	7.3	6.8	11.6	10.5	6.5	12.9	4.9	8.2	3.6	6.0	8.1	13.9	15.0	6.3	8.8	14.1	13.0	16.0	3.5	5.0	5.8	7.1	13.4	5.9	8.7	12.9	23.0	2.5	4.9	6.8	4.5	4.4	14.9	8.0	3.5	11.6	14.4	9.3	11.8	13.7	9.7	5.8	14.7	3.7	3.3	9.7	6.9	4.9	3.4	14.2	4.5	14.0	5.9	4.6	4.3	5.4	10.2	8.0	5.0	15.5	11.3	5.1	2.9	5.9	15.0	2.4	2.3	5.4	18.9	11.0	9.2	5.1	6.5	11.6	4.8	7.7	12.9	7.3	8.5	6.6	6.8	5.2	9.3	7.9	5.5	6.5	10.5	2.6	9.0	4.9	16.1	17.2	16.0	21.4	15.1	15.4	14.7	15.8	17.0	10.2
ATM	"ATA, ATC, ATD, ATDC, TEL1, TELO1"	ENSG00000149311	"ATM serine/threonine kinase"	Q13315	11	108222484-108369102	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000102, HPA067142"	Supported		Enhanced	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"CAB000102: , HPA067142: "	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-1)"	8.3	10.9	12.7	26.5	19.3	16.8	9.4	17.7	14.4	10.9	8.5	10.9	8.8	6.0	11.2	11.4	6.9	9.5	9.2	9.6	12.4	8.5	7.7	9.5	10.1	33.4	19.6	6.7	20.5	20.7	15.7	29.2	8.8	14.5	9.1	7.9	7.2	15.1	9.8	6.2	8.4	16.5	10.6	23.4	22.6	8.9	6.1	17.9	19.5	10.7	5.1	26.9	10.7	10.7	13.7	6.1	13.5	12.5	7.6	18.5	4.4	2.6	3.8	7.5	4.0	9.8	14.3	1.9	6.0	6.7	3.5	5.8	4.7	6.3	9.4	8.9	4.8	4.0	5.7	5.0	5.4	7.5	3.3	8.5	4.7	4.7	5.1	10.2	9.2	9.2	3.1	5.2	10.2	7.2	8.2	6.4	6.8	1.9	7.0	9.4	6.1	3.8	5.5	5.2	14.8	3.9	5.4	5.1	6.3	6.9	3.2	10.3	4.9	5.8	11.3	8.6	4.8	4.9	5.6	4.3	4.5	47.4	5.7	11.3	9.6	13.5	5.7	3.8	14.9	5.3	10.4	11.1	10.5	11.3	2.7	13.7	18.5	17.9	10.8	7.6	12.5	6.1	5.3	4.4	12.7	19.3	17.7	14.4	12.4	8.5	19.6	6.7	14.5	17.9
ATP10A	"ATP10C, ATPVA, ATPVC, KIAA0566"	ENSG00000206190	"ATPase phospholipid transporting 10A (putative)"	O60312	15	25677273-25865172	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 12.8;fHDF/TERT166: 18.7;HMC-1: 12.5;RPTEC TERT1: 10.0;SK-MEL-30: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"dendritic cells: 3.0;NK-cells: 4.7;T-cells: 4.0"	"Low region specificity"	"Detected in all"							"HPA041496, HPA042509"	Uncertain									"HPA041496: , HPA042509: "	"unprognostic (3.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.18e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (6.60e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.42e-2)"	7.4	14.1	5.3	5.4	9.8	4.7	5.7	3.4	11.0	5.3	3.3	6.2	1.4	1.5	1.9	2.1	3.7	3.1	7.1	2.9	8.0	5.8	6.0	1.0	12.2	14.8	9.3	9.0	1.6	1.9	1.9	2.5	3.6	11.3	3.6	2.3	4.0	14.4	1.5	0.7	3.3	3.6	5.3	6.4	3.5	4.0	6.0	6.2	1.5	3.0	1.6	3.3	4.2	3.3	0.0	3.0	0.0	0.3	4.7	4.0	1.7	0.0	3.3	0.6	0.0	2.7	2.5	0.0	12.8	6.2	3.9	6.9	0.0	0.0	0.0	0.7	18.7	0.0	6.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.6	0.0	0.5	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.9	0.7	2.3	2.3	0.8	10.0	0.0	0.0	0.0	0.0	0.0	16.9	5.1	0.5	0.0	5.2	0.2	7.5	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.3	0.0	1.9	0.2	1.9	0.0	2.2	2.1	0.4	0.0	4.0	3.7	0.0	4.7	0.1	3.0	0.7	1.7	5.3	9.8	3.4	11.0	8.0	5.8	9.3	9.0	11.3	6.2
ATP13A2	"CLN12, HSA9947, PARK9"	ENSG00000159363	"ATPase 13A2"	Q9NQ11	1	16985958-17011928	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuronal ceroid lipofuscinosis, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 17.9"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037038, CAB037111, HPA050910, HPA054717"	Enhanced									"CAB037038: AB_1840715, CAB037111: AB_1840714, HPA050910: , HPA054717: "	"unprognostic (3.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (3.33e-7)"	"unprognostic (1.04e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.84e-3)"	9.6	12.3	21.9	16.3	25.8	8.7	6.7	25.5	45.3	6.0	12.5	12.0	4.7	10.4	5.3	6.1	8.9	7.1	7.6	4.5	23.8	34.6	6.5	2.5	9.6	13.2	28.4	20.3	5.3	30.1	7.8	22.2	10.5	52.2	7.2	8.3	9.6	15.6	7.2	7.5	10.0	11.1	7.3	10.9	16.1	10.7	6.2	9.9	5.2	8.6	2.9	8.1	9.2	5.2	2.1	17.9	0.4	2.9	2.2	2.5	1.1	10.2	10.8	5.9	23.0	5.5	4.8	15.7	5.9	5.7	6.5	6.9	19.0	11.9	4.6	25.5	9.9	16.2	11.8	21.7	2.3	6.2	22.7	15.9	10.2	9.8	7.2	5.8	7.5	3.8	12.1	18.4	13.5	12.8	10.2	8.8	26.7	8.4	6.7	3.2	8.7	7.4	7.4	22.4	18.1	7.4	15.7	15.9	10.3	26.9	35.0	22.7	11.7	7.0	12.8	7.3	13.7	12.2	11.9	1.8	2.1	4.8	13.7	31.6	11.6	0.0	1.3	0.3	2.4	2.9	2.5	1.2	1.9	2.0	0.4	2.1	1.0	1.4	0.4	2.2	2.7	17.9	1.5	1.1	21.9	25.8	25.5	45.3	23.8	34.6	28.4	20.3	52.2	9.9
ATP13A4	"DKFZp761I1011, FLJ37958"	ENSG00000127249	"ATPase 13A4"	Q4VNC1	3	193402077-193593111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 46.4;parathyroid gland: 52.5;thyroid gland: 51.2"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 9.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051932			Approved	Nucleoplasm				Nucleoplasm		"HPA051932: "	"unprognostic (4.97e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.72e-2)"	"prognostic favourable (3.91e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.00e-1)"	0.6	0.7	11.2	0.6	11.1	0.6	17.8	2.6	10.1	1.8	2.2	8.4	9.0	0.9	0.6	46.4	11.8	2.7	4.3	0.6	11.1	5.1	0.8	0.7	22.0	0.8	7.5	7.7	0.8	3.9	52.5	3.5	0.6	9.0	0.6	3.2	0.5	4.5	16.7	0.6	11.2	0.6	0.7	6.1	0.7	7.6	0.8	7.5	0.0	51.2	7.8	9.5	0.6	3.7	0.4	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.2	0.2	0.1	1.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	1.9	0.9	1.4	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	11.2	11.1	2.6	10.1	11.1	5.1	7.5	7.7	9.0	7.5
ATP1A2	"FHM2, MHP2"	ENSG00000018625	"ATPase Na+/K+ transporting subunit alpha 2"	P50993	1	160115759-160143591	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"brain: 109.8;skeletal muscle: 305.8"	"Cell line enhanced"	"Detected in some"		"AF22: 32.2;HHSteC: 9.4;RH-30: 10.5;U-87 MG: 6.5"	"Cancer enriched"	"Detected in many"	18	"glioma: 91.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022230	Enhanced									"CAB022230: "	"unprognostic (1.08e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.63e-4)"	"unprognostic (1.70e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.32e-3)"	12.6	3.9	61.4	2.8	80.1	2.3	6.5	30.4	109.8	4.7	6.6	27.4	2.4	3.7	4.2	7.4	15.3	6.0	5.3	35.4	42.2	27.0	3.3	2.5	3.8	2.4	45.6	37.9	9.9	2.6	2.4	4.6	3.6	58.0	13.8	5.6	12.5	3.1	14.2	305.8	2.8	4.4	5.4	51.5	2.7	2.8	3.9	28.3	0.0	2.6	17.7	2.5	5.5	1.3	0.6	1.4	1.7	0.4	0.6	0.5	0.3	0.0	0.0	32.2	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	2.8	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	1.3	0.4	0.3	0.3	0.3	0.2	0.4	0.3	0.2	0.7	0.6	0.3	0.5	1.7	0.6	0.2	1.4	0.2	0.3	61.4	80.1	30.4	52.0	42.2	27.0	45.6	37.9	58.0	28.3
ATP1A3	DYT12	ENSG00000105409	"ATPase Na+/K+ transporting subunit alpha 3"	P13637	19	41966582-41997497	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"		"Deafness, Disease mutation, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 146.4;heart muscle: 78.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 20.4;Karpas-707: 13.0;REH: 12.8;SCLC-21H: 48.3;SH-SY5Y: 20.8"	"Group enriched"	"Detected in many"	6	"glioma: 21.6;testis cancer: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.2"									"CAB033630, HPA045367, HPA056446"	Enhanced	Approved								"CAB033630: AB_781528, HPA045367: , HPA056446: "	"unprognostic (1.90e-1)"	"unprognostic (8.65e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.16e-2)"	"unprognostic (7.66e-2)"	"unprognostic (8.02e-2)"	"prognostic unfavourable (3.44e-4)"	"prognostic favourable (6.15e-5)"	"unprognostic (4.02e-3)"	"prognostic unfavourable (3.02e-6)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.27e-1)"	1.9	12.8	34.0	2.5	30.8	2.1	1.8	42.8	146.4	1.8	2.4	4.8	0.0	2.4	1.8	1.8	2.0	1.8	1.9	78.3	48.3	54.6	1.8	1.8	1.9	2.3	39.9	42.6	1.8	2.3	1.8	3.0	1.8	94.4	1.8	2.3	17.3	2.2	1.8	1.8	2.0	2.7	2.2	18.5	2.1	2.0	18.6	6.9	0.0	1.8	0.0	2.1	1.9	0.1	0.3	0.1	0.0	0.0	0.1	2.2	0.3	0.0	0.8	0.2	8.5	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.3	1.6	20.4	0.9	0.1	0.2	6.0	0.0	0.2	3.8	1.1	1.7	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.1	0.0	0.0	13.0	0.1	0.3	3.7	0.0	1.1	5.2	12.8	7.0	0.6	0.0	0.2	48.3	20.8	0.1	1.5	0.0	1.2	0.9	0.0	1.1	1.1	0.0	0.3	1.3	0.9	4.6	1.9	7.1	0.1	0.0	0.0	0.0	2.2	0.0	0.2	0.3	0.6	1.7	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.1	0.7	0.3	34.0	30.8	42.8	66.6	48.3	54.6	39.9	42.6	94.4	6.9
ATP2A1	"ATP2A, SERCA1"	ENSG00000196296	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1"	O14983	16	28878405-28904509	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"skeletal muscle: 456.3;tongue: 209.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 19.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"thalamus: 14.3"	"Low region specificity"	"Detected in all"			"CAB002310, CAB032706"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB002310: AB_564139, CAB032706: AB_2061286"	"unprognostic (2.37e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.23e-5)"	"unprognostic (5.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-2)"	7.6	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.1	1.1	5.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.6	0.1	12.6	7.0	0.3	456.3	0.2	0.2	0.1	0.1	0.1	0.1	0.9	0.0	0.0	4.2	209.0	6.5	0.2	0.1	1.6	3.1	0.7	0.2	4.7	1.5	0.6	4.8	5.2	9.6	5.7	0.4	1.6	8.9	2.3	1.3	0.4	0.4	2.9	4.4	7.6	2.7	0.4	5.1	2.4	0.1	0.7	3.8	19.8	2.7	11.8	9.0	0.2	1.1	2.5	4.1	1.1	0.6	0.5	0.2	5.1	6.5	0.3	9.7	10.9	6.1	9.6	7.4	16.8	6.8	5.7	0.0	0.6	6.1	4.9	3.3	4.5	3.4	3.4	2.7	2.0	3.0	6.3	5.6	2.8	9.5	5.7	7.4	5.9	15.0	2.9	0.0	0.1	0.7	1.0	0.0	1.3	1.6	1.1	1.0	0.0	0.8	1.4	1.3	0.0	4.7	0.2	3.1	1.5	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ATP2A2	"ATP2B, DAR, SERCA2"	ENSG00000174437	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2"	P16615	12	110280756-110351093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 188.3;skeletal muscle: 319.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062605	Enhanced					38000000	38000000			"HPA062605: "	"unprognostic (4.81e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.50e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.91e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.93e-2)"	8.4	8.8	7.3	8.5	14.5	5.7	7.5	7.4	20.8	8.2	9.6	8.0	8.3	7.3	9.4	10.3	24.1	9.4	9.3	188.3	10.1	5.0	6.7	11.8	8.9	5.6	5.6	13.1	8.5	7.6	8.7	6.1	8.1	10.2	13.0	11.2	22.3	18.3	9.6	319.7	9.3	9.3	14.3	7.4	5.4	7.9	11.9	7.1	3.1	12.6	51.3	12.7	13.4	11.4	0.8	2.2	0.2	4.4	1.7	1.7	0.7	34.9	69.8	35.4	28.4	23.5	30.2	51.0	43.7	55.0	44.3	29.9	50.5	37.3	43.2	37.0	41.5	51.2	58.5	69.0	50.4	35.7	29.3	37.7	28.0	29.5	40.0	43.0	36.5	31.7	48.6	56.3	54.6	34.2	43.9	21.2	36.0	33.6	23.2	26.7	40.3	35.3	24.6	31.8	35.7	21.8	72.3	37.4	28.1	54.9	45.2	25.5	60.7	23.2	36.7	41.1	22.1	27.3	33.3	43.6	53.0	48.5	37.4	18.6	46.5	0.0	1.9	0.0	1.7	4.4	0.9	0.7	1.3	1.1	1.9	0.8	1.3	1.2	0.2	1.7	2.3	2.2	1.2	0.7	7.3	14.5	7.4	20.8	10.1	5.0	5.6	13.1	10.2	7.1
ATP2B3	"CFAP39, CLA2, PMCA3, SCAX1"	ENSG00000067842	"ATPase plasma membrane Ca2+ transporting 3"	Q16720	X	153517676-153582939	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Calmodulin-binding	"Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 18.6;brain: 23.2"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 14.3;SH-SY5Y: 4.2;THP-1: 3.5;U-937: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001583	Enhanced									"HPA001583: AB_1079641"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.68e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.71e-12)"	"unprognostic (1.44e-3)"	"unprognostic (2.04e-1)"		"unprognostic (2.42e-2)"	0.8	18.6	5.4	0.9	11.3	0.8	0.8	16.1	23.2	0.8	0.9	3.9	0.0	0.9	0.9	2.6	0.8	3.1	0.8	0.8	7.8	5.5	1.0	0.8	0.8	0.8	4.3	11.5	0.8	0.9	0.8	1.2	1.7	13.6	0.8	0.8	1.4	1.3	1.3	0.8	0.9	0.9	0.9	1.4	0.8	0.8	1.1	0.9	0.0	0.8	0.0	0.8	0.8	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.3	4.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	11.3	16.1	20.7	7.8	5.5	4.3	11.5	13.6	0.9
ATP6AP2	"APT6M8-9, ATP6IP2, ATP6M8-9, M8-9, PRR, RENR"	ENSG00000182220	"ATPase H+ transporting accessory protein 2"	O75787	X	40579372-40606848	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 176.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003156	Approved									"HPA003156: AB_1078245"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.01e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.86e-2)"	25.0	23.8	33.8	17.4	39.3	30.6	31.7	31.5	76.0	35.0	24.0	22.1	13.0	10.0	30.8	25.5	21.4	22.7	23.9	19.3	35.5	36.7	48.7	30.0	30.2	37.9	32.1	34.7	22.3	16.3	176.7	16.1	30.2	37.8	26.4	25.0	21.0	16.8	31.8	8.7	24.0	16.8	35.7	27.8	22.6	15.8	11.9	17.2	16.2	56.1	12.6	19.1	25.7	20.0	16.1	53.2	60.8	78.0	20.0	29.6	85.8	14.7	19.3	14.1	19.0	93.6	59.6	8.8	33.2	51.5	24.5	28.7	11.1	24.2	8.5	16.5	48.4	15.2	21.7	25.8	33.5	16.6	17.1	10.6	18.8	10.7	34.4	18.8	19.8	51.6	34.6	30.1	24.2	32.6	10.7	23.0	37.0	18.5	8.1	16.4	13.0	21.8	7.7	24.8	28.5	31.6	16.5	10.2	9.5	32.3	20.1	20.2	26.1	17.3	32.0	30.9	16.9	36.8	11.1	7.1	12.3	8.4	25.5	15.9	24.0	34.4	78.0	60.8	25.9	55.1	27.0	16.1	26.4	26.6	53.2	15.7	29.6	27.0	39.5	20.0	54.1	19.3	24.7	85.8	33.8	39.3	31.5	76.0	35.5	36.7	32.1	34.7	37.8	17.2
ATP6V0A4	"a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2"	ENSG00000105929	"ATPase H+ transporting V0 subunit a4"	Q9HBG4	7	138706294-138799560	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 40.6;salivary gland: 55.4"	"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 35.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018029, HPA064555"	Enhanced		Approved	Cytosol				Cytosol		"HPA018029: AB_1845190, HPA064555: AB_2685284"	"unprognostic (1.99e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.73e-1)"	"prognostic favourable (1.32e-6)"	"unprognostic (4.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-2)"	0.1	0.0	0.5	0.0	0.3	0.0	2.2	0.1	0.4	1.7	0.0	0.3	3.1	0.0	0.3	0.5	2.7	0.0	0.0	0.0	0.4	0.3	40.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.2	1.0	0.2	0.5	0.0	0.3	55.4	1.2	0.0	6.5	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	1.8	7.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.4	1.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	3.0	1.1	0.0	0.1	0.0	0.0	0.4	0.0	2.9	0.1	0.0	0.0	0.0	35.0	1.2	0.1	0.0	0.1	0.4	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.1	0.4	0.4	0.3	0.3	0.0	0.2	0.1
ATP6V1E1	"ATP6E, ATP6E2, ATP6V1E, P31, Vma4"	ENSG00000131100	"ATPase H+ transporting V1 subunit E1"	P36543	22	17592136-17628818	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009528, CAB018699, HPA029196"	Enhanced		Approved	Nucleoplasm		61000	61000	Nucleoplasm		"CAB009528: AB_2062678, CAB018699: AB_781534, HPA029196: "	"unprognostic (1.53e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-3)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.72e-3)"	"prognostic favourable (4.18e-4)"	"prognostic favourable (7.66e-8)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.75e-1)"	32.8	45.9	59.5	20.4	69.0	24.9	31.5	48.9	90.3	30.2	26.7	34.5	25.2	17.6	27.7	44.4	37.5	26.7	26.7	67.4	58.9	55.4	71.7	26.1	31.7	24.5	54.5	52.3	27.0	15.8	48.3	29.6	46.2	69.8	31.1	32.0	24.1	21.5	42.1	48.5	26.9	19.1	38.1	53.7	23.9	23.8	20.2	32.4	17.5	31.9	26.1	32.5	32.1	22.0	24.2	26.3	55.3	34.8	22.6	29.4	30.1	21.5	19.7	17.8	17.3	59.5	32.2	19.6	28.9	38.6	36.8	42.7	24.4	17.9	13.5	24.9	38.6	34.3	27.8	25.3	32.9	25.9	31.5	24.4	19.7	32.7	87.1	28.0	42.3	40.3	49.7	35.4	25.9	31.0	30.4	27.8	62.6	22.5	24.2	20.3	13.1	27.8	14.2	26.1	8.0	61.0	34.2	13.1	22.8	26.5	18.8	62.2	18.2	32.5	26.4	25.9	13.7	32.3	21.4	27.3	47.8	17.1	41.7	13.7	34.7	45.2	32.9	55.3	21.4	30.8	20.8	24.2	21.9	20.5	26.3	19.0	20.8	21.5	44.3	22.6	34.8	25.4	29.4	30.1	59.5	69.0	48.9	90.3	58.9	55.4	54.5	52.3	69.8	32.4
ATP7A	MNK	ENSG00000165240	"ATPase copper transporting alpha"	Q04656	X	77910656-78050395	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012887, HPA048107"	Approved		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA012887: AB_1845205, HPA048107: "	"unprognostic (3.14e-2)"	"unprognostic (3.48e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (8.38e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.52e-1)"	9.8	7.4	2.6	8.6	4.6	6.4	8.5	2.3	2.9	8.2	7.7	5.9	9.6	4.8	9.5	7.6	10.0	5.7	4.5	5.1	2.9	2.8	9.0	3.3	9.3	9.3	4.1	1.7	7.3	6.3	13.2	15.9	5.0	4.3	8.2	4.4	5.2	12.3	10.3	6.1	15.9	8.5	7.8	6.3	10.8	7.0	2.7	6.0	15.6	6.0	7.1	11.7	11.8	7.0	2.3	1.4	10.7	2.4	1.7	3.0	1.2	2.5	6.7	4.5	4.6	4.3	4.5	0.8	3.9	5.4	2.3	4.8	0.9	3.0	3.7	5.8	3.8	3.1	5.8	3.1	4.4	5.5	4.0	1.9	6.5	0.7	5.4	3.3	3.5	4.8	1.3	5.0	1.5	6.1	15.3	14.4	4.3	2.2	3.5	1.1	1.3	1.4	2.9	7.5	12.6	3.9	7.2	1.4	17.1	9.6	2.4	4.9	1.8	1.1	7.7	3.1	3.1	4.3	1.5	4.7	8.3	4.3	5.1	2.0	4.7	8.3	2.0	5.5	2.4	1.9	1.2	2.0	1.7	1.7	1.3	2.3	2.1	3.0	10.7	1.7	2.4	1.4	0.6	1.2	2.6	4.6	2.3	2.9	2.9	2.8	4.1	1.7	4.3	6.0
ATP7B	WND	ENSG00000123191	"ATPase copper transporting beta"	P35670	13	51930436-52012125	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 18.5;liver: 13.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.8;CACO-2: 10.8;HEL: 28.6;Hep G2: 9.9;RPTEC TERT1: 16.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA009137, HPA013187"	Supported		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA009137: , HPA013187: AB_1845206"	"unprognostic (1.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (5.01e-4)"	"unprognostic (3.49e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.40e-1)"	3.4	0.7	1.8	2.4	2.9	1.8	1.6	7.0	2.8	1.4	6.8	1.1	1.1	10.5	1.6	1.9	1.1	1.9	18.5	1.8	2.1	2.1	2.1	13.5	1.2	1.1	1.6	1.1	2.0	1.7	7.7	1.2	7.1	3.5	1.9	2.6	1.4	3.0	1.1	1.1	0.7	9.6	1.5	1.1	1.6	4.5	7.1	1.6	1.1	1.1	1.1	1.1	2.1	1.1	0.0	0.0	1.0	0.3	0.0	0.5	0.1	0.4	1.6	2.9	2.6	0.6	0.5	18.8	0.8	0.2	0.9	0.6	10.8	0.1	0.0	0.3	1.4	0.2	2.0	2.4	0.6	0.2	4.0	28.6	0.3	9.9	0.9	0.3	6.7	1.2	2.8	0.1	1.1	2.0	7.6	0.0	0.8	0.5	0.1	0.7	0.9	0.9	1.0	0.8	0.0	16.7	1.8	2.2	1.2	1.0	1.6	1.1	4.5	0.2	1.1	0.1	1.0	1.6	0.3	0.3	0.4	0.1	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.8	2.9	7.0	2.8	2.1	2.1	1.6	1.1	3.5	1.6
ATP8A2	"ATPIB, ML-1"	ENSG00000132932	"ATPase phospholipid transporting 8A2"	Q9NTI2	13	25372071-26025851	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 34.9;pituitary gland: 37.0;testis: 10.4"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 21.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3;naive CD8 T-cell: 3.3"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039926, HPA040033"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA039926: AB_10794205, HPA040033: "	"unprognostic (3.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.95e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.96e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.20e-5)"	"unprognostic (9.10e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.22e-2)"	1.1	4.9	11.2	1.4	11.4	0.8	2.2	34.9	30.2	1.1	1.3	1.3	0.0	1.4	2.1	4.8	0.9	0.9	1.0	1.0	9.4	11.8	1.3	0.8	2.3	1.9	6.7	10.4	1.2	1.9	0.9	37.0	1.2	19.8	1.1	1.3	3.1	1.0	1.0	1.3	0.9	1.5	1.0	3.5	1.3	1.8	10.4	1.4	0.0	1.0	0.0	1.2	1.2	0.3	0.0	0.0	0.2	0.0	0.2	3.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	1.0	0.0	0.6	1.4	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	21.9	0.2	0.0	0.0	0.0	0.5	0.0	0.0	1.7	0.3	3.7	0.0	2.0	0.7	0.0	2.7	1.0	0.2	0.1	3.3	0.0	0.2	0.3	0.1	0.0	0.4	0.2	0.1	1.1	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.8	0.6	0.0	0.0	2.3	3.3	0.2	0.2	0.0	0.0	0.7	0.6	11.2	11.4	34.9	18.4	9.4	11.8	6.7	10.4	19.8	1.4
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803101	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"		"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.1;HBF TERT88: 24.3;RT4: 57.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA018673, HPA018674"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Nuclear bodies, Cytosol"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favourable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favourable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	3.8	2.3	0.0	1.8	0.0	0.0	3.4	0.0	0.3	4.5	21.3			8.9	2.4	0.8	6.7	2.6	4.8	1.8	0.2	0.0	2.1	3.0	3.6	0.0	0.1		0.7	10.7	2.7	1.1	1.3		6.0	19.3		5.8	2.8	0.4	3.6	11.1	2.0	0.2	1.2	13.3	0.0			5.7		0.2	12.8	5.4	6.0	2.0	4.7	2.1	0.7	1.3	0.3	10.1	3.4	0.1	0.1	3.5	6.4	4.9	19.6	19.1	20.6	12.9	2.6	8.8	0.7	5.9	27.1	15.0	0.1	4.1	24.3	0.2	0.4	0.1	0.9	0.9	1.1	0.2	0.1	1.0	3.7	6.2	10.9	10.8	0.1	0.4	11.9	4.8	0.2	0.2	0.2	1.0	0.1	0.1	0.2	2.8	57.5	0.4	0.3	0.4	12.1	0.1	3.7	0.6	12.4	16.8	0.6	2.7	4.5	0.2	0.1	0.2	0.4	0.2	0.9	0.8	2.1	0.5	1.3	0.9	1.0	2.7	1.0	0.7	0.5	6.0	0.9	1.0	4.7	0.7	1.2	2.0	0.4	0.3										
ATR	"FRP1, MEC1, SCKL, SCKL1"	ENSG00000175054	"ATR serine/threonine kinase"	Q13535	3	142449235-142578826	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054320			Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA054320: "	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.42e-2)"	"prognostic unfavourable (8.39e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (1.23e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	10.5	24.3	7.7	11.4	15.9	10.1	14.8	11.3	14.6	10.1	8.5	10.0	10.4	6.0	14.7	16.8	9.4	12.1	9.3	8.8	9.8	7.1	9.6	12.0	10.3	16.0	10.0	8.1	12.3	13.6	18.0	22.5	8.8	12.5	11.0	11.2	9.5	12.5	10.8	7.7	11.2	10.9	9.8	8.8	14.2	9.0	15.3	9.7	19.0	13.8	7.7	15.1	10.9	10.6	5.8	2.8	2.2	4.0	6.7	6.0	0.8	22.5	11.1	7.4	8.4	10.6	11.6	8.8	12.4	7.0	9.3	9.6	5.2	7.2	18.4	12.9	8.8	14.6	10.9	11.5	14.1	5.9	7.2	10.1	8.4	5.0	4.7	16.9	5.7	9.1	6.4	8.8	10.5	9.6	7.0	8.3	9.5	9.9	12.7	7.0	7.1	7.9	10.6	10.8	13.3	9.4	10.5	5.3	5.3	22.9	8.3	8.1	12.1	6.9	12.4	9.5	4.8	12.3	13.3	10.8	6.4	17.1	12.3	6.6	7.5	0.7	2.7	2.2	4.4	4.0	6.0	3.1	3.2	4.2	2.8	5.8	4.1	4.0	1.7	6.7	2.5	2.5	2.4	0.8	7.7	15.9	11.3	14.6	9.8	7.1	10.0	8.1	12.5	9.7
ATRX	"JMS, MRX52, RAD54, XH2, XNP"	ENSG00000085224	"ATRX, chromatin remodeler"	P46100	X	77504878-77786269	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001906, CAB009372, HPA064684, CAB068176"	Supported		Supported	"Nuclear bodies"				"Nuclear bodies"		"CAB009372: AB_2061023, CAB068176: , HPA001906: AB_1078249, HPA064684: "	"unprognostic (1.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.24e-1)"	16.4	16.6	24.5	18.9	29.3	24.3	16.3	48.2	26.4	20.6	15.4	7.1	18.9	10.2	20.2	17.1	13.5	13.8	13.4	15.1	22.9	15.8	16.6	12.2	15.9	18.6	21.1	21.3	25.4	18.3	35.7	28.1	15.9	20.2	18.4	12.6	7.1	15.8	16.5	20.1	14.1	13.5	22.3	15.3	20.1	15.6	6.5	22.4	23.7	19.8	12.7	16.5	19.9	21.1	21.9	12.8	21.5	11.5	14.6	17.7	5.7	15.1	24.4	25.1	16.8	12.5	16.8	8.9	13.1	12.1	9.7	11.5	8.3	13.3	21.0	13.5	13.9	13.5	20.0	7.8	16.6	11.8	13.1	12.7	29.0	6.1	6.8	16.5	4.4	11.1	7.7	14.3	13.7	17.1	14.9	24.2	12.1	11.9	12.7	8.6	18.1	18.9	20.6	34.6	10.8	9.5	20.3	14.3	24.7	26.4	10.4	8.7	8.3	8.4	23.6	13.7	21.3	15.4	9.2	7.2	22.3	18.9	10.1	13.1	12.1	21.3	6.9	13.8	17.7	8.7	17.1	19.2	16.3	13.7	5.1	21.9	16.8	13.5	21.5	14.6	11.5	12.8	12.8	5.7	24.5	29.3	48.2	26.4	22.9	15.8	21.1	21.3	20.2	22.4
ATXN3	"ATX3, JOS, MJD, SCA3"	ENSG00000066427	"Ataxin 3"	P54252	14	92044496-92106625	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB021976, HPA024123, HPA069338"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB021976: , HPA024123: AB_1845133, HPA069338: "	"unprognostic (1.06e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.94e-3)"	"unprognostic (4.22e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.11e-1)"	17.8	10.3	10.2	9.1	11.6	14.3	12.8	18.7	12.1	16.0	11.8	12.2	11.9	6.4	17.9	12.4	17.7	9.5	11.2	10.4	9.0	9.9	9.9	16.0	12.3	11.6	16.3	9.5	14.0	10.3	11.9	17.2	11.7	13.8	15.8	11.7	8.6	11.4	10.2	6.1	21.0	8.7	20.6	16.5	12.6	9.0	14.8	14.3	16.2	11.5	12.0	15.6	15.4	13.6	9.8	14.5	11.4	18.8	7.0	8.5	5.3	5.6	11.1	10.0	9.3	14.6	14.3	19.6	6.4	10.4	8.2	11.4	8.0	15.7	11.5	12.8	10.5	9.8	7.7	14.0	18.1	13.1	2.3	4.9	5.4	11.7	12.1	8.6	8.8	11.6	12.5	14.3	15.0	12.6	6.5	8.6	12.4	21.9	9.0	7.8	7.1	9.2	7.2	18.5	6.5	10.5	12.8	3.4	6.0	15.5	6.6	8.8	12.3	6.0	6.7	8.1	11.9	5.2	3.4	7.5	12.5	10.6	6.0	8.5	4.7	11.4	13.4	9.4	5.9	14.5	7.0	7.1	6.9	6.5	14.5	9.8	7.6	8.5	11.3	7.0	18.8	8.4	6.8	5.3	10.2	11.6	18.7	12.1	9.0	9.9	16.3	9.5	13.8	14.3
AUH		ENSG00000148090	"AU RNA binding methylglutaconyl-CoA hydratase"	Q13825	9	91213815-91361913	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	"Lyase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004171	Enhanced				"Intracellular and membrane"					"HPA004171: AB_1845215"	"unprognostic (4.10e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (0.00e+0)"	"unprognostic (8.23e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	13.0	39.6	14.3	15.6	20.1	3.8	15.2	22.5	20.7	14.1	19.8	10.5	25.3	19.2	11.1	16.0	8.9	10.7	11.4	30.4	15.4	19.7	50.4	21.3	9.7	6.7	19.1	9.0	11.8	20.7	27.0	10.1	13.1	16.3	23.8	14.4	10.6	20.1	35.4	31.0	6.7	16.0	10.4	15.2	7.7	17.7	6.1	12.1	9.1	17.5	11.8	8.9	10.2	10.5	8.7	5.8	16.1	4.6	9.9	10.0	5.3	4.5	4.4	6.3	3.2	7.8	8.4	9.7	4.1	5.2	3.2	3.7	2.5	5.9	5.4	4.3	4.3	6.7	9.3	5.2	4.6	41.3	7.9	3.6	4.9	14.8	5.9	5.3	3.8	7.0	6.6	2.6	8.9	3.9	5.1	8.1	3.7	4.4	7.2	11.9	7.8	6.5	4.3	5.0	9.2	14.0	2.4	6.4	4.6	6.1	14.7	7.7	2.7	3.5	4.0	3.2	4.0	4.7	3.9	9.3	7.8	1.8	5.1	4.3	2.1	15.2	4.6	16.1	6.9	3.2	7.9	7.8	7.6	10.0	4.2	8.7	9.6	8.8	7.1	9.9	2.1	5.8	9.3	5.3	14.3	20.1	22.5	20.7	15.4	19.7	19.1	9.0	16.3	12.1
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;lymphoid tissue: 59.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 10.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"CAB005862: AB_449204, HPA037708: "	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.2	1.3	0.4	22.1	0.6	19.7	2.0	0.6	0.6	2.6	5.8	0.5	0.9	5.9	0.9	1.3	17.1	0.3	2.2	1.0	0.4	0.2	1.4	1.8	2.4	17.8	0.4	0.4	0.8	0.6	0.0	0.4	3.8	0.8	0.9	5.5	0.7	2.7	0.4	2.1	5.0	8.1	1.3	0.7	11.2	4.2	1.2	0.4	59.9	0.5	8.0	19.1	2.1	5.0	2.3	0.8	1.2	0.6	0.5	10.9	1.4	41.0	28.2	42.0	20.2	0.9	1.4	16.1	19.7	10.6	40.8	37.7	36.5	12.4	41.0	10.2	7.8	30.2	30.5	13.5	33.8	18.0	50.1	24.4	16.1	30.8	0.1	12.9	24.0	0.7	0.6	23.9	15.0	18.8	15.2	15.9	17.9	19.5	46.8	18.3	26.1	12.6	31.7	38.7	17.0	8.9	8.1	9.1	13.0	17.5	7.9	13.4	13.8	8.7	7.3	16.4	16.9	14.7	51.2	11.6	7.7	30.8	7.9	19.6	33.1	0.0	0.6	0.9	0.6	0.4	0.2	1.6	1.9	3.1	0.8	2.3	0.2	1.0	1.2	0.5	0.3	0.2	10.9	1.4	0.4	0.6	0.6	0.6	0.4	0.2	0.4	0.4	0.8	0.4
AURKC	"ARK3, AurC, STK13"	ENSG00000105146	"Aurora kinase C"	Q9UQB9	19	57230802-57235548	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"testis: 72.0"	"Cell line enriched"	"Detected in some"	7	"NTERA-2: 29.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA034859	Uncertain									"HPA034859: AB_10670298"	"unprognostic (7.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.07e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-5)"	"unprognostic (4.26e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.46e-4)"	0.6	0.5	0.9	0.9	1.2	0.7	1.5	0.7	2.0	0.4	0.6	0.6	0.2	0.0	0.8	1.3	0.5	0.6	2.6	0.9	0.9	1.1	0.8	1.8	1.3	2.2	1.2	0.2	0.4	0.5	0.1	1.3	1.2	1.7	0.5	0.8	1.1	0.5	0.9	2.3	0.6	0.4	1.1	2.1	3.4	0.4	72.0	0.6	0.7	0.8	1.0	1.3	0.5	0.4	2.1	1.0	1.7	1.0	1.0	0.6	0.2	0.2	0.1	0.7	0.3	0.2	0.7	0.3	1.2	0.6	0.9	3.4	0.8	0.1	0.0	0.1	0.5	0.0	0.0	0.7	0.6	0.0	3.7	0.1	0.3	0.0	1.1	0.0	0.2	0.9	0.7	0.7	0.5	0.6	0.1	0.0	1.2	0.0	1.1	0.6	29.3	0.8	0.1	0.2	0.6	0.6	1.2	1.4	0.4	0.0	0.2	0.1	0.1	1.3	0.3	0.2	4.1	0.3	0.7	1.4	1.8	0.6	0.8	0.0	0.0	0.0	0.1	1.7	0.6	1.0	0.0	1.9	0.0	0.0	0.9	2.1	0.0	0.0	0.1	1.0	0.3	1.0	0.0	0.2	0.9	1.2	0.7	1.6	0.9	1.1	1.2	0.2	1.7	0.6
AXL	"ARK, JTK11, Tyro7, UFO"	ENSG00000167601	"AXL receptor tyrosine kinase"	P30530	19	41219203-41261766	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Oncogene, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 66.1;U-251 MG: 70.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 8.8;plasmacytoid DC: 18.3"	"Group enriched"	"Detected in many"	14	"dendritic cells: 18.3;NK-cells: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032501, HPA037422, HPA037423, HPA075217"	Uncertain		Supported	"Vesicles,Plasma membrane,Actin filaments"		61000000	61000000	"Plasma membrane"	"Vesicles, Actin filaments"	"CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: , HPA075217: "	"unprognostic (2.20e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.53e-7)"	"unprognostic (1.16e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.83e-3)"	38.0	15.4	10.6	11.7	12.7	1.3	27.1	6.3	12.1	26.2	26.8	13.4	8.1	9.1	28.0	19.4	21.8	17.4	17.8	18.5	11.5	6.1	7.8	13.0	20.0	7.6	10.6	9.3	20.9	5.1	9.6	5.6	26.6	10.1	19.5	10.2	16.8	7.8	20.4	14.1	13.8	12.8	29.4	10.7	27.3	16.2	22.4	10.4	3.4	12.0	8.4	5.8	35.6	18.3	0.1	18.3	0.9	0.2	8.8	0.3	0.2	52.5	21.2	1.3	0.1	4.8	4.8	0.0	41.8	37.6	61.4	38.1	1.1	24.7	0.0	17.0	66.1	4.4	0.0	28.1	52.9	0.0	0.0	0.0	14.0	0.8	17.4	0.0	0.0	3.6	0.5	36.2	56.2	22.7	2.0	0.0	38.0	0.0	0.0	0.0	0.5	10.2	0.0	22.4	0.0	27.4	0.0	0.0	0.0	10.8	0.0	0.2	0.1	0.9	46.6	43.5	29.7	41.5	70.8	0.0	0.1	0.1	29.0	0.0	32.3	0.9	0.2	0.1	0.1	0.2	0.2	0.1	0.3	0.1	4.2	0.1	0.2	0.2	0.3	8.8	0.1	18.3	0.2	0.2	10.6	12.7	6.3	12.1	11.5	6.1	10.6	9.3	10.1	10.4
B3GALNT2	MGC39558	ENSG00000162885	"Beta-1,3-N-acetylgalactosaminyltransferase 2"	Q8NCR0	1	235449923-235504481	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 35.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012502, HPA050662"	Approved		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			Nucleoplasm	"Golgi apparatus"	"HPA012502: AB_1845228, HPA050662: "	"unprognostic (5.50e-2)"	"unprognostic (3.16e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.34e-3)"	5.0	6.3	3.9	4.3	5.1	1.3	8.4	4.7	4.5	5.4	7.6	3.5	5.1	3.3	8.0	8.7	10.3	6.1	9.7	7.9	2.8	2.9	3.7	4.6	3.7	3.1	3.0	3.2	5.9	35.7	9.8	8.9	4.5	4.7	8.3	5.8	8.5	8.7	7.3	21.6	6.1	6.9	16.9	2.5	3.3	9.2	5.8	3.9	4.7	7.1	7.0	5.0	9.7	5.9	1.5	5.7	2.4	2.7	1.9	1.9	1.3	10.0	6.6	7.3	10.8	11.8	10.0	17.6	8.8	8.0	6.7	6.2	5.1	9.0	5.3	11.7	10.0	12.7	14.2	10.3	8.2	10.4	9.8	3.3	8.4	5.8	7.5	10.8	3.7	7.2	6.7	6.9	16.6	10.2	8.1	7.1	6.2	4.8	6.8	3.9	10.4	3.8	7.5	12.2	13.4	4.3	12.0	9.4	12.0	15.3	5.8	7.6	11.1	11.0	10.0	5.9	9.7	9.9	11.8	10.4	8.5	3.2	3.8	7.8	13.6	2.4	2.3	1.1	1.1	2.7	1.7	1.5	0.8	1.9	5.7	1.1	1.0	1.3	0.2	1.9	2.5	3.1	0.5	1.3	3.9	5.1	4.7	4.5	2.8	2.9	3.0	3.2	4.7	3.9
B3GALT6	beta3GalT6	ENSG00000176022	"Beta-1,3-galactosyltransferase 6"	Q96L58	1	1232265-1235041	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (9.76e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (9.89e-2)"	12.2	9.4	13.4	9.9	11.7	3.0	10.2	10.3	17.2	10.0	7.5	11.1	9.5	7.2	11.9	9.3	7.7	11.9	7.1	12.6	13.7	12.9	9.8	19.5	10.1	12.3	9.4	7.9	11.4	14.7	14.1	10.4	12.3	10.4	9.6	6.0	11.4	9.9	8.7	9.6	13.4	7.0	9.3	8.4	12.9	9.2	8.4	10.8	14.7	10.1	7.0	7.7	8.2	9.0	5.2	5.1	2.9	4.1	6.0	6.6	2.2	10.4	5.3	9.1	9.5	9.2	6.2	7.1	11.1	9.5	9.4	7.7	4.7	10.7	7.9	6.7	6.6	9.4	3.9	6.0	5.7	13.7	14.9	14.5	5.3	4.4	9.5	9.0	9.2	5.8	4.5	6.2	6.1	7.0	10.1	7.1	9.5	5.9	12.1	16.2	11.7	20.1	11.7	3.6	6.3	9.3	3.2	37.5	15.4	8.3	9.8	5.6	8.2	12.9	7.5	9.7	4.3	6.0	16.0	4.4	3.8	7.2	7.6	20.2	11.0	2.9	2.8	0.9	3.8	3.5	6.6	3.1	3.9	4.5	3.8	5.2	3.4	4.1	1.4	6.0	4.1	5.1	1.6	2.2	13.4	11.7	10.3	17.2	13.7	12.9	9.4	7.9	10.4	10.8
B3GAT3	GlcAT-I	ENSG00000149541	"Beta-1,3-glucuronyltransferase 3"	O94766	11	62615296-62622175	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051328	Approved				"Intracellular and membrane"	1600000	1600000			"HPA051328: "	"unprognostic (1.55e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (4.69e-4)"	"unprognostic (3.80e-2)"	"prognostic unfavourable (5.11e-6)"	"unprognostic (4.94e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.46e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.58e-2)"	14.4	21.6	24.8	15.9	29.2	15.0	19.7	28.9	29.1	15.4	12.9	24.2	8.1	17.6	14.9	18.8	10.6	21.1	15.3	13.1	25.8	25.6	17.4	21.5	12.8	22.9	30.0	16.8	17.0	22.4	18.5	25.6	19.9	25.7	18.2	6.8	19.0	24.9	20.9	6.4	23.1	16.5	14.2	24.4	17.5	15.5	12.0	24.8	17.5	14.5	5.4	12.9	14.4	17.4	11.2	15.7	15.7	18.9	24.5	14.1	9.4	9.7	16.1	8.8	15.3	12.1	11.9	6.5	8.1	11.5	7.7	8.7	7.1	14.5	8.6	28.1	8.2	6.3	8.9	8.1	1.7	19.2	17.2	4.1	7.4	9.0	29.2	5.8	9.7	21.2	13.8	10.1	4.2	6.8	13.7	21.7	9.1	24.8	9.9	20.8	13.6	15.1	10.1	6.3	47.4	16.0	1.9	9.3	15.3	9.3	11.0	37.1	14.8	11.5	5.3	7.9	6.1	20.9	15.6	22.7	7.6	10.0	23.9	10.5	16.4	15.7	18.4	15.5	14.1	18.3	9.3	11.2	9.8	11.4	15.7	9.1	9.8	11.4	5.4	24.5	18.9	9.3	11.7	9.4	24.8	29.2	28.9	27.7	25.8	25.6	30.0	16.8	25.7	24.8
B4GALNT1	"beta1-4GalNAc-T, GALGT, SPG26"	ENSG00000135454	"Beta-1,4-N-acetyl-galactosaminyltransferase 1"	Q00973	12	57623410-57633355	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 22.0;HDLM-2: 18.7"	"Cancer enriched"	"Detected in many"	6	"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.9"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008968	Enhanced				"Intracellular and membrane"	9500	9500			"HPA008968: AB_1078253"	"unprognostic (3.18e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-5)"	"unprognostic (1.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (3.18e-14)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.92e-4)"	3.0	2.1	12.9	2.3	16.4	1.0	1.5	26.5	32.4	1.9	2.4	1.0	0.0	1.4	2.2	3.8	1.3	1.4	1.5	3.9	15.3	11.2	1.3	1.3	1.7	1.6	6.5	14.3	1.0	1.2	1.1	1.0	1.3	11.6	4.2	2.2	1.6	3.2	6.8	8.1	1.6	1.9	3.2	2.3	1.3	1.4	1.6	2.3	0.0	1.3	0.6	1.8	1.5	0.9	0.0	0.0	0.0	0.0	0.8	1.9	0.0	2.8	14.6	3.2	5.6	0.2	0.0	0.0	1.4	3.0	6.0	6.4	0.9	7.6	0.8	22.0	4.1	1.4	2.5	1.1	2.0	18.7	0.9	0.2	3.7	4.8	0.2	0.7	1.4	0.0	0.4	3.6	0.2	0.1	2.3	4.6	1.0	3.8	0.6	0.0	3.8	2.9	0.0	4.4	2.3	0.0	0.0	12.3	3.1	0.8	0.4	0.1	2.7	1.0	0.0	3.5	8.3	6.9	9.1	11.5	8.6	0.8	8.1	0.9	9.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	12.9	16.4	26.5	25.9	15.3	11.2	6.5	14.3	11.6	2.3
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 55.7;SiHa: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 56.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	98000000	98000000	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favourable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	32.0	19.5	4.5	22.5	4.5	22.1	35.1	5.9	3.5	25.4	20.4	6.4	29.1	6.5	19.5	34.1	24.7	26.3	24.2	33.1	3.2	2.5	31.7	91.2	34.9	44.9	5.8	2.2	56.8	20.1	30.2	11.9	79.0	5.9	22.6	11.1	32.1	39.1	42.7	15.0	17.6	18.9	17.7	6.4	38.5	19.9	37.6	3.6	23.1	39.3	16.9	41.0	26.4	21.6	24.8	56.4	24.9	9.1	18.2	16.5	5.4	15.9	11.8	2.2	3.0	11.2	19.8	39.9	16.6	20.9	10.0	10.0	7.2	18.6	6.1	10.6	24.2	8.6	2.2	20.6	10.1	55.7	2.2	3.5	49.2	5.5	22.1	2.8	5.9	22.1	36.9	11.4	14.0	10.6	3.9	7.6	9.5	13.9	2.5	5.7	1.3	3.6	3.4	2.0	4.0	30.1	13.9	1.6	2.1	105.0	20.5	4.1	25.9	5.2	9.8	7.2	8.5	23.1	6.4	1.2	2.8	3.8	22.3	3.9	2.6	6.2	9.1	5.0	13.0	7.8	16.5	24.8	8.7	11.4	6.1	20.7	5.3	6.7	24.9	18.2	6.0	56.4	5.7	5.4	4.5	4.5	5.9	3.5	3.2	2.5	5.8	2.2	5.9	3.6
B4GALT7	"beta4Gal-T7, XGALT-1"	ENSG00000027847	"Beta-1,4-galactosyltransferase 7"	Q9UBV7	5	177600100-177610347	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042330	Supported									"HPA042330: AB_10796576"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.97e-2)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.19e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.00e-2)"	13.8	33.0	16.0	20.4	14.3	20.7	19.1	10.6	19.6	13.3	12.4	14.9	20.4	16.1	15.5	15.9	11.7	13.3	20.3	17.3	13.7	18.0	16.2	21.3	12.0	21.5	15.1	17.9	16.9	37.0	15.5	23.9	15.3	14.3	16.4	11.7	14.7	22.4	20.9	14.4	12.9	13.7	12.2	10.8	16.3	16.2	16.1	11.7	10.4	16.7	9.8	18.6	13.0	10.2	15.8	16.3	11.2	16.1	8.5	12.5	9.0	8.5	15.1	6.4	15.9	12.7	9.6	28.7	13.3	14.1	12.1	13.9	14.3	13.6	11.0	24.6	13.5	10.2	4.3	28.5	5.3	36.7	11.5	5.8	11.8	9.9	18.4	6.0	10.1	14.6	10.1	13.0	10.6	13.4	5.0	10.6	12.3	19.9	5.0	7.3	6.2	22.3	10.4	4.6	12.0	9.2	13.0	5.6	6.5	6.6	13.4	11.7	8.6	7.0	10.3	15.5	8.9	10.1	13.1	13.3	6.1	7.8	13.1	14.4	14.0	11.2	14.6	7.8	12.5	16.1	11.3	12.8	11.6	11.0	16.3	15.8	10.5	10.3	1.0	8.5	15.3	12.8	7.5	9.0	16.0	14.3	10.6	19.6	13.7	18.0	15.1	17.9	14.3	11.7
BAAT	BAT	ENSG00000136881	"Bile acid-CoA:amino acid N-acyltransferase"	Q14032	9	101360417-101383519	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Serine esterase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 128.4"	"Cell line enhanced"	"Detected in some"		"A549: 6.1;CACO-2: 3.4;Hep G2: 2.4"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 181.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021251, HPA021330"	Enhanced		Uncertain	Vesicles		470000	470000	Vesicles		"HPA021251: AB_1845247, HPA021330: "	"unprognostic (2.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.68e-2)"	"prognostic favourable (4.97e-4)"	"unprognostic (2.14e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (4.24e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.8	0.0	0.1	0.1	0.2	128.4	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.0	0.7	0.1	0.1	6.1	0.4	0.3	0.0	0.0	0.0	0.3	0.1	0.1	0.3	3.4	0.1	0.6	0.2	0.0	0.3	0.1	0.2	0.5	0.3	0.1	0.5	0.2	2.4	0.0	0.9	0.3	0.0	1.0	0.1	0.0	0.0	0.7	0.4	0.5	0.1	0.2	0.3	1.0	0.7	0.2	1.1	0.2	0.6	0.2	0.3	0.4	0.4	0.2	0.5	0.0	0.2	0.1	0.6	0.6	0.2	0.4	0.4	0.6	0.5	0.5	0.2	0.6	0.3	0.2	0.0	0.7	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0
BAP1	"hucep-6, KIAA0272, UCHL2"	ENSG00000163930	"BRCA1 associated protein 1"	Q92560	3	52401013-52410350	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004322, HPA028814, HPA028815, HPA055560"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: , HPA055560: "	"unprognostic (1.52e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.41e-3)"	"unprognostic (8.53e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.64e-3)"	"unprognostic (3.30e-3)"	"prognostic favourable (3.29e-7)"	"unprognostic (6.37e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.92e-1)"	13.8	17.6	35.6	14.7	33.3	37.3	13.5	21.8	50.4	12.5	17.0	16.3	11.5	12.4	14.7	14.6	21.2	12.1	15.7	16.4	41.5	15.5	16.6	19.0	14.9	15.2	19.4	27.6	16.9	16.3	30.0	11.1	14.8	19.6	14.4	14.9	15.6	17.9	14.6	24.8	40.5	13.9	14.5	10.0	16.1	13.3	37.3	14.7	18.6	15.3	12.9	16.0	14.1	11.7	5.5	8.4	11.3	5.0	3.0	8.5	3.9	15.3	17.5	21.2	18.0	20.5	13.2	23.9	15.2	19.7	24.7	19.2	21.1	14.4	22.0	7.6	21.2	12.5	22.3	24.5	15.8	21.8	21.1	27.3	37.0	21.8	19.1	25.6	24.3	19.7	32.9	27.3	14.7	19.7	23.3	19.5	18.6	13.3	30.3	35.1	23.9	21.3	13.1	17.2	21.7	15.2	24.9	8.1	26.1	18.7	5.4	22.2	15.3	35.4	21.1	22.4	20.6	26.8	28.2	29.6	38.9	31.5	24.4	27.0	26.4	3.4	5.0	7.4	8.5	3.9	4.0	5.0	6.8	6.9	3.3	5.5	4.9	6.4	11.3	3.0	3.1	8.4	6.0	3.9	35.6	33.3	21.8	50.4	41.5	15.5	19.4	27.6	19.6	14.7
BAZ1B	"WBSCR10, WBSCR9, WSTF"	ENSG00000009954	"Bromodomain adjacent to zinc finger domain 1B"	Q9UIG0	7	73440398-73522278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037081, CAB037158, HPA067010"	Supported		Supported	"Nuclear bodies"				"Nuclear bodies"		"CAB037081: AB_477637, CAB037158: AB_477636, HPA067010: "	"unprognostic (1.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	23.3	22.3	21.4	26.4	23.9	20.7	24.6	32.4	23.4	24.6	24.2	21.1	34.1	15.3	26.3	19.8	18.1	20.6	16.5	19.8	22.4	21.4	17.1	23.4	19.4	24.7	29.3	19.4	31.8	20.2	34.9	27.0	23.1	22.3	23.1	20.5	16.4	18.0	30.8	28.9	14.6	19.2	28.7	22.9	22.2	18.8	16.2	27.3	46.5	23.5	17.9	27.7	24.7	24.4	5.3	6.2	6.1	3.1	5.6	6.3	1.7	20.6	21.3	29.4	32.8	15.2	16.3	9.8	20.1	15.5	19.4	20.5	17.3	15.7	39.1	4.7	17.9	14.6	35.7	13.4	29.3	22.0	18.1	23.3	25.3	14.9	17.0	35.1	19.7	11.6	13.1	23.9	29.5	15.4	40.5	24.6	21.7	19.6	35.9	16.2	19.0	16.0	36.6	25.8	26.0	11.0	16.3	29.5	25.2	28.7	32.1	16.8	19.7	17.6	18.0	33.7	19.4	20.2	34.2	14.3	22.7	67.1	19.1	33.3	30.5	6.1	3.1	1.9	6.3	2.2	5.5	2.5	4.8	4.6	2.1	5.3	3.8	4.1	2.2	5.6	1.7	6.2	4.7	1.7	21.4	23.9	32.4	23.4	22.4	21.4	29.3	19.4	22.3	27.3
BCAP31	"6C6-Ag, BAP31, CDM, DXS1357E"	ENSG00000185825	"B cell receptor associated protein 31"	P51572	X	153700492-153724746	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport"		"Deafness, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003906, CAB015350, CAB015424"	Supported	Approved	Enhanced	"Endoplasmic reticulum"		6800000	6800000	"Endoplasmic reticulum"		"CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270"	"unprognostic (1.02e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (9.87e-4)"	"unprognostic (3.25e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	60.7	43.4	38.3	20.3	38.8	27.4	71.3	22.2	48.1	28.7	31.8	27.1	27.5	28.8	30.2	48.6	42.4	31.0	26.8	26.7	34.1	36.5	41.6	52.4	42.2	50.0	38.1	26.0	29.1	67.6	36.0	27.4	43.6	44.5	34.3	36.6	30.7	44.5	37.7	15.6	37.3	37.8	32.4	33.6	36.7	24.8	31.6	21.1	25.4	53.1	27.2	37.1	38.1	30.8	72.7	109.7	104.4	97.5	68.2	89.8	150.4	54.7	51.7	14.4	71.8	63.8	19.4	33.3	26.6	30.6	31.8	40.8	41.6	40.3	32.1	121.7	43.1	55.6	35.8	55.9	26.6	15.8	53.4	20.2	40.9	35.7	31.3	32.9	43.9	25.8	48.6	30.9	36.4	38.8	27.4	58.6	35.5	57.3	21.1	44.8	16.4	53.5	23.0	16.0	71.9	49.7	60.2	18.8	26.6	11.9	59.3	40.0	21.7	37.2	40.4	27.9	27.5	37.7	53.3	60.1	115.8	42.6	54.5	44.6	24.4	80.3	80.6	77.5	89.0	86.1	79.5	71.2	89.8	88.1	69.9	72.7	79.4	86.4	104.4	68.2	97.5	109.7	72.4	150.4	38.3	38.8	22.2	48.1	34.1	36.5	38.1	26.0	44.5	21.1
BCKDHA	"MSU, OVD1A"	ENSG00000248098	"Branched chain keto acid dehydrogenase E1, alpha polypeptide"	P12694	19	41397460-41425005	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036640	Supported									"HPA036640: AB_10671964"	"unprognostic (4.50e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.26e-2)"	"prognostic favourable (9.37e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.53e-1)"	"prognostic favourable (5.33e-10)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (3.27e-5)"	"unprognostic (9.66e-2)"	18.4	36.1	11.5	9.2	14.9	11.4	12.9	9.3	19.3	12.5	11.2	16.6	25.0	11.2	11.0	11.2	31.0	15.0	12.4	41.1	10.8	9.5	23.4	47.6	12.3	17.0	16.0	17.6	13.8	28.2	15.7	12.6	13.4	12.7	12.6	8.8	15.0	23.1	31.1	61.7	15.6	10.4	10.8	11.2	13.2	22.0	21.2	13.5	15.8	21.8	25.3	15.9	14.0	15.1	16.5	45.9	17.6	38.0	25.9	19.7	27.1	14.2	26.2	2.3	14.0	6.6	4.0	6.0	3.5	6.7	6.9	8.8	6.0	9.9	11.5	7.9	3.7	5.7	4.4	7.1	3.6	12.0	12.6	8.0	13.7	5.6	14.1	8.4	5.9	7.3	10.2	4.6	10.2	13.3	8.0	21.8	6.2	12.9	7.2	5.1	3.9	6.5	8.7	7.8	27.4	9.7	6.7	10.2	12.2	12.4	28.2	8.6	14.5	22.6	10.0	7.4	7.6	4.3	7.5	48.8	19.7	11.3	26.8	15.7	8.6	13.5	36.9	17.6	15.8	38.0	18.2	16.5	15.9	16.1	45.9	16.4	13.4	15.3	10.9	25.9	26.1	17.6	19.7	27.1	11.5	14.9	9.3	19.3	10.8	9.5	16.0	17.6	12.7	13.5
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoli,Mitochondria	"Intracellular and membrane"			Mitochondria	Nucleoli	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favourable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	13.9	12.0	9.9	9.0	12.2	5.8	18.1	9.5	14.3	10.2	17.3	22.7	9.4	9.1	11.6	7.7	10.2	10.9	7.4	14.7	11.9	7.6	24.7	58.6	6.4	8.1	11.3	11.2	13.9	12.1	13.7	15.5	5.5	14.1	13.1	16.5	11.7	30.5	10.3	8.2	8.6	11.8	11.5	16.7	5.3	15.0	10.0	12.4	11.2	12.5	7.9	7.7	14.0	8.2	9.1	10.3	2.6	4.3	13.4	15.7	5.2	6.9	2.6	9.9	13.2	10.0	8.8	7.9	4.9	10.3	8.1	11.2	4.2	9.6	19.7	5.3	11.8	7.0	5.5	6.5	11.5	24.5	8.1	9.7	6.8	5.7	11.2	13.9	4.4	8.4	6.8	5.6	7.0	9.7	8.2	17.7	18.2	3.8	5.0	8.1	7.3	3.4	12.8	30.7	16.8	22.6	10.6	6.6	9.3	8.4	7.0	4.9	9.0	10.7	4.1	4.9	3.4	4.5	6.6	12.6	12.3	6.5	6.0	10.4	7.3	2.6	3.4	0.8	8.5	4.0	11.1	9.1	7.2	7.2	6.6	9.1	9.6	10.0	0.7	13.4	4.3	10.3	15.7	5.2	9.9	12.2	9.5	14.3	11.9	7.6	11.3	11.2	14.1	12.4
BCKDK		ENSG00000103507	"Branched chain ketoacid dehydrogenase kinase"	O14874	16	31106107-31112791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 26.8;granulocytes: 26.6;monocytes: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017995, HPA056067"	Supported		Supported	Mitochondria				Mitochondria		"HPA017995: AB_1845309, HPA056067: "	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.85e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.97e-2)"	15.4	29.7	11.9	13.1	15.0	9.4	18.3	18.8	21.3	11.7	14.1	9.6	19.9	11.2	14.8	14.9	14.9	13.8	15.1	39.2	14.2	10.3	21.3	46.5	18.2	32.5	10.7	17.3	15.1	52.4	17.4	8.9	11.4	13.2	14.9	9.9	10.4	33.9	25.7	67.7	21.5	12.2	19.9	15.6	16.0	19.9	11.2	9.3	8.0	11.7	25.9	10.6	15.3	12.0	6.9	26.8	26.6	33.0	6.3	6.8	13.6	18.1	20.4	11.5	17.3	14.2	14.3	12.5	15.8	19.5	24.6	24.1	13.3	12.1	17.0	23.0	19.7	12.6	8.1	27.5	15.9	13.7	25.3	18.4	13.9	24.2	25.1	9.5	16.9	21.0	11.1	21.1	17.6	26.2	9.3	16.1	36.8	30.9	8.8	12.6	9.8	16.5	17.8	16.8	31.3	18.8	12.5	17.8	16.3	12.3	30.3	9.8	18.2	9.2	16.8	18.8	10.9	19.2	13.1	16.8	6.0	6.0	21.3	13.8	17.6	12.2	33.0	23.1	5.7	27.4	5.6	6.9	5.2	4.2	26.8	5.4	4.4	5.0	26.6	6.3	19.3	5.8	6.8	13.6	11.9	15.0	18.8	21.3	14.2	10.3	10.7	17.3	13.2	9.3
BCO1	"BCDO, BCDO1, BCMO, BCMO1, FLJ10730"	ENSG00000135697	"Beta-carotene oxygenase 1"	Q9HAY6	16	81238448-81291142	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 28.1;retina: 62.0"	"Cell line enhanced"	"Detected in some"		"A549: 12.5;EFO-21: 9.5;HAP1: 3.6;NTERA-2: 5.1;RPTEC TERT1: 9.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA043811			Uncertain	"Actin filaments,Centriolar satellite"				"Actin filaments, Centriolar satellite"		"HPA043811: AB_10962487"	"unprognostic (2.78e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.01e-4)"	"unprognostic (1.65e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.09e-1)"	0.1	0.0	1.3	0.2	1.4	0.0	0.2	0.2	1.6	0.3	28.1	0.3	1.4	11.0	0.7	0.5	0.7	0.6	1.4	0.1	1.7	1.9	4.2	2.5	0.3	0.1	0.8	0.1	2.0	0.4	0.0	1.9	0.1	5.9	1.3	3.6	62.0	1.3	2.8	0.6	0.3	16.9	0.4	0.4	0.1	2.3	0.2	0.3	0.3	0.2	0.5	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	2.5	0.0	9.5	0.0	0.1	3.6	0.0	0.0	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	5.1	0.0	0.0	0.0	0.0	9.6	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.2	1.6	1.7	1.9	0.8	0.1	5.9	0.3
BCS1L	"BCS, BJS, h-BCS, Hs.6719"	ENSG00000074582	"BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone"	Q9Y276	2	218658764-218663443	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Chaperone	"Deafness, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037700, HPA037701"	Supported									"HPA037700: AB_10794619, HPA037701: AB_10805235"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.28e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.21e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.38e-2)"	"prognostic favourable (3.31e-4)"	13.4	19.5	16.4	12.6	19.8	10.5	16.2	15.6	23.4	14.1	15.8	18.3	15.8	15.2	22.0	15.1	18.1	19.7	15.2	26.8	14.3	13.5	18.8	29.1	10.7	13.2	19.5	18.5	21.2	26.6	18.9	18.4	11.4	21.9	17.2	16.6	14.8	17.2	18.3	23.4	18.1	13.0	16.7	14.2	15.9	15.5	7.3	18.9	7.2	16.2	15.8	13.2	14.5	14.9	10.9	19.7	11.5	9.8	5.2	10.2	7.9	6.7	14.0	8.0	11.1	18.3	12.3	12.0	11.6	6.4	18.8	13.8	37.1	11.4	10.2	17.0	11.6	18.8	25.9	29.9	10.7	14.8	28.2	16.3	18.0	30.4	21.0	14.1	10.0	15.6	23.0	25.5	33.5	18.8	22.9	14.7	16.7	22.9	10.5	19.0	9.9	17.9	15.2	10.0	15.9	15.7	12.9	17.2	7.5	8.2	19.9	14.6	10.3	14.1	10.9	14.2	11.7	9.1	15.8	11.5	8.9	16.9	8.9	21.7	13.2	11.5	9.8	7.9	8.7	5.8	10.0	10.9	7.0	8.2	19.7	10.1	8.5	10.2	1.2	5.2	0.8	11.1	9.9	7.9	16.4	19.8	15.6	23.4	14.3	13.5	19.5	18.5	21.9	18.9
BEST1	"BEST, BMD, RP50, VMD2"	ENSG00000167995	"Bestrophin 1"	O76090	11	61949821-61965515	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 218.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 9.2;SK-MEL-30: 32.8;U-266/70: 8.8"	"Group enriched"	"Detected in some"	6	"glioma: 2.0;melanoma: 6.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 23.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 23.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057464	Enhanced									"HPA057464: "	"unprognostic (2.41e-3)"	"unprognostic (3.67e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-10)"	"unprognostic (1.38e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.72e-3)"	5.2	2.9	7.4	9.5	11.8	26.4	2.3	1.6	12.6	2.0	1.4	16.0	0.7	2.1	2.6	9.6	3.0	2.6	6.2	2.5	9.2	5.3	1.4	1.1	4.7	2.5	14.8	6.0	3.7	2.2	0.5	1.4	2.8	9.4	1.6	1.3	218.0	1.2	1.9	0.7	3.0	2.0	2.1	16.9	5.4	1.3	3.9	13.3	0.3	2.3	0.4	0.6	3.9	2.3	0.3	1.6	23.3	2.8	0.1	0.1	0.9	0.5	0.5	0.2	0.4	9.2	1.9	0.9	0.6	1.1	0.2	0.7	0.2	0.3	0.1	1.3	0.6	0.7	0.0	0.0	0.1	0.1	0.1	0.0	3.5	0.5	2.8	0.1	0.3	2.6	1.1	1.2	2.5	0.0	0.4	5.1	1.1	0.3	0.1	0.4	0.0	1.3	0.0	0.1	0.2	0.0	1.2	0.6	0.5	1.0	0.1	32.8	0.5	1.3	0.1	0.5	0.3	0.5	0.2	8.8	0.5	0.5	3.4	0.3	1.0	1.5	2.3	2.1	0.1	2.7	0.1	0.3	0.1	0.1	1.6	0.1	0.1	0.0	23.3	0.1	2.8	0.3	0.1	0.9	7.4	11.8	1.6	5.9	9.2	5.3	14.8	6.0	9.4	13.3
BIRC3	"API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49"	ENSG00000023445	"Baculoviral IAP repeat containing 3"	Q13489	11	102317450-102339403	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.0;lymphoid tissue: 46.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.5;Daudi: 33.0;HDLM-2: 31.2;hTERT-HME1: 32.8;U-266/70: 22.0;U-266/84: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 32.9;naive B-cell: 32.9"	"Group enriched"	"Detected in many"	10	"B-cells: 32.9;T-cells: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002317	Enhanced	Approved	Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA002317: AB_1846748"	"prognostic favourable (3.60e-4)"	"unprognostic (2.89e-1)"	"prognostic favourable (9.35e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavourable (7.28e-4)"	"unprognostic (5.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (3.03e-4)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (6.66e-6)"	"unprognostic (6.42e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.85e-2)"	6.9	3.3	1.4	43.9	2.3	5.1	5.4	0.5	2.0	5.3	13.1	0.5	2.8	6.8	2.9	3.7	8.4	3.9	13.9	6.0	2.2	1.3	10.8	12.5	21.8	46.3	2.8	1.2	3.4	7.0	1.1	14.5	0.9	2.2	8.7	6.2	1.1	9.2	4.7	2.2	5.5	46.0	7.3	3.0	34.9	15.9	3.2	2.7	34.2	3.0	4.1	34.0	12.6	6.2	32.9	0.8	2.0	2.6	2.5	17.1	2.8	6.3	5.1	0.0	0.1	0.1	0.7	0.6	0.5	4.3	0.6	0.7	0.9	37.5	33.0	17.0	0.3	3.6	0.0	0.9	2.1	31.2	0.1	0.1	1.5	0.2	6.5	0.5	0.7	0.7	4.6	2.1	32.8	0.1	0.1	0.0	0.8	0.0	2.2	0.3	0.1	0.2	0.0	0.3	1.6	8.5	3.3	0.0	0.1	0.5	0.5	0.3	1.6	0.3	1.7	7.2	0.7	0.4	6.5	22.0	18.8	11.6	1.3	1.8	0.8	2.0	0.9	0.4	1.4	2.2	2.5	32.9	10.7	3.5	0.8	32.9	7.5	2.2	0.5	2.5	2.6	0.3	17.1	2.8	1.4	2.3	0.5	2.0	2.2	1.3	2.8	1.2	2.2	2.7
BLK	MGC10442	ENSG00000136573	"BLK proto-oncogene, Src family tyrosine kinase"	P51451	8	11486894-11564604	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"blood: 47.8;intestine: 23.5;lymphoid tissue: 39.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 43.0;REH: 11.6;RPMI-8226: 14.2;U-698: 21.0;U-87 MG: 8.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 47.8;naive B-cell: 33.9"	"Lineage enriched"	"Detected in many"	5	"B-cells: 47.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005093, HPA069571"	Approved		Approved	Nucleoplasm				Nucleoplasm		"CAB005093: AB_2274756, HPA069571: "	"unprognostic (6.50e-5)"	"unprognostic (4.22e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.98e-6)"	"unprognostic (1.59e-2)"	"unprognostic (8.94e-4)"	"unprognostic (1.02e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (9.05e-6)"	"unprognostic (5.62e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.16e-1)"	0.5	0.2	0.1	32.3	0.1	1.7	0.2	0.1	0.1	0.1	1.2	0.0	0.0	0.3	0.1	0.0	1.9	0.2	0.4	0.3	0.1	0.1	1.3	0.5	0.6	27.6	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.3	2.4	0.0	0.1	0.1	23.5	0.0	0.1	31.9	1.4	0.2	0.0	3.9	0.7	0.4	39.8	2.5	0.4	47.8	4.3	0.1	0.0	0.0	9.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.6	0.0	14.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	3.7	21.0	8.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	9.8	47.8	0.3	1.1	0.0	33.9	0.2	0.1	0.1	0.0	0.0	4.3	0.4	1.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"Bloom syndrome RecQ like helicase"	P54132	15	90717327-90816165	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 36.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	1.8	0.4	3.1	11.4	1.5	5.5	0.6	4.7	2.6	0.7	1.9	0.9	0.5	1.4	1.2	1.1	2.9	0.4	1.3	1.0	2.3	2.4	0.9	0.5	2.0	7.7	2.8	0.2	0.9	0.4	0.0	1.2	3.6	0.5	0.7	2.5	0.7	7.8	0.0	1.7	0.6	2.8	0.5	1.9	6.7	1.4	4.9	0.5	36.7	0.6	3.1	9.3	1.4	0.7	7.4	1.2	4.3	1.6	4.6	5.0	1.6	5.4	7.8	8.7	5.1	0.0	0.4	5.5	4.1	1.2	4.7	5.1	6.8	3.8	14.1	2.6	1.1	9.1	13.4	3.7	6.1	8.5	9.9	14.7	8.4	2.2	0.0	14.1	7.3	0.0	0.0	4.7	2.4	3.3	12.7	4.4	4.9	3.4	10.6	7.8	9.3	1.7	10.8	16.4	5.4	1.1	9.8	6.5	6.1	3.3	4.4	2.6	3.1	11.6	1.8	3.4	6.3	3.5	8.7	3.2	13.1	14.7	1.9	10.0	5.8	2.5	1.0	4.3	3.1	1.2	4.8	7.4	2.8	3.8	1.2	4.3	2.0	2.2	0.8	4.6	1.6	1.2	5.0	1.6	3.1	1.5	4.7	1.7	2.3	2.4	2.8	0.2	0.5	0.5
BLVRA	BLVR	ENSG00000106605	"Biliverdin reductase A"	P53004	7	43758680-43807342	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019709, HPA042865, HPA054322"	Approved		Supported	Cytosol		1600000	1600000	Cytosol		"HPA019709: , HPA042865: AB_10797024, HPA054322: "	"unprognostic (2.47e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.79e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.45e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.63e-2)"	"prognostic favourable (8.65e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.56e-2)"	31.7	13.1	14.5	16.2	14.7	23.8	22.5	13.3	21.9	22.7	25.9	9.1	12.6	5.2	19.3	58.7	35.8	18.7	17.5	21.7	11.9	16.2	26.8	6.0	27.7	25.1	15.8	15.4	26.4	14.8	19.3	13.1	12.2	20.5	21.8	8.8	17.2	17.9	21.1	23.0	15.1	12.2	26.4	10.6	40.9	17.7	9.3	6.7	12.1	19.0	21.3	21.5	28.5	18.9	4.9	23.2	27.5	61.6	3.4	14.0	30.7	11.4	22.3	6.5	27.1	13.9	18.6	0.3	7.8	24.3	13.4	16.4	5.3	6.9	0.0	15.1	12.4	15.1	19.9	19.8	11.5	53.8	13.9	24.7	20.5	32.6	35.5	2.7	9.3	12.6	33.6	14.1	9.4	22.7	16.4	13.7	10.1	12.4	8.6	1.5	8.8	25.7	19.0	11.3	62.2	29.7	6.4	8.4	25.9	16.0	16.0	13.0	36.0	18.5	13.8	12.3	13.7	5.4	13.3	18.5	14.6	0.0	20.1	11.2	19.1	7.8	50.5	27.5	7.0	61.6	6.6	4.9	14.0	11.7	23.2	2.4	7.5	5.8	4.5	3.4	57.7	3.4	13.6	30.7	14.5	14.7	13.3	21.9	11.9	16.2	15.8	15.4	20.5	6.7
BMP1	PCOLC	ENSG00000168487	"Bone morphogenetic protein 1"	P13497	8	22164736-22212326	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"lung: 72.2;placenta: 106.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014572	Enhanced				"Secreted to extracellular matrix"	2100000	2100000			"HPA014572: AB_1845390"	"unprognostic (1.24e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.75e-3)"	"unprognostic (7.05e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavourable (3.37e-9)"	"unprognostic (2.11e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.34e-2)"	6.9	11.7	2.7	3.6	4.6	1.1	5.9	7.8	4.2	8.1	5.8	3.1	3.7	4.4	9.4	5.2	4.8	7.7	5.4	3.4	2.6	1.3	4.9	9.2	72.2	3.2	3.4	1.5	5.2	3.7	2.8	2.2	106.2	3.5	6.5	4.7	4.6	2.4	4.6	2.4	6.8	5.7	11.0	3.6	3.2	2.9	2.2	3.6	1.0	7.1	2.4	2.9	9.9	9.5	0.0	0.9	0.1	1.4	0.8	2.2	0.4	4.6	4.8	1.3	6.2	15.3	11.3	6.8	20.3	16.9	10.4	9.6	2.5	3.0	1.1	12.7	18.6	10.2	1.6	5.4	2.0	1.0	2.1	1.7	7.3	2.9	12.5	0.7	3.5	12.9	8.5	8.1	2.6	10.0	2.2	2.1	5.6	1.7	0.5	1.0	0.8	2.6	1.1	3.3	4.9	9.0	0.7	0.8	3.3	14.6	0.8	3.3	0.9	2.0	12.7	2.7	6.0	6.5	6.0	1.0	0.6	0.2	5.3	2.7	7.5	0.0	1.4	0.0	2.2	0.7	1.4	0.0	0.4	1.0	0.0	0.0	0.3	1.7	0.1	0.8	0.5	0.9	0.0	0.4	2.7	4.6	7.8	4.2	2.6	1.3	3.4	1.5	3.5	3.6
BMPR1B	"ALK6, CDw293"	ENSG00000138696	"Bone morphogenetic protein receptor type 1B"	O00238	4	94757968-95158448	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Chondrogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.0;ductus deferens: 25.1;prostate: 25.3;seminal vesicle: 32.0"	"Cell line enhanced"	"Detected in many"		"A549: 18.3;MCF7: 9.2;SH-SY5Y: 15.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 32.4;prostate cancer: 24.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-3)"	"prognostic favourable (2.84e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-3)"	"unprognostic (7.89e-4)"	"unprognostic (6.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.63e-2)"	1.1	5.6	12.7	0.8	15.0	0.7	1.7	11.6	12.7	28.0	1.2	5.5	25.1	0.7	5.3	3.2	1.1	14.3	3.4	1.3	13.4	5.9	9.3	1.4	2.4	0.5	5.4	8.6	7.6	1.7	0.6	2.4	1.2	12.1	25.3	0.8	0.7	1.4	32.0	3.3	1.4	0.6	1.2	7.5	1.4	2.8	4.3	11.2	10.8	0.8	0.1	0.6	0.7	0.7	0.4	0.5	1.9	0.9	0.8	1.6	0.3	0.0	18.3	4.9	0.0	1.9	4.5	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.8	1.0	2.9	6.7	0.0	0.0	4.5	0.0	1.1	0.0	0.5	0.4	0.0	2.8	7.5	2.8	5.6	0.0	0.0	0.0	7.0	9.2	0.6	0.1	1.8	3.1	0.1	2.7	0.1	3.5	0.1	0.2	15.3	0.2	2.5	2.5	1.9	0.0	0.0	3.9	3.1	0.1	3.3	0.0	0.0	0.0	1.5	0.0	0.4	1.9	0.3	0.5	0.4	0.5	0.7	0.4	0.6	0.3	0.3	0.3	0.5	0.5	0.8	0.8	0.9	0.5	1.6	0.3	12.7	15.0	11.6	11.8	13.4	5.9	5.4	8.6	12.1	11.2
BPGM		ENSG00000172331	"Bisphosphoglycerate mutase"	P07738	7	134646808-134679813	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"placenta: 184.7"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 37.1;RT4: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016493, HPA028735"	Enhanced		Approved	Nucleoplasm,Nucleoli		69000000	69000000	Nucleoli	Nucleoplasm	"HPA016493: AB_1845414, HPA028735: AB_10600791"	"unprognostic (2.56e-1)"	"prognostic favourable (7.95e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.67e-3)"	"unprognostic (7.42e-2)"	"unprognostic (5.69e-2)"	"prognostic favourable (1.54e-8)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.78e-2)"	6.1	7.3	13.6	4.5	11.1	37.7	6.9	11.7	11.6	7.1	6.9	9.1	6.1	4.3	5.4	10.2	14.6	4.7	6.9	7.3	12.5	14.2	19.1	8.1	8.0	5.2	13.9	7.8	5.7	5.4	16.5	14.4	184.7	12.4	7.5	5.4	6.7	10.6	10.3	17.7	5.5	6.0	6.6	15.9	8.6	6.8	7.4	8.8	8.5	7.5	22.2	13.3	24.9	9.5	11.6	10.2	28.2	12.8	9.8	14.5	12.8	4.4	5.4	7.2	9.7	8.3	4.9	7.2	13.4	16.2	5.2	7.8	2.1	6.0	5.4	4.0	7.5	3.6	7.6	7.4	9.2	37.1	6.7	3.1	5.0	2.5	5.7	5.9	4.1	4.8	6.7	9.8	5.3	18.9	9.0	6.8	12.3	2.1	9.6	8.2	7.4	5.2	7.3	5.1	3.9	11.8	59.6	6.2	10.4	6.2	7.5	6.7	4.9	3.8	14.3	8.3	2.0	11.1	10.8	11.3	12.9	6.8	14.4	5.7	14.2	28.2	9.8	27.6	14.5	12.8	10.4	11.6	9.5	12.7	10.2	10.5	13.2	13.4	18.0	9.8	12.5	6.7	12.0	12.8	13.6	11.1	11.7	11.6	12.5	14.2	13.9	7.8	12.4	8.8
BRCA1	"BRCC1, FANCS, PPP1R53, RNF53"	ENSG00000012048	"BRCA1, DNA repair associated"	P38398	17	43044295-43170245	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 9.1;granulocytes: 9.7;monocytes: 12.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001946, HPA004840, HPA034966, HPA057371"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: "	"unprognostic (7.87e-3)"	"unprognostic (6.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.56e-3)"	"unprognostic (4.14e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.31e-2)"	4.8	4.3	6.0	9.6	11.3	15.3	5.1	12.9	10.6	5.4	9.2	3.4	6.8	4.3	5.4	5.5	9.1	5.5	3.3	6.5	6.6	5.3	4.2	7.7	4.9	13.0	7.5	5.9	5.1	4.7	4.2	11.0	5.3	10.5	4.1	10.4	3.7	5.4	7.4	7.3	8.3	6.7	5.5	9.2	5.9	5.1	17.6	7.0	10.9	15.6	7.3	14.6	5.5	5.6	2.0	9.1	9.7	12.7	1.4	1.3	10.7	15.5	25.2	13.9	11.1	2.3	5.2	13.6	18.3	7.9	15.4	14.7	15.3	12.1	35.9	3.4	7.0	18.0	18.9	10.2	25.9	16.4	13.8	16.9	19.8	13.2	0.5	30.1	14.7	1.4	1.7	23.2	7.4	7.9	25.4	15.4	14.5	10.3	25.2	9.9	7.6	6.7	17.4	29.3	14.7	5.7	15.1	9.6	10.3	14.1	4.7	6.9	12.4	13.9	5.2	13.8	11.2	17.8	19.1	7.2	17.6	27.6	11.1	17.9	14.4	4.6	12.7	1.8	1.3	4.0	1.3	1.1	1.3	1.0	9.1	2.0	1.2	1.3	9.7	1.4	1.5	1.4	0.4	10.7	6.0	11.3	12.9	10.6	6.6	5.3	7.5	5.9	10.5	7.0
BRCC3	"BRCC36, C6.1A, CXorf53"	ENSG00000185515	"BRCA1/BRCA2-containing complex subunit 3"	P46736	X	155071420-155123074	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Metalloprotease, Protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA048737			Supported	Nucleoplasm				Nucleoplasm		"HPA048737: "	"unprognostic (1.16e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.71e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.90e-1)"	12.9	14.8	11.3	11.2	16.5	14.0	12.9	20.0	18.6	11.8	19.5	9.1	15.2	16.7	9.4	11.8	20.4	12.1	8.3	10.3	10.3	12.1	18.3	12.3	9.4	12.5	10.4	10.5	10.7	12.2	14.3	11.8	14.2	15.3	12.2	19.5	8.7	15.5	12.6	21.3	10.0	19.2	13.1	8.9	11.1	13.7	3.9	12.9	10.2	13.9	13.7	12.7	11.4	11.6	13.4	16.2	25.0	17.8	21.0	19.0	12.3	31.4	19.5	8.2	6.4	6.2	5.1	13.6	12.9	8.2	7.9	17.5	17.6	13.8	30.3	23.6	8.2	12.2	21.1	11.5	11.5	17.6	16.9	6.1	30.7	14.6	5.5	21.4	9.5	6.3	5.2	12.9	11.0	10.8	9.9	9.0	6.4	13.3	8.2	7.6	7.3	13.9	12.9	14.1	12.6	9.5	14.9	13.5	5.8	8.5	13.6	7.7	9.4	7.3	12.1	7.1	10.9	10.4	19.4	11.5	18.7	39.4	10.3	20.1	8.2	22.6	14.7	25.0	16.2	17.8	19.0	13.4	16.0	14.8	16.2	11.8	12.5	14.0	8.0	21.0	16.9	10.4	18.6	12.3	11.3	16.5	20.0	18.6	10.3	12.1	10.4	10.5	15.3	12.9
BRIP1	"BACH1, FANCJ, OF"	ENSG00000136492	"BRCA1 interacting protein C-terminal helicase 1"	Q9BX63	17	61681266-61863521	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.1"	"Cell line enhanced"	"Detected in many"		"MCF7: 41.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.2;granulocytes: 2.1;T-cells: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005474	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA005474: AB_2667333"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"prognostic favourable (3.45e-5)"	"unprognostic (6.85e-4)"	"unprognostic (3.09e-1)"	"prognostic favourable (3.62e-4)"	"unprognostic (2.60e-3)"	"unprognostic (5.60e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.41e-12)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.62e-3)"	1.0	0.9	0.7	6.3	3.5	9.1	1.1	0.6	1.4	1.4	2.6	0.2	0.6	2.8	1.5	1.2	3.7	0.8	1.8	0.4	0.5	0.5	0.6	2.3	1.3	4.0	0.5	0.9	2.1	1.3	0.1	0.4	1.7	0.7	1.0	2.8	0.4	1.4	0.0	0.4	2.7	5.5	1.0	0.5	2.3	1.3	10.8	0.4	30.1	0.4	2.0	6.6	1.3	1.7	2.2	0.5	2.1	0.3	0.6	3.7	0.5	12.3	4.2	12.2	6.9	0.4	1.1	2.7	11.4	6.7	12.2	15.8	4.3	3.9	7.3	2.6	2.4	4.5	6.3	2.3	16.4	1.8	7.7	7.5	6.7	5.3	0.1	9.6	4.4	0.2	0.1	9.7	2.6	2.6	5.2	5.0	7.6	41.4	15.2	3.3	2.6	3.6	9.5	23.4	3.5	1.6	5.6	4.9	12.7	4.4	1.5	1.8	4.1	3.7	2.2	18.0	13.1	6.6	13.1	3.1	6.0	7.9	3.7	4.6	4.5	2.1	0.3	1.5	0.5	0.2	0.6	2.2	1.2	0.6	0.4	1.8	1.8	0.9	1.0	0.6	0.2	0.5	3.7	0.5	0.7	3.5	0.6	1.4	0.5	0.5	0.5	0.9	0.7	0.4
BSND	"BART, DFNB73"	ENSG00000162399	"Barttin CLCNK type accessory beta subunit"	Q8WZ55	1	54998193-55011784	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Bartter syndrome, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 3.9;kidney: 12.3;salivary gland: 4.2"	"Cell line enriched"	"Detected in single"	20	"RPMI-8226: 12.9"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.5"					"Group enriched"	"Detected in some"	5	"basophil: 1.3;neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053836, HPA060617"	Enhanced									"HPA053836: AB_2682277, HPA060617: AB_2732651"	"unprognostic (3.38e-2)"	"unprognostic (9.17e-2)"		"unprognostic (2.27e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.35e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.51e-1)"		"unprognostic (1.78e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.57e-1)"			0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.3	0.0		0.0	0.0		4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2			0.0		0.0	0.0	0.0	0.4	0.2	3.9	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	12.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.3	0.2	0.5	0.2	0.4	0.1	0.1	0.1	0.4	0.2	0.2	3.9	0.1	0.4	0.2	0.1	0.1										
BTD		ENSG00000169814	Biotinidase	P43251	3	15601341-15647640	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052275	Uncertain				"Secreted to blood"	2900000000	2900000000			"HPA052275: "	"unprognostic (6.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.37e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.37e-3)"	"unprognostic (4.26e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (2.60e-9)"	"unprognostic (2.44e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.73e-2)"	18.5	17.9	7.5	3.9	10.2	4.4	13.5	17.0	11.8	11.2	28.1	19.6	12.2	25.3	12.3	34.1	7.1	10.3	10.4	6.9	8.0	6.8	20.0	50.7	8.2	5.2	12.3	9.5	17.2	26.6	19.6	11.1	10.7	9.3	10.7	9.4	20.0	11.6	12.1	6.9	6.5	40.5	7.9	8.8	7.6	12.9	15.0	12.6	5.9	14.8	3.8	6.2	11.7	9.1	8.4	13.7	31.0	11.9	7.5	15.6	8.7	3.8	10.8	3.3	3.2	28.2	7.8	19.6	7.0	9.4	8.3	15.0	3.8	10.3	1.0	8.4	16.1	4.3	2.6	8.3	9.7	3.3	5.5	5.9	14.5	11.6	6.8	2.9	6.9	9.5	8.6	21.8	2.2	15.9	3.8	13.7	23.3	4.6	1.6	3.4	3.6	6.0	2.1	8.2	13.0	8.0	7.8	2.3	5.7	8.3	2.0	11.0	10.2	5.6	10.8	9.0	6.9	8.3	4.4	3.2	4.8	1.2	10.5	3.5	6.5	31.0	11.9	25.2	13.2	11.1	12.3	8.4	14.1	11.3	12.1	7.8	12.2	9.2	10.8	7.5	8.4	13.7	15.6	8.7	7.5	10.2	17.0	11.8	8.0	6.8	12.3	9.5	9.3	12.6
BUB1B	"Bub1A, BUBR1, MAD3L, SSK1"	ENSG00000156970	"BUB1 mitotic checkpoint serine/threonine kinase B"	O60566	15	40161023-40221136	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 49.5;testis: 25.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.8;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA008419			Supported	Cytosol				Cytosol		"HPA008419: AB_1078308"	"unprognostic (4.40e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (7.43e-6)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (3.69e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (1.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.94e-2)"	1.0	0.9	0.3	18.4	0.6	11.4	1.5	0.4	0.5	1.3	4.0	0.4	0.1	3.3	1.1	0.8	6.5	0.5	1.1	0.6	0.4	0.4	0.8	0.7	1.8	8.7	0.4	0.3	0.6	0.5	0.0	0.4	3.4	0.5	0.6	4.4	0.3	1.6	0.1	0.7	2.3	2.9	1.2	0.6	5.4	1.7	25.6	0.1	49.5	0.5	3.1	10.6	1.1	2.0	2.8	2.8	0.0	0.2	0.7	0.7	0.5	21.6	11.0	35.1	13.9	0.8	2.5	11.3	20.5	11.5	22.0	19.1	16.0	8.3	19.6	11.5	7.4	24.4	33.1	11.1	24.0	16.8	17.8	28.6	28.4	14.9	0.0	25.7	15.7	0.5	0.6	13.4	12.7	15.9	24.6	20.9	21.9	7.3	20.2	15.7	23.7	12.5	21.7	28.8	14.8	6.7	11.0	22.9	14.1	12.7	12.1	4.5	14.1	13.4	9.2	16.9	17.9	16.8	18.2	10.9	18.5	32.0	9.0	29.0	21.9	0.0	0.0	0.0	0.2	0.2	0.3	2.4	0.7	0.6	0.7	2.8	0.1	0.4	0.0	0.7	0.1	2.8	0.0	0.5	0.3	0.6	0.4	0.5	0.4	0.4	0.4	0.3	0.5	0.1
C1QBP	"gC1Q-R, gC1qR, HABP1, p32, SF2p32"	ENSG00000108561	"Complement C1q binding protein"	Q07021	17	5432777-5448830	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA026483	Supported		Approved	"Plasma membrane,Mitochondria"	"Intracellular and membrane"	930000	930000	"Plasma membrane"	Mitochondria	"HPA026483: AB_1847108"	"unprognostic (2.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-3)"	"unprognostic (6.03e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.97e-1)"	24.1	51.6	34.0	51.0	31.4	36.3	42.3	25.8	46.2	22.0	48.8	21.1	22.5	33.9	25.8	25.7	51.1	27.1	33.0	47.1	34.8	35.4	48.4	69.0	26.6	81.1	35.4	25.1	25.2	51.9	32.7	31.2	26.7	36.6	23.8	52.2	24.9	25.1	28.0	55.0	27.3	30.0	29.2	27.8	43.8	26.4	21.3	17.2	55.4	28.1	71.9	46.0	25.5	25.4	59.5	68.1	9.9	35.8	39.0	55.6	65.7	48.8	76.0	26.9	43.4	20.1	24.8	36.4	37.5	30.7	87.4	53.8	72.7	16.4	105.0	37.1	28.3	43.8	86.4	50.9	80.9	24.0	148.7	48.3	39.5	84.5	32.1	58.9	38.5	27.4	46.8	48.0	69.5	44.5	57.4	26.9	33.9	34.1	83.6	42.6	60.6	45.5	66.7	38.1	57.3	50.4	37.0	21.6	40.5	30.8	39.6	52.2	25.0	29.8	26.1	28.1	25.6	31.9	81.4	14.1	21.5	46.2	26.8	56.7	43.0	9.9	34.7	8.3	40.1	35.8	52.5	59.5	45.0	39.9	68.1	49.4	55.6	46.3	2.8	39.0	26.9	56.9	34.3	65.7	34.0	31.4	25.8	46.2	34.8	35.4	35.4	25.1	36.6	17.2
C2		ENSG00000166278	"Complement C2"	P06681	6	31897785-31945672	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 132.7"	"Group enriched"	"Detected in some"	5	"Hep G2: 16.9;Karpas-707: 52.8"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 100.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"classical monocyte: 2.9;intermediate monocyte: 6.4;non-classical monocyte: 6.5"	"Lineage enriched"	"Detected in single"	8	"monocytes: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			CAB016775	Supported				"Secreted to blood"	52000000000	52000000000			"CAB016775: "	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.27e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavourable (2.64e-7)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.55e-2)"	9.2	3.2	0.9	4.8	1.5	0.8	5.0	1.2	1.3	2.0	5.3	1.8	1.6	2.5	2.0	4.8	1.9	3.3	3.2	5.4	0.8	0.8	13.1	132.7	19.4	13.1	1.2	0.3	2.7	2.1	0.8	2.8	7.6	1.7	1.8	4.3	2.9	2.4	1.5	0.7	1.6	6.6	3.5	1.8	12.1	1.9	2.0	1.0	1.8	1.2	0.8	3.4	2.7	1.5	0.2	0.5	0.8	6.5	0.1	0.3	1.2	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.6	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	16.9	0.3	0.0	0.2	0.9	0.1	0.2	0.0	0.0	0.1	52.8	0.0	0.0	0.1	0.2	0.1	0.0	0.0	1.3	0.6	0.0	0.0	0.1	0.1	1.0	0.1	0.0	0.1	2.3	0.1	0.1	0.2	0.2	0.0	0.2	6.6	1.0	0.2	0.3	0.0	0.1	2.9	0.0	0.1	6.4	0.1	0.1	0.1	0.1	0.5	0.2	0.3	0.2	0.8	0.1	6.5	0.0	0.1	1.2	0.9	1.5	1.2	1.2	0.8	0.8	1.2	0.3	1.7	1.0
C6		ENSG00000039537	"Complement C6"	P13671	5	41142234-41261438	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 176.1"	"Group enriched"	"Detected in some"	13	"ASC diff: 5.1;ASC TERT1: 7.1;HSkMC: 18.8"	"Group enriched"	"Detected in many"	7	"liver cancer: 49.0;pancreatic cancer: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA043823, CAB069427"	Enhanced				"Secreted to blood"	7600000000	7600000000			"CAB069427: AB_1614336, HPA043823: AB_10960262"	"unprognostic (9.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.04e-3)"	"prognostic favourable (4.31e-4)"	"unprognostic (2.69e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	2.3	0.1	0.2	0.1	0.2	0.0	1.0	0.1	0.2	0.3	0.5	0.5	0.1	0.1	0.2	2.7	0.3	8.8	2.4	24.1	0.2	0.0	5.2	176.1	0.9	0.8	0.1	0.1	3.2	10.1	0.0	0.4	0.4	0.6	0.2	0.0	0.2	0.1	0.1	0.2	0.0	0.8	0.1	0.2	0.1	0.4	1.7	0.1	0.1	0.4	0.7	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	7.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	18.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.6	0.1
C8A		ENSG00000157131	"Complement C8 alpha chain"	P07357	1	56854806-56918221	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	305	"liver: 210.3"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 5.4"	"Cancer enriched"	"Detected in single"	279	"liver cancer: 85.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"								"Secreted to blood"	3400000000	3400000000										"unprognostic (3.73e-3)"	"unprognostic (2.44e-1)"			"unprognostic (1.28e-1)"			"unprognostic (6.40e-2)"		"unprognostic (9.82e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	210.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CA5A	"CA5, CAV, CAVA"	ENSG00000174990	"Carbonic anhydrase 5A"	P35218	16	87881546-87936529	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 26.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 6.7"	"Cancer enriched"	"Detected in single"	26	"liver cancer: 2.0"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (1.91e-1)"	"unprognostic (8.64e-3)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.39e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.23e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.77e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.76e-2)"	0.0	0.0	0.3	0.8	0.4	2.7	0.0	0.1	0.7	0.0	0.0			0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.3	0.0	26.4	0.2	0.3	0.4		0.0	0.0	0.0	0.0	0.1		0.0	0.1		0.0	0.0	0.3	0.7	0.1	0.0	0.3	0.8	0.0	0.3			0.1		0.0	0.0	0.0	1.9	1.6	4.7	1.1	1.9	1.1	0.4	0.2	0.3	0.3	0.7	0.1	0.0	0.5	0.4	0.1	0.0	0.1	0.5	0.6	0.6	0.2	0.2	0.5	0.2	0.2	0.1	0.4	0.3	0.4	1.1	6.7	0.0	0.4	1.7	0.7	0.0	0.2	0.4	0.3	0.4	1.6	0.1	0.5	0.2	1.0	0.5	0.6	0.4	0.4	0.2	0.2	0.5	0.4	0.2	0.2	0.3	0.1	0.6	0.3	0.4	0.8	0.2	0.5	0.3	0.7	0.4	0.4	0.5	0.9	0.4	4.1	1.1	1.0	0.8	0.7	0.8	0.9	0.8	0.6	0.3	1.9	1.1	1.1	4.7	1.9	0.7	1.6	0.5	0.4										
CACNG2	"MGC138502, MGC138504, stargazin"	ENSG00000166862	"Calcium voltage-gated channel auxiliary subunit gamma 2"	Q9Y698	22	36563921-36703558	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 30.7"	"Group enriched"	"Detected in some"	8	"SCLC-21H: 7.6;SH-SY5Y: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																		"unprognostic (7.54e-2)"					"unprognostic (3.06e-1)"	"unprognostic (8.80e-3)"			"unprognostic (2.34e-2)"	"unprognostic (3.07e-2)"			0.7	2.7	5.6	0.8	6.4	0.9	0.7	30.7	21.9	0.6	0.7	0.3	0.0	0.8	0.6	0.6	0.7	0.6	0.6	0.6	3.8	4.7	0.7	0.7	0.7	0.7	2.9	7.8	0.6	1.1	0.6	2.7	0.7	6.9	0.7	0.7	0.1	0.6	0.6	1.0	0.8	0.8	0.7	1.7	0.7	0.7	1.0	0.8	0.0	0.7	0.0	0.6	0.7	0.1	0.3	1.0	1.0	0.3	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.2	7.6	3.4	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.4	0.4	0.3	0.1	0.3	0.3	0.2	0.0	0.3	0.4	0.4	1.0	0.3	0.2	1.0	0.2	0.1	5.6	6.4	30.7	12.3	3.8	4.7	2.9	7.8	6.9	0.8
CAD	GATD4	ENSG00000084774	"Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"	P27708	2	27217390-27243943	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007781, HPA057266, HPA069341"	Supported		Supported	Nucleoplasm		26000	26000	Nucleoplasm		"CAB007781: AB_562057, HPA057266: AB_2683387, HPA069341: AB_2686125"	"unprognostic (1.69e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (1.72e-11)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavourable (1.82e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.93e-3)"	12.0	11.9	10.1	23.1	12.4	11.1	18.9	13.3	13.1	14.6	12.4	10.9	9.7	12.1	21.0	18.0	16.3	16.6	15.8	9.8	8.6	8.8	13.1	22.9	13.0	27.9	11.8	9.5	24.4	18.1	10.7	16.4	10.6	10.1	12.5	11.6	12.9	11.7	18.3	12.3	26.0	13.2	17.3	12.5	18.7	11.4	21.3	10.8	35.2	13.8	14.1	18.5	12.7	13.1	5.1	4.9	0.8	2.3	3.7	7.9	2.6	25.2	22.9	10.2	20.4	16.6	13.7	8.1	10.7	7.5	13.6	9.7	25.9	10.1	22.6	9.7	9.8	14.3	30.0	14.2	10.2	14.8	24.2	32.3	17.4	13.5	8.3	25.4	16.3	10.4	11.7	19.7	22.5	14.5	22.7	12.6	11.9	25.4	16.2	37.8	24.5	17.4	28.4	30.6	23.5	10.0	12.9	20.5	10.3	15.0	10.7	12.5	8.3	10.7	13.0	20.6	17.0	16.0	21.5	26.2	16.9	46.2	8.3	24.5	17.7	0.0	1.2	0.5	4.7	2.3	4.0	5.1	6.5	7.7	2.7	5.0	4.3	4.3	0.8	3.7	1.2	4.9	7.9	2.6	10.1	12.4	13.3	13.1	8.6	8.8	11.8	9.5	10.1	10.8
CANT1	"SCAN-1, SHAPY"	ENSG00000171302	"Calcium activated nucleotidase 1"	Q8WVQ1	17	78991717-79009867	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019627, HPA019639, HPA022818"	Enhanced					2300000	2300000			"HPA019627: AB_1845969, HPA019639: AB_1845970, HPA022818: AB_1845971"	"unprognostic (1.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (1.41e-4)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (6.21e-4)"	"unprognostic (7.04e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.23e-2)"	13.8	15.3	9.6	13.1	10.2	8.1	13.0	12.2	10.8	17.7	43.8	12.3	25.4	25.5	12.0	14.3	27.5	10.0	19.5	10.8	9.0	6.9	10.3	17.7	11.1	11.5	12.5	7.7	10.4	14.7	13.1	11.8	33.0	12.0	36.7	41.5	7.9	30.3	41.4	9.0	8.9	27.2	8.0	12.4	18.1	25.8	19.0	10.3	14.1	12.4	8.9	14.4	10.3	13.7	4.1	3.8	17.5	4.4	3.1	6.2	4.4	26.4	29.0	8.1	11.7	7.7	9.2	10.4	16.3	14.3	17.6	14.9	13.7	25.0	6.4	9.6	11.4	13.4	6.9	12.9	17.6	10.6	12.6	8.3	8.8	11.4	6.6	7.9	13.1	9.5	8.3	16.2	8.8	30.3	10.4	10.9	11.7	14.3	12.0	4.7	5.5	30.9	6.7	13.3	7.2	7.7	13.3	11.7	11.7	8.7	57.8	12.3	71.4	9.5	15.1	26.3	23.8	11.8	20.4	12.9	10.7	6.2	16.8	6.1	16.4	6.1	3.8	8.1	6.2	4.4	6.1	4.1	4.6	5.2	3.8	2.9	4.5	4.4	17.5	3.1	2.9	2.7	3.8	4.4	9.6	10.2	12.2	10.8	9.0	6.9	12.5	7.7	12.0	10.3
CAPN1	"CANP, CANPL1, muCANP, muCL"	ENSG00000014216	"Calpain 1"	P07384	11	65180566-65212006	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 88.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005992	Enhanced		Supported	Cytosol		28000000	28000000	Cytosol		"HPA005992: AB_1845924"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (4.30e-4)"	"unprognostic (3.33e-1)"	"prognostic favourable (7.06e-8)"	"unprognostic (5.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-1)"	22.0	15.6	9.6	23.8	11.6	18.2	18.8	17.7	20.1	25.8	33.3	8.4	23.0	25.4	19.3	30.2	86.9	28.1	39.1	21.4	8.8	11.2	27.8	21.3	19.4	19.5	10.8	9.7	21.4	24.9	13.3	14.1	38.1	16.8	27.3	17.0	15.8	39.7	24.3	24.2	38.9	49.9	16.5	7.7	21.3	20.7	8.3	6.7	32.1	37.5	50.2	53.7	33.7	35.2	16.7	22.8	34.5	24.8	15.7	19.6	28.5	47.4	25.3	7.2	16.1	13.2	16.7	22.0	14.1	22.5	16.6	12.7	16.1	42.7	11.9	23.6	26.8	70.2	9.4	59.6	5.3	12.6	7.5	28.3	14.6	15.7	13.1	6.6	39.8	18.4	32.1	14.1	6.9	28.5	16.8	9.6	13.6	30.5	13.1	21.0	20.9	22.9	13.0	7.4	7.2	22.6	88.3	13.0	9.6	14.9	57.7	13.6	24.8	13.1	24.7	13.0	8.9	27.6	6.3	5.9	4.3	14.1	22.6	8.1	14.0	34.3	24.8	34.5	19.6	23.7	15.7	15.6	15.5	17.7	22.8	16.7	9.1	12.5	15.8	15.7	14.0	17.9	16.6	28.5	9.6	11.6	17.7	20.1	8.8	11.2	10.8	9.7	16.8	6.7
CAPN10		ENSG00000142330	"Calpain 10"	Q9HC96	2	240586716-240617705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004170, HPA056098"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA004170: AB_1078381, HPA056098: "	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.09e-2)"	"unprognostic (5.44e-3)"	"prognostic favourable (8.47e-5)"	"prognostic unfavourable (4.78e-6)"	"unprognostic (7.48e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.31e-2)"	"prognostic favourable (7.94e-5)"	"unprognostic (1.46e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.58e-3)"	9.2	11.8	16.8	12.9	15.1	10.9	6.6	20.5	15.7	8.3	13.6	12.8	10.0	20.8	11.3	8.0	9.7	9.8	10.2	11.5	15.9	10.7	14.2	9.3	8.4	15.3	11.2	18.1	10.0	13.0	8.6	13.2	7.3	11.1	10.6	12.2	12.4	14.6	10.7	6.5	19.5	16.2	8.3	8.1	21.0	15.0	10.7	13.7	15.1	9.3	5.6	13.2	8.3	7.0	1.5	2.0	7.7	1.8	5.8	2.2	0.8	5.1	7.8	7.7	6.0	3.0	2.5	13.4	6.6	2.8	4.4	4.3	5.7	12.4	3.9	2.3	2.3	8.8	1.9	4.4	2.3	14.9	13.6	7.2	12.9	10.0	4.9	4.6	10.2	2.2	3.1	4.6	1.9	3.3	8.0	4.9	1.8	4.5	10.3	17.7	11.5	5.5	9.8	5.4	8.3	6.9	6.2	19.4	15.2	4.2	6.0	8.3	3.0	5.7	5.7	7.6	6.5	6.1	7.9	12.2	2.7	7.0	7.2	8.5	7.1	1.7	1.8	3.3	2.0	1.0	0.5	1.5	1.3	2.0	0.8	1.5	1.2	1.8	7.7	5.8	1.1	2.0	2.2	0.8	16.8	15.1	20.5	15.7	15.9	10.7	11.2	18.1	11.1	13.7
CAPN3	"CANP3, LGMD2, LGMD2A, nCL-1, p94"	ENSG00000092529	"Calpain 3"	P20807	15	42359500-42412318	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.6;skeletal muscle: 210.9"	"Cell line enriched"	"Detected in some"	23	"SK-MEL-30: 75.1"	"Cancer enriched"	"Detected in some"	10	"melanoma: 9.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040052	Enhanced									"HPA040052: "	"unprognostic (1.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.11e-4)"	"unprognostic (3.12e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.37e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.91e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.43e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.38e-1)"	5.7	1.8	13.0	2.3	32.1	16.7	3.8	3.1	22.9	2.1	2.4	65.6	0.0	2.2	3.1	47.0	4.2	2.5	3.0	3.6	19.9	11.5	22.1	6.3	6.7	3.4	50.7	19.5	3.1	1.4	3.4	1.7	2.0	39.0	3.0	3.2	5.0	3.1	3.1	210.9	19.7	2.3	2.8	52.6	3.3	2.1	4.1	47.3	0.0	1.6	27.6	3.0	2.7	2.3	1.5	1.7	0.9	2.6	1.3	3.2	1.4	0.1	0.2	0.2	0.3	3.2	3.1	0.3	1.2	0.7	0.1	0.2	0.3	0.2	0.0	0.4	0.6	1.8	0.1	1.3	0.1	0.3	0.3	0.2	0.4	1.0	0.1	0.5	0.6	2.1	1.9	0.2	0.5	0.0	0.0	0.9	0.1	0.0	0.0	0.5	0.1	0.2	0.5	0.0	0.7	0.8	0.5	0.0	0.0	0.0	0.1	75.1	0.0	1.7	0.3	0.0	0.1	1.6	0.2	0.4	0.7	0.0	0.2	0.9	0.7	0.0	2.6	0.0	2.8	0.6	2.8	0.4	0.3	1.0	1.7	1.5	0.2	3.2	0.9	1.3	0.2	1.6	1.3	1.4	13.0	32.1	3.1	22.9	19.9	11.5	50.7	19.5	39.0	47.3
CAPN5	"ADNIV, HTRA3, nCL-3, VRNI"	ENSG00000149260	"Calpain 5"	O15484	11	77066932-77126155	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 49.5;intestine: 47.8"	"Cell line enhanced"	"Detected in many"		"U-2197: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.8"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033237, HPA072319"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB033237: AB_2069673, HPA072319: "	"unprognostic (6.81e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavourable (2.16e-6)"	"unprognostic (3.47e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.35e-3)"	"unprognostic (4.64e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.30e-3)"	3.9	7.1	5.6	19.5	5.4	1.5	3.9	6.3	10.8	7.4	34.1	6.0	4.8	32.7	6.3	8.3	18.3	6.6	49.5	4.4	5.4	4.6	8.7	26.8	2.8	1.2	3.7	7.0	15.4	3.2	0.7	3.3	2.6	10.2	9.3	27.9	7.4	4.7	7.5	1.8	1.9	47.8	9.3	4.1	2.2	29.3	22.0	2.3	0.6	3.1	4.6	7.3	9.8	6.3	0.2	0.7	0.0	0.9	0.0	4.8	2.1	0.4	6.7	4.5	4.4	17.0	16.4	0.4	6.8	11.8	7.0	5.1	3.9	2.0	0.2	4.9	11.7	0.3	1.8	0.5	3.0	0.4	0.4	1.3	0.2	0.4	4.2	0.1	0.4	8.1	0.7	11.2	2.7	8.1	0.1	0.1	12.9	9.4	1.1	0.2	3.8	5.3	1.0	15.2	0.2	2.3	8.5	0.3	8.1	1.6	1.3	3.0	1.0	0.0	16.7	13.6	8.0	18.7	0.8	0.4	0.9	0.0	7.0	0.2	3.1	0.0	0.7	0.0	4.8	0.9	0.4	0.0	0.5	1.6	0.7	0.2	2.4	2.5	0.0	0.0	0.2	0.3	0.0	2.1	5.6	5.4	6.3	10.8	5.4	4.6	3.7	7.0	10.2	2.3
CARS	CARS1	ENSG00000110619	"Cysteinyl-tRNA synthetase"	P49589	11	3000922-3057613	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002383, HPA002384, CAB075734, CAB075735, CAB075736, CAB075737"	Enhanced		Enhanced	Cytosol		110000	110000	Cytosol		"CAB075734: , CAB075735: , CAB075736: , CAB075737: , HPA002383: AB_1078399, HPA002384: AB_1846033"	"unprognostic (9.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-1)"	24.9	15.9	15.8	15.8	17.7	9.0	15.9	9.5	29.1	13.4	16.3	19.1	11.1	15.9	14.0	10.7	16.0	10.8	14.2	12.5	15.3	18.7	10.7	22.1	15.1	17.2	23.3	15.9	14.5	42.5	14.9	15.9	14.0	23.0	10.8	17.6	7.4	20.3	14.8	24.6	18.8	17.8	21.0	16.1	14.8	22.8	13.4	17.3	9.8	23.0	14.5	22.7	14.4	19.4	8.3	13.3	18.0	23.9	16.4	18.1	11.6	7.5	3.8	5.0	15.0	19.5	18.0	4.5	19.3	22.0	13.3	24.1	9.4	18.0	11.7	5.7	24.3	19.4	16.3	21.9	18.4	34.1	3.7	6.6	6.6	7.2	46.8	13.7	14.5	29.6	17.3	11.5	12.9	17.5	11.0	41.5	13.1	11.5	9.6	0.0	18.7	6.9	4.6	8.3	14.6	0.0	12.6	10.7	14.2	4.7	13.6	21.1	0.0	0.0	6.0	5.5	5.1	13.6	0.2	30.9	28.1	7.4	0.0	7.2	10.8	7.7	12.0	8.8	15.2	10.5	13.0	8.3	13.6	13.6	13.3	6.0	7.5	12.1	18.0	16.4	23.9	5.2	18.1	11.6	15.8	17.7	9.5	29.1	15.3	18.7	23.3	15.9	23.0	17.3
CARS2	FLJ12118	ENSG00000134905	"Cysteinyl-tRNA synthetase 2, mitochondrial"	Q9HA77	13	110641412-110713603	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041776	Uncertain		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA041776: "	"unprognostic (2.34e-3)"	"unprognostic (9.50e-2)"	"unprognostic (6.62e-2)"	"prognostic favourable (1.84e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.75e-2)"	"prognostic unfavourable (2.49e-5)"	"unprognostic (4.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.71e-2)"	19.6	28.1	11.9	24.8	13.0	25.6	37.1	18.2	14.5	21.8	20.2	17.6	21.2	17.8	18.5	23.0	20.2	16.8	26.9	26.0	9.9	10.3	17.0	21.4	19.9	26.7	11.3	14.1	17.6	31.7	11.5	19.7	12.5	11.7	17.5	15.0	16.6	19.0	21.3	39.7	16.1	20.1	22.1	11.7	19.7	17.9	11.2	11.4	21.8	19.2	18.5	21.9	16.9	16.7	3.4	4.0	3.1	6.8	0.6	2.2	1.7	35.1	11.7	6.7	16.4	18.0	16.9	9.1	15.7	14.3	15.9	19.6	16.4	15.9	16.4	22.0	17.1	18.7	11.5	19.6	13.0	15.0	19.2	10.2	24.8	18.7	18.4	25.0	12.5	21.0	15.7	13.8	16.7	11.3	7.0	5.2	22.4	8.2	11.1	8.1	5.7	11.6	16.4	4.9	6.7	17.0	10.3	12.0	9.1	12.6	19.5	18.1	9.4	27.8	10.1	13.3	5.0	16.7	15.7	9.3	10.6	9.5	65.0	15.0	13.1	0.0	4.7	0.7	2.0	5.1	2.2	3.4	0.6	0.8	4.0	1.4	2.0	1.0	3.1	0.6	6.8	3.4	0.7	1.7	11.9	13.0	18.2	14.5	9.9	10.3	11.3	14.1	11.7	11.4
CASK	"CAGH39, FGS4, LIN2, TNRC8"	ENSG00000147044	"Calcium/calmodulin dependent serine protein kinase"	O14936	X	41514934-41923645	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001949, HPA023857"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB001949: , HPA023857: AB_1846035"	"unprognostic (6.30e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavourable (6.11e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.85e-2)"	9.1	15.9	13.9	18.8	12.7	9.8	13.2	14.2	15.7	11.1	22.1	20.0	7.1	27.1	12.2	13.7	17.2	9.9	16.0	7.0	12.1	12.8	14.6	10.8	10.3	13.6	16.3	8.5	13.9	14.2	11.1	9.8	13.4	11.9	10.7	23.8	10.4	15.9	7.7	5.8	12.8	32.9	12.1	10.1	9.6	16.2	2.9	14.3	30.9	9.3	8.1	14.0	11.8	13.1	0.6	0.3	26.3	0.8	2.4	2.3	0.3	10.8	13.9	13.3	7.9	9.0	7.4	4.3	9.5	7.9	5.6	5.1	29.9	17.7	0.1	4.9	11.8	21.8	14.7	9.7	9.4	9.6	8.2	0.0	12.5	10.6	9.3	1.7	1.4	8.4	26.7	10.6	13.6	4.5	0.8	8.5	12.1	12.7	3.1	0.7	12.2	9.1	5.1	32.8	5.2	12.6	23.7	12.2	6.5	17.9	7.1	5.4	7.7	0.3	5.3	10.5	10.6	8.9	5.2	3.3	2.0	3.6	10.3	1.2	6.7	26.3	0.8	4.8	0.5	0.7	0.5	0.4	0.6	0.8	0.2	0.6	0.7	0.7	1.1	2.4	0.4	0.3	2.3	0.3	13.9	12.7	14.2	14.2	12.1	12.8	16.3	8.5	11.9	14.3
CASP10	MCH4	ENSG00000003400	"Caspase 10"	Q92851	2	201182881-201229406	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 42.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB003780, HPA017059"	Approved		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	Vesicles	"CAB003780: AB_289592, HPA017059: AB_1846040"	"unprognostic (4.01e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (8.54e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (6.05e-7)"	"unprognostic (3.23e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.38e-2)"	16.0	3.3	3.4	10.1	3.4	14.9	7.6	1.9	3.3	7.0	17.7	4.4	4.3	18.6	8.3	8.2	10.4	4.9	7.2	4.8	3.6	3.0	10.3	7.8	14.2	10.4	4.1	1.4	3.4	6.1	1.4	2.1	8.5	4.7	5.0	11.9	4.1	6.9	6.9	3.6	5.4	42.4	4.8	5.6	26.1	8.7	2.1	2.5	17.1	6.8	8.2	17.9	9.4	6.1	7.8	6.0	4.7	15.4	7.1	7.1	5.8	2.9	2.3	0.1	0.2	0.1	0.2	5.1	0.5	3.4	0.3	1.3	3.1	6.8	0.2	4.9	1.7	1.9	0.1	1.6	0.9	1.4	3.3	8.2	2.4	10.2	1.1	5.4	8.9	0.3	1.4	3.7	0.3	17.7	9.8	12.1	0.3	0.1	10.5	5.1	0.3	1.5	5.7	0.3	12.1	6.2	4.1	0.1	0.1	2.8	0.1	1.3	0.0	5.2	7.1	0.2	0.5	2.3	0.1	13.2	7.8	0.3	3.3	4.2	0.1	4.7	9.6	0.6	6.2	13.5	5.2	7.8	5.2	3.4	5.3	5.0	7.1	6.0	1.9	7.1	15.4	6.0	1.0	5.8	3.4	3.4	1.9	3.3	3.6	3.0	4.1	1.4	4.7	2.5
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049384-15058293	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Hydrolase, Protease, Thiol protease"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 109.4"	"Cell line enriched"	"Detected in some"	7	"hTCEpi: 32.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010059, HPA027062"	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		2200000	2200000	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010059: AB_626800, HPA027062: "	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavourable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavourable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.2	0.2	0.2	0.0	0.3	0.0	1.9	0.2	0.3	17.9	0.2	0.0	0.8	0.0	1.1	0.3	1.2	0.1	0.0	0.2	0.3	0.2	0.4	0.3	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.2	0.5	0.0	7.7	0.0	0.0	0.8	2.7	0.3	109.4	0.2	0.0	0.2	0.1	0.2	1.6	0.0	2.3	0.2	0.9	0.0	0.6	4.0	0.8	0.5	2.3	0.6	0.1	0.6	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.6	0.4	0.4	0.2	0.4	0.3	0.6	0.4	0.1	0.8	0.5	0.4	2.3	0.1	0.2	0.5	0.6	0.0	0.2	0.3	0.2	0.3	0.3	0.2	0.2	0.0	0.0	0.0
CASP8	"Casp-8, FLICE, MACH, MCH5"	ENSG00000064012	"Caspase 8"	Q14790	2	201233443-201287711	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 52.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001302, CAB002047, HPA005688, HPA006191"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: "	"unprognostic (5.21e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.79e-2)"	"prognostic favourable (1.25e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavourable (1.27e-6)"	"unprognostic (7.67e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.53e-3)"	14.1	10.6	2.0	31.6	2.6	27.1	10.2	1.4	1.8	7.9	18.5	3.9	7.0	9.6	9.6	12.0	11.7	9.1	12.1	4.4	2.1	2.3	16.4	14.8	17.1	28.3	3.9	1.1	8.2	7.6	1.8	5.9	12.3	3.2	9.8	8.7	4.4	9.6	8.4	2.7	7.4	34.7	5.1	5.0	37.7	7.4	3.8	2.7	43.7	6.7	10.7	43.4	9.6	7.3	13.8	13.7	52.5	17.0	22.2	26.4	12.0	14.3	12.2	3.6	9.9	10.0	14.6	5.5	6.3	6.2	7.5	12.4	16.4	25.0	1.6	13.9	4.9	7.3	7.8	7.5	14.8	9.3	7.1	14.0	9.9	15.6	8.1	10.8	15.2	12.7	18.5	14.2	11.1	7.1	12.5	31.2	6.8	5.9	14.1	11.5	5.8	10.9	10.6	7.4	25.5	14.1	16.0	1.0	0.5	8.2	13.6	8.1	3.6	8.5	8.8	8.1	8.4	4.2	4.9	28.3	12.6	9.7	12.2	14.6	7.6	20.7	13.0	24.9	25.0	17.0	23.1	13.8	20.5	26.4	13.7	7.8	13.3	16.9	52.5	22.2	15.6	6.1	24.0	12.0	2.0	2.6	1.4	1.8	2.1	2.3	3.9	1.1	3.2	2.7
CASQ1	"CASQ, PDIB1"	ENSG00000143318	"Calsequestrin 1"	P31415	1	160190556-160201886	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"Muscle protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 320.9;tongue: 83.5"	"Group enriched"	"Detected in some"	9	"BEWO: 10.4;HDLM-2: 19.8;RT4: 35.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA007845, CAB015170, HPA026823"	Enhanced		Uncertain	Nucleoplasm,Mitochondria	"Intracellular and membrane"			"Nucleoplasm, Mitochondria"		"CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557"	"unprognostic (1.87e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.65e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"prognostic favourable (8.93e-5)"	6.1	0.1	0.5	0.0	0.3	0.1	0.2	0.3	2.0	0.1	0.1	0.0	0.1	0.0	0.1	11.9	3.9	0.2	0.1	4.0	0.4	0.3	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.5	0.0	1.3	0.0	0.2	4.5	0.4	320.9	0.1	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.0	0.9	83.5	4.7	0.4	0.1	0.9	0.0	0.9	0.7	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	10.4	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	19.8	0.2	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.1	0.0	35.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.1	0.1	0.0	0.0	0.9	0.7	0.2	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.9	0.1	0.1	0.9	0.2	0.1	0.0	0.3	0.0	0.5	0.3	0.3	2.0	0.4	0.3	0.2	0.0	0.0	0.0
CATSPER2		ENSG00000166762	"Cation channel sperm associated 2"	Q96P56	15	43628503-43668118	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 43.7"	"Cell line enhanced"	"Detected in many"		"HeLa: 12.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 9.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"unprognostic (6.88e-3)"	"unprognostic (6.79e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.48e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.87e-2)"	"unprognostic (8.23e-5)"	1.1	0.9	1.1	1.1	1.4	3.2	1.3	9.0	1.1	1.1	1.7	1.1	1.1	2.7	1.1	5.2	1.9	1.1	1.1	1.1	1.1	1.3	1.1	1.1	1.1	1.3	1.1	1.1	1.4	1.1	4.0	3.0	1.1	1.1	1.3	1.9	1.1	1.1	1.9	1.1	4.8	3.1	1.1	1.6	1.1	1.3	43.7	1.1	1.1	1.7	1.1	1.1	1.2	1.1	3.3	1.8	2.3	1.2	1.8	2.9	0.2	2.4	3.5	1.5	5.5	0.0	0.0	2.5	0.9	2.1	1.5	3.7	0.8	1.3	2.9	1.3	0.6	5.4	1.4	4.8	1.5	2.5	6.7	8.4	12.6	1.2	2.3	1.9	2.8	0.3	3.8	2.1	5.4	1.9	3.3	3.1	0.5	0.6	1.6	3.4	0.5	1.5	2.3	1.7	1.4	3.1	3.9	3.3	1.1	1.4	2.1	0.1	4.1	1.9	0.5	3.9	1.6	0.0	2.3	0.6	0.3	5.8	2.7	6.0	1.4	0.4	1.2	0.5	1.3	0.5	1.6	3.3	1.1	1.8	0.8	1.7	1.5	2.9	2.3	1.8	1.2	1.8	0.5	0.2	1.1	1.4	9.0	1.1	1.1	1.3	1.1	1.1	1.1	1.1
CAV1	CAV	ENSG00000105974	"Caveolin 1"	Q03135	7	116524785-116561184	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 142.2;BJ hTERT+: 149.8;HBEC3-KT: 145.9;LHCN-M2: 152.1;U-138 MG: 121.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 10.6;memory B-cell: 6.0"	"Group enriched"	"Detected in many"	37	"B-cells: 6.0;granulocytes: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003791, HPA049326"	Enhanced		Supported	"Golgi apparatus"				"Golgi apparatus"		"CAB003791: AB_562068, HPA049326: "	"unprognostic (5.98e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.35e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.35e-3)"	"unprognostic (8.07e-2)"	"prognostic unfavourable (7.17e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.92e-2)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (1.65e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.14e-3)"	143.9	2.3	2.4	27.5	5.9	0.0	70.5	1.0	3.8	73.8	57.4	2.6	32.3	4.3	84.6	40.9	51.1	31.4	42.0	60.2	2.7	2.3	5.7	4.2	132.7	8.6	7.9	4.5	26.6	3.8	2.0	1.9	92.0	4.2	42.3	13.7	13.6	12.8	26.5	33.3	21.7	18.6	104.0	5.5	28.6	30.1	21.5	5.2	2.8	92.1	34.7	6.6	85.9	33.7	6.0	0.1	10.6	0.0	0.0	0.2	1.1	27.4	22.4	0.6	0.2	92.9	142.2	1.3	65.5	149.8	36.2	38.2	0.1	40.9	0.0	23.2	77.0	51.8	0.1	145.9	55.1	1.8	1.2	0.0	8.9	0.0	12.8	0.0	0.1	48.5	31.0	52.8	35.0	109.0	0.0	1.5	152.1	2.8	0.0	0.0	2.1	10.8	0.3	1.5	15.6	20.5	0.1	0.0	0.0	20.1	1.3	3.2	0.1	0.2	83.7	121.4	13.9	46.3	18.0	6.1	0.9	0.1	48.9	0.0	43.8	10.6	0.0	0.0	0.0	0.0	0.0	6.0	0.2	0.1	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	2.4	5.9	1.0	3.8	2.7	2.3	7.9	4.5	4.2	5.2
CAV3	"LGMD1C, LQT9, VIP-21, VIP21"	ENSG00000182533	"Caveolin 3"	P56539	3	8733800-8841808	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 65.8;tongue: 44.6"	"Cell line enriched"	"Detected in some"	4	"RH-30: 45.1"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB017518, CAB018557, HPA054488"	Enhanced		Approved	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: "	"unprognostic (1.79e-1)"				"unprognostic (1.43e-1)"	"unprognostic (1.40e-2)"		"unprognostic (6.43e-2)"		"unprognostic (8.79e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.38e-3)"		"unprognostic (9.79e-2)"	"unprognostic (1.36e-1)"			1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	6.3	2.3	0.0	0.3	10.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.7	1.3	0.1	65.8	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	44.6	1.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0
CBL	"c-Cbl, CBL2, RNF55"	ENSG00000110395	"Cbl proto-oncogene"	P22681	11	119206276-119313926	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004350, HPA027956"	Enhanced		Supported	Cytosol				Cytosol		"CAB004350: AB_2244054, HPA027956: AB_10601094"	"unprognostic (2.52e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.10e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	9.9	5.5	9.1	17.0	11.1	11.1	8.8	10.7	12.0	6.2	7.5	8.7	3.0	5.7	9.9	5.3	7.5	7.4	6.3	5.9	8.0	9.6	5.5	4.0	10.3	16.3	8.1	6.9	6.3	5.6	16.6	4.1	9.1	9.3	5.3	7.5	6.4	5.4	7.1	3.9	7.4	8.6	10.6	8.9	13.3	7.3	32.3	5.1	40.9	6.0	5.5	15.6	7.6	7.7	1.8	3.3	11.8	3.7	0.6	1.9	1.0	6.3	4.8	16.8	10.5	5.0	6.0	9.9	6.8	7.1	6.6	6.6	10.2	7.8	15.0	6.2	8.6	9.3	11.5	5.8	14.5	8.5	2.7	15.4	3.6	3.1	6.2	17.9	17.6	5.2	6.5	16.9	18.2	16.3	12.4	6.3	11.9	6.8	9.5	10.0	8.7	5.3	10.3	8.4	2.8	5.9	5.1	2.3	7.0	12.7	5.5	4.5	5.8	15.1	13.6	10.3	7.3	7.2	8.9	2.1	3.1	12.2	4.2	15.5	7.3	0.8	3.2	2.4	1.3	3.7	1.1	1.8	1.6	1.3	3.3	1.8	1.8	1.9	11.8	0.6	3.1	1.8	1.4	1.0	9.1	11.1	10.7	12.0	8.0	9.6	8.1	6.9	9.3	5.1
CBS	HIP4	ENSG00000160200	Cystathionine-beta-synthase	P35520	21	43053191-43076943	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Allosteric enzyme, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 55.7;pancreas: 43.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 40.2;HAP1: 38.3;HHSteC: 51.8;MCF7: 44.3;RPMI-8226: 42.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	84	"neutrophil: 8.3"	"Lineage enriched"	"Detected in single"	84	"granulocytes: 8.3"									HPA001223	Supported		Approved	Nucleoli,Vesicles				Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-4)"	"unprognostic (3.62e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	1.3	1.5	6.5	2.4	5.1	0.4	1.0	12.3	6.7	4.8	1.3	2.0	0.8	1.6	0.9	0.8	0.8	2.0	2.1	2.0	5.6	5.5	1.3	55.7	1.7	1.4	4.8	2.8	13.9	43.0	0.3	1.4	1.4	2.3	4.0	0.7	2.8	9.3	3.4	0.8	0.6	2.9	1.4	3.7	0.8	2.7	2.2	3.3	0.8	5.0	0.8	0.9	2.6	0.8	0.0	0.0	8.3	0.0	0.0	0.0	0.0	6.3	3.8	5.0	19.6	11.3	7.3	40.2	7.8	2.0	3.2	3.3	11.8	0.3	0.0	4.2	14.7	0.4	38.3	2.7	0.6	0.0	4.8	2.6	15.3	14.2	51.8	1.6	3.8	4.4	0.4	3.5	3.1	8.6	29.6	22.3	2.4	44.3	2.7	0.0	4.7	6.7	0.0	0.0	42.4	0.1	3.5	10.4	15.3	17.2	1.0	7.4	6.1	20.0	1.1	0.2	9.9	0.1	0.8	7.8	6.2	8.8	3.6	2.3	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	6.5	5.1	12.3	5.2	5.6	5.5	4.8	2.8	2.3	3.3
CD151	"PETA-3, RAPH, SFA-1, TSPAN24"	ENSG00000177697	"CD151 molecule (Raph blood group)"	P48509	11	832843-839831	"Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Blood group antigen"	"Deafness, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002428, HPA011906"	Supported					680000	680000			"CAB002428: AB_564129, HPA011906: AB_1846245"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.45e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (5.58e-4)"	"prognostic unfavourable (9.46e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.02e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.24e-1)"	"prognostic favourable (6.92e-4)"	"unprognostic (7.83e-2)"	63.1	28.1	7.4	19.1	8.1	3.4	133.2	7.9	11.3	39.8	36.0	9.5	37.8	23.2	55.7	45.3	43.1	29.3	63.0	85.2	7.3	7.9	52.8	47.2	45.8	16.3	7.5	10.3	29.8	82.7	27.8	14.1	58.6	10.7	52.0	16.5	31.2	62.9	41.1	19.2	17.1	46.0	62.4	6.7	15.8	31.7	20.8	5.5	2.4	43.2	27.1	16.1	35.9	34.9	2.1	8.1	14.9	14.3	5.2	4.8	6.5	39.5	54.8	7.9	23.7	113.5	47.2	12.4	62.0	42.3	31.3	26.5	28.5	56.5	0.0	24.8	92.6	36.1	7.0	54.7	7.9	14.8	26.9	10.9	16.9	21.7	43.2	8.8	15.2	45.6	36.6	18.3	32.3	36.9	13.3	5.1	46.7	22.2	0.2	10.4	5.2	65.8	2.0	16.4	8.5	69.6	11.5	10.9	12.2	57.4	32.0	10.8	12.9	10.7	63.1	42.6	21.1	13.7	34.3	6.9	7.1	0.4	42.0	9.2	23.5	14.9	12.0	9.6	4.2	12.6	4.8	2.1	3.5	3.6	8.1	1.5	1.5	2.2	5.7	5.2	14.3	1.3	2.1	6.5	7.4	8.1	7.9	11.3	7.3	7.9	7.5	10.3	10.7	5.5
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Transport"	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 464.3;breast: 156.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 80.8;HEL: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 104.4;intermediate monocyte: 30.4;myeloid DC: 56.9"	"Group enriched"	"Detected in many"	45	"dendritic cells: 56.9;monocytes: 104.4"	"Low region specificity"	"Detected in many"							"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"		92000000	92000000	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: "	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavourable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	464.3	3.6	1.2	8.9	1.3	10.9	156.1	0.5	0.5	1.8	31.8	0.6	3.3	9.8	1.8	7.5	7.5	3.3	7.2	76.8	1.8	1.9	2.2	13.3	11.5	4.8	0.6	0.3	2.5	3.9	3.1	0.8	37.9	2.9	9.2	3.5	0.8	4.6	2.3	23.6	5.4	23.4	4.7	0.8	42.8	5.0	6.0	0.5	2.7	13.6	15.3	1.4	9.4	19.2	0.3	56.9	1.8	104.4	0.7	0.2	60.2	0.0	0.0	0.2	0.1	80.8	0.8	0.1	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.0	0.1	0.0	0.1	0.1	38.4	0.1	6.1	0.0	0.0	0.0	7.8	3.1	0.0	0.0	0.2	1.3	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.0	2.7	4.4	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.0	13.2	10.2	0.9	104.4	0.3	0.2	30.4	0.2	0.3	0.0	0.0	56.9	0.0	0.1	0.0	1.8	0.7	7.5	14.3	0.1	60.2	1.2	1.3	0.5	0.5	1.8	1.9	0.6	0.3	2.9	0.5
CD81	"TAPA-1, TAPA1, TSPAN28"	ENSG00000110651	"CD81 molecule"	P60033	11	2376177-2397419	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 231.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 41.4;naive B-cell: 37.6"	"Lineage enriched"	"Detected in all"	4	"B-cells: 41.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002507, HPA007234"	Supported		Supported	"Plasma membrane"		1900000	1900000	"Plasma membrane"		"CAB002507: AB_563639, HPA007234: AB_1846333"	"unprognostic (2.96e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavourable (7.56e-4)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (8.21e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (3.86e-4)"	"unprognostic (3.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.06e-1)"	102.5	43.7	52.8	40.1	57.0	9.6	79.3	31.7	63.2	124.7	88.9	75.8	261.4	21.1	143.5	141.5	56.8	123.1	86.8	101.2	46.6	52.8	65.5	123.9	107.4	82.4	70.4	51.3	77.9	62.4	41.4	42.9	61.2	63.0	89.3	34.0	46.6	59.7	263.3	22.6	59.6	39.7	138.9	59.3	64.5	52.1	57.6	53.3	25.3	66.3	38.5	37.9	93.5	80.2	41.4	2.1	5.7	1.8	3.5	9.9	2.7	24.5	25.5	20.5	31.3	231.4	131.6	17.2	46.5	103.0	37.6	38.0	23.9	0.1	21.0	16.8	130.3	32.3	12.6	33.1	15.5	9.9	38.9	3.2	9.7	0.0	76.6	13.6	27.6	95.6	47.3	15.3	23.3	35.9	14.3	36.9	52.5	18.8	11.5	17.4	24.6	20.7	23.7	10.3	13.4	40.4	16.6	22.1	24.5	14.8	39.0	28.0	12.9	24.9	47.8	19.2	14.2	35.9	15.9	27.3	6.2	38.3	27.9	8.1	32.8	0.2	0.9	5.7	6.0	1.4	9.9	41.4	4.3	9.4	0.6	37.6	2.6	5.0	0.3	3.5	1.8	2.1	3.0	2.7	52.8	57.0	31.7	63.2	46.6	52.8	70.4	51.3	63.0	53.3
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Cell line enhanced"	"Detected in many"		"K-562: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	6.2	2.4	5.8	6.5	5.5	13.7	12.2	1.8	6.2	7.7	11.8	4.8	2.2	7.2	15.1	4.8	3.4	13.7	3.6	4.1	8.8	3.5	6.6	2.4	12.3	15.4	3.8	5.4	5.8	6.7	9.8	8.1	7.6	4.6	10.0	6.3	8.3	7.7	3.9	4.3	5.6	22.6	5.0	3.2	9.6	6.0	38.2	4.7	12.0	6.1	3.4	11.3	5.8	8.4	4.8	6.1	11.6	3.7	3.9	13.0	4.1	2.2	1.8	5.8	6.5	2.1	1.6	4.0	2.8	1.9	2.8	2.3	6.1	1.9	1.1	2.1	1.7	1.7	3.9	1.6	2.9	2.2	9.7	3.9	1.7	1.9	0.8	5.2	7.0	1.3	0.4	3.0	1.0	4.9	30.0	3.4	4.1	0.9	4.2	5.9	3.5	2.3	4.6	7.5	1.1	1.9	5.0	1.0	1.8	3.0	2.9	3.9	1.3	6.8	2.1	1.6	3.5	2.6	1.6	1.7	0.6	1.7	1.9	4.9	0.9	11.6	3.7	8.4	7.3	3.3	13.0	4.8	11.3	8.4	3.5	3.1	11.0	5.8	5.5	3.9	2.3	6.1	5.6	4.1	5.8	5.5	1.8	6.2	8.8	3.5	3.8	5.4	4.6	4.7
CDK10	PISSLRE	ENSG00000185324	"Cyclin dependent kinase 10"	Q15131	16	89680737-89696364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007451, HPA059634, HPA067060"	Uncertain		Supported	"Nucleoplasm,Midbody,Midbody ring"				Nucleoplasm	"Midbody, Midbody ring"	"HPA007451: , HPA059634: , HPA067060: "	"unprognostic (7.89e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.53e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.13e-1)"	"prognostic favourable (2.69e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.88e-2)"	"prognostic favourable (3.63e-4)"	12.3	19.9	16.8	16.4	23.8	17.3	10.1	14.8	21.9	11.1	18.3	8.1	16.4	23.4	12.1	21.7	14.4	14.4	19.4	8.7	15.3	12.6	22.2	33.9	11.8	14.0	13.3	19.4	11.3	22.2	21.6	27.7	13.6	15.8	13.6	12.6	8.1	17.2	8.9	17.5	14.1	20.7	9.0	10.7	15.9	19.0	8.7	13.6	8.0	27.1	10.1	12.1	10.8	14.5	7.8	14.5	3.4	15.3	15.2	13.3	8.8	14.5	9.5	7.7	3.1	3.2	6.1	8.0	12.0	6.8	8.6	2.9	7.3	11.1	12.9	6.2	10.4	10.2	3.3	16.8	5.4	2.8	8.0	5.1	10.6	0.8	13.2	8.2	9.3	7.4	5.6	5.4	8.2	15.0	13.3	1.7	9.8	19.0	9.9	23.5	15.6	7.2	14.4	10.4	18.1	15.4	11.6	7.5	16.3	15.1	7.0	3.5	16.5	13.0	13.2	5.9	15.1	6.1	8.2	6.6	3.6	4.0	8.9	14.2	8.3	3.2	11.7	3.4	12.9	15.3	10.9	6.8	11.4	8.9	14.5	7.8	13.3	10.9	1.5	15.2	11.2	10.0	8.8	8.8	16.8	23.8	14.8	21.9	15.3	12.6	13.3	19.4	15.8	13.6
CDK12	"CRK7, CRKR, CRKRS, KIAA0904"	ENSG00000167258	"Cyclin dependent kinase 12"	Q9NYV4	17	39461511-39564907	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 85.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008038, HPA073305"	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA008038: AB_1078570, HPA073305: "	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.32e-1)"	16.0	13.1	12.4	17.4	9.2	32.4	14.0	23.4	17.8	18.2	17.6	9.6	15.7	11.1	15.7	12.0	16.9	12.2	12.5	11.0	10.1	6.7	10.2	18.5	13.5	15.2	10.9	14.3	17.4	11.3	19.0	12.2	18.4	9.5	12.7	11.7	10.4	15.6	11.1	11.1	17.0	16.5	11.0	10.6	16.3	11.8	18.9	8.3	29.0	15.0	5.4	17.3	16.3	20.5	5.1	4.0	10.4	2.9	6.6	4.0	0.9	8.7	10.8	6.5	6.1	4.8	5.4	6.1	7.9	6.7	10.9	8.1	13.3	5.4	12.4	7.0	8.3	14.2	13.0	10.0	10.5	8.1	11.2	13.4	7.4	10.3	4.7	18.3	9.4	5.8	6.9	13.2	10.5	6.6	22.7	8.2	6.2	4.1	14.9	4.7	6.8	4.9	9.9	14.1	7.0	4.1	10.5	7.0	4.5	10.1	85.6	6.9	11.0	7.9	7.1	9.9	7.9	6.9	10.2	6.7	4.8	17.5	7.0	7.8	6.4	10.4	2.9	4.1	4.0	2.2	3.0	2.9	2.5	2.7	1.8	5.1	2.9	2.7	9.7	6.6	1.8	4.0	2.0	0.9	12.4	9.2	23.4	17.8	10.1	6.7	10.9	14.3	9.5	8.3
CDK13	"CDC2L, CDC2L5, CHED, KIAA1791"	ENSG00000065883	"Cyclin dependent kinase 13"	Q14004	7	39949646-40099580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059241	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA059241: "	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.42e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.53e-2)"	16.9	15.3	16.0	29.0	14.5	26.7	20.4	23.3	18.2	16.6	18.3	16.4	14.2	11.3	20.3	17.7	20.9	18.1	20.2	13.6	14.3	11.3	14.7	17.5	19.6	21.9	16.5	15.1	24.2	15.3	26.3	15.3	14.8	12.0	15.5	15.5	14.9	17.6	14.5	19.4	16.7	16.3	16.4	11.5	17.4	14.5	20.2	15.7	31.2	23.1	14.6	21.5	18.5	23.6	14.0	3.9	7.9	3.4	5.0	5.0	1.4	15.6	9.3	16.3	15.5	14.7	14.4	11.2	12.5	13.6	11.5	14.4	9.7	10.8	28.4	7.3	13.1	19.1	13.3	11.0	17.0	13.9	9.8	12.6	11.4	8.8	14.1	19.2	13.8	8.5	14.8	13.1	17.6	13.5	21.3	19.7	11.9	8.0	15.2	13.6	23.5	10.9	16.9	10.8	11.4	10.8	15.8	11.6	16.8	15.9	34.4	11.3	14.1	23.9	16.0	15.9	15.2	10.2	17.0	16.2	13.7	23.4	11.6	17.4	20.2	7.9	2.7	4.4	5.0	2.2	3.4	7.6	4.8	3.7	1.5	14.0	4.9	4.9	7.6	5.0	3.4	3.9	4.3	1.4	16.0	14.5	23.3	18.2	14.3	11.3	16.5	15.1	12.0	15.7
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053812-151058530	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB008909: , HPA064535: "	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	4.5	11.3	24.4	6.9	30.4	6.1	5.3	13.6	36.1	5.3	6.1	6.7	4.5	7.9	4.5	17.4	6.5	5.0	6.2	5.8	25.0	19.7	9.0	7.7	5.3	6.0	15.4	15.4	3.2	5.8	8.9	7.9	5.3	20.8	5.8	6.3	3.2	6.0	6.3	5.7	6.5	6.2	6.0	8.6	5.2	5.7	3.1	7.7	6.8	6.0	3.6	6.9	6.7	3.1	6.6	21.5	9.0	21.7	9.5	14.9	10.6	11.6	14.0	13.1	21.3	14.5	10.7	6.5	7.7	12.8	15.2	12.6	9.9	10.9	11.5	27.7	9.5	8.3	21.0	11.8	7.0	9.1	12.5	12.6	12.3	9.8	9.6	10.2	23.7	11.5	8.8	12.5	3.9	10.2	12.8	8.4	15.2	22.6	27.4	20.8	14.4	22.1	13.4	5.4	12.8	13.2	8.8	8.3	35.7	11.1	13.7	14.6	6.4	9.0	8.6	15.0	3.9	11.2	14.4	19.6	21.4	4.5	23.6	14.7	26.8	7.8	19.0	9.0	6.9	21.7	5.4	6.6	6.8	6.8	21.5	5.9	5.1	6.2	2.8	9.5	16.4	12.8	14.9	10.6	24.4	30.4	13.6	36.1	25.0	19.7	15.4	15.4	20.8	7.7
CDK9	"C-2k, CDC2L4, PITALRE, TAK"	ENSG00000136807	"Cyclin dependent kinase 9"	P50750	9	127785679-127790787	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004216, HPA006738"	Supported		Approved	"Nucleoplasm,Cytoplasmic bodies"				Nucleoplasm	"Cytoplasmic bodies"	"CAB004216: AB_627245, HPA006738: AB_1078493"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"prognostic unfavourable (8.92e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.78e-3)"	26.2	27.0	22.8	18.9	22.4	33.9	17.4	31.0	26.8	23.1	21.9	22.9	24.7	16.6	22.5	20.1	22.7	29.1	21.5	22.9	26.3	23.4	18.5	48.7	23.3	26.6	23.4	18.8	43.7	29.1	15.5	28.4	19.8	20.6	20.7	10.8	18.7	20.6	21.6	14.6	26.6	21.4	21.0	17.9	29.0	17.7	22.3	16.1	29.3	25.8	18.3	24.2	17.0	17.6	6.0	8.9	5.1	6.4	18.6	9.9	2.9	8.8	16.1	10.1	11.1	11.5	9.0	13.2	9.1	13.4	9.5	8.6	11.9	10.0	15.5	10.7	10.3	17.9	6.6	14.9	3.6	13.9	8.0	14.5	17.4	9.8	16.8	14.0	23.3	15.8	18.2	10.1	11.4	19.6	12.5	20.9	8.5	23.3	15.3	21.1	22.3	17.2	44.3	8.6	22.3	13.8	9.9	10.0	11.9	13.7	14.5	8.2	18.2	13.3	22.4	11.4	12.9	9.8	8.8	38.1	29.2	13.9	10.7	9.6	10.4	3.7	3.4	4.9	9.9	4.5	9.9	3.5	5.6	7.9	4.4	6.0	6.3	7.7	5.1	18.6	6.4	8.9	3.8	2.9	22.8	22.4	31.0	26.8	26.3	23.4	23.4	18.8	20.6	16.1
CDKAL1	FLJ20342	ENSG00000145996	"CDK5 regulatory subunit associated protein 1 like 1"	Q5VV42	6	20534457-21232404	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"tRNA processing"	Transferase	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SCLC-21H: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057474			Uncertain	Vesicles				Vesicles		"HPA057474: "	"unprognostic (9.64e-2)"	"unprognostic (7.23e-3)"	"unprognostic (8.40e-2)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.72e-3)"	"unprognostic (1.61e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.79e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	18.5	9.8	10.9	18.0	12.2	14.7	13.9	24.1	10.6	16.6	11.4	14.6	9.6	8.1	19.4	12.1	12.1	13.5	11.4	10.8	9.0	7.8	10.8	9.7	11.9	13.4	12.4	7.7	16.6	14.1	12.0	29.9	12.6	11.2	10.8	12.0	14.3	15.7	11.0	22.2	15.0	11.4	13.7	13.4	13.9	11.7	11.4	13.8	22.9	17.1	13.6	19.4	13.2	12.6	8.1	5.4	3.3	11.2	12.0	9.7	3.6	2.9	1.8	4.2	5.4	2.4	3.2	4.4	3.0	2.8	4.5	6.0	3.3	2.6	6.9	7.7	2.6	2.9	5.6	3.1	6.1	12.4	3.1	5.9	3.1	4.4	3.1	5.8	4.1	2.9	3.3	4.3	4.0	4.1	7.6	2.8	3.3	2.4	7.3	6.9	2.9	2.0	4.3	5.6	6.5	5.8	3.3	66.0	3.9	3.4	5.5	4.4	4.0	2.9	4.0	5.3	3.7	2.1	5.6	4.5	11.9	6.1	1.9	3.3	8.9	1.5	3.6	3.3	7.8	5.9	6.5	8.1	7.7	7.7	4.9	7.8	9.7	8.6	1.9	12.0	11.2	5.4	8.2	3.6	10.9	12.2	24.1	10.6	9.0	7.8	12.4	7.7	11.2	13.8
CDKL5	"CFAP247, EIEE2, STK9"	ENSG00000008086	"Cyclin dependent kinase like 5"	O76039	X	18425583-18653629	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0"	"Cell line enhanced"	"Detected in many"		"A549: 12.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 7.7;eosinophil: 2.1;neutrophil: 4.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002847, CAB011577"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB011577: AB_727019, HPA002847: AB_1080107"	"unprognostic (7.01e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.63e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.66e-1)"	"prognostic favourable (5.54e-4)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.99e-1)"	3.3	3.2	8.0	1.8	24.7	3.2	4.3	3.9	28.0	5.4	2.7	7.7	1.8	1.5	4.5	2.8	5.2	2.8	3.1	5.0	8.0	3.7	6.3	2.2	6.9	1.4	3.5	13.2	6.7	4.5	6.2	5.0	5.4	5.9	6.7	2.2	2.0	3.9	4.4	3.0	3.5	1.9	4.0	5.7	2.3	4.9	14.0	5.7	1.6	5.1	0.8	2.1	5.6	4.6	0.7	1.0	7.7	1.0	0.5	0.6	0.2	1.7	12.3	3.5	3.1	3.3	4.5	2.5	2.0	3.8	2.8	3.2	4.0	2.3	1.9	0.4	1.3	0.5	4.0	3.0	5.9	0.5	2.6	0.0	7.1	3.1	1.6	0.1	0.8	2.6	3.1	6.8	7.1	1.3	0.1	1.9	4.2	1.7	0.8	0.8	7.1	3.0	0.7	3.8	0.1	2.4	8.9	0.7	4.4	4.5	1.1	2.2	1.6	0.7	7.3	4.3	1.9	7.9	1.5	0.3	0.1	0.3	2.4	0.5	4.2	7.7	1.0	2.1	0.6	0.6	0.3	0.2	0.4	0.3	0.3	0.7	0.6	0.6	4.7	0.5	0.6	1.0	0.2	0.2	8.0	24.7	3.9	28.0	8.0	3.7	3.5	13.2	5.9	5.7
CDKN3	"CDI1, KAP"	ENSG00000100526	"Cyclin dependent kinase inhibitor 3"	Q16667	14	54396849-54420218	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 80.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.1"	"Group enriched"	"Detected in all"	5	"NK-cells: 5.8;T-cells: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005285, HPA039311, HPA058874"			Enhanced	Cytosol				Cytosol		"CAB005285: AB_2078884, HPA039311: , HPA058874: "	"unprognostic (3.46e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-3)"	"prognostic unfavourable (4.52e-4)"	"unprognostic (2.50e-3)"	"unprognostic (2.85e-3)"	"prognostic unfavourable (7.46e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.71e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.31e-2)"	2.4	1.0	1.6	6.5	1.7	12.8	1.5	1.5	2.5	1.0	4.5	0.2	0.2	3.8	0.9	1.1	4.4	0.7	0.9	3.0	1.4	1.9	1.0	1.1	1.1	8.8	1.7	1.9	0.9	0.7	0.0	1.0	2.3	2.8	0.9	5.8	0.9	1.7	0.1	3.9	1.8	4.0	2.2	1.0	2.3	1.8	80.3	0.3	18.3	1.1	6.4	9.5	2.1	1.8	2.0	1.6	1.1	1.4	5.8	16.1	2.9	55.8	21.5	16.5	16.4	2.7	3.3	9.5	13.4	19.7	28.5	31.6	16.1	27.9	27.5	9.8	20.8	41.2	25.0	16.2	53.3	32.9	12.1	14.0	15.4	26.7	2.0	17.5	10.0	1.2	1.0	17.8	31.0	18.1	7.0	35.3	34.2	39.8	24.0	14.2	5.8	46.6	14.9	14.5	5.9	15.1	12.3	6.7	8.6	24.4	14.5	10.7	30.0	14.9	6.6	12.7	43.4	19.9	31.6	8.5	9.8	18.9	21.2	25.2	23.1	0.0	1.3	1.1	1.2	1.4	0.6	2.0	5.2	4.3	1.6	0.9	2.7	2.2	0.9	5.8	0.9	1.2	16.1	2.9	1.6	1.7	1.5	2.5	1.4	1.9	1.7	1.9	2.8	0.3
CELSR1	"ADGRC1, CDHF9, FMI2, HFMI2, ME2"	ENSG00000075275	"Cadherin EGF LAG seven-pass G-type receptor 1"	Q9NYQ6	22	46360834-46537170	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 23.8;HaCaT: 15.0;T-47d: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"memory B-cell: 3.0;naive B-cell: 3.0"	"Lineage enriched"	"Detected in single"	4	"B-cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052976, HPA060521"			Supported	"Plasma membrane"				"Plasma membrane"		"HPA052976: , HPA060521: "	"unprognostic (5.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	3.4	0.5	0.6	5.0	1.4	0.3	4.1	0.4	0.3	8.7	1.3	0.9	3.6	0.3	5.7	7.5	14.2	11.1	5.3	4.6	0.7	0.7	16.2	0.8	19.3	4.2	0.4	0.0	6.0	2.6	7.5	3.8	3.4	2.2	7.2	0.4	3.8	22.6	3.0	0.3	13.9	2.3	3.1	0.4	1.8	3.6	2.8	0.0	1.8	5.7	12.7	12.8	3.1	5.0	3.0	0.2	0.0	0.0	0.7	0.1	0.0	8.5	23.8	4.5	3.9	0.0	0.0	2.1	0.7	1.5	1.4	0.3	5.7	6.7	0.0	11.8	0.1	15.0	3.7	11.4	0.5	0.0	4.6	0.0	9.5	0.2	0.2	1.5	0.6	0.0	10.6	0.0	9.5	0.0	0.0	0.0	0.0	10.8	0.0	1.7	1.7	3.8	0.0	0.0	2.8	6.3	5.3	0.2	0.3	7.4	6.0	1.2	17.0	5.0	0.3	0.0	0.1	0.0	0.1	4.5	0.2	2.4	5.9	0.0	5.1	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.6	1.4	0.4	0.3	0.7	0.7	0.4	0.0	2.2	0.0
CERS3	"LASS3, MGC27091"	ENSG00000154227	"Ceramide synthase 3"	Q8IU89	15	100400395-100544995	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 25.6;skin 1: 29.0;testis: 37.9"	"Cell line enriched"	"Detected in some"	6	"hTCEpi: 37.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 14.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006092, HPA024356"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA006092: AB_1079236, HPA024356: AB_1852721"	"unprognostic (5.01e-3)"	"unprognostic (3.43e-2)"	"unprognostic (6.47e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.84e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.31e-5)"	"unprognostic (2.65e-1)"	"unprognostic (4.74e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-3)"	0.4	0.0	0.4	0.4	0.4	0.0	1.9	0.4	0.4	6.0	0.4	0.4	0.4	0.0	0.4	0.4	25.6	0.3	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.4	3.6	0.4	0.4	29.0	0.4	0.4	0.4	0.4	0.0	37.9	0.4	0.4	0.4	0.4	8.5	0.4	11.2	0.0	0.0	1.5	0.6	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.1	0.2	0.2	0.0	0.7	0.3	0.0	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
CETP	BPIFF	ENSG00000087237	"Cholesteryl ester transfer protein"	P11597	16	56961850-56983845	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Atherosclerosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.5;lymphoid tissue: 54.5"	"Cell line enhanced"	"Detected in some"		"HEL: 5.1;HUVEC TERT2: 8.6;TIME: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.1;plasmacytoid DC: 5.8"	"Low lineage specificity"	"Detected in many"																"Secreted to blood"	380000000	380000000				"unprognostic (6.52e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-3)"	"unprognostic (4.92e-3)"	"unprognostic (7.17e-3)"	"unprognostic (2.62e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.97e-2)"	16.0	1.9	0.6	4.8	1.0	2.0	4.8	0.3	0.7	0.3	0.9	0.3	0.2	0.3	0.3	0.7	1.3	0.3	1.8	3.1	0.7	0.5	4.1	23.5	2.9	54.5	0.7	0.7	0.6	0.6	0.3	3.0	17.7	0.9	0.7	0.1	9.7	7.7	0.5	0.4	0.5	1.7	0.2	0.7	36.7	0.5	0.4	0.0	3.7	4.6	0.1	3.4	0.7	0.3	1.7	5.8	0.3	5.1	4.2	0.2	2.3	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	0.9	1.0	1.6	0.0	0.1	0.0	0.1	0.0	0.0	8.6	0.0	0.8	0.1	0.0	0.0	1.7	0.0	0.0	0.8	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.4	0.0	0.6	0.0	0.4	0.1	0.8	0.2	0.0	0.0	0.0	0.9	0.0	0.2	1.2	0.0	1.7	0.0	0.0	0.7	0.3	0.1	0.0	0.3	4.2	5.1	5.8	0.1	2.3	0.6	1.0	0.3	0.7	0.7	0.5	0.7	0.7	0.9	0.0
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 461.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 6.0;ASC TERT1: 5.8;CAPAN-2: 6.9;fHDF/TERT166: 11.3;HSkMC: 18.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"											"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	180000000000	180000000000	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: AB_627562, HPA000951: , HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favourable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavourable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	9.3	1.0	0.3	4.1	0.4	0.3	2.4	0.2	0.4	1.3	9.0	0.4	0.9	3.2	0.5	3.7	2.2	4.0	8.9	3.3	0.2	0.0	16.1	461.5	2.5	2.1	0.7	0.1	2.8	5.8	0.4	1.0	4.0	1.0	4.0	1.6	2.6	3.1	0.3	0.5	0.5	4.7	2.6	0.6	0.8	4.1	1.4	0.3	0.3	1.8	0.5	1.7	1.6	0.4	0.1	1.6	0.0	0.8	0.0	0.2	0.0	0.0	1.8	0.1	0.1	6.0	5.8	0.0	0.0	0.3	1.5	0.6	0.0	6.9	0.1	5.1	11.3	0.0	0.0	1.9	1.4	0.4	0.3	0.4	0.3	0.5	0.0	0.7	0.1	18.7	0.1	0.9	0.6	0.2	0.2	0.7	0.1	0.1	0.1	0.4	0.3	0.1	0.2	0.4	0.2	1.6	0.0	0.0	0.0	0.5	1.2	0.2	0.0	0.2	0.0	0.2	0.5	0.3	0.3	0.5	1.9	0.5	3.1	0.5	0.5	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.3	0.4	0.2	0.3	0.2	0.0	0.7	0.1	1.0	0.3
CFD	"ADN, DF, PFD"	ENSG00000197766	"Complement factor D"	P00746	19	859643-863630	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"ASC diff: 39.8;THP-1: 56.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 125.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	8000000000	8000000000				"unprognostic (3.00e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.10e-2)"	"prognostic favourable (1.77e-4)"	"unprognostic (9.53e-2)"	"prognostic unfavourable (7.09e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.75e-2)"	161.3	4.6	0.0	16.4	0.0	5.6	96.7	0.0	1.7	44.2	35.2	0.2	42.2	10.9	8.9	89.8	54.1	15.6	59.0	102.0	0.0	0.0	1.9	2.3	34.0	6.2	0.0	0.0	13.7	6.0	1.7	0.1	20.2	0.1	102.0	4.3	3.4	22.7	15.1	40.5	35.8	16.5	97.3	0.1	3.7	19.7	33.6	0.0	0.8	52.6	55.6	9.0	83.7	130.3	0.6	5.6	125.0	25.8	0.1	1.0	10.4	0.7	1.9	0.0	0.3	39.8	6.2	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.5	0.2	0.0	0.0	1.1	2.8	0.0	1.7	0.6	0.6	0.3	1.0	6.3	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.9	0.0	8.9	0.1	2.8	0.2	0.0	0.9	0.0	0.1	0.3	0.3	0.8	0.2	0.0	1.1	56.5	0.0	0.0	0.9	0.4	0.1	1.7	0.7	0.0	0.0	3.3	0.0	125.0	18.2	58.8	0.7	20.1	1.0	0.6	0.5	0.9	5.6	0.2	0.7	0.8	43.2	0.1	25.8	0.5	0.3	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109802179	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 90.7;liver: 198.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 28.9;Hep G2: 45.8;HSkMC: 19.0;RPTEC TERT1: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	11000000000	11000000000			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (6.06e-4)"	9.5	13.2	1.5	2.3	1.4	0.0	3.9	0.9	2.5	5.0	4.1	1.1	2.9	4.9	5.0	12.0	4.4	9.7	9.3	6.2	1.6	0.8	90.7	198.4	7.2	3.1	1.8	0.7	10.6	7.6	0.5	3.8	3.2	2.6	3.9	0.7	6.8	3.6	3.6	1.4	0.5	4.6	3.0	3.0	7.8	1.7	3.6	1.6	0.5	5.3	2.3	1.4	3.8	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	28.9	0.0	9.2	0.0	0.0	0.0	0.0	0.0	9.7	0.3	0.0	0.1	45.8	2.0	0.0	0.0	19.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	51.2	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	0.9	2.5	1.6	0.8	1.8	0.7	2.6	1.6
CHAT		ENSG00000070748	"Choline O-acetyltransferase"	P28329	10	49609095-49665104	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Acyltransferase, Transferase"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.4;placenta: 10.4"	"Cell line enriched"	"Detected in some"	11	"NB-4: 15.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"basal ganglia: 5.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 18.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 7.7;pons and medulla: 8.1"	"CAB002313, HPA048547, CAB079053"	Supported	Supported								"CAB002313: AB_563661, CAB079053: , HPA048547: "					"unprognostic (2.34e-2)"	"unprognostic (6.10e-2)"		"unprognostic (5.28e-2)"		"unprognostic (6.96e-2)"	"unprognostic (2.80e-2)"			"unprognostic (3.98e-1)"	"unprognostic (1.09e-1)"			0.2	0.0	0.2	0.3	5.4	0.0	0.2	0.2	0.2	0.2	0.6	0.2	0.2	1.6	0.2	0.5	0.2	0.0	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.9	0.0	0.2	10.4	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	1.1	0.2	0.4	0.2	0.0	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	1.0	0.3	0.2	0.6	1.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.0	15.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.3	0.4	0.1	0.5	0.3	1.0	0.4	0.1	0.6	0.5	0.3	0.0	0.6	0.1	1.0	0.2	0.0	0.2	5.4	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2
CHD2	"DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614"	ENSG00000173575	"Chromodomain helicase DNA binding protein 2"	O14647	15	92900189-93028005	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060744, HPA060960"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA060744: , HPA060960: "	"unprognostic (1.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.85e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.70e-2)"	23.7	16.6	18.7	23.6	21.1	66.7	21.8	35.1	22.8	24.1	19.9	19.7	17.6	15.7	26.1	31.9	20.3	18.4	16.8	15.3	18.5	15.7	17.7	17.6	30.4	25.2	22.1	13.9	26.3	20.9	27.5	41.9	33.1	19.1	22.4	16.1	22.1	21.2	19.9	24.3	25.2	24.3	20.3	30.8	26.9	20.8	20.4	22.4	39.5	28.8	11.3	37.4	34.7	19.0	25.5	17.2	34.5	6.3	8.0	17.5	4.6	10.7	5.8	15.9	7.0	9.9	24.5	12.2	10.1	10.3	6.8	8.5	7.4	14.1	2.6	8.5	8.7	16.0	9.2	9.9	9.6	0.0	5.4	12.7	11.7	6.4	13.4	13.4	10.0	15.4	12.2	8.1	16.5	11.5	13.2	30.3	10.3	6.6	6.9	7.0	10.1	6.6	10.0	14.5	14.5	7.1	14.5	8.8	9.5	17.5	6.4	13.1	7.2	11.4	18.4	5.6	7.4	4.8	6.4	28.9	11.6	11.0	8.6	8.1	4.8	14.9	6.3	15.0	12.9	3.3	11.8	25.5	12.6	10.1	3.3	23.4	17.5	12.5	34.5	8.0	5.8	17.2	12.3	4.6	18.7	21.1	35.1	22.8	18.5	15.7	22.1	13.9	19.1	22.4
CHD4	"Mi-2b, Mi2-BETA"	ENSG00000111642	"Chromodomain helicase DNA binding protein 4"	Q14839	12	6570082-6614524	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012008	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA012008: AB_1846633"	"unprognostic (6.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.40e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.36e-3)"	"prognostic unfavourable (6.03e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.66e-1)"	23.5	34.9	21.9	50.0	33.5	27.2	25.9	29.4	25.1	28.1	29.5	29.3	38.5	18.6	37.2	35.4	29.1	28.0	40.3	52.8	23.5	19.2	29.5	25.0	25.5	30.9	33.6	19.4	34.6	27.4	58.4	25.3	29.5	27.2	21.5	26.0	26.5	24.8	46.2	33.7	31.1	24.4	36.6	30.3	29.4	27.2	29.7	28.9	75.7	38.4	33.7	38.4	34.7	24.3	12.6	16.8	12.8	9.1	13.5	16.7	5.8	20.5	18.7	46.5	17.4	19.1	21.5	27.3	22.8	22.2	25.2	23.2	31.2	16.0	44.2	9.1	25.7	18.4	43.6	25.1	34.0	33.0	22.4	61.7	29.1	19.5	16.6	48.4	29.6	20.7	12.5	24.3	17.1	29.3	48.5	22.1	23.9	25.7	45.9	15.8	44.5	17.7	39.4	28.6	24.1	15.9	24.3	22.0	28.3	29.3	32.6	22.6	14.9	27.6	27.2	25.7	54.8	18.8	26.6	35.8	21.3	56.4	17.0	29.6	18.8	9.0	7.7	9.2	12.2	9.1	12.0	10.5	10.3	11.1	7.9	12.6	13.0	12.3	12.8	13.5	8.1	16.8	16.7	5.8	21.9	33.5	29.4	25.1	23.5	19.2	33.6	19.4	27.2	28.9
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101793-6180123	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.4;pituitary gland: 22.3;testis: 16.4"	"Group enriched"	"Detected in some"	4	"SCLC-21H: 16.6;U-2 OS: 7.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	1.1	7.9	19.8	1.3	17.1	1.0	1.0	12.1	41.4	1.2	1.4	0.7	0.0	1.3	1.2	1.2	1.5	1.2	1.2	1.6	15.3	10.1	1.3	1.0	1.2	1.0	4.3	19.1	1.1	1.4	1.3	22.3	1.0	8.0	1.9	1.3	2.3	1.2	4.8	1.2	1.0	1.4	1.2	1.6	1.1	1.2	16.4	0.8	0.0	1.0	0.0	1.0	1.1	0.4	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.2	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	1.5	0.0	0.3	1.3	0.0	0.0	0.0	0.0	16.6	0.2	0.1	0.0	0.0	2.8	0.1	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.8	17.1	12.1	34.2	15.3	10.1	4.3	19.1	8.0	0.8
CHD6	"CHD5, dJ620E11.1, FLJ22369, KIAA1335, RIGB"	ENSG00000124177	"Chromodomain helicase DNA binding protein 6"	Q8TD26	20	41402101-41618494	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015543			Approved	Nucleoplasm				Nucleoplasm		"HPA015543: "	"unprognostic (5.13e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.72e-3)"	"prognostic favourable (3.42e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.12e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-2)"	12.1	12.6	16.5	12.7	16.2	18.1	19.4	34.1	24.9	17.4	11.3	16.6	15.4	6.5	20.4	19.9	11.0	16.3	11.7	12.1	15.8	13.9	11.8	10.7	11.7	12.1	14.7	16.8	26.1	12.5	31.4	30.3	12.9	24.3	19.7	10.0	14.2	14.5	17.0	9.4	14.4	10.5	14.4	17.3	12.0	12.3	11.1	18.2	21.4	21.4	6.7	15.3	16.9	15.0	12.0	11.5	15.1	9.3	10.4	10.4	2.3	6.4	7.6	16.4	7.2	9.3	9.6	10.9	5.6	11.6	10.0	12.3	10.4	5.3	7.7	10.2	9.5	9.5	10.2	9.6	11.5	2.4	4.9	10.5	6.9	10.0	5.2	8.2	5.2	9.6	9.0	7.3	8.1	8.6	8.2	8.7	7.7	17.6	12.9	8.9	5.3	12.7	10.0	19.4	5.4	6.2	14.8	14.8	10.2	17.1	4.6	11.4	7.8	6.2	9.9	15.8	7.8	8.4	4.8	7.9	6.3	9.9	7.1	4.0	4.9	15.1	6.5	7.1	8.9	6.2	8.9	8.8	7.7	7.3	5.1	12.0	10.4	8.7	0.9	10.4	9.3	11.5	5.9	2.3	16.5	16.2	34.1	24.9	15.8	13.9	14.7	16.8	24.3	18.2
CHD7	"CRG, FLJ20357, FLJ20361, KIAA1416"	ENSG00000171316	"Chromodomain helicase DNA binding protein 7"	Q9P2D1	8	60678778-60868028	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.1"	"Cell line enhanced"	"Detected in many"		"AF22: 25.8;SCLC-21H: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 12.2;granulocytes: 12.6;T-cells: 5.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 110.3"	HPA053075			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA053075: "	"unprognostic (3.77e-2)"	"unprognostic (3.28e-3)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (5.34e-5)"	"unprognostic (9.59e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.17e-1)"	3.9	2.2	7.0	7.9	11.2	25.1	4.1	47.1	9.0	2.3	5.7	13.4	3.1	5.9	2.6	3.2	5.1	3.2	3.1	4.1	8.1	4.3	3.6	3.6	4.7	7.0	8.1	3.3	1.4	6.4	12.4	9.9	5.6	9.9	2.9	5.5	6.4	5.7	2.8	10.3	5.7	6.6	2.4	7.5	6.1	4.5	4.3	12.2	1.6	5.4	2.2	7.3	2.9	5.9	12.2	0.6	12.6	0.6	0.0	5.5	0.4	3.8	1.9	25.8	4.5	0.0	0.0	8.1	0.2	0.0	0.9	0.8	4.8	3.6	7.5	0.4	0.0	2.3	13.2	3.8	0.8	2.8	7.1	17.6	3.2	6.3	1.1	5.3	3.3	0.5	2.9	0.0	4.3	3.8	1.3	6.7	0.6	3.9	8.3	6.0	17.7	0.9	17.3	6.1	2.4	2.0	4.4	23.6	11.7	0.7	2.9	7.2	5.2	5.0	4.4	0.2	4.2	0.2	2.1	7.1	4.1	11.7	1.5	0.6	6.6	10.4	0.3	12.6	2.6	0.1	3.3	8.0	2.9	0.9	0.1	12.2	5.5	2.0	7.1	0.0	0.6	0.6	0.2	0.4	7.0	11.2	47.1	6.5	8.1	4.3	8.1	3.3	9.9	12.2
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA052186: , HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favourable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	13.9	14.5	13.0	14.8	21.5	34.8	17.0	28.9	25.7	15.8	14.4	26.6	14.1	11.1	18.3	13.4	17.4	15.9	11.7	12.3	13.5	13.3	14.0	11.2	15.5	18.5	15.4	15.2	20.7	19.0	34.7	25.3	15.2	20.3	16.3	14.6	19.3	15.7	14.9	16.9	24.5	16.4	17.2	13.1	19.2	16.1	15.2	18.1	29.9	17.4	10.4	24.8	16.6	14.5	12.3	7.8	12.8	7.4	8.7	8.6	3.0	16.2	21.3	23.6	11.0	15.1	13.1	13.4	12.9	14.9	19.7	19.7	18.5	14.1	26.9	8.2	17.3	20.0	28.9	18.2	25.0	20.6	13.2	23.6	14.3	22.4	14.0	32.6	22.5	17.6	14.8	22.1	15.9	17.5	16.4	14.4	14.9	17.5	23.4	13.3	18.0	18.1	22.0	17.9	9.1	14.6	30.1	17.3	16.6	20.3	15.8	11.2	11.1	15.8	20.5	16.4	12.6	9.6	15.3	16.4	19.5	26.9	6.6	12.1	16.3	12.8	4.8	12.1	7.7	5.0	8.6	5.8	6.8	7.5	3.3	12.3	7.4	6.4	11.0	8.7	7.4	7.8	5.7	3.0	13.0	21.5	28.9	25.7	13.5	13.3	15.4	15.2	20.3	18.1
CHEK2	"bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53"	ENSG00000183765	"Checkpoint kinase 2"	O96017	22	28687743-28742422	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001878, CAB002030"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"CAB002030: AB_563660, HPA001878: AB_1078514"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.08e-3)"	"unprognostic (3.33e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (7.80e-9)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.79e-3)"	5.6	8.3	2.5	13.0	7.0	13.7	5.6	0.7	5.6	6.6	9.8	2.5	4.8	6.8	4.8	10.9	10.0	4.3	6.0	6.0	4.1	2.3	5.3	6.5	7.9	10.1	6.7	1.6	12.9	6.7	1.2	4.2	10.1	5.1	8.3	10.6	8.7	7.0	5.8	2.2	6.3	8.5	5.4	5.0	9.8	5.8	9.7	3.6	13.1	7.5	4.8	13.7	6.2	6.7	11.8	8.7	6.5	8.4	2.9	4.4	3.7	14.7	4.7	13.5	16.7	3.8	19.2	8.7	7.3	8.6	9.7	14.2	12.0	10.1	17.4	6.2	5.1	14.2	20.5	13.4	11.3	12.4	15.7	22.9	9.0	19.8	3.8	14.5	16.8	8.1	6.2	12.4	11.0	10.7	13.8	15.2	9.0	20.7	11.6	23.3	19.0	12.0	25.3	9.2	20.3	6.0	6.1	7.9	4.5	8.1	14.5	8.0	9.9	13.4	3.7	7.8	9.3	6.8	3.8	9.2	16.2	34.0	7.4	15.2	9.9	6.5	3.7	1.2	1.1	8.4	2.3	11.8	2.2	2.1	8.7	8.4	4.4	2.8	0.3	2.9	4.1	7.0	2.8	3.7	2.5	7.0	0.7	5.6	4.1	2.3	6.7	1.6	5.1	3.6
CHRNB1	CHRNB	ENSG00000170175	"Cholinergic receptor nicotinic beta 1 subunit"	P11230	17	7445061-7457707	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.6;tongue: 33.9"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 18.1;RH-30: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005822, CAB011200"	Approved									"CAB011200: AB_262151, HPA005822: AB_1079484"	"unprognostic (2.89e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-1)"	4.5	11.5	5.7	1.9	5.1	6.1	3.7	2.3	4.4	3.4	2.0	4.5	3.7	2.3	2.4	5.5	3.6	2.9	1.6	5.0	4.8	3.9	3.9	5.5	2.4	2.6	6.0	3.5	2.9	18.2	8.3	2.5	5.8	4.0	2.6	2.1	4.5	4.5	2.6	81.6	4.0	2.2	2.6	5.1	3.1	2.0	1.2	4.4	4.5	6.0	33.9	3.2	2.4	2.5	7.8	8.2	15.2	11.1	12.3	11.7	7.1	0.8	1.1	2.0	2.4	3.2	2.2	4.5	0.6	2.0	3.0	2.5	0.7	1.1	3.2	2.2	1.2	7.1	0.7	13.0	1.1	3.9	2.5	1.8	1.2	4.1	1.4	1.1	4.6	4.8	3.6	1.8	5.8	2.0	2.3	1.8	18.1	0.5	3.4	2.1	1.4	0.6	2.2	37.6	8.0	8.1	0.7	0.3	5.9	1.2	2.2	2.4	2.1	1.5	1.9	1.3	3.5	0.9	2.5	4.3	4.7	0.9	1.1	2.5	1.1	10.6	6.6	15.2	9.9	7.2	7.7	7.8	11.0	10.0	8.2	7.6	9.0	11.7	2.2	12.3	11.1	6.3	8.9	7.1	5.7	5.1	2.3	4.1	4.8	3.9	6.0	3.5	4.0	4.4
CHRND	ACHRD	ENSG00000135902	"Cholinergic receptor nicotinic delta subunit"	Q07001	2	232525993-232536667	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 49.1"	"Cell line enriched"	"Detected in single"	72	"RH-30: 42.8"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory region: 1.4"	"HPA056404, HPA065404"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA056404: , HPA065404: "				"unprognostic (1.69e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.75e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.90e-1)"		"unprognostic (4.97e-8)"	"unprognostic (7.52e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-1)"		2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	49.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHRNE	ACHRE	ENSG00000108556	"Cholinergic receptor nicotinic epsilon subunit"	Q04844	17	4897774-4903074	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"heart muscle: 53.3;pituitary gland: 19.0"	"Group enriched"	"Detected in some"	13	"HEL: 5.9;HMC-1: 14.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 5.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	14	"basal ganglia: 5.7"												"unprognostic (2.00e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.35e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.80e-4)"	"unprognostic (7.75e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.39e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.70e-2)"	0.3	0.1	0.1	0.4	0.1	0.4	0.1	0.3	0.4	0.1	0.2	0.1	0.1	0.3	0.4	0.8	0.2	0.1	0.4	53.3	0.1	0.0	0.1	1.3	0.3	0.2	0.3	0.1	0.3	0.6	0.3	19.0	0.4	0.2	0.1	0.0	0.5	0.5	0.1	1.0	0.8	0.1	0.2	0.1	0.7	0.1	0.2	0.1	0.1	0.1	1.4	0.2	0.1	0.1	1.0	0.3	1.0	0.4	1.6	5.9	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.2	5.9	0.0	0.7	0.5	0.0	14.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	5.9	0.2	0.0	0.0	0.0	2.1	0.2	1.0	0.1	1.6	0.2	1.6	0.4	0.3	0.0	1.5	0.1	0.1	0.3	0.4	0.1	0.0	0.3	0.1	0.2	0.1
CHRNG	ACHRG	ENSG00000196811	"Cholinergic receptor nicotinic gamma subunit"	P07510	2	232539727-232546403	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"epididymis: 16.7;skeletal muscle: 40.0"	"Group enriched"	"Detected in some"	18	"HSkMC: 4.9;RH-30: 13.7"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (2.26e-1)"	"unprognostic (8.97e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.38e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.19e-6)"	"unprognostic (6.13e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.24e-2)"	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.6	0.0	40.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	0.6	0.3	0.5	0.5	1.1	0.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.2	0.1	0.1	0.1	13.7	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.5	0.2	0.2	0.2	0.7	0.2	0.4	0.5	0.2	0.6	0.8	0.8	0.2	1.1	0.2	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHST11	"C4ST, C4St-1, C4ST1, HSA269537"	ENSG00000171310	"Carbohydrate sulfotransferase 11"	Q9NPF2	12	104455295-104762014	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052828	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	22000	22000	"Golgi apparatus"		"HPA052828: "	"unprognostic (6.35e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.28e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.21e-3)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.44e-2)"	"prognostic unfavourable (7.59e-11)"	"unprognostic (1.64e-2)"	"unprognostic (5.60e-2)"	"unprognostic (5.40e-3)"	"prognostic unfavourable (8.42e-4)"	6.7	14.3	14.6	21.6	16.6	37.3	4.9	5.7	16.1	6.6	6.2	8.2	9.7	3.9	15.7	16.1	4.4	5.2	11.1	6.6	13.4	11.9	4.4	4.0	15.3	22.5	11.5	6.7	8.7	6.3	1.9	6.8	17.2	10.0	6.4	5.2	16.1	3.3	13.4	1.7	2.7	7.7	12.6	10.5	17.5	8.3	3.3	11.8	26.5	4.3	2.9	15.6	8.5	5.3	2.0	2.6	13.8	1.3	1.3	2.8	0.6	13.5	6.3	2.9	1.8	7.4	3.6	10.3	1.3	0.4	0.6	0.5	0.0	17.8	0.0	2.0	1.8	3.4	1.7	7.1	0.7	0.1	2.5	18.1	1.6	0.0	1.1	21.0	21.5	1.3	1.0	11.6	1.9	4.5	27.9	4.6	1.2	3.3	16.1	24.9	2.4	2.3	18.3	9.7	4.5	6.0	0.1	4.9	8.0	0.8	9.2	17.1	2.7	21.4	10.4	2.0	2.2	10.4	11.2	24.1	25.9	3.4	9.4	14.8	20.2	9.3	1.3	9.4	2.8	1.2	1.6	0.9	1.5	2.1	0.7	2.0	0.7	1.8	13.8	1.3	1.1	2.6	2.8	0.6	14.6	16.6	5.7	10.4	13.4	11.9	11.5	6.7	10.0	11.8
CHST14	"D4ST-1, D4ST1, HD4ST"	ENSG00000169105	"Carbohydrate sulfotransferase 14"	Q8NCH0	15	40470998-40474571	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA057697, HPA071601"	Enhanced		Approved	Vesicles				Vesicles		"HPA057697: , HPA071601: "	"unprognostic (5.46e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.01e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.25e-2)"	10.3	7.9	7.1	7.5	6.9	2.3	22.7	6.5	7.4	14.9	7.9	6.0	13.8	3.6	17.5	11.1	6.5	12.3	14.1	12.6	5.5	2.9	8.1	9.6	15.9	20.9	8.1	4.5	18.8	11.6	10.2	11.4	22.4	7.1	10.7	3.8	9.8	12.7	17.2	5.5	6.8	7.1	13.3	5.9	10.5	7.3	9.2	6.3	7.5	12.4	8.3	6.1	12.1	18.2	2.1	3.4	8.0	1.9	5.5	4.0	1.1	11.0	7.3	11.7	31.6	18.4	14.3	18.3	10.9	20.8	19.4	18.4	8.8	5.6	1.8	16.7	18.5	19.1	10.4	6.1	9.1	13.2	6.1	5.7	7.8	8.4	10.0	2.4	14.8	17.4	5.1	6.8	5.2	17.0	5.5	6.6	14.4	8.4	4.0	12.7	7.5	8.5	11.1	14.9	3.2	13.0	5.7	8.5	13.0	9.6	10.8	3.6	15.7	10.2	13.8	32.9	12.2	10.3	10.8	13.4	9.2	5.1	14.8	8.4	23.6	8.0	1.9	3.6	4.0	1.9	1.1	0.5	2.0	3.4	3.4	2.1	1.8	1.4	0.3	5.5	0.9	1.2	1.3	1.1	7.1	6.9	6.5	7.4	5.5	2.9	8.1	4.5	7.1	6.3
CHST3	"C6ST, C6ST1"	ENSG00000122863	"Carbohydrate sulfotransferase 3"	Q7LGC8	10	71964365-72013564	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047523, HPA055704"	Enhanced		Approved	"Golgi apparatus,Cytosol"		510000	510000	"Golgi apparatus, Cytosol"		"HPA047523: , HPA055704: "	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.54e-3)"	22.2	11.6	9.2	7.0	19.4	0.7	12.0	2.9	11.6	10.4	9.0	19.4	4.8	1.7	13.7	7.4	8.4	13.6	6.2	11.9	11.3	5.1	8.6	1.8	6.3	2.2	30.1	5.5	25.0	6.1	1.9	4.0	10.0	15.6	10.7	3.3	5.7	6.3	19.5	13.6	7.1	4.0	21.0	16.2	2.9	11.6	19.4	25.2	0.5	7.3	4.8	2.2	7.5	18.5	0.2	0.3	0.8	0.1	0.1	0.2	0.0	6.7	7.3	3.8	9.3	17.3	6.8	0.1	14.4	13.9	8.9	5.9	6.4	13.7	0.0	10.0	17.0	8.9	3.3	9.9	7.1	0.2	2.5	0.0	12.8	6.1	8.8	0.0	0.0	9.4	11.5	8.8	12.1	2.6	2.0	0.0	9.4	0.2	0.0	0.0	1.6	2.4	0.0	4.5	0.0	12.5	7.0	0.2	3.7	10.9	0.2	10.6	0.8	1.4	5.4	11.0	12.7	18.2	28.8	0.0	0.0	0.0	8.0	0.0	7.7	0.3	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.8	0.1	0.0	0.3	0.1	0.0	9.2	19.4	2.9	11.6	11.3	5.1	30.1	5.5	15.6	25.2
CHSY1	"CSS1, KIAA0990"	ENSG00000131873	"Chondroitin sulfate synthase 1"	Q86X52	15	101175723-101251932	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 72.5"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048902	Uncertain				"Secreted - unknown location"					"HPA048902: "	"unprognostic (7.28e-2)"	"unprognostic (6.39e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (6.33e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	23.2	15.6	14.4	14.6	13.7	15.7	17.7	8.5	11.1	17.7	6.5	9.6	8.6	4.9	15.6	11.6	9.1	14.1	19.0	19.0	11.4	7.5	9.0	8.1	20.6	12.4	15.3	5.5	21.9	6.0	5.9	8.7	72.5	12.9	13.6	7.0	12.1	9.8	10.1	7.3	13.7	6.8	16.4	11.9	18.4	9.3	10.8	13.5	8.3	9.7	9.2	8.7	14.3	20.0	1.9	1.5	8.7	2.4	1.2	3.2	1.0	2.7	3.4	11.7	5.9	6.1	8.2	7.8	6.8	6.0	8.2	8.4	2.9	2.2	6.7	4.0	11.2	7.7	7.7	8.6	9.1	7.4	3.9	13.3	3.9	3.5	7.6	20.1	13.7	7.5	7.3	7.1	6.5	9.7	4.8	68.3	6.2	2.4	2.7	13.8	13.4	2.5	6.2	11.7	9.9	5.7	5.5	2.0	11.0	7.1	3.5	12.3	4.0	24.9	8.1	13.5	7.7	6.3	14.2	12.1	28.0	3.9	10.4	19.1	10.0	0.0	2.4	5.1	2.9	1.5	3.1	1.7	1.8	3.1	1.5	1.9	1.0	1.9	8.7	1.2	1.6	0.9	3.2	1.0	14.4	13.7	8.5	11.1	11.4	7.5	15.3	5.5	12.9	13.5
CHUK	"IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16"	ENSG00000213341	"Conserved helix-loop-helix ubiquitous kinase"	O15111	10	100188298-100229619	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001402, CAB004240, CAB018564"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (1.27e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.22e-1)"	16.6	16.6	14.0	14.3	18.9	21.3	14.2	16.0	15.8	11.8	15.0	13.0	13.9	16.1	14.7	12.4	13.5	12.0	11.7	14.5	13.3	17.6	27.2	35.8	14.0	20.8	17.9	6.9	11.4	14.5	19.6	18.2	14.2	16.4	12.9	17.6	9.5	13.9	12.5	23.6	11.0	20.6	16.1	18.6	18.7	15.1	12.5	15.6	22.5	14.5	11.7	15.5	13.8	13.6	3.7	3.4	7.2	4.8	4.0	4.3	1.4	15.6	13.2	13.6	20.2	13.1	11.8	10.5	19.9	19.6	18.6	22.8	14.8	9.3	21.2	11.8	13.5	15.5	22.6	10.6	21.0	22.5	19.5	14.1	10.5	16.3	11.2	26.0	20.7	9.4	11.3	21.5	21.0	13.2	15.9	17.6	20.3	9.5	20.5	16.1	8.8	9.7	13.4	15.1	9.7	11.8	10.1	8.1	12.1	10.8	8.4	17.3	16.7	15.9	13.9	11.7	13.2	12.7	22.6	20.8	18.7	20.7	12.8	21.2	9.2	2.6	3.0	5.1	2.4	4.8	4.0	3.7	3.0	4.3	3.4	2.1	3.3	4.2	7.2	4.0	3.2	2.1	2.8	1.4	14.0	18.9	16.0	15.8	13.3	17.6	17.9	6.9	16.4	15.6
CIITA	"C2TA, MHC2TA, NLRA"	ENSG00000179583	"Class II major histocompatibility complex transactivator"	P33076	16	10866222-10943021	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Kinase, Transferase"	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 22.8;REH: 40.0;U-698: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016084, HPA054757"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB016084: AB_627261, HPA054757: "	"unprognostic (1.45e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-2)"	8.0	5.9	4.6	47.7	7.1	4.3	6.8	1.5	5.5	6.3	3.7	10.6	4.2	10.4	8.1	10.4	4.8	5.2	8.1	4.9	4.7	3.5	8.8	2.9	15.0	27.0	9.4	1.1	2.5	3.5	1.9	4.0	1.2	6.6	5.5	4.3	5.5	13.3	4.3	2.9	4.4	17.4	3.7	15.6	25.9	6.2	1.5	7.4	12.6	6.1	5.2	67.2	6.3	6.8	27.3	19.0	6.5	11.9	0.7	0.5	1.7	0.1	0.2	0.3	0.3	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.3	5.5	5.0	0.8	0.0	0.9	0.0	0.0	0.1	22.8	0.2	2.9	1.0	0.6	0.0	0.4	0.4	1.0	0.0	0.1	0.0	0.0	0.3	2.0	0.1	0.3	0.2	0.4	0.1	0.1	40.0	0.3	3.5	0.0	1.6	0.9	0.1	0.9	0.3	0.9	0.5	1.6	0.3	2.1	0.3	0.6	0.2	8.4	0.6	11.8	7.5	0.5	6.8	0.2	11.9	6.5	0.3	9.5	0.1	17.9	0.1	0.5	17.7	27.3	0.1	0.2	2.8	0.7	10.0	19.0	0.4	1.7	4.6	7.1	1.5	5.5	4.7	3.5	9.4	1.1	6.6	7.4
CIT	"CITK, CRIK, KIAA0949, STK21"	ENSG00000122966	"Citron rho-interacting serine/threonine kinase"	O14578	12	119685790-119877291	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3;brain: 35.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA019082, HPA048812, HPA075506"	Uncertain		Approved	Cytosol				Cytosol		"HPA019082: AB_1846803, HPA048812: , HPA075506: "	"unprognostic (5.64e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.61e-6)"	"unprognostic (6.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.30e-1)"	1.4	4.4	14.7	3.3	14.0	15.3	1.6	12.7	35.0	1.6	4.6	2.9	0.0	4.0	1.3	1.5	3.2	0.9	1.6	1.0	9.8	5.7	5.7	1.4	3.0	3.4	3.2	21.9	0.7	0.7	1.2	2.9	2.6	7.4	1.0	5.3	0.6	1.3	1.0	1.3	5.1	3.5	2.6	5.0	5.6	3.5	8.3	9.5	5.9	1.5	0.1	4.9	1.7	1.7	0.4	0.0	0.0	0.1	0.0	1.2	0.8	15.0	13.5	11.9	11.2	1.1	3.3	7.0	11.5	9.6	12.1	9.1	8.6	6.2	10.8	6.2	8.9	9.4	8.1	6.7	16.7	7.7	5.9	13.7	8.7	5.3	0.1	7.2	12.6	0.7	0.7	14.4	8.9	9.2	8.7	9.2	11.3	7.5	13.0	11.0	6.4	9.1	11.9	21.6	3.6	2.4	6.6	8.5	4.7	19.1	3.7	9.1	13.5	5.2	7.0	15.1	13.9	10.3	12.5	6.3	7.0	7.4	10.0	7.9	23.3	0.0	0.0	0.0	0.4	0.1	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	14.7	14.0	12.7	35.0	9.8	5.7	3.2	21.9	7.4	9.5
CLCN1	"ClC-1, CLC1"	ENSG00000188037	"Chloride voltage-gated channel 1"	P35523	7	143316126-143352083	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"skeletal muscle: 38.9;tongue: 21.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.4;HSkMC: 5.4;NTERA-2: 1.2;PC-3: 3.6"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.4;intermediate monocyte: 2.6;myeloid DC: 1.8;non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.8;monocytes: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (5.16e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.12e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.55e-3)"	"unprognostic (3.57e-2)"	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	38.9	0.0	0.8	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.7	21.1	0.9	0.1	0.0	0.0	1.8	0.5	3.8	0.0	0.2	0.9	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	1.2	3.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	2.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	3.8	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CLCN4	"ClC-4, CLC4"	ENSG00000073464	"Chloride voltage-gated channel 4"	P51793	X	10156945-10237660	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1;epididymis: 22.8;skeletal muscle: 34.6"	"Cell line enhanced"	"Detected in many"		"HEL: 16.7;SCLC-21H: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.3;memory B-cell: 1.7;naive B-cell: 6.8;neutrophil: 4.4"	"Group enriched"	"Detected in many"	9	"B-cells: 6.8;granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031313, HPA063637"	Enhanced		Approved	Vesicles				Vesicles		"HPA031313: AB_10601358, HPA063637: "	"unprognostic (1.01e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.07e-2)"	"prognostic unfavourable (2.13e-5)"	"unprognostic (2.96e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.99e-2)"	"prognostic favourable (9.55e-4)"	"unprognostic (9.70e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	3.1	3.4	9.7	2.0	21.3	2.1	1.6	18.6	29.1	2.0	1.4	15.7	0.0	1.2	1.3	22.8	2.3	3.0	2.8	11.4	13.0	10.5	3.4	3.5	3.4	2.9	23.5	10.4	2.2	2.4	8.9	3.9	1.7	18.2	2.1	1.1	6.0	2.3	1.7	34.6	1.2	1.2	1.4	15.2	3.2	2.1	2.2	17.9	0.0	6.8	2.0	2.2	2.3	0.8	6.8	0.6	4.4	0.5	0.0	0.0	0.6	4.9	3.1	2.3	0.0	1.1	2.0	0.1	0.1	0.0	0.0	0.0	6.0	3.4	3.7	9.0	1.0	1.1	1.4	3.4	0.1	0.0	3.5	16.7	1.7	2.5	5.5	0.0	0.0	10.0	2.7	4.3	1.1	6.4	1.2	0.0	2.3	0.5	0.0	0.1	2.9	10.8	0.0	3.8	0.0	1.5	0.5	17.3	6.5	7.1	0.7	0.0	1.8	2.1	6.3	2.7	4.6	11.8	0.4	0.4	8.3	1.3	8.6	0.0	3.4	2.3	0.5	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.6	6.8	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.6	9.7	21.3	18.6	26.7	13.0	10.5	23.5	10.4	18.2	17.9
CLCN7	"CLC-7, CLC7, OPTA2, PPP1R63"	ENSG00000103249	"Chloride voltage-gated channel 7"	P51798	16	1444934-1475580	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"		"Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043019, HPA043586"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA043019: AB_10964727, HPA043586: AB_10965322"	"unprognostic (2.69e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.90e-2)"	"prognostic favourable (5.23e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.49e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavourable (3.21e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.54e-1)"	19.5	34.7	23.2	18.7	23.0	35.0	19.4	22.9	26.8	16.7	15.5	29.3	15.4	18.3	18.8	16.8	12.5	15.8	17.0	15.0	21.9	17.5	19.5	22.7	17.7	19.6	30.3	18.5	14.2	24.1	30.9	19.5	15.5	22.2	14.6	9.4	34.4	17.5	17.5	22.5	21.7	18.9	17.3	18.0	24.8	18.1	17.6	29.5	16.4	21.8	10.9	14.9	17.2	10.2	2.5	2.3	2.0	6.4	0.5	1.6	1.5	5.1	14.3	8.0	12.7	18.3	9.3	12.7	6.9	16.0	15.2	19.0	11.1	19.1	5.8	14.3	9.4	10.8	7.3	8.9	4.6	9.3	11.4	4.2	13.3	11.0	32.0	10.7	17.1	18.5	12.4	13.7	11.8	9.7	16.8	11.4	7.7	10.2	7.5	18.3	8.0	8.1	35.1	5.4	16.2	7.5	7.3	9.1	9.3	11.1	14.1	44.7	12.4	28.6	9.5	13.4	6.1	14.7	6.5	17.3	11.2	6.1	11.2	20.3	8.3	0.0	3.0	2.0	1.6	5.4	0.7	2.2	0.9	0.7	2.3	2.5	0.4	0.6	0.6	0.5	6.4	2.3	0.3	1.5	23.2	23.0	22.9	26.8	21.9	17.5	30.3	18.5	22.2	29.5
CLDN1	"ILVASC, SEMP1"	ENSG00000163347	"Claudin 1"	O95832	3	190305701-190322475	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 134.3;skin 1: 73.9"	"Group enriched"	"Detected in some"	4	"EFO-21: 105.2;HaCaT: 36.8;hTCEpi: 45.9;RPTEC TERT1: 65.8;RT4: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"CAB002602, HPA048319"	Enhanced									"CAB002602: , HPA048319: "	"unprognostic (5.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (7.92e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (5.23e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.43e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.22e-1)"	11.4	14.7	1.0	4.9	0.5	0.0	5.8	0.2	0.7	10.1	7.2	1.2	11.4	0.1	46.5	18.8	13.8	18.8	9.2	3.2	0.7	0.6	7.2	134.3	5.5	0.0	1.0	0.4	13.3	18.0	0.0	1.3	30.5	2.0	13.0	0.3	0.5	10.6	18.2	0.6	73.9	0.4	31.1	1.3	1.2	0.4	7.1	0.1	6.7	8.5	12.2	19.8	9.7	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.6	0.0	0.0	0.0	0.0	0.0	0.3	8.2	0.1	0.3	2.7	10.7	0.0	105.2	0.0	36.8	0.2	12.0	1.0	0.1	0.2	0.0	1.5	6.3	8.0	0.0	0.0	0.0	45.9	0.9	13.9	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.8	0.0	0.1	0.0	65.8	41.2	0.0	0.0	4.8	0.9	2.7	8.4	0.0	1.9	0.1	1.5	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.2	0.7	0.7	0.6	1.0	0.4	2.0	0.1
CLDN16	"HOMG3, PCLN1"	ENSG00000113946	"Claudin 16"	Q9Y5I7	3	190322541-190412143	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"kidney: 55.9"	"Group enriched"	"Detected in some"	131	"EFO-21: 99.0;RPTEC TERT1: 34.8"	"Group enriched"	"Detected in many"	15	"ovarian cancer: 39.8;thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056020	Enhanced									"HPA056020: "	"unprognostic (5.01e-2)"	"unprognostic (7.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (1.99e-5)"	"unprognostic (6.06e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.15e-1)"	0.2	0.8	0.4	0.2	0.3	0.0	0.2	0.2	0.5	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.6	0.2	0.2	0.3	0.4	55.9	1.2	0.2	0.7	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.6	0.5	0.2	1.8	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	3.4	0.2	0.4	0.3	0.2	0.5	0.4	1.4	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	1.4	0.1	0.2	0.2	0.2	0.1	0.4	0.2	0.1	0.0	0.5	0.3	0.2	1.2	0.3	0.2	0.4	0.1	0.0	0.4	0.3	0.2	0.5	0.3	0.4	0.3	0.2	0.2	0.2
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"		"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 13.8;kidney: 22.5;placenta: 20.9;retina: 37.0"	"Group enriched"	"Detected in some"	6	"CACO-2: 5.3;Hep G2: 11.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Group enriched"	"Detected in some"	54	"midbrain: 13.8;pons and medulla: 9.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"olfactory region: 6.7"	"Low region specificity"	"Detected in all"														"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	1.0	0.2	0.1	0.1	0.2	0.2	1.6	0.2	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.9	0.6	0.3	0.1	0.4	0.2	0.1	22.5	0.2	0.2	0.1	13.8	0.0	0.2	0.2	0.1	0.2	20.9	9.5	0.4	0.1	37.0	1.2	2.7	0.4	0.8	0.3	1.0	6.2	0.1	0.5	0.2	0.0	1.3	0.1	2.6	0.1	0.8	1.0	0.5	0.4	1.4	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.3	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.5	0.5	0.5	1.4	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	13.8	0.0	9.5	0.0
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 100.4;thyroid gland: 91.6"	"Cell line enhanced"	"Detected in some"		"MCF7: 65.0;PC-3: 13.9;RPMI-8226: 11.1;SCLC-21H: 17.2;T-47d: 30.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 3.1;pons and medulla: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA014361	Enhanced		Supported	"Cell Junctions"		15000	15000	"Cell Junctions"		"HPA014361: "	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favourable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.3	0.1	0.1	11.5	0.1	0.2	7.1	3.1	0.2	3.8	77.9	1.6	21.8	24.3	2.8	8.8	0.3	9.4	11.3	0.1	0.2	0.4	20.7	16.0	6.0	0.2	0.0	0.0	4.3	38.0	0.2	7.4	3.1	3.0	14.6	8.0	1.9	31.1	32.1	0.1	2.1	100.4	0.5	0.0	0.1	0.7	1.2	0.0	2.2	91.6	0.9	3.6	0.8	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.5	0.7	1.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.2	10.3	0.0	2.9	0.0	0.3	0.1	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.0	0.1	0.3	0.6	13.9	0.0	0.0	11.1	0.6	0.0	17.2	0.2	0.0	9.9	0.0	30.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	3.1	0.2	0.2	0.4	0.0	0.0	3.0	0.0
CLDN4	"CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8"	ENSG00000189143	"Claudin 4"	O14493	7	73799542-73832693	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 141.0"	"Cell line enhanced"	"Detected in some"		"A-431: 43.1;BEWO: 50.7;CAPAN-2: 94.7;MCF7: 48.3;PC-3: 61.7;RT4: 41.7;SK-BR-3: 80.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002610	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB002610: "	"unprognostic (1.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavourable (3.28e-4)"	"unprognostic (2.16e-3)"	"unprognostic (5.11e-1)"	"prognostic favourable (3.46e-10)"	"unprognostic (5.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.63e-2)"	0.7	0.2	0.4	17.1	0.4	0.0	17.1	0.4	0.5	17.5	53.7	0.7	23.2	25.0	5.1	15.9	62.3	15.4	15.4	0.5	0.4	0.3	30.2	2.0	28.8	0.4	0.4	0.4	5.5	32.4	2.7	3.5	78.1	1.3	31.8	24.7	0.7	52.0	25.7	0.6	35.3	93.3	2.7	0.4	0.4	2.7	2.5	0.4	3.8	141.0	60.9	55.7	38.5	21.0	0.1	0.1	0.2	0.1	0.1	0.6	0.0	43.1	0.5	0.0	0.2	0.0	0.0	50.7	0.4	0.0	0.0	0.0	22.5	94.7	0.0	3.5	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	15.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	48.3	0.0	0.2	0.0	61.7	0.0	0.8	1.0	11.6	41.7	10.1	0.2	0.0	80.3	0.1	31.4	0.1	0.0	0.1	1.8	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.4	0.5	0.4	0.3	0.4	0.4	1.3	0.4
CLIC2	XAP121	ENSG00000155962	"Chloride intracellular channel 2"	O15247	X	155276211-155334657	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 62.3;vagina: 66.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 36.5;K-562: 19.7;Karpas-707: 18.2;RPMI-8226: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 9.5;myeloid DC: 24.5;non-classical monocyte: 6.5"	"Group enriched"	"Detected in many"	14	"dendritic cells: 24.5;monocytes: 9.5"					"Low region specificity"	"Detected in all"			"HPA047381, HPA060101"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		290000	290000	"Plasma membrane"	Nucleoplasm	"HPA047381: , HPA060101: "	"unprognostic (3.27e-2)"	"unprognostic (5.21e-3)"	"unprognostic (9.70e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavourable (1.74e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-1)"	26.5	3.7	3.8	7.5	6.1	3.4	24.1	2.6	4.8	15.5	6.8	0.6	3.3	4.0	11.3	10.5	10.4	6.5	9.8	9.4	3.7	3.4	5.4	6.3	31.0	15.6	7.5	1.4	12.5	2.6	2.0	7.8	4.5	6.8	9.1	6.9	3.0	5.4	3.2	10.3	5.2	7.3	10.2	5.2	32.1	4.7	5.6	4.3	6.9	62.3	8.7	12.4	14.0	66.1	0.0	24.5	0.6	9.5	1.1	0.1	1.0	0.2	0.0	0.4	0.3	0.3	2.0	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	36.5	0.2	5.1	0.1	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	19.7	18.2	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	31.1	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.4	0.0	1.7	0.5	0.7	0.3	1.1	1.6	0.0	0.9	1.1	0.6	0.0	1.8	0.1	0.0	9.5	0.1	0.0	0.0	0.1	24.5	0.0	0.0	0.0	0.6	1.1	6.5	2.5	0.0	1.0	3.8	6.1	2.6	4.8	3.7	3.4	7.5	1.4	6.8	4.3
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hearing, Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel, Voltage-gated channel"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.6;intestine: 46.2;skeletal muscle: 99.9"	"Group enriched"	"Detected in some"	8	"CAPAN-2: 13.3;EFO-21: 9.4;HDLM-2: 4.9;REH: 11.4;U-266/70: 12.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 8.8"	"Lineage enriched"	"Detected in single"	23	"T-cells: 8.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		1000000	1000000	"Plasma membrane"	"Nuclear speckles"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	7.4	0.6	0.8	3.2	1.5	0.0	2.3	0.6	1.1	6.0	10.2	0.3	0.4	5.6	0.8	2.5	2.2	1.2	2.1	65.6	0.9	1.2	17.5	0.5	32.8	0.4	1.1	1.4	0.7	0.7	0.4	1.3	22.0	0.8	0.9	7.5	7.8	2.0	0.4	99.9	0.7	46.2	1.4	0.9	16.1	0.9	1.0	0.0	0.2	4.8	18.8	1.5	1.0	4.3	0.3	0.0	0.0	0.0	0.3	8.8	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.3	0.0	9.4	0.0	0.3	0.0	0.1	0.0	4.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	11.4	0.3	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	8.8	0.3	3.6	2.2	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	1.6	0.8	0.8	1.5	0.6	1.1	0.9	1.2	1.1	1.4	0.8	0.0
CLN3	"BTN1, BTS, JNCL"	ENSG00000188603	"CLN3, battenin"	Q13286	16	28474111-28495575	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 52.7;SK-BR-3: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA063280	Uncertain									"HPA063280: "	"unprognostic (2.38e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.06e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.38e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.27e-2)"	"unprognostic (5.26e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.05e-2)"	14.0	23.8	10.6	15.7	11.8	9.0	15.8	14.5	10.3	12.5	27.1	14.6	61.5	14.8	11.7	23.0	15.2	10.6	10.1	9.2	10.8	7.1	18.2	22.3	20.6	15.3	14.4	8.0	14.6	18.4	22.2	6.7	26.0	11.4	13.3	20.4	11.9	22.6	45.3	9.3	16.9	17.4	9.6	13.1	15.8	18.6	7.5	16.5	8.9	19.1	9.4	10.0	15.4	14.8	11.6	28.2	39.6	25.0	15.3	24.1	17.6	6.2	10.7	4.4	10.6	11.9	5.9	52.7	3.9	12.1	8.9	10.8	5.2	15.5	4.6	13.2	7.1	6.6	7.6	7.3	3.8	11.3	10.2	4.4	7.3	15.7	18.4	6.6	19.2	8.0	17.5	6.9	4.4	9.8	7.8	14.1	8.9	14.9	5.9	10.9	6.8	6.9	10.2	4.3	14.4	8.6	14.1	6.0	6.2	1.9	51.8	5.0	16.7	9.1	5.3	5.2	3.0	7.3	6.5	16.0	17.9	4.4	8.5	13.7	3.7	18.1	25.0	39.6	24.1	19.5	18.0	9.6	19.4	23.3	27.2	11.6	16.1	18.2	9.4	15.3	14.3	28.2	19.7	17.6	10.6	11.8	14.5	10.3	10.8	7.1	14.4	8.0	11.4	16.5
CLP1	"hClp1, HEAB"	ENSG00000172409	"Cleavage and polyadenylation factor I subunit 1"	Q92989	11	57648992-57661868	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	"Kinase, Transferase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057770	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA057770: "	"unprognostic (1.33e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.82e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.31e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.07e-1)"	10.8	11.7	7.0	11.2	8.8	23.5	9.6	7.2	10.9	8.5	9.3	5.6	7.6	9.0	12.0	10.0	13.6	10.1	6.2	8.1	6.0	4.5	9.9	12.8	8.7	9.9	6.5	5.1	7.3	11.8	7.2	6.8	17.3	6.1	10.5	9.2	5.6	10.3	8.1	16.7	11.8	11.7	11.2	5.0	15.4	11.5	11.3	6.5	15.4	11.8	10.8	13.2	8.8	6.9	16.2	19.0	23.7	19.1	12.8	20.9	11.6	14.0	14.1	14.1	14.9	15.6	10.4	13.5	13.8	15.3	20.9	17.6	13.0	12.7	23.3	16.9	11.5	17.3	19.5	22.3	23.3	15.8	11.4	12.6	10.1	14.7	11.9	19.3	15.3	11.5	15.9	17.7	12.7	18.9	20.4	8.1	16.8	10.0	13.9	22.0	21.6	14.8	15.0	22.8	24.7	11.2	10.0	7.7	15.1	11.7	12.1	18.9	22.5	14.8	13.1	11.3	15.2	19.2	11.1	13.0	16.5	25.4	12.3	10.4	11.9	23.7	19.1	19.9	17.6	16.0	20.9	16.2	15.8	17.8	19.0	14.1	18.2	16.6	22.3	12.8	15.7	11.0	16.0	11.6	7.0	8.8	7.2	10.9	6.0	4.5	6.5	5.1	6.1	6.5
CLPB	"ANKCLB, FLJ13152, HSP78, SKD3"	ENSG00000162129	"ClpB homolog, mitochondrial AAA ATPase chaperonin"	Q9H078	11	72285495-72434680	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 87.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 18.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039005, HPA039006, HPA064571"	Enhanced									"HPA039005: AB_2676305, HPA039006: AB_10672767, HPA064571: "	"unprognostic (9.36e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"prognostic favourable (8.36e-8)"	"unprognostic (9.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.28e-2)"	4.4	6.1	5.7	4.8	7.2	7.9	3.4	5.6	10.5	3.1	3.1	6.7	2.5	3.2	3.8	3.1	3.7	2.9	2.9	4.1	4.9	4.1	6.7	8.5	3.7	3.0	5.7	5.9	3.2	5.5	8.6	3.4	6.5	7.9	2.7	3.1	3.1	4.2	3.3	6.5	2.8	2.9	4.5	3.9	3.9	3.7	87.9	6.4	2.7	4.7	1.8	2.9	3.7	3.0	1.6	18.3	4.0	11.7	1.8	2.4	5.2	6.4	18.5	5.8	11.9	7.9	5.8	15.0	7.0	4.3	10.5	7.9	24.7	9.8	16.7	16.1	6.6	13.8	15.5	15.3	12.9	15.1	11.6	14.1	19.2	14.7	6.8	14.1	25.1	7.7	5.1	18.6	18.8	11.8	19.1	11.8	7.5	17.1	12.7	13.4	6.1	18.5	11.6	8.7	7.2	6.1	11.1	14.6	11.1	9.5	21.9	16.3	11.3	12.3	9.2	15.0	9.7	15.1	13.5	5.7	8.1	9.5	8.0	12.0	11.4	4.0	11.7	0.6	2.4	9.3	2.4	1.5	1.4	2.1	18.3	1.6	1.8	1.4	1.0	1.8	5.2	3.3	0.8	5.2	5.7	7.2	5.6	10.5	4.9	4.1	5.7	5.9	7.9	6.4
CLPP		ENSG00000125656	"Caseinolytic mitochondrial matrix peptidase proteolytic subunit"	Q16740	19	6361452-6368910	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010649	Supported		Supported	Mitochondria				Mitochondria		"HPA010649: AB_1078538"	"unprognostic (2.28e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.17e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.31e-1)"	"prognostic favourable (6.50e-4)"	"unprognostic (1.21e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.86e-3)"	22.1	27.3	18.4	22.5	18.8	20.1	19.9	16.6	20.9	16.1	23.2	17.9	22.2	25.4	16.9	15.1	26.6	15.3	19.2	28.9	17.4	16.7	28.5	64.7	15.5	35.5	19.0	15.2	23.7	32.7	11.6	18.5	18.4	13.6	19.1	14.1	18.6	26.3	23.4	73.1	17.8	26.0	14.8	16.7	21.2	21.3	21.1	11.4	54.8	27.0	25.1	25.3	20.7	23.2	29.7	37.5	14.9	20.0	27.6	46.3	32.9	31.6	21.1	15.4	28.1	9.7	13.5	16.0	18.8	13.8	26.8	24.0	16.9	11.6	31.9	29.3	15.0	19.8	15.2	23.7	10.1	33.1	47.9	23.5	18.6	25.0	26.3	21.2	31.1	17.1	17.4	18.6	20.8	26.0	23.2	43.2	17.5	37.0	36.3	22.2	22.2	49.4	25.6	18.6	48.3	19.9	17.7	25.5	24.4	11.9	29.1	27.6	15.0	30.4	18.1	17.7	16.4	41.6	35.4	55.6	46.4	30.7	24.3	29.9	28.1	5.5	20.0	10.5	28.0	17.7	33.2	28.3	39.9	34.5	24.1	29.7	35.2	34.1	14.9	27.6	12.1	37.5	46.3	32.9	18.4	18.8	16.6	20.9	17.4	16.7	19.0	15.2	13.6	11.4
CLRN1	"RP61, USH3, USH3A"	ENSG00000163646	"Clarin 1"	P58418	3	150926163-150972999	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Sensory transduction, Vision"		"Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"adrenal gland: 11.2;retina: 16.2"	"Cell line enriched"	"Detected in single"	32	"NTERA-2: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"											HPA054636	Uncertain									"HPA054636: "	"unprognostic (1.00e-3)"				"unprognostic (1.26e-1)"					"unprognostic (5.54e-1)"					"unprognostic (9.68e-2)"			0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.1	0.0	1.6	0.0	2.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.8	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.7	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNGA1	"CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49"	ENSG00000198515	"Cyclic nucleotide gated channel alpha 1"	P29973	4	47935977-48016672	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.1;RT4: 10.5;U-2 OS: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076168			Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	Nucleoplasm	"HPA076168: "	"unprognostic (2.68e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.48e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	4.9	1.1	0.6	2.7	1.0	0.1	2.9	0.3	0.5	5.7	6.1	0.2	1.6	2.1	0.6	12.1	13.7	3.9	1.5	1.0	0.6	0.6	4.9	23.7	0.5	0.0	1.3	0.0	1.6	2.1	5.2	4.2	21.3	0.4	6.2	2.3	14.7	4.9	1.7	4.2	5.3	12.7	0.5	0.9	8.2	2.5	1.4	0.2	0.1	2.2	3.6	2.7	8.2	8.8	0.7	2.7	1.2	0.4	1.9	1.6	0.1	3.2	1.1	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.2	2.9	13.1	0.1	0.7	0.0	2.0	0.3	0.4	0.1	0.0	0.8	0.0	0.3	1.0	0.0	0.1	0.3	0.1	0.6	0.0	0.1	0.0	0.8	0.7	0.2	1.3	0.1	0.2	0.6	3.0	0.1	0.0	0.1	0.6	10.5	0.3	0.1	0.2	0.6	0.2	1.1	0.0	0.6	0.3	4.1	0.1	0.1	0.9	1.0	0.1	0.1	0.1	2.3	0.2	0.4	0.0	0.5	0.4	0.1	0.3	0.2	1.6	0.3	0.7	0.3	0.6	1.2	1.9	0.2	2.7	0.1	0.1	0.6	1.0	0.3	0.5	0.6	0.6	1.3	0.0	0.4	0.2
CNGA3	"ACHM2, CCNC1, CCNCa, CNCG3, CNG3"	ENSG00000144191	"Cyclic nucleotide gated channel alpha 3"	Q16281	2	98346155-98398601	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pituitary gland: 32.0"	"Cell line enriched"	"Detected in some"	7	"U-87 MG: 12.5"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 1.9;hypothalamus: 2.2"	"Not detected"	"Not detected"			"HPA049378, CAB079025"	Approved	Approved								"CAB079025: , HPA049378: "	"unprognostic (2.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.18e-1)"		"unprognostic (4.17e-4)"		"unprognostic (4.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.88e-1)"		"unprognostic (3.85e-3)"	"unprognostic (8.98e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.71e-2)"	0.1	0.0	0.3	1.4	0.7	0.0	0.7	0.1	2.9	0.1	6.1	2.4	0.1	2.8	0.1	0.1	4.6	0.8	0.4	0.1	1.2	4.0	0.1	0.1	0.2	0.1	0.8	0.4	0.1	1.5	0.0	32.0	0.1	4.9	0.1	3.2	1.2	0.2	0.5	0.1	0.0	4.0	2.2	4.3	0.1	3.0	1.1	0.3	0.1	0.1	0.1	0.1	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	1.5	1.2	4.0	0.8	0.4	4.9	0.3
CNGB1	"CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45"	ENSG00000070729	"Cyclic nucleotide gated channel beta 1"	Q14028	16	57882340-57971116	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Olfaction, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 79.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.9;RPMI-8226: 3.3;SCLC-21H: 9.4;SiHa: 5.4"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 2.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA039159, HPA060355"			Approved	Vesicles,Cytosol				Cytosol	Vesicles	"HPA039159: AB_10795579, HPA060355: "	"unprognostic (5.52e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.08e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.14e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.07e-2)"	0.2	7.2	13.1	3.0	3.0	0.7	0.2	0.2	6.3	0.2	1.7	0.0	0.0	0.5	0.2	0.5	0.2	0.4	0.8	0.2	7.1	11.0	0.2	0.2	0.4	0.7	1.3	4.0	0.1	1.5	0.0	0.5	1.2	4.2	0.2	1.2	79.8	0.3	0.4	0.1	0.5	1.8	0.2	0.7	0.2	0.2	1.3	0.0	0.0	0.2	0.0	0.4	0.3	0.2	0.4	0.3	2.6	0.3	0.3	0.4	0.0	0.6	1.2	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.6	1.7	0.9	0.0	0.0	0.2	0.0	0.1	0.0	1.7	0.0	0.0	0.4	0.0	0.1	0.6	0.1	0.2	0.2	0.1	0.0	3.3	0.0	1.2	9.4	0.1	5.4	2.7	0.0	0.1	0.1	0.7	0.3	0.4	0.4	0.1	0.2	0.5	0.1	0.1	0.3	0.1	0.6	0.3	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.4	0.4	0.2	2.6	0.3	0.3	0.3	0.0	0.0	13.1	3.0	0.2	6.3	7.1	11.0	1.3	4.0	4.2	0.0
CNGB3	"ACHM1, ACHM3, RMCH"	ENSG00000170289	"Cyclic nucleotide gated channel beta 3"	Q9NQW8	8	86553977-86743675	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"retina: 68.9"	"Cell line enriched"	"Detected in some"	13	"SCLC-21H: 21.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057244	Enhanced									"HPA057244: "	"unprognostic (5.35e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.82e-1)"	"unprognostic (9.28e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.40e-4)"	"unprognostic (1.66e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.84e-1)"	0.2	0.1	0.4	0.4	0.2	7.9	0.2	0.2	1.0	0.9	0.1	0.1	0.1	0.9	0.7	0.4	0.2	2.8	0.1	0.3	0.2	0.2	0.2	0.1	0.1	0.3	0.6	0.1	1.0	1.5	0.0	0.6	0.1	1.8	0.1	0.0	68.9	0.3	0.1	0.1	2.4	0.4	0.1	0.8	0.1	0.6	5.4	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	1.3	0.1	0.0	0.0	0.3	0.0	0.0	0.4	0.0	1.6	21.2	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.2	0.2	1.0	0.2	0.2	0.6	0.1	1.8	0.1
CNNM4	"ACDP4, KIAA1592"	ENSG00000158158	"Cyclin and CBS domain divalent metal cation transport mediator 4"	Q6P4Q7	2	96760902-96811891	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Biomineralization, Ion transport, Sensory transduction, Transport, Vision"		"Amelogenesis imperfecta, Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017732	Enhanced		Uncertain	"Plasma membrane,Actin filaments"				"Actin filaments"	"Plasma membrane"	"HPA017732: AB_1847395"	"unprognostic (1.98e-3)"	"unprognostic (8.95e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (9.14e-4)"	"unprognostic (3.42e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (8.75e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.72e-1)"	"unprognostic (8.14e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	3.7	4.0	4.8	17.0	9.6	4.5	7.4	24.1	11.1	6.8	31.2	11.3	8.3	6.3	10.4	5.2	7.7	10.8	7.3	11.5	5.4	5.0	5.9	4.9	8.1	4.3	6.0	6.6	6.1	11.4	9.0	10.6	17.1	5.5	7.4	33.5	13.9	10.8	11.3	21.3	7.4	11.1	5.7	5.2	6.1	12.6	11.8	6.1	4.6	9.7	6.1	9.3	6.5	7.4	3.7	2.2	2.8	2.3	0.8	3.2	1.1	6.8	4.5	3.7	6.7	3.8	2.6	10.1	3.0	4.3	4.4	6.1	8.2	7.5	5.0	8.8	3.1	8.9	9.5	5.1	4.1	10.0	7.5	4.0	3.0	4.4	5.4	1.9	4.0	2.5	6.5	7.1	4.3	2.4	2.0	14.3	2.3	9.7	4.0	2.7	4.8	6.2	6.0	1.7	5.8	4.5	5.4	17.3	5.2	5.7	29.3	4.3	14.3	3.3	2.2	2.6	5.9	5.6	3.3	5.0	4.0	2.5	3.8	3.8	4.6	2.8	1.6	0.5	3.2	1.8	1.1	3.7	1.7	1.7	2.2	2.1	1.1	2.1	0.7	0.8	2.3	1.7	0.8	1.1	4.8	9.6	24.1	11.1	5.4	5.0	6.0	6.6	5.5	6.1
CNTN2	"AXT, TAG-1, TAX, TAX1"	ENSG00000184144	"Contactin 2"	Q02246	1	205042937-205078284	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 78.5"	"Group enriched"	"Detected in some"	7	"NTERA-2: 5.6;SCLC-21H: 14.0"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001397, HPA012497"	Approved				"Secreted in brain"	13000	13000			"HPA001397: AB_1847146, HPA012497: AB_1847147"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.44e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.73e-7)"	"unprognostic (9.82e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.07e-2)"	2.0	2.4	15.6	2.1	52.5	1.6	1.6	11.0	68.8	1.8	2.3	78.5	0.0	1.7	1.6	1.7	1.9	1.7	1.8	1.7	27.4	15.9	1.6	1.6	1.6	1.7	59.8	22.0	1.6	1.6	1.6	2.7	1.6	41.9	1.8	2.3	0.0	2.2	2.4	1.6	2.3	2.2	1.8	55.4	1.7	1.7	9.1	48.3	0.0	1.6	0.0	2.0	1.6	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	15.6	52.5	11.0	28.4	27.4	15.9	59.8	22.0	41.9	48.3
COASY	"CoASY, DPCK, NBP, PPAT"	ENSG00000068120	"Coenzyme A synthase"	Q13057	17	42561467-42566277	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022875, HPA022912, HPA023273"	Approved				"Intracellular and membrane"	10000	10000			"HPA022875: AB_1847066, HPA022912: AB_1847067, HPA023273: AB_1847068"	"unprognostic (2.83e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.81e-1)"	"prognostic favourable (2.15e-4)"	"unprognostic (1.01e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (7.54e-5)"	"unprognostic (4.06e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.55e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.16e-1)"	15.4	28.3	14.6	15.5	16.9	18.1	20.6	19.4	25.9	16.9	22.8	16.7	31.9	30.2	17.7	17.0	32.7	21.4	20.4	12.7	14.6	10.2	40.6	66.0	20.7	15.6	14.1	15.1	18.7	33.9	27.2	19.3	18.0	20.5	20.9	18.5	14.5	43.2	36.6	21.2	25.1	32.1	12.3	14.4	27.1	24.7	25.7	14.6	21.5	30.2	22.7	20.9	16.3	18.2	14.6	28.5	21.2	26.2	16.3	18.8	18.0	28.4	46.3	8.6	17.3	19.1	11.1	28.2	12.0	17.2	21.3	15.2	26.5	28.0	16.3	21.4	15.5	45.0	22.7	26.0	14.3	14.8	39.5	16.4	29.6	42.0	22.9	17.1	23.1	17.1	31.3	21.0	22.3	20.1	30.3	22.0	15.1	17.5	21.6	26.0	11.7	23.7	12.2	29.7	26.7	28.8	20.4	20.7	15.7	11.7	11.9	22.7	49.4	21.7	12.6	21.8	20.2	16.9	12.9	26.6	37.0	9.3	25.3	17.0	15.0	15.3	24.5	21.2	18.2	26.2	18.8	14.5	14.5	17.2	28.5	14.6	14.1	14.5	16.7	16.3	17.8	19.4	15.3	18.0	14.6	16.9	19.4	25.9	14.6	10.2	14.1	15.1	20.5	14.6
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 63.0;pancreas: 136.8"	"Cell line enhanced"	"Detected in many"		"HEK 293: 30.1;Hep G2: 19.7;K-562: 38.7;NB-4: 32.1;SCLC-21H: 35.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"basal ganglia: 63.0"	"Group enriched"	"Detected in some"	13	"memory B-cell: 24.0;naive B-cell: 7.7"	"Lineage enriched"	"Detected in many"	20	"B-cells: 24.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 25.4;basal ganglia: 40.0;cerebral cortex: 16.6;hippocampal formation: 15.6"	HPA065086			Supported	Vesicles	"Secreted to extracellular matrix"	88000	88000	Vesicles		"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	1.1	1.4	2.1	1.1	63.0	1.3	0.9	1.1	2.3	4.0	0.8	1.4	1.6	0.6	0.6	1.0	0.6	2.2	1.2	0.9	1.2	2.9	1.8	0.5	0.5	3.1	0.8	1.9	0.6	136.8	0.4	3.3	0.9	2.1	14.7	1.0	0.8	1.8	21.8	0.6	4.6	0.7	0.7	1.4	0.8	0.8	1.8	7.9	0.0	0.6	0.7	2.4	1.1	7.8	24.0	0.0	0.1	0.3	0.0	1.1	0.6	0.0	11.0	1.0	0.0	0.2	0.0	6.9	0.0	0.0	2.0	5.5	6.5	0.3	0.1	0.5	0.0	0.0	6.9	0.0	3.4	0.0	30.1	5.5	2.5	19.7	0.0	0.5	2.3	0.4	0.0	0.2	0.0	0.1	38.7	1.6	0.5	0.2	2.7	32.1	3.7	1.1	8.1	0.0	0.2	0.3	1.0	35.7	9.6	0.8	0.1	0.0	0.0	15.0	0.2	0.0	0.0	0.1	0.0	1.8	4.7	3.4	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	24.0	0.2	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.6	2.1	63.0	1.1	2.3	1.2	2.9	0.8	1.9	2.1	7.9
COQ2	"CL640, FLJ26072"	ENSG00000173085	"Coenzyme Q2, polyprenyltransferase"	Q96H96	4	83261536-83284914	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease mutation, Neurodegeneration, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056599, HPA068727"	Approved		Approved	Cytosol				Cytosol		"HPA056599: AB_2683184, HPA068727: AB_2686022"	"unprognostic (8.26e-2)"	"unprognostic (7.40e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.46e-1)"	6.6	25.5	4.9	8.4	7.0	8.9	9.9	1.9	6.0	7.4	12.1	5.8	8.4	7.8	8.0	10.2	13.1	5.4	7.4	17.5	4.3	4.1	8.0	14.9	9.8	9.0	6.5	3.4	8.0	5.9	6.7	12.3	7.2	5.0	6.6	12.5	5.2	12.7	8.5	21.8	13.8	8.2	5.8	6.7	14.1	4.8	6.6	6.7	2.9	10.1	23.9	9.2	6.2	7.4	3.6	11.8	6.0	17.4	3.7	2.0	6.8	11.6	6.8	6.8	12.8	5.3	5.4	4.8	7.6	12.5	14.4	16.8	4.7	16.8	7.9	5.5	13.4	9.0	11.4	12.3	18.1	8.0	7.2	7.0	8.9	6.7	5.7	14.2	33.9	8.0	7.8	6.9	12.0	14.3	4.5	9.4	13.3	12.0	3.7	9.6	5.0	9.7	6.5	5.3	10.2	20.9	5.6	4.7	3.1	8.7	11.0	3.8	7.1	7.8	9.9	6.7	7.0	5.1	10.5	2.8	2.2	4.6	13.2	16.8	9.2	1.1	16.3	2.3	1.6	14.4	1.2	3.6	1.8	1.5	11.8	3.5	1.3	2.0	6.0	3.7	17.4	6.2	2.0	6.8	4.9	7.0	1.9	6.0	4.3	4.1	6.5	3.4	5.0	6.7
COQ8A	"ADCK3, CABC1, COQ8, SCAR9"	ENSG00000163050	"Coenzyme Q8A"	Q8NI60	1	226897536-226987545	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Kinase, Transferase"	"Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 216.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 33.0;RPMI-8226: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061662			Supported	Mitochondria				Mitochondria		"HPA061662: "	"unprognostic (6.37e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.15e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.62e-1)"	13.3	25.4	2.8	2.7	4.5	5.3	8.5	14.5	3.9	3.2	7.3	4.1	4.2	6.9	3.6	5.5	7.3	5.0	6.1	41.0	2.7	1.8	3.8	17.7	2.7	4.1	5.0	2.4	7.2	20.3	1.6	1.6	2.0	3.8	6.5	2.0	1.9	7.2	5.0	216.5	4.4	4.4	7.8	2.9	3.5	8.8	3.0	4.7	2.7	4.6	50.2	5.8	10.2	3.5	15.2	9.3	32.3	11.5	9.9	11.8	11.6	3.2	5.8	1.5	4.5	4.7	3.1	23.6	1.5	1.3	2.2	2.9	9.2	5.2	9.5	7.3	1.0	3.7	2.9	3.3	0.5	9.9	33.0	6.6	4.8	15.1	1.0	10.0	4.1	5.9	5.1	1.7	2.3	1.0	11.4	7.8	0.3	4.3	5.8	14.7	6.4	12.0	5.7	7.1	30.2	0.7	2.4	24.3	9.9	3.0	11.8	8.5	6.2	13.6	1.2	2.5	2.3	3.5	5.5	17.6	15.4	5.0	2.3	11.4	2.4	19.7	11.5	32.3	8.7	8.6	8.3	12.1	8.5	7.7	9.3	15.2	11.8	9.0	21.9	9.9	6.5	4.1	10.6	11.6	2.8	4.5	14.5	3.9	2.7	1.8	5.0	2.4	3.8	4.7
COQ8B	"ADCK4, COQ8, FLJ12229"	ENSG00000123815	"Coenzyme Q8B"	Q96D53	19	40691529-40718207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027229, HPA027277, HPA027279, HPA028303"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551"	"unprognostic (7.57e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.65e-2)"	13.6	17.8	21.1	13.1	16.4	11.5	10.0	24.1	19.2	13.6	13.6	18.6	14.8	17.9	15.0	13.2	16.6	26.5	16.7	14.7	15.7	10.7	11.8	15.6	12.1	12.2	15.5	12.1	16.3	19.4	12.6	32.7	7.9	13.2	15.1	5.7	12.3	16.8	17.6	10.3	12.9	18.6	16.2	15.6	12.1	17.5	12.5	16.7	16.8	15.5	6.9	13.2	14.8	11.8	12.9	15.0	17.7	15.6	9.7	13.1	10.5	8.2	33.7	6.9	13.3	6.2	6.0	6.4	7.7	8.3	5.8	6.2	10.5	15.0	11.0	14.9	4.4	7.1	4.8	8.6	2.1	13.2	10.0	10.6	20.5	5.8	10.7	3.6	16.5	7.9	9.2	4.2	5.1	6.5	5.6	6.0	4.0	5.0	4.7	4.4	5.3	3.5	7.9	9.7	8.3	10.1	13.9	12.4	10.1	10.3	15.8	16.7	14.2	13.8	6.1	5.0	17.0	3.6	4.5	6.7	5.4	5.6	18.9	4.2	6.9	15.8	15.6	14.6	11.6	15.4	13.1	12.9	9.0	12.4	15.0	11.7	8.9	9.1	17.7	9.7	13.7	8.7	8.8	10.5	21.1	16.4	24.1	19.2	15.7	10.7	15.5	12.1	13.2	16.7
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593998-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 11.6;heart muscle: 39.5"	"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 31.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.7"	"Low region specificity"	"Detected in single"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"			"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: "	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.3	0.1	0.3	0.0	0.1	0.0	0.8	0.1	0.1	3.1	0.1	0.1	2.6	0.0	3.4	11.6	0.7	1.2	4.5	39.5	0.0	0.2	2.0	0.0	1.3	0.0	0.2	0.0	0.6	0.1	0.0	1.5	0.6	1.6	1.7	0.0	0.4	0.3	4.6	0.2	5.3	0.4	0.5	0.0	3.5	0.3	3.7	0.0	0.2	0.1	1.7	0.4	0.8	3.2	0.2	0.0	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	7.3	31.8	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.0	1.6	0.0
COX4I2	"COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2"	ENSG00000131055	"Cytochrome c oxidase subunit 4I2"	Q96KJ9	20	31637888-31645006	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 60.7"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	11	"naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	11	"B-cells: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (2.64e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.51e-2)"	"prognostic favourable (6.04e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavourable (9.78e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.59e-2)"	9.9	0.7	1.6	1.7	1.9	0.1	7.9	0.7	2.5	4.7	2.2	1.5	0.9	1.1	5.9	3.5	7.1	2.6	5.4	15.5	1.7	1.4	2.0	0.5	24.6	4.9	2.4	1.0	1.9	1.9	2.1	1.1	60.7	2.7	5.2	1.6	4.1	2.4	2.8	12.8	2.5	2.7	3.9	1.2	0.8	2.0	1.5	2.1	0.5	8.0	7.5	2.3	3.7	3.7	2.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	1.9	0.7	2.5	1.7	1.4	2.4	1.0	2.7	2.1
COX5A		ENSG00000178741	"Cytochrome c oxidase subunit 5A"	P20674	15	74919791-74938168	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 209.7;skeletal muscle: 222.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027526	Supported					5400000	5400000			"HPA027526: AB_10602802"	"unprognostic (7.32e-2)"	"prognostic favourable (2.15e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.62e-2)"	"prognostic favourable (6.06e-7)"	"unprognostic (9.78e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-3)"	22.4	20.1	30.4	25.9	29.1	20.6	36.1	22.4	57.9	15.0	70.8	12.1	21.6	51.5	11.6	19.3	31.6	14.6	22.7	209.7	26.7	25.4	42.6	49.4	17.7	29.0	32.7	27.3	8.7	41.1	27.7	16.4	15.0	26.7	15.6	65.7	13.7	32.2	23.1	222.8	17.2	49.4	15.9	20.9	17.3	31.7	26.2	12.2	21.9	19.9	86.5	30.6	17.9	15.1	52.2	81.2	47.3	80.6	58.8	64.1	65.7	34.5	38.5	47.7	41.6	29.4	34.0	52.5	31.5	27.9	40.4	37.8	42.8	43.9	79.3	38.8	27.1	68.5	112.6	45.8	33.9	44.8	105.1	65.8	40.1	53.2	36.9	75.1	41.4	34.5	49.7	25.2	57.1	47.2	60.4	54.0	40.3	27.2	62.7	57.8	50.6	57.0	58.5	45.7	92.1	59.0	58.6	69.9	30.0	47.7	71.7	98.6	35.9	61.3	31.9	30.6	28.9	38.2	49.9	61.9	113.5	87.9	32.8	99.8	27.8	47.3	65.5	36.1	37.6	80.6	44.9	52.2	46.7	44.2	81.2	37.8	33.2	38.5	15.8	58.8	72.1	64.7	64.1	65.7	30.4	29.1	22.4	57.9	26.7	25.4	32.7	27.3	26.7	12.2
CP		ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149222055	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 311.1"	"Cell line enriched"	"Detected in some"	9	"EFO-21: 80.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 98.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001834, CAB008591"	Supported				"Secreted to blood"	830000000000	830000000000			"CAB008591: AB_1613734, HPA001834: AB_1078502"	"unprognostic (3.58e-1)"	"unprognostic (4.24e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (1.14e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.70e-1)"	1.8	0.7	2.6	0.6	5.7	0.4	3.5	2.6	3.5	10.5	2.0	2.5	0.0	1.7	2.3	0.3	1.1	1.5	0.5	6.6	3.6	1.7	1.6	311.1	2.1	2.4	4.2	0.9	0.4	1.2	1.4	5.3	1.9	9.4	2.1	2.7	15.5	6.9	0.4	1.2	2.0	2.6	0.7	4.8	3.5	0.7	0.5	4.4	0.0	2.8	0.4	3.0	3.2	2.9	1.3	0.8	0.6	1.0	0.3	1.3	0.4	0.0	4.7	4.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.7	4.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	1.0	0.5	0.8	0.6	0.8	0.9	0.4	0.5	0.6	1.3	0.4	1.3	0.4	0.3	0.4	0.8	0.4	0.4	2.6	5.7	2.6	3.5	3.6	1.7	4.2	0.9	9.4	4.4
CPA6	CPAH	ENSG00000165078	"Carboxypeptidase A6"	Q8N4T0	8	67422038-67746385	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.2;prostate: 10.6;retina: 13.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;CACO-2: 6.2;EFO-21: 3.5;Hep G2: 9.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"olfactory region: 15.5"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"						"unprognostic (2.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.57e-4)"	"unprognostic (9.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-2)"	0.2	0.1	0.1	9.8	0.1	0.2	0.2	0.1	0.1	9.4	16.2	0.7	0.8	0.2	8.3	1.7	3.7	0.2	0.3	0.1	0.2	0.1	0.3	0.1	0.7	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.3	0.3	10.6	7.2	13.0	0.1	0.7	0.1	0.2	1.3	3.4	0.7	0.3	0.5	1.3	0.0	0.0	0.2	1.5	0.6	4.1	5.5	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	3.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.3	0.0
CPN1		ENSG00000120054	"Carboxypeptidase N subunit 1"	P15169	10	100042193-100081877	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	127	"liver: 76.8"	"Cell line enriched"	"Detected in some"	17	"SK-MEL-30: 55.2"	"Group enriched"	"Detected in some"	12	"liver cancer: 26.6;melanoma: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted to blood"	22000000000	22000000000						"unprognostic (2.97e-2)"	"unprognostic (2.23e-2)"			"unprognostic (3.93e-2)"		"unprognostic (1.64e-1)"		"unprognostic (6.75e-2)"		"unprognostic (2.93e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.63e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPOX	"CPO, CPX, HCP"	ENSG00000080819	"Coproporphyrinogen oxidase"	P36551	3	98521132-98593723	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.9"	"Cell line enhanced"	"Detected in all"		"HEL: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015736, HPA054448"			Enhanced	Mitochondria		140000	140000	Mitochondria		"HPA015736: AB_1847194, HPA054448: "	"unprognostic (2.14e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavourable (1.04e-5)"	"unprognostic (1.62e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.57e-1)"	6.6	8.9	12.6	9.0	29.9	30.2	6.6	10.1	21.1	7.5	8.2	29.6	5.7	17.7	8.8	6.4	14.1	6.4	7.2	6.9	17.5	11.7	5.6	29.3	6.3	9.1	42.9	16.2	9.5	6.9	9.9	5.5	14.8	23.7	7.4	10.3	3.4	7.2	7.2	8.5	10.8	12.3	7.7	32.8	9.1	7.7	3.9	36.0	7.7	6.2	7.0	9.8	8.5	10.4	1.7	1.7	0.0	2.1	2.1	3.0	0.7	16.3	7.9	7.0	12.4	13.2	9.8	20.3	10.5	7.6	10.9	12.4	13.1	5.1	1.7	11.9	5.5	11.9	8.7	11.4	18.6	5.2	7.6	56.9	4.5	16.9	6.7	12.0	13.5	7.7	9.6	10.3	4.3	10.3	10.9	7.4	10.2	5.0	12.1	10.3	8.3	14.5	8.6	16.0	7.5	9.2	6.8	4.6	4.6	11.1	3.8	31.6	5.9	7.7	8.6	16.2	15.9	9.2	7.7	11.3	8.9	9.1	16.1	13.2	11.8	0.0	2.1	0.0	1.4	1.0	2.5	1.7	2.4	2.9	1.7	1.5	0.8	3.0	0.0	2.1	0.7	1.1	1.1	0.7	12.6	29.9	10.1	21.1	17.5	11.7	42.9	16.2	23.7	36.0
CPT1C	"CPT1P, CPTIC, FLJ23809"	ENSG00000169169	"Carnitine palmitoyltransferase 1C"	Q8TCG5	19	49690898-49713731	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0"	"Cell line enhanced"	"Detected in many"		"AF22: 18.4;AN3-CA: 15.5;SH-SY5Y: 33.2;U-87 MG: 13.9"	"Cancer enhanced"	"Detected in many"		"glioma: 9.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014529, HPA063621"	Approved		Approved	Centrosome				Centrosome		"HPA014529: AB_1847206, HPA063621: "	"unprognostic (1.09e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"prognostic favourable (1.84e-4)"	"unprognostic (4.36e-1)"	"unprognostic (1.92e-10)"	"unprognostic (9.44e-4)"	"unprognostic (3.35e-2)"	"unprognostic (3.91e-1)"	"unprognostic (4.72e-3)"	3.4	9.3	11.2	3.1	18.9	0.8	1.1	16.3	34.0	4.1	1.9	8.9	0.2	2.7	6.4	5.3	1.8	4.1	7.6	2.8	11.9	12.8	1.6	1.6	2.5	2.6	8.0	13.4	3.8	1.2	0.7	15.6	1.9	11.4	2.8	1.7	7.4	1.5	4.8	1.7	1.5	2.4	7.8	6.6	4.2	1.4	4.1	6.3	0.0	1.7	0.2	1.7	4.4	1.9	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	18.4	15.5	6.7	5.2	0.0	5.8	11.7	7.5	10.6	0.3	0.0	0.3	0.0	5.8	1.3	0.0	0.0	4.0	0.2	0.0	0.0	0.0	0.0	10.8	0.0	0.0	6.1	0.0	6.1	0.0	10.4	0.0	0.0	0.4	0.3	0.1	0.0	0.8	3.8	0.0	0.0	0.0	0.4	0.0	12.9	33.2	0.0	0.0	0.0	0.0	0.0	8.4	0.3	0.1	3.5	2.9	0.1	1.3	0.1	13.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	11.2	18.9	16.3	23.4	11.9	12.8	8.0	13.4	11.4	6.3
CREBBP	"CBP, KAT3A, RSTS, RTS"	ENSG00000005339	"CREB binding protein"	Q92793	16	3725054-3880726	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004212, HPA055861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB004212: AB_626817, HPA055861: "	"unprognostic (1.17e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.09e-2)"	"unprognostic (9.59e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"prognostic favourable (6.24e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.23e-2)"	18.5	10.9	17.2	22.8	17.5	37.0	17.4	42.6	18.8	20.1	17.2	16.8	17.1	9.9	25.1	15.2	14.1	18.9	21.3	14.5	17.1	8.7	11.1	12.3	16.9	14.4	20.5	12.0	31.6	23.4	24.3	13.0	13.3	15.8	18.4	11.6	14.6	14.9	16.7	28.2	20.4	16.4	17.0	13.6	17.4	14.7	29.1	20.2	29.6	19.5	13.8	16.1	19.0	29.9	4.7	2.3	10.6	3.8	2.0	2.7	1.1	5.5	14.3	18.6	8.2	11.4	11.3	9.6	8.0	13.5	13.9	13.5	12.9	10.5	15.4	9.6	15.3	10.8	21.4	6.6	15.8	26.0	8.6	12.1	13.2	8.2	12.6	12.1	17.4	10.0	6.7	15.4	18.6	10.4	13.7	21.1	7.5	19.1	8.0	5.8	15.2	5.9	37.8	14.7	11.8	5.4	7.5	15.5	10.2	13.7	13.5	8.1	12.0	11.9	16.1	17.0	16.9	8.7	7.3	9.9	10.6	29.9	3.4	7.3	11.9	2.9	1.7	1.3	2.7	2.2	1.4	4.7	1.3	2.0	1.0	3.3	1.4	1.7	10.6	2.0	3.8	2.3	1.3	1.1	17.2	17.5	42.6	18.8	17.1	8.7	20.5	12.0	15.8	20.2
CRYM	DFNA40	ENSG00000103316	"Crystallin mu"	Q14894	16	21238874-21303083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.7;brain: 61.3;heart muscle: 45.9"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 30.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 61.3"	"Cell type enriched"	"Detected in single"	26	"plasmacytoid DC: 23.7"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 23.7"	"Group enriched"	"Detected in many"	12	"amygdala: 129.0;basal ganglia: 245.8;cerebral cortex: 127.4;hippocampal formation: 355.0"	"Low region specificity"	"Detected in all"			"HPA019086, HPA030619"	Enhanced		Supported	Cytosol		110000	110000	Cytosol		"HPA019086: AB_1847260, HPA030619: AB_2673551"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.31e-1)"	1.4	0.5	7.6	0.5	61.3	0.5	1.0	15.6	21.2	1.8	2.2	0.0	0.0	0.7	0.8	0.3	2.3	0.5	2.3	45.9	6.5	2.1	17.8	4.2	2.7	0.5	1.0	15.5	0.5	0.8	0.6	3.3	0.3	0.1	10.5	2.6	1.0	4.8	0.3	4.0	1.4	1.0	2.0	0.9	0.5	0.6	1.6	1.2	0.0	0.5	0.0	1.5	8.3	0.8	0.9	23.7	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	1.6	0.0	0.0	0.0	0.4	7.0	0.0	0.7	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.3	3.2	0.0	0.0	0.0	0.2	30.5	0.0	1.2	1.7	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.2	2.6	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.3	7.6	61.3	15.6	20.7	6.5	2.1	1.0	15.5	0.1	1.2
CSNK1D	"CKID, CKIdelta, HCKID"	ENSG00000141551	"Casein kinase 1 delta"	P48730	17	82239023-82273731	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015410	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"CAB015410: AB_831049"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (7.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (2.38e-6)"	"unprognostic (8.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.00e-2)"	"prognostic favourable (9.62e-5)"	"unprognostic (2.23e-3)"	"prognostic unfavourable (8.34e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.74e-2)"	30.1	36.3	30.8	25.9	30.8	21.0	26.3	36.3	42.8	30.9	33.0	27.7	32.9	32.6	37.9	29.8	31.3	38.0	34.9	28.5	26.2	26.9	32.0	33.5	30.1	25.8	27.2	27.8	31.4	42.8	34.2	35.9	32.8	30.3	35.3	19.3	28.4	38.0	37.7	52.3	26.7	42.3	34.1	21.4	36.4	32.5	48.3	24.6	29.2	33.0	31.8	33.7	31.4	26.1	6.4	11.4	29.6	12.1	8.7	7.6	7.1	21.3	25.4	14.5	19.9	19.1	20.4	29.1	31.4	19.8	22.5	21.1	20.8	18.4	19.5	24.8	22.3	20.7	13.6	31.8	18.2	16.5	32.9	24.2	20.2	22.3	55.5	19.9	18.5	30.9	22.6	15.3	22.8	32.8	27.2	10.4	21.2	24.9	25.5	20.8	15.5	40.0	22.0	17.9	17.3	23.7	33.5	17.9	32.3	37.5	31.3	35.1	22.4	26.1	34.5	32.4	29.1	28.1	23.8	22.7	11.0	20.9	26.0	17.1	23.5	4.7	11.0	14.6	7.6	12.1	7.4	6.4	5.9	7.3	11.4	5.6	5.0	5.3	29.6	8.7	11.1	5.5	5.2	7.1	30.8	30.8	36.3	42.8	26.2	26.9	27.2	27.8	30.3	24.6
CSNK2A1	"Cka1, Cka2"	ENSG00000101266	"Casein kinase 2 alpha 1"	P68400	20	472498-543835	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB020680, HPA059206, HPA061698, CAB069395"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB020680: , CAB069395: AB_1611912, HPA059206: , HPA061698: "	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.44e-2)"	"unprognostic (8.28e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (4.11e-6)"	"unprognostic (4.08e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.47e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.37e-2)"	21.5	26.7	23.2	20.6	31.3	16.7	24.1	26.3	32.8	22.2	26.1	28.2	19.5	21.9	24.3	15.7	31.9	23.3	17.7	29.2	21.8	21.9	24.5	23.1	18.6	21.9	21.3	22.6	24.9	27.5	27.7	24.6	23.1	29.4	20.7	24.2	19.6	23.8	22.4	58.8	27.0	22.5	23.3	21.3	21.8	26.5	51.6	23.2	30.3	22.4	22.4	25.7	26.2	22.8	19.8	25.4	23.3	27.3	18.7	19.4	15.7	43.6	39.0	35.9	22.1	13.8	24.0	23.3	25.6	25.9	29.7	33.1	39.2	28.6	39.0	16.4	21.0	33.9	39.5	38.3	42.4	13.6	14.3	52.7	10.4	37.9	23.6	45.8	11.7	22.0	40.6	27.3	76.2	32.0	51.7	25.6	27.1	14.4	55.0	16.3	51.5	26.8	32.7	31.5	31.7	25.6	27.6	37.7	30.0	21.9	42.2	38.9	28.1	18.0	30.1	31.6	27.1	20.4	37.9	26.6	62.8	38.4	15.8	27.5	31.8	23.3	19.7	22.2	16.1	27.3	19.4	19.8	15.7	15.5	25.4	18.9	16.0	15.0	12.1	18.7	25.2	21.1	16.4	15.7	23.2	31.3	26.3	32.8	21.8	21.9	21.3	22.6	29.4	23.2
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776445	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 365.3;lymphoid tissue: 130.6;tongue: 138.8"	"Cell line enhanced"	"Detected in all"		"RT4: 90.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol		6100000	6100000	Cytosol	Nucleoli	"CAB047320: , HPA017380: AB_1847414, HPA058557: "	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	21.1	7.5	5.6	6.1	5.9	3.2	13.6	3.0	5.3	57.8	8.8	4.4	3.9	5.6	6.1	6.4	365.3	6.0	7.2	6.5	4.6	5.0	9.6	17.3	17.2	11.2	5.3	4.9	7.8	5.0	3.2	7.6	5.2	5.8	7.1	7.2	7.8	65.2	6.2	4.8	9.4	7.5	6.3	5.1	7.4	10.4	4.1	4.1	8.6	11.6	138.8	130.6	14.0	81.5	11.4	43.2	25.4	69.1	7.7	22.3	21.3	57.8	17.5	5.8	7.3	30.9	25.4	14.4	12.5	14.5	7.9	7.9	13.5	32.5	4.7	9.7	19.5	10.4	13.3	14.0	5.0	19.4	15.8	13.1	13.5	15.6	27.6	3.2	10.9	26.9	14.6	21.8	10.8	11.0	9.7	25.8	11.6	14.6	4.1	10.1	14.0	30.2	6.8	3.3	53.1	22.7	90.4	5.5	4.9	16.5	8.8	35.2	8.2	8.1	16.9	13.2	6.9	12.3	7.9	6.4	11.2	8.7	57.4	15.2	9.2	16.8	28.2	16.9	14.5	45.9	13.3	11.4	18.6	15.0	43.2	9.7	13.2	13.0	25.4	7.7	69.1	5.3	22.3	21.3	5.6	5.9	3.0	5.3	4.6	5.0	5.3	4.9	5.8	4.1
CTDP1	FCP1	ENSG00000060069	"CTD phosphatase subunit 1"	Q9Y5B0	18	79679801-79756623	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032641, HPA040394, HPA070389"	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: "	"unprognostic (1.71e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	"prognostic favourable (6.43e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"prognostic favourable (5.51e-5)"	"unprognostic (5.16e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.74e-2)"	10.6	8.2	6.2	12.8	9.5	21.8	9.5	7.5	12.2	7.9	12.0	14.4	5.3	13.4	11.9	9.3	11.4	9.8	10.0	6.6	6.8	5.7	8.9	13.4	10.2	14.4	12.3	5.1	7.7	13.4	4.6	7.9	10.6	9.1	9.1	6.2	8.4	10.6	8.3	12.1	20.9	13.8	8.2	6.8	15.3	12.2	27.2	10.6	26.2	9.4	8.8	14.8	11.4	8.9	0.7	1.5	6.4	1.0	2.4	2.0	0.5	8.0	9.0	5.0	7.2	4.0	3.4	16.7	5.4	4.0	5.0	4.9	5.9	5.1	10.3	2.5	3.5	9.9	4.3	5.7	2.1	9.5	7.7	5.3	4.5	8.0	5.9	23.4	13.2	5.6	5.4	5.3	2.5	6.0	6.5	5.3	1.9	7.2	15.7	18.4	7.9	12.1	12.2	6.6	12.4	3.7	8.4	7.8	8.1	6.4	6.4	8.6	5.2	13.8	8.1	8.6	12.5	3.4	5.8	4.4	16.5	10.2	7.3	11.8	6.0	0.0	1.0	6.4	1.3	0.9	1.1	0.7	1.0	2.0	1.5	0.4	1.3	0.7	2.7	2.4	0.9	0.2	0.3	0.5	6.2	9.5	7.5	12.2	6.8	5.7	12.3	5.1	9.1	10.6
CTH		ENSG00000116761	"Cystathionine gamma-lyase"	P32929	1	70411218-70439851	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Calmodulin-binding, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 104.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 19.7;Karpas-707: 30.6;SK-MEL-30: 40.0"	"Group enriched"	"Detected in all"	5	"liver cancer: 30.0;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.5;T-cells: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021591, HPA023300"	Enhanced					25000	25000			"HPA021591: AB_1847321, HPA023300: AB_1847322"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.45e-3)"	"prognostic favourable (8.69e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.26e-1)"	2.2	8.3	2.3	1.0	3.2	2.2	2.0	3.7	3.6	1.9	3.3	2.2	1.8	3.3	1.7	1.4	2.7	2.3	1.5	1.6	2.1	2.7	8.2	104.5	2.2	1.0	2.4	2.2	18.3	11.6	1.5	1.7	1.0	3.2	2.9	4.1	11.2	4.8	2.8	2.1	1.0	3.2	1.2	2.4	0.8	3.7	5.4	1.3	0.0	11.4	1.2	1.5	2.7	1.2	4.5	1.3	1.1	0.6	0.6	6.4	1.1	5.0	0.7	3.4	4.8	4.2	2.4	7.6	2.0	1.8	1.7	7.6	1.4	3.1	2.7	1.6	1.4	2.4	13.3	1.4	3.5	8.4	2.9	3.2	2.5	4.3	19.7	3.7	0.8	3.7	11.9	3.6	4.2	1.5	6.4	30.6	1.1	1.4	1.3	0.8	3.5	2.7	1.3	1.8	7.7	3.5	0.0	1.9	1.6	3.2	3.8	40.0	1.3	2.0	0.5	0.5	3.9	2.7	1.9	11.8	6.9	1.4	4.7	7.5	1.3	1.1	0.6	0.2	2.5	0.4	4.6	4.5	2.3	3.5	1.0	2.9	6.4	3.1	0.9	0.6	0.5	1.3	0.7	1.1	2.3	3.2	3.7	3.6	2.1	2.7	2.4	2.2	3.2	1.3
CTNS	"CTNS-LSB, PQLC4"	ENSG00000040531	"Cystinosin, lysosomal cystine transporter"	O60931	17	3636468-3661542	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Melanin biosynthesis, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046947			Supported	"Vesicles,Intermediate filaments"				"Vesicles, Intermediate filaments"		"HPA046947: "	"unprognostic (1.64e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.39e-2)"	"prognostic favourable (7.33e-4)"	"unprognostic (1.28e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.62e-3)"	"prognostic favourable (6.39e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	9.6	19.0	8.5	8.2	11.9	8.3	12.1	5.0	9.9	18.8	8.2	16.1	34.8	10.8	10.3	7.2	7.3	8.3	10.6	9.3	7.7	5.9	23.9	16.4	11.4	9.1	12.1	5.6	12.6	32.7	11.3	14.5	13.2	8.5	10.2	6.4	11.4	10.5	46.2	22.6	18.0	9.2	7.9	10.2	12.2	12.9	27.0	13.0	11.7	9.0	6.5	9.0	10.1	9.1	3.5	19.6	13.7	5.6	2.5	3.3	3.7	6.1	13.8	8.1	6.9	13.2	6.7	5.1	6.0	10.1	6.9	8.7	7.7	6.1	3.7	6.4	4.0	15.8	7.1	4.1	5.3	46.0	12.5	4.2	10.4	6.2	17.8	2.8	28.8	8.3	5.2	7.3	5.9	7.6	4.3	5.8	6.5	5.6	2.8	2.7	3.6	6.1	6.2	3.3	8.7	6.2	6.3	1.6	5.9	7.0	9.4	7.0	6.6	2.8	8.9	6.8	4.3	15.4	4.9	4.7	6.0	1.7	10.5	3.0	4.6	13.7	5.6	12.1	1.9	3.7	2.7	3.5	2.3	3.3	5.4	3.1	2.9	3.1	2.0	2.5	3.8	19.6	2.6	3.7	8.5	11.9	5.0	9.9	7.7	5.9	12.1	5.6	8.5	13.0
CTPS1	"CTPS, GATD5"	ENSG00000171793	"CTP synthase 1"	P17812	1	40979335-41012565	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Pyrimidine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017111, HPA051322"	Enhanced		Supported	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"CAB017111: , HPA051322: "	"unprognostic (6.60e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.89e-2)"	7.1	10.0	4.5	10.8	7.8	9.7	5.1	5.9	9.8	14.4	23.6	5.8	16.3	4.3	25.9	8.4	11.3	21.9	13.4	6.7	4.7	5.1	8.6	26.4	7.0	9.4	7.9	4.7	10.1	6.3	16.8	5.4	7.7	6.2	14.4	9.8	9.1	56.5	19.6	13.2	5.8	13.5	35.8	5.1	7.5	9.0	11.8	6.7	14.6	4.5	11.3	13.2	21.3	9.5	6.0	12.8	0.0	7.3	6.6	7.0	3.8	21.1	19.4	27.5	22.1	7.6	9.5	43.2	37.2	16.0	40.9	27.6	38.1	18.8	39.7	16.9	17.0	15.0	29.4	27.8	40.9	16.6	22.3	24.3	25.9	12.0	24.9	32.4	19.1	10.4	15.1	42.3	30.4	18.6	24.4	17.5	28.6	11.9	35.0	12.1	37.5	23.1	27.0	33.4	25.7	20.7	19.3	36.9	18.0	23.2	25.0	9.2	8.7	44.8	15.2	27.1	35.4	18.2	46.2	11.3	13.2	35.3	17.7	25.8	28.1	0.0	4.0	0.0	4.6	7.3	6.6	6.0	5.3	4.8	12.0	3.9	4.4	7.0	0.0	6.6	6.1	12.8	6.6	3.8	4.5	7.8	5.9	9.8	4.7	5.1	7.9	4.7	6.2	6.7
CTRC	"CLCR, ELA4"	ENSG00000162438	"Chymotrypsin C"	Q99895	1	15438439-15449242	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	417	"pancreas: 1443.7"	"Cell line enhanced"	"Detected in some"		"A-431: 3.6"	"Cancer enriched"	"Detected in some"	168	"pancreatic cancer: 236.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046920	Enhanced				"Secreted to digestive system"					"HPA046920: "	"unprognostic (2.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.55e-11)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1443.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.4	3.4	0.7	1.5	0.6	0.1	3.6	0.6	0.5	0.7	0.2	0.0	0.2	0.3	0.4	0.0	0.0	0.0	1.7	0.5	1.1	0.0	0.5	0.0	0.1	0.2	1.1	0.5	0.4	0.3	0.1	0.9	0.2	1.7	0.2	0.0	0.0	0.0	0.0	0.1	1.7	0.2	0.5	1.0	1.6	0.4	0.0	0.5	0.1	0.3	0.0	0.1	0.4	1.0	0.4	0.2	0.2	0.3	0.1	0.9	0.4	1.4	0.9	0.2	0.8	1.6	0.3	0.8	0.8	0.3	3.4	0.4	0.4	0.4	0.2	0.2	0.3	0.3	0.6	0.1	1.1	0.3	0.4	1.7	1.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CTSA	"GSL, PPGB"	ENSG00000064601	"Cathepsin A"	P10619	20	45890144-45898820	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 125.7"	"Cell line enhanced"	"Detected in all"		"ASC diff: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024930, HPA031068"	Enhanced		Enhanced	Vesicles	"Intracellular and membrane"	18000000	18000000	Vesicles		"CAB024930: , HPA031068: AB_10601205"	"unprognostic (8.61e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (6.33e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.40e-2)"	29.0	125.7	12.0	22.8	19.5	22.1	35.3	11.4	30.0	14.1	50.6	17.4	16.2	29.4	18.2	19.3	20.7	12.7	28.0	32.6	11.5	11.6	88.2	43.8	28.4	38.9	12.3	16.1	23.9	19.2	28.3	16.5	47.7	15.7	18.2	50.5	30.1	20.5	15.1	19.3	28.2	40.6	19.6	11.9	38.8	19.7	14.3	11.2	8.0	18.1	24.9	22.4	23.3	18.7	7.0	16.6	81.1	46.1	12.0	31.2	50.0	14.4	14.9	2.8	12.7	116.2	60.2	6.4	20.8	55.4	22.8	29.7	27.9	38.9	3.1	24.1	38.9	23.1	7.5	14.0	14.3	6.0	7.0	8.2	10.4	48.6	25.9	13.0	33.9	47.8	16.9	14.7	3.3	24.8	8.1	47.8	24.7	29.7	3.3	12.0	2.8	35.4	5.2	14.5	17.2	18.2	12.7	5.6	5.3	34.6	60.6	58.0	14.8	18.7	22.8	45.8	10.7	25.9	16.3	23.6	29.7	2.2	82.5	17.3	18.8	60.6	46.1	81.1	7.5	26.6	31.2	7.0	12.9	13.2	16.6	3.6	4.7	6.9	24.7	12.0	17.7	6.6	23.9	50.0	12.0	19.5	11.4	30.0	11.5	11.6	12.3	16.1	15.7	11.2
CTSC	"DPP1, PALS, PLS"	ENSG00000109861	"Cathepsin C"	P53634	11	88293592-88337787	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 218.6"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025364, HPA066610, HPA068434"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	19000000	19000000	Vesicles		"CAB025364: , HPA066610: , HPA068434: "	"unprognostic (4.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavourable (9.30e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-1)"	"prognostic favourable (4.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.07e-2)"	40.7	20.5	6.7	44.5	10.6	12.0	35.3	1.5	5.6	14.0	25.3	7.1	6.2	20.4	16.1	24.0	21.8	16.7	36.6	53.3	6.8	6.5	62.7	18.1	110.1	218.6	12.5	3.6	11.0	24.8	3.8	17.3	43.4	9.4	13.8	33.1	27.0	35.1	5.8	10.0	11.7	28.5	14.2	14.6	86.6	13.5	10.8	9.2	19.5	17.7	25.3	30.0	30.2	16.9	8.5	75.9	52.5	92.6	34.7	42.4	31.2	11.2	11.5	4.5	9.4	12.2	33.0	30.2	77.1	112.0	44.0	31.8	31.2	51.8	17.5	41.0	41.8	18.2	7.0	32.6	35.2	30.8	12.7	22.8	31.9	35.1	16.2	28.9	15.4	45.9	23.1	33.9	69.6	43.2	20.7	21.1	5.3	2.1	13.0	40.0	23.6	35.7	17.0	4.7	31.0	56.6	18.9	1.2	9.5	13.0	17.2	10.1	3.8	19.8	21.0	3.0	27.3	20.9	48.9	9.0	12.8	17.7	8.0	61.1	16.7	12.5	32.5	52.5	42.4	69.3	36.5	8.5	19.5	37.8	35.1	4.6	9.9	23.8	37.2	34.7	92.6	75.9	28.4	31.2	6.7	10.6	1.5	5.6	6.8	6.5	12.5	3.6	9.4	9.2
CTSD	"CLN10, CPSD"	ENSG00000117984	"Cathepsin D"	P07339	11	1752752-1764573	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Alzheimer disease, Cancer-related genes, Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 215.7;SK-BR-3: 206.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB000109, HPA003001"	Supported				"Secreted to blood"	540000000	540000000			"CAB000109: , HPA003001: AB_1078404"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-2)"	"prognostic favourable (4.93e-5)"	"unprognostic (8.98e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.60e-1)"	151.9	148.7	21.4	32.8	27.0	83.7	67.7	18.6	47.4	56.3	59.3	41.4	41.9	61.6	25.9	48.2	46.2	34.2	90.0	86.0	25.3	27.6	150.5	163.5	102.6	81.1	49.6	25.7	41.2	62.3	21.3	24.9	56.1	42.8	33.9	33.7	234.4	64.1	42.3	76.2	50.8	90.9	23.3	36.7	87.6	47.0	29.8	29.7	21.1	36.3	42.9	41.4	64.6	43.5	4.9	22.7	51.1	83.8	28.4	26.1	58.7	15.6	42.4	4.9	20.4	62.1	21.2	7.9	11.6	36.2	15.6	18.5	10.5	215.7	3.8	30.1	29.9	84.4	7.1	13.0	4.3	16.1	15.4	5.8	8.0	13.2	65.5	13.3	61.6	34.2	57.0	8.4	15.5	11.4	6.9	23.2	27.6	57.7	3.4	7.5	11.6	17.0	4.9	6.0	14.1	55.0	49.0	6.8	6.7	13.8	206.2	39.1	80.7	18.4	14.3	47.5	7.3	6.5	18.6	32.0	40.1	2.4	69.2	36.1	39.8	29.0	83.8	25.2	26.1	47.6	15.1	4.9	12.2	18.3	22.7	3.2	14.3	18.3	51.1	28.4	38.5	19.2	13.5	58.7	21.4	27.0	18.6	47.4	25.3	27.6	49.6	25.7	42.8	29.7
CTSF	"CATSF, CLN13"	ENSG00000174080	"Cathepsin F"	Q9UBX1	11	66563463-66568841	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 28.2;SK-MEL-30: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"NK-cells: 7.5;T-cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002141, HPA031431, HPA055610"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	3600000	3600000	Cytosol	"Vesicles, Plasma membrane"	"CAB002141: AB_563471, HPA031431: , HPA055610: "	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.12e-2)"	"prognostic favourable (8.92e-7)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.42e-1)"	28.1	29.4	24.7	8.0	29.0	1.8	31.1	38.4	47.1	37.3	23.8	32.6	25.2	5.8	38.1	29.8	12.9	34.3	37.3	34.5	25.3	20.5	29.8	45.4	17.3	8.5	28.0	26.0	68.2	23.1	42.6	15.9	20.2	25.4	32.3	8.1	35.0	35.5	37.8	35.8	19.7	9.4	34.6	22.4	10.4	17.8	37.1	30.1	0.8	18.6	14.2	6.3	22.2	21.5	2.1	1.1	0.5	0.7	7.5	9.7	2.4	0.1	9.2	5.0	12.9	21.3	8.6	3.6	6.5	16.5	6.8	4.8	0.0	8.2	0.0	11.0	14.2	0.9	8.5	2.8	3.6	2.2	0.0	0.3	3.8	0.0	11.9	0.1	5.0	28.2	9.6	1.5	1.1	4.3	2.8	1.5	8.5	1.9	0.1	1.1	0.6	3.4	0.0	1.9	1.6	6.1	0.2	6.0	6.4	17.4	2.0	52.3	13.2	0.8	2.8	2.7	2.7	3.2	0.6	8.8	0.1	0.0	6.5	0.1	4.1	0.0	0.7	0.4	6.5	0.7	7.0	2.0	5.6	7.3	0.8	2.1	9.7	5.5	0.5	7.5	0.3	1.1	1.7	2.4	24.7	29.0	38.4	47.1	25.3	20.5	28.0	26.0	25.4	30.1
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150796208-150808323	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 104.1"	"Group enriched"	"Detected in some"	8	"ASC diff: 200.2;ASC TERT1: 73.3;BJ hTERT+: 161.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 6.7"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"			Vesicles		"HPA050346: "	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavourable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	104.1	2.4	1.2	6.5	1.6	1.3	79.3	2.4	2.3	70.6	23.6	2.2	10.1	2.7	72.5	25.9	26.5	12.5	53.4	14.7	1.1	1.1	3.4	1.8	8.7	10.4	1.1	1.7	25.4	2.9	0.3	3.0	30.6	2.6	24.2	11.5	56.0	10.9	6.8	19.9	44.0	11.0	26.9	2.0	5.6	8.6	24.1	0.9	1.1	7.1	13.2	10.7	38.0	48.2	0.1	1.0	1.0	6.7	0.5	1.2	1.8	0.1	0.1	0.3	0.3	200.2	73.3	0.2	5.7	161.8	0.4	0.8	0.0	0.1	0.1	0.2	11.1	0.2	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.0	1.0	0.1	0.4	14.6	0.5	4.5	0.1	0.6	0.0	0.5	0.4	0.3	0.0	0.7	1.1	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.6	0.3	0.0	3.0	0.2	0.2	0.4	0.2	0.1	0.2	0.2	0.6	0.5	1.1	17.0	0.0	0.9	0.0	6.7	1.0	0.7	3.4	0.2	0.0	0.6	0.2	0.4	0.1	0.3	0.5	0.6	0.5	2.0	1.0	1.2	1.8	1.2	1.6	2.4	2.3	1.1	1.1	1.1	1.7	2.6	0.9
CWC27	"NY-CO-10, SDCCAG-10, SDCCAG10"	ENSG00000153015	"CWC27 spliceosome associated protein homolog"	Q6UX04	5	64768930-65018763	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Dwarfism, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020344, HPA024149, HPA065809"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: "	"unprognostic (1.71e-1)"	"unprognostic (6.47e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavourable (5.27e-6)"	"unprognostic (1.58e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.45e-3)"	15.6	16.4	22.0	14.9	30.4	21.7	16.4	30.1	25.6	16.5	17.5	13.8	14.0	11.8	19.4	15.7	17.3	14.9	13.8	22.1	20.6	19.9	17.5	12.1	12.8	17.0	22.3	20.7	23.3	10.9	21.4	28.8	17.5	26.2	18.6	18.7	11.4	13.3	16.0	24.0	13.8	15.9	24.7	23.3	15.0	13.9	19.6	23.6	22.5	17.2	18.2	18.6	18.6	20.0	15.1	14.6	8.6	11.5	17.0	15.9	9.0	15.2	10.2	18.3	33.9	15.7	19.2	20.5	16.0	13.4	18.0	18.9	17.0	19.4	22.6	28.1	16.6	9.7	19.2	29.0	32.8	18.8	15.7	17.0	17.2	14.1	24.1	17.7	11.5	12.8	22.3	22.6	28.8	19.0	16.5	14.9	17.8	15.1	24.6	16.1	14.8	12.3	22.9	24.7	23.5	17.1	13.3	21.8	9.6	19.5	8.0	18.1	17.4	26.1	15.7	10.6	18.7	16.9	25.5	11.7	15.1	22.2	19.8	31.2	18.7	8.6	11.5	7.9	12.8	11.3	15.5	15.1	14.2	15.9	14.6	11.9	15.4	15.9	2.5	17.0	8.5	12.0	15.1	9.0	22.0	30.4	30.1	25.6	20.6	19.9	22.3	20.7	26.2	23.6
CX3CR1	"CCRL1, CMKBRL1, CMKDR1, GPR13, V28"	ENSG00000168329	"C-X3-C motif chemokine receptor 1"	P49238	3	39263494-39281735	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"	"Age-related macular degeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 69.2;brain: 51.6"	"Cell line enriched"	"Detected in some"	20	"RPMI-8226: 112.1"	"Cancer enhanced"	"Detected in many"		"glioma: 21.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 69.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032478, HPA046587"	Approved									"CAB032478: AB_638830, HPA046587: "	"unprognostic (2.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.59e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.12e-1)"	2.3	3.8	14.9	6.0	17.3	0.9	4.8	2.5	34.1	2.7	1.2	51.6	0.0	1.2	2.7	4.2	1.4	5.9	2.5	2.2	12.4	11.9	2.5	1.9	9.0	1.8	21.8	7.4	1.8	1.8	5.2	2.5	4.3	21.8	3.7	1.2	3.5	6.4	7.0	5.2	2.4	1.2	3.3	33.5	10.3	1.5	1.8	16.3	0.8	2.4	0.7	4.7	2.8	1.3	0.1	15.7	3.5	69.2	6.5	46.5	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	112.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.5	0.0	1.2	15.9	0.2	46.5	43.3	0.5	0.1	10.4	25.2	15.7	0.1	3.7	22.7	3.5	6.5	69.2	1.1	0.2	29.8	14.9	17.3	2.5	19.9	12.4	11.9	21.8	7.4	21.8	16.3
CYB5R3	DIA1	ENSG00000100243	"Cytochrome b5 reductase 3"	P00387	22	42617840-42649568	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 115.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001566	Approved		Supported	"Endoplasmic reticulum"		67000000	67000000	"Endoplasmic reticulum"		"HPA001566: AB_1078601"	"unprognostic (4.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (2.13e-5)"	"unprognostic (2.45e-1)"	"unprognostic (8.22e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.24e-2)"	79.7	57.1	33.2	22.8	32.6	19.3	86.8	19.5	33.1	52.4	31.9	37.6	51.8	25.9	51.9	35.0	39.1	39.3	38.6	86.4	31.3	24.1	43.3	78.2	43.5	30.3	31.8	25.4	58.8	21.9	15.1	27.2	32.1	33.9	40.6	21.3	37.9	29.3	96.4	34.4	43.1	32.5	55.5	36.3	20.2	33.7	44.0	25.9	14.1	30.1	28.4	23.2	43.4	53.5	28.6	37.6	70.3	39.7	14.2	22.3	19.7	16.2	10.4	17.2	10.5	115.5	91.8	10.1	47.8	44.4	35.7	31.9	13.6	12.8	7.7	21.4	88.4	15.0	11.4	23.7	18.4	8.3	25.6	10.9	18.0	26.2	29.4	15.2	20.4	55.3	18.8	25.7	17.1	29.5	9.4	40.0	48.5	17.9	14.9	14.0	6.8	19.2	11.0	20.9	17.0	27.5	11.9	7.6	9.9	15.8	15.3	17.4	12.2	14.7	45.2	38.8	24.2	26.1	18.0	10.6	11.5	9.4	45.2	8.9	31.9	26.3	25.7	70.3	19.7	32.4	19.9	28.6	19.1	21.6	37.6	26.4	13.6	14.3	13.4	14.2	39.7	34.3	22.3	19.7	33.2	32.6	19.5	33.1	31.3	24.1	31.8	25.4	33.9	25.9
CYBA	p22-PHOX	ENSG00000051523	"Cytochrome b-245 alpha chain"	P13498	16	88643283-88651152	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport"	Oxidoreductase	"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.7;lymphoid tissue: 129.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 138.7;THP-1: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 94.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009492	Enhanced									"CAB009492: AB_2090309"	"prognostic favourable (8.19e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.32e-2)"	"prognostic favourable (4.75e-5)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.88e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (1.83e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.63e-2)"	31.4	12.6	9.7	60.1	14.9	116.7	16.5	2.0	8.6	16.1	40.5	11.5	25.8	35.7	11.4	20.0	19.6	19.2	43.6	18.0	7.8	8.0	49.3	19.8	46.7	120.1	15.7	3.4	14.8	37.4	0.9	8.2	19.3	11.8	14.7	15.2	15.1	21.7	22.5	6.7	7.1	41.0	9.0	16.7	129.2	41.1	7.4	12.7	31.0	25.6	14.0	60.4	27.0	13.6	15.3	28.4	94.1	20.7	5.2	11.9	5.7	0.2	54.2	0.2	0.1	0.1	0.0	29.3	13.3	7.2	3.8	2.2	36.1	77.3	41.5	39.4	5.5	22.6	2.1	0.0	0.5	13.2	44.8	8.1	20.3	57.7	7.2	13.8	36.8	7.7	0.0	0.1	0.0	2.0	23.3	56.7	0.3	84.1	13.3	65.5	9.9	0.1	39.0	0.1	138.7	31.6	45.5	7.7	6.9	39.7	7.8	12.5	0.1	115.8	11.0	0.1	0.5	0.1	0.2	33.9	40.6	45.7	18.8	39.4	5.0	15.9	14.7	94.1	11.9	20.7	8.7	14.5	5.8	11.0	15.7	15.3	4.6	5.7	28.5	5.2	19.3	28.4	5.8	5.7	9.7	14.9	2.0	8.6	7.8	8.0	15.7	3.4	11.8	12.7
CYBB	"CGD, GP91-PHOX, NOX2"	ENSG00000165168	"Cytochrome b-245 beta chain"	P04839	X	37780011-37813461	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"	"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.3;lung: 49.4;lymphoid tissue: 74.5"	"Group enriched"	"Detected in some"	5	"Daudi: 16.1;NB-4: 19.4;REH: 16.5;RPMI-8226: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 50.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA051227	Enhanced					640000	640000			"HPA051227: "	"unprognostic (5.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.32e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.72e-2)"	16.4	11.0	9.7	44.2	13.2	42.6	8.1	2.5	6.7	3.7	6.0	10.4	0.2	5.2	3.4	6.3	3.2	6.0	7.5	10.1	6.8	6.5	6.2	11.8	49.4	74.5	12.6	2.9	5.3	4.5	1.4	4.9	16.1	10.3	4.8	8.9	4.5	6.0	2.7	2.5	2.2	16.1	15.3	20.3	49.9	4.9	2.3	10.3	5.4	3.4	3.5	20.2	13.9	3.1	8.1	17.5	20.0	50.3	0.1	0.1	22.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	16.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.1	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	19.4	0.0	0.1	16.5	0.0	63.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.0	0.0	2.7	0.0	0.3	45.5	20.0	0.0	50.3	0.1	8.1	0.0	0.0	12.1	7.2	0.0	0.0	3.7	0.1	42.7	17.5	0.1	22.0	9.7	13.2	2.5	6.7	6.8	6.5	12.6	2.9	10.3	10.3
CYLD	"CYLD1, KIAA0849, USPL2"	ENSG00000083799	"CYLD lysine 63 deubiquitinase"	Q9NQC7	16	50742050-50801935	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011713, HPA050095"	Approved		Supported	"Nucleoplasm,Centriolar satellite"				"Centriolar satellite"	Nucleoplasm	"CAB011713: AB_731794, HPA050095: "	"unprognostic (9.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.24e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.42e-2)"	9.3	16.2	13.9	22.9	26.4	51.1	9.1	14.2	20.9	9.2	10.3	18.8	12.8	10.2	16.1	8.1	15.3	8.5	13.3	12.7	15.7	17.0	9.4	13.2	15.6	30.7	16.3	14.3	11.5	12.2	20.3	27.8	9.8	20.0	11.0	12.7	13.3	12.6	10.9	31.7	12.4	14.2	12.5	16.3	23.4	12.4	22.6	13.7	16.9	16.2	8.0	29.3	14.1	12.6	9.2	10.2	31.4	9.8	13.6	19.1	10.2	9.1	2.9	3.3	3.7	5.3	7.7	3.0	13.6	19.9	14.2	8.4	2.4	4.3	10.6	4.9	13.2	3.6	3.9	8.2	21.1	46.4	6.0	5.3	5.1	1.9	10.6	5.2	24.9	8.4	6.7	17.1	17.9	5.7	2.2	9.2	19.8	1.3	5.1	7.6	3.5	4.8	4.6	6.8	10.1	4.6	3.2	4.3	3.3	11.5	3.9	3.3	3.9	6.6	6.4	24.3	5.5	8.5	5.5	24.3	23.1	11.8	17.8	5.9	5.1	31.4	8.6	20.8	10.7	9.8	12.9	9.2	15.8	14.4	10.2	6.2	14.7	11.4	19.4	13.6	9.5	6.2	19.1	10.2	13.9	26.4	14.2	20.9	15.7	17.0	16.3	14.3	20.0	13.7
CYP11B2	"ALDOS, CPN2, CYP11B, CYP11BL, P-450C18, P450aldo"	ENSG00000179142	"Cytochrome P450 family 11 subfamily B member 2"	P19099	8	142910559-142917843	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	259	"adrenal gland: 51.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049171, HPA056348, HPA057752"	Supported									"HPA049171: , HPA056348: , HPA057752: "																		0.0	51.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CYP1B1	"CP1B, GLC3A"	ENSG00000138061	"Cytochrome P450 family 1 subfamily B member 1"	Q16678	2	38066973-38109902	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Disease mutation, Glaucoma, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.0;lung: 39.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.2;ASC TERT1: 25.9;HSkMC: 103.9;SiHa: 48.4;U-87 MG: 26.4"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in some"	6	"classical monocyte: 45.0"	"Lineage enriched"	"Detected in many"	22	"monocytes: 45.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB011705, HPA026863"	Approved		Uncertain	Mitochondria				Mitochondria		"CAB011705: AB_731810, HPA026863: AB_10600900"	"unprognostic (7.25e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (4.39e-6)"	"unprognostic (1.87e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"prognostic unfavourable (2.76e-4)"	9.1	3.1	0.5	9.4	1.2	0.0	11.4	1.0	1.2	11.4	2.1	0.7	4.5	0.0	12.8	5.9	3.5	15.0	6.9	17.5	1.2		8.8	3.5	39.2	26.3	3.1	1.0	6.1	3.6	0.0	1.3	0.8	3.3	10.7	0.0	19.3	0.0	13.0	4.8	0.5	1.4	10.6	5.1	15.7	0.3	3.9	0.5	5.1	2.5	1.1	4.2	6.9	2.1	0.0	0.4	2.0	45.0	0.0	0.0	16.2	1.2	13.0	0.4	0.0	24.2	25.9	0.0	0.1	0.8	0.2	2.3	0.0	5.4	0.0	3.5	3.2	10.6	0.0	0.7	0.4	0.9	0.7	0.0	3.9	0.0	6.6	0.0	0.0	103.9	10.1	5.6	0.2	0.0	0.1	0.0	0.1	5.1	0.0	3.9	1.4	2.5	0.0	0.0	0.0	2.4	0.1	0.1	0.4	48.4	7.0	0.0	9.0	1.9	0.0	0.1	0.0	19.8	0.0	0.0	0.0	0.0	26.4	0.0	2.1	0.4	45.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	0.0	5.5	0.2	0.0	16.2										
CYP21A2	"CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B"	ENSG00000231852	"Cytochrome P450 family 21 subfamily A member 2"	P08686	6	32038265-32041670	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Steroidogenesis	"Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"adrenal gland: 170.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.5;Hep G2: 1.8;Karpas-707: 3.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA048979, HPA053371"	Enhanced				"Intracellular and membrane"					"HPA048979: AB_2680584, HPA053371: AB_2682131"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.67e-7)"	"unprognostic (7.39e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-1)"	0.1	170.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	6.7	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	7.4	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	3.6	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153449-54173973	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2"	"Group enriched"	"Detected in some"	16	"A549: 92.9;Hep G2: 27.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022261, HPA063771"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"				"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA022261: AB_1847427, HPA063771: "	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.1	0.1	0.4	0.2	0.7	0.0	2.5	0.1	0.4	2.5	0.1	0.0	0.3	0.0	11.2	0.4	4.4	0.3	0.0	0.1	0.4	0.8	38.8	0.3	1.6	0.1	0.2	0.0	0.1	0.1	0.0	0.7	7.0	0.3	7.0	0.0	0.1	0.3	1.5	0.1	1.0	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.4	1.4	5.9	25.8	31.2	14.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	92.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.0	0.7	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.7	0.1	0.4	0.4	0.8	0.2	0.0	0.3	0.0
CYP27A1	"CP27, CTX, CYP27"	ENSG00000135929	"Cytochrome P450 family 27 subfamily A member 1"	Q02318	2	218781749-218815293	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 149.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 72.6;HSkMC: 13.9;RPTEC TERT1: 18.5;SK-MEL-30: 29.8;WM-115: 11.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 176.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 38.2;neutrophil: 30.6"	"Group enriched"	"Detected in many"	20	"granulocytes: 30.6;monocytes: 38.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059155	Enhanced		Supported	Mitochondria				Mitochondria		"HPA059155: "	"prognostic favourable (1.05e-4)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.71e-3)"	"unprognostic (1.31e-2)"	"prognostic favourable (8.62e-6)"	"unprognostic (6.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.25e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	14.4	12.3	6.3	4.7	13.4	0.7	5.5	2.4	7.5	6.5	21.9	16.9	24.9	21.0	5.0	5.4	3.5	9.2	5.1	6.9	8.3	6.2	12.6	149.0	22.4	5.6	19.9	5.7	9.5	2.4	6.3	7.1	2.0	12.1	11.6	6.0	15.1	10.0	21.5	10.0	3.9	36.8	5.0	18.8	3.1	3.5	3.7	15.7	3.7	3.1	4.0	7.6	5.5	5.7	0.1	1.7	30.6	38.2	0.0	0.1	10.0	0.0	0.0	0.7	0.0	1.3	0.8	0.1	0.8	3.0	1.0	2.1	3.6	0.1	0.0	1.5	2.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.1	72.6	4.2	0.1	0.0	13.9	0.1	0.0	0.0	1.4	0.0	0.0	2.0	0.0	0.0	0.1	0.8	0.1	0.0	0.7	0.1	18.5	0.0	0.0	0.0	0.0	0.0	29.8	0.5	0.7	1.6	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	11.6	0.0	38.2	0.1	0.0	4.3	0.0	0.1	0.0	0.1	1.7	0.0	0.0	0.0	30.6	0.0	0.3	0.2	0.0	10.0	6.3	13.4	2.4	7.5	8.3	6.2	19.9	5.7	12.1	15.7
CYP27B1	"CYP1, P450c1, PDDR, VDD1"	ENSG00000111012	"Cytochrome P450 family 27 subfamily B member 1"	O15528	12	57762334-57768986	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"kidney: 45.7"	"Cell line enriched"	"Detected in many"	6	"RH-30: 33.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (8.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.75e-3)"	"unprognostic (4.10e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavourable (6.79e-4)"	"unprognostic (5.67e-3)"	0.5	1.1	0.3	1.4	0.3	1.5	0.6	0.3	0.4	0.4	0.3	0.3	0.9	0.3	0.8	1.0	0.6	0.2	0.8	0.3	0.3	0.1	45.7	0.8	0.8	1.4	0.3	0.3	0.3	3.6	0.7	0.6	0.5	0.3	0.5	0.8	1.1	0.7	0.3	0.3	0.8	0.4	0.3	0.3	0.3	0.7	0.5	0.3	1.0	4.4	0.3	0.8	0.6	0.3	0.0	0.0	0.0	0.0	0.0	2.4	0.1	1.1	0.2	0.5	1.6	0.0	0.3	1.9	0.0	1.7	0.2	0.9	1.9	0.5	2.4	0.2	0.3	1.6	0.8	2.8	1.1	0.5	0.8	1.5	0.3	0.0	0.1	2.6	2.5	0.0	1.1	1.1	0.1	0.0	1.6	5.3	0.0	0.5	0.4	1.1	1.6	1.6	1.2	33.2	1.2	0.0	0.9	0.7	0.7	1.3	0.0	0.2	1.3	1.8	0.0	1.4	2.4	1.3	0.8	2.4	2.2	1.3	0.8	3.2	0.8	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.7	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.3	0.3
CYP2R1		ENSG00000186104	"Cytochrome P450 family 2 subfamily R member 1"	Q6VVX0	11	14877440-14892252	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042949	Approved				"Intracellular and membrane"					"HPA042949: "	"unprognostic (1.62e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.23e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (2.86e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-2)"	5.4	4.4	3.5	7.4	6.5	6.4	10.1	7.7	6.8	5.4	8.6	4.2	4.6	10.8	4.6	7.9	10.3	4.3	6.9	6.9	4.3	3.4	6.4	9.1	6.3	6.7	5.3	5.8	4.9	12.0	5.1	7.7	2.7	4.7	8.1	8.0	5.6	10.2	5.5	6.2	15.8	12.6	8.7	5.4	9.3	9.5	14.9	6.2	9.3	5.2	9.7	9.1	7.7	6.8	5.6	3.5	4.2	3.8	3.2	8.8	2.0	4.8	2.9	2.9	1.2	1.3	2.1	0.0	1.6	0.9	0.9	1.0	3.4	5.5	6.0	1.3	0.3	0.0	1.0	2.2	0.4	4.9	4.6	2.6	3.3	0.2	4.5	4.6	2.8	2.0	8.6	0.0	3.6	1.1	3.9	21.0	0.6	1.2	5.0	9.2	2.7	2.8	3.6	2.2	8.8	1.1	0.5	2.4	3.8	3.6	4.4	4.0	3.2	1.7	3.0	2.9	3.6	1.8	2.1	10.5	12.1	7.1	4.1	6.0	2.6	4.2	3.7	2.7	5.9	3.2	8.8	3.0	4.7	3.5	3.0	5.6	6.8	5.6	0.6	3.2	3.8	3.5	5.6	2.0	3.5	6.5	7.7	6.8	4.3	3.4	5.3	5.8	4.7	6.2
CYP2U1	SPG49	ENSG00000155016	"Cytochrome P450 family 2 subfamily U member 1"	Q7Z449	4	107931369-107953457	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 122.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041622, HPA046754, HPA064827"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA041622: , HPA046754: , HPA064827: "	"unprognostic (3.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.19e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.02e-1)"	"prognostic favourable (2.75e-5)"	"prognostic unfavourable (6.97e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	8.6	7.9	7.7	4.4	9.1	0.4	7.3	11.3	9.2	7.8	7.3	7.0	4.1	4.0	9.5	4.6	6.3	9.8	6.6	8.8	7.1	7.9	6.4	6.8	6.6	6.7	8.3	5.2	12.0	2.6	10.3	8.1	2.7	7.8	12.4	4.7	8.6	4.5	11.0	4.3	3.1	6.0	12.3	7.0	8.5	4.6	3.9	7.4	122.7	4.7	3.5	5.4	7.3	5.3	2.6	2.7	0.7	5.9	1.6	1.7	0.4	2.5	1.2	3.4	6.3	18.8	9.0	0.5	10.8	16.3	6.6	10.5	0.0	1.7	6.9	0.8	6.4	0.1	5.3	4.0	10.4	1.9	1.6	1.4	2.4	0.3	7.5	2.0	0.0	10.1	3.4	3.1	2.1	2.5	0.1	3.3	5.5	1.8	7.4	0.0	3.5	3.0	4.2	4.1	0.0	2.1	4.3	6.7	5.0	2.7	4.7	11.5	2.3	1.0	6.8	4.3	0.5	6.1	4.3	14.0	13.2	2.2	3.5	0.0	4.8	0.0	0.3	0.7	1.2	1.1	0.9	2.0	0.9	1.0	2.2	2.6	1.7	1.3	0.0	1.6	5.9	2.7	0.0	0.4	7.7	9.1	11.3	6.9	7.1	7.9	8.3	5.2	7.8	7.4
CYP4F2		ENSG00000186115	"Cytochrome P450 family 4 subfamily F member 2"	P78329	19	15878023-15898120	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 69.1;liver: 102.9"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 8.8"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 29.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 8.5"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 8.5"									"HPA014048, HPA017265, HPA058960"	Supported				"Intracellular and membrane"					"HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: "	"unprognostic (7.46e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.89e-1)"		"unprognostic (7.79e-3)"	0.1	0.1	0.2	0.5	0.1	0.0	0.2	0.1	0.2	0.2	10.1	0.2	0.1	24.5	0.1	8.8	0.2	0.1	1.8	0.1	0.2	0.1	11.9	102.9	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.2	1.9	0.0	0.1	0.1	0.2	0.1	0.5	69.1	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.4	0.3	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.7	0.1	0.3	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.2	8.8	0.0	0.9	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.5	0.1	0.1	0.3	0.6	0.8	0.1	0.4	0.4	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1
CYP4V2	CYP4AH1	ENSG00000145476	"Cytochrome P450 family 4 subfamily V member 2"	Q6ZWL3	4	186191520-186213456	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sensory transduction, Vision"	"Monooxygenase, Oxidoreductase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 12.9;SK-MEL-30: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029122	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA029122: AB_10601806"	"unprognostic (1.65e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.35e-1)"	"prognostic favourable (5.86e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (1.85e-4)"	"unprognostic (6.66e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.49e-2)"	"unprognostic (9.89e-2)"	"prognostic favourable (1.49e-7)"	"unprognostic (3.25e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	6.6	16.6	7.8	5.0	12.4	1.6	5.5	8.9	7.5	6.7	8.0	8.9	4.9	11.4	5.7	4.2	5.2	6.2	13.7	7.4	7.7	4.6	21.6	64.7	7.3	4.1	7.7	9.0	6.3	12.1	30.8	16.1	3.0	6.7	5.6	8.2	19.1	6.2	9.1	3.3	2.8	14.7	6.4	7.0	7.5	5.2	3.2	7.4	4.4	11.9	2.1	3.8	8.0	5.1	2.3	2.5	0.0	6.2	1.3	4.0	1.5	2.6	1.8	0.6	0.0	11.1	4.6	0.1	3.7	7.9	1.4	1.9	0.0	10.7	1.0	0.5	2.4	1.3	1.3	1.1	0.4	6.4	1.3	4.0	0.4	0.5	3.3	2.2	2.0	4.1	0.5	1.4	0.6	0.1	1.6	12.9	4.6	2.2	2.4	0.6	1.4	0.0	2.1	0.5	1.1	4.5	5.1	2.8	4.0	0.9	0.0	19.0	1.9	3.5	4.2	2.9	0.7	3.3	1.6	0.0	0.0	0.5	8.8	8.2	3.5	0.0	1.2	0.0	4.0	4.1	2.5	1.0	2.5	3.4	1.5	2.3	2.7	2.3	0.0	1.3	6.2	2.5	2.1	1.5	7.8	12.4	8.9	7.5	7.7	4.6	7.7	9.0	6.7	7.4
CYP7B1	SPG5A	ENSG00000172817	"Cytochrome P450 family 7 subfamily B member 1"	O75881	8	64587763-64798761	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Disease mutation, Hereditary spastic paraplegia, Intrahepatic cholestasis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HSkMC: 16.5;SH-SY5Y: 6.1;WM-115: 12.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	36	"basophil: 6.4;eosinophil: 6.2"	"Lineage enriched"	"Detected in single"	36	"granulocytes: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017761	Uncertain									"HPA017761: AB_1847455"	"unprognostic (3.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.07e-1)"	"unprognostic (5.80e-3)"	"unprognostic (3.80e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.11e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.00e-1)"	"unprognostic (3.04e-3)"	"unprognostic (6.75e-3)"	10.1	8.5	5.0	7.5	12.2	0.8	9.8	2.1	10.8	8.7	3.8	20.7	3.5	2.4	4.1	3.9	10.8	5.4	8.0	6.6	5.8	4.2	10.0	24.6	11.0	5.7	5.0	7.8	5.6	8.2	31.0	4.4	1.7	13.5	5.8	4.8	7.3	6.6	7.1	1.8	6.7	3.5	6.1	12.6	19.1	3.9	3.2	7.5	0.2	16.2	5.5	3.8	8.4	10.1	0.0	0.1	6.4	0.0	0.0	0.1	0.0	1.8	0.8	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.4	0.0	2.1	6.1	0.0	0.1	2.6	0.0	1.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	6.4	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	12.2	2.1	10.8	5.8	4.2	5.0	7.8	13.5	7.5
DAG1	"156DAG, A3a, AGRNR, DAG"	ENSG00000173402	"Dystroglycan 1"	Q14118	3	49468703-49535618	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001960, CAB016353"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	70000000	70000000	Vesicles		"CAB001960: , CAB016353: AB_627292"	"unprognostic (1.58e-1)"	"unprognostic (5.14e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.27e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.10e-1)"	"prognostic favourable (2.59e-4)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-2)"	19.2	17.4	16.5	10.1	21.1	2.8	16.2	17.3	27.1	17.3	23.9	24.1	13.1	14.1	23.4	14.3	19.1	19.6	19.7	40.9	19.9	10.3	22.7	31.7	18.9	6.3	16.7	15.7	22.6	35.0	32.7	15.8	45.6	18.1	18.6	18.9	22.2	19.9	24.3	57.3	18.7	17.5	27.9	14.0	7.3	22.2	29.4	16.3	6.0	15.3	24.0	14.3	20.4	15.0	3.2	3.6	1.8	6.1	1.9	3.7	3.3	19.5	19.5	13.6	33.6	18.2	8.9	62.0	13.8	20.5	23.7	15.3	16.0	20.8	2.7	14.0	22.5	36.7	11.8	17.9	14.7	2.6	3.9	1.8	19.6	18.2	8.1	2.4	3.9	7.8	16.2	22.5	7.5	21.2	2.8	2.1	6.4	15.7	2.0	1.6	14.5	6.5	1.2	13.2	4.6	18.6	27.5	4.8	9.9	16.6	45.8	22.4	38.6	4.8	11.0	9.0	14.3	16.7	19.7	2.4	4.9	1.7	10.9	2.6	54.2	1.8	2.8	1.1	3.3	3.5	3.7	3.2	2.8	2.5	1.8	2.6	3.0	2.4	0.6	1.9	6.1	3.6	1.9	3.3	16.5	21.1	17.3	27.1	19.9	10.3	16.7	15.7	18.1	16.3
DAO	DAMOX	ENSG00000110887	"D-amino acid oxidase"	P14920	12	108858932-108901043	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"brain: 37.0;kidney: 39.0;liver: 64.2"	"Cell line enhanced"	"Detected in some"		"AF22: 1.3;ASC TERT1: 1.3;BEWO: 1.5;Hep G2: 4.4;HL-60: 1.7;HMC-1: 1.3;RH-30: 1.2"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 13.2"	"Group enriched"	"Detected in many"	5	"cerebellum: 37.0;pons and medulla: 31.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"cerebellum: 74.4;pons and medulla: 21.1"	"Low region specificity"	"Detected in many"			"HPA038653, HPA038654"	Enhanced				"Intracellular and membrane"					"HPA038653: AB_10673016, HPA038654: AB_10673285"	"unprognostic (1.50e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.59e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.13e-2)"	"prognostic favourable (4.11e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.96e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	0.3	0.2	0.0	0.2	2.7	0.2	0.2	37.0	0.7	0.2	0.9	11.5	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.9	39.0	64.2	0.3	0.2	6.4	0.5	0.2	0.3	0.2	0.0	0.2	31.2	0.2	1.1	0.0	0.2	0.2	0.2	0.2	0.2	0.3	35.9	0.2	0.2	0.2	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	37.0	0.5	0.8	0.9	6.4	0.5	31.2	0.4
DARS		ENSG00000115866	"Aspartyl-tRNA synthetase"	P14868	2	135906677-135986100	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020451, HPA029804, HPA029805"	Enhanced		Enhanced	Cytosol		160000	160000	Cytosol		"HPA020451: AB_1847479, HPA029804: AB_10599178, HPA029805: AB_10601994"	"unprognostic (6.13e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavourable (2.39e-6)"	"unprognostic (2.98e-3)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (6.00e-3)"	"prognostic unfavourable (6.54e-4)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (1.24e-5)"	"unprognostic (1.04e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.00e-1)"	30.3	29.7	35.0	27.6	35.5	19.7	34.9	18.0	28.3	27.6	25.4	25.6	26.9	14.8	30.1	26.7	44.4	26.9	19.6	29.8	29.0	28.8	34.6	35.5	19.7	32.3	32.1	25.6	34.0	27.0	26.4	24.5	31.7	23.8	31.0	20.3	20.6	26.6	28.3	45.1	30.6	21.4	42.4	33.8	29.8	23.6	12.8	25.0	42.0	33.0	33.1	36.7	45.3	30.2	48.6	30.5	11.2	18.8	36.6	42.7	30.6	47.1	19.4	16.6	17.5	18.5	23.2	38.0	23.6	26.5	25.9	25.4	41.8	20.6	55.1	37.0	19.4	27.2	25.4	30.6	47.1	25.2	22.7	33.5	19.2	43.4	23.9	44.8	22.3	22.3	24.7	28.9	26.1	14.2	35.9	17.6	21.4	22.2	34.3	38.6	19.5	18.5	42.0	36.1	38.5	31.1	18.4	11.8	22.5	18.1	16.4	18.4	18.0	32.0	10.7	22.7	22.7	16.7	23.4	48.5	26.4	59.3	35.7	34.2	14.0	6.0	18.8	11.2	27.5	18.3	41.2	48.6	41.3	36.0	30.5	43.8	42.7	37.0	7.3	36.6	14.0	29.2	36.9	30.6	35.0	35.5	18.0	23.8	29.0	28.8	32.1	25.6	23.8	25.0
DARS2	FLJ10514	ENSG00000117593	"Aspartyl-tRNA synthetase 2, mitochondrial"	Q6PI48	1	173824503-173858546	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026506, HPA026528"	Enhanced		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA026506: AB_1847482, HPA026528: AB_1847483"	"unprognostic (3.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-1)"	"prognostic favourable (1.74e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.73e-3)"	17.0	22.2	6.3	10.1	8.1	5.4	9.0	7.5	8.6	7.8	15.1	6.7	8.3	11.7	10.4	6.1	13.4	6.4	5.9	11.2	5.5	6.0	21.9	14.8	8.2	11.0	6.4	4.2	9.5	14.9	18.1	15.3	10.9	10.0	8.5	16.6	10.2	10.2	6.2	10.6	6.0	16.1	6.2	9.0	11.4	11.3	8.4	6.9	26.1	12.2	6.3	12.5	9.7	8.1	9.3	9.0	4.8	10.7	5.0	9.3	5.2	29.2	19.6	12.2	7.6	9.3	13.3	15.6	12.9	10.7	18.7	14.3	18.3	26.4	15.9	17.7	10.3	30.1	33.7	21.8	25.6	18.1	16.5	13.7	9.8	12.8	9.1	11.6	12.5	9.6	10.0	18.9	19.3	18.6	27.7	12.5	15.5	8.1	14.7	6.5	23.6	17.6	17.4	15.6	29.2	17.0	9.8	16.0	14.7	14.2	31.6	20.3	33.1	15.3	8.2	9.6	15.2	13.2	20.6	9.8	24.8	18.4	5.6	12.9	20.7	4.4	7.0	4.8	6.6	10.7	9.3	9.3	7.2	5.8	9.0	7.3	7.7	4.8	0.7	5.0	7.4	3.7	5.1	5.2	6.3	8.1	7.5	8.6	5.5	6.0	6.4	4.2	10.0	6.9
DBT		ENSG00000137992	"Dihydrolipoamide branched chain transacylase E2"	P11182	1	100186919-100249834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026481, HPA026485, HPA026533"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.90e-1)"	"prognostic favourable (8.79e-12)"	"unprognostic (1.63e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.67e-2)"	"unprognostic (9.92e-2)"	8.6	14.1	8.3	5.0	13.6	3.9	8.7	8.0	11.8	8.5	7.8	7.9	13.6	6.6	9.8	6.6	13.6	8.6	5.2	18.1	8.6	7.3	22.2	29.1	8.0	5.3	10.2	8.2	9.1	13.7	10.2	12.3	7.3	9.4	12.0	7.6	5.2	11.3	8.3	15.7	8.1	5.8	11.2	8.6	6.0	12.6	5.7	8.2	9.6	13.0	8.7	6.3	12.8	7.7	4.4	2.6	3.3	3.1	4.0	5.0	2.1	11.5	5.7	5.2	10.6	11.6	10.1	12.2	7.9	6.4	7.1	8.6	11.8	4.4	10.5	11.6	4.7	10.4	11.6	8.4	8.9	11.1	6.7	7.6	10.9	5.8	9.9	10.0	3.6	9.8	9.3	5.8	9.1	6.6	12.2	11.5	5.6	2.6	8.3	3.2	11.0	11.4	8.1	19.2	7.9	7.8	10.5	9.2	5.7	17.5	15.6	13.2	12.3	6.2	7.6	7.0	4.7	8.9	7.1	8.1	8.2	5.4	8.3	6.2	3.1	3.3	2.2	1.8	4.9	3.1	5.0	4.4	4.4	4.2	2.2	4.1	4.5	4.2	2.1	4.0	2.7	2.6	3.4	2.1	8.3	13.6	8.0	11.8	8.6	7.3	10.2	8.2	9.4	8.2
DCPS	"HINT-5, HSL1, HSPC015"	ENSG00000110063	"Decapping enzyme, scavenger"	Q96C86	11	126303752-126345749	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Hydrolase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039632, HPA058597"	Supported		Supported	Nucleoplasm,Cytosol		1400000	1400000	Nucleoplasm	Cytosol	"HPA039632: AB_10794200, HPA058597: "	"unprognostic (1.45e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.40e-2)"	11.1	13.1	6.8	14.4	8.2	13.5	9.2	8.5	14.5	12.1	10.6	6.8	8.0	7.8	12.4	9.6	14.4	9.9	13.9	10.9	5.5	6.1	13.3	39.6	9.9	18.5	6.3	5.8	11.8	17.2	7.0	9.5	14.1	6.8	12.7	11.7	13.3	17.4	9.4	21.8	11.3	9.7	11.3	7.1	21.9	9.6	13.4	6.5	22.0	12.7	18.5	22.1	15.1	9.8	13.2	39.5	3.2	14.3	7.8	14.6	7.1	10.5	6.6	8.3	13.7	6.4	8.6	6.9	5.6	8.3	8.6	8.7	12.5	21.7	14.4	21.2	8.9	12.4	11.7	17.6	5.7	27.2	6.3	21.1	7.6	10.8	14.0	22.6	19.1	8.7	11.1	10.9	14.9	11.5	8.5	24.7	9.4	15.2	14.4	25.9	5.8	22.7	10.0	12.1	27.4	8.3	11.8	10.7	8.2	17.0	13.9	10.3	23.6	14.2	7.3	13.5	6.3	6.4	10.5	9.9	9.2	14.9	3.9	39.2	33.8	1.7	9.2	3.2	8.8	14.3	8.2	13.2	8.5	9.0	15.4	9.0	6.0	6.8	0.5	7.8	12.6	39.5	14.6	7.1	6.8	8.2	8.5	14.5	5.5	6.1	6.3	5.8	6.8	6.5
DCXR	"DCR, KIDCR, SDR20C1"	ENSG00000169738	"Dicarbonyl and L-xylulose reductase"	Q7Z4W1	17	82035136-82037732	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Xylose metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 293.8"	"Cell line enhanced"	"Detected in all"		"Hep G2: 64.9;MCF7: 79.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 305.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023371, HPA023863"	Enhanced		Uncertain	Nucleoli,Microtubules		2700000	2700000	"Nucleoli, Microtubules"		"HPA023371: AB_1847530, HPA023863: AB_1847531"	"unprognostic (3.33e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-2)"	"prognostic favourable (4.70e-4)"	"unprognostic (1.72e-1)"	"prognostic favourable (2.13e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.10e-2)"	12.7	6.1	12.8	4.3	12.1	5.7	12.2	9.0	15.1	9.9	9.5	8.4	18.1	7.8	4.4	62.7	11.7	6.1	4.8	11.8	9.8	9.7	50.8	293.8	10.5	5.3	14.4	7.3	8.1	13.0	6.7	7.2	9.0	13.4	22.3	5.4	7.8	19.3	14.0	22.5	8.6	6.8	3.6	8.4	4.4	14.9	8.7	9.7	8.3	15.6	12.6	9.1	7.5	6.4	32.8	52.7	25.3	33.1	35.2	43.7	35.8	8.9	12.3	5.7	10.3	23.0	5.8	15.2	4.6	6.0	12.7	8.7	21.8	3.9	18.5	9.0	6.4	10.6	10.4	9.2	4.4	3.9	26.7	17.7	9.2	64.9	24.7	13.6	21.8	8.4	11.5	4.0	14.6	7.1	20.2	13.5	6.7	79.8	11.4	32.7	6.6	13.1	10.5	7.7	24.2	9.4	12.7	15.9	9.4	6.4	55.0	8.0	41.2	13.5	3.6	6.7	8.4	9.0	8.6	13.9	10.2	8.7	5.7	15.0	4.9	13.9	33.1	25.3	24.7	30.6	23.6	28.6	30.8	23.6	52.7	32.8	43.7	31.9	16.5	35.2	28.0	42.5	33.1	35.8	12.8	12.1	9.0	15.1	9.8	9.7	14.4	7.3	13.4	9.7
DDX11	"CHL1, CHLR1, KRG2, WABS"	ENSG00000013573	"DEAD/H-box helicase 11"	Q96FC9	12	31073845-31104791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA065197	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"				Nucleoplasm	"Nucleoli fibrillar center, Centrosome"	"HPA065197: "	"unprognostic (6.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.79e-3)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (5.23e-8)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.03e-3)"	6.3	5.3	6.4	8.0	8.7	21.0	5.9	18.1	10.5	7.6	6.1	6.0	8.8	7.1	11.0	3.7	7.6	7.5	5.1	4.0	7.0	2.7	6.5	7.0	4.9	14.9	8.4	4.6	9.6	19.0	7.7	9.3	5.6	7.1	8.0	8.6	5.0	11.3	7.1	8.8	14.2	12.1	8.0	6.7	10.9	8.0	8.2	9.4	33.2	7.2	6.4	11.1	5.8	7.8	5.8	4.9	1.3	7.3	4.3	5.5	1.9	12.4	12.2	14.1	12.6	2.2	4.7	20.8	7.7	3.9	9.1	9.7	14.4	21.2	16.3	10.8	4.1	12.3	11.1	10.6	7.3	14.9	22.8	19.4	20.2	8.9	0.8	13.6	12.6	4.5	4.7	11.5	9.0	4.4	9.5	36.5	6.5	10.3	23.3	20.4	29.7	6.5	18.8	22.1	22.7	4.8	14.2	10.2	7.5	7.9	12.2	3.9	10.3	8.7	3.6	7.9	15.6	15.3	14.0	14.8	11.4	39.0	9.4	10.9	7.2	0.0	2.3	1.3	4.2	2.5	3.3	5.2	4.0	3.1	3.1	5.8	4.1	5.5	1.1	4.3	7.3	4.9	3.4	1.9	6.4	8.7	18.1	10.5	7.0	2.7	8.4	4.6	7.1	9.4
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3, X-linked"	O00571	X	41333284-41364472	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol		110000	110000	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: "	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	80.9	49.3	26.1	40.0	34.5	49.3	46.5	31.1	36.2	52.4	43.3	35.1	21.3	29.5	56.4	25.9	53.5	56.3	42.6	47.6	30.8	24.5	55.6	77.9	45.3	40.4	41.4	29.0	60.1	30.9	68.7	60.2	79.9	37.9	30.0	29.2	30.8	37.4	26.5	63.4	42.2	54.0	57.2	53.9	46.1	43.0	27.0	39.0	49.2	45.6	44.0	42.6	55.8	50.2	13.1	20.5	32.0	21.6	17.3	21.5	17.9	45.4	50.5	47.2	25.9	55.6	47.2	28.8	33.1	46.6	34.0	27.4	51.9	30.6	0.5	23.7	37.1	30.7	57.7	46.6	56.7	26.9	45.0	28.9	50.3	31.2	28.9	54.1	52.0	34.1	33.1	57.3	55.4	53.3	53.0	28.6	31.6	34.4	34.1	16.9	45.4	20.4	40.0	50.3	37.0	32.0	61.2	32.3	48.9	75.0	38.5	39.7	34.6	36.8	48.1	35.1	37.6	37.5	39.3	33.4	39.6	44.9	35.4	32.8	33.2	22.5	20.2	17.5	14.8	21.1	21.5	13.1	14.5	16.3	20.5	9.0	16.3	15.1	32.0	17.3	21.6	6.9	14.3	17.9	26.1	34.5	31.1	36.2	30.8	24.5	41.4	29.0	37.9	39.0
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3, Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 40.6;HEL: 41.4;U-266/84: 34.4;U-698: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: "			"unprognostic (3.89e-2)"		"unprognostic (1.70e-1)"	"prognostic favourable (4.70e-5)"	"unprognostic (6.50e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.22e-2)"		"unprognostic (4.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.87e-2)"	12.0	10.5	4.9	29.5	14.1	46.1	8.7	17.0	16.3	0.4	24.4	12.6	31.5	7.6	0.4	29.7	12.2	0.4	14.2	10.8	5.6	7.1	8.9	26.5	20.0	17.7	5.7	0.0	0.4	14.5	0.4	12.2	14.0	20.2	26.7	15.8	15.1	20.4	32.6	17.7	8.4	16.0	40.7	6.2	34.3	8.9	41.9	0.0	26.9	10.8	21.4	19.3	14.4	0.0	6.1	8.8	6.5	7.1	6.5	8.4	3.8	0.1	7.5	0.0	0.0	0.0	0.0	5.5	18.6	13.3	9.8	12.1	0.0	0.0	40.6	0.0	18.3	0.0	0.0	0.0	17.3	10.2	0.0	41.4	0.0	12.2	9.7	0.0	0.0	10.3	11.6	0.0	0.0	0.0	0.0	0.0	11.6	0.0	16.0	0.0	7.4	0.0	0.0	4.9	7.4	10.5	11.2	12.2	0.0	0.0	0.0	13.6	0.0	9.7	13.3	15.3	0.0	0.0	12.2	21.9	34.4	30.2	1.8	0.0	0.0	1.6	6.2	5.7	8.4	7.1	7.7	6.1	6.4	7.1	8.8	5.9	7.8	6.5	6.5	6.5	4.6	2.5	5.7	3.8	4.9	14.1	17.0	16.3	5.6	7.1	5.7	0.0	20.2	0.0
DDX41	"ABS, MGC8828"	ENSG00000183258	"DEAD-box helicase 41"	Q9UJV9	5	177511577-177517469	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017911, HPA048803"	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA017911: AB_1847558, HPA048803: "	"unprognostic (2.52e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavourable (2.21e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.75e-1)"	17.9	22.7	27.0	25.1	30.7	17.2	16.5	22.8	39.2	19.1	21.2	16.9	18.5	25.5	19.5	16.5	23.0	22.1	17.1	15.3	29.3	20.1	23.7	29.3	16.8	19.9	22.1	24.8	21.2	18.0	22.2	15.1	22.1	27.4	16.3	15.4	19.0	19.0	17.5	36.6	21.7	26.8	16.7	14.8	21.9	19.7	16.8	15.4	24.9	22.9	18.2	23.5	19.6	18.4	15.9	22.5	16.4	22.8	18.6	20.6	18.0	21.0	24.1	13.2	15.5	13.6	16.1	44.5	18.9	11.5	13.9	10.3	39.2	19.7	23.6	28.8	17.8	17.3	17.2	43.3	9.5	56.4	21.6	30.0	24.5	23.2	18.0	31.0	31.9	15.8	15.3	13.2	17.8	17.7	26.0	16.9	16.4	45.4	25.8	15.2	23.2	19.5	28.1	16.0	27.8	15.5	24.5	15.7	17.2	20.1	26.8	22.6	18.7	45.3	18.9	25.5	15.1	16.2	29.4	20.3	23.8	40.3	27.9	34.2	16.7	10.6	22.8	16.4	16.1	21.5	20.6	15.9	16.0	15.3	22.5	14.1	14.8	15.5	7.7	18.6	21.4	10.2	15.6	18.0	27.0	30.7	22.8	39.2	29.3	20.1	22.1	24.8	27.4	15.4
DDX58	"DKFZp434J1111, FLJ13599, RIG-I"	ENSG00000107201	"DExD/H-box helicase 58"	O95786	9	32455705-32526324	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 44.8;BJ hTERT+ SV40 Large T+ RasG12V: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012643, HPA047193"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"CAB012643: , HPA047193: "	"unprognostic (1.10e-1)"	"unprognostic (4.65e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.15e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	27.7	8.2	5.7	14.5	7.9	5.6	11.3	4.2	5.7	9.9	9.5	5.2	9.1	7.2	12.7	11.7	10.8	7.6	10.3	7.1	6.0	5.1	14.7	8.5	13.7	14.3	6.3	4.5	9.2	7.7	6.6	10.2	14.8	7.5	12.1	8.1	5.5	12.4	5.8	8.3	10.7	16.1	10.8	7.7	13.8	8.0	4.5	6.4	35.4	13.0	7.4	9.7	9.9	9.4	4.9	2.0	24.8	5.7	6.1	6.5	3.0	2.9	1.1	1.6	0.9	3.8	4.0	2.5	1.8	8.8	44.8	46.8	1.2	2.6	0.8	3.2	1.6	2.4	1.7	1.9	6.3	7.2	0.6	2.8	2.5	2.0	3.1	1.8	2.2	2.8	0.7	5.2	1.5	8.1	0.6	0.6	5.9	0.4	2.5	4.6	1.3	1.2	2.4	1.2	0.3	6.8	1.6	1.2	0.7	2.6	1.1	4.9	1.9	1.5	9.3	1.3	1.3	1.1	0.9	0.1	0.5	0.5	2.0	0.8	0.9	8.5	3.8	10.3	6.2	5.7	5.5	4.8	5.6	5.6	2.0	4.9	5.1	5.6	24.8	6.1	3.9	0.1	6.5	3.0	5.7	7.9	4.2	5.7	6.0	5.1	6.3	4.5	7.5	6.4
DDX59	"DKFZP564B1023, ZNHIT5"	ENSG00000118197	"DEAD-box helicase 59"	Q5T1V6	1	200623896-200669969	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047166	Approved		Approved	"Nucleoplasm,Actin filaments"				"Nucleoplasm, Actin filaments"		"HPA047166: AB_2679966"	"unprognostic (1.99e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.43e-3)"	"unprognostic (4.16e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (9.02e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.98e-2)"	14.0	14.4	12.1	16.4	14.8	23.7	22.7	16.7	11.2	14.5	11.6	10.8	12.6	8.1	15.8	17.6	12.0	13.8	11.4	18.0	12.0	9.9	13.6	15.1	11.8	15.1	15.1	6.7	17.1	21.6	13.9	10.7	46.5	12.8	14.1	12.5	15.0	19.4	12.9	28.6	21.5	12.4	14.0	17.2	20.9	10.4	9.9	14.5	18.5	15.1	10.1	13.2	12.8	12.7	12.2	9.5	23.1	16.2	12.4	15.6	7.9	9.2	10.8	12.5	10.5	5.7	9.8	28.0	10.5	9.4	11.2	9.1	3.4	11.0	9.5	5.3	8.3	8.9	7.0	10.7	8.0	29.9	7.2	7.2	13.8	10.0	11.4	10.4	13.4	10.6	16.2	8.5	23.2	8.6	9.1	14.1	10.9	10.7	6.2	15.6	13.2	8.8	5.3	8.7	18.2	12.0	10.9	7.6	19.8	16.6	17.3	18.4	14.9	14.6	7.7	9.5	5.4	9.3	10.8	10.8	14.0	12.6	9.1	6.6	16.2	23.1	10.3	19.0	13.0	8.9	10.6	12.2	10.9	11.7	8.5	11.5	11.3	10.3	18.2	12.4	16.2	9.5	15.6	7.9	12.1	14.8	16.7	11.2	12.0	9.9	15.1	6.7	12.8	14.5
DDX6	"HLR2, RCK"	ENSG00000110367	"DEAD-box helicase 6"	P26196	11	118747766-118791149	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004668, HPA024201, HPA026644"	Approved		Supported	"Cytosol,Cytoplasmic bodies"				"Cytoplasmic bodies"	Cytosol	"CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582"	"unprognostic (1.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"prognostic unfavourable (6.56e-4)"	"unprognostic (3.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (4.55e-2)"	29.8	23.0	25.0	24.1	41.0	43.3	25.1	41.9	39.2	26.9	23.2	29.4	14.5	17.1	30.1	22.9	31.8	23.4	17.5	26.8	25.5	25.1	22.8	24.6	23.4	32.2	21.9	27.1	38.2	27.9	30.9	43.2	26.1	29.6	24.9	20.8	25.4	26.8	22.9	43.8	23.9	24.1	27.8	30.4	30.6	21.2	19.9	24.0	46.0	27.9	19.4	42.8	33.0	25.7	12.2	6.5	17.8	10.3	7.2	12.6	5.7	11.7	16.0	25.8	25.4	22.6	23.3	16.9	15.9	20.9	14.8	14.1	23.3	18.1	26.9	16.7	26.0	18.8	30.1	23.2	23.9	20.2	6.0	51.8	10.3	18.9	15.0	37.1	20.0	24.6	17.1	21.9	35.7	23.6	23.8	39.1	20.9	32.0	27.0	17.2	18.3	11.8	29.8	20.8	21.5	17.3	30.4	17.1	23.6	30.0	24.1	9.5	28.2	14.6	26.9	24.6	13.5	14.0	16.0	12.2	15.8	32.1	9.8	17.9	21.0	10.5	4.1	11.6	10.1	5.7	12.6	11.4	9.9	10.4	4.7	12.2	12.4	10.8	17.8	7.2	10.3	6.5	8.9	5.7	25.0	41.0	41.9	39.2	25.5	25.1	21.9	27.1	29.6	24.0
DECR1	"DECR, SDR18C1"	ENSG00000104325	"2,4-dienoyl-CoA reductase 1"	Q16698	8	90001405-90052092	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 120.2"	"Cell line enriched"	"Detected in many"	4	"SK-BR-3: 129.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023160, HPA023162, HPA023238"	Enhanced		Supported	Mitochondria,Cytosol		740000	740000	Mitochondria	Cytosol	"HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587"	"prognostic unfavourable (1.49e-4)"	"unprognostic (5.76e-3)"	"unprognostic (8.37e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (1.79e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (6.06e-4)"	26.9	45.7	13.2	18.1	17.6	9.2	15.6	10.3	14.5	13.0	29.0	10.4	11.8	32.4	11.9	13.7	16.2	8.5	12.6	70.0	15.4	9.0	44.8	120.2	12.9	14.0	12.5	12.8	12.7	14.4	22.2	16.8	5.8	13.6	11.0	22.9	9.5	15.7	9.9	37.9	12.5	42.7	11.5	11.9	20.1	12.7	17.0	14.5	20.3	15.0	32.1	15.3	11.6	10.6	23.4	52.3	37.2	42.8	19.8	31.3	27.8	10.3	5.9	17.4	19.7	12.2	19.9	3.7	9.1	15.7	5.9	9.3	2.3	10.3	7.9	7.2	10.9	7.8	6.4	9.2	9.9	11.9	0.7	19.0	5.3	9.4	15.3	4.1	3.9	15.7	7.1	4.7	8.0	17.7	19.7	15.7	28.5	11.9	11.8	6.1	1.1	17.8	10.0	4.6	14.1	29.2	26.0	0.7	6.6	13.8	129.9	10.9	16.6	10.7	15.9	10.1	4.8	13.3	5.4	7.9	6.0	9.3	9.6	9.4	12.8	15.0	31.5	10.2	21.4	42.8	22.6	23.4	20.1	21.8	52.3	19.2	21.3	21.0	37.2	19.8	37.2	20.4	31.3	27.8	13.2	17.6	10.3	14.5	15.4	9.0	12.5	12.8	13.6	14.5
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"intestine: 161.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 15.8;PC-3: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum"				"Endoplasmic reticulum"	Nucleoli	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	11.8	18.5	3.6	5.7	4.7	6.4	6.8	6.6	5.6	3.3	60.2	4.0	6.4	44.7	3.9	3.6	5.5	3.1	7.9	6.3	3.7	2.7	6.7	14.4	3.8	3.1	4.1	2.7	3.3	3.9	5.0	4.0	4.3	3.6	3.4	6.3	4.1	5.9	4.3	10.0	4.8	161.0	3.6	2.6	5.3	5.7	10.7	4.2	5.1	3.8	6.2	5.0	4.7	3.4	0.7	2.2	2.8	2.0	0.3	1.7	0.8	3.8	4.1	1.9	3.6	3.2	1.3	2.3	2.7	2.7	2.6	1.8	9.7	2.6	1.5	10.6	1.7	3.3	1.6	3.7	0.5	2.8	4.0	2.8	3.3	15.8	2.3	0.7	2.9	1.8	2.9	1.6	1.9	2.0	2.2	3.5	1.7	3.2	4.8	3.1	0.9	17.6	6.2	0.8	2.5	2.4	2.1	2.0	3.4	3.6	4.4	1.8	2.5	2.7	1.6	1.4	4.9	2.8	2.2	2.0	0.4	0.6	1.4	4.9	2.3	0.0	2.0	2.8	1.2	1.3	1.7	0.7	0.9	1.1	2.2	0.5	0.7	0.3	2.3	0.3	1.7	1.1	0.7	0.8	3.6	4.7	6.6	5.6	3.7	2.7	4.1	2.7	3.6	4.2
DGKE	"DAGK6, DGK"	ENSG00000153933	"Diacylglycerol kinase epsilon"	P52429	17	56834099-56869567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 42.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017167	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA017167: AB_1847638"	"unprognostic (1.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.69e-1)"	"prognostic favourable (3.92e-5)"	"unprognostic (4.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-3)"	7.8	4.9	7.8	8.3	17.7	5.5	5.2	21.3	18.6	9.5	7.4	4.4	5.6	5.4	13.3	8.9	5.0	8.2	9.4	4.9	7.4	9.2	4.2	4.9	8.1	9.3	5.6	10.0	7.3	6.5	9.5	14.5	5.5	9.9	8.9	7.0	17.4	4.3	7.3	2.4	3.4	7.1	9.3	6.8	12.7	6.4	12.5	5.4	14.5	8.3	2.5	8.6	6.5	15.3	2.4	2.4	1.2	0.8	1.9	4.5	0.8	1.6	1.6	1.5	0.1	0.2	0.5	0.7	2.8	2.3	1.9	2.3	3.7	2.0	2.4	3.5	1.5	2.0	3.6	1.5	4.0	7.8	4.6	3.1	3.9	2.4	1.7	6.0	4.5	0.9	2.0	2.0	4.1	2.6	2.5	42.7	2.4	2.4	14.2	3.4	1.1	4.8	4.4	6.2	5.8	1.9	3.7	2.3	1.6	2.3	1.2	0.1	2.6	2.9	2.4	0.5	2.7	0.8	0.4	5.6	11.5	1.6	1.7	3.5	0.1	0.3	0.5	0.0	2.7	0.4	2.0	2.4	1.9	2.3	0.6	0.9	1.9	2.5	1.2	1.9	0.8	2.4	4.5	0.8	7.8	17.7	21.3	18.6	7.4	9.2	5.6	10.0	9.9	5.4
DGUOK	dGK	ENSG00000114956	"Deoxyguanosine kinase"	Q16854	2	73926826-73958961	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034766, HPA057246"	Approved									"HPA034766: AB_10669850, HPA057246: "	"unprognostic (3.40e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.84e-2)"	"prognostic unfavourable (8.69e-7)"	"unprognostic (3.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.98e-2)"	"prognostic favourable (7.47e-4)"	23.8	34.8	25.8	26.2	32.3	26.3	33.7	18.4	33.7	26.1	28.0	23.6	24.9	19.4	30.7	40.9	26.6	35.4	28.0	24.5	28.3	26.5	26.7	31.7	24.7	37.2	23.5	22.6	35.5	20.9	11.2	39.9	30.6	27.1	28.6	34.1	25.2	22.5	28.2	14.1	29.2	29.3	25.8	23.5	33.1	23.6	34.3	17.9	41.7	29.0	21.8	44.2	27.2	27.4	43.5	36.4	50.5	31.4	30.0	42.3	31.3	15.7	26.9	27.9	24.8	18.1	19.9	13.7	10.5	21.2	25.4	23.6	34.0	19.1	29.8	10.1	15.5	12.5	31.7	20.5	30.5	16.3	19.1	23.4	10.2	38.4	26.7	21.4	23.8	18.7	19.4	18.6	21.9	17.9	23.8	13.7	29.1	19.2	20.1	37.8	28.3	19.7	25.9	28.0	19.8	20.2	18.4	32.1	31.4	10.3	10.1	27.1	12.2	12.2	16.8	16.3	26.2	14.1	19.0	11.2	10.8	30.0	23.5	23.2	34.6	41.3	27.4	50.5	25.3	31.4	29.8	40.6	31.4	27.9	32.4	43.5	42.3	33.1	22.5	30.0	30.8	36.4	29.3	31.3	25.8	32.3	18.4	33.7	28.3	26.5	23.5	22.6	27.1	17.9
DHCR24	"DCE, KIAA0018, seladin-1"	ENSG00000116133	"24-dehydrocholesterol reductase"	Q15392	1	54849633-54887218	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 164.5;liver: 119.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 131.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017981, CAB037247, HPA063005"	Enhanced									"CAB037247: AB_796187, HPA017981: , HPA063005: AB_2684919"	"unprognostic (2.88e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-3)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.82e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.97e-2)"	10.6	164.5	6.6	3.9	22.1	0.7	22.0	6.5	27.5	7.7	11.1	43.8	1.2	11.9	2.2	1.1	40.8	12.3	8.6	3.7	12.0	9.2	6.4	119.6	40.9	2.0	36.2	13.0	7.8	4.6	28.4	2.6	4.4	47.9	26.1	8.3	4.8	20.2	2.1	24.6	47.6	7.3	2.7	71.7	24.3	17.6	14.1	31.1	1.7	4.3	17.1	14.3	2.5	13.0	5.4	7.0	7.3	3.1	3.7	9.0	5.5	39.9	7.4	26.1	31.5	131.0	28.2	6.1	11.5	20.0	16.7	34.4	41.0	25.3	6.4	23.3	10.1	38.4	31.3	60.9	14.9	0.9	19.6	35.6	17.4	49.0	21.3	14.8	8.3	20.5	53.1	51.5	9.5	8.1	25.9	0.0	6.1	16.8	3.1	13.0	72.3	20.2	0.0	6.6	19.7	91.6	32.5	18.0	6.6	21.9	41.4	15.1	53.9	17.3	7.5	5.6	16.2	8.0	21.8	2.8	6.3	11.0	4.0	25.5	7.2	7.3	2.4	1.1	9.0	3.1	0.5	5.4	4.0	4.2	7.0	2.4	3.9	4.7	0.1	3.7	1.0	4.2	0.7	5.5	6.6	22.1	6.5	27.5	12.0	9.2	36.2	13.0	47.9	31.1
DHCR7	SLOS	ENSG00000172893	"7-dehydrocholesterol reductase"	Q9UBM7	11	71428193-71452868	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044280	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum"	Cytosol	"HPA044280: AB_10794893"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-3)"	"unprognostic (8.57e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.45e-2)"	"prognostic favourable (6.93e-7)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavourable (5.67e-4)"	8.0	40.1	12.1	5.6	14.5	19.0	16.8	5.3	22.8	5.5	9.3	27.9	8.8	20.8	4.0	27.3	14.6	5.2	5.8	10.7	13.7	13.2	7.1	64.8	12.0	2.7	20.6	12.3	21.5	7.3	14.0	7.0	3.7	23.4	10.0	6.6	16.6	10.0	3.9	5.4	22.9	15.8	4.5	20.5	5.9	8.5	17.7	15.5	2.8	5.4	12.1	7.7	4.3	7.4	6.3	6.2	3.5	1.9	4.6	12.1	5.7	21.6	19.6	19.2	21.2	9.0	14.0	6.0	8.9	23.8	7.6	20.8	73.0	71.1	15.1	14.3	8.5	41.6	22.8	48.3	8.1	5.7	17.1	5.7	16.6	31.2	23.1	10.8	2.8	16.2	21.4	28.6	19.7	11.2	27.0	32.3	7.6	58.1	8.9	12.2	27.5	11.7	8.1	27.0	65.0	28.6	32.7	26.1	9.7	8.5	28.2	20.3	27.3	5.9	10.6	2.1	11.6	0.6	10.7	10.7	12.9	16.1	6.1	19.2	8.6	3.5	1.9	1.7	9.7	1.2	11.8	6.3	8.2	9.0	2.5	5.4	10.5	12.1	1.0	4.6	1.2	6.2	5.1	5.7	12.1	14.5	5.3	22.8	13.7	13.2	20.6	12.3	23.4	15.5
DHDDS	"DS, FLJ13102, HDS, RP59"	ENSG00000117682	"Dehydrodolichyl diphosphate synthase subunit"	Q86SQ9	1	26432282-26471294	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Transferase	"Disease mutation, Epilepsy, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026721, HPA026727"	Uncertain		Uncertain	"Plasma membrane"				"Plasma membrane"		"HPA026721: AB_1847643, HPA026727: AB_1847644"	"unprognostic (1.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.71e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.81e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-2)"	"prognostic favourable (4.08e-7)"	"unprognostic (9.42e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.95e-1)"	31.8	14.4	11.2	10.8	15.9	6.4	15.0	45.9	18.8	10.4	23.1	12.5	8.3	12.2	15.4	21.9	18.9	9.2	10.9	14.8	9.7	10.7	16.2	15.3	9.5	10.3	12.1	15.8	9.8	14.7	23.2	15.5	13.1	20.6	9.6	23.9	22.0	56.9	9.1	10.3	13.1	12.2	11.3	7.6	10.5	14.2	12.9	8.9	9.7	12.1	11.1	16.9	10.6	9.8	11.1	11.2	11.8	19.5	8.1	11.6	8.2	14.7	12.0	8.0	11.0	16.5	13.9	13.8	25.2	15.7	19.5	19.5	18.5	16.2	16.7	15.4	23.5	10.8	10.8	19.7	18.7	10.2	5.7	16.5	29.9	13.6	15.6	18.0	24.4	19.0	11.8	26.9	15.1	24.6	11.8	18.4	17.9	10.1	9.2	7.6	12.6	16.1	11.0	14.2	14.2	10.6	13.9	11.3	9.0	17.0	18.7	11.1	14.1	10.2	31.2	13.6	13.2	25.5	14.3	22.3	29.9	18.0	21.4	22.7	13.2	6.5	13.4	7.1	11.6	19.5	8.4	11.1	7.7	7.5	11.2	9.3	6.5	9.0	11.8	8.1	18.0	9.1	7.3	8.2	11.2	15.9	45.9	18.8	9.7	10.7	12.1	15.8	20.6	8.9
DHTKD1	"CMT2Q, DKFZP762M115, KIAA1630, MGC3090"	ENSG00000181192	"Dehydrogenase E1 and transketolase domain containing 1"	Q96HY7	10	12068972-12123225	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.5"	"Cell line enhanced"	"Detected in all"		"T-47d: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037949, HPA037950, HPA066098"	Approved		Supported	Mitochondria				Mitochondria		"HPA037949: , HPA037950: AB_10673650, HPA066098: "	"unprognostic (3.76e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.02e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.56e-1)"	"prognostic favourable (3.43e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.88e-3)"	5.7	6.3	6.5	4.7	6.6	2.2	5.0	5.7	7.2	5.5	5.7	9.8	5.0	4.5	4.7	5.0	5.1	4.2	4.5	7.7	5.3	4.8	23.8	69.5	4.2	6.9	7.5	5.2	7.1	16.6	5.4	4.1	4.7	6.2	7.6	6.3	7.2	9.7	7.1	10.5	3.6	4.3	3.5	6.1	5.1	6.1	4.4	6.6	10.1	6.8	6.7	8.0	5.2	4.1	9.5	12.5	16.8	11.0	10.2	4.1	3.3	11.2	8.7	13.0	10.3	8.1	4.8	15.7	5.7	3.7	10.2	9.1	5.5	6.7	8.1	1.9	3.5	16.1	13.6	4.4	11.7	4.5	6.1	4.4	3.4	4.2	7.9	1.7	1.7	5.9	3.5	5.9	2.4	5.5	6.9	6.6	2.7	21.8	5.9	3.2	7.2	2.0	10.1	4.2	6.8	6.6	2.7	3.4	15.3	11.2	20.1	6.7	44.2	6.4	2.4	3.3	2.4	6.9	4.1	5.9	4.1	5.2	4.3	3.1	5.5	16.8	4.8	10.7	3.2	6.8	3.4	9.5	2.5	2.1	8.6	7.8	2.5	3.3	14.0	10.2	11.0	12.5	4.1	3.3	6.5	6.6	5.7	7.2	5.3	4.8	7.5	5.2	6.2	6.6
DICER1	"Dicer, HERNA, K12H4.8-LIKE, KIAA0928, MNG1"	ENSG00000100697	"Dicer 1, ribonuclease III"	Q9UPY3	14	95086228-95158010	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000694, CAB068185"	Approved		Supported	Cytosol				Cytosol		"CAB068185: , HPA000694: AB_1078661"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.52e-3)"	"unprognostic (5.73e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.74e-2)"	23.2	12.5	18.4	22.4	33.3	20.5	23.2	28.5	29.9	19.0	18.1	31.4	22.4	13.0	20.8	20.6	23.4	18.5	16.2	15.3	22.0	14.1	19.5	23.6	22.4	20.3	29.7	19.6	23.8	19.8	26.9	30.9	29.9	23.2	20.3	19.7	14.5	19.5	18.9	28.0	20.7	17.3	19.0	26.8	20.7	17.1	20.6	32.0	17.0	23.8	14.7	20.3	20.7	24.1	2.5	1.8	10.7	7.2	1.2	3.3	1.0	12.8	13.4	25.1	9.3	6.5	9.8	19.9	10.6	6.4	6.8	8.2	17.0	9.9	14.5	11.5	9.8	15.2	19.9	10.0	14.2	22.5	8.9	21.9	7.4	12.2	6.6	13.4	13.5	9.1	8.3	9.1	13.9	10.1	9.2	12.9	11.4	18.0	15.0	8.9	7.1	6.6	12.0	20.5	8.0	9.0	20.5	20.8	11.8	10.7	11.0	12.0	12.4	9.9	10.0	5.2	10.3	10.1	11.9	14.8	21.1	20.6	5.4	10.9	9.3	3.1	3.0	1.2	1.6	3.1	3.3	1.9	1.5	1.2	1.8	2.5	1.5	1.3	10.7	1.2	7.2	1.6	1.6	1.0	18.4	33.3	28.5	29.9	22.0	14.1	29.7	19.6	23.2	32.0
DIRC2	"FLJ14784, RCC4"	ENSG00000138463	"Disrupted in renal carcinoma 2"	Q96SL1	3	122794795-122881139	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072579			Supported	Vesicles				Vesicles		"HPA072579: "	"unprognostic (1.40e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavourable (7.48e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (1.87e-1)"	"prognostic favourable (8.81e-11)"	"unprognostic (2.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.13e-2)"	7.6	7.8	6.5	4.0	7.7	7.9	6.8	5.2	8.8	5.0	6.2	10.0	4.4	3.0	4.2	6.1	8.8	5.0	5.9	9.9	6.4	6.3	7.5	9.2	8.0	6.9	7.5	4.5	4.9	12.9	18.4	7.6	34.8	6.7	7.8	6.9	11.9	7.7	6.0	27.0	9.7	6.1	6.7	7.8	5.8	5.9	4.2	3.8	3.1	8.0	11.2	7.4	7.4	5.4	0.6	0.3	4.2	0.8	0.0	0.5	0.1	5.6	4.7	4.6	2.6	6.0	4.9	15.6	2.4	5.3	3.9	4.0	11.0	6.3	0.8	3.1	2.7	8.2	3.4	4.3	3.7	1.2	2.5	0.9	2.6	4.7	4.5	0.5	0.6	4.1	11.9	2.8	4.7	4.4	0.5	1.0	4.9	2.5	0.7	0.6	4.2	7.7	1.5	10.5	1.2	5.5	6.6	4.8	3.8	7.1	3.2	6.3	3.8	1.2	6.1	6.1	2.3	3.7	2.0	1.1	0.9	0.3	3.1	1.0	3.3	0.0	0.7	0.1	0.5	0.8	0.0	0.1	0.0	0.0	0.3	0.6	0.5	0.3	4.2	0.0	0.7	0.0	0.1	0.1	6.5	7.7	5.2	8.8	6.4	6.3	7.5	4.5	6.7	3.8
DLAT	"DLTA, PDC-E2"	ENSG00000150768	"Dihydrolipoamide S-acetyltransferase"	P10515	11	112024814-112064390	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 55.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003782, HPA040786, HPA062766"	Supported		Enhanced	Mitochondria				Mitochondria		"CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864"	"unprognostic (4.57e-3)"	"unprognostic (1.75e-1)"	"prognostic favourable (6.19e-6)"	"unprognostic (7.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.70e-2)"	"prognostic unfavourable (7.49e-5)"	"unprognostic (8.68e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.23e-3)"	"unprognostic (6.25e-2)"	"prognostic favourable (1.95e-14)"	"unprognostic (5.82e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.15e-2)"	14.1	10.7	10.6	8.8	11.9	4.8	10.9	10.5	14.2	6.7	13.3	6.3	7.8	12.4	6.3	8.1	12.2	7.2	6.4	55.4	10.4	13.5	19.1	12.0	6.6	8.7	11.2	9.7	7.9	6.0	15.8	7.8	8.3	13.0	8.3	13.5	7.6	10.4	9.9	41.0	7.2	13.0	6.6	7.3	6.9	8.1	7.3	4.2	12.7	10.7	22.1	8.8	7.5	6.7	9.2	9.1	7.9	8.9	7.2	10.3	8.0	6.0	6.1	8.1	10.8	11.4	8.5	9.7	8.3	4.8	9.2	10.4	19.3	17.8	24.8	16.3	7.6	13.0	16.9	8.9	10.5	8.9	10.5	15.7	6.5	11.9	8.2	19.9	9.0	10.3	9.8	9.2	9.3	8.4	25.7	11.9	10.8	4.7	9.0	23.9	9.5	11.8	14.0	11.0	27.9	16.9	6.4	15.6	9.5	10.0	28.3	6.3	21.0	12.4	5.6	9.2	10.0	9.2	10.6	3.9	6.2	37.6	2.6	21.8	7.2	7.9	6.6	4.7	8.3	8.9	9.5	9.2	8.2	8.9	9.1	7.5	10.3	8.3	0.5	7.2	8.9	7.4	8.8	8.0	10.6	11.9	10.5	14.2	10.4	13.5	11.2	9.7	13.0	4.2
DLD	"DLDH, GCSL, LAD"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107890970-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Supported	Mitochondria		16000000	16000000	Mitochondria		"HPA044849: "	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favourable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	25.7	37.9	14.5	12.7	25.4	12.0	15.2	16.6	27.2	13.2	28.0	10.6	12.2	20.9	13.6	9.6	25.6	11.6	12.7	69.1	16.4	14.4	40.7	37.9	11.0	13.0	16.7	20.1	15.1	14.8	24.6	22.4	15.4	29.3	14.7	26.8	12.8	19.4	14.4	71.5	13.8	29.5	23.7	10.6	17.4	23.0	10.6	10.7	18.7	17.0	31.8	16.9	20.1	11.7	13.5	30.4	45.8	37.8	22.9	19.4	20.2	39.9	32.4	18.0	31.0	25.9	22.9	20.4	23.0	19.4	26.8	20.8	37.9	22.4	39.1	39.7	24.4	26.6	36.2	32.4	40.5	26.1	21.5	27.5	43.0	27.0	19.9	45.2	28.4	26.1	23.6	28.4	15.5	32.1	68.6	29.2	29.0	44.9	36.9	32.8	21.4	23.5	26.6	28.8	53.0	36.6	59.8	22.4	23.7	37.7	63.7	33.8	24.2	38.7	20.3	29.6	24.3	57.6	34.9	22.1	42.1	26.3	27.9	48.3	30.6	36.5	22.3	45.8	17.5	28.2	18.5	13.5	17.7	17.3	30.4	12.3	18.7	19.4	14.0	22.9	37.8	10.5	16.8	20.2	14.5	25.4	16.6	27.2	16.4	14.4	16.7	20.1	29.3	10.7
DMD	"BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85"	ENSG00000198947	Dystrophin	P11532	X	31097677-33339441	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 16.1;Hep G2: 14.7;RH-30: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.6;naive B-cell: 4.9;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	18	"B-cells: 4.9;dendritic cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000119, HPA002725, HPA023885"	Enhanced									"CAB000119: , HPA002725: AB_1078714, HPA023885: AB_1847931"	"unprognostic (3.91e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.51e-2)"	19.8	11.8	12.5	11.6	11.1	0.7	11.8	15.6	11.6	18.9	25.6	6.8	30.3	4.5	22.2	10.0	13.1	12.5	22.3	27.5	10.0	7.6	4.4	36.2	5.9	3.7	8.5	9.8	11.7	34.5	4.9	4.1	10.3	7.8	14.5	6.8	10.7	19.7	31.6	57.7	8.5	7.4	48.2	6.1	1.9	11.9	4.6	7.4	0.0	6.2	34.5	4.7	32.6	7.9	4.9	1.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	16.1	0.0	0.1	0.1	4.8	3.2	0.3	1.7	1.9	8.0	0.0	0.2	0.0	8.8	5.4	6.4	8.2	2.7	4.7	5.1	0.2	7.3	14.7	9.3	0.0	1.5	2.1	6.0	3.0	11.3	4.3	0.6	0.1	4.6	0.3	2.5	0.0	8.1	7.4	0.1	20.3	0.0	0.1	1.3	0.3	4.5	0.0	1.2	2.3	1.1	0.0	0.5	0.1	0.0	0.2	3.3	0.1	6.6	0.3	0.4	0.0	8.8	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.1	0.0	0.7	4.9	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	12.5	11.1	15.6	11.6	10.0	7.6	8.5	9.8	7.8	7.4
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997606-79236038	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 50.2;liver: 81.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.6;Hep G2: 11.3;hTEC/SVTERT24-B: 3.5;Karpas-707: 3.6"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria		440000	440000	Mitochondria		"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: "	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favourable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favourable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	2.8	2.2	0.8	0.8	1.3	0.0	1.5	0.4	0.6	0.5	0.5	0.7	1.9	0.1	0.9	5.9	0.4	0.4	0.6	1.3	0.8	0.8	50.2	81.8	0.1	0.1	0.8	0.3	1.0	0.5	0.3	2.1	0.0	1.1	0.9	0.1	2.7	0.4	1.1	0.6	0.2	0.3	2.0	1.7	0.0	0.4	1.2	0.2	0.0	1.5	0.8	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.5	0.5	1.4	0.4	0.3	5.6	1.3	2.3	0.0	0.1	0.0	0.4	1.7	0.0	0.1	0.0	1.8	0.3	0.0	0.0	0.0	11.3	3.1	0.0	0.0	2.7	3.3	3.5	2.5	0.0	0.0	3.6	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.2	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	1.3	0.4	0.6	0.8	0.8	0.8	0.3	1.1	0.2
DMPK	"DM, DM1, DM1PK, DMK, MDPK, MT-PK"	ENSG00000104936	"DM1 protein kinase"	Q09013	19	45769717-45782552	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007164, HPA008905"	Enhanced		Approved	Vesicles,Cytosol				Cytosol	Vesicles	"HPA007164: AB_1078687, HPA008905: AB_1078685"	"unprognostic (7.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (9.39e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.24e-3)"	9.0	18.7	5.1	9.7	6.3	1.7	4.9	8.8	6.2	16.5	23.4	4.4	15.6	8.7	21.2	15.0	31.2	13.7	20.3	56.7	5.0	5.3	4.9	2.2	6.5	4.1	4.8	6.5	8.4	33.3	3.1	10.7	6.8	5.6	16.3	3.8	22.0	6.1	19.7	79.6	5.1	11.3	65.1	4.2	5.3	12.0	5.9	4.0	1.1	6.1	36.6	5.0	44.9	8.2	1.5	0.0	0.0	0.8	0.3	2.2	0.0	7.2	10.1	12.0	7.4	8.1	11.3	7.2	16.2	12.0	6.5	6.3	1.2	3.9	2.3	2.4	18.5	10.6	3.4	1.6	2.4	11.3	10.6	0.9	12.6	1.7	7.9	0.1	4.1	16.5	5.7	5.6	2.7	3.0	7.1	5.8	9.4	8.0	1.1	2.7	7.1	2.2	3.7	44.2	3.7	3.5	8.3	6.5	10.3	8.8	18.5	5.2	15.2	3.5	9.1	7.6	7.5	7.2	11.8	11.2	9.6	2.3	6.9	1.0	10.6	0.0	0.0	0.0	2.2	0.8	0.5	0.3	0.7	0.2	0.0	1.5	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	5.1	6.3	8.8	6.2	5.0	5.3	4.8	6.5	5.6	4.0
DNA2	"DNA2L, KIAA0083"	ENSG00000138346	"DNA replication helicase/nuclease 2"	P51530	10	68414064-68472121	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Disease mutation, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 49.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 5.5"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037487, HPA057526"	Approved		Supported	Mitochondria				Mitochondria		"HPA037487: AB_10672493, HPA057526: "	"unprognostic (1.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.50e-5)"	"unprognostic (3.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.09e-10)"	"unprognostic (3.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.23e-2)"	1.6	1.2	2.0	13.7	2.4	7.0	3.0	6.2	3.8	1.6	4.5	1.1	0.8	3.5	3.0	1.8	3.2	1.0	2.4	2.0	2.5	2.2	3.4	6.2	3.3	8.4	2.9	5.0	1.9	2.4	1.1	2.3	4.0	1.7	3.0	5.0	0.9	2.3	0.8	2.3	2.9	5.2	1.9	3.0	5.2	2.6	7.0	1.4	49.1	1.5	5.1	10.8	2.3	2.0	0.4	0.1	0.9	0.1	5.5	0.6	0.1	13.7	7.1	16.3	11.5	1.8	1.3	11.5	6.8	5.7	9.8	12.1	17.0	9.0	14.1	2.6	2.1	8.5	9.3	3.6	11.8	8.7	7.0	8.6	4.4	6.5	0.5	14.7	9.3	1.0	1.4	7.0	2.0	4.4	12.5	12.8	5.6	4.8	22.7	10.7	11.5	13.4	17.8	11.3	4.5	4.2	6.4	7.4	8.9	9.4	11.9	2.2	9.2	6.3	1.8	3.8	11.7	4.8	12.9	6.5	7.3	21.1	3.2	14.1	4.9	0.0	0.0	0.9	0.2	0.0	0.2	0.4	0.2	0.6	0.1	0.4	0.3	0.3	0.1	5.5	0.1	0.0	0.4	0.1	2.0	2.4	6.2	3.8	2.5	2.2	2.9	5.0	1.7	1.4
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415869	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 91.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.9;HEL: 55.8;K-562: 21.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: "	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favourable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	2.1	12.1	18.6	2.2	28.5	5.0	2.0	24.2	91.4	2.2	2.8	26.9	0.0	2.3	1.9	1.8	1.7	2.4	2.3	9.0	25.0	26.7	8.5	1.6	2.7	1.6	28.8	23.8	1.9	3.4	2.1	7.5	8.0	40.5	2.5	3.0	2.2	1.7	2.1	1.6	2.1	2.3	2.2	28.7	3.2	2.9	3.2	21.1	0.0	3.0	0.0	1.7	1.8	0.6	0.5	0.5	0.0	0.0	0.6	1.5	0.3	3.5	0.9	0.0	1.6	0.7	0.2	8.3	7.0	11.4	11.5	11.3	0.9	0.1	3.3	0.6	2.9	0.8	5.0	1.1	9.1	20.9	2.4	55.8	1.9	0.2	0.0	1.8	1.4	1.0	0.8	1.1	4.9	0.2	21.7	0.4	2.3	0.6	0.7	0.0	2.3	0.7	0.0	1.7	0.1	8.7	0.0	13.9	9.6	4.1	5.5	1.9	2.6	0.1	2.1	1.7	1.2	0.2	2.0	2.1	1.3	1.0	4.7	1.4	2.8	0.0	0.0	0.0	1.5	0.0	0.1	0.5	0.5	0.9	0.0	0.0	0.4	0.6	0.0	0.6	0.0	0.5	0.0	0.3	18.6	28.5	24.2	37.4	25.0	26.7	28.8	23.8	40.5	21.1
DNASE1	DNL1	ENSG00000213918	"Deoxyribonuclease 1"	P24855	16	3611728-3680143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Actin-binding, Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 26.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010703	Enhanced		Supported	Vesicles	"Secreted in other tissues"	160000	160000	Vesicles		"HPA010703: AB_10600806"	"unprognostic (5.18e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.69e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (1.14e-4)"	1.5	1.4	1.5	2.6	1.6	1.7	1.5	3.8	2.5	2.2	12.2	1.8	1.5	14.9	1.5	2.2	3.4	1.2	2.5	1.5	1.5	1.2	11.4	1.5	1.5	4.4	1.5	1.5	2.0	13.7	1.6	12.2	1.9	3.1	5.1	2.1	1.5	3.3	1.5	1.5	3.9	26.7	1.5	1.5	2.3	6.0	2.7	1.5	1.5	1.6	2.6	3.8	1.9	2.3	4.5	2.2	9.2	2.0	1.9	3.4	1.0	2.4	5.7	10.0	5.2	2.9	2.5	4.8	4.0	0.7	3.2	4.7	6.8	6.0	10.5	3.2	0.6	4.2	3.6	1.1	3.5	4.6	5.5	3.7	8.5	4.5	1.5	2.6	8.5	2.0	4.2	4.3	1.0	2.1	9.2	4.7	2.7	10.2	5.2	11.3	6.1	3.1	12.4	4.6	5.1	2.7	2.1	7.1	6.6	2.9	9.1	1.6	9.0	6.5	2.9	6.0	4.5	3.8	2.2	4.2	6.0	18.2	1.7	4.8	5.8	4.3	2.0	5.3	3.0	1.3	1.9	2.5	2.3	2.4	1.0	4.5	2.7	3.4	9.2	1.9	1.2	2.2	2.4	1.0	1.5	1.6	3.8	2.5	1.5	1.2	1.5	1.5	3.1	1.5
DNM1	DNM	ENSG00000106976	"Dynamin 1"	Q05193	9	128191655-128255248	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 133.5"	"Cell line enhanced"	"Detected in many"		"A549: 48.8;U-87 MG: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005920, HPA049910, HPA061801"	Enhanced		Supported	Nucleoplasm		440000	440000	Nucleoplasm		"CAB005920: , HPA049910: , HPA061801: "	"unprognostic (3.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.95e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.62e-3)"	"unprognostic (6.30e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-3)"	5.9	6.1	31.5	3.3	36.9	2.3	4.6	57.7	133.5	11.7	3.0	2.5	0.0	2.4	4.6	2.7	3.3	6.3	9.0	2.7	33.4	24.0	2.9	1.8	2.5	2.5	18.3	33.0	1.6	4.7	3.2	5.5	2.7	33.0	2.9	2.9	4.3	2.6	3.1	2.3	4.6	3.3	4.4	5.1	1.6	2.6	4.0	1.8	0.0	1.9	0.4	2.3	3.6	3.7	0.3	0.4	0.5	0.3	0.0	0.3	0.7	3.2	48.8	4.4	1.0	1.4	14.9	0.2	3.0	7.3	6.2	2.6	0.6	1.0	0.0	4.2	6.3	5.8	0.7	0.3	3.4	0.0	4.7	3.1	7.0	0.2	1.0	0.4	2.2	3.9	0.1	4.8	0.0	0.0	1.1	0.2	0.0	1.3	0.2	1.0	4.7	8.9	5.8	0.1	1.5	0.9	0.0	6.3	10.6	10.4	0.3	0.4	0.1	4.2	0.2	0.2	14.1	14.2	6.2	0.4	0.1	0.3	18.6	0.1	1.0	0.0	0.3	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.4	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.7	31.5	36.9	57.7	71.8	33.4	24.0	18.3	33.0	33.0	1.8
DNM1L	"DRP1, DVLP, DYMPLE, HDYNIV, VPS1"	ENSG00000087470	"Dynamin 1 like"	O00429	12	32679200-32745650	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Endocytosis, Necrosis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009952, HPA039324"	Supported		Enhanced	Vesicles,Cytosol		10000000	10000000	Cytosol	Vesicles	"CAB009952: AB_2093533, HPA039324: "	"unprognostic (2.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavourable (6.27e-6)"	"unprognostic (8.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.57e-2)"	15.4	16.2	24.9	14.8	34.4	22.3	14.3	40.5	37.8	13.0	14.5	12.4	14.9	12.3	16.5	16.5	19.8	13.3	11.9	25.4	26.1	28.1	19.4	12.8	11.2	13.8	23.4	23.2	14.1	9.8	28.7	18.8	16.0	27.9	19.3	16.0	12.1	11.1	21.1	25.6	11.8	11.0	21.7	21.7	11.6	12.2	23.1	14.9	13.4	15.2	17.4	15.8	16.9	12.2	5.9	17.0	5.0	14.6	7.2	7.9	7.1	22.1	22.1	23.2	23.8	18.8	19.3	44.9	24.9	19.2	23.5	21.8	31.0	17.0	29.8	17.5	22.5	19.9	24.4	28.6	28.3	15.7	19.9	33.9	21.3	17.0	15.5	24.0	17.9	17.4	14.5	24.9	25.7	28.4	24.5	12.9	26.9	8.6	9.6	20.2	48.9	10.8	16.2	43.7	20.3	19.8	30.5	20.3	20.8	26.5	18.2	19.4	20.9	16.4	25.6	20.1	20.2	47.1	23.1	9.1	24.6	31.1	19.5	16.1	15.2	5.0	9.7	3.1	5.6	14.6	6.8	5.9	6.0	5.9	17.0	5.2	7.3	7.9	1.7	7.2	13.6	5.4	6.1	7.1	24.9	34.4	40.5	37.8	26.1	28.1	23.4	23.2	27.9	14.9
DNM2	"CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII"	ENSG00000079805	"Dynamin 2"	P50570	19	10718079-10833488	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Phagocytosis"	"Hydrolase, Motor protein"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054246	Supported		Approved	"Golgi apparatus,Cytosol"		500000	500000	"Golgi apparatus, Cytosol"		"HPA054246: "	"unprognostic (2.30e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (8.91e-4)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.35e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	23.8	32.6	18.5	29.3	31.2	53.4	20.4	25.7	29.7	20.1	51.4	57.5	46.0	32.1	20.4	16.8	29.9	19.7	27.0	35.0	20.8	18.0	38.5	25.1	39.2	28.2	48.3	18.0	17.9	32.2	19.5	20.0	32.3	32.2	24.0	42.5	24.5	24.7	37.7	46.6	40.6	50.8	18.6	43.1	37.6	48.2	23.3	36.4	39.1	23.5	21.1	41.5	35.7	31.5	3.4	11.1	8.6	9.8	10.1	5.8	4.6	34.9	28.9	21.2	16.9	21.9	21.5	27.2	23.4	22.2	34.7	29.5	28.8	23.1	25.4	42.2	25.2	30.7	28.9	25.4	29.1	31.1	23.0	48.7	25.8	32.2	27.0	26.7	46.3	22.0	19.6	26.5	25.0	33.7	39.1	43.7	21.3	42.3	37.2	25.5	24.1	35.0	37.8	23.0	28.6	22.8	52.7	30.6	20.0	26.7	22.9	16.7	18.4	31.8	30.5	38.1	12.9	53.5	30.9	36.2	36.9	23.4	28.5	40.9	18.8	3.0	4.5	8.6	5.6	8.2	5.1	3.4	4.2	5.8	5.3	3.1	2.4	4.1	8.5	10.1	9.8	11.1	4.8	4.6	18.5	31.2	25.7	29.7	20.8	18.0	48.3	18.0	32.2	36.4
DNMT3A		ENSG00000119772	"DNA methyltransferase 3 alpha"	Q9Y6K1	2	25227855-25342590	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 25.5;REH: 25.1;SH-SY5Y: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009469, HPA026588"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB009469: AB_2093990, HPA026588: AB_1847812"	"unprognostic (2.38e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (8.38e-2)"	"unprognostic (7.27e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-1)"	"prognostic favourable (1.18e-4)"	"unprognostic (2.35e-2)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-2)"	7.8	12.4	13.7	12.7	15.5	10.8	8.6	21.6	20.1	9.0	12.7	14.5	7.6	9.1	13.0	12.2	8.0	9.6	8.9	8.2	12.3	6.7	9.4	6.9	9.5	13.6	15.3	10.1	18.3	12.1	6.3	12.6	20.8	10.7	9.3	9.2	12.0	8.5	9.2	29.1	6.6	11.4	11.3	7.9	17.5	11.6	6.6	15.2	20.8	9.1	10.5	11.8	9.8	8.4	3.0	4.1	4.9	4.1	8.7	8.3	2.3	1.0	3.5	14.7	3.6	1.6	1.2	19.4	1.0	0.9	2.0	1.6	8.7	5.7	0.0	2.2	1.9	0.9	1.6	2.2	1.2	3.6	2.5	6.3	5.3	10.4	3.8	1.3	4.1	3.6	1.1	2.6	0.9	8.2	7.3	1.3	1.5	8.4	13.8	14.9	25.5	1.9	25.1	16.2	2.1	1.2	1.5	8.8	31.0	1.2	8.4	2.6	0.9	6.7	2.8	2.5	3.2	0.6	1.3	3.1	2.2	8.5	0.9	3.8	2.6	4.7	1.8	3.1	5.2	3.0	7.0	2.3	3.4	4.9	2.0	3.0	8.3	6.6	4.9	8.7	4.1	4.1	2.8	2.3	13.7	15.5	21.6	20.1	12.3	6.7	15.3	10.1	10.7	15.2
DNMT3B		ENSG00000088305	"DNA methyltransferase 3 beta"	Q9UBC3	20	32762385-32809356	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.7;testis: 23.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 55.9;CACO-2: 21.0;HEL: 22.0;K-562: 21.1;NB-4: 18.6;NTERA-2: 75.5"	"Cancer enriched"	"Detected in all"	25	"testis cancer: 111.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA001595, HPA001803, CAB069896"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: "	"unprognostic (7.65e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (5.04e-4)"	"unprognostic (3.42e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.18e-3)"	"unprognostic (8.60e-3)"	"unprognostic (8.48e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (1.87e-7)"	"unprognostic (6.62e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.55e-2)"	1.1	0.8	0.9	2.5	0.9	4.7	2.4	4.5	1.4	1.6	2.1	0.7	0.5	0.9	1.3	4.7	1.6	1.1	1.6	1.8	0.8	0.7	2.7	1.2	1.2	1.9	0.9	0.5	1.2	7.5	2.5	1.1	2.8	0.8	1.1	0.8	1.2	3.5	1.6	0.5	5.5	0.8	1.0	0.5	1.3	1.1	23.3	0.8	17.7	2.6	1.7	2.5	2.7	2.2	0.7	1.0	0.0	0.2	0.9	1.3	0.1	0.8	1.1	6.1	1.4	0.1	0.5	55.9	0.7	0.5	0.8	0.8	21.0	0.9	2.2	2.2	0.3	0.5	3.9	0.3	0.6	0.2	3.1	22.0	0.7	4.0	0.2	0.9	2.2	0.5	0.4	1.2	0.2	1.4	21.1	0.6	0.3	3.4	3.3	18.6	75.5	0.7	3.3	1.0	0.5	2.0	0.9	1.9	1.3	1.3	1.9	0.5	1.3	1.2	0.3	1.2	2.8	0.6	0.5	1.3	0.6	0.8	0.6	6.0	0.5	0.0	0.2	0.0	0.1	0.1	0.1	0.7	0.2	0.0	1.0	0.0	1.3	0.0	0.0	0.9	0.1	0.9	0.0	0.1	0.9	0.9	4.5	1.4	0.8	0.7	0.9	0.5	0.8	0.8
DOLK	"DK1, KIAA1094, TMEM15"	ENSG00000175283	"Dolichol kinase"	Q9UPQ8	9	128945530-128947619	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066767, HPA068706"			Enhanced	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA066767: , HPA068706: "	"unprognostic (6.35e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-2)"	"prognostic favourable (5.53e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (6.88e-5)"	"unprognostic (6.13e-3)"	11.0	20.2	7.9	7.8	13.8	1.4	9.5	7.0	18.6	9.8	8.6	14.9	7.1	8.8	12.4	16.8	10.9	10.8	10.8	12.0	7.6	9.9	17.5	22.0	10.6	10.6	8.1	6.7	13.2	16.9	19.2	8.0	19.5	16.3	12.3	8.0	14.2	15.5	12.8	7.9	11.4	10.9	11.1	5.9	11.6	12.4	22.4	6.0	12.5	11.0	11.9	12.1	10.4	7.3	9.4	14.2	5.6	16.4	9.8	13.7	9.0	5.1	19.1	6.8	10.0	20.1	10.6	9.2	10.7	17.4	13.2	9.8	15.0	8.1	2.8	5.7	15.5	36.4	9.2	13.4	6.8	4.7	8.1	3.5	13.1	10.8	20.3	3.8	6.3	14.6	12.4	14.2	7.8	12.8	8.5	4.5	14.2	25.2	3.1	3.2	8.7	11.9	3.1	9.0	11.1	11.8	7.7	6.2	7.0	14.2	11.7	6.3	20.5	5.0	10.6	11.9	4.3	14.9	8.8	4.3	10.7	2.8	11.2	3.5	9.0	2.3	13.5	5.6	10.2	13.3	9.1	9.4	9.2	11.2	14.2	9.2	12.1	12.3	2.1	9.8	16.4	8.1	13.7	9.0	7.9	13.8	7.0	18.6	7.6	9.9	8.1	6.7	16.3	6.0
DPAGT1	"ALG7, CDG-Ij, D11S366, DGPT, DPAGT, DPAGT2, GPT"	ENSG00000172269	"Dolichyl-phosphate N-acetylglucosaminephosphotransferase 1"	Q9H3H5	11	119096503-119108331	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053878	Approved									"HPA053878: "	"unprognostic (1.66e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.76e-1)"	"unprognostic (7.83e-3)"	"unprognostic (6.50e-2)"	"unprognostic (8.53e-3)"	"prognostic unfavourable (2.03e-5)"	"unprognostic (2.52e-1)"	"unprognostic (3.95e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.08e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.57e-2)"	13.0	20.0	6.8	9.7	6.7	5.5	10.0	5.2	9.3	13.2	13.1	8.5	13.0	11.0	10.9	12.0	14.5	11.6	11.3	8.3	5.9	5.8	12.5	53.0	10.0	6.9	7.5	3.6	11.6	32.1	18.4	5.8	12.5	7.4	10.6	11.1	8.1	26.3	13.6	8.0	6.9	15.3	10.6	6.4	12.2	11.9	5.4	8.0	7.7	11.8	7.2	12.4	16.1	8.3	10.1	16.4	9.2	14.4	7.6	11.8	8.0	5.5	14.0	4.9	15.1	18.9	11.3	6.7	10.1	10.6	6.8	10.2	13.7	23.5	11.8	16.0	14.4	18.0	13.7	18.4	7.8	6.5	7.5	21.0	4.5	16.7	15.6	13.3	10.5	14.5	15.4	18.5	25.8	15.8	13.0	22.9	15.3	17.6	3.2	8.1	5.6	15.7	5.4	6.7	16.5	17.6	13.1	6.6	6.7	7.4	24.9	4.1	33.5	5.5	8.0	16.9	6.4	7.5	5.3	3.3	8.7	3.8	3.2	17.1	13.1	9.2	14.4	1.4	9.8	13.2	11.8	10.1	7.5	9.7	16.4	7.3	6.0	6.0	1.4	7.6	11.5	15.2	6.7	8.0	6.8	6.7	5.2	9.3	5.9	5.8	7.5	3.6	7.4	8.0
DPH1	"DPH2L, DPH2L1, OVCA1"	ENSG00000108963	"Diphthamide biosynthesis 1"	Q9BZG8	17	2030110-2043430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069750, HPA073864"	Approved		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA069750: , HPA073864: "	"unprognostic (5.54e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"prognostic favourable (1.78e-5)"	"unprognostic (2.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.41e-1)"	16.6	22.9	17.6	19.0	22.7	10.3	17.0	38.6	26.5	17.8	17.1	17.2	21.1	17.0	22.2	17.0	17.9	29.0	22.6	20.2	14.1	13.1	21.4	32.7	15.7	22.7	17.0	21.6	25.2	29.4	28.4	42.9	17.3	15.4	26.1	13.3	21.3	25.7	23.9	33.3	29.0	17.3	18.9	11.4	17.8	18.4	19.5	19.9	17.5	21.0	25.8	19.0	17.2	16.0	11.3	9.3	0.7	6.8	5.6	12.0	5.5	9.0	15.8	4.3	10.6	13.6	9.9	11.9	11.9	17.9	20.3	13.2	15.1	7.4	17.6	15.4	35.2	7.2	14.5	13.4	11.0	4.6	33.3	4.1	7.4	9.0	12.9	5.1	6.7	14.9	13.7	16.2	13.2	9.1	13.8	7.2	7.9	11.9	9.0	3.3	4.0	16.2	10.4	3.1	13.6	9.0	5.6	8.2	9.5	10.8	12.2	11.9	17.8	4.2	6.3	14.2	6.5	17.4	10.7	7.2	5.0	4.3	13.9	7.0	4.9	0.0	4.6	0.7	9.5	6.8	10.4	11.3	7.8	8.6	9.3	9.5	12.0	8.7	0.3	5.6	4.6	6.7	10.4	5.5	17.6	22.7	38.6	26.5	14.1	13.1	17.0	21.6	15.4	19.9
DPM1	"CDGIE, MPDS"	ENSG00000000419	"Dolichyl-phosphate mannosyltransferase subunit 1, catalytic"	O60762	20	50934867-50958555	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA051818	Approved									"HPA051818: "	"unprognostic (2.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavourable (1.94e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.02e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.74e-1)"	32.3	39.7	20.2	23.3	30.0	32.9	29.0	22.5	35.1	31.1	28.1	21.3	28.9	24.0	29.9	32.9	36.0	25.6	24.0	38.7	22.2	21.5	41.7	54.0	24.2	33.0	21.6	17.2	30.8	38.9	21.2	35.1	43.9	31.4	29.8	28.9	22.8	35.9	31.5	44.7	27.1	35.6	24.9	21.1	38.6	30.4	25.6	21.7	36.1	34.5	49.1	36.4	35.3	28.3	20.7	25.0	22.2	19.6	20.3	25.1	15.7	34.6	14.1	21.8	13.0	19.0	21.6	23.9	13.8	15.8	26.7	21.1	63.5	28.2	21.2	30.1	17.8	39.9	17.4	32.7	27.2	10.1	13.9	22.0	18.3	42.7	27.1	34.8	13.2	18.5	48.3	18.5	19.3	20.3	33.1	26.9	26.5	15.3	31.5	36.8	22.3	32.2	17.5	31.9	28.0	26.6	21.1	16.4	17.9	35.6	52.6	46.0	35.8	41.3	16.8	34.3	28.5	20.1	28.3	19.2	24.3	30.4	37.8	23.3	15.5	12.2	16.8	18.6	19.0	19.6	23.0	20.7	21.8	20.3	21.9	19.3	23.7	25.1	22.2	20.3	18.9	25.0	21.0	15.7	20.2	30.0	22.5	35.1	22.2	21.5	21.6	17.2	31.4	21.7
DPP10	"DPL2, DPPY, DPRP3"	ENSG00000175497	"Dipeptidyl peptidase like 10"	Q8N608	2	114442299-115845752	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 15.6;brain: 30.3;pancreas: 23.4"	"Cell line enhanced"	"Detected in some"		"AF22: 5.0;HAP1: 7.5;HMC-1: 5.3;NTERA-2: 4.5;RT4: 8.0;SCLC-21H: 11.9;SH-SY5Y: 4.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048767	Uncertain									"HPA048767: "	"unprognostic (1.19e-1)"		"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"		"unprognostic (2.03e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.33e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.22e-2)"	0.7	15.6	13.4	1.1	15.9	0.9	0.9	1.9	30.3	1.3	3.6	7.9	0.0	2.4	1.4	0.8	0.8	0.9	1.9	0.8	17.5	9.9	1.1	0.9	1.0	0.7	7.1	21.3	0.9	23.4	0.7	1.5	1.8	10.8	0.8	4.6	0.0	1.0	0.8	0.7	0.9	2.4	1.9	12.7	0.7	1.5	2.1	10.3	0.0	1.6	0.0	0.8	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	8.0	11.9	4.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	15.9	1.9	30.3	17.5	9.9	7.1	21.3	10.8	10.3
DPP6	"DPL1, DPPX"	ENSG00000130226	"Dipeptidyl peptidase like 6"	P42658	7	153887097-154894285	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.7;endometrium 1: 24.5;thyroid gland: 24.1"	"Cell line enriched"	"Detected in some"	9	"NTERA-2: 11.0"	"Cancer enriched"	"Detected in some"	11	"glioma: 12.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050509	Enhanced	Supported								"HPA050509: "	"unprognostic (1.29e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.83e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.85e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.61e-3)"	"unprognostic (6.11e-2)"	1.6	7.2	15.4	1.4	32.5	1.3	1.5	26.6	45.7	2.3	6.8	8.7	0.0	1.6	24.5	3.1	1.5	4.6	1.3	1.4	26.6	15.2	3.6	1.2	2.2	1.3	14.0	22.7	1.3	4.0	1.2	4.9	1.3	18.8	1.5	2.4	0.4	1.3	8.1	4.6	3.7	2.0	15.8	7.2	4.2	3.5	7.9	10.0	0.0	24.1	0.0	1.2	1.3	0.4	0.6	0.6	1.9	0.9	0.9	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	11.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.9	0.4	0.7	0.4	0.6	0.7	0.6	0.6	0.4	0.4	0.6	0.7	0.7	1.6	0.9	0.9	0.6	0.5	0.3	15.4	32.5	26.6	32.4	26.6	15.2	14.0	22.7	18.8	10.0
DPYS	DHPase	ENSG00000147647	Dihydropyrimidinase	Q14117	8	104330324-104467053	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"kidney: 42.2;liver: 103.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.7;HSkMC: 2.4;U-266/84: 2.0"	"Group enriched"	"Detected in some"	21	"liver cancer: 57.6;renal cancer: 11.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024785	Enhanced					89000	89000			"HPA024785: AB_1847856"	"unprognostic (1.54e-3)"	"unprognostic (2.33e-1)"		"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.16e-4)"	"unprognostic (1.56e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-1)"	2.5	0.6	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.2	2.1	0.1	0.0	0.0	0.0	1.6	0.1	0.2	1.3	0.0	0.0	0.1	42.2	103.6	0.2	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.1	0.1	0.9	0.0	0.2	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.7	0.0	0.0	1.2	0.0	0.0	2.7	0.0	0.1	0.0	0.2	0.0	1.3	1.1	2.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	1.4	0.0	0.7	0.1	0.6	1.3	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.0	1.5	0.0	0.7	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0
DSE	"DS-Epi1, DSEPI, SART2"	ENSG00000111817	"Dermatan sulfate epimerase"	Q9UL01	6	116254173-116444860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA014764, HPA052151"	Uncertain		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA014764: AB_1856587, HPA052151: "	"unprognostic (1.28e-1)"	"prognostic unfavourable (3.36e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavourable (6.34e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-2)"	32.3	10.6	7.4	22.3	10.7	13.1	34.8	5.4	7.7	16.0	12.8	4.9	9.9	5.3	11.7	18.5	13.5	15.3	12.9	16.1	8.1	4.3	11.2	10.4	17.7	13.1	9.8	4.5	21.0	4.0	15.4	20.9	21.7	13.1	13.0	7.1	14.3	9.3	9.4	8.5	16.9	10.7	12.8	16.1	24.9	7.6	10.9	9.0	8.3	8.7	10.9	8.3	14.6	29.4	3.6	8.9	2.5	3.9	0.2	1.1	1.2	10.4	2.2	7.8	7.3	21.1	14.0	8.8	12.3	29.0	15.5	22.7	0.0	2.9	0.2	1.1	21.4	19.9	1.1	28.9	20.3	10.7	4.8	0.7	3.3	0.1	23.6	0.4	0.5	29.6	12.5	17.1	16.8	9.1	0.2	4.8	7.3	0.3	1.3	0.6	4.2	0.6	1.8	7.2	4.9	10.2	0.7	2.6	2.0	11.9	0.0	0.2	0.1	1.2	3.4	15.6	4.6	3.9	9.8	1.0	0.3	0.5	8.3	1.3	1.8	0.7	3.1	0.1	1.0	3.9	0.6	3.2	0.9	0.4	8.9	3.6	1.1	0.4	2.5	0.2	2.2	4.2	0.2	1.2	7.4	10.7	5.4	7.7	8.1	4.3	9.8	4.5	13.1	9.0
DSTYK	"DustyPK, KIAA0472, RIP5, RIPK5"	ENSG00000133059	"Dual serine/threonine and tyrosine protein kinase"	Q6XUX3	1	205142505-205211566	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044140	Uncertain		Uncertain	"Nuclear speckles,Intermediate filaments"				"Nuclear speckles, Intermediate filaments"		"HPA044140: AB_10965031"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (8.73e-5)"	6.4	9.2	13.8	4.4	13.3	19.6	8.2	20.4	16.4	8.4	6.5	6.8	4.2	3.3	10.5	7.4	6.7	9.2	5.4	5.7	10.7	9.0	9.3	2.5	7.3	5.4	8.1	11.8	14.0	5.9	22.0	11.0	7.1	12.2	7.2	4.6	9.2	6.2	8.8	14.6	14.0	4.8	8.8	11.0	7.0	5.3	11.5	9.2	7.1	8.4	3.6	5.3	7.6	6.4	3.5	3.1	9.8	3.5	4.8	5.1	1.6	6.8	4.5	4.8	5.8	7.0	11.9	3.4	8.6	8.6	9.0	6.2	2.0	3.8	5.1	2.6	14.5	4.9	5.2	5.5	9.2	2.4	5.7	9.2	5.9	2.1	6.3	2.6	4.9	7.0	8.4	9.2	8.8	6.6	11.9	3.4	7.1	4.7	2.0	2.3	5.2	5.4	1.8	8.7	4.4	6.0	4.3	2.7	5.2	7.3	7.6	24.1	5.6	3.4	6.5	5.6	5.7	8.5	5.7	3.5	2.5	3.0	6.6	3.6	20.1	9.8	3.5	6.0	4.6	2.5	4.3	2.7	3.4	3.8	3.1	3.5	5.1	3.7	5.1	4.8	1.8	2.3	2.0	1.6	13.8	13.3	20.4	16.4	10.7	9.0	8.1	11.8	12.2	9.2
DUOX2	"LNOX2, P138-TOX, P138(TOX), THOX2"	ENSG00000140279	"Dual oxidase 2"	Q9NRD8	15	45092650-45114344	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"	"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 151.5;gallbladder: 80.4"	"Cell line enriched"	"Detected in some"	8	"HaCaT: 11.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 60.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"basophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Low region specificity"	"Detected in some"														"unprognostic (3.19e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.63e-2)"	0.1	0.6	0.1	8.4	0.3	0.0	0.1	0.1	0.2	5.1	3.2	0.2	151.5	0.3	0.4	0.8	10.9	0.0	80.4	0.3	0.1	0.0	0.3	0.8	1.2	0.1	0.1	0.1	0.2	0.8	0.0	0.1	0.2	0.2	3.4	1.4	0.4	7.3	1.2	0.6	2.1	3.5	0.6	0.1	0.1	14.9	0.5	0.1	0.1	29.0	6.1	6.6	20.4	9.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.6	0.0	11.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.3	0.2	0.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347232-89353271	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 125.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 80.6;NB-4: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Group enriched"	"Detected in many"	11	"granulocytes: 125.0;monocytes: 79.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favourable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	37.7	7.5	7.2	15.9	11.7	41.3	24.1	3.4	14.7	11.6	12.4	6.2	5.8	6.1	9.8	8.7	12.0	15.4	25.1	16.2	10.5	6.5	17.1	38.4	28.2	13.3	6.9	7.4	7.5	12.2	15.0	13.7	19.7	7.9	17.4	15.3	44.4	64.3	6.3	12.0	8.5	14.6	11.3	7.1	28.4	10.3	4.8	6.4	6.1	21.0	13.3	17.8	15.2	6.9	1.2	9.2	125.0	79.7	1.2	0.9	32.4	1.1	1.1	24.0	80.6	20.8	17.7	0.0	8.7	11.1	1.7	1.3	7.0	1.2	0.0	2.0	3.7	9.3	0.1	21.6	2.5	0.1	0.1	3.6	0.2	11.2	14.7	15.5	39.5	3.4	7.6	15.3	14.3	40.1	0.0	3.8	5.5	0.5	0.5	57.8	14.6	19.7	39.3	3.0	1.5	24.8	23.3	0.4	17.1	0.2	0.1	45.9	1.2	8.6	10.7	5.9	0.1	1.1	4.1	0.6	3.1	0.0	24.5	10.9	37.4	125.0	49.5	22.4	0.9	79.7	0.4	0.2	0.2	0.3	9.2	1.2	0.1	0.3	22.5	1.2	74.4	1.2	0.6	32.4	7.2	11.7	3.4	14.7	10.5	6.5	6.9	7.4	7.9	6.4
DUX4		ENSG00000260596	"Double homeobox 4"	Q9UBX2	4	190173774-190185942	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 3.4"	"Cell line enhanced"	"Detected in some"		"A549: 2.4;U-2 OS: 3.6;U-266/70: 7.8;U-266/84: 10.1;U-698: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058451			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				"Nucleoplasm, Nucleoli"	"Golgi apparatus, Cytosol"	"HPA058451: "																		0.0	0.4		0.0		0.0	0.0		0.5	0.0	0.0			1.0	0.1	0.0	0.0	0.9	0.0	0.0			0.0	0.0	0.5	0.1			0.1	0.5	0.3		0.0		1.1	0.0		0.5	0.1	0.0	0.3	0.0	0.0		0.0	0.3	3.4			0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	2.4	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.6	0.0	0.0	0.0	3.6	0.7	0.0	7.8	10.1	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
DYRK1A	"DYRK, DYRK1, MNBH"	ENSG00000157540	"Dual specificity tyrosine phosphorylation regulated kinase 1A"	Q13627	21	37365573-37526358	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015323, HPA015810"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"				Cytosol	"Nucleoli fibrillar center"	"HPA015323: AB_1847922, HPA015810: AB_1847921"	"unprognostic (2.71e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.39e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.40e-2)"	20.0	18.5	19.2	23.4	20.0	49.7	19.9	31.6	24.6	23.7	23.0	16.3	17.6	15.4	24.4	18.7	16.8	19.4	19.0	23.2	18.8	17.9	16.9	16.1	24.8	27.3	15.5	17.8	25.7	17.8	31.0	25.1	25.0	14.0	17.6	18.1	18.5	18.7	22.7	39.8	20.1	18.7	22.7	13.8	24.1	18.5	23.5	16.3	60.9	22.7	17.4	22.1	22.7	29.3	3.0	3.3	6.0	2.5	1.3	3.8	0.8	10.2	8.0	16.3	11.5	7.8	8.5	14.5	9.1	11.7	9.3	9.8	11.4	9.0	13.8	6.2	16.0	7.0	11.9	8.9	10.9	21.1	5.1	40.8	13.3	6.9	11.7	16.1	15.0	8.6	10.6	12.0	18.5	9.6	15.4	32.0	9.6	10.3	21.1	11.0	17.3	4.8	27.4	9.0	12.7	9.7	13.4	16.9	9.4	20.8	14.3	14.3	13.4	15.0	12.3	12.7	3.8	7.9	7.6	21.8	16.9	19.8	10.1	18.2	13.8	5.5	1.5	2.0	3.4	2.1	2.1	2.8	3.6	2.6	1.8	3.0	3.8	3.7	6.0	1.3	2.5	3.3	3.1	0.8	19.2	20.0	31.6	24.6	18.8	17.9	15.5	17.8	14.0	16.3
DYRK1B	MIRK	ENSG00000105204	"Dual specificity tyrosine phosphorylation regulated kinase 1B"	Q9Y463	19	39825350-39834201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.1"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.1;SH-SY5Y: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028522, HPA028786"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA028522: , HPA028786: AB_10670831"	"unprognostic (2.22e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.67e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.22e-2)"	"prognostic favourable (8.83e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.88e-2)"	4.8	7.9	7.4	3.7	10.2	5.0	4.0	10.1	13.1	4.5	4.2	7.4	6.1	6.2	6.4	12.3	6.7	8.0	4.6	9.0	6.6	6.1	6.1	3.2	5.4	5.1	4.4	6.7	6.1	5.2	7.1	12.3	3.8	6.4	5.5	3.4	6.7	5.5	5.8	89.1	6.3	5.1	3.9	3.4	5.9	5.2	28.8	4.6	11.2	6.4	25.3	5.3	5.6	4.1	4.7	8.3	4.8	3.2	6.2	7.0	2.6	0.4	8.6	8.3	5.9	4.7	4.5	0.7	2.7	1.7	2.5	2.2	0.8	3.3	1.3	10.6	3.2	2.9	1.2	1.9	2.2	4.9	7.2	0.6	5.3	0.8	4.0	0.3	1.8	6.0	1.2	0.8	2.8	0.6	1.3	1.9	0.4	4.2	1.9	0.7	2.0	1.9	0.9	0.1	0.6	5.4	2.1	12.1	13.7	4.2	4.2	0.2	4.1	0.5	4.2	1.1	1.9	0.9	0.8	3.1	1.0	0.9	7.1	0.8	0.4	1.2	3.1	3.2	5.9	3.2	7.0	4.7	4.0	5.9	3.5	3.5	2.2	3.5	4.8	6.2	2.9	8.3	4.2	2.6	7.4	10.2	10.1	13.1	6.6	6.1	4.4	6.7	6.4	4.6
DYSF	"FER1L1, LGMD2B"	ENSG00000135636	Dysferlin	O75923	2	71453722-71686768	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 39.9;skeletal muscle: 53.3"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 32.4;LHCN-M2: 29.4;RH-30: 31.1;TIME: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 19.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 19.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002510, HPA017071, HPA021945"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"				"Plasma membrane, Centriolar satellite"		"CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928"	"unprognostic (1.04e-1)"	"unprognostic (7.66e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.97e-3)"	6.6	2.1	1.1	7.2	1.3	18.6	7.9	1.2	2.0	1.9	6.4	0.0	3.9	1.6	4.2	4.9	5.1	3.6	3.3	20.8	1.2	2.0	4.7	13.4	9.1	17.8	2.1	0.7	4.1	1.4	2.0	2.1	39.9	7.0	4.8	1.9	3.3	1.9	3.6	53.3	1.7	3.3	12.1	1.4	26.5	3.2	1.5	0.3	0.8	4.9	8.3	1.0	8.7	11.9	0.0	0.0	19.9	2.6	0.3	0.3	0.7	0.4	0.0	1.3	1.1	0.0	0.0	2.4	0.0	0.3	0.8	0.6	0.1	0.3	0.0	4.8	0.0	0.9	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.9	4.2	32.4	3.1	0.0	29.4	0.0	0.0	2.1	3.2	0.3	0.0	31.1	0.0	1.0	0.0	0.0	0.0	1.5	0.2	0.0	0.1	0.3	21.2	0.1	1.5	0.1	0.4	0.0	0.0	0.0	0.0	5.1	0.0	0.0	2.6	0.0	0.3	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	19.9	0.3	0.1	0.0	0.0	0.7	1.1	1.3	1.2	2.0	1.2	2.0	2.1	0.7	7.0	0.3
EARS2	"KIAA1970, MSE1"	ENSG00000103356	"Glutamyl-tRNA synthetase 2, mitochondrial"	Q5JPH6	16	23522014-23557731	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043289, HPA043633"	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA043289: AB_10963932, HPA043633: AB_10959901"	"unprognostic (3.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.20e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	"prognostic unfavourable (7.20e-4)"	"unprognostic (8.09e-2)"	"prognostic favourable (3.16e-6)"	"unprognostic (2.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.29e-2)"	8.4	19.0	11.0	8.5	19.0	2.7	13.6	13.4	16.8	11.1	10.0	10.8	12.7	6.4	11.4	10.2	10.5	13.1	7.8	14.9	10.9	11.9	14.5	18.3	7.3	8.1	9.9	14.0	12.0	18.9	32.7	10.9	12.4	10.3	11.3	11.0	8.8	16.4	11.7	17.3	11.1	6.9	8.3	9.3	7.6	9.2	12.6	10.4	6.3	14.5	9.0	11.0	8.6	16.9	3.0	6.2	0.5	5.5	10.6	7.9	3.3	8.1	16.4	7.7	12.4	5.4	7.8	9.4	9.0	6.9	11.2	9.4	11.9	8.2	11.3	9.3	8.3	9.1	29.1	16.6	10.7	4.5	14.1	6.5	10.1	20.2	8.7	7.2	8.2	8.3	9.9	10.0	14.2	5.0	20.3	6.0	7.9	17.1	7.2	5.2	20.4	5.7	12.9	8.9	21.7	14.1	7.0	13.8	10.1	7.1	13.4	7.2	18.1	8.2	4.0	8.8	7.8	9.7	11.4	11.0	10.4	9.1	9.0	10.1	13.0	0.0	2.8	0.3	4.2	3.6	7.9	3.0	4.7	4.3	6.2	3.0	4.6	4.5	0.5	10.6	5.5	4.5	3.4	3.3	11.0	19.0	13.4	16.8	10.9	11.9	9.9	14.0	10.3	10.4
EBP	"CDPX2, CHO2, CPX, CPXD"	ENSG00000147155	"Emopamil binding protein (sterol isomerase)"	Q15125	X	48521158-48528716	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase	"Cataract, Disease mutation, Dwarfism, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003130	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA003130: AB_1078717"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.36e-1)"	3.7	33.2	5.3	4.3	5.7	10.5	10.5	10.1	6.3	8.6	19.6	2.8	3.4	17.2	4.0	3.7	20.6	3.9	4.5	21.7	4.7	4.3	12.8	74.1	14.9	13.0	3.5	8.0	4.8	11.7	6.0	3.7	4.2	8.8	8.6	15.7	5.2	8.7	4.8	3.5	9.1	30.0	5.6	7.0	7.9	8.1	5.4	2.8	9.0	4.6	9.8	10.4	5.0	10.0	17.1	22.9	21.5	12.6	13.3	29.9	18.1	33.0	7.0	18.6	11.1	10.4	7.7	6.0	8.5	7.1	11.3	16.3	13.9	55.3	17.9	6.0	5.9	37.3	31.1	45.9	8.6	13.7	15.5	9.0	9.4	11.9	7.6	33.2	22.4	7.5	16.7	15.1	11.2	7.5	11.5	17.0	9.2	14.5	18.4	20.4	18.6	23.0	12.8	1.8	50.7	27.6	5.9	15.8	8.0	31.3	16.1	4.4	17.7	7.9	7.8	5.8	9.8	22.4	9.2	7.3	11.4	18.1	13.5	33.5	5.5	17.4	8.9	21.5	29.9	11.7	25.1	17.1	22.2	27.5	12.3	12.6	20.1	25.5	1.8	13.3	12.6	22.9	22.4	18.1	5.3	5.7	10.1	6.3	4.7	4.3	3.5	8.0	8.8	2.8
ECE1	ECE	ENSG00000117298	"Endothelin converting enzyme 1"	P42892	1	21217247-21345504	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 114.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 101.6;TIME: 90.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001490, HPA013616"	Enhanced					2100000	2100000			"HPA001490: AB_1078718, HPA013616: AB_1847963"	"unprognostic (7.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-2)"	44.0	49.9	10.3	18.7	14.5	17.3	33.7	3.6	15.6	29.5	27.5	19.2	11.2	12.4	24.0	10.5	15.6	19.1	23.0	30.9	12.4	8.0	14.9	41.8	30.1	14.4	13.9	13.4	34.2	42.1	114.4	21.6	27.0	14.6	27.9	14.6	26.5	14.7	11.4	15.2	14.8	23.2	24.1	13.2	23.5	18.9	19.1	14.7	9.5	23.2	10.7	19.1	34.2	37.0	4.6	2.0	21.5	7.5	1.0	6.1	4.2	13.6	9.2	11.8	5.9	17.1	18.2	6.8	20.3	35.5	11.1	10.2	6.6	42.0	4.9	51.2	20.5	5.8	4.8	9.7	9.7	12.4	4.0	7.1	14.2	5.3	22.8	1.0	1.8	9.5	11.4	17.1	8.5	101.6	1.4	2.6	9.4	2.8	2.0	1.6	3.6	7.2	2.5	6.8	7.1	17.3	2.5	4.0	9.8	20.2	11.9	8.8	8.5	2.9	90.1	25.0	12.2	11.0	11.7	4.1	6.9	5.7	52.0	2.4	30.2	0.1	5.8	2.2	2.2	7.5	3.3	4.6	4.6	3.5	0.5	3.1	3.1	1.9	21.5	1.0	5.2	2.0	6.1	4.2	10.3	14.5	3.6	15.6	12.4	8.0	13.9	13.4	14.6	14.7
ECEL1	"DINE, XCE"	ENSG00000171551	"Endothelin converting enzyme like 1"	O95672	2	232479827-232487828	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;ovary: 57.1"	"Group enriched"	"Detected in some"	6	"AN3-CA: 29.4;HeLa: 15.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 28.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA067560, HPA069756, HPA077424"	Approved	Supported	Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA067560: , HPA069756: , HPA077424: "	"unprognostic (1.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.96e-4)"	"unprognostic (7.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.24e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.68e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.45e-2)"	0.9	2.6	0.5	0.9	4.0	0.2	0.4	0.7	1.2	0.3	0.4	0.5	0.1	0.3	0.6	4.9	0.3	1.7	1.0	1.1	0.1	28.6	1.0	0.7	0.2	1.2	0.3	0.1	57.1	0.6	0.3	8.9	0.4	5.5	0.3	0.2	11.5	0.3	1.2	1.8	0.3	0.3	1.1	4.5	2.0	0.3	0.8	1.6	0.1	0.5	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.0	0.0	2.6	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.0	0.7	1.2	0.1	28.6	0.3	0.1	5.5	1.6
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362480-133373689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria		1500000	1500000	Mitochondria		"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (3.68e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (8.57e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	36.5	18.7	16.6	9.1	16.6	5.0	15.2	8.2	18.3	8.8	21.8	13.0	34.7	22.8	9.5	14.1	16.5	12.2	17.4	29.8	14.6	11.5	62.1	148.2	6.3	7.8	14.8	10.3	11.6	16.3	9.2	11.0	12.8	11.1	13.9	14.0	11.0	40.2	38.4	35.7	8.8	32.1	9.9	11.9	7.3	11.0	10.2	10.2	3.9	16.2	17.5	13.0	11.2	7.8	39.4	53.7	18.3	45.7	33.5	32.1	44.5	28.7	36.1	19.7	49.1	28.6	18.4	18.0	21.2	28.0	29.6	25.1	79.2	28.0	21.7	18.4	23.8	27.0	25.5	21.5	21.4	16.6	44.8	21.6	21.8	56.3	24.0	28.0	15.4	20.5	18.6	19.6	25.1	26.2	19.5	19.1	28.8	68.2	13.9	54.7	13.7	43.4	24.0	23.9	11.6	36.5	36.9	12.7	20.2	21.9	36.4	27.5	28.3	27.0	21.0	13.4	19.4	27.7	27.9	14.4	8.8	24.6	31.7	15.3	11.0	17.0	41.7	18.3	24.9	45.7	32.1	39.4	28.1	27.1	53.7	32.2	28.9	27.9	4.4	33.5	34.3	23.2	26.0	44.5	16.6	16.6	8.2	18.3	14.6	11.5	14.8	10.3	11.1	10.2
EGLN1	"C1orf12, HIFPH2, PHD2, SM-20, ZMYND6"	ENSG00000135766	"Egl-9 family hypoxia inducible factor 1"	Q9GZT9	1	231363751-231425044	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Congenital erythrocytosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 14.9;skeletal muscle: 46.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"neutrophil: 14.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022129	Approved									"HPA022129: AB_1848046"	"unprognostic (4.20e-1)"	"prognostic unfavourable (2.99e-7)"	"unprognostic (8.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.81e-2)"	4.9	4.2	4.4	1.4	4.5	0.8	3.5	3.6	4.3	3.0	3.3			3.9	3.1	2.6	3.5	2.3	2.9	7.0	4.4	3.5	5.2	7.2	1.6	1.6	4.1		4.1	4.4	5.5	2.1	4.4		2.6	2.8		2.3	3.5	46.9	5.6	3.9	2.8	4.1	3.0	2.0	1.3			2.8		1.8	2.5	2.7	0.6	0.7	14.9	1.4	0.7	1.1	0.3	13.4	12.9	4.1	7.9	10.9	7.6	4.6	6.6	9.7	9.2	12.7	9.4	10.7	4.0	11.6	9.4	6.8	5.8	7.7	16.4	5.8	14.7	1.9	5.3	8.0	7.8	9.5	2.7	6.0	7.1	6.2	7.7	12.0	9.1	7.6	8.7	2.6	2.3	3.5	4.9	7.2	5.0	5.7	4.9	11.7	4.8	4.2	11.2	8.2	10.7	21.8	5.7	27.3	14.2	10.8	5.9	10.7	12.4	18.9	11.5	3.6	15.0	3.6	15.0	4.1	0.6	2.5	0.7	0.9	0.5	0.6	0.8	0.6	0.7	0.6	0.9	1.1	14.9	0.7	1.4	0.6	0.6	0.3										
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 37.1;liver: 91.2"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced									"HPA036401: AB_10670165, HPA042021: "	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favourable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	4.1	1.2	1.2	1.7	1.4	0.1	1.5	0.5	1.2	1.7	6.4	0.8	0.4	5.2	1.0	2.0	2.9	0.8	3.0	3.2	1.2	0.9	37.1	91.2	1.9	1.0	1.7	0.7	0.8	2.5	2.7	0.9	1.3	2.1	1.7	2.6	8.3	2.7	0.4	0.7	1.1	9.9	1.0	1.4	1.7	2.4	0.9	0.9	1.4	2.1	1.7	1.2	1.8	1.0	1.5	6.0	0.2	2.2	2.7	2.7	1.1	8.2	3.5	1.0	0.0	5.2	4.5	1.1	4.0	1.2	2.6	2.9	15.1	5.2	0.0	15.7	3.9	4.0	0.0	3.3	5.5	11.0	3.7	5.8	0.9	15.2	3.4	0.7	0.1	6.3	4.3	2.6	2.4	3.8	3.8	4.3	5.0	4.3	0.1	3.4	2.1	4.4	0.0	7.0	0.3	10.8	4.7	3.1	4.5	7.8	4.5	7.2	16.6	6.8	1.8	1.7	2.6	1.3	0.3	1.2	3.7	0.3	0.5	2.6	2.8	0.2	2.2	0.0	1.6	2.1	1.0	1.5	1.1	2.4	6.0	0.2	1.6	2.7	0.1	2.7	2.0	2.4	1.4	1.1	1.2	1.4	0.5	1.2	1.2	0.9	1.7	0.7	2.1	0.9
EHMT1	"bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D"	ENSG00000181090	"Euchromatic histone lysine methyltransferase 1"	Q9H9B1	9	137618963-137870016	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060022			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA060022: "	"unprognostic (1.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"prognostic favourable (6.56e-4)"	"unprognostic (1.03e-1)"	"prognostic favourable (8.91e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (4.24e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.75e-2)"	16.6	18.3	16.4	23.2	22.3	24.9	17.1	23.7	20.4	16.3	20.7	21.6	20.4	17.1	22.0	13.0	17.9	18.5	20.0	12.1	12.8	9.6	12.7	14.9	14.9	25.0	27.8	12.1	21.4	13.6	15.1	16.2	17.9	18.6	16.9	12.4	19.1	16.5	18.0	23.1	17.3	17.9	21.5	12.5	22.1	16.4	30.8	21.5	22.3	18.9	11.0	22.2	19.2	15.7	20.0	19.0	25.0	13.7	13.1	15.6	6.9	11.0	22.1	24.8	22.9	10.5	10.9	20.7	14.6	9.2	10.7	8.7	14.4	13.8	33.8	14.2	11.0	23.7	14.8	15.9	8.5	18.9	10.5	14.3	22.1	9.2	9.2	21.7	17.1	9.8	11.2	12.9	12.6	17.5	21.4	11.7	7.6	25.5	25.4	10.8	24.1	14.7	32.7	21.3	19.5	8.9	20.3	21.9	17.8	27.7	19.5	6.3	21.9	17.5	16.4	12.6	13.1	19.3	13.8	7.5	20.8	27.8	9.3	11.6	13.6	13.6	13.7	16.3	15.6	11.7	10.0	13.3	13.5	13.3	10.4	20.0	13.3	11.8	25.0	13.1	12.0	19.0	11.1	6.9	16.4	22.3	23.7	20.4	12.8	9.6	27.8	12.1	18.6	21.5
EI24	"EPG4, PIG8, TP53I8"	ENSG00000149547	"EI24, autophagy associated transmembrane protein"	O14681	11	125569216-125584687	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 164.6"	"Cell line enhanced"	"Detected in all"		"HEL: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047165, HPA051029"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Golgi apparatus"	"HPA047165: AB_2679965, HPA051029: AB_2681317"	"unprognostic (2.04e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (9.28e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.01e-1)"	13.4	10.2	13.3	8.9	16.2	4.6	16.7	11.2	22.1	12.7	17.0	14.4	13.8	11.3	13.6	12.9	22.7	12.1	15.8	16.4	10.6	10.7	14.6	55.5	12.1	11.2	12.0	11.1	13.1	34.2	164.6	9.2	11.9	11.0	13.7	18.9	13.2	20.9	14.3	26.5	17.2	16.1	15.9	9.2	10.5	17.7	10.4	10.5	9.9	12.0	14.2	13.0	16.2	12.9	8.5	15.5	5.4	7.3	6.5	10.0	4.9	24.5	18.7	21.4	25.8	35.2	26.8	26.8	25.2	19.1	17.4	15.7	28.4	49.6	24.7	42.9	23.7	28.4	32.5	53.0	22.6	6.5	20.6	117.8	13.4	26.6	26.2	26.5	12.8	25.0	48.6	26.1	38.6	36.7	53.4	10.1	24.4	17.3	12.1	13.6	28.2	20.5	17.8	25.3	21.0	29.0	44.0	20.0	19.2	29.5	35.2	9.5	71.9	26.5	30.5	22.4	15.2	15.6	20.3	6.3	12.7	32.2	9.8	40.8	29.8	4.1	7.3	5.4	8.2	7.0	8.1	8.5	6.5	10.0	11.6	7.3	9.4	7.6	0.9	6.5	5.1	15.5	9.0	4.9	13.3	16.2	11.2	22.1	10.6	10.7	12.0	11.1	11.0	10.5
EIF2AK3	"PEK, PERK"	ENSG00000172071	"Eukaryotic translation initiation factor 2 alpha kinase 3"	Q9NZJ5	2	88556741-88627576	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Stress response, Translation regulation, Unfolded protein response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009204, HPA015737"	Approved									"CAB009204: AB_2230863, HPA015737: AB_1848062"	"unprognostic (7.25e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.03e-3)"	"unprognostic (9.32e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.25e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.90e-3)"	12.7	10.3	7.2	12.3	7.6	18.6	10.7	8.8	6.6	15.8	10.7	6.1	20.9	7.3	9.6	12.4	9.5	8.9	8.5	11.1	5.7	5.5	11.5	15.9	10.4	9.3	7.9	5.0	8.8	36.7	18.5	18.4	14.4	8.3	11.4	12.6	7.3	28.0	20.9	12.7	8.9	10.8	7.0	7.5	11.1	19.0	4.6	7.3	8.7	15.7	6.3	17.3	21.5	19.2	6.6	2.6	1.5	0.7	1.6	2.4	0.6	4.8	3.2	7.1	4.6	13.0	9.1	11.3	7.0	9.0	5.0	7.4	7.2	3.5	37.3	4.2	4.7	4.4	5.1	3.9	7.3	13.1	3.3	4.0	3.3	7.4	8.1	4.9	9.5	3.4	6.3	4.6	10.0	5.3	2.3	13.4	3.8	5.4	4.6	4.0	5.2	3.7	18.1	9.8	6.7	6.2	9.2	5.5	7.5	4.1	10.7	7.0	3.9	2.9	4.2	4.3	4.6	9.7	4.3	25.2	12.6	26.4	6.1	4.5	5.7	1.1	0.7	1.5	1.7	0.6	1.9	4.7	1.7	2.4	0.9	6.6	1.5	1.1	0.2	1.6	0.2	2.6	1.4	0.6	7.2	7.6	8.8	6.6	5.7	5.5	7.9	5.0	8.3	7.3
EIF2AK4	"GCN2, KIAA1338"	ENSG00000128829	"Eukaryotic translation initiation factor 2 alpha kinase 4"	Q9P2K8	15	39934146-40035591	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Activation of host autophagy by virus, Adaptive immunity, Antiviral defense, Cell cycle, Growth arrest, Host-virus interaction, Immunity, Neurogenesis, Stress response, Translation regulation"	"Activator, Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, tRNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.9;monocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011811	Approved		Approved	Cytosol				Cytosol		"HPA011811: "	"unprognostic (3.10e-1)"	"unprognostic (4.78e-3)"	"unprognostic (5.97e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.11e-3)"	20.7	16.5	20.2	19.4	27.3	20.2	36.0	22.4	27.3	16.8	16.3	13.6	17.1	12.2	35.7	17.9	17.8	18.1	19.4	18.2	19.5	20.5	15.4	22.7	22.5	16.6	18.6	14.2	20.1	21.5	20.3	34.7	20.5	17.6	22.0	14.6	17.9	16.7	20.3	20.4	20.7	12.2	24.3	14.6	16.1	16.4	11.5	15.1	17.7	24.1	10.6	15.9	27.0	14.4	5.0	32.9	4.2	9.3	3.8	4.5	2.4	13.8	6.6	11.9	17.9	19.6	33.0	11.3	19.5	22.4	16.0	15.8	9.5	6.0	7.3	10.2	26.5	14.8	15.9	23.6	22.4	34.8	7.9	15.7	12.3	11.4	16.8	9.4	10.9	26.0	16.2	15.2	27.5	22.3	11.6	7.0	31.5	4.6	7.8	13.0	7.3	14.9	9.5	16.5	12.1	19.9	9.4	6.2	9.6	13.9	8.5	12.1	11.9	16.3	23.6	21.4	16.2	10.7	12.6	9.7	17.4	2.3	15.0	13.0	29.8	4.2	5.8	4.0	3.6	6.7	3.1	3.5	4.0	4.1	8.4	5.0	4.5	4.2	1.7	3.8	9.3	32.9	2.7	2.4	20.2	27.3	22.4	27.3	19.5	20.5	18.6	14.2	17.6	15.1
EIF4A3	"DDX48, EIF4AIII, Fal1, KIAA0111"	ENSG00000141543	"Eukaryotic translation initiation factor 4A3"	P38919	17	80135214-80147183	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA021878	Supported		Supported	Nucleoplasm		73000	73000	Nucleoplasm		"HPA021878: AB_1848090"	"unprognostic (7.24e-2)"	"unprognostic (7.33e-3)"	"prognostic favourable (3.57e-5)"	"unprognostic (1.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (1.68e-5)"	"prognostic unfavourable (1.87e-4)"	"unprognostic (3.71e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.91e-3)"	27.3	37.0	19.6	23.6	21.5	71.7	22.0	20.3	19.8	24.2	23.8	16.9	19.2	16.2	24.9	18.0	41.5	29.4	17.1	24.2	17.8	12.3	24.5	20.3	21.6	25.4	16.8	19.7	37.5	16.8	17.1	21.9	38.3	13.1	24.7	20.9	14.7	22.1	31.2	19.8	31.2	18.6	18.5	13.7	25.5	20.4	35.1	19.3	30.7	26.9	26.4	30.6	28.9	25.8	38.7	80.4	33.1	41.9	30.2	38.9	48.3	47.5	42.7	28.2	20.9	21.7	13.3	24.7	25.3	18.0	35.9	28.9	45.5	22.3	43.6	17.0	22.1	31.8	38.7	27.0	40.0	16.1	40.5	27.3	33.8	49.0	21.4	49.1	28.6	20.3	13.9	30.0	24.4	29.3	36.3	28.3	21.2	36.4	44.3	25.0	30.3	39.6	36.7	57.2	34.4	17.5	40.8	39.4	21.5	34.8	68.1	29.2	44.5	33.1	20.1	22.3	28.6	32.8	39.8	24.8	21.4	80.5	18.0	31.1	22.8	25.7	41.1	33.1	26.7	41.9	34.5	38.7	34.5	30.8	50.3	31.6	32.0	30.7	24.4	30.2	32.9	80.4	38.9	48.3	19.6	21.5	20.3	19.8	17.8	12.3	16.8	19.7	13.1	19.3
ELAC2	"FLJ10530, HPC2"	ENSG00000006744	"ElaC ribonuclease Z 2"	Q9BQ52	17	12992391-13018187	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"	"Disease mutation, Primary mitochondrial disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019535	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA019535: AB_1848106"	"unprognostic (4.24e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (3.24e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.70e-2)"	20.3	35.9	15.2	17.2	23.5	13.8	18.6	16.9	30.0	17.5	21.2	24.6	17.9	15.8	22.1	13.1	25.9	19.5	19.6	28.1	14.2	14.3	23.5	34.8	14.2	19.4	18.2	19.5	20.3	24.5	27.5	14.0	21.2	20.5	20.7	25.1	19.4	19.1	26.2	49.2	20.7	18.7	26.6	15.6	25.5	22.8	29.5	17.1	28.1	20.7	20.1	25.9	23.0	16.3	19.9	23.5	9.4	20.4	24.0	25.1	20.9	20.2	32.2	22.4	24.9	17.9	17.5	13.6	22.2	17.9	36.3	24.4	25.9	10.8	36.7	24.2	21.1	27.4	40.5	25.7	36.3	19.0	40.8	21.4	25.2	17.0	13.3	18.3	29.7	15.6	21.9	28.2	26.3	25.4	29.3	11.2	27.5	18.0	32.3	18.3	18.5	21.6	22.7	38.2	23.0	20.5	18.2	11.5	16.8	28.2	18.4	11.4	18.3	8.0	24.7	44.9	14.9	17.7	32.6	7.0	13.0	14.8	17.8	19.6	16.3	9.4	14.7	9.3	21.4	20.1	23.0	19.9	20.7	21.3	23.5	17.4	21.5	19.2	2.2	24.0	20.4	13.3	25.1	20.9	15.2	23.5	16.9	30.0	14.2	14.3	18.2	19.5	20.5	17.1
ELOVL4	"CT118, SCA34, STGD2, STGD3"	ENSG00000118402	"ELOVL fatty acid elongase 4"	Q9GZR5	6	79914812-79947580	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Ichthyosis, Mental retardation, Neurodegeneration, Spinocerebellar ataxia, Stargardt disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 92.6;skin 1: 41.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 21.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 19.1"	"Lineage enriched"	"Detected in single"	191	"T-cells: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.67e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.08e-6)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (6.27e-4)"	1.2	2.6	6.0	1.6	8.8	0.6	4.7	16.0	15.5	2.2	1.4	2.3	0.2	1.1	2.8	1.6	11.0	0.9	2.2	0.9	8.4	10.4	1.9	0.6	0.7	0.9	6.3	4.8	2.3	1.0	10.7	7.6	2.2	19.3	4.7	1.6	15.5	3.0	2.3	0.7	41.9	1.3	3.2	3.5	1.0	1.0	5.8	2.3	92.6	2.0	4.4	2.2	1.8	2.6	0.0	0.0	0.0	0.0	0.0	19.1	0.6	0.0	0.6	7.5	8.3	6.3	6.1	1.1	3.8	4.2	3.3	7.2	1.0	0.0	0.0	0.7	5.2	0.7	9.7	5.4	2.4	0.0	12.6	0.3	1.6	0.0	5.8	2.9	1.2	4.9	2.0	3.3	3.4	5.3	0.0	0.0	6.9	1.3	21.5	0.0	7.2	3.9	0.0	10.8	0.0	0.1	0.0	9.9	2.9	4.1	6.6	1.1	2.6	0.2	0.5	1.5	2.9	2.2	2.9	5.0	10.0	0.0	3.5	0.0	2.2	0.0	0.0	0.0	1.8	0.0	19.1	0.0	2.6	3.1	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.2	0.6	6.0	8.8	16.0	13.5	8.4	10.4	6.3	4.8	19.3	2.3
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB017042: , HPA047752: , HPA054197: "	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavourable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavourable (6.80e-4)"	"unprognostic (2.76e-2)"	75.7	48.7	17.9	24.2	22.0	33.9	78.8	13.3	22.1	18.2	13.9	38.3	91.2	9.7	15.7	18.0	10.8	16.5	18.0	14.6	18.3	17.5	13.5	36.8	24.4	33.6	41.1	12.3	13.1	5.7	8.1	11.6	13.6	26.4	45.2	6.7	16.1	9.4	88.4	3.6	11.4	17.3	18.0	46.4	18.5	9.5	34.8	29.1	28.7	17.6	5.6	33.6	16.6	19.4	23.8	18.1	60.7	11.3	8.4	25.3	10.4	25.5	18.7	32.8	59.9	87.1	50.6	14.0	29.9	33.6	24.2	34.0	16.5	29.7	29.1	21.7	31.0	15.2	32.3	27.3	36.3	24.5	22.7	28.7	17.4	23.0	47.9	22.6	21.0	46.7	21.5	24.2	30.4	26.8	35.8	16.9	17.4	2.8	67.2	20.1	17.7	14.3	26.2	22.5	10.1	45.5	15.3	30.6	21.1	24.7	12.9	25.0	29.5	21.2	25.4	26.6	23.6	47.3	39.3	14.3	13.1	22.1	13.8	33.0	18.8	9.0	11.3	40.7	8.8	8.1	14.2	21.6	14.7	10.6	18.1	23.8	7.2	6.7	60.7	8.4	9.6	4.8	25.3	10.4	17.9	22.0	13.3	20.2	18.3	17.5	41.1	12.3	26.4	29.1
EMC1	KIAA0090	ENSG00000127463	"ER membrane protein complex subunit 1"	Q8N766	1	19215664-19251552	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048904	Approved					5600	5600			"HPA048904: "	"unprognostic (9.46e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.31e-3)"	"prognostic unfavourable (8.56e-6)"	"unprognostic (5.98e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.19e-2)"	"prognostic unfavourable (1.43e-4)"	18.9	15.2	13.5	12.8	28.3	9.3	14.4	19.7	37.5	15.7	14.6	21.8	9.7	10.0	19.6	16.1	16.1	14.6	13.5	18.2	12.6	15.5	13.5	20.5	14.6	10.1	13.6	15.7	19.0	13.1	24.4	20.0	31.4	22.8	16.1	16.9	14.8	18.7	13.8	27.0	13.5	12.0	22.0	12.4	12.2	13.5	15.2	12.7	12.1	16.6	10.5	13.9	13.4	14.4	5.7	10.9	3.2	10.8	18.3	8.3	7.2	13.6	12.3	14.0	36.3	22.6	17.7	27.3	22.2	20.9	30.8	30.6	12.9	31.7	12.2	29.4	34.0	15.5	19.4	24.8	36.0	10.3	10.1	14.7	16.8	15.2	16.5	18.7	17.7	18.7	16.2	36.4	30.3	25.9	18.0	18.5	23.7	7.8	7.6	9.2	8.4	11.6	11.4	17.3	21.3	12.5	6.3	17.3	11.9	24.3	12.8	18.4	14.0	11.8	22.8	27.9	18.3	21.2	25.2	10.3	21.7	15.9	26.5	24.7	37.2	3.2	10.8	2.6	7.5	8.1	8.3	5.6	7.4	8.3	10.9	5.7	7.5	7.5	0.4	18.3	10.0	5.2	5.1	7.2	13.5	28.3	19.7	37.5	12.6	15.5	13.6	15.7	22.8	12.7
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"skeletal muscle: 638.2;tongue: 320.3"	"Group enriched"	"Detected in many"	4	"HDLM-2: 70.1;HeLa: 30.0;HMC-1: 29.6;RH-30: 48.2;RPMI-8226: 25.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"		100000000	100000000	"Plasma membrane, Cytosol"		"HPA000793: AB_1078742, HPA068284: , HPA068721: "	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.6	0.3	0.2	0.6	0.2	0.7	0.5	0.6	0.2	0.2	0.4	0.0	0.1	0.8	0.4	8.5	8.6	0.4	0.1	38.3	0.2	0.1	0.5	5.0	0.4	0.5	0.2	0.0	0.4	0.3	0.3	0.5	0.2	0.1	2.1	0.1	1.2	11.8	0.1	638.2	0.3	0.7	0.4	0.2	0.8	0.4	0.5	0.0	0.6	4.8	320.3	10.5	0.3	0.3	13.3	21.0	27.1	24.8	18.5	23.3	36.0	2.8	6.2	2.8	2.6	2.4	0.6	6.8	5.0	0.6	0.3	0.3	3.0	1.9	5.2	6.8	0.4	3.6	1.0	0.4	0.2	70.1	5.7	5.1	30.0	4.4	0.9	1.5	29.6	4.1	1.0	0.5	1.0	0.3	2.3	9.7	1.5	1.5	1.8	6.2	3.6	2.6	8.3	48.2	25.2	0.7	1.9	1.8	6.8	3.2	2.8	3.6	2.5	1.6	1.5	3.0	5.5	1.3	3.7	6.9	3.8	4.3	1.7	5.0	2.9	13.5	15.6	27.1	21.8	22.5	14.7	13.3	18.7	20.3	21.0	11.1	12.3	19.7	19.7	18.5	24.8	16.6	23.3	36.0	0.2	0.2	0.6	0.2	0.2	0.1	0.2	0.0	0.1	0.0
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 22.6;LHCN-M2: 13.5;U-138 MG: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"	2500000	2500000			"CAB032904: AB_2099635, HPA062066: "	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.28e-3)"	17.2	2.1	0.5	1.9	0.5	0.0	30.5	0.6	0.4	8.5	2.8	1.6	8.3	1.1	25.7	7.1	1.5	6.4	2.6	1.9	0.5	0.7	10.9	19.4	2.0	0.7	1.1	0.0	7.3	17.5	22.2	27.0	28.9	0.8	3.3	1.2	13.4	5.4	6.5	2.1	1.7	2.6	6.8	2.0	1.2	1.7	4.6	0.3	2.0	13.2	6.9	1.4	3.2	7.7	0.6	2.2	1.4	0.3	4.6	1.7	0.1	0.0	0.8	0.8	0.0	22.6	3.5	0.0	5.8	6.0	2.3	6.3	2.5	0.7	0.0	0.5	3.7	0.0	0.8	0.1	9.7	0.2	1.1	0.0	0.7	7.5	0.7	0.0	2.7	5.8	0.2	6.2	0.2	2.7	0.0	1.2	13.5	1.6	0.0	0.0	5.1	0.8	0.0	6.6	0.1	0.1	0.3	2.2	0.0	0.1	0.8	2.6	2.5	0.0	1.8	18.1	0.6	1.2	5.7	2.2	0.0	0.0	8.3	0.0	2.2	1.4	0.2	0.3	0.3	0.2	1.7	0.3	0.3	0.3	2.2	0.6	0.3	0.3	1.0	4.6	0.3	0.3	0.2	0.1	0.5	0.5	0.6	0.4	0.5	0.7	1.1	0.0	0.8	0.3
ENTPD1	"ATPDase, CD39, NTPDase-1, SPG64"	ENSG00000138185	"Ectonucleoside triphosphate diphosphohydrolase 1"	P49961	10	95711779-95869695	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 59.4"	"Group enriched"	"Detected in some"	7	"HDLM-2: 56.0;Karpas-707: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 37.4"	"Low lineage specificity"	"Detected in many"											"CAB002494, HPA014067"	Enhanced		Uncertain	Microtubules				Microtubules		"CAB002494: AB_563557, HPA014067: AB_1848178"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.67e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (5.33e-5)"	"unprognostic (9.79e-2)"	"unprognostic (2.30e-1)"	"prognostic favourable (7.89e-4)"	"unprognostic (5.09e-2)"	10.4	7.5	7.4	16.2	8.4	15.6	8.8	7.6	6.9	18.9	12.7	13.1	8.7	5.8	59.4	12.8	13.2	15.6	22.2	6.8	7.4	7.4	6.2	3.9	14.8	14.5	8.5	4.9	10.3	2.8	3.0	4.3	24.0	9.9	14.7	9.1	10.8	6.7	12.7	3.3	5.5	12.2	37.2	17.9	25.3	7.5	5.4	7.2	3.5	13.4	12.5	21.1	25.2	12.4	6.0	11.8	37.4	15.2	0.5	5.1	4.6	0.1	0.3	0.9	0.8	0.0	0.0	0.5	0.5	0.4	0.0	0.0	0.5	0.1	1.0	0.6	0.0	0.2	0.0	0.0	0.0	56.0	0.7	0.6	0.4	0.7	0.0	1.5	0.2	0.0	0.0	0.2	0.0	7.4	0.6	46.0	0.0	0.6	0.4	1.5	0.6	0.2	2.3	0.3	0.7	0.5	0.2	0.7	1.0	0.3	1.1	0.7	0.5	1.6	0.8	0.4	0.2	0.6	0.6	6.6	0.9	0.0	0.6	3.1	0.2	0.1	15.2	37.4	0.1	10.7	0.3	6.0	0.6	0.3	11.8	4.6	0.1	0.1	26.7	0.5	2.4	0.7	5.1	4.6	7.4	8.4	7.6	6.9	7.4	7.4	8.5	4.9	9.9	7.2
EOGT	"AER61, C3orf64, FLJ33770"	ENSG00000163378	"EGF domain specific O-linked N-acetylglucosamine transferase"	Q5NDL2	3	68975214-69013961	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019460	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"			"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA019460: AB_1844628"	"unprognostic (2.62e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.96e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavourable (8.97e-5)"	"unprognostic (7.41e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	14.9	5.8	3.4	10.1	4.4	3.0	11.9	2.5	4.8	16.8	12.1	4.4	10.2	4.8	23.3	10.4	15.1	11.4	18.1	18.2	3.9	3.6	6.6	5.5	15.8	9.6	4.2	5.0	12.7	7.8	3.9	5.5	15.2	5.1	18.9	5.8	8.7	14.0	24.0	28.0	6.1	7.7	29.4	4.9	10.2	10.1	7.4	2.4	8.3	5.4	14.2	7.3	27.0	9.8	1.7	3.4	5.5	2.2	3.3	9.2	1.8	8.1	2.7	5.4	6.5	7.6	14.9	3.9	11.0	13.5	7.0	9.3	3.7	4.6	0.4	1.7	11.9	2.7	3.7	14.3	8.8	26.3	2.6	8.4	6.2	5.2	8.4	4.7	3.5	12.4	12.2	9.0	11.5	38.4	2.3	5.0	23.4	2.1	0.7	1.5	6.2	1.3	0.3	5.6	3.5	6.0	18.7	0.5	3.0	12.6	1.0	10.0	2.8	6.5	20.3	19.7	6.0	2.2	10.6	2.5	8.3	4.0	7.8	7.3	11.0	5.5	2.2	0.0	3.0	1.9	3.5	1.7	4.8	6.4	3.4	1.2	4.1	4.1	0.3	3.3	0.7	0.6	9.2	1.8	3.4	4.4	2.5	4.8	3.9	3.6	4.2	5.0	5.1	2.4
EP300	"KAT3B, p300"	ENSG00000100393	"E1A binding protein p300"	Q09472	22	41091786-41180079	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000146, HPA003128, HPA004112"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000146: AB_2533138, HPA003128: AB_1078745, HPA004112: AB_1078746"	"unprognostic (7.67e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.54e-2)"	"prognostic favourable (7.45e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	16.8	14.8	19.1	13.9	15.5	45.3	14.5	33.0	20.6	14.8	16.8	15.6	18.9	11.1	18.1	11.6	16.8	15.7	16.5	10.7	16.6	8.3	11.5	12.2	14.1	12.9	16.9	12.7	20.2	15.7	26.4	14.5	27.7	13.8	13.2	12.2	12.3	15.3	17.9	19.5	18.2	17.4	13.8	12.7	15.9	14.7	20.6	18.6	29.3	16.9	10.9	14.1	18.7	22.5	4.3	4.4	9.8	3.9	5.7	3.9	2.3	15.5	11.2	19.0	11.8	12.1	13.0	17.0	7.5	10.9	11.3	10.8	14.2	5.7	16.2	6.6	14.8	12.5	27.4	10.3	12.5	15.8	18.2	12.2	12.8	11.1	13.7	28.8	13.8	12.7	10.8	16.3	13.6	12.5	12.8	22.3	8.9	5.7	8.3	9.0	13.7	7.8	17.1	8.9	10.1	10.7	20.7	6.1	6.4	26.6	13.6	13.0	9.6	16.8	16.1	11.3	13.7	8.0	10.6	15.3	7.2	25.3	8.3	8.9	10.7	5.0	3.2	3.0	3.7	3.9	3.2	4.3	3.6	3.9	4.4	2.9	3.1	2.6	9.8	5.7	2.1	3.0	2.6	2.3	19.1	15.5	33.0	20.6	16.6	8.3	16.9	12.7	13.8	18.6
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.7"	"Cell line enhanced"	"Detected in many"		"HEL: 39.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"cerebellum: 375.3"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		3400000	3400000	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: , HPA028096: , HPA028412: , HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavourable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favourable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavourable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	9.2	9.6	3.3	19.4	10.2	28.0	9.6	59.7	11.6	8.2	12.4	2.0	9.8	9.3	10.5	5.7	10.8	5.5	7.9	7.5	3.3	4.8	10.0	13.2	11.0	25.4	3.9	3.0	12.3	10.4	9.1	9.0	8.7	10.3	8.3	12.5	14.6	10.1	10.8	15.0	8.9	14.6	9.2	5.8	13.5	14.0	7.9	6.9	42.2	8.1	8.8	19.8	11.3	12.4	9.9	3.0	30.1	2.1	5.7	15.9	7.7	7.3	1.7	18.3	8.6	1.5	0.2	6.1	1.8	2.8	2.3	2.9	4.9	8.8	13.6	4.9	2.5	3.3	22.8	1.7	2.5	24.5	7.0	39.0	5.5	7.9	2.8	13.2	26.0	0.5	5.4	2.2	3.9	4.0	36.7	10.8	0.0	2.5	21.4	8.6	19.2	2.8	32.9	8.0	19.5	2.2	9.3	24.7	18.3	5.7	5.4	12.4	4.1	5.1	0.3	0.1	3.8	3.6	3.8	16.3	21.1	24.3	3.5	13.6	2.0	17.2	2.1	12.6	8.5	0.7	9.6	9.9	12.4	9.3	2.4	9.3	14.8	8.9	30.1	5.7	0.8	3.0	15.9	7.7	3.3	10.2	59.7	11.6	3.3	4.8	3.9	3.0	10.3	6.9
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107524-89482134	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 39.0"	"Cell line enriched"	"Detected in some"	6	"AF22: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"			"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	9.7	1.1	2.3	1.7	4.5	0.2	5.1	1.3	8.7	12.3	5.8	0.6	1.4	2.2	13.9	1.3	6.3	2.6	17.2	10.0	2.2	2.5	1.5	4.4	2.7	3.0	2.5	3.4	4.2	2.8	1.2	3.4	17.5	11.9	39.0	5.9	5.4	3.8	6.8	1.7	1.7	3.5	17.3	2.9	1.2	3.7	1.3	2.0	0.0	16.3	6.0	3.0	11.8	12.2	0.3	0.1	0.5	0.1	0.3	0.2	0.0	0.0	0.0	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.8	0.0	0.0	4.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	2.3	4.5	1.3	8.7	2.2	2.5	2.5	3.4	11.9	2.0
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 22.8;HUVEC TERT2: 31.1;TIME: 30.7;U-251 MG: 26.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	290000	290000	"Plasma membrane"	Nucleoplasm	"CAB013647: , HPA071200: "	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favourable (4.98e-4)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.7	2.9	3.4	15.4	5.4	0.9	2.5	1.9	8.2	3.8	23.9	16.2	4.6	21.6	2.5	3.2	1.1	5.4	4.4	5.4	5.6	6.5	3.5	1.1	3.0	5.5	12.7	3.8	17.9	5.4	6.1	5.4	12.0	8.2	3.3	25.0	2.2	6.6	4.0	0.7	1.8	22.6	4.0	12.1	3.3	2.3	2.9	9.3	0.1	8.4	1.0	2.1	5.3	3.3	0.1	0.6	0.3	2.5	0.1	0.1	0.4	16.7	7.1	6.8	10.9	0.6	0.6	0.0	3.9	0.2	11.8	2.5	2.4	6.7	0.2	8.4	1.7	15.8	4.6	22.8	3.1	0.0	1.6	0.0	0.7	0.0	7.1	0.0	1.7	2.3	7.3	21.1	0.1	31.1	0.6	0.0	2.3	2.5	0.3	0.1	1.6	4.6	2.0	7.0	0.3	5.8	1.6	7.4	7.8	6.8	0.2	0.1	0.4	0.2	30.7	4.7	12.4	11.9	26.8	0.0	0.1	0.0	8.8	0.3	0.1	0.3	2.5	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.4	3.4	5.4	1.9	8.2	5.6	6.5	12.7	3.8	8.2	9.3
EPHB4	"HTK, Tyro11"	ENSG00000196411	"EPH receptor B4"	P54760	7	100802565-100827521	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.6;neutrophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013537	Uncertain					1000000	1000000			"CAB013537: "	"prognostic unfavourable (8.56e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (4.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.51e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavourable (8.84e-4)"	14.0	20.7	1.8	4.2	2.9	2.2	17.1	1.9	3.0	29.1	9.5	2.9	14.6	4.1	28.8	10.3	11.0	13.1	35.0	19.0	3.4	1.1	16.8	29.8	16.5	12.0	2.2	0.9	24.6	11.6	5.6	3.1	35.5	3.2	13.7	5.4	11.6	10.8	14.7	5.1	14.2	7.0	12.4	2.2	50.5	8.6	12.2	2.1	2.3	10.2	13.1	7.0	7.7	21.5	0.0	1.6	7.4	3.6	0.0	0.0	1.2	12.5	11.1	11.1	32.2	7.1	4.6	32.9	4.9	10.7	7.7	10.1	9.1	9.6	1.6	22.4	5.0	13.1	4.8	12.9	4.1	2.0	8.9	0.4	6.4	14.1	4.1	0.2	0.3	5.4	19.5	4.9	11.4	28.7	23.6	0.6	6.2	21.8	0.2	4.9	19.0	16.7	17.0	5.5	2.9	9.8	6.6	0.0	9.6	7.5	3.5	7.3	8.9	2.2	24.1	9.6	15.3	17.7	7.2	0.1	0.2	0.5	1.4	4.1	17.4	0.0	3.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	7.4	0.0	0.2	0.3	0.0	1.2	1.8	2.9	1.9	3.0	3.4	1.1	2.2	0.9	3.2	2.1
EPHX1	EPHX	ENSG00000143819	"Epoxide hydrolase 1"	P07099	1	225810092-225845563	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 156.4;liver: 265.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 153.8;SiHa: 73.1"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 1047.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020593, HPA048847"	Enhanced					83000	83000			"HPA020593: AB_10601373, HPA048847: AB_2680538"	"unprognostic (2.85e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.92e-2)"	"prognostic favourable (7.02e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.32e-4)"	"unprognostic (8.10e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.88e-2)"	39.5	156.4	16.8	5.7	20.1	3.4	31.3	8.3	25.1	31.3	12.6	28.7	15.3	16.6	21.8	15.7	24.9	26.2	17.8	11.5	16.3	11.2	36.8	265.0	24.1	6.9	17.1	14.5	45.6	85.0	39.5	14.0	5.4	23.6	25.9	8.4	27.3	26.3	21.3	16.4	8.8	9.6	18.6	10.7	8.3	12.1	22.7	12.6	3.6	24.9	15.6	14.9	20.9	32.3	0.5	2.2	0.5	6.6	1.4	1.3	2.3	4.4	42.3	1.6	15.6	153.8	16.0	3.4	5.1	6.4	3.7	5.2	8.7	45.0	0.1	19.3	19.2	4.9	4.6	2.4	1.5	0.9	8.0	3.1	17.9	48.8	16.7	1.9	1.8	15.0	5.6	10.5	1.0	2.7	2.2	3.9	6.6	5.1	1.9	3.6	9.1	11.9	4.1	2.0	12.8	11.1	27.9	14.6	1.9	73.1	26.2	6.7	19.4	5.7	8.1	6.3	5.1	8.5	8.1	1.3	6.7	0.5	9.5	2.1	8.3	0.0	6.6	0.2	0.5	1.9	0.9	0.3	0.9	0.5	1.5	0.5	1.3	1.0	0.5	1.4	0.8	2.2	0.7	2.3	16.8	20.1	8.3	25.1	16.3	11.2	17.1	14.5	23.6	12.6
EPM2A	"LD, LDE"	ENSG00000112425	"EPM2A, laforin glucan phosphatase"	O95278	6	145382535-145736023	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease mutation, Epilepsy, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA053643, HPA055468"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA053643: , HPA055468: "	"unprognostic (2.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.28e-1)"	"prognostic favourable (4.08e-7)"	"unprognostic (4.12e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	5.4	6.0	8.8	1.9	9.0	2.2	3.6	4.0	8.9	3.9	11.1	8.6	2.5	3.4	4.8	4.8	8.9	4.3	3.9	19.4	9.6	8.7	8.0	5.7	3.5	3.4	11.9	5.5	5.9	2.9	5.5	3.3	2.0	9.6	6.2	3.4	5.6	3.1	9.2	60.9	2.4	3.3	13.9	13.6	2.5	4.6	3.3	7.1	3.7	4.2	15.7	2.9	10.4	6.0	1.4	1.0	0.3	1.4	5.4	2.4	1.0	1.1	1.7	3.2	6.2	8.0	2.5	1.4	2.9	3.4	2.7	3.4	1.5	1.6	19.9	2.5	3.5	1.7	1.2	1.2	2.5	7.7	1.6	3.2	2.3	2.5	4.9	11.0	2.0	2.0	6.6	1.6	0.5	1.9	1.4	5.1	3.4	2.6	7.3	2.4	3.3	1.7	4.2	2.9	5.8	2.4	1.6	6.0	5.9	5.2	3.1	6.8	1.8	6.4	4.2	2.8	1.3	2.6	2.3	3.7	3.7	8.0	2.4	2.7	4.3	0.0	0.1	0.1	0.4	1.4	1.1	1.3	1.1	0.9	1.0	1.4	1.2	2.4	0.3	5.4	0.3	0.9	0.2	1.0	8.8	9.0	4.0	8.9	9.6	8.7	11.9	5.5	9.6	7.1
EPX	"EPO, EPP, EPX-PEN"	ENSG00000121053	"Eosinophil peroxidase"	P11678	17	58192737-58205174	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 27.2;lymphoid tissue: 15.5"	"Cell line enriched"	"Detected in some"	69	"NB-4: 72.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	41	"eosinophil: 5.5"	"Lineage enriched"	"Detected in single"	41	"granulocytes: 5.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA076792	Enhanced									"HPA076792: "	"unprognostic (5.67e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.34e-3)"	"unprognostic (4.83e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.71e-4)"	"unprognostic (7.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.73e-1)"	0.1	0.1	0.3	0.2	0.8	27.2	0.1	2.0	0.6	0.1	0.1	0.5	0.1	0.1	0.4	0.1	0.1	0.2	0.1	1.4	0.3	0.3	0.1	0.2	4.2	0.4	0.2	0.1	0.2	0.1	0.0	0.3	0.2	0.6	0.1	0.0	0.1	0.3	0.1	0.1	0.5	0.1	0.1	0.2	4.5	0.1	0.1	0.1	15.5	0.1	0.1	0.1	0.1	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	2.0	0.6	0.3	0.3	0.2	0.1	0.6	0.1
ERBB3	"HER3, LCCS2"	ENSG00000065361	"Erb-b2 receptor tyrosine kinase 3"	P21860	12	56076799-56103505	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 31.1;MCF7: 20.3;RT4: 24.3;SK-BR-3: 28.6;SK-MEL-30: 38.1;T-47d: 31.7;WM-115: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.3"	"Low region specificity"	"Detected in many"							"CAB025331, HPA045396"	Uncertain		Approved	"Plasma membrane,Actin filaments"	"Secreted - unknown location"	420000	420000	"Actin filaments"	"Plasma membrane"	"CAB025331: , HPA045396: "	"unprognostic (2.97e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.07e-2)"	1.1	1.4	11.6	12.6	16.5	0.6	26.8	2.0	16.7	6.8	40.5	40.3	12.0	37.7	2.8	7.5	29.4	5.7	22.9	3.4	18.6	9.0	16.5	33.9	13.4	0.5	23.5	9.3	0.9	21.5	11.4	1.0	15.4	14.9	16.8	29.7	5.5	36.8	22.3	1.1	30.7	41.3	3.2	27.4	0.5	32.9	1.2	23.8	0.0	4.5	7.4	8.5	11.8	14.4	0.9	0.7	5.3	0.6	1.2	1.2	0.2	10.1	0.6	0.8	0.3	0.0	0.0	16.5	0.8	1.9	1.1	1.1	5.5	18.3	0.0	0.2	0.2	8.6	1.2	1.9	0.6	0.2	0.8	0.0	0.3	31.1	0.0	0.0	0.1	0.4	2.5	0.2	0.0	0.0	0.7	0.3	0.1	20.3	0.1	0.3	2.8	0.4	0.1	1.9	0.5	2.1	24.3	0.9	0.3	0.7	28.6	38.1	31.7	0.1	0.0	0.1	1.1	0.6	0.1	0.3	0.1	0.1	0.1	0.0	40.5	5.3	0.4	0.8	0.9	0.4	0.4	0.4	0.7	0.3	0.3	0.9	0.6	1.2	3.3	1.2	0.6	0.7	0.8	0.2	11.6	16.5	2.0	16.7	18.6	9.0	23.5	9.3	14.9	23.8
ERCC2	"EM9, MAG, MGC102762, MGC126218, MGC126219, TFIIH, XPD"	ENSG00000104884	"ERCC excision repair 2, TFIIH core complex helicase subunit"	P18074	19	45349837-45370918	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005375, HPA038057, HPA069266"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB005375: AB_2100152, HPA038057: , HPA069266: "	"unprognostic (1.10e-1)"	"unprognostic (5.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (3.26e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.47e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.45e-2)"	7.4	15.6	11.4	10.6	17.7	6.7	7.1	9.5	23.8	9.4	8.1	11.7	7.8	7.9	11.7	6.0	6.7	10.0	10.1	7.9	9.4	9.1	8.7	13.2	6.5	9.9	8.2	10.5	9.5	13.1	12.9	10.9	7.2	14.0	8.2	6.4	12.5	9.5	11.8	15.9	10.7	7.1	11.2	5.3	9.7	8.3	17.2	7.8	10.8	10.2	5.1	8.3	9.3	6.6	7.8	17.2	5.0	13.9	11.3	9.8	8.7	12.3	6.0	12.6	17.7	7.5	8.9	6.7	17.6	12.1	22.8	17.5	14.0	8.5	4.4	10.1	17.1	6.4	8.8	14.8	8.7	10.6	14.5	7.5	11.5	14.7	15.9	11.9	13.3	10.2	2.3	26.0	14.8	13.2	18.2	5.0	15.7	6.0	7.0	7.9	5.8	10.6	13.5	8.9	3.7	6.5	10.9	7.4	8.0	15.6	11.1	6.2	10.5	15.8	17.1	21.8	11.9	9.2	39.1	11.6	6.7	6.4	6.4	7.3	9.6	0.0	13.3	5.0	7.7	13.9	9.8	7.8	7.4	7.4	17.2	5.8	7.1	7.4	0.4	11.3	10.9	8.3	7.4	8.7	11.4	17.7	9.5	23.8	9.4	9.1	8.2	10.5	14.0	7.8
ERCC3	"BTF2, GTF2H, RAD25, TFIIH, XPB"	ENSG00000163161	"ERCC excision repair 3, TFIIH core complex helicase subunit"	P19447	2	127257290-127294176	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037153, HPA046077"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB037153: AB_796181, HPA046077: "	"unprognostic (2.31e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.85e-2)"	"prognostic unfavourable (1.62e-7)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavourable (4.30e-6)"	"unprognostic (3.71e-1)"	"unprognostic (8.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.92e-2)"	17.4	20.0	26.1	23.8	28.9	20.5	21.0	35.9	32.0	22.1	19.4	19.7	17.1	11.5	21.6	15.7	19.1	23.6	20.4	20.4	23.2	18.8	17.5	17.4	19.4	23.1	19.7	25.8	23.3	22.4	32.0	26.4	16.3	21.5	20.1	17.1	18.3	18.0	21.8	30.1	19.7	17.3	26.1	16.0	24.5	17.4	39.5	20.1	24.1	19.3	15.8	25.9	22.4	20.8	11.8	13.9	7.2	9.7	18.8	16.2	11.7	21.8	15.1	18.6	19.7	20.8	14.2	23.1	20.1	26.2	32.6	31.6	22.9	16.0	16.6	16.7	18.3	19.6	28.4	21.2	28.4	25.9	25.4	20.8	18.4	24.2	15.4	18.1	22.7	14.7	19.9	37.7	16.1	20.9	20.2	10.9	20.5	21.6	25.7	19.5	27.1	23.5	21.2	21.4	13.7	18.2	20.4	22.6	24.4	17.2	26.2	26.3	14.1	20.8	16.6	19.6	22.5	17.8	23.9	19.5	38.1	26.0	17.3	8.7	20.9	6.6	9.5	7.2	16.0	9.7	16.2	11.5	11.8	13.5	13.9	11.8	15.8	10.9	3.1	18.8	7.9	11.3	16.1	11.7	26.1	28.9	35.9	32.0	23.2	18.8	19.7	25.8	21.5	20.1
ERLIN1	"C10orf69, Erlin-1, KE04, SPFH1, SPG62"	ENSG00000107566	"ER lipid raft associated 1"	O75477	10	100150094-100188334	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011252	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"		"HPA011252: AB_1853965"	"unprognostic (3.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (1.26e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	12.9	8.0	5.4	6.9	10.1	23.2	13.9	6.7	6.1	11.3	18.6	5.7	7.0	13.8	11.9	6.6	17.9	11.2	6.8	6.8	6.2	3.7	12.3	81.4	8.7	10.1	7.3	3.8	13.9	17.7	5.9	8.8	24.2	4.7	9.2	13.5	8.2	9.8	5.7	5.5	10.8	18.9	7.7	4.1	9.7	12.7	17.4	5.4	8.6	11.8	10.3	14.3	14.7	14.6	6.2	12.6	18.2	16.0	7.5	9.0	7.0	23.1	23.1	11.8	21.4	28.5	28.0	24.1	36.9	34.3	30.5	35.2	15.4	27.1	10.3	14.9	34.1	24.2	10.5	21.7	42.3	6.2	9.4	8.9	10.4	19.5	11.8	31.0	9.8	15.8	13.2	26.7	32.4	22.0	8.7	6.3	32.1	9.4	7.9	11.4	8.4	9.6	6.8	19.4	7.5	13.1	9.2	4.8	7.7	21.0	5.9	13.0	14.7	25.7	24.9	30.6	23.6	18.2	38.7	4.9	8.3	14.1	26.9	49.1	15.0	4.3	16.0	18.2	8.5	11.7	7.6	6.2	6.6	7.0	12.6	5.5	6.8	9.0	11.6	7.5	8.6	2.9	3.8	7.0	5.4	10.1	6.7	6.1	6.2	3.7	7.3	3.8	4.7	5.4
ERLIN2	"C8orf2, Erlin-2, NET32, SPFH2, SPG18"	ENSG00000147475	"ER lipid raft associated 2"	O94905	8	37736599-37759101	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002025, CAB014894"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"		"CAB014894: , HPA002025: AB_1080077"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-1)"	"prognostic favourable (5.16e-4)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (4.51e-4)"	"unprognostic (3.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.67e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.78e-3)"	"prognostic favourable (6.67e-6)"	"unprognostic (4.78e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.33e-1)"	14.5	17.7	15.6	9.5	17.6	8.9	17.5	11.0	13.8	16.6	16.2	21.4	26.9	11.8	18.1	23.1	19.5	21.8	20.6	11.9	13.1	11.3	28.5	31.1	12.0	16.5	13.2	16.0	22.3	45.7	34.2	12.9	26.8	15.2	21.2	17.9	23.3	23.2	18.9	13.0	12.4	19.1	22.8	15.3	12.0	16.6	15.9	12.5	13.8	32.4	14.8	14.0	20.5	13.5	4.9	8.7	14.8	9.8	2.8	5.8	3.5	16.1	17.0	18.5	12.4	20.7	15.4	19.4	24.3	23.1	13.7	14.8	8.5	20.6	7.9	41.1	26.8	16.8	14.0	21.0	22.6	4.5	10.4	11.3	10.8	9.4	13.7	7.2	16.3	18.9	21.2	20.4	21.5	14.3	21.0	7.6	20.7	8.0	10.4	5.7	18.7	7.1	7.3	13.1	5.8	16.6	17.7	3.5	9.0	15.7	4.8	14.4	26.5	10.9	12.8	13.1	11.7	24.4	13.0	10.1	16.4	9.9	23.5	11.8	17.8	1.7	7.5	14.8	5.2	7.5	4.3	4.9	3.5	4.2	6.0	2.8	5.4	4.8	9.6	2.8	9.8	8.7	5.8	3.5	15.6	17.6	11.0	13.8	13.1	11.3	13.2	16.0	15.2	12.5
ETFDH	ETFQO	ENSG00000171503	"Electron transfer flavoprotein dehydrogenase"	Q16134	4	158672125-158709623	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase	"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 72.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041978	Enhanced									"HPA041978: AB_10795605"	"unprognostic (7.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.76e-2)"	"prognostic favourable (5.76e-10)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.74e-1)"	11.3	20.1	7.0	3.9	8.6	2.8	12.9	10.3	8.2	5.1	12.5	6.5	6.1	23.0	5.7	6.4	10.9	4.3	5.2	47.8	7.2	5.0	17.3	72.8	4.3	2.9	8.0	5.3	5.0	8.9	11.4	8.8	9.0	8.5	5.2	10.5	7.4	7.2	5.6	33.7	7.7	20.4	8.5	4.8	4.8	9.2	4.1	8.4	4.9	6.0	17.5	5.4	5.8	6.1	5.8	11.0	24.5	13.5	6.2	9.2	5.4	5.6	3.5	5.9	10.7	25.6	15.3	2.8	10.0	10.0	7.4	7.2	1.9	12.5	13.8	2.1	12.1	6.6	11.4	9.9	10.4	21.9	8.3	12.7	8.1	3.3	11.2	10.9	12.1	14.1	12.5	8.0	6.8	14.4	7.0	26.1	11.8	5.8	10.5	5.5	2.3	8.6	8.5	2.0	9.7	11.1	4.9	9.0	3.5	10.0	19.9	9.4	13.5	8.4	6.4	6.0	3.1	8.8	5.1	14.7	18.3	9.4	12.4	9.2	6.4	2.5	13.5	24.5	6.7	13.3	8.1	5.8	6.3	6.8	11.0	5.4	7.8	6.6	4.6	6.2	11.7	8.4	9.2	5.4	7.0	8.6	10.3	8.2	7.2	5.0	8.0	5.3	8.5	8.4
ETHE1	"HSCO, YF13H12"	ENSG00000105755	"ETHE1, persulfide dioxygenase"	O95571	19	43506719-43527244	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 57.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028360, HPA029028, HPA029029"	Enhanced		Enhanced	Mitochondria		13000	13000	Mitochondria		"HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998"	"unprognostic (8.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (9.58e-4)"	"unprognostic (7.75e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.73e-2)"	7.7	10.5	5.2	28.3	6.3	13.1	8.8	4.5	6.7	10.9	80.7	4.6	9.6	27.4	7.1	12.2	28.2	7.1	18.4	8.9	4.4	4.1	19.0	21.3	11.4	15.5	5.6	4.9	7.4	12.7	3.0	7.2	16.7	5.1	12.0	72.1	5.6	18.5	6.7	9.4	9.1	40.3	11.8	4.5	11.0	13.2	3.3	4.7	12.0	26.2	23.3	24.4	10.9	13.3	7.9	35.8	7.4	24.3	9.9	20.2	15.1	13.4	17.7	3.6	12.6	19.8	13.5	1.4	20.9	57.0	18.0	18.5	5.3	13.8	0.0	15.7	20.0	11.0	5.2	31.5	4.8	6.7	1.7	3.4	7.7	14.7	9.0	5.0	4.7	13.8	24.8	6.9	19.5	13.3	2.2	22.6	8.8	9.1	5.8	4.6	0.9	8.6	6.6	1.6	3.0	39.1	28.0	0.0	4.5	5.3	19.2	12.5	5.8	8.4	11.2	2.9	12.4	3.5	3.8	6.4	5.0	0.3	12.6	20.8	15.0	7.4	24.3	0.6	17.2	12.7	20.0	7.9	20.2	16.3	35.8	3.4	15.6	14.8	0.7	9.9	8.5	7.1	19.4	15.1	5.2	6.3	4.5	6.7	4.4	4.1	5.6	4.9	5.1	4.7
EXT1	"LGCR, LGS, ttv"	ENSG00000182197	"Exostosin glycosyltransferase 1"	Q16394	8	117794490-118111853	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Hereditary multiple exostoses, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 55.1;fHDF/TERT166: 55.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044394	Uncertain					9600000	9600000			"HPA044394: AB_10963838"	"unprognostic (1.29e-2)"	"prognostic unfavourable (7.04e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (1.70e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.27e-2)"	"unprognostic (9.84e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (1.85e-1)"	13.8	11.9	5.8	20.5	4.6	2.1	16.5	7.3	7.4	13.3	17.1	4.1	8.7	23.2	11.5	12.5	11.2	8.8	19.3	14.4	4.6	3.1	8.8	66.4	19.9	8.3	3.0	6.8	10.4	17.9	7.1	6.4	15.6	4.8	9.8	16.0	13.2	9.8	13.3	4.2	12.3	32.0	16.8	4.3	20.1	11.5	5.0	2.7	8.7	12.0	10.3	7.2	11.0	18.5	0.8	1.7	1.2	4.5	0.7	2.4	1.0	17.2	5.0	7.5	2.9	13.6	11.0	3.4	32.3	55.1	23.8	21.9	5.1	1.7	0.3	14.5	55.7	10.9	3.3	18.9	33.5	6.5	5.6	0.6	4.7	4.1	6.4	0.0	1.2	6.9	5.1	28.9	26.6	14.6	0.4	4.8	11.0	1.4	0.8	0.0	2.4	6.4	0.0	2.8	0.5	9.4	6.3	2.3	2.2	4.9	2.3	4.8	3.2	0.2	19.4	20.1	18.4	18.4	9.5	2.7	2.7	1.6	18.6	0.0	5.3	0.3	4.4	0.2	0.2	4.5	1.3	0.8	0.5	0.6	1.0	0.1	0.5	0.9	1.2	0.7	2.2	1.7	2.4	1.0	5.8	4.6	7.3	7.4	4.6	3.1	3.0	6.8	4.8	2.7
EXT2	SOTV	ENSG00000151348	"Exostosin glycosyltransferase 2"	Q93063	11	44095549-44245429	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, Hereditary multiple exostoses, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078409			Supported	"Golgi apparatus"		20000000	20000000	"Golgi apparatus"		"HPA078409: "	"unprognostic (5.87e-2)"	"unprognostic (3.05e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (1.77e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.70e-2)"	"prognostic unfavourable (5.36e-6)"	"unprognostic (7.07e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.36e-2)"	24.5	19.5	11.6	17.2	18.5	6.6	25.8	14.5	23.0	26.8	25.0	15.5	17.5	17.6	37.1	25.5	16.7	26.0	23.4	22.7	11.7	13.0	19.2	36.3	22.3	16.8	11.8	12.3	29.3	21.8	25.7	17.3	58.0	16.2	23.7	20.6	22.9	24.7	22.8	16.9	20.2	34.0	35.0	12.2	18.7	19.3	20.0	11.4	16.2	24.7	16.7	13.0	20.2	23.2	6.7	14.9	13.0	12.0	17.8	17.6	9.8	12.9	17.9	9.7	30.2	44.8	33.0	13.4	40.2	50.3	23.8	32.4	12.7	8.9	8.9	18.3	47.0	20.6	10.4	28.5	28.8	17.9	14.3	8.2	9.4	9.7	17.7	8.2	17.8	25.6	18.9	14.4	22.5	33.8	11.0	16.2	17.3	9.9	5.7	5.0	10.4	12.8	7.2	27.8	4.5	13.7	12.3	7.0	7.8	25.4	10.4	6.7	17.3	8.8	30.5	32.2	21.1	31.5	25.7	7.3	9.5	6.5	21.2	6.4	34.3	9.3	11.9	13.0	15.6	12.0	17.6	6.4	12.5	14.4	14.9	6.7	11.9	11.7	2.6	17.8	8.5	5.1	9.6	9.8	11.6	18.5	14.5	23.0	11.7	13.0	11.8	12.3	16.2	11.4
EXTL3	"botv, REGR"	ENSG00000012232	"Exostosin like glycosyltransferase 3"	O43909	8	28600469-28755599	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025387	Approved									"CAB025387: "	"unprognostic (1.35e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.19e-3)"	"unprognostic (9.83e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (1.14e-5)"	"unprognostic (4.25e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.19e-3)"	"prognostic favourable (2.47e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.39e-2)"	12.1	19.0	15.4	7.9	19.5	4.0	11.6	14.8	26.9	11.3	10.5	16.2	8.8	6.3	15.0	7.9	14.0	13.7	9.6	34.6	15.4	13.4	8.5	6.7	10.1	5.9	11.6	18.1	12.2	13.0	26.1	13.8	15.7	12.9	10.2	6.5	15.2	8.8	14.8	20.7	13.5	6.8	19.8	11.7	9.3	9.6	14.3	10.8	5.4	9.2	8.7	5.9	12.2	9.5	0.8	2.4	10.0	2.3	1.0	3.6	1.5	19.0	14.4	32.2	16.5	8.8	9.1	7.1	14.4	14.6	9.2	7.7	12.2	6.9	5.1	20.9	17.5	12.9	14.8	23.7	9.9	3.7	8.2	7.3	7.2	6.2	5.1	3.5	20.8	10.2	16.1	7.0	6.4	19.6	6.7	6.7	7.2	3.6	6.4	2.3	21.8	5.9	7.7	13.8	3.0	15.7	12.4	6.9	12.0	6.1	3.8	8.3	3.7	4.4	14.9	12.0	28.4	11.1	12.2	3.6	7.2	5.8	10.1	4.4	10.7	4.0	2.0	3.3	3.6	2.3	2.1	0.6	1.3	1.9	2.4	0.8	1.1	0.9	10.0	1.0	2.3	2.3	0.8	1.5	15.4	19.5	14.8	26.9	15.4	13.4	11.6	18.1	12.9	10.8
EYA1	BOR	ENSG00000104313	"EYA transcriptional coactivator and phosphatase 1"	Q99502	8	71197433-71592025	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 45.5;pituitary gland: 30.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.4;RH-30: 12.7;SH-SY5Y: 31.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"NK-cell: 9.8"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028917			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA028917: "	"unprognostic (3.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.91e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-12)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.25e-2)"	1.0	1.1	2.8	0.6	16.8	0.5	0.6	0.2	6.8	4.0	0.6	1.9	0.0	0.7	0.6	2.2	1.0	2.5	0.8	4.6	2.8	2.2	0.6	0.5	1.0	0.6	2.9	2.8	0.8	0.6	45.5	30.8	0.6	4.2	12.4	0.7	15.3	1.2	4.6	3.2	0.6	0.7	3.9	0.4	0.7	0.9	1.3	5.1	4.4	0.9	2.9	0.6	3.5	5.7	0.8	1.9	1.8	2.3	9.8	2.3	0.2	0.1	0.0	3.7	16.4	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.9	0.0	0.0	2.7	0.0	1.2	0.0	0.0	0.3	0.0	3.6	0.0	0.0	0.1	0.0	0.0	1.2	0.6	0.0	0.0	0.0	1.2	0.9	0.0	12.7	5.4	0.0	0.0	1.3	31.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.7	0.0	1.2	1.8	0.3	0.6	0.9	0.9	1.9	0.8	0.7	1.9	0.7	0.8	1.3	1.4	1.6	9.8	2.3	1.9	2.3	0.2	2.8	16.8	0.2	2.8	2.8	2.2	2.9	2.8	4.2	5.1
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532120	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 65.6"	"Cell line enhanced"	"Detected in many"		"A549: 12.6;HeLa: 35.3;RH-30: 12.0;U-87 MG: 12.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.6	3.0	1.2	0.2	1.3	0.1	2.4	0.4	1.2	9.7	0.6	2.5	11.1	0.4	2.6	1.9	0.7	8.3	0.7	6.2	1.5	1.2	6.1	0.4	2.0	0.2	2.1	0.8	1.6	0.4	0.2	7.2	0.2	3.5	6.6	0.4	2.7	0.8	13.9	65.6	0.4	0.5	1.9	3.5	0.6	0.7	7.4	1.4	1.8	2.5	5.5	0.7	2.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	1.2	0.0	0.0	0.0	0.0	0.0	10.1	0.2	1.5	0.0	0.0	0.0	10.0	0.0	0.0	7.6	3.2	0.0	0.0	9.9	1.3	35.3	0.0	0.3	0.0	3.4	2.6	0.0	7.3	2.2	0.0	0.0	5.4	4.0	0.0	0.0	0.0	0.0	0.7	0.1	12.0	0.0	0.0	1.9	1.8	2.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	9.0	3.6	1.6	0.0	12.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.4	1.2	1.5	1.2	2.1	0.8	3.5	1.4
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.5;lymphoid tissue: 44.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009589	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB009589: "	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavourable (8.18e-12)"	"prognostic favourable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	2.0	1.7	1.8	10.6	1.6	25.5	1.4	4.9	2.7	2.6	4.8	1.1	0.1	3.8	1.7	2.8	11.0	0.9	3.0	0.9	0.8	0.6	1.7	3.3	2.3	12.6	1.3	0.3	2.2	3.8	0.6	1.7	3.4	1.4	1.4	5.1	1.8	3.2	1.6	3.7	6.4	4.8	1.5	1.2	5.8	2.7	19.6	1.3	44.1	0.9	5.5	12.4	2.6	3.5	1.5	4.7	1.3	3.9	8.5	10.3	1.7	16.9	7.9	27.1	18.0	0.8	1.4	14.8	13.2	5.3	10.9	11.0	11.9	19.6	29.9	6.4	4.9	10.4	13.9	4.5	13.9	42.8	13.9	12.7	9.8	9.2	2.2	28.4	10.5	1.2	2.6	8.1	4.3	6.4	27.1	19.9	9.7	19.2	55.1	23.7	21.5	10.7	34.1	15.2	18.5	5.0	8.1	25.9	16.5	16.6	12.6	4.3	9.2	12.2	3.9	11.6	5.4	23.1	23.6	17.9	19.4	30.1	10.6	19.4	22.7	0.5	2.2	1.3	1.7	1.5	1.3	1.5	3.4	2.9	4.7	0.8	1.9	1.2	0.2	8.5	3.9	1.0	10.3	1.7	1.8	1.6	4.9	2.7	0.8	0.6	1.3	0.3	1.4	1.3
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 109.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041370, HPA044093"	Enhanced		Approved	Cytosol		230000000	230000000	Cytosol		"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavourable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	32.1	17.8	4.6	6.1	3.6	4.7	22.8	2.3	3.3	4.7	8.6	3.1	8.3	4.1	5.1	14.8	4.4	6.8	7.1	6.8	4.1	2.8	18.9	109.4	7.9	6.2	4.0	2.1	7.2	6.5	4.8	4.4	2.3	3.5	4.9	3.4	2.4	5.3	5.4	7.7	2.4	7.6	4.4	5.9	6.0	3.3	9.7	3.0	2.3	4.2	4.9	3.9	4.1	6.1	0.1	16.0	16.9	11.7	3.6	5.8	6.1	4.4	7.5	3.1	3.8	14.5	14.8	7.6	5.7	13.1	6.0	5.2	4.5	8.2	0.0	9.4	12.0	6.6	11.0	13.6	5.9	2.8	6.2	38.1	4.4	23.3	75.2	18.0	21.1	25.6	8.5	5.2	9.4	8.4	15.9	8.1	11.3	6.7	4.9	9.0	2.2	8.6	2.7	4.4	28.5	17.5	5.4	0.1	1.9	6.4	17.7	17.8	13.5	12.3	29.3	11.1	7.0	5.9	9.6	7.4	15.2	3.0	23.1	42.2	6.2	16.9	11.7	1.9	5.8	4.9	1.5	0.1	1.6	3.9	16.0	0.0	2.0	1.8	0.7	3.6	4.8	1.2	1.5	6.1	4.6	3.6	2.3	3.3	4.1	2.8	4.0	2.1	3.5	3.0
FAM20C	"DKFZp547D065, DMP4, G-CK, IMAGE:4942737"	ENSG00000177706	"FAM20C, golgi associated secretory pathway kinase"	Q8IXL6	7	192969-260745	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	Biomineralization	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 80.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 52.0;U-87 MG: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019823			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted in other tissues"	160000000	160000000	"Golgi apparatus"	Nucleoplasm	"HPA019823: AB_1848389"	"unprognostic (1.94e-1)"	"prognostic unfavourable (8.89e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavourable (9.40e-6)"	"unprognostic (1.97e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.83e-3)"	27.5	10.2	10.8	19.3	16.6	3.3	25.6	7.4	14.9	8.3	20.1	13.5	15.1	12.9	9.5	6.9	11.1	9.7	15.0	15.0	8.8	7.2	31.8	31.6	12.7	5.1	16.9	5.6	11.8	14.8	2.6	9.2	7.2	15.8	15.0	4.6	8.8	80.6	11.8	20.4	6.8	16.5	17.0	17.0	6.9	20.0	5.9	14.8	0.4	9.6	8.4	4.4	20.5	17.5	0.0	0.6	0.0	1.6	0.2	0.0	0.0	13.8	6.7	0.2	9.6	12.3	20.4	0.0	12.3	20.9	6.7	5.4	0.8	8.5	0.0	6.8	18.4	12.0	1.0	0.6	1.7	2.9	0.6	0.0	3.2	3.7	9.3	0.0	0.9	52.0	1.5	0.2	0.7	4.6	0.0	0.1	1.7	1.8	0.0	0.7	6.5	0.4	1.5	0.4	0.0	5.0	0.0	3.2	0.1	12.8	0.0	1.9	9.1	6.3	12.9	8.4	4.2	7.1	3.7	0.0	0.0	0.0	32.0	0.8	23.8	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.8	16.6	7.4	14.9	8.8	7.2	16.9	5.6	15.8	14.8
FAN1	"KIAA1018, MTMR15"	ENSG00000198690	"FANCD2 and FANCI associated nuclease 1"	Q9Y2M0	15	30903852-30943108	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048198			Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA048198: "	"unprognostic (7.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.67e-2)"	"prognostic favourable (1.42e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.29e-1)"	5.9	8.9	11.6	6.9	17.4	6.3	12.7	19.6	18.4	15.0	11.4	17.7	11.9	4.6	11.6	22.9	6.5	8.5	8.5	13.0	12.6	11.0	14.7	14.4	6.9	5.5	18.5	11.8	12.5	18.2	7.2	17.0	10.6	15.4	16.4	9.7	8.6	17.3	8.3	16.8	9.3	6.7	11.5	13.0	7.3	8.5	9.4	15.0	5.1	14.3	6.3	5.8	9.0	9.1	4.0	3.6	0.6	1.7	4.5	5.4	1.6	6.4	11.0	3.6	2.0	13.0	11.6	2.4	4.5	1.9	4.8	5.1	7.5	3.3	1.5	8.1	4.9	13.0	6.1	9.5	4.7	5.1	2.9	1.1	11.2	1.3	5.6	0.9	6.1	3.5	7.0	2.9	7.7	2.3	5.5	10.1	7.8	1.4	10.0	4.4	2.8	2.5	8.5	11.9	2.8	7.1	5.1	8.3	5.8	9.9	6.8	3.5	6.1	7.6	8.3	15.1	3.6	4.2	5.8	13.9	9.7	1.7	6.6	4.8	1.3	0.1	0.8	0.6	3.7	1.3	4.7	2.8	3.5	1.7	2.7	4.0	5.4	2.8	0.3	4.5	1.7	3.6	3.2	1.6	11.6	17.4	19.6	18.4	12.6	11.0	18.5	11.8	15.4	15.0
FANCL	"FAAP43, FLJ10335, PHF9, Pog"	ENSG00000115392	"Fanconi anemia complementation group L"	Q9NW38	2	58159243-58241372	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 62.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033842, HPA036685, HPA036686"	Supported		Approved	"Nuclear bodies,Vesicles"				"Nuclear bodies"	Vesicles	"CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844"	"unprognostic (3.02e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavourable (2.81e-7)"	"unprognostic (4.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (1.12e-7)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.08e-3)"	"prognostic favourable (7.80e-5)"	6.3	29.2	16.0	11.2	22.9	10.6	16.2	7.1	18.1	11.6	9.6	30.7	7.9	9.2	16.6	15.7	8.6	11.7	9.8	10.2	17.0	23.5	7.1	16.7	7.7	10.9	25.0	15.2	21.3	10.8	16.8	62.5	10.0	33.5	11.6	12.4	13.7	14.8	9.1	6.5	14.4	10.1	11.3	23.4	12.0	10.5	14.7	28.2	8.6	14.2	6.9	12.0	10.1	12.7	10.8	7.1	5.6	6.9	8.8	5.5	2.7	18.4	13.5	27.6	13.5	4.9	6.5	14.7	13.6	8.5	13.5	17.6	11.9	23.3	12.8	17.7	4.4	10.8	15.3	10.3	22.6	30.0	24.2	21.0	19.0	16.1	5.3	20.2	11.6	4.8	4.9	9.8	3.9	10.5	19.5	11.7	9.1	9.4	7.1	25.1	29.8	2.8	13.5	20.9	10.0	11.8	18.3	31.3	15.7	19.4	8.0	12.7	7.3	13.6	6.2	12.1	18.2	8.8	14.9	12.1	7.6	7.5	25.7	13.7	18.3	2.7	3.7	5.6	4.9	6.9	3.8	10.8	4.1	5.4	7.1	10.0	1.4	3.1	1.1	8.8	4.9	6.5	5.5	2.7	16.0	22.9	7.1	18.1	17.0	23.5	25.0	15.2	33.5	28.2
FAR1	"FLJ22728, MLSTD2, SDR10E1"	ENSG00000197601	"Fatty acyl-CoA reductase 1"	Q8WVX9	11	13668670-13732346	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Cataract, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017322	Approved		Supported	Peroxisomes				Peroxisomes		"HPA017322: AB_1848424"	"unprognostic (3.96e-2)"	"unprognostic (1.92e-1)"	"prognostic favourable (2.27e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-3)"	16.3	11.1	19.0	14.2	28.2	42.7	13.7	24.4	24.0	17.3	20.9	33.8	11.1	24.7	17.4	17.1	38.1	12.7	9.2	13.9	20.4	16.1	9.7	3.3	13.9	12.2	32.8	24.0	16.7	15.8	25.1	16.5	15.8	30.0	14.1	25.1	10.0	14.6	10.9	11.4	8.0	13.4	20.2	47.8	13.9	39.4	12.8	32.2	13.2	13.2	17.2	15.0	16.7	22.1	2.8	15.8	21.8	13.7	5.0	4.5	4.0	26.9	17.6	17.5	13.6	16.7	19.3	9.5	24.2	9.7	17.9	19.0	18.5	23.3	34.7	10.8	19.2	29.5	25.7	24.4	27.5	10.2	20.9	14.8	16.1	0.1	16.1	29.7	12.0	14.6	25.2	12.9	38.8	17.4	23.1	10.4	14.6	13.6	22.0	8.9	9.1	25.6	19.4	22.3	9.7	17.3	43.9	13.5	9.8	22.9	21.8	11.8	13.4	18.6	21.6	24.7	21.1	22.6	20.1	5.8	19.7	29.5	15.7	9.1	14.9	4.6	13.7	15.0	4.5	11.9	3.1	2.1	2.2	3.8	15.8	2.8	2.0	3.4	21.8	5.0	9.4	2.4	2.8	4.0	19.0	28.2	24.4	24.0	20.4	16.1	32.8	24.0	30.0	32.2
FARS2	"dJ236A3.1, FARS1"	ENSG00000145982	"Phenylalanyl-tRNA synthetase 2, mitochondrial"	O95363	6	5261044-5771580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018148, HPA028836"	Approved		Uncertain	"Plasma membrane"				"Plasma membrane"		"HPA018148: AB_1848426, HPA028836: AB_10601377"	"unprognostic (2.73e-1)"	"unprognostic (4.08e-3)"	"prognostic favourable (5.14e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.31e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.50e-1)"	"prognostic favourable (1.24e-6)"	"unprognostic (2.81e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	14.2	19.0	10.6	16.5	14.5	13.2	14.8	16.5	18.8	14.7	13.5	16.4	13.4	9.6	15.3	12.7	13.7	19.8	11.6	19.0	10.5	9.0	18.4	18.5	13.0	21.8	8.9	15.0	11.7	14.0	18.9	29.2	11.4	10.6	12.2	15.2	19.3	15.3	13.5	22.8	15.4	13.0	13.2	8.5	15.0	13.9	15.4	11.0	20.6	19.7	16.0	22.0	13.1	12.9	13.9	16.8	3.2	10.3	14.9	17.5	10.9	8.2	7.9	8.5	9.1	10.6	12.8	7.0	9.1	10.7	11.8	11.6	10.7	6.3	11.6	14.2	8.7	8.2	10.9	14.6	12.4	34.6	7.2	4.6	7.0	9.2	5.5	11.1	6.9	10.1	14.5	13.5	9.6	14.2	13.6	2.7	8.6	8.4	11.8	12.2	5.2	7.7	11.8	10.6	22.7	11.3	9.8	14.6	7.3	8.3	6.7	10.2	13.4	12.0	8.0	12.9	5.9	7.5	11.6	5.6	19.3	6.3	7.1	6.5	15.9	0.1	9.4	3.2	15.6	10.3	13.9	13.9	14.1	14.5	16.8	11.3	15.6	15.5	0.7	14.9	7.3	9.9	17.5	10.9	10.6	14.5	16.5	18.8	10.5	9.0	8.9	15.0	10.6	11.0
FBP1	FBP	ENSG00000165140	"Fructose-bisphosphatase 1"	P09467	9	94603133-94640249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 248.1;lung: 87.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 20.1;MCF7: 62.8;RT4: 41.2;SK-BR-3: 12.0;U-698: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 73.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA005857, HPA012513, CAB033869"	Enhanced		Uncertain	Mitochondria		23000000	23000000	Mitochondria		"CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.40e-1)"	"prognostic favourable (5.16e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.37e-1)"	"prognostic favourable (1.79e-4)"	"unprognostic (6.94e-3)"	"unprognostic (4.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.12e-1)"	"prognostic favourable (6.86e-7)"	"unprognostic (6.91e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (1.64e-5)"	19.3	5.8	0.6	2.3	0.9	1.1	7.0	0.4	0.8	2.2	48.8	0.7	17.6	40.7	0.6	2.5	0.7	0.9	9.7	1.3	0.8	0.5	34.6	248.1	87.8	8.9	0.9	0.7	1.0	8.1	17.1	1.9	1.0	1.0	6.4	3.0	1.5	9.1	17.7	0.5	1.7	60.4	3.1	1.2	2.8	10.4	1.0	0.8	0.5	4.3	1.0	1.1	22.4	9.6	0.6	17.1	73.5	30.7	2.8	3.3	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	20.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.3	5.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	62.8	0.0	1.1	0.2	2.2	0.0	0.2	0.4	0.0	41.2	0.2	1.2	0.1	12.0	0.0	7.2	1.7	0.0	0.0	0.2	0.2	0.0	0.0	0.1	29.9	0.0	0.3	0.0	10.6	13.0	73.5	1.5	30.7	2.3	0.6	0.9	0.9	17.1	0.6	3.3	1.6	2.3	2.8	16.3	6.1	0.4	5.2	0.6	0.9	0.4	0.8	0.8	0.5	0.9	0.7	1.0	0.8
FBXO18	"FBH1, Fbx18, FLJ14590"	ENSG00000134452	"F-box protein, helicase, 18"	Q8NFZ0	10	5890203-5937594	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002844	Supported									"HPA002844: AB_1078829"	"unprognostic (3.14e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.35e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.98e-3)"	"prognostic unfavourable (7.73e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.54e-2)"	21.3	30.6	21.0	22.4	28.2	18.8	32.7	23.0	21.8	23.5	21.9	18.1	26.3	21.7	30.6	21.2	23.8	28.7	22.8	35.1	21.0	13.4	20.4	23.2	22.5	24.2	19.4	18.0	27.5	26.2	23.3	24.5	23.6	22.5	23.9	22.1	23.1	21.0	24.8	23.6	26.2	23.4	27.5	13.5	29.7	22.4	27.1	20.1	36.8	22.8	14.9	23.3	23.8	33.8	6.1	6.1	4.8	3.2	7.2	9.2	2.5	14.4	15.8	14.9	16.3	34.4	22.8	13.4	16.8	11.6	16.7	18.8	18.7	13.3	13.6	11.1	24.4	21.7	20.1	17.9	15.2	14.7	14.8	13.0	12.5	15.9	23.7	6.4	12.7	28.5	17.4	21.1	9.4	28.2	22.9	14.4	17.6	22.0	15.5	9.5	6.8	9.0	17.2	7.1	22.6	16.3	11.8	8.5	12.8	17.2	15.7	23.3	16.0	13.1	17.6	10.7	12.0	28.2	12.9	14.8	11.6	7.6	14.4	9.5	7.4	0.0	3.2	4.8	3.2	2.5	2.1	4.9	3.3	4.1	3.0	6.1	4.0	2.9	2.1	7.2	1.9	6.1	9.2	2.5	21.0	28.2	23.0	21.8	21.0	13.4	19.4	18.0	22.5	20.1
FDXR	ADXR	ENSG00000161513	"Ferredoxin reductase"	P22570	17	74862497-74873031	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Oxidoreductase	"Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 93.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 29.5;Hep G2: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008597, CAB009818, HPA044393, HPA053673"	Enhanced		Enhanced	Mitochondria				Mitochondria		"CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-3)"	"unprognostic (7.51e-2)"	"prognostic favourable (2.38e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.13e-1)"	1.7	93.9	2.6	2.1	3.1	1.3	1.8	8.4	2.7	2.1	4.6	3.2	6.4	2.6	2.6	23.8	8.7	6.6	6.1	1.9	3.4	1.7	2.7	4.1	4.4	1.7	2.9	3.5	7.1	3.9	2.3	1.5	2.6	3.6	3.3	2.1	0.9	5.3	4.2	7.9	5.6	2.5	2.0	4.4	9.7	2.2	32.1	3.0	3.9	2.0	7.7	3.7	3.0	3.0	5.4	7.4	4.8	6.4	10.0	15.2	5.6	3.9	21.1	3.1	3.5	2.3	3.0	29.5	4.7	5.2	2.8	5.7	5.9	3.5	9.4	0.8	2.0	8.1	2.3	5.9	0.8	8.9	4.9	7.1	3.5	54.0	6.4	1.5	25.0	9.9	6.7	2.9	1.0	14.4	11.3	1.5	4.3	16.7	6.1	3.3	1.7	4.6	3.3	5.3	5.0	2.3	6.7	1.7	4.0	3.2	7.1	3.4	15.4	1.5	6.7	1.9	17.6	3.1	2.3	4.4	0.7	2.0	5.3	2.4	6.6	1.8	6.4	4.8	6.2	4.3	5.3	5.4	5.6	7.3	7.4	2.8	4.9	6.1	2.1	10.0	3.2	1.4	15.2	5.6	2.6	3.1	8.4	2.7	3.4	1.7	2.9	3.5	3.6	3.0
FECH		ENSG00000066926	Ferrochelatase	P22830	18	57548283-57586772	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 87.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044100, HPA048177"	Approved									"HPA044100: , HPA048177: "	"unprognostic (2.30e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.85e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.36e-1)"	"prognostic favourable (2.38e-10)"	"unprognostic (1.10e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.05e-3)"	"unprognostic (3.58e-2)"	10.0	18.0	9.9	6.5	14.1	87.9	9.9	7.9	17.4	7.9	9.5	23.1	8.0	7.6	10.5	7.9	13.6	8.5	6.9	17.6	10.4	9.7	28.2	28.3	7.2	9.8	12.0	13.9	9.1	9.5	11.4	8.8	14.8	15.6	14.5	9.3	12.1	10.1	11.1	36.2	8.6	7.2	12.3	11.7	10.6	8.5	5.8	13.1	18.4	11.6	10.8	7.1	12.1	8.8	4.2	12.4	14.9	10.9	13.8	9.3	9.1	7.3	20.0	7.4	11.9	4.7	10.8	13.0	10.5	10.7	15.2	13.6	5.3	6.7	3.3	10.8	14.4	9.4	10.9	8.8	12.3	19.2	11.6	24.3	13.9	11.0	12.1	16.9	44.4	11.2	9.4	9.4	4.3	11.4	34.5	13.9	8.5	8.7	17.6	3.5	5.6	8.7	12.6	10.3	19.8	15.1	13.9	7.4	11.2	13.6	14.6	6.2	13.9	7.1	9.0	5.3	7.0	2.1	7.6	40.6	17.4	7.1	8.6	8.3	8.9	14.0	9.6	14.9	9.3	10.9	6.7	4.2	5.7	8.3	12.4	2.6	4.2	5.9	0.7	13.8	10.2	9.5	5.9	9.1	9.9	14.1	7.9	17.4	10.4	9.7	12.0	13.9	15.6	13.1
FES	FPS	ENSG00000182511	"FES proto-oncogene, tyrosine kinase"	P07332	15	90883695-90895776	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 60.8;lymphoid tissue: 49.7"	"Cell line enhanced"	"Detected in many"		"HEL: 20.9;HL-60: 18.6;HMC-1: 39.8;NB-4: 24.4;THP-1: 36.6;U-937: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 60.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 32.6;granulocytes: 60.8;monocytes: 30.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001376	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	Vesicles	"HPA001376: AB_1078847"	"unprognostic (1.07e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (5.78e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.05e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-1)"	14.9	3.4	4.8	9.7	4.1	38.3	12.7	2.4	5.7	6.8	5.4	3.2	4.7	3.0	7.4	5.6	4.9	7.6	7.3	7.9	4.2	2.2	5.2	11.8	12.7	23.3	3.7	0.9	6.4	3.7	1.8	2.7	8.1	7.2	7.7	2.4	5.3	33.8	6.3	3.4	3.5	5.2	5.4	6.9	49.7	4.3	3.2	4.7	3.1	7.2	4.1	4.5	7.2	9.4	1.1	32.6	60.8	30.5	9.3	0.1	13.8	0.1	0.2	0.3	3.5	1.0	3.1	6.0	0.9	0.0	1.7	1.0	0.8	0.0	2.2	0.1	2.0	0.5	0.6	0.1	0.5	1.1	0.3	20.9	0.0	3.7	2.0	18.6	39.8	3.0	0.0	2.6	0.0	10.5	0.6	0.0	0.0	6.8	0.5	24.4	1.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.8	0.0	36.6	8.3	0.0	3.6	0.1	0.0	0.0	2.6	0.8	0.1	15.8	0.8	10.4	30.5	60.8	0.1	17.6	0.0	1.1	0.0	0.0	32.6	0.9	0.0	0.0	20.0	9.3	7.3	12.9	0.0	13.8	4.8	4.1	2.4	5.7	4.2	2.2	3.7	0.9	7.2	4.7
FGF23		ENSG00000118972	"Fibroblast growth factor 23"	Q9GZV9	12	4368227-4379728	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	Differentiation	"Growth factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.1;heart muscle: 9.1;liver: 10.1;urinary bladder: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 5.4;HBEC3-KT: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"									"unprognostic (1.31e-1)"						"unprognostic (2.18e-2)"				"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"			0.3	0.4	0.2	0.2	0.2	0.8	0.2	0.2	0.8	0.2	0.2	0.2	0.2	0.4	0.5	3.5	1.2	0.5	0.2	9.1	0.2	0.2	0.3	10.1	0.3	2.6	0.2	0.2	0.3	0.2	0.1	0.4	0.3	0.2	0.2	1.4	0.2	1.0	0.2	2.5	0.4	0.3	0.7	0.2	1.1	0.2	0.9	0.2	0.6	0.3	0.2	1.3	6.7	0.2	3.1	2.9	11.1	3.6	3.4	3.1	1.7	0.2	0.0	5.4	1.8	2.8	0.6	0.8	0.1	0.1	0.0	0.2	1.0	1.9	0.3	0.2	0.9	1.2	0.8	3.9	0.2	0.2	0.6	0.2	0.7	0.6	1.6	1.1	0.5	1.6	0.1	2.5	3.2	0.4	0.5	2.3	0.1	0.0	0.7	1.3	1.4	0.2	0.9	0.1	0.8	0.6	1.1	1.2	1.1	0.0	1.8	0.2	1.3	0.8	0.0	2.0	0.5	1.4	0.3	0.1	0.2	0.3	1.2	0.4	1.3	11.1	2.3	2.9	2.6	2.4	3.1	2.9	2.5	2.0	1.8	3.1	2.8	2.9	7.2	3.4	3.6	2.9	2.3	1.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635277	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3"	"Group enriched"	"Detected in some"	4	"Daudi: 29.4;U-266/70: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"				"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	20.8	2.6	2.2	23.6	4.5	73.6	5.6	1.1	4.2	2.9	2.8	1.5	4.2	1.6	4.0	2.3	2.2	6.3	5.3	8.5	2.6	2.3	3.0	4.2	30.9	34.1	6.6	1.7	1.9	2.4	0.4	1.2	3.3	4.2	2.5	1.8	2.1	2.9	2.6	4.4	1.7	3.7	6.4	4.8	54.3	2.5	2.6	4.1	1.9	2.9	2.5	7.8	5.1	6.1	13.3	28.9	40.8	68.0	36.3	29.6	55.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	10.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	54.6	0.7	2.2	0.0	6.7	0.0	3.1	52.4	32.3	29.6	68.0	1.7	7.7	2.6	13.6	28.9	13.3	1.3	12.8	40.8	36.3	55.6	1.3	0.1	55.0	2.2	4.5	1.1	4.2	2.6	2.3	6.6	1.7	4.2	4.1
FH	fumarase	ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519761	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Tricarboxylic acid cycle"	Lyase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria		2800000	2800000	Mitochondria		"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	14.3	28.1	15.7	10.4	20.2	9.3	13.3	15.7	24.4	10.5	22.7	9.9	16.7	23.2	13.7	10.7	17.7	10.3	9.5	59.0	22.9	13.9	35.0	93.4	9.9	13.3	15.2	19.4	9.4	13.9	25.2	11.4	14.3	18.4	12.3	24.4	10.2	18.4	20.6	65.1	13.4	21.4	14.7	14.4	11.1	17.5	14.0	11.7	13.8	12.3	45.2	13.4	13.4	11.2	16.0	26.4	4.5	18.8	10.4	13.9	8.9	29.2	24.5	23.3	21.0	22.9	27.0	36.9	36.3	28.5	41.0	25.8	35.1	18.3	18.6	24.1	27.8	41.7	35.6	27.0	35.8	21.2	11.5	17.4	26.0	29.9	20.5	40.7	15.9	19.5	16.8	23.0	26.0	25.2	53.0	24.1	29.8	14.6	35.1	27.2	24.7	52.7	29.0	25.5	83.5	39.5	24.9	30.0	25.9	30.6	36.3	23.2	27.6	27.7	24.7	18.4	23.8	32.5	60.5	21.6	23.1	22.6	20.6	46.8	26.4	4.5	12.8	2.7	9.7	18.8	12.6	16.0	11.4	9.0	26.4	14.1	13.9	12.7	0.7	10.4	15.7	13.2	13.2	8.9	15.7	20.2	15.7	24.4	22.9	13.9	15.2	19.4	18.4	11.7
FHIT	"AP3Aase, FRA3B"	ENSG00000189283	"Fragile histidine triad"	P49789	3	59749310-61251459	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 11.9;U-266/70: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"naive CD4 T-cell: 38.3"	"Lineage enriched"	"Detected in all"	14	"T-cells: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002684, HPA018840, HPA018909"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane"				"Nucleoli fibrillar center, Plasma membrane"		"CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537"	"unprognostic (2.36e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.77e-2)"	"prognostic favourable (1.36e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.80e-2)"	6.4	24.0	13.7	8.0	17.5	9.0	12.1	4.7	13.3	7.9	8.0	21.0	12.4	8.2	6.2	9.5	5.1	9.2	13.0	14.9	15.3	13.8	30.9	10.7	5.2	9.3	19.5	9.3	8.9	11.8	16.3	15.2	4.1	14.4	5.8	7.8	14.0	11.4	9.9	11.6	7.0	7.6	9.1	17.1	6.0	8.1	10.5	18.2	3.7	15.6	5.7	6.9	7.3	6.1	1.6	2.4	1.8	1.8	2.6	38.3	4.7	0.0	0.0	1.0	0.0	0.6	0.0	1.6	0.1	0.1	0.0	0.0	1.8	3.0	2.6	0.5	0.1	0.0	10.0	2.1	0.0	1.4	3.4	2.2	1.3	4.1	2.6	5.6	0.1	6.8	4.1	0.1	5.1	0.0	1.6	8.3	0.1	2.5	10.1	4.5	0.8	0.6	7.5	0.0	11.9	11.2	1.3	2.1	2.8	1.0	6.9	6.5	0.4	0.1	0.0	1.2	0.4	0.1	1.5	24.4	7.4	0.0	2.7	0.0	1.4	1.8	1.8	0.2	0.9	1.2	0.5	1.6	6.9	0.7	2.2	1.4	38.3	6.7	0.3	2.6	0.4	2.4	7.4	4.7	13.7	17.5	4.7	13.3	15.3	13.8	19.5	9.3	14.4	18.2
FKBP10	"FKBP6, FLJ20683, FLJ22041, FLJ23833, hFKBP65"	ENSG00000141756	"FK506 binding protein 10"	Q96AY3	17	41812680-41823217	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 72.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051171, HPA057021"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	5500	5500	Vesicles		"HPA051171: , HPA057021: "	"unprognostic (8.30e-2)"	"prognostic unfavourable (4.16e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.34e-2)"	"unprognostic (5.77e-2)"	"prognostic unfavourable (3.43e-5)"	"prognostic unfavourable (4.99e-4)"	16.9	16.5	6.6	13.2	7.2	0.2	14.9	3.4	8.4	43.0	11.5	6.0	15.8	3.8	42.7	39.0	14.0	21.4	28.6	19.2	5.6	3.6	10.3	3.2	16.2	17.1	5.3	6.7	35.5	13.5	24.7	22.7	33.8	5.2	21.3	5.7	17.1	6.5	17.0	9.6	8.8	7.6	27.9	5.5	7.9	8.5	15.1	5.7	1.2	16.9	9.5	8.1	24.4	19.2	0.3	0.0	0.0	0.0	2.0	0.9	0.1	0.0	16.1	14.9	48.7	52.4	61.2	13.1	66.3	66.4	25.0	21.6	8.3	0.6	0.0	0.9	72.0	0.1	8.9	17.7	10.6	4.4	13.3	6.4	18.1	23.8	57.2	0.0	0.0	65.7	0.0	20.5	15.7	21.2	0.2	2.3	20.8	20.9	0.0	0.0	11.6	5.4	1.3	17.5	2.1	4.3	0.0	3.7	13.0	0.1	47.7	22.2	7.5	0.4	24.0	30.2	15.7	20.0	10.1	0.1	0.0	0.0	41.3	0.0	28.7	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.9	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.1	6.6	7.2	3.4	5.8	5.6	3.6	5.3	6.7	5.2	5.7
FKBP14	"FKBP22, FLJ20731"	ENSG00000106080	"FK506 binding protein 14"	Q9NWM8	7	30010587-30026684	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Deafness, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013329, HPA026829"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"			Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA013329: AB_1848613, HPA026829: AB_10601651"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.12e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.41e-3)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (6.06e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavourable (4.57e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-3)"	"prognostic unfavourable (4.25e-4)"	8.8	7.4	8.7	9.2	7.3	5.1	8.8	17.6	7.7	14.9	7.8	4.1	6.9	4.2	12.1	14.2	8.0	8.1	8.5	9.8	7.1	5.2	5.4	9.2	7.6	8.1	9.2	5.2	13.0	9.8	8.6	27.8	10.7	7.1	9.8	6.9	8.4	7.6	10.9	3.3	6.4	5.3	18.8	8.1	6.7	7.2	4.2	7.1	2.6	5.6	5.9	7.7	13.4	8.7	1.6	3.3	2.7	1.2	1.0	1.6	0.6	3.4	2.6	7.3	17.0	19.1	24.5	3.4	17.5	16.4	6.1	12.0	2.2	2.2	1.2	8.3	15.3	7.5	4.1	6.4	12.3	0.6	5.8	2.7	4.9	6.4	9.7	1.9	4.8	15.3	6.7	10.6	12.6	13.5	4.4	2.5	11.0	1.4	1.0	2.4	3.8	4.7	0.0	4.9	4.0	6.1	3.0	1.9	6.4	6.2	14.0	4.3	3.2	2.6	10.9	6.6	7.7	11.2	6.9	3.9	4.0	2.1	9.3	1.9	20.3	1.9	1.2	1.2	1.3	0.8	1.0	1.1	1.6	1.1	2.2	1.6	1.5	1.3	2.7	1.0	0.5	3.3	1.4	0.6	8.7	7.3	17.6	7.7	7.1	5.2	9.2	5.2	7.1	7.1
FLAD1	"FAD1, PP591"	ENSG00000160688	"Flavin adenine dinucleotide synthetase 1"	Q8NFF5	1	154983338-154993111	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028476, HPA028486, HPA028563"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286"	"unprognostic (2.64e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.04e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.32e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavourable (2.55e-6)"	"unprognostic (1.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.17e-2)"	16.5	16.5	20.3	15.5	18.9	12.1	17.4	15.9	20.8	14.1	16.4	19.3	14.7	19.6	15.9	21.2	19.8	16.7	11.8	16.1	18.2	10.4	19.0	36.5	13.5	20.0	20.8	15.6	14.5	19.0	13.6	12.0	18.5	15.9	18.7	19.0	16.1	16.2	16.3	26.3	23.3	23.9	17.6	12.4	22.9	16.1	19.1	18.9	15.7	20.8	18.4	22.0	15.5	15.4	25.1	24.5	15.2	24.1	14.9	26.4	22.7	13.1	21.2	13.5	23.0	11.8	8.7	25.7	10.0	8.3	14.6	12.5	18.8	16.3	15.4	20.2	9.2	17.3	25.8	20.7	9.5	16.0	19.4	12.5	16.8	13.2	16.1	18.0	16.3	12.4	27.2	16.6	17.8	16.9	20.0	12.5	12.3	28.4	12.4	12.6	29.4	22.0	20.9	6.7	35.3	13.9	18.4	22.8	31.3	15.6	35.4	19.7	30.3	27.4	10.7	9.2	12.7	11.8	15.7	19.6	24.3	26.5	11.1	14.7	14.7	15.2	23.0	14.8	24.0	20.9	26.4	25.1	22.1	22.7	24.1	20.5	20.5	20.2	5.2	14.9	24.1	24.5	23.3	22.7	20.3	18.9	15.9	20.8	18.2	10.4	20.8	15.6	15.9	18.9
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374638	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 396.7;urinary bladder: 276.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"		2900000000	2900000000	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: , HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavourable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (3.88e-4)"	42.8	8.8	2.9	46.4	3.9	22.9	30.7	2.0	5.2	106.5	204.2	6.3	86.0	13.1	158.9	54.4	140.2	79.9	121.0	18.8	3.2	2.2	17.2	5.5	29.1	21.1	3.4	5.9	77.4	7.3	1.6	4.8	20.0	9.4	129.3	13.4	19.0	12.6	98.8	13.7	15.0	50.2	396.7	3.6	25.5	82.7	29.9	2.9	12.1	11.7	16.3	15.1	276.1	64.5	6.3	13.1	7.1	19.7	5.9	22.6	24.1	87.2	67.8	23.9	30.8	20.9	27.7	39.4	58.4	65.1	53.6	47.7	43.9	16.2	7.5	151.6	90.7	50.1	21.5	51.2	15.1	30.8	7.5	24.2	88.7	15.2	38.5	28.6	31.8	26.5	12.4	79.8	31.9	39.8	6.8	52.3	38.3	20.0	13.6	9.9	25.2	45.1	13.7	21.7	6.7	20.8	18.2	5.3	12.1	48.8	7.9	39.3	7.6	9.0	95.2	61.2	59.0	62.0	107.6	32.8	19.2	15.2	56.9	19.2	61.2	4.1	11.5	7.1	22.6	15.2	14.3	6.3	10.5	18.7	13.1	3.0	4.0	9.1	2.6	5.9	19.7	1.7	12.8	24.1	2.9	3.9	2.0	5.2	3.2	2.2	3.4	5.9	9.4	2.9
FLNB	"ABP-278, FH1, FLN1L, LRS1, TABP, TAP"	ENSG00000136068	"Filamin B"	O75369	3	58008400-58172251	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Differentiation, Myogenesis"	"Actin-binding, Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 70.2;TIME: 79.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004747, HPA004886, CAB019322"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Actin filaments,Cytosol"		37000000	37000000	"Plasma membrane"	"Golgi apparatus, Actin filaments, Cytosol"	"CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavourable (8.45e-5)"	"unprognostic (9.23e-2)"	"prognostic favourable (3.45e-6)"	"unprognostic (4.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.33e-1)"	24.7	17.8	7.8	25.3	10.6	2.2	30.0	12.6	7.4	21.3	33.5	17.2	49.6	19.4	36.1	47.4	18.6	17.3	16.0	7.7	10.6	8.5	20.6	29.2	14.1	9.4	16.1	5.3	22.9	22.4	25.6	7.8	36.0	13.2	35.8	28.5	20.1	25.5	44.0	7.7	28.9	50.2	39.7	24.3	12.1	21.2	11.7	13.5	49.3	28.2	12.0	13.0	32.8	34.7	3.8	15.9	7.4	1.2	5.9	4.9	1.2	19.8	34.0	3.4	5.0	2.3	4.0	59.9	7.4	6.0	16.5	16.9	34.0	34.0	3.2	2.8	26.0	32.7	6.4	47.2	16.1	17.9	3.1	2.7	28.9	16.5	17.1	2.3	9.8	6.3	20.5	22.9	70.2	55.8	4.5	1.0	10.2	4.3	7.2	5.7	5.3	29.4	3.2	0.9	2.8	22.1	33.9	3.8	3.6	37.5	20.6	4.1	17.0	6.6	79.1	4.3	13.5	51.5	26.3	0.7	0.2	2.6	16.0	4.3	4.5	7.4	0.3	4.2	0.5	0.8	2.6	3.8	1.6	0.7	1.2	1.6	4.9	3.5	0.1	5.9	1.2	15.9	1.7	1.2	7.8	10.6	12.6	7.4	10.6	8.5	16.1	5.3	13.2	13.5
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830377-128859274	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 546.8"	"Cell line enhanced"	"Detected in many"		"BJ: 78.6;fHDF/TERT166: 35.8;hTEC/SVTERT24-B: 38.9;U-2 OS: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006135	Enhanced		Supported	"Plasma membrane,Cytosol"		54000000	54000000	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavourable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavourable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavourable (3.73e-5)"	2.6	0.8	0.5	7.1	0.7	0.2	0.7	0.3	1.0	5.2	24.4	1.4	18.4	1.9	14.0	10.1	16.0	4.8	13.3	70.0	0.8	0.5	0.4	0.3	1.4	0.3	1.4	0.5	3.1	0.6	1.0	0.3	0.6	1.9	11.9	2.1	1.7	3.1	20.2	546.8	1.0	5.2	69.0	4.7	0.3	10.0	1.3	0.6	0.0	4.7	40.0	2.2	39.6	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	7.1	8.6	0.8	78.6	14.9	22.4	10.8	24.4	0.2	0.0	13.3	35.8	0.0	4.8	0.1	13.3	0.0	2.6	0.0	4.0	0.0	9.0	0.0	0.0	16.3	0.0	38.9	0.0	13.9	9.4	0.0	15.2	0.0	0.0	0.3	13.1	4.5	0.0	26.0	0.2	0.0	0.0	0.4	1.4	0.1	0.0	0.0	0.1	0.3	28.8	7.8	33.6	2.0	0.0	0.0	0.0	0.0	26.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.6	0.8	0.5	1.4	0.5	1.9	0.6
FLVCR1	"AXPC1, FLVCR, MFSD7B, PCA"	ENSG00000162769	"Feline leukemia virus subgroup C cellular receptor 1"	Q9Y5Y0	1	212858255-212899363	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Erythrocyte maturation, Transport"	Receptor	"Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.6"	"Cell line enhanced"	"Detected in all"		"NTERA-2: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046646	Approved		Approved	"Cell Junctions"				"Cell Junctions"		"HPA046646: "	"unprognostic (2.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (2.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.88e-2)"	"prognostic favourable (3.50e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (1.06e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-2)"	"unprognostic (7.29e-3)"	3.2	3.8	4.6	4.5	7.2	7.8	4.8	11.3	5.9	4.4	12.9	4.7	3.3	13.5	4.0	7.5	3.2	3.6	3.6	2.5	5.0	7.5	3.5	3.1	3.7	4.1	5.3	5.9	4.0	5.1	7.0	16.8	3.5	7.2	5.3	4.4	4.0	2.9	4.3	1.6	4.3	40.6	3.8	4.8	4.2	7.1	4.0	5.5	5.4	3.6	2.1	3.3	4.0	5.0	1.2	1.6	4.7	0.8	0.7	1.4	0.2	4.7	6.3	9.9	3.0	1.7	2.0	18.5	1.4	1.0	2.8	1.7	9.2	8.8	5.2	2.6	1.0	7.2	10.6	3.1	2.8	3.0	4.6	3.1	6.2	8.4	1.9	8.1	5.0	1.6	2.1	3.0	3.9	2.2	8.1	4.4	1.9	1.8	2.3	4.0	32.4	4.5	5.1	9.0	6.0	3.5	4.6	10.7	7.5	6.5	6.5	5.9	10.6	3.8	1.3	1.4	3.4	4.5	6.3	2.7	5.4	6.2	2.0	4.7	1.7	1.6	0.8	4.7	0.8	0.6	0.9	0.9	1.2	1.0	0.5	1.2	1.2	1.1	2.6	0.7	0.8	1.6	1.4	0.2	4.6	7.2	11.3	5.9	5.0	7.5	5.3	5.9	7.2	5.5
FLVCR2	"C14orf58, FLJ20371, MFSD7C"	ENSG00000119686	"Feline leukemia virus subgroup C cellular receptor family member 2"	Q9UPI3	14	75578617-75663214	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 45.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.5;ASC TERT1: 11.5;BEWO: 35.4;MCF7: 12.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 11.3;intermediate monocyte: 12.1;myeloid DC: 6.2;non-classical monocyte: 8.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 6.2;monocytes: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037984	Enhanced									"HPA037984: AB_10672733"	"unprognostic (2.42e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.44e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.80e-2)"	"prognostic favourable (2.53e-5)"	"unprognostic (6.69e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.16e-1)"	5.6	11.6	1.4	6.5	2.6	3.0	2.4	0.7	2.4	2.5	24.1	1.9	0.9	12.5	1.4	2.9	2.4	2.0	2.6	3.0	1.7	1.0	8.3	19.0	11.5	7.7	4.8	0.7	2.4	0.8	0.8	4.1	25.6	5.0	2.3	5.2	30.9	8.7	2.5	7.6	5.1	45.7	2.8	6.0	17.5	1.1	15.6	2.6	1.1	3.2	5.6	3.3	2.2	4.2	0.1	6.2	0.5	12.1	0.3	1.3	3.0	1.7	1.3	0.4	1.9	26.5	11.5	35.4	0.3	1.4	1.5	1.2	2.9	0.2	0.0	0.1	0.1	0.2	4.6	0.1	0.6	8.9	0.3	0.0	1.3	6.1	2.1	0.0	0.3	5.3	3.7	1.9	1.1	0.3	0.1	0.2	4.8	12.2	0.0	0.9	0.8	2.1	0.0	1.2	0.0	1.7	2.4	0.0	0.0	0.9	3.9	0.7	2.1	4.7	4.1	1.9	0.7	1.0	0.0	0.3	0.5	0.0	5.5	1.1	0.3	0.0	11.3	0.5	0.3	12.1	1.0	0.0	0.9	0.3	6.2	0.1	0.7	0.1	0.3	0.3	8.9	0.1	1.3	3.0	1.4	2.6	0.7	2.1	1.7	1.0	4.8	0.7	5.0	2.6
FMO3		ENSG00000007933	"Flavin containing monooxygenase 3"	P31513	1	171090877-171117819	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 170.2"	"Group enriched"	"Detected in some"	4	"ASC diff: 24.8;ASC TERT1: 18.8"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 94.9"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013750	Enhanced									"HPA013750: AB_1848968"	"unprognostic (1.87e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.31e-3)"	"prognostic favourable (3.46e-4)"	"prognostic favourable (5.60e-5)"	"unprognostic (2.95e-1)"	"unprognostic (9.34e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.27e-2)"	9.5	2.0	0.0	0.8	0.2	0.0	1.3	0.1	0.1	0.2	0.8	0.1	0.1	0.3	0.6	1.2	1.7	2.3	0.3	0.8	0.0	0.1	6.4	170.2	3.7	1.5	0.2	0.0	0.9	0.7	0.3	2.7	0.0	1.4	0.2	0.1	3.6	0.9	0.1	1.9	0.8	0.4	0.2	0.1	0.1	0.6	0.5	0.1	0.0	0.8	1.2	2.6	0.2	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	18.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.0	1.4	0.1
FOLR1	FOLR	ENSG00000110195	"Folate receptor 1"	P15328	11	72189558-72196323	"Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 157.6;salivary gland: 101.2"	"Group enriched"	"Detected in some"	7	"HeLa: 81.7;RPTEC TERT1: 86.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Region enriched"	"Detected in many"	20	"pons and medulla: 157.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 23.1;hippocampal formation: 49.6;pons and medulla: 45.9;thalamus: 34.0"	"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"	81000	81000	"Nuclear membrane"		"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.0	0.7	1.3	0.2	1.7	0.0	6.6	0.6	3.5	31.4	0.1	21.4	2.8	0.0	1.0	3.5	1.6	46.7	1.0	0.2	7.9	1.8	38.8	0.2	47.0	0.0	0.8	0.4	8.9	1.8	0.4	3.5	24.5	157.6	1.5	0.0	17.0	101.2	4.0	0.1	0.9	0.1	0.0	0.7	0.0	7.4	0.4	0.2	0.0	12.7	2.6	3.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	7.6	7.7	0.0	7.9	0.1	0.1	0.4	0.3	0.0	0.0	0.2	0.1	81.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.6	0.0	86.8	0.0	0.0	0.5	0.2	1.2	0.0	11.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.3	1.7	0.6	3.5	7.9	1.8	0.8	0.4	157.6	0.2
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	"Lyase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 126.8"	"Cell line enriched"	"Detected in some"	29	"Hep G2: 44.4"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.5"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.5"									"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"		580000	580000	Cytosol	"Plasma membrane"	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favourable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favourable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.2	0.0	0.6	0.2	1.6	0.0	0.2	0.2	0.7	0.2	0.3	0.2	0.2	0.3	0.2	2.0	0.2	0.0	0.2	0.2	0.5	0.4	25.9	126.8	0.2	0.2	0.4	0.2	0.2	1.0	0.0	0.2	0.2	0.2	0.3	0.0	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.2	0.1	1.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	44.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	2.5	0.1	0.6	1.6	0.2	0.7	0.5	0.4	0.4	0.2	0.2	0.2
FTSJ1	"CDLIV, JM23, MRX44, MRX9, SPB1, TRM7, TRMT7"	ENSG00000068438	"FtsJ RNA methyltransferase homolog 1"	Q9UET6	X	48476021-48486364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002718	Approved		Approved	Cytosol				Cytosol		"HPA002718: AB_1078914"	"unprognostic (2.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.77e-2)"	"prognostic unfavourable (1.74e-5)"	"unprognostic (1.95e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.96e-3)"	"unprognostic (2.06e-3)"	"unprognostic (7.82e-2)"	"prognostic unfavourable (5.24e-10)"	"unprognostic (2.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.23e-1)"	17.6	19.4	12.3	18.2	21.6	18.4	17.1	18.7	21.2	23.3	11.7	13.6	20.8	10.7	18.5	12.6	19.0	15.9	12.8	15.0	9.9	10.3	15.9	21.3	16.9	22.9	13.6	9.2	17.4	36.6	13.9	16.2	11.3	14.9	13.3	10.6	12.4	20.8	18.6	17.3	18.0	12.0	16.6	11.0	19.6	17.8	14.6	15.2	17.2	20.0	24.8	18.6	17.3	17.2	17.1	16.8	10.7	16.1	15.9	26.9	15.1	25.5	17.7	6.8	26.9	9.7	10.2	11.1	12.6	12.1	18.4	14.6	10.5	35.9	14.9	9.4	19.2	17.3	13.5	44.3	8.3	11.3	12.7	9.5	22.4	11.8	27.7	13.0	24.0	9.5	22.4	23.1	22.8	12.8	8.0	12.5	23.8	14.5	16.8	9.3	15.3	30.4	13.7	22.2	30.9	17.3	8.6	9.2	9.1	20.0	11.0	9.2	12.6	7.5	12.5	14.6	19.8	30.3	15.3	16.9	13.1	10.7	32.2	24.5	15.2	9.2	14.1	10.7	21.9	16.1	26.9	17.1	18.9	22.1	16.8	16.9	17.3	21.9	2.0	15.9	15.1	11.6	17.5	15.1	12.3	21.6	18.7	21.2	9.9	10.3	13.6	9.2	14.9	15.2
FUCA1		ENSG00000179163	"Alpha-L-fucosidase 1"	P04066	1	23845077-23868294	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046542, HPA056371"	Enhanced				"Intracellular and membrane"	65000000	65000000			"HPA046542: AB_2679691, HPA056371: AB_2683108"	"unprognostic (6.94e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.68e-3)"	"prognostic favourable (2.45e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.99e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.23e-2)"	"prognostic favourable (5.70e-13)"	"unprognostic (3.75e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-3)"	15.8	18.0	4.6	24.1	7.1	0.9	8.9	4.2	8.1	13.1	30.2	6.9	28.4	20.4	9.9	35.7	8.7	12.7	22.6	15.0	4.7	6.4	28.9	39.3	20.7	66.7	4.8	4.7	19.4	15.5	12.2	10.9	31.9	8.0	15.2	33.5	13.8	22.6	18.5	6.9	6.6	42.3	7.4	7.1	32.3	14.8	15.6	2.9	11.6	27.3	8.0	25.1	23.6	7.8	8.3	15.2	16.8	34.8	14.4	9.9	19.0	5.2	3.6	0.7	10.9	1.4	0.1	3.8	5.6	11.7	5.9	11.1	4.8	56.3	7.9	14.2	7.1	3.2	5.2	12.0	7.8	5.6	8.7	6.5	3.2	10.8	5.0	0.6	21.8	5.4	6.8	2.1	2.8	2.3	3.0	0.1	7.0	5.7	1.6	5.8	1.8	5.7	8.9	0.0	8.6	22.0	13.6	3.7	3.6	16.2	6.3	8.5	4.7	2.6	0.6	2.0	3.2	13.4	1.9	9.9	10.0	2.8	5.0	19.7	3.2	13.7	34.8	16.8	9.9	34.5	8.5	8.3	7.2	8.4	15.2	4.7	7.0	8.2	4.3	14.4	28.7	8.8	7.0	19.0	4.6	7.1	4.2	8.1	4.7	6.4	4.8	4.7	8.0	2.9
FXN	"CyaY, FA, FARR, FRDA, X25"	ENSG00000165060	Frataxin	Q16595	9	69035259-69120427	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022164, HPA068304"	Supported		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"CAB022164: , HPA068304: "	"unprognostic (3.38e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.37e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.74e-2)"	8.7	19.9	10.8	9.1	9.8	21.9	11.8	13.9	11.0	8.3	9.3	12.3	11.6	6.6	12.4	11.7	9.2	9.6	7.2	20.2	8.7	10.1	10.2	40.2	9.5	12.8	11.7	8.5	16.8	25.9	18.8	8.6	8.4	10.5	9.9	11.6	12.1	11.9	13.6	25.1	5.2	7.2	16.6	8.9	12.9	9.2	13.3	9.7	3.7	11.1	9.5	9.6	10.5	7.9	15.8	17.7	2.0	18.5	24.2	28.3	19.1	11.2	9.6	15.7	7.5	7.2	10.7	15.2	8.2	7.2	12.5	9.7	5.1	7.3	20.2	6.3	8.5	12.4	18.5	18.7	15.8	23.6	21.1	28.5	6.3	37.5	12.3	20.8	12.4	11.8	15.1	12.5	13.6	16.7	21.3	19.8	11.6	11.0	5.9	9.1	21.2	19.1	14.0	10.8	13.8	14.4	9.4	12.1	5.4	8.4	5.5	8.5	6.2	6.4	9.9	8.2	14.3	10.7	11.8	5.6	4.8	12.0	3.8	17.2	8.2	2.0	16.7	0.1	21.5	18.5	16.3	15.8	22.0	21.2	17.7	10.3	28.3	27.1	0.8	24.2	14.1	15.0	17.0	19.1	10.8	9.8	13.9	11.0	8.7	10.1	11.7	8.5	10.5	9.7
FZD4	"CD344, EVR1"	ENSG00000174804	"Frizzled class receptor 4"	Q9ULV1	11	86945679-86955391	"CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 75.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;Hep G2: 31.8;HSkMC: 18.3;HUVEC TERT2: 36.0;TIME: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042328, HPA074833"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA042328: AB_10962494, HPA074833: "	"unprognostic (6.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.22e-1)"	"prognostic favourable (8.60e-5)"	"unprognostic (1.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.97e-1)"	75.7	5.3	3.4	6.0	4.8	0.5	57.8	1.5	4.3	11.5	9.0	1.4	32.6	2.0	13.1	13.5	6.3	9.6	8.7	12.5	3.1	2.2	17.0	8.9	19.0	4.7	2.9	3.2	12.8	6.0	4.4	10.1	7.3	5.5	9.3	4.3	20.0	7.1	56.0	17.9	3.7	5.4	8.6	2.8	8.6	8.2	5.5	1.6	0.5	11.4	11.1	3.0	8.3	20.7	0.4	0.2	0.8	0.4	1.4	0.3	0.0	0.5	0.4	1.0	2.0	25.4	6.6	1.4	3.2	2.9	1.2	1.3	2.7	0.3	0.0	0.7	1.0	1.0	1.2	0.5	1.0	0.1	0.8	1.0	0.8	31.8	7.5	0.0	0.0	18.3	0.2	1.1	0.2	36.0	1.4	0.1	0.8	0.8	0.0	0.0	1.5	7.2	0.0	1.9	0.0	3.5	5.2	0.2	0.3	1.3	0.3	0.5	4.6	0.0	17.6	3.0	2.0	3.6	0.6	0.1	0.5	0.0	0.4	0.0	0.8	0.7	0.3	0.1	0.3	0.2	0.1	0.2	0.3	0.2	0.1	0.4	0.2	0.3	0.8	1.4	0.4	0.2	0.0	0.0	3.4	4.8	1.5	4.3	3.1	2.2	2.9	3.2	5.5	1.6
FZD6	Hfz6	ENSG00000164930	"Frizzled class receptor 6"	O60353	8	103298433-103332866	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017991	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA017991: AB_1849138"	"unprognostic (8.22e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (1.20e-6)"	"unprognostic (3.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.54e-2)"	13.1	9.2	3.4	5.2	3.8	0.5	13.3	4.3	5.9	12.1	10.7	3.5	8.6	4.0	12.0	16.4	17.9	17.8	12.3	9.6	3.7	3.8	17.4	5.8	17.1	4.7	4.2	2.9	11.6	14.4	21.3	27.2	14.1	10.0	12.4	4.9	11.6	15.3	8.8	4.3	16.9	7.7	12.7	4.2	6.1	8.0	7.2	1.5	10.9	21.2	18.7	14.7	15.9	11.3	1.7	1.0	0.2	0.0	7.9	2.2	0.5	19.4	4.0	9.4	0.0	2.2	7.0	5.8	10.4	11.4	9.3	6.1	2.1	15.0	0.0	17.8	9.2	28.9	5.3	21.5	16.5	4.4	6.4	10.3	4.5	2.6	31.1	0.0	0.0	7.9	41.5	9.8	30.4	19.0	1.0	8.5	9.9	8.0	9.1	0.8	2.2	6.9	0.7	4.5	0.0	18.8	12.3	3.3	2.6	14.5	7.6	18.8	0.0	3.5	1.5	2.2	10.9	8.3	10.6	2.2	1.1	4.2	6.1	0.0	13.4	0.0	0.0	0.2	0.6	0.0	0.0	0.9	2.1	0.9	1.0	1.7	2.2	1.0	0.0	7.9	0.0	0.2	0.6	0.5	3.4	3.8	4.3	5.9	3.7	3.8	4.2	2.9	10.0	1.5
G6PC	"G6PT, GSD1a"	ENSG00000131482	"Glucose-6-phosphatase catalytic subunit"	P35575	17	42900797-42913369	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 305.4"	"Cell line enhanced"	"Detected in some"		"RH-30: 2.2"	"Cancer enriched"	"Detected in some"	72	"liver cancer: 151.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052324	Enhanced									"HPA052324: "				"unprognostic (4.23e-2)"	"unprognostic (1.49e-2)"		"prognostic favourable (5.42e-5)"				"unprognostic (8.37e-2)"		"prognostic favourable (3.79e-5)"	"unprognostic (4.79e-2)"	"unprognostic (6.46e-2)"		"unprognostic (2.56e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	5.0	0.0	0.0	5.8	0.1	0.0	0.1	0.1	1.9	0.1	0.1	0.1	23.7	305.4	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	33.7	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.5	1.1	0.2	0.5	0.4	0.0	0.4	0.2	0.2	0.5	0.6	0.0	0.7	0.2	0.2	0.0	0.1	0.2	0.3	0.7	0.2	0.2	0.4	0.0	0.0	0.2	0.3	0.1	0.1	0.5	0.8	0.0	1.3	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.7	0.0	0.1	0.5	1.1	0.3	0.3	0.6	2.2	0.2	0.1	0.7	0.4	0.6	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.7	0.2	0.9	0.3	1.4	0.2	1.1	0.2	0.1	0.3	0.1	0.2	1.0	0.2	0.2	0.0	2.2	0.4	0.4	1.1	0.5	0.1	0.5	0.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
G6PC3	UGRP	ENSG00000141349	"Glucose-6-phosphatase catalytic subunit 3"	Q9BUM1	17	44070735-44076344	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067052			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA067052: "	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.61e-1)"	"prognostic favourable (1.11e-4)"	"unprognostic (1.88e-3)"	"unprognostic (3.16e-1)"	"prognostic unfavourable (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.87e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.49e-2)"	25.4	38.1	25.8	15.6	25.4	11.1	23.4	12.9	35.3	25.3	17.8	37.8	28.3	21.1	22.0	50.9	14.4	27.7	20.5	22.2	25.4	37.8	42.8	15.3	18.7	29.8	32.9	21.3	28.1	29.1	38.4	37.7	22.2	34.0	26.1	15.2	37.4	27.7	33.8	22.9	9.9	17.7	17.8	33.1	19.7	18.2	20.7	16.0	18.5	35.1	11.4	14.8	21.4	14.0	5.9	33.4	3.1	19.0	7.2	6.1	6.5	10.0	60.3	21.1	34.0	22.5	16.7	14.8	11.6	23.8	27.1	18.2	24.9	16.4	23.2	16.7	25.8	17.4	16.1	24.7	13.0	11.9	24.7	12.7	40.8	45.4	23.4	11.4	16.2	22.0	11.9	25.7	18.1	22.5	13.1	29.7	20.2	28.1	5.6	17.7	26.4	39.3	11.8	13.2	53.8	36.8	23.8	25.4	22.5	12.8	15.3	14.8	42.3	11.7	22.4	26.9	14.3	7.2	16.1	19.7	14.1	6.6	29.9	10.0	34.1	1.2	15.2	3.1	4.6	19.0	5.6	5.5	3.6	4.4	24.6	5.9	4.6	6.1	0.5	7.2	11.1	33.4	3.5	6.5	25.8	25.4	12.9	35.3	25.4	37.8	32.9	21.3	34.0	16.0
G6PD	G6PD1	ENSG00000160211	"Glucose-6-phosphate dehydrogenase"	P11413	X	154531391-154547572	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.1"	"Cell line enhanced"	"Detected in all"		"A549: 225.5;MCF7: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 77.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 77.3"					"Low region specificity"	"Detected in all"			"HPA000247, HPA000834"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		12000000	12000000	Cytosol	"Centriolar satellite"	"HPA000247: AB_1078978, HPA000834: AB_1078977"	"unprognostic (1.73e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavourable (9.45e-13)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.25e-2)"	21.9	29.4	10.4	15.6	10.7	51.4	18.2	8.4	14.7	12.2	7.5	13.6	4.8	7.2	14.0	13.2	29.0	11.0	24.7	10.1	8.8	10.1	15.4	3.7	20.8	31.0	10.3	8.0	19.8	7.9	5.9	20.7	9.2	10.9	11.3	7.3	17.8	13.9	8.6	4.4	11.3	7.3	17.5	11.1	20.3	9.9	83.1	9.5	22.5	24.6	44.8	25.7	24.1	19.0	3.6	7.6	77.3	16.2	12.7	10.3	11.8	15.4	225.5	4.6	17.8	19.5	26.7	4.1	10.8	31.0	11.0	19.1	10.3	5.8	10.0	16.8	24.7	13.8	7.2	18.3	5.7	10.2	5.0	10.6	51.0	23.2	38.2	10.6	36.4	12.9	5.4	21.6	4.6	22.9	6.3	4.4	19.9	85.5	6.8	7.6	3.3	16.7	6.7	2.6	10.9	33.2	19.3	4.7	5.9	10.8	42.1	9.0	6.3	8.9	27.2	7.0	24.7	9.7	16.6	5.3	6.9	17.1	19.4	7.0	14.3	29.3	16.2	77.3	10.3	13.6	6.6	3.4	2.7	7.4	7.6	3.6	3.5	5.9	27.1	12.7	11.1	3.5	3.5	11.8	10.4	10.7	8.4	14.7	8.8	10.1	10.3	8.0	10.9	9.5
GAD1	GAD	ENSG00000128683	"Glutamate decarboxylase 1"	Q99259	2	170813213-170861151	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 53.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 10.5;HEL: 34.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"olfactory region: 888.9"	"CAB004415, HPA031949, HPA058412, CAB078176"	Enhanced	Supported	Approved	Vesicles				Vesicles		"CAB004415: AB_627650, CAB078176: , HPA031949: , HPA058412: "	"unprognostic (1.28e-1)"	"prognostic favourable (7.31e-4)"	"unprognostic (1.87e-2)"	"prognostic favourable (8.61e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.97e-7)"	"unprognostic (1.51e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.27e-4)"	"unprognostic (6.75e-2)"	"unprognostic (9.18e-3)"	"unprognostic (6.90e-5)"	"unprognostic (2.93e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.08e-3)"	1.2	2.0	14.5	0.9	28.1	3.7	1.0	10.6	53.9	1.8	1.0	3.1	0.0	1.0	2.6	5.5	1.2	1.1	1.0	1.0	10.8	24.4	6.0	1.0	1.1	1.1	8.6	17.5	1.1	1.1	9.5	2.8	1.4	6.0	1.8	1.0	1.3	1.0	1.3	0.9	1.0	1.1	1.0	2.6	1.0	1.0	4.0	3.4	0.0	1.1	0.0	1.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.3	0.0	3.7	0.0	0.0	0.0	0.2	0.0	1.4	0.9	2.5	3.5	0.0	0.5	0.2	10.5	1.2	0.3	0.8	1.4	7.2	34.2	3.0	0.1	0.0	0.1	0.6	0.0	3.1	0.0	1.2	0.0	8.8	0.1	0.4	0.8	0.0	0.0	4.2	3.7	0.5	2.5	0.2	4.6	4.9	3.6	1.1	6.5	0.0	1.8	0.1	0.0	0.0	6.4	0.9	1.3	3.7	0.0	0.0	0.0	6.2	1.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	28.1	10.6	36.7	10.8	24.4	8.6	17.5	6.0	3.4
GALC		ENSG00000054983	Galactosylceramidase	P54803	14	87837820-87993665	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism, Sphingolipid metabolism"	"Glycosidase, Hydrolase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 35.1;HMC-1: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022196	Approved				"Intracellular and membrane"	16000	16000			"CAB022196: "	"unprognostic (1.27e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.44e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-2)"	13.8	17.7	21.2	13.2	32.2	18.9	15.4	16.3	25.5	12.3	15.8	28.8	9.6	30.3	10.7	12.1	6.5	20.1	17.4	19.6	22.0	19.5	20.5	11.1	23.0	18.0	30.7	20.1	17.3	13.6	14.4	12.6	15.6	24.9	14.1	16.9	13.3	8.9	10.1	9.3	9.4	30.2	9.3	33.8	14.3	14.9	21.6	26.1	8.6	23.5	5.8	7.3	12.6	11.4	1.7	5.7	20.8	10.5	9.4	16.3	6.4	0.0	8.2	3.0	0.0	10.2	9.2	0.0	3.7	7.6	3.6	4.3	4.5	35.1	2.1	11.4	3.6	0.5	0.0	0.4	4.4	1.1	0.2	12.1	0.3	0.0	8.4	0.0	33.2	9.0	2.8	2.4	0.0	9.6	4.0	1.6	6.0	0.8	0.0	1.8	2.7	0.9	0.0	0.2	0.1	5.7	3.3	2.8	6.7	10.3	1.7	0.0	8.5	8.3	8.1	0.0	5.6	2.3	0.0	1.7	3.2	0.0	1.0	2.8	8.0	12.8	9.5	20.8	7.5	10.5	16.3	1.7	5.7	7.2	5.7	0.8	4.2	4.9	7.8	9.4	8.0	1.0	3.2	6.4	21.2	32.2	16.3	25.5	22.0	19.5	30.7	20.1	24.9	26.1
GALE	SDR1E1	ENSG00000117308	UDP-galactose-4-epimerase	Q14376	1	23795599-23800804	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007340			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA007340: AB_1078934"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.51e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (2.68e-4)"	"unprognostic (1.41e-2)"	4.4	5.5	4.8	5.6	6.1	1.8	5.0	4.3	8.7	9.1	22.3	3.2	12.4	20.0	3.0	6.0	26.2	6.4	34.7	3.7	4.0	4.1	18.2	26.1	7.7	3.9	3.7	5.2	2.4	15.9	7.7	3.5	29.4	3.5	4.8	23.8	5.5	32.1	6.9	1.7	3.9	30.4	4.1	3.6	8.6	46.7	3.4	2.6	3.7	2.3	9.8	19.6	8.1	8.4	3.1	10.6	2.0	18.6	19.4	5.2	4.7	16.2	19.5	7.8	12.4	2.9	4.1	7.6	11.1	15.0	19.7	14.7	17.8	54.5	3.8	15.6	6.5	18.0	6.9	28.4	15.0	8.2	4.5	10.9	9.9	19.3	29.8	4.7	3.2	8.8	15.0	18.1	45.5	16.9	12.1	1.0	14.0	17.3	7.7	5.0	2.2	19.0	9.2	7.6	4.9	31.9	10.9	3.0	6.9	20.1	18.3	19.7	13.4	3.9	9.2	14.4	21.4	14.8	13.6	5.0	12.1	5.0	15.2	20.0	7.7	1.1	7.7	1.7	5.1	15.5	5.2	3.1	3.1	4.1	10.6	1.0	3.6	2.5	2.0	19.4	18.6	3.0	5.1	4.7	4.8	6.1	4.3	8.7	4.0	4.1	3.7	5.2	3.5	2.6
GALK1	GALK	ENSG00000108479	"Galactokinase 1"	P51570	17	75751594-75765711	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Kinase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 36.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007094, HPA016960"	Approved		Approved	"Golgi apparatus,Cytosol"		8600	8600	Cytosol	"Golgi apparatus"	"HPA007094: AB_1078939, HPA016960: AB_1849430"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavourable (1.55e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavourable (1.62e-5)"	6.4	3.3	3.8	6.2	4.4	3.6	14.2	4.6	5.1	4.7	9.3	3.7	3.5	15.9	4.7	5.0	9.0	4.8	3.8	7.2	3.6	3.6	12.3	31.6	4.7	11.7	4.3	3.8	5.2	16.0	1.9	2.6	4.6	3.2	4.7	1.3	3.6	14.9	4.7	5.4	6.2	17.3	3.7	4.0	7.2	5.3	5.7	3.3	7.6	3.3	5.1	4.8	3.6	5.0	10.6	36.7	20.7	30.2	5.7	9.4	14.6	8.0	30.3	1.8	8.5	2.7	6.8	7.1	6.5	5.4	6.7	6.3	16.8	1.6	12.5	8.2	3.4	4.7	2.0	1.9	0.7	5.4	19.0	7.8	11.5	28.1	9.2	5.2	17.3	6.0	2.6	3.3	1.4	15.6	6.2	7.7	4.1	34.4	14.4	19.7	2.1	15.7	17.3	21.1	20.8	3.7	3.3	4.1	11.4	5.6	14.4	14.2	11.7	8.6	13.7	10.0	9.6	9.5	5.7	19.5	4.8	3.2	11.2	12.2	7.7	2.6	30.2	8.3	9.4	25.5	8.5	10.6	7.8	8.6	27.2	6.8	4.2	6.2	20.7	5.7	20.2	36.7	8.7	14.6	3.8	4.4	4.6	5.1	3.6	3.6	4.3	3.8	3.2	3.3
GALNS	"GALNAC6S, GAS"	ENSG00000141012	"Galactosamine (N-acetyl)-6-sulfatase"	P34059	16	88813734-88856970	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Dwarfism, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 7.1;granulocytes: 19.3;monocytes: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026404, HPA042433"	Supported		Approved	Cytosol	"Intracellular and membrane"	2400000	2400000	Cytosol		"CAB026404: , HPA042433: "	"unprognostic (3.16e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.03e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavourable (3.66e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.24e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.84e-2)"	11.9	14.9	9.3	11.2	11.1	25.0	14.8	12.9	15.4	11.1	15.5	11.5	8.8	13.3	9.0	19.9	10.2	14.8	12.7	12.5	11.2	13.9	13.7	17.8	14.7	10.6	11.8	5.2	11.9	7.3	9.9	13.2	15.6	11.6	10.5	8.3	7.1	10.6	9.0	7.1	10.0	17.2	9.4	9.4	10.4	9.5	27.4	8.8	7.9	14.5	6.1	9.0	11.1	13.0	2.1	7.1	19.3	11.2	2.4	3.1	4.7	2.5	19.3	2.8	19.8	22.3	10.7	19.4	8.1	12.6	8.9	6.9	10.1	16.7	3.2	17.2	13.2	14.9	4.1	6.4	5.4	2.1	6.4	2.0	7.9	5.7	15.0	1.5	13.1	14.9	12.5	9.9	2.8	7.6	4.3	1.9	5.2	14.8	4.0	6.4	6.5	9.0	8.6	2.5	5.3	5.5	5.9	7.3	5.6	19.2	1.8	9.6	12.5	14.2	14.1	19.5	14.9	19.9	4.4	2.0	1.9	5.4	21.1	13.1	11.5	0.9	11.2	19.3	3.1	8.0	2.6	2.1	1.8	2.7	7.1	0.9	1.7	2.1	14.2	2.4	5.6	3.0	3.0	4.7	9.3	11.1	12.9	15.4	11.2	13.9	11.8	5.2	11.6	8.8
GALNT11	GalNAc-T11	ENSG00000178234	"Polypeptide N-acetylgalactosaminyltransferase 11"	Q8NCW6	7	152025674-152122347	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Notch signaling pathway"	"Glycosyltransferase, Transferase"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 82.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039330	Uncertain									"HPA039330: AB_10795249"	"unprognostic (6.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.48e-2)"	"prognostic unfavourable (9.54e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.64e-1)"	"prognostic favourable (2.24e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.51e-2)"	10.7	9.4	11.1	5.1	18.7	3.8	10.4	20.8	21.8	9.1	7.5	11.4	7.1	5.1	9.6	9.2	9.8	8.3	9.3	9.2	11.4	9.3	82.0	7.1	9.6	4.9	7.0	13.4	10.6	29.7	19.3	10.5	15.9	34.1	12.0	6.5	21.7	7.8	9.8	8.8	8.3	6.9	9.5	6.5	8.5	7.6	7.3	4.4	4.6	12.5	5.6	6.4	9.4	8.1	6.3	8.3	8.2	12.5	15.7	19.3	8.7	10.5	9.4	14.0	15.6	32.5	32.1	14.4	8.4	9.6	7.1	6.7	7.6	11.1	0.0	22.0	13.6	5.0	6.6	11.9	8.8	8.7	9.8	2.1	8.6	6.7	10.7	9.4	11.2	28.2	15.4	5.9	5.0	12.8	10.6	0.1	17.7	9.1	8.1	8.6	11.5	7.6	0.0	6.1	0.3	23.4	16.3	12.5	16.6	14.0	6.8	11.3	10.1	8.2	11.5	9.6	3.4	12.0	9.2	3.1	4.0	0.1	19.9	9.2	32.6	5.8	8.3	8.2	19.3	9.4	19.0	6.3	10.7	17.7	8.3	3.8	9.2	14.0	4.4	15.7	12.5	2.5	7.9	8.7	11.1	18.7	20.8	21.8	11.4	9.3	7.0	13.4	34.1	4.4
GALNT12	GalNAc-T12	ENSG00000119514	"Polypeptide N-acetylgalactosaminyltransferase 12"	Q8IXK2	9	98807699-98850081	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 34.7"	"Cell line enriched"	"Detected in many"	4	"U-2197: 58.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 17.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048292	Enhanced				"Intracellular and membrane"	15000	15000			"HPA048292: "	"unprognostic (7.85e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.97e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.71e-2)"	"prognostic favourable (3.24e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-3)"	"unprognostic (6.87e-2)"	7.5	1.7	1.0	9.5	2.3	0.6	3.7	17.7	1.6	4.0	29.6	1.7	7.4	14.6	1.8	34.7	15.2	3.2	20.5	1.1	1.4	1.6	2.9	0.4	13.8	1.1	3.3	1.0	1.0	9.2	4.0	3.1	1.0	2.7	4.2	24.8	4.0	15.2	6.6	1.1	2.6	22.4	15.4	1.3	1.5	23.5	3.4	1.1	2.8	9.3	8.1	23.9	9.0	3.4	0.8	0.4	1.6	0.0	2.2	2.5	0.4	1.8	1.4	1.2	4.8	3.7	2.9	0.0	0.5	0.7	0.7	1.7	0.3	7.7	0.0	1.8	0.3	13.5	1.0	0.4	0.6	9.1	0.6	0.8	0.1	0.0	0.1	0.5	0.2	1.4	0.3	2.3	0.0	0.8	10.3	0.0	0.2	4.8	0.9	1.6	6.0	2.0	2.2	0.1	0.0	0.8	2.7	4.5	0.4	0.2	11.0	1.0	1.6	1.6	1.5	0.0	0.1	58.4	0.0	0.7	1.6	0.8	13.6	0.0	0.3	0.0	0.0	1.6	1.4	0.0	2.5	0.1	1.9	0.8	0.2	0.8	2.3	1.5	0.1	2.2	0.0	0.4	0.1	0.4	1.0	2.3	17.7	1.6	1.4	1.6	3.3	1.0	2.7	1.1
GALNT17	"GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17"	ENSG00000185274	"Polypeptide N-acetylgalactosaminyltransferase 17"	Q6IS24	7	71132169-71713600	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.9"	"Cell line enhanced"	"Detected in some"		"AF22: 9.5;NTERA-2: 7.2;RPMI-8226: 7.9;SK-BR-3: 30.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA013624, HPA047986"	Approved		Uncertain	"Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoli, Nuclear bodies"	"HPA013624: AB_1858787, HPA047986: "	"unprognostic (2.79e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (4.60e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.63e-3)"	"prognostic favourable (3.91e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.94e-3)"	1.8	7.8	8.2	2.1	13.9	0.5	1.2	25.7	42.9	2.3	4.9	1.7	1.9	0.8	7.9	4.6	8.9	4.4	2.7	19.4	13.2	4.6	2.3	0.6	3.5	0.5	2.1	12.0	22.3	9.4	0.6	4.1	0.7	4.5	9.1	1.4	1.2	1.7	8.3	1.9	0.8	1.5	12.3	1.2	3.3	1.1	3.8	0.8	0.3	9.4	0.0	1.8	10.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	7.9	0.0	0.0	0.5	0.0	0.0	30.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	13.9	25.7	22.5	13.2	4.6	2.1	12.0	4.5	0.8
GALNT3	"GalNAc-T3, HFTC, HHS"	ENSG00000115339	"Polypeptide N-acetylgalactosaminyltransferase 3"	Q14435	2	165747591-165794682	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 32.5;HaCaT: 37.5;HBEC3-KT: 25.3;hTCEpi: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA007613	Enhanced		Supported	"Golgi apparatus"		88000	88000	"Golgi apparatus"		"HPA007613: AB_1078941"	"unprognostic (1.95e-1)"	"prognostic unfavourable (2.08e-4)"	"unprognostic (1.16e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (4.10e-4)"	"unprognostic (4.13e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-1)"	1.5	1.7	1.5	6.3	1.7	14.6	12.0	2.2	1.7	11.9	21.3	3.6	6.5	15.5	2.4	8.8	23.4	15.7	26.4	0.9	1.9	2.1	15.1	2.1	15.3	0.6	4.2	1.2	6.4	31.2	3.0	23.0	7.0	4.2	13.8	21.2	1.7	35.7	5.4	0.7	6.7	37.4	0.5	4.8	23.3	28.9	17.6	3.3	1.5	37.6	15.1	20.8	11.7	9.3	3.3	7.5	21.1	5.7	5.8	5.3	2.3	20.1	0.0	0.1	0.0	0.0	0.8	13.4	4.4	1.7	1.7	4.5	12.4	32.5	0.1	0.0	0.0	37.5	0.0	25.3	3.8	0.2	3.6	0.0	3.7	0.1	0.1	3.7	0.1	0.1	35.7	0.0	9.5	0.0	0.0	16.7	1.4	14.4	0.1	1.5	0.0	2.0	0.0	0.0	0.6	6.7	16.9	2.0	0.0	0.0	18.2	4.1	8.1	0.1	0.1	0.0	0.3	0.0	0.0	8.6	4.2	0.3	0.0	3.9	0.1	21.1	3.1	13.8	5.3	4.5	4.1	3.3	1.7	3.3	5.3	3.1	0.6	1.9	10.5	5.8	5.7	7.5	2.9	2.3	1.5	1.7	2.2	1.7	1.9	2.1	4.2	1.2	4.2	3.3
GALT		ENSG00000213930	"Galactose-1-phosphate uridylyltransferase"	P07902	9	34638133-34651035	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Nucleotidyltransferase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004868, HPA005729"	Enhanced		Approved	Cytosol		120000	120000	Cytosol		"HPA004868: AB_1079130, HPA005729: AB_1079131"	"unprognostic (2.38e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-2)"	"prognostic favourable (3.11e-5)"	"unprognostic (9.68e-2)"	"prognostic favourable (6.25e-6)"	"unprognostic (7.90e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.75e-2)"	6.3	16.1	8.0	13.8	12.5	7.4	6.6	9.3	7.3	8.5	19.4	5.8	12.4	18.1	7.2	8.4	7.7	6.5	10.5	10.9	6.7	8.6	11.8	47.0	6.8	10.8	9.0	6.0	8.7	7.6	12.1	10.3	21.7	7.5	7.2	6.8	11.0	12.5	13.4	9.5	14.4	26.1	5.9	5.0	9.4	8.1	2.6	7.1	11.3	8.5	7.2	10.6	7.0	6.5	16.3	15.9	10.9	17.5	20.5	21.1	13.1	4.9	6.6	6.0	2.4	8.3	8.3	7.0	3.7	10.6	3.9	4.4	8.2	4.6	5.6	3.8	4.4	2.7	1.1	10.3	0.7	8.3	4.5	2.3	13.2	8.3	8.1	1.3	2.9	12.1	6.6	2.5	3.1	9.3	1.9	6.1	6.2	4.3	4.7	9.4	2.1	1.2	7.3	5.5	2.9	10.7	6.9	1.4	5.3	4.7	9.3	5.0	8.3	7.2	1.4	1.7	3.2	3.3	0.0	3.5	2.0	1.1	4.0	3.9	9.8	10.9	17.5	8.3	12.1	15.0	16.7	16.3	19.8	16.3	15.9	9.3	12.2	12.0	3.3	20.5	14.1	13.3	21.1	13.1	8.0	12.5	9.3	7.3	6.7	8.6	9.0	6.0	7.5	7.1
GARS	"CMT2D, DSMAV, GlyRS, SMAD1"	ENSG00000106105	"Glycyl-tRNA synthetase"	P41250	7	30594681-30634033	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Hydrolase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017896, HPA019097"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	660000	660000	Cytosol		"HPA017896: AB_1849478, HPA019097: AB_1849480"	"prognostic unfavourable (1.02e-4)"	"unprognostic (2.46e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavourable (8.48e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavourable (8.95e-5)"	"unprognostic (7.31e-3)"	"unprognostic (4.76e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavourable (1.70e-5)"	"unprognostic (3.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.32e-2)"	"prognostic unfavourable (3.04e-5)"	25.8	27.3	24.5	26.2	28.5	24.6	32.4	31.1	44.7	21.5	23.7	17.0	11.5	17.2	24.1	23.3	43.7	18.6	18.4	25.7	21.1	26.8	27.6	57.2	27.9	28.0	22.9	28.4	35.4	49.4	44.4	33.3	24.3	37.6	17.2	30.2	14.1	28.7	21.6	35.6	33.2	18.1	30.1	17.6	23.5	30.5	29.7	14.9	28.6	31.4	33.9	38.4	22.8	25.7	22.5	26.4	21.2	27.2	15.3	27.6	21.2	33.0	16.4	14.5	51.5	27.2	40.9	27.6	49.5	44.8	25.5	51.7	21.8	16.5	55.7	14.9	60.2	26.2	36.2	31.4	44.9	13.3	16.9	25.7	13.4	18.3	86.4	37.8	22.8	38.9	55.2	36.6	43.5	32.7	50.9	64.9	40.4	20.3	32.9	26.2	39.2	31.4	16.7	12.8	43.2	29.2	14.9	17.6	29.4	13.2	37.0	70.3	33.0	58.0	30.0	12.1	40.7	24.3	31.2	64.2	53.8	65.5	42.3	57.3	56.9	21.2	19.0	17.7	23.2	25.8	23.7	22.5	23.7	25.1	26.4	19.3	25.5	27.6	5.6	15.3	27.2	18.0	25.9	21.2	24.5	28.5	31.1	44.7	21.1	26.8	22.9	28.4	37.6	14.9
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"kidney: 186.3;liver: 252.2;pancreas: 286.1"	"Group enriched"	"Detected in some"	4	"RH-30: 55.9;RT4: 14.7;U-266/70: 34.5;U-266/84: 43.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 12.8;myeloid DC: 6.9;naive B-cell: 5.9;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	6	"B-cells: 12.8;dendritic cells: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		620000	620000	Mitochondria		"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favourable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	1.8	2.5	18.5	1.6	14.7	0.6	2.9	11.4	16.2	1.5	3.1	24.9	0.3	17.8	1.3	2.2	3.0	1.7	5.0	5.5	15.2	10.3	186.3	252.2	1.2	2.1	20.6	14.3	17.6	286.1	0.7	1.2	7.8	14.5	1.7	1.7	1.5	5.5	2.1	13.5	13.9	10.8	2.7	26.1	3.5	10.0	8.0	18.4	0.7	6.6	2.5	3.1	2.2	2.0	12.8	6.9	0.3	1.5	0.1	1.5	0.8	3.4	1.7	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	5.7	8.8	0.3	0.0	0.6	4.4	0.1	0.1	0.4	0.0	0.7	0.0	0.0	0.2	5.1	0.7	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.6	0.1	3.1	0.0	0.1	55.9	0.4	0.9	14.7	6.5	1.1	1.8	0.1	0.3	0.7	5.8	0.0	0.0	0.1	0.0	1.7	34.5	43.6	0.2	0.4	0.1	0.3	0.0	1.1	0.3	0.3	1.5	0.0	12.8	0.0	0.3	6.9	5.9	0.0	1.5	0.0	0.1	0.6	6.8	0.0	0.8	18.5	14.7	11.4	16.2	15.2	10.3	20.6	14.3	14.5	18.4
GBA	"GBA1, GLUC"	ENSG00000177628	"Glucosylceramidase beta"	P04062	1	155234452-155244699	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease mutation, Gaucher disease, Ichthyosis, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 101.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006667, CAB037171, CAB037289"	Supported				"Intracellular and membrane"	200000	200000			"CAB037171: AB_1078958, CAB037289: AB_1078957, HPA006667: AB_1078979"	"unprognostic (6.03e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.00e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.94e-2)"	19.2	29.7	14.8	13.9	24.5	21.9	15.3	8.7	33.4	16.5	20.1	25.2	18.1	13.8	16.9	30.4	18.9	12.7	16.5	13.6	15.8	18.9	31.8	24.6	17.9	15.4	18.5	16.5	13.1	19.2	101.2	32.1	46.2	28.1	14.4	23.5	25.3	22.3	24.3	6.0	21.6	16.6	17.7	19.3	24.5	14.6	9.7	13.1	13.7	22.2	8.7	17.5	16.3	15.2	7.3	13.9	17.9	22.3	6.6	14.0	12.4	8.5	16.5	5.9	8.0	61.7	13.6	6.8	15.1	53.7	22.5	28.5	9.6	31.3	5.9	16.8	35.3	17.3	8.3	10.7	12.0	12.4	5.8	4.9	10.9	5.2	17.7	5.8	20.6	17.8	9.0	47.3	7.2	20.0	5.1	10.0	26.4	18.5	7.1	2.6	3.7	11.7	6.0	9.6	24.2	15.1	6.6	5.6	7.7	13.2	31.7	33.4	23.8	14.1	15.1	17.0	7.6	21.3	12.0	20.0	16.9	4.6	29.7	5.3	13.0	12.2	21.6	9.1	13.4	22.3	8.7	7.3	10.3	9.0	13.9	5.5	7.4	7.8	17.9	6.6	21.2	7.8	14.0	12.4	14.8	24.5	8.7	33.4	15.8	18.9	18.5	16.5	28.1	13.1
GBA2	"AD035, DKFZp762K054, KIAA1605, SPG46"	ENSG00000070610	"Glucosylceramidase beta 2"	Q9HCG7	9	35736866-35749228	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024026	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024026: AB_1849530"	"unprognostic (3.34e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.69e-2)"	"prognostic favourable (6.00e-4)"	"unprognostic (9.01e-3)"	"prognostic favourable (1.24e-11)"	"unprognostic (7.62e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.69e-2)"	"prognostic favourable (6.60e-4)"	15.6	19.3	28.9	17.0	23.3	11.0	24.3	42.3	41.6	14.8	35.1	17.0	28.4	41.5	19.0	22.3	16.6	16.8	21.4	34.6	22.4	21.0	34.8	25.0	20.9	17.3	23.7	19.5	16.4	20.9	27.9	27.1	19.3	36.6	23.9	32.8	28.4	27.7	25.5	46.1	23.5	51.1	23.3	21.0	23.4	26.9	11.6	19.5	10.9	25.4	15.5	16.4	18.2	16.9	5.6	6.8	12.2	6.1	3.1	7.3	3.1	8.1	13.5	18.7	18.1	9.1	5.6	19.0	11.1	8.8	11.4	12.0	15.0	6.5	8.8	8.1	6.7	8.6	17.9	7.5	5.7	12.4	12.2	9.4	35.4	16.1	10.1	14.0	23.5	9.6	14.1	9.6	10.1	29.7	9.2	16.9	10.5	8.1	3.8	14.5	19.4	21.5	7.0	7.5	7.4	15.8	19.3	15.3	20.5	6.2	15.7	11.0	10.7	12.7	20.6	12.3	14.9	10.5	13.5	11.5	7.3	7.3	15.5	5.1	9.5	12.2	4.4	2.9	6.0	6.1	4.1	5.0	5.8	7.3	4.2	5.6	3.7	3.2	4.9	3.1	3.7	6.8	4.0	3.1	28.9	23.3	42.3	41.6	22.4	21.0	23.7	19.5	36.6	19.5
GBE1		ENSG00000114480	"1,4-alpha-glucan branching enzyme 1"	Q04446	3	81489699-81762161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9"	"Cell line enhanced"	"Detected in all"		"ASC diff: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038073, HPA038074, HPA038075"	Enhanced		Approved	Nucleoplasm,Cytosol		5900000	5900000	"Nucleoplasm, Cytosol"		"HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545"	"unprognostic (3.10e-1)"	"unprognostic (1.02e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.83e-3)"	"unprognostic (3.78e-3)"	23.1	22.4	2.2	7.8	4.2	5.6	19.2	4.2	4.6	6.4	7.7	5.2	5.2	4.1	8.4	4.9	7.5	4.9	11.5	19.7	3.6	4.3	14.0	36.3	11.3	7.5	7.9	3.4	8.2	5.7	8.2	11.6	11.4	8.4	5.7	4.5	9.9	8.0	10.1	56.9	5.9	6.3	7.2	6.1	8.0	4.5	4.6	4.1	5.4	6.5	11.2	4.5	9.6	10.0	11.6	13.6	14.5	11.4	13.0	7.2	6.1	12.0	7.3	2.4	34.6	60.9	46.3	4.4	20.0	28.6	12.0	20.4	1.4	3.1	13.5	8.8	24.6	1.4	2.0	9.2	28.3	6.3	1.1	4.2	15.1	4.5	41.9	14.1	3.7	34.1	6.9	19.3	19.9	26.6	3.2	7.8	39.0	3.5	2.3	16.8	2.4	11.1	4.4	11.0	15.8	8.5	4.1	1.2	1.6	13.0	3.8	4.1	2.7	11.7	37.0	24.9	5.8	17.4	18.5	35.7	4.1	4.9	40.5	9.5	10.1	6.3	11.4	14.5	5.6	10.4	5.4	11.0	6.0	5.9	13.6	11.6	7.0	7.2	11.0	13.0	10.8	4.5	5.0	6.1	2.2	4.2	4.2	4.6	3.6	4.3	7.9	3.4	8.4	4.1
GCDH	ACAD5	ENSG00000105607	"Glutaryl-CoA dehydrogenase"	Q92947	19	12891026-12914207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043252, HPA048492"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA043252: AB_2678390, HPA048492: AB_2680418"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.79e-3)"	"unprognostic (8.07e-3)"	"unprognostic (8.20e-3)"	"unprognostic (3.14e-2)"	"prognostic favourable (7.28e-5)"	"prognostic favourable (3.35e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.46e-2)"	"prognostic favourable (6.79e-8)"	"unprognostic (7.09e-3)"	"unprognostic (3.42e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.59e-1)"	12.5	12.1	11.4	8.6	13.3	8.2	9.5	11.5	14.0	9.5	10.5	15.5	8.6	9.1	11.7	7.3	9.1	10.5	7.5	19.8	9.3	8.0	20.2	62.6	6.3	12.1	15.5	14.1	13.7	12.3	7.9	8.7	4.9	9.7	10.4	6.9	9.6	14.7	9.7	17.5	6.6	8.1	8.2	8.7	8.6	11.3	4.9	11.8	13.0	10.9	13.7	9.0	12.0	6.6	10.9	14.5	7.2	8.1	21.7	20.6	12.3	11.2	6.2	6.7	12.4	9.9	4.9	6.2	8.4	5.0	9.8	7.4	11.5	4.8	16.3	15.8	4.6	7.1	9.3	7.2	4.9	14.0	9.9	10.4	10.9	14.1	11.3	19.6	8.3	6.3	9.0	6.9	7.5	8.4	25.3	5.1	4.8	12.3	23.0	17.2	7.6	16.2	22.0	6.9	31.6	5.7	5.1	14.9	9.0	11.8	10.3	7.2	8.0	13.0	5.9	8.0	6.0	14.8	8.0	27.3	13.8	17.1	5.6	22.5	6.9	7.2	8.1	4.6	11.7	7.1	11.6	10.7	15.0	13.7	14.5	10.9	20.6	15.5	2.0	21.7	5.3	8.6	12.5	12.3	11.4	13.3	11.5	14.0	9.3	8.0	15.5	14.1	9.7	11.8
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902852	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease mutation, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.8;liver: 58.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.6;Daudi: 13.2;SH-SY5Y: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 15.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favourable (8.69e-4)"	"prognostic favourable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (6.67e-4)"	4.8	5.2	1.3	5.7	4.5	26.8	2.1	0.6	1.1	2.2	5.5	1.2	1.5	7.5	1.8	1.9	3.8	1.3	1.6	1.5	1.6	4.3	7.9	58.2	11.6	6.7	2.9	0.7	1.4	3.2	0.3	2.5	2.5	2.8	2.9	4.0	5.2	2.5	4.7	1.4	2.5	9.1	2.0	1.7	10.0	4.2	3.6	1.1	13.0	2.3	2.0	8.5	2.9	2.5	1.6	3.0	0.4	11.5	2.3	3.2	1.3	1.9	0.6	0.7	3.5	0.0	0.0	11.6	0.0	1.2	0.8	2.2	0.9	0.6	13.2	3.3	0.1	2.0	5.7	0.9	0.0	5.1	4.9	0.3	0.2	1.9	5.6	0.0	1.2	1.4	1.6	1.9	0.0	0.4	0.8	0.0	0.0	6.8	7.1	0.2	1.1	4.5	5.8	1.4	0.0	1.6	2.7	5.8	29.3	2.4	1.5	0.7	5.6	1.6	0.2	0.1	1.9	3.7	2.3	5.6	4.2	3.2	2.4	4.5	0.0	0.0	3.0	0.2	3.0	6.3	2.5	0.8	1.6	2.1	3.0	1.6	3.2	1.8	0.4	2.3	11.5	0.1	2.3	1.3	1.3	4.5	0.6	1.1	1.6	4.3	2.9	0.7	2.8	1.1
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44144271-44198170	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pituitary gland: 46.8"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 12.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.4;naive CD4 T-cell: 4.8"	"Group enriched"	"Detected in many"	17	"B-cells: 4.4;T-cells: 4.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	1.1	0.5	3.2	0.7	2.8	0.0	0.7	9.5	3.7	1.4	1.4	1.3	0.7	0.3	1.5	1.5	0.7	2.3	0.9	7.1	2.1	7.5	0.7	8.7	0.7	0.7	2.9	1.2	2.2	2.9	0.0	46.8	3.3	1.6	0.8	0.5	0.8	0.7	1.6	0.7	1.2	0.7	0.7	1.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.9	4.4	0.2	0.0	0.0	0.0	4.8	0.7	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.6	0.3	0.0	0.0	0.0	0.1	0.8	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.6	0.9	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	2.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.6	4.4	1.6	0.4	0.2	0.7	4.8	0.9	0.0	0.0	0.0	0.0	0.0	0.7	3.2	2.8	9.5	2.4	2.1	7.5	2.9	1.2	1.6	0.7
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Cell line enhanced"	"Detected in all"		"A549: 54.7;Hep G2: 46.7;RT4: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		3600000	3600000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favourable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavourable (8.24e-4)"	"unprognostic (2.30e-2)"	15.8	11.1	12.9	9.0	16.0	14.4	13.0	5.4	15.1	6.8	16.2	21.6	8.2	18.9	9.2	5.3	20.0	29.1	14.9	7.4	13.1	10.6	15.4	69.2	12.9	10.1	21.6	12.2	6.2	12.4	6.6	5.4	6.2	13.0	13.0	12.2	5.2	11.2	10.1	7.0	8.6	14.8	11.9	13.6	16.8	14.8	5.2	17.5	3.1	14.1	32.4	10.6	34.4	12.3	1.6	4.2	2.2	1.9	8.0	2.3	0.6	8.1	54.7	4.5	10.6	5.4	2.4	6.0	4.1	6.7	3.1	3.7	8.0	19.0	15.5	7.9	3.7	11.6	13.7	30.1	4.2	12.2	8.4	10.4	10.6	46.7	6.2	13.6	6.4	3.8	12.8	3.5	15.7	4.7	5.7	4.9	1.5	8.6	11.7	5.4	8.3	5.1	3.9	2.7	13.7	10.1	50.4	13.0	6.4	6.9	11.1	7.2	7.6	6.5	6.5	2.8	9.8	7.1	6.1	6.6	10.1	9.0	7.0	9.8	4.7	2.2	1.1	0.6	1.2	1.9	0.8	1.6	1.0	2.3	4.2	1.0	0.6	1.3	0.5	8.0	1.8	3.0	1.6	0.6	12.9	16.0	5.4	11.9	13.1	10.6	21.6	12.2	13.0	17.5
GCNT2	"bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3"	ENSG00000111846	"Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)"	Q8N0V5	6	10492223-10629368	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 26.2;Hep G2: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 54.8"	"Low region specificity"	"Detected in all"			HPA026776	Approved		Supported	"Golgi apparatus"		560000	560000	"Golgi apparatus"		"HPA026776: AB_1849573"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.54e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	2.0	0.9	2.5	7.9	2.8	0.7	12.7	7.6	1.9	6.0	13.0	2.0	0.9	7.8	5.6	1.3	3.7	1.7	2.8	11.8	2.2	2.4	19.6	14.3	10.4	3.3	2.4	0.4	0.9	5.5	1.0	6.2	3.1	4.0	21.9	3.7	8.1	7.4	0.9	2.3	2.5	25.1	2.6	2.2	4.2	8.3	9.0	2.9	0.9	2.4	1.2	7.2	2.0	3.0	2.1	2.5	4.2	3.1	0.5	0.4	0.7	4.2	3.5	1.2	2.9	0.0	0.0	3.5	0.0	3.1	0.8	0.2	6.2	3.1	2.4	26.2	0.0	0.1	0.3	3.2	1.8	1.6	0.9	0.5	1.8	10.9	0.0	1.1	2.9	0.0	0.0	0.3	0.0	6.9	0.3	0.0	0.3	0.0	0.0	2.2	3.9	2.4	0.1	2.4	3.8	9.3	2.3	2.6	1.8	0.0	9.2	8.8	0.1	0.4	5.9	0.5	0.4	0.0	3.4	0.0	0.0	1.7	0.5	0.2	1.4	4.2	3.1	1.3	0.3	2.3	0.1	2.1	0.3	0.4	2.5	1.3	0.4	0.4	0.2	0.5	0.8	0.6	0.2	0.7	2.5	2.8	7.6	1.9	2.2	2.4	2.4	0.4	4.0	2.9
GFER	"ALR, ERV1, HERV1, HPO1, HPO2, HSS"	ENSG00000127554	"Growth factor, augmenter of liver regeneration"	P55789	16	1984207-1987749	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Growth factor, Oxidoreductase"	"Cataract, Deafness, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041227, HPA063553"	Approved		Enhanced	Mitochondria,Cytosol	"Intracellular and membrane"			"Mitochondria, Cytosol"		"HPA041227: AB_10795538, HPA063553: "	"unprognostic (5.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-2)"	"prognostic favourable (4.06e-4)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.09e-2)"	9.7	12.2	9.7	15.2	9.9	10.7	14.8	15.2	12.5	8.1	24.8	10.8	15.2	29.6	10.1	10.2	11.0	10.2	16.1	17.8	9.8	9.7	13.7	33.5	17.1	18.1	10.7	9.7	9.4	43.8	19.2	10.9	18.0	8.0	11.9	18.0	10.5	22.5	12.5	27.5	8.3	33.2	9.2	9.6	15.2	12.8	20.0	7.8	7.7	15.1	15.0	11.4	12.4	17.1	16.1	9.1	9.8	12.7	7.8	17.7	7.7	11.3	18.1	14.9	12.1	6.3	12.6	19.3	13.2	12.9	18.6	15.2	26.0	19.0	6.4	18.0	9.8	17.1	11.3	17.4	11.8	19.7	23.1	8.8	17.8	29.5	11.4	12.7	16.6	8.1	13.5	16.2	14.6	8.7	13.7	21.4	13.5	26.7	14.5	13.8	23.8	18.1	31.8	11.4	20.7	18.9	8.9	13.1	12.5	17.8	38.0	14.1	18.1	13.6	8.1	18.1	20.2	10.1	22.6	36.3	19.6	18.3	6.0	8.7	15.2	3.1	12.6	9.8	9.2	10.5	9.9	16.1	12.6	15.6	9.1	13.4	11.5	7.9	1.1	7.8	12.7	4.0	17.7	7.7	9.7	9.9	15.2	12.5	9.8	9.7	10.7	9.7	8.0	7.8
GFPT1	"GFA, GFAT, GFAT1, GFPT"	ENSG00000198380	"Glutamine--fructose-6-phosphate transaminase 1"	Q06210	2	69319769-69387254	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms"	"Aminotransferase, Transferase"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047240			Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA047240: "	"unprognostic (4.38e-3)"	"unprognostic (8.20e-2)"	"prognostic favourable (7.13e-5)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	16.7	11.4	6.4	12.7	7.8	5.6	18.3	7.8	10.1	16.8	27.0	6.4	41.2	14.5	10.1	18.7	11.6	9.5	19.4	11.3	6.0	9.8	17.8	49.1	14.1	4.7	6.5	5.7	11.1	34.9	13.9	39.6	36.5	7.0	17.2	27.5	7.7	39.7	34.0	9.2	6.1	28.2	8.7	6.2	8.2	24.6	13.9	4.8	8.5	35.2	7.7	18.1	10.6	16.2	5.6	4.1	5.9	3.4	4.1	6.8	3.0	9.5	6.6	8.5	5.3	24.0	16.5	18.5	18.2	17.0	8.6	11.0	21.2	8.7	8.6	6.7	16.9	4.6	10.7	5.6	14.3	7.8	4.1	10.0	4.9	21.8	28.4	6.8	4.0	10.4	27.3	16.7	32.0	8.0	8.3	14.0	16.8	5.6	7.2	7.1	11.1	5.5	7.2	17.8	4.4	14.0	7.6	5.3	3.0	6.8	12.6	24.4	5.0	4.3	12.2	7.7	10.3	13.2	8.7	10.0	6.7	6.5	12.5	4.6	8.8	5.9	2.8	3.4	6.8	3.2	6.5	5.6	6.1	6.6	3.6	3.4	6.1	5.6	1.3	4.1	3.4	4.1	4.3	3.0	6.4	7.8	7.8	10.1	6.0	9.8	6.5	5.7	7.0	4.8
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24583750-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.1;seminal vesicle: 41.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.8;Karpas-707: 52.7;RPMI-8226: 51.8;RPTEC TERT1: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA045635, HPA047534, HPA065444"	Supported		Approved	Vesicles	"Intracellular and membrane"	4600000	4600000	Vesicles		"HPA045635: , HPA047534: , HPA065444: "	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favourable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favourable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	1.6	0.5	1.7	1.7	2.2	2.7	8.2	2.3	2.6	7.3	7.9	1.6	23.7	22.3	1.4	19.9	1.2	0.8	12.2	2.0	1.8	1.2	54.1	29.2	14.3	3.2	1.7	1.6	1.3	17.3	0.0	1.6	1.4	2.2	14.7	2.4	1.4	8.7	41.7	0.9	1.1	20.9	1.7	1.9	4.7	6.6	5.0	2.1	2.4	4.8	1.6	5.5	2.1	1.1	3.3	7.5	15.9	14.6	6.6	8.6	6.6	0.2	19.4	0.2	0.0	0.0	0.1	0.5	0.1	0.6	0.2	0.2	2.6	4.3	0.2	4.3	0.0	2.8	1.4	0.2	0.1	35.8	2.9	0.1	8.6	14.1	1.5	0.3	12.0	0.4	0.2	0.6	0.4	0.1	2.0	52.7	0.2	0.4	0.3	14.6	1.4	0.2	0.2	2.2	51.8	48.2	0.6	0.2	0.3	0.1	9.4	0.2	9.4	11.1	2.2	3.5	2.3	10.9	0.3	15.8	6.0	0.2	7.4	15.1	0.1	5.2	14.6	0.4	1.4	6.8	5.2	3.3	7.7	3.4	7.5	0.3	1.0	1.9	15.9	6.6	5.5	0.1	8.6	6.6	1.7	2.2	2.3	2.6	1.8	1.2	1.7	1.6	2.2	2.1
GHSR		ENSG00000121853	"Growth hormone secretagogue receptor"	Q92847	3	172445133-172448456	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.4;blood: 2.4;pituitary gland: 7.4"	"Cell line enriched"	"Detected in single"	4	"HMC-1: 1.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	25	"NK-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"NK-cells: 2.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.8"	"Low region specificity"	"Detected in all"																								"unprognostic (1.27e-1)"			"unprognostic (3.31e-2)"				0.0	2.4	0.0	0.8	0.5	0.7	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1.8	0.0	0.0	0.6	0.0	0.0		0.0	0.1	0.0	7.4	0.0		0.0	0.1		0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1										
GJA3	"CX46, CZP3"	ENSG00000121743	"Gap junction protein alpha 3"	Q9Y6H8	13	20138255-20161049	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 23.1;parathyroid gland: 6.2"	"Cell line enhanced"	"Detected in some"		"A-431: 5.6;CAPAN-2: 10.1;HL-60: 8.3;U-266/84: 5.9"	"Cancer enhanced"	"Detected in some"		"melanoma: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014821	Supported									"HPA014821: "	"unprognostic (2.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.04e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.02e-2)"	"unprognostic (9.65e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-2)"	"unprognostic (8.04e-3)"	0.2	0.0	0.1	0.1	0.9	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.3	0.1	0.8	0.1	0.5	23.1	0.1	0.0	1.2	0.1	0.2	0.1	0.1	0.1	0.1	0.3	6.2	0.1	3.9	0.2	0.4	0.0	0.2	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.2	0.0	4.2	0.1	0.2	0.1	1.0	1.6	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	5.6	0.3	0.0	4.9	0.2	1.5	0.0	0.7	4.6	0.8	0.9	0.5	10.1	0.0	0.2	1.7	0.1	3.2	2.7	0.7	0.2	2.5	2.4	0.0	0.0	0.1	8.3	0.0	0.3	1.6	0.2	0.4	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.7	1.9	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	4.9	1.1	1.9	0.0	0.0	0.0	2.0	0.3	2.2	5.9	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1
GJA8	"CAE, CAE1, CX50, CZP1"	ENSG00000121634	"Gap junction protein alpha 8"	P48165	1	147907956-147909257	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	76	"testis: 18.0"	"Cell line enriched"	"Detected in single"	13	"RPTEC TERT1: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014715, HPA062940"	Enhanced									"HPA014715: AB_2732411, HPA062940: AB_2732693"										"unprognostic (3.73e-2)"					"unprognostic (2.35e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJB1	"CMTX, CMTX1, CX32"	ENSG00000169562	"Gap junction protein beta 1"	P08034	X	71215194-71225516	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.4;liver: 114.4;pancreas: 37.1"	"Group enriched"	"Detected in some"	6	"Hep G2: 45.7;SK-MEL-30: 50.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 163.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012994	Uncertain									"CAB012994: AB_2533228"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.80e-1)"	"prognostic favourable (2.85e-6)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.97e-2)"	0.4	0.4	7.2	2.5	9.3	0.3	2.6	1.9	14.4	3.3	12.0	46.3	2.5	14.6	0.9	8.1	0.5	9.5	19.8	0.4	13.4	8.0	14.8	114.4	1.2	0.4	22.4	5.6	0.4	37.1	0.3	0.4	0.4	23.0	4.3	8.3	0.5	19.6	8.7	0.4	0.6	11.7	1.0	52.4	0.4	5.7	3.1	12.1	0.0	0.4	0.0	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	9.3	1.9	14.4	13.4	8.0	22.4	5.6	23.0	12.1
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20193010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease mutation, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 52.8;esophagus: 128.1;lymphoid tissue: 71.1;tongue: 129.0;vagina: 64.9"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 43.5;hTCEpi: 32.4;RT4: 50.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria				Mitochondria		"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavourable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	0.2	0.0	0.2	1.5	0.3	0.5	0.7	1.0	0.5	52.8	3.9	0.4	0.4	2.4	4.2	0.6	128.1	0.1	2.7	0.1	0.5	0.1	3.5	9.1	0.1	0.0	1.3	0.7	0.1	0.1	0.0	0.5	0.2	4.5	0.3	3.4	0.3	19.7	0.2	0.2	10.3	1.9	0.4	3.7	0.0	1.5	0.2	0.2	3.2	0.2	129.0	71.1	2.3	64.9	0.0	0.0	0.4	0.6	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.3	43.5	0.0	0.2	0.0	8.6	1.6	4.3	0.0	3.6	0.5	0.0	0.0	0.1	0.0	0.0	1.5	0.7	32.4	0.5	6.0	0.0	0.0	3.2	0.0	0.4	0.3	0.0	0.1	4.3	0.0	0.0	2.4	0.0	50.5	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.7	6.5	2.6	2.7	0.0	5.2	0.0	0.6	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.5	0.5	0.1	1.3	0.7	4.5	0.2
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781189-34786369	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1"	"Cell line enhanced"	"Detected in some"		"A-431: 25.9;CAPAN-2: 36.9;HaCaT: 30.0;HBEC3-KT: 25.6;hTCEpi: 42.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"				"Vesicles, Cell Junctions"		"HPA074472: "	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.1	0.1	1.0	2.4	0.4	0.0	3.4	1.4	1.2	6.3	2.2	0.0	0.6	0.0	0.7	3.0	40.1	0.5	4.1	0.1	0.2	0.1	0.5	0.8	0.6	0.4	0.1	0.1	0.2	0.2	0.0	0.1	11.3	0.0	3.7	2.8	0.0	3.7	0.9	0.2	49.3	0.6	0.2	0.1	0.1	3.2	0.5	0.0	0.7	0.2	32.1	25.0	4.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	3.5	0.0	30.0	0.0	25.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	42.1	0.0	10.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	6.7	0.0	0.0	0.0	12.5	9.9	0.0	0.0	3.9	0.2	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	1.4	1.2	0.2	0.1	0.1	0.1	0.0	0.0
GK	"GK1, GKD"	ENSG00000198814	"Glycerol kinase"	P32189	X	30653359-30731456	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.4;intestine: 37.9;kidney: 35.4;liver: 40.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 51.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 51.4"									HPA060687	Supported									"HPA060687: "	"unprognostic (8.78e-3)"	"unprognostic (8.41e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.58e-2)"	"prognostic favourable (3.24e-9)"	"unprognostic (1.59e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.11e-3)"	2.8	4.9	2.4	17.0	7.6	1.6	1.8	2.5	4.7	3.0	7.5	2.7	1.5	28.4	2.5	4.0	4.9	2.7	7.9	4.9	4.6	2.6	35.4	40.7	11.7	8.1	3.8	2.5	2.0	1.9	3.2	5.3	2.3	4.1	1.9	3.4	2.9	6.6	0.6	1.4	3.1	37.9	1.9	6.0	6.4	2.0	2.0	2.2	5.4	2.2	3.8	4.5	4.3	1.7	1.7	4.0	51.4	6.6	1.2	3.2	1.6	2.5	2.0	2.7	4.7	1.7	6.4	1.1	6.2	22.1	4.6	5.2	3.3	2.4	7.4	1.0	2.4	0.1	5.0	2.0	6.1	4.7	5.6	4.3	4.2	26.8	10.6	8.0	9.4	3.9	3.1	14.5	13.8	3.6	2.3	10.5	1.2	3.7	6.2	8.6	4.5	2.4	8.6	4.2	7.6	3.4	8.7	2.9	3.6	5.5	5.6	12.3	6.4	5.8	1.4	3.3	1.4	0.1	2.8	5.5	5.9	7.2	5.8	5.3	3.3	1.3	6.6	2.2	0.5	2.0	0.4	0.8	0.9	0.6	4.0	1.7	0.5	0.6	51.4	1.2	2.4	1.2	3.2	1.6	2.4	7.6	2.5	4.7	4.6	2.6	3.8	2.5	4.1	2.2
GLA	GALA	ENSG00000102393	"Galactosidase alpha"	P06280	X	101397803-101407925	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000237, HPA000966"	Enhanced				"Intracellular and membrane"	910000	910000			"HPA000237: AB_1078968, HPA000966: AB_1078969"	"unprognostic (7.27e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (5.62e-5)"	"unprognostic (2.53e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.73e-2)"	"prognostic favourable (6.16e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.21e-1)"	21.1	22.2	5.2	10.0	6.3	15.6	19.2	6.2	5.7	10.8	12.7	7.3	23.2	14.8	11.7	14.1	9.4	11.5	9.1	10.5	5.2	6.3	28.7	18.9	18.7	12.0	9.4	3.2	9.7	8.3	9.8	10.5	17.9	8.6	8.3	11.2	9.4	9.5	47.7	5.9	8.9	21.3	10.8	11.9	20.8	8.5	4.9	5.8	10.2	8.3	13.4	11.2	12.2	8.9	5.4	15.9	12.8	20.9	3.0	6.1	10.1	7.2	28.4	8.2	8.4	19.0	7.4	3.7	8.3	13.0	15.8	45.2	15.4	11.2	8.0	17.7	8.5	17.3	16.1	9.0	13.7	4.9	11.9	4.4	23.6	18.1	4.9	6.1	81.0	6.5	2.9	18.2	5.3	12.8	6.8	17.7	15.1	12.9	6.1	12.7	12.0	11.5	4.4	10.1	19.5	23.2	14.7	3.0	5.1	19.3	8.2	7.7	3.8	12.6	7.3	5.5	6.6	13.1	6.7	5.4	6.2	6.1	9.5	10.2	6.1	9.5	20.8	6.2	4.6	20.9	6.1	5.4	3.7	5.7	15.9	4.9	3.8	4.7	12.8	3.0	20.8	6.7	4.3	10.1	5.2	6.3	6.2	5.7	5.2	6.3	9.4	3.2	8.6	5.8
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996608-33097230	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	1700000	1700000	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: , HPA069503: "	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favourable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	17.3	33.1	9.6	14.9	14.7	9.5	18.4	8.9	19.8	18.3	21.9	12.1	19.8	21.2	18.3	55.0	12.7	15.2	25.8	13.7	9.7	10.0	35.0	33.2	24.3	25.0	9.2	9.7	18.3	25.3	28.4	16.4	26.5	14.0	13.6	23.7	23.5	21.1	17.7	6.1	12.9	28.3	15.6	9.8	21.4	22.7	10.0	8.0	8.3	26.9	7.7	19.5	18.4	13.6	11.1	45.2	22.7	39.2	6.8	20.9	20.9	5.6	9.8	6.3	7.6	39.1	20.3	136.7	9.1	24.7	11.7	15.1	13.9	13.6	2.8	8.1	18.6	5.5	6.0	11.6	8.7	16.0	5.0	10.9	5.9	7.1	20.1	7.6	11.2	23.4	11.2	10.6	6.3	18.0	9.8	10.6	12.8	6.6	4.5	5.0	4.3	4.3	3.9	4.2	13.0	12.6	8.4	1.9	6.6	11.7	19.0	11.4	12.6	19.9	10.5	7.5	5.2	10.3	7.7	8.4	13.4	0.9	15.9	11.0	5.7	10.5	39.2	22.7	8.3	34.6	11.8	11.1	10.2	9.1	45.2	10.0	5.4	6.5	15.5	6.8	23.7	9.5	20.9	20.9	9.6	14.7	8.9	19.8	9.7	10.0	9.2	9.7	14.0	8.0
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532464-6645783	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 22.3;liver: 40.3;placenta: 10.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 65.3;CACO-2: 15.5;HMC-1: 14.2;RPTEC TERT1: 27.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria		570000	570000	Mitochondria	Nucleoplasm	"HPA002318: AB_1849700, HPA052887: "	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavourable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favourable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.2	0.3	3.9	1.0	3.4	0.4	0.4	3.1	5.6	0.3	0.8	1.6	0.0	0.7	0.4	4.2	1.4	0.6	0.6	0.1	2.9	2.2	22.3	40.3	0.8	1.1	1.9	2.9	0.3	0.1	0.0	1.7	10.6	2.1	0.4	0.3	3.2	0.9	0.8	0.9	1.5	0.6	0.1	1.9	0.8	0.8	1.1	1.8	0.0	2.6	0.0	1.9	0.8	0.0	2.9	0.7	2.3	0.5	0.8	0.6	1.1	0.1	1.3	0.5	7.0	0.0	0.1	65.3	0.0	0.0	0.0	0.0	15.5	0.1	0.1	1.5	0.0	0.1	0.0	0.1	0.0	0.3	3.7	0.0	0.0	10.3	0.0	0.0	14.2	0.0	0.0	0.5	0.0	2.7	0.0	0.1	0.3	0.3	0.2	0.0	7.6	1.2	0.3	0.0	0.1	27.0	0.3	6.2	3.2	0.0	6.0	0.0	1.4	0.0	0.9	0.1	0.2	0.7	0.3	0.3	8.9	0.0	0.2	0.7	1.5	1.5	0.5	0.5	0.5	0.3	0.5	2.9	0.6	0.4	0.1	0.9	0.4	0.5	2.3	0.8	0.5	0.7	0.2	1.1	3.9	3.4	3.1	5.6	2.9	2.2	1.9	2.9	2.1	1.8
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1, RNA export mediator"	Q53GS7	9	128504700-128542288	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"				"Nuclear membrane"	Nucleoli	"HPA041689: , HPA043538: , HPA061560: "	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favourable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	12.5	17.0	11.1	13.5	13.2	12.2	14.7	22.1	13.8	13.1	15.7	16.5	17.6	14.6	13.8	11.4	18.5	13.5	12.6	13.2	10.5	8.9	13.1	20.4	11.3	23.0	11.2	9.9	15.7	21.1	20.8	16.3	16.4	10.6	13.4	17.2	13.1	13.6	16.7	23.3	18.3	14.9	12.0	9.8	17.5	12.1	42.8	11.8	27.2	12.4	14.6	20.0	14.3	13.5	16.0	19.2	26.2	22.5	22.6	20.5	15.8	10.8	20.4	10.0	17.0	9.9	10.1	13.3	11.0	9.4	15.4	11.0	13.6	7.6	22.0	8.9	12.3	38.3	17.3	15.6	13.4	20.8	11.3	11.2	22.4	12.7	11.2	18.1	14.9	7.1	15.2	17.5	18.8	8.7	16.1	19.4	17.7	25.1	17.8	12.8	8.4	17.7	18.3	24.6	29.0	10.4	9.7	11.9	8.9	26.8	16.2	9.6	30.0	12.8	6.3	16.4	11.0	19.2	15.2	19.6	47.0	17.2	15.4	13.9	17.7	26.2	18.1	20.3	20.5	22.5	16.7	12.0	16.0	18.1	19.2	16.0	14.4	16.6	15.4	22.6	22.0	11.4	18.3	15.8	11.1	13.2	22.1	13.8	10.5	8.9	11.2	9.9	10.6	11.8
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050486-87094866	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 182.4"	"Cell line enhanced"	"Detected in all"		"Hep G2: 106.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"	26000000	26000000	Mitochondria		"HPA042492: , HPA044839: , HPA061369: "	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavourable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favourable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	15.5	21.5	57.8	9.9	54.5	5.9	23.2	13.4	37.9	12.1	14.5	19.9	5.5	18.4	10.9	7.5	17.0	11.5	12.6	16.7	44.1	35.3	56.2	182.4	13.1	11.5	40.6	30.8	17.5	15.2	8.7	6.6	13.5	31.1	26.5	14.6	8.1	10.0	13.3	9.2	15.3	19.8	14.0	22.7	10.2	12.2	6.4	33.2	12.6	16.1	8.7	13.1	14.0	9.5	9.2	15.8	9.2	14.6	13.7	11.9	5.9	24.0	19.5	15.3	25.9	29.1	35.9	16.7	19.0	33.0	18.5	20.3	44.9	23.6	27.1	15.6	27.7	38.0	19.9	19.2	19.8	19.5	15.7	13.1	11.7	106.0	65.0	30.7	19.1	24.7	36.2	20.5	61.4	22.0	13.2	24.5	19.9	17.5	27.6	27.6	17.4	15.7	21.0	19.5	17.6	53.1	19.7	7.9	14.8	17.1	13.6	24.3	18.6	21.6	21.8	9.6	8.5	19.4	19.3	14.7	15.1	32.4	23.2	35.2	5.7	5.5	13.8	9.2	8.7	11.1	10.9	9.2	11.8	10.6	15.8	8.8	10.6	8.5	1.3	13.7	14.6	5.9	11.9	5.9	57.8	54.5	13.4	37.9	44.1	35.3	40.6	30.8	31.1	33.2
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182381704-182392206	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 138.5;ASC TERT1: 97.9;HSkMC: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 92.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 92.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	Mitochondria,Cytosol		28000	28000	"Mitochondria, Cytosol"		"CAB008636: AB_1616669, HPA007316: AB_1078981, HPA007571: AB_1078980"	"prognostic favourable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	173.3	19.2	83.7	37.2	91.0	47.6	63.1	48.5	80.7	41.9	20.4	49.9	9.4	6.2	20.5	29.7	54.0	31.6	26.2	23.5	74.0	48.7	15.6	64.9	39.5	36.9	71.0	48.8	66.2	49.0	7.4	8.9	41.8	70.6	17.4	23.3	39.3	30.4	25.5	159.8	27.9	16.4	30.5	51.3	36.1	71.4	24.0	55.2	8.6	63.9	15.5	24.2	34.7	32.2	2.5	11.0	92.2	21.1	3.4	6.3	18.6	2.9	1.2	13.7	0.0	138.5	97.9	10.1	5.0	16.2	3.0	2.7	7.2	3.0	2.5	5.4	9.7	6.8	5.9	35.6	2.5	6.8	16.6	33.5	5.7	14.0	7.3	14.7	26.8	84.6	42.8	3.8	45.4	6.1	28.2	1.5	10.7	1.6	22.9	14.1	10.1	6.4	8.3	3.6	4.3	5.3	13.0	9.4	6.2	1.4	18.3	1.9	17.8	18.7	4.5	0.1	0.2	0.0	1.1	0.5	0.3	0.0	2.6	8.4	0.5	43.6	21.1	54.9	6.3	20.5	2.6	1.6	4.5	5.2	11.0	2.5	2.3	3.9	92.2	3.4	17.1	6.1	1.7	18.6	83.7	91.0	48.5	80.7	74.0	48.7	71.0	48.8	70.6	55.2
GLYCTK	"HBEBP2, HBEBP4"	ENSG00000168237	"Glycerate kinase"	Q8IVS8	3	52287089-52293476	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 108.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 18.9;Hep G2: 25.1"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 52.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006913	Approved		Approved	"Golgi apparatus,Cytosol,Rods & Rings"				Cytosol	"Golgi apparatus, Rods & Rings"	"HPA006913: AB_1078993"	"unprognostic (1.51e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"prognostic favourable (1.64e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.00e-3)"	6.4	4.9	1.9	8.4	5.0	5.2	4.8	2.7	6.2	2.3	7.9	7.1	4.2	23.8	4.3	4.8	2.8	2.5	7.2	2.7	1.9	2.2	10.7	108.4	3.1	6.5	2.5	4.9	2.3	3.6	1.9	2.5	3.1	3.9	2.8	3.5	4.7	3.2	3.0	7.0	1.9	17.8	1.9	1.8	5.5	6.0	2.7	1.8	3.3	3.1	2.4	5.9	2.7	2.2	8.3	9.1	10.9	9.5	5.7	11.8	6.3	2.2	5.5	3.0	1.1	16.0	2.2	1.8	2.5	2.6	4.7	3.5	18.9	1.9	5.9	1.5	2.2	1.5	1.7	6.2	0.9	1.6	1.9	8.3	6.7	25.1	1.5	2.7	5.0	2.1	3.1	6.9	2.7	9.0	2.2	4.3	3.6	1.7	4.6	2.2	1.6	4.6	1.5	2.7	8.9	4.8	3.1	2.2	2.2	2.4	1.3	2.5	3.1	1.3	3.8	3.7	4.4	2.4	4.8	4.5	3.1	3.8	2.5	4.5	2.8	3.0	9.5	10.9	11.8	5.1	6.1	8.3	9.0	10.3	9.1	5.7	6.8	10.1	7.8	5.7	6.1	5.6	11.7	6.3	1.9	5.0	2.7	6.2	1.9	2.2	2.5	4.9	3.9	1.8
GMPPB	KIAA1851	ENSG00000173540	"GDP-mannose pyrophosphorylase B"	Q9Y5P6	3	49716844-49723951	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014657	Uncertain		Supported	Nucleoplasm		10000	10000	Nucleoplasm		"HPA014657: AB_1849852"	"unprognostic (3.48e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.77e-2)"	"prognostic favourable (6.19e-6)"	"unprognostic (1.01e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.01e-3)"	"unprognostic (5.73e-2)"	"prognostic favourable (3.17e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	7.5	17.1	7.6	17.5	8.1	7.4	9.7	4.3	9.6	14.4	13.2	7.2	28.7	12.1	11.5	23.2	15.3	12.6	13.3	10.9	5.2	4.7	13.1	41.3	12.9	15.9	8.3	6.8	10.1	32.0	8.9	23.0	15.3	6.9	16.6	11.3	7.9	50.8	37.2	7.2	8.2	12.2	7.9	4.3	16.8	18.1	6.9	5.8	16.5	16.8	8.6	17.5	8.8	9.3	13.4	34.5	10.1	11.1	5.5	11.2	8.1	17.6	17.2	12.5	7.6	10.0	7.6	12.9	20.4	12.1	20.7	19.7	11.2	13.1	10.3	9.1	12.7	10.2	10.4	22.0	7.0	9.3	8.6	7.4	19.1	13.2	23.1	11.2	11.9	5.3	9.5	29.3	23.4	18.7	5.5	17.1	11.9	13.3	15.1	5.7	6.9	20.8	5.3	6.4	17.7	11.5	16.6	8.3	8.8	9.3	22.7	6.7	12.9	7.3	12.9	14.9	14.5	20.2	21.8	19.7	5.3	7.3	15.8	7.9	17.1	10.1	8.6	3.7	10.8	11.0	11.0	13.4	9.5	11.2	8.2	10.3	7.3	8.8	2.2	5.5	11.1	34.5	6.3	8.1	7.6	8.1	4.3	9.6	5.2	4.7	8.3	6.8	6.9	5.8
GMPS	GATD7	ENSG00000163655	"Guanine monophosphate synthase"	P49915	3	155870536-155944026	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	Ligase	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046630			Approved	Cytosol				Cytosol		"HPA046630: "	"unprognostic (3.89e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavourable (5.54e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (8.73e-7)"	"unprognostic (1.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavourable (1.04e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.79e-2)"	15.9	18.3	10.4	19.7	14.0	24.6	22.4	22.1	24.9	16.1	13.9	9.8	15.3	10.3	17.5	15.4	19.5	14.0	10.8	15.3	9.2	7.7	11.0	14.7	15.8	19.5	9.3	12.1	15.7	23.5	19.1	14.1	13.5	14.8	13.0	15.3	9.0	21.6	18.6	16.6	21.0	12.6	16.1	8.9	14.6	15.4	60.9	10.5	28.3	13.6	12.5	18.4	15.9	18.5	11.1	17.2	10.9	18.1	19.0	20.7	10.8	55.8	22.1	30.1	24.5	12.2	19.4	29.0	23.8	22.1	31.5	31.9	40.3	37.7	40.4	28.5	18.3	27.5	25.5	25.0	43.4	23.4	19.6	43.0	16.2	21.8	14.0	43.7	16.8	14.3	15.4	24.3	37.3	19.3	30.2	15.5	23.4	37.5	35.4	23.1	28.8	16.4	34.9	35.6	48.7	16.2	24.6	18.0	16.7	26.5	38.0	23.8	39.7	28.8	13.5	20.9	16.9	29.5	48.0	21.7	13.3	69.1	21.0	32.6	18.6	10.9	10.4	7.2	17.3	13.1	20.7	11.1	16.8	15.7	17.2	8.8	16.8	15.8	1.4	19.0	18.1	9.5	17.6	10.8	10.4	14.0	22.1	24.9	9.2	7.7	9.3	12.1	14.8	10.5
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		Transducer	"Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 303.3;thyroid gland: 304.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"			Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favourable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	56.2	79.0	84.2	34.4	44.5	42.1	87.4	86.0	107.4	43.2	42.3	25.4	27.0	33.2	37.2	44.7	41.0	43.6	34.4	106.0	71.0	144.0	39.6	35.3	46.6	44.6	75.8	64.7	43.6	118.1	120.9	303.3	49.8	85.6	36.3	31.5	42.7	171.6	31.1	172.9	26.3	34.9	40.5	61.4	36.9	42.4	18.2	27.4	56.0	304.5	80.6	41.0	37.3	44.6	27.3	41.5	29.9	36.2	25.3	24.2	24.6	9.6	32.5	54.8	25.5	93.1	42.6	49.2	55.8	51.0	63.9	45.8	94.7	50.1	31.7	86.9	72.5	41.8	50.2	74.3	43.3	20.9	30.2	35.2	49.4	62.0	43.1	20.4	22.2	50.7	37.8	31.0	41.7	48.3	30.9	43.3	42.0	132.2	104.3	50.1	17.4	34.4	64.2	48.0	55.9	51.2	38.2	68.0	155.7	77.6	77.0	62.2	58.9	56.1	53.1	84.8	76.2	30.5	52.5	75.9	49.0	66.9	37.2	10.0	43.2	29.9	24.8	29.5	20.7	35.7	22.1	26.7	22.0	22.2	37.8	27.3	21.3	24.2	29.1	25.3	36.2	41.5	23.3	24.6	84.2	44.5	86.0	107.4	71.0	144.0	75.8	64.7	85.6	27.4
GNB1		ENSG00000078369	"G protein subunit beta 1"	P62873	1	1785285-1891117	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040736	Supported		Approved	"Golgi apparatus,Plasma membrane"		60000000	60000000	"Plasma membrane"	"Golgi apparatus"	"HPA040736: "	"unprognostic (9.49e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.07e-3)"	"prognostic unfavourable (3.61e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.27e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.90e-2)"	55.2	42.1	84.7	55.1	82.3	41.7	37.8	78.8	112.5	44.0	52.1	46.4	26.0	55.4	44.3	31.2	41.7	38.8	36.6	39.6	74.7	65.7	43.9	38.7	47.1	47.1	68.5	52.1	45.0	33.9	48.9	36.9	45.3	56.6	40.1	41.0	70.7	37.6	41.7	19.7	35.5	65.3	51.2	61.0	51.0	40.8	31.4	39.2	44.5	37.6	19.5	45.6	42.2	54.1	7.7	18.8	18.4	13.2	10.6	9.9	6.0	54.0	51.2	60.8	42.4	34.8	38.3	23.5	76.8	51.3	69.8	54.8	41.7	54.2	56.5	56.6	77.4	28.6	60.9	55.7	63.8	86.6	30.0	54.8	48.5	47.4	43.8	32.9	60.2	33.8	39.3	66.6	62.0	56.6	33.9	51.1	66.5	33.7	72.1	25.9	35.0	41.5	70.4	47.0	44.6	47.8	33.7	74.8	85.3	71.2	46.4	62.3	32.4	45.2	86.2	61.5	41.3	47.8	55.7	34.7	60.4	129.3	52.6	69.5	34.6	7.4	11.1	17.1	8.7	13.2	8.0	7.4	8.7	9.7	10.9	7.7	5.9	6.5	18.4	10.6	13.2	18.8	9.9	6.0	84.7	82.3	78.8	112.5	74.7	65.7	68.5	52.1	56.6	39.2
GNE	"IBM2, Uae1"	ENSG00000159921	"Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase"	Q9Y223	9	36214441-36277056	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.0;salivary gland: 45.3"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007045, HPA027258"	Approved		Supported	Cytosol				Cytosol		"HPA007045: AB_1079003, HPA027258: AB_1849873"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.20e-2)"	"prognostic favourable (9.28e-11)"	"unprognostic (2.90e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.72e-2)"	7.7	6.7	6.0	6.5	8.3	8.3	16.6	11.1	12.1	7.9	20.7	7.0	4.6	2.9	8.0	3.9	7.6	6.7	5.2	7.6	7.8	6.8	6.8	55.0	5.5	6.0	6.0	7.8	9.8	8.4	4.1	7.0	20.2	10.2	10.1	30.1	4.8	45.3	5.0	10.5	3.7	7.2	11.7	10.9	4.5	4.9	3.4	5.3	3.2	4.6	4.2	7.9	8.6	7.9	3.9	2.2	1.2	2.7	2.4	4.2	1.8	4.4	19.9	8.9	7.6	10.1	10.1	12.9	6.2	7.9	8.6	11.1	4.8	14.2	5.8	6.6	10.3	1.7	6.7	2.0	9.6	10.9	0.6	5.0	11.7	6.6	6.9	0.1	14.3	6.6	2.0	14.3	13.5	3.6	6.3	12.1	8.3	0.7	8.1	2.6	5.1	11.2	6.7	7.5	1.6	47.6	8.2	7.6	6.9	6.6	2.3	5.7	2.1	5.1	5.2	5.7	5.9	6.8	5.4	5.3	11.3	3.2	7.8	4.3	8.1	0.7	1.7	0.9	2.7	2.2	1.8	2.4	3.4	2.9	1.4	3.9	4.0	4.2	1.2	2.4	2.7	2.2	1.5	1.8	6.0	8.3	11.1	12.1	7.8	6.8	6.0	7.8	10.2	5.3
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960758-42963880	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 83.9;pancreas: 100.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 10.3;SCLC-21H: 12.2;T-47d: 7.8"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"cerebellum: 17.7"	"Low region specificity"	"Detected in all"			HPA027501	Enhanced		Approved	Cytosol		150000	150000	Cytosol		"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favourable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.3	0.1	0.2	0.2	0.2	0.7	1.8	0.5	0.5	0.3	0.5	0.2	1.3	0.0	0.2	0.9	0.3	0.1	0.2	1.3	0.2	0.2	0.3	83.9	1.3	0.1	0.1	0.2	0.4	100.1	0.0	2.5	0.1	0.4	5.2	0.0	0.9	8.2	0.9	0.6	0.1	0.2	0.4	0.1	0.3	6.5	0.6	0.1	0.2	0.9	0.3	0.4	0.2	0.1	0.7	3.2	2.0	0.9	0.0	1.2	0.3	0.5	0.4	1.8	5.0	0.6	0.2	0.3	0.4	2.0	0.8	1.2	0.1	0.1	1.6	0.2	0.4	0.5	0.3	0.3	0.2	2.0	1.6	1.3	1.0	10.3	0.0	1.1	2.4	0.4	0.0	0.4	0.2	0.0	1.4	1.9	0.3	2.2	2.0	3.7	0.2	0.5	1.7	1.6	1.0	0.8	0.2	12.2	1.7	0.1	1.7	0.6	7.8	3.5	0.4	0.9	0.9	0.5	1.0	1.3	1.1	1.4	0.2	2.0	1.0	0.0	0.8	0.1	0.2	0.9	0.1	0.7	0.3	0.3	0.9	0.1	0.6	1.2	2.0	0.0	0.1	3.2	0.3	0.3	0.2	0.2	0.5	0.5	0.2	0.2	0.1	0.2	0.4	0.1
GNPAT	"DAP-AT, DAPAT, DHAPAT"	ENSG00000116906	"Glyceronephosphate O-acyltransferase"	O15228	1	231241207-231277973	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cataract, Disease mutation, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (8.87e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (8.29e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.68e-1)"	14.7	20.1	18.3	17.9	17.0	9.6	34.6	18.9	17.8	12.6	18.6	14.7	16.6	18.9	13.9	16.0	14.5	18.4	13.5	39.3	16.9	13.9	16.7	19.5	20.3	24.4	17.1	15.0	15.3	26.7	14.3	15.0	12.3	16.5	15.3	16.3	10.8	20.6	18.0	61.1	14.9	19.1	24.7	17.7	13.5	18.0	26.5	15.0	16.2	13.6	20.2	15.9	14.4	13.6	23.7	23.8	23.4	30.3	16.4	23.9	18.5	15.2	17.0	24.2	18.3	20.0	29.6	16.3	12.9	14.7	13.7	15.9	21.7	19.1	22.0	16.3	19.3	16.5	16.0	17.5	20.3	24.8	14.7	15.8	16.7	31.3	20.3	26.9	12.6	20.5	21.5	14.2	16.0	32.1	23.1	21.1	28.4	5.0	23.9	15.6	38.7	19.6	26.4	32.4	25.7	17.1	11.4	16.1	23.0	21.7	12.2	18.8	21.3	42.8	16.7	14.0	13.1	20.1	32.0	27.4	34.8	25.3	20.2	22.7	25.8	17.7	24.1	23.4	16.5	24.0	19.0	23.2	21.6	21.6	23.8	23.7	19.1	17.4	9.5	16.4	30.3	11.3	23.9	18.5	18.3	17.0	18.9	17.8	16.9	13.9	17.1	15.0	16.5	15.0
GNPTAB	"GNPTA, KIAA1208, MGC4170"	ENSG00000111670	"N-acetylglucosamine-1-phosphate transferase alpha and beta subunits"	Q3T906	12	101745497-101830938	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Cancer-related genes, Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014558, HPA042343"	Approved		Supported	"Golgi apparatus"		47000	47000	"Golgi apparatus"		"HPA014558: , HPA042343: "	"unprognostic (6.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.71e-3)"	"prognostic favourable (8.48e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.86e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.98e-2)"	15.2	6.5	21.9	11.9	23.0	15.2	12.2	13.9	25.6	14.0	21.3	10.3	5.9	10.3	9.0	6.5	11.7	7.1	11.0	15.9	17.9	13.7	11.0	7.3	19.6	20.3	14.4	13.0	6.6	11.4	29.9	9.0	10.8	10.9	15.6	22.5	11.3	37.6	10.2	10.8	18.1	14.5	11.7	13.1	15.4	15.2	7.4	10.8	24.5	10.5	8.6	12.6	14.7	14.8	3.9	5.8	5.9	3.4	14.2	16.4	2.7	8.3	8.1	3.0	5.1	25.6	12.2	9.4	11.9	24.6	11.8	15.5	6.2	5.9	17.5	8.6	16.3	10.9	14.0	15.3	18.5	8.2	7.3	7.5	7.5	8.8	4.8	6.8	15.2	9.4	8.5	11.2	6.6	20.7	11.6	5.2	11.0	12.7	20.4	9.6	10.4	5.9	4.8	15.5	23.5	19.0	21.7	6.6	5.4	19.8	14.1	28.0	14.5	4.5	20.3	11.2	6.1	9.3	6.6	14.3	14.6	10.0	12.7	10.1	6.9	5.9	3.1	3.4	16.4	2.9	5.4	2.4	3.6	8.9	5.8	3.9	4.6	7.1	1.2	14.2	3.4	5.8	2.6	2.7	21.9	23.0	13.9	25.6	17.9	13.7	14.4	13.0	10.9	10.8
GNS		ENSG00000135677	"Glucosamine (N-acetyl)-6-sulfatase"	P15586	12	64713445-64759447	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 73.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"non-classical monocyte: 50.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013695, CAB026011, HPA048508"	Enhanced				"Intracellular and membrane"	940000	940000			"CAB026011: , HPA013695: AB_1849741, HPA048508: "	"unprognostic (8.07e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (7.76e-4)"	"unprognostic (9.33e-2)"	"prognostic unfavourable (1.94e-5)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.04e-1)"	57.0	96.7	9.0	18.2	10.1	7.4	47.5	7.7	11.6	22.6	19.1	15.4	17.7	11.5	27.1	27.4	14.3	18.7	21.9	33.0	9.0	10.7	48.9	36.7	26.6	48.8	9.6	8.7	32.7	16.0	32.2	16.6	43.5	15.5	18.6	12.8	38.2	17.9	17.1	18.2	13.5	21.6	23.6	10.8	33.6	16.5	19.3	8.4	9.1	31.4	10.4	11.7	23.9	18.2	3.0	18.2	12.9	50.0	3.9	7.0	19.0	8.1	12.6	10.4	17.1	52.4	31.6	22.2	19.0	44.3	22.6	24.9	11.6	11.1	3.5	24.8	24.1	6.7	10.3	10.9	25.6	10.3	7.5	8.3	10.3	7.4	23.8	6.1	73.8	30.2	13.4	23.0	10.5	41.7	5.7	24.8	33.0	6.5	1.5	3.6	4.1	10.7	4.8	16.3	10.8	19.7	24.1	7.1	7.6	24.6	12.0	17.2	21.5	8.2	38.4	22.3	11.8	21.5	11.1	23.5	28.0	3.1	32.1	11.9	15.1	8.8	30.3	5.9	7.0	37.0	5.2	3.0	3.8	5.3	18.2	2.4	4.0	4.0	12.9	3.9	50.0	4.3	2.8	19.0	9.0	10.1	7.7	11.6	9.0	10.7	9.6	8.7	15.5	8.4
GPD1		ENSG00000167588	"Glycerol-3-phosphate dehydrogenase 1"	P21695	12	50103819-50111319	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 116.3;skeletal muscle: 106.9"	"Cell line enriched"	"Detected in some"	4	"ASC diff: 52.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044620	Enhanced					3800000	3800000			"HPA044620: AB_10796803"	"unprognostic (2.65e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.19e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-2)"	116.3	1.2	2.4	3.6	3.0	0.3	44.9	1.6	3.9	0.3	13.4	12.2	0.4	16.2	0.3	3.0	1.2	0.3	8.1	3.9	4.3	2.7	30.6	31.4	4.0	1.6	6.8	1.2	0.2	1.8	2.3	0.3	0.2	13.5	0.5	0.9	0.1	17.7	0.5	106.9	2.0	23.5	0.5	24.7	0.2	0.8	0.3	2.0	0.0	0.7	14.1	0.3	1.1	0.3	0.7	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	52.2	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.1	0.0	0.2	0.0	0.0	0.6	0.3	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	3.0	1.6	3.9	4.3	2.7	6.8	1.2	13.5	2.0
GPD1L	KIAA0089	ENSG00000152642	"Glycerol-3-phosphate dehydrogenase 1 like"	Q8N335	3	32105689-32168713	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Brugada syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 65.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.23e-1)"	"unprognostic (3.12e-2)"	"prognostic favourable (7.05e-4)"	"unprognostic (2.63e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (1.35e-5)"	"prognostic favourable (5.71e-5)"	"unprognostic (2.49e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-1)"	"prognostic favourable (3.33e-15)"	"unprognostic (1.50e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.31e-3)"	"unprognostic (5.51e-3)"	14.6	18.8	7.4	4.5	12.2	2.9	13.3	8.3	15.7	10.0	16.1	7.2	5.3	10.6	7.1	6.7	17.0	11.0	6.7	49.5	8.3	8.4	14.2	1.4	12.7	6.1	8.2	11.7	7.5	9.0	7.9	5.7	8.3	10.8	25.1	15.2	8.5	15.2	18.0	65.5	5.4	15.5	14.5	11.6	4.9	11.9	3.2	6.3	0.8	16.9	22.5	9.6	22.4	9.0	1.9	6.6	6.5	4.1	8.3	10.1	3.2	3.9	3.5	1.2	5.7	18.4	4.4	50.2	3.2	1.1	3.6	2.6	3.8	2.0	7.0	4.9	2.2	4.6	8.4	3.3	4.3	2.9	7.7	4.0	5.6	5.9	4.6	10.2	14.5	13.3	4.4	3.4	4.5	5.9	2.7	2.2	2.6	5.2	4.4	3.4	0.7	16.4	8.3	5.8	14.1	5.4	23.9	5.6	5.5	2.5	22.1	8.8	14.4	5.0	3.0	3.9	2.0	6.2	8.5	1.7	0.7	6.9	9.0	7.9	2.2	0.4	3.2	6.5	4.3	4.1	10.1	1.9	5.5	5.1	6.6	1.7	3.2	4.7	1.9	8.3	2.5	5.3	10.0	3.2	7.4	12.2	8.3	15.7	8.3	8.4	8.2	11.7	10.8	6.3
GPHN	KIAA1385	ENSG00000171723	Gephyrin	Q9NQX3	14	66507407-67181803	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	"Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003116, CAB004419, HPA024694"	Enhanced		Uncertain	"Cytoplasmic bodies"				"Cytoplasmic bodies"		"CAB004419: AB_627670, HPA003116: AB_1078963, HPA024694: AB_1849616"	"unprognostic (8.37e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.89e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.54e-2)"	"prognostic favourable (5.25e-12)"	"unprognostic (9.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.50e-2)"	"prognostic unfavourable (4.61e-5)"	13.0	12.4	26.1	10.9	31.1	5.2	17.1	40.9	31.2	11.0	18.2	9.3	15.6	11.1	12.3	20.8	8.6	7.5	8.2	11.9	26.4	22.9	34.5	49.0	14.1	7.3	18.3	11.5	7.2	22.9	17.4	24.5	5.8	13.9	11.1	13.2	7.4	10.8	21.3	23.4	10.7	10.8	11.6	16.4	5.6	13.5	7.8	16.2	3.1	12.2	10.0	6.8	7.4	15.1	3.1	3.0	0.5	2.5	2.3	6.2	1.5	22.3	4.4	7.8	8.6	9.3	7.9	5.0	6.4	3.1	6.5	6.6	1.3	10.1	0.0	1.1	3.1	7.9	7.8	12.4	8.6	6.8	8.5	6.6	6.3	13.6	4.8	3.7	9.9	6.7	7.3	1.8	7.2	7.6	4.5	8.5	3.6	11.9	6.6	14.0	3.3	10.2	0.0	15.1	6.5	10.5	4.4	13.9	5.4	4.3	19.0	7.0	10.2	6.4	2.8	6.6	14.6	6.4	6.5	11.3	4.8	0.1	5.2	0.5	6.3	0.0	1.3	0.5	3.9	2.5	6.2	2.4	4.9	2.9	1.9	3.1	3.5	3.3	0.0	2.3	1.9	3.0	5.3	1.5	26.1	31.1	40.9	27.0	26.4	22.9	18.3	11.5	13.9	16.2
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	140000000	140000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	62.1	66.6	43.4	27.6	58.2	83.3	34.8	62.6	88.7	20.6	36.6	20.8	23.7	48.2	21.1	20.6	45.3	24.2	33.5	107.2	42.0	45.6	51.3	77.9	19.6	29.6	39.3	64.3	22.5	21.4	66.9	33.7	20.4	50.2	23.7	37.2	36.2	34.6	33.9	144.7	29.4	44.3	34.2	22.8	23.1	26.7	19.7	19.0	23.8	26.1	68.5	32.6	32.5	25.2	16.2	26.3	74.8	40.9	14.5	27.5	24.6	76.1	107.4	9.4	73.5	30.9	23.0	22.5	29.4	23.2	37.1	44.8	60.5	27.0	50.2	43.7	28.8	53.1	56.8	63.9	42.2	55.8	22.9	64.5	51.8	63.6	20.0	83.5	42.0	31.5	26.4	43.9	22.8	34.6	32.8	39.8	26.1	64.6	36.3	29.2	25.4	38.0	34.0	24.9	94.8	46.5	51.3	51.4	29.9	59.3	104.6	21.4	23.7	26.6	29.8	14.0	30.9	39.8	45.3	73.5	41.7	45.5	46.8	63.5	28.4	38.5	22.9	74.8	22.5	35.2	27.5	16.2	20.7	25.5	26.3	13.3	17.5	20.7	1.6	14.5	40.9	8.7	21.6	24.6	43.4	58.2	62.6	88.7	42.0	45.6	39.3	64.3	50.2	19.0
GPR101		ENSG00000165370	"G protein-coupled receptor 101"	Q96P66	X	137030148-137031674	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	16	"brain: 11.1"	"Cell line enriched"	"Detected in single"	4	"HEK 293: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 44.7"	"Low region specificity"	"Detected in many"			HPA001084	Uncertain									"HPA001084: AB_1078920"																		0.0	0.0	0.0	0.0	11.1	0.1	0.0	0.0	1.7	0.0	0.0			0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1			0.0		0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GPR143	OA1	ENSG00000101850	"G protein-coupled receptor 143"	P51810	X	9725346-9786297	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"retina: 51.5"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 57.3"	"Cancer enriched"	"Detected in all"	9	"melanoma: 84.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"basophil: 5.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 5.0"	"Not detected"	"Not detected"							HPA003648	Enhanced									"HPA003648: "	"unprognostic (4.60e-2)"	"prognostic favourable (8.73e-4)"	"unprognostic (7.43e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.40e-2)"	"prognostic favourable (2.45e-5)"	"unprognostic (2.75e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.59e-2)"	0.8	1.3	4.2	0.0	7.6	0.0	2.1	1.5	4.5	2.0	1.6	3.0	3.6	0.6	3.9	7.0	2.8	3.7	1.1	0.4	3.4	3.7	6.6	2.0	1.2	0.4	5.7	3.1	4.5	2.1	3.0	2.0	7.9	6.3	3.4	1.8	51.5	4.1	6.3	0.2	11.5	0.5	1.2	4.3	0.2	0.9	1.0	2.2	1.0	4.2	1.0	1.8	1.8	1.1	0.5	0.1	5.0	0.3	0.1	0.3	0.0	0.6	0.1	1.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.9	0.0	1.3	0.0	0.6	0.0	0.0	2.5	0.0	0.0	0.0	4.3	0.0	0.0	4.1	0.0	0.0	0.0	0.0	8.3	1.1	0.3	0.0	0.1	0.0	57.3	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.3	0.2	0.3	0.1	0.1	0.4	0.1	0.1	0.1	0.5	0.1	0.2	0.8	0.1	0.1	0.0	0.0	0.0	4.2	7.6	1.5	4.5	3.4	3.7	5.7	3.1	6.3	2.2
GPR68	OGR1	ENSG00000119714	"G protein-coupled receptor 68"	Q15743	14	91232532-91253925	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Amelogenesis imperfecta, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 7.1;U-87 MG: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 16.4"	"Group enriched"	"Detected in many"	10	"NK-cells: 12.8;T-cells: 16.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (3.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"prognostic favourable (3.06e-5)"	"unprognostic (3.20e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.84e-2)"	"unprognostic (9.63e-2)"	"unprognostic (9.42e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.31e-9)"	"unprognostic (1.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.78e-3)"	5.1	1.6	2.1	7.9	2.0	1.6	4.4	6.1	6.1	3.9	2.6	0.4	0.0	2.6	1.0	0.7	8.6	0.9	6.3	3.0	1.1	5.2	1.1	0.8	5.4	7.8	0.9	3.9	0.8	1.8	1.5	17.0	4.8	2.3	3.1	2.2	0.9	4.0	0.8	0.5	9.2	3.2	5.3	1.4	4.3	6.5	1.5	0.0	0.8	2.2	3.7	9.6	7.3	3.2	0.4	0.1	1.5	0.1	12.8	16.4	2.5	0.1	0.1	0.4	0.0	0.1	1.0	0.4	0.8	0.4	0.0	0.0	0.1	0.8	0.7	0.3	7.1	0.7	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.4	3.3	0.3	0.0	4.3	0.0	0.3	4.3	0.7	3.1	0.9	0.6	4.9	0.1	0.1	0.3	0.2	0.2	0.1	0.3	2.6	3.7	0.1	0.1	0.0	1.2	0.3	2.1	5.3	0.1	0.9	0.3	0.8	0.9	0.1	26.0	0.9	0.1	0.0	0.1	0.0	16.4	0.0	10.1	0.4	3.6	9.4	0.1	0.2	0.5	3.4	1.5	12.8	0.0	0.0	5.8	2.5	2.1	2.0	6.1	6.1	1.1	5.2	0.9	3.9	2.3	0.0
GPR88		ENSG00000181656	"G protein-coupled receptor 88"	Q9GZN0	1	100538137-100542018	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Mental retardation"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 62.7"	"Group enriched"	"Detected in some"	8	"HSkMC: 4.8;SCLC-21H: 5.9"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 12.0"	"Group enriched"	"Detected in many"	7	"basal ganglia: 62.7;thalamus: 32.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	11	"basal ganglia: 643.5"	"Region enriched"	"Detected in some"	35	"basal ganglia: 223.4"	HPA007488		Approved								"HPA007488: "	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.37e-3)"	"unprognostic (5.41e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.76e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.93e-4)"	"unprognostic (1.85e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-2)"	0.7	0.6	1.2	0.5	62.7	0.2	10.9	0.0	6.8	0.1	0.3	0.8	0.0	0.6	0.2	0.2	0.2	0.1	0.2	0.4	0.9	0.8	0.3	13.1	0.2	0.3	0.7	1.1	3.8	0.1	4.6	0.5	0.2	7.0	0.6	0.5	0.3	0.7	0.1	0.3	0.1	0.5	0.3	0.5	13.7	0.4	0.2	32.8	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	62.7	0.0	6.8	0.9	0.8	0.7	1.1	7.0	32.8
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884378-46931297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 103.0;skeletal muscle: 60.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria				Mitochondria		"HPA051514: "	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favourable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	19.9	4.1	20.2	2.1	17.8	1.9	6.4	3.9	15.1	2.5	3.4	11.8	10.0	1.3	2.1	13.4	30.8	3.7	4.4	3.0	13.4	8.0	9.8	40.4	1.4	2.1	12.9	7.8	1.5	103.0	4.3	4.3	1.8	11.3	10.2	2.6	1.5	27.6	8.5	60.9	14.9	1.7	1.9	11.3	1.4	15.4	6.0	12.3	0.7	3.6	19.0	14.6	1.9	2.1	4.2	1.4	1.3	0.7	0.0	0.4	0.4	12.9	5.9	7.5	28.5	10.6	2.3	13.7	9.0	3.4	9.7	6.2	20.1	5.5	9.1	7.9	6.4	10.4	13.5	13.3	6.5	4.2	6.6	3.2	3.4	48.5	7.3	22.7	3.0	4.9	11.7	9.5	14.8	4.7	2.6	7.3	3.2	23.1	4.5	19.0	7.9	17.0	0.1	8.3	21.1	3.9	6.4	23.5	12.0	4.6	24.1	12.2	6.2	20.8	3.5	6.8	13.3	4.5	7.2	35.1	10.6	25.7	10.4	14.8	3.6	1.3	0.7	0.0	0.3	0.0	0.0	4.2	0.0	0.3	1.4	2.5	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.4	20.2	17.8	3.9	15.1	13.4	8.0	12.9	7.8	11.3	12.3
GPX4	"MCSP, PHGPx"	ENSG00000167468	"Glutathione peroxidase 4"	P36969	19	1103926-1106791	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Oxidoreductase, Peroxidase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008630, HPA047224, HPA058546"	Enhanced		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	220000	220000	"Nucleoplasm, Mitochondria"		"CAB008630: AB_1616685, HPA047224: , HPA058546: "	"unprognostic (8.42e-3)"	"prognostic favourable (7.18e-4)"	"unprognostic (8.14e-3)"	"prognostic favourable (1.84e-5)"	"unprognostic (1.00e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-1)"	"prognostic favourable (7.72e-4)"	"unprognostic (1.29e-1)"	"prognostic favourable (8.61e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	163.0	76.4	63.3	27.1	73.7	33.3	102.3	33.5	83.7	53.3	49.1	42.4	33.8	56.9	27.2	74.7	35.6	38.4	46.9	64.4	54.2	60.2	75.3	119.0	44.7	41.7	74.6	47.3	47.1	35.1	33.1	54.7	46.4	49.3	44.7	25.5	82.3	61.6	46.9	98.2	36.3	58.5	43.6	46.5	32.4	27.7	170.4	36.5	29.9	52.8	49.8	39.2	51.2	47.0	56.7	64.0	85.2	85.2	28.4	58.5	110.5	28.3	32.3	46.7	98.7	141.7	84.0	52.0	22.5	81.3	42.9	43.8	65.9	38.5	10.3	24.6	45.5	32.0	27.3	32.6	21.0	57.6	49.3	19.4	29.0	92.9	82.4	22.7	31.1	83.3	49.7	21.7	36.6	60.0	27.1	25.9	35.4	72.9	38.4	39.0	44.2	52.1	53.3	6.3	29.7	46.6	70.6	40.3	25.5	44.1	41.9	45.8	40.9	55.6	50.8	45.7	30.4	78.3	28.2	91.1	61.7	24.0	43.0	45.6	26.2	75.6	85.2	85.2	37.0	62.0	43.0	56.7	54.3	38.6	64.0	47.8	58.5	41.7	42.4	28.4	68.3	44.1	46.8	110.5	63.3	73.7	33.5	83.7	54.2	60.2	74.6	47.3	49.3	36.5
GPX7	"FLJ14777, GPX6, NPGPx"	ENSG00000116157	"Glutathione peroxidase 7"	Q96SL4	1	52602372-52609051	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 22.4;HEL: 20.6;REH: 24.6;RPMI-8226: 41.5;THP-1: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"						"unprognostic (5.87e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.18e-1)"	"unprognostic (5.64e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.17e-1)"	"unprognostic (2.48e-3)"	"prognostic unfavourable (2.26e-5)"	"unprognostic (1.14e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.44e-2)"	8.6	9.4	6.9	10.1	7.5	13.8	10.4	5.8	5.8	13.7	9.6	6.6	6.2	2.8	14.8	6.8	5.5	11.1	12.0	11.0	5.2	4.9	9.9	5.5	7.3	12.8	5.5	4.2	14.1	18.3	9.9	15.4	32.9	6.8	11.1	5.1	10.0	7.7	9.2	9.3	5.7	6.5	9.7	5.2	9.3	6.0	7.8	5.2	22.6	20.5	7.9	14.1	14.0	8.2	13.6	29.8	2.0	0.6	12.0	19.8	9.3	0.0	0.0	6.1	11.3	2.3	6.6	0.0	4.1	0.2	5.0	5.2	3.9	0.0	0.0	3.3	22.4	0.0	9.6	0.0	2.7	0.0	0.0	20.6	1.2	3.6	8.2	0.0	0.0	15.2	0.0	0.8	0.0	7.6	0.0	0.0	9.3	0.0	1.0	10.7	10.5	0.0	24.6	0.0	41.5	0.4	0.0	4.6	9.1	10.9	0.0	7.1	0.0	32.8	0.4	0.0	1.2	1.2	0.0	0.0	0.0	15.4	0.0	0.0	3.7	0.0	0.6	2.0	9.9	0.1	13.6	13.6	15.1	11.6	2.2	13.3	19.8	12.8	0.3	12.0	0.0	29.8	10.8	9.3	6.9	7.5	5.8	5.8	5.2	4.9	5.5	4.2	6.8	5.2
GRHPR	"GLXR, PH2"	ENSG00000137106	"Glyoxylate and hydroxypyruvate reductase"	Q9UBQ7	9	37422666-37436990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 172.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022971	Uncertain		Approved	Nucleoplasm,Cytosol		1400000	1400000	Cytosol	Nucleoplasm	"HPA022971: AB_1849975"	"prognostic favourable (7.00e-5)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-3)"	"unprognostic (5.78e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.36e-1)"	"prognostic favourable (5.39e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	12.8	33.7	16.3	13.8	17.4	9.9	12.3	9.5	22.3	12.1	17.6	27.5	11.6	17.2	14.3	18.1	17.6	12.9	18.1	29.2	15.8	14.7	41.9	172.0	9.7	13.8	20.0	16.5	17.0	15.5	9.5	8.8	13.2	15.5	14.2	10.2	13.5	21.6	14.0	40.0	14.8	14.6	14.2	19.4	10.0	13.3	13.0	18.7	9.5	15.1	25.2	13.6	13.4	11.7	30.6	33.2	17.8	30.3	28.9	25.9	22.4	31.3	45.2	25.6	23.4	23.6	26.2	26.0	25.1	33.3	34.2	37.2	17.1	13.6	30.1	14.8	29.4	14.2	14.7	32.7	20.5	40.2	18.4	17.6	42.1	30.3	37.3	16.7	18.3	31.3	28.7	19.8	25.5	29.6	32.2	12.4	30.0	24.0	16.3	17.2	15.6	19.7	16.1	18.8	16.7	45.6	17.8	10.7	19.2	21.6	41.2	23.4	23.2	21.6	32.2	18.8	30.2	13.0	21.6	9.8	7.6	20.1	26.7	9.6	27.5	17.8	30.2	15.0	19.4	30.3	16.2	28.6	20.7	22.0	33.2	30.6	20.4	17.3	7.0	28.9	24.7	29.8	25.9	22.4	16.3	17.4	9.5	22.3	15.8	14.7	20.0	16.5	15.5	18.7
GRIA3	"GluA3, GLUR3, GLURC, MRX94"	ENSG00000125675	"Glutamate ionotropic receptor AMPA type subunit 3"	P42263	X	123184153-123490915	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.8"	"Cell line enhanced"	"Detected in some"		"BJ: 14.1;BJ hTERT+: 20.4;fHDF/TERT166: 26.9;U-2197: 9.0"	"Cancer enriched"	"Detected in some"	11	"glioma: 10.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058659, HPA073344"	Enhanced				"Intracellular and membrane"					"HPA058659: , HPA073344: "	"unprognostic (2.14e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.94e-3)"	"unprognostic (5.09e-2)"	"unprognostic (4.29e-4)"	"unprognostic (2.42e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.05e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	1.5	10.7	31.4	1.0	27.4	0.7	2.3	3.5	40.8	9.1	1.3	3.7	0.1	0.9	3.0	4.9	1.1	2.0	1.9	2.7	26.1	8.1	3.4	9.3	1.0	1.1	10.2	21.2	5.6	2.6	0.6	0.6	1.1	4.9	2.1	1.5	0.7	0.9	3.0	0.9	1.2	1.0	2.9	8.4	0.7	3.0	1.4	7.8	0.0	0.8	0.0	1.5	1.3	1.8	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	14.1	20.4	0.2	0.5	0.0	0.0	0.0	0.0	26.9	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	9.0	0.1	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	27.4	3.5	27.5	26.1	8.1	10.2	21.2	4.9	7.8
GRK1	"GPRK1, RHOK, RK"	ENSG00000185974	"G protein-coupled receptor kinase 1"	Q15835	13	113667155-113737735	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"retina: 51.5"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035200, HPA059376"	Enhanced									"HPA035200: AB_2674515, HPA059376: AB_2683996"	"unprognostic (7.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.24e-5)"	"unprognostic (1.76e-3)"	"unprognostic (1.53e-1)"		"unprognostic (3.59e-2)"		"unprognostic (2.21e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.11e-2)"		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	51.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0
GRM1	"GPRC1A, mGlu1, MGLUR1, PPP1R85"	ENSG00000152822	"Glutamate metabotropic receptor 1"	Q13255	6	146027646-146437598	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.6;HeLa: 1.4;Karpas-707: 1.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 39.9"	"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015701	Approved	Supported	Approved	Vesicles				Vesicles		"HPA015701: AB_1853917"	"unprognostic (1.04e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.77e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.48e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.76e-2)"	0.5	0.5	6.6	0.4	6.0	0.4	0.5	39.9	13.0	0.5	0.5	0.9	0.0	0.4	0.5	0.7	0.5	0.7	0.5	7.7	6.0	2.7	2.7	0.5	0.6	0.5	2.6	4.1	0.5	0.5	0.4	0.2	0.5	3.6	0.5	0.4	2.6	0.5	0.8	0.4	0.5	0.5	0.5	1.0	0.6	0.5	1.3	0.9	0.0	0.8	0.0	0.4	0.5	0.1	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.1	1.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.4	1.4	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	1.5	0.1	0.0	0.0	0.4	0.2	0.8	0.0	0.0	0.0	0.1	0.0	1.1	0.6	0.1	0.1	0.5	0.0	0.5	0.1	0.1	0.1	0.7	0.2	0.2	0.1	0.1	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	6.6	6.0	39.9	10.5	6.0	2.7	2.6	4.1	3.6	0.9
GRM6	"CSNB1B, GPRC1F, mGlu6, MGLUR6"	ENSG00000113262	"Glutamate metabotropic receptor 6"	O15303	5	178978327-178996206	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Receptor, Transducer"	"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 22.0"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014511	Enhanced									"HPA014511: "	"unprognostic (1.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.25e-3)"	"unprognostic (7.72e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.34e-4)"	"unprognostic (2.58e-1)"	"unprognostic (3.36e-4)"	"unprognostic (1.23e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.97e-1)"	0.3	0.5	0.6	0.4	0.6	1.6	0.3	1.9	1.6	0.4	0.4	0.3	0.3	0.3	0.6	0.5	0.3	0.5	0.7	0.4	0.5	1.2	0.4	0.4	0.4	0.5	0.8	0.3	0.7	0.9	0.1	2.9	0.3	1.2	1.1	0.1	22.0	0.6	0.3	1.3	1.8	0.3	0.3	0.3	0.5	0.3	2.2	0.3	0.3	0.9	0.3	0.3	0.3	0.3	0.9	1.1	2.4	0.4	0.6	0.6	0.1	0.5	0.3	0.7	1.3	0.3	0.1	0.7	0.2	0.0	0.1	0.0	0.5	0.9	0.8	0.6	0.0	0.7	0.0	0.1	0.0	0.2	0.7	0.5	0.7	1.0	0.2	0.8	0.9	0.1	0.3	0.1	0.5	0.0	0.9	1.7	0.0	1.0	0.2	0.7	0.6	0.6	0.6	0.3	0.8	0.1	0.6	0.9	1.2	0.5	0.7	0.5	0.9	1.1	0.9	0.5	0.5	0.4	0.5	0.7	0.6	0.4	0.4	0.7	0.3	1.9	0.4	0.5	0.6	0.3	0.4	0.4	0.4	0.3	0.2	0.9	0.4	0.4	2.4	0.6	0.2	1.1	0.2	0.1	0.6	0.6	1.9	0.5	0.5	1.2	0.8	0.3	1.2	0.3
GSDME	"DFNA5, ICERE-1"	ENSG00000105928	"Gasdermin E"	O60443	7	24698351-24758113	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Necrosis		"Deafness, Non-syndromic deafness, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 8.7;myeloid DC: 6.9;naive B-cell: 8.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011326, CAB019306"	Approved		Enhanced	Cytosol				Cytosol		"CAB019306: , HPA011326: AB_1847629"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (2.49e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.48e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.90e-2)"	8.1	6.5	7.7	2.2	10.3	0.5	6.1	5.9	12.1	12.0	14.5	7.8	0.5	6.1	18.4	12.8	4.2	9.9	6.7	7.4	7.5	8.8	10.7	3.6	4.0	4.0	9.3	4.5	14.1	2.3	2.2	4.5	27.1	10.1	5.9	2.1	9.0	2.0	17.7	5.1	1.8	31.3	12.2	25.4	1.5	2.7	9.9	5.0	0.8	11.7	4.0	2.9	9.5	7.0	8.7	6.9	0.0	2.1	0.0	0.1	0.7	9.8	7.2	3.1	13.4	17.2	9.7	5.4	7.7	20.6	8.0	11.4	7.5	0.3	0.1	6.9	21.2	6.7	1.8	33.8	14.2	0.0	0.7	0.2	12.7	15.1	14.4	0.0	0.5	10.6	24.8	14.2	34.2	13.7	0.9	1.7	17.9	0.1	0.6	0.2	3.3	5.2	0.0	11.0	0.0	24.4	6.9	0.1	19.8	12.1	0.2	13.4	0.7	0.9	9.2	7.6	13.4	10.3	9.2	0.8	0.2	4.7	23.1	0.0	1.9	0.0	2.1	0.0	0.0	0.2	0.0	8.7	0.1	0.0	6.9	8.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	7.7	10.3	5.9	9.5	7.5	8.8	9.3	4.5	10.1	5.0
GSTZ1	"GSTZ1-1, MAAI, MAI"	ENSG00000100577	"Glutathione S-transferase zeta 1"	O43708	14	77320884-77331597	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Isomerase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 90.4"	"Cell line enhanced"	"Detected in all"		"MCF7: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004701	Approved		Approved	Nucleoplasm,Cytosol		62000	62000	Cytosol	Nucleoplasm	"HPA004701: AB_1078990"	"prognostic favourable (4.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"prognostic favourable (3.73e-4)"	"unprognostic (7.90e-2)"	"unprognostic (1.73e-1)"	"prognostic favourable (1.12e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.92e-2)"	4.6	12.9	5.6	5.9	6.8	2.8	8.5	2.1	9.0	5.0	8.1	10.8	7.5	8.1	4.1	9.5	9.0	5.5	8.0	5.5	5.4	5.0	8.9	90.4	4.4	10.7	6.9	6.9	2.8	7.1	9.3	5.1	11.0	5.8	8.0	8.0	9.5	22.5	4.7	14.8	7.4	7.2	3.8	7.9	5.0	5.9	18.2	5.2	8.6	8.3	14.3	8.9	4.9	4.5	8.2	15.3	7.2	16.0	3.4	5.6	5.0	6.4	12.4	9.8	6.9	6.2	8.6	16.6	4.1	4.1	7.6	10.8	4.2	16.4	14.4	5.8	4.8	8.3	6.7	7.8	7.3	7.6	6.6	7.0	4.7	8.8	9.8	2.6	5.8	8.1	8.5	4.4	7.5	6.5	5.8	13.3	5.1	60.2	4.0	5.5	2.9	9.9	6.9	10.3	11.2	11.6	8.0	10.8	9.8	9.0	18.0	12.7	29.4	3.8	4.4	5.9	20.2	6.7	3.0	10.0	10.7	12.7	15.5	3.9	7.5	6.6	11.1	7.2	1.9	16.0	1.9	6.4	3.4	2.8	15.3	8.2	2.9	2.4	1.1	3.4	13.5	10.4	5.6	5.0	5.6	6.8	2.1	9.0	5.4	5.0	6.9	6.9	5.8	5.2
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666711-155732349	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 55.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.0;Karpas-707: 8.5;MOLT-4: 15.6;RPTEC TERT1: 10.7;RT4: 12.5;SH-SY5Y: 7.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 7.6;non-classical monocyte: 9.2;plasmacytoid DC: 11.6"	"Group enriched"	"Detected in many"	27	"dendritic cells: 11.6;monocytes: 9.2;NK-cells: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm		6100	6100	Nucleoplasm		"CAB010887: AB_259901, HPA056004: , HPA058617: "	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favourable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	10.9	5.3	12.4	10.2	19.9	0.9	11.1	3.4	11.6	13.7	31.2	7.3	2.8	5.6	14.7	6.0	7.0	6.8	8.3	21.0	9.0	7.2	11.6	5.1	13.2	7.3	4.7	12.5	5.4	8.5	55.2	5.8	16.3	6.3	17.2	6.9	39.7	7.0	9.8	4.5	3.6	10.1	18.8	6.6	8.5	12.9	2.1	8.5	4.5	8.1	7.3	5.9	6.4	10.6	0.1	11.6	0.3	9.2	7.6	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	6.0	0.0	0.0	0.0	4.8	1.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	8.5	0.0	0.0	15.6	0.0	0.0	0.2	3.5	0.0	2.6	10.7	12.5	2.1	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.3	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	7.6	9.2	11.6	0.0	1.0	12.4	19.9	3.4	11.6	9.0	7.2	4.7	12.5	6.3	8.5
GUCY2D	"CORD6, CYGD, GUC1A4, GUC2D, LCA, LCA1, retGC, RETGC-1, ROS-GC1"	ENSG00000132518	"Guanylate cyclase 2D, retinal"	Q02846	17	8002594-8020339	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"cGMP biosynthesis, Sensory transduction, Vision"	Lyase	"Cone-rod dystrophy, Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 10.6;retina: 33.3"	"Cell line enriched"	"Detected in single"	7	"HMC-1: 5.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	31	"plasmacytoid DC: 10.6"	"Lineage enriched"	"Detected in single"	53	"dendritic cells: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (3.57e-4)"	"unprognostic (5.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.75e-5)"	"unprognostic (5.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.44e-1)"	"unprognostic (7.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.07e-1)"	0.1	0.0	0.1	0.3	0.1	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	1.3	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.4	0.0	33.3	0.4	0.1	0.1	0.4	0.1	0.1	0.1	0.6	0.1	5.0	0.1	0.2	0.1	0.1	0.9	0.1	0.2	0.0	10.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	5.3	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.3	0.1	0.1	0.1
GUSB		ENSG00000169919	"Glucuronidase beta"	P08236	7	65960684-65982314	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036322, HPA036323"	Approved		Supported	Vesicles	"Intracellular and membrane"	48000	48000	Vesicles		"HPA036322: AB_10670796, HPA036323: "	"unprognostic (1.54e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.45e-1)"	23.5	12.0	3.7	7.9	5.5	20.7	25.4	5.7	4.4	10.4	14.6	7.7	22.0	10.0	10.4	12.2	9.3	7.6	11.1	8.0	3.7	2.9	11.8	50.4	15.3	12.3	6.3	3.1	8.6	17.1	9.0	7.3	30.0	4.5	12.1	11.4	9.9	17.2	11.8	5.9	10.0	16.1	8.3	3.9	17.5	11.0	7.9	5.8	14.7	17.7	5.9	13.0	9.2	7.4	9.7	27.7	22.1	36.0	15.2	11.5	15.8	16.8	6.5	6.4	14.3	21.9	13.1	9.3	5.3	14.9	11.8	10.9	9.3	17.4	7.7	8.4	6.8	6.9	4.1	6.4	7.0	7.2	8.4	10.5	9.8	6.4	10.7	22.4	17.5	9.0	6.9	6.8	8.9	10.2	15.9	55.9	7.6	12.2	8.2	24.1	4.3	5.5	8.5	14.8	43.7	7.4	10.2	9.4	8.3	14.3	33.6	18.7	18.7	22.4	7.2	14.4	13.1	5.4	13.3	31.8	38.1	13.0	10.8	29.9	17.5	7.4	28.1	22.1	11.5	36.0	10.3	9.7	9.0	10.2	27.7	7.8	6.2	7.3	4.5	15.2	30.0	11.3	11.3	15.8	3.7	5.5	5.7	4.4	3.7	2.9	6.3	3.1	4.5	5.8
GYG1	GYG	ENSG00000163754	"Glycogenin 1"	P46976	3	148991341-149027668	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030497	Approved		Supported	Vesicles				Vesicles		"HPA030497: AB_10602326"	"unprognostic (2.68e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (6.15e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	10.8	7.9	7.0	8.5	8.5	55.7	10.0	9.2	7.5	10.6	31.0	6.0	11.9	4.8	15.6	15.4	18.1	11.1	12.0	32.0	8.0	9.0	8.5	6.3	9.1	14.7	11.6	7.1	13.3	14.3	6.5	7.8	6.5	10.0	16.3	7.6	7.7	11.3	19.4	113.0	4.7	8.4	32.5	8.1	13.6	12.8	47.3	7.4	4.2	9.4	39.6	8.5	28.7	14.6	7.0	26.7	16.8	26.7	17.7	32.5	17.5	18.5	12.0	9.0	10.0	24.9	26.1	12.2	27.4	22.8	40.0	37.4	15.7	19.0	0.0	13.6	31.7	5.7	23.5	12.1	40.4	6.2	10.1	14.2	5.7	17.8	22.5	14.4	21.4	14.3	19.8	13.2	16.7	22.9	8.7	33.8	22.9	32.6	2.8	11.5	10.7	9.8	7.9	13.6	26.6	11.0	17.4	7.4	3.5	14.4	19.9	15.5	19.8	15.4	19.0	20.5	6.1	14.6	20.0	30.7	17.1	13.2	17.3	22.2	6.6	7.2	23.4	16.8	17.4	24.5	32.5	7.0	11.6	18.1	26.7	5.1	6.3	10.7	11.6	17.7	26.7	10.7	15.9	17.5	7.0	8.5	9.2	7.5	8.0	9.0	11.6	7.1	10.0	7.4
GYS1	"GSY, GYS"	ENSG00000104812	"Glycogen synthase 1"	P13807	19	48968125-48993310	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007793, HPA041598"	Enhanced		Approved	Microtubules,Cytosol		10000	10000	"Microtubules, Cytosol"		"CAB007793: AB_562291, HPA041598: "	"unprognostic (3.37e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.83e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavourable (3.46e-4)"	"unprognostic (4.04e-2)"	"unprognostic (6.76e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.81e-2)"	9.7	7.3	5.1	6.1	6.5	16.0	10.6	11.3	6.2	5.3	7.3	6.2	5.8	6.1	6.2	6.9	11.5	5.9	6.1	37.3	6.8	4.0	7.2	4.3	5.0	6.3	5.3	5.5	6.8	4.4	6.4	5.1	5.0	5.9	8.7	6.1	12.4	7.2	7.6	106.1	8.1	6.1	6.8	6.0	5.8	7.3	2.2	5.5	6.4	5.2	42.6	9.0	7.9	6.9	6.7	15.9	8.2	10.5	12.8	10.9	7.3	28.3	11.3	8.4	11.5	19.6	7.7	16.7	19.7	13.9	20.8	24.4	11.0	9.3	11.8	12.0	19.2	20.3	14.0	25.0	18.2	7.3	20.3	9.8	14.5	9.7	11.0	10.7	7.3	19.0	12.0	13.4	11.4	17.4	6.8	15.9	26.0	10.8	13.2	9.3	4.5	13.1	11.2	14.7	11.6	20.6	30.4	5.2	7.3	17.5	22.9	4.6	12.1	11.1	13.4	25.6	9.9	11.5	21.3	13.2	13.6	5.8	26.1	9.4	5.7	8.2	10.5	7.5	8.8	6.3	10.9	6.7	7.6	8.2	15.9	5.5	6.3	5.6	4.4	12.8	8.5	8.6	10.1	7.3	5.1	6.5	11.3	6.2	6.8	4.0	5.3	5.5	5.9	5.5
GYS2		ENSG00000111713	"Glycogen synthase 2"	P54840	12	21536189-21604847	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 75.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.1;HEL: 1.8"	"Cancer enriched"	"Detected in single"	29	"liver cancer: 12.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039482	Approved									"HPA039482: AB_10795107"	"unprognostic (7.22e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.16e-1)"	"prognostic favourable (7.62e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.66e-4)"	8.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.1	75.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	2.4	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.4	0.2	0.6	1.8	0.2	0.0	0.3	0.5	0.4	0.5	0.2	0.0	0.4	0.0	0.0	0.1	0.6	0.0	0.3	0.3	0.2	0.0	0.5	0.2	0.0	1.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.1	0.2	0.1	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H6PD	GDH	ENSG00000049239	"Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase"	O95479	1	9234775-9271337	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 116.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.6;ASC TERT1: 32.8;HSkMC: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004824, HPA005440"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	91000000	91000000	Cytosol		"HPA004824: AB_1079037, HPA005440: AB_1079036"	"unprognostic (4.83e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.35e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.95e-1)"	18.3	16.1	4.1	10.7	5.5	4.8	12.2	4.1	6.3	16.6	11.9	10.5	8.2	6.3	22.0	18.0	11.1	15.6	11.9	11.9	3.7	3.0	7.0	116.9	12.2	11.1	6.8	2.6	38.3	10.6	8.0	8.7	14.9	6.0	11.6	5.3	11.8	29.8	8.1	24.7	20.7	10.4	10.2	6.6	10.7	9.9	12.4	5.5	16.2	12.6	12.9	14.1	12.2	10.1	4.5	3.7	4.1	6.3	3.1	4.7	3.0	3.8	3.1	2.7	10.2	28.6	32.8	2.6	3.9	9.6	2.9	4.5	0.6	7.9	4.2	4.5	6.0	4.0	0.7	1.9	4.2	12.6	0.9	0.0	1.0	2.6	16.0	1.3	1.6	32.2	3.7	6.9	4.5	13.1	1.1	7.3	5.6	2.2	1.5	3.2	1.5	1.8	0.4	0.3	3.5	3.7	1.6	0.9	4.9	5.1	4.0	4.8	3.0	6.8	13.0	9.9	1.6	2.5	1.0	9.8	2.9	1.0	16.6	6.1	6.2	3.5	6.2	0.9	4.7	6.3	3.7	3.5	3.5	4.1	2.8	4.5	3.4	3.2	4.1	3.1	5.8	3.7	2.8	3.0	4.1	5.5	4.1	6.3	3.7	3.0	6.8	2.6	6.0	5.5
HAAO		ENSG00000162882	"3-hydroxyanthranilate 3,4-dioxygenase"	P46952	2	42767089-42792593	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 78.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.8;Hep G2: 31.1;REH: 6.5;THP-1: 5.9"	"Group enriched"	"Detected in all"	5	"liver cancer: 46.5;renal cancer: 13.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 15.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 15.7;granulocytes: 12.6;monocytes: 11.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA036394, HPA042024"	Enhanced					150000	150000			"HPA036394: AB_10673131, HPA042024: AB_2677803"	"unprognostic (6.97e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.23e-3)"	"prognostic favourable (5.77e-4)"	"unprognostic (6.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.03e-1)"	2.9	1.8	1.6	6.8	1.2	0.7	3.5	0.4	1.1	5.8	11.9	1.9	3.5	5.8	3.6	6.2	2.7	3.2	2.7	2.2	0.9	0.8	10.9	78.7	1.8	2.1	1.4	1.6	5.0	8.6	1.7	1.6	3.8	1.4	6.5	2.9	12.1	1.4	3.1	0.9	1.6	24.5	6.5	1.5	1.8	2.4	1.7	0.9	1.6	2.0	1.3	1.9	4.3	3.2	2.8	15.7	12.6	11.8	0.5	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	3.0	8.8	0.1	0.0	0.1	0.3	0.0	3.1	0.0	0.5	0.0	1.0	3.5	0.0	31.1	0.3	1.2	0.1	1.5	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	1.8	0.0	6.5	0.7	0.1	0.0	0.0	0.1	0.0	0.4	0.7	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.7	11.8	12.6	0.0	7.0	0.0	2.2	0.0	0.0	15.7	2.8	0.0	0.0	3.7	0.5	1.8	5.1	0.0	3.5	1.6	1.2	0.4	1.1	0.9	0.8	1.4	1.6	1.4	0.9
HABP2	"FSAP, HABP, HGFAL, PHBP"	ENSG00000148702	"Hyaluronan binding protein 2"	Q14520	10	113550837-113589602	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 135.4"	"Cell line enriched"	"Detected in some"	6	"RPTEC TERT1: 33.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 92.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019518	Uncertain				"Secreted to blood"	3200000000	3200000000			"HPA019518: AB_1850467"	"unprognostic (3.89e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.05e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.6	0.6	0.3	0.0	0.4	26.4	0.4	0.0	0.0	20.9	135.4	0.2	0.0	0.0	0.0	0.8	11.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	33.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
HACD1	"CAP, PTPLA"	ENSG00000165996	"3-hydroxyacyl-CoA dehydratase 1"	B0YJ81	10	17589032-17617377	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Developmental protein, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 80.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	10	"T-reg: 27.6"	"Lineage enriched"	"Detected in many"	16	"T-cells: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.73e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.10e-1)"	"unprognostic (5.67e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.49e-2)"	6.6	4.7	2.1	3.8	3.9	5.4	12.6	3.4	3.1	5.1	17.6	3.9	7.4	2.3	13.1	6.0	12.6	6.5	4.8	80.1	2.4	3.7	3.6	1.1	7.9	1.1	5.1	1.8	3.9	2.5	0.6	2.4	1.5	3.8	8.8	3.3	9.4	2.1	13.2	22.8	2.5	4.2	21.5	4.8	1.5	9.4	3.0	3.4	2.6	5.9	6.2	1.2	12.6	9.8	0.6	1.6	1.7	0.5	1.6	27.6	0.7	11.0	9.5	2.7	13.1	12.2	2.3	0.2	15.7	9.5	20.6	19.5	6.3	13.5	0.1	2.3	25.5	2.7	6.8	4.7	11.4	7.2	4.0	25.5	6.8	17.3	15.8	0.1	1.9	5.7	6.8	11.8	4.6	4.0	0.2	0.5	27.1	8.0	18.8	2.6	5.7	2.6	16.9	2.8	0.3	8.1	2.1	3.0	7.6	13.4	0.2	22.0	9.5	6.3	3.8	12.2	7.0	7.4	7.1	0.4	0.3	0.1	8.9	2.9	1.7	1.7	0.5	0.4	0.6	0.1	0.1	0.2	2.8	0.5	1.6	0.6	0.5	0.4	1.6	1.6	0.1	0.8	27.6	0.7	2.1	3.9	3.4	2.8	2.4	3.7	5.1	1.8	3.8	3.4
HACE1	KIAA1320	ENSG00000085382	"HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1"	Q8IYU2	6	104728093-104859919	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 41.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046071			Supported	"Nuclear bodies,Endoplasmic reticulum"				"Endoplasmic reticulum"	"Nuclear bodies"	"HPA046071: "	"unprognostic (6.32e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (7.50e-4)"	"unprognostic (1.75e-1)"	6.4	5.4	12.7	3.7	16.1	4.3	6.1	15.5	13.1	6.6	4.8	6.8	2.5	3.6	8.5	2.9	8.1	5.4	5.0	5.2	7.5	8.6	9.4	2.9	5.7	3.5	8.8	9.6	6.4	3.8	12.0	7.4	41.9	10.2	6.1	3.3	7.7	6.2	6.9	4.4	4.8	3.6	6.5	9.5	4.1	3.9	14.1	8.9	5.4	7.1	2.7	3.9	6.4	5.8	2.9	2.4	2.2	2.9	2.2	3.9	1.6	3.5	2.5	10.7	13.4	6.4	8.5	12.7	7.2	11.1	4.6	6.9	2.3	2.1	2.0	3.2	5.4	2.4	2.7	4.9	9.7	8.2	6.8	7.1	2.3	3.1	6.4	6.1	2.3	5.7	4.5	5.9	5.0	7.5	6.8	2.3	9.0	2.6	4.5	3.6	4.7	2.4	7.2	12.2	0.8	3.7	6.1	5.8	8.7	3.9	4.1	2.1	2.6	8.4	7.9	3.7	3.1	9.9	6.8	3.3	3.6	6.9	3.9	5.8	6.7	0.0	1.9	2.2	3.7	2.9	3.9	2.9	3.7	3.6	1.9	2.7	3.9	3.0	0.4	2.2	1.5	2.4	1.2	1.6	12.7	16.1	15.5	13.1	7.5	8.6	8.8	9.6	10.2	8.9
HADH	"HADH1, HADHSC, SCHAD"	ENSG00000138796	"Hydroxyacyl-CoA dehydrogenase"	Q16836	4	107989714-108035175	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 98.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039588, HPA043888"	Supported		Supported	Mitochondria		8700000	8700000	Mitochondria		"HPA039588: AB_10673425, HPA043888: AB_2678716"	"unprognostic (1.73e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.05e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.18e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-2)"	36.6	19.5	8.5	15.6	9.2	6.1	41.7	5.4	9.7	15.2	29.7	10.6	9.4	23.3	18.3	13.3	20.5	15.7	12.4	98.3	7.8	8.1	37.2	60.3	10.6	8.8	10.0	7.0	17.1	17.8	9.8	6.8	5.1	9.2	15.6	25.0	11.6	20.4	12.5	64.6	9.0	37.1	19.6	10.2	8.0	19.1	12.6	7.2	40.9	16.1	38.0	13.1	14.2	10.6	18.6	22.6	5.6	10.7	20.2	13.0	8.9	8.8	8.3	18.0	13.1	43.3	13.9	8.7	13.0	19.4	14.2	14.0	5.9	16.7	50.4	7.0	10.7	11.9	23.9	18.1	15.7	15.4	12.5	11.7	15.9	13.2	6.9	24.7	5.5	14.5	9.7	10.0	9.2	9.5	14.5	26.8	16.0	16.1	41.9	9.9	8.5	11.1	32.0	25.2	25.2	15.3	36.1	21.7	12.5	12.6	45.1	12.8	21.5	19.6	5.3	10.0	5.7	14.1	7.1	15.2	17.6	21.9	13.6	16.8	7.7	0.0	6.1	5.6	10.1	7.8	12.5	18.6	11.4	12.1	19.7	15.5	13.0	13.0	0.7	20.2	10.7	22.6	10.0	8.9	8.5	9.2	5.4	9.7	7.8	8.1	10.0	7.0	9.2	7.2
HADHA	"GBP, LCEH, LCHAD, MTPA"	ENSG00000084754	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha"	P40939	2	26190635-26244726	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015536, HPA056070"	Approved		Enhanced	Mitochondria		2700000	2700000	Mitochondria		"HPA015536: AB_1850473, HPA056070: "	"unprognostic (2.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (3.68e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.64e-2)"	41.6	35.3	18.1	13.1	19.5	17.0	23.9	17.4	16.9	20.2	44.9	26.5	15.7	48.1	21.1	15.3	30.8	20.5	15.1	80.0	15.6	15.5	41.3	71.7	17.7	19.3	21.6	13.1	27.3	37.5	29.8	23.5	21.3	24.8	21.9	32.2	23.6	21.1	16.6	117.5	23.3	66.4	25.1	27.8	24.0	24.1	18.7	19.0	25.2	25.1	41.3	24.6	26.9	18.8	15.3	28.9	12.4	32.2	13.5	17.6	26.0	23.3	20.8	13.7	22.4	54.5	34.1	11.7	18.3	19.8	18.9	16.4	26.3	22.7	15.4	12.0	32.1	14.9	24.0	35.5	17.1	34.5	29.4	23.1	22.1	43.8	18.8	29.1	17.0	34.8	23.3	26.8	26.9	31.6	31.4	31.3	24.3	28.6	12.7	32.6	11.7	40.2	11.7	29.6	33.1	21.6	28.2	9.7	19.3	21.5	22.4	24.8	11.9	28.2	28.9	11.0	16.3	16.4	13.4	10.3	20.3	27.4	17.1	34.5	13.2	8.1	27.7	12.4	12.3	32.2	14.8	15.3	14.2	15.0	28.9	11.2	16.7	15.3	7.4	13.5	28.0	11.0	17.6	26.0	18.1	19.5	17.4	16.9	15.6	15.5	21.6	13.1	24.8	19.0
HADHB	MTPB	ENSG00000138029	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta"	P55084	2	26243170-26290468	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.0;skeletal muscle: 155.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037539, HPA037540, HPA066099"	Enhanced		Supported	Mitochondria		1100000	1100000	Mitochondria		"HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618"	"unprognostic (5.15e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (8.67e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-2)"	"unprognostic (7.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.94e-2)"	"prognostic favourable (1.37e-9)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.68e-2)"	23.3	45.5	24.8	11.0	24.7	9.9	16.6	16.6	17.4	13.8	21.4	31.1	19.3	43.6	17.1	16.2	20.6	13.9	12.6	126.0	18.0	20.0	45.8	62.4	12.8	16.1	34.8	18.3	16.2	23.7	19.9	13.1	12.6	27.8	15.8	22.8	19.9	27.2	15.9	155.6	13.2	35.0	20.3	29.5	15.3	19.5	15.8	23.8	10.6	22.4	44.9	14.5	18.5	12.8	20.2	45.2	21.5	49.1	23.8	26.8	33.9	22.7	18.0	12.6	22.5	77.7	43.0	12.7	19.2	29.4	19.8	19.4	21.5	22.2	11.4	13.5	31.4	18.0	20.9	27.1	24.3	25.7	18.2	26.2	10.7	42.0	33.3	21.1	20.1	41.6	44.8	20.5	33.5	36.6	21.9	18.5	41.2	16.7	11.8	40.8	8.7	19.6	13.1	41.6	21.7	40.7	32.4	6.0	20.7	32.9	37.5	50.4	23.2	37.8	25.3	18.7	19.5	17.5	13.8	13.9	20.9	20.1	21.5	33.8	18.5	21.0	49.1	18.9	14.2	43.4	18.1	20.2	19.3	17.6	45.2	14.8	18.0	16.3	21.5	23.8	33.2	15.3	26.8	33.9	24.8	24.7	16.6	17.4	18.0	20.0	34.8	18.3	27.8	23.8
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 29.5;liver: 96.8;skin 1: 26.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;NB-4: 3.9;THP-1: 15.1"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 20.1;neutrophil: 29.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 29.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol		67000	67000	Cytosol		"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"	0.5	0.0	0.1	1.1	0.3	4.4	0.9	0.1	0.3	0.3	0.2	0.1	0.1	0.1	1.1	0.3	0.5	0.2	0.3	0.2	0.1	0.0	0.2	96.8	1.7	2.3	0.5	0.1	0.3	0.5	0.0	7.4	0.4	0.2	0.2	0.0	0.1	0.2	0.1	0.2	26.9	0.2	0.2	0.3	2.7	0.1	0.2	0.2	0.1	0.2	0.9	1.3	0.2	0.5	0.0	1.4	29.5	6.3	0.3	0.1	1.6	0.5	0.0	0.2	0.1	0.0	0.0	3.1	0.0	0.2	0.1	0.2	0.0	0.1	0.9	0.0	0.0	0.2	0.3	0.1	0.1	0.2	0.5	0.4	0.2	0.0	0.0	0.6	0.6	0.0	0.9	0.4	0.4	0.3	0.0	0.2	0.1	0.0	0.2	3.9	1.3	0.6	0.2	0.1	0.1	0.1	0.8	0.2	0.4	0.4	0.1	0.0	0.0	15.1	0.2	0.1	0.2	0.2	0.2	0.6	0.7	0.2	0.0	2.4	0.0	20.1	6.3	0.9	0.0	2.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	29.5	0.3	5.1	0.1	0.1	1.6	0.1	0.3	0.1	0.3	0.1	0.0	0.5	0.1	0.2	0.2
HAMP	"HEPC, HFE2B, LEAP-1, LEAP1"	ENSG00000105697	"Hepcidin antimicrobial peptide"	P81172	19	35280716-35285143	"Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hormone"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 716.5"	"Cell line enriched"	"Detected in single"	229	"Hep G2: 68.3"	"Group enriched"	"Detected in many"	12	"glioma: 6.5;liver cancer: 16.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"myeloid DC: 2.5;plasmacytoid DC: 7.6"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 7.6"					"Not detected"	"Not detected"								"Secreted to blood"	3900000	3900000				"unprognostic (5.53e-2)"	"unprognostic (5.02e-4)"	"unprognostic (2.10e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.68e-7)"	"unprognostic (4.11e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.77e-2)"	0.4	0.5	1.8	0.6	10.8	1.2	0.7	0.2	4.4	0.6	0.3	0.2	0.0	0.5	0.4	0.4	0.4	0.9	0.4	45.1	10.0	1.8	0.3	716.5	0.4	1.0	4.2	0.0	1.1	8.7	0.4	0.5	0.7	6.7	0.6	0.3	0.0	0.4	0.6	0.5	0.4	0.3	0.4	13.9	0.3	0.4	0.5	4.0	0.0	0.3	0.0	1.0	0.4	0.0	0.5	7.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	68.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	2.5	0.5	0.0	0.0	0.0	0.5	0.0	7.6	0.0	0.0	1.8	10.8	0.2	4.4	10.0	1.8	4.2	0.0	6.7	4.0
HARS	USH3B	ENSG00000170445	"Histidyl-tRNA synthetase"	P12081	5	140673904-140691862	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036539	Approved		Enhanced	Cytosol		52000	52000	Cytosol		"HPA036539: AB_10669796"	"unprognostic (9.35e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.57e-2)"	"prognostic unfavourable (1.96e-7)"	"unprognostic (6.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.36e-1)"	22.4	24.5	28.5	21.1	35.5	18.1	21.0	41.1	46.3	20.6	22.7	20.0	23.6	17.4	21.6	23.5	26.9	23.7	17.5	25.1	29.5	35.9	20.6	34.2	16.7	22.4	36.9	33.0	24.7	25.2	29.5	38.7	15.0	38.2	21.7	24.8	13.6	22.1	27.9	27.1	33.9	16.4	28.0	21.0	18.3	18.8	16.6	23.5	17.6	19.4	20.3	28.5	19.9	20.9	16.8	22.1	10.7	22.9	25.2	29.4	23.4	20.5	30.0	18.1	39.5	23.1	25.1	19.1	33.1	23.9	38.3	35.9	54.7	17.4	27.4	29.2	37.1	21.6	27.5	53.3	36.1	23.2	34.0	19.7	39.0	34.6	28.7	30.9	16.9	26.6	16.7	41.7	23.8	38.4	17.2	22.7	39.8	35.3	22.0	28.8	14.2	19.8	20.3	26.3	22.3	30.8	26.2	28.5	27.5	27.4	40.0	26.1	29.5	17.4	32.0	36.0	13.8	20.2	44.6	22.9	27.2	27.7	27.3	26.0	24.5	6.7	14.1	10.7	29.4	20.8	26.3	16.8	25.8	27.3	22.1	14.8	28.2	26.9	4.3	25.2	22.9	15.6	22.1	23.4	28.5	35.5	41.1	46.3	29.5	35.9	36.9	33.0	38.2	23.5
HARS2	"HARSL, HARSR, HO3"	ENSG00000112855	"Histidyl-tRNA synthetase 2, mitochondrial"	P49590	5	140691426-140699318	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035941	Approved		Approved	Cytosol	"Intracellular and membrane"			Cytosol		"HPA035941: AB_10671237"	"prognostic unfavourable (6.49e-4)"	"unprognostic (3.15e-2)"	"prognostic favourable (6.19e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.30e-3)"	"prognostic unfavourable (2.92e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.31e-2)"	17.1	23.8	14.2	22.9	19.4	13.4	25.0	24.7	19.0	15.0	21.6	16.6	19.7	17.7	20.2	16.9	16.7	14.9	16.7	25.2	15.7	12.6	19.6	14.5	21.4	25.2	15.5	11.2	17.4	13.6	22.9	21.1	15.8	14.4	14.3	24.4	16.4	16.4	15.4	32.7	18.3	17.2	15.6	12.9	18.5	17.9	15.1	15.6	16.5	15.8	13.9	18.8	20.6	18.4	13.7	12.0	22.9	15.0	22.8	17.6	9.7	10.7	24.4	10.6	27.2	12.1	16.0	17.5	14.0	16.0	19.6	17.2	22.4	13.6	13.7	22.6	15.4	13.7	14.6	26.2	18.2	13.8	12.0	10.0	23.4	14.7	11.6	13.4	14.7	15.0	17.8	19.1	21.7	14.1	9.2	13.0	19.0	13.8	13.1	16.6	12.2	15.5	13.4	10.8	13.8	18.4	25.3	14.7	21.2	20.2	32.9	27.6	29.0	13.3	17.2	17.7	9.8	9.8	18.3	12.8	18.7	13.2	13.9	15.4	17.6	22.9	10.5	21.3	16.2	15.0	17.5	13.7	15.6	16.2	12.0	12.5	16.4	17.6	12.1	22.8	11.4	9.5	15.3	9.7	14.2	19.4	24.7	19.0	15.7	12.6	15.5	11.2	14.4	15.6
HAS2		ENSG00000170961	"Hyaluronan synthase 2"	Q92819	8	121612116-121641390	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 22.8"	"Group enriched"	"Detected in some"	4	"HBF TERT88: 33.9;hTEC/SVTERT24-B: 32.6;LHCN-M2: 43.3;U-138 MG: 85.2;U-251 MG: 25.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052060			Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA052060: "	"unprognostic (7.01e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.57e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-7)"	"unprognostic (1.47e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-3)"	22.8	0.9	1.6	9.1	2.4	0.0	5.5	0.8	1.7	4.0	8.5	2.0	0.0	2.6	1.5	2.5	4.8	3.9	7.7	8.3	1.7	1.7	1.2	2.7	6.5	4.5	1.8	0.6	1.2	1.8	0.3	0.7	2.1	5.7	4.3	5.6	2.7	1.9	0.1	2.7	3.8	9.5	3.7	4.2	0.3	2.3	3.2	2.6	0.4	1.7	5.5	2.1	5.7	1.4	0.0	0.2	0.7	0.2	0.3	0.1	0.0	0.0	0.5	0.0	0.0	1.0	2.5	0.0	4.8	3.6	6.3	11.0	0.0	0.0	0.0	0.0	4.3	0.8	0.0	0.0	33.9	0.0	0.1	0.0	0.1	0.0	4.3	0.0	0.0	6.7	0.0	32.6	3.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.7	0.0	5.6	0.0	0.0	0.4	0.0	0.1	2.0	0.0	1.1	0.0	0.0	0.0	85.2	0.3	7.9	25.2	0.0	0.0	0.0	1.8	0.0	1.7	0.5	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.7	0.3	0.2	0.2	0.1	0.0	1.6	2.4	0.8	1.7	1.7	1.7	1.8	0.6	5.7	2.6
HCCS	"CCHL, MLS"	ENSG00000004961	"Holocytochrome c synthase"	P53701	X	11111301-11123078	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002946	Approved		Enhanced	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA002946: AB_1079041"	"prognostic unfavourable (8.69e-5)"	"unprognostic (6.89e-3)"	"unprognostic (8.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.44e-2)"	"prognostic unfavourable (1.35e-5)"	"unprognostic (9.18e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (6.17e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.93e-2)"	10.6	14.2	8.8	9.0	12.7	11.8	9.6	11.0	17.7	6.7	15.5	7.4	8.0	17.2	8.5	5.5	15.8	6.9	9.8	36.9	8.4	8.3	15.9	19.0	9.5	10.1	8.2	11.1	10.0	11.4	11.5	10.0	12.8	10.6	7.8	15.2	9.3	12.8	8.0	41.6	13.8	14.4	10.4	6.3	12.3	12.2	10.5	6.0	10.3	10.8	16.4	11.8	11.4	17.3	18.1	28.4	13.3	29.7	8.4	11.1	8.7	23.2	26.8	12.5	12.0	11.8	11.4	13.3	23.5	17.9	29.7	25.5	31.1	17.0	14.5	12.1	18.8	21.6	25.9	22.4	29.0	13.5	20.3	14.5	34.4	15.5	20.9	15.8	17.7	11.1	17.5	28.2	19.3	21.0	26.8	16.8	19.9	31.5	11.4	12.8	22.7	29.0	11.2	25.2	28.4	20.0	18.3	9.1	10.7	23.4	25.5	15.0	19.7	11.4	20.6	19.3	10.4	49.2	20.0	12.4	12.6	19.2	15.5	12.7	18.4	10.1	22.5	13.3	9.9	29.7	9.5	18.1	9.7	8.9	28.4	15.5	8.5	11.1	6.2	8.4	24.8	25.9	10.4	8.7	8.8	12.7	11.0	17.7	8.4	8.3	8.2	11.1	10.6	6.0
HCK	JTK9	ENSG00000101336	"HCK proto-oncogene, Src family tyrosine kinase"	P08631	20	32052188-32101856	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 107.1;lymphoid tissue: 72.6"	"Group enriched"	"Detected in some"	8	"THP-1: 22.6;U-937: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 50.8;eosinophil: 62.5;intermediate monocyte: 96.5;myeloid DC: 31.6;neutrophil: 73.0;non-classical monocyte: 107.1"	"Group enriched"	"Detected in many"	15	"dendritic cells: 31.6;granulocytes: 73.0;monocytes: 107.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005195, HPA063768"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB005195: AB_631619, HPA063768: "	"unprognostic (6.22e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (4.92e-2)"	"unprognostic (4.42e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.12e-1)"	12.3	5.8	5.9	40.8	13.1	20.8	4.0	1.8	5.3	3.0	5.8	6.1	0.9	5.9	2.5	5.7	3.1	5.9	6.5	8.8	6.0	3.7	4.0	7.9	20.9	50.3	11.2	1.2	3.4	2.8	0.7	2.9	8.8	8.0	3.8	5.9	3.1	4.1	1.9	3.1	2.8	7.8	10.2	9.1	72.6	3.7	2.6	8.2	5.8	3.3	1.2	16.4	9.4	3.5	4.7	31.6	73.0	107.1	1.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	22.6	0.0	0.0	0.1	0.0	0.0	0.6	0.1	3.3	0.0	64.8	0.0	0.5	50.8	62.5	0.1	96.5	0.1	4.7	0.1	0.1	31.6	3.7	0.1	0.0	73.0	1.1	107.1	2.8	0.1	40.2	5.9	13.1	1.8	5.3	6.0	3.7	11.2	1.2	8.0	8.2
HCN1	"BCNG-1, BCNG1, HAC-2"	ENSG00000164588	"Hyperpolarization activated cyclic nucleotide gated potassium channel 1"	O60741	5	45254950-45696498	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.4;retina: 16.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.6;WM-115: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019195	Enhanced									"HPA019195: "	"unprognostic (1.30e-1)"		"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.24e-3)"			"unprognostic (6.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.63e-3)"	"unprognostic (4.11e-3)"		"unprognostic (6.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-3)"		1.0	2.8	6.0	1.0	13.0	1.3	1.2	9.8	26.4	0.9	1.0	0.5	0.0	0.9	1.1	0.9	1.1	1.0	1.0	4.6	8.1	4.5	0.9	1.0	1.0	1.0	2.6	11.1	1.1	1.7	0.9	4.0	0.9	9.2	1.0	1.0	16.1	1.0	0.9	3.6	1.6	1.1	0.9	1.2	1.1	1.1	1.2	0.0	0.0	1.1	0.0	0.9	0.9	0.3	0.6	0.2	0.6	0.2	0.3	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.1	0.3	1.6	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.2	0.3	4.6	0.5	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.2	0.3	0.6	0.3	0.1	0.2	0.0	0.0	6.0	13.0	9.8	26.4	8.1	4.5	2.6	11.1	9.2	0.0
HCN4		ENSG00000138622	"Hyperpolarization activated cyclic nucleotide gated potassium channel 4"	Q9Y3Q4	15	73319859-73369264	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Brugada syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 4.3;heart muscle: 12.5;testis: 9.6"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;CACO-2: 3.1;HDLM-2: 2.1;NTERA-2: 9.4;U-2 OS: 4.1"	"Group enriched"	"Detected in some"	8	"testis cancer: 3.1;thyroid cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073174	Approved									"HPA073174: "	"unprognostic (2.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.05e-5)"	"unprognostic (5.56e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (7.95e-2)"	0.2	1.3	4.3	0.2	1.1	0.1	0.1	0.9	3.4	0.2	0.4	2.1	0.0	1.2	0.1	0.2	0.1	0.3	0.2	12.5	0.6	2.0	0.4	0.1	0.3	0.1	1.8	0.9	0.1	0.2	0.1	2.1	0.1	3.9	0.6	0.3	0.2	0.1	1.0	0.1	0.2	0.4	0.2	0.7	0.1	0.6	9.6	1.9	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	1.5	0.0	0.2	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.1	0.9	3.4	0.6	2.0	1.8	0.9	3.9	1.9
HECW2	"KIAA1301, NEDL2"	ENSG00000138411	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2"	Q9P2P5	2	196189099-196593692	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.6;HUVEC TERT2: 15.0;SCLC-21H: 17.4;TIME: 19.7;U-138 MG: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.7;non-classical monocyte: 5.2"	"Group enriched"	"Detected in many"	9	"granulocytes: 7.7;monocytes: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034609	Enhanced									"HPA034609: AB_10669993"	"unprognostic (2.65e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (5.18e-5)"	"unprognostic (8.05e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.48e-2)"	8.8	3.3	6.7	2.6	12.6	0.6	4.2	15.7	17.2	4.6	1.2	11.6	0.0	1.1	3.0	1.0	5.5	6.3	4.8	14.0	6.7	4.3	3.4	5.6	16.4	3.5	8.2	9.3	1.3	2.1	14.7	5.9	15.5	9.5	1.5	1.3	1.2	2.2	1.3	2.7	2.7	1.7	3.1	5.8	11.6	2.1	5.8	8.8	0.0	7.9	1.6	4.2	2.4	2.5	0.6	0.7	7.7	5.2	0.0	0.1	0.1	0.0	0.7	1.2	0.0	0.7	2.3	0.9	1.5	3.9	1.2	1.4	0.1	0.0	0.7	0.3	7.2	1.7	0.5	0.1	2.5	26.6	0.9	0.0	1.1	0.1	0.1	0.2	0.2	0.5	0.7	8.9	3.1	15.0	0.1	0.0	3.6	0.9	0.0	0.3	1.4	0.6	0.0	0.3	0.0	0.0	0.0	17.4	1.4	1.1	0.2	0.0	0.0	0.1	19.7	12.0	0.8	2.6	0.3	0.1	0.0	0.7	3.0	0.0	0.1	0.2	0.5	1.3	0.0	1.9	0.0	0.5	0.1	0.0	0.7	0.6	0.1	0.0	7.7	0.0	5.2	0.0	0.1	0.1	6.7	12.6	15.7	17.2	6.7	4.3	8.2	9.3	9.5	8.8
HEPACAM	"FLJ25530, GLIALCAM, hepaCAM"	ENSG00000165478	"Hepatic and glial cell adhesion molecule"	Q14CZ8	11	124919193-124936412	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell cycle, Growth arrest, Growth regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adipose tissue: 17.3;brain: 64.7;liver: 19.6"	"Cell line enriched"	"Detected in single"	31	"Hep G2: 24.3"	"Cancer enriched"	"Detected in some"	12	"glioma: 29.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017613, CAB025486"	Enhanced		Approved	Vesicles				Vesicles		"CAB025486: , HPA017613: AB_1850595"	"unprognostic (3.22e-3)"	"unprognostic (1.06e-2)"		"unprognostic (1.64e-1)"	"unprognostic (6.41e-2)"		"unprognostic (1.47e-1)"		"unprognostic (9.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.06e-6)"	"unprognostic (2.62e-1)"	"unprognostic (3.21e-1)"			17.3	1.8	25.6	1.7	25.7	1.5	2.6	8.5	64.7	1.6	1.8	55.4	0.0	1.6	1.6	1.7	1.6	1.6	1.6	1.7	31.0	10.8	1.6	19.6	1.6	1.7	30.3	22.4	1.5	1.6	1.5	0.6	1.5	27.9	1.6	1.8	0.0	1.7	2.1	1.6	1.6	1.6	1.6	21.5	1.5	1.6	1.7	35.5	0.0	1.6	0.0	2.3	1.5	0.3	1.5	1.2	3.0	1.4	2.0	1.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.0	1.1	1.2	1.1	1.2	1.5	1.5	1.4	1.0	1.2	1.3	1.7	1.5	1.3	2.0	1.4	1.0	1.1	1.5	25.6	25.7	8.5	29.7	31.0	10.8	30.3	22.4	27.9	35.5
HERC1	"p532, p619"	ENSG00000103657	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 1"	Q15751	15	63608618-63833942	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049749	Uncertain									"HPA049749: "	"unprognostic (9.72e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.35e-1)"	"prognostic favourable (4.87e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.89e-3)"	"prognostic favourable (3.66e-4)"	"unprognostic (1.24e-1)"	"prognostic favourable (1.36e-6)"	"unprognostic (2.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.04e-3)"	"unprognostic (3.94e-1)"	14.4	11.7	20.3	12.9	23.5	28.9	15.5	30.4	29.7	17.4	15.3	14.7	13.8	7.0	15.8	8.9	10.3	10.7	12.1	17.6	19.4	14.3	11.9	11.4	14.9	15.2	12.8	23.7	23.8	11.5	44.8	20.1	12.7	19.1	11.4	11.8	11.0	11.4	14.0	31.7	14.6	13.9	15.7	11.7	17.4	13.5	13.5	15.8	16.6	17.2	11.3	15.3	12.9	11.6	9.8	7.0	17.6	5.7	2.8	6.6	1.4	7.4	9.8	10.9	3.8	19.4	12.5	3.6	5.9	7.6	6.2	7.1	6.0	3.0	11.1	5.5	11.0	8.1	17.6	5.0	8.4	8.5	6.0	24.1	13.9	4.3	3.2	17.8	14.5	8.9	4.9	8.6	8.5	12.8	24.2	5.0	5.3	12.1	6.2	3.5	5.4	5.0	6.8	12.1	6.5	2.5	18.4	9.8	4.9	10.4	7.1	6.2	3.5	7.1	14.2	8.0	7.4	6.8	7.7	5.5	9.4	7.8	4.5	13.3	2.7	17.6	3.7	7.4	5.0	3.3	3.8	5.3	5.5	4.4	3.2	9.8	5.6	5.6	12.9	2.8	5.7	7.0	6.6	1.4	20.3	23.5	30.4	29.7	19.4	14.3	12.8	23.7	19.1	15.8
HERC2	"D15F37S1, jdf2, p528"	ENSG00000128731	"HECT and RLD domain containing E3 ubiquitin protein ligase 2"	O95714	15	28111040-28322152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 32.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017188, HPA048389, HPA074166"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB017188: , HPA048389: , HPA074166: "	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.64e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.74e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.60e-2)"	"prognostic favourable (1.41e-7)"	"unprognostic (7.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-1)"	2.5	3.3	3.2	2.2	4.5	3.9	3.1	7.0	5.7	3.2	4.6			2.7	4.4	1.7	2.8	4.1	2.1	4.6	3.5	3.6	3.3	1.6	2.5	2.1	3.8		8.5	3.6	9.2	3.5	2.7		3.0	3.0		2.3	3.3	8.2	3.1	3.1	4.1	4.1	2.3	3.4	3.2			5.6		2.4	3.3	2.3	1.0	1.1	0.5	0.4	0.2	1.1	0.4	5.1	10.1	7.0	2.9	5.9	4.4	2.0	3.7	4.4	4.8	4.6	5.2	0.6	5.1	4.5	6.3	5.2	7.4	3.6	3.5	3.1	4.8	32.6	11.7	1.7	2.2	7.6	2.6	3.7	2.9	5.7	7.1	6.3	12.5	2.1	4.5	2.3	1.7	2.5	2.1	4.4	6.1	10.0	0.4	1.6	11.1	7.8	4.5	8.9	2.5	2.9	3.0	9.0	9.4	8.9	5.8	3.4	5.5	1.4	1.9	4.8	4.1	3.6	4.7	0.0	0.4	0.5	1.1	0.1	0.6	0.5	0.2	0.5	1.1	1.0	0.9	0.5	0.0	0.2	0.3	0.9	0.4	0.4										
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340919-72376476	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA054583	Supported				"Intracellular and membrane"	20000000	20000000			"HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favourable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	30.1	37.4	23.1	18.0	22.9	35.5	37.8	23.3	28.1	30.6	20.5	19.4	30.1	18.5	25.9	65.7	11.7	21.8	29.2	33.8	23.4	12.8	34.6	29.5	43.9	31.4	24.9	21.1	20.9	22.2	18.1	22.9	37.9	18.8	18.1	26.0	26.9	24.8	22.0	17.7	17.9	24.6	23.4	21.4	31.5	22.6	18.0	22.9	12.1	31.2	11.1	16.4	26.7	17.1	16.1	37.9	22.4	32.7	17.8	18.1	21.3	7.4	12.7	5.5	10.5	45.0	51.4	7.8	10.5	53.3	22.8	36.5	6.7	54.8	6.2	10.1	21.0	15.0	14.4	6.7	14.5	5.0	5.8	7.8	12.6	11.5	34.9	18.7	22.4	43.7	20.0	9.9	17.8	20.8	12.1	38.8	30.3	6.4	4.0	9.4	3.1	0.1	4.2	11.9	14.0	25.5	11.8	4.7	5.2	26.3	24.8	59.3	4.6	23.6	10.4	34.2	14.3	31.4	11.1	20.7	27.9	6.5	12.4	25.0	16.5	8.9	32.7	22.4	18.1	13.7	15.8	16.1	12.0	15.8	37.9	15.6	9.5	14.0	3.1	17.8	4.8	14.4	10.7	21.3	23.1	22.9	23.3	28.1	23.4	12.8	24.9	21.1	18.8	22.9
HEXB		ENSG00000049860	"Hexosaminidase subunit beta"	P07686	5	74640023-74722647	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 174.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 112.8;BJ hTERT+: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055409, HPA056010"	Enhanced				"Intracellular and membrane"	43000000	43000000			"HPA055409: AB_2682808, HPA056010: AB_2683008"	"unprognostic (3.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.44e-3)"	"prognostic unfavourable (3.36e-8)"	"unprognostic (2.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	48.0	21.9	7.7	13.6	11.6	11.1	26.1	7.4	11.2	25.8	34.2	9.5	18.0	21.6	22.1	77.3	20.6	17.3	28.1	46.3	7.1	9.1	30.4	44.5	40.9	19.3	8.5	6.7	22.7	30.4	21.8	14.3	174.3	9.3	22.6	26.3	21.0	34.6	13.3	21.0	15.3	33.6	21.0	8.7	20.5	20.7	16.2	6.1	10.8	33.7	15.2	15.4	24.0	19.7	8.9	59.8	23.8	65.9	7.6	16.4	42.9	21.1	16.7	5.8	19.2	112.8	34.8	19.0	26.0	84.4	25.4	55.2	19.5	27.7	0.0	20.7	21.3	17.0	6.2	26.5	33.6	11.8	11.2	2.8	16.2	14.7	33.1	2.3	22.9	30.7	15.6	26.7	17.9	29.1	7.8	34.7	27.8	21.5	2.7	5.3	5.4	7.5	6.4	8.5	27.6	17.5	19.4	3.8	4.7	20.2	13.7	25.1	14.5	15.7	17.2	16.8	4.2	30.8	24.0	16.1	27.6	0.1	38.2	20.8	30.4	14.5	65.9	18.6	14.2	24.5	16.4	8.9	11.7	13.1	59.8	5.5	11.2	10.9	23.8	7.6	14.6	18.0	13.7	42.9	7.7	11.6	7.4	11.2	7.1	9.1	8.5	6.7	9.3	6.1
HFM1	"FLJ36760, FLJ39011, MER3, SEC63D1"	ENSG00000162669	"HFM1, ATP dependent DNA helicase homolog"	A2PYH4	1	91260766-91404869	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Helicase, Hydrolase"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3;testis: 19.9"	"Cell line enhanced"	"Detected in some"		"AF22: 9.1;AN3-CA: 4.8;K-562: 4.9;SCLC-21H: 3.1;SH-SY5Y: 3.8;U-266/70: 4.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035036, HPA035557"			Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA035036: , HPA035557: AB_10696507"	"unprognostic (1.35e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.76e-4)"	"unprognostic (2.81e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.77e-4)"	"unprognostic (9.59e-2)"	0.8	0.7	2.6	0.3	4.1	0.4	0.8	11.3	4.4	1.7	0.9	1.5	2.7	0.6	3.7	2.5	0.4	1.2	0.6	1.0	2.3	0.9	1.3	0.4	0.5	1.6	0.7	1.4	6.4	1.2	0.1	7.8	0.9	3.9	1.1	0.7	2.7	1.0	2.0	2.3	0.4	0.5	1.7	4.7	0.7	0.6	19.9	1.5	0.0	2.7	0.5	0.4	0.7	2.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.1	4.8	0.0	0.2	0.1	0.5	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.1	0.2	1.1	0.0	0.5	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.6	0.2	2.4	0.0	0.3	1.4	0.1	0.0	0.0	3.1	3.8	0.0	0.0	1.2	0.0	0.8	0.1	0.0	1.0	0.9	0.1	4.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	4.1	11.3	4.4	2.3	0.9	0.7	1.4	3.9	1.5
HGD	"AKU, HGO"	ENSG00000113924	"Homogentisate 1,2-dioxygenase"	Q93099	3	120628173-120682571	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 176.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.1;EFO-21: 23.3;Hep G2: 44.9;RPTEC TERT1: 58.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 119.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047374, HPA052359"	Enhanced		Approved	"Golgi apparatus"		210000	210000	"Golgi apparatus"		"HPA047374: AB_2680019, HPA052359: AB_2681798"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.93e-2)"	"prognostic favourable (1.78e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.65e-3)"	"unprognostic (7.20e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.43e-1)"	0.2	0.2	0.2	0.6	0.6	0.0	1.8	0.2	0.5	3.7	7.2	0.3	1.4	4.7	0.6	4.0	0.2	0.4	11.5	0.3	0.2	0.1	33.3	176.7	0.7	0.3	0.2	0.2	0.3	6.9	0.0	0.4	0.3	0.3	6.7	2.7	5.9	3.3	1.0	0.4	0.3	15.0	0.3	0.4	0.3	3.9	0.3	0.2	0.2	8.1	0.3	0.3	0.2	0.2	0.0	0.3	2.8	0.4	0.0	0.0	5.1	0.0	2.9	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.1	3.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	44.9	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	5.1	0.2	0.6	0.2	0.5	0.2	0.1	0.2	0.2	0.3	0.2
HGF	"DFNB39, F-TCF, HGFB, HPTA, SF"	ENSG00000019991	"Hepatocyte growth factor"	P14210	7	81699008-81770438	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Serine protease homolog"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 116.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 44.8;HHSteC: 35.1;HL-60: 19.6;hTEC/SVTERT24-B: 22.0;Karpas-707: 60.7;U-87 MG: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"basophil: 33.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 33.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010333, HPA040360, HPA044088"	Approved		Approved	Centrosome,Cytosol	"Secreted to blood"			Cytosol	Centrosome	"CAB010333: AB_647965, HPA040360: , HPA044088: "	"unprognostic (5.24e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.45e-5)"	"unprognostic (1.66e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.29e-2)"	"prognostic unfavourable (5.59e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.06e-2)"	6.2	10.6	1.4	2.9	1.2	4.6	4.8	0.5	4.5	5.1	4.0	0.4	2.9	1.5	5.2	3.1	2.9	4.0	7.1	9.3	3.6	1.3	7.3	27.5	15.8	2.0	1.3	1.4	3.2	1.4	1.6	4.3	116.9	1.9	10.8	1.9	2.0	2.2	3.2	1.4	0.9	1.8	15.1	6.0	6.6	2.3	2.0	0.9	0.5	5.3	1.4	1.4	10.5	21.5	0.0	2.0	33.5	7.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.5	44.8	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	35.1	19.6	0.1	10.6	0.0	22.0	0.0	0.5	0.0	60.7	0.1	0.0	0.0	13.6	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	16.1	4.1	0.0	33.5	6.6	1.6	0.0	7.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.0	6.7	0.4	0.0	1.5	1.4	1.2	0.5	4.5	3.6	1.3	1.3	1.4	1.9	0.9
HGSNAT	"FLJ32731, HGNAT, TMEM76"	ENSG00000165102	"Heparan-alpha-glucosaminide N-acetyltransferase"	Q68CP4	8	43140455-43202855	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease mutation, Mucopolysaccharidosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029578	Approved									"HPA029578: AB_10602423"	"unprognostic (5.35e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (3.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.54e-3)"	"unprognostic (5.02e-2)"	"prognostic favourable (6.33e-5)"	"unprognostic (2.55e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.45e-2)"	24.8	16.9	21.4	16.0	18.8	16.0	29.6	18.5	20.6	28.5	17.8	20.3	24.5	15.4	27.5	29.7	20.4	24.0	22.1	18.7	18.0	16.5	16.9	19.9	21.8	14.9	12.9	19.8	31.1	28.8	26.5	24.8	25.6	15.7	21.6	14.7	20.9	20.7	20.7	11.9	29.5	18.1	25.3	18.2	14.9	18.6	8.5	11.7	9.1	21.9	18.4	18.2	21.1	23.2	2.3	14.5	8.3	8.0	8.2	3.1	4.0	11.5	15.6	3.9	7.9	32.3	24.4	5.9	13.2	15.7	9.6	8.6	2.2	17.0	7.0	9.2	18.4	6.7	1.7	8.0	5.6	2.8	3.2	6.9	9.9	3.9	10.4	1.5	1.1	16.3	11.5	5.3	11.1	17.0	3.1	9.9	17.5	5.2	6.2	3.0	3.7	2.3	0.7	7.2	3.4	15.8	9.8	2.1	6.2	17.2	5.5	7.6	19.1	8.9	19.9	14.8	2.5	9.2	5.4	8.0	7.5	2.6	11.9	2.7	9.0	0.2	8.0	8.3	2.8	5.0	3.1	1.8	2.3	2.8	14.5	2.3	1.7	1.9	3.0	8.2	7.2	1.9	1.5	4.0	21.4	18.8	18.5	20.6	18.0	16.5	12.9	19.8	15.7	11.7
HIBCH		ENSG00000198130	"3-hydroxyisobutyryl-CoA hydrolase"	Q6NVY1	2	190189735-190344193	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036540, HPA036541"	Enhanced		Approved	Nucleoplasm,Mitochondria		90000	90000	"Nucleoplasm, Mitochondria"		"HPA036540: AB_10673355, HPA036541: AB_2675182"	"unprognostic (3.60e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.88e-1)"	"prognostic favourable (1.22e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.37e-2)"	"prognostic favourable (1.04e-10)"	"unprognostic (1.34e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-3)"	13.7	38.6	18.1	10.1	19.5	5.0	15.8	16.4	18.7	16.3	15.8	14.5	13.0	24.7	17.0	13.0	20.2	10.2	10.0	13.7	18.5	12.7	65.7	56.8	7.6	8.2	20.1	10.8	9.5	29.5	35.8	24.7	7.8	21.0	11.7	18.7	15.0	10.6	12.2	17.5	23.7	16.5	11.3	18.2	9.0	10.4	10.6	22.2	10.5	17.4	15.4	9.3	12.5	49.2	24.2	15.1	14.6	7.6	17.3	20.0	7.3	9.8	7.5	16.2	10.2	15.2	13.5	8.9	10.6	5.7	10.0	10.9	23.3	8.7	14.8	15.1	9.1	18.7	17.1	14.5	15.1	21.3	13.3	19.8	15.8	20.4	5.2	14.1	7.4	10.9	7.9	11.7	2.1	16.2	24.0	13.0	10.9	9.0	14.3	16.2	5.1	15.4	17.9	11.6	37.7	22.6	29.7	12.3	11.6	9.2	13.1	29.9	14.8	11.0	11.5	10.6	9.9	7.1	7.4	8.3	17.7	12.4	9.7	12.3	8.3	12.9	6.7	14.6	11.9	7.6	12.8	24.2	13.3	12.5	11.1	18.7	14.2	18.2	3.5	17.3	5.7	15.1	20.0	7.3	18.1	19.5	16.4	18.7	18.5	12.7	20.1	10.8	21.0	22.2
HK1		ENSG00000156515	"Hexokinase 1"	P19367	10	69269984-69401884	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycolysis, Immunity, Inflammatory response, Innate immunity"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007043, HPA007044, CAB010052, HPA011956"	Supported		Supported	Mitochondria		16000000	16000000	Mitochondria		"CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049, HPA011956: AB_1850758"	"unprognostic (8.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (3.39e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.86e-2)"	17.5	10.5	21.1	19.9	30.4	23.5	15.8	40.0	48.6	16.6	16.9	10.1	7.6	6.3	13.5	9.4	44.8	15.2	12.6	61.6	19.8	23.3	10.8	4.4	17.2	14.3	19.8	31.3	9.0	4.6	12.5	14.7	22.6	31.3	25.5	15.4	21.2	21.5	26.8	62.1	30.7	8.6	25.6	9.7	13.3	20.3	28.9	10.6	18.9	33.6	32.6	23.0	25.8	23.1	11.4	25.5	17.8	39.3	8.9	23.0	29.6	17.4	9.9	13.3	12.7	14.9	11.2	8.5	17.4	45.8	23.3	25.2	2.9	1.9	1.2	13.8	29.1	15.3	12.4	38.9	22.3	11.6	9.7	43.4	10.6	0.2	17.0	0.8	32.9	16.9	22.7	33.3	74.5	24.1	72.3	9.2	31.9	28.9	5.0	2.2	20.4	44.3	7.7	8.1	0.1	16.1	20.6	13.7	16.1	19.9	38.7	11.5	21.1	2.8	24.7	34.8	15.9	19.1	24.2	11.0	7.2	3.0	45.1	22.8	10.0	17.8	27.3	13.4	14.0	39.3	23.0	11.4	16.2	15.8	25.5	6.8	14.5	11.5	6.6	8.9	39.3	2.9	17.8	29.6	21.1	30.4	40.0	48.6	19.8	23.3	19.8	31.3	31.3	10.6
HLCS	HCS	ENSG00000159267	"Holocarboxylase synthetase"	P50747	21	36750888-36990236	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Ligase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017379	Approved		Supported	Cytosol				Cytosol		"HPA017379: AB_1850768"	"prognostic unfavourable (7.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-3)"	"unprognostic (3.02e-1)"	6.3	9.6	7.1	9.8	10.3	2.9	10.6	12.2	8.5	7.7	7.2	10.3	12.1	5.7	6.4	9.4	7.1	8.1	9.9	5.3	8.4	8.0	9.1	16.4	6.7	5.8	10.2	6.0	5.5	15.6	23.3	23.9	9.9	9.4	12.8	6.4	11.7	9.9	11.6	13.5	4.3	8.1	7.3	10.6	4.5	7.6	7.7	5.1	4.9	14.3	6.1	8.0	9.2	4.9	3.9	5.3	3.2	10.0	8.5	7.8	2.9	17.6	6.5	9.9	7.2	11.8	10.8	9.7	10.8	10.4	4.9	5.5	7.1	8.4	9.6	5.2	15.5	6.0	5.0	8.2	4.4	19.0	10.3	14.1	6.4	4.5	14.1	7.6	7.4	8.5	12.7	7.4	19.9	6.2	15.3	24.5	12.4	10.7	3.4	3.5	15.5	9.2	6.0	5.6	7.8	7.6	17.8	7.0	7.2	14.2	6.6	10.8	11.5	7.8	8.3	7.1	2.2	6.5	5.8	23.8	14.5	5.9	10.2	9.6	8.2	3.2	2.1	1.6	7.8	4.0	6.1	2.6	4.5	5.2	2.0	3.9	5.4	5.5	2.7	8.5	10.0	5.3	2.7	2.9	7.1	10.3	12.2	8.5	8.4	8.0	10.2	6.0	9.4	5.1
HMBS	"PBGD, PORC, UPS"	ENSG00000256269	"Hydroxymethylbilane synthase"	P08397	11	119084866-119093549	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006114, HPA050659"	Supported		Approved	"Lipid droplets"		28000000	28000000	"Lipid droplets"		"HPA006114: AB_1079067, HPA050659: "	"unprognostic (6.24e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.91e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	5.5	11.0	5.3	6.2	9.3	75.2	8.6	5.2	8.0	5.5	8.3	6.0	6.0	7.9	6.9	7.9	9.4	5.5	6.4	11.5	5.9	5.5	9.9	22.2	5.8	14.5	8.8	4.5	3.7	21.2	7.9	5.9	9.7	8.4	5.5	9.2	4.1	10.1	7.2	17.4	6.0	7.9	6.8	9.7	10.4	7.1	7.4	7.5	6.0	8.4	13.0	9.3	5.7	4.8	7.7	19.1	12.0	14.0	3.8	7.4	9.4	9.1	14.0	6.7	11.9	5.4	6.7	10.1	7.3	8.3	10.8	9.3	17.3	14.5	14.2	16.4	9.3	13.0	10.0	14.2	6.9	9.7	10.2	23.3	5.6	12.6	9.9	8.7	7.6	7.3	9.1	17.0	13.0	5.0	34.5	6.3	8.5	36.8	8.4	16.8	7.5	8.9	9.7	6.6	13.8	10.8	8.4	7.4	10.1	5.9	9.2	6.4	15.7	12.1	4.6	8.2	6.2	8.0	8.5	3.4	4.0	8.4	5.4	11.5	9.7	12.0	14.0	1.4	5.1	12.2	6.7	7.7	4.8	5.7	19.1	7.2	7.4	5.6	0.4	3.8	7.3	12.3	4.9	9.4	5.3	9.3	5.2	8.0	5.9	5.5	8.8	4.5	8.4	7.5
HMGCL	HL	ENSG00000117305	"3-hydroxymethyl-3-methylglutaryl-CoA lyase"	P35914	1	23801885-23838620	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004727	Enhanced				"Intracellular and membrane"	120000	120000			"HPA004727: AB_1079074"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-2)"	"prognostic favourable (7.67e-4)"	"unprognostic (1.23e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.05e-1)"	"unprognostic (8.24e-2)"	"prognostic favourable (5.07e-8)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.39e-3)"	7.4	18.5	6.4	8.2	6.6	1.6	14.3	4.3	7.7	7.6	13.9	9.0	12.0	12.0	6.2	13.2	9.1	9.7	12.8	11.2	5.9	6.0	30.3	81.4	8.8	11.1	7.5	7.1	6.1	15.2	13.1	7.8	8.5	7.9	8.7	14.2	10.0	8.9	11.5	15.2	7.0	15.4	11.7	9.3	8.6	10.8	7.2	6.1	8.3	14.5	8.1	8.3	8.8	6.7	24.1	27.7	40.8	33.8	24.5	21.2	26.8	10.7	6.2	7.0	5.2	28.5	21.8	2.7	8.5	15.0	9.3	11.3	3.9	20.9	5.6	17.6	13.3	8.7	8.3	13.8	10.1	11.5	6.3	7.5	5.5	8.8	36.9	2.9	5.0	25.2	20.6	12.2	23.4	12.6	7.6	8.0	16.9	11.0	4.5	5.8	1.8	8.6	6.5	5.7	10.4	21.8	5.6	5.9	5.2	11.1	4.2	18.8	13.3	7.3	9.3	7.7	4.7	14.0	3.6	11.4	5.6	5.0	19.1	10.9	8.9	40.8	32.4	30.1	18.4	30.4	20.1	21.9	20.0	21.2	27.7	24.1	20.3	19.4	12.2	24.5	33.8	20.6	20.8	26.8	6.4	6.6	4.3	7.7	5.9	6.0	7.5	7.1	7.9	6.1
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119747996-119768905	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 257.0"	"Cell line enriched"	"Detected in some"	16	"RT4: 66.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA027423, HPA027442, CAB032906"	Enhanced		Supported	Mitochondria		820000	820000	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favourable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favourable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favourable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	0.3	0.1	0.3	8.7	0.3	0.0	20.6	0.3	0.3	0.3	30.8	0.4	0.3	13.8	0.3	0.3	0.7	0.1	4.4	42.0	0.4	0.0	7.4	257.0	0.8	0.3	0.3	0.3	0.3	1.4	0.0	0.3	0.8	0.7	3.8	19.8	18.9	5.1	0.3	1.4	1.8	12.2	1.9	0.3	0.3	8.1	6.1	0.3	0.4	0.3	0.6	2.1	7.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	66.2	0.0	0.2	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.4	0.0	0.3	0.3	0.7	0.3
HMOX1	"bK286B10, HO-1"	ENSG00000100292	"Heme oxygenase 1"	P09601	22	35380361-35394214	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 209.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 110.9;U-138 MG: 64.7;U-87 MG: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.7;intermediate monocyte: 40.5;non-classical monocyte: 53.4"	"Lineage enriched"	"Detected in many"	6	"monocytes: 53.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000635, CAB017444"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane"		17000	17000	"Golgi apparatus, Plasma membrane"		"CAB017444: AB_10617276, HPA000635: AB_1079089"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.47e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	28.4	10.3	4.1	12.5	8.7	16.3	13.8	0.8	20.6	5.7	12.0	6.1	0.6	22.0	2.5	8.5	8.8	9.8	9.8	10.2	4.1	3.1	23.0	63.7	54.0	76.3	12.5	1.3	28.6	8.8	0.5	2.7	21.1	7.5	3.6	4.9	3.3	3.5	0.8	21.9	13.8	22.8	6.9	11.2	209.8	4.6	5.9	7.6	3.6	4.2	7.3	8.3	6.7	10.2	4.8	7.9	8.4	53.4	1.1	0.3	10.1	1.4	22.6	0.2	4.6	18.5	5.4	110.9	10.4	6.2	4.9	5.3	10.0	1.4	0.0	2.3	8.5	1.2	1.3	0.2	1.5	37.3	1.1	0.5	6.9	20.4	25.7	1.4	7.0	17.0	0.4	32.3	2.1	14.7	0.0	10.8	15.6	1.1	0.0	0.5	2.2	2.5	0.1	1.9	3.4	3.5	12.1	0.3	0.3	26.9	2.4	1.8	1.0	0.3	5.5	64.7	2.9	10.5	10.1	6.8	8.7	1.0	62.8	0.6	1.0	2.0	17.7	1.2	0.2	40.5	0.0	4.8	0.1	0.3	7.9	0.5	0.0	0.0	8.4	1.1	53.4	0.2	0.2	10.1	4.1	8.7	0.8	4.8	4.1	3.1	12.5	1.3	7.5	7.6
HNMT		ENSG00000150540	"Histamine N-methyltransferase"	P50135	2	137964020-138016364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 61.3;HSkMC: 25.1;RT4: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"classical monocyte: 34.6;intermediate monocyte: 26.7;myeloid DC: 20.9;non-classical monocyte: 14.6"	"Group enriched"	"Detected in many"	22	"dendritic cells: 20.9;monocytes: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035480, HPA035481, HPA073754"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		64000	64000	"Nucleoplasm, Cytosol"	Centrosome	"HPA035480: , HPA035481: AB_10672094, HPA073754: "	"unprognostic (1.32e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (3.41e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.21e-1)"	"prognostic favourable (4.68e-4)"	41.4	5.8	12.2	12.3	11.1	3.3	28.8	10.7	11.3	27.6	16.3	8.6	13.9	8.7	22.2	21.4	11.6	14.6	21.6	14.7	12.7	7.8	33.4	74.2	21.9	17.0	13.7	9.2	33.1	14.1	24.5	5.5	14.3	11.2	22.3	17.7	8.7	14.1	20.1	4.9	8.1	11.1	13.2	14.8	18.5	11.5	11.7	14.6	1.0	7.3	8.5	6.5	21.3	12.0	0.5	20.9	1.2	34.6	0.1	0.2	9.2	0.2	0.3	1.5	4.1	17.6	18.9	0.1	1.1	1.7	0.1	0.7	7.8	4.4	0.2	13.9	4.6	0.4	3.2	0.0	0.0	0.2	1.6	0.1	13.1	61.3	7.9	0.0	0.2	25.1	0.0	6.2	0.0	4.4	0.2	0.3	13.2	1.0	0.0	0.2	7.8	1.6	0.1	0.5	0.0	18.9	31.8	0.1	0.4	6.0	7.7	0.0	0.2	14.4	1.3	1.3	3.4	1.8	4.4	0.1	0.0	0.2	6.0	7.5	0.9	0.8	34.6	0.2	0.2	26.7	0.1	0.5	0.1	0.1	20.9	0.3	0.1	0.2	1.2	0.1	14.6	0.6	0.2	9.2	12.2	11.1	10.7	11.3	12.7	7.8	13.7	9.2	11.2	14.6
HOGA1	"C10orf65, DHDPS2, DHDPSL, FLJ37472, NPL2"	ENSG00000241935	"4-hydroxy-2-oxoglutarate aldolase 1"	Q86XE5	10	97584323-97612802	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 39.8;liver: 31.0"	"Group enriched"	"Detected in some"	4	"AN3-CA: 6.0;EFO-21: 7.2;Hep G2: 18.5;RPTEC TERT1: 22.8"	"Group enriched"	"Detected in many"	5	"liver cancer: 4.5;renal cancer: 9.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039466	Approved					15000	15000			"HPA039466: "	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-3)"	"unprognostic (4.72e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.80e-2)"	"prognostic favourable (9.08e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.94e-3)"	"unprognostic (7.20e-4)"	3.3	5.4	3.3	0.6	3.8	0.8	2.1	7.0	4.3	0.8	0.6	8.2	1.5	0.7	0.9	4.0	1.3	2.0	3.8	10.1	4.2	2.8	39.8	31.0	0.9	0.7	9.3	5.2	0.6	12.0	2.0	2.4	0.6	7.2	1.3	0.6	3.6	1.8	2.2	2.0	1.2	0.6	0.8	8.2	0.7	0.6	0.7	6.9	0.0	1.8	4.1	0.6	0.8	0.6	2.1	1.7	4.4	1.2	1.2	1.3	0.5	0.3	2.7	0.1	6.0	1.2	0.3	0.1	0.1	0.2	0.1	0.0	2.2	0.3	0.2	7.2	0.1	2.0	0.1	0.2	0.1	0.2	3.1	0.1	1.0	18.5	0.8	0.2	0.2	0.3	0.6	0.2	0.1	0.3	0.1	0.4	0.4	1.2	0.1	0.2	0.2	0.0	0.2	0.5	0.4	22.8	0.4	0.5	0.9	0.1	1.1	0.7	2.1	0.1	0.3	0.7	0.2	0.4	0.2	0.4	0.6	0.1	1.5	0.3	0.1	2.4	1.1	1.2	1.2	0.9	1.0	1.1	1.3	0.9	0.5	2.1	1.1	1.2	4.4	1.2	1.2	1.7	0.9	0.5	3.3	3.8	7.0	3.9	4.2	2.8	9.3	5.2	7.2	6.9
HP		ENSG00000257017	Haptoglobin	P00738	16	72054592-72061055	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Immunity"	"Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"liver: 1156.9"	"Group enriched"	"Detected in some"	5	"Hep G2: 64.7;HSkMC: 37.1"	"Cancer enriched"	"Detected in many"	81	"liver cancer: 1297.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 20.0;eosinophil: 30.9"	"Group enriched"	"Detected in many"	7	"granulocytes: 30.9;monocytes: 20.0"									"CAB003787, HPA047750"	Enhanced		Approved	Vesicles	"Secreted to blood"	140000000000	140000000000	Vesicles		"CAB003787: , HPA047750: "	"unprognostic (6.38e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"prognostic unfavourable (6.94e-13)"	"unprognostic (4.34e-4)"	"unprognostic (1.80e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.49e-2)"	9.8	0.0	0.3	0.4	0.3	4.4	0.3	0.3	0.3	1.5	0.4	0.3	0.3	0.0	0.3	0.5	0.3	1.1	0.3	3.0	0.3	0.0	0.4	1156.9	1.4	0.4	0.3	0.3	0.3	0.5	0.0	0.5	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	1.4	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.0	3.5	30.9	20.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	64.7	0.1	9.2	1.7	37.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.5	0.1	0.7	0.0	0.3	6.9	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	2.1	1.4	0.0	0.2	0.0	0.0	1.2	0.0	4.4	0.0	3.6	0.0	2.6	20.0	30.9	0.0	0.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	5.8	0.0	0.9	0.0	0.0	5.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490177-174523154	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 193.3"	"Cell line enhanced"	"Detected in some"		"A549: 27.3;ASC diff: 16.9;HEL: 59.7;RT4: 92.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 3.8"	"Group enriched"	"Detected in many"	5	"basophil: 37.7;T-reg: 15.1"	"Group enriched"	"Detected in many"	71	"granulocytes: 37.7;T-cells: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favourable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	5.1	2.6	0.5	7.9	0.6	0.0	24.6	0.4	0.6	23.0	73.3	0.5	2.5	22.9	13.4	7.5	32.0	4.5	10.7	1.2	0.6	0.7	8.5	63.7	22.9	7.9	0.8	0.5	2.3	0.4	0.0	0.9	193.3	3.8	20.1	8.4	4.6	3.0	1.1	1.6	15.3	64.5	9.3	0.5	2.9	36.3	1.9	0.5	5.5	0.4	5.0	7.9	61.2	31.8	0.1	0.2	37.7	0.1	0.3	15.1	1.0	0.0	27.3	0.0	0.0	16.9	1.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	2.5	2.5	0.0	0.0	0.0	0.5	59.7	2.0	0.0	0.0	0.3	0.1	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.4	2.8	0.0	0.2	5.6	92.8	0.1	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	37.7	0.1	5.4	3.7	0.0	5.7	0.1	1.9	1.6	0.2	0.0	0.6	1.5	0.4	0.3	0.0	0.0	15.1	1.0	0.5	0.6	0.4	0.6	0.6	0.7	0.8	0.5	3.8	0.5
HSD11B1	"HSD11, HSD11B, SDR26C1"	ENSG00000117594	"Hydroxysteroid 11-beta dehydrogenase 1"	P28845	1	209686178-209734950	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 183.4"	"Cell line enriched"	"Detected in some"	5	"ASC diff: 148.3"	"Cancer enriched"	"Detected in all"	28	"liver cancer: 197.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 9.2"	"Lineage enriched"	"Detected in single"	20	"T-cells: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047729	Enhanced					77000	77000			"HPA047729: "	"unprognostic (1.08e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.63e-2)"	"unprognostic (8.35e-3)"	"unprognostic (8.69e-2)"	"prognostic unfavourable (1.97e-10)"	"unprognostic (3.41e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.59e-2)"	4.6	1.6	1.1	3.0	3.1	0.3	2.4	9.9	3.9	0.6	1.0	1.6	2.7	0.5	0.8	8.7	1.5	0.9	1.9	3.0	1.8	0.9	2.6	183.4	7.2	1.3	8.2	2.0	12.6	0.9	0.3	1.5	26.5	3.3	7.1	0.9	1.5	0.6	3.0	1.5	6.3	0.9	2.7	1.3	3.5	1.4	2.3	2.5	0.0	1.0	0.6	0.6	3.9	1.4	0.2	0.0	0.2	0.1	0.4	9.2	0.8	0.0	0.0	0.0	0.0	148.3	15.4	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	1.2	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.6	0.2	9.2	2.0	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	2.4	0.8	1.1	3.1	9.9	3.9	1.8	0.9	8.2	2.0	3.3	2.5
HSD17B10	"17b-HSD10, ABAD, CAMR, ERAB, HADH2, MHBD, MRPP2, MRXS10, SDR5C1"	ENSG00000072506	"Hydroxysteroid 17-beta dehydrogenase 10"	Q99714	X	53431258-53434373	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase	"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001432	Approved					1800000	1800000			"HPA001432: AB_1078740"	"unprognostic (1.27e-1)"	"prognostic favourable (2.80e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.92e-1)"	"unprognostic (9.51e-2)"	20.9	29.8	13.2	19.1	14.5	16.4	15.9	7.9	14.0	16.9	20.6	16.2	20.2	17.2	17.1	19.0	31.3	14.8	19.6	42.6	11.9	14.0	33.9	96.7	12.7	21.6	16.1	9.7	21.0	32.7	12.5	18.4	25.0	14.9	15.3	19.4	13.0	23.2	17.8	35.4	22.9	17.4	18.6	14.8	19.7	17.4	8.6	14.0	25.6	28.4	39.0	26.0	16.1	17.9	30.4	53.2	12.8	38.2	27.7	33.3	32.9	22.0	37.8	18.5	34.2	18.2	8.0	27.9	13.7	13.7	36.6	24.1	38.8	19.1	37.7	12.5	15.7	23.2	59.4	27.7	20.1	29.9	33.3	17.7	54.2	32.1	30.5	33.5	27.8	17.0	26.4	28.3	15.9	26.7	25.4	29.9	16.9	77.9	29.6	50.3	51.1	48.9	30.3	34.1	66.7	28.1	24.5	32.7	43.1	39.5	47.3	25.0	49.8	31.2	11.9	15.7	25.0	32.7	20.7	24.5	34.1	46.6	21.8	70.5	23.1	12.8	38.2	11.4	27.0	36.7	27.8	30.0	25.1	26.7	53.2	30.4	21.1	22.2	3.2	27.7	26.8	29.0	33.3	32.9	13.2	14.5	7.9	14.0	11.9	14.0	16.1	9.7	14.9	14.0
HSD17B3	SDR12C2	ENSG00000130948	"Hydroxysteroid 17-beta dehydrogenase 3"	P37058	9	96235306-96302152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 41.9"	"Group enriched"	"Detected in some"	5	"HBEC3-KT: 4.9;HEL: 4.3;U-2 OS: 8.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056833	Enhanced		Supported	Vesicles				Vesicles		"HPA056833: "	"unprognostic (2.78e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.08e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.26e-4)"	"unprognostic (3.45e-1)"	"unprognostic (5.48e-8)"	"unprognostic (8.47e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.11e-2)"	0.5	0.4	1.0	0.5	1.0	0.4	0.5	0.5	0.9	0.8	0.5	0.5	0.5	0.4	0.5	0.5	0.5	1.3	0.5	0.5	1.7	0.5	1.0	6.3	0.5	0.5	1.6	0.5	0.5	1.3	0.4	0.5	0.5	0.5	0.8	0.4	0.5	0.5	0.5	0.5	0.5	1.1	0.5	1.9	0.5	0.4	41.9	0.5	0.5	4.5	0.5	0.5	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.0	1.0	0.5	0.9	1.7	0.5	1.6	0.5	0.5	0.5
HSD17B4	"DBP, MFE-2, SDR8C1"	ENSG00000133835	"Hydroxysteroid 17-beta dehydrogenase 4"	P51659	5	119452443-119637199	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Oxidoreductase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021302, HPA021311, HPA021479"	Enhanced		Enhanced	Peroxisomes		6900000	6900000	Peroxisomes		"HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (1.33e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"prognostic favourable (6.31e-6)"	"unprognostic (1.60e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-3)"	25.1	42.4	22.1	15.5	21.3	6.4	46.0	12.3	23.6	27.8	30.1	24.1	83.8	28.6	16.2	20.7	24.6	15.1	20.6	27.3	23.8	21.2	31.3	116.3	30.5	16.7	27.0	21.7	15.1	29.9	33.2	20.5	19.0	23.9	20.9	25.2	10.7	20.0	86.2	20.7	19.2	30.5	15.6	33.6	16.9	20.7	8.1	25.5	10.8	48.9	17.3	14.5	24.1	25.3	6.1	11.1	31.4	13.6	3.2	4.2	5.3	17.7	15.3	28.8	38.1	71.9	33.8	15.2	17.3	23.3	16.4	29.9	12.6	29.5	23.7	35.6	18.7	17.8	21.1	37.6	25.6	25.9	19.5	31.2	16.6	24.1	18.3	9.8	48.9	29.4	15.8	17.6	16.5	28.0	10.6	13.8	17.8	15.4	15.0	6.4	21.3	10.8	19.2	28.8	25.6	26.2	49.0	21.7	18.7	40.6	6.4	18.9	23.6	16.6	19.9	16.1	11.0	17.7	14.1	7.0	14.7	8.7	18.3	26.3	15.8	31.4	13.6	24.7	3.4	8.0	4.2	6.1	3.2	2.9	11.1	5.8	3.1	2.9	2.4	3.2	7.8	6.9	2.0	5.3	22.1	21.3	12.3	23.6	23.8	21.2	27.0	21.7	23.9	25.5
HSD3B7	"C(27)-3BETA-HSD, SDR11E3"	ENSG00000099377	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7"	Q9H2F3	16	30985207-30989152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	Oxidoreductase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.0;Hep G2: 22.7;HMC-1: 35.2;U-2197: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"basophil: 24.5;eosinophil: 13.5"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050521, HPA060847"	Uncertain		Enhanced	"Lipid droplets"				"Lipid droplets"		"HPA050521: , HPA060847: "	"unprognostic (5.41e-3)"	"unprognostic (4.14e-3)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (1.60e-6)"	"unprognostic (2.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.79e-1)"	21.6	11.2	2.5	7.5	4.7	1.8	7.3	2.7	4.0	4.9	8.3	4.6	2.8	11.2	5.3	6.4	9.4	4.4	7.4	5.2	3.1	1.6	25.6	74.1	6.4	5.6	3.5	1.4	9.3	17.7	5.6	2.6	6.1	3.7	5.9	3.2	2.9	4.5	2.6	5.1	7.8	13.3	6.7	4.8	8.3	4.8	3.6	3.7	1.0	2.9	4.5	4.6	8.0	3.9	0.1	0.8	24.5	0.8	0.2	0.0	0.3	6.9	8.0	0.8	4.0	2.9	10.5	0.5	8.7	13.7	1.7	3.6	0.5	12.1	0.4	2.9	10.6	2.1	0.7	1.2	0.9	31.0	1.9	0.5	6.3	22.7	2.7	0.1	35.2	5.0	2.1	8.3	1.6	0.7	1.6	0.3	6.5	14.8	0.2	4.9	0.6	1.1	0.8	2.8	7.6	5.3	0.4	3.0	1.5	1.1	5.6	0.7	11.0	0.5	4.0	3.6	1.0	34.3	0.9	0.6	5.0	0.4	14.0	0.8	0.3	24.5	0.8	13.5	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.3	2.5	4.7	2.7	4.0	3.1	1.6	3.5	1.4	3.7	3.7
HSPA5	"BiP, GRP78"	ENSG00000044574	"Heat shock protein family A (Hsp70) member 5"	P11021	9	125234853-125241330	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 200.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005221, HPA038845, HPA038846"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	1000000000	1000000000	Cytosol		"CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478"	"unprognostic (3.98e-2)"	"unprognostic (2.50e-3)"	"unprognostic (6.64e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.54e-3)"	"unprognostic (6.02e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.66e-2)"	44.2	40.3	26.3	40.8	38.4	125.0	58.8	19.5	26.9	37.7	29.3	19.8	47.0	25.5	31.6	75.3	34.1	31.1	25.5	72.7	23.3	28.6	60.4	147.6	43.6	32.7	34.3	14.3	36.2	110.3	41.1	47.6	62.6	43.5	34.3	33.0	16.5	84.9	40.7	23.9	32.3	38.3	33.8	28.2	33.8	35.1	33.0	41.5	23.2	219.3	21.7	29.8	50.4	75.1	33.3	53.8	57.4	55.3	51.9	63.0	90.0	35.5	24.1	31.7	41.9	38.0	43.9	74.7	64.1	50.9	47.7	56.0	37.2	71.2	41.1	40.1	46.8	45.5	28.3	57.3	51.3	23.8	14.3	24.6	30.1	67.2	200.7	33.5	46.6	27.0	112.5	38.3	167.9	74.1	18.2	57.5	34.7	26.3	14.8	23.7	35.8	24.2	14.0	32.3	66.7	46.2	23.6	16.4	29.2	40.8	43.7	65.4	45.0	24.5	49.7	29.1	28.4	29.7	29.8	60.2	57.5	34.8	70.7	28.3	43.8	57.4	55.3	44.3	61.9	54.8	63.0	33.3	45.7	57.7	48.6	24.9	37.6	46.6	44.3	51.9	35.5	53.8	31.2	90.0	26.3	38.4	19.5	26.9	23.3	28.6	34.3	14.3	43.5	41.5
HSPD1	"GroEL, HSP60, SPG13"	ENSG00000144381	"Heat shock protein family D (Hsp60) member 1"	P10809	2	197486581-197516737	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 162.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA001523, CAB002775, HPA050025, CAB072816"	Supported		Enhanced	Mitochondria		53000000	53000000	Mitochondria		"CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995"	"unprognostic (2.79e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (2.25e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.47e-2)"	"unprognostic (7.83e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.10e-2)"	28.5	125.2	28.7	23.4	31.8	21.0	55.9	18.2	24.3	17.4	30.3	17.8	23.3	28.9	17.5	18.5	27.2	25.3	16.3	24.0	24.2	27.8	67.1	147.5	22.4	25.3	35.5	16.1	30.2	50.6	32.5	25.9	27.1	33.6	25.9	37.2	11.9	17.6	21.0	36.4	13.7	32.0	23.6	32.4	22.7	25.2	10.9	35.8	22.7	38.7	29.4	30.3	33.3	162.6	25.6	30.3	6.2	29.3	23.1	33.5	22.2	40.4	49.8	41.8	37.5	28.7	30.0	60.8	42.2	22.3	50.8	37.3	167.0	24.4	123.1	55.1	22.0	41.4	163.6	46.5	72.1	30.2	65.6	87.4	80.6	193.3	27.0	96.8	27.5	33.9	54.0	45.0	79.4	39.8	107.6	48.3	37.3	51.8	60.1	98.0	82.6	104.2	72.3	51.6	88.9	53.4	42.3	54.8	31.0	42.3	45.8	54.1	31.7	57.5	17.7	31.6	43.8	40.6	66.6	27.1	59.6	102.2	37.1	58.5	33.9	4.5	19.7	5.3	15.5	29.3	28.8	25.6	25.0	21.8	30.3	21.0	33.5	29.0	6.2	23.1	25.8	20.2	19.7	22.2	28.7	31.8	18.2	24.3	24.2	27.8	35.5	16.1	33.6	35.8
HTRA1	"ARMD7, HtrA, IGFBP5-protease, PRSS11"	ENSG00000166033	"HtrA serine peptidase 1"	Q92743	10	122461525-122514908	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 198.9;ASC TERT1: 73.9;fHDF/TERT166: 67.4;HSkMC: 129.7;LHCN-M2: 98.6;U-87 MG: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;memory CD4 T-cell: 1.6"	"Group enriched"	"Detected in many"	20	"monocytes: 2.4;T-cells: 1.6"	"Low region specificity"	"Detected in all"							HPA036655	Approved		Supported	"Plasma membrane"	"Secreted to blood"	2600000	2600000	"Plasma membrane"		"HPA036655: AB_10671966"	"unprognostic (3.84e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.71e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.83e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (7.90e-7)"	"unprognostic (7.12e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (5.62e-6)"	40.8	21.8	64.5	9.1	79.0	0.5	48.2	16.2	62.8	50.4	19.3	60.8	7.2	5.6	47.6	67.0	15.6	19.5	78.7	28.7	50.8	35.4	34.7	60.4	14.6	9.1	62.7	32.5	111.3	14.5	37.6	26.9	114.1	41.9	19.5	14.0	20.7	19.3	31.5	7.5	29.6	9.3	40.5	46.5	10.5	12.9	9.8	49.5	1.7	13.3	8.5	7.1	41.5	27.3	0.0	0.0	0.0	2.4	0.0	1.6	0.7	0.0	3.4	1.5	0.4	198.9	73.9	0.0	8.5	15.6	3.5	1.9	0.0	0.0	0.0	2.3	67.4	1.0	0.6	9.7	0.5	0.0	0.3	0.0	5.7	0.0	10.1	0.0	0.0	129.7	35.7	2.0	16.6	16.3	0.0	0.1	98.6	1.7	0.0	0.0	1.6	5.4	0.0	0.1	0.0	22.5	0.1	0.1	0.3	21.4	0.0	9.2	0.6	0.0	10.7	25.1	0.3	11.3	7.2	0.0	0.0	0.0	81.4	0.0	11.7	0.0	2.4	0.0	0.6	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	64.5	79.0	16.2	54.6	50.8	35.4	62.7	32.5	41.9	49.5
HTRA2	"OMI, PARK13, PRSS25"	ENSG00000115317	"HtrA serine peptidase 2"	O43464	2	74529377-74533348	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004004, HPA006602, HPA027366"	Uncertain		Supported	Mitochondria				Mitochondria		"CAB004004: AB_326421, HPA006602: , HPA027366: AB_1851301"	"unprognostic (3.09e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (7.77e-8)"	"unprognostic (2.12e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-2)"	16.4	12.7	10.6	14.9	11.3	18.9	12.9	10.7	17.7	12.3	12.8	12.6	9.7	12.6	12.9	6.9	10.7	10.6	9.0	12.9	11.6	8.7	13.1	11.4	11.3	13.2	10.8	11.9	18.7	12.9	10.5	9.0	10.4	13.5	11.6	5.5	10.2	13.1	9.2	17.6	9.0	12.6	11.8	9.1	17.3	11.8	13.9	12.6	12.2	16.8	12.6	9.3	10.4	15.2	12.9	9.4	5.9	8.1	5.5	7.8	7.0	7.9	4.9	5.7	4.9	7.9	3.2	15.2	6.9	3.6	4.2	2.4	9.1	3.5	7.2	5.4	3.9	9.0	6.7	7.9	1.1	16.2	13.4	14.4	4.7	8.0	7.4	6.7	10.6	3.8	5.3	7.9	6.7	5.2	18.9	10.7	3.1	5.2	12.4	14.2	4.7	14.2	8.5	16.1	7.9	3.4	3.2	6.6	7.9	3.7	8.5	13.2	3.9	6.6	3.7	7.3	9.0	14.7	15.4	13.1	4.3	4.7	6.3	10.7	5.8	5.9	8.1	4.8	7.3	6.2	7.8	12.9	7.3	6.2	9.4	11.6	6.3	6.4	3.2	5.5	4.7	6.6	7.4	7.0	10.6	11.3	10.7	17.7	11.6	8.7	10.8	11.9	13.5	12.6
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase"	Q7Z6Z7	X	53532096-53686729	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol		3400	3400	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	24.6	28.2	27.7	23.8	43.3	22.4	28.0	37.0	41.1	31.8	25.9	34.3	26.6	17.1	31.9	52.4	27.4	26.5	23.1	27.1	28.0	31.8	30.3	26.2	20.3	23.1	30.0	30.2	43.3	27.8	59.8	34.2	27.2	34.6	27.3	22.7	25.6	26.4	29.6	59.1	50.1	22.1	33.9	23.9	26.6	25.7	28.4	27.7	32.4	27.6	20.7	28.6	27.0	22.9	5.1	7.2	8.2	7.0	6.9	8.9	3.5	50.1	30.9	20.1	14.2	35.3	21.1	24.8	15.1	19.5	15.9	16.7	23.5	16.2	26.3	10.3	27.4	24.1	45.4	25.3	21.8	37.9	20.1	20.9	27.7	18.3	32.5	31.3	12.9	20.1	19.0	38.2	43.9	27.5	20.8	17.1	20.6	30.9	16.9	17.5	27.5	22.3	15.7	27.8	15.9	26.4	34.8	16.8	12.1	42.6	19.0	13.6	27.2	15.2	35.0	14.7	21.1	20.9	19.2	15.0	14.7	23.0	15.7	30.7	21.1	4.0	4.7	8.2	7.2	3.8	8.9	5.1	6.9	7.6	6.7	5.1	4.9	4.9	4.2	6.9	7.0	7.2	5.7	3.5	27.7	43.3	37.0	41.1	28.0	31.8	30.0	30.2	34.6	27.7
HYAL1	"FUS2, HYAL-1, LUCA1, NAT6"	ENSG00000114378	"Hyaluronoglucosaminidase 1"	Q12794	3	50299889-50312381	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 105.8"	"Group enriched"	"Detected in some"	4	"Hep G2: 44.8;SK-BR-3: 13.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002112	Uncertain				"Secreted to blood"	15000	15000			"HPA002112: AB_1857412"	"unprognostic (1.39e-1)"	"unprognostic (8.68e-2)"	"prognostic favourable (2.07e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.16e-1)"	"prognostic favourable (1.56e-11)"	"unprognostic (4.51e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.90e-2)"	4.9	6.3	1.0	0.9	1.3	0.0	8.4	0.9	1.4	2.9	1.8	1.7	1.3	1.2	3.5	3.5	5.8	1.9	19.3	18.2	1.1	0.5	25.0	105.8	11.3	2.5	1.2	0.9	1.9	3.1	8.0	0.8	1.3	2.9	1.4	1.0	3.1	3.6	1.2	5.2	5.8	1.4	2.7	1.2	28.0	7.2	1.7	0.8	0.2	3.1	4.2	1.0	1.3	4.3	1.2	1.1	7.3	0.9	0.7	1.5	0.2	1.3	0.8	0.1	0.4	0.2	0.3	0.2	0.0	0.1	0.0	0.2	5.1	1.3	0.0	0.3	0.2	3.1	0.1	0.2	0.0	0.0	0.0	0.1	3.8	44.8	2.1	0.3	0.3	1.8	6.5	0.0	0.2	1.3	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.1	2.7	0.1	0.0	1.0	0.0	13.0	0.1	0.9	0.1	0.8	0.3	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	2.2	0.9	2.9	0.7	0.3	1.5	0.9	0.7	1.0	0.4	1.2	1.5	0.8	7.3	0.7	0.7	1.1	0.9	0.2	1.0	1.3	0.9	1.4	1.1	0.5	1.2	0.9	2.9	0.8
IARS	"IARS1, ILRS"	ENSG00000196305	"Isoleucyl-tRNA synthetase"	P41252	9	92210207-92293756	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029806	Approved		Supported	Cytosol				Cytosol		"HPA029806: AB_10601818"	"unprognostic (1.32e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavourable (4.98e-7)"	"unprognostic (2.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.76e-3)"	20.6	31.0	19.1	21.1	28.5	13.8	24.8	24.5	32.1	22.8	23.7	17.5	25.8	13.6	31.9	24.8	29.7	23.8	15.1	26.0	21.4	18.5	24.5	29.9	24.4	24.1	21.6	20.6	28.4	42.8	57.4	29.0	21.1	31.6	23.6	26.7	17.1	25.2	27.7	47.4	25.4	18.8	32.6	20.0	23.1	29.0	18.7	16.9	25.1	52.3	26.7	28.8	22.1	20.5	14.5	15.3	1.9	7.3	18.6	18.6	9.7	35.9	37.3	20.9	32.8	34.4	38.8	33.0	38.2	36.5	30.3	37.1	13.1	23.2	48.9	15.0	58.9	45.0	64.3	49.7	38.3	30.7	23.9	29.8	32.1	23.2	72.7	40.6	22.0	37.8	55.9	52.8	87.4	31.8	52.5	44.5	42.5	26.2	37.5	15.8	33.8	34.5	26.3	31.7	23.5	25.0	18.1	26.7	22.1	25.9	28.5	36.0	22.8	25.4	23.4	22.4	28.0	36.9	31.0	32.6	41.6	25.9	52.4	31.3	41.3	1.9	6.7	0.5	14.7	7.3	18.6	14.5	14.5	14.9	15.3	10.7	14.7	15.3	0.8	18.6	6.2	6.2	12.9	9.7	19.1	28.5	24.5	32.1	21.4	18.5	21.6	20.6	31.6	16.9
IARS2	FLJ10326	ENSG00000067704	"Isoleucyl-tRNA synthetase 2, mitochondrial"	Q9NSE4	1	220094102-220148041	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cataract, Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024212, HPA024594, HPA024596"	Enhanced		Enhanced	Mitochondria		26000	26000	Mitochondria		"HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370"	"unprognostic (2.15e-2)"	"prognostic unfavourable (1.04e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (9.24e-5)"	"unprognostic (9.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.27e-3)"	25.9	39.3	18.0	17.9	16.9	6.7	31.9	15.1	20.8	16.9	26.2	14.8	24.3	18.9	21.5	16.8	23.8	18.8	16.5	40.0	17.5	12.6	29.5	37.3	16.8	25.9	15.6	16.0	20.5	20.5	42.5	15.3	26.2	17.4	18.5	24.9	15.0	22.4	22.3	57.8	22.2	23.4	17.7	15.7	16.1	18.5	15.7	13.7	19.5	17.8	25.9	20.1	24.9	18.7	16.8	20.0	17.2	19.0	18.5	22.6	16.8	37.7	35.4	20.4	20.0	30.8	31.1	49.1	23.0	24.8	25.5	20.7	34.0	39.5	34.9	31.2	28.5	36.7	28.2	28.7	29.5	24.1	34.0	17.3	29.0	38.2	19.1	27.5	18.8	22.4	29.3	27.5	28.5	24.7	42.7	20.3	33.3	20.9	21.6	19.8	26.4	23.5	19.2	40.6	55.8	36.7	25.4	11.0	30.9	34.8	54.1	35.8	62.6	31.1	25.3	25.1	21.0	33.7	38.5	17.4	26.7	25.4	26.6	21.6	27.8	17.2	16.7	15.1	16.8	19.0	22.6	16.8	18.4	22.0	20.0	13.6	20.8	19.0	3.3	18.5	14.5	7.3	19.7	16.8	18.0	16.9	15.1	20.8	17.5	12.6	15.6	16.0	17.4	13.7
ICK	"KIAA0936, LCK2, MGC46090, MRK"	ENSG00000112144	"Intestinal cell kinase"	Q9UPZ9	6	53001279-53061802	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000791, HPA001113"	Approved		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA000791: , HPA001113: AB_1851385"	"unprognostic (1.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-1)"	9.8	28.2	10.1	6.5	10.7	2.8	13.4	14.3	12.7	11.5	12.3	20.1	6.6	11.3	10.6	6.8	10.4	9.2	8.3	9.6	10.8	7.7	5.4	9.6	8.2	5.5	13.3	8.1	11.8	8.2	9.0	5.3	44.3	12.3	12.2	13.0	9.7	20.7	12.7	5.9	10.1	14.2	13.7	16.8	6.2	15.0	5.6	12.6	14.8	7.6	7.0	7.9	10.6	9.1	4.5	4.1	6.2	3.1	3.2	5.0	2.1	5.2	2.0	10.3	7.0	6.4	10.1	11.9	4.7	8.6	7.6	8.7	2.8	1.7	3.8	2.8	14.3	3.5	12.2	4.9	10.1	13.2	4.8	2.9	2.4	15.0	3.2	3.5	3.8	9.0	5.3	3.2	3.7	7.1	5.4	15.8	17.3	4.5	3.7	4.3	3.9	4.3	5.9	4.5	5.1	3.1	3.8	16.6	7.4	4.6	11.4	6.5	6.6	7.4	5.8	12.2	5.7	4.5	11.6	4.4	3.1	1.5	2.5	3.4	5.9	6.2	3.1	5.6	5.0	2.3	4.8	3.7	3.6	4.1	2.9	4.5	4.2	3.6	1.7	3.2	2.5	4.1	4.8	2.1	10.1	10.7	14.3	12.7	10.8	7.7	13.3	8.1	12.3	12.6
IDH1		ENSG00000138413	"Isocitrate dehydrogenase (NADP(+)) 1, cytosolic"	O75874	2	208236227-208266074	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 108.5;RT4: 75.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB033218, HPA035248, HPA057936, CAB062556"	Enhanced		Approved	"Nuclear bodies,Cytosol"		16000000	16000000	"Nuclear bodies, Cytosol"		"CAB033218: AB_2123166, CAB062556: , HPA035248: AB_10600714, HPA057936: "	"unprognostic (2.79e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavourable (6.93e-5)"	"unprognostic (3.32e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.03e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.18e-3)"	"prognostic unfavourable (2.45e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.69e-2)"	41.3	82.3	6.2	8.8	7.0	1.3	20.9	6.5	8.3	12.6	35.2	8.7	38.0	30.6	8.0	29.9	30.3	8.8	18.7	10.8	6.3	6.2	20.5	91.0	19.8	14.3	8.1	4.7	19.4	21.5	4.8	6.2	24.1	8.7	38.5	23.1	15.4	18.7	39.0	4.7	7.4	54.1	10.1	9.3	21.3	20.4	15.6	8.4	3.5	7.9	11.0	11.9	43.4	12.1	4.9	22.8	6.4	31.6	7.4	6.6	12.0	9.6	16.2	23.2	9.4	42.2	30.1	13.2	4.0	18.4	6.8	16.6	25.6	23.6	1.9	25.6	12.5	14.9	16.7	19.4	6.6	1.3	6.3	8.3	13.4	108.5	56.2	5.4	8.3	25.9	41.3	15.5	11.3	18.7	8.3	6.7	10.4	6.1	3.8	9.3	42.4	6.7	3.7	8.4	5.4	30.6	75.8	4.0	6.9	15.3	14.8	50.1	5.7	15.8	12.3	6.9	7.0	9.8	4.3	3.2	5.0	2.5	22.4	32.8	5.5	5.7	31.6	4.8	4.5	14.5	5.1	4.9	4.0	5.3	22.8	4.9	3.3	3.9	6.4	7.4	6.5	8.4	6.6	12.0	6.2	7.0	6.5	8.3	6.3	6.2	8.1	4.7	8.7	8.4
IDS	SIDS	ENSG00000010404	"Iduronate 2-sulfatase"	P22304	X	149476990-149521096	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 107.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA078003	Approved				"Intracellular and membrane"	8900000	8900000			"HPA078003: "	"unprognostic (9.88e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.76e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-1)"	11.6	20.4	92.9	12.1	81.5	16.0	12.0	30.4	107.9	13.1	9.3	15.0	8.1	9.1	17.8	29.5	11.3	14.8	12.3	16.2	83.6	42.7	10.5	7.0	17.9	12.5	36.7	51.8	22.6	10.6	19.5	17.8	7.4	33.0	14.0	10.7	7.7	9.1	19.5	8.9	12.9	11.6	14.1	21.0	14.1	10.6	3.8	14.7	1.9	13.2	4.9	14.7	11.4	8.6	8.7	11.7	63.4	16.6	8.5	18.2	13.3	14.3	16.3	7.2	4.2	7.9	14.1	3.0	8.3	21.8	7.7	14.8	3.3	10.8	34.5	22.2	12.3	8.4	6.9	13.0	10.0	12.4	5.9	3.7	5.3	1.9	6.1	5.9	33.3	7.7	7.0	16.7	11.0	12.2	1.7	25.2	11.4	18.3	5.9	3.1	5.6	11.2	3.9	6.5	6.6	9.9	3.6	9.6	22.2	3.2	7.4	10.2	2.3	2.6	14.3	10.2	10.4	16.5	22.4	17.7	13.9	25.2	45.9	14.2	7.2	23.9	13.8	39.6	18.2	14.9	13.5	8.7	11.2	13.6	11.7	6.6	7.5	11.3	63.4	8.5	16.6	8.8	16.9	13.3	92.9	81.5	30.4	90.7	83.6	42.7	36.7	51.8	33.0	14.7
IDUA	MPS1	ENSG00000127415	"Iduronidase, alpha-L-"	P35475	4	986997-1004506	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025901, HPA046979, HPA054254"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	130000	130000	Vesicles		"CAB025901: , HPA046979: , HPA054254: "	"unprognostic (3.62e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.64e-2)"	"unprognostic (4.61e-3)"	"prognostic unfavourable (7.87e-5)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"prognostic favourable (8.04e-5)"	11.0	15.0	14.7	12.0	15.3	10.8	12.9	36.5	15.7	12.4	9.2	10.9	16.9	17.1	13.0	13.4	7.7	12.1	15.9	8.9	13.4	6.5	13.4	10.7	12.8	11.2	11.6	10.0	14.6	22.6	13.0	15.2	4.0	12.8	14.5	6.0	14.1	20.2	15.8	6.2	16.8	11.8	7.3	9.0	15.3	21.3	4.7	12.6	7.6	14.0	3.4	10.0	10.4	11.2	0.8	4.1	0.0	3.8	3.1	4.5	1.1	3.0	5.7	0.0	2.4	13.2	4.7	8.7	8.3	7.3	2.8	1.7	2.0	9.8	1.3	9.3	5.6	1.9	0.3	1.1	0.6	8.3	0.4	4.9	5.9	0.7	5.5	4.0	13.2	9.0	4.1	2.3	0.0	2.0	2.4	0.1	2.7	3.3	2.7	4.2	1.9	5.4	7.5	0.0	1.4	4.6	6.1	0.1	3.8	0.9	0.0	4.7	6.7	3.4	8.6	15.4	1.7	8.6	2.2	32.0	3.6	1.6	7.5	5.4	3.7	0.0	3.5	0.0	3.3	2.7	4.5	0.6	2.7	2.6	4.1	0.8	3.4	2.0	0.0	3.1	3.8	2.5	1.3	1.1	14.7	15.3	36.5	15.7	13.4	6.5	11.6	10.0	12.8	12.6
IFIH1	"Hlcd, IDDM19, MDA-5, MDA5"	ENSG00000115267	"Interferon induced with helicase C domain 1"	Q9BYX4	2	162267079-162318703	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 31.5;BJ hTERT+ SV40 Large T+ RasG12V: 39.2;Karpas-707: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002656	Approved									"HPA002656: AB_1079344"	"unprognostic (2.85e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.65e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.29e-2)"	17.2	11.3	5.8	23.1	5.8	26.9	10.5	2.8	6.4	10.3	12.5	4.9	9.5	12.3	7.3	11.0	9.9	8.3	10.8	6.3	6.1	4.7	10.4	11.8	19.7	17.2	6.1	3.2	11.2	11.5	11.6	14.0	15.6	7.0	12.3	7.8	5.9	15.7	17.2	4.7	6.4	18.0	5.8	7.4	25.3	9.0	4.3	4.2	20.5	15.9	8.3	12.9	9.1	10.4	12.3	10.5	14.5	11.6	3.6	9.4	7.1	3.0	0.3	0.1	0.0	4.0	3.1	1.2	0.5	8.4	31.5	39.2	0.5	7.5	6.1	4.6	0.5	3.3	0.5	4.1	3.3	14.5	1.7	3.6	0.5	1.8	3.6	4.0	2.7	2.4	2.7	3.8	0.8	2.4	0.1	18.6	0.5	6.3	4.1	4.0	0.0	1.5	3.0	0.0	8.7	3.6	3.9	0.1	0.0	1.8	10.3	18.0	2.7	3.2	1.9	0.9	0.8	0.4	1.2	7.2	11.8	0.9	1.6	3.2	2.8	4.2	11.0	4.0	6.5	11.6	9.3	11.4	8.3	7.2	10.5	12.3	6.9	7.1	14.5	3.6	11.0	1.5	9.4	7.1	5.8	5.8	2.8	6.4	6.1	4.7	6.1	3.2	7.0	4.2
IGHMBP2	"CATF1, CMT2S, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7"	ENSG00000132740	"Immunoglobulin mu binding protein 2"	P38935	11	68903842-68940602	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Ribonucleoprotein, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004092, HPA060994"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA004092: , HPA060994: "	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.19e-1)"	"prognostic favourable (5.89e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (1.29e-8)"	"unprognostic (1.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	7.2	6.0	6.9	8.1	11.0	13.8	9.4	17.7	14.9	8.1	14.6	8.3	14.3	9.7	12.0	5.4	8.8	8.5	7.8	7.7	6.6	5.3	6.7	8.7	7.3	7.9	4.6	7.0	9.4	9.6	7.7	6.0	6.5	6.6	9.0	6.1	7.9	12.7	10.0	12.2	11.7	9.4	8.1	4.1	8.9	9.1	36.9	5.7	10.0	7.3	5.9	8.8	8.8	8.3	5.0	3.3	4.7	12.1	2.7	5.1	2.7	8.0	9.2	5.5	8.8	4.5	3.5	8.4	8.0	5.0	10.0	6.6	18.7	8.0	7.0	11.4	4.1	12.8	9.2	5.0	4.2	8.2	7.8	10.0	10.9	6.0	5.2	7.5	9.5	2.6	6.0	10.6	5.4	5.1	11.7	9.0	3.4	6.3	11.9	13.5	4.8	9.8	9.9	8.4	8.5	4.7	7.3	8.8	6.4	9.5	8.2	19.0	12.6	5.7	6.9	8.6	7.5	11.5	8.3	10.1	7.7	8.1	6.0	7.3	7.8	0.0	3.9	2.2	5.1	3.3	4.7	5.0	3.4	4.0	3.3	3.3	2.4	3.3	4.7	2.7	12.1	2.5	4.0	2.7	6.9	11.0	17.7	14.9	6.6	5.3	4.6	7.0	6.6	5.7
IMMP2L	"IMMP2L-IT1, IMP2"	ENSG00000184903	"Inner mitochondrial membrane peptidase subunit 2"	Q96T52	7	110663051-111562517	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA026711	Approved		Approved	Mitochondria				Mitochondria		"HPA026711: AB_1851760"	"unprognostic (2.55e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (1.89e-5)"	"unprognostic (5.64e-3)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.71e-1)"	12.4	12.4	7.9	7.3	10.8	2.9	11.8	5.4	9.1	12.4	11.1	5.7	10.6	5.2	23.8	10.4	8.0	11.5	5.8	8.6	7.1	6.0	23.8	17.7	7.4	4.4	5.7	6.1	14.4	10.0	13.4	15.7	8.0	6.3	13.8	5.8	31.6	11.6	15.8	18.6	7.5	10.9	14.4	5.6	5.3	9.8	9.0	5.6	8.2	16.7	8.3	9.5	11.0	9.2	18.1	11.7	5.8	8.4	24.3	15.1	5.1	7.8	4.7	2.8	11.7	7.6	7.7	5.0	5.4	5.5	3.6	3.8	2.3	9.2	12.9	14.9	4.7	4.4	3.0	10.9	6.0	8.0	3.1	4.4	18.7	6.4	11.6	8.1	0.5	13.4	14.5	1.5	10.1	4.7	14.1	10.0	2.7	5.4	10.8	9.1	2.8	7.4	2.3	23.5	6.7	13.2	3.3	3.3	10.4	2.3	11.1	30.0	4.5	4.7	3.0	5.6	5.8	5.6	6.5	5.7	1.5	7.9	6.1	3.8	29.3	5.8	5.1	1.6	6.4	6.4	11.4	16.3	10.8	7.2	9.4	18.1	15.1	10.5	0.2	24.3	8.4	11.7	6.4	5.1	7.9	10.8	5.4	9.1	7.1	6.0	5.7	6.1	6.3	5.6
IMPA1	IMPA	ENSG00000133731	"Inositol monophosphatase 1"	P29218	8	81657961-81686693	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037489	Approved		Approved	Nucleoplasm,Mitochondria		390000	390000	Mitochondria	Nucleoplasm	"HPA037489: AB_10671757"	"unprognostic (1.78e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-3)"	10.8	10.9	16.2	10.5	20.9	20.8	9.2	11.2	29.7	9.4	22.4	15.3	4.7	20.1	10.8	12.0	17.2	10.3	11.0	22.3	17.6	19.7	25.5	29.4	9.8	14.3	18.9	20.7	12.1	8.5	8.6	20.1	7.2	27.3	10.6	25.4	14.8	8.9	7.3	11.2	5.0	23.5	15.0	19.1	12.9	12.2	30.5	13.8	16.2	20.3	12.0	13.7	10.5	10.7	13.2	8.2	24.1	7.5	13.6	12.9	7.2	5.7	15.8	11.0	8.3	6.4	10.2	4.5	16.6	12.0	14.9	18.0	7.4	9.1	21.8	13.3	11.8	4.4	12.7	5.7	20.1	22.8	13.0	16.4	8.7	9.2	11.6	16.4	16.8	9.7	8.3	11.4	22.6	16.2	14.8	18.5	14.9	3.6	20.8	9.5	4.7	16.9	9.8	8.3	8.9	17.2	18.6	4.5	19.0	10.9	2.9	19.9	9.5	13.2	12.5	12.3	15.7	9.5	20.5	21.7	25.8	30.5	14.3	9.9	16.8	24.1	4.7	19.5	9.9	6.6	12.1	13.2	10.1	10.7	5.0	9.5	10.7	12.6	7.5	13.6	7.5	8.2	12.9	7.2	16.2	20.9	11.2	29.7	17.6	19.7	18.9	20.7	27.3	13.8
IMPAD1	"FLJ20421, gPAPP, IMPA3"	ENSG00000104331	"Inositol monophosphatase domain containing 1"	Q9NX62	8	56957933-56993844	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009411	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		560000	560000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA009411: AB_1079138"	"unprognostic (1.62e-2)"	"unprognostic (7.89e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	30.6	33.9	17.8	13.9	23.7	9.6	17.6	23.6	33.1	24.7	17.7	30.9	17.8	11.7	23.2	15.2	17.7	15.6	18.0	25.2	19.9	21.6	21.3	32.6	16.5	10.3	23.6	21.1	16.0	25.2	30.4	20.4	23.3	27.2	28.8	16.2	25.2	28.7	22.5	41.4	13.4	12.3	23.0	21.7	13.0	14.7	19.0	19.5	12.0	24.4	18.1	13.0	17.2	14.9	1.9	2.0	6.1	4.6	6.8	2.4	0.6	17.1	14.3	11.0	11.3	33.9	23.3	15.2	26.1	25.4	18.7	16.4	7.1	12.2	10.7	20.0	27.7	14.1	13.3	17.6	27.9	14.7	9.5	20.9	10.1	12.7	21.1	13.2	14.9	18.7	17.7	16.8	27.4	24.8	9.0	19.5	20.5	9.1	16.1	8.0	8.2	5.3	11.3	9.9	12.1	19.5	10.2	4.3	12.0	14.6	18.1	14.8	16.1	9.7	20.7	25.4	14.7	25.0	18.7	20.2	16.8	11.5	34.8	11.1	15.6	2.9	1.9	1.1	2.0	1.2	1.6	1.3	1.3	1.2	1.4	1.9	1.5	2.4	6.1	6.8	4.6	2.0	0.9	0.6	17.8	23.7	23.6	33.1	19.9	21.6	23.6	21.1	27.2	19.5
INPP5E	"CORS1, JBTS1, pharbin, PPI5PIV"	ENSG00000148384	"Inositol polyphosphate-5-phosphatase E"	Q9NRR6	9	136428619-136439823	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Ciliopathy, Disease mutation, Joubert syndrome, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065758	Approved									"HPA065758: "	"unprognostic (1.99e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.00e-1)"	"unprognostic (6.92e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.65e-2)"	"prognostic favourable (1.82e-4)"	"unprognostic (2.03e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.66e-2)"	14.3	11.2	14.9	15.3	10.4	8.9	19.2	19.9	19.1	10.5	10.7	11.5	11.1	10.3	13.1	10.1	8.4	17.2	9.4	11.9	12.6	12.0	10.2	9.0	10.1	13.5	8.4	12.3	14.7	11.6	11.4	12.3	9.8	13.2	9.9	5.2	11.0	14.4	12.9	11.6	18.2	10.7	10.7	6.6	19.4	8.6	15.2	10.3	8.5	12.5	6.2	10.7	8.8	19.3	2.6	1.0	1.9	0.5	0.0	2.4	0.6	6.1	7.1	8.3	8.2	4.2	5.5	10.3	7.3	4.3	5.7	3.6	7.2	4.3	7.6	7.6	6.1	17.2	3.7	5.1	2.2	23.9	14.4	5.1	12.2	4.8	7.2	6.0	8.3	5.9	4.7	6.3	5.6	5.5	8.6	7.0	4.8	10.1	7.6	13.2	5.4	11.8	14.1	6.4	5.7	5.1	6.0	8.8	7.8	7.1	6.7	5.1	10.7	8.9	7.9	17.6	6.6	7.1	12.8	7.6	6.1	3.2	9.0	5.3	6.4	0.0	0.5	1.9	2.0	0.0	1.3	2.6	2.3	1.5	0.5	1.7	0.8	1.6	0.4	0.0	0.3	1.0	2.4	0.6	14.9	10.4	19.9	19.1	12.6	12.0	8.4	12.3	13.2	10.3
INPP5K	SKIP	ENSG00000132376	"Inositol polyphosphate-5-phosphatase K"	Q9BT40	17	1494571-1516888	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Congenital muscular dystrophy, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 114.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (7.47e-2)"	"prognostic favourable (3.91e-4)"	"unprognostic (8.91e-2)"	"prognostic favourable (2.33e-5)"	"unprognostic (3.25e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-2)"	"prognostic favourable (1.47e-6)"	"unprognostic (4.71e-2)"	"unprognostic (9.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.04e-1)"	27.9	10.5	12.7	13.8	13.5	25.9	37.0	14.9	17.7	13.4	13.4	14.9	9.8	9.1	12.8	12.2	12.0	10.4	12.9	17.5	12.8	12.6	11.6	10.5	20.8	14.3	12.8	12.0	14.3	18.9	12.0	10.8	15.9	21.2	13.5	11.4	114.9	12.9	12.2	26.4	22.3	13.9	10.9	10.7	16.2	12.8	20.8	11.3	22.1	27.3	13.8	16.4	12.5	14.1	12.1	16.5	36.4	27.0	17.0	30.8	24.6	9.4	13.1	5.4	10.3	14.0	7.8	8.0	7.9	13.4	9.0	11.5	8.1	5.6	8.4	15.2	12.1	12.4	12.8	5.1	9.3	21.8	21.6	5.2	10.0	3.2	17.7	4.9	10.2	9.2	13.7	9.0	8.9	14.3	5.7	15.2	5.9	6.7	14.9	4.0	2.3	8.9	11.5	4.2	8.0	7.3	5.8	4.2	10.8	6.2	12.2	14.1	10.3	4.0	10.1	7.9	8.1	11.4	10.2	8.0	13.4	4.5	8.9	5.1	9.9	36.4	19.9	31.9	22.2	18.7	18.2	12.1	20.7	22.4	16.5	11.3	17.7	18.9	33.3	17.0	27.0	11.9	30.8	24.6	12.7	13.5	14.9	17.7	12.8	12.6	12.8	12.0	21.2	11.3
INPPL1	SHIP2	ENSG00000165458	"Inositol polyphosphate phosphatase like 1"	O15357	11	72223701-72239105	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Immunity"	"Actin-binding, Hydrolase"	"Cancer-related genes, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037601	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA037601: AB_10672281"	"unprognostic (2.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (7.37e-4)"	"unprognostic (2.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.07e-1)"	20.9	23.7	22.2	20.4	19.5	25.1	18.6	11.1	18.9	25.2	32.0	22.7	28.8	19.8	24.7	18.4	17.4	24.3	29.6	29.5	24.1	10.3	23.9	17.1	24.9	19.0	27.6	10.4	30.1	22.7	21.6	26.9	31.9	20.4	28.7	13.5	30.7	27.5	24.2	60.0	17.7	23.0	34.7	27.5	28.3	24.5	11.8	24.3	16.0	29.1	19.3	18.3	25.0	18.1	2.6	5.2	7.0	7.6	4.2	4.5	3.3	6.4	13.8	16.6	11.3	8.2	9.8	29.6	29.8	13.9	18.7	11.9	18.9	16.3	18.4	30.5	22.8	24.6	13.6	8.4	6.4	23.8	14.2	19.1	70.0	6.9	16.1	12.6	42.8	13.9	8.9	18.1	7.2	10.0	13.4	7.9	10.2	17.4	9.3	51.0	16.9	21.6	43.9	37.7	4.1	21.7	10.8	8.1	11.8	32.0	19.3	41.6	20.4	23.9	16.9	20.1	23.5	30.7	9.7	22.9	3.8	17.9	5.7	12.0	10.8	5.2	7.6	7.0	4.5	4.4	3.7	2.2	3.7	3.0	5.2	2.6	2.7	3.7	5.2	4.2	7.0	3.9	3.3	3.3	22.2	19.5	11.1	18.9	24.1	10.3	27.6	10.4	20.4	24.3
IRAK3	IRAK-M	ENSG00000090376	"Interleukin 1 receptor associated kinase 3"	Q9Y616	12	66188879-66254622	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.7;ASC TERT1: 12.2;HEL: 12.6;HL-60: 16.7;NB-4: 13.3;THP-1: 20.2;U-937: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 5.6;classical monocyte: 13.1;intermediate monocyte: 13.2;myeloid DC: 6.2;neutrophil: 7.2;non-classical monocyte: 20.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 6.2;granulocytes: 7.2;monocytes: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043097	Approved		Approved	Vesicles	"Intracellular and membrane"			Vesicles		"HPA043097: AB_10795612"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.52e-2)"	"prognostic unfavourable (6.23e-4)"	"unprognostic (5.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.23e-2)"	21.8	3.7	2.1	10.6	3.6	58.0	13.4	1.0	2.4	8.7	6.5	2.3	5.5	1.7	6.2	8.6	4.9	7.0	7.6	16.0	2.9	2.1	3.6	2.9	22.1	25.6	4.6	0.3	5.9	2.7	1.3	17.9	6.1	3.7	7.0	3.0	5.5	6.0	5.5	5.5	3.3	4.9	6.4	5.9	25.3	6.2	5.1	2.8	1.0	4.9	4.5	5.4	9.5	11.4	0.4	6.2	7.2	20.6	0.9	0.3	3.6	0.0	0.0	0.2	0.0	14.7	12.2	0.0	1.6	0.0	0.9	1.3	0.0	1.2	0.0	0.8	3.0	0.0	1.8	0.0	0.7	0.0	0.0	12.6	0.7	0.0	7.7	16.7	2.3	7.7	0.0	0.7	0.0	4.3	0.0	0.0	0.5	0.0	0.0	13.3	0.7	0.0	0.0	3.6	0.0	0.1	1.8	0.1	0.0	6.5	0.0	0.7	0.0	20.2	4.6	0.0	0.0	0.0	0.0	0.5	0.1	1.2	0.0	14.7	0.0	5.6	13.1	2.2	0.0	13.2	0.0	0.0	0.0	0.0	6.2	0.4	0.0	0.0	7.2	0.9	20.6	0.0	0.3	3.6	2.1	3.6	1.0	2.4	2.9	2.1	4.6	0.3	3.7	2.8
IRAK4	NY-REN-64	ENSG00000198001	"Interleukin 1 receptor associated kinase 4"	Q9NWZ3	12	43758944-43789543	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016685, CAB022077"	Uncertain		Approved	Nucleoli,Microtubules,Cytosol				Microtubules	"Nucleoli, Cytosol"	"CAB016685: AB_1618505, CAB022077: "	"unprognostic (2.76e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.47e-2)"	"prognostic favourable (3.46e-5)"	"unprognostic (6.15e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.00e-3)"	"unprognostic (6.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (4.42e-5)"	18.0	9.4	5.1	15.0	10.4	10.3	11.3	3.7	6.0	10.3	12.2	9.1	12.5	10.2	13.0	14.1	15.0	9.4	10.8	7.6	6.7	5.2	13.3	11.8	12.0	24.0	13.2	3.9	9.3	20.1	9.1	16.1	14.0	9.8	10.5	10.0	11.9	11.9	15.1	4.1	15.2	15.0	11.8	13.0	25.0	12.3	7.1	11.7	30.3	17.0	7.7	18.9	11.1	10.7	5.1	5.8	16.9	6.0	8.8	7.7	4.7	5.3	3.9	2.8	3.7	10.1	17.0	4.0	7.5	5.3	6.0	5.5	3.3	5.1	9.1	7.4	6.2	4.4	3.1	4.8	8.6	13.0	2.9	8.7	3.0	2.1	5.8	12.0	10.7	9.0	7.8	7.6	4.4	8.8	8.0	6.8	16.4	2.9	10.4	6.8	1.0	4.6	6.9	3.4	4.8	4.6	5.1	2.0	1.9	3.6	4.7	3.6	5.9	10.7	7.8	7.4	1.4	9.0	5.1	8.4	10.8	7.9	7.6	32.4	4.0	16.9	4.6	9.4	7.4	5.4	7.7	4.0	6.1	6.3	4.5	5.1	5.5	5.9	9.3	8.8	6.0	5.8	7.5	4.7	5.1	10.4	3.7	6.0	6.7	5.2	13.2	3.9	9.8	11.7
ISPD	"hCG_1745121, IspD, Nip"	ENSG00000214960	"Isoprenoid synthase domain containing"	A4D126	7	16087527-16421322	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 8.3;HEL: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	17	"basophil: 10.7"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043810, HPA053554"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA043810: AB_10964489, HPA053554: "	"unprognostic (4.65e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.07e-1)"	"prognostic favourable (1.38e-11)"	"unprognostic (4.01e-2)"	"unprognostic (1.78e-4)"	"unprognostic (6.26e-2)"	"unprognostic (2.79e-1)"	3.0	3.8	4.2	1.9	4.5	2.6	3.0	7.7	7.7	3.7	2.9	3.9	3.4	1.8	4.7	2.4	2.0	2.8	3.2	7.1	4.4	4.5	7.0	10.0	2.9	1.5	4.7	3.9	2.7	3.9	3.6	5.7	8.0	4.6	3.5	3.0	5.7	5.5	10.1	4.5	2.6	1.8	3.7	4.9	1.4	10.2	3.9	2.4	1.1	2.6	2.4	1.4	3.2	3.7	0.3	0.4	10.7	0.1	0.4	0.3	0.0	0.3	2.3	1.2	1.8	1.0	1.5	8.3	1.8	1.2	1.6	1.3	2.6	2.2	0.0	4.0	2.6	3.0	1.4	0.0	2.9	1.0	1.4	11.5	1.4	0.6	1.3	0.9	1.4	2.7	1.2	1.3	0.2	1.2	2.7	0.2	4.1	0.5	1.1	1.0	2.2	0.3	0.0	1.8	0.1	2.7	0.8	2.0	1.3	1.3	2.4	2.5	1.7	2.6	1.3	2.3	2.1	0.3	2.2	0.2	0.0	0.0	1.9	2.7	2.8	10.7	0.1	0.4	0.3	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.3	0.2	0.6	0.4	0.0	0.4	0.0	0.0	4.2	4.5	7.7	7.7	4.4	4.5	4.7	3.9	4.6	2.4
ITCH	AIP4	ENSG00000078747	"Itchy E3 ubiquitin protein ligase"	Q96J02	20	34363235-34511393	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021126, HPA049032, CAB072824, CAB072825"	Supported		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: "	"unprognostic (2.51e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.21e-1)"	20.7	16.7	18.9	15.4	26.9	20.5	17.5	19.8	26.7	23.9	18.2	37.9	15.2	16.9	18.4	15.1	35.9	14.5	14.5	17.9	20.4	15.9	21.1	46.5	18.5	16.8	29.2	16.5	19.3	17.1	21.6	26.3	26.9	29.0	17.5	20.4	16.7	20.1	18.4	24.0	19.2	20.3	19.8	30.4	17.3	17.3	34.8	32.3	22.3	22.7	13.0	23.6	19.6	21.0	7.3	11.4	19.6	6.2	6.2	11.4	2.7	20.0	13.2	13.5	9.7	14.9	21.3	16.2	16.3	18.7	20.4	20.0	37.2	30.9	9.8	15.8	20.8	25.4	20.5	32.9	24.9	7.4	6.6	28.4	11.2	22.2	15.6	11.6	12.9	10.8	16.8	17.2	27.0	15.3	16.1	17.0	15.9	10.0	17.0	6.2	6.5	15.7	14.3	28.5	22.6	12.1	34.8	8.3	6.1	30.5	11.9	18.3	14.3	10.5	14.8	24.4	14.7	15.9	12.0	13.5	14.1	14.3	15.1	7.5	14.3	3.6	5.8	6.1	10.8	6.2	11.4	7.3	3.8	5.7	4.5	6.9	3.3	4.9	19.6	6.2	3.8	11.4	4.8	2.7	18.9	26.9	19.8	26.7	20.4	15.9	29.2	16.5	29.0	32.3
ITGA6	CD49f	ENSG00000091409	"Integrin subunit alpha 6"	P23229	2	172427354-172506282	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 50.1;HaCaT: 55.2;HBEC3-KT: 108.5;hTCEpi: 47.3;hTERT-HME1: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 16.2"	"Group enriched"	"Detected in many"	34	"granulocytes: 16.2;NK-cells: 5.5;T-cells: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009009, HPA012696, HPA027582"	Enhanced					45000000	45000000			"CAB009009: AB_2128038, HPA012696: AB_1851822, HPA027582: AB_10602606"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.93e-2)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-3)"	"unprognostic (9.34e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (2.35e-11)"	"unprognostic (3.35e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.21e-3)"	28.0	3.1	9.8	19.1	10.5	1.6	30.1	3.0	8.4	27.0	34.9	9.4	42.3	28.5	28.2	11.3	17.0	11.1	23.8	21.7	9.7	8.2	22.0	4.9	29.0	14.9	9.8	5.1	7.6	31.3	7.4	4.9	38.7	12.6	14.3	25.2	17.6	37.1	32.4	13.5	17.5	44.2	15.2	9.6	14.9	25.0	12.4	6.9	15.1	11.5	35.2	13.2	24.1	17.3	0.3	0.1	16.2	0.2	5.5	10.0	3.3	11.4	9.8	4.3	7.7	0.2	0.1	23.6	50.1	5.4	5.1	3.2	5.5	22.0	0.1	14.1	13.3	55.2	2.8	108.5	9.3	0.1	2.6	0.2	10.5	9.1	0.7	3.1	0.3	1.0	47.3	0.3	48.1	32.8	0.0	0.8	6.4	0.5	0.8	2.7	7.8	8.4	0.1	12.8	0.2	7.8	16.1	0.1	0.5	9.2	0.0	10.7	2.0	0.2	14.7	7.2	6.5	13.2	8.6	0.7	0.5	0.3	0.2	1.1	28.9	2.6	0.2	16.2	4.2	0.0	8.5	0.2	5.4	5.0	0.1	0.3	10.0	4.6	0.5	5.5	0.0	0.0	5.7	3.3	9.8	10.5	3.0	8.4	9.7	8.2	9.8	5.1	12.6	6.9
ITK	"EMT, LYK, PSCTK2"	ENSG00000113263	"IL2 inducible T cell kinase"	Q08881	5	157142933-157255191	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 28.0;lymphoid tissue: 60.5"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 21.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	28	"gdT-cell: 13.8;MAIT T-cell: 9.1;memory CD4 T-cell: 19.5;memory CD8 T-cell: 18.9;naive CD4 T-cell: 28.0;naive CD8 T-cell: 22.8;NK-cell: 9.2;T-reg: 23.1"	"Group enriched"	"Detected in many"	29	"NK-cells: 9.2;T-cells: 28.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"														"unprognostic (2.08e-3)"	"unprognostic (6.57e-4)"	"unprognostic (5.06e-3)"	"unprognostic (4.96e-5)"	"unprognostic (1.52e-2)"	"unprognostic (1.12e-4)"	"unprognostic (8.45e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.52e-6)"	"unprognostic (3.64e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.26e-2)"	2.3	0.7	0.5	12.2	0.6	2.5	1.3	1.9	0.5	1.4	3.3	0.0	0.0	0.5	1.2	1.1	1.8	1.4	4.3	0.9	0.5	0.5	1.4	1.2	6.6	60.5	0.9	0.0	0.7	0.7	0.0	0.9	0.1	0.3	1.1	1.3	1.5	3.5	1.1	0.5	1.0	8.9	0.4	1.2	10.7	2.3	1.4	0.0	60.3	1.6	2.7	24.3	4.1	1.3	0.0	0.0	0.4	0.6	9.2	28.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	3.6	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	9.1	0.0	19.5	18.9	0.0	0.0	28.0	22.8	0.4	9.2	0.6	0.0	23.1	13.6	0.5	0.6	1.9	0.5	0.5	0.5	0.9	0.0	0.3	0.0
ITPA	"C20orf37, dJ794I6.3, HLC14-06-P"	ENSG00000125877	"Inosine triphosphatase"	Q9BY32	20	3208868-3223870	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022824, HPA073963"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		69000	69000	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA022824: AB_1851960, HPA073963: "	"unprognostic (1.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.53e-2)"	"prognostic unfavourable (2.54e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.84e-1)"	17.7	27.5	18.6	24.7	21.2	20.4	17.7	10.2	22.7	21.3	21.4	18.3	20.6	22.9	18.1	17.3	31.0	26.6	19.6	25.9	18.1	13.5	22.9	20.3	22.7	30.6	20.5	24.1	16.5	43.8	17.6	10.2	17.0	16.2	14.6	16.8	13.2	19.9	21.5	19.5	23.4	19.0	16.3	16.3	20.6	19.3	16.7	19.5	15.2	24.9	29.0	24.1	14.6	17.7	19.3	30.7	11.3	31.0	24.7	24.1	18.2	33.1	26.2	13.0	13.4	8.6	12.7	8.6	15.0	21.0	19.8	17.4	21.0	30.9	14.3	13.8	13.8	28.9	17.8	22.6	13.9	9.3	26.6	35.8	10.9	31.8	16.3	15.3	12.2	12.1	17.3	18.7	11.6	15.1	24.5	9.9	17.8	15.2	18.0	44.4	21.7	26.5	17.3	18.1	37.5	27.1	10.5	19.7	23.2	11.9	41.7	27.6	17.3	25.6	10.6	22.3	12.4	14.6	31.8	14.7	18.4	27.0	10.4	28.4	24.2	11.3	25.7	8.8	20.7	31.0	18.0	19.3	18.9	21.8	30.7	17.8	14.2	17.2	1.4	24.7	21.9	28.3	24.1	18.2	18.6	21.2	10.2	22.7	18.1	13.5	20.5	24.1	16.2	19.5
ITPKC	"IP3-3KC, IP3KC"	ENSG00000086544	"Inositol-trisphosphate 3-kinase C"	Q96DU7	19	40717103-40740860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 24.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050760, HPA053003"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA050760: , HPA053003: "	"unprognostic (4.27e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.31e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavourable (4.91e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.32e-1)"	26.0	8.2	6.6	9.8	10.9	2.4	13.4	4.4	7.7	14.2	9.3	3.7	7.6	8.5	8.8	5.2	46.8	11.0	17.1	10.8	13.2	3.7	7.3	7.7	18.4	6.9	4.4	2.7	6.8	16.4	6.4	9.9	10.8	23.8	12.1	5.2	6.0	15.4	8.4	8.1	21.6	9.8	11.9	17.8	6.5	11.4	3.8	5.2	3.2	7.8	31.4	28.0	10.6	17.1	3.3	2.3	3.9	3.2	0.9	3.5	1.7	6.5	6.2	3.8	6.0	17.5	15.2	6.2	3.9	8.3	4.1	3.6	8.9	6.8	1.8	4.5	5.0	6.9	3.8	16.9	1.7	3.4	3.9	1.4	2.2	6.2	17.3	1.5	1.9	21.1	24.7	3.8	14.2	9.9	5.3	3.2	3.9	8.0	2.2	2.3	1.9	2.8	2.4	1.9	2.5	6.3	11.1	2.7	3.4	3.9	16.1	3.6	7.4	3.9	6.3	2.6	3.9	1.7	2.6	1.8	0.4	1.9	4.1	1.5	2.8	3.9	3.2	1.7	3.5	1.6	1.4	1.4	2.7	1.9	1.5	3.3	1.9	2.2	1.6	0.9	2.2	2.3	2.6	1.7	6.6	10.9	4.4	7.7	13.2	3.7	4.4	2.7	23.8	5.2
ITPR1	"ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29"	ENSG00000150995	"Inositol 1,4,5-trisphosphate receptor type 1"	Q14643	3	4493348-4847840	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 46.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.3;HeLa: 25.0;HMC-1: 16.5;U-87 MG: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 782.1"	"Low region specificity"	"Detected in all"			"HPA014765, HPA016487"	Approved		Approved	Vesicles		37000	37000	Vesicles		"HPA014765: AB_1851843, HPA016487: AB_1851842"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (2.40e-1)"	4.8	8.2	6.1	7.4	18.6	3.2	11.9	39.5	30.2	10.2	7.4	1.7	21.5	2.4	18.4	13.2	7.8	10.1	11.8	5.3	8.7	5.1	8.7	2.5	6.4	7.1	4.8	10.4	14.2	2.7	46.6	7.3	4.6	3.8	15.0	3.7	12.5	9.6	27.4	3.2	3.2	5.0	17.4	3.7	6.0	5.5	3.0	4.3	7.0	19.3	0.6	8.6	14.1	10.6	8.9	3.6	5.4	1.6	1.2	2.2	1.2	0.0	1.2	0.2	0.6	9.8	0.4	3.2	0.2	0.2	0.3	0.3	0.3	0.3	4.3	0.4	0.4	0.0	0.9	1.1	0.5	34.3	1.3	12.4	25.0	1.6	13.5	5.2	16.5	2.6	0.7	1.7	0.5	1.4	1.3	5.0	1.3	0.5	2.3	1.8	0.9	3.8	1.4	0.2	0.3	1.1	1.1	0.1	8.3	2.2	1.4	2.3	0.9	7.5	1.7	0.8	1.4	1.1	1.0	7.6	3.7	2.9	20.4	5.6	1.7	5.4	1.6	1.9	1.5	1.0	1.9	6.6	1.7	1.5	2.1	8.9	2.2	1.9	0.8	1.2	0.7	3.6	1.3	1.2	6.1	18.6	39.5	30.2	8.7	5.1	4.8	10.4	3.8	4.3
IVD	ACAD2	ENSG00000128928	"Isovaleryl-CoA dehydrogenase"	P26440	15	40405795-40435947	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041391, HPA044250"	Enhanced		Supported	Nucleoplasm,Mitochondria		66000	66000	Mitochondria	Nucleoplasm	"HPA041391: , HPA044250: "	"unprognostic (9.30e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.74e-1)"	"prognostic favourable (1.95e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.31e-1)"	"prognostic favourable (2.91e-9)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.46e-3)"	12.3	32.0	15.4	13.2	20.6	6.7	24.3	14.4	18.0	12.7	13.7	20.5	23.3	12.3	11.8	16.6	8.9	17.2	22.7	30.4	13.8	16.1	28.9	71.9	14.2	10.4	16.1	15.9	19.4	18.9	19.5	23.9	7.4	16.3	21.0	13.0	14.4	11.8	31.9	30.6	3.5	9.8	13.7	14.7	11.0	14.4	11.2	15.7	8.6	55.7	12.2	9.0	11.2	7.9	11.6	34.1	14.3	29.8	14.7	13.5	8.6	8.7	5.3	9.6	17.3	15.4	13.5	0.4	13.5	13.1	17.3	10.7	19.7	7.6	0.3	25.7	16.9	10.3	18.4	19.8	10.6	12.5	14.8	22.6	15.4	18.9	27.0	9.2	22.5	20.5	6.9	9.6	20.1	17.0	1.0	1.1	15.4	13.7	11.4	14.2	8.1	16.8	16.7	13.3	10.4	20.4	23.6	16.5	9.2	18.5	40.4	8.1	34.7	40.6	14.5	14.3	9.4	10.1	10.7	21.8	14.9	0.3	13.5	9.1	14.1	5.8	10.2	14.3	13.5	16.1	12.6	11.6	7.5	11.4	22.3	9.9	8.4	11.7	1.3	14.7	29.8	34.1	9.7	8.6	15.4	20.6	14.4	18.0	13.8	16.1	16.1	15.9	16.3	15.7
IYD	"C6orf71, DEHAL1, dJ422F24.1"	ENSG00000009765	"Iodotyrosine deiodinase"	Q6PHW0	6	150368892-150405969	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"thyroid gland: 212.3"	"Group enriched"	"Detected in some"	6	"CACO-2: 3.3;SK-BR-3: 8.2"	"Cancer enriched"	"Detected in many"	20	"thyroid cancer: 80.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"hippocampal formation: 8.1;thalamus: 2.6"	"Low region specificity"	"Detected in all"			HPA059627	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA059627: "	"unprognostic (3.73e-4)"	"unprognostic (2.93e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-2)"	"prognostic favourable (6.22e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.07e-9)"	"unprognostic (9.79e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.18e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	8.2	0.1	0.1	3.6	0.1	0.3	0.1	0.1	6.7	0.1	0.1	0.1	5.4	6.8	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.5	0.1	1.2	0.0	0.3	0.0	0.1	0.2	13.5	0.0	0.1	0.1	0.3	0.1	0.0	0.0	212.3	0.0	0.1	0.1	0.1	1.4	1.0	5.9	1.3	2.3	0.7	2.3	0.2	0.0	0.2	0.3	0.1	0.9	0.5	0.0	0.0	0.1	0.0	3.3	0.6	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.5	0.8	0.3	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.5	0.0	0.4	0.3	0.2	0.3	0.2	0.2	0.0	0.8	0.4	0.2	0.0	8.2	0.0	0.8	0.1	0.2	0.2	0.2	0.3	0.0	0.3	0.1	0.1	0.5	0.3	0.2	3.3	1.3	0.7	0.7	1.1	0.5	0.6	0.6	0.5	0.1	1.4	0.6	0.7	5.9	2.3	0.5	1.0	0.5	2.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.0
KALRN	"ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD"	ENSG00000160145	"Kalirin RhoGEF kinase"	O60229	3	124080023-124726325	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;retina: 31.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 32.1;HEL: 19.6;SH-SY5Y: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.3"	"Low region specificity"	"Detected in many"							"HPA011913, CAB026456"	Approved		Approved	Nucleoplasm,Cytosol		110000	110000	"Nucleoplasm, Cytosol"		"CAB026456: , HPA011913: AB_1850494"	"unprognostic (2.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.12e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.26e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.81e-3)"	5.5	4.3	12.7	2.4	14.1	0.6	4.2	1.8	35.2	4.0	3.8	3.7	0.5	2.7	5.6	2.3	9.6	4.2	3.1	12.1	17.6	3.9	2.6	7.3	2.9	1.1	4.1	15.8	2.3	11.9	2.5	14.4	6.8	9.4	3.1	2.1	31.2	2.2	5.4	23.5	1.5	7.2	6.4	3.6	8.0	11.5	2.2	2.4	0.0	5.3	6.7	3.1	2.9	4.1	0.1	0.0	0.9	0.0	0.1	4.3	1.2	0.3	0.6	3.6	0.7	0.5	0.1	4.6	1.4	0.8	1.4	0.6	32.1	2.5	0.1	0.4	3.6	0.2	0.8	0.0	1.1	0.0	0.3	19.6	0.3	4.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	1.6	4.5	0.1	0.4	2.3	0.0	0.0	2.0	3.1	1.0	1.6	0.0	0.1	0.3	1.2	9.2	0.4	0.3	0.3	0.7	0.1	8.1	4.1	1.6	0.6	0.6	0.0	0.3	0.0	0.5	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.3	0.0	0.0	2.4	0.7	0.9	0.1	0.0	0.0	4.3	1.2	12.7	14.1	1.8	35.2	17.6	3.9	4.1	15.8	9.4	2.4
KARS	"DFNB89, KARS1, KARS2"	ENSG00000065427	"Lysyl-tRNA synthetase"	Q15046	16	75627474-75648643	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041345, HPA041550"	Enhanced		Supported	Cytosol	"Intracellular and membrane"			Cytosol		"HPA041345: AB_10795589, HPA041550: AB_10794520"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavourable (8.84e-6)"	"unprognostic (6.24e-3)"	"unprognostic (8.97e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.71e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	25.4	21.1	19.2	29.2	22.0	24.6	28.0	17.5	19.5	26.3	28.3	15.2	28.1	20.6	23.4	26.7	35.8	24.1	27.5	49.6	16.3	18.6	31.7	47.1	25.8	26.6	18.8	16.2	34.9	62.6	28.5	22.4	30.4	19.6	30.7	29.7	20.1	31.7	23.2	80.0	26.6	32.3	28.4	17.1	37.3	26.3	33.6	14.5	41.3	34.4	43.6	34.7	38.6	33.4	32.8	39.0	35.5	44.2	35.0	62.4	39.5	26.7	31.3	22.9	31.5	24.6	24.9	45.1	22.7	27.9	50.0	37.8	55.3	35.3	48.4	25.1	30.2	38.6	46.1	41.5	54.7	14.1	23.7	26.5	27.4	57.2	45.0	39.9	29.9	29.2	29.8	44.2	72.0	40.7	44.2	11.6	37.7	61.9	41.0	42.7	48.4	23.1	54.0	20.5	59.0	40.0	22.8	34.5	28.0	57.0	20.9	25.3	28.2	37.8	22.4	27.7	28.6	21.1	32.4	24.9	28.5	115.3	24.2	34.1	33.7	20.9	31.5	35.5	34.1	44.2	62.4	32.8	42.3	40.2	39.0	27.6	40.1	36.1	7.2	35.0	43.2	24.6	43.5	39.5	19.2	22.0	17.5	19.5	16.3	18.6	18.8	16.2	19.6	14.5
KAT2B	"GCN5, GCN5L, P/CAF, PCAF"	ENSG00000114166	"Lysine acetyltransferase 2B"	Q92831	3	20040023-20154404	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002470, CAB004526"	Supported		Supported	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"CAB004526: AB_2128417, HPA002470: "	"unprognostic (2.91e-2)"	"unprognostic (6.85e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.13e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.63e-2)"	10.6	6.6	30.1	9.4	27.5	24.9	6.8	22.0	20.1	10.2	9.4	27.6	7.9	10.9	7.8	5.4	17.3	7.7	8.0	21.9	24.7	18.0	10.8	24.0	10.1	12.7	26.8	15.9	18.2	11.6	38.1	8.7	8.5	24.2	9.5	8.1	10.7	20.9	9.2	33.4	8.9	13.0	8.7	21.4	11.7	9.0	1.8	31.1	8.7	10.0	7.4	12.0	8.7	11.0	2.1	2.7	5.5	1.5	1.1	4.8	0.8	1.5	3.9	2.2	3.6	9.0	8.4	5.1	5.0	7.4	5.3	7.8	1.1	2.6	13.4	2.1	9.4	1.1	5.4	1.6	4.5	12.2	5.1	11.8	6.2	0.4	4.2	1.8	15.3	3.6	2.9	4.6	3.0	5.0	7.5	19.0	7.5	1.8	3.8	3.5	0.9	3.9	5.1	4.1	2.8	7.2	8.0	1.1	2.4	2.8	4.5	17.0	4.7	8.0	4.8	9.0	3.6	3.3	5.7	7.3	15.1	3.2	8.2	7.8	18.9	1.3	1.1	2.8	3.6	1.5	3.4	1.0	3.1	2.5	0.9	2.1	1.1	2.1	5.5	1.1	1.1	2.7	4.8	0.8	30.1	27.5	22.0	20.1	24.7	18.0	26.8	15.9	24.2	31.1
KAT6A	"MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220"	ENSG00000083168	"Lysine acetyltransferase 6A"	Q92794	8	41929479-42051990	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017023, HPA063266, HPA065052"	Supported		Approved	"Nucleoli,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nucleoli, Cytosol"	"CAB017023: , HPA063266: , HPA065052: "	"unprognostic (3.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	20.8	10.9	15.3	19.8	20.3	36.8	22.6	29.9	18.7	19.7	14.6	19.4	14.4	10.7	20.6	12.1	16.9	16.5	14.3	13.0	15.5	11.5	12.3	13.6	26.9	28.2	23.2	10.3	27.2	13.1	26.8	22.3	20.9	15.7	14.1	12.0	12.8	15.1	17.0	21.0	25.5	18.0	25.0	22.9	20.4	14.0	14.1	21.7	30.4	17.9	14.3	20.1	16.9	24.2	4.7	1.8	10.9	1.6	3.1	3.9	1.4	12.9	10.6	17.5	11.1	9.8	11.2	5.9	8.7	11.3	10.8	8.4	6.7	6.2	19.2	8.7	8.5	8.3	13.6	8.2	12.7	9.9	7.9	27.6	6.6	5.0	7.4	14.5	12.7	9.3	9.4	10.0	12.4	10.3	23.1	12.2	9.8	5.7	29.5	4.6	6.7	4.2	23.6	19.6	6.1	5.3	14.9	10.9	9.4	10.1	6.8	7.0	15.6	6.4	12.0	13.3	9.4	11.8	9.3	10.0	16.1	20.8	7.1	6.6	11.5	3.5	1.6	2.8	3.5	1.2	3.9	2.4	2.6	3.3	1.0	4.7	3.6	2.9	10.9	3.1	1.2	1.8	3.5	1.4	15.3	20.3	29.9	18.7	15.5	11.5	23.2	10.3	15.7	21.7
KAT6B	"Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B"	ENSG00000156650	"Lysine acetyltransferase 6B"	Q8WYB5	10	74825582-75032622	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006104	Supported		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA006104: AB_1079445"	"unprognostic (4.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.32e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.78e-2)"	"prognostic favourable (4.82e-4)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.15e-1)"	11.6	9.5	11.1	13.2	11.9	15.1	12.4	19.0	11.6	16.7	12.2	13.3	15.3	7.2	25.1	13.0	12.0	13.2	12.0	10.0	10.6	9.5	9.0	7.3	9.2	9.0	9.0	9.9	24.6	13.3	24.8	31.1	9.4	8.9	13.5	9.6	10.1	17.9	12.0	15.3	10.6	11.3	16.2	9.3	10.4	13.0	12.8	12.1	26.6	13.0	8.9	12.5	14.3	12.7	3.2	1.9	1.6	1.1	5.3	3.7	1.5	3.9	4.1	7.4	6.2	5.8	8.6	3.6	3.5	6.9	3.0	3.3	2.7	4.6	8.4	1.9	6.4	3.1	3.9	3.0	4.9	3.5	5.7	3.1	3.3	3.8	4.4	7.3	2.1	5.6	5.0	4.1	6.6	3.4	3.3	7.3	3.8	4.2	7.0	3.4	4.1	22.7	11.0	3.8	1.8	2.2	2.0	3.7	6.1	3.6	6.5	3.2	3.7	2.9	4.2	4.2	5.0	2.8	3.3	5.4	6.2	5.6	4.6	7.8	0.9	0.7	1.1	1.6	3.2	0.9	3.4	2.4	2.4	2.7	1.2	3.2	3.7	3.4	0.9	5.3	0.8	1.9	2.4	1.5	11.1	11.9	19.0	11.6	10.6	9.5	9.0	9.9	8.9	12.1
KCNH1	"eag, eag1, h-eag, Kv10.1"	ENSG00000143473	"Potassium voltage-gated channel subfamily H member 1"	O95259	1	210676823-211134180	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 20.2"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 4.2;RH-30: 7.1;RPTEC TERT1: 4.1;SH-SY5Y: 9.0;SK-MEL-30: 8.5;T-47d: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA014551, HPA019445"	Enhanced		Supported	Vesicles				Vesicles		"HPA014551: , HPA019445: AB_1852118"	"unprognostic (9.12e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.70e-2)"	0.9	2.3	6.3	1.3	13.3	0.7	0.6	19.1	20.2	1.0	1.3	3.3	0.2	1.2	1.5	1.0	0.9	1.2	1.0	0.7	3.8	1.7	1.0	0.7	0.7	0.7	1.1	7.5	0.8	0.9	0.9	0.8	1.1	1.7	1.3	1.3	0.0	0.8	0.9	0.7	0.9	1.0	1.0	2.1	0.6	1.5	2.4	1.5	0.0	0.8	0.0	0.7	0.9	0.7	0.1	0.7	0.7	0.1	0.1	0.3	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.1	0.6	0.1	1.4	1.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.1	0.0	0.0	7.1	0.0	4.1	0.0	0.3	9.0	1.6	0.1	8.5	6.3	0.0	0.0	1.1	0.1	1.3	0.8	0.0	0.0	0.0	0.2	0.0	0.5	0.7	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.7	0.1	0.0	6.3	13.3	19.1	20.2	3.8	1.7	1.1	7.5	1.7	1.5
KCNJ10	"Kir1.2, Kir4.1"	ENSG00000177807	"Potassium voltage-gated channel subfamily J member 10"	P78508	1	159998651-160070483	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Deafness, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 74.1;kidney: 28.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 11.4;SK-MEL-30: 3.6;U-266/70: 3.7"	"Cancer enriched"	"Detected in some"	6	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.5"	"Group enriched"	"Detected in many"	6	"NK-cells: 1.7;T-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078302	Enhanced									"HPA078302: "	"unprognostic (2.64e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.98e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.80e-4)"	"unprognostic (9.52e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.70e-3)"	1.4	1.5	23.6	3.0	28.1	1.3	1.3	10.5	74.1	1.4	1.7	37.9	0.0	1.5	1.3	1.3	1.4	1.3	1.3	1.3	21.8	13.2	28.1	3.1	1.3	7.1	28.1	15.1	1.3	1.3	1.3	0.3	1.3	25.5	1.3	1.5	0.5	1.5	1.5	1.2	1.6	1.7	1.3	42.9	10.3	2.0	1.8	25.5	0.0	1.5	0.0	2.9	1.5	0.1	0.0	0.0	0.0	0.3	1.7	2.5	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.3	0.0	0.2	1.7	0.2	0.0	0.4	0.3	0.0	0.2	0.0	0.2	0.1	0.1	11.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.0	2.1	0.1	0.0	0.0	0.2	0.4	0.0	0.3	3.6	0.1	0.5	0.1	0.1	0.3	0.9	0.0	3.7	1.7	0.0	0.2	0.2	1.7	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.8	0.0	1.7	0.3	0.0	2.5	0.2	23.6	28.1	10.5	22.2	21.8	13.2	28.1	15.1	25.5	25.5
KCNJ13	"Kir1.4, Kir7.1, LCA16"	ENSG00000115474	"Potassium voltage-gated channel subfamily J member 13"	O60928	2	232766464-232776568	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cataract, Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 22.9;intestine: 49.5;retina: 70.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;CACO-2: 2.7;U-2197: 4.7"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.9"	"Region enriched"	"Detected in some"	7	"pons and medulla: 22.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"														"unprognostic (4.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.03e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-2)"		"unprognostic (2.26e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-2)"	0.2	0.2	0.5	0.0	0.7	0.1	0.3	0.4	0.9	0.2	10.1	7.0	1.3	4.3	0.2	0.3	0.2	0.1	1.6	0.2	3.2	0.5	1.9	0.3	0.2	0.0	0.4	0.4	0.3	0.4	8.5	0.3	0.0	22.9	0.3	0.0	70.3	0.3	1.6	0.2	1.8	49.5	0.0	0.6	0.2	1.1	0.5	0.1	0.0	3.8	0.0	0.0	0.3	0.3	1.1	0.8	5.4	1.1	1.1	2.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.5	0.0	0.3	0.2	0.9	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.3	1.1	0.2	0.3	0.0	0.1	0.0	4.7	0.4	1.4	0.1	0.8	0.8	0.4	0.0	5.4	1.1	0.9	1.0	0.2	1.2	0.8	1.8	0.7	0.4	1.1	2.1	1.1	0.8	1.1	1.0	0.8	2.7	0.1	0.5	0.7	0.4	0.9	3.2	0.5	0.4	0.4	22.9	0.1
KCNJ2	"IRK1, Kir2.1, LQT7"	ENSG00000123700	"Potassium voltage-gated channel subfamily J member 2"	P63252	17	70168673-70180048	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Atrial fibrillation, Disease mutation, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;parathyroid gland: 34.8"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 5.1;REH: 6.0;RH-30: 24.2;U-138 MG: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 20.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 20.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029109	Approved									"HPA029109: AB_10602913"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.60e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.49e-3)"	3.0	1.5	6.2	6.3	17.9	2.5	6.6	1.3	12.8	1.8	5.0	23.7	5.1	1.6	1.5	1.2	4.7	8.4	2.2	11.4	6.4	4.4	1.7	1.9	3.9	4.4	22.4	8.5	1.4	1.0	34.8	1.6	9.0	11.7	2.6	4.3	3.1	2.7	2.9	10.3	6.0	2.1	1.6	14.9	10.4	2.0	0.9	18.2	0.5	1.9	6.0	2.2	2.6	3.3	0.1	0.7	20.8	4.7	0.0	0.0	0.4	0.0	0.7	1.5	0.0	1.6	0.4	0.0	0.5	3.7	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.4	0.1	0.2	0.1	0.0	0.2	0.0	0.5	0.0	4.6	0.0	0.0	1.7	0.1	2.3	0.2	5.1	0.0	0.0	1.5	0.0	0.5	0.0	0.1	0.1	6.0	24.2	0.0	0.6	0.0	0.3	0.7	0.4	0.1	0.0	0.2	0.4	0.1	8.9	0.1	0.0	1.9	0.0	0.0	0.1	1.9	0.0	1.2	1.8	2.5	3.6	0.0	4.7	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	20.8	0.0	4.6	0.1	0.0	0.4	6.2	17.9	1.3	12.8	6.4	4.4	22.4	8.5	11.7	18.2
KCNJ5	"CIR, GIRK4, KATP1, Kir3.4, LQT13"	ENSG00000120457	"Potassium voltage-gated channel subfamily J member 5"	P48544	11	128891356-128921035	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cancer-related genes, Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 40.7;ductus deferens: 54.6;pituitary gland: 23.4"	"Cell line enriched"	"Detected in some"	13	"HBEC3-KT: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"basal ganglia: 3.1;hypothalamus: 8.0;midbrain: 2.2;thalamus: 4.0"	"Low region specificity"	"Detected in all"			"HPA014722, HPA017353, CAB022569"	Enhanced									"CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.56e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-2)"	1.8	40.7	0.8	0.3	1.9	0.2	0.9	0.3	1.2	0.8	0.8	1.9	54.6	0.4	0.3	1.1	0.6	0.6	1.3	8.7	1.6	2.5	2.0	0.3	3.4	0.8	3.7	0.8	0.8	16.6	0.7	23.4	4.3	3.4	0.8	0.4	3.3	0.9	21.7	0.3	0.4	0.5	0.7	4.5	7.7	1.5	0.7	0.9	2.3	0.7	0.4	0.3	1.1	0.5	0.9	0.4	2.9	0.7	0.6	0.4	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.1	0.4	17.1	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.3	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.5	0.2	0.1	0.1	1.3	0.0	2.2	0.7	0.6	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.9	0.3	0.4	2.9	0.6	0.4	0.4	0.2	0.4	0.8	1.9	0.3	1.2	1.6	2.5	3.7	0.8	3.4	0.9
KCNJ6	"BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2"	ENSG00000157542	"Potassium voltage-gated channel subfamily J member 6"	P48051	21	37607376-38121345	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Congenital generalized lipodystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;pituitary gland: 12.2"	"Cell line enriched"	"Detected in some"	7	"LHCN-M2: 25.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"basophil: 4.2;eosinophil: 3.6;neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.43e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.75e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.96e-10)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.21e-1)"	2.0	1.2	7.7	0.9	8.4	1.0	1.1	24.0	15.6	0.9	1.4	0.8	0.0	1.1	1.4	0.6	0.7	0.7	0.8	1.2	14.6	1.1	1.2	0.9	1.0	1.4	1.3	10.8	0.8	2.7	0.7	12.2	7.4	13.5	1.5	0.9	0.0	0.8	0.6	2.2	1.1	1.1	0.5	1.5	1.6	2.7	2.0	0.4	0.0	0.8	0.0	0.6	0.8	0.8	0.3	0.3	4.2	0.3	0.3	0.2	0.0	0.0	0.0	0.6	0.3	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.7	1.4	0.0	2.9	0.1	25.0	0.1	0.0	0.0	0.2	2.4	0.0	0.1	0.8	3.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	0.0	0.0	0.1	3.7	1.0	0.0	0.0	0.0	0.0	4.2	0.3	3.6	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.2	2.0	0.3	0.2	0.3	0.1	0.0	7.7	8.4	24.0	15.6	14.6	1.1	1.3	10.8	13.5	0.4
KCNK18	"K2p18.1, TRESK, TRESK-2, TRESK2, TRIK"	ENSG00000186795	"Potassium two pore domain channel subfamily K member 18"	Q7Z418	10	117197489-117210299	"Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"brain: 1.5;testis: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA044739	Uncertain									"HPA044739: AB_10795008"																		0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	1.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KCNQ4	"DFNA2, Kv7.4"	ENSG00000117013	"Potassium voltage-gated channel subfamily Q member 4"	P56696	1	40783814-40840452	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Hearing, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 40.1;retina: 23.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.9;HEK 293: 5.8;K-562: 5.8;MCF7: 3.4;REH: 3.0;THP-1: 3.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018305	Uncertain									"HPA018305: AB_1855556"	"unprognostic (1.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.59e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.40e-2)"	"unprognostic (5.18e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.44e-2)"	2.5	0.9	1.1	1.5	2.9	0.4	1.3	3.8	3.6	2.5	9.1	0.9	1.5	1.5	5.8	0.9	3.5	4.6	2.8	2.1	1.6	0.7	0.4	0.4	1.4	0.4	1.4	2.1	1.6	40.1	0.5	0.6	2.1	1.3	3.3	1.7	23.0	5.4	5.3	5.9	1.1	2.3	7.5	2.0	0.4	2.9	1.2	1.4	0.5	0.6	0.9	0.4	5.3	2.5	0.0	0.5	0.0	0.0	0.0	0.4	0.4	0.1	0.2	0.3	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.3	1.6	0.3	0.6	0.0	0.0	3.9	0.0	0.0	0.1	5.8	1.9	0.3	0.0	0.4	0.4	0.2	0.5	0.0	0.0	0.0	0.0	5.8	0.1	0.0	3.4	0.7	0.0	0.4	0.1	3.0	0.0	0.0	0.6	0.0	2.6	0.5	0.0	1.5	0.6	0.3	3.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.4	1.1	2.9	3.8	3.6	1.6	0.7	1.4	2.1	1.3	1.4
KCNQ5	Kv7.5	ENSG00000185760	"Potassium voltage-gated channel subfamily Q member 5"	Q9NR82	6	72621792-73198851	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 6.6;brain: 23.0;skeletal muscle: 26.1;thyroid gland: 6.9"	"Cell line enhanced"	"Detected in many"		"BJ: 20.1;HL-60: 17.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016655	Enhanced		Approved	Vesicles				Vesicles		"HPA016655: AB_1855557"	"unprognostic (4.91e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.09e-2)"	"unprognostic (8.55e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.39e-3)"	0.7	2.8	4.2	3.0	14.9	6.6	1.1	0.6	19.6	0.6	0.9	0.0	0.0	0.8	0.7	0.6	1.7	1.0	0.9	0.6	6.9	2.7	0.6	0.8	0.8	3.4	3.0	7.5	0.7	0.6	0.6	0.5	1.0	23.0	2.4	0.9	2.2	2.1	1.9	26.1	0.6	0.9	1.7	0.9	2.0	0.8	2.0	0.7	1.6	6.9	0.4	3.1	1.2	0.7	2.7	0.5	1.2	0.0	2.2	1.7	0.2	2.5	0.6	0.0	0.1	0.0	0.9	0.0	20.1	3.0	3.0	2.6	0.0	0.0	12.0	0.0	6.8	0.4	0.1	1.2	3.6	0.1	4.2	13.1	0.0	0.0	0.5	17.6	0.0	0.2	0.5	8.6	9.0	0.0	0.7	8.3	5.9	0.1	0.0	7.5	0.7	4.2	0.0	0.6	8.2	1.1	0.0	3.4	1.6	0.0	0.0	8.2	2.5	1.3	0.0	12.5	5.5	0.0	13.3	8.7	0.2	5.5	0.1	8.5	0.7	1.2	0.0	0.0	0.2	0.0	1.1	2.7	0.5	1.5	0.5	1.4	1.7	1.2	0.0	2.2	0.0	0.0	0.0	0.2	4.2	14.9	0.6	19.6	6.9	2.7	3.0	7.5	23.0	0.7
KCNT1	"KCa4.1, KIAA1422, SLACK, Slo2.2"	ENSG00000107147	"Potassium sodium-activated channel subfamily T member 1"	Q5JUK3	9	135702185-135795508	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.7;skeletal muscle: 19.5"	"Cell line enhanced"	"Detected in some"		"RH-30: 2.0;RPMI-8226: 4.5;SCLC-21H: 6.8;SH-SY5Y: 1.4"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059880	Uncertain									"HPA059880: "	"unprognostic (1.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.98e-13)"	"unprognostic (9.26e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.89e-7)"	"unprognostic (9.15e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	1.4	0.8	7.3	1.0	12.4	1.0	0.7	29.7	29.3	0.7	0.9	0.2	0.0	1.0	0.8	0.9	1.2	0.9	1.1	1.8	5.3	4.2	0.7	0.7	0.9	0.8	1.8	12.0	7.3	0.8	0.7	4.7	1.2	6.1	0.8	0.8	0.0	0.7	0.8	19.5	0.8	0.8	0.8	2.1	9.6	1.4	1.9	3.1	0.0	0.8	0.0	0.7	1.1	0.1	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	2.0	4.5	0.0	0.0	6.8	1.4	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	7.3	12.4	29.7	29.3	5.3	4.2	1.8	12.0	6.1	3.1
KCNV2	Kv8.2	ENSG00000168263	"Potassium voltage-gated channel modifier subfamily V member 2"	Q8TDN2	9	2717502-2730037	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 82.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HDLM-2: 2.8;HeLa: 2.3"	"Cancer enriched"	"Detected in single"	78	"testis cancer: 6.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031131	Enhanced									"HPA031131: AB_10609996"	"unprognostic (5.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-8)"	"unprognostic (3.01e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-2)"	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	82.3	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.6	0.0	0.2	0.7	0.2	0.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.9	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	2.8	1.3	0.8	2.3	0.3	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.5	0.6	0.1	0.2	0.0	0.3	0.0	0.0	0.4	0.3	0.0	0.1	0.2	0.1	0.6	0.0	0.0	0.7	0.3	0.5	0.3	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0
KDSR	"DHSR, FVT1, SDR35C1"	ENSG00000119537	"3-ketodihydrosphingosine reductase"	Q06136	18	63327726-63367510	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Palmoplantar keratoderma, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003673, HPA044884"	Approved									"CAB003673: AB_425440, HPA044884: "	"unprognostic (4.44e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.88e-3)"	"unprognostic (7.50e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.81e-2)"	"prognostic favourable (9.53e-6)"	"unprognostic (3.32e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-3)"	21.1	19.4	19.0	11.1	22.4	6.4	29.7	12.5	17.2	18.2	17.3	23.9	14.2	10.0	19.4	30.0	17.8	14.3	17.7	15.8	19.7	16.9	21.3	52.6	15.3	11.5	32.1	14.6	29.1	14.3	19.6	10.5	24.9	19.5	18.0	11.0	15.9	16.1	17.4	12.4	28.8	13.1	18.9	39.0	9.1	11.8	10.4	23.3	8.8	21.2	12.3	9.9	19.9	22.8	4.0	5.6	0.9	5.6	9.8	19.5	3.7	5.9	2.6	2.8	3.1	22.0	16.5	5.4	19.5	12.0	4.3	5.8	1.1	4.0	6.0	8.4	7.6	26.1	3.5	11.0	5.3	11.2	5.8	4.6	3.5	1.3	16.9	8.4	3.2	15.7	20.9	6.9	19.8	4.2	3.7	8.6	11.4	2.4	9.3	3.9	3.3	9.8	6.3	8.1	8.5	11.9	3.8	3.5	6.8	9.4	4.6	8.4	2.5	4.8	10.0	18.4	4.4	6.1	8.5	37.6	17.1	3.4	13.8	5.2	5.4	0.0	3.7	0.3	4.8	5.6	19.5	4.0	10.2	7.6	5.6	3.6	7.3	4.6	0.9	9.8	2.6	2.8	12.9	3.7	19.0	22.4	12.5	15.9	19.7	16.9	32.1	14.6	19.5	23.3
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100772	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 60.2;kidney: 38.4;liver: 67.0"	"Cell line enhanced"	"Detected in many"		"HEL: 18.5;Hep G2: 26.9"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Cytosol		320000	320000	Cytosol		"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	0.9	1.9	2.1	1.2	2.7	0.7	1.9	5.2	3.9	1.1	22.3	1.9	0.2	40.0	1.5	0.9	1.1	1.6	0.6	0.6	2.2	2.2	38.4	67.0	0.7	0.8	3.5	1.9	1.8	4.2	0.6	0.7	0.4	3.0	0.9	0.6	0.6	1.7	0.7	1.4	1.0	60.2	0.9	1.8	0.8	1.0	1.6	3.6	0.0	0.5	1.2	0.6	0.7	0.9	5.1	7.3	0.6	6.6	5.4	8.8	6.0	13.9	10.6	1.6	6.4	1.2	0.3	1.4	0.9	0.6	1.3	0.8	5.1	3.0	2.1	3.4	0.0	6.2	5.5	1.8	0.4	4.9	10.0	18.5	2.8	26.9	0.6	2.5	2.2	0.1	0.8	1.6	0.1	1.2	3.3	3.5	0.1	9.1	3.0	2.0	2.3	4.2	10.6	0.8	11.8	1.6	1.7	6.0	9.3	2.0	3.6	3.9	1.6	1.1	1.1	0.4	2.1	0.9	3.7	4.4	7.8	3.6	1.8	6.0	1.0	0.0	6.6	0.4	5.4	3.8	7.4	5.1	8.8	7.8	6.1	5.1	6.4	7.8	0.6	5.4	1.6	7.3	5.5	6.0	2.1	2.7	5.2	3.9	2.2	2.2	3.5	1.9	3.0	3.6
KISS1R	"AXOR12, GPR54, HOT7T175"	ENSG00000116014	"KISS1 receptor"	Q969F8	19	917287-921015	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8;lymphoid tissue: 12.4"	"Cell line enhanced"	"Detected in some"		"K-562: 10.5;RPMI-8226: 25.7;SCLC-21H: 5.4;SH-SY5Y: 14.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0;neutrophil: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007156, HPA071913"	Approved		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA007156: , HPA071913: "	"unprognostic (1.54e-1)"	"unprognostic (3.01e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.46e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.17e-2)"	"prognostic unfavourable (3.33e-6)"	"unprognostic (1.87e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-2)"	0.2	0.2	2.1	2.1	4.1	0.2	0.3	0.1	4.7	0.1	0.3	0.1	0.1	0.4	0.2	0.1	0.1	0.2	0.1	0.1	1.0	6.8	1.4	0.1	0.3	12.4	1.1	0.1	0.4	3.6	0.1	2.0	1.0	0.8	0.2	0.2	0.3	0.3	0.1	0.1	0.1	0.7	0.5	1.0	2.4	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.5	0.1	0.6	0.0	1.8	0.0	0.0	2.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.2	2.8	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.2	0.1	0.0	0.4	0.3	0.7	0.0	25.7	0.0	0.0	5.4	14.4	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.7	0.0	0.0	0.1	2.0	0.6	1.8	0.0	0.0	0.0	0.1	0.0	2.1	4.1	0.1	1.5	1.0	6.8	1.1	0.1	0.8	0.1
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016433-33066145	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Glycosidase, Hormone, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5"	"Group enriched"	"Detected in some"	5	"HMC-1: 5.0;SK-BR-3: 9.4"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 11.6"	"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"												"Secreted to blood"						"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favourable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favourable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	4.8	0.6	0.8	0.9	4.3	0.1	7.4	0.0	0.8	0.7	2.1	3.3	0.2	1.0	1.0	3.2	0.8	0.7	0.9	0.9	2.4	0.8	64.3	0.2	10.4	0.9	0.5	0.3	0.4	1.6	76.9	0.3	25.5	11.6	3.3	0.4	0.3	0.7	1.0	0.9	0.4	3.2	0.7	0.4	3.1	1.9	0.6	0.3	0.0	1.4	1.3	0.3	1.5	1.1	0.0	0.0	0.0	1.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.8	4.3	0.0	0.8	2.4	0.8	0.5	0.3	11.6	0.3
KLK4	"EMSP, EMSP1, KLK-L1, PRSS17, PSTS"	ENSG00000167749	"Kallikrein related peptidase 4"	Q9Y5K2	19	50906352-50910738	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization	"Hydrolase, Protease, Serine protease"	"Amelogenesis imperfecta, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"prostate: 79.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 8.2;HaCaT: 10.1;SK-BR-3: 6.5"	"Cancer enriched"	"Detected in many"	55	"prostate cancer: 463.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA051839	Enhanced				"Secreted in male reproductive system"					"HPA051839: "	"unprognostic (3.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.66e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.35e-1)"	"unprognostic (3.18e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.69e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-3)"	"unprognostic (3.27e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.34e-1)"	0.2	0.8	0.1	0.3	0.1	0.1	0.7	0.2	0.5	2.0	1.2	0.0	3.8	1.8	1.5	7.7	0.4	0.2	0.1	0.1	0.3	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.5	79.3	0.8	0.2	3.2	2.1	0.7	2.4	1.2	0.6	0.1	0.1	0.3	0.6	0.1	0.0	8.7	0.0	0.0	0.2	0.2	0.1	0.4	0.6	0.1	0.0	0.3	0.0	5.0	2.1	0.2	0.3	0.0	0.0	4.5	0.1	0.0	0.0	0.0	4.6	8.2	0.5	0.4	0.1	10.1	0.0	5.4	0.0	1.3	1.4	1.6	3.7	1.7	0.0	1.7	2.3	0.0	2.6	0.0	0.0	0.0	0.9	4.2	0.0	1.2	0.1	2.5	0.1	0.4	0.3	0.5	1.1	0.0	3.3	0.0	0.6	0.3	6.5	0.0	5.2	0.4	1.1	0.3	0.3	1.3	0.3	2.6	1.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.5	0.3	0.2	0.2	0.0	0.5	0.1
KMT2A	"ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1"	ENSG00000118058	"Lysine methyltransferase 2A"	Q03164	11	118436490-118526832	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017794, CAB024270, HPA044910"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB017794: , CAB024270: , HPA044910: "	"unprognostic (6.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.52e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.90e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	14.4	11.3	17.7	17.0	19.2	28.6	16.8	43.8	21.2	17.3	14.6	19.8	18.1	8.5	21.8	17.1	10.6	15.7	14.1	10.2	17.3	13.4	13.1	9.3	15.3	19.6	16.6	18.7	35.6	16.8	28.9	21.8	10.2	15.4	15.6	12.4	14.4	14.2	19.2	11.1	16.8	14.2	15.2	12.1	15.7	12.3	7.9	23.4	16.6	16.6	7.8	19.4	18.8	24.6	6.7	3.5	8.3	2.0	6.5	5.3	0.8	11.9	5.5	14.9	11.2	9.1	10.9	4.4	5.4	7.8	5.7	6.6	11.1	8.7	14.7	11.1	7.9	10.4	15.8	5.9	11.3	16.2	6.1	28.8	5.1	6.0	5.1	17.2	5.6	5.2	6.1	12.4	16.7	8.8	18.7	12.6	7.1	9.3	11.4	10.1	9.0	8.2	8.7	14.3	4.9	8.4	9.0	12.3	8.0	13.5	4.4	2.8	7.6	5.8	13.0	9.8	8.8	7.1	9.6	3.7	2.8	9.9	3.7	12.7	5.8	8.3	2.0	4.6	5.3	1.3	4.3	6.2	4.8	4.6	0.8	6.7	4.9	4.8	1.3	6.5	1.4	3.5	3.9	0.8	17.7	19.2	43.8	21.2	17.3	13.4	16.6	18.7	15.4	23.4
KMT2B	"CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7"	ENSG00000272333	"Lysine methyltransferase 2B"	Q9UMN6	19	35718019-35738878	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA006487			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006487: AB_1080587"	"unprognostic (1.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.33e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.63e-3)"	"unprognostic (9.47e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	10.2	9.3	11.4	14.2	13.1	18.4	10.4	23.9	11.4	10.0	12.0	14.2	12.9	13.8	13.0	7.1	11.4	11.6	12.6	7.5	11.0	5.3	9.9	8.9	10.6	14.7	14.7	6.8	15.3	19.6	10.8	13.3	9.3	11.2	12.1	5.6	13.8	14.7	10.0	13.3	19.9	12.3	12.2	12.4	15.8	12.1	21.5	14.9	14.1	14.9	7.0	14.2	12.4	14.2	0.4	0.7	3.2	0.7	2.1	0.7	0.2	11.3	19.2	8.9	9.7	4.6	4.5	9.3	5.5	4.0	5.6	4.3	12.8	5.8	10.1	8.7	4.6	7.5	8.0	4.7	2.5	15.0	8.9	18.2	9.0	6.4	4.5	11.1	20.9	6.1	6.4	5.7	6.3	5.5	15.2	12.7	3.6	11.6	9.4	9.6	8.2	6.8	14.8	5.8	5.5	3.1	10.1	10.1	8.1	8.4	13.6	5.8	8.3	11.8	7.6	11.3	12.2	7.5	11.7	17.5	10.7	8.1	6.1	10.3	7.8	1.0	0.7	0.6	0.7	0.4	0.4	0.3	0.2	0.3	0.2	0.4	0.3	0.4	3.2	2.1	0.3	0.7	0.2	0.2	11.4	13.1	23.9	11.4	11.0	5.3	14.7	6.8	11.2	14.9
KMT2C	"HALR, KIAA1506, MLL3"	ENSG00000055609	"Lysine methyltransferase 2C"	Q8NEZ4	7	152134922-152436005	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074736			Approved	Nucleoplasm				Nucleoplasm		"HPA074736: "	"unprognostic (7.75e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (8.01e-6)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.64e-1)"	13.9	12.6	11.7	16.7	18.6	29.7	14.5	24.8	14.1	18.4	12.6	15.5	21.4	9.7	20.2	20.6	14.4	12.8	12.7	10.8	13.4	9.5	10.3	11.4	13.0	12.1	17.7	9.4	18.8	18.4	18.8	18.9	38.0	12.6	14.0	11.8	12.6	15.8	22.9	30.3	25.2	13.1	13.6	16.0	14.6	14.9	13.6	19.6	22.6	16.9	9.3	16.8	17.8	31.6	5.6	3.5	16.1	3.9	5.5	2.9	0.6	9.5	4.8	9.0	9.5	16.2	9.8	10.5	5.0	3.8	4.0	4.9	9.1	5.8	15.2	7.3	9.1	5.5	9.6	7.3	6.7	9.6	4.9	9.0	7.2	6.3	7.9	15.3	11.1	8.2	10.1	5.7	7.6	5.7	14.5	13.2	8.7	13.3	11.0	13.9	5.4	4.8	7.4	8.1	7.9	6.9	9.9	13.1	10.3	8.2	14.7	5.4	4.8	12.5	7.2	6.7	3.5	7.1	7.1	13.8	6.7	16.4	8.7	12.5	6.8	8.8	3.5	4.3	2.1	2.2	2.9	5.6	1.7	1.7	1.7	3.8	2.7	1.8	16.1	5.5	3.9	3.5	1.3	0.6	11.7	18.6	24.8	14.1	13.4	9.5	17.7	9.4	12.6	19.6
KMT2D	"ALR, CAGL114, MLL2, MLL4, TNRC21"	ENSG00000167548	"Lysine methyltransferase 2D"	O14686	12	49018975-49059774	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA035977	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA035977: AB_10670673"	"unprognostic (8.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.14e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.91e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.60e-2)"	12.1	7.6	4.9	6.7	10.8	26.1	6.8	11.7	10.5	9.5	6.5	5.8	13.0	5.5	15.7	7.4	8.8	8.9	5.8	9.1	6.1	3.5	6.2	6.5	22.9	9.6	6.7	3.3	9.7	11.6	13.3	9.2	12.9	13.7	6.7	6.6	9.8	7.6	8.0	16.1	13.6	9.4	7.1	9.1	13.6	8.3	7.3	5.7	6.2	11.0	6.1	7.6	7.0	6.3	2.0	2.2	5.9	0.5	1.5	0.8	0.6	17.0	16.2	16.4	13.2	17.0	11.4	17.6	9.0	9.4	11.7	6.3	28.4	7.2	17.7	11.7	12.6	11.6	21.6	10.0	9.8	10.3	17.3	22.5	16.9	15.2	11.7	26.7	22.6	9.7	14.3	16.4	17.0	17.4	28.2	9.8	13.2	18.7	13.2	24.9	15.5	14.0	19.9	10.1	6.4	9.8	18.9	13.7	11.6	13.9	13.7	9.5	13.6	23.4	23.1	9.2	16.5	8.1	15.1	14.0	9.0	17.2	10.6	13.8	6.9	0.6	0.5	3.0	0.8	0.2	0.4	0.3	0.3	0.5	0.3	2.0	0.3	0.8	5.9	1.5	0.1	2.2	0.0	0.6	4.9	10.8	11.7	10.5	6.1	3.5	6.7	3.3	13.7	5.7
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877498-143055832	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;liver: 41.1;placenta: 34.3"	"Cell line enhanced"	"Detected in some"		"A549: 40.1;HeLa: 44.8;Hep G2: 27.2;hTEC/SVTERT24-B: 23.5;SiHa: 22.2;U-87 MG: 70.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9"	"Group enriched"	"Detected in many"	21	"B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol		360000	360000	Cytosol	Nucleoplasm	"HPA031686: "	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	9.0	3.7	2.2	11.0	3.7	3.9	15.4	0.6	1.7	3.0	1.2	1.3	0.8	0.2	1.1	2.6	5.6	1.5	4.4	3.8	1.4	1.1	8.4	41.1	12.7	13.7	2.9	0.4	1.7	1.0	0.2	1.6	34.3	2.7	1.9	1.2	1.5	3.0	0.8	0.7	1.5	2.7	2.0	6.3	16.0	2.4	7.0	2.6	2.7	2.2	1.7	13.0	12.4	2.6	19.7	28.4	1.3	35.9	0.4	0.1	11.1	0.0	40.1	0.1	0.1	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.7	0.5	2.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	44.8	27.2	0.5	0.1	0.2	3.9	3.2	23.5	0.1	0.0	0.1	0.2	0.3	20.5	0.0	2.4	0.1	0.1	0.0	0.2	0.1	0.6	20.7	0.1	0.0	22.2	3.3	0.2	11.1	5.7	0.3	1.3	0.1	19.6	0.0	0.1	0.0	0.0	70.2	4.6	0.1	0.1	28.7	0.5	0.1	35.9	0.1	19.7	0.1	0.1	28.4	12.7	0.1	0.0	1.3	0.4	29.2	19.9	0.1	11.1	2.2	3.7	0.6	1.7	1.4	1.1	2.9	0.4	2.7	2.6
L2HGDH	"C14orf160, FLJ12618"	ENSG00000087299	"L-2-hydroxyglutarate dehydrogenase"	Q9H9P8	14	50237563-50312548	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065409, HPA069708"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA065409: , HPA069708: "	"unprognostic (1.74e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.33e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favourable (9.75e-10)"	"unprognostic (1.24e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	5.4	5.1	6.9	3.6	8.4	3.5	5.1	12.7	10.9	3.5	5.6	4.9	4.8	6.2	3.4	4.3	9.0	4.4	3.2	7.7	6.1	4.7	25.5	16.0	2.5	3.3	7.7	4.7	4.2	5.4	7.1	5.8	2.6	5.7	4.6	6.8	7.7	5.0	5.6	17.7	7.0	5.0	4.7	5.3	2.3	5.6	6.0	6.0	3.7	6.5	6.2	5.2	4.6	4.4	1.4	1.5	10.5	0.6	2.4	3.3	0.8	13.8	9.8	4.0	3.9	2.0	1.3	11.4	4.6	2.6	7.3	8.7	15.6	6.4	10.9	5.4	1.8	10.2	12.1	4.8	8.2	8.7	6.9	23.7	6.7	2.1	1.9	8.3	8.2	1.2	3.1	4.8	4.2	3.1	8.3	6.9	1.9	16.7	9.4	3.8	5.9	10.4	8.9	13.2	8.5	6.8	16.3	8.3	5.9	13.6	10.4	5.9	13.6	2.3	2.9	4.6	13.1	5.3	6.1	6.3	14.3	15.4	2.6	4.2	5.2	10.5	0.6	1.4	1.5	0.3	3.3	1.4	1.7	1.6	0.9	1.2	2.1	2.6	0.9	2.4	0.3	1.5	2.4	0.8	6.9	8.4	12.7	10.9	6.1	4.7	7.7	4.7	5.7	6.0
LAMP2	CD107b	ENSG00000005893	"Lysosomal associated membrane protein 2"	P13473	X	120427827-120469365	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 112.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 112.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005272, HPA029100, HPA029101"	Supported		Approved	"Vesicles,Plasma membrane"		820000000	820000000	"Vesicles, Plasma membrane"		"CAB005272: AB_647855, HPA029100: AB_10795022, HPA029101: "	"unprognostic (2.99e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.53e-3)"	21.8	33.6	39.9	16.1	87.9	22.6	27.1	16.2	55.5	33.0	18.3	88.7	27.9	25.1	20.8	37.5	34.6	22.4	43.3	20.9	52.5	30.3	55.0	83.7	25.3	14.3	131.0	36.9	22.7	27.4	28.8	20.2	35.4	58.6	37.3	19.7	17.2	47.8	32.9	32.4	26.9	20.5	21.1	84.3	17.9	23.6	11.9	116.9	21.2	33.7	14.3	15.4	21.1	27.0	3.7	11.6	112.9	21.7	5.4	5.8	10.5	11.8	11.7	8.6	11.1	113.5	38.8	23.9	20.5	35.8	20.0	37.4	9.7	21.2	8.4	18.1	35.6	20.0	12.5	15.5	32.6	9.4	8.9	6.6	13.0	13.0	37.8	29.0	18.4	42.0	31.2	26.6	17.6	27.2	7.6	30.0	32.3	21.9	8.0	14.8	6.7	10.4	6.2	14.6	15.0	29.2	8.8	2.9	4.6	22.0	22.4	43.8	13.3	32.4	28.1	28.7	13.9	36.9	55.3	15.1	14.4	5.5	27.4	35.1	68.7	4.9	21.7	41.3	5.0	18.7	4.0	3.1	4.8	4.7	11.6	3.7	4.3	4.1	112.9	5.4	17.3	6.3	5.8	10.5	39.9	87.9	16.2	55.5	52.5	30.3	131.0	36.9	58.6	116.9
LARS	"FLJ10595, FLJ21788, HSPC192, LARS1, LEUS, RNTLS"	ENSG00000133706	"Leucyl-tRNA synthetase"	Q9P2J5	5	146113038-146182660	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036424, HPA040881"	Supported		Enhanced	"Nuclear bodies,Cytosol"		14000	14000	"Nuclear bodies, Cytosol"		"HPA036424: AB_10670102, HPA040881: "	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavourable (3.78e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (2.98e-4)"	"unprognostic (2.96e-2)"	32.2	30.1	27.0	25.8	31.2	17.8	38.6	31.8	33.7	25.5	25.3	30.1	23.9	16.8	35.8	31.3	28.5	26.8	16.4	29.0	24.2	22.2	26.5	18.4	20.0	24.8	27.3	26.1	32.0	40.8	35.0	43.0	20.6	31.6	26.3	29.9	19.5	39.9	24.8	55.5	24.1	21.5	32.5	30.9	25.2	24.9	20.5	30.5	25.6	30.8	22.8	28.9	30.9	29.2	21.3	28.0	5.8	18.3	19.0	21.8	11.2	20.4	24.2	28.0	45.9	23.2	30.3	43.6	23.9	17.7	24.2	35.1	25.2	22.4	31.1	14.8	31.4	17.5	47.3	39.3	42.4	26.7	27.8	35.5	30.6	14.6	32.2	50.4	23.5	23.8	39.6	39.6	68.8	33.0	39.4	58.3	26.0	16.9	38.9	30.9	43.4	26.8	30.1	35.3	31.0	18.5	18.5	27.6	34.8	26.0	28.7	60.4	32.6	43.5	32.2	28.3	18.8	25.6	35.7	30.3	44.7	50.9	30.8	53.2	33.0	2.5	13.5	5.8	14.8	18.3	19.8	21.1	16.4	13.6	18.6	21.3	21.8	18.0	1.2	19.0	13.6	28.0	14.8	11.2	27.0	31.2	31.8	33.7	24.2	22.2	27.3	26.1	31.6	30.5
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388506-45549421	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: , HPA066085: "	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favourable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favourable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	9.6	14.3	18.8	9.6	21.8	6.7	8.1	11.9	17.9	9.2	14.8	13.1	8.3	9.6	9.8	8.9	10.4	11.2	8.4	14.2	14.6	13.6	18.9	17.2	7.0	10.3	15.7	9.5	10.2	8.2	20.0	14.0	10.6	12.3	10.8	15.3	10.0	8.7	9.8	14.1	7.8	8.8	11.0	8.8	10.0	8.9	7.3	11.8	16.1	10.5	8.3	12.8	11.3	7.8	5.1	5.9	2.4	3.3	8.4	6.0	3.7	6.2	7.9	9.2	8.7	8.4	9.5	9.9	9.8	10.1	18.3	13.7	14.0	8.8	13.0	8.4	11.4	6.8	34.2	20.5	13.9	11.4	8.6	14.1	12.8	13.5	8.8	20.4	5.2	12.3	12.7	17.5	9.2	11.4	21.9	7.4	11.4	6.9	14.6	7.5	23.0	14.6	8.3	9.2	14.5	16.3	15.2	7.3	9.1	15.6	8.8	8.1	14.0	12.0	10.0	11.2	8.3	9.3	11.7	5.8	10.6	13.9	13.2	13.9	9.9	0.6	2.8	2.4	6.0	3.3	5.8	5.1	4.4	5.4	5.9	4.0	4.8	5.4	1.2	8.4	3.0	4.5	3.9	3.7	18.8	21.8	11.9	17.9	14.6	13.6	15.7	9.5	12.3	11.8
LCAT		ENSG00000213398	"Lecithin-cholesterol acyltransferase"	P04180	16	67939750-67944131	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 64.4;liver: 154.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 35.1;Hep G2: 27.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 64.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044767			Approved	Nucleoplasm	"Secreted to blood"	9500000000	9500000000	Nucleoplasm		"HPA044767: AB_2756312"	"unprognostic (3.34e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (8.50e-4)"	"unprognostic (5.43e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"prognostic favourable (4.21e-8)"	"unprognostic (6.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.90e-3)"	4.4	3.6	6.3	2.2	3.7	0.9	4.3	64.4	9.6	4.5	4.4	7.3	1.4	1.3	5.3	3.0	1.8	3.5	3.5	4.5	8.4	1.8	3.9	154.2	5.6	1.9	5.5	6.3	4.7	2.5	5.9	2.7	5.5	9.2	6.4	1.3	1.8	2.4	6.2	3.4	9.9	2.4	3.8	7.5	3.9	2.3	2.2	6.1	1.4	7.6	1.6	1.4	2.6	4.5	1.8	0.8	5.0	1.1	1.3	1.4	0.1	2.4	4.0	5.9	6.7	5.2	7.3	35.1	9.8	4.2	6.6	4.7	13.1	3.0	1.3	1.8	14.1	8.7	1.4	13.4	4.1	0.6	3.6	1.7	8.7	27.3	7.1	0.3	4.7	12.6	12.8	13.7	4.8	4.8	3.7	0.5	4.7	4.0	1.6	4.2	3.9	2.2	1.7	6.5	1.4	1.8	4.3	0.2	3.0	14.8	0.7	1.6	8.4	2.6	9.2	8.6	13.4	9.4	3.5	8.1	2.1	3.7	4.1	1.1	7.4	2.4	1.1	5.0	0.9	0.1	1.3	1.2	0.7	0.8	0.2	1.8	1.4	0.4	2.8	1.3	0.5	0.8	0.0	0.1	6.3	3.7	64.4	9.6	8.4	1.8	5.5	6.3	9.2	6.1
LCT		ENSG00000115850	Lactase	P09848	2	135787840-135837180	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	133	"intestine: 255.5"	"Group enriched"	"Detected in some"	5	"MOLT-4: 6.8;RPMI-8226: 13.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Region enriched"	"Detected in single"	16	"hippocampal formation: 17.3"																"unprognostic (2.21e-2)"	"unprognostic (1.65e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (8.03e-4)"	"unprognostic (3.55e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.64e-4)"	"unprognostic (4.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.02e-1)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.1	209.8	0.0	0.0	67.7	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	255.5	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.8	1.1	0.0	0.0	1.6	0.0	13.6	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.1	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.0
LFNG	SCDO3	ENSG00000106003	"LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q8NES3	7	2512529-2529177	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 55.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.9;RH-30: 23.5;U-2 OS: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069130	Approved				"Intracellular and membrane"	620000	620000			"HPA069130: "	"unprognostic (4.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.52e-2)"	"prognostic favourable (6.36e-4)"	"unprognostic (1.85e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.28e-2)"	10.4	4.9	8.3	12.6	13.5	6.5	15.7	8.3	12.0	10.9	17.3	11.2	0.8	11.9	15.0	5.9	7.9	4.1	16.9	10.1	7.1	11.8	6.6	1.9	15.6	18.1	15.0	6.6	3.0	55.0	1.7	2.6	6.2	19.4	13.0	9.6	8.4	16.5	7.3	3.7	43.0	11.6	6.0	10.2	13.2	28.4	3.4	5.2	5.8	4.4	10.4	19.8	9.0	8.3	2.6	2.5	12.8	7.7	1.3	4.5	1.5	0.7	7.0	9.3	1.3	1.0	0.9	0.6	2.7	1.4	2.4	3.0	3.0	18.9	0.5	8.5	7.3	13.5	1.4	2.5	1.2	4.1	0.3	2.1	3.7	1.5	0.0	3.0	3.9	1.7	6.4	3.9	0.4	0.9	0.3	0.1	1.8	16.8	0.0	4.2	11.3	5.2	0.8	23.5	1.4	0.9	2.2	8.6	2.1	3.1	0.7	0.1	5.1	3.6	2.2	5.4	26.0	0.2	7.4	0.1	0.0	0.7	6.0	8.1	1.0	5.3	5.9	12.8	2.0	7.7	2.4	1.3	2.0	1.0	2.5	2.6	2.2	2.0	3.2	1.3	7.0	0.6	4.5	1.5	8.3	13.5	8.3	12.0	7.1	11.8	15.0	6.6	19.4	5.2
LGR4	GPR48	ENSG00000205213	"Leucine rich repeat containing G protein-coupled receptor 4"	Q9BXB1	11	27365961-27472775	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, Immunity, Innate immunity, Spermatogenesis, Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 29.7;RPTEC TERT1: 36.4;U-2197: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.4;intermediate monocyte: 1.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030267, HPA054350"	Uncertain		Approved	"Centriolar satellite"				"Centriolar satellite"		"HPA030267: AB_10610004, HPA054350: "	"unprognostic (5.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.10e-1)"	"prognostic favourable (2.00e-7)"	"unprognostic (5.01e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.76e-1)"	7.6	10.4	9.4	4.0	11.2	0.9	8.2	15.6	7.6	6.0	18.7	7.8	8.5	11.4	6.5	7.3	9.5	5.7	9.5	14.7	7.1	3.7	30.6	30.5	2.3	0.5	9.1	6.9	12.5	37.0	5.0	5.6	24.9	12.1	8.3	19.3	15.7	8.7	13.3	7.5	11.7	17.5	6.8	8.2	6.5	15.8	7.5	6.8	2.1	7.9	7.2	3.3	7.0	8.4	0.5	0.2	1.4	1.3	0.1	0.5	0.0	9.7	17.9	17.9	2.0	1.6	1.1	20.3	5.6	5.2	5.0	4.3	2.6	0.2	0.0	3.7	7.4	16.4	29.7	11.0	8.6	0.0	13.3	5.3	10.4	12.5	0.5	0.5	0.0	1.5	7.0	3.4	7.6	2.5	1.5	0.0	2.0	3.1	0.0	0.9	17.2	7.3	0.0	12.2	1.1	36.4	4.2	0.2	2.1	2.7	16.4	1.6	5.4	8.2	8.0	3.7	3.1	29.8	5.1	6.8	5.1	0.0	6.3	0.0	2.3	1.4	0.3	0.0	0.2	1.3	0.2	0.3	0.0	0.5	0.2	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	9.4	11.2	15.6	7.6	7.1	3.7	9.1	6.9	12.1	6.8
LHFPL5	"DFNB67, dJ510O8.8, MGC33835, Tmhs"	ENSG00000197753	"LHFPL tetraspan subfamily member 5"	Q8TAF8	6	35805293-35833874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"bone marrow: 7.4;brain: 6.7;epididymis: 12.0;pancreas: 12.3"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055110	Uncertain									"HPA055110: AB_2682697"	"unprognostic (2.35e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"		"unprognostic (4.89e-3)"		"unprognostic (2.96e-3)"	"unprognostic (2.46e-2)"		"unprognostic (1.47e-8)"	"unprognostic (5.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.41e-1)"	0.5	0.5	3.9	1.2	4.1	7.4	0.5	0.4	5.8	0.4	0.4	0.2	0.0	0.9	0.9	12.0	0.3	0.3	0.7	0.3	3.5	2.8	0.4	0.4	0.3	1.5	1.2	6.7	0.6	12.3	0.0	2.2	0.6	2.0	0.6	0.3	0.2	1.1	0.1	0.6	2.3	0.8	0.1	0.6	1.0	0.5	0.8	0.0	0.0	0.8	0.0	0.4	0.3	0.4	1.0	0.3	1.0	0.8	0.5	0.9	0.0	1.5	1.9	3.5	2.1	0.6	1.7	3.2	2.5	0.9	0.4	1.1	2.1	2.2	3.5	1.9	1.3	1.9	0.6	1.4	0.9	1.8	2.9	3.8	5.5	1.9	0.1	1.6	2.6	1.4	0.7	0.7	1.0	0.5	2.0	7.1	2.0	1.2	2.3	1.8	2.3	1.5	2.0	1.5	1.0	1.1	3.3	3.3	2.2	1.6	1.8	1.1	2.9	1.3	3.6	2.4	2.1	3.2	1.0	4.0	3.3	2.8	1.1	2.4	1.5	1.0	0.3	0.2	0.9	0.6	0.5	0.5	0.5	0.3	0.0	1.0	0.6	0.8	0.9	0.5	0.8	0.3	0.4	0.0	3.9	4.1	0.4	5.8	3.5	2.8	1.2	6.7	2.0	0.0
LHFPL6	"LHFP, MGC22429"	ENSG00000183722	"LHFPL tetraspan subfamily member 6"	Q9Y693	13	39342892-39603528	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 65.0;HSkMC: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 9.4;plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058975	Approved		Approved	Nucleoli				Nucleoli		"HPA058975: "	"unprognostic (6.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (1.20e-7)"	"unprognostic (4.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavourable (2.30e-4)"	57.2	26.8	12.5	14.8	17.7	0.9	45.7	40.8	19.0	20.3	16.4	12.3	8.5	5.3	28.6	23.7	17.9	27.0	34.9	49.4	12.7	12.9	12.8	6.9	27.0	27.4	19.3	12.6	25.7	8.3	7.1	14.3	62.0	16.8	21.4	8.4	19.8	11.4	18.8	13.6	13.1	9.6	33.1	18.5	18.5	10.2	16.2	11.9	1.3	22.7	22.1	8.3	20.1	25.8	0.2	9.4	0.1	0.6	0.0	0.0	0.4	2.7	0.9	29.5	1.2	65.0	29.5	12.9	15.0	21.7	7.7	5.8	0.1	2.8	4.2	0.3	20.9	4.2	3.7	8.8	6.4	4.0	4.3	11.3	0.9	0.0	6.8	0.2	0.3	47.5	1.1	6.9	11.5	7.1	0.0	0.0	14.7	2.3	0.0	3.4	2.2	3.9	1.8	12.8	0.0	5.1	3.6	0.1	0.9	1.3	1.8	4.0	1.6	0.0	13.2	19.6	2.9	6.0	8.1	0.2	0.0	11.8	8.1	0.0	14.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.4	0.2	0.0	0.0	0.1	0.0	0.1	3.2	0.0	0.4	12.5	17.7	40.8	19.0	12.7	12.9	19.3	12.6	16.8	11.9
LIAS	LAS	ENSG00000121897	"Lipoic acid synthetase"	O43766	4	39458587-39485109	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018842, HPA019076"	Approved	Supported	Approved	Nucleoplasm,Mitochondria,Cytosol				Mitochondria	"Nucleoplasm, Cytosol"	"HPA018842: AB_1852864, HPA019076: AB_1852866"	"unprognostic (3.61e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.80e-2)"	"prognostic favourable (4.11e-7)"	"unprognostic (9.41e-3)"	"unprognostic (2.35e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.98e-2)"	9.8	12.9	9.9	7.0	12.7	10.2	11.3	10.2	13.3	7.0	10.7	12.9	8.1	10.4	9.1	10.7	11.6	11.9	7.4	14.0	10.6	10.6	15.7	15.5	5.7	9.0	12.3	10.5	19.2	12.4	10.0	11.5	6.8	15.7	8.2	12.4	9.0	7.8	7.0	42.7	8.8	9.9	13.6	12.4	8.9	9.9	20.1	13.2	8.7	8.8	13.5	8.3	10.0	7.9	9.6	5.8	3.7	7.1	6.9	16.7	4.3	3.9	3.0	4.0	3.7	8.3	8.1	3.4	4.6	2.5	4.3	2.9	5.0	5.5	14.4	5.3	1.7	3.5	11.1	6.3	5.7	1.6	2.8	6.0	1.6	5.0	7.6	13.1	3.9	7.8	10.4	5.0	16.0	4.9	14.3	3.6	5.2	2.5	7.3	16.8	5.2	10.0	6.4	10.7	8.7	5.1	2.1	4.3	3.7	2.6	3.5	14.8	3.9	6.0	1.8	3.4	7.6	4.5	10.6	7.0	10.6	10.1	5.3	15.3	2.9	2.0	6.2	3.7	6.1	7.1	12.6	9.6	8.3	8.0	5.8	8.5	16.7	11.5	3.3	6.9	5.1	5.4	5.2	4.3	9.9	12.7	10.2	13.3	10.6	10.6	12.3	10.5	15.7	13.2
LIG4		ENSG00000174405	"DNA ligase 4"	P49917	13	108207439-108218368	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001334, HPA057325"	Supported		Supported	"Nucleoplasm,Cytoplasmic bodies"				Nucleoplasm	"Cytoplasmic bodies"	"HPA001334: AB_1078689, HPA057325: "	"unprognostic (9.93e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.03e-3)"	8.8	12.4	11.6	10.4	15.9	4.3	9.1	14.2	20.6	5.4	7.1	10.2	7.8	8.9	5.8	11.4	8.1	5.9	8.7	8.8	15.6	14.4	11.2	16.7	8.7	12.7	15.5	10.6	7.9	8.3	17.0	20.3	8.3	19.6	7.5	8.7	3.8	6.7	7.1	9.5	6.6	8.6	8.4	14.4	12.6	9.7	11.7	13.6	18.6	10.0	5.4	10.2	8.1	5.3	3.3	2.1	6.8	10.7	2.7	2.7	1.5	9.4	3.6	9.8	6.5	8.2	8.8	3.5	9.4	7.1	7.2	8.7	4.3	4.3	16.2	7.7	6.1	3.9	6.5	6.3	12.5	9.4	6.2	7.6	8.3	2.2	9.8	10.2	8.1	8.0	10.5	7.0	6.3	8.6	2.7	3.0	11.1	5.1	16.8	7.4	2.5	2.3	15.5	3.9	2.6	9.4	6.1	6.2	6.4	2.1	5.8	7.1	4.9	15.7	12.7	4.3	4.7	4.8	8.4	8.0	5.2	26.3	16.6	5.9	9.7	0.8	2.3	6.8	1.8	3.8	2.5	2.6	2.0	1.9	2.1	3.3	2.0	2.7	3.2	2.7	10.7	1.4	2.7	1.5	11.6	15.9	14.2	20.6	15.6	14.4	15.5	10.6	19.6	13.6
LIMK1	LIMK	ENSG00000106683	"LIM domain kinase 1"	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.2"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028064, HPA028516"	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA028064: AB_10600111, HPA028516: AB_10601751"	"unprognostic (1.45e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (4.95e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavourable (7.79e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (6.63e-8)"	"unprognostic (4.14e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.79e-2)"	8.8	8.6	31.6	18.2	18.6	6.3	7.4	14.3	44.1	11.5	6.6	7.1	6.6	6.9	7.3	5.3	6.4	6.0	10.8	6.3	26.8	32.9	5.2	2.6	12.5	22.0	33.4	22.2	12.1	8.1	4.0	7.2	8.0	45.2	6.1	4.7	4.8	18.1	9.6	10.9	6.8	7.2	7.6	10.8	18.4	7.8	10.4	6.5	4.3	7.5	3.7	18.1	14.1	7.2	4.6	8.6	3.8	7.7	6.9	2.4	3.1	17.2	13.5	10.3	17.1	13.6	18.5	7.5	10.7	10.3	8.7	9.7	7.8	17.0	10.7	4.8	13.1	10.4	3.8	6.6	3.3	18.5	6.7	7.9	4.6	8.9	15.6	6.0	29.0	18.2	5.9	7.0	3.7	12.9	5.3	3.4	10.8	15.1	5.1	10.8	19.5	8.4	7.5	16.0	6.7	9.6	3.7	4.1	9.4	6.9	16.5	8.6	5.2	5.4	15.3	13.9	12.9	35.7	17.1	3.9	4.3	19.5	51.4	4.4	9.4	0.1	6.5	3.8	2.4	7.7	1.8	4.6	0.6	1.5	8.6	2.4	0.2	0.7	0.7	6.9	4.7	0.8	0.4	3.1	31.6	18.6	14.3	44.1	26.8	32.9	33.4	22.2	45.2	6.5
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 139.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 60.3;ASC TERT1: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 31.8;intermediate monocyte: 68.4;myeloid DC: 23.3;non-classical monocyte: 35.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.3;monocytes: 68.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	150000	150000	Vesicles		"CAB034892: AB_784329, HPA057052: "	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	139.0	16.3	15.8	14.4	22.7	7.8	19.9	8.8	21.4	13.4	28.1	61.3	3.4	37.4	10.2	5.2	9.5	9.0	19.4	8.7	22.5	13.8	10.8	49.3	38.5	45.7	41.6	13.4	10.4	9.5	17.5	6.3	17.8	28.4	7.4	16.7	5.7	11.0	8.8	4.1	6.8	65.8	11.3	55.1	87.3	7.9	3.1	37.2	7.0	8.3	4.7	10.0	15.1	8.6	7.0	23.3	3.2	68.4	5.5	8.3	25.5	53.8	8.3	5.5	60.3	56.9	75.6	1.6	28.6	33.5	11.9	21.5	3.2	29.1	9.9	5.6	44.8	54.1	2.4	15.5	8.9	14.0	5.6	4.1	3.5	12.8	15.0	8.0	8.2	33.6	11.1	12.7	6.9	2.3	0.0	18.6	9.3	4.5	6.9	5.4	3.6	9.4	4.5	6.5	9.2	11.0	8.5	1.8	3.8	6.9	9.0	21.0	10.3	10.3	4.3	10.2	2.7	21.8	6.9	9.7	10.2	4.1	12.2	17.6	12.7	0.8	31.8	3.2	8.2	68.4	8.2	6.5	7.3	7.8	23.3	7.0	7.7	8.3	1.4	5.5	35.6	4.7	7.1	25.5	15.8	22.7	8.8	21.4	22.5	13.8	41.6	13.4	28.4	37.2
LIPC	"HL, HTGL"	ENSG00000166035	"Lipase C, hepatic type"	P11150	15	58410569-58569843	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 91.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.8;EFO-21: 5.2;Hep G2: 19.5;HMC-1: 5.7;MOLT-4: 4.4;U-2197: 15.4"	"Group enriched"	"Detected in some"	14	"liver cancer: 20.4;renal cancer: 10.4"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"granulocytes: 3.7;NK-cells: 3.0;T-cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	3200000	3200000				"unprognostic (1.76e-2)"	"unprognostic (9.15e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.15e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.27e-2)"	0.2	0.1	0.4	1.1	0.7	0.0	0.7	0.1	0.4	0.3	0.2	0.6	0.0	0.7	0.1	0.4	0.2	0.4	0.3	0.3	0.4	0.2	3.0	91.7	0.3	0.2	1.2	0.2	0.3	1.0	0.0	1.0	0.1	1.5	0.3	0.3	0.5	0.1	1.5	0.1	0.3	0.3	0.1	1.2	0.4	0.2	0.1	0.5	2.7	0.5	0.0	0.1	1.1	0.2	0.1	0.2	3.7	0.4	3.0	4.5	2.5	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.7	0.0	0.0	6.8	0.0	0.0	5.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	2.4	0.0	19.5	0.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	4.4	0.6	0.0	0.0	0.9	0.3	0.0	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	15.4	0.0	0.0	0.0	0.1	0.1	0.4	0.0	3.7	0.3	0.0	3.0	0.2	4.5	0.0	0.8	2.2	0.2	0.1	1.0	3.2	0.4	3.0	0.4	0.1	2.1	2.5	0.4	0.7	0.1	0.4	0.4	0.2	1.2	0.2	1.5	0.5
LIPE	HSL	ENSG00000079435	"Lipase E, hormone sensitive type"	Q05469	19	42401507-42427426	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Hydrolase	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 207.4;breast: 65.1"	"Cell line enriched"	"Detected in many"	7	"ASC diff: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006567, CAB017700"	Enhanced		Supported	Cytosol				Cytosol		"CAB017700: AB_2135504, HPA006567: "	"unprognostic (4.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.44e-2)"	"prognostic favourable (1.15e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.63e-10)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.34e-3)"	207.4	6.0	3.2	2.9	9.4	2.1	65.1	2.0	6.8	1.2	6.7	19.6	0.8	2.4	1.7	1.3	2.2	1.6	3.6	4.8	6.2	4.2	1.5	1.1	1.4	2.7	18.0	2.3	1.5	2.2	2.2	0.8	1.7	9.9	1.7	1.3	3.7	5.4	1.7	3.7	2.9	3.4	1.7	19.2	3.1	1.6	9.0	10.8	1.7	1.5	1.8	1.9	2.0	3.7	6.1	4.8	10.8	12.1	4.1	5.2	4.0	4.8	3.7	2.4	0.9	56.0	0.5	0.0	2.3	1.2	3.7	3.4	0.9	1.8	8.0	2.5	0.7	2.1	1.4	4.5	0.4	1.5	2.4	2.2	1.8	0.1	1.1	0.0	5.5	0.4	4.3	0.6	0.8	1.0	1.0	5.1	0.4	0.0	5.6	0.2	0.3	1.1	4.6	0.4	2.6	1.0	5.1	3.4	3.5	2.0	2.3	2.1	0.6	2.9	1.8	1.0	3.2	0.4	2.0	3.8	3.1	5.9	2.5	0.2	3.4	10.8	12.1	4.7	3.6	6.0	3.3	4.8	4.6	5.2	4.8	6.1	4.1	3.7	2.0	4.1	3.3	3.9	3.9	4.0	3.2	9.4	2.0	6.8	6.2	4.2	18.0	2.3	9.9	10.8
LIPT2		ENSG00000175536	"Lipoyl(octanoyl) transferase 2"	A6NK58	11	74491712-74493733	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Ligase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040249	Approved		Approved	Vesicles,Centrosome				Vesicles	Centrosome	"HPA040249: AB_10795275"	"unprognostic (8.80e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.11e-2)"	"prognostic favourable (1.63e-4)"	"unprognostic (6.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.35e-1)"	2.0	4.1	2.6	2.6	3.0	2.1	5.8	2.3	4.3	3.1	4.0	3.4	6.5	5.8	3.4	6.5	3.6	5.8	8.8	2.9	3.3	2.6	8.1	5.3	4.0	8.4	3.5	1.0	6.2	10.8	6.2	4.3	8.3	2.9	4.6	3.6	3.8	5.9	6.9	11.3	2.4	6.3	3.1	2.9	4.2	5.6	19.0	0.8	8.7	6.4	5.5	4.3	4.6	3.8	11.2	7.2	6.6	4.9	8.1	14.8	5.4	2.5	3.2	7.0	3.3	2.9	0.6	9.9	0.9	1.6	4.4	2.8	10.5	3.5	15.5	6.0	0.6	3.7	3.2	2.4	1.7	3.6	3.2	4.5	2.8	2.8	3.3	5.2	6.2	1.6	2.6	2.2	2.9	0.3	3.5	4.4	1.3	4.0	6.9	7.9	6.2	4.2	5.6	7.7	4.3	2.9	8.7	7.1	4.5	6.5	2.0	9.4	6.3	3.9	1.2	1.0	2.6	1.5	2.3	7.3	6.5	10.5	0.8	3.0	3.4	0.0	4.9	6.6	5.9	3.0	8.8	11.2	7.9	7.2	5.3	11.0	14.8	11.2	1.1	8.1	3.7	7.2	3.7	5.4	2.6	3.0	2.3	4.3	3.3	2.6	3.5	1.0	2.9	0.8
LMBRD1	"bA810I22.1, C6orf209, cblF, FLJ11240"	ENSG00000168216	"LMBR1 domain containing 1"	Q9NUN5	6	69675802-69797111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019547	Uncertain									"HPA019547: AB_2281256"	"unprognostic (1.44e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.47e-1)"	"prognostic favourable (1.07e-7)"	"unprognostic (7.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.68e-2)"	21.3	44.1	34.1	14.2	32.5	5.4	29.1	32.9	34.1	23.7	20.9	38.1	20.0	23.1	18.4	32.1	20.6	25.5	23.9	19.8	35.8	32.7	53.1	38.9	24.7	21.9	37.9	22.8	29.0	36.8	58.9	23.6	25.0	32.5	19.0	21.8	26.5	22.4	24.6	17.9	18.6	30.2	17.2	57.8	19.9	19.9	11.9	30.6	17.8	41.8	13.2	18.7	22.7	19.4	24.4	9.9	37.8	18.5	7.8	14.4	11.5	6.7	3.2	7.5	10.2	22.8	24.4	11.3	5.4	19.7	4.4	9.4	5.3	13.9	8.9	15.3	14.1	10.7	8.3	8.0	8.1	17.5	10.7	8.7	6.3	7.6	13.9	5.2	11.7	17.2	16.9	5.2	7.3	8.0	15.8	13.5	14.3	4.6	3.6	5.6	3.8	3.4	4.1	18.6	25.2	30.8	11.1	4.9	8.1	6.8	9.2	9.9	9.8	18.9	12.1	6.3	3.9	5.9	5.3	8.1	7.0	3.4	7.8	8.5	11.9	25.2	10.6	19.0	8.4	13.2	8.6	24.4	11.2	9.5	9.9	21.7	12.8	9.0	37.8	7.8	18.5	9.6	14.4	11.5	34.1	32.5	32.9	34.1	35.8	32.7	37.9	22.8	32.5	30.6
LONP1	"hLON, LonHS, PIM1, PRSS15"	ENSG00000196365	"Lon peptidase 1, mitochondrial"	P36776	19	5691834-5720572	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Hydrolase, Protease, Serine protease"	"Cataract, Deafness, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 78.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002034, HPA002192"	Supported		Enhanced	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA002034: AB_2756304, HPA002192: AB_1079695"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	15.8	78.3	16.4	12.8	19.8	12.5	13.9	16.1	22.8	11.3	13.6	15.8	13.3	13.7	10.5	13.8	12.7	12.7	15.7	27.3	15.4	15.3	19.9	49.6	10.3	14.5	17.7	14.9	15.5	17.7	17.6	16.8	16.6	16.2	11.7	8.5	12.7	18.5	14.7	38.0	14.7	13.9	11.5	12.7	15.5	13.5	9.8	13.3	13.8	21.2	15.3	11.8	14.7	12.5	6.7	6.5	6.0	6.2	4.0	7.2	3.0	23.0	23.9	7.9	25.3	9.4	6.7	24.7	14.7	11.7	15.9	19.5	20.4	8.3	29.0	20.6	15.4	9.8	20.4	17.8	7.7	17.1	16.8	16.0	20.9	26.7	43.7	36.4	16.8	12.6	25.6	15.1	29.9	12.7	42.3	57.8	7.3	15.3	18.0	21.7	28.3	31.6	19.0	11.4	31.2	8.8	13.7	21.1	21.1	12.9	18.9	51.6	11.1	45.7	9.0	8.1	8.9	22.5	21.4	60.9	37.5	25.7	36.5	39.9	14.6	6.0	4.1	0.8	6.4	6.2	4.1	6.0	5.6	6.1	4.3	6.7	7.2	4.8	0.5	4.0	2.4	6.5	4.0	3.0	16.4	19.8	16.1	22.8	15.4	15.3	17.7	14.9	16.2	13.3
LOX		ENSG00000113083	"Lysyl oxidase"	P28300	5	122063195-122078360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		Oxidoreductase	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 103.5;fHDF/TERT166: 157.7;HSkMC: 38.5;U-138 MG: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043930			Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	290000	290000	"Endoplasmic reticulum"		"HPA043930: "	"unprognostic (5.10e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-3)"	"unprognostic (8.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (3.93e-8)"	"unprognostic (1.11e-3)"	"unprognostic (9.92e-2)"	"unprognostic (4.31e-2)"	"prognostic unfavourable (3.32e-4)"	33.8	1.8	1.0	7.2	1.2	0.0	37.4	0.9	0.9	16.1	11.7	0.1	4.1	3.8	6.3	20.1	11.1	7.6	12.8	21.4	1.2	1.3	6.5	2.4	20.6	4.3	0.9	1.1	15.7	6.0	0.8	1.5	14.8	1.6	11.2	3.0	3.2	3.4	3.5	12.7	11.3	4.5	9.5	1.5	7.7	4.0	10.6	0.1	0.7	10.8	4.2	2.7	36.9	10.4	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.1	0.0	0.2	0.1	18.0	21.3	0.0	103.5	21.8	8.0	28.2	0.1	0.0	0.0	2.4	157.7	0.0	0.4	0.2	17.2	0.0	0.3	0.0	2.0	0.8	22.8	0.0	0.0	38.5	0.4	13.3	0.5	10.0	0.0	0.0	9.3	0.0	0.0	0.0	0.7	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.5	7.3	0.0	0.6	0.0	0.0	0.8	52.4	3.5	31.0	1.4	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	1.0	1.2	0.9	0.9	1.2	1.3	0.9	1.1	1.6	0.1
LOXL3		ENSG00000115318	"Lysyl oxidase like 3"	P58215	2	74532414-74555690	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Oxidoreductase	"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 26.7;U-138 MG: 47.1;WM-115: 101.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 11.1;non-classical monocyte: 8.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035281	Approved				"Secreted to extracellular matrix"	15000	15000			"HPA035281: AB_10601766"	"unprognostic (7.54e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.55e-3)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (7.97e-8)"	"unprognostic (1.22e-2)"	"unprognostic (7.33e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-2)"	7.9	7.1	6.3	8.5	5.0	15.9	9.7	2.9	6.5	6.6	8.4	13.1	2.2	5.1	10.2	7.5	4.1	5.8	8.0	10.8	4.5	5.0	3.2	2.0	6.8	8.0	5.7	6.7	4.2	3.3	2.3	3.9	18.8	7.4	4.4	4.8	7.8	3.6	5.5	1.6	2.1	4.9	10.2	9.7	12.3	3.7	3.5	4.8	0.6	3.0	3.4	2.9	6.1	6.0	0.1	3.4	2.7	11.1	0.0	0.0	2.5	0.2	0.0	3.8	0.6	3.2	4.1	0.7	13.1	26.7	6.4	6.1	4.4	0.2	0.0	0.1	13.4	0.1	0.4	0.3	3.8	19.8	0.0	3.1	0.2	0.0	1.0	0.1	3.2	4.2	0.0	16.9	0.7	0.1	0.1	0.3	1.1	0.6	0.0	1.1	2.1	0.1	0.3	0.4	0.0	0.0	0.1	1.8	2.4	0.0	0.1	2.7	0.3	0.2	0.0	47.1	1.6	0.2	0.1	0.1	0.1	0.0	17.7	1.2	101.0	0.1	5.6	0.3	0.0	11.1	0.0	0.1	0.0	0.0	3.4	0.1	0.0	0.0	2.7	0.0	8.7	0.3	0.0	2.5	6.3	5.0	2.9	6.5	4.5	5.0	5.7	6.7	7.4	4.8
LPAR6	"P2RY5, P2Y5"	ENSG00000139679	"Lysophosphatidic acid receptor 6"	P43657	13	48389567-48444704	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"testis: 54.2"	"Cell line enhanced"	"Detected in many"		"AF22: 13.2;HUVEC TERT2: 21.5;MOLT-4: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028934	Approved									"HPA028934: "	"unprognostic (1.19e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.82e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.57e-2)"	"unprognostic (7.40e-2)"	"prognostic favourable (6.22e-4)"	"unprognostic (1.07e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (3.60e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.94e-2)"	10.9	6.0	7.6	5.3	10.0	0.3	11.0	5.4	10.6	8.7	4.5	11.1	2.9	2.7	6.5	9.7	25.6	4.9	8.0	5.6	8.4	4.1	7.6	4.7	9.6	9.4	7.9	10.9	3.7	2.9	2.0	4.8	18.7	14.1	17.7	6.3	5.9	18.3	7.8	3.4	7.5	5.5	6.0	17.4	9.4	4.4	54.2	12.6	2.9	7.3	2.9	9.1	9.6	21.3	0.3	7.3	1.6	31.0	1.8	23.0	16.3	0.0	1.2	13.2	0.0	4.4	5.5	0.1	2.7	7.7	0.5	1.5	0.0	3.9	0.0	0.0	2.9	7.7	0.4	4.3	0.2	0.0	2.6	0.1	0.1	9.5	2.9	0.0	0.1	7.2	7.7	0.4	4.3	21.5	0.0	0.2	2.6	0.0	11.7	3.7	5.2	3.5	10.0	0.0	0.1	3.6	7.9	0.0	0.0	0.0	0.0	2.6	1.3	0.1	5.5	1.5	0.0	0.1	0.7	0.0	0.0	0.0	0.4	0.6	4.7	0.3	20.8	0.0	7.6	31.0	4.1	0.3	21.5	9.0	7.3	0.1	15.5	4.8	1.6	1.8	26.6	0.3	23.0	16.3	7.6	10.0	5.4	10.6	8.4	4.1	7.9	10.9	14.1	12.6
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	18.1	10.1	13.0	10.7	18.3	6.0	22.1	20.0	16.4	10.5	8.6	10.9	7.3	8.9	11.0	15.0	20.0	7.0	10.4	12.8	11.6	11.9	7.6	13.2	8.0	15.4	13.2	11.2	19.3	7.5	17.2	32.0	9.0	17.9	9.6	7.1	9.0	14.4	11.6	88.4	6.5	9.2	11.0	10.3	8.4	7.6	39.0	13.2	8.3	8.1	14.0	19.2	10.4	21.7	6.5	9.6	11.6	2.8	8.0	11.1	3.2	5.4	6.5	5.4	12.1	25.1	27.9	2.8	7.6	13.2	5.0	8.6	2.3	5.4	2.7	1.0	6.5	5.9	6.1	16.8	4.6	11.2	3.4	6.7	3.6	3.5	8.8	4.6	31.6	25.1	7.5	20.5	7.8	9.5	9.2	24.3	3.6	2.1	4.3	4.0	5.6	6.6	6.0	10.0	17.0	12.5	3.5	15.1	11.9	2.7	6.6	17.3	1.6	2.6	6.7	7.9	7.1	5.0	6.6	38.2	29.5	5.1	11.1	8.3	5.8	9.5	2.8	11.6	10.3	2.1	11.1	6.5	9.6	9.7	2.5	5.0	8.4	7.1	1.1	8.0	2.1	9.6	10.5	3.2	13.0	18.3	20.0	14.4	11.6	11.9	13.2	11.2	17.9	13.2
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013315	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 83.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"granulocytes: 20.8;NK-cells: 10.1;T-cells: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"				Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: "	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	6.8	5.6	13.0	10.5	18.4	9.2	7.7	11.9	16.5	6.6	25.2	10.4	2.4	31.6	6.7	3.9	5.9	6.3	14.3	5.1	11.0	14.5	20.7	83.9	11.8	11.8	11.2	9.8	8.8	9.0	9.7	8.2	16.3	15.3	5.8	7.4	6.8	4.4	5.3	2.2	2.7	43.3	6.1	9.6	10.7	15.6	13.5	9.6	6.3	7.5	1.5	10.0	6.8	6.7	1.2	1.1	20.8	2.0	10.1	9.5	2.1	4.9	6.7	10.6	3.7	18.4	17.1	6.3	11.9	14.6	11.9	11.6	8.7	4.2	3.6	7.3	18.3	0.2	8.7	3.7	9.4	7.0	1.8	9.2	5.2	9.9	17.2	7.3	10.1	17.2	2.5	11.8	10.3	14.8	8.3	1.9	16.6	3.7	9.1	6.3	3.4	9.6	16.0	9.2	13.4	9.5	11.1	8.9	6.2	11.2	5.3	3.8	0.0	10.0	20.8	15.4	18.7	19.7	8.8	3.5	5.3	7.8	13.6	7.5	5.4	6.5	2.0	6.1	9.3	1.3	9.5	0.9	7.1	5.3	0.8	1.2	7.3	4.7	20.8	10.1	0.6	1.1	6.3	2.1	13.0	18.4	11.9	16.5	11.0	14.5	11.2	9.8	15.3	9.6
LRAT	LCA14	ENSG00000121207	"Lecithin retinol acyltransferase"	O95237	4	154626945-154753118	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"Acyltransferase, Transferase"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 82.4"	"Cell line enriched"	"Detected in some"	8	"NTERA-2: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 4.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA070726			Uncertain	"Endoplasmic reticulum,Golgi apparatus"				"Golgi apparatus"	"Endoplasmic reticulum"	"HPA070726: "	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-4)"	"unprognostic (4.49e-6)"	"unprognostic (6.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-1)"	0.9	0.8	2.2	0.8	3.2	1.8	1.4	0.7	1.1	0.9	4.2	3.0	0.8	3.7	0.5	1.2	0.5	0.9	2.3	0.6	3.1	4.2	0.6	3.3	1.0	0.5	2.9	2.4	1.0	2.9	0.3	1.0	0.3	8.9	1.6	0.4	82.4	0.5	1.6	2.3	1.4	11.1	0.3	7.0	0.7	0.9	2.9	3.1	0.0	4.9	0.2	0.6	0.5	0.7	0.9	3.7	2.0	4.5	0.6	0.3	3.9	0.6	0.5	0.4	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.8	0.6	0.1	0.1	0.2	0.5	0.3	0.3	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.3	16.1	0.0	0.1	0.0	0.1	1.9	0.5	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.4	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.2	0.5	1.0	4.5	0.4	0.3	1.6	0.3	0.5	0.3	0.3	3.7	0.9	0.3	0.3	2.0	0.6	0.5	0.5	0.2	3.9	2.2	3.2	0.7	1.1	3.1	4.2	2.9	2.4	8.9	3.1
LRP2	"DBS, gp330"	ENSG00000081479	"LDL receptor related protein 2"	P98164	2	169127109-169362685	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Hearing, Neurogenesis, Transport"	Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 61.7;parathyroid gland: 61.4"	"Group enriched"	"Detected in some"	12	"AF22: 21.4;CACO-2: 35.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 8.1;renal cancer: 29.9;thyroid cancer: 7.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005980, HPA064792"	Enhanced		Approved	Vesicles,Mitochondria				"Vesicles, Mitochondria"		"HPA005980: AB_1079278, HPA064792: "	"unprognostic (1.87e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.38e-1)"	"prognostic favourable (3.43e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.62e-2)"	1.7	0.4	2.7	0.4	12.9	0.5	7.4	0.7	5.7	0.6	0.4	18.5	0.0	0.4	0.5	4.8	0.4	0.4	0.6	0.5	6.2	3.4	61.7	0.6	1.8	0.4	20.7	1.9	0.4	0.4	61.4	0.4	10.5	8.5	0.5	0.4	7.9	1.1	0.5	0.5	0.5	0.4	0.4	17.2	0.4	0.5	0.6	17.0	0.0	18.2	0.0	0.4	0.4	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.7	12.9	0.7	5.7	6.2	3.4	20.7	1.9	8.5	17.0
LRRC8A	"FLJ10337, KIAA1437, LRRC8, SWELL1"	ENSG00000136802	"Leucine rich repeat containing 8 VRAC subunit A"	Q8IWT6	9	128882112-128918039	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 49.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"														"unprognostic (6.33e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.38e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavourable (3.83e-4)"	"unprognostic (3.53e-1)"	"prognostic favourable (5.27e-5)"	"unprognostic (3.69e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.02e-2)"	25.8	10.6	24.3	14.2	26.8	13.4	17.8	28.5	50.4	13.8	14.0	18.5	10.9	9.0	18.8	7.4	37.9	12.4	21.1	14.5	22.6	21.0	11.6	16.4	20.3	7.7	27.2	19.5	11.4	19.0	21.3	7.4	21.8	21.1	18.4	8.2	12.1	16.2	24.8	8.0	16.0	9.5	25.8	13.0	10.5	16.7	9.2	22.6	8.4	13.5	12.0	14.3	20.9	18.7	2.5	2.8	3.2	1.9	6.1	7.4	1.7	10.3	16.3	9.9	8.4	23.2	9.0	12.5	12.0	8.0	7.4	5.3	7.2	22.3	3.8	13.5	13.0	49.6	6.1	26.5	3.5	3.8	4.9	3.4	10.5	8.6	15.8	4.0	6.3	7.0	18.8	13.2	15.8	25.7	7.5	3.8	9.7	8.9	4.5	3.8	29.4	17.8	6.3	11.4	6.1	11.7	5.2	5.9	12.3	13.4	8.4	4.7	6.1	3.0	45.0	21.8	9.4	9.2	17.4	4.4	10.4	4.6	12.0	3.0	12.6	1.2	1.4	3.2	7.4	1.9	3.4	2.5	3.7	4.7	1.8	2.0	3.7	3.6	2.6	6.1	0.5	2.8	6.1	1.7	24.3	26.8	28.5	32.6	22.6	21.0	27.2	19.5	21.1	22.6
LRRK2	"DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2"	ENSG00000188906	"Leucine rich repeat kinase 2"	Q5S007	12	40196744-40369285	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Differentiation"	"GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 40.4;lung: 50.4"	"Cell line enhanced"	"Detected in some"		"A549: 9.7;ASC TERT1: 10.0;BJ hTERT+: 5.6;RPTEC TERT1: 10.7"	"Group enriched"	"Detected in many"	7	"lung cancer: 5.3;renal cancer: 17.1;thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 40.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 40.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014293, CAB037160"	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"CAB037160: AB_1840989, HPA014293: AB_1853353"	"unprognostic (2.67e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"prognostic favourable (3.02e-6)"	"unprognostic (2.55e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.01e-3)"	"unprognostic (5.21e-3)"	3.7	3.4	2.3	7.0	3.9	8.6	3.0	1.7	5.0	5.1	4.5	1.7	2.6	0.7	5.3	2.9	5.3	3.8	4.5	4.0	1.8	1.4	10.6	4.5	50.4	6.8	2.2	3.6	5.8	3.3	10.9	2.5	1.0	1.9	3.6	1.6	3.3	4.2	2.0	5.6	2.6	3.4	6.7	4.9	8.6	2.7	1.2	2.4	0.5	3.9	2.7	4.9	4.6	6.8	0.9	1.5	40.4	5.8	0.0	0.0	0.8	0.0	9.7	0.1	0.0	3.9	10.0	0.1	2.1	5.6	0.4	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.3	0.0	0.4	0.0	0.7	0.3	0.2	0.0	0.7	0.5	0.1	2.5	0.7	0.0	0.2	0.6	0.0	0.0	0.7	0.0	0.0	1.2	0.2	0.1	0.0	0.0	0.0	10.7	0.0	0.1	0.6	0.0	0.2	2.7	2.8	2.2	1.4	1.1	1.1	1.2	0.7	0.0	0.0	0.0	2.3	0.0	0.5	0.0	5.8	1.2	0.0	3.1	0.0	0.9	0.0	0.0	1.5	0.9	0.0	0.0	40.4	0.0	3.0	0.2	0.0	0.8	2.3	3.9	1.7	5.0	1.8	1.4	2.2	3.6	1.9	2.4
LRSAM1	"CMT2P, FLJ31641"	ENSG00000148356	"Leucine rich repeat and sterile alpha motif containing 1"	Q6UWE0	9	127451486-127503501	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021403, HPA021844, CAB037304"	Supported		Approved	Cytosol				Cytosol		"CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368"	"unprognostic (8.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.48e-3)"	"unprognostic (4.15e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.72e-2)"	"prognostic favourable (6.78e-6)"	"unprognostic (1.27e-1)"	"prognostic favourable (5.72e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.33e-2)"	9.5	13.6	15.6	10.1	17.2	15.3	9.2	24.2	22.6	10.7	18.0	15.3	10.9	10.8	12.6	17.6	12.3	11.0	11.9	18.7	13.3	17.3	11.2	15.6	11.7	11.5	13.5	22.7	16.0	9.6	17.6	11.8	9.2	17.9	13.6	8.6	10.2	11.9	13.7	20.4	28.3	11.1	16.0	18.7	12.6	12.2	6.1	13.9	5.5	11.6	9.6	11.5	17.2	12.9	4.1	5.4	17.4	6.6	1.3	4.8	3.2	5.7	8.7	5.3	10.1	8.9	8.8	8.3	5.4	6.7	8.3	6.2	10.0	5.6	9.8	5.5	7.5	18.9	6.4	11.3	3.3	10.4	4.9	5.3	11.3	8.7	7.1	5.8	11.2	5.1	9.3	5.7	10.9	8.9	4.7	10.2	3.6	14.4	4.1	5.1	5.0	8.8	6.7	4.7	15.3	9.0	5.0	9.7	8.0	3.5	12.0	7.0	24.6	3.1	10.4	5.6	5.7	7.0	3.6	11.3	8.4	1.6	9.2	5.4	2.9	14.6	4.9	17.4	4.4	6.6	4.8	4.1	3.0	3.7	5.4	3.1	1.5	2.0	5.7	1.3	5.5	4.6	2.4	3.2	15.6	17.2	24.2	22.6	13.3	17.3	13.5	22.7	17.9	13.9
LRTOMT	"CFAP111, COMT2, DFNB63, LRRC51"	ENSG00000184154	"Leucine rich transmembrane and O-methyltransferase domain containing"	"Q8WZ04, Q96E66"	11	72080331-72110782	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Catecholamine metabolism, Hearing, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 49.8;testis: 47.8"	"Cell line enhanced"	"Detected in many"		"T-47d: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA039949	Approved		Uncertain	Microtubules				Microtubules		"HPA039949: AB_10960708"	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.85e-2)"	"prognostic favourable (7.70e-4)"	"unprognostic (8.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.22e-2)"	"prognostic favourable (5.36e-4)"	"unprognostic (6.12e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	3.5	3.7	10.6	2.0	11.1	2.1	7.1	3.7	8.9	7.1	4.2	14.0	6.1	3.2	6.0	13.6	3.5	49.8	5.3	2.6	8.8	7.6	9.0	6.2	6.2	2.6	7.7	8.5	8.5	7.0	7.1	8.9	4.4	10.6	7.5	6.2	7.3	4.3	4.7	5.2	4.5	2.5	4.8	7.7	3.2	3.6	47.8	8.9	3.1	9.3	2.4	3.5	3.5	2.6	4.3	4.2	9.2	2.9	10.1	6.2	2.0	2.6	9.8	6.2	5.0	5.4	4.8	1.5	3.1	2.5	2.8	2.5	4.7	14.3	3.4	4.8	5.3	5.3	4.4	7.5	3.2	6.4	4.3	2.5	4.5	3.3	0.9	2.0	2.7	2.1	3.8	4.3	3.3	1.0	2.7	5.3	4.1	9.4	6.0	4.0	3.1	2.6	7.3	6.3	5.2	11.0	3.2	5.8	4.5	6.1	14.1	7.5	27.8	2.4	4.7	3.0	4.2	8.0	2.1	5.7	6.2	4.0	2.9	1.7	3.3	2.3	2.9	5.0	3.1	2.8	3.2	4.2	3.3	2.6	1.7	4.3	3.0	3.0	9.2	10.1	1.8	4.2	6.2	2.0	10.6	11.1	3.7	8.9	8.8	7.6	7.7	8.5	10.6	8.9
LSS	OSC	ENSG00000160285	"Lanosterol synthase"	P48449	21	46188141-46228824	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Isomerase	"Cataract, Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032060, HPA032062, CAB034116"	Supported		Approved	Cytosol				Cytosol		"CAB034116: AB_2138611, HPA032060: AB_10671085, HPA032062: "	"unprognostic (2.78e-3)"	"unprognostic (8.53e-3)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-2)"	"prognostic unfavourable (6.80e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (3.07e-4)"	21.1	22.9	17.9	9.9	38.8	5.0	14.7	22.5	33.9	11.2	16.9	37.7	5.8	26.4	16.6	12.5	23.4	11.0	12.1	17.8	19.0	17.3	8.4	33.8	19.7	8.3	49.5	14.9	25.7	15.8	10.4	22.7	10.3	42.7	24.0	10.7	13.2	11.0	13.2	24.5	26.2	10.3	12.2	33.3	7.1	14.1	13.8	46.9	6.0	7.5	9.8	8.3	12.3	11.8	4.8	8.0	5.2	3.3	2.7	8.3	5.0	20.0	6.5	21.2	9.0	28.8	27.7	5.9	7.8	55.1	9.6	18.9	21.4	16.0	4.3	6.6	15.0	9.6	18.7	32.5	3.9	4.2	10.0	10.7	10.7	13.8	26.3	3.9	7.5	27.3	12.4	17.9	7.7	7.9	10.4	26.0	8.2	6.8	8.4	5.6	34.5	5.9	10.0	6.5	26.2	24.9	11.1	12.4	11.0	9.1	7.1	8.0	11.3	9.7	11.8	11.4	9.3	10.0	6.0	9.5	8.1	8.7	11.9	17.2	4.9	5.2	3.3	3.5	6.9	3.0	4.7	4.8	5.0	8.3	3.8	3.0	4.2	6.2	0.0	2.7	2.5	8.0	2.3	5.0	17.9	38.8	22.5	33.9	19.0	17.3	49.5	14.9	42.7	46.9
LTC4S	MGC33147	ENSG00000213316	"Leukotriene C4 synthase"	Q16873	5	179793980-179796647	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Leukotriene biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 31.3"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 50.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 8.5;eosinophil: 31.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 31.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044688			Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"				Nucleoplasm	"Endoplasmic reticulum, Cytosol"	"HPA044688: "	"unprognostic (8.94e-2)"	"unprognostic (2.40e-2)"			"unprognostic (9.35e-3)"		"unprognostic (3.57e-2)"	"unprognostic (1.24e-2)"		"unprognostic (9.40e-2)"	"unprognostic (4.53e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.62e-1)"	9.0	6.7	3.5	2.8	3.5	8.6	4.6	1.7	5.0	6.9	5.0	9.4	5.4	3.6	8.7	10.4	4.2	13.0	15.7	11.3	3.9	3.1	6.2	2.3	28.3	8.0	6.8	4.2	5.8	2.4	2.0	3.2	2.9	4.3	5.6	1.9	3.3	7.4	11.6	2.7	3.5	5.7	4.5	6.3	6.7	5.0	3.3	3.9	0.8	5.3	5.6	3.2	3.6	3.9	0.1	4.5	31.3	0.3	2.2	1.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	5.1	0.0	0.2	0.2	0.3	50.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	8.5	0.2	31.3	0.5	0.3	1.7	0.1	1.2	0.8	4.5	0.1	0.2	0.5	0.1	2.2	0.0	0.2	0.1	0.3	3.5	3.5	1.7	5.0	3.9	3.1	6.8	4.2	4.3	3.9
LTK	TYK1	ENSG00000062524	"Leukocyte receptor tyrosine kinase"	P29376	15	41503638-41513887	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lung: 15.1"	"Cell line enhanced"	"Detected in some"		"HEL: 5.3;NB-4: 10.3;RH-30: 5.0;THP-1: 15.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 8.3;plasmacytoid DC: 7.0"	"Group enriched"	"Detected in many"	10	"dendritic cells: 7.0;T-cells: 8.3"	"Low region specificity"	"Detected in many"							HPA059545	Uncertain		Approved	Vesicles				Vesicles		"HPA059545: "	"unprognostic (9.47e-4)"	"unprognostic (5.52e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.74e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.81e-3)"	"unprognostic (9.36e-3)"	"unprognostic (5.36e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	1.0	0.5	0.5	5.1	1.6	3.1	0.5	2.0	3.2	0.6	8.2	0.5	1.9	10.6	1.3	1.1	1.2	0.3	2.0	2.2	0.5	0.1	3.5	4.3	15.1	0.6	0.5	0.5	1.0	0.5	1.0	0.7	8.9	0.5	0.7	4.8	4.3	11.7	0.5	2.0	0.9	10.7	0.5	0.5	5.5	8.3	2.4	0.8	0.5	0.7	0.5	2.2	0.6	0.7	0.7	7.0	0.0	0.0	0.0	8.3	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.1	0.6	0.9	1.3	2.4	0.0	0.0	0.1	0.7	0.0	2.9	0.0	0.4	0.2	1.4	5.3	0.0	0.0	2.3	0.0	0.0	0.4	0.4	0.0	0.1	0.0	2.0	0.0	2.0	0.0	0.0	10.3	0.4	0.2	0.2	5.0	0.1	0.0	0.0	0.5	3.3	0.1	0.2	0.0	0.2	15.8	0.0	0.0	0.2	0.2	0.0	0.4	0.2	0.2	0.0	0.5	0.9	0.0	0.0	0.0	0.6	0.0	8.3	0.7	0.5	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	7.0	0.0	0.2	0.5	1.6	2.0	3.2	0.5	0.1	0.5	0.5	0.5	0.8
LYN	JTK8	ENSG00000254087	"LYN proto-oncogene, Src family tyrosine kinase"	P07948	8	55879813-56014168	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.9"	"Cell line enhanced"	"Detected in many"		"HEL: 56.8;HMC-1: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 36.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001231, CAB004492"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		11000000	11000000	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB004492: AB_627897, HPA001231: AB_1079286"	"unprognostic (7.87e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.15e-2)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	8.8	6.8	4.5	34.0	6.3	33.6	11.1	9.5	4.1	5.3	10.5	5.8	7.2	15.6	3.4	7.8	7.2	6.7	13.7	8.9	4.8	3.6	6.1	13.8	34.6	70.9	7.7	2.1	5.3	9.8	3.1	4.9	19.1	5.6	5.7	6.6	6.3	14.9	8.5	2.7	3.4	16.2	6.6	8.5	69.4	7.4	3.6	5.1	3.8	9.4	5.3	25.8	10.7	7.5	8.4	9.2	36.8	26.5	1.9	0.9	2.7	12.6	7.5	1.7	0.3	0.1	0.0	13.7	9.7	14.2	6.1	4.3	5.2	4.4	12.2	4.3	3.8	5.9	7.1	7.2	5.2	19.8	7.1	56.8	2.3	1.8	1.9	5.7	57.7	0.3	2.5	0.1	4.4	8.2	30.0	26.5	0.9	0.7	0.0	6.0	10.9	0.8	0.9	2.8	1.5	3.9	6.0	1.1	22.0	4.8	0.0	2.0	1.1	13.4	9.6	0.0	2.8	0.0	4.4	8.9	3.2	27.6	0.6	11.3	0.4	2.1	7.2	12.3	0.9	16.8	0.7	8.2	0.2	0.3	6.4	8.4	0.1	0.4	36.8	1.9	26.5	9.2	0.0	2.7	4.5	6.3	9.5	4.1	4.8	3.6	7.7	2.1	5.6	5.1
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348341-69354234	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 490.0;salivary gland: 1017.8"	"Group enriched"	"Detected in some"	6	"Hep G2: 126.5;THP-1: 65.3;U-937: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 490.0;myeloid DC: 308.1"	"Group enriched"	"Detected in all"	18	"dendritic cells: 308.1;monocytes: 490.0"					"Not detected"	"Not detected"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	2600000000	2600000000	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: , HPA066182: "	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favourable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	19.1	2.4	1.7	42.1	1.8	187.0	2.9	1.6	1.6	2.9	52.5	2.0	0.1	72.4	2.3	6.9	3.9	3.4	105.0	15.4	1.8	1.8	4.8	4.8	81.0	57.2	2.1	0.0	4.5	5.0	0.0	1.8	8.3	0.9	2.4	5.0	2.7	1017.8	2.8	1.8	2.1	95.0	1.8	2.5	34.2	212.1	1.6	0.5	24.5	2.4	207.7	75.7	6.6	2.4	1.6	308.1	21.9	490.0	2.3	1.1	407.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.8	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	7.7	0.1	126.5	0.0	14.8	7.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	14.4	0.3	0.0	0.2	0.2	2.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	65.3	0.0	0.0	0.3	0.3	0.1	0.3	0.1	0.1	0.0	70.7	0.0	7.5	490.0	5.9	0.7	102.3	1.1	1.6	0.4	0.5	308.1	0.4	0.4	0.4	21.9	2.3	17.6	6.5	0.6	407.9	1.7	1.8	1.6	1.6	1.8	1.8	2.1	0.0	0.9	0.5
MAGI2	"ACVRIP1, AIP1, ARIP1, KIAA0705, MAGI-2"	ENSG00000187391	"Membrane associated guanylate kinase, WW and PDZ domain containing 2"	Q86UL8	7	78017057-79453574	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.7;parathyroid gland: 31.8"	"Cell line enriched"	"Detected in some"	4	"Karpas-707: 42.0"	"Cancer enhanced"	"Detected in many"		"glioma: 7.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013650	Approved									"HPA013650: AB_1853501"	"unprognostic (4.32e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-4)"	"unprognostic (5.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"prognostic favourable (1.08e-4)"	"unprognostic (4.34e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.01e-2)"	5.4	8.3	21.0	2.2	20.5	1.8	3.9	43.7	36.8	5.5	3.2	17.7	2.5	3.1	5.6	5.6	3.6	4.8	4.6	3.9	21.8	12.7	7.6	2.5	4.4	1.6	13.6	19.5	11.5	5.1	31.8	7.7	2.3	16.5	11.9	3.0	3.5	2.8	11.6	2.9	2.3	3.2	4.1	15.1	3.1	2.9	5.1	24.4	0.0	9.0	0.0	1.4	4.1	2.9	2.0	1.4	3.8	0.9	1.0	0.9	0.2	0.0	0.3	10.1	0.2	2.1	3.3	0.1	1.8	3.3	0.4	0.5	0.0	0.1	0.0	0.0	1.1	0.1	0.6	0.0	0.5	0.5	0.4	0.1	0.2	0.5	3.1	0.2	0.5	2.5	0.1	0.2	0.1	0.4	0.3	42.0	0.9	0.4	0.1	0.2	2.2	0.1	0.1	0.1	0.7	0.1	0.1	1.5	2.6	0.4	0.1	0.9	0.2	0.3	0.5	1.5	0.5	4.1	0.2	0.2	0.0	0.1	0.9	0.1	0.6	2.7	0.7	0.8	0.9	0.6	0.6	1.1	0.6	0.5	0.4	2.0	0.6	0.8	3.8	1.0	0.9	1.4	0.6	0.2	21.0	20.5	43.7	34.5	21.8	12.7	13.6	19.5	16.5	24.4
MAGT1	"DKFZp564K142, IAP, MRX95, OST3B"	ENSG00000102158	"Magnesium transporter 1"	Q9H0U3	X	77826364-77895593	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049851	Approved				"Intracellular and membrane"	14000	14000			"HPA049851: "	"prognostic unfavourable (1.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavourable (8.98e-4)"	"unprognostic (2.03e-2)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.66e-1)"	17.3	17.1	11.3	11.7	15.4	9.2	18.3	4.7	10.1	21.4	15.5	25.9	17.5	12.7	17.5	28.1	18.4	14.2	13.1	22.3	11.5	9.5	29.0	69.5	20.4	20.3	19.3	8.2	19.8	49.8	20.0	21.3	28.6	14.0	17.3	13.8	13.6	28.9	17.6	13.7	14.1	22.4	13.4	22.6	21.0	14.5	11.1	18.2	19.8	45.3	11.0	17.6	18.2	15.4	14.3	23.6	13.2	21.3	18.5	20.8	17.3	22.7	13.4	16.1	18.1	27.7	19.1	24.8	24.7	24.6	19.4	21.3	16.7	37.8	16.3	33.9	26.6	21.3	33.7	18.1	30.7	12.1	20.4	11.0	19.9	14.8	24.6	22.8	12.2	16.8	15.7	25.7	21.4	27.4	13.2	47.8	23.0	14.5	13.4	8.2	20.7	15.1	16.4	26.9	30.6	22.3	16.8	5.4	9.8	34.0	23.2	20.4	16.6	12.2	27.9	17.7	20.2	27.4	12.3	16.8	37.4	21.3	19.5	21.3	22.9	12.8	14.2	13.2	20.6	21.1	20.8	14.3	17.9	18.9	12.4	12.3	17.8	20.7	11.9	18.5	21.3	23.6	13.0	17.3	11.3	15.4	4.7	10.1	11.5	9.5	19.3	8.2	14.0	18.2
MAK	"dJ417M14.2, RP62"	ENSG00000111837	"Male germ cell associated kinase"	P20794	6	10762723-10838555	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 38.1;testis: 19.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	7	"pons and medulla: 10.6"	"Cell type enriched"	"Detected in single"	13	"neutrophil: 11.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"														"unprognostic (1.23e-3)"	"unprognostic (8.77e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.73e-2)"	"unprognostic (6.59e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.59e-2)"	0.6	0.3	0.7	0.7	1.5	1.4	0.7	0.4	0.4	0.8	0.2	3.5	0.3	0.2	0.6	2.9	0.3	8.6	1.0	0.3	1.1	1.2	0.3	0.2	1.8	3.7	0.2	0.1	2.2	0.5	9.3	3.6	0.2	10.6	0.5	0.0	38.1	0.5	0.4	0.2	1.1	0.4	0.1	0.7	1.4	0.5	19.3	0.7	0.0	0.6	0.4	0.2	0.2	1.2	0.6	0.4	11.7	0.8	0.3	0.7	0.1	3.0	0.9	1.8	1.8	0.1	0.0	1.7	0.0	0.2	1.0	1.0	1.3	1.7	0.9	0.7	0.0	0.5	0.6	0.3	0.4	4.7	1.9	0.7	0.7	1.2	0.0	3.2	2.9	0.1	0.0	0.2	0.3	0.0	1.6	0.6	0.1	0.4	0.4	1.9	0.8	0.4	0.6	0.8	0.3	0.1	0.4	1.9	0.9	0.1	0.5	0.1	1.1	0.3	0.2	0.7	1.1	0.2	1.1	0.5	0.1	0.4	0.5	0.6	1.0	0.5	0.8	0.9	0.4	0.5	0.4	0.2	0.4	0.3	0.4	0.6	0.4	0.7	11.7	0.3	0.8	0.4	0.1	0.1	0.7	1.5	0.4	0.4	1.1	1.2	0.2	0.1	10.6	0.7
MALT1	"MLT, PCASP1"	ENSG00000172175	"MALT1 paracaspase"	Q9UDY8	18	58671386-58754477	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004494, HPA048432"	Enhanced		Approved	"Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	Cytosol	"CAB004494: AB_627909, HPA048432: "	"unprognostic (3.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.67e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.00e-2)"	11.2	3.9	4.1	21.7	5.6	10.2	10.6	9.1	6.8	11.0	10.7	3.9	10.9	5.5	8.1	10.5	16.4	6.6	8.1	8.7	4.0	4.3	14.9	10.5	14.3	29.0	4.1	1.8	8.1	6.2	10.0	9.3	8.8	4.9	18.1	7.9	7.5	10.7	8.4	10.7	12.6	12.2	6.6	6.2	19.9	6.2	11.8	4.8	22.4	7.9	12.4	24.0	9.6	12.3	6.3	3.6	1.2	1.7	1.6	4.8	1.1	7.4	10.6	13.0	3.2	2.6	5.8	5.8	13.3	9.4	11.6	9.9	8.6	9.6	11.8	6.0	16.5	7.3	5.6	5.5	14.3	7.9	3.1	4.2	7.6	13.8	4.2	8.5	5.7	3.6	11.7	9.1	9.2	2.5	6.8	20.6	6.3	2.4	1.8	3.6	3.2	3.6	6.4	7.7	8.3	50.8	3.1	1.4	3.0	7.3	3.8	5.0	3.7	4.9	3.4	15.0	6.6	4.4	12.2	18.4	21.8	10.3	6.0	6.4	5.9	0.8	1.5	1.0	2.7	1.7	2.1	3.6	4.8	2.9	2.2	6.3	4.3	2.8	1.2	1.6	1.6	3.6	2.9	1.1	4.1	5.6	9.1	6.8	4.0	4.3	4.1	1.8	4.9	4.8
MAN1B1	"ERManI, MANA-ER, MRT15"	ENSG00000177239	"Mannosidase alpha class 1B member 1"	Q9UKM7	9	137086927-137109187	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051516	Approved		Uncertain	Vesicles		540000	540000	Vesicles		"HPA051516: "	"unprognostic (1.21e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.25e-3)"	"unprognostic (4.67e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.44e-3)"	20.4	25.4	19.7	13.5	23.7	9.8	18.6	21.6	36.1	24.3	21.6	24.5	20.6	19.8	22.7	28.1	23.1	28.9	25.9	19.5	20.5	21.5	24.3	32.7	20.4	19.9	18.6	25.2	24.2	32.6	23.6	25.1	30.8	18.0	21.2	12.0	22.0	32.7	23.1	12.2	25.4	17.8	18.5	16.4	22.2	21.8	30.3	18.2	19.9	25.1	12.7	19.3	21.0	16.0	13.0	23.0	16.3	24.4	18.0	21.9	18.5	7.2	17.1	5.9	16.9	22.5	19.4	19.8	12.3	26.1	16.5	14.6	8.3	22.9	6.6	41.4	20.6	25.0	3.5	11.9	3.0	9.1	6.0	2.9	15.4	9.6	21.2	5.1	11.4	22.9	22.6	9.6	8.1	10.9	8.0	10.9	11.6	14.7	5.4	12.1	7.9	17.2	3.1	10.0	20.9	13.2	3.6	6.9	6.2	18.2	19.4	12.6	21.5	10.9	15.3	24.4	9.1	18.0	14.4	4.4	3.6	4.3	29.4	6.5	21.0	7.9	20.1	16.3	21.9	21.8	20.5	13.0	17.3	20.6	23.0	11.0	17.0	17.0	5.9	18.0	24.4	16.1	21.5	18.5	19.7	23.7	21.6	36.1	20.5	21.5	18.6	25.2	18.0	18.2
MAN2B1	"LAMAN, MANB"	ENSG00000104774	"Mannosidase alpha class 2B member 1"	O00754	19	12646511-12666742	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 42.1;intermediate monocyte: 39.4;myeloid DC: 35.2;non-classical monocyte: 28.4;plasmacytoid DC: 41.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 41.9;monocytes: 42.1"									"HPA041530, HPA053404"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	3400000	3400000	"Nucleoplasm, Vesicles"		"HPA041530: AB_10795639, HPA053404: "	"unprognostic (6.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (1.94e-5)"	"unprognostic (4.00e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.51e-1)"	25.2	15.6	7.9	26.7	11.0	33.4	24.4	4.4	7.0	10.5	15.0	14.0	8.6	14.2	15.3	16.5	12.2	13.4	16.4	19.4	6.4	4.4	13.6	16.3	30.2	68.6	10.0	4.7	12.2	21.7	9.1	7.2	15.8	8.6	13.7	10.6	12.0	22.0	8.1	7.7	18.0	20.0	10.2	11.7	51.3	19.5	6.3	8.2	22.1	11.3	7.8	30.0	18.7	11.2	7.7	41.9	6.5	42.1	2.7	8.4	26.0	16.3	8.4	8.6	10.1	28.8	19.3	24.3	12.2	25.8	10.9	10.7	6.7	6.9	18.0	14.8	9.6	12.9	4.4	8.1	5.2	8.9	13.4	6.2	4.2	10.9	14.6	41.0	42.9	23.0	16.1	6.1	7.7	10.3	7.9	13.6	5.7	12.8	5.5	23.1	7.1	10.7	12.8	11.8	8.9	12.8	19.0	2.7	8.4	12.1	10.4	19.8	16.0	25.4	13.5	14.8	6.1	14.4	11.4	18.2	20.0	8.9	10.0	40.5	16.5	2.2	42.1	6.2	7.5	39.4	8.4	7.7	6.9	6.7	35.2	6.5	3.8	3.8	6.5	2.7	28.4	41.9	6.8	26.0	7.9	11.0	4.4	7.0	6.4	4.4	10.0	4.7	8.6	8.2
MANBA		ENSG00000109323	"Mannosidase beta"	O00462	4	102630770-102760994	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053478	Approved		Supported	Vesicles	"Intracellular and membrane"	12000000	12000000	Vesicles		"HPA053478: "	"unprognostic (2.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (4.11e-2)"	"prognostic unfavourable (3.74e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.13e-1)"	12.7	23.5	8.5	12.2	11.9	8.6	17.1	13.4	8.4	12.1	9.9	12.9	11.7	8.1	11.6	13.6	9.3	11.0	15.5	12.1	8.7	8.6	11.8	10.3	17.7	20.2	15.1	6.2	16.7	18.1	25.1	18.4	25.0	10.8	12.0	10.8	12.4	27.4	11.4	5.4	7.8	14.0	14.2	15.3	21.3	14.4	4.6	13.5	9.4	19.2	3.6	12.8	17.9	12.6	3.9	9.5	25.2	11.6	3.6	3.1	3.9	7.3	4.1	2.0	1.9	39.0	18.1	5.1	5.1	10.1	2.2	4.4	5.3	8.5	7.9	6.9	7.1	3.5	5.2	11.3	1.8	5.5	2.1	4.5	4.6	8.1	11.9	8.3	20.5	15.4	19.3	9.5	7.9	4.1	7.5	8.2	8.0	3.3	2.0	8.0	2.8	3.4	4.1	4.7	2.2	6.4	8.7	1.3	1.0	6.1	10.5	7.9	15.0	5.7	3.1	6.1	3.0	13.6	2.7	4.3	9.0	0.8	11.0	3.7	4.4	6.2	11.5	25.2	1.8	10.6	1.4	3.8	3.1	2.0	9.5	3.9	3.0	2.0	10.1	3.6	11.6	2.3	1.6	3.9	8.5	11.9	13.4	8.4	8.7	8.6	15.1	6.2	10.8	13.5
MAP2K3	"MAPKK3, MEK3, MKK3, PRKMK3"	ENSG00000034152	"Mitogen-activated protein kinase kinase 3"	P46734	17	21284672-21315240	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018548	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB018548: AB_631927"	"unprognostic (2.31e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	16.1	12.1	5.5	14.8	7.3	66.9	29.0	12.4	8.9	10.2	12.4	6.3	10.3	18.1	7.6	11.1	24.2	11.6	25.1	26.8	5.6	5.3	15.8	37.1	25.5	34.0	7.4	3.9	10.1	26.3	9.6	15.8	26.7	9.5	12.2	9.3	12.7	18.5	9.2	46.4	20.9	23.8	18.1	7.6	26.7	16.3	5.3	4.1	16.4	11.5	45.0	21.4	16.0	17.3	13.2	17.3	49.2	33.3	5.4	16.2	10.0	21.6	22.0	2.9	13.3	17.8	11.4	11.1	33.6	36.5	26.8	24.7	24.3	14.0	19.6	13.7	52.5	21.5	9.3	29.8	19.1	20.3	17.0	11.4	12.6	22.0	5.5	14.9	23.4	8.8	8.5	36.5	11.0	12.0	2.2	9.8	22.3	21.5	7.4	14.2	8.4	12.6	15.5	18.9	14.5	15.1	22.9	8.0	2.8	12.4	13.4	23.3	6.7	5.1	10.9	25.5	20.8	27.2	21.6	12.3	6.2	25.2	24.6	12.9	13.1	14.5	16.0	25.2	14.6	24.0	12.6	13.2	12.1	13.6	17.3	10.6	7.8	10.1	49.2	5.4	33.3	12.7	16.2	10.0	5.5	7.3	12.4	8.9	5.6	5.3	7.4	3.9	9.5	4.1
MAP3K1	"MAPKKK1, MEKK, MEKK1"	ENSG00000095015	"Mitogen-activated protein kinase kinase kinase 1"	Q13233	5	56815574-56896152	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 27.0;THP-1: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"olfactory region: 22.5"	"Low region specificity"	"Detected in all"			"CAB004500, HPA046509"	Approved		Approved	Cytosol				Cytosol		"CAB004500: AB_627926, HPA046509: "	"unprognostic (1.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.48e-2)"	"unprognostic (5.39e-3)"	"unprognostic (5.20e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.11e-1)"	6.7	4.9	5.4	14.6	4.8	15.2	14.9	8.0	4.5	7.6	6.7	5.4	7.3	4.3	7.1	9.4	12.7	7.2	5.9	4.3	3.7	3.2	9.5	4.4	8.8	21.4	6.4	3.1	8.4	9.2	6.3	7.9	8.1	4.5	8.3	4.5	12.6	15.4	9.7	3.5	21.8	11.2	4.0	3.8	21.3	5.5	8.5	5.1	11.7	19.2	6.6	18.2	6.0	11.7	6.6	2.8	6.7	7.2	2.7	5.8	2.3	6.4	3.9	6.2	4.1	1.0	0.8	10.4	1.2	1.7	3.9	5.5	18.4	4.9	5.8	0.4	1.5	3.4	5.1	2.3	5.4	2.0	2.2	3.2	1.7	8.6	2.5	5.1	9.0	1.0	2.5	1.2	1.9	1.7	2.8	10.5	1.0	2.8	3.5	6.9	2.8	0.5	5.6	4.4	19.9	6.8	6.8	2.6	27.0	3.8	4.8	11.0	13.2	25.2	4.9	0.3	3.3	1.4	2.3	7.7	3.9	11.1	0.6	3.0	6.6	6.7	4.5	1.0	1.2	6.8	1.2	6.6	3.8	1.8	2.8	5.1	2.5	0.9	2.6	2.7	7.2	1.5	5.8	2.3	5.4	4.8	8.0	4.5	3.7	3.2	6.4	3.1	4.5	5.1
MAP3K20	"MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK"	ENSG00000091436	"Mitogen-activated protein kinase kinase kinase 20"	Q9NYL2	2	173075435-173268010	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 96.1"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 47.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 13.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 13.7;monocytes: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017205	Approved		Supported	Cytosol				Cytosol		"HPA017205: AB_1858933"	"unprognostic (2.90e-2)"	"unprognostic (9.99e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (3.41e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.19e-2)"	21.7	5.0	2.9	7.4	3.3	0.8	9.2	2.8	3.1	25.7	24.8	2.1	10.7	3.1	30.2	15.4	26.2	13.1	14.9	52.5	3.5	3.0	2.4	8.5	7.5	2.5	4.5	3.0	21.7	4.4	22.6	3.1	6.9	4.2	25.6	5.4	11.5	6.7	15.8	96.1	5.8	8.0	68.4	4.7	3.7	15.8	6.6	3.5	2.8	6.7	38.0	4.9	46.7	24.0	2.1	13.7	2.3	8.0	0.4	1.6	2.7	8.7	7.3	5.8	7.6	16.9	25.2	3.6	31.6	24.7	14.8	15.9	5.0	5.8	6.7	8.3	31.6	5.9	8.6	16.7	33.3	13.1	5.8	11.0	8.3	1.0	6.7	9.8	11.6	20.2	7.2	27.8	43.9	9.7	4.9	1.3	9.7	3.7	6.1	4.9	3.2	4.2	9.1	11.9	0.0	3.6	5.0	3.4	3.3	12.2	3.0	5.1	3.4	5.3	9.7	47.2	19.4	14.0	7.1	0.0	0.0	1.4	33.9	2.7	4.9	0.1	8.0	0.0	0.9	7.5	0.9	1.5	0.8	1.6	13.7	2.1	0.0	0.8	2.3	0.4	6.6	0.3	0.7	2.7	2.9	3.3	2.8	3.1	3.5	3.0	4.5	3.0	4.2	3.5
MAP3K7	"MEKK7, TAK1"	ENSG00000135341	"Mitogen-activated protein kinase kinase kinase 7"	O43318	6	90513573-90587045	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007633, HPA075335"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"				Cytosol	"Nuclear speckles, Plasma membrane"	"HPA007633: AB_1079359, HPA075335: "	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.17e-1)"	15.5	17.6	19.6	17.3	26.3	10.3	21.6	27.5	27.3	21.1	16.4	15.7	15.8	12.5	23.1	23.6	15.2	15.5	17.6	22.2	20.5	17.5	15.9	15.5	20.0	22.2	22.9	16.4	25.0	13.5	25.8	25.6	23.6	20.7	21.2	15.3	12.4	17.0	23.3	24.3	18.7	14.7	19.4	23.0	23.3	14.7	13.8	21.7	28.2	20.3	10.8	21.9	17.2	18.9	14.2	15.9	19.4	17.7	18.2	22.1	13.6	7.7	6.9	20.1	17.2	14.7	19.7	14.2	15.6	18.1	14.1	17.8	8.8	7.5	17.3	10.0	16.9	8.3	12.6	12.2	24.0	8.8	13.4	15.4	9.5	11.7	15.4	17.1	11.9	16.2	14.9	13.7	16.9	13.2	30.8	14.2	20.1	9.5	7.9	14.5	16.5	8.7	13.7	36.1	8.4	11.8	8.7	10.2	14.5	10.9	7.6	11.8	7.5	30.5	12.6	11.5	7.3	10.5	14.5	12.7	11.3	7.5	17.6	18.8	16.8	15.5	12.7	19.4	15.1	17.4	16.8	14.2	14.5	14.4	15.9	10.5	16.5	16.0	12.5	18.2	17.7	9.8	22.1	13.6	19.6	26.3	27.5	27.3	20.5	17.5	22.9	16.4	20.7	21.7
MAP3K9	"MEKK9, MLK1, PRKE1"	ENSG00000006432	"Mitogen-activated protein kinase kinase kinase 9"	P80192	14	70722526-70809534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1"	"Cell line enhanced"	"Detected in many"		"A-431: 17.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000942	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"			"Nucleoplasm, Nucleoli"		"HPA000942: AB_1079360"	"unprognostic (1.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.75e-5)"	"unprognostic (2.58e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.23e-6)"	"unprognostic (5.71e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-1)"	0.5	2.2	5.8	2.0	9.2	1.4	2.8	20.1	16.5	2.4	3.1	1.8	0.4	3.0	1.1	3.4	10.1	2.2	1.5	1.2	5.7	7.1	3.1	2.4	3.9	2.6	5.9	5.9	1.4	4.3	6.8	4.7	2.8	12.8	2.0	3.1	3.1	3.2	1.3	1.9	7.8	2.9	0.7	1.6	1.9	3.4	10.1	1.8	0.6	5.3	3.2	6.8	2.0	3.9	2.3	0.5	1.3	0.2	1.1	1.4	0.3	17.7	8.2	1.6	2.0	0.0	0.0	5.5	0.3	0.2	1.7	1.5	5.9	6.8	3.6	2.4	0.1	8.4	5.2	10.0	1.8	2.4	1.5	0.2	2.9	3.9	0.2	0.4	0.8	0.1	5.5	1.2	10.4	0.0	1.3	0.8	0.4	7.1	2.8	0.4	3.5	3.8	1.0	3.1	0.7	3.9	8.2	11.3	2.4	5.1	6.1	1.0	5.5	0.6	0.0	0.0	7.2	0.0	2.8	1.9	4.3	1.9	2.7	0.3	1.0	0.5	0.2	0.8	0.6	0.1	0.1	1.0	0.6	1.0	0.0	2.3	1.0	0.7	1.3	1.1	0.2	0.5	1.4	0.3	5.8	9.2	20.1	16.5	5.7	7.1	5.9	5.9	12.8	1.8
MAPK10	"JNK3, p493F12, p54bSAPK, PRKM10"	ENSG00000109339	"Mitogen-activated protein kinase 10"	P53779	4	85990007-86594625	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.3"	"Cell line enriched"	"Detected in many"	6	"AF22: 58.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022625	Approved									"CAB022625: "	"unprognostic (2.46e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.02e-2)"	"prognostic favourable (3.11e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.22e-3)"	"prognostic favourable (5.57e-4)"	17.2	11.9	31.6	3.7	34.5	9.7	6.2	26.1	58.3	11.4	4.0	12.6	8.1	3.2	11.0	14.2	7.4	11.9	10.4	5.1	36.0	28.6	15.0	2.7	6.5	3.9	31.5	36.4	11.3	5.6	10.9	31.5	3.4	37.9	16.6	4.3	5.4	3.4	18.9	2.0	3.5	3.9	11.4	23.1	5.3	4.3	18.2	15.8	0.0	15.3	0.4	3.6	11.1	10.2	3.7	3.0	6.9	1.8	3.3	3.6	2.3	1.0	1.9	58.9	1.8	1.6	1.3	2.2	1.2	1.1	1.0	0.4	1.1	1.7	2.6	2.0	0.7	3.6	0.6	1.5	1.7	3.7	1.6	2.1	2.3	1.9	1.4	0.9	1.2	1.6	0.7	1.4	1.9	1.2	1.9	9.7	0.6	1.5	1.7	1.1	3.4	1.2	1.8	1.5	0.9	4.2	6.2	3.6	3.2	1.2	4.8	0.8	3.5	1.2	2.7	2.6	2.6	1.1	1.0	3.2	1.9	1.6	3.7	1.3	1.4	6.9	1.8	3.3	2.3	1.6	2.4	3.7	1.9	2.5	1.6	3.3	2.7	3.6	6.2	3.3	1.5	3.0	2.7	2.3	31.6	34.5	26.1	58.3	36.0	28.6	31.5	36.4	37.9	15.8
MAPK12	"ERK6, p38gamma, PRKM12, SAPK-3, SAPK3"	ENSG00000188130	"Mitogen-activated protein kinase 12"	P53778	22	50245450-50261825	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"skeletal muscle: 104.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	31	"NK-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"NK-cells: 3.0"	"Region enhanced"	"Detected in many"		"cerebellum: 35.4"	"Low region specificity"	"Detected in all"			"CAB025483, HPA054562"	Enhanced		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB025483: , HPA054562: "	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.16e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.00e-6)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.28e-3)"	3.0	1.6	4.5	2.1	4.5	1.0	1.8	9.0	7.0	2.1	1.4	2.1	1.6	2.0	5.4	5.1	3.3	2.9	2.4	5.1	3.9	3.6	2.5	1.0	2.1	2.0	3.5	5.7	3.0	1.4	1.2	7.0	2.3	2.6	2.9	1.1	2.2	1.4	3.7	104.2	0.9	1.5	4.2	2.6	1.6	1.5	1.6	2.4	0.0	1.3	10.8	1.1	2.4	1.9	0.0	0.0	0.0	0.0	3.0	0.0	0.0	10.3	6.4	2.4	7.4	5.6	6.2	3.5	7.9	6.9	13.3	8.5	9.2	3.2	19.4	10.8	8.7	6.9	11.0	1.6	2.5	5.6	15.4	12.7	19.3	11.4	17.9	11.9	25.2	13.4	2.9	3.0	0.0	15.0	11.2	18.1	6.1	5.7	0.0	15.9	7.5	10.4	18.1	6.7	19.7	7.9	1.4	8.5	2.9	6.1	0.2	9.8	3.3	13.8	7.8	13.7	12.4	2.9	4.9	4.2	3.2	10.4	3.5	11.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	4.5	4.5	9.0	7.0	3.9	3.6	3.5	5.7	2.6	2.4
MAPKAPK3	"3pK, MAPKAP3"	ENSG00000114738	"Mitogen-activated protein kinase-activated protein kinase 3"	Q16644	3	50611520-50649297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 86.7;skeletal muscle: 70.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 30.2;eosinophil: 23.0;intermediate monocyte: 50.0;myeloid DC: 27.1;neutrophil: 20.5;non-classical monocyte: 61.4;plasmacytoid DC: 16.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 27.1;granulocytes: 23.0;monocytes: 61.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058275			Supported	Nucleoplasm				Nucleoplasm		"HPA058275: "	"unprognostic (6.46e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (8.08e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.96e-2)"	"unprognostic (8.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.90e-8)"	"unprognostic (2.15e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.69e-1)"	8.9	16.1	5.6	9.3	7.2	30.4	6.3	1.9	6.2	5.5	9.5	7.1	7.5	9.9	5.5	8.6	16.8	5.1	8.5	86.7	4.8	3.7	17.9	11.9	11.0	15.1	7.2	4.1	8.7	24.2	11.2	9.0	9.0	6.0	7.6	6.7	10.9	12.4	9.2	70.1	17.6	12.0	5.2	5.9	12.5	9.0	4.0	5.2	25.9	22.6	40.9	14.3	6.1	7.5	3.0	27.1	23.0	61.4	7.3	6.4	19.5	23.0	7.1	3.0	8.5	4.6	11.5	6.7	5.6	8.0	8.7	7.4	11.1	21.5	9.3	5.7	18.7	8.2	20.5	22.1	7.8	20.4	4.9	48.7	10.2	10.1	9.1	35.0	25.9	9.1	13.8	20.2	27.5	7.6	13.6	6.1	18.2	9.4	14.9	35.3	11.2	29.5	6.6	7.2	13.9	40.3	13.2	5.6	4.0	5.0	14.2	6.4	8.9	21.7	5.5	6.8	15.7	35.3	13.8	4.1	7.6	7.7	36.4	55.1	2.8	6.4	30.2	23.0	5.5	50.0	5.4	3.0	6.2	6.4	27.1	1.8	4.9	5.5	20.5	7.3	61.4	16.9	5.2	19.5	5.6	7.2	1.9	6.2	4.8	3.7	7.2	4.1	6.0	5.2
MARK1	"MARK, PAR-1C"	ENSG00000116141	"Microtubule affinity regulating kinase 1"	Q9P0L2	1	220528183-220664461	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 9.4;RT4: 35.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007421, HPA008061"	Uncertain									"HPA007421: AB_1079311, HPA008061: AB_1079310"	"unprognostic (1.51e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (2.63e-4)"	"unprognostic (4.59e-2)"	"prognostic favourable (2.23e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.27e-2)"	"unprognostic (9.56e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.74e-2)"	14.3	5.6	11.4	4.6	13.5	0.9	9.0	15.2	22.7	9.8	6.7	4.7	6.4	2.1	7.8	26.6	9.4	5.9	5.0	19.1	10.0	12.5	4.7	1.5	4.8	2.3	10.3	12.4	3.7	3.0	5.8	12.1	3.9	13.2	7.2	4.1	6.2	5.0	11.3	4.2	3.5	3.4	10.1	7.1	3.2	4.3	16.0	4.6	0.4	8.4	5.3	5.7	8.8	14.9	0.8	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.0	4.5	1.2	0.0	0.0	1.8	1.5	2.2	1.5	2.3	0.0	0.0	0.0	0.0	0.0	2.3	9.4	6.1	1.1	0.0	6.9	0.0	2.4	0.0	0.0	0.7	0.9	0.7	5.2	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.7	2.2	0.0	7.0	0.0	0.0	35.3	6.5	5.8	0.3	0.3	0.4	0.7	0.0	0.0	0.0	3.5	4.8	6.1	0.0	0.0	0.0	1.4	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.4	13.5	15.2	17.5	10.0	12.5	10.3	12.4	13.2	4.6
MARS	"CMT2U, MetRS, SPG70"	ENSG00000166986	"Methionyl-tRNA synthetase"	P56192	12	57475445-57517569	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004125, CAB017097"	Supported	Approved	Enhanced	Cytosol		21000	21000	Cytosol		"CAB017097: , HPA004125: AB_1079312"	"prognostic unfavourable (1.73e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavourable (4.55e-7)"	"unprognostic (8.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-2)"	23.8	26.7	35.1	27.3	29.1	23.0	19.8	25.1	36.0	17.4	23.9	23.1	23.9	17.3	23.3	36.3	29.5	17.9	16.1	25.0	28.0	29.5	20.5	45.9	24.3	25.1	40.1	25.5	25.8	48.3	35.7	34.0	22.2	30.9	25.6	24.7	19.8	26.0	30.0	24.5	18.4	20.1	33.7	30.7	30.7	31.3	29.6	30.9	21.4	26.9	22.3	34.3	24.3	27.9	12.9	29.3	19.0	27.0	14.1	18.9	15.5	16.5	23.0	15.4	26.7	17.3	10.5	28.4	23.7	27.8	25.1	26.9	24.7	18.4	29.1	15.7	28.7	18.8	35.1	30.6	26.3	25.2	15.2	20.5	8.6	13.9	38.5	30.9	23.6	15.3	47.6	28.7	74.4	17.9	31.7	62.4	17.4	22.9	27.6	23.3	29.1	25.4	24.0	116.3	30.1	18.9	13.0	20.6	20.9	12.3	18.9	32.8	25.0	40.5	13.2	9.1	26.9	13.1	14.0	57.2	57.8	35.1	22.3	23.5	31.0	12.1	14.6	19.0	18.9	27.0	17.2	12.9	12.9	17.1	29.3	7.7	11.1	15.2	7.2	14.1	21.8	28.4	13.1	15.5	35.1	29.1	25.1	36.0	28.0	29.5	40.1	25.5	30.9	30.9
MARS2	"mtMetRS, SPAX3"	ENSG00000247626	"Methionyl-tRNA synthetase 2, mitochondrial"	Q96GW9	2	197705369-197708387	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035589, HPA035590"	Uncertain									"HPA035589: AB_10601870, HPA035590: "	"unprognostic (2.12e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (3.50e-4)"	"prognostic favourable (1.12e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.86e-3)"	"prognostic favourable (6.14e-5)"	"unprognostic (1.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.74e-2)"	5.9	12.1	5.8	8.4	11.4	6.0	9.9	9.6	10.6	3.8	10.0	6.9	3.3	8.9	5.3	3.0	12.3	4.9	5.1	7.7	7.8	5.0	7.9	14.1	4.9	12.1	17.8	5.5	4.0	14.6	6.7	3.4	5.0	9.3	4.5	9.9	3.2	11.4	6.0	12.1	7.4	8.8	5.1	10.8	10.9	7.7	5.5	12.0	6.1	6.0	9.9	12.3	6.3	5.4	4.1	4.8	0.8	4.8	9.9	8.1	4.3	3.7	4.6	4.4	7.4	4.2	2.1	8.3	2.9	2.3	5.6	4.2	11.7	3.5	24.0	4.4	1.7	7.1	15.4	6.3	6.0	6.5	9.0	14.7	5.3	10.3	4.0	21.6	7.1	2.2	8.0	3.8	6.5	3.7	17.1	8.6	3.2	6.4	10.9	10.2	7.6	11.7	11.4	4.6	16.9	6.7	6.8	7.8	3.7	3.6	10.0	6.5	4.2	7.6	2.9	4.6	3.6	3.5	8.5	5.7	4.3	19.8	3.4	13.2	4.2	0.0	3.0	0.8	5.5	4.8	6.5	3.5	4.6	4.9	4.8	4.1	7.6	8.1	0.1	9.9	2.3	3.4	8.0	4.3	5.8	11.4	9.6	10.6	7.8	5.0	17.8	5.5	9.3	12.0
MARVELD2	"DFNB49, FLJ30532, MRVLDC2, TRIC"	ENSG00000152939	"MARVEL domain containing 2"	Q8N4S9	5	69415065-69444330	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.1;CAPAN-2: 15.5;HaCaT: 12.1;RT4: 13.9;SCLC-21H: 16.3;T-47d: 12.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"cerebellum: 8.8"	"Low region specificity"	"Detected in all"			"HPA018119, HPA061726"	Uncertain		Supported	"Cell Junctions"				"Cell Junctions"		"HPA018119: , HPA061726: "	"unprognostic (4.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"prognostic favourable (2.84e-13)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.82e-1)"	0.6	0.7	1.1	2.3	1.4	0.2	4.5	0.7	1.3	2.6	13.2	1.6	9.5	9.4	1.6	6.4	9.1	4.4	9.2	0.9	1.4	1.2	12.2	24.2	11.2	0.4	1.7	0.8	1.0	18.9	3.9	8.0	9.9	2.1	5.0	7.3	5.2	10.9	7.4	0.4	5.4	21.8	1.4	1.3	0.6	8.9	2.7	0.7	1.1	25.7	6.4	7.3	4.7	4.1	1.4	0.4	1.5	0.8	1.1	2.3	1.0	6.4	2.4	0.0	0.0	0.0	0.0	18.1	0.1	0.0	0.1	0.4	8.4	15.5	0.0	1.8	1.1	12.1	0.0	9.0	0.3	0.1	3.5	0.0	0.8	4.5	1.0	0.0	0.0	0.3	10.1	0.1	1.4	0.7	0.0	0.1	0.0	6.5	0.0	0.0	1.3	0.2	0.0	0.0	0.3	6.8	13.9	16.3	0.0	1.6	1.6	0.2	12.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.1	0.0	1.5	0.8	0.2	0.4	0.2	1.1	1.2	2.3	0.2	0.3	1.4	0.7	0.5	0.9	1.1	0.1	0.4	0.1	1.0	1.1	1.4	0.7	1.3	1.4	1.2	1.7	0.8	2.1	0.7
MAS1		ENSG00000130368	"MAS1 proto-oncogene, G protein-coupled receptor"	P04201	6	159906690-159916530	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.5;cervix, uterine: 1.9"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 13.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	25	"amygdala: 40.1;basal ganglia: 26.8;cerebral cortex: 31.9;hippocampal formation: 71.0"	"Group enriched"	"Detected in many"	7	"amygdala: 8.6;cerebral cortex: 13.2;hippocampal formation: 26.9"												"unprognostic (3.31e-1)"	"unprognostic (2.25e-3)"		"unprognostic (2.91e-1)"	"unprognostic (2.22e-3)"	"unprognostic (8.15e-3)"		"unprognostic (7.05e-2)"		"unprognostic (1.88e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.69e-1)"	"unprognostic (7.67e-2)"	"unprognostic (6.28e-1)"		0.1	0.0	0.9	0.0	0.0	0.8	0.0	0.0	4.5	1.9	0.0			0.0	0.3	0.7	0.0	0.3	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.7	0.0		0.4	0.0	0.0	0.0	0.0		0.2	0.0		0.2	1.2	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.3			0.0		0.0	0.0	1.0	0.5	0.3	1.5	0.2	0.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	13.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.5	0.1	1.5	0.2	0.3	0.2	0.1	0.2	0.3	0.2	0.2	0.1	0.5	0.3	0.3	1.5	0.3	0.1	0.3	0.1	0.1										
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217285-187292022	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 43.4;liver: 80.1"	"Group enriched"	"Detected in some"	8	"BJ: 26.5;BJ hTERT+: 101.0"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	1800000000	1800000000	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favourable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	2.1	1.4	3.6	1.2	3.8	0.1	1.2	1.9	10.2	43.4	19.1	14.8	2.4	0.8	34.9	7.1	4.1	6.7	3.3	39.6	6.1	2.5	1.6	80.1	2.2	0.4	6.4	3.0	1.7	0.2	0.2	0.5	3.2	13.0	17.4	2.1	0.1	0.9	19.4	12.2	2.5	2.6	17.1	21.8	0.4	0.6	1.5	6.7	0.0	1.3	6.3	3.5	4.4	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.7	0.0	26.5	101.0	0.3	0.1	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.8	1.9	3.5	6.1	2.5	6.4	3.0	13.0	6.7
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047233	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	98	"liver: 185.1"	"Cell line enriched"	"Detected in many"	7	"Hep G2: 20.1"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	880000000	880000000	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favourable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	0.3	0.2	0.3	0.4	0.3	1.8	0.3	1.7	0.5	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.3	185.1	0.3	0.6	0.3	0.3	0.5	0.4	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.7	0.3	1.4	1.4	0.5	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.4	1.2	1.2	0.2	0.8	1.3	0.0	0.5	0.3	2.9	1.6	0.0	0.1	0.4	0.8	0.0	0.0	0.0	1.3	1.1	2.3	0.6	0.0	0.7	0.0	0.0	0.0	0.6	2.3	1.4	2.5	20.1	0.0	2.1	1.6	0.0	0.0	0.1	0.0	0.0	0.8	0.5	0.0	0.6	0.6	1.1	0.4	0.6	1.8	1.0	0.5	0.0	1.4	1.8	0.7	0.9	0.5	0.5	0.6	1.3	1.1	0.9	0.6	1.0	0.6	0.7	1.1	1.7	0.6	1.9	0.4	1.2	0.2	1.1	0.7	0.1	1.0	0.7	0.9	0.8	0.5	1.4	1.3	1.3	0.2	0.8	0.2	1.2	0.1	0.0	0.3	0.3	1.7	0.3	0.3	0.1	0.3	0.3	0.3	0.3
MASTL	"FLJ14813, Gwl, THC2"	ENSG00000120539	"Microtubule associated serine/threonine kinase like"	Q96GX5	10	27154824-27186924	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027175, HPA054273"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA027175: AB_1853591, HPA054273: "	"unprognostic (4.10e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (2.52e-6)"	"unprognostic (2.19e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavourable (4.81e-5)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (1.71e-6)"	"unprognostic (1.55e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.79e-1)"	9.1	7.0	3.6	8.9	6.1	21.1	8.3	4.0	7.5	7.4	7.6	3.8	5.7	5.7	6.0	6.7	12.3	5.4	5.3	5.6	6.8	4.5	6.5	7.1	10.2	14.8	5.4	5.7	7.0	12.7	6.7	6.3	14.2	6.7	5.5	7.1	5.6	8.0	4.7	4.0	10.1	10.0	6.1	5.6	8.7	6.2	11.3	2.3	21.1	6.5	4.3	12.3	8.7	7.5	3.9	2.6	5.6	4.9	2.3	4.0	1.8	11.7	9.5	18.1	6.7	2.8	4.1	10.7	17.6	7.4	29.2	36.0	11.4	11.8	9.4	6.7	7.4	11.4	11.5	6.9	20.8	8.0	11.1	11.1	6.6	6.6	1.6	4.2	8.4	2.4	3.1	17.6	3.5	6.3	8.4	21.3	17.7	7.8	13.7	4.7	13.4	3.9	8.8	30.2	7.7	7.2	4.4	8.1	11.6	11.1	7.4	7.8	7.5	9.0	5.4	7.3	15.3	18.6	15.4	2.6	4.1	13.9	8.0	12.9	6.0	0.1	4.4	3.8	2.0	4.3	3.0	2.6	2.5	1.8	2.5	3.9	2.5	2.3	5.6	2.3	4.9	2.6	4.0	1.8	3.6	6.1	4.0	7.5	6.8	4.5	5.4	5.7	6.7	2.3
MAT1A	"MAT, MATA1, SAMS, SAMS1"	ENSG00000151224	"Methionine adenosyltransferase 1A"	Q00266	10	80271820-80289684	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 178.8"	"Cell line enriched"	"Detected in some"	15	"Hep G2: 44.8"	"Cancer enriched"	"Detected in many"	54	"liver cancer: 209.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048627	Supported					530000	530000			"HPA048627: "	"unprognostic (6.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.59e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.98e-2)"	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	12.5	0.1	0.2	0.2	0.1	0.0	0.0	0.3	178.8	0.1	0.1	0.1	0.0	0.7	9.9	0.0	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.7	0.0	0.0	0.4	0.2	0.0	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	44.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0
MBOAT7	"BB1, hMBOA-7, LENG4, LPIAT"	ENSG00000125505	"Membrane bound O-acyltransferase domain containing 7"	Q96N66	19	54173412-54189882	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"basophil: 15.7;eosinophil: 30.6;neutrophil: 30.0"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055967	Approved		Approved	Cytosol				Cytosol		"HPA055967: "	"unprognostic (1.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavourable (5.55e-6)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (6.62e-5)"	"unprognostic (1.31e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.95e-1)"	"prognostic favourable (4.31e-4)"	10.7	63.1	16.8	14.8	24.2	15.9	7.9	11.3	37.8	10.3	17.7	9.2	15.6	30.3	10.5	8.0	10.5	11.5	14.3	6.9	18.5	23.4	10.5	11.6	11.5	14.7	10.0	18.8	15.1	24.4	23.8	12.4	11.9	21.6	11.4	6.1	8.1	10.8	28.8	7.9	10.0	28.5	6.5	9.2	14.4	16.4	30.8	6.8	7.6	12.7	5.0	6.3	22.6	17.5	0.3	2.9	30.6	2.1	0.9	0.5	0.8	14.0	8.4	1.3	13.8	4.5	3.6	12.2	24.7	8.8	5.7	11.3	4.8	16.0	3.6	11.1	5.3	28.8	0.0	5.0	1.1	5.0	16.4	3.9	9.0	3.1	4.4	8.9	56.5	6.6	3.4	2.8	1.9	10.2	14.5	11.6	2.0	8.5	2.6	3.1	5.8	17.9	8.3	2.4	7.4	5.7	17.0	0.5	3.7	16.5	10.0	5.0	10.2	0.8	20.4	12.1	4.3	3.6	9.7	5.3	9.2	1.5	17.4	6.3	8.0	15.7	2.1	30.6	0.2	1.5	0.5	0.2	0.2	0.2	2.9	0.3	0.1	0.2	30.0	0.9	0.8	0.8	0.2	0.8	16.8	24.2	11.3	37.8	18.5	23.4	10.0	18.8	21.6	6.8
MBTPS2	"KFSD, S2P"	ENSG00000012174	"Membrane bound transcription factor peptidase, site 2"	O43462	X	21839636-21885424	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005494, CAB009486"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria, Cytosol"		"CAB009486: AB_2140370, HPA005494: AB_1079329"	"unprognostic (7.97e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.05e-2)"	12.0	17.4	9.3	7.2	13.9	2.5	12.7	20.8	18.5	11.8	9.3	13.4	6.9	7.6	14.7	9.1	9.3	10.9	10.1	11.6	9.9	10.7	13.9	26.0	8.6	6.6	10.6	13.0	18.7	12.2	17.9	15.6	22.3	17.4	15.7	9.1	12.4	14.1	13.1	14.5	8.2	8.1	14.6	14.6	7.5	9.1	6.9	7.0	7.1	13.1	7.4	6.7	11.4	9.1	3.9	6.9	1.5	4.8	4.6	5.9	3.3	9.1	19.0	9.1	9.2	11.5	14.3	4.4	13.5	13.8	12.9	11.3	7.5	12.6	7.9	7.1	14.4	8.6	12.5	7.8	16.0	5.9	10.0	3.9	12.1	6.2	15.8	8.4	3.9	13.5	8.4	19.5	14.4	9.9	10.9	8.9	14.7	5.7	3.4	4.4	8.5	14.1	4.3	16.9	8.8	9.0	4.6	2.2	18.7	19.1	12.1	16.7	16.3	7.2	11.7	16.3	3.8	23.7	10.1	10.9	13.8	3.8	18.1	3.5	15.6	0.1	4.3	1.5	4.5	4.8	4.2	3.9	3.5	4.1	6.9	3.8	4.7	5.6	0.5	4.6	4.8	4.8	5.9	3.3	9.3	13.9	20.8	18.5	9.9	10.7	10.6	13.0	17.4	7.0
MC1R	MSH-R	ENSG00000258839	"Melanocortin 1 receptor"	Q01726	16	89912119-89920977	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 24.6;T-47d: 13.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in single"																						"unprognostic (3.90e-2)"	"unprognostic (9.05e-2)"	"unprognostic (5.39e-7)"	"unprognostic (5.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.55e-2)"	"unprognostic (8.26e-2)"	"prognostic favourable (7.88e-4)"	"unprognostic (1.02e-2)"	"unprognostic (5.20e-3)"	"unprognostic (4.25e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.16e-2)"	1.7	2.7	4.0	2.6	9.3	1.0	1.1	13.9	9.2	4.4	2.2	1.6	3.2	2.5	2.4	4.2	2.0	3.9	3.9	3.7	0.9	2.0	3.2	0.8	1.8	2.2	1.7	1.8	3.8	1.9	1.3	13.8	5.0	4.5	3.8	1.0	2.0	2.2	2.4	1.4	9.0	2.5	2.7	2.2	1.6	2.5	13.1	2.6	1.3	7.0	0.8	1.1	2.6	1.8	0.3	1.5	0.0	0.2	0.0	0.9	0.2	2.1	8.3	1.6	2.2	1.5	2.7	2.0	2.5	2.1	1.8	1.1	2.1	2.2	1.6	3.4	2.5	4.9	0.9	0.6	0.7	0.9	2.4	0.3	3.0	5.6	0.3	0.5	2.1	3.7	1.2	2.6	0.8	1.5	1.8	2.3	1.1	12.9	0.0	11.2	1.7	1.5	1.0	2.0	1.6	1.6	1.1	3.1	1.6	3.1	1.1	24.6	13.4	1.9	1.0	3.0	6.7	1.5	1.0	9.8	5.5	0.8	3.9	6.2	8.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.3	0.9	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.2	4.0	9.3	13.9	9.2	0.9	2.0	1.7	1.8	4.5	2.6
MC4R		ENSG00000166603	"Melanocortin 4 receptor"	P32245	18	60371110-60372775	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 9.8;fallopian tube: 10.3"	"Cell line enriched"	"Detected in single"	69	"fHDF/TERT166: 45.9"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016719	Uncertain									"HPA016719: AB_1853617"	"unprognostic (2.29e-1)"			"unprognostic (5.31e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.41e-1)"		"unprognostic (1.35e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"			"unprognostic (2.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.59e-1)"		0.4	1.1	4.0	0.3	9.8	0.2	0.9	0.7	6.4	0.5	0.5	0.3	0.0	0.6	0.4	1.3	0.4	10.3	0.4	0.4	3.0	7.8	0.4	0.2	0.3	0.4	1.1	7.6	0.6	0.2	0.2	0.3	0.2	3.3	0.4	0.5	0.1	2.5	0.5	0.2	0.3	0.4	0.2	0.8	0.8	0.6	0.6	5.1	0.0	0.2	0.0	1.4	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	9.8	0.7	6.4	3.0	7.8	1.1	7.6	3.3	5.1
MCCC1	MCCA	ENSG00000078070	"Methylcrotonoyl-CoA carboxylase 1"	Q96RQ3	3	183015218-183116075	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008310	Approved		Supported	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA008310: AB_1853620"	"unprognostic (4.01e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.82e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.65e-2)"	"prognostic favourable (3.68e-4)"	"unprognostic (4.73e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	25.1	26.0	14.1	10.4	16.4	9.0	24.6	23.1	20.6	9.0	12.6	15.1	10.1	12.6	11.0	11.4	15.8	9.5	11.6	24.4	12.2	10.1	42.4	41.1	13.8	8.0	17.0	14.4	12.8	32.3	10.2	15.8	5.5	13.4	11.4	13.7	9.9	14.2	15.6	19.4	11.5	10.1	11.3	10.5	8.3	17.7	8.9	16.4	8.9	14.0	8.5	13.2	23.2	9.5	13.1	19.4	17.1	11.3	18.9	11.6	7.6	14.1	5.4	3.4	3.6	15.0	6.8	6.9	6.5	9.1	7.2	8.2	7.4	5.7	15.6	10.6	5.7	7.3	5.2	4.3	9.2	5.2	5.8	13.3	6.2	7.8	9.9	8.9	7.6	7.7	4.9	3.4	7.7	9.6	7.3	8.2	8.0	11.6	8.6	4.4	3.8	5.9	7.2	7.7	20.0	10.5	22.5	7.7	5.6	24.9	34.4	7.0	52.6	12.5	4.6	5.5	4.4	4.4	9.6	8.4	15.4	15.8	6.0	12.8	5.1	8.5	9.7	17.1	8.3	11.3	9.4	13.1	10.8	9.0	19.4	11.1	11.6	10.4	1.6	18.9	11.2	12.7	6.8	7.6	14.1	16.4	23.1	20.6	12.2	10.1	17.0	14.4	13.4	16.4
MCCC2	MCCB	ENSG00000131844	"Methylcrotonoyl-CoA carboxylase 2"	Q9HCC0	5	71587288-71658704	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 74.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038300, HPA038301, HPA061546"	Enhanced		Enhanced	Mitochondria				Mitochondria		"HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557"	"unprognostic (2.39e-1)"	"unprognostic (6.89e-3)"	"prognostic favourable (3.62e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.07e-2)"	"prognostic favourable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.38e-1)"	"prognostic favourable (6.43e-8)"	"unprognostic (1.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	12.4	29.4	9.2	11.8	13.6	2.7	30.5	7.9	10.0	11.2	15.3	12.2	15.1	13.0	9.7	20.0	14.5	9.1	12.3	74.3	7.6	8.1	35.6	61.9	8.4	11.6	7.8	8.0	9.6	18.9	14.1	10.3	15.1	13.4	24.6	18.1	12.8	20.6	29.4	17.6	10.8	14.1	7.8	17.0	11.0	13.6	6.9	6.9	9.4	22.2	13.3	14.3	15.7	8.5	8.8	16.7	1.7	11.5	12.9	10.2	6.7	11.8	16.3	7.0	26.9	7.5	7.8	12.0	5.6	9.5	11.7	8.5	28.7	15.1	27.5	20.9	8.2	9.8	12.2	18.9	14.7	14.5	15.6	14.9	8.5	31.5	13.2	7.4	14.2	9.9	9.9	10.7	8.5	10.3	18.8	10.3	8.1	32.3	0.1	13.5	9.2	9.2	14.4	20.2	40.4	30.4	21.4	11.1	12.3	24.7	36.7	12.0	30.4	18.8	7.5	4.8	7.4	8.6	15.2	7.4	13.7	17.0	7.8	20.6	11.8	1.7	7.4	1.6	6.1	11.5	7.9	8.8	7.9	6.9	16.7	8.6	8.0	8.7	1.2	12.9	6.8	7.4	10.2	6.7	9.2	13.6	7.9	10.0	7.6	8.1	7.8	8.0	13.4	6.9
MCEE	GLOD2	ENSG00000124370	"Methylmalonyl-CoA epimerase"	Q96PE7	2	71109684-71130239	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035196			Approved	Nucleoli	"Intracellular and membrane"	16000	16000	Nucleoli		"HPA035196: AB_10601871"	"unprognostic (7.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	"prognostic favourable (4.76e-4)"	"prognostic favourable (5.78e-4)"	"unprognostic (4.86e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.38e-2)"	10.5	20.4	8.5	10.1	9.2	4.3	18.9	10.5	9.8	14.1	13.8	9.4	24.6	11.1	8.8	19.7	16.9	8.6	12.6	19.8	6.6	6.2	18.8	39.7	9.1	9.5	13.1	6.6	12.4	29.0	9.8	24.5	9.9	9.1	13.7	13.5	11.1	28.9	20.5	18.2	15.2	14.9	10.9	11.5	10.1	13.1	5.7	11.4	9.3	11.0	18.7	10.9	13.0	13.3	15.9	17.6	20.0	18.4	11.2	24.9	11.1	6.3	3.1	5.6	4.0	19.2	26.2	16.4	9.8	12.5	5.0	7.6	7.6	7.9	9.9	3.0	9.7	6.7	6.8	5.1	5.2	9.1	5.9	6.7	8.7	22.0	10.8	7.5	5.6	17.4	7.4	3.4	6.7	5.7	8.8	17.2	4.8	8.1	5.6	8.8	5.2	7.6	6.6	6.4	18.3	7.7	5.1	6.5	4.7	3.7	21.7	9.7	17.2	7.2	7.3	5.9	4.5	5.9	3.9	16.5	6.8	10.5	9.5	12.3	5.3	13.0	18.3	20.0	12.8	18.4	17.3	15.9	15.7	12.3	14.9	13.2	14.6	12.3	4.5	11.2	17.6	17.6	24.9	11.1	8.5	9.2	10.5	9.8	6.6	6.2	13.1	6.6	9.1	11.4
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598223-127622436	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 69.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000303, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		8600	8600	Nucleoplasm		"CAB000303: AB_322519, HPA031495: AB_2673904, HPA031496: "	"unprognostic (2.43e-1)"	"prognostic favourable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	2.9	3.7	2.1	24.3	4.0	32.5	3.5	6.7	3.2	4.7	7.1	3.3	2.2	4.7	4.7	5.9	11.2	4.8	5.4	3.6	2.0	2.3	3.9	3.4	3.4	14.6	2.2	3.5	5.1	3.0	2.4	2.4	26.4	3.0	3.2	6.0	2.5	4.7	1.9	7.0	6.0	7.1	2.9	2.9	13.3	3.8	20.3	3.9	69.9	4.1	16.6	20.7	3.4	5.1	10.4	3.6	0.9	1.4	5.8	10.6	3.4	24.8	21.2	23.2	20.3	1.4	3.0	22.7	13.1	8.4	26.3	28.7	35.1	16.5	26.8	12.8	6.4	20.0	41.5	15.0	16.4	22.1	25.9	44.3	28.4	25.5	0.9	41.4	19.4	1.6	1.7	17.8	2.7	8.2	22.1	24.6	9.6	33.0	38.3	30.4	34.0	18.7	43.1	33.3	38.4	5.4	19.3	28.9	21.9	33.5	10.0	3.4	21.4	32.5	4.2	20.5	17.5	25.2	17.6	25.5	28.9	66.6	14.2	31.4	7.8	0.0	0.6	0.2	4.7	1.4	5.9	10.4	4.1	5.5	2.8	9.2	3.9	5.0	0.9	5.8	0.3	3.6	10.6	3.4	2.1	4.0	6.7	3.2	2.0	2.3	2.2	3.5	3.0	3.9
MCM4	"CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21"	ENSG00000104738	"Minichromosome maintenance complex component 4"	P33991	8	47960185-47978160	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004497, HPA004873, HPA031052"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: "	"unprognostic (4.55e-2)"	"unprognostic (3.16e-3)"	"prognostic favourable (2.19e-4)"	"prognostic unfavourable (2.84e-5)"	"unprognostic (7.71e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (1.23e-4)"	"unprognostic (1.12e-3)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (2.65e-2)"	"prognostic unfavourable (2.38e-4)"	"unprognostic (5.16e-2)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.40e-1)"	4.9	8.7	6.7	18.4	12.6	33.1	9.3	13.9	14.8	6.7	11.9	6.9	3.6	8.3	4.7	7.8	21.6	5.9	6.8	8.3	6.6	7.1	8.0	6.6	4.4	20.3	5.9	7.7	5.3	5.5	4.3	4.1	29.2	7.7	4.2	13.2	5.3	9.0	3.1	8.7	16.2	10.3	5.9	6.4	10.1	6.3	39.0	4.1	56.6	4.0	21.8	23.7	8.0	9.5	5.1	4.9	3.4	4.3	4.9	12.9	4.5	34.1	21.2	39.4	14.4	3.9	6.8	17.4	26.0	17.1	32.8	37.2	22.5	31.0	37.0	14.6	12.9	25.2	49.6	21.1	37.1	11.6	32.8	63.4	25.5	24.9	1.0	33.8	13.9	4.1	4.2	26.1	9.3	11.5	34.9	30.8	22.6	21.1	74.8	24.7	42.7	9.2	47.6	30.9	24.1	11.9	30.6	37.8	18.2	52.7	22.0	7.8	26.3	17.8	7.7	25.1	24.4	28.1	23.8	10.1	24.2	75.5	20.1	31.4	22.4	3.4	2.1	1.5	5.5	3.7	2.7	5.1	5.0	6.8	4.9	2.1	4.6	3.4	0.1	4.9	4.3	1.7	12.9	4.5	6.7	12.6	13.9	14.8	6.6	7.1	5.9	7.7	7.7	4.1
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400063-35425430	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.0;lymphoid tissue: 60.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: "	"unprognostic (6.71e-2)"	"prognostic favourable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (1.78e-4)"	"prognostic unfavourable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavourable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	12.1	4.9	6.1	27.5	9.0	57.0	9.1	6.7	5.7	10.4	11.5	12.3	5.0	9.5	10.8	10.8	15.8	8.7	9.4	5.2	4.4	3.4	6.8	8.0	9.3	31.1	8.8	3.7	17.9	10.8	6.2	3.6	19.3	5.8	7.2	8.3	6.5	8.9	5.1	8.8	10.3	16.7	6.0	7.8	31.2	8.4	16.4	8.8	60.6	9.0	17.7	33.0	8.7	9.6	46.8	30.9	19.0	26.0	21.3	32.9	24.0	38.9	28.3	22.4	22.8	2.1	4.4	19.6	26.0	13.8	38.9	37.0	18.8	19.4	25.8	15.1	13.2	19.4	22.3	20.6	12.5	20.8	41.0	36.8	28.4	37.5	0.7	75.9	33.3	2.4	1.9	23.2	6.3	17.2	22.7	38.6	14.7	32.1	61.8	25.3	29.7	16.8	70.0	31.7	32.5	7.7	22.6	17.3	18.4	35.8	14.4	8.0	15.0	29.0	10.1	39.3	29.9	24.4	26.8	21.5	26.4	48.5	25.4	28.7	30.0	19.0	20.7	14.5	18.4	24.1	13.1	46.8	16.1	19.4	27.1	37.0	13.1	14.8	9.9	21.3	26.0	30.9	32.9	24.0	6.1	9.0	6.7	5.7	4.4	3.4	8.8	3.7	5.8	8.8
MCM8	"C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC"	ENSG00000125885	"Minichromosome maintenance 8 homologous recombination repair factor"	Q9UJA3	20	5950652-5998977	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045141, HPA066433"			Supported	Nucleoplasm				Nucleoplasm		"HPA045141: , HPA066433: "	"unprognostic (6.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.78e-2)"	"prognostic unfavourable (9.30e-8)"	"unprognostic (5.21e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (7.50e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.47e-1)"	4.9	5.4	7.3	11.0	7.6	11.2	9.3	17.9	12.7	5.4	6.2	3.1	12.0	5.4	5.9	3.9	6.6	4.3	2.7	11.3	4.8	2.2	4.3	3.1	6.3	9.6	10.6	5.1	5.0	5.6	5.1	4.8	5.4	7.1	5.9	6.0	3.5	5.1	7.2	11.2	6.1	6.1	7.0	8.3	6.1	5.6	21.9	7.7	8.8	4.4	7.0	9.5	6.0	6.1	1.8	1.7	3.3	0.7	1.9	3.0	0.4	18.9	14.8	12.8	12.9	3.4	4.1	11.3	15.6	6.3	12.2	14.7	16.2	12.0	19.4	4.7	5.2	20.4	21.2	12.3	22.1	5.3	8.7	21.4	7.1	15.7	0.5	22.5	3.3	1.9	2.0	20.6	8.5	5.7	21.8	19.1	12.5	5.3	11.6	11.8	17.1	8.7	14.2	21.7	7.8	3.1	7.6	9.5	10.1	15.9	17.7	9.5	11.4	8.0	3.8	21.7	18.1	11.7	22.6	8.2	20.5	32.9	4.4	14.6	17.8	3.3	0.5	1.7	1.8	0.5	3.0	1.8	1.1	2.1	0.1	1.7	1.1	1.7	2.1	1.9	0.7	1.7	2.0	0.4	7.3	7.6	17.9	12.7	4.8	2.2	10.6	5.1	7.1	7.7
MCM9	"C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304"	ENSG00000111877	"Minichromosome maintenance 9 homologous recombination repair factor"	Q9NXL9	6	118813442-118935162	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031137	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA031137: AB_10602027"	"unprognostic (3.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.95e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.79e-2)"	8.6	7.2	5.9	11.9	8.4	14.5	17.7	5.2	6.9	9.4	11.2	8.2	9.8	7.3	9.0	16.0	10.2	8.6	8.2	6.6	5.9	4.0	9.3	7.6	15.6	12.1	11.5	4.7	8.7	12.2	11.9	11.2	13.8	6.3	10.5	8.4	7.0	11.8	8.7	4.2	9.8	12.6	10.9	5.7	10.2	7.3	7.9	8.1	27.0	13.1	7.1	9.9	9.6	10.5	3.1	5.2	8.0	5.3	10.2	6.4	3.9	4.6	7.4	11.8	12.7	5.3	5.3	9.1	4.4	7.8	6.5	8.3	6.0	8.3	14.0	5.5	7.5	14.0	8.2	4.7	9.1	8.2	11.3	11.1	8.7	5.9	3.1	11.9	7.5	5.8	5.6	6.6	7.7	6.2	13.4	6.5	4.2	9.7	10.5	9.6	5.8	3.3	8.4	7.4	3.7	6.6	9.3	10.2	7.4	7.7	5.7	4.0	8.4	16.9	6.3	5.1	4.6	3.6	6.4	8.6	7.2	16.6	6.6	9.8	6.0	7.2	4.5	8.0	4.9	5.3	3.8	3.1	3.0	5.0	5.2	3.0	3.6	3.5	5.4	10.2	3.2	3.7	6.4	3.9	5.9	8.4	5.2	6.9	5.9	4.0	11.5	4.7	6.3	8.1
MCOLN1	"ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1"	ENSG00000090674	"Mucolipin 1"	Q9GZU1	19	7522626-7534009	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Ion channel"	"Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 30.9;monocytes: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031763, CAB032637, HPA069495"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: "	"unprognostic (5.51e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"prognostic favourable (5.60e-5)"	"unprognostic (1.36e-1)"	"prognostic favourable (5.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	18.9	27.5	10.1	10.3	11.9	10.0	10.3	8.2	19.7	7.7	9.6	11.2	7.2	9.6	8.8	9.5	11.2	8.4	11.7	11.7	9.0	9.2	11.5	20.6	17.9	20.6	10.6	10.0	7.8	10.5	9.8	26.0	17.9	13.6	8.8	6.9	9.7	9.2	8.0	14.2	13.9	8.0	9.5	10.4	38.3	8.9	6.5	9.4	7.0	6.2	7.6	5.1	12.5	8.7	1.3	6.2	30.9	28.9	2.8	2.7	4.4	6.3	6.5	3.2	10.8	18.7	6.0	9.2	11.9	9.6	14.4	12.5	5.0	5.6	3.5	14.7	8.0	2.9	5.4	4.1	4.3	6.9	11.9	3.1	6.4	4.0	16.4	3.6	14.0	8.5	9.6	13.8	2.4	6.1	5.9	15.9	8.3	2.1	4.9	3.6	7.1	14.1	6.8	5.4	7.6	5.4	5.5	8.3	10.2	5.1	9.0	15.0	5.4	6.3	7.5	6.9	3.9	27.8	8.8	12.3	18.8	2.5	11.1	5.0	10.3	30.9	13.7	29.7	2.3	27.5	2.0	1.1	2.0	1.9	5.6	1.3	1.9	2.0	12.2	2.8	28.9	6.2	2.7	4.4	10.1	11.9	8.2	19.7	9.0	9.2	10.6	10.0	13.6	9.4
MDM2	"HDM2, MGC5370"	ENSG00000135679	"MDM2 proto-oncogene"	Q00987	12	68808176-68850686	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 93.7;U-698: 90.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000086, CAB016303"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB000086: AB_563872, CAB016303: AB_627920"	"unprognostic (1.16e-1)"	"prognostic favourable (3.23e-4)"	"unprognostic (6.16e-2)"	"prognostic favourable (4.51e-7)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.95e-2)"	16.6	15.3	11.1	12.5	10.8	23.1	12.5	12.0	11.3	13.1	16.6	13.6	11.9	5.2	8.8	9.4	14.2	12.6	12.3	9.0	8.8	8.6	11.2	25.7	15.9	13.3	14.2	7.1	11.0	21.4	11.4	10.4	24.5	11.9	12.6	21.5	7.8	10.5	11.1	19.5	9.8	7.2	10.8	10.8	15.3	9.8	6.5	11.5	29.5	13.6	10.8	14.1	13.5	12.6	4.9	4.0	19.3	6.4	3.6	4.4	3.0	3.1	7.3	7.7	3.9	10.0	9.3	39.4	8.7	8.7	4.6	7.4	4.4	1.4	32.6	2.4	5.7	1.8	5.2	93.7	7.5	8.6	3.7	6.0	6.2	19.8	9.8	5.3	5.5	14.3	8.0	18.4	12.5	12.9	6.1	7.9	8.8	5.0	7.0	1.7	6.5	1.4	24.8	5.3	2.7	2.8	26.1	5.9	3.4	5.5	4.3	1.9	10.1	3.5	13.8	3.5	6.7	2.9	3.1	12.1	7.6	90.1	5.4	2.1	14.4	5.3	5.4	4.8	4.4	4.0	3.9	4.7	3.7	4.1	2.8	4.9	4.0	3.7	19.3	3.6	6.4	4.0	3.8	3.0	11.1	10.8	12.0	11.3	8.8	8.6	14.2	7.1	11.9	11.5
MECR	"CGI-63, ETR1, FASN2B, NRBF1"	ENSG00000116353	"Mitochondrial trans-2-enoyl-CoA reductase"	Q9BV79	1	29192873-29230942	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA022018, HPA022030, HPA028740"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA022018: AB_1853714, HPA022030: AB_1853716, HPA028740: AB_10601133"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.06e-2)"	"unprognostic (8.66e-2)"	"prognostic favourable (5.81e-6)"	"unprognostic (7.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (5.29e-4)"	16.4	11.9	16.0	6.6	17.0	6.0	12.3	7.8	17.7	13.0	9.7	8.6	7.1	7.8	10.5	8.4	9.4	10.9	8.5	24.8	15.7	11.5	11.0	13.7	8.3	10.0	14.7	16.3	11.7	14.3	8.1	10.0	10.8	12.8	7.5	8.9	10.8	12.6	10.0	45.5	11.3	5.9	10.2	10.7	5.4	8.1	8.2	10.5	4.4	8.3	12.8	7.6	8.0	7.2	8.3	14.7	0.3	11.5	11.6	13.1	6.5	10.3	9.9	4.8	22.5	4.9	8.8	17.8	7.8	8.9	10.3	10.0	7.5	21.2	13.6	15.8	7.7	12.9	6.1	16.0	6.4	9.3	12.6	11.8	6.3	9.5	15.4	13.0	6.0	8.7	14.2	5.4	20.1	11.3	10.1	14.1	12.8	11.6	11.0	7.2	13.0	12.7	6.8	8.2	24.0	10.9	6.0	7.4	11.4	11.6	16.5	14.5	6.1	12.6	11.4	7.5	8.1	11.7	11.6	13.5	5.6	10.2	20.2	17.4	14.1	0.1	7.0	0.0	8.3	11.5	13.1	8.3	7.8	6.7	14.7	7.4	8.4	8.5	0.3	11.6	7.0	8.6	6.3	6.5	16.0	17.0	7.8	17.7	15.7	11.5	14.7	16.3	12.8	10.5
MELK	KIAA0175	ENSG00000165304	"Maternal embryonic leucine zipper kinase"	Q14680	9	36572862-36677683	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 4.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 4.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA017214	Uncertain									"HPA017214: AB_1853798"	"unprognostic (5.03e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.42e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (2.91e-7)"	"prognostic unfavourable (3.99e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (4.58e-4)"	"unprognostic (4.69e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (8.86e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.35e-1)"	1.5	1.1	0.3	11.4	0.6	7.7	2.6	0.2	0.8	2.1	5.9	0.3	0.1	4.5	1.2	1.5	12.2	0.4	1.6	1.3	0.5	0.4	1.2	1.3	2.0	8.3	0.4	0.1	0.7	0.8	0.0	0.3	6.3	0.5	0.7	7.8	0.4	2.3	0.1	0.9	2.8	4.6	1.9	1.0	5.2	2.9	11.3	0.4	42.4	0.5	7.2	12.6	1.5	3.3	0.1	0.6	1.0	0.1	0.4	4.8	0.5	35.4	18.2	24.6	14.5	3.4	5.9	14.3	26.3	18.6	36.9	45.6	14.0	14.0	11.9	8.5	12.9	12.2	21.4	16.5	40.8	32.3	8.5	9.3	21.7	13.9	1.3	14.4	11.8	2.1	3.0	28.5	16.2	18.6	11.9	19.0	30.2	11.8	17.9	6.8	19.6	14.3	16.6	16.6	7.6	11.3	12.0	16.7	12.4	14.0	13.5	8.5	11.3	6.9	9.1	19.9	25.2	16.8	23.9	3.7	13.5	17.8	12.6	10.7	27.0	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.8	1.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.6	4.8	0.5	0.3	0.6	0.2	0.8	0.5	0.4	0.4	0.1	0.5	0.4
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898479-112029561	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.8;Hep G2: 21.6;HUVEC TERT2: 21.5;RT4: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 10.3;non-classical monocyte: 6.4"	"Lineage enriched"	"Detected in single"	48	"monocytes: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"		29000000	29000000	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: "	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favourable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	55.1	13.1	12.5	17.8	1.9	31.8	6.2	13.8	10.8	13.8	6.8	27.7	11.5	11.3	25.4	8.4	12.8	11.7	7.1	16.5	6.3	14.2	18.9	12.7	30.3	8.1	10.1	12.9	9.0	23.9	14.3	18.4	18.6	14.1	7.9	20.4	6.8	24.9	6.4	6.4	12.8	13.6	12.2	38.4	12.3	17.3	9.8	1.7	9.9	2.0	8.4	14.1	26.6	0.0	0.2	0.1	10.3	0.0	0.0	0.3	0.5	0.9	4.3	9.7	0.2	0.1	6.9	0.0	0.1	0.5	1.0	20.8	1.3	0.1	4.6	0.0	0.1	5.7	0.0	0.8	0.8	3.0	3.7	0.0	21.6	0.1	0.1	0.8	0.2	0.0	5.0	0.3	21.5	1.1	2.0	1.6	0.9	0.0	4.9	2.7	3.4	1.4	1.2	1.6	10.9	12.9	0.1	4.1	0.1	0.3	1.7	0.0	0.2	3.2	0.6	2.0	0.0	0.0	1.7	2.5	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	6.4	0.1	0.0	0.3	13.1	17.8	6.2	13.8	16.5	6.3	8.1	10.1	18.6	9.8
MEX3C	"FLJ38871, RKHD2, RNF194"	ENSG00000176624	"Mex-3 RNA binding family member C"	Q5U5Q3	18	51174550-51218304	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040603	Uncertain		Approved	Vesicles	"Intracellular and membrane"			Vesicles		"HPA040603: AB_10805714"	"unprognostic (1.09e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.30e-2)"	"prognostic unfavourable (8.49e-5)"	"unprognostic (4.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.17e-1)"	12.6	12.2	13.8	14.5	13.5	27.5	19.4	21.7	13.7	14.7	11.3	10.7	8.8	8.7	13.4	9.5	11.7	11.1	13.0	11.3	15.1	9.1	9.3	10.3	12.0	19.8	16.3	8.3	14.5	10.1	16.6	9.5	11.7	12.3	10.3	9.8	7.6	12.4	10.1	9.0	10.2	12.7	13.6	12.6	16.3	10.5	43.7	12.7	40.0	13.6	9.3	18.4	13.0	17.5	2.8	2.0	10.3	1.3	5.8	3.8	1.5	7.5	4.5	21.8	8.1	12.1	15.0	17.0	10.8	14.1	6.3	7.7	7.2	5.8	15.4	3.8	14.3	13.8	9.4	15.4	12.1	11.3	4.2	3.3	4.5	9.4	19.6	20.9	6.3	12.6	21.7	8.8	27.6	16.2	3.5	27.0	16.2	5.5	15.6	10.4	10.5	4.5	15.8	11.4	15.8	14.5	2.5	9.7	13.3	8.1	4.4	42.5	4.4	11.7	12.1	15.2	10.1	4.6	9.2	19.6	2.9	24.6	10.4	10.6	34.3	10.3	1.3	1.5	3.6	1.3	3.1	2.8	3.8	3.7	2.0	2.1	1.6	3.8	0.7	5.8	0.9	2.0	3.1	1.5	13.8	13.5	21.7	13.7	15.1	9.1	16.3	8.3	12.3	12.7
MFN2	"CMT2A2, CPRP1, KIAA0214, MARF"	ENSG00000116688	"Mitofusin 2"	O95140	1	11980181-12013514	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"	Hydrolase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.9;skeletal muscle: 111.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030554	Uncertain									"HPA030554: AB_10603018"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.55e-1)"	"prognostic favourable (2.36e-8)"	"unprognostic (4.69e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.12e-1)"	12.8	10.1	16.4	8.9	20.3	17.2	10.1	15.9	32.1	8.7	17.0	17.0	11.2	16.5	12.1	8.7	20.1	9.0	9.0	100.9	17.9	16.0	14.8	20.4	10.6	8.0	18.8	19.3	10.2	9.0	22.0	9.3	12.9	20.8	14.1	13.2	16.5	10.7	23.7	111.1	18.8	25.7	22.9	15.7	10.2	14.0	11.3	10.9	7.3	18.7	28.5	12.1	16.3	10.6	7.3	8.9	18.5	16.9	5.8	10.2	13.4	25.8	15.9	18.0	23.6	18.3	13.8	20.9	20.5	19.0	28.2	22.0	26.1	17.3	19.0	22.2	24.8	27.8	29.7	47.6	25.3	68.9	22.6	27.2	25.5	20.3	18.9	27.6	17.1	17.3	36.7	39.6	36.7	19.8	28.1	16.8	20.8	13.0	16.7	12.6	12.4	23.3	19.6	26.2	17.7	16.9	17.3	21.0	13.7	24.0	25.7	23.7	13.9	16.6	19.8	18.9	18.9	28.6	21.4	20.0	21.0	31.1	22.4	31.0	20.4	8.5	10.3	7.1	9.6	13.5	10.2	7.3	7.2	8.6	8.9	6.6	6.3	8.0	18.5	5.8	16.9	4.6	8.0	13.4	16.4	20.3	15.9	32.1	17.9	16.0	18.8	19.3	20.8	10.9
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Symport, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 96.9;liver: 87.9;placenta: 111.3;seminal vesicle: 121.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.5;THP-1: 58.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.3;intermediate monocyte: 4.6;myeloid DC: 10.3;plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 16.7;monocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"				Cytosol	"Plasma membrane, Cytoplasmic bodies"	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.33e-4)"	2.0	0.9	6.0	1.6	7.2	3.3	6.2	2.4	6.5	1.6	5.6	4.3	96.9	6.4	4.3	45.0	5.0	1.5	1.2	0.7	7.6	6.1	7.2	87.9	15.8	1.1	7.5	2.6	0.8	0.5	0.3	3.0	111.3	7.8	1.0	2.5	2.0	1.7	121.2	0.3	27.0	20.4	1.8	7.3	0.8	1.0	17.7	2.3	0.2	2.9	4.7	1.7	2.6	4.6	1.1	16.7	0.9	9.3	0.1	0.1	2.3	2.1	0.9	4.4	6.6	3.1	0.6	0.0	2.0	3.9	4.5	5.4	0.2	1.1	13.0	1.2	1.0	5.2	4.3	7.5	3.5	1.6	2.1	1.5	0.0	0.0	10.5	2.3	7.7	3.5	4.7	18.5	7.6	1.1	0.0	3.3	2.0	0.2	3.5	3.5	3.5	1.6	2.5	6.5	3.0	0.7	6.1	1.6	2.4	1.5	11.1	1.1	0.5	58.2	0.7	1.0	1.9	3.3	8.5	0.6	1.1	2.9	10.4	8.8	3.2	0.0	9.3	0.9	0.1	4.6	0.1	1.1	0.0	0.1	10.3	0.2	0.0	0.0	0.5	0.1	0.8	16.7	0.0	2.3	6.0	7.2	2.4	6.5	7.6	6.1	7.5	2.6	7.8	2.3
MFSD8	"CLN7, MGC33302"	ENSG00000164073	"Major facilitator superfamily domain containing 8"	Q8NHS3	4	127917732-127966034	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044802	Approved		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA044802: AB_10963221"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.14e-1)"	"prognostic favourable (2.21e-4)"	8.9	9.6	9.1	11.7	15.4	5.3	13.0	19.6	15.4	12.2	12.1	14.6	9.4	17.1	19.0	11.9	10.3	9.8	9.2	7.5	8.9	10.1	12.6	19.1	9.1	9.7	9.3	11.8	13.2	14.5	16.7	21.5	18.0	15.8	10.2	15.6	14.8	10.9	9.7	7.2	11.0	15.0	12.4	11.8	13.5	12.0	9.4	10.2	12.9	13.6	7.1	15.0	9.9	10.5	7.0	5.8	7.1	8.2	5.4	8.3	4.1	8.3	6.9	7.2	4.0	6.4	5.7	6.2	6.2	8.0	8.1	8.2	4.3	11.9	3.9	12.2	11.2	6.9	8.4	6.3	11.8	9.0	6.7	4.7	7.8	6.6	7.1	5.0	5.9	6.2	2.1	7.6	5.8	8.6	8.1	5.2	11.5	7.6	4.3	1.7	1.4	4.6	4.6	0.5	4.5	5.8	11.8	7.3	2.6	7.8	7.9	3.3	4.6	3.4	4.5	2.7	2.8	10.1	5.8	11.4	18.9	8.8	8.7	4.3	7.3	4.6	5.6	7.1	7.1	6.2	6.2	7.0	7.9	6.6	4.5	3.6	8.3	8.3	6.3	5.4	8.2	5.8	8.0	4.1	9.1	15.4	19.6	15.4	8.9	10.1	9.3	11.8	15.8	10.2
MGAT2	GNT-II	ENSG00000168282	"Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase"	Q10469	14	49620795-49623481	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043721, HPA056824"	Approved		Supported	"Golgi apparatus"		5000000	5000000	"Golgi apparatus"		"HPA043721: , HPA056824: "	"unprognostic (1.20e-2)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (2.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-2)"	14.0	17.0	7.4	14.0	7.1	5.0	12.3	7.3	8.4	11.7	16.5	7.8	16.5	13.9	12.9	14.1	11.7	11.4	16.8	10.1	6.2	6.6	13.2	34.4	10.3	20.5	6.1	7.2	15.3	27.9	4.8	8.2	14.1	5.8	9.4	13.7	10.7	34.9	19.1	5.1	6.3	29.1	9.7	7.1	20.9	12.3	27.7	5.8	18.2	9.0	7.2	14.8	11.6	9.1	15.5	28.2	22.1	22.8	12.0	24.7	23.2	18.7	9.3	7.1	12.0	17.0	16.5	4.6	20.8	20.7	19.3	17.5	11.2	14.3	19.0	17.8	18.9	15.0	10.0	12.0	20.9	19.4	8.9	12.1	6.9	11.0	13.4	27.8	28.4	12.6	9.7	11.4	16.2	23.1	9.2	52.6	20.3	7.1	9.6	17.8	7.3	15.0	10.9	20.8	16.4	15.1	10.9	7.4	8.0	14.9	3.9	11.7	12.0	19.0	23.9	17.6	19.1	12.7	14.8	56.9	27.3	17.0	8.5	13.9	11.8	21.7	22.8	22.1	23.0	20.0	24.7	15.5	21.3	20.7	23.6	10.4	12.6	17.3	6.8	12.0	21.6	28.2	18.2	23.2	7.4	7.1	7.3	8.4	6.2	6.6	6.1	7.2	5.8	5.8
MIB1	"DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6"	ENSG00000101752	"Mindbomb E3 ubiquitin protein ligase 1"	Q86YT6	18	21704957-21870957	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019100, CAB037044"	Approved		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"CAB037044: AB_1841007, HPA019100: AB_1853934"	"unprognostic (1.38e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.29e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.85e-2)"	12.1	9.1	15.3	7.9	20.6	5.9	15.7	16.1	17.4	16.6	10.9	16.3	9.7	6.9	19.1	13.7	11.4	11.5	12.0	9.4	16.3	12.9	15.7	14.1	10.1	9.6	17.4	16.5	17.2	11.7	18.4	11.5	14.9	15.5	14.7	10.1	14.6	12.0	12.6	9.6	12.5	8.4	17.9	13.8	9.4	10.7	11.5	18.1	13.9	19.1	9.8	10.6	13.0	13.8	1.2	1.2	3.5	1.7	2.5	2.0	0.6	8.4	3.3	16.5	11.4	8.8	10.6	3.9	6.8	7.6	4.9	7.1	4.9	3.1	7.2	6.3	9.4	5.7	9.6	9.2	11.1	9.4	4.5	8.0	4.3	6.8	7.2	16.3	3.4	6.8	10.2	5.7	14.7	12.2	11.0	21.3	7.5	4.1	7.8	6.2	4.2	4.4	51.5	13.6	17.8	8.3	7.5	5.4	13.3	11.7	5.4	6.0	3.9	10.7	10.4	12.5	6.3	5.2	9.0	11.2	3.9	11.1	5.3	10.4	7.4	3.5	1.7	0.6	1.0	0.9	1.2	1.2	1.5	1.0	0.6	0.6	1.2	0.9	1.5	2.5	0.5	1.2	2.0	0.6	15.3	20.6	16.1	17.4	16.3	12.9	17.4	16.5	15.5	18.1
MICU1	"CALC, CBARA1, EFHA3, FLJ12684"	ENSG00000107745	"Mitochondrial calcium uptake 1"	Q9BPX6	10	72367327-72626191	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"		Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037479, HPA037480"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA037479: AB_2675495, HPA037480: AB_10696934"	"unprognostic (8.18e-2)"	"unprognostic (6.98e-3)"	"unprognostic (6.71e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.38e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.23e-2)"	"prognostic favourable (4.66e-7)"	"unprognostic (1.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.70e-2)"	16.8	36.4	22.9	14.4	25.3	17.0	15.4	56.3	30.7	18.2	16.9	18.9	11.6	20.9	29.7	14.3	13.3	20.5	18.6	24.0	23.3	21.7	58.9	64.7	16.7	11.2	20.9	22.7	25.0	11.6	21.1	23.4	16.3	25.2	14.9	19.2	15.1	15.5	13.8	36.9	16.3	21.5	22.2	17.5	18.1	24.1	11.8	15.0	15.1	13.8	14.6	11.9	20.0	15.2	6.5	9.5	39.0	21.7	5.6	6.5	11.5	15.8	28.0	17.9	20.9	28.9	27.2	8.1	17.5	39.8	26.2	36.2	16.4	30.1	21.5	14.9	24.5	19.0	22.4	15.8	31.0	19.1	18.3	14.5	15.7	23.7	22.9	19.9	16.0	27.1	14.3	28.7	26.8	22.5	22.3	25.4	30.4	14.4	17.4	18.9	7.5	6.8	19.1	24.1	14.1	32.1	11.8	13.8	19.8	20.7	25.9	16.1	15.4	19.3	13.8	13.0	20.2	25.7	14.5	13.5	22.4	15.1	26.0	26.6	8.8	7.3	21.7	39.0	6.5	18.3	5.7	5.8	5.8	6.0	9.5	6.5	5.7	4.8	18.3	5.6	18.4	6.1	5.5	11.5	22.9	25.3	56.3	30.7	23.3	21.7	20.9	22.7	25.2	15.0
MID1	"FXY, OS, RNF59, TRIM18"	ENSG00000101871	"Midline 1"	O15344	X	10445310-10833654	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 56.8;AF22: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002878, HPA003715"	Approved		Approved	"Centriolar satellite"				"Centriolar satellite"		"HPA002878: , HPA003715: AB_1079384"	"unprognostic (1.99e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.88e-2)"	13.4	3.6	6.5	10.4	8.4	0.3	8.6	16.3	7.1	17.5	21.5	3.8	11.7	7.7	17.9	11.3	12.2	7.7	13.1	13.2	6.2	4.2	7.9	4.9	10.4	4.2	4.5	3.7	12.0	4.8	2.7	6.6	7.8	4.9	14.6	12.8	15.9	7.1	19.1	2.8	3.9	8.7	30.6	2.6	1.3	5.3	6.5	4.1	0.8	6.2	7.1	5.8	17.1	20.5	1.0	0.7	3.3	0.0	0.0	0.1	0.1	12.2	56.8	43.0	6.6	2.5	3.6	5.3	7.7	6.4	7.9	8.1	10.4	3.7	4.1	2.5	7.0	8.4	3.5	5.3	5.9	0.2	5.1	0.9	8.1	0.2	1.1	0.0	0.2	4.1	2.8	5.2	5.5	7.6	0.6	0.7	3.1	1.9	1.6	0.1	13.7	4.1	1.2	11.0	0.0	5.8	11.3	3.0	1.1	3.3	9.7	3.6	6.7	0.0	4.8	2.6	0.3	13.3	6.7	0.6	0.3	0.1	5.6	0.0	12.8	0.1	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.1	6.5	8.4	16.3	5.2	6.2	4.2	4.5	3.7	4.9	4.1
MID2	"FXY2, MRX101, RNF60, TRIM1"	ENSG00000080561	"Midline 2"	Q9UJV3	X	107825755-107927193	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 23.8;Karpas-707: 20.8;MCF7: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 4.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (8.28e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.69e-4)"	"unprognostic (6.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.19e-2)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.77e-1)"	"unprognostic (5.97e-3)"	12.7	11.3	3.6	4.8	11.4	0.4	13.0	9.3	8.0	10.8	9.0	5.1	9.4	2.0	12.6	9.7	15.1	10.0	8.6	4.4	4.0	5.2	6.6	6.2	9.0	6.2	4.3	5.8	11.5	10.2	16.0	11.1	4.7	7.1	12.9	4.0	12.4	12.7	10.9	16.6	14.5	4.6	17.2	5.4	5.8	7.7	4.7	4.7	0.5	14.5	8.3	6.6	16.7	11.9	0.7	0.0	0.0	0.0	0.0	4.2	1.1	4.7	4.1	0.1	6.6	5.3	7.5	0.1	3.4	8.6	2.9	2.2	0.3	0.8	0.0	4.5	6.5	3.0	2.4	6.9	0.7	0.0	3.2	0.0	2.5	0.0	7.9	0.0	0.0	4.7	7.9	0.1	8.7	23.8	0.0	20.8	3.2	15.1	0.0	0.0	0.7	7.6	0.0	1.9	0.0	3.6	4.3	0.4	0.0	7.2	0.3	10.9	2.7	0.2	4.9	0.0	1.2	5.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.3	0.1	1.8	3.5	0.0	0.7	4.2	2.3	0.0	0.0	0.0	0.0	0.3	1.1	3.6	11.4	9.3	8.0	4.0	5.2	4.3	5.8	7.1	4.7
MINPP1	MIPP	ENSG00000107789	"Multiple inositol-polyphosphate phosphatase 1"	Q9UNW1	10	87504875-87553460	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026859	Approved				"Intracellular and membrane"	320000000	320000000			"HPA026859: AB_1853961"	"unprognostic (9.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.55e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-2)"	"unprognostic (6.50e-3)"	"prognostic unfavourable (6.98e-5)"	"unprognostic (2.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.01e-2)"	9.9	27.6	8.5	8.0	8.9	24.6	14.2	12.0	9.2	9.1	13.3	8.0	12.8	16.7	12.1	10.0	5.4	8.4	9.5	7.2	8.5	10.0	19.4	28.9	9.5	10.1	8.2	6.3	11.1	18.2	10.2	18.5	31.4	7.6	11.6	12.4	9.3	8.9	12.2	5.9	9.5	19.4	7.4	8.2	8.2	8.9	8.8	8.5	13.5	13.1	5.3	6.5	8.7	13.9	8.9	13.5	8.5	12.9	10.4	16.4	9.3	8.3	12.9	12.9	18.9	22.0	18.2	10.9	13.6	23.3	13.5	18.1	6.8	16.4	7.2	12.7	16.0	13.0	13.6	12.4	15.4	16.5	16.2	18.5	5.2	25.2	16.5	7.9	16.9	15.9	16.0	15.0	9.1	16.9	10.8	35.3	15.6	6.2	5.2	11.2	9.3	9.3	0.0	7.4	4.9	17.7	4.7	4.7	14.8	12.9	2.7	22.6	7.8	6.6	14.8	8.7	10.5	10.3	13.0	11.5	11.8	1.9	13.9	12.2	6.3	8.5	10.3	4.6	11.6	12.9	10.3	8.9	11.0	13.2	13.5	7.3	10.6	11.9	0.7	10.4	10.8	7.8	16.4	9.3	8.5	8.9	12.0	9.2	8.5	10.0	8.2	6.3	7.6	8.5
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889419	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favourable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	7.3	14.9	6.2	7.1	12.2	4.4	11.0	4.7	10.3	8.1	12.2	12.9	12.1	8.4	9.6	20.4	14.4	17.1	11.7	16.9	8.8	5.3	24.7	12.0	8.2	8.4	5.1	8.0	8.5	14.7	8.1	15.4	5.3	9.1	10.9	13.1	9.1	12.9	10.1	16.2	22.0	8.9	11.5	4.4	6.5	9.8	13.9	4.9	8.9	10.9	15.7	11.1	11.2	8.6	9.2	6.5	1.2	10.6	9.7	10.0	3.9	8.9	10.1	5.0	11.7	11.5	15.5	10.7	6.5	10.1	9.8	8.2	13.4	17.8	10.5	6.6	5.2	22.6	11.5	13.6	12.2	6.1	7.3	4.6	4.8	11.5	9.4	10.7	2.5	7.6	17.1	10.1	9.0	12.2	8.8	1.7	15.2	6.6	7.6	6.0	6.9	10.2	8.5	13.5	9.1	21.8	6.0	11.8	3.9	6.9	11.4	13.6	11.7	6.0	6.7	6.0	5.0	9.8	6.9	1.7	2.4	5.6	10.3	5.5	7.4	0.0	3.0	1.2	7.9	3.7	10.0	9.2	7.7	7.1	6.5	7.7	7.4	7.3	0.0	9.7	10.6	5.6	5.1	3.9	6.2	12.2	4.7	10.3	8.8	5.3	5.1	8.0	9.1	4.9
MKRN3	"D15S9, MGC88288, RNF63, ZFP127, ZNF127"	ENSG00000179455	"Makorin ring finger protein 3"	Q13064	15	23565678-23630075	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell line enhanced"	"Detected in many"		"K-562: 17.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 5.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.7"	"Low region specificity"	"Detected in many"							HPA029494	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029494: AB_10603873"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.78e-2)"	1.0	0.7	5.1	1.2	10.4	4.0	1.2	1.0	11.1	0.5	1.1	8.4	0.0	1.3	1.3	3.2	5.6	0.9	0.8	0.8	6.4	3.4	1.1	0.7	1.0	1.9	14.4	3.0	1.2	1.7	0.5	3.8	8.5	5.1	1.2	0.8	3.1	5.2	1.0	1.4	1.2	1.9	0.8	8.2	1.5	0.9	5.7	13.3	5.0	0.9	1.1	1.7	0.7	0.6	1.0	0.9	1.3	0.5	0.4	5.7	0.7	4.7	3.4	3.0	3.1	0.0	0.0	7.1	0.3	0.0	2.9	2.0	8.5	0.0	0.2	0.1	0.0	8.2	1.3	0.0	0.7	0.0	0.3	6.8	9.1	0.3	0.2	8.0	6.1	0.1	0.0	6.0	0.0	0.0	17.5	7.5	0.8	0.0	8.4	3.5	0.0	10.4	6.0	1.1	4.2	0.0	0.1	0.7	2.4	0.0	3.4	0.0	2.7	2.4	0.1	8.0	6.7	0.4	5.6	9.4	11.5	5.6	4.7	0.1	0.1	1.3	0.5	0.4	1.8	0.2	1.0	1.0	0.6	1.4	0.2	0.9	2.0	5.7	1.3	0.4	0.3	0.9	0.4	0.7	5.1	10.4	1.0	6.8	6.4	3.4	14.4	3.0	5.1	13.3
MLC1	"KIAA0027, LVM, MLC, VL"	ENSG00000100427	"Megalencephalic leukoencephalopathy with subcortical cysts 1"	Q15049	22	50059391-50085902	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.0;brain: 95.3"	"Cell line enhanced"	"Detected in some"		"HL-60: 45.7;NB-4: 42.4;THP-1: 80.2;U-266/70: 28.0;U-266/84: 23.9"	"Cancer enriched"	"Detected in some"	69	"glioma: 122.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003040	Enhanced									"HPA003040: AB_1079387"	"unprognostic (2.68e-2)"	"unprognostic (5.46e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.54e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.51e-3)"	"unprognostic (8.39e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.92e-1)"	1.6	1.4	42.3	1.9	45.4	27.0	1.4	17.6	95.3	2.5	1.5	25.9	0.0	1.8	1.5	2.3	1.4	2.8	2.1	1.6	30.9	19.6	1.4	1.6	2.3	1.6	22.5	28.9	1.4	1.4	1.4	0.1	3.2	18.4	2.9	1.4	0.0	1.5	2.6	1.4	2.2	1.5	1.6	18.9	2.8	1.5	2.8	17.3	0.0	1.4	0.0	1.8	1.8	2.6	0.1	0.7	0.1	7.1	15.8	3.3	2.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	45.7	14.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	42.4	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.2	0.0	0.0	0.0	0.0	0.0	28.0	23.9	0.0	0.0	7.0	0.4	0.0	0.7	0.0	3.3	5.7	0.1	0.1	0.2	1.4	0.7	0.0	0.1	1.6	0.1	15.8	7.1	0.1	0.1	2.7	42.3	45.4	17.6	29.8	30.9	19.6	22.5	28.9	18.4	17.3
MLYCD	"hMCD, MCD"	ENSG00000103150	"Malonyl-CoA decarboxylase"	O95822	16	83899126-83927026	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 39.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA031625	Enhanced									"HPA031625: AB_10602028"	"unprognostic (6.23e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.84e-4)"	"unprognostic (2.33e-1)"	"prognostic favourable (2.61e-7)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.56e-2)"	"unprognostic (1.51e-3)"	6.6	10.1	3.3	3.7	4.2	2.3	4.6	2.4	5.4	4.1	6.9	6.3	6.2	4.6	4.4	4.4	5.1	4.9	7.0	39.1	3.7	3.3	6.7	17.4	4.1	3.6	6.9	3.1	6.2	21.5	6.9	5.1	3.1	4.6	5.6	4.4	8.0	6.4	4.1	31.0	4.0	5.1	5.8	3.3	3.8	6.7	7.1	5.7	3.3	5.6	5.7	4.6	6.4	5.4	0.7	0.7	2.3	0.8	0.1	0.9	0.2	0.5	2.3	1.6	2.6	4.9	2.4	3.6	1.1	1.7	1.1	0.5	2.2	1.6	0.4	2.8	2.1	2.4	2.7	0.8	1.0	1.8	2.1	1.6	0.9	1.3	2.8	1.4	3.2	3.0	2.7	0.7	1.1	1.2	2.1	0.8	1.3	4.3	1.5	4.4	2.0	1.0	3.4	1.4	2.1	2.9	2.7	2.4	2.2	4.4	0.6	2.0	4.2	1.8	1.6	1.7	0.4	1.3	0.5	2.7	2.6	3.1	1.7	2.1	1.9	0.8	0.7	2.3	0.5	0.5	0.3	0.7	0.8	0.7	0.7	0.3	0.8	0.9	0.3	0.1	0.8	0.3	0.0	0.2	3.3	4.2	2.4	5.4	3.7	3.3	6.9	3.1	4.6	5.7
MMAB	"cblB, CFAP23"	ENSG00000139428	"Methylmalonic aciduria (cobalamin deficiency) cblB type"	Q96EY8	12	109553737-109573874	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039017	Approved		Approved	Mitochondria				Mitochondria		"HPA039017: AB_10673603"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.58e-1)"	"prognostic favourable (1.55e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.65e-2)"	7.3	26.1	12.7	7.2	12.2	5.2	13.0	7.2	17.2	7.0	12.2	12.6	9.4	12.7	7.7	21.9	14.8	9.8	11.8	18.1	11.6	11.5	13.6	47.9	11.8	13.0	12.4	8.2	14.2	20.2	9.1	11.7	5.3	14.0	15.7	8.3	11.2	15.1	10.6	16.5	8.9	8.5	8.7	15.7	6.7	10.7	7.8	14.8	4.3	16.6	15.7	7.5	6.0	7.5	14.1	9.4	3.8	8.1	8.5	13.9	9.2	13.2	9.0	9.4	7.4	3.8	7.8	4.8	2.9	6.9	4.3	4.6	10.5	12.5	8.5	8.6	3.3	13.9	6.2	23.0	2.0	3.3	25.3	3.5	6.7	17.2	13.7	7.4	3.1	10.5	14.4	9.5	4.2	4.1	11.1	6.5	3.1	30.7	6.7	12.0	11.6	12.9	5.6	3.6	22.1	19.2	12.6	14.6	6.3	6.7	12.4	5.1	25.9	20.9	2.2	3.8	1.5	2.6	4.3	5.1	3.8	9.6	8.2	9.1	10.2	3.8	5.9	0.8	13.5	8.1	10.8	11.1	9.9	10.7	9.4	14.1	13.9	13.1	1.7	8.5	8.0	7.7	4.7	9.2	12.7	12.2	7.2	17.2	11.6	11.5	12.4	8.2	14.0	14.8
MOCOS	"FLJ20733, HMCS, MOS"	ENSG00000075643	"Molybdenum cofactor sulfurase"	Q96EN8	18	36187519-36272157	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.0;liver: 36.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 20.4;hTERT-HME1: 25.1;SiHa: 26.9;SK-MEL-30: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039412, HPA047958"	Uncertain		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA039412: , HPA047958: "	"unprognostic (3.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (2.91e-2)"	"prognostic unfavourable (3.03e-12)"	"unprognostic (8.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.35e-2)"	3.7	12.7	0.6	1.6	0.5	0.2	6.4	0.4	0.4	1.4	10.4	0.7	8.0	6.7	1.3	4.6	4.8	1.9	5.8	1.3	0.4	0.5	1.7	36.6	1.8	0.2	0.4	0.1	17.2	3.2	1.1	9.4	11.2	2.2	2.8	1.8	2.1	2.5	7.2	1.3	2.6	33.0	1.0	0.4	0.7	1.7	1.3	0.2	0.0	1.2	2.9	3.5	2.6	1.7	0.4	0.3	1.9	0.3	1.1	0.3	0.1	6.8	2.3	0.1	0.0	2.2	2.8	1.4	4.0	2.2	1.9	5.0	1.5	2.1	0.0	1.2	6.5	4.2	1.4	6.3	2.7	1.1	1.1	0.1	6.8	5.6	7.5	0.0	1.9	4.4	20.4	7.6	25.1	0.3	2.3	0.0	3.1	1.7	0.0	0.0	0.4	2.0	0.0	0.0	0.0	2.7	9.0	0.0	0.6	26.9	1.7	18.7	1.2	0.1	1.3	1.5	1.9	3.3	0.6	0.0	0.0	0.0	3.9	0.0	0.6	1.7	0.3	0.3	0.3	0.2	0.2	0.3	0.2	0.3	0.1	0.4	0.2	0.3	1.9	1.1	0.2	0.3	0.1	0.1	0.6	0.5	0.4	0.4	0.4	0.5	0.4	0.1	2.2	0.2
MOCS1	MOCOD	ENSG00000124615	"Molybdenum cofactor synthesis 1"	Q9NZB8	6	39899578-39934551	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.9;naive CD8 T-cell: 2.5"	"Group enriched"	"Detected in many"	9	"NK-cells: 1.5;T-cells: 2.9"	"Low region specificity"	"Detected in all"							"HPA045783, HPA058177, HPA075505"	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA045783: AB_10960058, HPA058177: , HPA075505: "	"unprognostic (1.22e-1)"	"prognostic unfavourable (1.07e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (6.07e-5)"	"unprognostic (5.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	26.6	9.6	4.6	5.3	7.9	0.2	27.1	5.9	8.7	6.4	17.5	10.5	5.0	15.4	10.1	8.7	6.9	7.9	8.0	18.0	6.2	2.3	17.5	34.9	19.6	9.2	9.5	6.2	9.0	10.9	4.5	6.3	30.2	7.0	6.7	5.2	11.2	5.9	7.6	19.9	7.1	13.1	8.9	7.1	3.5	6.5	4.0	7.6	0.2	15.4	5.9	3.1	9.7	7.7	0.0	0.1	0.0	0.2	1.5	2.9	0.8	0.0	1.4	5.0	8.0	13.5	5.2	10.1	5.4	9.9	7.8	7.1	26.4	0.1	0.0	5.7	5.4	0.4	6.0	6.6	6.1	0.0	5.4	0.0	0.0	8.3	8.6	0.0	2.2	9.1	2.4	5.4	3.0	6.7	5.4	0.5	7.9	3.4	10.2	0.0	4.5	2.9	0.0	3.8	0.8	4.8	5.1	4.1	5.2	0.0	3.2	4.6	3.4	1.0	10.4	7.9	6.8	5.1	2.8	0.0	1.0	0.0	0.9	0.0	2.8	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.6	0.5	0.1	0.0	2.9	2.5	0.0	1.5	0.2	0.0	0.0	0.8	4.6	7.9	5.9	8.7	6.2	2.3	9.5	6.2	7.0	7.6
MOCS2	MOCO1	ENSG00000164172	"Molybdenum cofactor synthesis 2"	"O96007, O96033"	5	53095679-53110063	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037679, HPA037680"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA037679: AB_2675604, HPA037680: AB_10673635"	"unprognostic (3.27e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	"prognostic favourable (3.68e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.86e-2)"	18.1	34.6	41.5	9.8	38.0	4.0	19.6	21.7	41.8	16.0	17.1	20.7	10.4	17.6	14.8	28.2	17.0	12.9	15.9	39.9	36.7	32.1	49.7	52.0	13.1	11.4	30.0	22.4	21.2	18.4	30.4	23.3	16.2	28.7	18.6	14.9	17.2	21.2	20.8	38.3	8.9	17.6	16.1	27.1	10.7	16.6	11.0	20.0	8.2	31.5	19.4	11.2	16.9	15.4	16.9	12.5	6.3	10.9	17.3	25.8	12.9	20.1	16.6	12.0	28.6	24.6	22.7	15.2	24.8	26.1	22.2	26.3	22.6	15.2	20.7	37.5	19.6	12.3	24.0	25.5	35.0	5.2	23.4	15.9	16.3	20.4	25.3	17.1	11.9	18.0	12.8	25.2	22.4	23.8	15.3	11.3	36.9	30.0	18.5	9.8	10.6	34.5	9.3	25.8	18.8	38.4	15.4	8.9	10.3	18.1	14.8	18.6	28.6	4.4	15.2	21.3	22.0	18.9	31.9	13.2	19.6	23.4	30.5	4.9	32.8	5.2	9.2	6.3	16.9	10.9	20.2	16.5	19.0	19.2	12.5	16.9	25.8	22.2	1.7	17.3	9.8	11.4	18.3	12.9	41.5	38.0	21.7	41.8	36.7	32.1	30.0	22.4	28.7	20.0
MOGS	"CWH41, DER7, GCS1"	ENSG00000115275	"Mannosyl-oligosaccharide glucosidase"	Q13724	2	74461057-74465410	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011322, HPA011969"	Approved		Supported	"Endoplasmic reticulum"		88000000	88000000	"Endoplasmic reticulum"		"HPA011322: , HPA011969: AB_1849579"	"unprognostic (5.66e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavourable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (2.34e-6)"	"unprognostic (1.48e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.36e-1)"	"prognostic unfavourable (2.79e-8)"	"unprognostic (1.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	15.8	12.8	8.7	15.2	10.6	8.5	13.1	11.3	12.1	13.9	19.4	10.8	24.9	36.5	14.2	15.8	15.5	13.4	16.4	11.2	7.7	6.1	14.8	40.5	17.2	15.6	9.2	7.9	14.2	30.6	20.4	15.7	35.8	8.3	15.9	11.2	11.7	24.5	25.3	14.1	17.4	35.8	9.8	7.1	22.4	22.3	11.9	8.1	17.6	18.9	11.4	19.5	14.1	12.9	3.9	3.4	2.3	4.4	12.7	5.1	2.5	22.1	19.7	13.1	12.6	27.0	19.1	40.1	18.2	26.3	27.6	26.6	36.0	23.7	24.0	16.2	18.3	22.3	19.7	20.5	17.1	20.7	19.1	11.2	12.8	27.6	22.3	26.3	22.6	11.1	32.9	19.5	19.1	30.9	19.5	23.3	12.1	27.6	14.2	20.2	17.3	11.0	16.3	29.1	31.1	15.0	13.8	10.8	14.1	8.6	36.1	23.6	17.5	14.2	22.0	12.7	22.2	18.4	24.0	36.0	14.8	10.6	20.0	21.5	17.2	2.3	4.0	1.1	5.0	2.5	5.1	2.5	4.2	4.5	3.4	3.9	3.7	2.4	0.7	12.7	4.4	3.2	3.8	2.5	8.7	10.6	11.3	12.1	7.7	6.1	9.2	7.9	8.3	8.1
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.8;liver: 129.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria				Mitochondria		"HPA045119: AB_10960421, HPA055790: "	"unprognostic (3.30e-2)"	"prognostic favourable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favourable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favourable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	13.1	9.4	27.1	7.2	28.5	10.9	12.2	12.3	21.6	12.4	21.1	26.1	8.3	18.8	8.4	10.5	16.0	8.3	9.5	149.8	27.6	21.5	56.1	129.7	10.0	8.7	39.2	18.3	10.5	14.9	12.4	9.4	5.4	23.8	10.3	19.9	11.5	23.0	10.5	63.3	9.2	16.9	11.0	43.3	9.2	19.7	5.0	25.8	9.0	18.6	43.9	9.9	10.6	8.1	12.2	26.5	32.2	43.7	13.9	24.5	17.1	6.5	1.9	8.1	28.1	23.8	13.7	12.1	7.6	12.3	11.9	11.6	10.0	4.6	13.8	13.7	11.7	6.3	12.2	9.5	8.4	9.3	20.9	6.8	10.1	33.1	9.9	26.4	9.0	10.9	13.5	9.7	7.0	9.6	23.8	22.0	7.3	10.4	18.3	48.9	4.2	9.3	10.1	13.6	34.5	22.1	5.2	25.6	22.8	8.7	38.2	8.7	9.0	39.6	6.6	6.9	7.2	24.4	7.7	15.1	10.3	11.5	6.3	32.6	11.0	18.6	23.0	32.2	16.4	35.3	15.4	12.2	19.4	17.6	26.5	9.2	18.2	17.4	20.4	13.9	43.7	15.7	24.5	17.1	27.1	28.5	12.3	21.6	27.6	21.5	39.2	18.3	23.8	25.8
MPI		ENSG00000178802	"Mannose phosphate isomerase"	P34949	15	74890005-74902219	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007200	Approved		Approved	"Plasma membrane,Cytosol"		170000	170000	Cytosol	"Plasma membrane"	"HPA007200: AB_1854079"	"unprognostic (1.38e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.65e-3)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (2.39e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.58e-2)"	13.6	33.3	24.2	11.2	26.2	7.4	14.7	19.2	33.7	16.7	22.6	26.1	15.3	32.6	15.7	26.8	17.1	20.7	13.4	28.8	22.7	22.2	22.5	30.2	10.6	16.2	28.1	28.3	23.2	34.2	24.7	15.0	11.4	37.4	20.6	23.1	18.3	18.6	17.9	33.3	11.7	27.4	16.4	21.7	14.7	14.3	23.5	17.7	16.4	17.1	15.0	16.6	15.6	11.7	12.8	10.2	2.4	7.4	17.7	27.1	12.9	10.4	14.5	12.0	13.6	27.5	13.4	10.5	9.0	14.8	15.5	21.8	14.3	13.9	14.9	19.7	13.1	26.1	23.8	26.3	14.8	11.3	29.8	26.6	13.8	15.3	19.6	12.2	7.9	17.8	6.8	14.6	26.3	21.0	8.9	12.2	20.0	8.9	13.1	5.4	6.6	12.4	13.5	11.3	36.4	18.2	11.9	22.5	9.8	10.5	19.0	11.3	26.1	8.5	9.5	9.3	8.0	6.9	8.7	30.3	17.9	9.7	19.5	17.8	6.7	0.7	7.2	2.4	13.5	7.4	17.5	12.8	18.3	15.4	10.2	12.5	27.1	19.7	1.1	17.7	6.3	8.5	22.7	12.9	24.2	26.2	19.2	33.7	22.7	22.2	28.1	28.3	37.4	17.7
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269856-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 315.2"	"Group enriched"	"Detected in some"	93	"HL-60: 212.9;NB-4: 279.1"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"classical monocyte: 7.6;intermediate monocyte: 3.8;myeloid DC: 3.2;neutrophil: 2.0"	"Group enriched"	"Detected in many"	30	"dendritic cells: 3.2;granulocytes: 2.0;monocytes: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	15000000	15000000	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.2	0.1	0.5	0.1	0.8	315.2	0.1	0.4	1.0	0.1	0.1	1.4	0.0	0.1	0.2	0.2	0.1	0.1	0.1	21.5	0.6	0.8	0.1	1.4	6.9	0.8	0.6	0.0	0.6	0.1	0.1	1.0	2.9	0.4	0.2	0.1	0.2	6.3	0.1	0.7	0.5	0.1	0.1	0.4	17.8	0.1	0.4	0.2	19.7	0.6	0.0	0.5	0.1	0.0	0.0	3.2	2.0	7.6	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	279.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.6	0.0	0.0	3.8	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	2.0	0.0	0.8	0.0	0.1	7.2	0.5	0.8	0.4	1.0	0.6	0.8	0.6	0.0	0.4	0.2
MPST	"MST, TST2, TUM1"	ENSG00000128309	"Mercaptopyruvate sulfurtransferase"	P25325	22	37019635-37029822	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 106.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001240	Enhanced		Approved	Mitochondria,Cytosol		2800000	2800000	Mitochondria	Cytosol	"HPA001240: AB_1079408"	"unprognostic (7.18e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.98e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.52e-1)"	"prognostic favourable (5.89e-4)"	8.7	7.2	4.5	6.8	6.4	10.5	22.7	2.6	5.4	8.8	39.1	8.0	2.8	36.8	6.1	3.0	19.8	4.3	15.3	14.1	4.6	2.3	14.1	106.2	10.3	5.4	8.8	3.8	12.6	20.7	0.7	2.7	4.2	5.6	6.6	5.7	3.8	13.4	3.9	11.5	15.9	33.7	4.8	4.8	4.1	12.8	24.9	7.1	2.1	6.3	6.2	5.1	8.7	11.6	9.6	37.1	18.5	26.5	28.8	16.1	12.5	14.1	16.7	8.2	16.9	9.6	6.0	13.0	7.7	6.9	8.4	11.4	15.9	6.3	22.3	11.2	5.5	9.9	7.1	11.2	1.2	13.4	39.7	8.6	7.3	37.4	30.6	9.2	12.1	10.5	21.9	5.5	5.1	17.0	15.3	6.5	2.3	11.0	0.8	31.5	15.4	17.4	23.9	9.7	16.6	8.5	4.6	4.2	31.6	5.1	8.1	14.7	8.7	15.0	13.1	7.3	20.7	8.0	5.2	11.4	5.3	6.7	2.6	11.3	3.7	15.3	26.5	18.5	11.8	9.4	16.1	9.6	7.7	9.9	37.1	9.6	1.1	4.1	7.9	28.8	4.3	6.0	15.2	12.5	4.5	6.4	2.6	5.4	4.6	2.3	8.8	3.8	5.6	7.1
MPV17	SYM1	ENSG00000115204	"MPV17, mitochondrial inner membrane protein"	P39210	2	27309492-27325680	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																		"unprognostic (9.34e-3)"	"unprognostic (2.70e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (6.99e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.59e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.10e-3)"	"unprognostic (4.62e-2)"	25.2	49.2	25.5	18.3	26.6	13.8	20.9	15.2	41.5	20.0	15.1	29.5	8.4	12.8	20.7	25.3	17.0	20.4	18.7	39.5	24.0	23.6	25.0	16.0	20.2	19.8	24.9	22.9	23.6	17.7	26.3	21.2	17.5	27.7	17.7	18.1	28.8	18.4	19.2	8.8	15.0	13.4	30.1	25.8	20.5	15.1	10.3	22.8	15.2	26.8	12.6	23.8	21.0	14.7	30.7	45.6	18.7	35.8	26.4	30.1	30.7	17.7	16.8	12.4	10.7	52.4	60.5	11.8	17.6	35.5	17.0	15.3	13.4	13.0	10.1	18.4	23.9	15.2	15.8	33.0	17.7	13.8	12.8	18.8	14.8	25.1	31.4	11.3	12.4	59.3	28.4	29.9	43.0	24.8	18.1	19.3	27.6	25.8	10.9	15.8	13.9	13.4	15.7	17.0	20.5	36.3	14.4	8.3	26.8	9.3	11.0	18.7	12.3	14.7	22.0	17.1	17.3	21.0	18.5	26.0	24.9	30.6	27.8	23.9	18.9	18.7	35.8	15.7	24.0	29.8	26.1	30.7	25.0	27.0	45.6	26.5	24.2	27.9	3.2	26.4	28.3	33.0	30.1	30.7	25.5	26.6	15.2	41.5	24.0	23.6	24.9	22.9	27.7	22.8
MSMO1	"DESP4, ERG25, SC4MOL"	ENSG00000052802	"Methylsterol monooxygenase 1"	Q15800	4	165327623-165343160	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 171.6"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 61.6;HBEC3-KT: 61.1;Karpas-707: 69.6;RPTEC TERT1: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056127	Enhanced									"HPA056127: "	"unprognostic (5.76e-2)"	"prognostic unfavourable (2.97e-4)"	"unprognostic (3.35e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.28e-1)"	"prognostic favourable (9.21e-4)"	"unprognostic (2.39e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.40e-1)"	5.0	26.5	17.1	6.7	23.7	3.5	21.5	7.7	29.6	15.6	12.6	22.8	4.0	22.6	6.1	31.5	44.9	7.1	7.4	5.8	18.8	20.8	16.3	171.6	30.0	6.4	13.1	18.6	18.0	7.5	10.9	7.0	7.4	41.1	19.1	10.8	12.1	10.6	4.7	2.2	22.5	20.7	5.7	33.5	4.3	10.3	15.8	12.5	4.3	7.5	17.6	12.9	8.6	17.7	21.2	10.1	6.2	9.8	12.1	20.8	15.8	14.3	3.5	33.8	6.1	16.8	53.8	6.3	5.8	26.4	7.5	20.9	6.7	61.6	7.1	3.5	7.0	11.8	16.9	61.1	8.4	6.0	10.4	3.2	3.6	20.7	33.7	5.8	4.5	33.3	40.2	27.7	17.2	9.7	5.6	69.6	12.4	7.4	5.1	9.4	19.4	3.5	2.7	3.7	21.4	67.1	16.8	6.7	5.0	9.0	13.0	5.4	6.0	7.2	11.1	3.5	6.2	3.1	3.9	12.8	13.5	9.4	7.4	5.9	4.7	6.2	4.6	4.5	19.0	5.9	14.2	21.2	18.3	17.6	7.8	18.9	20.0	20.8	3.4	12.1	9.8	10.1	15.8	15.8	17.1	23.7	7.7	29.6	18.8	20.8	13.1	18.6	41.1	12.5
MSRB3	"DFNB74, DKFZp686C1178, FLJ36866"	ENSG00000174099	"Methionine sulfoxide reductase B3"	Q8IXL7	12	65278643-65491430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 75.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 37.7;U-937: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 23.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014432	Uncertain				"Intracellular and membrane"					"HPA014432: AB_1854146"	"unprognostic (1.40e-2)"	"prognostic unfavourable (3.84e-4)"	"unprognostic (2.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (8.85e-8)"	"unprognostic (3.29e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (2.17e-4)"	15.2	3.8	4.5	11.6	5.3	6.4	26.8	5.1	5.2	19.0	39.4	3.6	20.4	4.0	40.3	15.0	23.0	16.1	23.4	30.9	4.8	4.3	4.1	1.4	11.7	4.4	5.0	5.0	13.3	2.5	0.8	3.1	8.7	4.7	19.8	10.2	11.8	4.7	38.4	32.2	3.8	10.0	75.9	5.0	6.5	17.2	6.1	4.8	0.4	6.0	11.2	2.5	33.9	20.9	0.2	6.5	23.4	0.6	4.4	0.1	0.8	2.6	5.7	5.0	23.2	22.5	19.9	0.1	26.2	28.2	10.2	6.1	0.2	0.3	0.0	5.6	37.7	0.5	2.3	6.6	9.3	0.0	4.8	0.0	5.1	0.2	14.7	13.7	0.1	10.5	3.7	8.6	12.1	20.7	0.1	0.1	23.4	0.8	0.0	3.2	1.6	3.1	0.0	6.8	0.1	2.3	0.3	0.1	2.4	9.0	0.5	6.4	4.2	13.2	23.7	13.1	7.1	5.9	10.1	2.4	1.9	0.0	3.6	31.8	8.1	6.3	0.3	23.4	0.1	0.6	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	4.0	4.4	0.2	6.5	0.0	0.8	4.5	5.3	5.1	5.2	4.8	4.3	5.0	5.0	4.7	4.8
MST1R	"CD136, CDw136, PTK8, RON"	ENSG00000164078	"Macrophage stimulating 1 receptor"	Q04912	3	49887002-49903873	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.7;intestine: 34.3;skin 1: 28.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 35.3;HaCaT: 19.5;HBEC3-KT: 21.2;hTCEpi: 29.8;RT4: 22.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007657, HPA008180, CAB008972"	Enhanced		Approved	Cytosol				Cytosol		"CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291"	"unprognostic (3.84e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.00e-3)"	"prognostic favourable (2.33e-5)"	1.7	0.1	0.4	7.5	0.6	0.0	2.4	0.5	0.7	1.8	20.5	0.7	2.0	11.2	1.2	1.3	6.1	0.6	27.7	0.9	0.5	0.1	1.4	0.4	5.0	1.1	0.4	0.6	0.5	4.1	0.0	1.3	0.8	0.9	1.7	9.7	2.5	2.1	0.4	0.5	28.7	34.3	0.7	0.4	0.6	19.1	1.9	0.4	7.7	1.3	6.0	4.5	4.3	3.5	0.2	0.0	0.0	0.0	0.6	2.1	0.0	12.7	4.9	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.2	35.3	0.5	3.1	0.2	19.5	0.0	21.2	0.0	0.3	0.3	0.0	8.4	0.3	0.3	0.0	0.4	0.1	29.8	0.1	4.2	0.0	0.2	0.1	0.0	1.7	0.0	0.0	0.1	10.3	0.8	0.0	0.3	13.0	22.8	0.3	0.0	3.6	8.2	0.0	6.5	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.4	0.6	0.5	0.7	0.5	0.1	0.4	0.6	0.9	0.4
MT-CO1	"COI, COX1, MTCO1"	ENSG00000198804	"Mitochondrially encoded cytochrome c oxidase I"	P00395	MT	5904-7445	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Deafness, Disease mutation, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7"	"Cell line enhanced"	"Detected in all"		"HeLa: 859.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016241, HPA069328"	Enhanced		Supported	Mitochondria				Mitochondria		"CAB016241: AB_2229888, HPA069328: "	"unprognostic (4.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.31e-1)"	"prognostic favourable (2.29e-4)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.44e-2)"	57.6	82.5	184.1	22.2	164.2	26.4	37.4	40.6	117.1	31.5	80.8			78.1	25.7	42.7	43.5	24.8	32.4	345.0	161.8	111.7	151.0	150.5	20.9	22.6	126.3		23.7	42.5	62.3	10.1	29.0		35.8	84.4		65.6	54.2	380.7	68.9	60.0	38.2	61.2	28.1	65.5	27.8			23.8		21.9	31.6	15.3	292.2	232.9	177.4	396.5	182.8	192.4	130.5	112.7	170.5	232.0	252.3	531.8	243.6	246.0	257.3	85.7	65.0	108.8	205.2	367.8	298.0	123.7	195.5	428.5	26.5	228.0	93.1	140.8	162.5	178.9	859.1	383.8	73.7	103.2	226.6	284.1	237.4	64.2	142.7	78.2	113.5	213.9	192.4	273.1	84.4	462.1	58.9	139.6	110.6	69.3	178.8	329.5	298.3	110.9	147.9	89.2	345.8	160.5	198.4	347.4	311.5	260.6	177.4	255.7	129.0	101.3	97.0	67.6	128.7	272.4	126.6	177.4	396.5	169.3	156.6	236.0	176.4	255.6	154.9	171.8	163.0	292.2	159.7	192.4	93.5	182.8	260.1	232.9	138.6	130.5										
MT-CO2	"CO2, COX2, MTCO2"	ENSG00000198712	"Mitochondrially encoded cytochrome c oxidase II"	P00403	MT	7586-8269	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 489.9;skeletal muscle: 343.4"	"Cell line enhanced"	"Detected in all"		"HeLa: 1055.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016243, HPA051505, HPA054758"	Enhanced					1300000	1300000			"CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595"	"unprognostic (2.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.96e-2)"	"prognostic favourable (2.89e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.72e-3)"	"prognostic favourable (7.10e-4)"	"unprognostic (1.25e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.72e-3)"	54.6	64.8	149.7	21.7	194.8	30.2	45.5	48.9	99.5	27.0	106.9			73.6	23.8	46.3	35.8	25.1	23.7	252.1	151.9	112.4	158.4	173.8	22.7	22.8	154.6		21.2	46.4	50.4	22.5	41.4		38.2	106.4		61.7	56.0	343.4	56.4	51.1	40.0	77.8	25.9	68.5	28.2			23.3		29.5	29.9	16.2	379.8	278.1	489.9	409.1	220.4	273.9	181.4	109.3	176.1	234.4	226.5	479.4	184.8	172.7	142.7	115.8	81.1	122.6	189.3	247.3	228.7	119.5	209.8	415.6	31.0	293.5	109.9	177.1	158.8	164.0	1055.8	364.0	104.4	137.9	184.3	271.0	434.3	41.7	149.8	89.8	153.1	223.1	222.2	236.8	100.8	397.3	61.3	112.1	105.4	71.4	191.6	330.8	305.7	87.7	145.1	117.5	289.9	206.1	201.8	559.1	221.4	196.6	170.7	185.4	100.3	113.3	112.7	129.0	104.6	278.6	129.1	489.9	409.1	476.0	194.9	292.9	236.6	379.8	217.1	218.8	205.5	378.1	227.9	273.9	180.3	220.4	308.7	278.1	170.3	181.4										
MT-CO3	"CO3, COIII, COX3, MTCO3"	ENSG00000198938	"Mitochondrially encoded cytochrome c oxidase III"	P00414	MT	9207-9990	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 319.5"	"Cell line enhanced"	"Detected in all"		"HeLa: 798.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042788	Approved									"HPA042788: AB_10793985"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.93e-1)"	"prognostic favourable (2.01e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.05e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.33e-2)"	56.5	83.7	174.1	20.5	149.4	34.8	55.5	47.4	106.2	30.5	90.9			76.1	27.5	46.0	40.4	26.3	28.7	290.4	159.6	111.4	190.3	143.1	21.0	22.8	120.2		27.9	38.9	60.5	26.7	32.5		37.3	95.5		79.0	64.3	319.5	70.0	55.3	39.0	61.9	21.7	60.5	36.5			31.0		31.0	26.9	18.7	247.1	126.7	244.3	245.3	141.7	181.1	106.8	128.9	153.1	235.3	334.1	468.7	193.4	128.7	168.0	99.6	66.4	102.5	204.9	192.7	288.5	72.8	139.5	354.1	37.0	201.8	117.7	97.8	161.8	153.4	798.5	340.3	94.7	91.2	202.1	185.7	287.1	73.0	108.9	122.8	121.5	292.4	219.2	263.4	92.6	532.0	52.2	110.5	99.1	74.2	207.9	413.9	228.0	105.4	146.4	78.3	85.8	162.3	179.3	402.5	196.6	111.4	190.9	207.8	109.6	120.4	77.5	161.1	111.2	297.5	73.1	132.0	245.3	121.5	110.0	128.3	137.4	198.7	119.5	127.0	126.7	247.1	153.2	181.1	244.3	141.7	122.3	107.8	79.5	106.8										
MT-ND1	"MTND1, NAD1, ND1"	ENSG00000198888	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1"	P03886	MT	3307-4262	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Alzheimer disease, Amyloidosis, Diabetes mellitus, Disease mutation, Epilepsy, Leber hereditary optic neuropathy, MELAS syndrome, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 314.4;skeletal muscle: 398.2"	"Cell line enhanced"	"Detected in all"		"HeLa: 660.0"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"basophil: 314.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 314.4"	"Low region specificity"	"Detected in all"							CAB033779	Approved									"CAB033779: AB_2149736"	"prognostic favourable (3.63e-4)"	"unprognostic (3.55e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.05e-2)"	"prognostic favourable (3.26e-4)"	"unprognostic (8.67e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.85e-2)"	83.5	48.0	118.0	15.2	136.1	17.7	31.8	45.0	85.9	19.6	58.3			40.2	16.3	43.4	30.7	16.7	17.6	223.1	106.1	74.3	96.0	104.7	20.5	12.1	101.8		14.2	48.2	35.1	14.3	32.2		26.6	58.6		71.2	48.4	398.2	75.4	33.3	24.6	55.2	16.7	45.0	29.8			13.8		17.1	19.9	9.4	60.8	32.2	314.4	54.4	35.8	46.4	19.5	99.9	102.3	83.9	76.4	318.6	58.0	107.9	86.3	25.5	24.0	25.3	177.8	109.1	122.7	54.9	65.0	66.8	9.2	51.9	48.1	87.5	72.1	136.6	660.0	251.9	68.4	64.6	135.0	137.5	142.0	37.1	53.5	25.7	62.8	76.7	71.0	137.5	52.0	267.8	22.5	77.1	54.8	38.1	65.9	132.8	162.3	34.9	55.6	47.8	76.6	83.7	68.3	224.3	135.2	80.2	72.5	102.2	71.6	85.2	52.5	56.8	53.9	114.6	21.9	314.4	54.4	103.0	25.7	31.4	37.3	54.3	30.8	34.0	20.6	60.8	41.1	46.4	157.8	35.8	32.0	32.2	22.0	19.5										
MT-ND2	"MTND2, NAD2, ND2"	ENSG00000198763	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2"	P03891	MT	4470-5511	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Alzheimer disease, Amyloidosis, Disease mutation, Leber hereditary optic neuropathy, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 432.3"	"Cell line enhanced"	"Detected in all"		"HeLa: 601.0"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in all"	5	"basophil: 432.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 432.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (5.82e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.77e-1)"	"unprognostic (4.79e-2)"	"unprognostic (9.56e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.55e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.92e-2)"	"unprognostic (4.35e-2)"	93.0	57.2	116.0	16.9	169.9	15.6	33.9	40.1	73.5	22.6	53.7			50.1	21.5	59.8	29.0	22.1	19.3	262.4	112.2	85.2	125.9	128.9	20.9	14.7	113.0		25.1	62.0	24.3	20.3	37.0		28.1	59.0		85.3	41.0	263.4	72.7	39.2	24.6	72.4	15.2	49.2	27.3			18.2		17.7	23.8	13.1	66.1	43.5	432.3	54.8	43.0	57.9	21.8	92.8	102.3	91.6	154.4	330.8	59.0	86.6	86.7	21.7	23.2	29.3	128.7	125.5	133.3	82.5	62.2	166.7	14.4	108.4	50.2	116.0	74.5	153.8	601.0	207.5	67.8	149.2	179.0	97.6	198.2	57.0	56.5	34.0	112.1	130.7	55.7	109.8	84.6	241.4	45.9	67.0	74.4	51.3	111.8	171.8	143.7	57.3	68.7	37.5	115.2	138.2	177.3	172.5	107.5	87.2	108.0	122.6	109.8	85.5	73.2	112.2	56.6	128.8	39.0	432.3	54.8	93.1	34.1	39.7	54.7	58.6	39.5	42.5	23.0	66.1	48.5	57.9	88.6	43.0	45.7	43.5	25.9	21.8										
MT-ND3	"MTND3, NAD3, ND3"	ENSG00000198840	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3"	P03897	MT	10059-10404	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 357.8"	"Cell line enhanced"	"Detected in all"		"ASC diff: 639.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063296	Enhanced		Approved	Cytosol				Cytosol		"HPA063296: "	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"prognostic favourable (4.63e-5)"	"unprognostic (2.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-3)"	102.1	73.9	117.3	17.6	137.2	17.9	59.3	33.7	70.5	31.2	76.3			64.0	25.9	49.2	21.7	24.7	19.7	256.8	110.3	81.7	138.1	145.8	19.7	17.4	92.0		27.5	77.8	14.6	22.2	34.6		39.1	59.1		67.6	50.7	357.8	42.2	48.9	28.4	66.8	19.1	60.6	21.0			25.0		20.3	24.2	15.9	84.8	32.6	159.6	48.5	48.6	75.3	24.4	84.7	138.5	92.5	90.7	639.2	128.1	77.0	71.4	42.0	38.8	43.9	208.4	132.2	88.4	111.0	91.8	176.8	39.7	156.2	66.7	126.6	190.5	86.9	461.1	343.0	99.8	127.8	131.5	221.5	289.5	64.9	73.3	60.3	68.4	103.3	73.1	277.1	67.1	170.7	47.5	128.2	58.2	90.9	81.3	235.9	234.2	38.1	82.9	34.5	69.2	141.3	160.1	206.6	102.3	60.0	91.1	104.2	76.4	40.2	52.6	190.4	48.7	77.7	34.0	159.6	48.5	36.6	36.7	36.4	49.8	73.1	42.6	44.8	32.6	84.8	63.1	75.3	100.7	48.6	32.7	32.3	27.6	24.4										
MT-ND4	"LHON, MTND4, NAD4, ND4"	ENSG00000198886	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4"	P03905	MT	10760-12137	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 392.9"	"Cell line enhanced"	"Detected in all"		"HeLa: 810.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053928	Approved									"HPA053928: "	"unprognostic (8.39e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (1.76e-4)"	"unprognostic (1.01e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.24e-2)"	82.5	72.4	124.2	19.8	138.2	14.9	34.5	43.8	78.5	34.1	68.7			56.5	27.8	37.1	32.9	25.2	23.7	292.7	122.4	90.3	129.8	178.5	20.8	17.4	101.6		25.5	58.3	37.8	19.7	39.1		37.3	82.1		61.7	65.6	288.4	61.1	41.0	37.8	63.6	21.7	67.7	29.6			24.3		23.4	26.0	15.3	164.7	87.6	392.9	119.5	87.1	129.7	53.0	101.4	105.5	137.2	202.5	322.5	81.3	96.1	103.3	39.6	24.0	46.9	160.1	116.2	180.6	91.2	88.0	190.1	12.2	167.3	43.1	104.2	66.4	111.2	810.9	268.4	48.7	111.7	132.3	137.5	177.3	35.3	126.8	58.0	92.6	223.7	86.4	228.8	44.0	253.9	38.8	71.8	59.8	43.1	108.9	175.6	219.4	50.6	68.5	60.1	199.9	103.3	139.9	264.1	160.8	98.3	95.6	131.5	80.0	134.2	54.4	80.4	64.1	194.2	52.2	392.9	119.5	268.8	82.9	91.3	115.5	148.0	93.0	98.9	65.9	164.7	109.6	129.7	105.7	87.1	89.0	87.6	67.6	53.0										
MT-ND4L	"MTND4L, NAD4L, ND4L"	ENSG00000212907	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L"	P03901	MT	10470-10766	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 434.4;skeletal muscle: 294.4"	"Cell line enhanced"	"Detected in all"		"HeLa: 879.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA075648			Approved	Mitochondria				Mitochondria		"HPA075648: "	"unprognostic (5.81e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (4.47e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.63e-3)"	"unprognostic (6.61e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.97e-2)"	"unprognostic (5.68e-2)"	101.1	71.9	102.4	20.3	114.5	13.2	39.4	41.5	73.3	39.4	83.8			48.0	26.1	34.1	30.7	23.9	23.4	187.5	102.7	79.1	123.5	185.7	20.2	13.1	88.6		26.2	43.4	29.7	18.5	30.9		34.2	80.0		43.2	75.4	294.4	31.8	38.4	38.6	59.2	16.1	62.5	27.5			24.6		24.4	25.8	14.3	200.8	111.2	434.4	139.9	112.1	153.0	66.8	96.4	89.7	161.9	164.8	567.3	119.4	71.4	207.0	51.9	32.5	59.4	149.1	89.1	239.3	84.9	139.8	183.9	25.1	221.6	64.7	94.2	103.6	172.0	879.2	276.9	83.3	176.8	154.7	209.0	227.1	61.9	216.8	65.0	94.8	171.6	119.0	172.3	67.2	226.9	40.8	108.4	39.0	69.8	106.4	172.8	203.7	49.1	66.5	101.6	160.9	69.4	114.4	222.6	207.8	85.3	106.2	124.8	79.2	155.3	72.7	127.4	61.2	240.6	39.8	434.4	139.9	290.0	102.4	110.6	140.6	166.9	110.0	117.5	86.1	200.8	132.4	153.0	78.4	112.1	99.4	111.2	79.0	66.8										
MT-ND5	"MTND5, NAD5, ND5"	ENSG00000198786	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5"	P03915	MT	12337-14148	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 193.9;heart muscle: 190.3;skeletal muscle: 223.2"	"Cell line enhanced"	"Detected in all"		"HeLa: 362.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.87e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.29e-3)"	"unprognostic (4.78e-2)"	"prognostic favourable (7.31e-5)"	"unprognostic (9.93e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.68e-2)"	47.2	30.4	71.2	14.8	94.5	11.3	16.5	23.2	45.8	13.6	30.3			38.9	16.6	24.9	26.2	21.4	19.1	190.3	65.0	52.8	56.3	66.6	19.3	9.4	56.1		18.6	22.9	23.1	7.9	15.1		27.5	28.0		25.7	21.5	223.2	63.9	29.5	25.3	37.9	12.6	41.4	14.6			12.8		13.2	24.9	8.0	124.1	89.3	193.9	123.4	79.6	99.3	33.7	69.1	73.7	90.2	87.1	272.5	71.4	48.6	142.1	21.8	15.9	26.7	108.2	91.2	168.2	72.1	66.3	148.5	8.4	74.6	26.6	94.1	57.4	123.2	362.2	182.8	31.4	86.1	128.3	106.6	59.7	18.1	43.4	32.1	44.8	80.5	54.4	131.1	32.2	106.4	17.8	40.4	61.9	42.3	72.1	96.6	137.8	27.0	41.2	66.2	118.6	39.5	86.3	129.4	224.8	92.1	64.2	108.4	55.0	30.7	53.1	46.9	49.2	78.7	40.0	193.9	123.4	79.9	81.3	100.2	99.3	99.4	79.3	87.3	73.4	124.1	78.5	86.6	45.3	79.6	95.9	89.3	62.1	33.7										
MT-ND6	"MTND6, NAD6, ND6"	ENSG00000198695	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6"	P03923	MT	14149-14673	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Dystonia, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 395.3;skeletal muscle: 593.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 514.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.96e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.02e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.06e-3)"	"unprognostic (2.91e-1)"	"prognostic favourable (8.91e-6)"	"unprognostic (3.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.92e-2)"	79.2	43.1	55.5	34.4	78.5	30.7	9.6	14.7	76.1	5.9	30.2			90.3	19.2	0.0	69.5	23.2	40.2	395.3	50.7	41.2	65.5	42.8	28.5	25.9	41.9		23.2	48.0	0.0	3.5	10.3		28.0	0.3		48.1	0.0	593.2	176.3	63.8	0.0	24.8	19.9	53.2	22.7			17.5		0.0	32.3	5.7	127.3	91.2	164.8	108.2	88.8	104.3	29.7	97.5	79.2	70.1	88.9	11.8	1.1	50.3	131.9	0.2	0.4	0.4	107.6	99.0	210.5	89.8	3.5	146.0	0.7	2.4	0.7	124.3	60.8	126.1	514.1	307.3	0.9	79.8	119.1	2.0	3.2	3.2	2.7	0.7	54.2	82.7	2.9	208.4	24.5	110.1	15.2	38.9	59.6	44.8	90.4	1.9	287.8	28.9	46.4	68.7	121.0	54.5	93.7	155.6	268.3	77.9	65.8	110.3	52.8	28.3	75.5	50.5	52.9	81.4	45.2	164.8	108.2	68.3	89.1	103.5	104.3	118.4	94.5	96.1	66.2	127.3	94.7	102.4	53.7	88.8	103.7	91.2	71.8	29.7										
MTAP	"c86fus, MSAP"	ENSG00000099810	"Methylthioadenosine phosphorylase"	Q13126	9	21802543-21937651	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046915			Approved	Cytosol		3100000	3100000	Cytosol		"HPA046915: "	"unprognostic (1.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.78e-1)"	"unprognostic (6.16e-2)"	"prognostic unfavourable (4.68e-4)"	"unprognostic (9.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	17.0	12.6	7.8	12.6	10.4	8.4	13.9	4.6	10.2	17.3	14.5	12.8	13.4	8.0	21.2	11.6	19.6	12.2	16.9	11.4	7.9	7.7	13.0	17.5	11.4	13.0	12.0	6.2	20.5	17.2	17.6	14.4	17.5	12.3	17.0	13.1	14.3	14.6	15.9	10.8	11.8	10.3	19.9	14.3	17.9	11.7	7.9	10.1	19.1	11.7	14.3	16.2	19.7	17.2	9.3	8.4	1.4	6.9	8.5	8.2	3.5	14.2	2.2	11.6	9.7	9.5	9.8	13.0	20.8	10.2	10.6	12.2	9.8	6.7	7.1	6.5	9.9	6.6	11.8	29.4	18.0	0.1	9.7	0.1	27.0	12.9	9.3	11.4	12.7	11.8	0.0	19.5	21.4	11.0	0.1	9.6	11.1	2.0	13.0	0.3	13.5	17.4	0.1	8.8	12.5	9.1	0.1	6.6	7.5	6.8	8.0	10.3	5.2	0.2	11.9	0.1	7.5	0.1	16.6	6.4	11.3	14.9	0.1	11.3	6.1	1.4	6.9	0.3	5.0	5.4	8.2	7.7	7.2	5.6	8.4	9.3	6.5	5.9	1.0	8.5	3.4	8.0	4.1	3.5	7.8	10.4	4.6	10.2	7.9	7.7	12.0	6.2	12.3	10.1
MTFMT	FMT1	ENSG00000103707	"Mitochondrial methionyl-tRNA formyltransferase"	Q96DP5	15	65001512-65029639	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Transferase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040710	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040710: AB_10794879"	"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.28e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.78e-1)"	"prognostic favourable (3.31e-8)"	"unprognostic (2.75e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.85e-2)"	8.7	10.2	7.9	10.0	11.5	11.6	7.5	13.5	12.7	9.5	12.7	6.8	8.0	9.7	11.8	10.6	9.5	10.9	9.7	13.8	8.0	7.8	12.8	13.4	8.4	8.6	6.8	9.4	14.0	5.9	7.3	9.3	7.5	10.3	10.8	10.8	12.2	8.7	9.8	13.3	11.6	13.9	12.0	5.7	9.2	8.7	7.2	5.2	9.2	11.7	4.6	8.8	12.0	9.1	5.0	9.6	16.9	3.6	4.6	5.9	1.9	2.6	3.6	3.5	6.1	5.0	3.5	3.1	2.4	4.3	3.2	3.0	2.2	3.0	9.1	3.3	4.4	7.7	6.5	4.3	3.1	3.5	4.8	3.9	3.4	2.5	5.9	5.3	1.2	5.1	5.4	1.7	3.8	2.9	4.1	4.4	4.8	3.6	4.2	5.6	4.8	6.2	3.9	5.1	4.2	5.2	3.1	3.6	3.6	5.8	5.4	4.4	3.3	3.8	5.3	3.8	3.9	4.4	4.8	3.7	5.4	3.6	3.3	8.6	3.9	3.1	3.6	2.4	4.9	2.9	4.9	4.7	4.9	5.2	5.6	5.0	5.5	5.9	16.9	4.6	2.0	9.6	4.9	1.9	7.9	11.5	13.5	12.7	8.0	7.8	6.8	9.4	10.3	5.2
MTHFD1	"MTHFC, MTHFD"	ENSG00000100714	"Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1"	P11586	14	64388031-64463457	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis"	"Hydrolase, Ligase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 121.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000704, HPA001290, HPA015006, HPA050052"	Approved		Enhanced	Cytosol		250000	250000	Cytosol		"HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: "	"unprognostic (3.58e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.85e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.84e-1)"	"prognostic favourable (5.93e-5)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.29e-2)"	18.9	9.0	8.1	8.4	18.1	9.7	12.2	5.7	15.9	7.1	9.3	9.0	4.0	7.5	8.5	6.9	12.0	6.7	6.4	10.6	8.4	6.5	20.5	121.6	6.8	9.2	8.0	10.4	10.1	13.4	13.1	5.6	5.6	10.0	5.5	11.4	9.3	11.6	5.6	26.5	7.6	7.3	8.8	6.9	8.3	7.9	2.3	7.4	15.6	8.6	14.0	12.5	8.7	7.3	21.1	12.8	0.5	13.2	12.8	14.9	8.4	72.1	41.1	15.6	34.0	16.8	13.7	25.3	28.3	19.5	36.8	36.5	39.9	33.3	30.4	13.4	16.8	35.5	48.2	28.2	43.1	30.1	31.7	37.6	41.2	30.2	12.4	28.8	20.5	10.7	9.1	32.8	17.8	22.9	28.0	25.0	27.8	59.9	46.4	16.9	28.6	43.6	37.1	54.3	27.5	27.6	42.3	33.8	13.1	47.4	25.8	14.2	40.1	14.6	14.1	27.8	48.1	25.5	33.9	16.7	20.5	53.5	25.4	33.4	31.4	0.2	8.2	0.1	8.1	13.2	10.9	21.1	9.0	9.9	12.8	11.6	7.6	10.1	0.5	12.8	10.3	3.2	14.9	8.4	8.1	18.1	5.7	15.9	8.4	6.5	8.0	10.4	10.0	7.4
MTHFR		ENSG00000177000	"Methylenetetrahydrofolate reductase"	P42898	1	11785723-11806920	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063389, HPA076180, HPA077255"	Enhanced		Approved	"Cell Junctions"				"Cell Junctions"		"HPA063389: , HPA076180: , HPA077255: "	"unprognostic (3.25e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.34e-1)"	"prognostic favourable (3.97e-5)"	"prognostic unfavourable (1.19e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.69e-2)"	"prognostic favourable (4.81e-5)"	"unprognostic (3.10e-1)"	"prognostic favourable (2.12e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	11.7	11.0	8.9	10.3	12.4	24.5	9.7	15.3	15.8	9.0	10.4	13.5	8.3	10.7	10.4	54.5	11.3	12.7	10.9	23.4	9.2	8.6	12.0	12.4	16.2	13.3	9.9	10.7	28.8	11.2	6.7	17.5	6.6	10.7	10.2	9.1	14.1	7.3	7.2	15.3	13.2	13.6	10.9	7.4	18.3	13.6	10.6	10.9	10.2	15.8	9.8	11.7	10.4	17.9	4.9	3.2	4.7	7.4	3.4	4.7	2.3	1.3	5.8	6.7	7.7	6.7	10.3	1.1	4.1	8.7	3.9	3.4	5.3	8.5	11.2	2.3	4.2	2.6	4.8	3.9	1.7	5.3	4.3	8.2	7.3	1.5	9.0	4.5	10.7	9.0	4.0	3.0	3.2	6.1	26.9	7.4	4.0	1.8	4.9	2.1	2.2	2.1	5.1	3.7	12.4	6.3	7.0	6.6	11.4	5.1	5.0	8.0	7.9	7.1	5.4	3.9	3.3	4.6	1.0	4.1	5.6	20.9	4.8	10.4	3.6	1.1	3.8	1.9	4.7	7.4	1.8	3.0	1.6	2.5	3.2	4.9	2.4	2.7	4.7	3.4	6.9	1.5	1.0	2.3	8.9	12.4	15.3	15.8	9.2	8.6	9.9	10.7	10.7	10.9
MTM1		ENSG00000171100	"Myotubularin 1"	Q13496	X	150568619-150673322	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010008, HPA010665"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA010008: AB_1079426, HPA010665: AB_1079425"	"unprognostic (3.66e-3)"	"unprognostic (8.43e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.74e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.59e-2)"	"prognostic favourable (7.40e-7)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	10.7	17.9	15.0	10.2	16.4	11.1	9.2	10.6	10.8	9.1	21.5	12.5	12.7	12.8	10.9	10.9	11.1	11.1	8.0	9.0	14.3	12.0	17.9	19.9	12.2	12.4	17.3	9.3	13.8	7.5	21.4	11.9	21.5	12.9	9.5	21.6	8.3	10.2	12.9	11.2	10.2	21.0	8.0	17.2	15.3	8.6	12.1	16.4	14.5	12.7	8.3	13.9	8.5	9.1	6.9	7.9	18.4	7.2	10.1	7.7	4.6	8.5	3.9	5.5	2.0	5.0	5.0	3.5	4.1	5.6	4.7	5.2	3.0	4.7	13.8	7.3	5.2	6.1	4.0	7.9	5.8	3.7	3.5	3.7	3.7	9.1	3.8	15.3	12.5	3.0	9.5	3.8	8.1	6.1	2.3	12.8	5.7	2.8	4.2	15.8	2.8	5.1	5.1	3.1	2.7	8.1	4.8	1.4	1.5	3.5	7.4	5.2	2.6	22.3	5.3	3.1	1.9	8.1	4.2	2.6	5.9	13.1	4.0	9.4	5.1	17.6	6.3	18.4	1.5	7.2	4.9	5.5	6.8	5.2	7.9	6.9	6.5	3.9	8.5	10.1	6.2	5.1	7.7	4.6	15.0	16.4	10.6	10.8	14.3	12.0	17.3	9.3	12.9	16.4
MTMR2	"CMT4B, KIAA1073"	ENSG00000087053	"Myotubularin related protein 2"	Q13614	11	95832882-95925315	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049831	Approved		Supported	Vesicles				Vesicles		"HPA049831: "	"unprognostic (1.71e-2)"	"unprognostic (2.55e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.18e-3)"	"unprognostic (5.36e-2)"	"prognostic unfavourable (1.61e-8)"	"unprognostic (3.23e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavourable (3.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.03e-3)"	16.4	10.4	14.2	12.1	19.9	5.3	15.4	14.9	23.3	14.1	13.5	22.6	4.9	8.0	14.1	7.5	15.5	13.3	15.4	13.8	18.1	13.9	16.9	4.5	14.3	13.6	27.5	13.6	14.5	11.0	15.9	8.2	25.1	21.3	17.6	14.5	19.6	18.8	12.3	6.8	9.7	9.5	18.2	30.0	10.5	13.6	29.0	21.8	12.2	11.3	7.7	11.7	13.4	14.3	5.4	6.6	9.7	4.9	11.8	14.2	6.6	9.2	9.9	22.9	16.5	8.0	12.5	19.1	17.3	15.5	17.3	15.6	23.4	18.8	6.6	20.8	18.3	12.9	18.6	18.9	15.5	12.2	9.0	13.9	24.8	13.1	18.4	23.4	11.4	10.4	12.6	22.6	22.7	25.9	17.1	6.4	16.1	6.9	11.6	10.9	18.6	14.1	9.8	13.4	6.3	17.7	49.8	14.6	17.1	17.1	14.5	7.7	11.5	10.0	26.5	20.1	18.5	14.7	15.9	6.0	16.5	6.1	8.5	6.5	20.4	9.7	3.3	1.4	11.4	3.9	12.3	5.4	7.7	14.2	6.6	4.8	4.1	11.0	0.9	11.8	4.9	3.4	6.9	6.6	14.2	19.9	14.9	23.3	18.1	13.9	27.5	13.6	21.3	21.8
MTPAP	"FLJ10486, mtPAP, PAPD1, SPAX4"	ENSG00000107951	"Mitochondrial poly(A) polymerase"	Q9NVV4	10	30309801-30374448	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transcription"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038620, HPA058232"	Approved		Supported	Mitochondria				Mitochondria		"HPA038620: AB_10673015, HPA058232: "	"unprognostic (2.76e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (4.20e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.39e-2)"	10.9	12.7	9.9	10.2	12.4	32.8	11.1	12.4	16.1	9.6	9.9	7.3	6.5	11.0	10.4	7.0	12.6	9.5	7.6	11.5	7.8	7.2	10.6	11.1	9.4	10.5	11.9	13.0	11.4	18.9	9.5	7.2	10.0	11.4	8.0	12.0	8.2	10.7	10.2	22.3	13.1	10.0	14.3	9.0	9.3	9.7	10.6	8.3	6.7	11.0	12.4	10.5	11.7	9.1	15.6	22.9	18.4	24.4	16.9	17.1	8.3	14.2	14.2	9.0	13.1	8.9	8.4	11.7	9.9	3.5	10.1	10.6	15.0	20.0	20.3	7.1	6.5	16.8	17.4	11.5	12.4	10.2	13.6	20.6	13.4	15.1	9.3	13.4	16.2	8.2	10.8	11.3	6.8	11.0	22.2	16.0	7.6	11.9	16.1	11.9	6.1	7.7	16.3	16.0	18.9	9.3	9.5	14.9	12.0	9.0	9.4	13.8	9.0	8.7	10.5	10.7	13.8	14.9	11.0	3.6	8.6	27.8	9.2	24.7	3.7	16.4	18.5	18.4	16.2	24.4	17.1	15.6	15.4	15.6	22.9	13.1	16.7	16.8	3.0	16.9	18.1	12.0	15.5	8.3	9.9	12.4	12.4	16.1	7.8	7.2	11.9	13.0	11.4	8.3
MTRR	cblE	ENSG00000124275	"5-methyltetrahydrofolate-homocysteine methyltransferase reductase"	Q9UBK8	5	7851186-7906025	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038113	Supported		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"				Nucleoplasm	"Intermediate filaments, Cytosol"	"HPA038113: AB_10671520"	"unprognostic (1.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (6.60e-4)"	"unprognostic (2.56e-2)"	"unprognostic (5.82e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	12.2	12.3	11.2	10.5	13.8	5.4	9.7	15.6	14.3	10.8	10.4	24.1	11.5	10.3	17.3	15.9	10.5	11.3	13.3	15.8	14.2	12.9	22.0	23.9	14.9	11.4	18.1	9.6	13.6	13.6	9.4	13.1	11.6	16.6	10.8	11.9	13.6	11.3	7.4	34.6	10.5	11.5	14.2	22.1	9.3	9.2	8.4	12.5	8.1	14.7	9.9	13.5	13.6	8.8	4.6	4.8	4.6	6.8	3.4	11.4	4.2	9.3	8.8	4.7	10.4	17.9	5.8	13.3	14.5	8.6	7.2	8.2	13.2	7.5	15.7	13.9	11.6	6.0	7.2	7.1	13.6	9.9	8.1	7.5	30.5	7.0	10.9	11.4	3.2	9.4	6.5	12.2	9.0	4.7	9.7	11.9	4.2	1.8	7.3	5.8	3.5	9.8	6.0	5.0	6.6	7.8	7.3	7.3	0.9	25.4	18.5	15.9	5.7	8.9	7.2	16.8	10.6	12.9	11.3	17.7	5.8	12.9	12.2	25.2	8.9	4.6	5.1	4.1	5.5	6.8	9.5	4.6	9.2	7.9	4.8	4.1	5.4	5.1	0.1	3.4	5.4	2.7	11.4	4.2	11.2	13.8	15.6	14.3	14.2	12.9	18.1	9.6	16.6	12.5
MUSK		ENSG00000030304	"Muscle associated receptor tyrosine kinase"	O15146	9	110668771-110801620	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein, Kinase, Muscle protein, Receptor, Transferase, Tyrosine-protein kinase"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 50.0"	"Group enriched"	"Detected in some"	15	"LHCN-M2: 19.3;RH-30: 19.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 4.5"	"Not detected"	"Not detected"														"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.20e-2)"		"unprognostic (1.50e-2)"		"unprognostic (2.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.03e-5)"	"unprognostic (4.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.11e-2)"	7.5	0.3	0.6	5.8	0.7	0.0	0.2	0.1	0.2	0.3	6.8	0.0	0.0	2.3	0.2	4.0	3.8	0.1	2.1	3.2	0.9	0.7	0.2	0.5	4.2	0.9	0.2	0.1	0.3	0.3	0.0	0.2	0.6	0.3	1.9	5.3	0.0	0.4	0.0	50.0	0.3	5.0	3.0	0.3	0.2	2.6	5.9	0.0	0.0	0.3	1.4	3.9	3.6	2.9	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.4	0.2	0.0	19.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.1	0.2	0.9	0.7	0.2	0.1	0.3	0.0
MUTYH	MYH	ENSG00000132781	"MutY DNA glycosylase"	Q9UIF7	1	45329163-45340470	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008732	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA008732: AB_1854219"	"unprognostic (6.30e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavourable (4.76e-8)"	"unprognostic (2.80e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.05e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (7.25e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.57e-2)"	"unprognostic (5.49e-3)"	7.7	8.4	10.3	12.7	14.8	11.1	8.3	31.6	12.4	10.5	10.1	15.1	11.0	11.1	11.5	9.8	8.3	11.0	10.0	6.1	10.9	7.3	9.7	9.0	7.2	14.0	13.6	10.1	12.9	8.4	7.5	12.5	12.5	11.6	9.1	11.0	12.6	9.5	11.7	8.5	11.1	9.8	7.5	12.6	12.8	11.8	4.9	16.6	14.1	11.9	7.4	12.0	9.3	9.2	7.2	6.5	1.9	8.9	6.6	15.4	6.3	4.9	4.4	10.3	7.0	7.4	5.5	17.9	3.5	4.8	7.5	6.2	9.3	7.1	14.1	6.2	2.4	7.8	5.4	6.4	3.5	11.6	4.1	6.9	7.0	6.6	6.8	5.9	5.0	3.6	6.6	10.1	16.9	5.4	10.7	5.5	3.2	8.1	16.2	5.6	25.9	5.4	22.0	7.9	7.6	3.9	9.5	9.3	7.4	7.6	5.9	11.7	4.7	6.8	3.4	6.6	4.1	5.0	5.5	8.4	9.6	8.6	5.7	9.0	5.0	1.5	5.6	1.9	9.8	8.9	15.4	7.2	10.2	9.9	6.5	7.2	11.3	11.0	0.9	6.6	6.8	5.5	10.3	6.3	10.3	14.8	31.6	12.4	10.9	7.3	13.6	10.1	11.6	16.6
MVD	MPD	ENSG00000167508	"Mevalonate diphosphate decarboxylase"	P53602	16	88651935-88663161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041404, HPA048250"	Uncertain		Approved	"Cell Junctions,Cytosol"		30000	30000	Cytosol	"Cell Junctions"	"HPA041404: , HPA048250: "	"unprognostic (1.67e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.42e-1)"	"prognostic favourable (2.17e-4)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.00e-2)"	11.9	18.5	15.8	16.9	19.7	7.6	12.5	21.7	27.9	10.8	19.4	17.1	10.8	39.6	8.4	7.3	30.0	7.4	8.7	11.9	17.2	18.2	9.2	25.9	14.6	12.6	14.6	17.3	11.1	19.0	11.0	7.8	7.6	24.5	13.7	5.1	10.8	16.1	8.7	27.8	18.3	20.7	6.6	23.8	11.1	21.2	23.0	14.6	4.3	9.2	18.6	12.2	7.3	13.8	15.0	17.6	2.5	8.9	18.1	18.1	9.4	14.6	9.4	15.7	10.2	5.3	11.8	8.9	7.3	7.6	5.0	4.2	24.8	37.1	7.1	11.7	4.3	21.8	7.0	38.6	1.4	4.4	11.9	5.2	5.2	37.7	10.8	3.3	3.7	9.3	7.4	13.2	4.2	5.3	14.4	3.9	2.7	34.2	11.1	16.8	18.9	9.2	11.7	4.5	18.3	14.6	9.2	15.9	5.3	18.1	4.1	5.3	20.6	14.8	11.3	4.6	9.4	8.2	4.1	10.8	4.8	24.2	5.6	16.2	7.6	2.5	8.2	1.5	18.1	8.6	13.5	10.3	12.1	11.9	9.5	15.0	9.4	11.5	1.1	18.1	8.9	17.6	12.6	9.4	15.8	19.7	21.7	27.9	17.2	18.2	14.6	17.3	24.5	14.6
MVK	"LRBP, MK"	ENSG00000110921	"Mevalonate kinase"	Q03426	12	109573255-109598117	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016961, HPA044110"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA016961: AB_1854220, HPA044110: "	"unprognostic (3.10e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.28e-1)"	4.7	14.3	6.8	5.9	11.7	6.8	11.2	6.3	13.1	7.1	7.8	16.7	5.1	11.5	4.2	9.5	23.0	5.1	5.3	6.7	7.8	9.0	16.5	33.1	8.7	4.9	12.5	8.3	8.5	9.3	7.0	6.5	5.5	22.5	9.0	6.3	6.4	8.1	5.8	6.3	19.5	6.9	3.7	18.0	3.8	6.1	17.5	10.5	2.8	11.9	8.5	8.8	5.5	9.9	11.5	7.4	3.4	5.9	8.3	12.2	5.4	12.3	10.4	12.7	6.3	4.1	10.1	6.8	4.5	8.4	11.8	12.9	15.0	15.1	8.7	3.5	4.5	15.1	13.5	21.2	5.7	8.5	9.6	4.6	7.1	22.4	12.7	4.9	5.9	11.0	17.9	21.4	5.8	8.0	8.0	8.3	5.3	15.6	5.0	15.7	10.7	16.1	4.6	9.7	17.0	27.2	18.4	11.8	10.2	8.8	25.1	6.2	23.1	8.6	7.0	5.4	7.1	5.2	5.7	7.0	9.2	12.8	6.5	12.7	7.4	0.7	5.9	3.4	12.2	5.8	9.9	8.4	7.4	11.6	7.4	11.5	11.7	8.3	1.7	8.3	3.7	6.2	6.2	5.4	6.8	11.7	6.3	13.1	7.8	9.0	12.5	8.3	22.5	10.5
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884331	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 191.1"	"Cell line enhanced"	"Detected in many"		"BJ: 36.5;BJ hTERT+: 55.2;fHDF/TERT166: 45.0;HBF TERT88: 29.0;RPTEC TERT1: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"basophil: 3.6;classical monocyte: 1.3;myeloid DC: 2.8;neutrophil: 4.5;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.8;granulocytes: 4.5;monocytes: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		3000000	3000000	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: "	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (4.46e-4)"	14.9	4.9	4.5	19.8	10.9	0.0	14.4	0.8	5.8	77.1	107.3	22.0	93.2	9.4	111.2	48.3	96.0	56.3	40.6	6.6	4.7	3.2	8.3	5.4	13.2	6.5	25.8	2.8	50.2	1.6	0.5	1.1	8.0	16.0	85.1	27.6	6.0	17.6	158.6	1.6	4.8	33.3	191.1	28.8	7.4	38.7	17.4	13.0	0.2	4.1	2.5	3.4	137.1	21.3	0.2	2.8	4.5	1.3	0.0	0.2	17.3	2.5	7.7	2.1	1.3	2.1	0.4	0.9	36.5	55.2	23.6	17.0	1.6	1.4	0.1	8.2	45.0	0.9	0.9	0.3	29.0	0.0	0.1	20.3	0.2	5.0	11.0	0.1	1.9	6.8	0.7	4.6	6.9	1.8	0.2	0.1	17.5	0.3	0.0	0.5	2.2	1.0	2.3	1.2	6.6	59.6	1.4	0.3	1.1	3.7	0.4	0.6	0.2	0.0	6.7	7.2	2.6	1.7	5.9	0.6	0.7	0.0	18.5	0.2	1.8	3.6	1.3	0.3	0.1	0.2	0.0	0.2	0.0	0.0	2.8	0.1	0.2	0.1	4.5	0.0	0.0	2.7	0.1	17.3	4.5	10.9	0.8	5.8	4.7	3.2	25.8	2.8	16.0	13.0
MYLK2	"KMLC, MLCK2, skMLCK"	ENSG00000101306	"Myosin light chain kinase 2"	Q9H1R3	20	31819308-31834689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 176.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.2;RH-30: 13.2;RPMI-8226: 10.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059704, HPA059890"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA059704: , HPA059890: "	"unprognostic (1.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.27e-2)"	"prognostic favourable (4.00e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.38e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.25e-11)"	"unprognostic (2.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.70e-2)"	1.4	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.4	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	176.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.1	18.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.8	0.0	0.0	0.5	0.1	0.0	0.4	0.1	0.3	0.3	0.6	0.4	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.7	0.3	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	1.0	0.2	5.2	0.1	0.8	0.7	0.4	0.6	0.4	0.7	13.2	10.7	0.1	0.1	0.7	0.6	3.4	0.1	0.0	0.1	0.1	2.6	0.2	1.0	0.6	2.9	0.1	0.9	0.2	0.2	3.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MYMK	"TMEM226, TMEM8C"	ENSG00000187616	"Myomaker, myoblast fusion factor"	A6NI61	9	133514586-133528612	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Myogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.3;epididymis: 3.1;skeletal muscle: 8.0"	"Group enriched"	"Detected in some"	34	"HSkMC: 18.0;RH-30: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051846, HPA055785"	Uncertain									"HPA051846: , HPA055785: "						"unprognostic (9.17e-3)"	"unprognostic (8.63e-2)"	"unprognostic (3.76e-1)"		"unprognostic (1.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.37e-1)"	"unprognostic (9.32e-2)"			"unprognostic (1.91e-1)"		0.6	0.2	0.5	0.0	3.3	0.2	0.0	0.7	2.6	0.0	0.0	0.8	0.0	0.0	0.0	3.1	0.6	0.1	0.0	0.3	1.0	0.4	1.7	0.2	0.3	0.0	0.9	2.1	0.0	0.0	0.0	0.1	2.0	1.6	0.6	0.0	0.0	0.2	0.0	8.0	0.2	0.0	0.0	0.4	0.1	0.0	1.5	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.3	0.7	2.6	1.0	0.4	0.9	2.1	1.6	0.4
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934071-26212536	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.1;testis: 12.5"	"Cell line enhanced"	"Detected in some"		"AF22: 2.3;CAPAN-2: 2.2;HEK 293: 2.6;SCLC-21H: 2.4;U-2 OS: 4.3;U-698: 10.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 5.0;cerebral cortex: 1.9;hypothalamus: 1.3;pons and medulla: 5.4"	"Cell type enriched"	"Detected in single"	12	"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA048951, HPA051893"	Approved		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"				"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA048951: , HPA051893: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.8	0.7	0.4	0.3	5.0	0.5	1.5	0.3	1.9	2.1	0.6	0.1	0.7	0.4	0.3	3.2	0.9	1.1	0.3	0.3	0.5	1.3	0.9	0.2	1.0	0.3	0.2	0.0	0.5	2.1	0.2	8.1	0.2	5.4	0.5	1.1	3.8	0.2	0.6	0.3	2.2	0.6	1.0	0.4	0.3	0.9	12.5	0.8	0.0	1.3	1.4	0.9	0.5	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.0	0.0	1.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.3	1.9	0.5	1.3	0.2	0.0	5.4	0.8
NAA10	"ARD1, ARD1A, DXS707, TE2"	ENSG00000102030	"N(alpha)-acetyltransferase 10, NatA catalytic subunit"	P41227	X	153929242-153935223	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006269, HPA030711"	Supported		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB006269: AB_425759, HPA030711: "	"unprognostic (7.57e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavourable (3.29e-8)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.48e-3)"	18.9	21.2	17.7	20.3	14.0	12.5	31.8	15.5	20.8	12.4	15.3	8.1	19.2	16.7	17.2	17.6	19.7	16.5	17.6	26.4	15.0	14.2	16.3	18.6	20.7	30.0	15.0	18.0	14.1	33.3	12.3	12.0	13.7	17.5	13.6	11.7	9.3	19.0	17.9	57.8	14.1	14.7	21.7	14.7	14.9	17.7	7.1	11.8	11.4	12.2	25.3	16.3	17.1	22.1	33.7	34.8	35.0	31.9	27.6	44.8	29.0	31.8	33.6	6.3	20.6	9.1	9.5	18.0	11.2	6.6	15.3	13.5	21.8	10.1	24.2	37.4	9.3	15.3	13.3	13.5	6.0	10.1	61.9	8.7	23.5	21.9	12.4	16.9	19.3	7.2	15.2	14.3	14.8	17.3	17.4	10.3	10.1	41.9	27.0	25.3	10.6	46.6	21.5	16.4	26.6	11.2	14.7	13.6	16.4	4.4	17.7	26.5	9.5	14.1	10.0	6.4	22.1	22.3	34.0	21.8	24.3	45.5	8.7	21.9	18.7	12.0	24.2	35.0	29.0	28.0	38.0	33.7	31.2	31.7	31.6	32.6	18.7	28.0	22.6	27.6	31.9	34.8	44.8	29.0	17.7	14.0	15.5	20.8	15.0	14.2	15.0	18.0	17.5	11.8
NADK2	"C5orf33, FLJ30596, MNADK, NADKD1"	ENSG00000152620	"NAD kinase 2, mitochondrial"	Q4G0N4	5	36192592-36242279	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 128.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038366, HPA038367, HPA061492"	Enhanced					28000	28000			"HPA038366: AB_2675977, HPA038367: AB_10672743, HPA061492: "	"unprognostic (1.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.06e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	5.7	10.2	13.7	4.1	12.5	4.4	6.8	6.7	13.4	6.6	6.0	13.3	5.9	7.0	5.9	4.1	4.9	6.0	5.5	8.3	14.3	8.5	10.0	128.6	4.0	4.2	11.6	12.0	8.8	12.2	4.8	3.1	7.2	11.6	9.5	6.2	3.9	5.6	7.7	11.1	3.3	5.5	24.8	20.3	3.8	7.6	7.3	11.4	2.5	7.6	3.5	5.1	15.2	5.9	5.1	3.3	9.1	4.2	9.5	3.2	1.7	8.9	5.9	9.0	10.3	13.8	11.8	12.3	8.4	5.6	7.8	5.7	16.5	11.3	32.2	6.3	9.6	6.3	8.4	6.1	10.8	8.9	7.4	8.6	17.4	9.6	10.1	18.7	3.5	12.9	9.5	8.5	12.9	8.1	22.7	11.6	7.7	3.6	17.4	7.2	5.0	8.5	16.9	22.3	6.9	9.9	7.7	4.0	9.2	43.4	13.8	4.5	9.8	16.4	6.1	15.1	8.2	11.3	10.0	10.5	12.7	9.5	6.4	24.3	5.9	9.1	2.0	1.9	2.1	2.0	2.7	2.2	3.2	2.5	3.3	5.1	2.7	2.2	0.1	9.5	4.2	1.5	2.9	1.7	13.7	12.5	6.7	11.4	14.3	8.5	11.6	12.0	11.6	11.4
NAGA	D22S674	ENSG00000198951	Alpha-N-acetylgalactosaminidase	P17050	22	42058354-42070842	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"classical monocyte: 38.5;intermediate monocyte: 47.6;myeloid DC: 37.9;non-classical monocyte: 46.1;plasmacytoid DC: 23.2"	"Group enriched"	"Detected in all"	9	"dendritic cells: 37.9;monocytes: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000649	Enhanced				"Intracellular and membrane"	2300000	2300000			"HPA000649: AB_1079448"	"unprognostic (3.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.92e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.53e-1)"	23.7	13.5	12.1	20.3	14.5	11.3	12.5	11.8	10.3	16.3	18.3	15.0	10.7	13.2	18.9	16.1	14.5	17.3	16.5	15.8	10.1	8.6	17.9	28.2	19.9	32.6	12.6	7.3	18.1	9.5	27.8	13.1	45.3	11.5	15.2	18.0	19.8	16.6	14.5	9.2	9.9	25.6	18.7	11.4	22.0	14.1	9.3	13.2	12.0	15.0	11.4	17.9	17.3	14.5	2.1	37.9	4.9	47.6	3.4	3.4	19.2	9.0	4.6	7.4	13.1	12.9	14.8	5.4	7.5	15.4	12.9	13.5	10.3	13.4	4.4	4.6	16.2	6.4	5.6	9.1	7.7	10.1	7.1	10.9	7.1	6.9	7.5	9.0	65.2	10.1	8.0	11.6	4.9	21.3	4.0	18.9	10.2	10.5	3.3	3.7	1.9	6.2	7.5	3.7	7.8	10.0	10.8	2.3	2.6	9.9	9.1	9.8	13.6	16.7	11.4	9.1	11.1	5.8	6.7	10.5	10.5	3.5	9.7	17.3	11.2	4.9	38.5	4.6	2.8	47.6	2.8	2.1	2.9	2.6	37.9	1.5	1.9	1.8	1.9	3.4	46.1	23.2	3.4	19.2	12.1	14.5	11.8	10.3	10.1	8.6	12.6	7.3	11.5	13.2
NAGLU	NAG	ENSG00000108784	N-acetyl-alpha-glucosaminidase	P54802	17	42536172-42544449	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Charcot-Marie-Tooth disease, Disease mutation, Mucopolysaccharidosis, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038815	Supported				"Intracellular and membrane"	300000000	300000000			"HPA038815: AB_10697398"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.48e-2)"	"prognostic favourable (4.17e-4)"	"prognostic unfavourable (6.59e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.68e-2)"	"prognostic favourable (6.90e-4)"	"unprognostic (8.07e-2)"	"prognostic favourable (2.58e-6)"	"unprognostic (2.25e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.62e-1)"	21.1	21.0	10.2	8.4	15.9	10.7	18.3	5.5	11.4	16.9	17.1	19.1	16.3	14.8	19.3	20.6	11.9	14.6	21.4	11.5	10.7	5.9	31.3	50.1	16.3	12.5	21.6	8.0	20.4	38.9	10.6	12.7	23.5	12.1	14.8	10.2	20.9	32.4	12.3	9.1	13.2	17.3	10.1	13.5	22.5	17.0	9.8	20.5	8.9	20.7	8.9	12.3	16.1	12.7	4.8	6.0	3.8	5.8	4.3	5.8	2.4	5.9	20.9	4.2	9.5	41.9	13.9	14.2	9.1	21.7	9.6	12.3	5.6	15.5	7.7	9.3	14.0	14.6	3.7	4.4	2.1	5.9	7.7	4.1	10.9	11.6	14.0	5.0	10.9	16.5	6.8	5.2	6.6	12.5	6.1	15.5	10.6	14.4	0.8	8.6	4.9	2.7	3.2	9.1	17.8	12.7	13.8	6.3	9.6	5.0	6.9	7.7	31.8	5.3	9.7	23.4	3.9	9.3	5.9	20.6	9.3	6.4	14.3	5.4	16.6	2.3	5.5	3.8	5.6	3.7	5.8	4.8	2.4	3.1	4.5	4.6	4.3	3.5	2.5	4.3	5.8	6.0	0.5	2.4	10.2	15.9	5.5	11.4	10.7	5.9	21.6	8.0	12.1	20.5
NAGPA	"APAA, UCE"	ENSG00000103174	"N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase"	Q9UK23	16	5024844-5034141	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064055	Approved					3600000	3600000			"HPA064055: "	"unprognostic (9.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.30e-3)"	"prognostic unfavourable (4.67e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.41e-2)"	"prognostic unfavourable (2.67e-5)"	"unprognostic (1.26e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.02e-1)"	8.3	6.3	9.9	9.0	20.1	8.7	4.7	4.7	25.0	6.8	8.5	4.6	5.8	11.4	6.2	4.7	6.1	4.8	5.6	5.0	15.3	5.3	7.2	7.6	7.6	9.1	5.0	9.5	4.2	7.3	7.6	4.9	6.8	6.6	4.9	5.1	4.0	6.0	6.2	6.7	8.5	9.2	5.5	4.4	10.9	12.4	2.7	5.5	4.3	5.1	2.6	5.6	6.0	4.4	9.5	26.5	5.1	20.9	5.1	9.9	9.7	1.5	5.9	1.0	6.4	2.5	3.3	6.7	4.4	7.9	5.8	7.3	4.9	12.3	0.6	5.6	6.0	4.6	2.7	4.9	1.7	7.2	8.3	2.1	3.8	31.8	8.2	5.3	9.3	5.0	5.1	3.8	1.7	9.0	6.8	8.8	3.5	6.7	2.4	14.2	3.1	6.3	6.4	2.4	11.6	3.7	2.3	2.6	3.5	3.5	8.8	9.0	6.0	6.5	6.6	6.4	4.6	14.8	3.3	4.8	3.7	1.4	3.0	8.1	5.3	1.2	20.9	5.1	9.9	18.2	7.9	9.5	9.8	8.8	26.5	8.3	8.1	7.4	0.6	5.1	11.7	6.8	8.7	9.7	9.9	20.1	4.7	25.0	15.3	5.3	5.0	9.5	6.6	5.5
NAGS	"AGAS, ARGA, NAT7"	ENSG00000161653	"N-acetylglutamate synthase"	Q8N159	17	44004546-44009063	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Urea cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.4;liver: 30.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.3;HHSteC: 6.4;TIME: 7.9;U-87 MG: 11.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027300			Supported	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA027300: "	"unprognostic (1.51e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	0.6	0.6	0.5	0.4	2.4	0.0	1.0	0.7	1.5	0.3	7.2	0.5	5.6	16.4	0.5	2.6	0.9	0.3	0.3	0.9	0.7	1.5	4.4	30.2	2.5	0.2	1.8	0.6	0.5	0.3	3.6	0.4	0.4	1.2	0.8	0.4	0.1	0.9	6.5	0.1	0.6	13.4	0.3	2.0	0.5	0.3	0.4	1.1	0.2	2.9	0.0	0.1	0.8	0.8	1.5	2.0	2.3	2.7	1.0	3.5	1.3	3.4	0.2	0.0	0.5	0.0	6.3	0.1	0.6	0.0	0.2	0.0	2.2	0.8	0.0	1.3	0.0	1.4	0.0	1.2	0.1	0.3	0.8	0.1	0.2	2.6	6.4	0.0	0.0	2.7	0.1	0.2	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.4	2.6	0.1	0.2	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.0	0.2	0.1	7.9	3.0	0.8	0.2	0.7	0.2	0.2	0.2	11.9	0.1	0.4	1.8	1.4	2.3	3.5	1.5	2.8	1.2	2.2	2.9	2.0	1.5	1.1	1.7	0.8	1.0	2.7	0.3	1.7	1.3	0.5	2.4	0.7	1.5	0.7	1.5	1.8	0.6	1.2	1.1
NALCN	"bA430M15.1, CanIon, VGCNL1"	ENSG00000102452	"Sodium leak channel, non-selective"	Q8IZF0	13	101053776-101416492	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 29.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.8;HaCaT: 11.7;HHSteC: 12.7;TIME: 15.3;U-87 MG: 9.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031889, HPA031890, HPA031958"	Approved									"HPA031889: AB_10669638, HPA031890: AB_10696056, HPA031958: AB_10601039"	"unprognostic (4.66e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-3)"	"unprognostic (8.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.58e-5)"	"unprognostic (1.77e-3)"	"unprognostic (5.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	1.5	8.3	9.8	1.4	18.3	1.6	5.2	13.4	29.4	3.6	1.3	18.6	0.0	1.1	1.5	3.4	1.1	2.6	4.6	6.0	10.8	11.4	1.2	2.3	2.7	1.0	11.0	13.1	5.6	2.1	4.2	13.0	5.6	17.0	1.3	1.7	4.3	1.6	2.5	1.0	1.6	1.4	1.3	12.7	1.3	1.8	2.0	14.1	0.0	4.8	0.0	0.8	1.6	0.6	1.4	0.8	5.4	0.5	0.9	0.9	0.3	0.1	6.6	1.3	0.2	0.6	0.3	0.1	0.7	0.6	1.6	0.4	0.1	7.8	0.0	0.4	3.1	11.7	0.0	1.8	4.2	0.0	0.8	0.4	3.8	0.1	12.7	0.2	0.2	0.2	0.5	1.4	3.9	6.9	0.1	0.4	5.0	0.0	0.1	0.0	0.3	1.4	0.0	0.0	0.0	3.9	1.6	1.0	0.2	0.1	0.1	0.6	0.2	0.1	15.3	0.4	0.1	0.3	1.5	0.0	0.1	0.0	9.6	0.0	0.3	5.4	0.5	0.8	0.9	0.3	0.4	0.7	0.5	0.5	0.1	1.4	0.6	0.5	1.8	0.9	0.2	0.8	0.4	0.3	9.8	18.3	13.4	18.2	10.8	11.4	11.0	13.1	17.0	14.1
NANS	SAS	ENSG00000095380	"N-acetylneuraminate synthase"	Q9NR45	9	98056739-98083075	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019223	Approved		Approved	Nucleoplasm		200000	200000	Nucleoplasm		"HPA019223: AB_1854298"	"unprognostic (2.95e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.24e-2)"	"prognostic favourable (1.71e-4)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (6.42e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.79e-1)"	17.2	10.1	8.8	20.2	11.4	22.2	16.4	7.0	11.7	20.2	47.6	6.4	17.0	19.4	11.0	15.1	18.6	10.4	25.0	20.9	14.4	12.4	15.0	49.6	17.1	20.1	11.5	10.6	14.1	59.2	6.1	16.3	15.8	12.1	37.2	49.6	9.4	80.0	18.3	11.9	10.3	18.9	11.0	9.0	22.2	28.3	11.5	9.8	10.6	19.7	15.2	25.0	15.7	14.8	12.3	41.9	16.4	49.8	7.4	12.1	18.3	74.0	21.9	6.5	18.8	13.1	14.2	14.1	23.7	18.6	19.4	15.9	26.2	10.6	22.8	11.5	26.0	26.4	12.1	20.4	16.3	18.3	18.0	13.5	24.5	52.1	36.3	15.3	11.1	12.0	13.9	20.6	23.6	20.7	24.5	23.9	14.1	50.9	10.2	22.0	11.2	28.5	19.8	17.8	23.2	15.5	22.8	13.2	6.9	15.2	82.6	20.1	27.4	16.5	53.7	15.2	14.7	38.7	24.3	22.2	18.5	8.7	17.9	18.5	11.8	5.3	42.1	6.0	8.0	49.8	12.1	12.3	10.5	8.3	41.9	10.1	11.5	7.8	16.4	7.4	43.0	38.4	11.9	18.3	8.8	11.4	7.0	11.7	14.4	12.4	11.5	10.6	12.1	9.8
NARS2	"DFNB94, FLJ23441, SLM5"	ENSG00000137513	"Asparaginyl-tRNA synthetase 2, mitochondrial"	Q96I59	11	78435961-78574874	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026793	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	Cytosol	"HPA026793: AB_1848833"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.79e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.62e-3)"	"prognostic favourable (1.39e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"prognostic favourable (1.22e-6)"	"unprognostic (8.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.60e-1)"	10.9	16.0	11.8	9.3	11.2	6.4	13.4	19.4	11.8	11.6	13.0	13.1	13.5	12.0	17.6	13.9	10.8	12.0	9.9	12.7	11.3	12.2	22.3	26.8	9.0	10.2	13.4	8.4	15.9	20.0	14.0	17.3	9.4	13.8	13.3	13.3	23.2	12.7	13.2	24.4	9.1	11.1	10.6	10.8	12.6	11.3	11.8	10.3	17.3	16.0	7.7	14.1	9.7	10.7	14.6	13.5	6.7	9.4	16.2	16.6	8.7	7.4	10.5	11.0	7.2	7.7	6.5	9.2	6.2	6.1	9.7	8.0	17.9	8.1	18.5	16.2	3.9	9.9	18.5	12.1	13.5	12.1	9.9	13.0	8.1	15.2	6.4	13.9	4.8	4.5	7.8	8.5	15.2	8.3	19.6	5.1	10.8	8.7	14.4	22.6	12.0	12.7	15.1	18.0	25.0	12.9	10.6	13.1	8.3	9.2	11.9	15.9	11.2	5.5	5.0	13.2	15.6	15.0	10.4	8.5	14.3	40.8	2.5	12.6	8.9	6.7	7.9	3.5	9.8	8.3	12.0	14.6	11.3	10.8	13.5	12.6	16.6	14.8	1.7	16.2	9.4	10.3	8.2	8.7	11.8	11.2	19.4	11.8	11.3	12.2	13.4	8.4	13.8	10.3
NAT8L	"FLJ37478, Hcml3"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059512-2069089	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 45.9;brain: 45.9;testis: 11.8"	"Cell line enhanced"	"Detected in many"		"NB-4: 14.4;SCLC-21H: 18.6;SK-MEL-30: 14.8"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria				Mitochondria		"HPA040677: AB_10794745"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavourable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	45.9	2.0	23.5	1.3	28.3	1.2	7.9	16.4	45.9	1.2	1.5	7.4	0.3	1.3	1.6	2.8	1.3	2.4	1.3	2.1	20.8	12.9	8.2	1.2	1.2	1.4	16.4	12.6	1.4	3.9	1.2	5.6	1.3	12.8	2.4	1.3	1.2	3.8	3.2	7.3	2.4	1.5	1.4	6.5	1.5	1.6	11.8	8.2	0.0	1.6	0.0	1.2	1.2	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	6.5	3.6	7.2	0.7	0.0	4.1	0.1	0.0	0.2	0.0	2.9	0.2	0.0	1.3	0.0	0.1	8.0	0.0	0.1	0.0	9.4	0.1	1.4	4.6	1.2	9.9	4.9	0.0	0.1	0.0	0.0	0.0	7.7	0.0	0.2	4.3	0.1	14.4	10.1	2.9	0.5	1.7	0.2	0.1	0.3	18.6	6.2	4.7	0.0	14.8	0.5	5.8	0.0	0.0	2.4	0.1	3.8	0.0	0.0	0.1	0.0	4.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	23.5	28.3	16.4	32.7	20.8	12.9	16.4	12.6	12.8	8.2
NAXE	"AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1"	ENSG00000163382	"NAD(P)HX epimerase"	Q8NCW5	1	156591762-156594299	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		Isomerase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043766, HPA048164"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	3300000	3300000	Nucleoplasm	Cytosol	"HPA043766: AB_2678660, HPA048164: AB_2680294"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (7.38e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-1)"	19.1	29.9	31.6	14.4	28.5	12.1	22.6	17.6	42.5	23.0	30.0	31.0	17.4	28.4	28.5	57.9	23.4	29.4	25.8	46.3	28.5	25.0	41.6	41.0	17.2	16.9	33.2	29.3	29.3	37.3	36.3	29.0	21.8	28.8	27.9	26.6	23.0	29.5	36.3	30.9	20.2	25.9	25.0	29.1	17.4	25.0	29.5	22.2	17.7	32.4	19.5	20.4	20.8	18.3	52.4	53.8	12.4	26.5	31.6	32.5	40.6	31.4	41.8	13.4	23.9	17.8	12.2	16.0	10.9	16.6	18.6	19.7	34.8	21.2	21.4	33.0	13.8	30.7	13.3	26.0	13.2	22.5	29.1	17.7	23.8	22.9	20.4	22.2	18.2	12.3	33.6	23.7	22.1	25.3	18.0	19.5	19.0	56.0	24.4	27.0	16.6	32.7	24.6	12.5	56.5	25.2	26.2	32.3	30.8	26.1	49.8	38.3	48.3	32.7	14.7	13.4	20.9	19.0	23.6	50.6	30.5	20.4	18.5	13.2	20.6	4.9	24.1	12.4	31.6	26.5	31.3	52.4	29.2	32.2	21.7	41.7	32.5	30.9	2.9	31.6	20.6	53.8	25.5	40.6	31.6	28.5	17.6	42.5	28.5	25.0	33.2	29.3	28.8	22.2
NCOA1	"bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1"	ENSG00000084676	"Nuclear receptor coactivator 1"	Q15788	2	24491914-24770702	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019402, HPA070213, HPA070520"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019402: AB_2196189, HPA070213: , HPA070520: "	"unprognostic (2.73e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.60e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.92e-2)"	9.8	10.0	15.3	7.3	18.0	8.9	10.5	15.9	17.1	13.7	8.9	13.5	4.9	12.5	13.0	11.5	10.8	10.0	8.3	8.8	20.8	12.2	11.9	8.8	9.4	8.2	10.8	9.9	17.2	10.3	23.9	16.0	10.1	14.2	9.6	10.1	19.9	10.6	13.0	42.5	9.3	10.9	11.6	9.7	9.6	7.6	11.4	10.7	8.5	7.0	12.2	9.3	9.7	10.8	2.5	5.5	14.2	3.5	3.4	4.1	1.8	6.6	4.9	8.7	4.5	9.6	8.8	13.3	3.5	7.1	4.5	4.0	4.6	2.8	4.8	1.5	6.4	1.6	5.2	3.0	4.9	22.8	7.5	17.2	2.0	1.9	6.0	7.9	14.4	14.0	4.6	4.3	3.5	4.5	10.4	8.0	6.8	4.4	7.0	2.8	4.1	3.3	5.5	40.1	2.4	4.9	9.0	8.0	6.3	8.2	5.0	3.6	6.0	4.0	4.9	7.5	5.9	5.1	3.5	9.3	8.0	8.4	4.3	5.0	3.7	11.0	3.5	6.9	3.8	2.7	4.1	1.8	3.4	4.1	2.6	2.5	3.3	4.0	14.2	3.4	2.8	5.5	3.7	1.8	15.3	18.0	15.9	17.1	20.8	12.2	10.8	9.9	14.2	10.7
NDST1	"HSST, NST1"	ENSG00000070614	"N-deacetylase and N-sulfotransferase 1"	P52848	5	150485818-150558211	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Multifunctional enzyme, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"dendritic cells: 5.5;granulocytes: 7.2;monocytes: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060532	Approved					1000000	1000000			"HPA060532: "	"unprognostic (1.36e-1)"	"unprognostic (5.54e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (6.99e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (4.97e-3)"	"unprognostic (6.92e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.08e-2)"	26.3	15.5	17.3	9.9	20.2	4.9	21.3	8.6	28.3	12.9	10.2	41.7	7.3	9.3	11.8	10.0	25.5	11.0	16.9	19.6	17.9	14.4	11.4	49.2	25.2	6.1	28.5	13.8	17.3	28.9	16.5	4.7	10.0	26.1	11.3	7.3	10.8	25.4	13.5	15.3	24.9	14.7	14.3	32.8	30.1	10.2	12.6	19.6	1.4	17.3	11.9	9.8	10.5	11.5	0.6	5.5	7.2	6.5	0.1	0.6	2.9	9.8	8.7	14.6	17.7	14.7	14.7	14.7	18.1	23.8	18.1	27.2	25.8	10.4	6.7	18.4	36.0	16.9	7.8	36.7	12.1	0.8	12.2	7.9	5.7	4.0	10.9	5.9	14.5	20.0	15.3	21.8	9.9	24.6	7.5	2.4	17.6	8.3	0.7	1.8	6.8	10.4	11.4	12.2	2.9	10.6	10.0	4.4	15.4	10.9	34.3	14.5	18.3	1.4	12.0	31.0	28.1	13.4	14.8	5.4	1.4	2.5	25.4	9.2	11.9	1.7	6.5	4.4	0.1	2.3	0.0	0.6	0.0	0.6	5.5	0.1	0.1	0.2	7.2	0.1	5.5	0.4	0.0	2.9	17.3	20.2	8.6	28.3	17.9	14.4	28.5	13.8	26.1	19.6
NDUFAF7	"C2orf56, MidA, PRO1853"	ENSG00000003509	"NADH:ubiquinone oxidoreductase complex assembly factor 7"	Q7L592	2	37231631-37253403	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045217	Uncertain									"HPA045217: AB_10960395"	"unprognostic (6.38e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.48e-4)"	"prognostic favourable (3.08e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.67e-3)"	7.1	14.3	10.1	7.5	15.9	7.3	8.3	24.1	17.0	9.3	12.6	7.7	6.1	6.4	10.0	11.0	6.7	6.4	8.1	18.3	9.4	9.7	12.2	13.5	6.6	8.3	9.4	10.5	8.8	7.6	9.4	15.2	7.9	14.5	7.7	8.1	7.8	7.0	7.9	21.0	5.8	7.3	9.8	7.2	7.8	7.1	44.4	10.5	8.2	6.4	6.5	7.5	7.8	7.2	8.9	9.9	5.3	8.1	6.9	8.3	4.1	16.0	8.6	10.8	9.7	7.0	15.0	6.1	5.2	8.6	9.3	11.8	18.3	6.9	13.6	6.7	5.0	12.1	13.4	6.8	11.0	9.3	9.8	10.0	10.7	16.6	8.7	9.8	5.2	11.6	11.4	7.7	4.7	14.3	12.2	9.3	5.4	6.0	9.9	10.8	14.3	7.4	9.0	8.5	11.5	12.9	6.0	11.5	9.2	6.8	11.6	11.4	7.0	4.0	2.8	7.8	10.4	9.5	9.7	8.1	4.6	15.4	11.4	13.6	6.6	4.6	8.1	4.5	8.3	7.0	3.8	8.9	7.4	7.1	9.9	7.8	7.4	6.4	5.3	6.9	4.9	8.1	8.3	4.1	10.1	15.9	24.1	17.0	9.4	9.7	9.4	10.5	14.5	10.5
NDUFS1	CI-75k	ENSG00000023228	"NADH:ubiquinone oxidoreductase core subunit S1"	P28331	2	206114817-206159603	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064605, CAB070844"	Approved		Supported	Mitochondria				Mitochondria		"CAB070844: , HPA064605: "	"prognostic unfavourable (3.85e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.22e-3)"	"unprognostic (5.01e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.75e-1)"	"unprognostic (3.72e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.28e-1)"	"prognostic favourable (1.47e-12)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-2)"	13.9	29.0	12.1	8.3	22.1	7.6	10.3	11.6	26.4	9.1	17.4	16.4	9.2	18.3	9.1	7.7	15.7	7.7	7.3	62.6	11.3	11.7	29.5	30.7	8.3	7.7	13.3	13.8	8.2	9.3	22.1	11.6	10.8	24.2	10.7	18.9	13.5	12.8	10.9	99.5	11.0	19.9	11.1	10.8	8.4	14.9	8.8	11.1	11.2	10.8	34.7	10.5	11.6	9.4	10.7	15.3	15.7	21.4	12.5	16.1	8.9	12.9	13.0	18.8	13.6	17.6	14.3	21.9	19.1	20.7	31.9	23.2	33.5	15.2	14.7	16.9	23.8	18.2	25.1	18.5	28.4	6.7	11.8	29.4	32.1	30.0	18.3	21.1	13.3	17.4	10.9	25.0	19.7	24.8	31.7	14.9	20.8	16.2	17.4	14.0	17.5	23.1	17.7	26.3	25.4	26.4	23.8	18.4	14.4	22.0	21.6	31.2	19.0	20.5	18.9	17.6	15.7	17.2	18.1	14.4	17.3	21.9	17.7	17.6	18.0	12.0	13.3	15.7	13.6	15.4	10.8	10.7	12.2	13.0	15.3	9.5	10.9	12.4	9.6	12.5	21.4	8.2	16.1	8.9	12.1	22.1	11.6	26.4	11.3	11.7	13.3	13.8	24.2	11.1
NDUFS2	CI-49	ENSG00000158864	"NADH:ubiquinone oxidoreductase core subunit S2"	O75306	1	161197104-161214395	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 104.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055140, HPA061953"	Enhanced		Supported	Mitochondria		16000	16000	Mitochondria		"HPA055140: AB_2682713, HPA061953: AB_2684646"	"unprognostic (2.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (2.32e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-1)"	14.6	30.7	16.6	8.0	25.4	10.2	15.5	23.4	25.4	13.0	25.6	17.9	11.7	23.6	12.3	11.2	16.7	14.5	10.6	75.4	17.6	14.8	37.4	52.6	12.8	9.2	28.0	25.0	14.1	14.3	25.6	10.7	11.5	24.1	12.7	27.2	11.4	14.6	14.5	104.9	14.0	22.1	15.7	16.1	13.0	19.4	8.8	25.3	10.4	12.3	37.1	15.1	13.2	10.5	18.9	47.3	26.6	42.2	20.3	29.2	32.4	18.0	29.1	18.4	21.3	27.0	24.0	15.9	16.4	24.1	32.4	25.6	31.8	18.8	22.9	30.9	25.2	24.2	29.3	29.3	28.7	15.2	24.7	22.4	21.8	27.8	28.0	24.2	20.8	34.6	25.9	26.2	30.0	37.1	28.6	12.5	30.4	20.8	15.3	12.9	33.5	26.8	13.3	19.0	32.2	38.5	21.6	19.5	29.0	19.8	48.9	27.9	44.0	63.4	23.7	15.8	13.5	11.0	22.1	17.6	27.9	19.2	24.1	20.5	20.3	26.6	35.9	18.9	20.5	42.2	19.9	18.9	20.9	20.7	47.3	15.7	21.6	21.8	20.2	20.3	37.0	31.8	29.2	32.4	16.6	25.4	23.4	25.4	17.6	14.8	28.0	25.0	24.1	25.3
NDUFS7	"CI-20, FLJ45860, FLJ46880, PSST"	ENSG00000115286	"NADH:ubiquinone oxidoreductase core subunit S7"	O75251	19	1383527-1395589	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 198.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (7.36e-2)"	"prognostic favourable (2.03e-4)"	"unprognostic (5.30e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.99e-3)"	"unprognostic (8.12e-2)"	"prognostic favourable (4.90e-7)"	"unprognostic (2.95e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-2)"	22.4	17.6	15.3	10.1	17.6	9.9	7.0	16.6	22.7	6.1	18.7	20.6	7.6	34.5	7.1	9.6	13.3	6.7	10.0	35.9	16.1	15.1	20.7	20.7	7.1	9.1	19.6	11.9	7.2	28.7	5.0	12.0	6.8	17.6	11.9	4.0	12.0	23.6	10.2	198.0	8.3	25.2	7.5	20.1	11.5	18.2	14.2	14.6	9.7	8.0	39.2	10.0	6.7	7.9	29.1	41.8	19.8	39.1	17.2	29.2	20.8	18.2	18.5	0.6	4.3	0.6	1.7	9.5	11.0	1.1	2.3	2.5	30.3	4.5	27.0	11.3	0.6	9.6	0.8	2.2	0.1	30.1	21.3	8.5	19.8	18.8	2.8	14.7	9.5	1.4	3.8	0.4	0.0	3.2	16.8	10.6	0.6	19.1	14.6	6.1	6.6	22.9	14.2	7.1	27.5	1.1	14.1	10.4	10.6	9.7	9.2	17.9	7.3	9.2	13.8	4.4	6.1	9.6	14.2	42.7	37.2	18.3	11.1	19.9	6.2	19.8	33.6	16.1	21.3	39.1	18.1	29.1	20.1	20.0	41.8	27.1	19.7	19.1	9.1	17.2	31.7	31.6	29.2	20.8	15.3	17.6	16.6	22.7	16.1	15.1	19.6	11.9	17.6	14.6
NDUFS8	"CI-23k, TYKY"	ENSG00000110717	"NADH:ubiquinone oxidoreductase core subunit S8"	O00217	11	68030617-68036644	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 156.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018524	Approved		Supported	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA018524: AB_1854355"	"unprognostic (2.90e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favourable (3.27e-8)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (9.45e-2)"	26.0	62.0	29.9	16.9	40.5	21.0	19.1	18.4	50.1	18.6	24.7	19.7	24.3	34.7	18.2	15.1	28.3	19.0	22.7	82.4	26.5	27.5	50.3	47.6	16.3	19.1	28.3	22.4	20.8	41.3	25.4	26.7	18.0	25.9	22.9	18.3	30.1	41.3	32.2	156.6	17.3	26.7	19.8	18.2	20.3	25.0	21.1	15.7	29.6	29.2	53.9	24.2	19.1	14.8	37.3	66.6	23.6	46.1	59.0	39.6	42.6	26.8	66.7	18.5	25.1	13.8	12.4	24.3	19.1	16.6	29.6	23.0	62.1	28.7	20.8	34.8	16.5	33.2	21.2	23.2	10.6	24.8	48.8	18.9	42.5	32.6	33.0	17.7	20.9	15.6	24.1	21.7	24.9	19.8	19.4	22.6	19.3	63.7	38.9	37.9	22.7	56.6	27.1	17.9	67.3	37.2	21.8	23.2	18.9	13.9	32.2	67.5	44.2	19.4	15.3	28.7	25.3	41.6	26.3	30.9	32.5	17.6	46.2	21.3	20.0	15.8	46.1	23.6	39.6	45.1	37.0	37.3	34.2	36.0	63.3	30.2	33.0	36.7	4.4	59.0	24.9	66.6	39.6	42.6	29.9	40.5	18.4	50.1	26.5	27.5	28.3	22.4	25.9	15.7
NDUFV1	CI-51K	ENSG00000167792	"NADH:ubiquinone oxidoreductase core subunit V1"	P49821	11	67606852-67612535	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 150.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045211, HPA075051"	Approved		Supported	Mitochondria,Cytosol				Mitochondria	Cytosol	"HPA045211: AB_10962830, HPA075051: "	"unprognostic (4.57e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.84e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.03e-2)"	"prognostic favourable (7.49e-10)"	"unprognostic (1.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	23.3	28.9	27.3	20.7	33.9	20.3	18.9	32.9	48.8	18.5	33.0	23.1	19.2	40.6	19.4	21.5	25.5	22.5	23.4	93.0	26.5	24.1	39.0	41.5	15.9	20.6	31.5	40.5	24.6	38.3	49.2	18.8	15.7	34.8	16.1	25.1	17.6	27.3	27.0	150.8	28.4	30.3	22.7	23.1	21.5	28.2	30.2	24.3	18.3	23.4	67.9	20.3	18.7	18.6	23.8	41.2	13.5	30.7	36.2	28.2	24.3	26.2	28.2	14.4	28.8	18.0	18.1	26.9	16.4	15.8	25.7	17.2	53.3	31.8	48.5	34.6	14.1	35.4	30.3	25.6	8.1	24.6	23.9	19.9	38.3	26.3	25.5	27.0	22.2	26.8	24.8	20.9	18.7	22.7	36.1	39.7	15.6	39.4	31.5	53.5	14.1	35.5	36.6	27.9	78.7	20.8	19.7	22.9	21.6	20.7	72.5	54.7	36.8	27.5	18.0	24.9	18.6	35.4	17.2	38.8	22.1	24.2	29.0	28.6	23.9	12.6	26.7	13.5	25.9	30.7	28.2	23.2	21.7	24.5	41.2	23.8	20.2	25.1	4.8	36.2	17.4	26.5	27.8	24.3	27.3	33.9	32.9	48.8	26.5	24.1	31.5	40.5	34.8	24.3
NEDD4L	"KIAA0439, NEDD4-2, RSP5"	ENSG00000049759	"Neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase"	Q96PU5	18	58044367-58401540	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 50.1;SK-MEL-30: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 8.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.7;T-cells: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024618	Approved									"HPA024618: AB_1854362"	"unprognostic (2.56e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.24e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (6.55e-15)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (4.75e-2)"	5.9	6.8	9.1	5.4	38.8	13.2	15.8	21.4	24.7	5.0	22.6	3.2	18.2	11.1	3.6	6.1	7.0	6.0	7.6	12.7	9.8	7.1	29.9	10.1	26.9	2.5	7.2	14.9	3.0	33.2	9.2	16.5	13.0	4.1	30.6	25.2	12.2	16.5	23.2	38.3	5.9	26.8	8.2	3.2	3.1	26.0	4.6	8.8	0.8	9.1	5.5	5.1	14.9	9.3	1.4	0.4	4.7	0.7	0.9	8.1	0.5	18.4	6.6	3.9	5.8	1.4	0.5	13.6	5.2	23.7	13.4	20.5	7.7	10.0	3.9	16.1	2.0	13.4	5.2	23.1	27.7	9.2	4.6	2.8	4.1	50.1	0.7	0.1	1.7	3.5	15.1	18.1	22.0	1.0	4.8	1.7	5.5	4.5	0.2	0.2	3.4	10.2	3.8	5.3	4.5	13.3	24.1	4.9	1.3	4.3	1.3	39.1	7.9	1.6	7.9	36.2	10.9	2.0	22.3	2.3	3.9	2.4	7.4	2.8	2.9	4.7	0.6	1.7	0.4	0.7	1.0	1.4	1.3	0.3	0.3	0.6	0.8	0.6	0.3	0.9	0.1	0.4	8.1	0.5	9.1	38.8	21.4	24.7	9.8	7.1	7.2	14.9	4.1	8.8
NEK1	"KIAA1901, NY-REN-55"	ENSG00000137601	"NIMA related kinase 1"	Q96PY6	4	169392857-169612629	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Ciliopathy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020873, HPA040413"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"				Cytosol	"Nucleoplasm, Centriolar satellite"	"HPA020873: AB_10671583, HPA040413: AB_10671169"	"unprognostic (4.10e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.21e-1)"	"prognostic favourable (1.42e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.46e-1)"	9.6	10.5	13.5	9.2	15.8	6.0	8.7	20.7	14.5	13.6	8.4	12.5	7.1	5.4	12.4	9.1	7.9	15.7	10.2	11.4	13.7	13.2	10.2	6.9	7.7	8.0	15.9	11.3	16.3	6.6	15.3	16.5	7.2	16.0	11.6	7.7	8.9	6.4	10.6	7.1	4.7	5.7	11.1	18.2	8.0	8.1	18.3	14.8	14.7	13.3	6.4	7.4	10.0	8.2	4.5	3.3	6.7	3.3	2.2	5.3	1.3	4.2	1.9	7.8	8.4	12.1	13.6	2.5	9.0	8.1	7.2	6.9	2.4	5.1	11.3	1.7	7.8	1.4	7.3	7.6	8.2	12.4	5.0	7.6	7.8	2.9	7.2	7.7	6.1	10.8	4.4	7.3	12.9	7.0	13.5	21.6	9.2	2.7	9.9	3.4	2.5	4.5	6.1	5.1	3.6	7.6	5.0	8.5	9.7	6.5	3.2	6.0	4.0	3.4	8.4	4.6	4.2	4.8	6.0	8.7	13.4	8.7	7.6	3.8	8.0	6.7	2.1	1.8	4.4	3.3	4.8	4.4	3.4	2.7	1.5	4.5	5.1	5.3	1.1	2.2	1.6	3.3	3.2	1.3	13.5	15.8	20.7	12.9	13.7	13.2	15.9	11.3	16.0	14.8
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.0;testis: 41.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Low region specificity"	"Detected in all"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: "	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (9.47e-6)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	1.1	0.7	0.6	6.7	0.5	7.4	1.3	0.3	0.9	0.9	2.5	0.3	0.3	3.4	0.3	1.2	4.2	0.7	1.4	0.9	1.0	0.3	0.6	0.6	1.0	3.9	0.3	0.3	0.6	0.3	0.0	0.3	1.2	0.4	0.9	3.6	0.4	1.0	0.3	0.3	1.8	3.0	0.6	0.6	1.6	1.1	41.0	0.4	14.0	0.3	1.5	4.8	0.6	1.6	1.8	0.9	2.7	0.5	3.9	4.3	0.9	30.3	21.9	16.8	12.0	1.0	1.7	18.5	11.7	11.0	20.7	17.8	11.7	29.8	16.1	5.7	9.0	16.3	14.5	8.8	26.1	24.6	12.1	7.7	19.1	15.7	0.1	15.2	10.5	0.5	1.0	15.9	17.2	13.2	21.1	28.4	20.7	8.4	16.5	10.3	15.9	11.2	16.4	25.7	24.5	7.2	8.7	15.2	16.9	16.9	19.0	14.7	29.2	9.1	6.9	10.3	20.5	20.3	31.4	11.8	21.7	21.3	9.0	11.7	17.1	2.7	0.5	0.4	0.5	0.3	0.2	1.5	0.6	0.3	0.1	1.8	1.1	0.7	2.4	3.9	0.4	0.9	4.3	0.9	0.6	0.5	0.3	0.9	1.0	0.3	0.3	0.3	0.4	0.4
NEK8	NPHP9	ENSG00000160602	"NIMA related kinase 8"	Q86SG6	17	28725897-28743455	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 14.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040661, HPA040679"	Approved									"HPA040661: AB_10794065, HPA040679: AB_10796226"	"unprognostic (2.63e-1)"	"unprognostic (4.57e-2)"	"prognostic unfavourable (6.98e-4)"	"unprognostic (6.25e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"prognostic favourable (4.52e-4)"	"unprognostic (7.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.67e-3)"	3.5	4.6	2.9	11.9	4.5	2.0	4.3	1.7	4.9	5.3	4.0	4.7	1.4	4.2	2.1	5.0	4.8	5.9	4.4	1.6	2.9	1.9	10.4	6.9	5.7	7.8	2.3	2.1	4.4	6.4	8.5	9.7	8.7	5.6	5.6	3.2	5.2	5.3	4.1	0.9	4.4	6.5	1.7	3.0	8.4	4.9	4.9	1.4	4.8	10.7	3.5	15.6	4.5	3.0	4.7	14.7	3.2	1.0	1.3	1.1	0.8	2.1	3.5	3.7	2.9	2.0	2.2	11.4	1.0	2.2	1.4	1.8	5.4	5.1	13.2	3.7	2.8	3.9	5.4	4.9	1.4	3.5	6.6	2.9	5.6	10.0	3.5	1.8	3.9	5.1	1.9	2.6	6.1	0.9	4.3	1.3	1.5	4.7	1.8	3.4	3.4	1.1	4.9	2.4	5.8	7.3	5.8	6.7	1.6	3.1	6.5	1.6	9.7	2.4	0.9	1.3	2.4	1.7	1.0	1.5	1.7	8.9	2.1	1.6	3.2	3.2	0.9	1.2	0.8	0.4	0.9	3.0	0.7	0.7	0.1	4.7	0.8	1.1	0.5	1.3	1.0	14.7	0.5	0.8	2.9	4.5	1.7	4.9	2.9	1.9	2.3	2.1	5.6	1.4
NEK9	"DKFZp434D0935, MGC16714, Nek8, NERCC"	ENSG00000119638	"NIMA related kinase 9"	Q8TD19	14	75079353-75127344	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001405	Approved		Approved	Mitochondria		190000	190000	Mitochondria		"HPA001405: AB_1079467"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-1)"	"prognostic favourable (5.63e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.57e-2)"	17.0	20.4	12.7	17.7	17.4	7.3	15.1	15.4	13.3	18.6	18.7	18.3	23.5	14.0	25.0	13.8	15.6	20.0	15.9	23.5	11.4	8.7	14.0	13.3	12.9	16.2	20.2	10.6	25.6	15.7	24.7	23.6	14.3	13.0	15.3	8.1	15.4	12.4	18.9	36.2	10.6	15.3	24.7	14.5	14.7	14.8	16.6	18.2	21.5	17.0	14.1	14.4	23.6	18.7	6.0	6.4	7.5	5.4	5.5	6.2	3.1	10.1	12.0	15.2	16.9	19.5	26.8	17.3	16.5	11.6	8.1	7.9	10.1	8.9	17.4	0.1	11.3	14.0	11.6	6.4	9.0	14.2	6.7	8.5	12.0	7.3	12.8	5.1	11.4	18.3	7.6	8.4	6.4	10.1	9.6	11.3	9.7	1.1	10.8	5.2	9.0	6.1	17.5	19.4	9.0	6.1	12.4	7.3	18.7	13.3	6.4	12.7	15.8	14.8	15.2	12.3	5.2	14.3	6.4	18.3	19.5	17.6	9.0	8.7	8.3	7.5	5.4	5.8	4.2	5.0	5.9	2.8	4.8	3.9	6.4	6.0	6.2	5.9	5.5	5.5	3.5	1.8	2.6	3.1	12.7	17.4	15.4	13.3	11.4	8.7	20.2	10.6	13.0	18.2
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862906	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"		86000	86000	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	10.5	30.2	8.6	9.4	11.1	5.2	10.5	15.5	14.6	13.4	14.1	7.4	16.1	14.1	9.8	13.9	9.0	8.3	16.1	9.8	8.0	9.5	29.7	24.2	16.1	7.2	9.4	6.6	12.7	20.6	13.6	16.5	19.8	10.3	15.1	9.1	14.7	18.1	13.8	10.0	9.1	23.5	9.8	4.7	13.4	12.7	6.5	10.0	5.8	22.7	7.0	9.6	13.6	9.5	4.2	7.7	15.2	13.4	3.0	5.1	7.4	2.9	3.0	3.0	6.9	10.1	3.8	5.9	2.7	9.3	8.1	11.8	17.4	3.3	1.0	7.0	3.6	1.7	6.3	2.5	3.1	2.5	4.2	1.5	1.8	20.3	18.1	1.9	8.5	6.3	4.7	9.7	5.0	7.2	3.2	7.2	4.1	5.3	1.6	2.9	2.3	2.4	2.1	1.6	10.4	13.3	6.5	2.3	1.3	3.0	4.0	7.1	7.7	8.7	3.0	5.3	3.1	7.4	4.8	8.9	14.2	2.1	3.9	4.8	3.7	6.4	13.4	8.7	5.1	10.3	4.2	3.9	3.9	4.1	7.7	4.2	4.0	3.9	15.2	3.0	9.2	4.3	4.8	7.4	8.6	11.1	15.5	14.6	8.0	9.5	9.4	6.6	10.3	10.0
NGLY1	"FLJ11005, PNG1"	ENSG00000151092	"N-glycanase 1"	Q96IV0	3	25718944-25790039	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036825	Approved				"Intracellular and membrane"					"HPA036825: AB_10672231"	"unprognostic (3.65e-2)"	"unprognostic (8.65e-2)"	"prognostic favourable (1.17e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavourable (1.96e-6)"	"unprognostic (2.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-2)"	10.7	14.4	11.4	19.6	11.4	12.9	15.0	17.1	15.0	9.5	12.4	6.9	11.7	10.5	10.2	13.8	13.2	8.4	10.5	14.3	12.0	9.0	12.8	18.1	13.9	17.4	9.5	12.5	10.6	20.7	9.0	11.3	8.7	11.0	10.9	15.2	7.8	12.4	18.0	46.6	9.0	11.2	8.7	10.1	14.6	11.9	42.0	9.0	18.0	10.3	10.9	18.1	11.5	10.6	26.1	39.7	19.9	10.8	22.6	14.7	10.3	12.2	10.5	5.9	12.4	11.4	10.4	8.4	10.5	8.9	13.3	12.0	6.5	9.3	31.2	12.0	8.9	5.5	19.8	5.5	18.1	14.7	8.4	23.2	8.0	10.5	12.6	21.3	12.7	9.3	7.5	14.6	13.6	14.2	21.9	22.4	13.5	5.3	25.3	12.6	7.9	19.0	25.9	7.7	22.2	12.2	15.1	3.6	4.4	15.3	14.7	9.7	13.9	17.8	9.6	10.5	10.8	12.6	13.5	27.7	23.8	21.7	12.6	23.1	8.2	19.9	10.8	18.9	13.7	10.1	14.7	26.1	13.8	12.6	16.3	21.7	14.0	13.6	12.8	22.6	8.4	39.7	10.4	10.3	11.4	11.4	17.1	15.0	12.0	9.0	9.5	12.5	11.0	9.0
NHLRC1	"bA204B7.2, EPM2B"	ENSG00000187566	"NHL repeat containing E3 ubiquitin protein ligase 1"	Q6VVB1	6	18120440-18122687	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 9.0;K-562: 7.6;SCLC-21H: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA066030			Uncertain	Vesicles				Vesicles		"HPA066030: "	"unprognostic (1.61e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	"prognostic unfavourable (9.01e-4)"	"unprognostic (6.95e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-2)"	"prognostic favourable (5.30e-4)"	2.5	3.6	5.0	1.8	6.5	2.1	4.6	2.6	8.5	1.9	3.3	7.1	1.7	3.2	2.0	6.1	2.4	3.5	2.7	3.9	5.0	5.1	1.9	9.0	5.1	4.7	5.4	3.9	3.5	12.2	2.4	2.8	1.0	5.2	3.4	3.0	3.3	5.1	2.8	5.2	8.5	4.3	1.8	5.4	2.4	3.0	2.1	3.8	2.4	3.6	0.9	1.8	2.5	1.8	3.3	7.2	0.6	7.2	2.2	2.5	2.6	3.3	2.0	0.8	0.1	1.8	1.7	0.0	3.4	1.1	1.3	0.7	0.1	2.8	0.1	9.0	2.5	4.0	0.0	2.2	1.0	0.1	1.1	0.5	1.0	0.2	2.8	0.0	2.2	2.9	3.3	1.3	1.2	2.8	7.6	0.1	2.8	3.5	0.0	0.0	0.0	2.0	0.0	0.0	0.1	1.8	3.6	8.0	0.1	6.8	5.7	2.0	4.1	2.2	0.5	0.2	1.7	2.4	0.0	0.1	0.0	0.1	0.1	0.0	3.4	0.5	6.6	0.6	1.1	7.2	1.2	3.3	1.7	0.8	7.2	2.3	2.5	1.6	0.5	2.2	3.2	0.9	1.8	2.6	5.0	6.5	2.6	8.5	5.0	5.1	5.4	3.9	5.2	3.8
NIPA1	"MGC35570, SLC57A1, SPG6"	ENSG00000170113	"Non imprinted in Prader-Willi/Angelman syndrome 1"	Q7RTP0	15	22773063-22829791	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 9.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.1"	"Low region specificity"	"Detected in all"							HPA023269	Uncertain									"HPA023269: AB_1854485"	"unprognostic (1.64e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.25e-2)"	"unprognostic (6.32e-2)"	"unprognostic (6.95e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.66e-2)"	3.4	4.9	15.2	4.1	18.1	1.3	3.4	8.3	27.0	4.6	4.6	20.7	1.3	7.3	2.7	2.6	4.5	3.1	5.5	2.9	18.7	15.7	7.3	4.7	5.3	5.4	26.9	11.8	1.6	7.6	12.3	2.9	4.0	24.8	7.9	5.0	2.2	3.9	4.2	2.4	5.6	7.2	2.9	36.7	4.5	7.4	4.9	15.1	2.6	8.5	0.4	6.0	3.6	2.6	2.0	9.1	0.6	0.2	0.6	1.7	0.8	9.7	11.4	3.5	8.2	4.6	3.8	2.9	11.4	8.3	5.7	4.7	8.7	4.8	4.4	9.6	4.8	6.6	10.6	3.1	6.7	26.2	6.9	6.8	7.0	7.3	5.5	0.1	13.8	1.3	10.3	3.7	6.4	5.4	5.4	7.7	3.2	3.6	3.7	6.1	4.0	13.0	8.3	5.0	3.5	8.8	9.7	10.1	10.3	9.1	1.0	10.7	7.8	8.9	9.8	16.0	9.4	6.6	17.8	8.6	8.6	8.4	8.4	0.0	10.6	0.6	0.2	0.3	1.1	0.1	1.2	1.8	1.7	1.2	1.4	2.0	0.8	0.6	0.5	0.6	0.1	9.1	1.3	0.8	15.2	18.1	8.3	19.7	18.7	15.7	26.9	11.8	24.8	15.1
NIPAL4	ICHYN	ENSG00000172548	"NIPA like domain containing 4"	Q0D2K0	5	157460019-157474717	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	Receptor	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;skin 1: 38.1"	"Group enriched"	"Detected in some"	11	"hTCEpi: 13.8;RT4: 45.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	33	"memory B-cell: 2.6;naive B-cell: 8.7"	"Lineage enriched"	"Detected in single"	51	"B-cells: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038259	Approved									"HPA038259: AB_10672510"	"unprognostic (6.74e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.55e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.28e-9)"	"unprognostic (3.12e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.18e-2)"	"prognostic favourable (6.82e-4)"	0.6	0.5	1.5	2.5	7.1	3.3	3.0	0.4	7.7	3.6	2.1	25.9	0.0	0.8	1.7	0.6	10.6	0.5	1.0	1.0	3.1	1.7	0.5	0.5	0.5	0.9	8.0	2.5	0.5	0.5	0.5	0.4	1.1	10.9	2.6	1.1	0.0	1.2	1.9	0.6	38.1	0.7	5.8	11.9	0.7	1.9	0.6	6.9	0.0	0.8	15.8	6.0	10.7	7.7	8.7	0.0	0.1	0.0	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.2	2.7	0.1	1.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	13.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	45.8	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.1	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	7.1	0.4	7.7	3.1	1.7	8.0	2.5	10.9	6.9
NKAIN2	"FAM77B, TCBA1"	ENSG00000188580	"Sodium/potassium transporting ATPase interacting 2"	Q5VXU1	6	123804141-124825657	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 43.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Daudi: 3.8;HEK 293: 6.4;HEL: 8.0;Karpas-707: 13.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	44	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045860			Approved	Cytosol				Cytosol		"HPA045860: AB_10983192"	"unprognostic (3.09e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	2.2	1.6	12.9	1.1	12.1	1.9	1.3	17.3	43.2	1.4	1.7	24.9	0.0	1.1	1.2	1.6	1.4	1.4	1.3	2.6	17.5	8.8	1.3	1.2	1.3	1.3	18.1	10.9	1.2	1.0	1.0	1.1	1.2	18.0	1.4	1.3	0.5	1.1	1.3	4.8	1.1	1.5	1.5	42.9	1.1	1.0	1.6	16.1	0.0	1.2	0.5	1.3	1.5	0.2	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	6.4	8.0	0.0	0.0	0.5	0.0	0.0	1.6	0.2	0.0	0.5	0.0	0.0	13.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	12.1	17.3	15.3	17.5	8.8	18.1	10.9	18.0	16.1
NMNAT1	"LCA9, NMNAT, PNAT1"	ENSG00000173614	"Nicotinamide nucleotide adenylyltransferase 1"	Q9HAN9	1	9943428-9985501	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059447	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA059447: "	"unprognostic (1.94e-1)"	"unprognostic (3.81e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.57e-1)"	"prognostic favourable (3.85e-14)"	"unprognostic (3.11e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.16e-2)"	7.2	13.2	8.1	7.2	9.0	4.0	8.8	4.1	8.1	8.8	12.8	9.3	11.9	8.9	10.1	8.8	8.7	7.4	7.3	13.9	7.6	6.8	11.5	12.6	5.3	5.6	10.3	8.3	5.1	14.1	10.3	9.3	5.6	13.0	7.0	13.6	10.1	17.7	8.4	29.1	8.1	9.2	8.3	9.0	8.6	7.1	10.7	8.3	6.8	10.8	11.5	6.8	6.2	10.4	5.3	4.3	12.8	4.9	3.1	2.7	2.3	3.7	4.7	6.5	6.3	12.4	11.3	1.5	7.4	6.1	8.7	5.6	2.0	6.5	4.0	4.8	11.3	3.9	7.9	10.6	10.5	8.3	4.0	6.6	2.9	6.1	9.9	5.4	6.5	11.9	12.0	10.5	15.1	9.0	7.7	2.7	9.6	6.4	3.0	3.5	0.8	8.4	3.5	4.0	2.1	10.1	2.1	4.7	2.4	9.8	8.4	8.4	3.1	5.8	8.5	3.6	3.2	7.3	3.4	3.9	3.7	3.9	6.1	11.4	7.3	6.6	4.9	3.9	2.4	3.3	1.1	5.3	2.3	2.7	4.2	3.6	2.1	2.5	12.8	3.1	4.5	4.3	1.9	2.3	8.1	9.0	4.1	8.1	7.6	6.8	10.3	8.3	13.0	8.3
NOTCH1	TAN1	ENSG00000148400	"Notch 1"	P46531	9	136494433-136545786	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 24.5;HMC-1: 21.3;hTCEpi: 23.6;MOLT-4: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 8.8;NK-cells: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008112, CAB022466, HPA067168"	Supported		Approved	Nucleoplasm		8100000	8100000	Nucleoplasm		"CAB008112: AB_2153490, CAB022466: , HPA067168: "	"unprognostic (1.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.50e-3)"	"unprognostic (8.78e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (5.45e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.84e-2)"	20.0	4.0	10.0	14.5	10.4	14.6	12.8	3.8	18.8	12.8	14.2	19.9	8.2	9.8	11.2	5.1	13.3	9.6	13.1	9.6	10.7	5.8	9.4	7.2	17.4	13.7	11.6	7.5	9.2	17.8	3.7	5.6	8.5	9.3	12.1	5.7	10.4	14.2	11.8	8.2	32.3	10.8	7.7	6.6	20.7	8.6	4.1	9.9	34.8	9.4	10.2	10.9	12.3	22.2	0.6	1.1	8.8	1.0	2.7	1.3	0.9	4.4	7.3	6.1	3.0	0.2	0.5	7.6	2.2	0.6	1.3	0.4	1.0	0.5	5.9	4.6	1.7	24.5	2.0	10.0	0.2	13.5	1.1	3.3	3.0	0.4	3.4	3.5	21.3	0.3	23.6	1.7	3.7	7.8	1.4	1.1	0.8	7.9	37.4	5.7	5.1	3.4	7.7	4.9	11.0	0.9	3.7	0.0	0.4	3.2	3.4	1.4	2.1	5.6	11.5	3.2	4.7	3.1	2.4	1.2	1.0	2.4	2.2	2.5	16.5	0.7	1.0	2.8	1.3	0.4	0.8	0.4	0.6	1.0	0.6	0.6	0.4	1.1	8.8	2.7	0.4	1.1	0.4	0.9	10.0	10.4	3.8	11.7	10.7	5.8	11.6	7.5	9.3	9.9
NOX1	"GP91-2, MOX1, NOH-1, NOH1"	ENSG00000007952	"NADPH oxidase 1"	Q9Y5S8	X	100843324-100874345	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 15.0;intestine: 36.3;seminal vesicle: 18.0"	"Cell line enriched"	"Detected in some"	21	"CACO-2: 25.9"	"Cancer enriched"	"Detected in many"	18	"colorectal cancer: 82.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"olfactory region: 1.8"												"unprognostic (8.31e-2)"	"unprognostic (2.07e-3)"	"prognostic favourable (9.71e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.55e-3)"	"unprognostic (5.48e-3)"	"unprognostic (8.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-3)"	0.1	0.1	0.2	8.8	0.2	0.0	0.1	0.2	0.2	0.2	28.3	0.0	15.0	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	36.3	0.0	0.1	18.0	0.1	0.8	1.7	0.7	0.1	0.1	0.1	0.4	0.0	0.4	0.1	0.0	0.1	0.6	0.1	0.2	0.7	0.9	0.6	0.8	1.5	0.2	0.4	0.9	0.4	0.3	0.2	0.0	0.3	0.3	0.0	0.0	0.0	25.9	0.3	0.3	0.6	0.0	0.6	0.0	0.0	0.0	0.3	1.2	0.4	0.6	0.7	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	1.1	1.0	0.7	0.9	0.6	0.6	0.4	0.0	0.9	0.4	0.5	0.6	0.3	0.6	0.2	0.8	0.2	0.3	0.2	0.5	0.6	0.3	0.6	0.3	0.7	1.1	0.2	0.9	0.3	0.3	0.5	0.3	0.3	0.2	1.1	0.2	0.1	0.1	1.5	0.6	0.1	0.8	0.6	0.7	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0
NPC1	SLC65A1	ENSG00000141458	"NPC intracellular cholesterol transporter 1"	O15118	18	23506184-23586898	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.6"	"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 70.3;U-87 MG: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.7;T-cells: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026618, CAB070132, HPA077445"	Approved		Supported	Nucleoplasm,Vesicles		27000	27000	"Nucleoplasm, Vesicles"		"CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: "	"unprognostic (1.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (2.26e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-3)"	13.4	38.8	17.4	11.2	30.9	26.4	15.8	7.1	25.1	10.1	8.7	65.6	3.4	10.2	11.1	11.7	12.8	8.2	11.2	7.1	23.4	14.3	9.9	10.3	17.8	13.0	46.0	15.4	12.0	7.9	51.8	9.9	18.9	27.7	9.7	8.9	12.0	25.4	10.1	13.7	17.0	12.2	10.9	41.4	11.5	12.0	9.5	38.4	7.0	8.3	5.3	10.7	10.8	10.8	3.6	32.7	3.8	5.8	4.6	14.5	4.1	5.3	10.6	4.5	7.4	14.9	11.6	10.5	9.3	20.2	9.9	21.4	7.1	7.8	4.5	7.2	13.4	15.0	5.8	15.9	8.8	3.5	4.6	1.6	9.6	16.0	21.4	6.1	7.3	11.1	15.8	20.8	70.3	9.7	4.8	12.0	11.0	8.1	2.5	3.6	3.2	9.6	3.6	7.2	11.2	23.0	13.3	1.9	3.7	11.1	16.1	13.7	4.0	4.8	12.5	21.0	4.1	8.3	8.0	7.5	23.1	3.1	46.2	5.4	9.4	1.8	4.1	3.8	14.5	3.8	9.8	2.4	5.9	9.9	1.7	3.6	2.7	7.3	3.7	4.6	5.8	32.7	7.7	4.1	17.4	30.9	7.1	25.1	23.4	14.3	46.0	15.4	27.7	38.4
NPC2	"EDDM1, HE1, NP-C2"	ENSG00000119655	"NPC intracellular cholesterol transporter 2"	P61916	14	74476192-74494177	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease mutation, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"epididymis: 982.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 146.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 769.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 139.0;granulocytes: 44.2;monocytes: 112.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000835	Enhanced				"Secreted to blood"	63000000	63000000			"HPA000835: AB_1079499"	"unprognostic (1.27e-3)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (4.83e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-3)"	"prognostic unfavourable (2.66e-4)"	"unprognostic (1.97e-1)"	"prognostic favourable (6.55e-4)"	"unprognostic (1.42e-1)"	34.8	23.7	9.0	14.7	12.2	13.9	27.2	2.4	7.6	21.1	16.0	12.5	92.3	11.9	16.8	982.9	17.1	14.9	17.5	34.1	9.1	9.9	29.2	13.6	65.0	48.8	15.1	6.7	25.3	14.6	4.5	21.3	22.1	25.5	17.8	14.4	39.8	21.8	54.0	9.4	16.6	19.1	12.1	26.5	30.0	13.6	26.6	10.6	7.6	49.8	15.9	15.4	16.4	18.1	18.7	139.0	44.2	112.5	6.3	12.2	67.2	30.2	19.1	12.7	16.1	146.9	43.2	40.1	21.8	73.6	19.3	43.1	32.6	38.2	7.3	16.1	17.0	60.0	16.4	40.5	17.0	11.8	12.8	3.0	9.9	25.0	32.8	4.8	56.5	43.8	34.4	17.4	33.6	24.9	3.0	57.1	18.6	12.7	7.4	7.4	6.6	30.7	3.6	22.8	25.0	43.9	66.2	0.5	8.9	31.3	11.6	27.3	19.8	20.7	27.0	27.3	37.4	39.6	19.2	26.6	45.4	2.6	29.1	15.2	15.3	34.1	83.8	17.9	6.6	112.5	6.2	18.7	9.2	6.6	39.1	17.0	9.0	7.5	44.2	6.3	76.2	139.0	12.2	67.2	9.0	12.2	2.4	7.6	9.1	9.9	15.1	6.7	25.5	10.6
NPHS2	"PDCN, SRN1"	ENSG00000116218	"NPHS2, podocin"	Q9NP85	1	179550539-179575952	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	143	"kidney: 66.5"	"Cell line enriched"	"Detected in single"	24	"NTERA-2: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB037267, HPA049486"	Enhanced									"CAB037267: AB_261982, HPA049486: "													"unprognostic (6.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPSR1	"GPR154, GPRA, PGR14"	ENSG00000187258	"Neuropeptide S receptor 1"	Q6W5P4	7	34658239-34878332	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.5;retina: 9.1;stomach 1: 3.7"	"Group enriched"	"Detected in some"	5	"HAP1: 4.6;SCLC-21H: 2.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"midbrain: 9.6"													"unprognostic (3.56e-1)"	"unprognostic (9.34e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.00e-2)"		"unprognostic (9.35e-2)"			"unprognostic (6.34e-3)"			"unprognostic (2.85e-1)"	"unprognostic (1.36e-2)"		"unprognostic (2.08e-2)"	0.0	0.2	0.5	1.0	0.1	0.0	0.0	3.5	1.0	0.1	0.9	1.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	3.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.0	0.6	9.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	3.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	3.5	1.0	0.6	3.2	0.6	0.0	1.1	0.0
NRXN1	"Hs.22998, KIAA0578"	ENSG00000179915	"Neurexin 1"	"P58400, Q9ULB1"	2	49918505-51225575	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Cell adhesion"		"Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 81.9"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 28.3"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 4.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071400			Supported	"Plasma membrane"	"Intracellular and membrane"	620000	620000	"Plasma membrane"		"HPA071400: "	"unprognostic (7.01e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.74e-4)"	"unprognostic (2.46e-1)"	"unprognostic (8.95e-2)"		"unprognostic (2.02e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.37e-4)"	"unprognostic (2.85e-2)"	"unprognostic (6.68e-7)"	"unprognostic (3.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.99e-3)"	2.1	3.2	22.4	2.1	20.3	1.4	1.7	56.5	81.9	2.8	5.1	3.0	0.5	2.1	2.1	3.7	3.0	1.4	2.2	3.8	16.9	13.8	1.5	1.6	1.5	1.4	8.3	25.9	2.1	2.3	1.3	4.8	1.1	12.6	2.5	3.8	2.0	3.5	9.3	1.3	2.0	3.1	2.1	6.5	1.3	2.3	6.5	4.7	0.0	1.4	0.0	1.4	2.0	1.6	0.0	0.0	4.4	0.1	0.3	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.2	0.0	0.0	28.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	2.4	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.3	0.0	0.0	0.0	0.0	22.4	20.3	56.5	33.2	16.9	13.8	8.3	25.9	12.6	4.7
NSD1	"ARA267, FLJ22263, KMT3B, STO"	ENSG00000165671	"Nuclear receptor binding SET domain protein 1"	Q96L73	5	177133025-177300215	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048431, HPA070333, HPA073705"	Supported		Supported	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA048431: , HPA070333: , HPA073705: "	"unprognostic (3.48e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.68e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.77e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.32e-2)"	11.8	13.2	11.9	25.4	15.7	23.9	14.0	28.9	16.7	15.6	14.2	18.5	17.0	10.6	19.0	13.9	17.8	13.6	15.8	11.7	12.8	11.5	14.4	10.5	12.3	19.4	12.9	11.7	16.6	27.1	24.6	19.3	16.0	13.4	14.2	14.3	13.8	13.5	18.7	20.6	16.1	14.5	15.6	13.2	16.1	13.1	28.1	16.1	27.3	20.1	10.6	22.7	13.4	20.2	10.2	8.9	18.7	10.8	10.9	7.8	2.9	9.7	12.6	13.1	11.3	6.4	8.3	0.4	8.8	8.9	12.4	11.6	2.8	8.2	20.1	10.0	12.1	8.4	20.8	19.6	15.1	34.0	12.6	8.9	14.2	0.1	10.7	19.2	10.6	7.8	11.9	14.7	13.8	18.0	12.1	7.1	12.5	20.4	13.3	6.2	14.2	11.1	14.8	1.7	6.2	8.0	11.8	15.9	11.0	22.9	10.0	6.9	10.0	16.0	13.3	8.7	12.6	5.5	10.9	8.3	7.2	14.4	5.0	9.4	9.3	10.7	9.1	9.4	7.5	6.1	6.3	8.5	6.3	5.0	6.7	10.2	7.8	6.3	18.7	10.9	10.8	8.9	5.7	2.9	11.9	15.7	28.9	16.7	12.8	11.5	12.9	11.7	13.4	16.1
NSD2	"KMT3G, MMSET, WHSC1"	ENSG00000109685	"Nuclear receptor binding SET domain protein 2"	O96028	4	1871424-1982207	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015801, CAB068246, CAB068247"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB068246: , CAB068247: , HPA015801: AB_1858830"	"unprognostic (3.70e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (3.24e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.25e-3)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.15e-2)"	8.7	7.6	17.6	11.5	16.2	35.1	8.5	20.6	18.2	7.0	14.8	12.4	6.3	14.0	9.5	7.4	12.7	6.8	6.9	11.9	15.1	10.9	8.4	7.5	11.1	18.8	14.7	16.1	7.0	11.7	10.7	11.8	9.8	14.6	8.7	17.7	9.4	10.2	7.4	11.8	12.1	14.6	10.5	15.3	13.5	11.0	26.3	13.4	46.7	13.8	5.5	17.7	8.6	9.4	4.9	3.9	4.1	1.8	2.7	4.3	0.6	27.4	13.9	41.9	18.3	4.5	6.7	12.2	22.2	19.7	27.2	30.5	12.2	32.6	29.6	7.6	18.3	12.0	27.0	18.3	46.8	14.2	11.1	35.2	19.2	7.2	5.7	21.5	18.5	2.6	4.6	23.9	23.0	21.4	19.0	31.1	22.3	10.8	57.5	22.6	17.6	16.0	32.9	27.3	10.2	11.2	13.0	26.0	20.8	18.2	6.8	8.3	16.1	14.5	16.5	27.2	20.3	17.2	44.6	14.6	15.4	26.8	16.3	21.4	25.2	2.1	1.7	1.7	2.9	1.8	3.2	1.8	3.2	3.2	1.5	4.9	2.8	2.3	4.1	2.7	1.4	3.9	4.3	0.6	17.6	16.2	20.6	18.2	15.1	10.9	14.7	16.1	14.6	13.4
NSD3	"FLJ20353, KMT3F, WHISTLE, WHSC1L1"	ENSG00000147548	"Nuclear receptor binding SET domain protein 3"	Q9BZ95	8	38269697-38382272	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005659, CAB013721, HPA018893"	Uncertain		Approved	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833"	"unprognostic (6.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (7.48e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.60e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.60e-2)"	19.2	11.3	31.1	15.8	31.4	36.3	20.1	51.5	37.7	18.5	15.5	16.7	14.0	16.2	16.0	12.5	17.0	16.8	17.0	12.7	24.4	16.6	14.2	11.2	17.9	22.3	25.0	26.8	26.5	16.3	21.0	24.2	22.5	21.9	16.4	18.7	12.3	18.3	17.9	12.3	16.2	17.7	16.0	15.3	17.2	19.7	9.3	25.6	16.7	19.2	6.9	20.4	19.6	23.3	26.7	5.6	26.2	5.1	8.6	18.0	2.9	23.9	13.8	23.7	16.0	16.6	19.2	17.6	20.1	22.3	17.4	20.3	7.3	13.3	28.6	18.5	13.7	14.4	18.7	16.1	24.9	11.3	11.0	36.4	11.1	8.6	17.1	16.0	13.2	10.3	16.4	15.7	32.1	20.0	25.8	19.0	16.5	8.6	46.7	13.6	16.1	6.5	21.4	25.9	9.0	12.4	18.6	13.4	18.1	16.3	14.3	14.0	18.1	12.2	19.0	18.2	18.9	27.0	11.8	17.0	20.2	27.6	15.3	16.2	13.1	13.9	5.1	9.1	8.0	2.4	5.3	16.5	12.0	7.1	4.1	26.7	15.0	6.3	26.2	8.6	1.5	5.6	18.0	2.9	31.1	31.4	51.5	37.7	24.4	16.6	25.0	26.8	21.9	25.6
NSDHL	"H105e3, SDR31E1, XAP104"	ENSG00000147383	"NAD(P) dependent steroid dehydrogenase-like"	Q15738	X	152830967-152869729	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000248, HPA000571"	Enhanced		Enhanced	"Endoplasmic reticulum,Lipid droplets"				"Endoplasmic reticulum"	"Lipid droplets"	"HPA000248: AB_1079507, HPA000571: AB_1079506"	"unprognostic (1.84e-1)"	"prognostic favourable (5.65e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (5.04e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.63e-1)"	"prognostic favourable (6.09e-5)"	"unprognostic (3.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.79e-2)"	17.4	24.8	11.0	7.7	10.5	6.0	20.4	7.7	15.0	13.4	23.4	13.9	20.5	13.3	10.4	35.7	36.2	11.9	7.4	16.7	14.3	11.4	11.6	38.1	9.9	8.7	9.7	10.4	9.8	7.9	9.8	6.9	7.9	18.9	12.0	10.7	7.9	12.2	17.7	6.9	14.5	24.0	9.9	14.2	7.3	9.6	8.6	9.3	6.0	11.0	22.2	17.0	7.5	16.1	16.2	17.5	16.4	17.7	17.0	17.3	13.0	43.6	16.1	21.9	11.4	18.9	14.4	12.4	8.7	11.7	15.9	20.3	22.2	23.9	21.6	29.4	11.8	22.5	28.5	40.2	14.1	7.2	16.3	8.8	15.7	22.4	13.8	8.8	7.2	17.6	15.6	31.1	7.9	14.7	14.6	9.8	12.0	19.3	8.7	11.5	8.7	19.4	6.5	15.9	17.7	33.0	18.1	7.9	9.0	7.8	11.7	9.2	7.7	11.3	12.4	7.4	12.3	17.8	16.7	13.9	9.3	37.2	13.7	13.8	7.0	16.4	17.7	15.8	15.6	16.2	15.7	16.2	15.6	13.5	17.5	12.9	11.4	12.6	1.9	17.0	12.1	15.6	17.3	13.0	11.0	10.5	7.7	15.0	14.3	11.4	9.7	10.4	18.9	9.3
NSUN2	"FLJ20303, Misu, MRT5, TRM4"	ENSG00000037474	"NOP2/Sun RNA methyltransferase family member 2"	Q08J23	5	6599239-6633291	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037896	Supported		Approved	Nucleoplasm				Nucleoplasm		"HPA037896: AB_10670532"	"unprognostic (3.99e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (8.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.44e-3)"	"unprognostic (5.12e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.48e-2)"	"prognostic unfavourable (5.69e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.70e-2)"	19.0	19.1	11.3	20.4	17.4	16.7	28.1	13.4	16.0	17.4	17.9	20.2	18.2	15.4	21.5	20.6	27.0	19.3	17.1	20.1	12.7	9.7	15.0	34.9	15.0	22.5	13.6	16.5	17.2	18.7	19.5	22.3	18.2	16.1	15.5	21.2	14.3	20.0	15.8	42.3	22.9	20.9	19.1	15.9	23.7	19.9	15.8	13.2	26.7	14.3	17.1	29.5	19.2	17.1	18.1	16.7	15.6	17.3	17.6	22.7	12.7	26.9	23.4	13.8	12.1	8.8	9.8	32.5	21.1	12.8	22.5	19.6	30.4	20.2	46.5	21.6	16.9	20.7	28.5	24.6	30.6	31.7	23.0	27.7	55.5	17.6	12.6	47.7	22.4	11.2	18.2	25.5	22.3	15.9	35.7	17.1	20.8	18.8	26.0	20.7	22.8	30.6	34.0	14.5	14.3	15.8	30.0	13.2	18.6	52.2	26.5	20.3	23.1	21.3	18.5	18.0	23.7	18.6	31.4	14.1	26.5	44.6	14.4	38.0	20.6	9.7	14.6	15.6	17.5	17.3	22.7	18.1	18.4	20.7	16.7	16.5	20.4	20.6	2.9	17.6	15.2	16.5	13.0	12.7	11.3	17.4	13.4	16.0	12.7	9.7	13.6	16.5	16.1	13.2
NT5C2	"cN-II, GMP, NT5B, PNT5, SPG65"	ENSG00000076685	"5'-nucleotidase, cytosolic II"	P49902	10	103088017-103193306	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Allosteric enzyme, Hydrolase"	"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003751	Approved									"HPA003751: AB_1854664"	"unprognostic (8.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.41e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.50e-1)"	15.0	17.0	17.6	18.2	21.2	31.6	19.7	22.5	19.6	17.5	20.7	25.4	24.5	10.9	24.6	19.6	38.6	14.8	17.0	16.5	16.7	20.7	19.6	15.5	18.8	16.8	21.8	17.3	24.8	19.4	18.7	29.5	16.9	29.1	22.9	17.0	26.2	67.2	21.6	41.6	11.7	13.9	20.4	19.1	20.5	15.9	21.7	14.5	29.7	39.2	16.3	31.5	21.1	31.1	6.7	9.7	23.8	14.5	10.5	8.7	7.1	50.1	20.4	14.2	31.9	12.5	14.0	8.1	25.2	24.5	12.3	12.7	14.8	40.2	24.0	19.6	17.4	25.7	9.4	12.9	14.4	14.5	8.8	17.3	8.7	14.4	22.4	25.0	8.6	21.4	14.4	10.7	17.3	11.2	11.2	16.8	21.2	29.6	22.3	32.4	13.5	25.3	36.5	12.3	6.9	17.6	28.7	4.3	10.7	13.2	10.4	19.7	15.9	19.4	11.4	9.8	9.8	14.0	18.3	14.7	24.4	32.2	9.9	28.9	2.8	19.8	11.7	23.8	8.1	11.9	8.7	6.7	7.0	6.5	9.7	4.2	6.0	6.2	21.4	10.5	14.5	7.3	6.5	7.1	17.6	21.2	22.5	18.0	16.7	20.7	21.8	17.3	29.1	14.5
NT5C3A	"cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1"	ENSG00000122643	"5'-nucleotidase, cytosolic IIIA"	Q9H0P0	7	33014113-33062797	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010630, HPA029058"	Uncertain				"Intracellular and membrane"					"HPA010630: AB_2668319, HPA029058: AB_10601380"	"unprognostic (7.50e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (9.37e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.43e-3)"	12.3	12.1	9.9	17.0	9.9	15.4	11.4	16.2	12.2	12.0	27.5	7.4	8.1	20.9	14.7	11.6	12.0	9.0	12.9	11.6	9.8	10.3	11.7	10.5	11.6	15.0	10.3	9.8	10.3	19.1	5.5	10.9	10.6	8.4	9.6	27.2	8.5	9.0	8.9	53.3	15.0	19.7	7.5	9.9	18.4	14.5	6.3	8.9	15.4	9.8	28.8	22.8	12.0	11.6	21.4	6.8	36.6	11.4	8.6	18.9	13.3	14.1	10.3	9.6	8.5	7.3	6.4	7.8	15.5	10.1	10.5	14.4	6.4	40.0	35.5	9.0	9.0	21.5	10.4	10.2	15.7	5.5	13.3	16.1	12.2	9.3	7.7	19.2	13.4	7.1	9.1	11.5	23.1	6.9	13.9	9.5	12.9	9.6	7.1	30.1	9.9	9.1	9.5	8.8	21.0	33.6	14.9	10.4	12.9	10.1	19.1	24.2	12.7	10.7	6.0	9.0	8.1	15.3	20.2	19.0	21.6	17.4	7.4	11.9	14.0	26.9	8.0	29.8	9.0	10.2	10.2	21.4	12.1	11.0	6.8	20.5	12.4	10.6	36.6	8.6	11.4	6.4	18.9	13.3	9.9	9.9	16.2	12.2	9.8	10.3	10.3	9.8	8.4	8.9
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 108.8;TIME: 63.0;U-87 MG: 98.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3"	"Group enriched"	"Detected in many"	47	"B-cells: 19.9;T-cells: 17.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	1600000	1600000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	12.2	3.2	9.3	7.7	11.6	0.5	16.6	1.1	6.9	58.8	13.9	3.6	8.1	18.6	33.3	14.8	7.6	12.2	15.4	6.1	5.7	5.5	8.8	26.0	3.4	6.8	6.3	6.6	25.4	1.4	1.6	9.3	42.2	5.3	16.4	15.6	15.3	4.6	17.8	5.7	4.5	14.9	35.3	6.3	7.0	6.0	12.4	4.2	1.6	26.5	7.3	7.1	16.6	20.2	19.9	0.0	0.2	0.0	0.4	17.3	3.9	5.4	2.9	5.0	0.1	11.5	36.7	0.0	35.5	38.9	17.5	32.9	0.0	54.5	0.0	12.8	31.0	2.8	0.0	35.7	41.7	0.0	0.0	0.0	0.8	0.6	5.7	0.0	0.0	9.4	0.4	35.7	22.8	14.5	0.0	0.1	108.8	0.9	0.0	0.0	0.1	3.9	0.1	1.1	0.1	37.9	2.4	0.0	0.6	0.4	2.2	12.0	0.0	0.9	63.0	14.3	0.1	18.0	57.7	2.7	1.7	0.0	98.1	0.0	44.8	0.0	0.0	0.2	2.0	0.0	3.5	13.4	2.3	6.6	0.0	19.9	2.4	17.3	0.2	0.4	0.0	0.0	0.8	3.9	9.3	11.6	1.1	6.9	5.7	5.5	6.3	6.6	5.3	4.2
NTHL1	"NTH1, OCTS3"	ENSG00000065057	"Nth like DNA glycosylase 1"	P78549	16	2039815-2047866	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025152	Supported									"CAB025152: "	"unprognostic (1.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.62e-2)"	10.5	8.2	13.4	10.5	19.9	6.0	7.8	15.6	17.9	14.8	12.3	9.0	15.1	9.7	11.8	6.9	9.4	20.5	14.7	10.6	12.5	12.1	7.4	17.5	11.1	10.4	13.6	15.7	18.8	24.6	5.8	8.7	8.3	13.3	9.8	8.2	9.1	22.2	18.2	12.4	6.3	11.2	7.8	10.4	15.2	11.1	6.4	11.6	9.6	9.5	6.6	8.4	7.8	9.3	21.4	14.7	2.4	14.2	9.7	18.8	8.5	10.7	26.4	7.7	11.6	3.1	6.0	8.5	4.5	4.8	8.6	5.4	18.8	10.5	22.9	9.5	3.7	9.6	9.5	10.6	1.5	10.6	23.3	7.1	16.7	20.8	4.3	8.1	8.4	5.0	5.5	4.5	4.9	11.9	7.7	8.3	3.3	12.0	12.1	30.4	17.1	17.3	29.0	8.1	36.7	6.2	3.9	16.3	16.3	4.9	15.1	8.7	10.8	8.0	4.6	7.3	8.1	6.5	8.3	11.3	13.2	9.3	3.3	11.4	9.1	2.4	8.7	2.0	8.8	14.2	9.8	21.4	10.5	9.8	14.7	17.1	7.8	9.5	0.3	9.7	12.1	14.6	18.8	8.5	13.4	19.9	15.6	17.9	12.5	12.1	13.6	15.7	13.3	11.6
NTRK2	TRKB	ENSG00000148053	"Neurotrophic receptor tyrosine kinase 2"	Q16620	9	84668551-85027070	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Epilepsy, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 133.8;thyroid gland: 63.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.4;HaCaT: 3.7;RPTEC TERT1: 11.6;SH-SY5Y: 13.3"	"Group enriched"	"Detected in many"	5	"glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007637, CAB010346"	Enhanced		Approved	Cytosol		13000000	13000000	Cytosol		"CAB010346: AB_2155274, HPA007637: AB_1080385"	"unprognostic (2.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-3)"	19.8	2.7	66.1	2.0	56.7	1.2	33.2	15.1	133.8	6.4	4.4	27.4	0.0	1.4	3.0	3.3	5.6	3.7	18.7	5.8	61.0	30.7	12.5	2.1	6.3	2.7	32.4	41.4	6.6	18.9	1.6	3.0	2.1	34.1	3.8	3.1	2.0	8.6	11.9	2.0	7.2	1.6	3.0	22.1	6.5	1.4	2.4	34.1	0.0	63.4	2.6	3.4	3.5	3.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.6	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.8	0.9	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	66.1	56.7	15.1	45.6	61.0	30.7	32.4	41.4	34.1	34.1
NTRK3	TRKC	ENSG00000140538	"Neurotrophic receptor tyrosine kinase 3"	Q16288	15	87859751-88256768	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8"	"Cell line enriched"	"Detected in some"	8	"U-138 MG: 47.4"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009233, HPA027484, HPA048065"	Approved		Supported	"Nuclear membrane,Nucleoli"		11000000	11000000	Nucleoli	"Nuclear membrane"	"CAB009233: AB_632555, HPA027484: , HPA048065: "	"unprognostic (1.27e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.49e-3)"	20.8	7.4	22.0	2.5	28.1	1.5	6.2	30.4	41.8	7.0	4.0	8.4	1.3	2.0	12.4	6.7	3.4	9.5	3.9	5.5	22.0	11.1	5.1	2.0	5.7	3.1	11.2	18.7	5.1	2.9	1.6	7.9	2.8	14.7	6.8	4.7	8.0	11.5	8.7	1.9	2.9	2.5	7.7	13.7	4.1	3.0	13.8	13.7	0.0	2.5	0.7	4.3	7.1	4.8	0.7	0.4	1.3	0.5	0.5	0.8	0.0	0.0	5.9	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.9	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.1	1.2	0.5	0.4	0.3	0.1	0.2	0.4	0.3	0.3	0.1	0.7	0.4	0.4	1.3	0.5	0.1	0.4	0.8	0.0	22.0	28.1	30.4	28.9	22.0	11.1	11.2	18.7	14.7	13.7
NUP107	NUP84	ENSG00000111581	"Nucleoporin 107"	P57740	12	68686734-68745809	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031679			Uncertain	"Nucleoplasm,Nuclear membrane,Centrosome"				Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA031679: "	"unprognostic (2.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"prognostic unfavourable (3.12e-9)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (1.28e-6)"	"unprognostic (3.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.96e-1)"	18.3	12.6	10.2	16.5	13.2	18.7	17.4	20.7	15.2	19.0	12.2	12.1	12.2	9.2	18.6	18.0	14.0	16.6	8.5	12.1	12.2	6.6	12.1	11.1	12.5	21.4	13.2	10.2	19.8	12.5	14.2	16.2	23.5	12.2	12.6	15.3	11.3	13.0	11.8	13.9	14.8	15.8	13.7	12.5	19.7	12.0	20.5	15.9	40.6	12.5	13.1	22.5	17.8	13.1	13.6	7.0	9.5	14.2	20.6	17.0	8.0	17.0	22.0	26.3	19.0	7.8	10.0	28.5	18.7	10.8	28.2	23.6	22.1	14.5	31.3	18.3	8.9	19.7	29.5	13.8	37.6	29.3	21.9	35.7	15.8	18.5	4.9	31.4	12.1	5.2	6.6	22.5	14.8	16.8	42.5	22.6	17.6	20.7	25.8	27.5	28.9	21.6	26.5	31.6	18.8	12.2	18.2	15.5	15.9	20.7	15.6	11.2	23.4	15.2	10.2	15.4	15.7	17.8	22.7	9.9	19.7	37.9	11.8	23.0	18.1	6.3	6.5	9.5	13.1	8.5	17.0	13.5	13.0	14.0	7.0	13.6	16.2	14.5	1.7	20.6	14.2	5.5	13.4	8.0	10.2	13.2	20.7	15.2	12.2	6.6	13.2	10.2	12.2	15.9
NUP155	"KIAA0791, N155"	ENSG00000113569	"Nucleoporin 155"	O75694	5	37288137-37371181	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Atrial fibrillation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"lymphoid tissue: 20.4;testis: 70.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037775	Enhanced		Enhanced	"Nuclear membrane"	"Intracellular and membrane"			"Nuclear membrane"		"HPA037775: AB_10671885"	"unprognostic (1.10e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (1.35e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	6.8	5.3	3.9	6.5	5.9	11.2	7.3	6.9	7.5	6.4	5.1	5.9	3.4	4.4	9.7	3.7	6.9	5.0	3.7	4.7	3.9	4.1	4.4	5.3	5.1	8.1	3.8	4.2	7.9	5.5	8.1	7.0	8.4	5.2	5.5	6.3	5.9	6.0	5.9	6.1	8.1	5.0	5.9	3.9	7.2	4.9	70.1	2.5	20.4	5.4	4.8	9.8	5.8	6.0	7.3	4.9	7.1	7.1	7.7	10.0	4.4	13.6	10.8	11.8	17.4	3.7	5.5	42.5	11.1	5.9	15.2	11.2	15.9	11.2	15.5	5.1	7.1	11.1	19.9	10.9	23.9	10.2	11.2	12.0	39.6	7.4	4.7	20.0	8.5	4.0	4.6	23.4	11.9	8.0	21.8	8.3	10.1	6.7	10.7	5.4	11.2	9.9	12.9	37.3	12.3	3.5	13.1	14.3	9.8	25.5	11.0	6.4	13.5	8.0	6.9	18.3	15.4	13.8	16.8	9.4	15.7	20.8	8.5	18.1	13.8	7.1	3.4	5.8	6.1	7.1	10.0	7.3	5.7	5.3	4.9	5.8	5.8	6.5	1.3	7.7	5.0	3.4	4.1	4.4	3.9	5.9	6.9	7.5	3.9	4.1	3.8	4.2	5.2	2.5
NUP188	KIAA0169	ENSG00000095319	"Nucleoporin 188"	Q5SRE5	9	128947699-129007096	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061750, HPA063942"	Approved		Uncertain	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA061750: , HPA063942: "	"unprognostic (4.64e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.36e-1)"	"prognostic favourable (5.20e-5)"	"unprognostic (9.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-3)"	"unprognostic (3.53e-3)"	10.2	11.1	7.6	12.6	9.2	14.3	14.0	13.3	8.7	9.2	9.3	10.1	9.6	5.8	9.8	6.7	16.6	8.3	7.6	9.2	5.6	6.3	8.1	9.6	13.1	16.6	6.5	6.7	10.8	13.3	12.6	13.6	9.1	7.3	9.5	9.3	11.2	9.9	8.3	10.9	16.4	9.0	11.0	7.7	12.2	9.5	60.3	7.3	26.5	9.2	11.3	17.3	8.5	10.5	6.1	7.9	6.3	10.7	6.0	12.0	7.0	10.8	20.7	17.2	23.4	13.0	13.0	15.4	15.2	12.0	27.9	18.6	24.9	8.7	19.0	5.7	16.7	32.1	38.5	18.8	20.9	15.2	18.5	16.9	38.7	19.7	8.3	28.8	17.1	9.0	8.9	29.3	15.0	16.0	37.0	13.5	19.7	27.4	24.6	11.8	23.0	19.9	22.6	37.2	19.3	8.6	12.3	24.2	11.7	39.4	15.0	5.8	16.5	10.6	12.9	23.2	16.5	23.3	27.2	11.6	21.3	25.7	13.5	18.5	17.1	6.3	5.3	1.9	9.3	10.7	12.0	6.1	7.9	9.0	7.9	5.9	8.1	8.6	0.8	6.0	5.9	3.3	9.5	7.0	7.6	9.2	13.3	8.7	5.6	6.3	6.5	6.7	7.3	7.3
NUP205	"C7orf14, KIAA0225"	ENSG00000155561	"Nucleoporin 205"	Q92621	7	135557919-135648757	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavourable (1.90e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.35e-2)"	13.7	12.6	11.4	14.2	11.9	10.8	13.1	23.3	10.5	12.5	11.9	13.4	11.4	9.0	17.6	9.7	19.3	16.1	7.4	9.5	8.6	6.1	10.3	8.3	12.2	16.1	11.7	6.9	17.4	10.3	23.0	20.9	13.1	10.6	10.6	14.7	14.6	18.4	11.3	16.6	15.1	13.8	14.7	10.8	16.7	12.7	17.4	11.4	31.6	12.4	13.4	22.1	15.6	14.4	4.9	5.7	2.2	6.1	5.3	6.0	2.7	21.8	17.8	24.0	23.4	5.7	9.5	15.7	13.9	10.7	21.6	24.2	18.4	15.9	28.0	11.0	8.3	17.0	30.1	15.5	28.0	13.8	21.5	16.2	18.4	8.3	4.3	31.6	12.8	5.1	7.1	21.2	14.2	16.1	37.6	13.4	16.3	14.9	34.1	9.6	36.8	15.8	25.6	22.3	22.1	6.6	17.6	24.0	24.5	22.9	18.8	11.2	10.8	12.1	13.0	17.8	8.9	21.6	26.4	9.9	18.5	38.0	18.1	24.9	23.9	2.2	2.5	0.8	4.9	6.1	6.0	4.9	6.0	5.2	5.7	4.3	5.1	5.6	1.1	5.3	3.3	3.8	5.6	2.7	11.4	11.9	23.3	10.5	8.6	6.1	11.7	6.9	10.6	11.4
NUP214	"CAIN, CAN, D9S46E, N214"	ENSG00000126883	"Nucleoporin 214"	P35658	9	131125561-131234670	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 131.5"	"Cell line enhanced"	"Detected in all"		"K-562: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 43.7;neutrophil: 131.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 131.5;monocytes: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048789			Approved	"Nucleoplasm,Vesicles,Focal adhesion sites"		100000	100000	Nucleoplasm	"Vesicles, Focal adhesion sites"	"HPA048789: "	"unprognostic (1.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.95e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.08e-1)"	"prognostic favourable (2.39e-5)"	"unprognostic (5.49e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	16.9	10.3	11.5	13.8	13.9	29.4	12.9	13.0	14.4	10.2	11.4	19.8	10.4	9.0	15.0	13.7	16.1	12.1	10.2	9.7	9.5	8.1	19.0	15.1	11.7	13.3	13.2	8.8	14.2	17.0	16.7	16.9	13.0	11.3	11.1	10.8	15.3	13.0	11.1	15.5	17.5	11.7	11.1	14.3	35.8	12.3	63.7	13.3	27.4	11.8	7.6	16.8	10.7	11.2	1.2	16.8	131.5	43.7	1.2	0.8	17.9	6.7	9.6	8.2	4.9	6.6	6.4	8.6	6.0	6.2	7.8	6.3	7.8	4.9	10.9	4.8	8.2	15.4	11.0	7.8	7.6	7.9	5.4	6.8	13.7	15.2	5.8	10.6	7.3	7.0	7.2	10.0	8.1	8.0	71.4	6.3	8.0	12.5	13.9	16.0	8.9	8.5	4.8	10.3	10.9	9.0	6.2	7.0	7.2	10.0	9.2	5.2	12.1	26.4	6.8	13.8	7.8	9.0	9.6	5.5	10.7	10.5	6.7	6.4	8.3	3.5	43.7	17.3	0.7	18.4	0.8	1.2	0.7	0.6	16.8	1.1	0.7	0.7	131.5	1.2	15.0	1.5	0.4	17.9	11.5	13.9	13.0	14.4	9.5	8.1	13.2	8.8	11.3	13.3
NUP62	"DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI"	ENSG00000213024	"Nucleoporin 62"	P37198	19	49906825-49929763	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005435, CAB020724"	Supported		Supported	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	Nucleoplasm	"CAB020724: , HPA005435: AB_1079510"	"unprognostic (2.26e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.68e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (2.50e-7)"	"unprognostic (2.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavourable (5.71e-12)"	"unprognostic (3.89e-3)"	"unprognostic (3.62e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.27e-3)"	19.1	25.7	15.8	29.1	18.5	19.8	16.1	28.3	21.7	18.2	17.1	21.0	13.4	20.0	24.1	13.7	21.5	22.1	20.9	16.9	14.3	15.1	16.8	27.5	16.2	29.0	15.2	14.2	26.6	18.6	14.0	21.3	24.1	17.4	19.8	17.7	16.2	18.8	20.2	27.1	18.8	20.2	23.3	14.2	26.0	16.4	70.9	17.6	45.5	16.8	17.3	29.6	18.9	19.4	10.7	21.1	6.2	22.3	13.7	16.9	12.5	31.5	30.1	22.3	18.9	7.0	8.0	20.8	23.9	16.4	25.2	25.2	20.2	18.6	35.5	13.1	15.2	18.8	27.1	16.6	24.5	51.4	28.9	28.5	15.1	18.7	8.4	26.1	28.5	8.2	11.5	16.7	13.9	18.5	34.8	34.8	17.2	15.2	47.3	20.0	21.1	26.7	42.7	26.0	30.2	12.1	24.5	24.9	17.7	22.8	26.1	11.9	21.2	13.4	14.3	39.7	23.3	12.8	38.8	25.2	68.7	32.7	16.4	22.9	29.5	6.2	20.7	4.2	12.0	22.3	16.9	10.6	12.0	13.2	21.1	10.7	8.2	10.5	3.3	13.7	11.8	18.3	10.7	12.5	15.8	18.5	28.3	21.7	14.3	15.1	15.2	14.2	17.4	17.6
NUP93	KIAA0095	ENSG00000102900	"Nucleoporin 93"	Q8N1F7	16	56730105-56850286	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017937	Uncertain									"HPA017937: AB_1854726"	"unprognostic (6.31e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavourable (1.72e-6)"	"unprognostic (9.18e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.22e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.74e-2)"	14.2	12.2	14.8	15.6	29.7	33.7	12.6	16.8	29.1	12.7	12.4	14.4	4.4	7.2	15.0	9.8	16.8	12.0	8.6	11.5	26.1	11.2	9.9	6.9	12.6	19.1	13.1	16.7	13.4	9.8	16.5	9.6	14.1	23.8	13.9	14.5	23.0	10.4	10.2	15.5	16.3	11.2	14.5	20.7	17.8	11.1	29.3	13.9	28.0	27.4	10.4	22.5	11.5	13.2	12.0	16.9	54.1	21.3	15.1	14.6	11.9	19.1	23.8	21.6	23.5	8.3	9.1	23.9	16.8	13.7	41.8	28.7	32.7	19.2	30.1	16.9	15.8	34.4	40.9	23.9	41.3	9.2	22.3	20.1	17.2	26.7	10.2	26.6	24.1	9.1	10.5	28.3	17.9	24.0	24.3	6.0	20.6	13.7	35.7	22.9	27.4	26.7	43.4	36.4	30.4	16.2	12.8	19.1	12.6	43.8	15.4	13.8	11.7	16.6	16.0	19.9	22.3	16.6	19.0	10.4	14.2	50.2	14.0	25.2	19.4	5.1	14.3	54.1	11.9	21.3	14.6	12.0	9.1	12.9	16.9	11.6	9.5	13.2	3.6	15.1	20.9	8.8	11.0	11.9	14.8	29.7	16.8	29.1	26.1	11.2	13.1	16.7	23.8	13.9
NUS1	"C6orf68, MGC7199, NgBR, TANGO14"	ENSG00000153989	"NUS1 dehydrodolichyl diphosphate synthase subunit"	Q96E22	6	117675502-117710640	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Angiogenesis, Differentiation, Lipid metabolism"	"Developmental protein, Receptor, Transferase"	"Congenital disorder of glycosylation, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027504	Supported		Approved	"Vesicles,Plasma membrane"				Vesicles	"Plasma membrane"	"HPA027504: AB_10603124"	"unprognostic (1.21e-2)"	"prognostic unfavourable (6.99e-4)"	"unprognostic (1.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.26e-3)"	"unprognostic (1.42e-3)"	"unprognostic (2.42e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	8.4	10.2	14.7	9.3	14.7	7.0	10.0	8.8	13.4	29.6	9.2	6.8	2.0	7.1	9.6	13.5	9.5	8.8	7.1	8.2	12.7	9.9	13.1	17.4	9.5	8.4	16.4	15.7	8.8	28.9	15.0	20.0	10.6	16.2	9.6	9.3	7.1	13.8	14.9	7.9	6.1	14.4	8.5	7.3	9.1	10.6	5.6	12.2	7.2	16.5	3.1	8.7	9.1	18.0	2.4	8.1	3.3	4.9	4.1	4.5	2.3	10.0	7.4	16.1	18.0	16.3	21.4	39.6	18.5	19.3	15.5	17.9	16.8	11.3	23.9	20.1	17.0	9.2	23.9	18.1	28.9	17.9	22.0	27.3	12.5	30.1	25.1	34.4	16.1	18.7	20.6	16.9	34.7	15.9	32.6	21.3	23.1	11.4	16.1	21.9	18.7	13.6	15.6	11.6	17.1	30.7	10.1	19.1	15.1	11.1	14.5	13.6	9.2	36.1	13.9	9.6	11.9	15.3	26.5	29.6	22.1	25.4	22.7	26.5	19.1	3.3	3.0	1.8	3.1	3.0	4.5	2.4	3.7	4.1	3.2	2.1	3.1	4.0	0.2	4.1	4.9	8.1	3.4	2.3	14.7	14.7	8.8	13.4	12.7	9.9	16.4	15.7	16.2	12.2
OAT	HOGA	ENSG00000065154	"Ornithine aminotransferase"	P04181	10	124397303-124418976	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 208.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB033576, HPA040098, HPA064742"	Enhanced		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: "	"unprognostic (1.61e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-2)"	13.5	37.1	25.9	9.1	26.7	20.3	33.8	17.2	39.8	24.7	71.9	22.8	33.9	164.0	21.6	15.5	26.1	14.9	16.0	12.7	25.6	29.8	25.6	36.8	11.6	9.3	27.9	30.1	21.8	12.3	12.1	18.0	14.8	37.8	17.9	15.8	13.3	55.2	29.1	13.7	16.3	208.5	22.5	25.5	8.4	17.3	14.6	19.4	4.9	15.9	23.1	15.2	15.5	18.2	10.2	26.5	23.0	23.6	9.6	20.1	16.3	41.4	7.5	4.9	17.6	50.3	48.5	16.8	25.1	51.3	22.5	24.7	19.2	5.4	0.0	18.3	42.4	44.2	22.5	47.0	24.5	7.3	31.2	46.4	5.3	14.3	25.9	0.0	30.6	31.7	24.3	20.2	23.6	26.1	79.8	8.9	31.3	10.7	12.2	2.6	9.8	10.6	11.4	18.8	11.2	21.5	0.6	10.3	11.0	15.8	42.1	35.3	14.0	11.4	20.1	12.8	12.0	21.2	15.6	7.6	8.0	11.2	17.7	12.5	6.1	18.6	23.6	20.7	18.5	20.7	20.1	9.6	15.6	19.4	26.5	10.2	19.6	19.1	23.0	9.6	20.8	5.7	14.4	16.3	25.9	26.7	17.2	39.8	25.6	29.8	27.9	30.1	37.8	19.4
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208130-228378874	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 180.2;tongue: 48.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA021186: AB_1854761, HPA065801: "	"unprognostic (8.47e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.99e-2)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (5.30e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-2)"	2.5	0.9	0.5	0.9	4.4	0.6	0.7	3.1	0.6	0.6	0.8	0.5	0.5	0.6	0.8	4.4	2.4	1.0	0.6	21.2	0.5	0.7	1.6	0.5	1.0	1.0	0.5	0.5	1.7	1.4	0.4	2.4	0.5	0.9	1.7	0.3	5.2	2.6	1.1	180.2	1.1	0.8	0.5	0.6	1.4	0.5	0.7	0.6	0.5	2.2	48.4	3.5	0.6	0.7	1.0	1.1	0.1	0.4	0.6	3.2	0.7	2.9	2.8	8.0	4.5	0.2	0.1	5.6	1.5	0.5	1.0	0.9	2.0	2.1	5.7	8.1	0.5	1.0	0.4	1.1	0.2	2.1	5.1	1.9	16.0	0.0	2.0	1.3	6.1	3.0	1.0	0.4	0.2	0.4	5.3	1.3	0.3	5.0	2.0	1.6	8.8	1.7	8.1	0.1	1.3	4.6	1.5	3.0	9.0	0.2	2.9	1.1	8.0	3.7	0.7	0.0	9.3	0.2	0.1	4.7	0.9	1.4	0.0	0.8	2.1	0.1	0.4	0.0	0.9	0.1	0.9	0.5	0.9	0.7	0.9	1.0	3.2	0.5	0.1	0.6	0.1	1.1	0.8	0.7	0.5	4.4	3.1	0.6	0.5	0.7	0.5	0.5	0.9	0.6
OCA2	"BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P"	ENSG00000104044	"OCA2 melanosomal transmembrane protein"	Q04671	15	27754875-28099358	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 37.9;skin 1: 12.3"	"Group enriched"	"Detected in some"	6	"SH-SY5Y: 5.8;SK-MEL-30: 22.2"	"Cancer enriched"	"Detected in many"	17	"melanoma: 19.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA036402			Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA036402: "	"unprognostic (6.07e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.60e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.28e-2)"	0.4	0.1	0.9	1.3	4.8	0.0	0.3	0.2	2.9	2.4	0.3	3.6	0.2	0.0	0.4	1.7	2.9	1.6	0.5	0.2	1.3	3.6	0.4	0.4	1.2	3.1	0.3	0.4	0.4	0.2	0.0	1.0	2.9	9.5	0.9	0.2	37.9	1.9	2.7	0.4	12.3	0.2	0.2	0.2	2.0	0.1	2.6	0.2	0.3	7.0	0.5	1.5	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.5	0.0	0.0	0.1	5.8	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	4.8	0.2	2.9	1.3	3.6	0.3	0.4	9.5	0.2
OCLN	PPP1R115	ENSG00000197822	Occludin	Q16625	5	69492292-69558104	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 58.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 20.9;CAPAN-2: 27.8;HaCaT: 22.4;MCF7: 22.1;RPTEC TERT1: 17.3;RT4: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005933, CAB013075, CAB068212, CAB068213, CAB068214"	Enhanced		Supported	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"			"Plasma membrane, Cell Junctions"		"CAB013075: AB_2533101, CAB068212: , CAB068213: , CAB068214: , HPA005933: AB_1079520"	"unprognostic (2.28e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.48e-1)"	"prognostic favourable (6.59e-11)"	"unprognostic (2.83e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.35e-1)"	1.2	0.8	3.4	3.8	3.7	0.5	7.6	3.9	2.9	4.3	15.5	3.2	21.9	10.2	1.7	7.4	10.6	7.9	17.1	1.1	4.0	2.9	15.3	31.7	29.2	0.4	4.0	1.7	2.3	33.2	12.0	3.2	9.0	6.7	5.7	10.9	7.7	7.1	25.0	0.5	8.7	24.5	1.2	3.8	2.1	15.1	2.0	1.5	0.4	58.1	9.8	8.6	5.0	6.5	1.2	1.2	1.8	0.3	2.0	0.9	0.1	15.0	6.1	0.1	0.5	0.2	0.3	12.2	0.0	1.5	2.0	3.0	20.9	27.8	0.1	5.3	0.3	22.4	6.2	3.0	5.6	0.1	10.8	1.1	0.2	6.3	0.1	0.5	1.5	0.0	3.1	4.7	0.2	1.2	0.0	0.1	0.0	22.1	0.6	0.4	2.4	2.5	0.0	4.6	0.5	17.3	18.9	2.0	0.9	0.1	16.5	0.2	9.3	1.9	0.2	0.1	6.2	1.2	1.5	0.3	0.1	0.1	0.1	0.1	0.1	0.8	0.3	0.7	0.8	0.2	0.2	0.8	0.9	0.3	0.1	1.2	0.7	0.9	1.8	2.0	0.2	1.2	0.4	0.1	3.4	3.7	3.9	2.9	4.0	2.9	4.0	1.7	6.7	1.5
OCRL	OCRL1	ENSG00000122126	"OCRL, inositol polyphosphate-5-phosphatase"	Q01968	X	129539849-129592561	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Hydrolase	"Cataract, Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012495	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"				Cytosol	"Microtubules, Centriolar satellite"	"HPA012495: AB_1851804"	"prognostic unfavourable (2.93e-5)"	"unprognostic (3.17e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.34e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.56e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.10e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	12.1	20.5	10.7	6.0	18.2	5.3	10.8	13.4	23.1	12.7	13.4	10.1	28.8	9.1	15.8	19.7	13.3	12.8	13.8	8.6	13.0	20.5	10.9	11.3	8.6	6.0	12.9	15.1	33.0	12.4	37.3	20.3	13.2	17.8	21.7	14.1	15.3	8.5	27.7	11.4	9.6	9.8	21.5	8.0	6.3	11.4	23.2	6.4	4.3	19.0	5.6	4.1	18.0	9.2	0.4	2.4	0.3	6.6	0.0	0.7	0.7	9.6	11.2	9.2	10.4	16.4	13.6	9.0	14.9	11.9	15.4	14.3	7.5	7.1	0.8	25.7	12.6	6.1	17.0	11.3	16.1	0.0	11.5	3.0	10.1	7.5	12.2	3.0	0.3	11.4	15.0	15.1	15.1	11.4	4.0	7.4	16.0	12.7	2.2	4.2	3.3	16.7	2.2	9.6	5.8	8.8	10.1	11.3	14.3	7.0	10.0	7.8	7.2	5.3	9.6	12.6	5.8	13.1	14.8	2.1	1.6	2.0	8.8	11.1	9.9	0.0	2.1	0.0	0.2	2.4	0.7	0.3	0.1	0.1	2.4	0.4	0.6	0.2	0.3	0.0	6.6	0.9	0.1	0.7	10.7	18.2	13.4	23.1	13.0	20.5	12.9	15.1	17.8	6.4
OGG1	"HMMH, HOGG1, MUTM, OGH1"	ENSG00000114026	"8-oxoguanine DNA glycosylase"	O15527	3	9749944-9788219	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027514, CAB047301"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB047301: , HPA027514: AB_10602189"	"unprognostic (6.95e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (5.77e-5)"	"unprognostic (7.83e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.66e-3)"	"unprognostic (4.23e-2)"	"prognostic favourable (2.65e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.59e-1)"	10.4	12.9	15.4	28.5	16.2	12.7	11.5	22.0	17.7	16.7	18.8	16.2	10.5	22.0	16.2	13.1	10.0	14.7	12.1	10.7	14.7	10.8	30.1	17.8	9.9	28.5	12.3	14.1	22.5	12.0	5.8	10.2	10.3	15.3	14.4	10.2	14.6	14.3	13.2	7.4	11.5	28.2	12.1	13.6	14.1	10.8	7.3	15.6	19.8	12.2	6.3	25.5	12.2	13.3	12.2	11.9	15.4	8.5	19.4	15.4	8.3	5.7	10.7	10.9	6.8	10.7	12.3	20.1	7.5	7.7	11.5	13.8	10.3	5.7	35.0	5.0	9.5	5.6	6.4	8.2	4.9	12.4	9.2	17.4	17.3	14.7	11.3	6.7	11.2	12.2	10.5	19.9	8.5	14.2	5.5	5.7	10.9	10.7	5.4	6.7	5.7	15.4	4.0	7.3	11.4	6.4	2.9	4.9	8.6	9.6	7.8	5.8	12.4	11.5	9.2	11.7	12.4	9.1	12.2	5.7	8.1	18.0	9.4	19.5	7.2	11.3	8.5	15.4	15.1	6.6	14.6	10.4	13.0	12.3	7.6	12.2	10.2	9.6	2.1	19.4	5.3	11.9	15.4	8.3	15.4	16.2	22.0	17.7	14.7	10.8	12.3	14.1	15.3	15.6
OGT	"FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1"	ENSG00000147162	"O-linked N-acetylglucosamine (GlcNAc) transferase"	O15294	X	71533083-71575897	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	"Chromatin regulator, Glycosyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030751, HPA030752, HPA030753, HPA030754, CAB034099"	Approved		Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: "	"unprognostic (1.37e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavourable (8.33e-4)"	"unprognostic (3.40e-2)"	"prognostic favourable (1.97e-4)"	"unprognostic (9.56e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.74e-3)"	"prognostic unfavourable (2.36e-6)"	"unprognostic (2.99e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.03e-3)"	"prognostic favourable (6.85e-7)"	26.1	24.0	33.3	39.7	36.6	38.7	33.7	75.7	43.8	25.0	23.0	22.0	31.1	22.5	36.7	48.3	24.3	33.4	21.2	25.1	29.3	15.4	27.4	20.3	31.0	47.9	30.2	25.6	42.8	46.1	26.5	34.5	19.5	26.6	34.2	30.3	29.9	35.9	30.9	35.0	45.4	38.4	31.1	32.3	56.7	28.2	11.8	36.6	35.7	34.1	27.6	41.4	24.9	31.0	9.7	7.6	3.2	7.2	12.5	9.9	6.0	14.3	13.5	17.5	15.3	18.9	17.4	11.8	11.0	19.9	12.0	18.5	14.2	16.5	17.1	7.8	13.5	17.9	19.1	10.8	14.8	14.6	19.6	10.8	32.1	10.1	14.3	22.2	17.9	16.6	22.0	13.1	24.8	11.1	10.9	59.5	11.4	12.2	17.1	26.7	11.6	18.4	17.0	19.6	21.9	18.5	16.7	9.0	7.9	17.1	11.4	10.6	8.4	15.1	12.9	13.0	10.6	13.5	6.4	16.3	11.7	20.6	9.1	23.4	7.9	3.2	5.3	2.3	9.9	7.2	9.0	9.7	8.3	8.0	7.5	8.5	9.7	9.5	2.4	12.5	6.5	7.6	7.6	6.0	33.3	36.6	75.7	43.8	29.3	15.4	30.2	25.6	26.6	36.6
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1, mitochondrial dynamin like GTPase"	O60313	3	193593144-193697823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		13000	13000	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: "	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavourable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favourable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	17.0	19.7	18.2	13.5	31.7	25.9	15.9	20.2	30.9	13.9	21.8	11.1	12.6	20.0	15.2	11.8	18.8	11.8	12.8	43.9	23.0	19.4	21.8	24.1	10.7	15.3	19.0	22.4	13.2	13.4	20.9	15.6	13.8	28.0	15.5	20.5	9.1	15.7	20.8	38.4	14.6	17.3	16.5	17.0	13.1	16.7	7.6	10.8	18.0	16.8	18.4	14.2	16.5	13.6	8.3	8.8	8.2	17.6	5.0	7.5	5.9	25.9	8.3	8.5	9.3	7.5	11.9	9.0	12.6	11.6	13.9	13.6	20.3	8.8	17.3	27.3	11.8	16.9	14.8	14.3	24.6	20.8	12.0	29.9	7.4	10.1	11.7	24.5	13.8	13.2	12.8	13.4	19.0	11.7	12.6	17.0	13.8	20.5	9.5	13.6	11.9	27.9	12.5	18.6	18.5	10.4	16.2	18.5	11.2	18.9	21.1	13.4	27.7	19.4	11.7	12.9	9.8	13.8	26.5	15.3	17.8	33.8	14.2	19.7	12.9	8.2	8.1	7.7	7.2	9.3	6.6	8.3	6.8	6.8	8.8	6.3	6.9	7.3	3.2	5.0	17.6	4.6	7.5	5.9	18.2	31.7	20.2	30.9	23.0	19.4	19.0	22.4	28.0	10.8
OPLAH	"5-Opase, OPLA"	ENSG00000178814	"5-oxoprolinase, ATP-hydrolysing"	O14841	8	144051266-144063965	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.2;BEWO: 13.9;Hep G2: 11.9;PC-3: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.0;intermediate monocyte: 1.0;neutrophil: 3.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 3.8;monocytes: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026562, HPA028260, HPA052429"	Uncertain		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA026562: AB_1854804, HPA028260: AB_10601383, HPA052429: "	"unprognostic (7.89e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-3)"	"unprognostic (2.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.62e-1)"	"prognostic favourable (1.53e-6)"	"unprognostic (4.03e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (8.24e-2)"	5.6	5.6	3.3	1.7	3.9	2.3	3.1	4.9	5.3	1.9	7.0	7.0	4.5	11.8	1.6	1.9	5.9	1.3	5.2	16.2	2.5	1.7	10.8	17.2	2.9	2.0	4.5	4.2	2.0	6.0	5.8	1.2	1.3	5.5	3.5	2.0	4.8	9.4	5.6	25.6	5.5	10.4	1.2	4.4	3.7	7.2	49.3	4.9	0.3	1.9	5.4	1.8	2.1	3.3	0.0	0.3	3.8	3.0	0.0	0.1	0.8	2.7	2.7	0.3	22.2	1.0	2.1	13.9	1.3	0.9	0.8	0.4	5.1	5.0	0.0	4.5	2.4	3.5	0.7	2.0	0.0	0.7	0.0	0.9	4.0	11.9	7.1	0.1	0.0	2.9	9.2	0.9	0.0	0.1	3.2	0.0	0.0	3.0	0.2	2.1	1.9	17.2	0.2	0.0	3.4	2.4	3.2	0.8	0.1	0.0	0.9	0.0	5.7	2.9	0.1	0.0	3.7	0.0	0.9	0.7	0.9	0.6	0.3	0.7	0.0	0.0	3.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	3.8	0.0	0.4	0.0	0.0	0.8	3.3	3.9	4.9	5.3	2.5	1.7	4.5	4.2	5.5	4.9
OPN1LW	"CBBM, CBP, COD5, RCP"	ENSG00000102076	"Opsin 1, long wave sensitive"	P04000	X	154144224-154159032	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	11	"retina: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																															"unprognostic (6.05e-2)"								0.3	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.1	0.0	1.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPN1MW	"CBBM, CBD, COD5, GCP, OPN1MW1"	ENSG00000268221	"Opsin 1, medium wave sensitive"	P04001	X	154182596-154196135	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.5"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.6		1.5		0.0	0.7		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.4	0.3		0.1	0.0	0.1			0.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
OPN1SW	"BCP, BOP, CBT"	ENSG00000128617	"Opsin 1, short wave sensitive"	P03999	7	128772491-128775790	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 11.4;retina: 23.9"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013562, HPA014083"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytokinetic bridge, Cytosol"	"HPA013562: AB_2668850, HPA014083: AB_2668938"	"unprognostic (2.88e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (8.50e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavourable (2.26e-8)"	"prognostic unfavourable (5.98e-8)"	"unprognostic (2.53e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavourable (9.33e-4)"	0.9	1.8	0.7	3.7	0.9	1.7	0.7	1.0	2.3	0.7	2.2	0.7	0.7	0.5	2.6	0.7	2.4	0.8	4.2	11.4	0.7	0.8	0.7	0.7	0.9	1.0	0.7	1.3	0.7	0.7	0.0	0.7	0.7	0.7	1.4	0.0	23.9	1.1	0.7	1.9	0.9	0.9	0.7	0.7	1.1	1.4	1.1	0.7	0.7	2.3	0.7	0.7	4.3	0.7	0.5	1.2	0.6	1.4	0.0	1.4	0.3	1.6	2.2	5.1	1.7	0.0	0.0	1.5	9.6	0.0	0.0	0.0	5.0	2.0	2.5	1.4	0.0	1.4	0.0	0.0	0.0	0.3	3.6	1.5	3.0	2.5	0.0	1.9	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.6	1.0	0.7	2.0	3.5	4.6	2.9	1.0	5.3	2.9	0.0	0.6	0.7	6.8	2.3	5.2	4.3	0.5	1.9	4.0	9.8	1.0	7.6	8.6	2.0	2.1	1.5	36.9	4.5	9.1	0.0	0.3	0.6	1.4	1.4	0.9	0.2	0.8	1.0	1.2	0.5	0.3	0.9	0.0	0.0	1.0	0.7	0.4	0.3	0.7	0.9	1.0	0.9	0.7	0.8	0.7	1.3	0.7	0.7
ORAI1	"CRACM1, FLJ14466, TMEM142A"	ENSG00000276045	"ORAI calcium release-activated calcium modulator 1"	Q96D31	12	121626550-121642677	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 26.0"	"Cell line enhanced"	"Detected in many"		"NB-4: 34.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016583, HPA061823"	Approved		Enhanced	Cytosol				Cytosol		"HPA016583: AB_1848720, HPA061823: "	"unprognostic (2.22e-2)"	"unprognostic (3.78e-3)"	"unprognostic (7.82e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.00e-2)"	"prognostic favourable (4.30e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	4.3	1.3	0.0	6.2	1.1	3.7	7.1	0.0	1.3	2.1	9.8	1.7	5.0	10.6	2.3	2.2	3.4	1.7	4.8	3.5	0.4		4.9	9.6	7.5	14.1	2.5	0.6	4.8	5.9	1.4	0.0	4.6	5.6	3.3	0.1	10.6	6.8	3.0	26.0	17.0	14.0	4.4	0.9	11.4	3.9	6.8	0.9	8.1	6.5	7.0	9.1	3.8	2.3	6.9	5.6	6.3	4.3	4.9	14.4	5.1	6.1	12.9	1.4	5.9	1.5	1.9	6.6	7.3	1.2	3.4	2.2	11.2	4.9	4.4	12.1	1.3	11.2	1.1	5.1	0.0	14.6	3.0	8.0	2.2	4.9	4.2	4.9	14.9	0.6	2.1	5.1	0.2	5.4	6.4	1.0	1.0	13.4	14.2	34.8	6.1	15.4	6.4	2.3	7.0	2.5	3.3	5.4	0.8	2.7	3.8	5.5	8.6	1.9	6.5	7.7	3.5	9.1	5.6	3.7	2.5	1.8	5.1	8.7	5.8	6.3	4.2	5.7	14.1	4.3	10.9	4.4	11.5	14.4	5.6	6.9	11.2	9.8	5.2	4.9	3.7	1.4	10.0	5.1										
OSGEP	"GCPL1, KAE1, OSGEP1, PRSMG1, TCS3"	ENSG00000092094	"O-sialoglycoprotein endopeptidase"	Q9NPF4	14	20446411-20455105	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Acyltransferase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039751	Uncertain		Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA039751: AB_10794754"	"prognostic favourable (1.48e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (4.64e-6)"	"unprognostic (4.83e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.91e-2)"	11.2	14.2	13.2	13.1	14.5	10.7	14.4	21.3	18.3	14.3	15.6	18.6	11.6	8.8	16.0	19.2	12.9	13.1	13.6	15.8	13.4	10.2	12.3	22.2	12.4	16.9	13.4	12.5	12.4	12.4	10.6	20.8	13.6	15.5	10.8	14.0	14.5	12.4	18.6	19.6	9.9	12.4	16.8	12.3	18.8	13.6	5.7	15.2	16.2	15.7	9.6	18.7	16.6	11.0	24.5	28.8	23.4	19.1	13.0	14.2	15.7	6.3	10.3	3.4	10.0	5.9	4.1	10.5	5.0	6.6	12.8	12.4	14.2	7.5	13.3	6.5	6.3	5.6	10.3	10.1	8.0	10.5	13.2	8.4	8.7	18.2	4.4	14.4	12.0	3.1	3.1	15.3	8.1	8.4	8.1	7.6	10.0	11.9	14.1	6.3	5.1	20.4	22.5	6.4	7.5	7.2	7.3	13.3	2.6	8.9	9.4	6.8	6.3	13.7	3.9	5.4	13.2	6.8	6.0	2.3	12.5	18.2	3.3	22.5	6.5	5.1	19.1	23.4	13.7	17.6	11.9	20.5	14.2	12.0	28.8	24.5	11.3	12.9	8.7	13.0	13.6	12.4	12.9	15.7	13.2	14.5	21.3	18.3	13.4	10.2	13.4	12.5	15.5	15.2
OSTM1	"GL, HSPC019"	ENSG00000081087	"Osteopetrosis associated transmembrane protein 1"	Q86WC4	6	108041409-108165854	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			Osteopetrosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010851	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		130000	130000	Cytosol	"Nucleoplasm, Vesicles"	"HPA010851: AB_1079533"	"prognostic unfavourable (4.36e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-3)"	"prognostic unfavourable (4.26e-4)"	"unprognostic (9.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (1.34e-6)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"	26.3	21.9	9.0	18.1	13.5	5.5	16.7	13.7	17.2	14.4	17.8	12.8	9.9	8.4	21.8	10.3	14.1	15.0	13.5	23.2	10.4	16.5	22.0	15.9	17.0	17.2	11.0	10.5	15.6	9.7	11.8	26.0	24.7	20.0	15.4	12.4	29.7	10.8	19.0	18.0	10.4	12.9	24.7	13.1	21.7	14.3	11.1	10.7	13.6	12.4	8.1	13.9	21.0	19.4	10.8	12.4	20.9	28.1	14.5	16.4	16.9	2.2	6.5	7.8	11.3	23.3	7.6	11.0	16.2	16.3	11.9	19.8	3.9	3.7	5.1	13.4	11.3	4.2	7.6	5.5	18.4	11.7	6.0	10.7	4.2	4.8	18.1	11.8	25.1	11.1	13.8	14.6	11.7	6.0	8.5	18.7	19.2	3.1	2.5	2.7	3.1	5.0	4.2	11.2	2.7	8.5	5.9	0.8	4.6	13.1	3.3	29.0	3.8	17.1	7.3	10.4	3.8	23.0	22.9	7.2	12.3	4.4	30.8	8.0	23.0	16.8	13.9	15.2	15.0	19.9	16.0	10.8	12.8	16.4	12.4	6.2	12.0	15.0	20.9	14.5	28.1	8.9	15.4	16.9	9.0	13.5	13.7	17.2	10.4	16.5	11.0	10.5	20.0	10.7
OTC		ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352545-38421450	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 59.1;liver: 90.3"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.8;RPMI-8226: 1.0;SH-SY5Y: 1.1;SiHa: 1.8"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria		1800000	1800000	Mitochondria		"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			0.4	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.1	0.8	16.5	0.0	0.2	26.9	1.1	0.2	0.2	0.3	5.3	0.2	0.1	0.2	0.1	90.3	0.7	2.3	0.2	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.1	0.1	59.1	0.8	0.3	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.6	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0
OTUD6B	"CGI-77, DUBA5"	ENSG00000155100	"OTU domain containing 6B"	Q8N6M0	8	91070196-91087095	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024046, HPA024503, HPA024772"	Approved	Approved	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846"	"prognostic unfavourable (7.50e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (5.71e-2)"	11.4	11.3	14.6	14.1	18.2	8.9	13.2	13.8	19.6	12.3	11.3	9.9	10.3	9.2	12.1	9.0	13.2	9.1	8.6	14.0	14.9	13.7	11.0	10.5	10.0	13.8	18.5	15.5	12.5	9.9	11.2	14.4	14.9	16.2	11.6	11.3	6.0	9.5	14.8	35.3	11.2	9.1	12.4	19.9	11.3	8.8	11.9	17.4	13.9	11.8	11.0	11.9	11.9	14.0	7.2	12.9	8.8	7.8	7.8	6.8	2.9	16.0	9.3	8.3	6.2	3.7	2.8	8.7	12.7	4.8	11.9	7.7	7.9	10.1	17.1	6.2	6.7	5.5	17.2	10.4	18.5	13.7	10.5	23.2	9.6	6.0	8.0	11.8	12.3	4.7	5.0	9.6	22.7	9.6	23.2	10.7	10.1	8.7	19.8	7.7	4.5	18.4	8.9	8.0	15.2	9.3	11.6	2.0	7.5	1.2	28.3	12.3	14.5	5.7	9.8	7.1	10.7	10.8	12.1	10.7	20.4	25.0	10.4	14.8	13.6	8.8	6.5	4.3	5.9	7.8	6.8	7.2	4.8	5.7	8.1	6.8	6.7	5.9	0.9	7.8	5.8	12.9	3.6	2.9	14.6	18.2	13.8	19.6	14.9	13.7	18.5	15.5	16.2	17.4
OTULIN	"FAM105B, FLJ34884"	ENSG00000154124	"OTU deubiquitinase with linear linkage specificity"	Q96BN8	5	14664664-14699711	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051074	Uncertain		Approved	"Plasma membrane,Mitochondria"				Mitochondria	"Plasma membrane"	"HPA051074: "	"unprognostic (4.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavourable (2.59e-7)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.02e-2)"	10.0	7.4	5.9	22.6	7.8	32.3	8.4	7.2	6.6	8.2	9.3	8.3	8.9	10.7	9.5	7.7	13.8	6.1	10.8	15.5	6.7	4.9	8.5	19.5	11.1	16.0	9.6	2.8	9.1	12.2	7.5	9.8	11.8	7.0	11.1	7.0	7.7	10.6	10.8	16.5	18.1	11.7	8.1	10.5	12.5	7.1	11.5	7.4	15.0	7.8	9.7	19.3	8.5	15.8	3.4	2.9	3.1	3.0	1.0	4.6	0.9	6.3	7.4	7.4	8.4	6.9	7.2	8.2	6.4	4.5	9.1	6.9	9.9	4.7	11.4	12.6	4.1	7.2	9.2	8.4	6.3	19.7	7.6	8.2	23.5	5.3	5.9	7.8	14.1	4.1	10.3	7.5	6.4	7.7	8.1	18.3	6.5	3.9	7.7	6.8	4.5	7.8	11.9	6.7	4.6	6.0	6.6	3.4	5.5	22.8	5.1	4.9	5.6	9.0	7.1	11.9	13.4	8.9	8.4	8.3	12.5	13.0	6.8	14.9	6.1	0.4	2.0	3.1	1.0	2.2	3.0	0.9	2.5	3.4	2.9	3.4	1.8	3.9	2.2	1.0	3.0	2.5	4.6	0.9	5.9	7.8	7.2	6.6	6.7	4.9	9.6	2.8	7.0	7.4
OXCT1	"OXCT, SCOT"	ENSG00000083720	"3-oxoacid CoA-transferase 1"	P55809	5	41730065-41870519	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 108.8"	"Cell line enhanced"	"Detected in many"		"HeLa: 56.1;SiHa: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012047, HPA061425"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	1000000	1000000	Mitochondria		"HPA012047: AB_1854857, HPA061425: AB_2684515"	"unprognostic (4.26e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (7.42e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.62e-1)"	"prognostic favourable (1.86e-8)"	"unprognostic (2.66e-2)"	"unprognostic (9.99e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.28e-3)"	21.9	8.0	17.3	7.5	30.3	5.8	9.5	26.6	36.8	6.7	9.2	8.3	10.7	4.4	8.6	8.7	13.1	6.9	7.5	108.8	19.3	15.2	25.3	1.2	4.2	9.5	13.1	25.7	7.2	3.0	20.9	8.4	2.8	21.2	12.5	10.4	6.6	8.5	14.7	13.4	10.7	6.5	17.0	8.9	5.2	14.6	6.2	5.3	22.8	13.0	10.7	11.8	8.0	7.5	8.0	4.6	3.3	1.6	7.5	15.6	5.1	7.8	0.3	6.5	7.7	20.1	10.8	0.0	14.1	8.9	11.7	7.1	1.2	5.4	20.4	3.5	10.7	4.6	17.8	12.7	13.8	17.4	2.0	14.3	56.1	2.6	8.8	27.7	4.8	10.1	3.4	11.5	19.4	10.7	2.9	26.3	13.4	1.0	23.1	1.3	1.4	5.6	18.4	18.2	15.4	9.5	0.6	6.5	6.7	72.9	0.0	8.6	0.1	6.0	6.4	9.3	12.2	15.9	11.3	4.3	3.6	0.8	14.1	20.4	7.1	1.0	1.0	3.3	9.1	1.1	10.9	8.0	9.2	9.8	4.6	6.1	10.8	8.9	0.3	7.5	1.6	1.8	15.6	5.1	17.3	30.3	26.6	36.8	19.3	15.2	13.1	25.7	21.2	5.3
P3H1	"GROS1, LEPRE1, LEPRECAN, MGC117314"	ENSG00000117385	"Prolyl 3-hydroxylase 1"	Q32P28	1	42746335-42767084	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA012113, HPA016980"	Approved		Approved	Nucleoli,Vesicles	"Intracellular and membrane"	13000	13000	Vesicles	Nucleoli	"HPA012113: , HPA016980: AB_2669498"	"unprognostic (3.24e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (4.95e-7)"	"unprognostic (5.41e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.60e-3)"	11.9	11.2	7.1	8.6	6.3	5.2	9.7	6.4	5.3	14.0	7.1	6.0	7.7	2.6	13.8	11.1	6.4	8.8	12.1	8.8	3.8	2.9	7.9	19.9	10.8	10.1	6.1	3.3	13.1	6.8	5.8	15.2	36.1	4.6	7.8	5.7	10.5	6.4	6.5	4.3	7.2	6.6	19.7	3.4	13.3	6.6	13.1	4.7	10.2	7.4	5.3	7.8	11.4	8.5	3.1	16.2	11.0	16.2	11.7	7.9	6.1	2.2	5.8	13.0	30.4	30.8	23.6	5.3	26.8	34.9	19.4	33.1	2.9	4.9	3.3	21.5	50.5	2.0	5.5	6.8	13.4	4.9	6.9	7.8	9.2	8.3	17.9	7.8	9.0	20.1	4.6	19.5	8.4	27.3	4.4	4.2	12.9	1.2	5.0	4.4	14.2	4.2	5.0	19.2	4.5	10.2	1.2	2.7	4.6	16.3	0.4	11.5	0.9	32.8	22.2	14.5	12.8	11.5	10.6	3.8	4.3	3.0	16.6	10.6	20.1	3.5	13.2	11.0	6.0	14.0	6.4	3.1	4.6	5.1	16.2	2.6	3.9	3.9	1.2	11.7	16.2	7.6	7.9	6.1	7.1	6.3	6.4	5.3	3.8	2.9	6.1	3.3	4.6	4.7
P3H2	"FLJ10718, LEPREL1, MLAT4"	ENSG00000090530	"Prolyl 3-hydroxylase 2"	Q8IVL5	3	189956728-190122437	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 74.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 36.0;RPTEC TERT1: 36.7;RT4: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	22	"plasmacytoid DC: 20.3"	"Lineage enriched"	"Detected in single"	104	"dendritic cells: 20.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA007890, HPA013355, HPA013611"	Approved		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"	Nucleoplasm	"HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: "	"unprognostic (4.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.76e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.97e-2)"	"unprognostic (7.75e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-2)"	2.4	22.6	2.9	4.0	3.9	0.2	3.1	0.7	2.2	14.3	11.8	6.2	11.5	1.2	15.0	13.5	8.9	4.6	8.4	3.8	2.8	2.1	74.5	3.5	22.5	3.6	8.1	1.0	11.2	3.9	1.4	6.1	11.0	5.6	19.9	5.3	10.3	2.7	14.3	0.6	8.6	3.6	16.3	7.6	33.7	12.0	2.8	5.3	2.0	1.7	6.3	2.7	5.7	9.8	0.0	20.3	0.1	0.1	0.0	0.0	0.1	14.9	5.9	11.7	0.0	0.2	0.4	14.0	15.9	6.3	2.6	4.2	4.8	5.9	0.0	9.1	2.8	36.0	0.0	21.3	5.5	0.1	2.0	0.0	4.0	0.0	12.1	0.0	0.1	5.7	7.2	5.0	1.8	0.4	0.0	0.1	4.0	0.3	0.0	0.1	3.6	1.2	0.0	2.3	0.8	36.7	25.1	0.8	0.1	21.6	1.2	9.5	0.0	0.2	7.9	15.5	5.8	0.1	2.8	1.1	0.0	0.1	3.6	0.0	19.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	20.3	0.0	0.1	2.9	3.9	0.7	2.2	2.8	2.1	8.1	1.0	5.6	5.3
P4HA2	C-P4Halpha(II)	ENSG00000072682	"Prolyl 4-hydroxylase subunit alpha 2"	O15460	5	132191838-132295315	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 61.3;U-87 MG: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA016997, HPA027824, CAB062557"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"			"Endoplasmic reticulum, Vesicles"		"CAB062557: , HPA016997: AB_2669501, HPA027824: AB_2672402"	"unprognostic (1.30e-3)"	"prognostic unfavourable (1.24e-5)"	"unprognostic (2.56e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (2.77e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (3.12e-4)"	10.2	5.6	7.1	6.5	5.4	0.8	12.2	9.5	7.8	14.4	12.5	4.6	6.1	9.8	20.0	35.3	11.6	13.7	9.7	26.1	6.6	7.0	34.4	6.3	16.0	4.3	6.3	4.2	6.7	42.5	6.7	15.8	15.1	9.5	9.3	14.6	15.1	21.1	8.4	7.1	9.3	17.1	23.3	5.1	6.3	12.6	5.1	4.4	4.1	12.2	10.8	5.4	11.3	34.5	0.2	1.0	3.1	1.3	2.6	2.6	0.7	10.1	6.2	2.0	9.9	27.9	33.3	11.3	47.5	40.6	20.2	50.0	14.0	8.9	0.2	14.0	50.8	12.8	6.2	24.8	32.0	7.5	2.1	0.0	9.1	8.4	61.3	0.0	6.1	20.1	36.7	23.9	22.0	10.6	3.6	0.6	24.7	4.0	0.0	0.0	0.5	5.1	0.1	0.6	1.5	5.6	1.9	1.0	2.8	12.1	4.0	8.0	5.0	0.7	16.3	30.7	12.0	9.3	10.2	4.3	4.6	2.0	59.2	0.0	8.5	0.0	1.3	0.0	2.6	1.1	2.4	0.0	1.4	0.4	0.6	0.2	0.0	0.4	3.1	2.6	0.2	1.0	0.0	0.7	7.1	5.4	9.5	7.8	6.6	7.0	6.3	4.2	9.5	4.4
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860694	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 383.4;pancreas: 677.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	140000000	140000000	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	18.0	34.7	6.3	15.4	8.4	35.0	16.1	6.1	6.5	22.1	40.5	9.0	45.0	42.6	14.7	29.1	40.3	12.8	42.3	20.7	6.3	5.9	27.2	383.4	20.9	29.1	7.9	4.5	14.3	677.5	6.4	23.4	58.5	7.2	22.5	8.5	12.3	251.9	42.5	31.0	24.3	112.8	11.0	5.2	36.7	31.6	9.1	7.2	10.5	29.7	50.7	46.4	16.5	20.5	21.6	71.3	45.8	60.8	38.8	55.9	70.8	57.7	50.3	18.6	60.0	50.4	59.3	44.2	112.8	72.8	49.2	66.6	36.9	50.6	23.3	49.6	72.5	41.0	20.5	44.1	28.5	15.0	34.7	34.9	52.9	150.1	66.3	110.1	57.7	44.7	30.0	39.3	41.7	81.0	24.7	100.7	35.0	52.7	31.5	87.5	14.6	45.8	25.8	33.3	46.2	38.2	69.8	22.4	24.8	56.2	162.4	58.5	73.4	129.7	62.9	92.4	46.3	52.4	55.0	72.4	52.4	22.0	121.4	42.4	70.4	45.8	60.8	38.3	53.5	38.7	55.9	21.6	36.4	42.8	43.4	18.7	21.2	31.5	20.0	38.8	27.6	71.3	25.7	70.8	6.3	8.4	6.1	6.5	6.3	5.9	7.9	4.5	7.2	7.2
PADI3	PDI3	ENSG00000142619	"Peptidyl arginine deiminase 3"	Q9ULW8	1	17249098-17284233	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 10.5;smooth muscle: 9.4;urinary bladder: 28.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.2;RT4: 15.8;T-47d: 11.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 48.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043739	Uncertain		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA043739: AB_10959466"	"unprognostic (4.47e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (1.05e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.10e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.47e-4)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (1.55e-11)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-3)"		"unprognostic (2.64e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.1	0.0	0.0	3.2	10.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.6	6.4	0.0	2.3	0.0	9.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	28.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	13.2	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	15.8	0.0	0.0	0.0	2.3	0.1	11.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PADI4	"PAD, PADI5, PDI4, PDI5"	ENSG00000159339	"Peptidyl arginine deiminase 4"	Q9UM07	1	17308195-17364004	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 48.2;bone marrow: 54.8;lymphoid tissue: 24.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;HEL: 4.1;NB-4: 1.6;RPMI-8226: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"basophil: 17.0;classical monocyte: 18.6;eosinophil: 24.6;neutrophil: 48.2"	"Group enriched"	"Detected in many"	9	"granulocytes: 48.2;monocytes: 18.6"	"Not detected"	"Not detected"							"HPA017007, HPA042825"	Enhanced					12000	12000			"HPA017007: AB_1854921, HPA042825: AB_2678189"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.49e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.80e-1)"	1.2	0.2	0.3	0.5	0.2	54.8	0.2	0.1	0.8	0.2	0.2	0.5	0.0	0.2	0.2	0.1	0.4	0.9	0.4	9.8	0.6	0.1	0.3	1.2	9.7	5.2	1.8	0.0	0.9	0.3	0.1	0.6	4.1	0.6	0.1	0.2	0.9	0.5	0.1	0.2	0.2	0.2	0.4	0.2	24.2	0.3	1.0	0.3	2.6	0.6	0.2	0.2	0.4	7.5	0.4	3.6	48.2	18.6	1.1	1.2	8.1	0.2	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	4.1	0.1	0.4	0.0	0.4	0.5	0.0	0.5	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.0	1.6	0.2	0.2	0.2	0.0	4.8	0.0	0.3	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.1	0.0	0.2	0.5	0.1	17.0	18.6	24.6	0.1	1.4	0.0	0.2	0.1	0.2	3.6	0.4	0.7	1.2	48.2	1.1	0.4	1.6	0.1	8.1	0.3	0.2	0.1	0.8	0.6	0.1	1.8	0.0	0.6	0.3
PADI6		ENSG00000276747	"Peptidyl arginine deiminase 6"	Q6TGC4	1	17372196-17401699	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"blood: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.5"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Low region specificity"	"Detected in single"														"unprognostic (1.19e-1)"					"unprognostic (4.36e-2)"			"unprognostic (3.02e-2)"				"unprognostic (6.56e-2)"		"unprognostic (1.23e-1)"			0.0	0.0		0.1		0.7	0.0		0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.1			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.7	0.0	0.0	0.0		0.1	0.0	0.5			0.0		0.0	0.0		0.0	3.5	0.0	0.8	0.0	1.9	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.9	0.1	0.0	0.0	0.2	1.1	3.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4										
PAK3	"bPAK, hPAK3, MRX30, MRX47"	ENSG00000077264	"P21 (RAC1) activated kinase 3"	O75914	X	110944285-111227361	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Allosteric enzyme, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.2;pancreas: 46.5;pituitary gland: 37.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.7;HAP1: 8.7;HDLM-2: 10.9;NTERA-2: 8.5;SCLC-21H: 11.1;SH-SY5Y: 6.9;U-2197: 6.7;U-251 MG: 11.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"MAIT T-cell: 4.3"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044791, HPA060219"	Approved		Approved	Cytosol				Cytosol		"HPA044791: , HPA060219: "	"unprognostic (1.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.27e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.63e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.89e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	2.0	6.8	17.6	2.5	17.5	1.0	6.4	1.8	24.6	3.7	1.6	0.9	9.1	1.0	6.8	7.6	1.7	3.7	2.6	1.2	26.2	20.8	1.6	1.1	1.8	2.5	7.9	21.9	7.9	46.5	0.9	37.2	1.6	12.9	4.8	1.7	1.4	3.0	7.1	2.4	2.0	1.4	6.1	5.8	2.9	3.0	3.6	1.9	0.0	7.7	0.0	1.7	2.0	1.5	0.1	0.1	0.6	0.1	0.2	4.3	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	9.7	1.0	0.0	8.7	0.5	1.2	10.9	0.3	0.0	1.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	2.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	8.5	1.9	0.1	4.0	0.0	0.8	0.0	11.1	6.9	0.0	0.4	0.0	0.0	0.0	0.0	0.6	4.3	6.7	11.6	0.0	0.1	0.1	1.2	0.0	0.1	0.6	0.1	0.1	0.1	0.0	4.3	0.0	0.7	0.4	0.0	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.3	0.0	17.6	17.5	1.8	18.5	26.2	20.8	7.9	21.9	12.9	1.9
PANK2	"C20orf48, FLJ11729, HARP, HSS, NBIA1, PKAN"	ENSG00000125779	"Pantothenate kinase 2"	Q9BZ23	20	3888839-3929882	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Kinase, Transferase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008440	Approved		Supported	Cytosol				Cytosol		"HPA008440: AB_1079559"	"unprognostic (4.50e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.00e-2)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (2.75e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.81e-1)"	15.2	21.5	18.7	18.5	18.9	20.8	19.7	21.8	24.8	14.7	14.4	16.8	10.7	11.8	15.5	15.5	28.9	19.1	14.3	11.0	17.4	18.6	18.8	20.3	16.1	18.5	16.2	16.2	14.4	13.5	15.3	15.7	18.1	20.8	14.5	16.4	17.0	15.8	13.2	14.4	12.8	14.5	16.6	12.3	20.6	12.1	28.9	14.1	23.2	17.0	10.5	24.6	17.3	16.4	5.8	8.6	8.0	12.8	8.3	6.4	3.1	21.4	13.9	15.0	7.6	18.0	15.6	8.2	14.1	15.5	18.6	24.1	18.7	11.5	17.4	6.5	15.8	17.7	16.1	27.4	23.8	5.1	7.1	23.8	9.9	34.9	15.1	15.8	7.9	13.7	12.0	20.7	13.4	17.4	17.5	16.3	20.0	5.3	13.6	14.0	15.0	10.4	11.2	20.9	11.0	11.5	19.7	19.6	9.6	17.5	19.2	34.9	11.6	12.8	11.9	22.3	11.2	29.1	21.6	9.2	26.6	13.3	6.6	14.5	17.4	1.6	11.2	4.7	4.4	12.8	4.3	4.7	4.3	4.5	8.6	5.8	4.4	4.0	8.0	8.3	10.7	3.0	6.4	3.1	18.7	18.9	21.8	24.8	17.4	18.6	16.2	16.2	20.8	14.1
PAPSS2	ATPSK2	ENSG00000198682	"3'-phosphoadenosine 5'-phosphosulfate synthase 2"	O95340	10	87659613-87747705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 59.2;liver: 49.0"	"Cell line enhanced"	"Detected in many"		"BJ: 34.9;fHDF/TERT166: 88.3;HHSteC: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 5.3;myeloid DC: 2.7;non-classical monocyte: 9.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.7;monocytes: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071224, HPA075267"	Enhanced		Approved	Mitochondria				Mitochondria		"HPA071224: , HPA075267: "	"unprognostic (3.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.33e-6)"	"unprognostic (3.50e-2)"	"prognostic favourable (6.58e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (3.21e-5)"	"unprognostic (3.46e-3)"	16.0	59.2	3.5	18.1	6.0	0.3	18.1	1.9	4.3	8.6	25.5	2.2	1.9	9.2	4.0	7.0	3.7	5.3	10.7	9.1	3.9	2.1	9.9	49.0	31.3	15.6	4.4	1.6	10.8	21.2	0.4	1.7	19.0	5.2	3.8	21.2	6.2	6.2	2.0	4.8	1.7	19.4	5.5	3.4	2.9	2.9	3.6	4.3	0.8	7.3	6.2	11.0	5.7	5.3	0.0	2.7	0.8	9.7	0.0	0.1	0.8	3.5	3.6	1.1	0.0	25.3	32.3	0.0	34.9	29.9	21.2	15.4	0.1	0.7	0.0	1.8	88.3	1.5	2.6	2.4	24.3	0.0	1.9	1.6	2.6	0.0	38.3	0.0	0.7	11.4	0.0	12.2	1.0	17.7	0.0	16.5	14.9	13.3	0.0	0.1	1.3	4.5	0.0	0.0	0.0	22.1	1.5	0.1	0.3	17.0	0.6	0.2	2.5	0.9	22.0	7.2	4.2	24.4	2.5	0.0	0.1	0.0	3.4	0.0	0.0	0.0	1.4	0.0	0.0	5.3	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.8	0.0	9.7	0.0	0.0	0.8	3.5	6.0	1.9	4.3	3.9	2.1	4.4	1.6	5.2	4.3
PARK7	"DJ-1, DJ1, GATD2"	ENSG00000116288	"Parkinsonism associated deglycase"	Q99497	1	7954291-7985505	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response"	"Chaperone, Hydrolase, Protease, RNA-binding"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004190, CAB005870"	Supported		Supported	Nucleoplasm,Cytosol		69000000	69000000	"Nucleoplasm, Cytosol"		"CAB005870: AB_444361, HPA004190: AB_1079566"	"unprognostic (6.88e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.68e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.43e-2)"	44.6	67.9	69.3	38.1	64.9	33.7	45.4	57.2	62.7	34.0	36.4	33.4	43.2	27.3	35.8	56.6	40.9	39.0	41.6	71.7	56.9	57.2	60.5	77.1	28.6	46.1	61.6	57.2	45.9	60.4	66.6	48.4	44.6	41.2	44.7	39.5	38.6	46.5	39.4	128.7	19.8	27.5	48.1	52.5	37.5	37.2	38.2	32.2	38.8	71.6	43.3	46.5	41.3	43.4	49.5	141.8	38.8	61.0	52.8	87.2	90.6	68.2	61.5	61.3	70.4	66.0	63.5	30.1	63.6	59.6	62.6	50.6	56.0	74.8	84.7	71.9	68.2	49.0	66.1	85.0	81.4	75.3	71.4	91.0	91.9	83.1	57.0	86.8	56.1	59.8	36.3	63.8	76.7	65.6	88.3	63.1	86.8	63.9	60.4	110.3	50.0	63.5	46.5	82.3	116.1	98.2	35.1	71.7	60.2	63.6	98.3	99.2	54.8	64.7	62.1	57.8	46.1	53.3	69.7	61.3	98.3	120.5	76.2	132.9	81.8	22.7	61.0	38.8	52.6	55.4	49.7	49.5	52.7	62.2	73.9	38.6	45.6	52.4	21.0	52.8	44.1	141.8	87.2	90.6	69.3	64.9	57.2	62.7	56.9	57.2	61.6	57.2	41.2	32.2
PARN	DAN	ENSG00000140694	"Poly(A)-specific ribonuclease"	O95453	16	14435701-14632728	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006314, CAB011673, HPA012010"	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB011673: AB_778216, HPA006314: AB_1079567, HPA012010: AB_1854976"	"unprognostic (2.54e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (2.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.09e-2)"	19.4	25.9	14.9	23.5	19.1	12.5	19.8	16.8	23.5	21.3	21.0	22.7	23.3	14.4	24.6	29.0	19.0	19.4	22.5	18.4	15.4	19.0	17.9	18.9	26.7	31.6	22.2	17.9	21.8	22.7	37.4	26.0	21.9	21.0	21.4	21.8	21.0	18.9	31.0	19.2	21.0	18.8	28.7	18.3	20.1	19.6	25.4	19.6	29.4	27.8	14.0	26.8	25.6	19.3	16.1	15.6	13.3	14.8	15.0	17.8	11.0	11.8	13.9	7.3	9.2	12.2	14.0	8.5	10.0	14.1	12.5	12.0	7.7	11.0	21.0	25.5	11.5	12.8	16.8	11.3	17.4	17.8	9.9	14.4	9.6	17.1	12.8	17.1	14.4	12.7	14.2	11.2	16.1	8.4	12.3	11.9	12.2	14.6	17.2	11.1	9.9	8.3	22.8	16.5	21.2	8.5	8.2	9.2	6.6	20.5	11.1	13.8	11.8	9.9	7.7	12.2	6.4	6.6	10.2	12.1	12.9	25.7	13.4	12.6	13.4	11.9	11.1	13.3	13.5	14.8	13.9	16.1	13.1	15.5	15.6	13.9	17.8	17.8	7.2	15.0	14.3	10.8	14.7	11.0	14.9	19.1	16.8	23.5	15.4	19.0	22.2	17.9	21.0	19.6
PARP9	"BAL, BAL1"	ENSG00000138496	"Poly(ADP-ribose) polymerase family member 9"	Q8IXQ6	3	122527924-122564577	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 34.9;BJ hTERT+ SV40 Large T+ RasG12V: 41.8;SK-MEL-30: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066708			Supported	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"HPA066708: "	"unprognostic (3.06e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.31e-1)"	"prognostic favourable (6.65e-4)"	"unprognostic (1.00e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.56e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.56e-2)"	27.1	20.2	8.7	17.2	12.4	9.1	13.8	2.9	13.9	13.1	13.1	9.9	7.4	10.4	23.3	10.1	15.6	12.3	14.9	8.5	7.4	6.0	17.8	38.6	18.9	17.5	8.5	6.0	12.1	14.4	16.0	20.3	11.9	10.3	15.1	10.1	11.5	19.1	6.6	8.6	5.7	21.2	14.8	16.3	27.3	11.1	5.4	10.3	21.8	17.5	9.0	19.1	13.7	9.8	7.3	11.9	38.2	18.0	13.0	10.6	9.1	8.0	2.7	1.0	0.7	6.2	13.0	0.9	2.7	14.7	34.9	41.8	4.2	8.9	1.8	6.0	5.4	8.9	2.3	4.8	7.3	13.9	1.6	8.7	2.8	2.2	6.7	2.8	5.8	10.5	4.7	4.9	1.2	7.4	0.8	7.5	1.4	3.5	8.9	3.5	0.4	7.6	9.5	9.9	0.6	13.4	4.6	0.6	2.4	7.1	1.2	32.3	3.8	3.1	4.4	1.5	4.4	0.3	1.6	4.6	2.4	3.3	5.2	3.0	2.7	14.4	12.7	15.3	9.2	17.7	8.6	7.3	9.8	10.3	11.9	5.0	7.5	9.1	38.2	13.0	18.0	1.4	10.6	9.1	8.7	12.4	2.9	13.9	7.4	6.0	8.5	6.0	10.3	10.3
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848233-66958376	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 41.1;liver: 76.0"	"Cell line enhanced"	"Detected in many"		"HeLa: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		96000	96000	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavourable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	41.1	10.7	11.1	2.8	14.6	3.1	12.9	13.1	14.9	2.4	3.8	10.7	21.4	5.6	2.1	2.4	5.0	2.7	2.9	4.0	11.3	8.9	18.7	76.0	2.1	1.6	15.5	11.5	4.4	4.3	19.4	4.0	4.1	10.9	5.4	3.1	3.4	24.2	24.4	5.7	2.8	6.7	1.8	9.4	1.5	3.3	6.1	13.1	0.6	4.2	2.5	2.5	2.2	2.1	0.6	2.6	0.0	3.8	0.3	2.9	2.0	2.9	8.9	3.3	8.1	13.7	5.4	3.5	1.8	7.8	3.5	3.4	4.4	3.2	0.0	3.7	2.9	3.8	3.7	20.6	1.0	1.7	5.2	4.4	27.7	17.0	10.7	0.0	5.7	20.6	5.3	2.8	6.4	2.9	8.4	0.0	1.2	19.0	5.0	2.4	6.3	7.4	3.7	6.9	1.8	3.2	0.9	7.2	10.2	17.3	9.2	7.0	7.5	1.2	3.2	3.9	3.6	4.6	2.0	1.9	2.2	0.0	4.0	2.8	3.3	0.0	3.8	0.0	1.2	0.9	1.4	0.2	0.5	1.9	2.6	0.6	2.9	1.6	0.0	0.3	0.5	1.0	1.5	2.0	11.1	14.6	13.1	13.6	11.3	8.9	15.5	11.5	10.9	13.1
PCBD1	"DCOH, PCBD, PCD"	ENSG00000166228	"Pterin-4 alpha-carbinolamine dehydratase 1"	P61457	10	70882280-70888784	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation"	"Activator, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 67.5;Hep G2: 66.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037575, HPA061723"	Approved		Enhanced	Nucleoplasm,Cytosol		210000	210000	Nucleoplasm	Cytosol	"HPA037575: AB_10671761, HPA061723: "	"unprognostic (1.02e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.43e-3)"	18.3	25.5	18.1	9.6	15.6	4.3	19.7	13.2	14.8	13.9	18.4	7.8	24.3	12.6	13.9	21.4	26.5	25.6	22.9	32.5	10.8	23.7	38.7	99.0	14.0	7.8	16.7	12.3	18.5	73.0	15.8	15.5	11.7	16.4	26.9	20.3	16.3	16.2	20.7	23.1	5.8	17.2	18.1	14.5	10.2	19.2	7.0	8.7	4.3	36.8	16.2	12.3	22.4	31.8	11.8	20.9	3.5	19.4	8.0	16.9	7.5	20.4	48.5	2.9	30.1	11.0	10.3	3.9	6.6	11.0	10.3	8.2	67.5	36.2	4.2	19.2	7.2	13.6	18.3	10.6	7.0	10.9	33.1	3.7	7.7	66.3	11.6	3.6	13.6	10.0	11.6	10.2	4.8	27.6	7.2	0.3	7.1	34.1	0.4	12.2	4.1	45.4	2.0	4.0	13.4	43.2	21.1	12.7	21.5	5.5	37.6	14.3	10.9	7.1	11.4	1.7	14.4	2.5	16.2	0.1	0.8	0.1	9.4	11.9	2.6	0.0	10.7	3.5	8.8	19.4	6.9	11.8	11.6	12.6	20.9	4.1	3.8	7.9	0.6	8.0	13.3	15.3	16.9	7.5	18.1	15.6	13.2	14.8	10.8	23.7	16.7	12.3	16.4	8.7
PCCA		ENSG00000175198	"Propionyl-CoA carboxylase alpha subunit"	P05165	13	100089015-100530437	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 106.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 53.2;SCLC-21H: 29.5;U-937: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041716, HPA047792"	Enhanced		Supported	Mitochondria		120000	120000	Mitochondria		"HPA041716: , HPA047792: "	"unprognostic (1.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (0.00e+0)"	"unprognostic (7.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.32e-2)"	15.6	26.2	9.7	11.3	11.1	3.2	12.0	24.0	10.7	12.0	17.5	12.0	14.3	6.7	16.4	106.7	8.8	8.4	7.6	12.4	9.5	7.5	51.3	44.3	8.1	4.0	11.2	8.2	9.7	12.7	5.5	12.4	10.5	12.6	13.1	13.7	11.7	12.2	10.4	10.7	7.7	7.8	17.0	12.0	8.2	16.1	4.7	10.9	4.2	11.9	5.0	6.9	10.8	8.8	3.7	13.0	1.6	10.8	7.3	6.1	4.7	3.2	5.8	9.6	3.1	9.2	8.0	5.4	3.2	4.8	3.0	2.8	7.2	4.4	0.2	4.9	3.2	3.7	2.8	4.5	5.0	5.3	3.2	7.5	4.1	15.4	5.1	0.3	3.7	7.4	4.8	2.8	4.7	6.2	3.0	4.3	5.5	3.5	0.8	16.9	5.9	2.6	6.6	4.1	5.2	53.2	6.4	29.5	3.5	2.2	12.3	5.4	8.9	13.4	4.5	3.1	2.6	2.1	2.2	4.2	3.8	0.1	6.0	41.0	2.2	1.5	8.5	1.6	4.6	10.3	6.1	3.7	3.0	4.3	13.0	2.6	4.1	5.1	1.3	7.3	10.8	1.1	6.0	4.7	9.7	11.1	24.0	10.7	9.5	7.5	11.2	8.2	12.6	10.9
PCCB		ENSG00000114054	"Propionyl-CoA carboxylase beta subunit"	P05166	3	136250306-136337896	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036939, HPA036940"	Enhanced				"Intracellular and membrane"	79000	79000			"HPA036939: AB_10671366, HPA036940: AB_10669779"	"unprognostic (2.74e-1)"	"unprognostic (7.88e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (6.47e-7)"	"unprognostic (2.43e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.50e-1)"	"unprognostic (4.13e-1)"	13.0	46.0	14.3	7.7	16.3	12.7	11.8	7.8	19.2	8.1	17.5	21.0	11.6	15.3	7.1	6.4	11.8	8.1	12.5	36.7	14.1	12.6	36.0	80.2	7.7	8.7	18.9	16.4	6.8	20.8	16.2	9.6	10.0	22.3	10.2	17.6	10.0	10.9	10.6	30.5	8.0	11.1	14.1	18.6	7.9	11.5	17.6	15.5	6.3	15.7	12.4	8.1	9.6	6.6	12.4	24.6	3.9	16.6	12.8	14.9	11.5	20.2	14.5	13.9	20.8	10.6	11.7	24.6	10.7	11.6	16.2	23.0	21.5	14.3	25.3	29.9	15.0	11.3	16.3	14.4	24.7	15.0	13.8	44.3	17.1	32.4	22.6	34.0	19.7	13.8	13.8	10.3	23.6	18.2	32.2	13.6	12.4	38.6	33.6	20.0	11.7	13.1	9.3	11.5	36.1	29.8	22.2	27.8	20.7	27.0	16.0	24.5	31.9	20.2	13.6	8.2	8.7	22.9	9.4	25.9	21.3	21.1	11.6	13.2	9.5	2.8	16.2	3.9	13.2	16.6	14.9	12.4	8.8	13.6	24.6	10.2	9.0	11.1	1.4	12.8	14.6	21.2	7.9	11.5	14.3	16.3	7.8	19.2	14.1	12.6	18.9	16.4	22.3	15.5
PCK1	PEPCK-C	ENSG00000124253	"Phosphoenolpyruvate carboxykinase 1"	P35558	20	57561080-57568112	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 419.5"	"Cell line enriched"	"Detected in some"	10	"ASC diff: 21.5"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 99.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA006277, HPA006507, CAB017027"	Approved					380000	380000			"CAB017027: , HPA006277: AB_1079579, HPA006507: AB_1079578"	"unprognostic (3.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.60e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.43e-2)"		"unprognostic (1.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.64e-1)"	"prognostic favourable (1.47e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-1)"	10.0	0.1	0.4	2.2	0.4	0.0	11.1	0.2	0.6	0.1	52.0	0.2	0.1	19.2	0.1	0.7	0.2	0.1	5.6	0.4	0.3	0.2	72.0	419.5	0.2	0.3	0.2	0.2	0.4	0.2	0.0	5.0	0.1	0.5	0.2	14.0	0.2	0.2	0.1	0.3	0.1	58.5	0.4	0.1	0.1	0.1	0.2	0.2	0.1	0.4	0.4	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.6	0.3	0.2	0.2	0.2	0.5	0.2
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 156.3;liver: 115.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 34.9;hTCEpi: 33.9;SK-MEL-30: 32.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria		3300000	3300000	Mitochondria		"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favourable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	8.2	2.5	1.0	4.9	1.9	1.0	4.3	1.3	1.3	1.3	69.7	1.4	6.9	51.8	1.3	8.5	4.5	1.2	4.2	2.6	1.5	1.0	26.4	115.1	6.0	4.4	1.7	1.2	1.8	8.5	3.4	1.7	1.2	1.8	2.0	5.4	1.9	11.5	4.9	1.0	2.7	156.3	1.1	1.7	6.7	3.3	3.9	1.3	1.3	5.8	1.9	4.6	2.8	1.9	8.8	10.8	2.4	15.1	1.5	6.5	3.9	5.4	3.1	0.9	5.8	3.6	3.7	14.8	6.8	8.2	5.7	9.3	5.1	6.3	13.9	0.8	10.5	8.0	6.0	8.8	4.7	7.1	0.2	2.5	1.7	27.2	34.9	4.8	11.0	4.3	33.9	3.6	8.8	4.6	7.1	25.8	2.2	23.7	1.2	2.4	1.0	4.1	2.8	3.4	7.9	1.7	8.5	3.7	5.9	5.2	6.8	32.1	9.1	7.5	0.8	1.2	6.6	1.8	1.9	17.7	5.5	3.4	3.5	7.7	3.0	0.1	8.2	2.4	3.1	15.1	3.4	8.8	3.5	3.5	10.8	6.1	2.2	2.0	1.0	1.5	14.4	1.9	6.5	3.9	1.0	1.9	1.3	1.3	1.5	1.0	1.7	1.2	1.8	1.3
PCSK1	"NEC1, PC1, PC3, SPC3"	ENSG00000175426	"Proprotein convertase subtilisin/kexin type 1"	P29120	5	96390415-96434143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.6"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 18.5;U-138 MG: 15.8;U-87 MG: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048564	Approved				"Secreted in other tissues"					"HPA048564: "	"unprognostic (1.86e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.20e-5)"	"prognostic unfavourable (9.13e-5)"	"unprognostic (8.47e-4)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-3)"	"unprognostic (4.71e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.89e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.90e-6)"	"unprognostic (5.25e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.37e-3)"	2.3	8.5	1.3	6.0	10.1	0.5	1.3	0.5	36.6	1.2	3.3	0.5	0.0	6.7	0.5	8.8	0.4	0.4	0.6	1.0	2.8	27.1	0.5	0.4	0.8	0.4	3.1	14.0	0.6	9.8	0.3	10.9	0.4	7.5	0.5	3.3	0.1	2.8	0.5	0.5	1.7	4.6	1.0	1.3	0.5	8.4	0.5	0.4	0.0	1.9	0.0	0.3	0.9	0.6	0.0	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.1	0.0	0.0	0.0	0.0	1.7	0.8	0.3	0.1	0.7	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	2.7	0.0	0.0	0.0	0.0	0.9	15.8	0.5	0.2	0.1	0.0	0.0	0.1	13.1	0.0	0.3	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	10.1	0.5	36.6	2.8	27.1	3.1	14.0	7.5	0.4
PCYT1A	"CT, CTPCT, PCYT1"	ENSG00000161217	"Phosphate cytidylyltransferase 1, choline, alpha"	P49585	3	196214222-196287957	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"	"Cone-rod dystrophy, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 72.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035428	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA035428: AB_10602045"	"unprognostic (8.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (8.65e-5)"	"unprognostic (8.52e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.41e-2)"	24.8	22.2	15.3	19.9	18.7	25.8	18.0	14.2	17.8	13.6	25.3	23.0	21.1	41.1	18.2	18.7	25.2	15.0	19.8	36.0	14.8	13.8	20.2	17.8	18.7	15.6	16.6	14.1	15.6	13.9	16.0	12.1	14.2	20.5	13.3	16.5	14.4	17.1	19.2	45.8	32.8	37.2	19.5	18.3	23.4	18.1	19.4	18.6	13.2	14.8	28.0	19.0	17.6	16.7	7.8	8.7	20.5	9.8	7.9	13.5	4.6	28.2	11.4	8.0	11.7	16.4	18.3	12.1	21.6	15.4	18.6	16.4	27.8	10.3	7.2	72.5	24.7	22.1	12.7	16.6	15.9	13.2	8.9	20.8	12.0	11.8	14.7	10.0	17.9	15.4	12.7	18.0	12.9	19.9	11.6	16.2	18.5	23.8	6.2	5.3	6.9	17.0	10.4	10.2	11.6	11.4	15.9	7.8	5.8	14.6	25.3	14.0	37.1	12.5	29.6	14.8	8.2	20.1	29.2	15.0	28.6	13.4	22.7	14.0	18.6	7.5	8.7	9.2	9.6	9.2	8.0	7.8	7.2	10.2	8.7	5.7	4.6	6.8	20.5	7.9	9.8	5.6	13.5	4.6	15.3	18.7	14.2	17.8	14.8	13.8	16.6	14.1	20.5	18.6
PDE6G	"PDEG, RP57"	ENSG00000185527	"Phosphodiesterase 6G"	P18545	17	81650459-81663112	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 260.3"	"Cell line enhanced"	"Detected in some"		"Hep G2: 6.4;NB-4: 6.8;NTERA-2: 11.8;REH: 13.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 29.7;NK-cell: 57.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 29.7;NK-cells: 57.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles				Vesicles		"HPA045118: "	"unprognostic (6.16e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.14e-1)"	0.9	1.3	0.4	2.9	0.5	4.7	0.7	0.5	0.6	0.4	0.8	0.5	0.4	0.0	0.4	0.5	0.6	0.3	1.6	0.5	0.5	0.7	3.8	2.6	2.0	13.8	0.6	0.5	0.5	0.4	0.0	0.5	8.6	0.5	0.5	0.5	260.3	0.5	0.4	0.6	0.8	2.8	0.4	0.8	17.9	0.7	2.2	0.5	2.5	0.6	0.4	4.6	2.1	0.4	1.3	8.6	29.7	7.7	57.8	2.4	3.7	0.2	0.3	0.5	0.0	0.3	0.0	0.0	0.3	1.2	1.2	1.3	0.1	0.8	0.6	0.2	0.7	0.1	0.2	0.2	2.9	0.2	0.0	0.9	0.1	6.4	1.0	0.1	0.2	0.0	0.2	1.2	0.0	3.3	0.1	0.3	1.3	0.8	0.1	6.8	11.8	0.4	13.7	0.1	2.1	0.0	0.0	0.1	0.3	0.0	0.3	0.5	0.1	0.8	1.3	0.4	0.1	0.2	0.3	0.1	0.6	1.0	1.6	2.7	0.2	29.7	5.1	8.6	1.2	7.7	0.4	0.8	0.3	0.6	8.6	1.3	0.7	2.4	0.7	57.8	4.2	0.8	0.0	3.7	0.4	0.5	0.5	0.6	0.5	0.7	0.6	0.5	0.5	0.5
PDE6H		ENSG00000139053	"Phosphodiesterase 6H"	Q13956	12	14973022-14981865	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"retina: 67.4"	"Group enriched"	"Detected in some"	4	"AN3-CA: 4.2;MOLT-4: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles				Vesicles		"HPA045118: "					"unprognostic (1.47e-3)"										"unprognostic (1.07e-2)"			0.1	1.3	1.2	0.2	1.5	9.4	0.1	0.1	4.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	1.0	2.1	0.1	0.1	0.2	0.2	2.2	0.1	0.1	0.1	0.0	0.1	2.5	0.7	0.1	0.1	67.4	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.8	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.6	0.7	0.0	0.0	1.4	0.2	0.0	0.8	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	1.2	1.5	0.1	4.2	1.0	2.1	2.2	0.1	0.7	0.1
PDHA1	PDHA	ENSG00000131828	"Pyruvate dehydrogenase E1 alpha 1 subunit"	P08559	X	19343893-19361705	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047487, HPA047864, HPA063053"	Approved		Supported	Mitochondria	"Intracellular and membrane"	15000	15000	Mitochondria		"HPA047487: , HPA047864: , HPA063053: "	"unprognostic (5.71e-3)"	"unprognostic (2.46e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.90e-2)"	"unprognostic (8.68e-2)"	"prognostic favourable (1.13e-7)"	"unprognostic (3.72e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.06e-2)"	22.5	16.1	14.7	11.7	24.3	20.4	14.7	18.6	25.0	12.3	28.6	13.0	27.7	22.7	13.0	21.6	17.2	12.4	11.8	89.3	15.5	12.2	36.6	26.6	10.5	8.9	14.8	19.9	12.2	28.7	25.0	11.6	14.9	19.0	10.8	28.2	12.7	41.8	18.3	107.3	12.7	21.1	21.2	12.7	11.5	24.9	6.3	12.0	11.3	15.0	44.9	14.9	13.1	12.4	39.4	45.1	34.8	46.1	35.5	36.6	31.9	25.7	32.1	23.3	24.5	22.6	17.3	28.6	17.8	15.9	37.0	28.6	45.7	16.6	44.1	13.2	21.4	33.7	71.4	30.9	39.0	14.6	39.8	21.9	55.3	40.2	24.0	34.9	17.9	22.3	28.8	34.1	33.8	22.4	19.2	18.7	25.8	34.1	29.1	35.9	23.7	56.2	30.1	39.0	54.0	63.6	26.4	12.9	13.7	28.4	36.0	32.2	38.0	24.5	13.9	19.1	17.2	52.0	22.5	15.9	16.4	29.2	18.0	24.5	16.5	34.8	35.0	24.2	30.3	46.1	36.6	39.4	29.4	32.8	45.1	29.3	29.0	30.6	6.1	35.5	39.1	29.8	31.1	31.9	14.7	24.3	18.6	25.0	15.5	12.2	14.8	19.9	19.0	12.0
PDHB	PDHE1B	ENSG00000168291	"Pyruvate dehydrogenase E1 beta subunit"	P11177	3	58427630-58433857	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033794, HPA036744, HPA036745"	Enhanced		Supported	Nucleoplasm,Mitochondria		6500000	6500000	Mitochondria	Nucleoplasm	"CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.35e-1)"	"prognostic favourable (2.79e-8)"	"unprognostic (2.67e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.85e-2)"	21.8	34.3	22.5	19.5	28.4	8.6	17.1	15.1	26.2	18.0	21.6	18.4	19.2	16.2	17.2	18.2	22.8	15.0	16.5	64.2	24.1	20.8	38.7	41.8	13.9	18.2	23.7	23.3	11.0	17.2	26.0	20.0	21.6	26.4	19.5	23.9	16.1	17.6	22.1	92.2	14.3	17.3	24.5	22.8	23.2	21.4	21.8	17.5	20.9	16.1	33.8	20.6	17.9	14.4	37.0	50.1	33.6	39.8	43.4	38.6	38.3	19.0	26.7	27.7	20.8	28.2	34.7	33.2	24.1	30.2	35.6	36.7	48.1	18.5	40.7	13.6	30.4	11.1	33.7	22.1	27.3	23.5	24.7	36.3	50.4	36.3	28.5	29.4	20.4	30.2	20.4	28.7	16.9	30.6	18.7	18.4	38.6	18.2	27.8	31.0	38.1	30.3	13.3	21.6	39.2	56.2	26.1	19.2	21.2	22.3	32.1	23.9	47.5	31.6	22.4	19.1	25.4	20.0	27.2	25.7	36.5	28.7	29.3	35.0	18.0	16.4	35.4	33.6	31.5	39.8	33.2	37.0	31.2	30.0	50.1	33.3	35.1	31.4	7.0	43.4	35.9	33.7	38.6	38.3	22.5	28.4	15.1	26.2	24.1	20.8	23.7	23.3	26.4	17.5
PDK3		ENSG00000067992	"Pyruvate dehydrogenase kinase 3"	Q15120	X	24465221-24539837	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046583, HPA072492"	Approved		Supported	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA046583: , HPA072492: "	"unprognostic (5.41e-3)"	"unprognostic (5.43e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-3)"	"unprognostic (5.38e-2)"	"prognostic unfavourable (2.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.43e-3)"	9.6	5.6	5.7	9.8	17.3	16.3	12.8	3.3	23.6	8.0	14.7	5.5	5.6	13.6	7.3	15.7	9.5	13.2	7.0	16.9	12.5	6.8	13.7	11.1	11.2	13.4	6.2	13.7	11.0	7.3	12.8	14.1	7.7	14.9	8.3	10.1	9.9	19.3	5.2	3.9	14.2	15.6	8.6	6.1	17.9	12.7	23.1	4.8	12.5	6.2	4.1	14.9	10.3	9.2	4.5	7.2	36.4	10.9	7.1	11.0	6.7	9.0	4.6	3.9	6.5	0.1	0.0	4.1	2.7	2.4	3.7	6.5	0.4	11.0	9.1	1.8	0.7	2.0	11.3	6.9	9.9	7.8	5.4	4.9	5.3	2.6	1.3	4.1	4.8	0.7	3.0	0.9	0.9	5.5	0.9	13.9	0.5	16.9	7.8	5.4	7.0	5.4	4.0	7.0	13.4	3.2	17.6	2.5	3.2	14.7	6.0	4.5	8.2	1.6	0.1	2.6	3.8	4.8	3.2	8.9	6.8	11.0	7.1	6.4	5.3	9.4	8.9	21.3	7.6	10.9	11.0	4.5	6.2	6.2	7.2	4.1	4.9	5.7	36.4	7.1	10.4	2.3	5.1	6.7	5.7	17.3	3.3	23.6	12.5	6.8	6.2	13.7	14.9	4.8
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926066	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 33.2;TIME: 33.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol				Nucleoplasm	"Mitochondria, Cytosol"	"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavourable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favourable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	5.1	32.3	11.0	4.6	38.9	5.9	7.9	7.5	62.2	7.5	4.3	4.7	1.6	3.3	7.7	8.6	8.0	6.1	9.6	22.9	10.1	8.0	6.3	2.2	6.0	5.6	5.1	32.5	9.7	9.3	20.6	4.2	6.6	4.4	5.2	6.2	4.4	6.6	4.7	31.8	3.2	5.5	5.5	3.4	5.8	5.5	12.9	4.8	4.1	9.3	7.0	5.8	7.7	5.1	11.0	12.7	7.8	21.5	2.8	19.5	8.8	8.9	4.4	9.6	4.0	8.0	14.6	3.2	7.0	7.8	8.3	9.8	4.6	33.2	5.0	23.7	11.2	19.9	4.1	5.9	12.3	0.5	2.0	2.3	5.5	1.6	9.1	1.1	3.3	9.4	11.8	14.1	22.6	18.7	0.8	8.2	10.1	2.1	6.9	3.6	4.4	5.7	1.7	5.7	0.9	5.7	6.2	0.8	4.2	4.6	0.5	21.6	1.5	1.4	33.2	10.1	6.5	23.6	8.3	4.6	1.9	4.2	12.9	4.2	8.9	3.1	15.4	7.8	5.6	14.3	5.3	9.3	9.1	7.2	12.7	11.0	5.5	4.8	1.8	2.8	21.5	2.1	19.5	8.8	11.0	38.9	7.5	62.2	10.1	8.0	5.1	32.5	4.4	4.8
PDSS1	"COQ1, TPRT, TPT"	ENSG00000148459	"Decaprenyl diphosphate synthase subunit 1"	Q5T2R2	10	26697659-26746798	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 22.4;lymphoid tissue: 31.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038032, HPA042741"	Uncertain		Approved	Cytosol				Cytosol		"HPA038032: AB_10670650, HPA042741: "	"unprognostic (1.41e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (6.79e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavourable (1.25e-5)"	"unprognostic (2.47e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.93e-3)"	"unprognostic (8.85e-2)"	"unprognostic (9.83e-2)"	"unprognostic (6.36e-2)"	3.1	2.6	2.4	7.0	3.1	5.6	3.5	5.6	5.1	3.1	18.2	1.5	1.2	20.6	3.8	2.1	8.3	3.4	3.7	4.2	2.2	2.2	8.6	7.2	4.0	7.8	2.1	2.3	2.8	3.8	1.7	2.5	2.8	2.9	2.3	17.0	3.2	3.5	1.8	10.4	2.7	22.4	3.6	3.1	5.7	3.8	3.0	1.6	31.8	2.1	4.7	5.0	2.9	4.0	3.2	5.2	0.9	5.3	0.8	3.4	1.3	7.5	5.9	4.5	8.2	1.5	2.8	6.2	7.0	1.8	10.2	7.0	9.0	4.2	17.3	3.7	3.4	9.6	14.3	10.7	8.7	7.2	12.0	14.9	5.1	6.5	2.2	9.9	5.9	3.5	4.6	9.5	2.5	5.3	13.7	4.6	7.1	11.9	31.2	7.0	9.0	5.7	14.5	12.9	12.5	6.0	3.6	13.2	8.1	6.8	14.0	7.6	4.9	11.6	3.4	5.7	9.1	11.7	11.1	1.8	6.7	12.6	5.6	25.2	4.4	0.0	5.3	0.9	0.9	4.1	2.1	0.5	1.8	1.3	5.2	3.2	3.4	1.5	0.3	0.8	2.1	1.4	0.1	1.3	2.4	3.1	5.6	5.1	2.2	2.2	2.1	2.3	2.9	1.6
PDSS2	"bA59I9.3, C6orf210"	ENSG00000164494	"Decaprenyl diphosphate synthase subunit 2"	Q86YH6	6	107152557-107459564	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Cancer-related genes, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029685, HPA029686"	Approved		Enhanced	Cytosol				Cytosol		"HPA029685: AB_10600219, HPA029686: AB_10602309"	"prognostic unfavourable (1.34e-5)"	"unprognostic (1.44e-1)"	"prognostic favourable (5.74e-5)"	"unprognostic (5.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.19e-1)"	"prognostic favourable (3.75e-7)"	"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	10.6	27.3	7.2	17.0	8.3	8.3	19.6	9.0	10.3	10.4	12.7	9.0	13.7	9.6	13.1	11.4	11.5	9.2	11.2	16.0	7.0	6.8	22.1	27.4	18.2	18.3	9.2	5.3	10.8	14.0	11.4	19.4	7.0	9.6	15.6	13.9	12.0	19.9	19.9	13.1	9.0	10.1	11.0	8.1	9.1	10.5	12.8	10.1	11.3	14.1	11.1	10.6	10.9	12.9	8.5	9.4	4.1	12.1	4.6	8.3	4.3	5.6	7.6	6.5	10.1	11.3	14.5	15.0	10.0	12.7	9.6	9.3	7.5	8.2	10.8	9.2	11.1	7.8	15.7	12.5	13.2	6.9	7.7	10.7	9.0	12.5	12.0	13.8	8.7	10.7	14.9	15.2	12.1	10.1	15.2	14.7	9.4	7.0	4.0	14.6	4.1	9.9	7.2	5.8	8.7	11.9	7.8	6.4	5.6	6.8	12.0	14.3	9.8	16.7	6.3	6.9	4.1	9.6	8.5	4.1	5.0	8.4	12.8	20.6	12.6	4.1	6.6	3.5	5.3	7.6	8.3	6.6	5.6	6.8	9.4	8.5	7.3	6.9	0.9	4.6	12.1	4.5	7.1	4.3	7.2	8.3	9.0	10.3	7.0	6.8	9.2	5.3	9.6	10.1
PDYN	"ADCA, PENKB, SCA23"	ENSG00000101327	Prodynorphin	P01213	20	1978757-1994285	"Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 55.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.5;NTERA-2: 2.8;THP-1: 2.6"	"Group enriched"	"Detected in some"	29	"glioma: 2.6;ovarian cancer: 1.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 55.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 150.7;hypothalamus: 70.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 131.1"	"HPA053342, CAB079777"	Enhanced	Supported			"Secreted in brain"					"CAB079777: , HPA053342: "					"unprognostic (7.00e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"					"unprognostic (3.73e-2)"			0.4	0.4	13.2	0.4	55.9	0.4	0.4	0.0	40.3	0.4	0.4	1.2	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	5.0	3.9	0.4	0.4	0.4	0.4	0.7	3.7	0.4	0.4	0.4	0.0	0.4	0.2	0.4	0.4	0.0	0.4	0.4	0.4	0.6	0.4	0.4	2.2	0.4	0.4	3.2	1.1	0.0	0.5	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	55.9	0.0	3.8	5.0	3.9	0.7	3.7	0.2	1.1
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521794	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 92.9;kidney: 106.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		1000000000	1000000000	Nucleoplasm		"HPA015599: AB_1855192, HPA072045: "	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favourable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	23.5	17.2	9.8	8.9	10.4	4.1	21.8	7.6	14.9	9.8	60.1	18.7	6.9	58.1	14.3	11.5	14.9	9.6	13.6	8.0	10.8	9.1	106.0	48.6	11.1	10.6	16.0	7.7	12.6	9.0	9.6	12.5	10.4	13.0	9.2	6.6	13.3	9.6	9.0	9.7	11.4	92.9	10.4	17.4	13.4	9.3	8.4	11.5	8.4	15.0	9.7	10.6	11.9	11.9	17.1	32.3	27.5	39.1	16.8	25.8	32.6	13.2	35.9	10.6	17.0	45.2	17.4	24.5	11.7	24.1	15.0	17.1	31.2	11.6	5.4	17.6	29.5	3.4	15.2	9.6	12.4	15.2	15.0	34.3	7.3	31.7	30.9	9.9	41.6	21.4	9.1	13.7	8.5	20.0	6.5	15.6	16.3	16.1	7.6	3.3	14.6	14.6	15.0	14.4	14.9	13.0	34.9	13.0	33.4	21.9	10.8	17.7	7.5	10.8	16.7	14.5	15.7	18.8	13.6	14.3	21.2	4.7	15.5	14.4	20.6	27.5	36.1	2.5	25.8	39.1	22.6	17.1	25.7	23.8	32.3	16.3	16.9	19.6	1.9	16.8	27.2	9.9	23.6	32.6	9.8	10.4	7.6	14.9	10.8	9.1	16.0	7.7	13.0	11.5
PEX1	"ZWS, ZWS1"	ENSG00000127980	"Peroxisomal biogenesis factor 1"	O43933	7	92487020-92528531	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis, Protein transport, Transport"		"Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020235	Approved		Supported	Peroxisomes				Peroxisomes		"HPA020235: AB_1855224"	"unprognostic (4.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.35e-3)"	"unprognostic (4.90e-2)"	11.3	13.8	8.9	13.1	19.1	5.8	14.0	14.3	14.7	12.7	13.2	15.8	19.0	10.2	12.2	18.7	13.0	9.5	10.6	13.4	9.5	9.3	22.4	20.3	8.4	9.9	15.4	9.3	14.3	17.5	23.3	22.5	8.0	18.5	12.9	15.4	13.7	13.6	20.6	16.1	15.0	12.7	12.2	15.0	10.2	12.9	10.2	13.6	15.2	13.8	14.6	11.1	11.5	11.6	5.5	2.1	3.1	3.6	7.9	6.2	1.9	5.6	6.3	10.3	17.4	6.5	5.6	9.3	3.8	5.0	4.5	6.5	3.8	6.1	8.5	8.6	4.3	5.8	7.8	6.8	7.2	8.7	6.9	4.0	6.7	4.7	4.5	7.2	4.6	6.1	6.2	6.8	9.2	7.0	14.9	12.1	7.1	10.7	14.4	7.1	7.1	5.9	10.2	11.5	10.5	6.4	8.4	7.6	12.3	8.8	24.4	7.5	5.0	3.1	5.8	4.4	5.9	16.5	3.9	13.6	10.7	11.7	4.1	4.3	6.9	1.1	2.0	3.1	4.7	3.2	4.6	5.5	4.9	5.1	2.1	4.7	5.7	6.2	1.6	7.9	3.6	1.3	4.6	1.9	8.9	19.1	14.3	14.7	9.5	9.3	15.4	9.3	18.5	13.6
PEX10	RNF69	ENSG00000157911	"Peroxisomal biogenesis factor 10"	O60683	1	2403964-2413797	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049458, HPA049755"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA049458: , HPA049755: "	"prognostic favourable (4.50e-6)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"prognostic favourable (4.16e-6)"	"unprognostic (4.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	14.6	18.7	20.5	6.2	19.9	5.6	16.3	7.6	24.6	9.8	9.2	23.1	6.6	10.1	7.6	13.6	10.6	11.4	8.3	12.9	17.8	15.5	12.0	12.1	8.3	7.6	19.2	13.5	13.0	19.4	12.5	12.2	10.2	16.0	15.4	7.0	11.4	17.4	12.3	22.1	10.8	9.0	6.6	21.3	8.9	10.1	17.3	12.6	6.0	10.5	11.8	9.0	8.1	6.8	7.4	11.5	2.2	10.7	4.5	6.4	4.8	12.0	10.1	7.8	8.7	5.7	6.6	7.3	6.4	7.4	10.6	7.7	16.0	18.2	6.3	16.9	8.4	9.4	7.1	11.8	5.0	10.2	13.8	4.8	10.3	31.9	11.0	8.5	2.6	6.5	6.2	7.8	10.7	9.0	5.8	7.9	9.3	15.7	7.9	4.0	6.7	20.2	6.5	8.1	13.1	11.4	4.2	12.3	9.4	7.5	11.4	20.7	9.9	3.4	8.7	9.7	4.3	14.9	8.5	11.5	4.7	5.7	11.2	6.6	7.7	1.9	6.9	2.2	5.2	10.7	6.0	7.4	4.5	6.4	11.5	6.9	5.2	3.9	1.6	4.5	8.7	9.8	2.5	4.8	20.5	19.9	7.6	24.6	17.8	15.5	19.2	13.5	16.0	12.6
PEX12		ENSG00000108733	"Peroxisomal biogenesis factor 12"	O00623	17	35574795-35578863	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069386	Enhanced									"HPA069386: "	"unprognostic (1.45e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.64e-2)"	"prognostic favourable (3.58e-5)"	"unprognostic (2.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	6.5	12.6	11.4	5.1	13.4	2.1	8.7	9.6	12.2	8.6	6.6	9.9	6.0	5.7	7.3	17.2	6.4	8.7	8.0	13.0	9.9	10.2	12.8	13.2	5.3	6.4	13.9	8.6	13.1	6.7	17.8	20.8	8.6	9.2	11.9	4.6	8.0	7.9	13.4	13.8	6.5	5.3	5.9	10.8	5.6	6.3	9.8	9.9	6.2	12.3	5.4	6.6	8.5	9.1	4.9	3.2	5.3	2.9	3.5	8.0	2.5	2.6	3.5	5.3	4.3	11.1	10.2	3.8	7.1	8.0	5.9	6.3	3.0	2.9	5.9	11.4	3.9	7.0	6.4	4.7	5.2	2.1	8.3	4.4	3.9	5.6	13.1	6.1	1.0	9.2	8.9	3.6	10.8	4.4	6.8	6.4	7.1	2.7	7.3	3.7	2.2	5.6	3.5	9.2	5.9	7.2	4.1	3.9	4.0	4.4	2.9	8.9	7.1	3.5	3.4	5.6	3.5	6.1	4.6	13.1	9.1	7.1	5.9	4.9	5.0	4.1	2.9	5.3	3.7	2.2	6.3	4.7	5.9	3.6	3.2	4.9	8.0	6.8	2.0	3.5	2.2	3.0	4.2	2.5	11.4	13.4	9.6	10.7	9.9	10.2	13.9	8.6	9.2	9.9
PEX13		ENSG00000162928	"Peroxisomal biogenesis factor 13"	Q92968	2	61017225-61051990	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032141, HPA032142, CAB032689"	Enhanced		Supported	Vesicles				Vesicles		"CAB032689: AB_2162137, HPA032141: AB_2674176, HPA032142: AB_10669676"	"unprognostic (2.44e-3)"	"unprognostic (4.10e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavourable (8.07e-5)"	"unprognostic (5.42e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.63e-2)"	11.7	11.5	14.2	9.1	14.7	8.4	29.2	21.4	14.9	14.3	13.1	10.3	6.0	13.0	12.3	10.3	15.7	8.9	11.6	16.3	14.1	11.7	17.7	31.8	16.8	13.1	11.7	11.7	16.5	19.5	10.9	18.7	11.9	10.8	19.6	14.1	11.6	13.7	8.7	20.7	11.5	15.3	17.4	12.2	8.2	12.7	18.2	12.3	11.7	18.0	9.7	11.0	13.7	13.3	8.3	7.9	15.1	7.0	8.0	10.5	6.2	10.4	7.7	11.0	14.1	10.6	8.4	17.0	10.9	8.5	7.5	7.7	11.5	15.9	6.8	11.8	10.6	15.7	9.7	13.1	14.2	6.6	6.7	6.2	10.4	18.9	12.6	9.2	7.6	10.2	20.3	10.2	15.8	13.4	15.1	6.1	11.3	9.5	6.9	11.2	12.0	7.8	7.4	12.2	8.5	14.1	26.2	12.5	8.6	12.2	16.6	9.8	11.1	4.8	10.5	14.4	19.2	8.3	9.2	10.0	7.7	17.2	9.1	9.6	10.1	15.1	6.1	8.8	8.3	5.8	7.9	8.3	9.7	9.2	7.9	6.7	10.5	7.9	6.0	8.0	7.0	7.0	8.2	6.2	14.2	14.7	21.4	14.9	14.1	11.7	11.7	11.7	10.8	12.3
PEX14		ENSG00000142655	"Peroxisomal biogenesis factor 14"	O75381	1	10472288-10630758	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046104, HPA049231"	Supported		Supported	"Nucleoli fibrillar center,Peroxisomes"				Peroxisomes	"Nucleoli fibrillar center"	"HPA046104: , HPA049231: "	"unprognostic (7.23e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-3)"	"unprognostic (9.67e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.75e-2)"	14.9	11.6	14.3	12.2	22.3	8.3	13.1	15.7	35.0	11.8	14.8	18.6	8.3	18.0	14.4	10.4	22.6	14.8	12.2	17.8	14.4	16.2	13.3	25.9	13.6	11.6	13.0	16.1	15.7	15.3	13.6	14.2	17.7	22.4	21.9	10.5	14.8	20.0	31.0	22.1	14.6	20.9	10.7	11.1	11.2	12.8	18.7	11.4	11.4	13.5	11.6	17.3	38.7	13.6	4.2	5.0	7.3	3.8	4.2	8.4	3.6	15.4	14.6	12.5	13.7	9.2	8.7	8.1	17.9	15.1	20.0	19.1	15.4	28.9	11.3	18.0	13.7	18.6	13.0	17.3	9.6	15.8	21.2	13.9	15.9	21.1	13.9	15.6	20.0	10.5	14.0	15.1	14.0	12.8	21.7	11.7	9.0	12.8	14.9	20.6	12.8	17.2	16.2	10.4	16.2	15.8	10.3	14.9	17.0	17.3	14.5	16.1	13.3	11.2	12.3	14.7	15.5	14.1	15.2	16.8	13.6	22.1	16.1	21.7	15.6	1.9	3.8	7.3	8.4	2.8	5.3	4.2	4.4	6.2	4.7	3.9	5.8	5.2	0.6	4.2	2.5	5.0	5.2	3.6	14.3	22.3	15.7	35.0	14.4	16.2	13.0	16.1	22.4	11.4
PEX16		ENSG00000121680	"Peroxisomal biogenesis factor 16"	Q9Y5Y5	11	45909669-45918812	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043286	Approved									"HPA043286: AB_10794179"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.06e-3)"	"unprognostic (9.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.75e-3)"	"unprognostic (5.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.00e-1)"	"prognostic favourable (9.06e-4)"	14.6	17.6	23.7	13.0	23.5	24.3	12.0	10.6	29.2	9.7	19.6	21.3	13.4	24.8	11.0	13.0	13.8	15.1	14.0	15.4	22.9	17.0	14.8	28.9	11.9	19.9	21.2	14.3	12.7	31.6	12.8	18.6	10.9	17.4	11.9	7.3	13.3	24.1	18.8	9.2	16.5	22.2	8.3	19.9	16.8	15.2	16.7	11.5	18.3	16.0	12.5	18.4	13.8	10.3	36.9	32.4	24.4	31.5	27.4	38.9	29.6	8.3	12.5	3.8	10.4	7.0	8.6	11.3	6.8	9.5	9.7	8.1	13.5	6.4	14.4	9.0	6.7	17.0	3.9	14.1	2.0	13.0	15.3	9.1	15.8	11.3	21.7	14.2	23.2	13.8	12.6	6.0	9.2	10.3	7.5	17.4	6.1	24.1	10.7	19.1	9.3	13.7	10.7	9.3	16.4	6.2	14.2	10.0	13.4	8.0	15.9	13.4	23.9	12.2	9.2	10.5	12.2	22.6	12.2	27.9	18.4	9.7	10.5	9.2	10.2	19.7	30.7	24.4	35.5	31.5	32.4	36.9	34.6	34.5	32.4	32.7	31.5	32.6	22.5	27.4	24.2	29.7	38.9	29.6	23.7	23.5	10.6	29.2	22.9	17.0	21.2	14.3	17.4	11.5
PEX19	"D1S2223E, HK33, PMP1, PMPI, PXF, PXMP1"	ENSG00000162735	"Peroxisomal biogenesis factor 19"	P40855	1	160276812-160286348	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044837, HPA051966"	Supported		Supported	Peroxisomes				Peroxisomes		"HPA044837: AB_10962496, HPA051966: "	"unprognostic (1.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (2.92e-5)"	"unprognostic (3.46e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.24e-2)"	41.9	20.4	21.5	8.0	27.8	6.2	24.4	10.0	30.6	12.5	12.9	23.8	8.9	11.0	13.0	15.0	14.6	13.6	11.3	21.7	18.5	21.0	19.5	61.6	12.2	8.7	20.3	17.2	14.5	12.6	17.5	14.3	15.0	25.0	16.8	13.8	17.8	16.2	16.3	32.9	14.1	12.7	10.0	17.4	11.8	12.7	11.4	12.9	9.1	22.2	12.1	11.3	13.4	8.7	9.7	13.0	11.8	15.6	6.9	10.2	7.5	12.4	7.6	29.5	9.1	25.2	24.9	22.2	10.2	21.1	19.0	15.1	14.0	15.2	15.3	17.5	15.5	12.2	14.1	18.3	15.0	13.3	7.0	10.7	10.8	14.3	20.5	19.3	13.6	37.3	21.2	25.7	16.5	13.3	16.1	11.8	21.3	6.9	14.5	6.3	21.0	20.1	18.3	14.5	18.3	19.2	25.2	9.6	16.0	40.8	20.7	15.4	20.2	19.1	10.1	11.0	13.2	12.5	12.0	17.7	22.7	28.0	18.2	8.4	16.2	9.2	12.2	11.8	10.2	15.6	8.3	9.7	5.9	7.2	13.0	5.6	7.5	6.8	4.8	6.9	10.2	6.3	8.7	7.5	21.5	27.8	10.0	30.6	18.5	21.0	20.3	17.2	25.0	12.9
PEX2	"PAF-1, PMP35, PXMP3, RNF72, ZWS3"	ENSG00000164751	"Peroxisomal biogenesis factor 2"	P28328	8	76980258-77001044	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010983, HPA011410, HPA027729"	Approved		Supported	Vesicles				Vesicles		"HPA010983: , HPA011410: AB_1854922, HPA027729: AB_10610416"	"unprognostic (6.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.09e-3)"	21.3	30.9	25.4	17.9	23.8	17.3	30.7	20.7	24.6	24.3	23.8	24.1	65.7	22.5	25.7	24.3	21.6	24.1	18.0	22.1	26.9	20.7	31.3	25.3	20.4	27.8	29.8	18.3	20.5	26.4	21.2	32.6	17.4	25.9	25.8	22.9	24.9	28.7	63.6	32.4	17.4	27.2	25.7	30.5	23.1	27.0	14.7	30.9	32.2	34.4	19.0	23.4	24.2	23.5	17.3	17.1	52.4	22.9	28.3	22.3	24.2	27.7	9.4	15.3	15.4	16.4	20.6	8.0	20.8	23.8	16.1	17.8	5.9	24.9	15.8	31.1	18.7	10.7	10.4	15.8	19.6	29.1	8.6	19.3	8.7	9.0	11.1	15.9	15.3	23.1	13.4	12.2	14.6	17.5	10.5	15.2	16.8	8.3	28.0	9.5	9.0	8.5	5.1	12.2	13.1	18.7	19.7	5.4	14.2	13.4	61.0	11.3	19.0	11.5	17.5	14.8	19.5	19.0	10.3	28.3	16.4	27.6	18.8	8.5	16.4	52.4	20.3	35.8	22.3	20.8	19.9	17.3	15.6	17.9	16.9	17.2	20.6	19.6	14.1	28.3	22.9	17.1	17.4	24.2	25.4	23.8	20.7	24.6	26.9	20.7	29.8	18.3	25.9	30.9
PEX26	FLJ20695	ENSG00000215193	"Peroxisomal biogenesis factor 26"	Q7Z412	22	18077920-18131138	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070429	Approved									"CAB070429: AB_11154363"	"unprognostic (2.25e-1)"	"unprognostic (5.75e-3)"	"prognostic favourable (9.92e-4)"	"unprognostic (1.77e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (3.10e-4)"	"unprognostic (1.59e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.96e-1)"	"prognostic favourable (1.38e-4)"	"unprognostic (3.17e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	13.2	16.2	16.7	11.8	18.2	16.5	11.1	14.7	22.0	10.1	28.9	13.6	11.5	28.6	12.3	9.3	14.4	12.0	14.7	11.5	17.1	16.5	14.8	17.8	10.1	11.8	14.7	20.0	10.8	21.8	18.6	14.5	8.3	16.3	10.3	24.3	13.1	12.3	11.1	11.7	11.4	29.0	12.0	10.2	11.9	14.4	5.8	11.1	15.1	13.8	9.6	11.7	11.0	11.3	4.8	7.3	3.8	6.0	4.4	7.0	2.8	17.0	9.4	11.3	10.4	15.3	7.9	18.4	11.5	12.5	11.7	11.2	13.7	14.5	12.0	12.6	19.6	17.6	17.6	18.1	10.0	18.9	15.2	22.2	12.6	13.4	11.4	26.7	20.5	11.2	11.2	18.9	17.8	17.3	22.9	9.1	16.2	28.1	19.9	10.1	13.2	16.8	17.5	13.3	3.7	17.1	20.8	20.6	15.2	19.7	12.6	15.2	19.1	9.3	21.5	23.7	10.6	12.5	13.6	19.8	14.6	15.7	10.4	14.0	17.0	2.2	4.0	3.8	5.8	2.5	4.6	3.4	4.8	7.0	3.7	4.8	5.5	3.8	3.0	4.4	6.0	7.3	1.8	2.8	16.7	18.2	14.7	22.0	17.1	16.5	14.7	20.0	16.3	11.1
PEX3		ENSG00000034693	"Peroxisomal biogenesis factor 3"	P56589	6	143450807-143490010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042830, HPA058006"	Supported		Supported	Nucleoplasm,Peroxisomes				"Nucleoplasm, Peroxisomes"		"HPA042830: AB_10794918, HPA058006: AB_2683576"	"unprognostic (3.52e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"prognostic favourable (3.80e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.12e-1)"	10.1	47.5	13.7	14.0	15.5	3.3	14.5	17.3	17.7	13.6	8.5	12.1	14.0	7.0	12.5	16.4	21.1	12.5	9.0	15.8	14.3	11.4	22.7	29.2	9.6	10.3	13.7	15.9	14.4	8.6	16.2	14.8	22.2	17.4	15.0	8.1	10.4	12.8	15.7	12.6	14.6	8.8	12.7	14.6	8.7	11.3	14.4	12.7	10.1	19.3	13.5	11.6	11.9	15.1	18.2	8.7	7.8	9.6	12.0	18.7	8.1	14.4	3.6	7.6	16.0	12.7	12.5	9.6	13.0	10.6	18.0	22.0	23.4	9.4	25.4	15.5	13.9	12.3	10.5	18.4	22.3	14.7	12.9	17.9	7.3	15.0	11.7	28.9	7.3	15.2	12.6	17.3	13.0	9.9	15.2	11.7	17.2	10.2	14.6	11.7	4.9	13.0	11.2	17.2	10.9	22.1	6.3	11.8	4.2	17.3	15.0	11.5	7.5	9.6	9.0	12.9	11.1	22.0	15.4	8.4	10.6	25.4	16.9	20.0	10.1	7.8	5.1	4.9	13.2	8.0	15.1	18.2	14.1	13.1	7.9	15.4	18.7	17.9	0.8	12.0	9.6	8.7	16.5	8.1	13.7	15.5	17.3	17.7	14.3	11.4	13.7	15.9	17.4	12.7
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963870-42979220	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 73.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"				"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	13.0	14.9	12.1	11.5	18.9	9.0	11.5	21.7	19.0	14.7	16.9	14.6	15.3	9.8	11.9	8.8	18.2	23.4	13.0	10.4	12.9	12.1	11.3	18.8	7.4	17.6	17.3	9.1	20.0	73.2	21.3	18.2	10.6	16.0	17.8	8.5	10.8	15.0	12.8	15.2	14.2	24.6	10.5	9.9	12.8	10.6	10.6	17.2	22.3	21.5	6.9	10.9	11.2	12.4	4.3	4.3	4.8	3.2	4.0	6.1	2.5	17.7	8.5	4.3	16.1	16.1	15.5	4.5	3.1	4.9	2.6	5.4	5.4	5.2	7.2	4.4	7.4	16.8	15.0	16.2	2.7	14.0	7.9	2.4	12.0	3.1	10.9	2.4	5.0	19.3	18.8	10.6	2.9	12.9	12.6	7.4	5.6	2.0	6.3	8.0	5.3	7.5	13.6	7.6	2.9	6.5	5.2	13.6	5.9	2.9	11.6	16.3	22.7	10.9	7.2	8.2	1.6	4.0	7.1	11.1	9.8	9.9	2.8	12.6	6.5	2.1	3.2	4.8	3.0	2.4	5.4	2.6	4.4	6.1	4.3	4.3	5.5	5.1	2.0	4.0	1.5	2.5	2.1	2.5	12.1	18.9	21.7	19.0	12.9	12.1	17.3	9.1	16.0	17.2
PEX7	"PTS2R, RD"	ENSG00000112357	"Peroxisomal biogenesis factor 7"	O00628	6	136822564-136913937	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cataract, Deafness, Disease mutation, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049202	Uncertain		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA049202: "	"unprognostic (1.36e-2)"	"unprognostic (2.07e-2)"	"prognostic favourable (1.61e-4)"	"unprognostic (4.01e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.88e-2)"	"prognostic favourable (1.85e-10)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-1)"	5.5	17.8	8.1	7.0	8.9	4.0	13.5	7.0	10.7	8.7	8.5	7.9	14.0	6.1	5.5	18.9	9.1	8.9	17.0	14.5	7.2	6.7	16.3	10.0	9.2	4.7	8.9	9.5	6.1	43.6	15.5	10.2	6.7	6.9	11.7	9.2	13.6	15.4	18.9	11.7	12.0	6.6	7.5	9.6	4.7	14.5	19.4	5.4	5.9	11.5	7.5	6.8	6.9	7.0	4.6	5.4	4.3	5.3	2.9	6.9	1.8	4.7	4.6	4.6	6.5	6.0	8.9	2.5	6.6	8.3	7.1	7.5	5.7	5.6	1.7	12.6	7.1	6.1	3.3	12.3	8.8	4.9	8.0	6.4	4.6	0.8	14.4	8.0	3.7	8.5	13.0	5.1	10.2	5.3	11.9	5.1	9.7	11.3	3.5	9.9	4.7	7.9	4.7	4.7	4.9	15.4	6.4	8.7	12.6	6.1	8.7	8.5	5.7	10.1	4.0	4.6	2.2	7.2	5.1	7.2	4.7	0.0	3.7	7.3	5.6	0.2	3.0	4.3	2.6	2.5	2.0	4.6	3.4	4.2	5.3	2.9	6.9	4.1	0.5	2.9	5.3	5.4	6.4	1.8	8.1	8.9	7.0	10.7	7.2	6.7	8.9	9.5	6.9	5.4
PFKM	"PFK-1, PFKX, PPP1R122"	ENSG00000152556	"Phosphofructokinase, muscle"	P08237	12	48105139-48146404	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 284.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002117	Approved		Approved	"Endoplasmic reticulum"		1100000	1100000	"Endoplasmic reticulum"		"HPA002117: AB_1855245"	"unprognostic (4.60e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavourable (5.85e-6)"	"unprognostic (4.97e-1)"	"prognostic unfavourable (7.91e-5)"	"unprognostic (5.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.29e-3)"	"unprognostic (6.73e-2)"	"prognostic favourable (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.30e-2)"	4.4	11.6	10.0	3.0	16.2	2.3	3.9	13.0	23.6	5.8	5.3	6.1	5.4	3.0	6.4	5.8	9.1	5.4	4.8	55.5	8.2	10.1	10.9	2.7	3.6	2.4	9.4	10.8	10.8	3.0	14.2	11.4	3.3	17.9	7.1	4.2	10.8	5.2	9.4	284.3	2.6	2.8	8.3	4.6	2.7	4.1	10.3	3.8	0.0	5.5	54.9	4.6	5.3	3.7	10.7	6.7	8.7	3.2	2.2	5.4	3.5	8.7	8.5	27.0	24.6	27.6	20.1	5.5	23.7	21.8	20.5	14.6	21.0	11.0	52.2	19.7	11.5	9.8	23.4	23.9	19.3	1.2	12.2	14.9	19.4	0.7	14.8	0.7	8.6	28.4	14.1	18.0	29.7	23.3	17.8	26.4	18.9	6.6	18.3	1.2	19.3	26.5	30.9	15.8	40.1	14.0	9.7	32.0	23.5	14.0	22.3	23.7	22.5	3.2	20.9	9.5	13.2	13.9	19.7	14.4	38.4	28.6	18.4	1.5	8.0	0.4	3.2	8.7	2.5	2.8	1.0	10.7	4.3	2.4	6.7	7.0	5.4	3.0	0.8	2.2	2.3	1.0	3.8	3.5	10.0	16.2	13.0	23.6	8.2	10.1	9.4	10.8	17.9	3.8
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065587	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 38.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		60000000	60000000	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: , HPA060173: "																		1.4	0.8	2.0	0.4	2.2	0.4	0.5	6.9	2.1	0.5	0.5	3.6	0.0	0.6	0.5	9.1	6.1	0.6	0.7	111.6	2.1	3.2	0.8	0.4	0.4	0.4	4.2	1.6	0.5	0.6	0.6	1.3	0.4	2.0	1.9	0.4	2.3	7.6	0.5	379.1	0.4	0.4	0.4	3.2	0.5	0.5	16.7	1.1	4.8	1.5	119.0	4.8	0.4	0.0	0.3	1.3	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	38.1	4.2	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.3	1.7	0.2	2.0	2.2	6.9	2.1	2.1	3.2	4.2	1.6	2.0	1.1
PGAP2	"CWH43-N, FRAG1, MRT21"	ENSG00000148985	"Post-GPI attachment to proteins 2"	Q9UHJ9	11	3797724-3826371	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"GPI-anchor biosynthesis"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 117.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063099	Approved		Approved	Microtubules				Microtubules		"HPA063099: "	"unprognostic (1.94e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavourable (7.49e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.67e-2)"	4.9	9.5	7.6	7.3	8.2	5.2	6.9	5.0	10.6	7.3	12.3	12.4	18.3	10.2	7.4	117.3	20.0	11.1	8.1	9.3	8.0	6.3	8.6	17.1	9.5	8.6	6.9	8.8	7.1	30.8	12.6	9.1	10.7	5.6	10.1	7.9	12.5	14.5	19.6	6.4	25.0	16.7	4.9	8.9	6.6	7.5	17.7	8.4	15.0	14.1	14.6	15.3	7.7	10.4	11.2	8.7	15.9	8.0	8.7	17.0	7.5	12.7	17.5	8.5	7.8	7.7	14.8	13.5	5.3	4.6	7.9	7.1	14.9	22.7	13.9	6.2	3.8	21.6	13.5	14.8	7.8	16.9	14.8	8.5	7.6	18.2	5.4	10.8	11.1	11.7	20.8	5.7	19.7	8.9	17.9	20.7	8.2	19.2	13.2	9.2	16.1	10.6	20.6	1.0	13.3	14.9	15.5	11.3	11.3	9.6	25.7	5.7	21.4	4.7	8.3	4.9	4.7	11.6	3.2	13.0	14.2	10.3	6.5	7.3	9.3	1.9	5.8	5.0	8.8	8.0	10.8	11.0	12.6	10.7	8.7	11.2	17.0	11.3	15.9	8.7	8.0	5.9	11.5	7.5	7.6	8.2	5.0	10.6	8.0	6.3	6.9	8.8	5.6	8.4
PGK1		ENSG00000102144	"Phosphoglycerate kinase 1"	P00558	X	77910739-78129296	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010065, HPA045385, HPA073644, HPA073656"	Approved					290000000	290000000			"CAB010065: AB_628116, HPA045385: , HPA073644: , HPA073656: "	"prognostic unfavourable (7.05e-8)"	"prognostic unfavourable (2.69e-5)"	"unprognostic (1.21e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.65e-6)"	"prognostic unfavourable (2.74e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"prognostic unfavourable (8.34e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.57e-2)"	45.0	50.9	29.2	41.3	38.4	62.2	29.9	43.8	67.9	31.9	36.6	24.2	27.5	35.5	25.7	23.3	62.1	25.6	32.4	69.4	28.6	35.0	71.8	58.5	37.5	47.6	32.1	32.7	26.8	21.2	45.7	29.0	43.7	49.9	28.3	42.8	40.0	38.2	32.0	115.5	38.7	41.9	33.9	30.1	43.7	29.7	11.3	24.9	51.8	39.1	61.1	52.4	42.2	38.0	20.9	53.7	49.2	79.0	21.0	26.3	77.0	98.9	45.9	15.4	31.0	26.6	21.6	36.6	50.7	35.3	44.6	74.9	41.6	31.2	39.7	52.5	35.0	43.1	68.0	78.8	89.5	24.2	26.8	30.7	75.7	36.1	29.2	70.3	34.3	26.9	33.3	40.4	21.5	45.5	32.0	60.7	60.8	39.1	61.4	53.2	47.5	87.4	44.5	41.3	121.5	46.5	41.4	23.0	31.7	52.5	44.8	44.0	23.5	36.9	36.6	47.8	33.0	47.7	34.9	67.5	126.1	41.7	134.5	80.0	31.2	22.7	54.6	49.2	20.8	59.9	23.2	20.9	25.0	22.6	53.7	15.8	23.0	24.4	45.7	21.0	79.0	20.9	26.3	77.0	29.2	38.4	43.8	67.9	28.6	35.0	32.1	32.7	49.9	24.9
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593276-63660245	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase	"Congenital disorder of glycosylation, Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 233.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Approved	Cytosol		20000000	20000000	Cytosol		"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: "	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	17.8	14.1	7.0	4.4	8.3	3.5	9.8	4.4	8.3	6.7	12.9	5.2	4.6	10.6	4.6	7.7	8.8	3.3	8.9	36.9	6.4	5.4	10.0	56.4	7.6	2.7	6.2	6.3	9.7	21.6	12.9	6.2	11.5	8.5	8.7	9.1	5.4	7.9	9.4	233.5	5.3	12.4	8.4	5.6	3.0	5.7	3.0	5.5	3.0	6.0	42.8	6.3	9.4	4.7	12.2	25.9	25.6	17.9	21.1	23.3	16.6	30.2	12.7	4.8	15.7	31.7	23.4	38.9	12.5	17.0	13.6	22.3	10.5	14.1	9.6	26.2	19.2	7.2	6.6	26.3	16.1	11.7	8.8	20.2	21.5	10.8	26.2	17.7	1.2	29.5	17.0	15.9	25.2	8.1	0.0	12.8	21.8	1.8	5.1	9.7	21.8	20.4	7.2	22.3	3.1	19.8	9.5	2.9	18.7	27.3	28.6	41.6	8.9	6.7	0.8	20.2	10.3	17.9	10.6	8.1	11.9	15.6	33.0	15.6	8.6	20.5	17.9	25.6	23.3	12.0	18.6	12.2	13.7	17.5	25.9	6.9	12.5	14.5	21.2	21.1	10.2	7.5	10.6	16.6	7.0	8.3	4.4	8.3	6.4	5.4	6.2	6.3	8.5	5.5
PGM3	"AGM1, DKFZP434B187, PAGM"	ENSG00000013375	"Phosphoglucomutase 3"	O95394	6	83161150-83193936	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004998, HPA029759, HPA029760"	Enhanced		Approved	Nucleoplasm,Cytosol		73000	73000	"Nucleoplasm, Cytosol"		"CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109"	"prognostic unfavourable (8.78e-4)"	"prognostic unfavourable (5.67e-4)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.11e-1)"	"prognostic favourable (9.96e-4)"	"unprognostic (4.00e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (2.39e-7)"	"unprognostic (2.21e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.22e-3)"	15.5	16.7	11.2	10.4	13.7	4.8	12.3	19.1	13.3	15.4	10.1	9.0	30.7	8.9	10.6	26.2	10.3	8.8	14.2	12.2	11.0	8.6	12.2	44.9	13.4	6.3	13.5	9.9	15.5	36.3	9.3	36.2	27.6	18.1	30.9	13.7	7.4	29.2	23.4	5.5	7.5	11.6	11.1	9.7	8.1	14.4	16.8	11.3	4.0	14.9	7.6	8.7	11.1	10.0	8.2	7.4	11.1	6.5	5.3	8.7	3.9	10.0	6.6	12.9	15.4	21.0	22.4	14.9	34.3	24.9	16.6	26.2	17.2	4.7	5.3	7.3	34.2	6.4	11.7	14.4	31.9	3.9	11.4	6.8	13.1	28.8	23.8	6.6	3.4	14.2	11.9	29.3	37.1	19.5	22.1	5.8	17.9	10.4	1.1	4.4	5.7	9.1	4.7	28.8	3.1	12.9	9.9	5.1	8.0	9.9	8.8	6.8	7.7	7.4	28.5	11.5	6.3	23.0	18.4	11.3	4.4	3.8	9.0	5.3	17.9	11.1	6.4	3.8	5.0	6.0	6.7	8.2	5.2	6.2	5.5	5.0	8.7	8.2	2.7	5.3	6.5	7.4	3.6	3.9	11.2	13.7	19.1	13.3	11.0	8.6	13.5	9.9	18.1	11.3
PHEX	"HPDR, HPDR1, HYP, HYP1, PEX, XLH"	ENSG00000102174	"Phosphate regulating endopeptidase homolog X-linked"	P78562	X	22032441-22251310	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Biomineralization	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 8.3;lung: 6.7"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 5.6;HUVEC TERT2: 4.3;PC-3: 4.7;TIME: 4.8;U-87 MG: 10.3;WM-115: 4.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	37	"plasmacytoid DC: 8.3"	"Lineage enriched"	"Detected in single"	37	"dendritic cells: 8.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"														"unprognostic (2.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-8)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-1)"	"prognostic favourable (2.51e-4)"	"unprognostic (7.68e-2)"	0.3	0.0	1.8	1.9	1.1	0.0	1.7	0.9	1.1	0.8	0.9	0.8	0.3	1.2	5.0	0.3	0.4	0.1	2.0	0.3	1.5	1.8	0.3	0.3	6.7	3.4	2.0	0.3	3.9	0.3	0.0	0.3	0.3	5.0	1.3	0.0	0.3	2.8	0.9	0.3	0.1	1.4	3.9	3.8	3.4	0.0	0.3	0.3	1.3	4.8	0.3	4.3	0.5	0.6	0.1	8.3	0.0	0.0	0.0	0.2	0.0	0.3	0.8	0.2	0.1	0.1	0.4	0.0	0.0	0.1	0.1	0.3	1.3	0.1	0.1	1.3	0.1	0.1	0.0	5.6	0.3	0.0	0.1	0.1	0.5	0.0	0.1	0.1	0.2	2.2	1.1	1.1	3.3	4.3	0.0	0.4	0.5	0.0	0.0	0.2	0.0	4.7	0.0	1.0	0.0	0.6	0.2	0.1	0.2	0.4	2.4	0.8	2.8	0.0	4.8	1.0	0.1	0.6	0.8	0.0	0.0	0.0	10.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	1.8	1.1	0.9	1.1	1.5	1.8	2.0	0.3	5.0	0.3
PHF8	"JHDM1F, KDM7B, KIAA1111, ZNF422"	ENSG00000172943	"PHD finger protein 8"	Q9UPP1	X	53936676-54048958	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038779, HPA062015"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA038779: AB_10675950, HPA062015: "	"unprognostic (6.35e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.85e-2)"	"prognostic favourable (3.74e-5)"	8.8	6.8	8.2	11.5	9.4	10.7	11.1	12.5	9.2	10.3	8.2	12.9	27.4	7.9	12.2	54.0	10.7	11.1	9.8	7.8	7.2	5.4	8.8	21.7	10.5	11.2	11.3	7.0	16.8	14.1	10.6	14.6	9.8	9.4	12.8	7.5	10.3	10.3	14.7	8.4	9.6	11.1	8.9	8.5	11.8	9.7	30.6	10.4	19.6	11.1	8.1	13.0	12.8	16.1	6.2	5.1	10.7	7.9	5.4	9.5	5.1	8.8	7.7	11.7	11.3	7.3	5.7	19.2	6.7	5.9	7.5	6.7	8.7	7.2	13.0	4.0	6.0	9.3	29.0	5.8	8.0	20.2	13.8	7.8	9.9	8.7	5.7	12.1	14.7	6.4	8.1	8.6	11.8	6.9	10.3	19.0	4.3	8.8	16.5	9.3	21.2	11.6	16.3	13.0	12.7	5.1	10.7	17.1	8.4	17.8	11.9	5.9	11.8	8.5	7.9	6.0	8.5	11.0	5.5	14.5	13.3	15.7	7.0	15.4	6.4	10.7	4.5	7.2	6.2	7.9	9.5	4.3	6.2	7.1	5.1	6.2	4.6	5.0	7.7	5.4	5.2	4.0	9.2	5.1	8.2	9.4	12.5	9.2	7.2	5.4	11.3	7.0	9.4	10.4
PHGDH	"PDG, PGDH, SERA"	ENSG00000092621	"Phosphoglycerate dehydrogenase"	O43175	1	119648411-119744226	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 16.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB003681, HPA021241, HPA024031, CAB068216"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		9000000	9000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB003681: AB_425928, CAB068216: , HPA021241: AB_1855299, HPA024031: AB_1855300"	"unprognostic (2.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.80e-2)"	"prognostic unfavourable (1.48e-4)"	"prognostic favourable (1.62e-4)"	"unprognostic (9.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-3)"	18.8	1.9	33.3	4.4	32.1	4.4	13.8	7.8	27.2	11.9	5.8	49.7	9.4	4.2	6.1	41.0	16.7	24.5	3.9	5.3	26.7	20.5	14.0	53.2	4.3	5.7	42.0	20.7	17.3	58.2	67.5	5.7	6.4	23.3	24.5	4.7	8.7	62.9	16.4	1.7	35.9	3.0	8.1	28.3	1.9	9.0	8.6	38.1	9.9	15.8	7.3	7.3	7.9	14.1	6.7	3.2	2.9	0.7	1.2	16.5	3.2	13.5	5.5	14.5	34.9	8.3	11.0	27.1	12.3	22.2	17.6	29.2	28.7	2.4	0.0	5.3	32.9	18.3	26.9	25.6	12.4	0.1	24.5	4.3	19.5	19.8	17.3	27.4	0.1	15.8	42.8	16.8	20.0	12.6	7.8	32.5	7.7	53.3	18.3	8.4	36.3	42.3	16.1	25.2	2.3	1.1	16.2	15.7	14.3	9.0	6.0	98.9	12.2	46.8	0.1	2.9	15.3	17.9	13.7	26.8	6.7	27.4	35.6	38.3	22.6	2.9	0.7	0.2	2.9	0.2	0.2	6.7	1.8	4.9	3.2	2.7	9.1	16.5	2.0	1.2	0.2	1.8	2.4	3.2	33.3	32.1	7.8	27.2	26.7	20.5	42.0	20.7	23.3	38.1
PHKG2		ENSG00000156873	"Phosphorylase kinase catalytic subunit gamma 2"	P15735	16	30748270-30761176	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 44.5;testis: 95.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065618, HPA068751"			Supported	Cytosol				Cytosol		"HPA065618: AB_2685520, HPA068751: AB_2686025"	"unprognostic (7.63e-3)"	"prognostic favourable (7.90e-4)"	"prognostic unfavourable (9.92e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.81e-2)"	"unprognostic (3.72e-2)"	"prognostic favourable (1.90e-4)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-2)"	"prognostic favourable (8.02e-4)"	"unprognostic (6.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	4.3	8.3	8.7	6.9	8.0	15.9	5.8	9.1	12.0	4.7	7.9	7.3	9.0	6.8	5.6	7.8	5.3	6.8	7.2	6.4	9.0	9.3	8.2	11.0	5.8	6.8	8.6	9.2	4.7	5.1	17.3	8.5	6.3	11.8	7.7	7.6	6.4	7.0	9.9	6.4	8.4	7.3	6.3	5.8	6.9	7.2	95.4	7.3	5.5	8.6	5.5	7.7	5.2	4.7	8.8	21.2	44.5	22.7	23.5	16.8	17.6	13.5	8.9	7.5	9.2	7.1	5.7	16.9	9.5	14.3	13.0	14.9	7.7	6.8	11.7	11.3	9.8	13.0	7.8	12.1	10.5	6.3	21.7	6.4	14.8	21.6	10.9	9.9	9.2	7.7	6.6	12.5	5.9	13.2	8.7	6.8	9.4	31.2	11.7	14.6	10.3	10.4	15.8	11.7	15.6	14.9	15.3	10.1	7.0	7.7	21.5	9.1	16.9	8.6	7.8	8.0	8.9	10.0	8.7	13.8	7.5	8.0	15.9	19.4	6.5	14.0	22.7	44.5	16.2	22.4	13.3	8.8	11.6	16.4	21.2	8.5	10.4	12.1	18.2	23.5	15.9	18.2	16.8	17.6	8.7	8.0	9.1	12.0	9.0	9.3	8.6	9.2	11.8	7.3
PHYH	"PAHX, PHYH1, RD"	ENSG00000107537	"Phytanoyl-CoA 2-hydroxylase"	O14832	10	13277796-13302412	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cataract, Deafness, Disease mutation, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 128.3;skeletal muscle: 83.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 42.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007598, HPA011796"	Enhanced									"HPA007598: AB_1855334, HPA011796: AB_1855335"	"unprognostic (5.78e-2)"	"unprognostic (3.83e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.09e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.24e-1)"	"prognostic favourable (7.28e-12)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.19e-1)"	10.5	16.8	5.3	5.3	6.2	1.4	7.7	5.1	8.7	6.0	10.7	5.4	5.7	11.4	5.4	5.6	6.8	3.6	8.5	38.0	4.0	4.9	36.4	128.3	6.4	3.2	6.5	3.7	7.6	9.9	6.8	6.7	4.5	5.3	6.2	7.4	7.1	6.3	5.4	83.8	3.8	15.5	10.2	4.4	3.0	8.5	4.1	4.1	1.9	13.0	29.5	3.6	7.6	9.4	9.2	13.3	10.7	16.0	3.3	15.4	10.2	6.1	12.8	5.8	8.3	42.1	26.9	4.6	6.3	8.8	7.2	7.2	3.3	11.2	0.3	4.9	10.5	2.9	7.5	7.4	4.5	14.8	4.0	5.3	3.6	13.0	20.9	0.9	10.0	19.1	10.7	7.8	3.1	6.9	3.0	11.9	16.7	5.7	3.2	4.2	5.3	4.7	5.7	9.0	2.0	15.0	7.9	2.0	6.3	23.6	0.5	11.5	24.0	15.9	2.3	11.1	4.1	13.6	4.2	13.7	9.2	1.2	14.4	6.8	4.3	10.7	16.0	6.5	7.2	11.7	15.4	9.2	9.1	9.2	13.3	4.9	11.5	11.7	0.6	3.3	9.0	12.2	8.6	10.2	5.3	6.2	5.1	8.7	4.0	4.9	6.5	3.7	5.3	4.1
PHYKPL	"AGXT2L2, MGC15875"	ENSG00000175309	"5-phosphohydroxy-L-lysine phospho-lyase"	Q8IUZ5	5	178208497-178232791	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036461, HPA063608"	Approved		Approved	Mitochondria		190000	190000	Mitochondria		"HPA036461: AB_10670717, HPA063608: "	"unprognostic (3.29e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.02e-3)"	"prognostic unfavourable (3.82e-5)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.41e-3)"	18.7	13.1	10.5	25.0	10.8	9.8	15.5	8.3	10.9	13.9	24.3	13.4	14.4	15.1	13.5	14.9	10.7	13.6	17.5	15.5	8.9	4.9	18.1	44.4	14.7	16.8	13.7	9.3	13.2	18.0	11.9	11.9	11.8	10.2	12.4	23.9	12.1	12.3	13.7	20.2	7.6	29.8	14.1	10.7	20.2	15.3	16.4	11.7	16.3	16.6	10.5	17.4	14.0	11.8	13.9	32.8	16.7	21.7	10.7	14.0	14.3	5.7	2.4	5.7	2.3	14.4	11.4	8.6	3.6	4.0	4.8	7.7	6.1	7.3	7.5	10.9	11.0	3.7	4.9	9.2	5.6	15.3	4.9	9.6	9.6	4.3	23.4	5.4	6.1	13.1	9.7	6.0	14.8	16.0	6.9	17.3	7.2	8.4	7.5	2.8	1.1	7.9	5.0	2.7	15.0	8.8	5.2	3.5	3.3	5.7	3.3	6.0	3.6	4.4	6.4	5.0	4.6	3.2	3.8	11.1	3.0	4.5	1.4	5.8	3.3	6.3	19.5	16.7	10.0	21.7	10.1	13.9	11.3	11.4	25.2	12.6	14.0	11.3	4.4	10.7	21.3	32.8	12.9	14.3	10.5	10.8	8.3	10.9	8.9	4.9	13.7	9.3	10.2	11.7
PI4KA	"PI4K-ALPHA, pi4K230, PIK4CA"	ENSG00000241973	"Phosphatidylinositol 4-kinase alpha"	P42356	22	20707691-20859417	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.0"	"Cell line enhanced"	"Detected in all"		"K-562: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009092, HPA075515"	Approved		Approved	"Nucleoplasm,Plasma membrane"		18000	18000	Nucleoplasm	"Plasma membrane"	"CAB009092: AB_2164033, HPA075515: "	"unprognostic (8.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.01e-3)"	"unprognostic (3.19e-2)"	"prognostic favourable (5.24e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (7.22e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.50e-1)"	7.7	9.2	28.8	10.5	34.2	12.5	6.5	14.1	48.0	9.7	8.8	10.1	4.9	9.1	9.7	6.1	8.3	8.4	8.0	8.5	30.4	19.2	9.0	12.6	9.0	11.2	19.0	25.9	10.2	8.6	25.6	12.5	10.4	19.3	9.8	8.9	10.8	6.8	10.6	7.1	6.6	10.0	13.2	6.8	10.2	9.9	13.1	8.2	17.9	9.9	2.9	10.2	8.4	4.8	5.0	12.5	7.6	5.5	9.1	7.7	2.9	9.7	8.2	7.3	10.9	20.8	12.6	10.4	8.9	13.5	13.1	12.8	6.4	4.2	18.4	5.3	17.8	8.6	13.8	8.5	8.0	15.6	21.2	18.9	11.2	7.3	10.4	18.7	15.2	11.2	5.4	11.1	6.2	10.6	51.5	15.6	10.1	13.5	16.3	6.4	5.7	8.5	16.4	15.9	3.4	7.3	15.6	17.9	13.1	11.6	13.5	9.2	11.4	8.6	10.7	23.9	12.4	8.8	7.4	12.0	12.2	14.6	15.8	13.5	9.9	3.1	5.5	7.3	5.1	5.4	4.9	4.6	5.6	6.1	3.6	5.0	5.7	7.7	7.6	9.1	4.6	12.5	5.8	2.9	28.8	34.2	14.1	48.0	30.4	19.2	19.0	25.9	19.3	8.2
PIEZO1	"FAM38A, KIAA0233"	ENSG00000103335	"Piezo type mechanosensitive ion channel component 1"	Q92508	16	88715338-88785220	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047185	Uncertain									"HPA047185: "	"unprognostic (1.76e-1)"	"prognostic unfavourable (2.37e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.64e-2)"	"prognostic unfavourable (2.36e-5)"	"unprognostic (4.39e-2)"	"prognostic unfavourable (3.78e-4)"	"unprognostic (3.51e-2)"	"unprognostic (3.05e-2)"	"prognostic unfavourable (8.89e-7)"	"unprognostic (2.04e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.74e-1)"	34.6	7.3	5.7	19.2	9.8	24.2	59.0	5.7	6.5	13.8	25.2	7.4	20.3	7.5	13.6	8.2	16.5	12.4	15.4	7.2	6.7	4.3	15.8	18.1	21.2	14.7	10.3	2.5	9.1	6.9	7.0	2.1	17.8	9.1	15.9	4.9	11.9	15.7	16.7	4.2	15.4	12.9	29.2	8.9	18.6	13.2	3.0	7.5	6.7	10.5	9.9	13.3	17.8	39.3	2.5	9.4	3.1	11.6	0.9	8.5	3.6	10.3	10.7	1.6	8.0	7.3	8.0	40.4	25.4	11.4	9.4	3.6	15.4	17.5	8.6	17.8	12.2	22.5	3.5	9.1	1.9	8.3	14.3	14.5	18.5	12.1	11.1	6.5	2.4	6.5	5.0	7.3	6.1	11.3	19.6	11.0	5.4	67.2	8.0	22.7	3.8	6.6	19.3	2.4	21.5	4.2	15.4	3.3	0.9	33.2	17.6	4.4	23.9	19.2	30.5	22.6	13.1	15.1	12.8	2.2	5.0	5.2	17.8	11.7	13.3	1.7	5.1	3.1	8.5	9.3	7.9	2.5	6.1	5.5	9.4	2.5	1.0	2.7	0.1	0.9	11.6	1.7	4.7	3.6	5.7	9.8	5.7	6.5	6.7	4.3	10.3	2.5	9.1	7.5
PIEZO2	"C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771"	ENSG00000154864	"Piezo type mechanosensitive ion channel component 2"	Q9H5I5	18	10666483-11148762	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.4;BJ hTERT+ SV40 Large T+: 10.5;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HeLa: 23.4;U-266/70: 14.9;U-698: 9.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"							"HPA015986, HPA031974, HPA031975, HPA040616"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA015986: AB_1848395, HPA031974: AB_10603675, HPA031975: , HPA040616: "	"unprognostic (1.36e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.34e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (9.57e-7)"	"unprognostic (1.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.83e-2)"	0.9	0.3	3.1	0.9	2.3	0.0	1.9	0.1	3.6	0.9	3.3			0.0	0.3	1.6	5.8	0.8	5.9	0.0	5.2	2.1	0.9	4.5	7.4	0.5	5.8		0.6	1.7	0.0	0.6	0.0		3.4	1.3		0.0	3.3	0.0	0.8	0.9	1.9	10.3	2.7	1.4	0.9			1.3		0.2	4.6	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.1	9.4	0.0	0.0	0.0	0.0	0.5	2.7	10.5	14.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	6.7	0.0	0.3	0.0	23.4	5.5	3.3	0.0	0.0	0.0	0.1	2.7	0.7	3.2	0.0	0.2	1.6	0.0	0.1	0.0	2.9	0.0	0.0	0.0	4.1	0.0	3.2	8.1	0.0	0.1	0.0	0.5	0.0	2.7	0.0	0.0	3.8	0.2	0.5	14.9	0.1	9.7	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PIGA	GPI3	ENSG00000165195	"Phosphatidylinositol glycan anchor biosynthesis class A"	P37287	X	15319451-15335580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001174	Approved									"HPA001174: "	"unprognostic (1.15e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.93e-3)"	"prognostic unfavourable (7.64e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.97e-3)"	"unprognostic (2.24e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-2)"	6.9	6.1	6.8	5.0	8.6	16.1	7.0	7.6	10.0	6.0	6.8	9.6	5.8	3.5	6.2	7.5	9.9	5.6	7.8	6.2	8.0	5.4	7.5	11.0	14.4	5.9	9.6	6.4	7.0	9.9	8.5	5.2	10.8	16.7	5.9	7.5	7.0	11.5	9.1	4.2	10.9	4.8	5.2	10.2	5.7	7.2	5.3	9.4	4.7	8.6	8.5	8.7	11.6	6.6	2.9	3.9	16.7	7.6	1.5	4.4	2.4	12.4	7.7	8.0	4.1	2.4	2.4	6.6	3.2	5.2	7.2	6.9	8.4	5.5	5.8	2.7	2.6	4.9	13.3	10.8	11.8	5.2	9.1	5.0	9.5	4.9	4.1	7.1	2.6	3.4	7.3	9.3	14.8	4.5	5.4	6.3	4.3	7.8	7.9	2.6	4.2	8.6	2.8	11.5	9.2	5.1	8.4	5.6	8.6	6.5	5.9	12.6	6.0	6.2	3.8	5.4	2.2	11.9	6.5	4.8	6.1	9.0	8.3	5.0	6.8	16.7	3.6	3.9	2.7	6.0	3.8	2.9	4.4	2.7	3.9	2.2	4.0	3.1	5.2	1.5	7.6	2.5	3.8	2.4	6.8	8.6	7.6	10.0	8.0	5.4	9.6	6.4	16.7	9.4
PIGL		ENSG00000108474	"Phosphatidylinositol glycan anchor biosynthesis class L"	Q9Y2B2	17	16217191-16351797	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"GPI-anchor biosynthesis"	Hydrolase	"Deafness, Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA012739	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"		"HPA012739: AB_1855367"	"unprognostic (3.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.39e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavourable (2.57e-4)"	"prognostic unfavourable (1.47e-4)"	"unprognostic (3.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.75e-3)"	17.3	12.6	11.1	14.3	18.8	8.6	18.0	14.6	15.6	12.9	13.0	17.6	12.8	17.1	19.8	20.2	12.6	13.1	12.7	8.8	8.5	7.5	11.2	18.5	12.5	12.0	14.5	10.7	16.5	16.5	11.9	18.1	10.3	13.6	14.0	14.4	15.5	14.8	16.3	13.4	20.0	15.8	10.1	9.7	12.3	14.8	11.1	13.6	13.7	15.7	11.1	20.4	10.9	12.3	5.2	7.4	5.5	3.7	5.4	9.3	3.3	8.2	11.8	8.0	6.6	11.5	10.8	3.3	4.6	5.5	7.7	13.8	12.0	10.6	4.0	9.4	4.4	12.1	9.8	5.8	11.1	8.6	25.7	8.0	8.2	14.3	12.3	3.4	5.2	9.1	15.2	13.5	15.4	8.8	9.5	5.1	6.1	8.2	6.2	8.0	3.1	6.1	6.1	6.7	11.6	8.7	4.5	4.2	6.0	4.8	3.4	9.4	3.7	3.1	5.7	7.0	4.3	4.6	13.0	3.6	0.1	6.5	8.8	8.5	4.4	0.0	3.7	5.5	6.5	3.2	5.6	5.2	8.5	5.0	2.7	4.4	9.3	7.5	0.0	5.4	2.4	7.4	6.7	3.3	11.1	18.8	14.6	15.6	8.5	7.5	14.5	10.7	13.6	13.6
PIGP	"DCRC, DSCR5, DSRC"	ENSG00000185808	"Phosphatidylinositol glycan anchor biosynthesis class P"	P57054	21	37059170-37073170	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026921	Uncertain		Approved	Vesicles				Vesicles		"HPA026921: AB_1847874"	"unprognostic (4.47e-3)"	"unprognostic (9.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.55e-2)"	20.0	30.3	12.3	7.9	13.4	4.2	18.0	6.9	14.3	13.1	13.8	15.6	23.1	9.9	11.7	60.6	12.5	13.9	15.2	27.8	12.3	15.2	19.0	27.4	14.7	9.9	16.1	9.8	15.0	45.4	23.9	28.9	16.2	17.9	21.3	14.3	16.6	22.2	17.4	25.0	7.0	12.8	24.0	24.8	10.1	14.8	19.3	8.4	16.3	20.3	17.3	9.9	17.2	9.2	18.2	16.7	1.7	11.1	8.7	19.3	8.7	9.5	4.5	9.6	5.8	17.3	11.4	6.4	7.7	14.3	7.0	7.9	6.0	20.2	13.1	17.3	11.6	7.7	7.9	8.8	7.4	13.6	13.8	29.8	5.7	8.3	10.5	8.8	6.5	10.3	16.6	12.6	15.8	12.0	17.7	23.5	15.4	6.3	11.7	9.7	7.3	11.1	11.4	4.9	13.8	17.6	5.3	19.7	11.8	21.8	16.4	29.2	14.0	19.3	6.2	5.2	2.5	6.0	7.0	31.3	34.0	15.0	15.0	11.3	17.0	0.2	7.1	1.7	11.3	10.4	14.0	18.2	14.5	12.1	11.1	15.3	19.3	16.7	1.0	8.7	11.1	16.7	10.7	8.7	12.3	13.4	6.9	14.3	12.3	15.2	16.1	9.8	17.9	8.4
PIKFYVE	"FAB1, KIAA0981, MGC40423, p235, PIKfyve, PIP5K, PIP5K3, ZFYVE29"	ENSG00000115020	"Phosphoinositide kinase, FYVE-type zinc finger containing"	Q9Y2I7	2	208266267-208358751	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042558, HPA042604"	Uncertain		Supported	Vesicles				Vesicles		"HPA042558: , HPA042604: AB_10796580"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.04e-2)"	"prognostic favourable (6.81e-4)"	"unprognostic (6.82e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"	15.9	13.5	17.7	21.1	21.9	36.1	24.9	25.6	23.1	14.8	12.1	14.0	16.6	9.1	14.7	18.3	11.2	12.6	11.1	12.5	19.4	14.3	16.2	15.2	16.5	23.1	14.4	15.3	15.6	31.5	21.5	17.0	14.1	20.6	17.7	11.5	13.8	13.7	19.7	13.6	12.9	15.3	13.5	24.4	21.7	12.1	19.3	15.8	23.5	18.2	7.8	22.6	12.4	14.0	7.5	2.1	1.4	1.2	5.6	2.6	0.5	5.0	5.0	12.0	9.3	12.1	14.5	5.6	6.2	12.6	7.3	10.0	7.2	4.2	5.8	6.5	10.6	5.2	10.4	6.9	12.5	4.9	6.6	20.8	9.9	6.4	9.2	18.3	18.8	10.8	7.6	8.5	16.0	11.8	14.0	10.5	9.1	2.1	16.6	13.8	9.9	3.8	6.2	9.3	7.9	9.4	7.3	3.8	9.1	6.8	4.4	12.3	2.8	19.8	13.5	9.2	6.1	6.1	5.7	7.4	8.7	12.4	7.3	16.0	9.0	1.4	1.0	0.7	1.7	0.8	1.1	7.5	2.3	2.6	0.9	5.4	1.8	2.1	1.4	5.6	1.2	2.1	1.5	0.5	17.7	21.9	25.6	23.1	19.4	14.3	14.4	15.3	20.6	15.8
PINK1	PARK6	ENSG00000158828	"PTEN induced putative kinase 1"	Q9BXM7	1	20633455-20651511	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 142.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 10.7;monocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001931, CAB026191"	Uncertain									"CAB026191: , HPA001931: AB_1079620"	"unprognostic (3.73e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (1.11e-16)"	"unprognostic (2.68e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.08e-1)"	17.9	35.9	38.9	6.7	38.0	6.0	10.1	16.8	45.0	9.8	13.0	17.8	10.0	15.2	9.3	9.8	20.7	10.7	11.4	51.4	31.0	28.7	20.2	26.1	10.0	5.1	39.5	27.1	11.6	24.3	16.3	7.1	13.9	31.0	12.4	7.7	10.6	23.9	15.4	142.0	10.8	12.7	10.8	30.2	8.3	10.5	27.2	16.8	3.3	16.0	21.5	4.6	12.7	9.5	1.2	1.4	10.7	4.4	0.7	1.7	0.8	17.9	8.2	3.8	11.0	13.4	12.7	4.0	25.2	25.4	12.3	21.4	2.8	14.6	4.2	20.0	25.7	8.3	5.6	13.4	6.1	5.0	21.2	2.1	22.9	4.4	10.4	2.2	6.7	11.9	14.5	15.3	5.3	7.9	5.1	5.4	8.8	7.6	3.2	5.1	1.7	27.0	2.8	6.8	3.3	7.6	4.2	14.3	5.6	27.5	9.1	7.6	3.0	7.8	12.0	11.1	5.7	18.5	3.5	6.3	1.2	1.9	24.1	6.5	5.2	4.8	2.2	4.7	1.1	1.4	1.4	0.3	1.0	1.5	0.7	1.2	0.8	1.1	10.7	0.7	4.4	1.4	1.7	0.8	38.9	38.0	16.8	45.0	31.0	28.7	39.5	27.1	31.0	16.8
PIP5K1C	"KIAA0589, LCCS3, PIP5Kgamma"	ENSG00000186111	"Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma"	O60331	19	3630183-3700479	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017168	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA017168: AB_1855395"	"unprognostic (1.20e-1)"	"prognostic favourable (1.79e-4)"	"unprognostic (1.36e-3)"	"prognostic favourable (7.28e-5)"	"unprognostic (7.03e-2)"	"unprognostic (4.02e-3)"	"unprognostic (5.80e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.57e-3)"	"prognostic favourable (2.32e-4)"	"unprognostic (1.51e-1)"	"prognostic favourable (3.00e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	16.1	10.2	20.5	12.8	25.8	4.5	8.0	58.6	46.3	10.7	23.5	8.5	14.8	10.9	19.8	10.0	12.3	12.8	12.7	13.8	22.8	10.7	7.5	3.8	11.5	7.5	11.3	17.1	11.5	17.2	10.0	9.2	13.7	19.0	16.7	6.4	16.9	20.0	33.4	13.5	10.2	11.5	19.2	6.3	15.8	13.6	23.9	8.7	5.3	9.3	3.9	6.0	17.3	19.0	2.5	3.2	3.6	3.0	1.7	2.8	2.0	9.0	8.6	6.8	8.8	13.3	10.8	10.2	17.5	11.1	7.5	6.1	7.6	2.6	3.8	6.7	18.8	8.1	3.2	5.6	3.1	13.5	5.7	4.4	7.1	6.2	11.0	4.4	13.5	12.0	5.4	6.1	2.3	12.8	6.6	7.1	7.1	7.5	5.3	3.3	7.0	12.0	10.0	5.2	5.2	5.6	7.8	6.8	5.9	9.1	4.9	5.3	3.9	6.6	28.0	10.6	6.0	37.3	8.1	8.2	6.5	1.7	14.3	9.3	7.6	3.6	2.8	0.0	2.8	2.6	1.2	2.5	2.1	2.0	3.2	1.3	1.0	1.6	2.2	1.7	3.0	2.2	1.4	2.0	20.5	25.8	58.6	46.3	22.8	10.7	11.3	17.1	19.0	8.7
PJVK	DFNB59	ENSG00000204311	Pejvakin	Q0ZLH3	2	178451346-178461409	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 6.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042621			Supported	Mitochondria				Mitochondria		"HPA042621: AB_10797503"	"unprognostic (4.01e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavourable (8.92e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.06e-3)"	2.2	1.4	2.5	1.0	3.5	0.7	4.4	1.3	3.7	2.1	1.5	1.2	3.5	0.7	3.5	7.2	2.2	2.6	2.6	1.0	2.7	2.2	2.1	2.2	1.0	1.3	2.8	4.4	7.0	1.0	1.4	3.9	1.0	2.0	2.3	0.9	2.4	2.1	2.7	2.7	3.5	1.3	1.7	2.7	1.0	0.9	35.2	1.3	1.0	2.3	1.7	1.2	1.6	1.2	1.5	6.5	0.6	0.3	0.4	1.3	0.1	0.4	3.1	4.0	3.2	5.4	5.9	2.1	2.5	2.5	2.3	3.5	1.2	5.2	3.6	2.6	1.5	1.5	2.9	1.6	1.5	1.1	1.1	1.1	4.3	0.7	5.2	0.9	0.3	5.5	3.9	2.6	5.6	2.6	0.6	2.2	2.6	0.5	3.4	2.2	4.8	1.3	4.4	3.0	2.1	3.6	1.6	2.8	2.4	1.2	0.6	1.0	1.2	1.0	1.7	2.6	1.0	0.8	0.3	7.3	4.5	1.1	1.2	2.0	1.0	0.0	0.3	0.0	0.3	0.2	0.4	0.8	0.4	0.2	0.1	1.5	1.3	0.7	0.6	0.4	0.0	6.5	0.0	0.1	2.5	3.5	1.3	3.7	2.7	2.2	2.8	4.4	2.0	1.3
PKD1	"PBP, Pc-1, TRPP1"	ENSG00000008710	"Polycystin 1, transient receptor potential channel interacting"	P98161	16	2088710-2135898	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB046448	Approved					120000	120000			"CAB046448: AB_2163360"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (7.43e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-1)"	"prognostic favourable (3.35e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-2)"	"prognostic favourable (3.38e-5)"	"unprognostic (7.86e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	4.5	4.6	2.6	2.3	3.6	1.5	1.4	45.3	7.9	2.8	5.1			1.8	5.4	0.7	2.6	3.4	1.8	7.1	3.5	4.2	0.7	0.6	2.2	1.3	1.9		6.8	3.3	1.2	11.3	1.7		3.7	0.4		4.3	5.4	18.0	7.8	2.8	3.3	1.5	2.7	2.6	2.2			1.0		0.3	3.1	1.8	0.1	0.1	0.0	0.1	0.0	0.4	0.7	3.0	6.5	3.6	8.2	6.3	6.8	7.1	10.5	4.4	3.0	3.1	5.8	2.3	4.6	6.7	5.4	7.7	1.0	1.6	1.1	5.3	5.2	2.8	16.6	2.3	12.5	3.9	5.9	6.3	5.3	5.7	3.5	2.3	4.0	4.6	1.9	4.9	5.5	11.8	3.2	4.9	15.6	5.9	6.8	1.5	2.1	15.1	16.9	9.5	6.4	6.5	5.2	13.3	5.4	9.7	7.9	7.2	7.6	6.8	3.0	5.1	5.4	3.6	6.1	0.0	0.1	0.0	0.4	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.7										
PKD1L1	PRO19563	ENSG00000158683	"Polycystin 1 like 1, transient receptor potential channel interacting"	Q8TDX9	7	47774652-47948491	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lung: 13.4;tongue: 16.7"	"Group enriched"	"Detected in some"	8	"T-47d: 6.3;U-266/70: 16.7;U-266/84: 6.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA020422, HPA022424"	Uncertain									"HPA020422: AB_1855434, HPA022424: AB_1855435"	"unprognostic (5.47e-2)"	"unprognostic (5.33e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-1)"	5.4	0.2	1.0	2.3	1.8	0.2	1.6	1.3	1.1	1.2	0.8	0.7	0.1	2.0	2.5	1.6	0.9	0.6	1.0	7.4	0.8	1.5	0.5	1.1	13.4	1.2	0.9	0.1	0.6	0.3	0.1	1.2	2.0	1.0	0.3	0.9	10.0	2.6	0.1	6.4	0.7	0.7	1.7	1.0	0.8	0.4	3.8	0.1	0.9	1.2	16.7	1.4	2.2	1.4	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.2	0.0	0.1	0.3	6.3	0.0	0.0	0.0	0.9	0.0	0.0	16.7	6.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.8	1.3	1.1	0.8	1.5	0.9	0.1	1.0	0.1
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007668-88077777	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 36.5;BJ hTERT+: 55.4;fHDF/TERT166: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794"	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB004544: AB_672377, HPA015794: AB_1855437"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.51e-1)"	18.4	13.6	8.2	7.7	10.9	5.0	15.1	15.1	10.7	31.4	19.4	15.5	18.5	5.6	42.7	9.8	13.9	25.7	15.3	12.8	9.0	5.2	27.5	7.9	13.4	5.5	12.6	6.4	27.0	9.8	21.9	8.1	12.8	9.2	15.6	7.3	14.1	7.4	22.3	5.4	6.2	9.6	29.3	7.2	5.4	14.8	9.9	12.0	5.5	10.2	3.3	4.9	13.9	21.4	0.5	1.3	4.8	0.8	1.0	1.4	0.4	1.9	10.8	12.2	6.2	28.2	18.9	3.6	36.5	55.4	17.1	17.1	0.5	3.4	1.0	8.0	43.9	2.4	2.1	5.4	15.0	5.5	1.9	1.7	5.5	1.1	15.7	4.1	3.5	15.6	2.4	13.4	7.2	7.7	0.2	2.9	14.9	3.7	2.9	2.0	6.3	1.8	5.6	7.2	1.5	15.2	4.5	2.4	5.5	6.7	0.3	8.6	2.6	3.1	11.8	16.2	3.5	4.5	4.9	2.3	0.7	1.1	9.6	0.6	14.8	4.8	0.5	0.9	0.8	0.8	1.4	0.5	0.8	0.6	0.3	0.5	0.9	0.6	0.9	1.0	0.3	1.3	0.4	0.4	8.2	10.9	15.1	10.7	9.0	5.2	12.6	6.4	9.2	12.0
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301434	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.2;kidney: 12.4;liver: 47.8"	"Cell line enriched"	"Detected in some"	9	"K-562: 47.4"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.7"	"Low region specificity"	"Detected in some"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	"Golgi apparatus,Cytosol"		2900000	2900000	"Golgi apparatus, Cytosol"		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: "	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.1	0.0	0.1	0.3	0.1	7.2	0.1	0.9	0.2	0.1	4.9	0.1	0.1	5.8	0.1	1.3	0.1	0.0	0.7	0.1	0.1	0.4	12.4	47.8	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	17.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1
PLA2G5		ENSG00000127472	"Phospholipase A2 group V"	P39877	1	20028179-20091190	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 48.3;retina: 58.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;HaCaT: 1.0;hTEC/SVTERT24-B: 1.5;U-138 MG: 3.1;U-2197: 6.6"	"Group enriched"	"Detected in many"	5	"glioma: 13.0;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053361	Approved				"Secreted - unknown location"					"HPA053361: "	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-3)"	"unprognostic (6.00e-5)"	"unprognostic (2.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.97e-3)"	2.6	0.5	2.8	2.0	6.7	0.2	1.9	1.9	5.2	0.3	10.5	2.1	2.5	1.2	0.5	2.1	5.7	1.9	3.0	48.3	2.6	2.4	0.2	1.8	3.2	1.0	6.1	2.0	17.3	1.2	0.2	0.1	8.3	6.8	6.9	3.2	58.3	1.0	10.3	0.4	0.4	1.0	19.3	1.0	0.8	2.3	3.3	1.3	0.0	0.7	0.0	1.7	7.3	2.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	3.1	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.8	6.7	1.9	5.2	2.6	2.4	6.1	2.0	6.8	1.3
PLA2G7	"LDL-PLA2, PAFAH"	ENSG00000146070	"Phospholipase A2 group VII"	Q13093	6	46704201-46735693	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Asthma, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 57.0;lymphoid tissue: 32.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.8;PC-3: 7.7;RT4: 3.5;U-2 OS: 3.7"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 37.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 24.2"	"Group enriched"	"Detected in many"	56	"dendritic cells: 7.9;monocytes: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	170000000	170000000				"unprognostic (3.63e-3)"	"unprognostic (2.82e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.26e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.08e-2)"	57.0	2.1	2.8	14.0	5.8	1.1	2.9	2.0	2.7	1.5	4.4	2.0	0.4	2.3	2.9	1.6	0.8	1.4	3.6	2.0	2.1	1.7	1.0	4.3	19.0	22.2	3.2	1.8	4.0	0.9	0.1	3.1	15.8	2.3	8.5	6.6	2.8	2.5	1.6	0.9	2.3	3.7	1.5	7.1	32.9	1.4	0.7	2.0	6.4	13.1	0.6	6.0	7.2	0.8	0.1	7.9	0.2	24.2	0.0	0.2	6.1	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	1.5	0.0	0.1	0.0	0.2	1.9	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.3	3.8	7.7	0.0	0.0	0.1	0.0	3.5	0.1	0.5	0.0	0.0	0.0	1.0	1.0	0.0	0.0	3.7	0.1	0.8	0.1	0.0	0.0	0.0	0.2	1.3	0.0	24.2	0.1	0.0	5.0	0.2	0.1	0.0	0.0	7.9	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	6.1	2.8	5.8	2.0	2.7	2.1	1.7	3.2	1.8	2.3	2.0
PLCB1	"KIAA0581, PLC-I, PLC154"	ENSG00000182621	"Phospholipase C beta 1"	Q9NQ66	20	8077251-8968360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 56.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.6;Hep G2: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004275, CAB005334, HPA034743, HPA057910"	Enhanced		Approved	"Plasma membrane"		5400	5400	"Plasma membrane"		"CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: , HPA057910: "	"unprognostic (2.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.12e-1)"	5.6	7.0	13.8	4.4	27.7	3.4	5.9	7.5	31.1	6.5	9.9	2.1	20.6	5.5	8.0	10.3	4.5	7.4	6.6	8.6	15.7	9.1	10.0	3.1	4.0	1.6	9.3	14.5	3.2	10.8	56.7	4.6	14.2	5.5	10.4	3.6	1.3	19.7	22.2	9.8	2.3	4.5	12.3	4.0	2.9	5.5	2.6	8.0	4.1	3.1	1.9	1.1	8.6	6.3	0.5	0.8	2.8	3.3	2.4	5.2	0.4	0.0	0.6	2.3	0.1	4.3	8.1	3.1	9.7	6.4	2.5	1.5	21.6	2.4	1.0	4.1	1.8	0.0	1.7	0.0	1.9	0.0	2.1	0.4	1.6	32.5	1.1	0.5	0.3	0.5	0.4	3.4	0.0	5.1	3.3	12.6	0.0	2.9	0.4	1.5	7.3	3.5	6.9	0.0	5.7	1.9	8.0	8.3	3.6	0.0	2.0	0.4	9.6	3.1	0.9	8.3	3.7	0.6	6.0	9.5	11.0	16.3	4.2	5.9	14.3	0.8	3.3	2.8	3.6	0.7	5.2	0.2	1.0	1.3	0.4	0.5	0.5	1.1	2.1	2.4	0.4	0.8	0.2	0.4	13.8	27.7	7.5	30.8	15.7	9.1	9.3	14.5	5.5	8.0
PLCB4		ENSG00000101333	"Phospholipase C beta 4"	Q15147	20	9068763-9481242	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.9;retina: 40.2;salivary gland: 39.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.0;hTERT-HME1: 18.6;LHCN-M2: 30.6;RPTEC TERT1: 39.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.5"	"Group enriched"	"Detected in all"	4	"cerebellum: 44.9;pons and medulla: 11.9"	"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 6.6"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007951	Approved		Approved	Nucleoplasm,Microtubules				Microtubules	Nucleoplasm	"HPA007951: "	"unprognostic (3.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.19e-2)"	"prognostic favourable (2.11e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.72e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.45e-2)"	5.5	5.0	2.1	4.5	4.6	0.2	5.6	44.9	5.2	6.0	13.1	2.7	2.4	1.6	12.3	16.2	6.9	10.9	6.2	12.4	2.3	6.6	2.3	0.9	4.4	1.0	4.0	3.3	2.9	1.3	0.5	15.1	4.4	11.9	6.9	12.6	40.2	39.8	7.1	2.5	4.3	3.1	12.3	3.1	1.1	9.7	2.1	2.4	4.3	21.9	4.4	2.0	7.1	8.8	0.0	6.6	0.0	0.0	0.3	0.0	0.0	0.0	6.1	3.0	0.0	0.0	0.1	0.0	13.3	3.8	4.0	2.5	1.1	0.9	0.0	0.2	38.0	0.0	0.9	2.9	6.0	0.0	1.8	1.6	2.2	0.0	0.5	0.0	0.0	0.9	1.2	5.1	18.6	0.0	1.5	0.1	30.6	1.9	0.0	0.0	3.2	3.8	0.0	0.0	0.2	39.1	2.8	10.2	7.0	0.0	9.2	5.6	7.8	0.0	0.1	4.3	0.3	0.4	5.2	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.0	0.0	2.1	4.6	44.9	5.2	2.3	6.6	4.0	3.3	11.9	2.4
PLCD1		ENSG00000187091	"Phospholipase C delta 1"	P51178	3	38007496-38029762	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.7;ASC TERT1: 14.0;fHDF/TERT166: 15.4;hTCEpi: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009913, HPA020107, HPA021677"	Approved		Approved	Microtubules				Microtubules		"CAB009913: AB_2163388, HPA020107: AB_1855318, HPA021677: AB_1855319"	"unprognostic (1.75e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.24e-1)"	"prognostic favourable (9.25e-11)"	"unprognostic (1.50e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.88e-2)"	10.9	11.3	11.2	5.6	12.1	5.1	8.0	6.0	11.2	11.6	19.3	15.2	7.3	6.6	9.1	7.6	21.9	8.6	8.5	8.0	13.0	6.9	7.8	5.8	9.4	9.3	10.5	11.4	12.8	6.2	4.7	7.3	6.9	15.9	10.6	12.7	8.3	10.9	12.6	4.5	17.0	6.5	12.3	15.5	6.3	6.5	37.3	8.7	7.7	6.6	21.2	12.2	14.6	23.1	1.0	2.6	8.6	2.4	3.7	13.2	5.4	0.6	1.7	5.6	1.5	15.7	14.0	1.7	1.7	6.7	2.6	4.0	0.6	1.3	0.4	0.9	15.4	9.0	2.9	1.7	0.8	2.5	0.7	0.2	0.9	2.8	9.2	0.0	1.0	11.3	19.2	7.8	1.0	4.9	9.4	0.8	5.7	0.7	1.3	0.6	1.5	1.7	0.5	0.8	2.1	3.1	3.0	0.0	1.6	0.5	7.5	1.8	1.6	0.7	2.8	1.6	4.0	4.1	0.0	3.4	1.3	0.3	4.0	0.0	0.8	8.6	1.9	0.1	10.2	2.4	11.6	1.0	13.2	9.8	2.6	0.5	7.8	6.1	6.9	3.7	1.4	1.5	11.8	5.4	11.2	12.1	6.0	10.7	13.0	6.9	10.5	11.4	15.9	8.7
PLCE1	"KIAA1516, NPHS3, PLCE"	ENSG00000138193	"Phospholipase C epsilon 1"	Q9P212	10	94030812-94332823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 44.6"	"Cell line enhanced"	"Detected in many"		"RT4: 18.7;U-2 OS: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015597, HPA015598"	Enhanced		Supported	Cytosol				Cytosol		"HPA015597: AB_1855321, HPA015598: AB_1855322"	"unprognostic (4.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.30e-2)"	3.2	2.4	4.1	9.1	5.5	0.0	2.2	1.8	7.9	9.2	13.8	3.1	1.6	5.0	11.4	4.6	4.5	4.2	3.8	12.8	4.1	2.6	6.3	0.7	7.2	0.4	2.4	6.8	3.2	12.8	0.1	5.2	3.1	6.4	3.3	12.6	44.6	2.1	7.7	4.3	0.7	4.6	5.8	2.4	5.8	8.7	1.7	2.3	0.0	15.1	7.3	1.1	7.9	5.4	3.2	1.2	0.8	0.9	1.1	2.3	0.5	6.0	8.3	1.8	1.0	1.0	5.9	2.3	3.7	1.0	0.8	1.2	5.4	1.5	0.7	1.9	3.0	2.6	4.2	1.0	1.3	0.4	2.1	0.4	4.6	0.5	0.1	0.8	0.3	2.4	0.0	2.2	0.0	0.0	0.4	0.3	7.2	0.2	0.7	0.8	0.6	8.7	0.1	5.7	0.2	0.2	18.7	0.8	1.5	4.4	6.0	0.5	5.1	0.5	0.6	3.9	11.2	2.3	4.9	0.5	0.2	0.3	3.1	1.0	3.5	0.4	0.5	0.1	1.5	0.9	1.3	2.6	1.6	1.1	0.6	3.2	2.3	1.8	0.8	1.1	0.8	1.2	0.6	0.5	4.1	5.5	1.8	7.9	4.1	2.6	2.4	6.8	6.4	2.3
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962693	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 39.6;HMC-1: 19.0;U-698: 87.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Vesicles		21000	21000	Vesicles		"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favourable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favourable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"	8.4	3.8	3.3	55.8	4.9	14.1	10.7	1.0	2.4	5.6	10.3	5.3	3.1	8.7	11.2	12.2	6.0	4.7	10.1	4.4	3.3	2.8	20.6	8.8	10.7	35.5	5.2	1.8	2.0	3.6	1.0	1.8	4.1	4.5	4.3	3.6	4.6	8.8	2.8	2.0	4.1	17.6	4.6	8.6	33.6	4.2	2.3	4.2	6.3	5.3	2.6	44.6	7.5	7.7	18.8	3.9	26.8	12.2	14.0	1.1	2.3	0.3	0.7	0.1	0.6	0.0	0.0	0.9	0.0	0.0	0.5	0.2	0.2	1.7	39.6	6.8	0.0	0.9	0.8	0.1	0.3	0.3	0.4	4.7	0.0	0.0	0.2	4.7	19.0	0.0	0.4	0.3	0.2	0.9	0.5	3.3	0.0	1.2	0.5	11.9	0.7	0.2	16.1	0.0	5.0	0.1	0.8	0.3	0.0	1.1	0.3	0.3	0.7	14.6	0.2	0.0	0.7	0.1	0.1	7.9	12.9	87.9	0.0	6.5	0.3	2.8	4.4	26.8	0.7	5.7	0.3	18.8	0.2	1.1	3.9	17.3	0.3	0.8	24.8	14.0	12.2	2.6	0.1	2.3	3.3	4.9	1.0	2.4	3.3	2.8	5.2	1.8	4.5	4.2
PLCZ1	"NYD-SP27, PLCzeta"	ENSG00000139151	"Phospholipase C zeta 1"	Q86YW0	12	18683169-18738057	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fertilization, Lipid degradation, Lipid metabolism"	"Developmental protein, Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"testis: 29.5"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 3.7;hTERT-HME1: 1.4;NTERA-2: 2.1;U-2 OS: 1.2;U-251 MG: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"														"unprognostic (1.95e-1)"					"unprognostic (2.79e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-2)"			"unprognostic (1.39e-2)"		"unprognostic (1.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.7	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLD1		ENSG00000075651	"Phospholipase D1"	Q13393	3	171600405-171810950	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 52.1"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 29.9;SK-MEL-30: 16.7;TIME: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004527, HPA042396"	Enhanced									"CAB004527: AB_677324, HPA042396: "	"unprognostic (3.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.82e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (4.76e-6)"	7.0	26.6	5.3	6.1	20.4	4.5	6.3	1.4	10.8	8.6	19.7	31.4	1.8	27.7	6.9	4.9	25.0	4.9	52.1	14.7	7.7	4.7	7.5	20.2	4.4	5.2	25.3	7.2	17.1	13.9	0.9	2.7	6.6	18.8	3.5	9.4	8.5	13.2	4.2	2.0	17.6	29.5	3.4	16.8	9.9	5.3	3.5	21.8	0.9	4.1	10.7	8.5	4.3	11.5	0.1	0.9	10.2	2.6	3.0	4.1	0.8	2.3	3.7	1.9	0.7	5.9	6.7	4.1	1.2	5.2	1.8	2.3	0.5	3.3	0.0	9.3	0.5	7.8	0.3	1.0	3.0	1.9	1.6	2.2	5.9	13.0	2.7	3.8	10.4	2.6	5.7	2.2	1.0	29.9	1.4	0.0	0.4	0.6	0.0	3.2	0.4	2.7	0.1	0.8	0.0	4.7	0.9	0.0	0.0	4.1	2.5	16.7	4.6	5.0	26.0	0.8	3.2	2.1	1.3	5.0	4.0	0.0	3.6	4.5	1.0	10.2	2.6	3.2	0.5	1.6	4.1	0.0	0.4	1.0	0.9	0.1	0.0	0.1	1.5	3.0	0.5	0.0	1.2	0.8	5.3	20.4	1.4	10.8	7.7	4.7	25.3	7.2	18.8	21.8
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response"	"Exonuclease, Hydrolase, Nuclease"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 149.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 149.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		490000	490000	"Endoplasmic reticulum, Cytosol"		"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favourable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favourable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	45.7	57.5	44.6	23.1	79.0	12.8	21.9	35.5	126.1	31.2	23.5	25.4	17.1	22.6	26.3	35.0	18.3	30.0	30.8	33.0	46.4	73.4	22.1	25.6	49.7	25.2	44.7	53.9	44.8	42.5	32.9	122.1	38.9	62.2	29.6	16.1	31.6	35.3	37.2	27.4	24.2	23.5	25.6	28.6	48.9	23.0	17.0	19.3	11.9	20.6	11.2	12.9	27.3	20.7	3.6	23.0	149.2	24.6	9.7	7.8	16.8	13.9	43.2	28.0	44.0	77.9	37.1	21.3	34.7	35.4	25.2	28.9	8.2	15.8	6.1	36.4	30.1	6.5	6.7	13.6	11.0	22.6	24.6	6.5	14.8	10.3	53.2	2.7	75.0	70.6	28.5	19.2	13.2	21.1	23.0	24.6	18.1	18.3	4.7	13.0	18.2	8.9	6.0	21.3	24.9	12.9	10.5	20.1	33.4	16.6	10.3	18.5	14.2	47.0	37.2	21.3	10.2	18.0	7.7	25.6	27.3	6.3	34.2	10.9	13.1	149.2	24.6	35.3	7.8	12.8	6.4	3.6	6.2	6.9	23.0	3.1	6.5	6.5	2.5	9.7	5.7	3.3	6.1	16.8	44.6	79.0	35.5	126.1	46.4	73.4	44.7	53.9	62.2	19.3
PLK1	PLK	ENSG00000166851	"Polo like kinase 1"	P53350	16	23677656-23690367	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 83.9;testis: 32.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"T-reg: 9.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 9.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA051638, HPA053229"	Approved									"HPA051638: , HPA053229: "	"unprognostic (7.21e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (4.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavourable (2.70e-7)"	"prognostic unfavourable (2.28e-5)"	"unprognostic (2.55e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (4.12e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.33e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-2)"	2.9	1.1	1.1	14.2	1.5	15.9	1.7	2.1	1.1	1.5	7.1	0.7	0.5	6.0	1.1	0.9	10.4	0.7	1.5	1.0	1.0	0.8	1.3	1.2	2.6	15.2	0.8	0.6	1.2	0.7	0.0	0.8	6.8	0.7	0.9	5.9	0.5	1.7	0.8	0.8	2.9	5.9	2.0	0.7	8.3	3.6	32.4	0.5	83.9	0.6	6.6	20.4	2.1	2.6	1.9	0.5	0.7	0.1	1.3	9.0	2.3	43.1	45.0	37.2	20.2	1.1	2.6	20.9	24.7	16.3	38.7	28.9	39.3	28.5	21.6	12.9	16.6	24.8	50.7	20.3	46.6	30.7	28.6	27.4	35.5	53.7	0.3	31.6	30.1	1.0	1.1	27.4	28.3	28.3	42.6	29.8	29.8	39.4	29.7	31.6	42.5	22.9	46.5	25.3	34.3	11.0	9.4	21.0	14.6	28.2	19.8	12.8	25.2	19.5	14.3	18.4	23.6	18.0	42.1	21.2	33.0	37.4	15.6	27.5	30.1	0.0	0.1	0.0	0.0	0.0	0.0	1.9	1.4	0.5	0.5	0.0	0.0	0.0	0.7	1.3	0.0	0.0	9.0	2.3	1.1	1.5	2.1	1.1	1.0	0.8	0.8	0.6	0.7	0.5
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880861-127899195	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA017327: , HPA035026: AB_10602080, HPA043198: "	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favourable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.4	1.3	1.5	4.7	2.4	16.5	2.2	0.5	2.2	2.0	3.2	0.3	0.6	2.3	1.3	1.3	5.4	1.1	1.2	2.0	1.2	1.3	1.5	0.9	1.5	5.9	1.2	1.4	1.5	0.9	0.3	0.6	5.0	2.6	1.4	3.7	0.8	1.7	0.7	0.4	2.7	3.2	1.9	1.8	2.7	1.6	21.7	1.0	21.7	1.0	2.1	6.0	1.5	2.2	0.7	0.7	1.5	0.8	1.4	4.0	0.8	11.6	5.5	20.7	10.6	0.7	2.0	9.4	11.4	8.1	15.2	15.8	7.7	12.0	15.7	4.2	6.3	7.7	14.6	9.1	23.5	12.2	6.0	14.2	8.8	7.2	0.2	20.0	16.9	0.6	0.9	13.9	6.4	11.7	16.5	21.0	12.8	8.1	30.8	9.0	9.6	6.3	16.1	14.5	5.4	5.0	7.4	11.5	9.4	7.2	6.6	3.5	5.3	8.7	5.0	12.0	11.6	8.1	14.2	10.9	11.9	22.4	6.1	15.3	13.2	0.0	0.4	1.5	1.6	0.8	1.1	0.3	1.8	1.7	0.7	0.7	0.6	2.3	0.0	1.4	0.3	0.4	4.0	0.8	1.5	2.4	0.5	2.2	1.2	1.3	1.2	1.4	2.6	1.0
PLN	"CMD1P, PLB"	ENSG00000198523	Phospholamban	P26678	6	118548298-118560730	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 337.5"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.4;Karpas-707: 1.6;NB-4: 1.9;U-2197: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.3;naive CD4 T-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005597, HPA026900"	Enhanced									"CAB005597: AB_2252716, HPA026900: AB_1855314"	"unprognostic (2.49e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.35e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavourable (4.11e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (5.59e-4)"	9.0	1.8	0.4	2.7	0.5	0.0	5.4	0.4	0.6	22.3	22.2	0.0	9.8	2.0	21.1	22.3	27.3	11.6	29.8	337.5	0.4	0.5	6.4	0.4	5.3	0.8	0.7	1.4	18.6	0.5	0.1	0.4	0.1	1.4	14.4	3.9	0.0	1.6	6.0	68.4	1.5	14.0	30.8	1.2	0.6	6.5	12.3	0.0	0.0	2.8	23.7	0.8	32.2	6.6	0.3	0.0	1.3	0.4	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.4	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.3	0.5	0.2	0.0	0.2	1.6	0.1	0.0	0.0	1.9	0.1	0.0	0.0	0.1	1.0	0.0	0.7	0.2	0.8	0.4	0.1	0.0	0.4	0.0	0.5	0.3	0.2	1.3	0.3	0.2	0.3	0.5	0.0	1.1	0.1	0.0	0.4	1.3	0.1	0.0	0.3	0.1	0.4	0.0	0.0	0.3	1.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.6	0.4	0.5	0.7	1.4	1.4	0.0
PLOD1	"LH1, LLH, PLOD"	ENSG00000083444	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1"	Q02809	1	11934205-11975538	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049137, HPA055799"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	2700000	2700000	Vesicles	Nucleoplasm	"HPA049137: AB_2680649, HPA055799: AB_2682924"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.21e-3)"	"unprognostic (5.43e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.15e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (1.91e-12)"	"unprognostic (2.79e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (2.43e-4)"	29.0	19.5	14.9	16.8	24.0	7.1	32.1	12.1	17.6	35.8	21.7	17.0	17.7	19.1	34.2	21.1	16.5	24.7	21.3	31.2	17.6	14.8	27.5	51.3	22.2	19.7	24.5	9.9	31.8	30.3	18.2	16.3	41.5	20.8	21.1	12.0	25.1	39.3	22.0	18.3	13.3	20.8	39.0	13.2	21.1	18.6	10.0	22.4	1.7	34.8	11.1	8.2	19.5	69.7	1.6	16.3	17.7	19.4	2.6	9.1	9.3	17.6	15.1	8.3	38.9	56.9	31.9	6.7	52.5	69.7	27.7	47.1	17.2	11.6	10.2	55.5	57.9	14.9	12.1	18.3	19.1	10.6	12.9	5.5	24.3	21.8	35.3	3.4	26.8	38.7	9.6	33.4	13.4	49.0	15.4	5.0	28.8	11.4	0.8	9.2	3.7	22.5	4.1	16.9	22.1	15.9	4.0	3.2	13.2	22.9	15.7	26.4	7.9	8.8	48.4	31.7	23.8	39.6	25.7	11.7	19.1	6.1	70.2	12.1	51.6	0.0	19.4	0.9	9.1	17.2	1.6	1.0	1.6	4.4	16.3	1.6	0.6	3.4	17.7	2.6	15.0	2.4	1.0	9.3	14.9	24.0	12.1	17.6	17.6	14.8	24.5	9.9	20.8	22.4
PLOD2	LH2	ENSG00000152952	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2"	O00469	3	146069440-146163653	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.1"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 85.3;U-87 MG: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025898, HPA069126"	Approved		Uncertain	Nucleoli,Cytosol	"Intracellular and membrane"			"Nucleoli, Cytosol"		"CAB025898: , HPA069126: "	"unprognostic (8.68e-2)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.29e-3)"	"prognostic unfavourable (7.64e-10)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (4.99e-11)"	"prognostic unfavourable (2.83e-4)"	"unprognostic (6.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.41e-3)"	36.7	14.1	11.2	18.0	12.1	0.7	28.5	7.9	13.5	8.8	25.2	5.1	8.3	21.6	14.8	7.5	12.0	8.0	22.3	16.6	12.5	8.2	16.4	73.1	9.3	3.0	10.7	4.8	17.7	14.4	13.9	7.8	41.0	13.0	11.1	16.1	7.2	7.7	11.3	4.8	3.2	24.7	24.2	19.4	3.2	13.6	6.3	10.9	6.1	47.6	3.5	3.0	21.8	28.7	0.0	0.0	1.5	0.3	0.0	0.0	1.9	17.0	12.2	3.8	1.2	13.9	15.0	9.7	60.4	18.5	32.9	62.1	0.9	1.7	0.0	11.8	10.2	3.6	4.4	51.9	85.3	0.0	7.0	4.2	11.9	8.4	35.8	0.0	0.0	26.2	7.5	28.5	13.9	45.4	5.6	0.2	58.1	6.2	0.0	0.0	2.4	5.2	0.0	2.5	0.0	13.8	0.8	1.9	0.0	48.1	5.2	5.1	14.1	0.5	57.0	40.8	12.4	12.9	36.0	18.5	2.6	0.0	76.0	0.0	7.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	11.2	12.1	7.9	13.5	12.5	8.2	10.7	4.8	13.0	10.9
PLOD3	LH3	ENSG00000106397	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3"	O60568	7	101205977-101218420	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Dioxygenase, Glycosyltransferase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 103.6;WM-115: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 13.4;monocytes: 14.3;T-cells: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001236	Uncertain				"Secreted - unknown location"	370000	370000			"HPA001236: AB_1855474"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.91e-5)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.11e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.87e-2)"	23.9	16.1	11.9	19.5	24.0	14.6	35.4	7.2	19.2	17.8	20.0	31.2	16.6	22.7	22.9	15.1	11.0	17.4	16.7	22.1	14.8	11.6	20.2	54.1	21.0	18.2	36.3	8.9	16.1	23.2	18.5	16.5	33.1	22.4	14.4	14.2	11.1	11.3	19.6	8.8	14.0	23.2	23.2	29.0	20.4	16.7	10.1	30.6	5.1	16.8	6.0	6.9	17.3	42.6	2.6	13.4	2.8	14.3	2.5	9.2	5.3	9.9	9.0	3.8	25.2	18.1	13.0	7.7	18.3	20.6	18.8	13.6	14.4	12.9	0.8	20.6	31.6	12.1	7.6	10.7	4.8	5.4	3.4	1.0	10.9	14.1	24.9	4.5	8.5	14.0	10.3	11.0	8.7	16.7	9.6	103.6	12.6	28.4	0.4	10.7	8.0	13.7	3.1	5.1	15.4	6.4	2.9	2.9	17.1	11.4	16.7	40.8	3.1	15.5	14.5	28.5	13.9	34.5	22.5	5.8	10.6	0.6	16.9	10.9	99.9	0.0	10.8	2.8	9.2	14.3	8.1	2.6	6.8	6.1	10.4	1.8	3.2	3.4	1.0	2.5	14.3	13.4	4.3	5.3	11.9	24.0	7.2	19.2	14.8	11.6	36.3	8.9	22.4	30.6
PMM2	"CDG1, CDG1a, CDGS, PMI, PMI1"	ENSG00000140650	"Phosphomannomutase 2"	O15305	16	8788823-8849331	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"basophil: 52.2"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 52.2"	"Low region specificity"	"Detected in all"							"HPA040852, HPA063649"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040852: AB_10794069, HPA063649: AB_2685074"	"unprognostic (8.62e-3)"	"unprognostic (8.00e-3)"	"prognostic favourable (1.04e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.14e-3)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (8.97e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.02e-2)"	14.8	13.1	6.8	15.4	9.0	4.3	13.6	8.2	8.2	11.4	19.4	7.0	11.6	18.9	9.7	13.1	22.7	10.0	13.9	10.7	4.7	2.9	14.6	43.3	11.8	11.2	6.6	4.3	7.8	40.4	7.8	28.3	19.9	6.6	12.0	20.4	8.8	21.2	13.5	12.5	13.2	19.6	9.5	5.7	12.0	15.2	9.7	7.8	7.6	10.0	12.0	22.0	10.5	12.2	2.9	3.5	52.2	4.9	1.6	3.6	3.0	10.9	24.5	5.4	14.2	9.7	15.3	12.1	17.1	20.7	17.2	18.6	18.3	13.6	17.5	7.2	29.8	15.2	11.1	20.9	17.6	13.0	13.0	5.8	14.8	31.2	18.4	15.3	13.9	22.8	14.9	18.3	16.9	17.5	7.8	17.1	11.4	28.7	15.6	14.1	23.0	15.9	19.9	12.1	34.8	19.1	19.4	10.3	19.5	14.1	31.1	10.2	20.2	13.4	20.3	12.4	14.0	33.4	16.7	21.2	17.7	22.0	10.3	19.3	16.4	52.2	4.9	0.9	2.5	3.7	3.6	2.9	2.2	3.2	3.5	2.4	2.5	2.4	7.8	1.6	2.3	3.2	1.6	3.0	6.8	9.0	8.2	8.2	4.7	2.9	6.6	4.3	6.6	7.8
PMP22	"GAS3, HNPP, Sp110"	ENSG00000109099	"Peripheral myelin protein 22"	Q01453	17	15229777-15265357	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes, Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 69.1;HMC-1: 54.6;WM-115: 83.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 14.1;eosinophil: 22.9;plasmacytoid DC: 12.8"	"Group enriched"	"Detected in many"	20	"dendritic cells: 12.8;granulocytes: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.00e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.63e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.33e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (1.83e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.08e-2)"	66.8	20.9	27.1	22.4	31.4	2.4	43.5	5.7	34.2	69.1	46.0	96.5	11.7	16.7	43.7	28.4	31.3	37.9	40.8	47.5	33.0	17.9	9.0	5.3	47.7	14.0	72.6	22.7	34.9	8.3	3.5	6.7	77.5	42.9	28.0	32.4	39.4	19.2	35.0	91.3	27.0	95.2	48.6	63.9	10.0	25.1	16.5	44.9	1.6	26.4	25.8	8.6	51.6	39.0	0.0	12.8	22.9	0.9	0.0	0.0	0.4	1.4	8.2	11.5	12.4	69.1	29.1	2.6	11.7	12.0	10.4	7.4	8.5	0.2	0.0	1.5	31.8	0.1	13.7	0.1	3.2	0.0	3.0	0.6	15.9	3.0	37.0	0.0	54.6	25.3	0.2	6.3	0.3	11.7	4.4	0.2	6.5	0.9	0.1	0.5	0.7	12.5	3.7	7.5	0.0	10.8	0.8	0.1	7.3	3.0	0.0	29.4	0.0	0.1	14.5	2.8	9.4	40.6	11.3	0.0	0.0	0.0	15.4	0.0	83.2	14.1	0.9	22.9	0.0	0.5	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.1	12.8	0.0	0.4	27.1	31.4	5.7	33.4	33.0	17.9	72.6	22.7	42.9	44.9
PMPCA	"Alpha-MPP, INPP5E, KIAA0123"	ENSG00000165688	"Peptidase, mitochondrial processing alpha subunit"	Q10713	9	136410570-136423761	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria		6500	6500	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favourable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favourable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	15.2	27.3	19.8	14.6	23.8	20.1	13.2	20.3	24.3	12.3	15.1	13.0	10.4	18.6	14.2	14.1	16.5	13.6	14.9	37.0	15.6	14.8	17.0	48.3	12.3	18.4	15.2	21.9	15.5	18.2	14.7	19.5	15.6	16.8	15.2	11.9	12.8	20.3	17.1	56.7	17.5	17.0	13.8	14.1	18.9	16.3	23.2	12.5	14.0	15.0	19.8	15.3	13.1	13.4	25.5	30.1	17.0	25.1	32.1	30.8	28.2	14.3	26.9	12.9	26.0	9.8	14.3	19.8	15.0	12.1	21.0	15.3	30.7	17.2	20.1	15.8	15.2	33.6	23.8	22.0	9.3	28.9	28.8	16.2	34.7	37.1	17.3	21.0	14.1	21.0	15.2	16.3	8.4	17.7	41.0	13.3	13.0	39.8	19.8	27.1	26.3	25.5	24.7	18.3	44.5	14.4	10.3	26.5	17.4	20.2	28.8	17.5	39.2	28.7	14.6	15.0	16.1	12.3	19.0	8.2	10.9	21.7	19.7	18.4	13.4	15.4	25.1	17.0	27.2	24.4	26.4	25.5	25.7	29.3	30.1	23.7	30.8	26.9	5.9	32.1	23.2	15.3	24.3	28.2	19.8	23.8	20.3	24.3	15.6	14.8	15.2	21.9	16.8	12.5
PMVK	"HUMPMKI, PMK, PMKA"	ENSG00000163344	"Phosphomevalonate kinase"	Q15126	1	154924734-154936991	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029900	Approved									"HPA029900: AB_10601390"	"unprognostic (2.52e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.47e-2)"	"unprognostic (8.22e-2)"	"prognostic favourable (9.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"prognostic favourable (4.96e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.10e-1)"	21.0	28.3	31.3	15.9	34.0	7.2	19.4	13.9	31.7	17.0	18.9	25.3	10.2	26.4	12.1	14.7	30.1	20.2	15.7	24.7	23.9	23.9	26.9	39.3	16.2	18.7	29.6	29.3	18.8	22.2	26.8	26.1	13.8	22.4	17.0	12.0	22.2	18.8	15.9	39.8	26.1	25.2	16.7	23.9	20.5	21.8	15.9	22.8	9.9	17.8	25.3	18.9	12.2	22.8	29.1	22.9	20.4	47.3	13.4	30.4	17.7	11.6	16.4	10.6	16.6	9.8	7.0	11.3	9.4	6.4	8.6	8.3	6.6	23.1	16.6	18.1	10.6	11.4	14.3	13.9	4.0	23.2	6.6	7.6	22.2	6.2	9.1	11.5	6.9	8.3	13.0	15.6	11.1	8.7	8.0	51.4	8.9	23.2	9.0	11.1	9.6	21.1	13.7	6.9	38.1	14.5	8.5	8.9	21.3	10.1	17.6	11.5	33.7	20.4	7.3	8.4	6.9	19.9	14.0	41.8	33.3	29.2	13.9	18.5	10.8	4.6	19.8	20.4	17.5	46.9	27.9	29.1	24.0	17.8	22.1	23.9	15.7	15.7	1.7	13.4	47.3	22.9	30.4	17.7	31.3	34.0	13.9	31.7	23.9	23.9	29.6	29.3	22.4	22.8
PNKP	PNK	ENSG00000039650	"Polynucleotide kinase 3'-phosphatase"	Q96T60	19	49859882-49878351	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006782	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA006782: AB_1855496"	"prognostic favourable (9.18e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.68e-3)"	13.1	32.4	11.2	22.0	11.8	24.3	15.0	18.0	13.8	14.0	17.4	17.0	26.4	15.6	16.7	25.3	13.6	18.1	18.2	16.8	12.3	9.5	20.1	16.8	15.9	21.0	13.9	14.2	17.1	22.5	19.7	26.8	17.1	12.9	18.7	15.0	19.6	20.3	22.4	12.8	15.3	15.7	13.2	10.1	30.7	17.9	17.2	13.9	22.3	23.0	17.0	20.6	14.6	12.4	7.9	7.5	19.3	12.7	2.7	7.7	3.8	12.8	8.7	8.8	13.8	8.4	6.5	14.3	20.8	10.6	9.6	8.4	6.9	16.9	8.3	6.6	6.3	10.5	3.1	11.7	5.7	10.7	13.3	14.1	16.4	6.0	6.3	13.3	19.0	6.1	6.2	8.7	5.7	12.6	6.9	16.8	12.5	8.2	13.5	10.7	8.2	17.7	11.5	8.1	16.8	9.9	27.5	10.4	16.8	9.1	27.4	4.6	4.7	8.3	17.8	18.8	11.5	4.5	17.1	18.6	7.5	6.7	17.0	6.0	14.9	1.4	8.8	12.2	7.7	8.5	6.4	6.5	6.6	5.8	7.5	7.9	4.9	4.4	19.3	2.7	12.7	4.3	6.8	3.8	11.2	11.8	18.0	13.8	12.3	9.5	13.9	14.2	12.9	13.9
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818902-825573	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 158.1;breast: 155.2"	"Cell line enhanced"	"Detected in all"		"ASC diff: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"				"Lipid droplets"	Nucleoplasm	"HPA055173: , HPA062602: , HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	158.1	7.2	1.6	9.4	1.8	11.2	155.2	2.7	2.3	4.1	35.9	1.5	3.8	5.6	4.5	7.8	8.6	4.3	7.2	12.6	1.7	1.1	15.6	7.4	11.3	4.5	1.6	1.6	4.9	11.8	2.5	4.2	11.6	1.8	5.2	1.5	1.9	8.1	8.1	25.0	6.1	23.1	3.0	2.1	4.9	8.2	4.0	1.5	1.5	11.3	4.8	5.1	13.0	18.6	4.2	6.5	18.7	8.5	3.6	5.3	3.6	10.4	8.2	1.7	4.4	64.1	5.7	11.0	11.1	9.0	7.0	6.2	6.9	10.5	6.2	6.6	8.3	9.4	2.5	4.6	2.1	7.9	22.7	8.5	3.6	11.1	21.0	5.8	10.8	11.2	6.0	4.7	5.4	5.7	7.2	6.3	6.2	6.1	7.8	12.9	4.9	17.6	7.6	3.7	13.8	6.8	2.4	6.3	8.4	20.6	17.6	6.4	7.5	6.8	10.2	6.3	4.9	4.1	5.0	24.3	15.0	5.2	15.8	8.4	4.4	9.3	8.5	18.7	3.6	5.5	3.5	4.2	4.6	5.2	5.7	3.6	5.3	4.3	7.7	3.6	6.0	6.5	3.9	3.6	1.6	1.8	2.7	1.9	1.7	1.1	1.6	1.6	1.8	1.5
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923739-43964488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 31.1;retina: 39.3"	"Cell line enhanced"	"Detected in many"		"AF22: 13.3;LHCN-M2: 15.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol				Nucleoli	"Mitochondria, Cytosol"	"HPA058058: "	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.8	0.4	0.5	0.7	1.0	0.3	4.0	0.3	2.4	0.8	1.3	0.4	0.0	1.0	0.5	1.9	0.4	1.1	0.5	0.9	0.8	0.6	4.6	31.1	1.4	0.4	0.3	1.8	0.5	0.2	0.6	0.2	0.4	2.2	0.2	0.2	39.3	0.9	0.2	2.2	5.3	0.6	0.2	0.5	0.6	0.3	0.5	0.3	0.0	0.2	0.0	0.3	0.2	0.4	1.2	0.7	1.8	0.6	0.9	0.8	0.0	3.9	1.2	13.3	5.4	3.8	4.2	0.4	2.4	1.4	3.3	7.1	3.8	7.0	0.0	2.0	4.0	3.3	8.3	3.9	2.7	0.0	0.7	0.2	3.1	7.1	6.1	0.0	0.2	4.8	3.0	10.4	0.5	0.4	0.0	0.0	15.0	0.6	0.2	0.0	9.1	0.0	0.0	7.2	0.1	1.4	0.2	1.2	0.1	2.7	1.0	3.7	4.2	4.5	0.4	1.3	4.0	0.1	0.1	0.0	0.0	0.0	11.4	0.0	4.7	1.5	0.6	0.4	0.5	0.4	0.3	0.7	0.4	0.3	0.2	1.2	0.6	0.8	1.8	0.9	0.3	0.7	0.2	0.0	0.5	1.0	0.3	2.4	0.8	0.6	0.3	1.8	2.2	0.3
PNPLA4	"DXS1283E, GS2, iPLA2eta"	ENSG00000006757	"Patatin like phospholipase domain containing 4"	P41247	X	7898247-7927739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA003656	Approved				"Intracellular and membrane"					"HPA003656: AB_1079033"	"unprognostic (2.97e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (5.29e-4)"	"prognostic unfavourable (5.37e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-1)"	"prognostic favourable (2.23e-12)"	"unprognostic (5.23e-2)"	"unprognostic (6.71e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.12e-1)"	11.3	18.1	12.6	6.0	18.8	4.7	13.9	5.0	11.5	8.9	8.9	8.5	13.3	11.2	9.2	11.4	13.2	15.0	6.2	24.0	10.9	11.9	26.5	39.8	5.8	6.3	12.0	8.7	14.0	21.0	13.3	17.0	4.7	12.2	8.0	7.5	13.1	18.9	10.7	40.9	10.8	10.5	7.4	11.2	5.4	11.5	7.8	10.6	7.2	23.6	21.1	8.9	6.6	9.5	13.2	18.3	7.6	10.4	9.0	10.3	8.4	18.6	7.6	1.2	19.3	0.4	0.2	5.2	5.8	0.6	10.1	6.2	7.7	6.9	5.9	0.0	1.9	11.0	0.0	19.5	17.3	0.2	13.7	4.2	14.8	16.1	12.8	7.3	6.2	13.2	20.0	5.1	12.1	7.0	16.4	0.2	0.1	4.9	0.1	7.2	20.4	16.3	0.1	0.1	6.5	13.3	8.5	11.1	5.6	17.6	7.3	9.9	11.3	5.5	4.0	0.1	5.1	15.5	0.1	8.9	0.1	11.1	0.1	0.1	1.6	5.2	9.8	7.6	5.4	10.4	6.2	12.3	7.8	5.9	18.3	13.2	10.3	9.8	0.7	9.0	9.7	13.5	4.8	8.4	12.6	18.8	5.0	11.5	10.9	11.9	12.0	8.7	12.2	10.6
PNPLA6	"iPLA2delta, NTE, SPG39, sws"	ENSG00000032444	"Patatin like phospholipase domain containing 6"	Q8IY17	19	7534004-7561764	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, Dwarfism, Hereditary spastic paraplegia, Hypogonadotropic hypogonadism, Mental retardation, Neurodegeneration, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007522	Uncertain									"HPA007522: AB_1079649"	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-1)"	"prognostic favourable (5.25e-4)"	"unprognostic (3.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (3.51e-5)"	"unprognostic (3.36e-1)"	"prognostic favourable (7.53e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	12.9	19.7	25.9	25.0	29.3	22.3	17.8	22.1	35.8	10.2	15.9	26.1	10.0	26.3	13.7	6.3	16.4	12.6	14.0	12.0	22.6	19.1	17.1	13.7	30.4	17.6	36.3	19.2	12.5	14.2	15.6	21.6	13.9	29.2	13.4	8.9	15.8	13.7	14.3	27.0	15.3	28.7	14.5	23.5	28.3	12.2	31.3	33.0	7.1	14.7	6.1	8.8	15.9	14.7	3.8	7.3	21.8	19.0	5.0	3.9	4.1	13.0	31.6	6.2	15.0	10.9	15.8	14.4	17.0	17.5	13.3	12.3	7.4	18.1	10.8	29.0	22.0	16.8	5.3	16.0	6.9	26.3	12.2	7.1	16.9	5.5	12.6	7.9	22.3	13.7	9.3	17.1	9.9	26.1	5.8	14.9	11.8	6.2	8.7	10.4	6.8	29.0	7.0	3.7	12.7	11.8	12.5	7.9	13.7	14.5	6.6	18.5	5.8	11.4	27.6	16.1	9.5	22.1	17.8	17.7	11.4	4.8	27.1	9.4	15.1	7.9	6.1	21.8	3.5	12.1	3.5	3.8	2.5	3.8	7.3	2.8	2.2	2.9	1.9	5.0	19.0	2.4	3.9	4.1	25.9	29.3	22.1	35.8	22.6	19.1	36.3	19.2	29.2	33.0
PNPLA8	"IPLA2-2, IPLA2G, iPLA2gamma"	ENSG00000135241	"Patatin like phospholipase domain containing 8"	Q9NP80	7	108470422-108569666	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020083	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA020083: AB_1851849"	"unprognostic (4.48e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.61e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.49e-1)"	"prognostic favourable (1.86e-6)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.24e-1)"	21.5	35.7	29.3	12.4	28.9	51.5	15.0	15.6	27.2	15.4	13.4	9.5	9.3	8.6	13.4	13.7	18.3	9.7	15.9	17.9	23.0	22.1	23.1	24.6	16.7	12.0	20.7	17.5	15.6	10.1	20.7	33.4	25.2	23.2	14.4	11.4	6.0	11.4	13.9	29.8	11.4	10.8	15.3	20.3	19.5	11.1	10.8	21.1	16.1	22.6	13.0	15.3	22.5	12.8	20.0	19.3	16.7	26.8	14.6	12.5	13.7	14.0	6.3	11.2	10.0	25.0	17.2	16.6	13.4	23.7	11.0	18.4	6.1	8.1	7.8	16.9	13.1	5.3	19.0	8.5	16.8	11.7	5.2	5.3	10.4	4.5	18.3	3.7	11.1	15.6	16.2	14.8	13.7	14.8	6.3	22.5	13.7	9.2	8.6	8.8	4.9	9.0	3.2	11.8	16.6	13.2	17.8	9.3	13.1	12.8	13.9	16.0	5.8	6.3	12.0	18.2	8.1	27.0	7.3	19.1	19.3	11.6	17.3	5.7	11.7	14.1	19.7	16.7	10.5	21.8	12.5	20.0	10.3	10.3	19.3	18.7	11.2	10.7	16.5	14.6	26.8	7.6	12.5	13.7	29.3	28.9	15.6	27.2	23.0	22.1	20.7	17.5	23.2	21.1
PNPO	PDXPO	ENSG00000108439	"Pyridoxamine 5'-phosphate oxidase"	Q9NVS9	17	47941506-47949308	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyridoxine biosynthesis"	Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023204, HPA027776"	Enhanced		Enhanced	Nucleoplasm,Cytosol		150000	150000	"Nucleoplasm, Cytosol"		"HPA023204: AB_1855506, HPA027776: AB_10601246"	"unprognostic (1.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.65e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.74e-1)"	6.0	13.1	9.9	5.1	13.0	2.9	8.6	8.3	16.5	6.2	7.0	8.6	6.9	8.5	4.2	9.6	8.1	8.4	10.1	10.2	8.7	12.0	26.0	64.7	5.3	7.7	11.2	9.9	8.0	13.7	17.3	7.4	5.8	11.1	6.9	7.4	8.4	8.3	7.1	14.7	5.5	9.6	5.2	7.1	6.8	6.7	6.4	6.0	5.2	14.4	8.2	6.1	5.4	5.2	6.8	12.2	2.4	16.4	7.7	8.2	8.7	17.5	14.5	1.1	2.7	7.4	5.7	0.0	5.9	3.9	6.7	5.8	23.8	13.0	16.7	28.5	5.9	10.6	9.1	16.2	9.7	20.3	7.8	11.8	6.8	24.7	8.0	10.4	8.1	7.6	12.7	12.4	15.4	8.7	11.1	5.8	7.8	13.1	10.5	3.4	2.1	18.0	8.9	5.1	12.2	18.5	9.1	5.9	4.9	5.4	8.8	5.0	15.6	3.8	9.1	10.8	6.3	10.7	12.4	13.8	15.2	8.8	8.8	9.1	5.5	2.1	11.0	2.4	6.8	16.4	8.0	6.8	6.2	7.4	12.2	5.7	8.2	7.9	1.1	7.7	10.4	8.9	6.4	8.7	9.9	13.0	8.3	16.5	8.7	12.0	11.2	9.9	11.1	6.0
PNPT1	"DFNB70, old-35, OLD35, PNPase"	ENSG00000138035	"Polyribonucleotide nucleotidyltransferase 1"	Q8TCS8	2	55634265-55693910	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transport"	"Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033424, HPA034602, HPA034603"	Supported		Enhanced	Mitochondria				Mitochondria		"CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130"	"unprognostic (9.09e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (1.95e-7)"	"unprognostic (1.88e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavourable (5.44e-5)"	"unprognostic (2.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	11.1	11.7	13.3	6.5	21.7	11.7	10.8	13.3	18.8	5.7	8.2	12.8	5.4	5.7	8.3	8.8	9.5	7.9	5.8	11.0	12.4	10.9	9.8	11.4	9.1	7.1	24.1	7.4	6.9	9.1	7.4	14.3	5.1	15.2	7.7	10.1	4.2	9.0	6.3	23.5	10.1	7.0	7.9	17.6	10.4	7.6	13.5	22.5	9.6	10.0	7.8	5.9	5.3	7.4	9.8	7.4	6.1	6.5	3.8	8.6	4.7	6.7	3.6	5.0	2.3	3.6	6.3	6.7	10.0	6.1	15.9	10.7	10.5	3.2	14.1	4.2	4.7	5.4	6.4	7.8	7.4	5.0	14.2	8.1	4.6	5.3	9.5	18.3	5.5	7.0	5.4	6.6	5.7	4.9	8.5	3.2	6.3	3.8	11.2	12.8	12.1	6.1	11.1	8.4	12.4	6.7	4.2	12.2	7.3	3.6	11.1	12.2	3.0	8.1	5.1	3.8	3.2	3.3	10.2	14.3	1.1	3.0	7.2	16.0	6.4	4.2	6.5	6.1	8.1	5.7	4.8	5.4	3.7	8.6	2.8	9.8	6.9	7.9	6.1	3.8	5.1	7.4	2.4	4.7	13.3	21.7	13.3	18.8	12.4	10.9	24.1	7.4	15.2	22.5
POFUT1	"FUT12, KIAA0180, O-Fuc-T, O-FUT"	ENSG00000101346	"Protein O-fucosyltransferase 1"	Q9H488	20	32207880-32238667	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Fucose metabolism, Notch signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in all"	4	"monocytes: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054519, HPA059935"	Approved		Approved	Centrosome	"Intracellular and membrane"	140000	140000	Centrosome		"HPA054519: , HPA059935: "	"unprognostic (6.61e-2)"	"unprognostic (4.10e-3)"	"unprognostic (8.83e-2)"	"unprognostic (5.51e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.86e-3)"	15.9	13.5	8.2	15.5	8.9	7.4	19.4	6.6	11.3	15.5	20.2	13.1	10.4	16.4	18.1	19.6	13.9	17.4	23.6	20.1	7.5	6.3	18.8	44.6	14.8	22.2	8.8	6.6	18.3	24.6	19.2	11.3	22.4	7.8	16.0	16.0	16.9	13.3	16.0	13.5	13.3	27.5	20.8	7.7	12.4	12.5	16.5	7.0	12.7	20.1	13.9	13.0	15.7	12.6	2.8	3.9	3.3	16.4	1.7	3.3	3.2	15.0	12.1	10.5	11.5	18.1	17.7	19.7	15.6	18.6	26.4	17.4	36.2	20.4	10.2	23.6	17.4	16.8	10.1	19.3	23.0	5.2	6.3	15.2	11.1	16.4	14.1	13.0	9.7	15.5	15.3	20.0	13.1	14.7	11.4	5.8	18.4	7.4	8.9	10.0	5.4	19.7	7.5	28.0	9.4	8.1	10.0	6.9	8.9	35.9	10.0	13.3	14.8	15.6	12.7	38.4	14.3	24.0	26.5	7.2	9.1	9.4	23.2	45.3	24.2	3.3	4.4	2.1	2.9	12.8	3.3	2.8	2.6	2.7	3.9	2.4	3.3	2.4	0.9	1.7	16.4	2.9	2.7	3.2	8.2	8.9	6.6	11.3	7.5	6.3	8.8	6.6	7.8	7.0
POGLUT1	"9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi"	ENSG00000163389	"Protein O-glucosyltransferase 1"	Q8NBL1	3	119468938-119494708	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Gastrulation	"Developmental protein, Glycosyltransferase, Transferase"	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037855, HPA037856"	Approved		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"			"Endoplasmic reticulum"	Cytosol	"HPA037855: AB_10672728, HPA037856: AB_2732477"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (7.02e-7)"	"unprognostic (3.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-3)"	"prognostic favourable (2.23e-4)"	11.9	12.1	7.6	10.7	12.0	3.9	10.9	13.9	10.6	10.1	9.5	9.8	27.4	5.9	13.7	11.7	9.3	10.1	6.9	8.3	7.3	8.9	8.3	10.3	9.1	14.3	15.0	5.6	10.5	29.2	12.1	14.5	11.5	10.9	9.4	10.9	8.7	7.8	25.7	5.1	14.0	12.1	15.2	14.0	14.9	8.2	4.7	8.9	11.7	8.6	4.1	15.6	10.6	10.2	9.9	14.3	9.4	11.5	19.8	16.0	10.3	7.4	5.0	8.7	9.6	22.0	12.6	6.2	11.9	12.2	9.7	13.3	8.1	4.9	11.5	16.2	15.0	8.8	11.6	11.8	15.4	9.9	7.5	13.5	7.9	8.8	14.3	14.8	15.9	12.9	7.7	9.6	13.5	11.0	7.3	14.1	9.8	7.5	8.4	14.3	8.9	9.2	8.4	8.8	16.9	8.4	9.6	9.5	14.6	5.7	3.6	9.2	9.5	12.4	13.9	9.5	5.9	2.8	6.1	19.4	16.8	15.7	8.3	15.0	13.4	1.9	11.5	9.4	12.0	10.8	13.8	9.9	13.6	12.5	14.3	7.0	16.0	15.2	0.9	19.8	7.0	8.0	14.7	10.3	7.6	12.0	13.9	10.6	7.3	8.9	15.0	5.6	10.9	8.9
POLD1	"CDC2, POLD"	ENSG00000062822	"DNA polymerase delta 1, catalytic subunit"	P28340	19	50384204-50418016	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004375, HPA046524"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB004375: AB_675487, HPA046524: "	"unprognostic (2.45e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (2.87e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.08e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.70e-2)"	7.9	5.7	5.4	18.3	9.9	31.6	6.6	9.4	5.4	8.2	10.0	6.1	5.9	6.8	9.5	7.2	11.3	6.9	5.2	5.5	4.4	3.2	7.6	9.3	10.9	15.7	7.0	3.6	8.2	8.4	5.2	5.1	10.9	6.7	6.3	5.2	4.9	8.1	5.4	7.2	13.1	9.9	6.2	7.7	14.1	6.5	13.2	6.5	27.4	12.1	8.1	14.2	5.9	7.8	9.3	10.5	2.1	8.5	5.4	7.3	5.6	18.1	25.0	13.7	7.9	1.7	1.5	14.1	11.3	5.0	13.9	17.8	13.6	14.4	26.0	6.4	3.4	14.9	16.2	12.3	4.8	21.9	43.5	22.6	24.2	17.9	1.6	21.5	20.0	2.9	3.8	12.6	3.8	7.1	24.3	20.2	5.8	12.2	33.3	33.7	16.1	18.2	33.1	23.0	22.8	4.4	17.3	14.3	12.9	11.2	13.8	2.6	7.6	20.4	5.6	7.1	23.0	7.6	19.8	19.1	31.4	27.8	7.7	24.3	6.9	1.6	6.2	2.1	7.3	7.8	6.2	7.8	6.5	5.9	5.7	9.3	6.5	5.9	1.1	5.4	8.5	10.5	4.5	5.6	5.4	9.9	9.4	5.4	4.4	3.2	7.0	3.6	6.7	6.5
POLG	"POLG1, POLGA"	ENSG00000140521	"DNA polymerase gamma, catalytic subunit"	P54098	15	89305198-89334861	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease mutation, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056821, HPA078482"	Approved		Supported	Mitochondria				Mitochondria		"HPA056821: , HPA078482: "	"unprognostic (1.87e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (5.73e-4)"	"unprognostic (2.65e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.45e-1)"	17.8	15.2	19.8	19.0	19.2	16.8	24.6	23.2	20.9	14.1	16.0	14.6	13.6	20.0	17.6	9.0	20.7	14.3	14.0	17.4	16.7	8.8	14.9	19.5	17.8	21.8	17.3	15.3	16.6	17.9	17.7	12.9	16.2	16.0	15.4	13.2	10.5	15.9	12.0	35.9	19.8	18.5	14.1	12.7	22.9	16.2	12.4	17.3	29.0	15.4	12.1	19.2	16.5	18.9	6.0	9.0	9.0	6.5	9.2	10.9	6.7	6.8	13.0	9.0	11.7	14.7	9.4	11.5	13.7	7.3	14.1	11.1	19.0	17.2	10.8	21.2	10.8	14.9	24.0	11.6	4.7	23.3	20.6	16.4	13.7	6.8	12.5	15.2	27.1	8.5	17.0	9.7	8.3	16.8	14.4	12.2	11.4	12.1	17.3	15.5	8.1	5.8	17.7	11.0	15.3	8.0	16.8	20.0	7.3	19.5	14.3	15.9	11.9	17.1	12.5	19.1	13.2	28.0	13.1	13.1	7.6	15.0	12.2	17.5	15.2	4.9	6.3	9.0	9.2	6.5	8.0	3.3	7.6	10.9	9.0	6.0	6.6	6.9	2.3	9.2	5.2	6.0	4.3	6.7	19.8	19.2	23.2	20.9	16.7	8.8	17.3	15.3	16.0	17.3
POLG2	"HP55, MTPOLB"	ENSG00000256525	"DNA polymerase gamma 2, accessory subunit"	Q9UHN1	17	64477785-64497036	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017030, HPA023202"	Approved		Approved	"Nuclear bodies,Mitochondria"				"Nuclear bodies"	Mitochondria	"CAB017030: , HPA023202: AB_1855523"	"unprognostic (1.76e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.91e-2)"	"prognostic unfavourable (1.39e-6)"	"unprognostic (4.38e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.17e-3)"	"prognostic unfavourable (6.59e-4)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (5.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.82e-2)"	6.7	9.3	5.4	17.5	10.0	8.1	8.2	10.9	8.7	7.7	7.8	7.0	11.1	7.9	10.2	6.8	6.4	7.5	7.9	7.3	5.6	4.4	7.8	7.8	10.4	12.2	10.8	5.2	13.0	9.4	5.0	9.9	6.9	8.7	8.0	5.7	5.8	8.6	11.9	10.7	10.5	8.4	9.3	5.6	11.5	6.9	24.2	7.9	9.8	9.6	5.4	13.3	6.6	11.5	12.2	10.5	6.5	8.2	6.0	12.2	4.4	6.7	8.3	6.0	7.4	5.7	4.6	7.3	4.0	3.8	6.1	5.3	8.6	5.4	12.4	4.9	2.1	5.6	8.2	3.8	7.7	3.5	9.4	8.4	10.0	8.5	6.4	11.9	9.4	4.6	4.4	4.9	7.3	4.4	14.7	4.8	5.9	9.0	12.6	15.7	6.3	9.3	11.8	19.6	13.1	5.6	2.0	8.4	9.4	3.2	7.3	7.4	7.1	10.0	4.9	6.6	8.9	5.7	10.4	8.5	5.7	9.4	5.2	11.1	4.6	6.5	5.9	6.5	7.9	3.5	7.5	12.2	8.8	7.6	10.5	12.1	12.2	11.6	1.2	6.0	8.2	4.8	8.4	4.4	5.4	10.0	10.9	8.7	5.6	4.4	10.8	5.2	8.7	7.9
POLH	"RAD30A, XP-V"	ENSG00000170734	"DNA polymerase eta"	Q9Y253	6	43576150-43615660	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"	"Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006721, HPA026762"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006721: AB_1847785, HPA026762: AB_10601248"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.11e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.02e-2)"	7.4	9.4	7.5	9.7	10.4	4.6	7.2	10.5	10.5	8.5	8.4	12.7	8.0	5.7	9.6	7.1	11.4	7.8	6.2	6.7	5.3	4.4	7.2	7.5	9.8	16.3	8.9	8.1	7.4	13.0	7.1	9.7	5.1	7.9	6.9	10.1	8.9	8.6	5.6	9.5	11.7	7.9	11.8	6.9	9.2	7.6	24.7	6.8	22.1	9.9	6.2	18.3	8.6	8.4	8.6	4.3	4.5	2.6	6.8	7.2	3.2	20.2	4.7	6.3	9.2	9.0	14.9	15.0	21.7	6.8	12.7	14.7	5.3	3.6	22.5	5.5	8.8	5.1	6.4	13.7	15.8	11.3	4.9	6.6	13.1	15.4	6.7	11.2	8.9	10.0	16.7	10.4	5.6	12.0	10.4	13.5	16.0	6.7	10.2	2.9	1.9	3.5	11.2	6.5	5.6	4.8	15.2	7.1	2.4	6.9	5.8	3.4	8.2	5.0	16.2	11.8	11.4	5.5	10.9	12.7	8.8	40.6	5.6	6.6	12.8	4.5	2.6	4.1	7.2	2.5	6.4	7.8	6.0	5.2	2.1	8.6	5.0	5.2	2.0	6.8	1.9	4.3	7.0	3.2	7.5	10.4	10.5	10.5	5.3	4.4	8.9	8.1	7.9	6.8
POLQ	POLH	ENSG00000051341	"DNA polymerase theta"	O75417	3	121431427-121546641	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.5;lymphoid tissue: 21.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.2"	"HPA048931, HPA053359"			Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA048931: , HPA053359: "	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (5.46e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.09e-5)"	"unprognostic (8.55e-3)"	"unprognostic (1.09e-4)"	"unprognostic (2.86e-1)"	"unprognostic (5.59e-5)"	"unprognostic (2.06e-3)"	"unprognostic (0.00e+0)"	"prognostic favourable (1.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.76e-2)"	0.5	0.8	0.2	8.2	0.7	9.5	0.6	0.6	0.4	0.9	3.5	0.2	0.8	2.0	0.9	0.6	6.0	0.3	0.4	0.8	0.3	0.2	0.4	0.6	0.9	4.7	0.3	0.0	0.4	0.4	0.0	0.2	2.8	0.3	0.4	3.7	0.1	1.1	0.8	1.2	2.4	3.9	0.5	0.4	2.6	1.1	5.8	0.6	21.4	0.3	5.6	7.5	0.6	1.7	0.5	1.1	1.6	0.4	0.0	0.4	0.0	13.3	9.1	7.8	5.5	0.7	0.9	7.1	6.3	2.4	7.5	10.1	7.2	5.0	15.9	2.9	3.4	10.6	9.2	4.1	12.8	4.6	5.0	10.2	5.6	4.5	0.0	11.0	9.3	0.1	0.3	6.8	4.2	3.7	6.7	12.1	7.8	5.2	9.9	6.4	7.4	4.4	8.4	9.4	5.6	2.4	7.7	4.3	3.8	7.3	4.0	2.6	3.7	10.9	2.8	6.6	8.7	2.6	8.2	6.1	4.9	16.5	3.2	8.2	4.9	1.6	0.2	0.0	0.3	0.2	0.0	0.3	0.4	0.3	0.4	0.5	0.0	0.2	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.7	0.6	0.4	0.3	0.2	0.3	0.0	0.3	0.6
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"				"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: , HPA049700: "	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (8.41e-4)"	"unprognostic (7.20e-2)"	14.3	12.9	10.1	12.4	16.5	9.7	10.3	12.2	20.3	11.1	11.0	17.4	8.3	9.4	19.5	7.4	13.5	12.3	11.7	12.7	9.0	9.2	11.5	15.1	9.4	9.6	9.0	9.4	12.6	14.3	18.2	15.9	11.4	13.8	10.7	11.8	13.9	11.2	12.5	22.5	12.3	8.6	16.0	8.0	11.2	10.4	14.9	10.9	14.0	10.3	11.4	14.2	10.9	9.6	2.6	2.6	1.8	2.5	2.0	3.8	1.2	9.3	21.3	9.5	18.3	9.3	7.5	13.8	8.6	5.7	12.4	7.7	26.7	7.4	21.5	9.2	8.8	10.9	24.5	12.7	11.1	8.9	12.6	18.5	9.1	17.9	6.6	17.5	10.0	5.7	8.0	18.4	14.4	9.6	24.5	5.4	8.5	8.3	12.9	7.5	17.3	14.1	15.6	20.9	10.0	5.5	15.4	14.8	7.7	9.5	12.6	6.8	7.4	6.1	15.2	15.1	11.9	12.8	17.3	7.7	7.4	18.8	7.8	15.1	13.3	1.8	1.5	0.2	3.0	2.5	3.8	2.0	1.5	2.5	1.8	2.6	1.4	1.8	0.7	2.0	1.9	2.6	0.7	1.2	10.1	16.5	12.2	20.3	9.0	9.2	9.0	9.4	13.8	10.9
POLR3A	"hRPC155, RPC1, RPC155"	ENSG00000148606	"RNA polymerase III subunit A"	O14802	10	77969251-78029545	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037926	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA037926: AB_10672400"	"unprognostic (6.83e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (3.64e-6)"	"unprognostic (3.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.11e-2)"	7.1	10.2	10.3	8.3	21.7	5.9	10.6	22.2	29.7	9.2	8.1	12.8	7.4	8.6	9.4	13.3	8.6	8.5	7.4	7.4	9.4	9.6	9.3	9.3	6.8	8.7	8.1	11.0	11.5	10.7	13.8	17.3	10.1	20.4	10.2	10.7	10.4	8.6	8.2	17.6	11.2	7.8	9.7	6.6	8.9	8.2	11.7	9.8	12.6	9.6	4.4	13.4	7.9	8.0	7.5	5.4	8.0	6.4	6.5	8.8	3.6	7.3	8.8	9.3	15.4	6.1	7.9	6.2	8.4	11.0	10.9	10.8	11.5	5.3	9.1	5.2	7.3	8.6	16.1	9.2	13.3	6.7	11.8	7.3	7.0	14.2	5.8	12.5	6.2	6.7	6.6	19.3	18.0	9.5	13.6	5.7	10.5	5.4	9.4	8.0	10.1	40.0	9.0	5.9	5.9	5.4	4.8	8.5	10.8	8.1	15.1	8.6	11.2	6.6	10.4	7.0	6.8	7.6	16.6	8.9	9.3	11.1	12.5	13.2	3.4	8.0	5.2	2.9	7.8	6.4	7.6	5.6	6.0	7.2	4.8	7.5	5.7	6.6	3.3	6.5	5.4	5.4	8.8	3.6	10.3	21.7	22.2	29.7	9.4	9.6	8.1	11.0	20.4	9.8
POLR3B	"FLJ10388, RPC2"	ENSG00000013503	"RNA polymerase III subunit B"	Q9NW08	12	106357658-106510198	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036466	Supported		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA036466: AB_10671842"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.09e-2)"	"prognostic favourable (1.21e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	6.4	14.0	7.1	7.9	14.6	6.5	6.9	8.6	13.6	8.6	7.2	8.2	5.7	6.0	10.1	7.2	14.8	7.7	5.8	8.2	8.9	7.1	9.9	17.5	7.1	11.4	6.2	10.4	11.3	11.9	22.5	17.0	22.9	12.3	8.0	8.3	6.2	8.6	9.9	12.1	15.3	5.7	7.8	6.0	6.4	7.5	9.9	4.7	10.3	8.5	10.2	10.0	7.3	10.1	4.3	4.9	9.8	4.1	3.7	6.3	3.1	11.1	5.3	11.8	5.6	10.5	9.6	16.4	15.7	9.5	10.9	8.5	9.7	3.1	14.2	5.6	9.7	10.4	13.6	13.4	13.6	11.5	9.1	11.3	7.1	8.2	6.7	17.9	12.3	8.5	9.6	10.9	12.7	8.1	16.6	4.7	8.3	8.2	13.0	6.0	12.7	19.9	7.9	7.0	9.3	6.2	15.2	12.8	7.0	9.6	12.9	9.2	12.0	5.3	7.7	6.0	7.1	9.7	9.0	5.8	14.8	21.2	2.9	11.1	6.4	9.8	3.9	2.6	4.1	4.1	5.5	4.3	4.5	4.3	4.9	2.6	6.3	3.9	2.6	3.7	4.0	1.8	4.7	3.1	7.1	14.6	8.6	13.6	8.9	7.1	6.2	10.4	12.3	4.7
POMGNT2	"AGO61, C3orf39, FLJ14566, GTDC2"	ENSG00000144647	"Protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)"	Q8NAT1	3	43079232-43106076	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034870, HPA040989"	Uncertain				"Intracellular and membrane"					"HPA034870: AB_10602701, HPA040989: "	"unprognostic (2.37e-3)"	"unprognostic (8.22e-2)"	"prognostic favourable (8.13e-5)"	"unprognostic (2.57e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (1.26e-5)"	"unprognostic (8.71e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.01e-1)"	"prognostic favourable (4.00e-7)"	"unprognostic (4.98e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.57e-1)"	8.4	12.7	13.9	4.1	20.2	16.6	6.8	28.4	32.7	14.2	7.1	13.1	6.2	3.8	28.2	12.0	7.9	21.7	10.3	15.6	12.5	13.2	7.8	6.8	7.3	2.9	10.6	12.3	21.1	14.7	14.0	10.6	5.6	13.5	10.6	3.2	11.1	13.5	15.8	15.0	7.2	4.1	20.1	7.3	4.4	7.4	9.1	8.8	4.4	10.6	3.4	3.4	7.6	7.6	2.9	1.2	1.0	0.9	1.6	5.7	1.8	11.4	8.8	5.1	15.5	19.7	5.1	8.1	3.3	6.0	11.8	13.9	10.6	8.1	0.0	12.5	6.0	0.2	8.3	9.6	5.2	0.0	23.3	8.1	7.0	10.1	7.5	5.6	9.7	5.9	7.1	7.9	4.7	4.5	6.6	0.0	4.6	6.8	10.2	1.5	11.2	16.5	4.0	3.6	7.2	6.9	8.4	8.1	7.4	6.9	5.6	6.3	10.7	5.0	2.1	9.6	13.5	14.0	13.5	8.7	13.0	0.1	12.3	11.4	10.1	0.0	0.9	1.0	5.7	0.8	5.1	2.9	3.8	3.8	1.1	1.9	4.9	3.8	0.0	1.6	0.8	1.2	2.9	1.8	13.9	20.2	28.4	32.7	12.5	13.2	10.6	12.3	13.5	8.8
POMK	"FLJ23356, SgK196"	ENSG00000185900	"Protein-O-mannose kinase"	Q9H5K3	8	43093506-43123434	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013321	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA013321: AB_2668809"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.10e-2)"	4.7	5.5	9.8	5.6	14.3	12.5	5.1	12.3	18.6	6.9	4.8	8.3	2.2	4.5	6.9	4.4	7.1	6.2	4.8	3.8	7.7	7.0	3.4	4.5	5.5	6.0	4.8	11.1	5.8	9.3	6.3	7.4	6.1	10.5	5.6	5.9	6.1	6.8	4.0	6.2	7.1	5.6	6.4	6.7	7.6	6.8	7.1	7.2	7.5	7.4	3.2	7.4	4.6	5.0	2.6	2.6	6.7	2.9	1.0	3.3	1.3	3.5	7.5	5.8	15.1	2.8	3.4	5.5	2.1	3.1	5.5	4.0	5.5	9.1	4.9	4.6	3.8	5.8	8.2	6.3	5.3	1.9	1.4	13.9	5.5	2.4	2.0	4.7	7.8	3.8	2.7	7.3	5.3	5.4	3.2	14.8	3.7	1.6	9.9	2.0	11.8	1.0	6.8	6.8	2.8	1.5	9.8	5.6	4.1	9.1	3.1	3.0	9.7	3.2	7.4	8.4	8.4	8.6	4.2	4.8	8.5	9.3	3.5	3.2	9.9	0.8	2.9	1.9	2.3	2.4	3.3	1.8	1.3	1.3	2.6	2.6	1.8	2.3	6.7	1.0	1.5	2.5	1.1	1.3	9.8	14.3	12.3	18.6	7.7	7.0	4.8	11.1	10.5	7.2
POMT1	LGMD2K	ENSG00000130714	"Protein O-mannosyltransferase 1"	Q9Y6A1	9	131502902-131523806	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065252			Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA065252: "	"unprognostic (2.00e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.76e-3)"	"unprognostic (2.84e-1)"	"prognostic favourable (3.90e-5)"	"unprognostic (8.36e-2)"	"prognostic favourable (4.68e-5)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-1)"	9.5	12.3	21.6	10.6	18.8	10.2	10.2	34.2	22.4	10.0	12.1	16.9	14.6	11.2	15.0	14.6	8.8	14.6	13.0	15.2	25.8	17.9	13.8	12.8	10.6	13.2	15.0	16.5	17.2	16.9	17.1	18.0	12.9	15.2	16.0	11.6	13.3	19.5	17.1	28.2	16.6	11.9	12.1	13.4	12.3	10.7	49.9	13.4	8.7	11.6	5.5	11.0	7.8	9.5	2.8	5.1	3.4	3.8	3.8	10.8	4.9	6.7	10.7	9.8	16.4	12.6	10.2	17.7	7.8	9.6	12.4	8.5	11.2	9.4	2.1	9.4	17.9	15.1	11.9	8.4	6.5	11.0	17.1	3.8	25.3	7.8	14.9	9.9	8.6	7.1	7.6	8.2	2.8	10.7	6.8	11.4	12.4	17.9	9.3	22.6	5.6	13.5	10.8	9.2	16.0	10.9	2.0	11.0	9.8	13.2	15.3	7.7	22.5	10.0	11.6	9.8	2.1	17.7	6.5	7.1	6.2	3.5	5.8	18.6	8.0	0.0	3.8	3.4	7.4	3.6	10.8	2.8	7.2	7.4	5.1	2.7	6.7	5.5	0.5	3.8	3.3	3.1	7.6	4.9	21.6	18.8	34.2	22.4	25.8	17.9	15.0	16.5	15.2	13.4
POMT2	LGMD2N	ENSG00000009830	"Protein O-mannosyltransferase 2"	Q9UKY4	14	77274956-77320884	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003663	Uncertain									"HPA003663: AB_1079655"	"unprognostic (2.15e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (7.10e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.94e-3)"	"unprognostic (8.50e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.75e-3)"	"unprognostic (3.46e-2)"	6.7	10.8	10.4	6.8	11.4	3.8	7.7	12.5	13.3	6.8	6.3	18.0	9.8	4.6	6.9	17.1	5.7	8.7	6.9	7.7	9.3	7.7	8.1	8.3	6.2	3.0	11.7	6.2	7.6	10.6	14.7	16.1	11.4	9.7	7.3	5.8	8.2	10.1	12.3	17.0	4.3	4.6	7.8	8.4	5.2	5.6	30.9	14.4	2.5	11.5	4.9	3.8	5.7	5.0	1.4	1.9	0.8	1.9	0.0	1.7	0.4	10.6	13.6	13.3	15.0	9.5	7.6	10.6	9.4	7.7	14.0	12.0	6.7	9.6	3.1	7.6	8.8	11.9	6.2	9.4	9.8	4.7	8.5	1.9	6.8	5.5	11.6	2.1	6.4	7.7	10.0	13.1	12.9	8.1	5.0	7.5	9.2	21.0	3.6	10.3	3.7	11.6	3.6	12.9	2.9	14.6	7.8	11.2	11.0	6.1	10.4	7.8	10.7	4.5	6.7	10.6	16.8	12.2	8.2	4.9	9.6	1.4	5.4	3.3	9.3	0.0	0.4	0.0	1.7	1.9	0.4	1.4	0.0	0.3	0.9	0.2	0.1	0.0	0.8	0.0	0.8	1.9	0.0	0.4	10.4	11.4	12.5	13.3	9.3	7.7	11.7	6.2	9.7	14.4
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324707	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 144.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.4;RH-30: 1.0"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001610	Approved				"Secreted to blood"	24000000000	24000000000			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favourable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	1.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	144.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.0	1.0	0.1	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.2	0.0	1.0	0.0	0.0	0.3	0.6	0.1	0.0	0.3	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.2	0.9	0.3	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
POP1		ENSG00000104356	"POP1 homolog, ribonuclease P/MRP subunit"	Q99575	8	98117297-98159834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066194			Supported	Nucleoli				Nucleoli		"HPA066194: "	"prognostic unfavourable (2.54e-4)"	"unprognostic (9.42e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.46e-2)"	"prognostic unfavourable (1.26e-6)"	"prognostic unfavourable (9.88e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (5.97e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-1)"	6.1	5.5	7.8	9.0	9.7	3.7	5.8	14.3	10.2	4.3	5.4	5.2	2.7	4.3	6.0	4.2	9.1	6.6	3.9	5.0	5.7	4.7	10.5	6.4	5.2	9.1	4.1	7.6	8.4	5.8	7.6	11.1	3.5	7.4	5.0	13.8	6.2	5.1	4.2	5.7	8.2	5.1	5.2	4.0	8.8	5.7	11.8	6.2	8.8	5.0	5.6	11.3	4.3	5.0	10.5	7.7	10.9	7.4	4.1	9.8	2.5	12.6	7.6	8.3	7.7	2.9	2.1	5.5	10.9	9.2	11.4	8.5	7.8	8.2	8.9	15.7	7.9	8.5	24.2	10.8	12.3	6.4	10.2	17.8	6.1	5.3	1.3	9.4	11.2	1.7	2.0	12.6	5.0	8.8	9.7	8.1	10.6	10.1	13.6	4.8	6.3	10.6	11.3	4.9	6.4	8.3	6.8	20.0	4.7	5.0	8.5	3.8	11.6	3.5	12.0	10.0	7.2	12.6	21.5	8.1	7.6	19.2	7.8	10.2	8.7	10.9	6.7	4.6	9.8	7.4	7.8	6.2	7.1	6.5	6.2	10.5	9.3	8.6	0.9	4.1	3.4	7.7	5.9	2.5	7.8	9.7	14.3	10.2	5.7	4.7	4.1	7.6	7.4	6.2
POR	"CYPOR, FLJ26468"	ENSG00000127948	"Cytochrome p450 oxidoreductase"	P16435	7	75899200-75986855	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004372, HPA010136"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"CAB004372: AB_627391, HPA010136: AB_1079657"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.67e-2)"	"prognostic unfavourable (8.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (9.89e-2)"	12.8	48.2	7.4	7.5	10.8	3.6	15.0	5.3	16.4	11.0	20.8	9.6	32.1	24.9	9.0	8.2	13.4	12.8	9.9	8.4	7.1	7.2	12.0	78.4	13.7	9.9	5.2	10.1	14.4	12.8	12.1	18.5	18.6	7.1	9.3	5.3	10.8	7.8	58.7	13.1	10.0	24.3	7.0	5.2	11.7	9.8	22.4	5.0	8.2	33.3	9.9	8.6	9.8	10.2	5.7	20.6	26.7	18.4	11.2	9.9	13.9	12.7	27.9	12.8	23.7	48.5	18.4	21.4	5.3	17.5	10.1	14.1	20.9	56.7	12.2	4.9	11.6	6.2	16.8	8.4	4.3	10.4	12.4	5.6	8.2	38.7	33.7	5.6	10.1	37.8	10.6	13.3	9.7	9.4	16.9	5.3	9.1	18.7	6.1	10.1	15.9	15.8	8.7	8.4	13.1	11.4	15.4	13.4	12.8	14.4	73.3	19.3	21.0	9.6	8.4	9.5	10.5	14.3	10.5	5.2	8.0	8.3	13.4	8.6	12.2	26.7	18.4	25.3	9.9	17.7	8.3	5.4	8.4	9.2	20.6	5.7	8.4	7.1	24.3	11.2	13.0	5.8	8.7	13.9	7.4	10.8	5.3	16.4	7.1	7.2	5.2	10.1	7.1	5.0
PORCN	"DHOF, MG61, por, PORC, PPN"	ENSG00000102312	"Porcupine O-acyltransferase"	Q9H237	X	48508962-48520814	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 59.9;LHCN-M2: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049215, HPA058413"	Enhanced		Approved	Vesicles				Vesicles		"HPA049215: , HPA058413: "	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.35e-1)"	4.6	31.4	9.1	4.4	14.1	3.6	4.4	20.0	15.4	12.6	4.6	7.2	12.2	3.4	10.1	3.2	13.9	7.0	6.2	13.4	10.9	9.2	3.3	1.7	5.0	6.6	7.1	8.8	4.9	4.6	6.9	4.1	4.0	8.4	5.0	2.5	7.6	5.8	16.4	5.9	6.8	2.9	6.3	5.5	4.8	5.4	5.4	5.9	2.6	8.5	4.7	5.9	6.5	5.4	4.1	7.2	13.7	5.8	7.8	12.0	4.7	4.3	5.2	1.3	9.1	5.6	3.3	0.5	1.2	2.6	2.0	1.3	0.6	6.7	0.3	5.5	2.8	5.9	1.8	59.9	0.6	2.7	0.6	0.7	3.2	1.2	8.3	0.7	7.8	4.3	7.1	5.8	12.6	1.8	0.3	4.1	20.8	1.2	0.6	0.9	1.6	3.5	1.3	1.6	6.7	3.3	1.7	1.5	2.2	10.4	2.0	2.0	2.3	0.3	1.0	5.2	2.7	12.5	2.2	3.6	2.0	0.5	15.0	1.6	2.9	13.7	5.8	7.1	12.0	5.2	9.4	3.7	8.0	10.0	7.2	4.1	5.4	8.1	1.2	7.8	4.2	3.9	5.2	4.7	9.1	14.1	20.0	14.4	10.9	9.2	7.1	8.8	8.4	5.9
PPA2	FLJ20459	ENSG00000138777	"Pyrophosphatase (inorganic) 2"	Q9H2U2	4	105369077-105474081	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030888, HPA031671, HPA031672"	Supported		Approved	Nucleoplasm,Mitochondria		8300	8300	Mitochondria	Nucleoplasm	"HPA030888: , HPA031671: AB_10603986, HPA031672: AB_2673988"	"prognostic unfavourable (2.98e-4)"	"unprognostic (5.64e-2)"	"prognostic favourable (6.60e-4)"	"unprognostic (9.26e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.54e-2)"	"prognostic favourable (1.27e-11)"	"unprognostic (3.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	9.2	18.0	18.4	17.2	15.4	24.0	20.6	12.3	17.6	10.2	19.8	9.3	20.3	18.1	13.3	20.7	14.8	10.7	18.7	42.5	15.6	15.3	23.7	21.2	23.1	34.8	17.2	12.1	9.5	25.0	10.4	15.0	9.3	15.4	16.1	16.7	12.6	21.4	26.8	29.6	15.0	16.8	22.8	12.4	12.1	15.0	9.7	10.7	9.4	14.3	28.2	10.6	12.2	9.5	20.0	35.3	14.7	20.8	22.0	17.0	14.6	11.5	5.5	10.7	18.1	6.8	5.5	7.8	6.5	8.6	8.0	5.7	12.1	17.0	9.5	8.7	5.3	5.8	21.4	10.3	9.5	13.4	7.6	8.5	8.9	11.0	5.4	20.1	8.2	5.3	10.7	5.5	4.3	7.7	14.1	13.1	7.3	14.6	17.1	14.5	7.8	18.7	15.2	6.6	9.3	26.5	8.9	11.0	6.6	4.5	26.7	9.4	14.0	16.4	4.1	5.8	11.3	6.2	11.3	11.6	14.6	9.9	10.1	10.9	7.8	14.7	15.0	9.7	15.3	20.8	13.3	20.0	16.0	16.2	35.3	16.6	15.5	17.0	6.4	22.0	16.2	17.7	15.9	14.6	18.4	15.4	12.3	17.6	15.6	15.3	17.2	12.1	15.4	10.7
PPIB	"CYPB, OI9"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155812-64163205	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"	120000000	120000000	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favourable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavourable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	56.9	64.3	23.9	49.3	26.9	54.9	48.1	15.1	32.1	75.3	44.1	35.4	102.8	42.0	64.2	106.9	48.0	54.8	58.1	44.5	23.8	27.3	89.5	285.9	57.2	63.8	29.7	19.6	67.5	193.7	26.7	71.8	120.2	27.5	51.0	47.7	36.2	123.3	95.4	19.5	33.1	57.5	54.3	30.7	78.0	47.7	27.2	29.5	53.7	154.3	45.7	69.1	49.2	51.7	63.5	191.6	41.0	51.1	44.9	71.6	87.1	39.3	49.5	44.7	101.6	156.7	91.0	39.3	94.0	123.5	74.4	88.5	71.2	73.1	37.6	76.4	145.5	64.2	81.7	63.1	38.4	23.8	30.8	53.0	54.7	93.1	164.3	52.9	48.0	83.8	68.1	43.4	105.8	89.8	37.0	131.0	56.4	62.8	16.1	81.1	39.0	31.8	30.9	47.5	191.8	77.2	61.4	25.3	39.9	43.0	74.0	68.4	44.2	161.8	55.2	74.4	61.7	41.6	63.4	71.2	68.9	39.5	69.5	85.2	74.2	41.0	51.1	33.9	71.6	39.2	71.5	63.5	50.5	58.1	67.4	38.0	33.0	44.2	25.5	44.9	25.2	191.6	40.1	87.1	23.9	26.9	15.1	32.1	23.8	27.3	29.7	19.6	27.5	29.5
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022277	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA022277: AB_1858839"	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favourable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	12.2	7.0	6.1	5.7	9.2	13.6	11.9	30.8	6.6	11.1	10.0	10.6	7.8	7.6	12.0	8.3	8.6	11.1	8.3	5.8	7.7	4.4	7.4	7.4	9.2	7.9	10.3	4.6	17.3	12.3	8.1	8.9	18.5	8.8	9.3	9.4	8.2	8.1	6.8	9.7	8.1	8.1	8.2	7.3	9.2	7.3	16.2	12.5	15.5	8.7	6.9	7.0	7.8	11.3	7.3	13.1	20.5	13.2	6.8	8.3	6.8	2.7	5.4	6.1	5.2	4.1	2.5	7.9	4.3	2.8	2.8	4.0	5.5	1.6	7.8	3.5	2.9	2.9	3.9	1.8	3.8	1.4	8.7	5.6	5.4	6.4	3.4	2.2	4.3	2.2	2.9	4.1	2.4	6.3	4.1	3.3	3.0	26.5	6.1	3.4	2.6	4.2	7.4	7.8	4.7	2.5	3.4	8.4	6.1	5.7	1.9	1.3	2.3	3.0	4.6	3.6	10.0	2.8	2.3	5.3	5.6	5.9	1.4	2.3	2.8	8.2	13.2	14.1	6.7	10.2	5.9	7.3	5.6	6.1	13.1	5.9	6.1	6.2	20.5	6.8	6.1	5.8	8.3	6.8	6.1	9.2	30.8	6.6	7.7	4.4	10.3	4.6	8.8	12.5
PPM1K	"BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm"	ENSG00000163644	"Protein phosphatase, Mg2+/Mn2+ dependent 1K"	Q8N3J5	4	88257620-88284769	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 59.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 27.1;Karpas-707: 23.6;U-698: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020066, HPA020862, HPA023891"	Approved		Supported	Mitochondria				Mitochondria		"HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630"	"unprognostic (2.38e-2)"	"unprognostic (5.86e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.28e-1)"	3.6	6.1	19.2	8.8	17.2	5.9	9.3	21.1	26.8	12.9	3.8	12.5	2.5	3.0	21.8	5.5	7.6	14.1	6.0	59.1	23.1	14.6	11.8	5.1	6.5	14.5	21.6	15.9	22.0	7.3	10.4	8.4	6.4	17.0	11.1	4.3	4.7	7.1	5.3	8.3	1.9	6.7	18.2	15.0	10.9	5.4	12.3	19.4	7.3	5.4	1.9	15.8	6.5	8.1	31.8	38.8	5.5	3.4	7.9	16.1	7.1	2.1	0.7	2.8	4.9	4.2	5.5	1.1	3.4	6.3	11.6	13.7	5.6	0.5	27.1	3.8	2.2	0.2	8.2	2.6	4.6	20.9	3.4	4.8	2.1	5.0	3.3	6.6	2.6	3.6	1.3	7.1	6.2	1.9	7.2	23.6	3.3	3.1	8.7	3.6	1.7	1.1	5.0	4.6	10.3	4.0	0.9	2.2	1.9	2.1	0.2	2.5	11.2	1.8	0.3	4.0	2.1	1.3	2.0	7.4	6.8	22.7	4.4	5.4	6.7	5.5	2.9	2.3	12.4	3.4	16.1	30.4	11.8	12.4	5.5	31.8	11.7	14.1	0.9	7.9	0.9	38.8	13.3	7.1	19.2	17.2	21.1	26.8	23.1	14.6	21.6	15.9	17.0	19.4
PPOX	"PPO, VP"	ENSG00000143224	"Protoporphyrinogen oxidase"	P50336	1	161166410-161178013	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030123, HPA054287"	Uncertain		Supported	"Golgi apparatus,Vesicles"				Vesicles	"Golgi apparatus"	"HPA030123: AB_10603987, HPA054287: "	"unprognostic (1.17e-1)"	"unprognostic (4.73e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.12e-3)"	"prognostic unfavourable (9.89e-4)"	"unprognostic (6.12e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.80e-2)"	7.3	14.8	11.6	9.1	12.1	31.7	10.2	23.5	16.5	11.0	9.9	13.2	8.5	6.0	11.7	13.5	7.5	33.2	9.5	9.5	11.5	12.5	12.0	9.1	10.2	11.2	14.2	16.1	13.0	13.1	10.5	12.3	10.1	12.1	11.0	6.7	14.4	11.3	14.6	8.5	15.9	7.1	10.0	10.6	12.0	8.2	6.9	13.7	9.2	11.0	6.1	8.7	8.7	8.2	9.8	11.5	6.9	7.7	12.3	16.7	8.9	7.0	6.5	9.8	6.4	7.4	7.9	3.3	4.9	5.7	6.0	8.1	7.7	6.8	5.5	11.8	3.4	4.9	7.5	7.9	5.5	3.8	14.9	6.7	14.7	17.5	7.9	2.2	3.7	6.3	7.9	5.9	8.3	11.4	19.7	8.6	4.4	6.6	8.9	7.0	7.0	14.0	10.8	6.8	13.1	11.4	3.1	7.8	12.5	5.9	8.7	9.8	15.6	10.4	4.0	5.6	6.2	4.8	6.2	15.4	11.2	8.5	5.7	4.9	4.3	6.9	7.7	5.5	12.7	7.7	8.4	9.8	9.8	8.8	11.5	8.6	8.6	8.8	1.6	12.3	5.3	7.2	16.7	8.9	11.6	12.1	23.5	16.5	11.5	12.5	14.2	16.1	12.1	13.7
PPP1CB	"PP-1B, PP1B, PP1beta"	ENSG00000213639	"Protein phosphatase 1 catalytic subunit beta"	P62140	2	28751640-28802940	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022558, HPA065425, CAB069426"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		7700000	7700000	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB022558: , CAB069426: , HPA065425: "	"unprognostic (2.90e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (6.52e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.26e-2)"	28.5	22.6	30.0	20.5	37.6	29.5	32.4	19.1	29.8	51.1	39.3	21.1	30.7	24.4	58.0	31.8	86.0	37.0	33.3	67.1	27.8	27.9	32.0	20.0	35.3	22.3	27.4	24.4	39.7	21.9	48.9	28.7	42.3	22.0	46.4	27.7	25.2	36.5	38.6	99.6	25.1	30.0	100.8	27.5	25.2	31.4	25.5	21.4	28.1	27.5	32.9	25.3	82.1	50.5	15.6	25.4	41.5	42.7	23.5	28.3	17.9	36.4	23.0	80.2	24.8	27.5	25.6	46.7	19.6	22.4	19.1	18.9	20.4	21.6	29.2	24.7	20.3	22.6	22.8	26.2	22.8	46.3	11.8	22.0	28.2	22.0	59.9	24.9	10.4	19.6	37.3	20.6	43.2	23.1	20.0	29.0	25.0	18.3	26.4	21.6	26.3	18.2	26.0	71.1	22.2	62.2	44.1	22.0	27.2	30.5	33.9	26.6	16.4	14.0	27.6	25.6	28.2	18.3	23.6	20.7	32.5	59.8	27.2	26.9	18.9	22.5	24.8	32.1	16.8	37.8	21.3	15.6	25.5	19.6	25.4	13.4	22.7	25.5	41.5	23.5	42.7	19.6	28.3	17.9	30.0	37.6	19.1	29.8	27.8	27.9	27.4	24.4	22.0	21.4
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.8"	"Low cell line specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol		35000	35000	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavourable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	12.2	9.2	22.7	7.4	71.8	7.7	10.6	42.1	52.4	9.4	9.5	4.8	9.8	5.8	6.2	6.9	7.4	7.2	6.8	4.3	36.0	13.5	5.8	8.4	10.0	6.7	10.1	22.1	9.6	4.7	7.0	4.2	6.6	11.9	34.6	8.4	2.6	10.4	21.1	23.7	11.4	6.4	7.9	7.5	6.9	11.0	5.3	13.0	3.8	6.8	6.8	8.9	8.4	6.8	27.7	18.3	44.3	14.9	22.3	15.5	6.6	19.4	13.8	3.8	7.4	21.6	16.4	7.4	21.4	19.7	8.7	9.2	7.9	24.3	9.2	9.0	19.3	9.7	13.9	28.5	14.8	22.6	6.4	14.7	19.7	10.2	15.8	23.5	7.5	16.9	15.0	18.9	21.7	16.3	5.7	25.5	13.9	23.3	4.9	17.7	6.4	8.9	9.0	34.9	10.7	8.4	15.4	30.3	11.5	17.7	15.2	10.2	13.6	13.4	18.9	20.6	23.4	18.8	14.1	11.9	12.2	16.4	11.4	13.3	5.5	24.6	11.8	24.8	13.6	11.4	15.5	27.7	12.9	13.1	9.9	23.4	6.2	12.3	44.3	22.3	14.9	18.3	8.6	6.6	22.7	71.8	42.1	51.5	36.0	13.5	10.1	22.1	11.9	13.0
PPT1	"CLN1, INCL, PPT"	ENSG00000131238	"Palmitoyl-protein thioesterase 1"	P50897	1	40071461-40097727	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 86.0;THP-1: 159.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021546	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	130000	130000	"Golgi apparatus, Vesicles"		"HPA021546: AB_1855667"	"unprognostic (5.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavourable (6.98e-8)"	"unprognostic (1.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.08e-2)"	33.3	27.1	37.6	31.0	41.5	33.3	39.7	35.2	41.0	30.3	21.0	31.5	17.2	12.9	31.3	19.4	18.5	20.7	23.2	18.1	32.7	35.8	29.4	18.4	47.3	48.5	35.3	29.1	24.7	17.4	30.4	21.2	25.9	34.6	28.0	26.0	26.3	22.1	23.6	8.3	13.8	16.6	36.5	33.6	61.3	17.9	13.8	29.1	19.8	18.7	14.4	30.0	23.0	19.8	9.3	77.4	59.9	90.0	7.2	19.1	91.6	10.0	6.8	11.0	6.2	13.3	11.4	21.6	5.6	10.2	13.6	16.8	39.2	16.9	11.5	11.0	5.9	17.7	17.1	10.1	18.7	14.5	17.6	6.0	16.8	19.3	15.1	13.5	14.5	10.7	11.1	10.8	10.1	18.3	13.9	16.8	7.6	20.1	7.7	10.1	20.8	10.6	8.7	14.8	20.0	9.5	18.0	8.8	9.3	11.0	86.0	34.2	12.5	159.9	6.4	6.6	14.2	6.2	16.7	15.1	31.6	11.1	8.5	33.0	12.0	6.2	90.0	48.2	9.9	77.6	11.8	9.3	14.7	11.5	77.4	9.2	19.1	14.7	59.9	7.2	58.3	7.6	16.8	91.6	37.6	41.5	35.2	41.0	32.7	35.8	35.3	29.1	34.6	29.1
PRDM6	"KMT8C, PRISM"	ENSG00000061455	"PR/SET domain 6"	Q9NQX0	5	123089121-123194266	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 19.7;smooth muscle: 29.7;urinary bladder: 18.4;vagina: 18.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.8;HEK 293: 9.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"pons and medulla: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA030324	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA030324: AB_10670032"	"unprognostic (2.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.12e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-7)"	"unprognostic (9.30e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-4)"	"unprognostic (1.27e-1)"	1.3	0.3	0.3	0.6	0.3	0.0	1.4	0.4	0.5	1.6	6.7	0.4	0.3	0.4	1.8	0.6	1.2	0.6	19.7	0.9	0.4	0.3	0.6	0.3	10.6	0.0	0.5	0.4	3.8	0.5	0.3	0.5	8.1	3.6	14.1	1.9	0.0	0.3	0.8	0.2	0.4	1.0	29.7	0.8	0.1	1.1	0.5	0.0	0.0	1.4	0.2	0.6	18.4	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.6	0.9	6.8	0.1	0.0	0.0	0.1	0.1	0.3	0.1	0.2	0.5	0.0	1.4	0.0	0.0	0.3	9.6	2.0	0.9	0.0	2.0	0.0	0.3	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	1.1	0.4	0.1	1.5	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.5	0.4	0.3	0.5	0.4	3.6	0.0
PREPL	KIAA0436	ENSG00000138078	"Prolyl endopeptidase like"	Q4J6C6	2	44316281-44361862	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063238	Approved									"HPA063238: "	"unprognostic (5.60e-3)"	"unprognostic (9.81e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.53e-2)"	"unprognostic (5.98e-3)"	"unprognostic (4.38e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.75e-1)"	11.5	24.5	32.6	8.2	78.4	2.5	15.0	57.3	75.8	18.1	11.3	18.7	6.0	12.0	22.1	34.2	10.9	16.4	13.4	28.2	51.8	50.2	30.4	9.9	11.4	7.6	28.5	44.0	24.3	11.6	34.9	33.2	9.9	69.4	18.1	14.1	13.0	11.7	16.5	13.7	10.2	12.6	16.3	31.3	10.5	12.1	12.6	21.5	5.2	28.9	7.1	8.2	10.7	10.3	8.8	6.3	4.7	4.8	11.1	12.5	5.8	18.3	14.1	16.3	20.7	26.5	27.8	12.5	20.7	15.7	14.9	12.9	15.3	13.0	23.6	28.7	21.5	15.9	23.5	15.0	28.7	21.6	16.6	16.5	11.3	11.6	19.2	15.6	15.2	17.9	30.0	28.7	23.3	14.3	20.2	34.3	19.9	9.8	17.1	7.6	15.7	16.1	13.5	19.9	16.8	28.5	10.7	28.1	21.8	13.5	14.2	29.9	19.0	12.4	15.0	26.5	15.0	20.7	14.0	18.9	12.4	15.5	31.0	18.6	19.5	4.7	4.5	3.4	8.5	4.8	12.2	8.8	8.1	9.2	6.3	7.4	12.5	9.7	1.3	11.1	4.1	3.1	8.7	5.8	32.6	78.4	57.3	75.8	51.8	50.2	28.5	44.0	69.4	21.5
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602775	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Cytolysis		"Cancer-related genes, Disease mutation, Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 100.3;lymphoid tissue: 38.7"	"Cell line enriched"	"Detected in some"	11	"HDLM-2: 71.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"gdT-cell: 100.3;MAIT T-cell: 70.9;memory CD8 T-cell: 54.9;naive CD8 T-cell: 36.1;NK-cell: 65.1"	"Group enriched"	"Detected in many"	48	"NK-cells: 65.1;T-cells: 100.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"	960000	960000	Cytosol		"CAB002436: AB_563955, HPA037940: "	"unprognostic (6.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.71e-1)"	"prognostic favourable (2.09e-4)"	"unprognostic (1.87e-2)"	"prognostic favourable (3.54e-4)"	"unprognostic (6.98e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.69e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (1.08e-5)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.97e-3)"	"unprognostic (5.22e-3)"	8.8	1.3	0.9	5.5	1.1	15.3	2.4	0.5	0.7	1.7	3.8	0.4	0.2	1.4	4.4	2.9	2.7	1.7	5.3	4.1	0.8	0.9	1.8	6.5	19.6	11.3	2.5	0.3	2.1	1.6	0.0	1.1	3.1	1.2	3.3	0.8	3.9	2.5	3.3	2.6	0.9	5.1	1.2	1.4	38.7	3.1	1.6	0.2	12.7	2.8	1.0	10.3	3.2	1.7	0.4	0.3	1.7	0.2	65.1	100.3	46.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.4	0.0	2.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.2	0.0	100.3	0.1	70.9	0.4	14.6	54.9	0.2	0.2	6.2	36.1	1.7	65.1	0.2	0.3	11.1	46.7	0.9	1.1	0.5	0.7	0.8	0.9	2.5	0.3	1.2	0.2
PRKACA	PKACa	ENSG00000072062	"Protein kinase cAMP-activated catalytic subunit alpha"	P17612	19	14091688-14118084	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010361, HPA071185"	Approved		Approved	Cytosol		1300000	1300000	Cytosol		"CAB010361: AB_2268772, HPA071185: "	"unprognostic (1.08e-1)"	"prognostic favourable (6.28e-6)"	"unprognostic (2.09e-2)"	"prognostic unfavourable (6.26e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.41e-1)"	"prognostic favourable (6.47e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.14e-3)"	25.6	43.4	19.6	17.8	22.7	9.1	34.1	29.1	39.6	20.6	17.5	16.0	16.2	13.4	19.8	15.6	20.9	18.8	16.4	91.6	20.7	29.4	14.7	34.5	16.5	28.2	21.6	27.5	47.0	15.6	20.8	24.6	15.4	26.9	16.6	16.2	18.4	15.5	24.9	92.4	13.4	14.4	29.0	16.2	28.1	13.9	24.4	11.1	15.2	15.7	26.2	14.8	21.1	17.3	1.7	2.4	8.6	5.3	0.7	1.7	1.2	25.7	15.0	34.0	40.5	30.1	32.0	6.1	27.4	25.4	39.0	35.8	18.2	9.2	11.1	22.2	43.4	16.9	23.9	26.0	37.1	20.3	12.0	20.5	28.3	17.6	25.8	12.6	21.7	30.4	12.5	31.0	10.8	32.8	19.2	29.2	39.8	38.2	28.4	9.5	12.2	33.4	25.7	31.4	25.7	19.0	16.3	26.8	17.1	24.8	15.2	11.3	21.7	12.2	25.4	46.1	12.9	61.6	25.6	20.2	20.7	16.4	30.9	19.2	17.2	0.3	3.4	0.4	1.7	5.3	0.8	1.7	0.9	1.1	2.4	1.3	1.2	1.7	8.6	0.7	4.6	1.6	0.8	1.2	19.6	22.7	29.1	39.6	20.7	29.4	21.6	27.5	26.9	11.1
PRKACG	PKACg	ENSG00000165059	"Protein kinase cAMP-activated catalytic subunit gamma"	P22612	9	69012529-69014113	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 27.4"	"Cell line enhanced"	"Detected in single"		"CACO-2: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB004530, HPA071185"	Supported		Approved	Cytosol				Cytosol		"CAB004530: AB_628137, HPA071185: "					"unprognostic (2.74e-1)"									"unprognostic (3.61e-2)"	"unprognostic (7.22e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRKCD		ENSG00000163932	"Protein kinase C delta"	Q05655	3	53156009-53192717	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 63.3;THP-1: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 17.7;classical monocyte: 22.9;eosinophil: 17.0;intermediate monocyte: 22.2;myeloid DC: 17.6;neutrophil: 20.7;non-classical monocyte: 15.3;plasmacytoid DC: 8.5"	"Group enriched"	"Detected in all"	7	"dendritic cells: 17.6;granulocytes: 20.7;monocytes: 22.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 124.2;thalamus: 366.1"	"Low region specificity"	"Detected in all"			"HPA001863, HPA001890, CAB010469, CAB013225"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		300000	300000	Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628"	"unprognostic (3.59e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavourable (2.24e-4)"	"prognostic favourable (9.01e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.95e-3)"	27.8	33.4	9.4	29.7	11.5	30.3	17.6	5.7	10.7	10.3	27.8	10.1	43.7	21.4	5.5	21.3	18.3	16.1	33.7	11.9	8.3	3.7	16.5	4.5	29.2	24.5	10.2	5.6	8.1	13.4	6.1	5.1	7.5	7.1	17.9	16.1	10.3	14.1	40.7	3.9	17.1	42.9	17.4	10.2	32.1	24.8	9.6	8.0	10.5	26.9	13.4	26.3	22.9	12.7	3.1	17.6	20.7	22.9	2.4	1.5	6.4	7.7	3.0	1.2	2.0	9.0	5.2	11.2	4.7	5.9	5.8	5.7	7.3	7.6	20.0	2.1	10.2	3.5	7.9	11.5	4.7	17.4	6.0	11.1	4.1	7.8	5.7	14.6	25.1	4.1	8.4	5.9	5.5	5.0	2.2	2.9	8.3	19.1	1.6	24.9	3.1	5.5	1.7	3.0	4.7	6.3	16.7	2.0	1.4	3.6	63.3	9.7	5.3	45.2	7.2	2.8	3.6	3.7	4.4	4.4	6.8	10.2	6.7	25.2	5.4	17.7	22.9	17.0	1.5	22.2	1.0	3.1	1.1	1.2	17.6	2.9	0.8	0.7	20.7	2.4	15.3	8.5	1.1	6.4	9.4	11.5	5.7	10.7	8.3	3.7	10.2	5.6	7.1	8.0
PRKCG	"MGC57564, PKCC, PKCG, SCA14"	ENSG00000126583	"Protein kinase C gamma"	P05129	19	53879190-53907652	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 49.9"	"Cell line enhanced"	"Detected in some"		"A549: 5.8;HAP1: 2.7;SH-SY5Y: 4.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB013051, HPA047870, HPA054560"	Enhanced									"CAB013051: AB_2533015, HPA047870: , HPA054560: "	"unprognostic (7.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.38e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.22e-7)"	"unprognostic (2.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	1.0	0.9	28.0	1.1	49.9	2.2	0.9	12.1	39.2	0.9	1.3	1.6	0.0	1.5	1.0	0.9	1.0	1.4	1.0	0.9	49.7	4.4	0.9	0.9	1.0	0.9	2.9	20.8	0.9	3.5	2.1	0.2	0.9	0.7	0.9	1.2	0.0	0.9	1.0	1.0	0.9	1.3	1.1	1.4	0.9	1.8	4.4	2.1	1.3	0.9	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	5.8	1.3	0.0	0.0	0.2	0.1	0.7	0.4	0.1	0.0	1.5	1.5	0.3	1.7	0.0	0.5	2.7	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.1	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.1	1.0	0.5	1.0	0.6	0.1	1.1	0.0	0.0	4.0	1.6	0.2	0.0	1.9	0.0	1.0	0.0	2.0	0.0	0.0	1.7	0.4	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	49.9	12.1	28.5	49.7	4.4	2.9	20.8	0.7	2.1
PRKCH	"PKC-L, PKCL, PRKCL"	ENSG00000027075	"Protein kinase C eta"	P24723	14	61187559-61550976	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.9;HUVEC TERT2: 39.2;MOLT-4: 26.0;RT4: 16.5;TIME: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"gdT-cell: 30.0;MAIT T-cell: 23.9;memory CD4 T-cell: 23.0;memory CD8 T-cell: 35.3;naive CD4 T-cell: 28.5;naive CD8 T-cell: 27.6;NK-cell: 27.3;T-reg: 18.6"	"Group enriched"	"Detected in many"	14	"NK-cells: 27.3;T-cells: 35.3"	"Group enriched"	"Detected in many"	6	"basal ganglia: 25.0;thalamus: 19.5"	"Low region specificity"	"Detected in many"			"HPA026294, HPA053709"	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA026294: AB_10603988, HPA053709: "	"unprognostic (1.42e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.04e-1)"	"prognostic favourable (8.55e-6)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.98e-2)"	"unprognostic (4.73e-3)"	17.5	5.4	5.0	21.6	22.0	11.2	14.7	2.8	6.1	13.6	10.3	6.2	6.9	5.1	19.1	7.0	20.1	8.6	12.7	10.1	6.8	4.4	8.1	5.5	24.1	27.6	5.9	2.5	7.1	5.9	8.8	15.5	22.7	7.2	9.8	5.0	9.1	24.7	10.8	9.1	15.9	16.0	10.5	5.7	25.9	6.0	4.3	6.4	54.6	15.1	10.6	34.6	13.2	14.4	0.4	2.2	1.5	0.7	27.3	35.3	17.9	6.2	2.2	0.3	1.7	1.0	0.2	29.9	0.1	0.5	0.3	0.3	0.6	3.7	0.1	4.5	0.0	4.4	0.2	4.8	0.5	0.7	2.8	0.0	0.7	0.2	0.4	0.0	0.9	0.8	5.0	0.2	3.4	39.2	0.0	0.1	2.2	11.5	26.0	0.2	0.5	3.0	2.2	1.1	0.0	0.0	16.5	1.1	1.9	0.7	5.8	3.6	5.7	0.5	25.7	0.7	5.2	0.7	0.3	0.5	0.1	0.2	1.1	0.3	1.2	0.1	0.7	0.5	30.0	0.4	23.9	0.4	23.0	35.3	2.2	0.3	28.5	27.6	1.5	27.3	0.2	0.7	18.6	17.9	5.0	22.0	2.8	6.1	6.8	4.4	5.9	2.5	7.2	6.4
PRKD1	"PKC-mu, PKCM, PKD, PRKCM"	ENSG00000184304	"Protein kinase D1"	Q15139	14	29576479-30191898	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.8;fHDF/TERT166: 19.0;HSkMC: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018367, HPA029834"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	Cytosol	"CAB018367: AB_2253119, HPA029834: AB_10602821"	"unprognostic (5.35e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (2.44e-5)"	"unprognostic (9.45e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (3.89e-1)"	7.4	10.6	8.0	5.3	9.7	0.7	19.0	4.9	8.9	5.1	8.7	5.1	24.1	3.1	8.3	9.0	3.5	6.8	9.0	6.3	9.8	5.9	15.1	2.3	14.9	1.6	5.6	6.6	15.7	7.3	35.7	9.2	4.5	10.8	20.1	3.5	4.9	3.5	24.4	3.1	2.7	3.5	19.7	16.4	2.4	4.8	16.1	8.6	0.5	8.2	2.9	1.8	14.1	12.2	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.6	4.0	17.8	16.7	0.1	12.1	9.3	12.4	6.7	0.0	0.5	0.0	1.2	19.0	0.1	5.9	1.4	6.8	0.0	4.1	0.0	0.1	0.4	9.0	0.0	0.1	17.7	0.6	0.8	1.4	2.5	1.2	0.4	11.6	1.3	0.0	0.0	2.5	6.2	0.0	7.0	3.2	13.2	5.6	3.6	7.1	2.1	0.0	4.7	0.0	0.1	6.3	11.7	4.8	1.0	3.5	0.0	0.0	0.0	3.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	8.0	9.7	4.9	8.9	9.8	5.9	5.6	6.6	10.8	8.6
PRKDC	"DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, p350, XRCC7"	ENSG00000253729	"Protein kinase, DNA-activated, catalytic polypeptide"	P78527	8	47773108-47960183	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005167, HPA035174"	Supported		Enhanced	Nucleoplasm		1100000	1100000	Nucleoplasm		"CAB005167: AB_2172845, HPA035174: "	"unprognostic (3.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.70e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.76e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.15e-2)"	21.3	20.5	16.0	22.3	22.0	27.4	30.2	16.5	23.1	19.6	20.6	17.3	18.1	12.0	26.2	14.5	27.4	24.4	13.0	21.1	20.8	15.2	16.7	18.4	17.0	33.6	16.6	18.2	24.6	23.8	33.4	29.4	20.5	17.3	17.9	20.3	17.8	17.9	17.8	34.0	23.9	18.4	27.0	20.3	24.4	19.1	20.5	15.9	44.4	20.8	15.9	27.9	21.3	19.1	17.0	13.9	7.1	11.5	11.5	11.3	2.3	32.4	27.8	27.1	25.7	16.9	17.9	11.5	13.8	13.6	19.5	19.2	18.1	10.7	31.0	12.0	16.9	18.5	35.8	18.9	30.6	6.8	22.2	60.9	25.0	22.2	7.3	23.1	12.7	12.9	6.2	30.7	32.2	20.0	40.5	13.1	21.4	15.2	32.6	19.1	29.8	8.4	16.0	21.3	10.9	9.8	28.0	13.6	17.3	42.6	13.9	13.4	19.9	16.0	23.2	25.5	21.7	20.1	27.7	11.5	14.6	44.6	14.4	26.3	20.6	6.7	8.1	3.5	8.7	6.3	10.9	12.6	10.8	8.8	5.9	17.0	11.3	10.3	7.1	11.5	11.5	13.9	7.4	2.3	16.0	22.0	16.5	23.1	20.8	15.2	16.6	18.2	17.3	15.9
PRKG1	"PGK, PKG, PRKG1B, PRKGR1B"	ENSG00000185532	"Protein kinase, cGMP-dependent, type I"	Q13976	10	50990891-52298350	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.3;BJ hTERT+: 15.5;fHDF/TERT166: 12.9;U-138 MG: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"basophil: 8.0"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007699, CAB009629"	Enhanced		Approved	Vesicles,Cytosol		33000	33000	"Vesicles, Cytosol"		"CAB009629: AB_2170663, HPA007699: AB_1079677"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.94e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.78e-4)"	8.0	10.9	5.2	6.6	7.3	0.8	6.9	2.8	5.4	19.2	14.4	2.1	6.8	2.9	22.8	10.7	6.0	9.9	12.6	14.8	7.0	4.9	4.4	2.1	19.5	2.6	3.1	4.8	8.9	2.6	13.7	8.4	11.0	4.6	9.5	6.2	6.2	6.4	9.4	24.9	2.8	5.3	28.2	2.7	2.7	5.9	5.0	3.1	0.2	9.2	12.7	1.2	13.4	15.8	0.1	0.1	8.0	0.1	0.3	0.0	0.1	0.0	0.1	1.4	11.3	5.4	5.2	0.0	4.9	15.5	1.6	2.3	0.1	0.7	0.2	0.0	12.9	0.1	0.0	0.0	1.4	0.0	4.2	0.8	0.3	0.0	4.7	0.0	0.0	6.6	0.0	4.1	0.1	0.0	0.0	0.1	4.3	0.1	0.0	0.0	3.2	1.9	0.0	3.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.1	0.1	0.0	0.0	9.5	1.7	4.8	2.9	1.2	0.5	0.0	8.4	0.0	2.0	8.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.0	0.1	5.2	7.3	2.8	5.4	7.0	4.9	3.1	4.8	4.6	3.1
PRKN	"AR-JP, PARK2, parkin, PDJ"	ENSG00000185345	"Parkin RBR E3 ubiquitin protein ligase"	O60260	6	161347420-162727771	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.6;HEL: 9.0;Karpas-707: 5.7;RPMI-8226: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016257, HPA036012"	Enhanced		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB016257: AB_628104, HPA036012: "	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.16e-2)"	"prognostic favourable (6.75e-12)"	"unprognostic (9.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-1)"	6.8	7.1	7.9	2.3	12.2	1.5	4.2	7.2	13.4	5.3	4.3	6.3	4.6	2.8	7.8	4.4	6.1	3.4	4.3	17.7	9.2	6.2	17.4	3.6	2.6	3.0	5.8	5.2	6.4	3.0	5.6	8.6	2.0	5.5	4.0	2.4	8.3	3.5	4.8	41.8	4.0	3.3	6.6	5.9	2.7	3.5	10.3	6.8	0.6	3.8	4.7	2.7	4.9	2.1	4.6	1.2	4.2	0.8	1.8	4.6	1.3	0.0	0.3	1.2	3.6	0.9	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.2	0.0	0.0	0.2	0.2	0.0	0.4	0.6	9.0	0.2	0.0	0.8	0.2	0.1	3.1	0.1	0.0	0.5	0.0	0.4	5.7	0.9	0.5	0.1	0.1	0.2	0.8	0.0	0.0	5.7	0.6	0.1	0.9	2.5	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.3	0.1	0.3	0.8	0.1	0.0	0.1	0.1	2.2	2.8	0.8	4.2	2.1	0.5	3.5	1.5	2.0	2.2	1.2	4.6	4.4	4.6	1.5	1.8	0.4	0.3	0.2	1.3	7.9	12.2	7.2	11.7	9.2	6.2	5.8	5.2	5.5	6.8
PRKX	PKX1	ENSG00000183943	"Protein kinase, X-linked"	P51817	X	3604370-3713608	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015324	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA015324: AB_1855715"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.70e-2)"	4.3	1.3	12.3	7.5	15.8	5.4	11.2	4.4	12.3	6.9	5.2	5.4	11.5	4.1	7.3	8.4	13.6	16.5	3.9	4.0	14.0	7.4	14.2	2.0	8.4	9.5	27.9	5.6	4.8	4.1	3.2	2.3	6.6	22.7	3.7	5.2	3.1	6.5	5.3	1.6	9.9	6.0	3.0	17.6	10.0	3.1	6.1	22.7	6.1	28.8	3.2	8.0	3.7	11.2	2.5	2.8	12.2	4.1	3.3	3.8	1.7	4.5	4.2	11.6	8.6	2.2	3.0	10.6	2.7	1.0	1.3	1.8	6.2	3.1	0.4	2.7	2.1	3.1	10.8	8.1	2.3	5.0	7.5	5.0	3.2	0.1	2.3	6.4	38.9	2.0	8.7	1.4	5.4	13.1	5.8	6.5	4.4	3.9	7.3	5.8	7.7	4.8	13.7	11.1	8.5	10.7	3.8	7.8	5.0	2.8	1.8	2.7	1.4	5.1	7.1	1.2	2.0	1.9	1.8	0.1	0.3	5.8	0.7	5.8	3.0	12.2	3.1	1.8	3.5	3.3	3.8	2.5	3.7	3.3	2.3	2.4	3.1	3.3	0.8	3.3	4.1	2.8	2.5	1.7	12.3	15.8	4.4	12.3	14.0	7.4	27.9	5.6	22.7	22.7
PRMT7	"FLJ10640, KIAA1933"	ENSG00000132600	"Protein arginine methyltransferase 7"	Q9NVM4	16	68310974-68358563	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044241	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA044241: "	"unprognostic (9.33e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.52e-1)"	"prognostic favourable (2.31e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.31e-1)"	14.8	14.4	15.6	12.7	22.0	11.1	12.9	29.4	20.5	11.4	11.7	20.2	13.9	7.0	18.9	11.9	12.7	18.1	9.3	23.1	14.4	13.1	9.5	12.2	9.7	17.0	11.2	18.7	21.9	14.8	12.0	14.0	11.4	13.3	12.8	7.6	20.8	17.3	16.2	34.0	16.9	9.9	18.5	11.6	12.4	9.9	17.0	13.1	24.4	11.1	12.0	14.9	13.3	10.4	10.8	26.2	9.9	8.5	18.6	18.1	11.5	10.1	16.5	7.8	19.7	7.5	7.1	26.3	10.2	5.5	12.9	10.7	41.6	10.2	21.6	17.1	8.6	13.2	11.1	10.3	7.1	7.7	16.7	6.4	18.5	18.8	5.5	11.8	10.0	7.8	4.4	10.6	10.0	7.7	15.1	1.2	7.0	17.0	14.5	18.2	12.9	11.2	19.5	11.5	14.6	6.0	9.3	10.8	8.4	34.0	8.6	6.9	14.3	11.7	9.2	9.2	8.1	10.9	9.0	6.6	12.3	22.1	11.6	12.6	9.4	9.9	7.0	5.9	15.8	8.5	18.1	10.1	10.6	13.9	10.2	10.8	16.1	14.1	0.8	18.6	7.7	26.2	11.7	11.5	15.6	22.0	29.4	20.5	14.4	13.1	11.2	18.7	13.3	13.1
PRNP	"AltPrP, CD230, CJD, GSS, PRIP, PRP"	ENSG00000171867	"Prion protein"	P04156	20	4686236-4701590	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"	Prion	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 108.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 108.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042754, HPA043398"	Enhanced		Approved	"Nuclear membrane,Vesicles,Cytosol"	"Intracellular and membrane"	2200000	2200000	"Nuclear membrane, Cytosol"	Vesicles	"HPA042754: AB_10964203, HPA043398: "	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (2.96e-4)"	"prognostic unfavourable (4.64e-4)"	"prognostic unfavourable (2.52e-4)"	"unprognostic (1.94e-2)"	"prognostic unfavourable (7.41e-5)"	"unprognostic (7.60e-3)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.75e-2)"	"unprognostic (7.28e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.69e-2)"	24.6	27.3	63.4	14.2	73.1	19.8	30.5	87.5	116.1	42.0	43.4	61.6	8.5	10.6	36.3	17.7	23.0	24.1	31.4	54.1	64.6	48.9	38.5	22.2	22.2	14.7	47.2	65.6	49.6	11.8	20.7	24.9	18.7	71.6	43.8	20.9	34.1	17.1	45.0	21.8	26.7	13.5	40.8	53.1	20.3	18.1	19.1	51.4	2.9	25.6	11.8	16.4	27.0	22.3	4.6	10.5	108.1	11.7	3.6	16.7	10.0	24.2	20.0	4.6	7.1	37.3	22.8	4.1	40.2	57.9	19.5	19.9	6.6	18.8	4.4	9.3	78.3	56.5	5.0	54.7	36.6	3.6	4.3	0.0	2.3	20.6	45.9	7.9	1.8	20.6	78.9	83.4	65.2	16.7	2.3	15.8	22.4	5.4	3.1	4.8	3.7	29.8	3.8	12.2	4.0	9.8	4.3	5.4	0.8	11.4	16.0	57.1	3.3	4.1	25.1	31.8	14.6	17.7	32.6	7.3	14.7	14.8	25.6	5.8	114.4	108.1	11.7	0.8	11.9	9.7	16.7	4.2	9.8	9.4	10.5	4.6	5.8	6.8	0.7	3.6	7.6	3.7	11.4	10.0	63.4	73.1	87.5	90.4	64.6	48.9	47.2	65.6	71.6	51.4
PRODH	"HSPOX2, PIG6, PRODH1, PRODH2, TP53I6"	ENSG00000100033	"Proline dehydrogenase 1"	O43272	22	18912777-18936553	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 48.9"	"Cell line enriched"	"Detected in some"	8	"RPTEC TERT1: 28.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"											HPA020361	Approved									"HPA020361: AB_10963116"	"unprognostic (2.46e-2)"	"prognostic favourable (1.54e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.94e-2)"	3.8	2.3	20.8	2.8	19.3	2.0	3.3	9.8	21.3	2.0	3.5	16.2	0.1	13.8	2.3	2.2	8.8	2.4	2.2	4.6	22.2	10.8	9.9	6.6	8.6	2.3	14.9	21.8	2.4	2.2	1.9	1.5	2.4	13.5	2.6	2.6	7.4	2.1	2.4	15.5	13.0	48.9	1.9	12.6	2.2	2.1	3.5	9.8	0.1	4.3	4.1	3.7	2.1	2.3	0.4	0.4	0.0	0.0	1.0	0.3	0.0	0.0	0.6	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.3	0.0	2.1	2.9	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	3.4	0.0	0.0	0.0	0.3	28.8	0.6	0.1	0.2	0.6	0.9	0.2	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	20.8	19.3	9.8	21.3	22.2	10.8	14.9	21.8	13.5	9.8
PROKR2	"dJ680N4.3, GPR73b, GPR73L1, GPRg2, KAL3, PKR2"	ENSG00000101292	"Prokineticin receptor 2"	Q8NFJ6	20	5302040-5314369	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.7;brain: 5.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.6;NTERA-2: 3.2;SCLC-21H: 1.1;SH-SY5Y: 6.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"memory CD8 T-cell: 1.6;neutrophil: 1.1"	"Group enriched"	"Detected in many"	8	"granulocytes: 1.1;T-cells: 1.6"	"Region enhanced"	"Detected in many"		"olfactory region: 20.9"	"Low region specificity"	"Detected in all"			HPA047281	Uncertain									"HPA047281: AB_10960057"										"unprognostic (1.36e-1)"					"unprognostic (1.69e-1)"			0.0	0.0	0.4	0.0	0.5	3.7	0.1	0.1	5.9	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.4	0.0	0.0	0.0	1.8	0.1		0.0	0.1	0.0	0.1	0.0		0.0	0.0		0.5	1.4	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.7			0.0		0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0										
PRPH2	"CACD2, rd2, RDS, RP7, TSPAN22"	ENSG00000112619	"Peripherin 2"	P23942	6	42696600-42722574	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Sensory transduction, Vision"		"Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 117.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2;ASC TERT1: 4.8;fHDF/TERT166: 6.9;HHSteC: 10.8;HSkMC: 8.4;LHCN-M2: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029458	Enhanced									"HPA029458: AB_10602193"	"unprognostic (2.37e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.96e-3)"	1.0	0.8	1.5	1.0	1.0	0.0	1.0	1.0	4.8	1.7	2.0	1.0	1.0	0.3	2.3	2.3	1.0	0.9	1.2	1.4	1.1	3.0	1.0	1.0	1.2	1.0	1.1	1.0	3.4	2.0	6.9	2.7	1.0	1.0	1.4	0.8	117.8	1.0	1.3	14.4	0.0	1.1	2.3	1.0	1.0	1.0	3.5	1.0	1.0	5.2	1.0	1.0	1.0	1.0	0.6	0.3	3.4	0.6	0.2	0.8	0.0	0.0	0.0	0.0	0.0	4.2	4.8	1.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	10.8	0.0	0.0	8.4	0.0	0.0	0.0	1.2	0.0	0.0	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.3	0.0	0.4	0.2	0.8	0.2	0.3	0.0	0.3	0.6	0.4	0.2	2.5	0.2	0.6	0.0	0.3	0.0	1.5	1.0	1.0	3.0	1.1	3.0	1.1	1.0	1.0	1.0
PRPS1	"CMTX5, DFN2, DFNX1"	ENSG00000147224	"Phosphoribosyl pyrophosphate synthetase 1"	P60891	X	107628424-107651026	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Nucleotide biosynthesis"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Gout, Mental retardation, Neurodegeneration, Neuropathy, Non-syndromic deafness, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA043760	Uncertain					140000	140000			"HPA043760: "	"unprognostic (4.47e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.30e-3)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.25e-2)"	16.8	19.0	18.8	18.7	22.4	33.5	13.0	27.0	30.3	13.5	12.1	20.5	7.0	7.3	16.6	10.4	11.8	17.6	9.6	19.9	19.0	26.5	18.5	45.1	14.9	25.4	21.8	17.5	21.4	17.8	20.0	18.2	10.0	26.9	14.9	12.4	15.0	11.2	12.4	31.2	8.4	10.8	20.0	19.3	19.4	10.8	11.3	13.6	32.3	29.9	11.3	28.6	16.9	10.7	18.2	8.5	12.6	8.7	14.4	22.1	11.6	20.2	30.2	13.4	15.5	7.5	5.9	4.6	59.7	12.4	34.0	28.8	13.0	8.7	33.5	25.9	21.7	8.3	39.9	12.3	34.9	16.6	24.8	17.8	30.0	16.9	6.9	33.0	13.3	6.7	7.2	20.6	13.5	11.6	28.4	40.6	15.7	10.9	22.3	17.8	48.5	26.1	26.0	21.5	26.9	13.3	11.7	22.1	11.9	29.6	17.9	12.0	8.2	13.8	6.9	22.1	10.4	24.2	23.6	13.9	22.7	36.5	11.4	35.8	13.8	4.8	5.2	12.6	15.7	8.2	17.6	17.0	19.7	19.3	6.2	18.2	22.1	18.7	3.1	14.4	8.7	8.5	20.1	11.6	18.8	22.4	27.0	30.3	19.0	26.5	21.8	17.5	26.9	13.6
PRRT2	"DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC"	ENSG00000167371	"Proline rich transmembrane protein 2"	Q7Z6L0	16	29811382-29815892	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Dystonia, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 86.7"	"Cell line enhanced"	"Detected in many"		"AF22: 19.9;REH: 15.2;U-138 MG: 13.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"NK-cell: 7.3"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 7.3"									"HPA014447, HPA019203"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA014447: AB_1855786, HPA019203: "	"unprognostic (7.60e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.43e-8)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.44e-2)"	3.7	7.2	27.2	2.8	40.5	0.8	2.1	86.7	53.6	10.1	6.0	6.0	3.1	6.2	20.7	8.3	4.4	10.2	10.3	5.3	18.9	13.0	2.1	0.9	5.7	3.5	5.5	33.2	35.7	2.4	8.6	17.6	7.1	18.0	16.2	2.6	5.2	4.6	14.4	4.3	3.1	6.8	10.3	7.4	1.8	7.3	9.9	10.2	0.0	2.8	0.3	1.6	5.1	10.7	0.2	0.0	0.5	0.2	7.3	0.6	0.3	0.3	1.2	19.9	7.4	1.0	3.8	0.5	2.4	4.0	0.8	0.9	1.1	2.3	0.2	0.5	3.3	2.0	2.7	0.4	0.3	5.3	1.6	1.3	8.9	0.8	0.2	0.0	0.3	3.4	0.1	1.4	0.1	1.0	0.2	1.6	0.6	3.3	0.5	0.6	5.7	1.0	15.2	1.1	0.4	0.1	0.7	4.3	4.5	0.2	2.9	0.4	7.4	0.1	1.1	13.7	4.8	0.8	1.3	3.4	0.4	0.1	5.4	0.1	0.5	0.5	0.0	0.1	0.2	0.1	0.3	0.1	0.6	0.4	0.0	0.2	0.4	0.2	0.2	7.3	0.2	0.0	0.1	0.3	27.2	40.5	86.7	53.6	18.9	13.0	5.5	33.2	18.0	10.2
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.5;testis: 31.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 20.4;SH-SY5Y: 64.8;THP-1: 29.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 11.6;basal ganglia: 8.7;cerebral cortex: 26.5;hippocampal formation: 15.3;olfactory region: 11.0"	"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"			"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favourable (2.66e-4)"	"prognostic favourable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.9	0.5	2.1	4.1	1.4	0.0	1.9	0.5	2.8	16.5	6.0	2.0	1.3	2.2	3.0	2.7	3.6	9.8	27.5	0.3	2.2	0.9	1.1	0.8	8.0	0.0	0.7	2.4	1.9	9.8	0.0	0.9	20.4	4.1	2.0	5.8	20.0	3.1	3.2	0.3	5.9	8.6	1.0	0.5	0.3	8.1	31.3	0.2	0.3	0.6	7.7	7.7	3.1	16.2	0.3	0.4	0.0	0.1	0.0	0.7	0.0	1.4	0.0	0.5	0.0	0.0	4.1	0.0	13.5	12.2	2.9	4.8	0.0	5.5	0.0	0.0	20.4	0.2	9.1	2.7	3.8	0.0	2.1	0.0	1.1	0.0	0.4	0.0	0.0	1.2	5.2	1.0	3.0	0.0	0.0	0.0	2.3	0.0	0.1	2.7	0.6	0.8	0.0	11.5	0.0	0.0	2.0	1.5	64.8	0.0	0.0	0.8	0.0	29.0	0.0	5.8	0.8	3.6	2.6	0.3	0.0	0.0	0.3	0.9	3.3	0.0	0.1	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.4	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.1	1.4	0.5	2.8	2.2	0.9	0.7	2.4	4.1	0.2
PRSS37		ENSG00000165076	"Serine protease 37"	A4D1T9	7	141836286-141841487	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	127	"testis: 39.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.3;U-937: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA020541	Enhanced				"Secreted in male reproductive system"					"HPA020541: AB_1853004"	"unprognostic (4.70e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.69e-1)"		"unprognostic (2.41e-1)"			"unprognostic (3.21e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.30e-7)"	"unprognostic (1.42e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.72e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS56		ENSG00000237412	"Serine protease 56"	P0CW18	2	232520463-232525716	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;retina: 8.6;skeletal muscle: 16.2"	"Cell line enriched"	"Detected in single"	5	"Daudi: 4.6"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.7"	"Region enhanced"	"Detected in many"		"hypothalamus: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"basal ganglia: 1.6;olfactory region: 5.2"	"Region enhanced"	"Detected in many"		"olfactory region: 32.6"														"unprognostic (3.26e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.73e-3)"			"unprognostic (2.28e-1)"	"unprognostic (7.15e-2)"				"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"			0.1	0.1	0.3	0.1	1.8	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.2	4.4	0.1	0.1	0.1	0.1	2.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.2	0.1	8.6	0.1	0.1	16.2	0.1	0.1	0.1	0.8	0.2	0.1	2.6	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.1	1.0	0.2	4.4	2.2	0.1	0.1	0.1
PRTN3	"ACPA, AGP7, C-ANCA, MBT, P29, PR-3"	ENSG00000196415	"Proteinase 3"	P24158	19	840960-848175	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 167.3"	"Cell line enriched"	"Detected in some"	5	"THP-1: 148.0"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.0"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA005938, CAB017558"	Enhanced				"Secreted to blood"	120000	120000			"CAB017558: AB_2172317, HPA005938: AB_1855764"	"unprognostic (2.81e-2)"			"unprognostic (2.10e-1)"	"unprognostic (3.83e-3)"		"unprognostic (4.20e-1)"	"unprognostic (3.31e-2)"		"unprognostic (3.34e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.67e-2)"	"unprognostic (8.62e-6)"	"unprognostic (5.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.14e-2)"		0.3	0.2	0.9	0.2	1.0	167.3	0.2	0.0	2.3	0.2	0.2	0.7	0.0	0.2	0.2	0.2	0.2	0.2	0.2	31.0	0.3	0.6	0.2	1.7	8.1	3.5	0.1	0.1	0.4	0.2	0.2	0.8	4.2	0.8	0.2	0.2	0.3	0.3	0.2	0.5	0.3	0.2	0.2	0.0	25.5	0.2	0.2	0.1	35.0	0.9	0.0	0.2	0.2	0.0	0.0	0.0	1.9	0.1	0.0	0.2	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	6.8	0.9	1.0	0.0	2.3	0.3	0.6	0.1	0.1	0.8	0.1
PRUNE1	"DRES-17, H-PRUNE, HTCD37, PRUNE"	ENSG00000143363	"Prune exopolyphosphatase 1"	Q86TP1	1	151008420-151035713	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028411	Uncertain		Supported	Cytosol		210000	210000	Cytosol		"HPA028411: AB_10603229"	"unprognostic (6.24e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (6.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (3.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	9.3	9.7	9.3	8.8	11.6	3.7	16.0	15.7	16.4	15.0	12.5	10.9	16.2	11.7	17.9	15.7	11.5	15.6	12.8	31.3	10.5	10.3	18.0	12.8	10.1	11.8	11.9	9.2	17.1	16.2	16.5	16.2	7.2	8.8	12.2	14.0	12.7	13.3	18.2	24.4	10.5	11.8	14.7	7.9	11.0	10.5	16.3	8.6	15.0	41.6	8.5	12.9	13.8	13.6	12.1	9.5	14.7	8.9	14.3	19.0	18.3	3.8	4.1	7.4	7.1	9.2	2.5	4.1	1.8	4.0	6.9	6.0	5.1	4.6	7.9	8.0	2.4	5.6	7.2	4.8	5.5	8.6	8.2	9.3	4.3	7.2	5.1	6.1	4.7	3.1	9.2	3.6	3.6	3.2	7.3	6.7	3.2	9.3	9.3	5.0	6.9	5.4	8.5	4.7	7.6	4.9	5.3	10.7	8.7	6.2	8.6	5.7	11.9	9.3	2.2	2.4	2.9	2.7	2.9	16.4	13.8	61.0	2.4	4.7	6.1	12.5	6.4	13.4	14.0	6.0	16.9	12.1	15.5	15.7	9.5	11.6	19.0	15.0	14.7	14.3	8.9	5.1	14.5	18.3	9.3	11.6	15.7	16.4	10.5	10.3	11.9	9.2	8.8	8.6
PSAP	"GLBA, SAP1"	ENSG00000197746	Prosaposin	P07602	10	71816298-71851375	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid metabolism, Sphingolipid metabolism"		"Disease mutation, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 296.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 252.0;intermediate monocyte: 322.1;myeloid DC: 97.2;neutrophil: 80.8;non-classical monocyte: 263.2"	"Group enriched"	"Detected in all"	12	"dendritic cells: 97.2;granulocytes: 80.8;monocytes: 322.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004426, CAB004647"	Supported		Supported	Vesicles	"Intracellular and membrane"	86000000	86000000	Vesicles		"CAB004647: AB_425625, HPA004426: AB_1079701"	"unprognostic (4.43e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.06e-1)"	151.5	178.6	106.6	95.1	137.9	79.7	93.3	93.2	143.4	136.7	74.4	134.2	89.5	53.7	116.0	118.2	71.7	88.1	129.7	164.0	99.5	93.7	108.5	119.6	125.5	136.8	135.4	128.0	137.1	93.7	134.8	76.0	165.5	106.7	94.1	73.4	118.2	88.1	117.0	151.6	67.6	63.3	133.5	109.3	159.8	87.4	60.5	126.1	84.4	103.1	54.1	61.4	102.8	76.3	13.4	97.2	80.8	322.1	9.5	12.5	306.2	24.6	46.6	30.3	63.2	296.6	170.6	107.0	44.8	133.4	35.3	42.1	43.0	62.9	13.4	92.5	73.1	54.1	11.4	36.4	25.0	26.1	21.5	15.7	21.1	24.3	114.3	10.2	90.3	108.5	84.1	35.2	67.6	62.6	22.3	65.0	43.7	15.7	44.9	15.3	13.9	22.7	9.4	17.3	37.3	41.1	42.4	33.6	29.7	41.9	127.1	168.9	25.8	23.4	81.3	49.9	35.4	33.3	36.5	72.6	55.1	23.8	79.2	20.4	36.6	19.4	252.0	30.1	12.5	322.1	10.3	13.4	10.3	10.8	97.2	11.8	11.3	10.6	80.8	9.5	263.2	48.5	11.3	306.2	106.6	137.9	93.2	143.4	99.5	93.7	135.4	128.0	106.7	126.1
PSAT1	PSA	ENSG00000135069	"Phosphoserine aminotransferase 1"	Q9Y617	9	78297143-78330093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 56.0;liver: 112.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 148.4;SK-MEL-30: 90.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014882, CAB040567, HPA042924"	Enhanced		Enhanced	Cytosol		1700000	1700000	Cytosol		"CAB014882: , CAB040567: , HPA042924: "	"unprognostic (8.26e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (5.62e-5)"	"unprognostic (4.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.00e-7)"	"unprognostic (3.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.71e-1)"	3.1	25.0	44.6	3.8	33.4	1.7	3.0	8.5	50.5	2.4	3.3	44.8	0.9	3.2	2.7	28.4	9.3	16.0	1.6	1.4	33.9	22.3	56.0	112.2	1.6	4.5	42.2	24.6	3.7	54.6	4.8	2.1	2.2	21.9	5.3	3.3	8.1	26.2	2.8	1.1	24.7	2.8	2.3	29.8	2.4	7.0	5.1	35.0	2.2	13.7	4.9	5.9	4.2	2.6	3.0	0.2	0.2	0.1	0.0	13.3	3.1	26.8	18.1	15.2	27.0	4.5	5.3	36.0	22.8	16.3	11.6	21.8	4.6	5.2	17.4	10.1	51.3	26.7	26.0	25.2	17.4	17.0	9.2	5.9	8.3	35.5	41.8	33.2	10.7	16.9	148.4	15.4	41.3	10.6	6.4	45.0	9.6	10.0	11.3	5.3	34.9	19.8	5.6	9.9	20.5	15.8	6.2	6.9	16.1	6.3	11.0	90.8	5.2	41.9	2.4	2.9	9.5	10.8	18.5	30.6	28.2	0.1	34.3	26.3	13.9	0.0	0.0	0.0	4.9	0.0	5.7	3.0	4.8	6.5	0.2	1.0	7.9	7.3	0.2	0.0	0.1	0.0	13.3	3.1	44.6	33.4	8.5	24.9	33.9	22.3	42.2	24.6	21.9	35.0
PSEN1	"AD3, FAD, PS1, S182"	ENSG00000080815	"Presenilin 1"	P49768	14	73136418-73223691	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006844, HPA030760, HPA067496"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cell Junctions"				"Golgi apparatus"	"Nucleoplasm, Cell Junctions"	"CAB006844: , HPA030760: AB_10696211, HPA067496: "	"unprognostic (1.67e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.84e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavourable (1.99e-5)"	"unprognostic (1.65e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"prognostic favourable (1.52e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.85e-1)"	16.3	15.3	21.0	13.4	34.9	19.2	15.7	15.5	24.7	16.5	26.2	66.1	9.5	26.6	14.2	15.4	19.0	12.6	17.1	9.9	28.6	18.2	19.7	16.9	16.9	10.8	42.1	20.7	13.5	15.0	21.8	9.2	22.7	31.8	13.6	25.6	15.0	16.8	13.4	13.0	24.7	27.9	14.6	61.9	14.6	16.3	16.8	39.7	15.4	19.7	8.7	15.9	17.2	13.5	9.0	24.4	38.1	34.0	11.7	10.5	17.1	14.2	21.9	20.5	8.1	28.7	20.5	18.7	21.0	24.1	21.5	27.2	27.2	35.7	9.3	13.9	19.9	38.0	17.2	15.9	23.6	21.2	10.7	10.6	14.9	13.2	26.5	10.7	20.8	21.0	28.9	17.8	22.0	17.2	11.8	19.0	20.1	28.3	8.1	13.9	8.9	16.3	10.3	17.4	11.8	30.0	30.3	11.4	15.2	22.9	21.5	18.7	26.6	23.9	18.2	21.9	18.1	17.9	9.9	12.4	18.2	9.4	18.4	13.0	13.3	29.2	27.1	27.1	7.2	30.8	7.0	7.2	7.0	5.9	24.4	9.0	6.6	6.4	38.1	11.7	34.0	12.8	10.5	17.1	21.0	34.9	15.5	24.7	28.6	18.2	42.1	20.7	31.8	39.7
PSEN2	"AD3L, AD4, PS2, STM2"	ENSG00000143801	"Presenilin 2"	P49810	1	226870184-226896105	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cardiomyopathy, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013634, HPA038005"			Supported	Nucleoplasm				Nucleoplasm		"CAB013634: , HPA038005: "	"unprognostic (3.40e-2)"	"unprognostic (4.73e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (8.25e-3)"	"unprognostic (8.53e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	8.9	13.2	9.5	5.9	7.9	1.2	8.1	16.6	10.7	9.2	9.2	5.9	7.3	9.4	16.4	9.0	9.4	8.7	12.0	9.7	6.5	10.8	7.8	7.7	9.0	11.6	8.1	9.3	13.1	31.6	14.0	15.2	7.6	14.8	12.8	6.9	15.9	9.6	13.4	22.1	6.8	12.2	17.0	4.9	10.6	7.1	21.8	5.3	1.4	6.0	7.2	7.0	9.0	7.2	5.1	7.7	19.4	18.7	12.3	3.4	3.1	8.9	13.4	4.0	12.4	5.5	1.8	6.7	7.6	14.9	9.5	7.3	10.5	11.5	0.1	10.3	9.7	4.6	7.1	7.2	3.9	9.6	12.9	6.1	9.5	6.8	9.2	4.7	10.0	5.3	8.1	11.4	6.2	4.4	10.4	4.1	5.5	7.5	0.1	5.4	12.3	11.1	0.1	14.7	14.4	8.4	7.6	7.0	11.7	6.1	16.9	30.2	14.5	6.0	4.8	6.8	5.7	6.2	9.5	16.4	24.1	0.4	12.0	1.5	8.9	19.4	5.7	12.1	3.2	6.5	3.4	5.1	1.1	2.9	7.7	2.6	0.6	1.7	1.2	12.3	18.7	0.6	1.4	3.1	9.5	7.9	16.6	10.7	6.5	10.8	8.1	9.3	14.8	5.3
PSPH	PSP	ENSG00000146733	"Phosphoserine phosphatase"	P78330	7	56011051-56051604	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020376, HPA029515"	Approved		Approved	Cytosol				Cytosol		"HPA020376: AB_1855867, HPA029515: AB_10601492"	"prognostic unfavourable (2.30e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavourable (2.75e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.45e-2)"	"prognostic favourable (3.77e-4)"	"unprognostic (3.78e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.05e-3)"	7.5	13.4	14.1	5.9	16.6	5.1	11.0	10.1	14.6	5.4	8.0	13.2	11.4	6.9	7.0	9.0	11.0	26.3	10.6	12.8	13.2	12.5	14.7	9.8	5.4	7.4	14.8	10.0	13.9	15.9	7.8	17.1	6.4	11.1	10.6	6.9	6.9	6.8	11.5	6.8	6.4	6.2	8.5	15.2	5.7	8.5	9.1	13.3	10.2	12.2	6.9	8.5	7.1	16.0	7.8	11.9	6.8	8.5	5.3	6.2	5.8	46.3	14.2	8.7	32.5	7.3	9.8	6.0	11.7	6.9	6.6	11.7	12.7	8.1	22.9	7.9	10.8	9.7	19.2	9.9	6.8	17.4	10.8	6.4	3.8	21.4	15.7	6.4	9.8	12.3	18.8	10.4	12.0	6.4	15.3	14.8	9.8	6.2	9.8	15.3	13.9	19.9	12.8	5.2	13.1	6.2	2.4	15.9	18.4	8.5	5.2	23.4	15.7	13.5	5.4	5.7	9.0	17.6	10.7	10.2	17.8	26.0	8.2	14.1	17.9	2.2	7.7	6.8	4.2	5.3	3.0	7.2	4.0	5.1	11.9	7.8	6.2	5.5	3.6	5.3	8.5	11.3	5.1	5.8	14.1	16.6	10.1	14.6	13.2	12.5	14.8	10.0	11.1	13.3
PTCH1	"BCNS, NBCCS, PTCH"	ENSG00000185920	"Patched 1"	Q13635	9	95442980-95517057	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, Disease mutation, Holoprosencephaly, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 15.5;WM-115: 37.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 8.9"	"Lineage enriched"	"Detected in many"	8	"T-cells: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013717, HPA075072"	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"CAB013717: , HPA075072: "	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-6)"	"unprognostic (8.63e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.82e-1)"	4.1	3.8	6.7	6.0	9.5	0.7	7.9	21.0	6.4	28.5	12.5	6.1	8.0	7.8	16.2	4.2	3.0	7.4	13.2	2.8	7.0	6.6	4.9	2.2	7.1	4.5	9.5	3.2	5.2	10.8	3.4	4.0	3.7	6.9	6.9	12.3	11.2	6.9	9.5	2.7	4.3	10.9	8.5	5.1	3.8	12.1	14.3	7.9	1.0	6.3	1.9	3.2	11.3	6.9	1.0	0.0	0.0	0.0	0.3	8.9	1.8	5.0	2.4	10.7	6.7	1.6	2.7	6.1	1.0	0.9	1.2	0.7	2.5	2.5	4.1	1.7	1.9	11.6	6.1	0.8	0.7	4.0	4.0	0.0	2.5	1.1	1.4	0.1	2.2	2.5	1.2	1.1	0.7	2.2	3.6	4.7	0.5	1.0	0.0	1.5	15.5	0.9	0.0	8.2	2.1	0.8	0.7	7.3	3.7	3.6	3.6	1.6	0.9	1.0	0.5	1.4	7.0	7.1	0.7	9.5	8.2	2.7	2.0	2.0	37.0	0.0	0.0	0.0	8.9	0.0	5.3	1.0	1.7	3.8	0.0	0.3	2.8	3.2	0.0	0.3	0.0	0.0	1.4	1.8	6.7	9.5	21.0	6.4	7.0	6.6	9.5	3.2	6.9	7.9
PTDSS1	"KIAA0024, PSS1, PSSA"	ENSG00000156471	"Phosphatidylserine synthase 1"	P48651	8	96261715-96336995	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016852	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum"				"Endoplasmic reticulum"	Nucleoplasm	"HPA016852: AB_1855878"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.89e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.68e-3)"	"prognostic unfavourable (1.08e-5)"	"prognostic unfavourable (9.83e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.55e-2)"	8.2	7.9	8.0	8.1	14.7	10.2	10.4	10.2	15.0	9.7	8.3	5.1	22.5	10.6	8.4	7.8	9.6	7.0	7.9	20.1	8.6	9.9	9.5	12.8	7.8	21.8	7.1	8.0	9.6	12.1	23.2	4.9	10.8	9.6	5.7	7.4	5.2	8.8	29.8	10.1	10.4	8.3	9.0	6.0	11.8	8.1	5.1	3.6	20.7	11.0	7.7	11.8	9.3	6.8	3.6	6.1	9.4	3.7	5.0	4.6	7.8	10.4	8.1	1.4	3.9	2.9	6.1	2.4	7.6	10.5	7.3	5.1	3.0	3.0	17.2	7.0	7.1	4.3	9.9	7.6	11.4	8.8	7.1	16.9	15.6	1.6	3.0	12.4	5.9	5.1	7.3	10.2	7.2	4.7	8.4	8.9	6.6	3.0	9.6	1.9	2.2	7.6	7.7	7.3	13.0	4.1	8.9	6.1	2.5	2.8	2.5	1.1	5.9	4.2	8.3	6.6	4.1	4.5	8.7	1.8	9.2	8.4	4.1	13.1	5.3	9.4	3.7	2.1	2.8	2.5	4.0	2.6	4.6	3.4	6.1	3.6	4.0	2.9	1.3	5.0	2.4	1.8	2.6	7.8	8.0	14.7	10.2	15.0	8.6	9.9	7.1	8.0	9.6	3.6
PTEN	"BZS, MHAM, MMAC1, PTEN1, TEP1"	ENSG00000171862	"Phosphatase and tensin homolog"	P60484	10	87863113-87971930	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Lipid metabolism, Neurogenesis"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 29.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004076, HPA031335"	Approved		Supported	Nucleoplasm,Cytosol	"Secreted - unknown location"			Nucleoplasm	Cytosol	"CAB004076: AB_390810, HPA031335: "	"unprognostic (8.72e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavourable (7.35e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.41e-1)"	42.4	24.1	17.7	20.9	17.7	13.5	32.8	39.9	19.7	43.1	26.7	9.9	19.0	15.1	29.8	22.8	26.8	30.3	21.0	19.1	16.0	17.4	19.6	32.4	27.2	30.4	15.7	19.5	29.1	21.3	16.4	23.6	36.4	14.2	35.3	17.7	21.6	16.8	20.8	16.8	20.4	25.4	26.0	11.7	40.9	17.8	18.7	12.5	49.7	25.2	13.3	18.6	29.6	30.9	4.3	5.1	29.6	11.0	4.3	4.7	2.0	10.4	4.9	5.7	5.1	13.1	9.0	5.1	5.6	12.5	6.6	9.3	5.0	12.9	12.3	3.8	9.2	6.3	7.5	6.4	10.5	6.2	2.1	4.1	12.8	6.1	14.0	13.8	7.1	6.1	17.9	8.3	10.8	9.3	3.1	33.6	6.0	8.0	7.7	25.1	2.1	0.0	12.0	3.0	9.1	10.3	6.0	2.0	9.2	7.5	3.5	9.4	9.9	20.0	8.1	21.9	5.1	8.5	4.5	11.1	14.3	14.1	6.8	13.1	1.3	8.3	7.9	12.2	3.6	11.0	3.9	4.3	4.0	3.5	5.1	3.7	4.7	4.5	29.6	4.3	7.2	4.2	3.5	2.0	17.7	17.7	39.9	19.7	16.0	17.4	15.7	19.5	14.2	12.5
PTGDR	"DP, DP1, PTGDR1"	ENSG00000168229	"Prostaglandin D2 receptor"	Q13258	14	52267713-52276724	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.1"	"Group enriched"	"Detected in some"	4	"ASC diff: 1.4;HSkMC: 1.5;REH: 2.4;U-138 MG: 1.8"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"pons and medulla: 13.9"	"Group enriched"	"Detected in many"	5	"gdT-cell: 25.4;MAIT T-cell: 12.7;memory CD8 T-cell: 15.2;naive CD8 T-cell: 8.9;NK-cell: 30.1"	"Group enriched"	"Detected in many"	30	"NK-cells: 30.1;T-cells: 25.4"	"Low region specificity"	"Detected in many"							HPA049668	Enhanced									"HPA049668: "	"unprognostic (9.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.60e-8)"	"unprognostic (1.14e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.89e-2)"	3.9	0.9	0.7	9.6	2.5	1.8	9.3	1.4	1.4	5.5	10.0	0.7	0.9	1.1	4.1	2.2	2.1	2.5	4.9	2.3	0.8	0.8	1.5	1.8	3.4	8.9	1.0	3.5	2.3	0.8	0.8	4.5	0.4	13.9	2.1	12.8	11.2	2.6	3.5	0.9	1.3	2.4	2.0	3.6	10.9	2.0	0.9	0.8	1.8	2.5	0.1	3.1	3.3	3.2	0.0	0.0	0.9	0.1	30.1	25.4	4.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	25.4	0.0	12.7	0.0	3.5	15.2	0.0	0.0	0.6	8.9	0.9	30.1	0.1	0.0	0.0	4.1	0.7	2.5	1.4	1.4	0.8	0.8	1.0	3.5	13.9	0.8
PTK2	"FADK, FAK, FAK1, PPP1R71"	ENSG00000169398	"Protein tyrosine kinase 2"	Q05397	8	140657900-141002216	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001842, CAB004036, HPA029671"	Approved		Supported	"Vesicles,Focal adhesion sites,Cytosol"		32000	32000	"Focal adhesion sites"	"Vesicles, Cytosol"	"CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288"	"prognostic unfavourable (3.21e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	22.6	20.4	36.0	14.4	42.3	3.1	19.3	20.5	40.8	24.9	17.9	55.7	23.5	14.5	20.2	29.9	14.6	18.7	18.4	20.0	43.5	23.9	22.3	17.0	21.5	13.0	41.4	31.4	19.4	18.2	33.1	13.0	42.1	30.0	19.2	20.7	11.0	21.9	25.5	17.9	13.5	16.3	21.9	38.0	12.2	17.5	21.2	46.1	2.8	22.5	10.2	14.0	22.2	17.8	8.6	7.2	1.8	3.9	5.2	5.7	4.1	14.6	23.4	32.5	11.7	13.7	14.7	21.0	14.5	20.2	13.6	13.4	10.2	12.2	8.9	33.0	18.6	17.4	19.1	33.3	20.6	0.1	8.9	19.7	12.9	14.0	18.7	0.0	9.4	10.0	16.4	17.0	24.0	40.1	19.8	0.2	18.2	25.5	0.2	0.2	12.6	26.2	13.1	17.8	0.4	28.7	33.5	12.9	16.1	22.7	7.3	14.7	17.2	0.3	24.2	13.4	25.3	15.8	16.3	0.0	0.1	0.9	17.4	0.1	18.1	1.8	3.9	0.0	0.3	1.6	0.0	6.8	0.8	0.1	5.3	8.6	5.7	2.0	1.7	5.2	0.9	7.2	0.2	4.1	36.0	42.3	20.5	40.8	43.5	23.9	41.4	31.4	30.0	46.1
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase, non-receptor type 11"	Q06124	12	112418351-112509913	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		160000	160000	Nucleoli	"Nucleoplasm, Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	25.4	16.8	38.6	14.4	39.0	17.7	30.8	17.5	39.5	18.3	14.7	26.9	9.9	11.9	19.1	13.3	17.6	11.1	13.1	30.1	38.0	32.2	18.0	23.1	15.1	14.5	45.3	22.5	13.1	14.0	29.3	12.9	16.6	26.2	16.2	13.9	9.4	12.0	20.0	34.0	14.1	11.1	28.0	45.7	10.9	12.8	7.6	32.1	10.9	21.2	8.2	13.7	17.4	15.4	17.3	17.1	22.0	11.8	11.3	15.4	6.3	34.8	33.3	24.3	23.0	35.4	34.6	28.8	42.4	46.3	33.4	25.2	33.1	13.5	36.9	22.1	39.2	20.9	31.2	37.6	55.7	28.0	25.7	53.7	31.0	18.1	35.4	43.0	34.3	28.0	37.9	35.9	51.1	27.6	40.7	13.0	32.2	25.2	30.2	20.9	29.4	21.8	31.1	35.9	21.2	30.8	39.2	16.9	20.8	40.8	31.3	26.0	36.0	29.9	33.6	39.4	35.3	23.4	37.1	25.2	41.5	36.9	32.7	30.2	36.8	22.0	11.0	15.0	14.8	9.5	14.1	15.5	13.4	12.1	12.6	17.3	15.4	11.8	10.3	11.3	11.8	17.1	9.8	6.3	38.6	39.0	17.5	39.5	38.0	32.2	45.3	22.5	26.2	32.1
PTPN14	PEZ	ENSG00000152104	"Protein tyrosine phosphatase, non-receptor type 14"	Q15678	1	214348696-214552449	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011469, HPA053864, CAB069441"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"CAB011469: AB_299202, CAB069441: , HPA053864: "	"unprognostic (1.54e-1)"	"unprognostic (8.19e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (7.43e-2)"	"unprognostic (8.34e-3)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-3)"	13.6	10.0	3.0	6.5	2.4	0.2	15.0	0.8	3.7	13.6	8.5	2.6	11.0	1.0	15.4	8.0	8.6	9.2	9.7	7.0	3.5	1.9	11.2	2.0	12.2	6.6	2.4	1.3	11.8	5.0	6.3	4.0	13.2	4.9	10.6	2.9	7.2	9.2	23.4	21.6	18.8	3.5	9.4	4.3	5.3	5.7	8.3	2.4	1.4	8.1	6.9	3.7	12.4	17.7	1.0	0.5	1.9	0.4	1.0	0.6	0.1	8.7	3.9	3.2	4.6	5.6	9.5	9.4	9.9	9.3	7.6	6.4	7.9	4.6	0.0	11.1	23.1	7.8	4.3	11.1	13.1	0.1	3.3	0.8	11.1	1.4	10.1	0.1	0.4	7.1	11.6	13.2	21.3	14.7	0.0	0.1	18.4	0.9	0.1	0.1	7.0	4.2	0.1	16.0	0.0	13.7	4.4	0.0	0.7	12.3	8.1	5.0	8.0	0.3	26.2	17.9	7.0	6.4	14.1	0.5	0.0	0.0	9.6	0.1	14.9	1.3	0.4	0.3	0.5	0.3	0.6	0.5	0.5	0.4	0.1	1.0	0.5	0.6	1.9	1.0	0.4	0.5	0.6	0.1	3.0	2.4	0.8	3.7	3.5	1.9	2.4	1.3	4.9	2.4
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase, non-receptor type 22"	Q9Y2R2	1	113813811-113871759	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease mutation, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.6;lymphoid tissue: 46.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 32.9;HL-60: 13.0;U-266/70: 14.2;U-698: 17.6;U-937: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	10	"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"				Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	4.2	1.4	0.5	17.1	0.8	23.6	1.9	1.0	0.5	2.4	3.3	0.3	1.0	4.1	2.0	2.2	2.0	1.7	3.2	2.5	0.6	0.7	3.4	1.8	9.0	14.9	0.7	0.4	1.5	2.4	0.0	0.9	0.9	1.0	1.7	2.8	1.3	2.7	3.0	0.6	1.0	9.9	0.9	2.1	19.0	3.1	1.1	0.4	46.0	1.5	2.4	12.8	4.8	1.7	7.2	6.2	17.2	3.5	7.5	14.9	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.3	0.0	0.2	32.9	0.0	0.1	0.0	0.0	0.0	0.2	3.1	0.0	4.6	0.0	0.0	0.1	13.0	10.3	2.9	0.0	1.4	0.1	5.1	0.0	7.5	5.0	0.1	9.2	7.4	0.0	0.0	0.5	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	2.3	7.8	0.1	0.1	0.2	14.2	3.0	17.6	5.4	13.4	0.0	10.2	3.5	17.2	12.8	0.9	14.9	7.2	6.5	10.1	6.2	4.7	3.9	9.4	1.7	7.5	0.4	3.7	10.0	4.6	0.5	0.8	1.0	0.5	0.6	0.7	0.7	0.4	1.0	0.4
PTPRF	LAR	ENSG00000142949	"Protein tyrosine phosphatase, receptor type F"	P10586	1	43525187-43623666	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 53.7;SK-BR-3: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012710	Uncertain		Approved	"Golgi apparatus"	"Intracellular and membrane"	95000000	95000000	"Golgi apparatus"		"HPA012710: AB_1855933"	"unprognostic (8.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (3.47e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.99e-2)"	"prognostic favourable (7.03e-4)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.58e-1)"	37.1	5.5	22.4	10.4	18.1	0.9	30.7	6.8	19.5	14.2	34.3	16.8	34.4	30.7	12.3	33.4	41.4	32.2	20.0	6.3	17.2	15.0	12.0	45.6	15.7	5.8	17.2	18.5	10.4	25.3	17.5	10.3	38.1	16.1	30.9	23.1	5.9	41.9	23.6	2.9	46.8	35.5	16.8	11.2	2.0	21.8	4.3	15.8	4.6	12.5	11.7	14.9	21.4	21.3	0.9	0.0	0.2	0.0	0.0	0.0	0.7	30.4	14.6	9.6	11.3	2.2	0.1	53.7	17.5	7.0	14.5	12.4	15.5	41.5	0.0	4.9	7.6	23.9	11.1	38.5	17.6	0.3	13.9	0.1	10.0	14.1	6.8	0.2	0.2	2.2	22.2	20.8	34.6	21.5	4.7	1.4	5.3	17.6	0.2	0.2	14.5	4.0	10.6	17.0	0.7	5.6	46.1	14.3	5.3	17.4	61.4	2.3	17.7	3.2	16.9	0.3	23.2	1.4	23.3	0.6	0.5	0.0	1.4	0.7	45.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	22.4	18.1	6.8	19.5	17.2	15.0	17.2	18.5	16.1	15.8
PTPRN2	"IA-2beta, ICAAR, KIAA0387, phogrin"	ENSG00000155093	"Protein tyrosine phosphatase, receptor type N2"	Q92932	7	157539056-158587788	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Protein phosphatase, Receptor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6;pancreas: 51.3"	"Cell line enhanced"	"Detected in some"		"AF22: 15.3;HDLM-2: 21.5;NB-4: 22.1;SCLC-21H: 12.2;SH-SY5Y: 12.4;THP-1: 10.8;U-87 MG: 15.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006900, HPA007255, HPA026656"	Enhanced		Approved	Vesicles				Vesicles		"HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912"	"unprognostic (2.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (9.37e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (8.68e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.16e-2)"	2.1	10.5	20.1	1.7	33.9	1.0	1.1	6.2	40.6	1.7	4.6	2.9	0.0	5.1	2.0	2.9	1.5	6.9	4.7	1.9	18.2	21.3	2.0	1.2	3.1	2.1	11.3	22.3	5.8	51.3	0.5	20.0	1.5	10.3	10.2	3.7	1.5	3.4	2.6	0.8	0.7	4.2	1.6	5.3	7.7	24.2	2.2	5.2	0.0	5.6	0.3	1.7	2.8	0.6	3.4	1.3	14.8	1.1	1.5	3.5	1.1	0.0	0.2	15.3	1.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.6	0.2	0.0	0.4	0.0	0.0	21.5	0.2	0.0	0.0	2.5	0.6	0.0	0.0	1.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	6.3	22.1	3.0	0.7	0.0	0.7	0.1	0.0	0.0	12.2	12.4	0.0	0.0	0.0	0.0	10.8	3.2	5.0	1.9	0.0	0.3	0.1	0.0	0.0	15.1	9.0	3.6	8.7	1.1	1.6	0.9	0.1	0.3	2.3	1.5	1.1	1.3	3.4	1.4	0.9	14.8	1.5	0.0	0.2	3.5	1.1	20.1	33.9	6.2	40.6	18.2	21.3	11.3	22.3	10.3	5.2
PTPRO	"GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2"	ENSG00000151490	"Protein tyrosine phosphatase, receptor type O"	Q16827	12	15322397-15597399	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1;intestine: 28.5;kidney: 21.6"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 9.3;SCLC-21H: 5.7;SH-SY5Y: 11.2;THP-1: 4.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 8.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 5.2;intermediate monocyte: 10.5;memory B-cell: 8.3;myeloid DC: 7.4;naive B-cell: 7.0;naive CD4 T-cell: 2.9;non-classical monocyte: 10.5;plasmacytoid DC: 9.5"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"olfactory region: 215.3"	"Low region specificity"	"Detected in many"			HPA034525	Enhanced				"Intracellular and membrane"					"HPA034525: AB_10669785"	"unprognostic (3.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	3.3	1.2	16.2	3.1	26.1	0.6	1.1	1.0	15.3	1.7	10.4	1.5	0.0	2.0	4.5	2.1	0.8	1.2	1.6	0.7	11.3	10.6	21.6	1.6	6.7	3.2	4.8	8.8	0.7	0.6	0.6	3.8	4.4	4.0	0.7	28.5	1.1	0.8	1.1	0.5	0.7	1.9	7.1	2.6	3.6	1.0	0.9	3.5	0.0	0.5	0.0	3.5	1.7	0.5	8.3	9.5	0.0	10.5	0.1	2.9	2.7	0.0	0.1	0.5	0.4	0.6	0.1	0.2	0.0	0.0	0.9	2.2	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.3	0.1	0.2	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.7	9.3	0.1	0.0	0.0	0.1	0.2	0.3	5.7	11.2	1.3	0.0	0.1	0.1	4.6	0.0	0.1	0.4	0.0	0.4	1.4	0.1	0.4	0.1	0.3	1.7	0.0	5.2	0.0	0.0	10.5	0.0	8.3	1.7	0.4	7.4	7.0	2.9	1.3	0.0	0.1	10.5	9.5	1.3	2.7	16.2	26.1	1.0	15.3	11.3	10.6	4.8	8.8	4.0	3.5
PTRH2	"BIT1, CFAP37, CGI-147, PTH2"	ENSG00000141378	"Peptidyl-tRNA hydrolase 2"	Q9Y3E5	17	59674636-59707626	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	Apoptosis	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012897	Supported		Supported	Mitochondria				Mitochondria		"HPA012897: AB_1855949"	"unprognostic (2.26e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (6.38e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.01e-8)"	"unprognostic (5.43e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-2)"	15.9	22.9	17.1	12.4	17.1	9.9	20.7	12.5	22.1	15.6	17.2	11.8	16.3	11.6	14.3	36.7	16.4	13.8	13.1	12.6	19.3	17.8	14.8	34.7	12.1	12.5	16.7	15.2	14.2	19.9	10.3	18.3	13.6	21.0	15.9	20.7	8.1	13.7	18.7	23.3	11.4	11.0	16.8	17.1	15.5	14.3	15.7	18.1	9.0	11.8	13.5	16.9	13.0	10.5	15.6	21.6	12.6	29.3	13.1	15.5	13.0	19.8	37.9	12.2	11.1	23.2	20.0	13.1	19.1	16.9	16.4	24.0	24.4	15.6	14.4	29.0	16.0	19.8	26.2	24.6	23.9	27.7	35.7	25.7	19.7	44.8	35.8	22.7	14.6	22.5	32.1	25.4	29.6	27.2	28.6	16.1	24.3	47.9	19.4	18.5	10.5	30.0	10.6	20.5	21.0	27.3	28.6	15.8	20.5	9.9	10.8	23.4	25.2	16.2	17.9	21.4	21.7	12.8	20.7	20.9	23.2	21.4	14.1	14.2	16.3	1.9	25.8	1.1	9.2	24.4	12.4	15.6	10.8	10.4	18.5	13.1	15.5	11.1	12.6	13.1	29.3	21.6	12.3	13.0	17.1	17.1	12.5	22.1	19.3	17.8	16.7	15.2	21.0	18.1
PTS	PTPS	ENSG00000150787	"6-pyruvoyltetrahydropterin synthase"	Q03393	11	112226365-112269955	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Lyase	"Disease mutation, Phenylketonuria"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA001481	Uncertain		Approved	Cytosol				Cytosol		"HPA001481: AB_1079716"	"unprognostic (2.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.66e-3)"	"unprognostic (8.38e-3)"	"unprognostic (4.58e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.65e-1)"	6.7	37.1	13.9	6.3	16.6	12.2	13.9	8.9	16.5	10.4	12.7	10.2	6.1	10.7	9.3	20.3	17.9	8.2	14.7	11.6	11.8	28.9	21.9	40.7	5.6	10.4	23.5	14.3	6.7	11.9	12.1	21.5	12.1	18.8	14.9	14.4	9.9	10.9	11.4	11.7	11.5	10.9	12.4	16.8	5.1	18.8	6.7	9.8	3.6	16.3	13.2	7.7	9.3	16.1	6.3	6.8	1.9	5.5	3.4	5.9	2.9	10.7	11.3	12.4	5.3	8.9	10.6	16.4	32.0	14.6	17.6	18.7	25.5	10.8	11.4	24.5	18.8	15.6	17.5	20.6	19.0	9.3	14.7	2.9	17.5	20.9	28.1	7.0	1.6	18.4	29.2	16.8	19.9	13.1	11.0	6.2	11.0	11.8	5.4	9.2	9.2	22.4	3.6	2.4	16.4	37.8	15.4	14.0	14.1	18.0	17.6	10.0	13.2	6.3	16.6	17.3	18.9	20.6	25.2	4.3	8.6	27.4	12.0	7.5	18.0	0.9	2.1	1.9	3.8	2.3	3.8	5.5	5.0	4.7	3.6	6.3	3.5	4.5	1.0	3.4	5.5	6.8	5.9	2.9	13.9	16.6	8.9	16.5	11.8	28.9	23.5	14.3	18.8	9.8
PUS1		ENSG00000177192	"Pseudouridylate synthase 1"	Q9Y606	12	131929200-131945896	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051636, HPA057593"	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA051636: , HPA057593: "	"unprognostic (2.72e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.69e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.07e-2)"	"unprognostic (4.57e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavourable (3.49e-8)"	"unprognostic (1.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.56e-2)"	12.7	15.8	18.8	19.5	23.3	26.2	11.2	8.8	16.9	8.7	11.9	9.4	11.0	12.4	13.6	18.7	16.5	12.9	25.1	8.6	15.6	8.3	10.7	22.8	11.0	21.4	11.7	15.8	10.1	19.8	7.2	9.5	8.3	11.7	11.7	10.5	7.6	11.4	15.7	13.5	15.4	13.9	9.7	6.2	17.4	13.6	11.9	16.4	11.6	10.3	11.6	15.8	10.8	12.8	5.9	4.6	1.9	2.0	9.1	4.0	1.3	15.2	20.0	4.7	8.4	4.6	7.9	29.2	11.8	5.0	9.0	5.8	22.1	10.0	18.3	13.7	6.4	19.4	15.6	11.2	5.9	8.1	31.6	18.4	9.7	19.3	12.4	31.4	16.9	7.9	9.1	10.3	8.8	8.8	22.8	5.6	5.2	26.6	20.6	28.2	25.1	30.5	19.7	6.8	18.9	7.3	21.3	13.3	7.4	9.9	13.6	10.9	14.9	34.0	7.7	7.2	15.4	15.3	17.1	15.5	11.6	21.7	7.4	25.2	9.9	1.2	2.0	0.4	3.2	1.4	2.2	5.9	2.7	3.3	1.6	5.5	4.0	2.1	1.9	9.1	1.3	4.6	2.4	1.3	18.8	23.3	8.8	16.9	15.6	8.3	11.7	15.8	11.7	16.4
PUS3	FKSG32	ENSG00000110060	"Pseudouridylate synthase 3"	Q9BZE2	11	125893485-125903221	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Isomerase	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038040, HPA063802"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038040: AB_10697092, HPA063802: "	"unprognostic (5.89e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.59e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (7.67e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.44e-1)"	8.6	8.8	5.9	7.4	7.7	2.3	8.7	9.0	8.4	7.4	9.2	3.6	4.6	9.9	8.4	8.6	8.1	6.4	5.9	7.6	8.0	6.4	9.6	36.6	6.1	11.0	8.7	7.2	7.7	17.9	8.2	21.1	7.6	7.7	10.4	7.4	5.4	10.6	5.1	15.2	8.2	11.5	13.9	9.7	8.9	9.3	5.3	7.3	9.6	12.4	10.6	9.2	11.1	7.3	13.0	8.8	9.9	12.3	13.0	16.5	7.1	3.5	4.3	13.3	14.9	13.7	17.5	6.4	11.9	10.0	6.8	7.6	14.1	13.4	18.1	19.6	5.2	12.4	21.6	11.0	6.9	15.4	10.4	18.6	5.5	10.1	14.5	11.7	5.5	13.8	13.3	8.1	17.4	12.5	18.9	9.5	7.3	2.1	13.0	12.5	11.5	8.5	2.6	12.2	10.2	11.2	5.6	15.5	13.8	8.1	11.4	6.5	24.3	7.6	8.4	14.4	5.9	6.8	9.8	7.1	10.6	19.1	3.9	18.8	9.8	9.9	9.7	7.8	13.0	9.4	15.2	13.0	12.8	12.5	8.8	12.2	16.5	15.6	3.7	13.0	12.3	7.8	12.9	7.1	5.9	7.7	9.0	8.4	8.0	6.4	8.7	7.2	7.7	7.3
PXDN	"D2S448, D2S448E, KIAA0230, MG50, PRG2, PXN"	ENSG00000130508	Peroxidasin	Q92626	2	1631887-1744852	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 60.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA012375	Approved				"Secreted to extracellular matrix"	4000000	4000000			"HPA012375: AB_1855965"	"unprognostic (4.37e-2)"	"prognostic unfavourable (6.28e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (2.75e-4)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (1.18e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.54e-3)"	36.4	3.2	2.6	13.1	2.0	0.5	60.8	0.3	3.7	15.5	17.7	2.7	5.1	4.3	20.4	8.9	7.4	9.7	12.9	16.2	2.0	2.6	5.8	6.9	14.3	8.5	1.8	1.4	19.2	2.1	1.5	6.5	18.3	3.6	15.2	5.0	7.6	7.3	6.8	8.4	3.7	8.4	41.0	2.6	13.7	7.8	5.8	1.2	4.3	5.9	4.8	3.4	26.3	20.1	0.5	2.0	0.0	0.0	0.0	1.1	0.1	6.7	2.4	12.7	0.0	36.0	33.1	9.7	40.2	32.0	17.6	19.3	0.0	0.1	0.0	57.8	39.7	1.4	0.0	24.7	22.5	0.1	0.4	0.0	25.2	0.0	35.8	0.1	0.0	36.4	7.3	19.9	15.0	43.3	0.0	0.0	25.0	4.0	1.1	1.3	10.3	9.2	2.2	44.5	0.1	20.7	0.0	0.0	23.5	0.0	13.0	0.0	4.7	0.1	42.0	29.2	14.4	1.1	31.0	0.0	33.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	2.0	0.0	0.1	2.6	2.0	0.3	2.7	2.0	2.6	1.8	1.4	3.6	1.2
PYCR1	P5C	ENSG00000183010	"Pyrroline-5-carboxylate reductase 1"	P32322	17	81932384-81942412	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis, Stress response"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"pancreas: 56.1;salivary gland: 53.3;stomach 1: 16.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 7.7"	"Group enriched"	"Detected in many"	7	"B-cells: 7.7;dendritic cells: 3.3;T-cells: 3.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA047660	Approved									"HPA047660: AB_2680115"	"unprognostic (1.12e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.04e-2)"	"unprognostic (7.27e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (2.80e-1)"	"unprognostic (9.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (3.02e-3)"	"unprognostic (7.12e-2)"	"prognostic unfavourable (7.33e-12)"	"unprognostic (7.98e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.92e-2)"	2.1	1.3	4.3	5.0	5.0	4.0	6.9	2.1	4.3	10.4	9.1	2.3	10.1	5.6	4.2	2.2	6.4	3.5	5.7	3.5	3.5	3.6	2.4	3.1	4.9	2.3	6.0	2.0	7.6	56.1	0.0	7.6	8.3	6.4	10.4	5.6	1.5	53.3	4.7	3.4	1.8	4.8	4.6	2.9	2.4	16.6	8.7	4.0	1.7	3.3	4.5	6.4	4.9	4.0	7.7	3.3	0.0	0.4	0.6	3.0	2.2	19.1	20.5	11.7	43.3	7.0	13.3	22.4	32.2	15.9	10.4	14.0	23.4	21.6	29.4	7.2	34.4	8.4	27.5	12.2	6.2	7.6	3.4	17.3	10.6	63.2	41.5	11.5	13.4	11.3	24.5	12.7	33.6	17.6	55.7	27.4	6.5	67.9	12.1	9.2	9.8	31.9	0.1	19.7	37.1	9.3	7.0	45.0	31.7	6.7	38.0	41.0	39.1	21.3	12.9	10.1	38.9	17.0	11.9	34.6	24.0	27.3	10.8	0.1	33.2	0.0	0.3	0.0	0.5	0.4	0.7	7.7	1.3	0.4	2.3	3.5	3.0	2.3	0.0	0.6	0.0	3.3	0.5	2.2	4.3	5.0	2.1	3.6	3.5	3.6	6.0	2.0	6.4	4.0
PYCR2	P5CR2	ENSG00000143811	"Pyrroline-5-carboxylate reductase 2"	Q96C36	1	225919877-225924340	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA056873	Approved		Approved	Mitochondria				Mitochondria		"HPA056873: "	"unprognostic (1.11e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavourable (5.02e-5)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.56e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.07e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (1.42e-6)"	"unprognostic (9.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.16e-3)"	21.4	37.2	25.7	24.0	28.2	29.5	17.2	14.3	38.2	21.8	17.4	40.0	25.8	16.1	25.3	20.0	17.7	33.2	24.6	38.0	27.9	28.3	23.4	35.0	22.0	30.3	34.0	30.8	34.5	29.0	26.6	29.8	22.2	29.5	22.4	13.7	21.5	26.3	32.1	36.0	15.3	16.7	22.3	38.4	25.9	20.1	17.6	24.7	35.0	19.2	20.0	23.5	24.6	16.2	19.3	25.9	16.4	12.7	28.3	36.1	18.1	16.7	13.8	8.5	14.2	9.6	10.0	17.9	17.7	11.1	12.1	10.8	18.1	14.0	29.5	38.1	13.0	19.4	12.1	13.9	6.9	35.4	25.4	28.1	14.4	18.1	14.9	24.7	46.3	9.6	17.6	13.6	15.8	11.5	40.6	19.8	12.2	13.8	31.0	28.1	47.3	19.3	27.9	19.0	61.1	15.6	13.4	10.7	13.8	14.8	11.8	37.0	15.1	47.3	9.6	9.5	11.4	20.1	24.3	31.7	34.7	29.2	15.0	18.9	26.2	15.1	8.7	16.4	21.1	12.7	22.2	15.9	20.6	19.5	13.6	19.3	36.1	29.2	6.0	28.3	10.8	25.9	18.6	18.1	25.7	28.2	14.3	38.2	27.9	28.3	34.0	30.8	29.5	24.7
PYGL		ENSG00000100504	"Glycogen phosphorylase L"	P06737	14	50857891-50944736	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 56.1;HMC-1: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 36.0;neutrophil: 41.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000962, HPA004119"	Enhanced		Supported	"Plasma membrane,Cytosol"		17000000	17000000	"Plasma membrane, Cytosol"		"HPA000962: AB_1079722, HPA004119: AB_1079723"	"unprognostic (2.70e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.41e-2)"	"prognostic unfavourable (5.97e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavourable (2.63e-4)"	"unprognostic (4.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-3)"	47.6	9.9	4.9	9.7	6.8	40.0	28.1	1.3	3.9	17.2	10.1	3.0	23.7	1.7	10.9	7.3	24.8	7.8	5.5	15.0	3.9	3.4	6.8	58.8	19.6	25.6	6.5	1.6	15.4	4.1	12.5	3.7	23.3	5.3	11.4	10.3	17.8	11.8	55.2	7.1	15.3	3.5	11.2	8.7	38.8	4.5	6.8	5.4	2.4	7.1	9.1	7.3	18.4	24.3	0.0	7.3	41.4	13.8	0.1	0.0	5.5	28.3	8.0	2.1	13.2	9.8	11.8	23.0	5.7	4.8	15.7	24.0	21.1	3.6	0.0	11.1	33.8	56.1	21.4	28.8	27.3	0.1	9.0	5.4	12.8	16.4	17.6	20.6	62.0	25.1	11.8	21.3	9.0	13.9	2.2	0.1	11.1	28.3	0.0	28.4	7.9	29.7	0.5	7.3	1.1	21.8	19.0	0.9	0.9	25.8	9.0	0.3	4.2	40.4	0.6	6.1	10.2	11.4	18.3	0.2	0.0	0.0	5.6	21.3	3.2	11.3	13.8	36.0	0.0	6.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	41.4	0.1	3.9	0.3	0.0	5.5	4.9	6.8	1.3	3.9	3.9	3.4	6.5	1.6	5.3	5.4
PYGM		ENSG00000068976	"Glycogen phosphorylase, muscle associated"	P11217	11	64746389-64760297	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	37	"skeletal muscle: 572.6;tongue: 172.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 8.2;NB-4: 4.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 9.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056003	Enhanced					12000000	12000000			"HPA056003: "	"unprognostic (3.33e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.87e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.33e-6)"	"unprognostic (3.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.68e-2)"	6.4	0.8	2.2	0.7	3.0	0.7	0.8	1.1	3.1	0.9	2.1	1.8	0.7	0.7	1.1	4.6	7.1	1.5	0.9	5.5	2.9	1.0	0.7	0.6	0.7	0.7	1.5	1.1	0.7	0.7	0.6	0.3	0.7	6.6	2.5	0.9	1.6	7.9	2.8	572.6	0.6	0.8	2.5	4.1	0.7	0.8	0.9	1.8	0.0	1.2	172.6	6.4	1.5	0.6	1.9	0.3	9.9	0.0	1.6	0.3	0.2	0.2	0.1	1.7	0.2	1.2	1.7	0.3	0.2	0.1	0.3	0.0	0.7	0.7	1.3	0.5	0.0	0.3	0.5	0.1	0.1	1.4	0.3	0.8	0.3	0.0	0.7	0.8	0.3	8.2	0.6	0.6	0.2	0.0	1.5	1.5	0.0	2.1	1.4	4.7	1.7	0.2	0.9	1.5	0.3	0.0	0.2	0.5	0.1	0.6	0.7	0.9	0.7	0.9	0.6	0.0	0.9	0.3	0.1	2.3	2.8	1.0	0.0	0.2	0.0	9.9	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.2	0.0	1.9	0.0	0.1	0.2	1.6	0.0	0.3	0.3	0.2	2.2	3.0	1.1	3.1	2.9	1.0	1.5	1.1	6.6	1.8
QARS		ENSG00000172053	"Glutaminyl-tRNA synthetase"	P47897	3	49095932-49105135	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036986, HPA036987"	Enhanced		Enhanced	Cytosol		21000	21000	Cytosol		"HPA036986: AB_10672344, HPA036987: AB_2675418"	"prognostic favourable (1.43e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.13e-3)"	"unprognostic (6.62e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.33e-1)"	"unprognostic (9.14e-2)"	"prognostic favourable (5.60e-6)"	"unprognostic (2.73e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.11e-1)"	20.9	16.3	9.7	19.3	10.2	18.4	22.7	15.8	13.2	17.6	27.3	13.1	27.7	17.2	12.3	19.8	35.1	16.4	20.0	22.0	9.8	9.6	27.1	26.0	15.0	33.9	12.4	7.2	21.6	33.8	20.3	13.7	25.7	9.6	16.2	29.9	15.2	31.7	28.7	33.3	26.7	31.8	16.7	11.2	21.1	16.9	30.1	11.3	36.8	16.5	34.8	33.3	19.4	18.5	20.4	40.0	8.9	32.3	21.8	24.0	19.6	18.6	19.0	31.6	45.3	40.8	44.4	32.6	20.7	47.4	41.2	40.5	23.9	24.2	57.6	13.3	34.3	23.7	44.9	34.1	29.6	16.4	35.9	45.4	30.4	41.8	21.5	36.9	28.0	46.7	29.9	31.7	27.0	44.9	20.2	25.6	30.1	10.0	26.6	33.1	27.2	29.6	17.5	26.6	42.5	27.6	27.8	11.6	32.4	18.4	46.7	28.6	38.7	43.1	25.9	18.8	26.6	30.9	23.1	22.1	37.6	32.3	19.2	33.3	11.9	8.9	23.1	8.7	13.5	32.3	18.1	20.4	16.8	14.9	40.0	15.2	15.5	15.4	2.6	21.8	26.1	16.9	24.0	19.6	9.7	10.2	15.8	13.2	9.8	9.6	12.4	7.2	9.6	11.3
QDPR	"DHPR, PKU2, SDR33C1"	ENSG00000151552	"Quinoid dihydropteridine reductase"	P09417	4	17460261-17512234	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Oxidoreductase	"Disease mutation, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.1;liver: 64.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058951, HPA065649"	Enhanced		Approved	Mitochondria		1800000	1800000	Mitochondria		"HPA058951: AB_2683861, HPA065649: AB_2685526"	"unprognostic (1.30e-2)"	"unprognostic (4.29e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.07e-1)"	"prognostic favourable (7.84e-6)"	"unprognostic (1.58e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.19e-1)"	22.5	25.9	67.8	3.4	111.9	4.4	7.4	16.0	54.1	5.7	7.5	56.3	2.6	9.1	5.5	12.5	5.2	6.4	6.3	15.0	80.7	58.2	36.1	64.8	8.0	3.7	114.1	36.7	6.7	10.3	13.7	6.2	4.1	82.5	10.3	5.9	2.6	12.4	7.5	34.2	4.6	8.1	6.4	93.6	4.8	9.1	4.1	94.7	0.7	7.7	2.8	4.4	4.5	2.6	7.5	42.5	1.0	21.9	9.9	15.0	12.3	11.3	22.3	8.8	12.3	21.4	10.9	15.6	16.3	6.9	15.2	13.4	17.8	15.1	4.2	10.5	9.0	6.5	12.5	18.4	9.5	12.9	2.5	11.5	11.6	42.1	12.9	15.0	1.0	13.5	11.7	9.6	13.1	7.6	12.4	9.7	16.3	5.9	22.3	24.1	15.0	15.1	9.3	6.8	16.9	15.7	6.3	16.7	21.4	10.8	1.8	46.3	4.9	5.8	13.2	8.8	15.8	8.7	12.9	15.1	23.5	29.6	17.6	13.3	14.6	0.0	14.4	1.0	12.3	21.9	11.1	7.5	13.3	12.8	18.0	6.2	15.0	12.9	0.4	9.9	16.3	42.5	6.9	12.3	67.8	111.9	16.0	54.1	80.7	58.2	114.1	36.7	82.5	94.7
QRSL1	"DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA"	ENSG00000130348	"Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1"	Q9H0R6	6	106629578-106668417	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"memory B-cell: 32.6;naive B-cell: 26.1"	"Lineage enriched"	"Detected in all"	7	"B-cells: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029585, HPA029587"	Approved		Approved	Vesicles,Centrosome				Vesicles	Centrosome	"HPA029585: AB_10599823, HPA029587: AB_10602311"	"unprognostic (1.86e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.19e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (7.97e-5)"	"unprognostic (8.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.66e-1)"	"prognostic favourable (3.83e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.46e-1)"	9.8	10.8	12.4	17.0	14.7	8.5	15.6	10.1	15.6	7.6	11.7	10.1	11.9	11.3	9.5	10.8	10.3	8.5	8.3	13.9	10.4	9.1	15.5	12.5	7.7	21.0	15.8	8.3	10.2	10.8	10.9	11.9	8.7	9.9	8.3	13.7	7.5	10.6	12.5	35.7	8.8	14.8	8.8	11.9	16.7	11.0	10.6	13.7	13.8	13.7	14.6	21.3	8.9	8.6	32.6	4.0	1.6	4.5	2.6	3.1	2.2	6.1	6.4	8.8	12.7	5.7	7.2	12.4	7.0	7.2	9.4	9.4	7.4	5.1	20.5	6.4	7.8	10.9	13.1	8.5	11.9	9.7	10.0	10.0	6.8	7.6	9.0	22.5	9.0	7.0	13.3	10.0	14.8	6.6	18.0	6.7	7.7	6.9	7.2	11.0	9.2	7.5	19.7	11.3	5.2	10.2	7.1	7.7	7.9	5.6	13.1	10.3	8.6	17.5	6.5	6.7	5.5	7.1	10.8	3.9	5.5	12.0	9.1	15.3	9.9	1.6	2.4	0.4	2.6	3.6	2.5	32.6	2.9	2.2	4.0	26.1	2.7	2.6	0.7	2.6	4.5	3.2	3.1	2.2	12.4	14.7	10.1	15.6	10.4	9.1	15.8	8.3	9.9	13.7
RAG1	"MGC43321, RNF74"	ENSG00000166349	"Recombination activating 1"	P15918	11	36510709-36593156	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA recombination, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	62	"lymphoid tissue: 462.4"	"Group enriched"	"Detected in some"	110	"MOLT-4: 65.8;REH: 62.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043939			Supported	Nucleoplasm				Nucleoplasm		"HPA043939: "	"unprognostic (7.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-9)"	"unprognostic (2.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-4)"	"unprognostic (1.53e-1)"	0.7	2.3	0.5	0.5	0.5	7.4	0.7	0.5	0.5	0.5	0.6	0.5	0.5	1.2	0.5	1.3	0.5	0.6	0.5	0.6	0.5	0.2	2.4	1.2	0.8	0.5	0.5	0.5	0.6	1.1	1.9	0.5	0.8	0.5	0.5	0.4	0.5	1.5	0.5	0.5	0.2	1.5	0.5	0.5	4.4	0.8	0.9	0.5	462.4	4.5	0.5	0.8	0.7	0.5	0.2	0.3	0.0	0.0	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	65.8	0.0	0.5	0.0	62.9	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.8	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.2	0.5	0.5	0.5	0.5
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719481-108785811	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Enhanced	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"		"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: , HPA049497: , HPA051675: , HPA067564: "	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.5	24.3	14.4	17.0	18.6	35.5	24.4	23.1	22.2	19.8	17.1	12.8	25.5	13.3	19.9	21.5	17.0	19.1	14.8	20.2	12.9	12.5	18.9	19.5	17.7	19.2	15.1	17.0	32.4	24.1	48.5	37.5	18.8	16.5	21.8	15.8	14.3	20.0	31.6	37.5	17.3	17.4	23.2	17.8	16.3	20.9	20.6	15.9	26.6	28.7	18.0	17.5	20.5	19.7	5.6	5.1	8.3	6.3	4.2	8.7	2.3	18.2	11.2	16.1	14.6	18.8	16.9	15.6	16.5	13.1	13.6	12.0	27.8	8.8	28.8	12.8	17.1	15.4	27.5	17.1	19.9	17.5	13.3	30.0	13.9	19.6	11.0	35.0	10.1	14.1	13.1	21.3	16.6	20.8	32.1	16.0	18.0	10.1	15.5	14.3	20.3	13.4	14.6	24.8	13.9	12.1	22.9	23.5	10.8	14.6	12.6	16.0	8.0	16.1	24.8	14.3	18.9	10.0	18.4	13.3	19.6	26.2	11.1	15.8	11.0	8.3	5.3	5.1	7.6	3.4	8.7	5.5	6.3	6.9	4.2	5.6	6.2	6.7	8.3	4.2	6.3	5.1	5.1	2.3	14.4	18.6	23.1	22.2	12.9	12.5	15.1	17.0	16.5	15.9
RARS	DALRD1	ENSG00000113643	"Arginyl-tRNA synthetase"	P54136	5	168486445-168519299	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003979, HPA004130"	Approved		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA003979: AB_1856083, HPA004130: AB_1856084"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (7.59e-5)"	"prognostic unfavourable (1.10e-8)"	"unprognostic (3.26e-3)"	"unprognostic (5.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.33e-2)"	21.8	26.3	16.0	18.3	15.3	6.2	22.6	17.1	18.4	21.2	29.4	9.1	20.4	33.3	22.9	21.4	34.7	19.5	14.4	21.7	19.8	12.3	29.8	33.5	18.7	18.6	13.9	15.2	21.3	33.0	19.9	34.5	30.3	15.8	18.9	27.4	15.5	34.0	15.4	27.8	27.9	48.7	21.5	14.5	22.1	24.4	17.2	11.8	20.5	21.5	32.3	23.7	22.4	22.6	11.1	21.8	5.2	17.7	16.8	16.3	11.7	27.1	32.2	23.9	26.4	33.1	37.9	41.1	40.0	34.4	41.7	48.8	54.7	29.6	28.9	32.8	38.0	26.4	31.2	53.8	54.4	30.0	21.5	19.4	29.4	34.3	28.7	45.7	20.7	29.1	28.8	45.4	21.8	33.3	28.9	14.7	44.6	25.1	19.0	18.3	39.2	22.0	8.4	34.8	27.4	37.1	31.0	22.8	28.0	30.6	35.4	41.2	32.1	19.2	33.0	30.2	27.8	23.3	46.6	14.6	26.8	29.6	32.9	32.7	28.7	3.4	14.4	5.2	12.5	17.7	14.3	11.1	12.6	13.3	21.8	6.6	15.6	16.3	4.0	16.8	16.4	10.3	12.8	11.7	16.0	15.3	17.1	18.4	19.8	12.3	13.9	15.2	15.8	11.8
RARS2	"DALRD2, dJ382I10.6, MGC14993, MGC23778, PRO1992, RARSL"	ENSG00000146282	"Arginyl-tRNA synthetase 2, mitochondrial"	Q5T160	6	87514378-87590003	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039987, HPA042645"	Uncertain									"HPA039987: , HPA042645: "	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.98e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.16e-3)"	27.0	44.1	13.3	21.1	15.9	16.0	22.9	24.0	17.3	25.1	21.4	18.6	25.2	17.5	35.5	25.5	20.4	21.1	19.2	21.5	14.4	12.8	23.7	32.1	20.5	24.4	17.3	14.2	22.2	30.1	20.5	36.9	28.3	17.2	20.7	23.1	24.0	23.5	27.7	23.0	20.4	30.5	24.7	16.8	21.1	20.5	23.9	13.6	28.0	21.2	20.5	27.3	24.3	20.2	16.7	18.9	22.8	20.2	18.1	28.8	16.2	10.0	9.9	23.9	25.9	24.3	26.6	17.0	24.0	28.7	16.6	21.1	19.1	11.2	12.7	14.3	24.6	14.0	20.1	13.8	23.6	9.3	19.0	13.0	12.6	30.3	30.6	15.4	11.3	26.5	13.4	14.0	17.8	21.9	30.2	12.6	24.5	18.4	5.0	16.4	15.5	10.7	10.1	24.1	11.1	20.4	21.0	21.6	29.2	12.6	6.3	16.8	11.7	23.6	14.8	11.1	8.9	12.1	19.8	13.3	22.4	10.6	17.3	16.3	19.1	15.9	19.1	22.8	18.1	19.3	21.3	16.7	23.4	17.0	16.7	16.2	23.0	19.1	11.6	18.1	20.2	18.9	28.8	16.2	13.3	15.9	24.0	17.3	14.4	12.8	17.3	14.2	17.2	13.6
RBCK1	"C20orf18, HOIL1, RBCK2, RNF54, UBCE7IP3, XAP4, ZRANB4"	ENSG00000125826	"RANBP2-type and C3HC4-type zinc finger containing 1"	Q9BYM8	20	407498-430966	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.94e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.15e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-2)"	"prognostic unfavourable (7.41e-9)"	"unprognostic (5.87e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.39e-3)"	24.6	36.4	18.8	30.7	23.9	24.2	26.0	40.2	18.8	21.4	34.0	25.4	22.5	31.9	25.7	29.7	27.6	23.5	31.4	23.2	18.6	15.1	28.1	53.0	31.3	29.8	27.2	19.1	28.9	28.7	22.9	28.9	30.5	19.1	28.0	17.5	18.2	39.7	30.4	21.7	27.1	43.3	20.9	20.9	34.6	25.0	18.2	24.3	44.4	26.2	18.5	19.4	23.4	23.3	17.5	26.6	50.3	30.1	18.5	23.2	18.4	18.3	22.1	5.4	9.6	10.0	13.3	14.6	11.6	13.7	14.1	18.6	12.8	18.4	9.2	14.8	16.7	16.6	6.6	37.1	4.8	6.7	9.4	8.1	5.1	35.1	45.7	8.0	6.0	19.7	63.6	10.2	44.3	13.6	7.8	14.1	9.3	8.4	15.1	21.4	5.4	22.5	11.5	7.0	10.4	18.2	13.8	11.2	11.4	8.3	29.7	36.1	17.2	16.0	9.3	13.1	7.6	9.0	13.0	12.7	15.5	9.9	7.1	16.0	9.6	17.3	18.9	30.1	23.2	24.8	16.8	17.5	18.3	23.1	16.3	16.0	15.2	17.6	50.3	18.5	30.1	26.6	19.5	18.4	18.8	23.9	40.2	18.8	18.6	15.1	27.2	19.1	19.1	24.3
RBP3	"D10S64, D10S65, D10S66, RP66"	ENSG00000265203	"Retinol binding protein 3"	P10745	10	47348371-47357875	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	Transport		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"retina: 135.2"	"Group enriched"	"Detected in some"	8	"HaCaT: 2.6;HDLM-2: 2.4;SH-SY5Y: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041301, HPA044239"	Enhanced				"Secreted in other tissues"					"HPA041301: , HPA044239: "	"unprognostic (3.48e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.36e-2)"		"unprognostic (4.02e-2)"	"unprognostic (1.40e-1)"		"unprognostic (1.58e-2)"		"unprognostic (5.09e-2)"	"unprognostic (5.14e-3)"			"unprognostic (7.44e-2)"	"unprognostic (1.23e-1)"		"unprognostic (4.68e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	135.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RDH11	"ARSDR1, MDT1, SDR7C1"	ENSG00000072042	"Retinol dehydrogenase 11 (all-trans/9-cis/11-cis)"	Q8TC12	14	67676801-67695814	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cataract, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 204.2"	"Low cell line specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	13	"prostate cancer: 286.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB046011	Enhanced				"Intracellular and membrane"	9100000	9100000			"CAB046011: AB_11129613"	"unprognostic (1.38e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.77e-1)"	"prognostic favourable (2.62e-4)"	"unprognostic (6.06e-2)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (9.29e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (1.30e-7)"	"unprognostic (1.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.74e-2)"	8.8	24.9	18.3	8.9	19.0	5.1	10.8	15.7	25.3	13.0	10.8	24.3	16.1	12.3	13.0	31.4	13.6	9.3	15.6	7.2	18.5	19.9	40.7	51.6	12.6	7.2	21.8	16.6	11.4	15.3	28.7	13.1	8.3	31.1	204.2	12.0	40.4	16.2	13.5	3.6	11.2	10.2	15.8	32.5	10.8	11.6	10.3	15.8	12.5	24.2	8.1	9.5	14.8	11.4	11.5	17.0	62.4	19.7	14.4	20.8	28.2	46.9	21.4	19.0	21.6	30.5	27.7	15.9	17.9	35.4	22.5	40.9	17.8	57.2	8.1	13.9	16.8	37.7	27.4	39.5	30.7	16.4	11.1	16.9	11.4	17.6	29.3	6.2	12.4	25.8	26.2	29.2	24.9	25.6	13.2	27.0	20.4	24.9	18.2	9.7	10.7	24.6	13.8	23.6	11.7	51.4	24.2	19.8	16.6	18.8	23.9	24.9	26.7	9.9	19.7	24.2	27.7	10.4	12.8	12.8	10.1	10.6	31.5	17.3	19.6	62.4	19.7	28.2	18.7	16.1	20.4	11.3	20.5	18.5	14.5	11.5	20.8	20.1	3.3	14.4	16.9	17.0	17.6	28.2	18.3	19.0	15.7	25.3	18.5	19.9	21.8	16.6	31.1	15.8
RDH5	"HSD17B9, RDH1, SDR9C5"	ENSG00000135437	"Retinol dehydrogenase 5"	Q92781	12	55720367-55724705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sensory transduction, Steroid metabolism, Vision"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 39.4;retina: 127.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.5;ASC TERT1: 16.8;hTEC/SVTERT24-B: 10.2;LHCN-M2: 10.1;U-87 MG: 18.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063345			Approved	Vesicles	"Intracellular and membrane"			Vesicles		"HPA063345: "	"unprognostic (1.04e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.12e-3)"	"unprognostic (3.27e-2)"	39.4	0.7	0.6	2.8	0.8	0.2	14.9	0.5	0.8	1.0	7.6	1.0	1.5	8.6	1.9	4.5	2.4	2.2	4.8	3.9	1.0	0.5	3.7	27.2	0.7	1.6	0.8	0.8	1.4	1.5	0.0	0.6	0.4	1.5	1.8	1.9	127.9	3.2	1.0	3.1	1.0	9.4	8.8	1.1	0.9	2.7	0.9	1.0	0.3	1.1	2.6	0.7	2.0	2.5	0.4	2.3	2.1	0.9	1.5	2.6	0.4	0.4	0.9	0.5	0.3	19.5	16.8	0.4	2.5	2.8	0.5	1.0	0.3	5.2	0.6	0.4	1.4	0.2	0.2	0.0	0.4	0.6	0.8	0.1	1.1	1.3	0.5	0.0	0.2	7.2	0.6	10.2	0.0	0.2	0.1	0.9	10.1	0.4	0.2	0.1	0.2	1.5	0.3	0.3	0.3	0.1	0.5	0.2	0.7	0.1	0.3	2.3	0.4	0.4	0.3	1.0	1.0	0.7	0.6	0.8	0.3	0.1	18.1	0.2	0.2	0.3	0.6	2.1	0.4	0.9	0.2	0.4	1.2	2.6	1.2	0.3	1.0	0.4	0.9	1.5	0.9	2.3	0.2	0.4	0.6	0.8	0.5	0.8	1.0	0.5	0.8	0.8	1.5	1.0
RFT1	CDG1N	ENSG00000163933	"RFT1 homolog"	Q96AA3	3	53088483-53130462	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA060327, HPA069022"	Approved		Approved	Vesicles				Vesicles		"HPA060327: , HPA069022: "	"unprognostic (5.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-3)"	"unprognostic (5.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (1.69e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.54e-2)"	12.9	19.1	10.8	13.8	14.7	7.2	13.2	11.0	19.2	11.9	11.7	17.0	9.6	10.2	16.2	14.0	16.9	13.0	11.0	12.4	10.2	7.4	10.1	17.7	11.6	15.3	10.5	10.5	15.5	43.7	15.4	9.4	13.8	10.6	11.0	13.8	13.4	18.6	11.3	7.0	13.4	10.5	11.6	11.5	14.5	12.8	23.8	11.1	16.8	15.2	9.1	16.3	12.5	12.1	16.5	27.5	25.9	23.1	11.7	14.5	13.6	16.2	15.4	10.6	16.9	12.5	13.3	22.1	14.8	13.9	25.9	23.7	15.2	32.1	21.5	9.3	14.2	17.5	23.9	24.2	23.0	20.2	10.5	21.2	11.2	15.0	21.8	19.3	12.5	14.0	20.5	34.8	25.2	16.4	11.1	19.7	17.0	16.5	18.1	11.4	21.2	20.3	7.5	10.2	32.6	14.3	11.0	6.0	8.2	18.3	13.5	13.3	10.1	27.6	10.8	24.1	15.6	16.4	29.0	12.5	15.0	16.3	17.2	24.8	25.1	25.9	23.1	9.9	13.3	22.4	13.4	12.2	12.5	13.6	24.1	16.5	14.5	14.5	7.7	11.7	15.5	27.5	10.9	13.6	10.8	14.7	11.0	19.2	10.2	7.4	10.5	10.5	10.6	11.1
RFWD3	"FANCW, FLJ10520, RNF201"	ENSG00000168411	"Ring finger and WD repeat domain 3"	Q6PCD5	16	74621394-74666881	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048258, HPA075649"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA048258: , HPA075649: "	"unprognostic (4.79e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.35e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.31e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	7.3	5.2	4.2	12.2	6.1	33.9	7.8	7.8	5.6	7.4	6.7	8.4	8.4	5.5	9.7	10.0	12.8	6.3	5.5	5.4	3.9	3.7	6.5	5.6	6.5	12.0	6.1	4.8	7.7	9.6	8.5	7.5	11.5	5.3	6.5	8.1	7.2	8.0	8.4	4.5	11.6	7.8	5.6	4.8	9.7	6.2	35.1	7.2	40.5	7.0	7.5	18.0	7.2	8.6	9.3	7.1	13.8	10.9	9.1	11.7	6.5	13.9	17.9	13.5	9.8	2.8	3.9	15.3	12.6	9.7	20.2	17.6	23.3	14.7	19.5	10.3	9.8	16.8	22.1	13.1	24.8	6.1	13.2	17.2	14.6	13.1	2.5	17.3	18.0	2.8	4.2	25.4	15.7	8.5	26.0	8.8	15.1	22.2	25.2	15.9	26.6	8.7	39.3	9.2	17.2	7.2	14.8	10.1	10.7	20.3	7.2	9.0	13.2	14.8	8.3	14.8	14.2	8.3	15.8	11.9	22.1	58.4	10.6	13.4	17.9	13.8	6.8	9.9	9.3	6.3	10.2	7.8	7.7	8.6	7.1	9.3	11.7	8.1	7.7	9.1	10.9	5.5	10.9	6.5	4.2	6.1	7.8	5.6	3.9	3.7	6.1	4.8	5.3	7.2
RGR	RP44	ENSG00000148604	"Retinal G protein coupled receptor"	P47804	10	84245053-84259960	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"retina: 228.3"	"Cell line enhanced"	"Detected in many"		"TIME: 4.0"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"midbrain: 30.1;olfactory region: 95.6;thalamus: 30.2"												"unprognostic (9.28e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.53e-2)"				"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"				"unprognostic (1.59e-1)"	"unprognostic (1.97e-1)"			0.4	0.4	6.6	0.5	6.1	1.3	0.6	0.4	18.1	0.5	0.4	0.6	0.0	0.3	0.5	1.1	0.6	0.3	0.3	0.3	3.0	2.2	0.4	0.4	0.4	0.6	3.2	1.3	0.5	0.3	0.2	0.4	0.4	1.1	0.5	0.6	228.3	0.6	0.4	0.6	1.1	0.5	0.2	0.2	0.5	0.4	1.2	0.7	0.0	0.4	0.0	0.3	0.3	0.0	0.9	0.9	2.2	0.8	1.0	0.7	0.1	0.6	0.7	0.8	1.6	0.6	0.5	0.4	0.4	0.4	1.0	0.4	1.5	0.2	0.8	0.7	1.2	1.2	0.3	0.7	0.2	0.5	0.2	0.3	3.0	1.0	0.2	1.4	1.7	0.3	0.7	0.5	1.2	0.3	0.6	1.4	0.0	1.2	0.5	0.9	1.5	0.2	0.5	0.6	1.5	0.0	1.5	0.3	0.4	1.0	0.7	1.4	0.2	0.1	4.0	1.6	2.1	0.8	0.3	1.2	0.3	1.2	0.3	1.3	1.0	1.0	0.8	0.8	0.6	0.8	0.4	0.8	0.7	0.5	0.3	0.9	0.6	0.6	2.2	1.0	0.4	0.9	0.2	0.1	6.6	6.1	0.4	7.3	3.0	2.2	3.2	1.3	1.1	0.7
RHAG	"CD241, RH50A, SLC42A1"	ENSG00000112077	"Rh associated glycoprotein"	Q02094	6	49605158-49636884	"CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"		"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 54.1"	"Group enriched"	"Detected in some"	190	"HEL: 85.7;K-562: 84.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046051, HPA055331"	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA046051: , HPA055331: "					"unprognostic (8.16e-2)"						"unprognostic (6.86e-2)"	"unprognostic (1.25e-3)"		"unprognostic (1.65e-1)"				1.2	0.2	0.0	1.1	0.5	54.1	3.2	0.0	0.1	2.3	1.0	0.5	1.7	0.2	0.4	0.1	2.6	0.5	0.8	5.3	0.0	0.0	0.1	0.7	3.3	0.1	0.0	0.0	0.1	0.2	0.1	0.1	5.8	0.1	1.3	0.2	0.0	0.2	0.5	0.4	0.1	0.9	0.1	0.0	4.5	0.6	0.2	0.0	1.7	1.8	0.0	0.1	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
RHBDF2	"FLJ22341, iRhom2, RHBDL5, RHBDL6, TOC, TOCG"	ENSG00000129667	"Rhomboid 5 homolog 2"	Q6PJF5	17	76470891-76501790	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Growth factor binding"	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA018080	Uncertain									"HPA018080: AB_2178634"	"unprognostic (1.19e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.11e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-3)"	"unprognostic (9.79e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (3.96e-11)"	"unprognostic (5.24e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.14e-1)"	18.7	7.6	11.6	29.1	17.5	25.9	11.2	3.2	11.5	6.7	6.8	16.4	1.8	6.3	5.4	5.0	16.7	7.5	11.0	6.0	12.8	7.1	9.5	5.2	17.1	24.5	18.2	3.8	6.3	18.9	4.7	4.4	9.9	15.3	6.6	4.6	7.0	9.4	4.7	8.9	19.4	18.2	6.0	23.4	31.6	8.5	4.0	15.3	3.5	8.9	8.1	26.8	10.7	10.0	12.5	9.3	10.7	12.2	4.5	8.2	6.5	16.4	18.8	0.6	5.3	0.1	0.4	13.8	4.3	12.9	3.8	4.6	5.5	22.1	17.7	14.3	4.9	13.9	3.1	19.3	3.0	3.1	5.8	1.2	1.3	9.0	12.9	0.7	2.7	2.5	10.1	8.5	9.8	9.5	2.2	8.6	2.2	13.4	1.9	2.0	3.2	11.0	4.6	0.1	34.8	8.4	6.0	4.2	6.1	4.2	14.3	18.6	11.8	5.0	14.3	0.3	7.1	0.3	4.8	21.3	10.0	14.9	11.7	5.4	12.8	3.9	11.6	3.7	8.2	12.2	5.7	12.5	2.3	5.8	5.9	7.7	1.4	3.4	10.7	4.5	10.4	9.3	1.2	6.5	11.6	17.5	3.2	11.5	12.8	7.1	18.2	3.8	15.3	15.3
RHO	"CSNBAD1, OPN2, RP4"	ENSG00000163914	Rhodopsin	P08100	3	129528640-129535169	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Congenital stationary night blindness, Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	151	"retina: 415.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebellum: 1.6;cerebral cortex: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013440, CAB022486, CAB034887, CAB034888"	Enhanced									"CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: "	"unprognostic (4.32e-2)"			"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"		"unprognostic (1.83e-1)"	"unprognostic (2.87e-1)"		"unprognostic (1.94e-1)"			"unprognostic (9.19e-11)"	"unprognostic (4.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.91e-1)"		0.2	0.0	0.0	0.0	0.3	0.0	0.1	1.6	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.1	415.0	0.3	0.2	0.0	1.8	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	2.7	0.2	0.2	0.0	0.0	0.0	0.0
RIPK4	"ANKK2, ANKRD3, DIK, PKK, RIP4"	ENSG00000183421	"Receptor interacting serine/threonine kinase 4"	P57078	21	41739369-41767106	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 16.3;HaCaT: 24.0;hTCEpi: 16.2;PC-3: 13.4;RPTEC TERT1: 14.5;RT4: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"naive CD4 T-cell: 1.5;neutrophil: 2.2"	"Group enriched"	"Detected in many"	17	"granulocytes: 2.2;T-cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA030942	Enhanced									"HPA030942: "	"unprognostic (8.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.32e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (6.22e-5)"	"prognostic unfavourable (3.48e-4)"	"unprognostic (9.98e-2)"	"prognostic favourable (6.52e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.78e-2)"	1.0	0.2	0.2	0.8	0.2	0.1	3.3	0.2	0.2	6.7	9.4	0.3	12.0	6.8	1.7	6.5	42.1	4.2	17.1	1.1	0.4	0.2	10.8	17.3	5.4	0.4	0.2	0.1	1.8	14.4	4.7	6.8	2.8	1.1	10.6	1.3	4.8	10.2	14.8	0.2	11.7	11.6	2.0	0.3	0.2	11.2	2.7	0.0	8.1	13.6	12.3	26.6	5.2	11.0	0.0	0.0	2.2	0.1	0.0	1.5	0.2	7.0	4.5	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	0.1	11.7	16.3	0.0	6.9	1.4	24.0	0.3	9.7	0.0	0.0	4.8	0.0	3.3	4.3	0.0	0.0	0.0	0.0	16.2	0.1	2.2	0.0	0.0	0.0	0.0	5.1	0.9	0.0	0.4	13.4	0.0	0.0	1.1	14.5	15.5	2.3	0.1	7.8	8.0	7.3	4.9	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	2.1	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.1	2.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.1	1.1	0.0
RLIM	"MGC15161, NY-REN-43, RNF12"	ENSG00000131263	"Ring finger protein, LIM domain interacting"	Q9NVW2	X	74585217-74614617	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018895	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA018895: AB_1856323"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (6.04e-4)"	"unprognostic (1.20e-1)"	11.8	14.3	17.5	10.6	25.6	37.4	12.4	12.6	20.5	12.2	7.4	8.3	5.6	6.4	10.6	8.0	10.2	9.5	10.7	10.5	17.1	16.6	11.6	9.7	13.8	9.2	12.4	13.7	12.4	9.7	19.5	18.5	10.5	28.6	11.9	7.6	5.2	8.9	8.7	11.2	10.2	7.1	10.1	13.9	9.8	8.4	6.9	12.4	9.7	13.0	6.2	10.1	10.5	9.3	3.5	4.8	16.3	7.4	5.2	4.6	3.0	13.5	13.8	13.4	11.2	13.5	14.3	13.2	13.1	15.2	11.7	14.5	10.7	14.2	7.3	15.3	16.4	11.8	26.9	15.7	18.0	6.6	14.2	12.8	24.3	6.5	12.0	19.3	22.9	13.8	9.9	16.7	28.7	13.6	11.1	13.3	15.4	10.3	14.3	10.9	20.6	13.3	13.7	28.4	12.3	10.9	16.2	9.9	11.5	24.5	11.9	15.2	6.7	15.2	18.0	14.2	13.8	14.5	11.4	7.1	13.6	11.7	15.5	19.6	13.8	16.3	5.9	5.6	3.2	7.4	3.3	3.0	4.1	4.0	4.8	3.5	4.5	4.1	11.4	5.2	5.4	2.6	4.6	3.0	17.5	25.6	12.6	20.5	17.1	16.6	12.4	13.7	28.6	12.4
RNASEH1		ENSG00000171865	"Ribonuclease H1"	O60930	2	3544793-3558616	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA043037	Uncertain				"Intracellular and membrane"					"HPA043037: "	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.81e-3)"	"unprognostic (4.32e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (7.83e-6)"	"unprognostic (9.43e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-3)"	16.6	12.8	10.1	14.5	15.4	14.7	16.1	11.0	13.1	9.7	12.1	11.4	10.8	11.8	13.3	14.0	14.1	10.0	11.0	18.5	13.1	10.3	10.9	17.0	11.2	18.3	12.9	11.4	10.1	15.1	10.5	10.8	11.5	12.3	11.2	12.6	9.5	11.2	16.0	35.3	11.3	11.3	17.7	11.9	12.4	11.8	13.8	12.5	10.9	10.1	10.3	14.5	12.8	11.8	16.6	15.9	7.4	12.8	17.2	14.6	10.8	8.9	21.0	7.3	12.3	7.6	7.9	16.2	14.8	12.8	12.6	10.2	16.0	10.9	17.3	16.0	13.2	9.9	12.1	12.0	10.1	12.9	7.9	14.9	12.5	26.8	14.5	19.5	14.1	7.0	10.1	13.6	16.1	11.1	20.4	17.4	12.9	17.8	11.5	10.9	14.1	15.7	14.1	11.9	18.1	7.6	15.9	12.2	16.0	12.5	8.8	12.4	7.4	7.5	11.4	16.7	11.5	13.3	20.5	25.7	34.7	28.9	15.6	14.7	21.8	2.8	11.5	7.4	14.5	12.8	14.6	16.6	12.7	13.6	14.2	13.8	12.9	12.5	3.2	17.2	11.1	15.9	11.2	10.8	10.1	15.4	11.0	13.1	13.1	10.3	12.9	11.4	12.3	12.5
RNASEH2A	"AGS4, RNASEHI, RNHIA, RNHL"	ENSG00000104889	"Ribonuclease H2 subunit A"	O75792	19	12806556-12815201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042692			Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042692: AB_10793981"	"unprognostic (6.74e-2)"	"prognostic favourable (1.18e-4)"	"prognostic favourable (6.18e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavourable (8.72e-5)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-2)"	"prognostic favourable (1.22e-4)"	"unprognostic (3.80e-3)"	"unprognostic (8.71e-2)"	"prognostic unfavourable (6.29e-6)"	"unprognostic (3.40e-3)"	"unprognostic (4.35e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.60e-2)"	6.5	5.5	6.4	11.4	10.6	21.9	6.6	11.0	7.5	6.8	6.6	9.2	1.6	8.6	6.8	4.4	14.1	6.0	5.7	5.1	6.7	4.8	8.7	5.9	5.5	9.2	10.6	5.8	7.3	7.0	6.2	4.1	11.8	6.1	5.3	5.7	5.5	8.8	4.3	7.1	13.4	7.1	4.4	7.8	12.0	7.4	14.1	8.4	44.8	8.6	13.4	17.4	6.0	8.0	11.3	7.8	7.1	6.8	12.9	8.6	5.0	14.8	11.2	6.8	6.8	1.0	1.9	8.4	6.9	2.9	10.4	12.1	8.8	5.7	15.9	10.5	1.6	8.9	5.5	6.8	5.7	8.6	15.0	7.6	11.9	6.8	0.7	7.0	7.1	1.0	1.7	8.8	3.2	4.0	10.5	4.7	4.9	25.5	12.8	6.9	6.7	19.6	13.8	9.8	11.4	2.6	5.9	14.1	8.2	7.5	2.7	3.1	7.4	4.3	3.8	12.4	6.2	17.6	11.4	11.5	12.7	12.6	7.3	11.2	10.0	7.1	6.8	6.4	8.6	6.6	7.0	9.8	7.0	6.1	4.2	11.3	6.6	6.5	6.8	12.9	5.9	7.8	5.5	5.0	6.4	10.6	11.0	7.5	6.7	4.8	10.6	5.8	6.1	8.4
RNF125	FLJ20456	ENSG00000101695	"Ring finger protein 125"	Q96EQ8	18	32018372-32073213	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041514	Uncertain		Supported	"Nucleoli,Golgi apparatus"				"Golgi apparatus"	Nucleoli	"HPA041514: AB_10795596"	"unprognostic (2.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.30e-3)"	"unprognostic (6.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"prognostic unfavourable (4.06e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.07e-3)"	21.9	2.3	4.1	9.1	5.7	18.2	20.4	1.2	6.6	5.0	8.9	12.2	3.3	12.3	7.2	5.5	3.9	4.3	6.0	5.4	6.1	4.1	2.1	14.1	10.3	13.5	7.7	3.1	2.4	4.2	2.5	1.3	4.4	7.0	3.1	7.8	1.6	5.0	1.9	4.4	6.0	26.0	4.1	12.0	7.4	4.2	3.3	8.3	14.8	3.2	2.9	7.2	4.5	6.2	2.1	3.4	9.0	3.8	11.7	12.5	5.1	0.7	0.1	0.1	0.2	0.3	0.5	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.5	0.9	0.7	0.1	3.9	1.6	0.2	0.2	0.2	0.1	5.1	31.8	1.0	1.5	0.0	1.7	0.3	0.1	1.1	0.0	1.1	1.3	4.8	2.6	0.9	5.4	0.3	0.1	0.3	0.3	0.5	0.2	0.1	0.1	7.8	0.8	2.5	0.1	0.1	0.5	0.1	0.0	3.7	0.1	0.1	0.4	6.8	4.2	9.0	3.8	3.3	12.5	2.0	8.2	2.0	10.1	10.5	3.4	2.1	8.2	10.6	1.5	11.7	1.9	3.4	10.0	5.1	4.1	5.7	1.2	6.6	6.1	4.1	7.7	3.1	7.0	8.3
RNF135	MGC13061	ENSG00000181481	"Ring finger protein 135"	Q8IUD6	17	30968785-30999911	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021576, HPA052404"	Approved		Approved	Vesicles				Vesicles		"HPA021576: AB_1856331, HPA052404: "	"unprognostic (1.13e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (7.51e-5)"	"unprognostic (6.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.47e-1)"	18.2	11.6	6.5	15.9	7.1	7.1	28.8	6.4	6.1	16.3	22.2	7.2	16.5	9.7	15.7	16.8	18.4	11.8	14.4	7.4	7.1	4.8	19.5	6.0	19.0	28.0	6.8	2.5	15.1	11.7	15.0	5.9	19.2	6.3	18.1	13.2	13.6	13.3	14.8	7.5	21.4	16.7	13.9	6.1	22.7	10.0	8.8	4.8	6.0	25.0	12.7	18.8	13.0	19.1	11.8	18.4	21.7	25.1	5.4	5.3	9.7	5.8	12.2	0.7	12.1	16.7	13.3	10.3	4.7	7.0	4.6	4.0	0.0	4.4	4.7	6.9	8.9	7.5	6.0	5.7	3.6	4.5	2.6	2.2	3.6	0.0	11.7	5.9	5.1	13.2	30.2	4.8	15.6	7.2	0.0	16.2	7.3	7.8	0.0	6.0	4.9	6.6	12.4	0.0	17.3	6.3	8.4	4.5	0.2	6.7	2.8	6.7	18.5	9.2	6.3	0.0	1.6	7.4	5.3	0.2	0.5	3.4	8.1	10.2	6.2	9.1	24.0	12.1	5.3	21.8	2.9	11.8	2.8	2.7	18.4	11.2	1.5	2.7	21.7	5.4	25.1	6.6	3.8	9.7	6.5	7.1	6.4	6.1	7.1	4.8	6.8	2.5	6.3	4.8
RNF139	"HRCA1, RCA1, TRC8"	ENSG00000170881	"Ring finger protein 139"	Q8WU17	8	124474738-124487914	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001202	Approved									"HPA001202: AB_1079824"	"unprognostic (3.28e-3)"	"unprognostic (2.92e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.71e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (3.54e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.45e-1)"	15.1	17.3	10.4	9.5	12.2	54.5	13.4	12.0	17.1	14.2	10.9	14.0	9.4	6.2	15.3	10.0	12.2	14.2	11.0	11.4	10.4	10.8	11.4	17.7	11.3	14.2	12.4	11.5	17.1	10.3	7.6	10.6	18.4	9.9	12.8	10.4	10.2	10.3	10.5	15.2	12.6	11.3	14.2	12.2	11.8	11.2	60.3	13.3	16.8	11.2	9.6	10.4	14.8	10.7	9.2	9.4	11.8	11.7	8.6	13.9	8.0	13.2	8.9	10.7	10.5	23.6	18.8	8.8	11.9	22.6	10.0	12.9	5.7	11.1	13.7	14.0	15.4	9.8	9.1	14.5	15.0	18.9	11.4	20.3	5.8	11.7	18.0	9.6	11.8	16.0	21.2	10.6	28.7	13.3	14.3	21.0	11.8	35.8	16.2	6.9	7.5	12.6	6.5	7.9	13.7	18.8	17.0	4.5	11.7	15.5	38.9	16.8	18.7	10.4	10.5	6.7	15.5	11.3	13.2	17.1	18.1	12.4	10.5	16.3	6.7	3.3	7.4	11.8	11.6	4.7	13.9	9.2	10.8	13.2	9.4	8.5	10.8	11.3	10.8	8.6	11.7	5.1	13.2	8.0	10.4	12.2	12.0	17.1	10.4	10.8	12.4	11.5	9.9	13.3
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266610-127288567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favourable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favourable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	27.3	20.9	28.5	16.6	29.1	5.1	23.9	63.7	34.5	22.7	18.6	29.2	10.5	11.8	32.0	35.2	14.2	17.9	21.3	25.2	26.3	21.7	20.9	16.8	21.0	17.3	30.0	27.7	28.5	12.6	26.5	27.4	27.8	31.3	18.6	17.6	17.5	16.7	20.3	55.9	16.0	15.2	26.1	28.7	24.6	15.5	16.3	27.7	9.2	26.7	15.5	17.6	19.2	18.7	11.7	14.2	22.8	22.8	11.5	10.3	9.1	5.5	7.0	26.7	23.5	24.7	24.8	9.7	18.9	30.2	10.1	14.5	9.1	8.4	10.0	13.4	15.4	7.1	7.9	8.8	14.8	11.5	6.9	12.7	8.4	12.7	24.5	7.5	9.0	21.6	18.7	11.4	22.8	17.7	13.6	9.8	22.2	10.6	7.3	13.6	9.7	7.3	9.4	6.9	5.0	14.4	6.1	16.0	16.1	7.3	10.4	11.6	7.1	26.0	20.8	17.8	5.9	18.4	13.3	14.2	8.8	6.6	13.6	13.2	16.8	16.8	18.9	16.1	9.3	20.0	9.7	11.1	8.0	10.3	14.2	11.7	7.3	10.2	22.8	11.5	22.8	7.1	8.6	9.1	28.5	29.1	63.7	34.5	26.3	21.7	30.0	27.7	31.3	27.7
RNF168	FLJ35794	ENSG00000163961	"Ring finger protein 168"	Q8IYW5	3	196468783-196503768	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046109			Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA046109: "	"unprognostic (6.15e-3)"	"prognostic favourable (8.21e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (6.81e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (8.31e-4)"	"unprognostic (4.83e-3)"	"unprognostic (2.80e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.65e-2)"	20.8	9.3	8.9	10.7	11.1	31.6	18.7	21.1	13.0	13.6	11.2	10.7	12.3	11.1	13.9	8.5	14.3	10.1	10.9	12.0	10.2	10.2	7.5	18.8	14.3	12.0	13.8	11.0	14.6	9.2	12.0	8.1	9.9	15.3	10.1	10.8	9.1	11.0	13.6	20.8	20.1	10.1	12.9	10.5	11.7	10.7	18.4	13.4	17.6	9.6	13.9	15.2	14.7	17.1	6.2	5.8	21.8	10.0	7.7	11.6	5.7	12.3	4.9	8.9	11.6	8.3	6.1	12.7	7.6	4.8	5.1	8.1	9.6	6.1	13.1	17.6	6.3	12.6	12.4	9.0	7.9	6.2	6.1	24.9	12.5	11.9	4.3	7.6	6.2	6.0	3.5	8.0	7.1	7.4	7.4	13.8	5.1	20.9	25.1	4.5	10.5	6.5	11.3	10.3	10.6	4.3	17.1	7.4	7.5	8.6	10.6	6.5	16.0	6.8	7.3	8.9	7.0	9.4	10.0	11.8	11.1	19.9	8.7	9.2	7.0	21.8	6.6	7.5	11.6	7.1	10.4	5.7	9.8	8.3	5.8	6.2	8.7	9.1	7.3	7.7	10.0	5.5	6.2	5.7	8.9	11.1	21.1	13.0	10.2	10.2	13.8	11.0	15.3	13.4
RNF170	"ADSA, DKFZP564A022, SNAX1"	ENSG00000120925	"Ring finger protein 170"	Q96K19	8	42849637-42897290	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA050931, HPA054621"	Uncertain									"HPA050931: , HPA054621: "	"unprognostic (3.06e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.54e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.61e-3)"	"unprognostic (4.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.13e-1)"	8.9	13.6	14.3	8.7	17.0	2.2	13.0	15.3	18.8	8.6	10.9	17.5	15.0	10.2	9.8	15.6	14.5	9.7	9.5	8.1	13.7	14.3	17.0	19.4	9.3	8.4	15.7	18.2	13.4	10.8	15.5	16.6	19.0	19.7	11.5	11.7	12.5	12.0	11.5	10.5	14.9	11.3	7.9	21.8	8.8	10.6	7.8	14.2	5.5	29.4	8.0	9.6	10.4	10.6	8.5	11.1	2.6	7.2	5.6	8.0	5.9	6.8	11.2	11.5	5.8	18.8	19.4	6.9	8.3	11.5	7.8	8.5	5.3	22.5	8.4	10.1	7.8	5.9	6.1	8.3	6.7	5.7	6.5	9.7	5.0	5.6	10.5	1.2	7.0	16.8	12.9	5.9	12.4	8.4	8.7	10.0	12.5	2.0	10.2	5.7	5.4	4.0	5.4	15.3	4.7	12.6	6.7	3.0	9.0	7.8	5.6	13.9	14.6	5.6	12.1	8.5	3.7	11.2	2.6	16.2	15.4	9.4	11.5	4.1	8.5	1.7	7.2	2.6	4.0	7.1	5.6	8.5	6.3	6.9	10.7	5.1	7.7	5.5	0.7	5.6	6.5	11.1	8.0	5.9	14.3	17.0	15.3	18.8	13.7	14.3	15.7	18.2	19.7	14.2
RNF213	"C17orf27, KIAA1554, KIAA1618, MYMY2, NET57"	ENSG00000173821	"Ring finger protein 213"	Q63HN8	17	80260866-80398786	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Ubl conjugation pathway"	"Hydrolase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003347, HPA026790"	Approved		Supported	Cytosol				Cytosol		"HPA003347: AB_1079204, HPA026790: AB_10602296"	"unprognostic (8.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.97e-3)"	"prognostic unfavourable (4.65e-5)"	"unprognostic (7.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-3)"	"unprognostic (8.92e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.56e-2)"	17.0	15.1	7.4	16.9	10.3	22.4	10.2	4.7	7.5	11.0	12.2	15.6	14.9	8.5	16.6	13.0	13.2	9.7	12.1	8.5	7.8	7.8	17.1	11.6	15.4	17.9	10.9	5.6	11.5	9.0	41.1	11.4	15.1	10.0	11.2	8.0	12.3	11.7	12.5	9.0	8.7	14.8	13.6	14.3	17.0	10.6	5.9	8.7	24.5	15.9	7.5	18.2	13.6	15.4	7.2	13.9	37.9	9.6	11.4	12.1	1.8	16.1	28.7	2.9	2.0	10.5	16.1	2.2	4.1	8.9	18.5	15.8	3.0	7.5	1.0	3.5	8.5	9.4	3.9	5.3	6.3	36.5	1.7	2.5	11.6	5.3	4.5	2.6	2.6	8.8	3.6	10.4	4.5	14.2	4.6	6.0	6.9	3.9	10.5	1.1	2.1	6.6	7.2	6.7	1.2	5.1	14.0	2.8	3.9	9.9	21.1	7.5	4.8	3.3	18.3	10.3	8.2	6.0	4.2	2.6	2.4	2.9	7.7	3.1	3.7	6.9	9.6	4.2	12.1	8.0	8.1	6.2	8.6	9.7	2.3	7.2	6.9	8.5	37.9	11.4	6.9	13.9	6.4	1.8	7.4	10.3	4.7	7.5	7.8	7.8	10.9	5.6	10.0	8.7
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favourable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	16.9	14.9	22.0	18.8	24.8	22.2	18.4	33.5	27.8	17.8	26.9	22.0	13.4	11.5	26.9	13.3	18.7	19.6	14.2	29.1	20.5	17.4	12.7	11.8	14.9	23.8	23.8	14.8	25.6	21.3	23.2	24.9	14.6	20.4	17.7	11.8	18.9	16.2	21.5	22.5	15.1	20.1	25.0	18.7	23.3	18.3	34.3	26.3	18.5	19.8	9.6	24.1	17.7	30.7	8.8	6.7	24.5	8.4	10.0	9.7	6.5	14.4	15.6	12.8	21.8	15.3	13.3	8.8	15.5	16.3	16.1	14.9	11.3	8.3	12.7	8.0	17.3	10.4	13.3	10.9	13.2	7.9	11.6	9.8	9.5	11.4	18.4	16.0	16.8	13.7	14.0	12.3	15.1	12.7	19.6	8.9	17.8	22.2	6.0	25.5	17.6	13.0	15.3	18.1	7.1	9.6	12.2	9.8	15.6	9.8	24.6	8.8	9.7	16.4	13.8	16.3	29.4	16.6	13.9	7.2	5.4	10.3	12.2	14.9	25.9	1.3	7.7	24.5	9.0	8.4	9.0	7.3	7.9	6.7	6.7	8.8	9.7	9.1	13.1	10.0	7.7	5.4	7.0	6.5	22.0	24.8	33.5	27.8	20.5	17.4	23.8	14.8	20.4	26.3
RNF43	"DKFZp781H0392, FLJ20315, URCC"	ENSG00000108375	"Ring finger protein 43"	Q68DV7	17	58352500-58417595	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 14.9;Hep G2: 29.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.7"	"Region enriched"	"Detected in many"	7	"cerebellum: 30.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA008079	Uncertain									"HPA008079: AB_1856371"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.79e-1)"	"prognostic favourable (6.04e-9)"	"unprognostic (3.61e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.04e-2)"	0.4	9.4	2.2	6.2	3.5	1.9	4.5	30.6	4.3	3.4	26.4	0.9	21.3	18.5	1.7	9.1	10.0	3.9	8.1	3.3	1.9	1.3	8.0	7.0	6.1	2.7	0.8	1.1	1.6	13.2	3.0	13.3	8.7	4.1	8.0	16.3	3.8	13.7	19.0	0.5	8.9	29.0	0.9	0.8	0.9	4.9	3.1	0.7	3.0	1.8	5.7	6.6	4.0	4.4	0.9	1.1	1.7	1.8	5.6	3.6	1.2	0.7	10.4	1.9	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	14.9	5.0	4.2	5.3	0.0	2.9	0.4	4.0	0.0	8.8	7.3	3.4	0.5	29.2	0.0	4.2	3.0	0.0	8.2	0.0	1.3	0.0	0.3	3.6	0.0	0.1	2.2	3.9	0.3	0.7	6.9	0.0	2.2	3.7	5.6	1.2	0.3	0.9	0.4	0.3	1.3	1.2	0.0	0.1	1.2	0.0	0.0	3.8	1.7	3.3	0.4	0.4	2.4	1.7	0.2	1.6	3.1	0.8	3.2	0.9	2.5	3.6	0.4	0.9	2.3	3.0	0.8	5.6	1.8	1.1	1.2	1.2	2.2	3.5	30.6	4.3	1.9	1.3	0.8	1.1	4.1	0.7
RNF6	DKFZp686P0776	ENSG00000127870	"Ring finger protein 6"	Q9Y252	13	26132115-26222493	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039343, HPA040048"	Approved		Supported	"Nuclear membrane"				"Nuclear membrane"		"HPA039343: AB_2676456, HPA040048: AB_10672969"	"unprognostic (3.22e-1)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.63e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	16.4	19.8	22.3	15.9	27.5	25.1	24.2	26.6	28.9	13.1	16.4	8.1	20.3	15.5	13.0	13.0	20.9	13.4	12.5	17.9	20.4	17.3	16.9	17.5	14.5	18.4	15.8	22.6	10.9	14.2	17.9	26.3	23.3	16.8	15.2	17.2	8.1	16.1	13.5	24.8	15.5	21.0	14.3	16.7	16.6	15.1	28.7	14.5	23.6	16.1	14.4	20.7	14.1	19.5	13.5	12.5	24.6	15.0	13.3	13.2	9.2	12.6	11.1	4.2	6.2	14.7	11.6	9.5	21.7	17.8	14.1	10.0	13.9	16.3	22.7	10.9	20.6	17.0	11.8	17.6	23.5	21.7	7.4	24.7	9.4	11.9	23.1	25.8	26.1	10.9	34.4	15.8	33.9	14.1	9.5	0.0	21.8	11.3	14.4	15.1	3.4	7.8	11.5	16.4	8.9	17.4	16.7	7.7	4.7	11.6	21.3	20.6	8.1	25.4	18.4	12.2	7.4	16.3	15.5	5.8	5.4	13.6	11.1	14.8	15.9	24.6	10.1	23.7	11.9	13.1	12.8	13.5	13.0	13.2	12.5	9.4	13.2	11.2	7.1	13.3	15.0	6.5	13.1	9.2	22.3	27.5	26.6	28.9	20.4	17.3	15.8	22.6	16.8	14.5
ROR1	NTRKR1	ENSG00000185483	"Receptor tyrosine kinase like orphan receptor 1"	Q01973	1	63774022-64181498	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Receptor, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 31.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.4;ASC TERT1: 24.3;CACO-2: 16.6;HHSteC: 18.5;HSkMC: 19.9;NTERA-2: 20.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 13.0"	"Group enriched"	"Detected in some"	5	"NK-cell: 3.3;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.1;NK-cells: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA057016			Approved	Microtubules	"Intracellular and membrane"	2800000	2800000	Microtubules		"HPA057016: "	"unprognostic (5.15e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.15e-2)"	5.5	1.7	1.3	3.5	2.7	0.4	3.4	13.0	2.8	16.7	8.8	2.2	4.4	2.0	14.2	5.0	4.9	5.5	10.7	10.6	1.3	1.1	3.6	0.8	9.7	1.1	1.0	2.4	8.3	9.8	31.2	3.6	2.9	3.0	10.9	3.9	7.9	2.8	6.3	2.1	4.5	4.1	17.8	1.1	3.1	9.2	2.7	0.9	1.8	1.5	4.6	2.1	10.2	8.8	0.4	1.1	0.1	0.1	3.3	0.1	0.0	7.0	5.5	2.8	0.3	19.4	24.3	1.9	1.3	3.8	0.7	2.0	16.6	2.2	0.1	3.2	3.2	1.5	0.0	1.3	0.5	0.0	1.7	0.0	0.7	0.2	18.5	0.0	0.0	19.9	5.1	10.2	12.0	0.3	0.0	0.1	5.1	0.1	0.1	0.0	20.2	2.8	0.1	0.1	4.3	4.1	0.1	1.6	6.5	0.4	0.1	2.9	0.0	0.0	3.8	1.5	2.9	10.8	2.8	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.1	3.3	0.1	1.1	0.0	0.0	1.3	2.7	13.0	2.8	1.3	1.1	1.0	2.4	3.0	0.9
ROR2	"BDB, BDB1, NTRKR2"	ENSG00000169071	"Receptor tyrosine kinase like orphan receptor 2"	Q01974	9	91563091-91950162	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 12.0;HHSteC: 31.7;HSkMC: 26.4;U-266/70: 18.3;U-266/84: 12.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"pons and medulla: 6.6"	"Cell type enriched"	"Detected in single"	6	"MAIT T-cell: 3.9"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"cerebellum: 13.5"	HPA021868	Uncertain									"HPA021868: AB_1856406"	"unprognostic (9.38e-3)"	"unprognostic (4.69e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (9.86e-7)"	"unprognostic (2.16e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavourable (4.28e-8)"	"unprognostic (1.25e-2)"	4.4	4.3	0.7	5.3	1.1	0.0	3.6	0.2	0.8	23.4	20.7	2.9	11.1	1.9	29.1	9.1	8.0	8.1	18.7	8.5	1.0	0.9	2.0	0.5	4.2	0.7	0.3	0.0	19.1	3.1	20.3	1.3	7.1	6.6	20.3	2.1	11.0	1.2	13.1	1.1	2.9	6.2	30.0	0.3	4.7	10.5	5.2	0.3	2.6	7.9	1.9	3.3	23.7	18.1	0.6	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.1	12.0	0.0	2.6	0.2	3.4	0.2	3.1	2.0	3.8	0.0	0.0	0.0	0.0	0.6	0.1	2.5	0.0	0.8	0.0	2.0	0.0	9.2	0.0	31.7	0.0	0.0	26.4	0.0	2.7	0.0	0.0	6.6	0.0	0.0	0.2	0.0	1.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.5	0.2	0.0	0.0	7.1	0.1	0.0	0.0	2.4	1.0	0.0	18.3	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.2	0.8	1.0	0.9	0.3	0.0	6.6	0.3
ROS1	"c-ros-1, MCF3, ROS"	ENSG00000047936	"ROS proto-oncogene 1, receptor tyrosine kinase"	P08922	6	117288300-117425855	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 38.6;lung: 20.2"	"Group enriched"	"Detected in some"	5	"HSkMC: 9.3;hTCEpi: 19.3;LHCN-M2: 13.4"	"Cancer enriched"	"Detected in some"	13	"lung cancer: 6.9"	"Group enriched"	"Detected in some"	10	"cerebral cortex: 7.4;olfactory region: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049098, HPA072424"	Uncertain		Approved	Vesicles				Vesicles		"HPA049098: , HPA072424: "	"unprognostic (8.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.56e-12)"	"unprognostic (1.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	0.3	0.2	0.2	0.0	0.4	0.0	0.2	0.2	7.4	0.2	0.4	0.0	7.9	0.0	0.2	38.6	0.2	0.2	0.0	0.2	0.2	0.2	0.4	0.2	20.2	0.0	0.2	2.5	0.2	0.2	0.0	0.3	0.7	0.0	0.2	0.3	0.0	0.2	2.3	0.2	0.7	0.3	0.0	0.2	0.2	0.3	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	9.3	19.3	0.2	1.7	0.0	0.0	0.0	13.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.8	0.0	2.3	1.5	0.1	1.8	0.0	0.0	0.0	1.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	7.4	0.2	0.2	0.2	2.5	0.0	0.0
RPIA		ENSG00000153574	"Ribose 5-phosphate isomerase A"	P49247	2	88691644-88750935	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042620, HPA057954"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		4100000	4100000	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA042620: AB_10793980, HPA057954: "	"unprognostic (3.35e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavourable (1.46e-5)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (8.70e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (8.53e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (8.79e-3)"	12.9	8.8	6.6	15.6	7.0	43.0	12.1	11.1	6.4	8.1	12.7	6.1	11.0	12.4	11.1	7.3	18.3	8.5	14.0	10.9	5.0	4.9	6.8	6.2	9.0	16.2	7.2	3.8	11.7	26.5	3.6	11.4	26.1	6.5	8.8	13.4	6.0	12.6	8.5	17.6	9.2	12.7	7.7	5.1	15.4	10.4	8.9	7.6	30.7	9.6	10.5	19.3	8.1	11.8	18.5	14.1	21.4	12.5	13.3	22.4	11.6	8.5	5.0	10.2	8.0	7.2	7.4	22.3	4.8	4.5	7.9	5.4	17.8	11.4	43.7	10.4	5.5	5.2	12.6	4.0	12.5	20.7	16.5	17.5	3.2	17.5	7.3	32.0	12.9	6.8	3.4	7.0	11.0	11.1	18.7	7.6	7.4	13.4	35.1	28.0	9.2	8.2	18.4	12.1	10.6	6.5	13.8	7.3	8.3	5.7	7.4	11.0	4.0	13.2	6.3	4.7	12.4	15.4	13.6	5.9	4.8	43.7	4.8	29.1	6.7	5.5	9.7	21.4	11.1	9.8	14.2	18.5	15.5	16.4	14.1	15.4	22.4	18.4	2.3	13.3	12.5	6.8	12.6	11.6	6.6	7.0	11.1	6.4	5.0	4.9	7.2	3.8	6.5	7.6
RPS6KA3	"CLS, HU-3, MRX19, RSK, RSK2"	ENSG00000177189	"Ribosomal protein S6 kinase A3"	P51812	X	20149911-20267519	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003221, CAB003853, CAB013520"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-1)"	19.7	12.5	9.9	23.0	12.5	8.2	16.5	15.2	12.1	11.4	23.2	4.4	22.1	13.7	12.4	10.1	13.6	12.7	15.7	21.3	9.7	8.8	14.1	25.8	21.6	34.0	9.9	10.0	12.7	14.0	36.6	9.8	11.0	10.2	14.5	18.8	7.7	14.3	11.3	45.2	11.7	23.7	16.1	11.7	25.8	11.8	4.8	9.7	29.4	13.5	15.0	18.2	20.3	19.0	4.2	8.6	12.5	6.9	8.3	11.3	2.7	12.6	22.2	8.4	4.3	8.2	14.5	2.5	11.0	16.8	8.2	11.3	25.1	16.4	8.3	3.8	11.5	9.0	9.6	9.3	15.3	7.0	7.6	9.8	14.0	67.5	8.4	19.0	10.2	9.2	7.5	12.9	16.3	29.8	6.4	23.9	8.6	6.0	12.3	5.8	6.0	13.4	6.6	17.8	9.6	7.1	10.6	3.9	3.8	14.8	4.5	16.0	0.0	5.7	16.6	9.0	6.3	28.5	6.2	19.1	11.6	9.3	17.0	9.5	21.2	12.5	4.7	9.5	6.3	6.9	11.3	2.9	7.3	6.9	7.0	4.2	5.0	6.0	7.5	8.3	6.9	8.6	3.5	2.7	9.9	12.5	15.2	12.1	9.7	8.8	9.9	10.0	10.2	9.7
RTEL1	"bK3184A7.3, C20orf41, DKFZP434C013, KIAA1088, NHL, RTEL"	ENSG00000258366	"Regulator of telomere elongation helicase 1"	Q9NZ71	20	63657810-63696253	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA020622, HPA067329, HPA078328"			Approved	"Nuclear speckles,Nuclear bodies"				"Nuclear speckles, Nuclear bodies"		"HPA020622: , HPA067329: , HPA078328: "	"unprognostic (3.63e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.27e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.30e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.50e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.84e-2)"	8.4	14.3	9.4	11.5	12.4	14.2	7.9	25.6	11.8	9.1	11.1	11.2	10.9	9.8	15.4	7.4	7.0	9.5	9.3	6.2	8.0	6.9	7.1	7.2	8.9	7.8	7.5	12.1	10.6	17.8	7.2	18.2	9.8	8.2	10.2	4.8	10.2	12.9	10.2	10.2	8.2	10.1	8.8	4.4	11.6	10.4	17.6	8.9	9.1	11.9	4.9	9.5	9.3	9.0	1.7	3.6	0.0	3.3	0.4	3.0	2.4	5.2	7.2	5.2	10.0	1.1	1.2	9.6	10.9	2.9	17.0	4.5	14.4	4.5	7.1	5.7	3.3	9.9	3.5	7.1	4.1	3.5	7.3	8.7	12.5	13.7	3.8	8.5	16.0	1.5	4.0	4.2	5.2	5.8	10.8	6.7	3.8	5.6	13.2	11.0	5.1	15.2	10.6	4.9	7.3	2.7	6.5	10.3	6.2	6.1	17.8	1.3	4.7	9.6	7.7	19.3	6.3	6.6	8.3	6.2	2.6	4.4	4.7	6.0	6.7	0.0	2.7	0.0	3.0	3.3	1.6	0.9	1.7	2.0	3.6	1.7	2.9	1.1	0.0	0.4	2.6	3.2	1.4	2.4	9.4	12.4	25.6	11.8	8.0	6.9	7.5	12.1	8.2	8.9
RXFP2	"GPR106, GREAT, INSL3R, LGR8, RXFPR2"	ENSG00000133105	"Relaxin/insulin like family peptide receptor 2"	Q8WXD0	13	31739542-31803388	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 8.3;epididymis: 28.4"	"Group enriched"	"Detected in some"	6	"U-2197: 2.1;U-87 MG: 4.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"basal ganglia: 8.3"	"Cell type enriched"	"Detected in single"	11	"classical monocyte: 5.0"	"Lineage enriched"	"Detected in single"	23	"monocytes: 5.0"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	7	"basal ganglia: 2.0"																											"unprognostic (1.77e-2)"		0.5	3.3	1.5	0.1	8.3	2.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.9	28.4	0.0	1.5	0.1	0.5	0.6	0.5	0.3	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.6	0.0	0.2	0.0	3.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	5.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	1.5	8.3	0.0	0.5	0.6	0.5	0.0	0.0	0.5	0.0
S1PR2	"AGR16, DFNB68, EDG5, Gpcr13, H218"	ENSG00000267534	"Sphingosine-1-phosphate receptor 2"	O95136	19	10221433-10231331	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.3;Daudi: 25.2;U-266/70: 18.9;U-698: 27.3;WM-115: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 23.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 23.7;T-cells: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014255, HPA014307"	Approved		Uncertain	"Nuclear speckles,Golgi apparatus"				"Golgi apparatus"	"Nuclear speckles"	"HPA014255: , HPA014307: AB_1847989"	"unprognostic (5.38e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.05e-3)"	"unprognostic (8.50e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (4.36e-10)"	"unprognostic (4.91e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.09e-2)"	17.1	2.3	1.4	13.7	1.3	0.9	7.2	0.9	1.5	13.3	4.1	1.7	3.9	1.8	8.3	9.2	6.4	7.9	6.5	6.1	1.3	1.5	2.4	9.5	11.2	10.6	1.3	0.0	12.9	2.6	3.9	2.2	31.3	1.7	9.8	2.5	3.2	9.4	5.7	3.4	4.0	3.9	8.7	1.7	2.2	4.2	21.8	1.0	2.0	3.3	6.3	15.6	8.0	12.0	0.3	1.6	23.7	1.9	2.1	7.4	1.2	1.4	0.2	1.6	3.3	9.2	11.2	14.3	2.1	4.3	0.9	2.0	0.9	0.8	25.2	2.5	3.9	0.8	0.6	1.0	0.6	2.5	1.3	0.6	0.6	0.6	3.0	0.7	0.5	6.1	0.5	1.8	0.6	0.1	0.6	5.5	0.6	1.1	0.3	1.2	1.7	0.8	1.7	0.7	0.9	0.8	1.2	1.2	2.3	1.2	0.7	1.7	0.6	0.6	0.2	3.5	1.1	7.8	0.6	18.9	8.9	27.3	1.3	1.3	18.7	23.7	1.9	0.4	4.9	1.5	5.9	0.2	6.2	4.6	1.6	0.3	2.6	2.6	0.5	2.1	0.6	0.2	7.4	1.2	1.4	1.3	0.9	1.3	1.3	1.5	1.3	0.0	1.7	1.0
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 25.3;liver: 52.8;pancreas: 39.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.9;Hep G2: 18.4;MOLT-4: 13.3;RH-30: 11.4;RPMI-8226: 23.0;SH-SY5Y: 9.2"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 4.1;naive CD4 T-cell: 8.4;T-reg: 9.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria		190000	190000	Mitochondria		"HPA057267: , HPA058086: "	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	0.5	1.1	1.7	1.0	1.8	0.3	0.4	0.8	1.9	0.9	0.5	1.1	2.9	0.8	1.4	25.3	0.3	0.9	1.2	1.1	1.1	1.4	5.8	52.8	1.3	1.7	1.2	2.1	3.4	39.4	2.0	1.9	0.3	1.2	1.4	0.1	3.7	8.2	0.9	0.3	0.2	0.6	0.6	0.6	0.7	1.2	1.1	0.8	2.2	0.8	0.2	1.2	0.6	0.6	0.4	0.3	0.6	0.1	0.1	9.7	1.6	0.0	0.1	0.8	10.9	0.0	0.3	1.4	0.1	0.4	0.5	0.7	0.2	0.1	0.0	1.5	0.1	0.0	0.0	0.2	0.4	0.0	0.2	1.5	0.0	18.4	1.2	0.0	0.2	2.6	0.0	1.3	0.0	0.1	0.0	0.2	6.9	1.9	13.3	1.4	1.7	0.1	0.9	11.4	23.0	0.0	0.1	1.0	9.2	0.0	0.3	2.3	1.5	0.1	0.0	2.1	1.9	0.2	0.0	0.1	0.0	0.7	1.3	0.8	0.0	0.1	0.1	0.1	0.4	0.0	1.0	0.0	4.1	1.0	0.0	0.4	8.4	1.5	0.6	0.1	0.0	0.3	9.7	1.6	1.7	1.8	0.8	1.9	1.1	1.4	1.2	2.1	1.2	0.8
SARS	SERS	ENSG00000031698	"Seryl-tRNA synthetase"	P49591	1	109213918-109238169	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Aminoacyl-tRNA synthetase, DNA-binding, Ligase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016939, HPA064668"	Uncertain		Enhanced	Cytosol		100000	100000	Cytosol		"HPA016939: AB_1856585, HPA064668: "	"unprognostic (4.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.78e-2)"	"prognostic favourable (9.47e-4)"	"prognostic unfavourable (5.75e-4)"	"prognostic unfavourable (6.13e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.45e-3)"	35.8	42.6	46.1	28.2	45.9	16.3	38.3	42.6	60.6	40.1	37.6	31.2	30.9	33.5	39.4	36.0	42.0	39.6	28.7	43.9	55.9	47.3	37.6	58.6	44.5	28.8	46.4	56.0	44.4	68.7	55.3	40.1	44.9	64.1	34.3	41.0	22.0	54.2	42.3	72.3	46.1	31.1	42.9	41.0	29.4	46.0	20.9	35.0	25.3	75.0	32.9	38.7	41.8	60.4	54.3	45.9	48.6	48.3	41.0	66.1	88.9	32.7	12.9	24.8	37.3	37.3	33.9	42.7	34.5	35.8	30.0	37.5	24.9	10.1	35.4	17.9	48.7	18.0	38.6	48.8	35.0	25.0	23.5	13.7	16.0	18.0	75.0	17.2	15.4	41.6	85.5	35.4	77.0	35.7	31.3	44.4	29.2	31.4	19.1	8.8	10.3	30.5	15.8	31.7	15.8	22.8	17.5	34.5	18.3	16.5	26.7	93.6	15.1	20.6	28.1	17.9	22.6	25.4	24.1	33.9	13.7	29.0	56.5	18.9	60.8	35.6	44.5	48.6	56.0	48.2	58.4	54.3	59.3	55.4	45.9	52.5	61.8	57.7	21.3	41.0	48.3	29.6	66.1	88.9	46.1	45.9	42.6	60.6	55.9	47.3	46.4	56.0	64.1	35.0
SARS2	"FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS"	ENSG00000104835	"Seryl-tRNA synthetase 2, mitochondrial"	Q9NP81	19	38915266-38930896	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA052730, HPA056957"	Approved		Uncertain	Nucleoplasm,Vesicles,Mitochondria				"Nucleoplasm, Mitochondria"	Vesicles	"HPA052730: , HPA056957: "	"unprognostic (3.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.62e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.62e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.69e-2)"	5.8	16.5	9.9	7.2	12.8	11.1	7.4	10.7	20.4	8.0	9.2	11.3	11.4	12.3	9.0	9.4	12.9	11.5	8.2	12.3	8.3	8.6	13.4	20.6	6.3	11.0	10.9	7.8	9.5	14.4	11.2	11.4	10.7	15.0	11.0	8.5	11.8	13.6	9.9	15.5	15.6	9.9	8.1	7.2	11.3	11.1	8.8	11.5	11.4	13.8	9.5	12.6	11.0	8.3	6.3	12.7	0.4	7.2	6.5	8.0	4.3	5.6	17.3	6.9	4.1	2.9	6.0	9.6	4.0	5.4	9.4	7.5	14.1	7.1	6.4	5.8	5.6	5.4	7.3	11.4	2.4	5.5	9.3	12.8	7.5	12.1	6.9	11.0	12.8	9.0	6.2	6.2	4.2	6.6	11.0	6.4	4.8	12.2	8.2	10.0	7.0	3.5	11.9	6.2	7.0	10.0	13.9	11.9	7.6	5.3	14.4	3.6	7.4	7.4	4.2	5.9	6.7	4.6	3.9	4.6	2.7	5.1	3.7	7.7	4.9	0.0	4.1	0.4	8.0	7.2	6.4	6.3	5.9	8.0	12.7	5.7	4.3	4.9	0.3	6.5	6.4	5.0	6.6	4.3	9.9	12.8	10.7	20.4	8.3	8.6	10.9	7.8	15.0	11.5
SAT1	"SAT, SSAT"	ENSG00000130066	"Spermidine/spermine N1-acetyltransferase 1"	P21673	X	23783173-23786226	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 71.3;hTERT-HME1: 109.8;RPTEC TERT1: 91.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 206.1"	"Group enriched"	"Detected in all"	9	"granulocytes: 206.1;monocytes: 136.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB047343, HPA055312, CAB069914"	Supported									"CAB047343: , CAB069914: AB_830224, HPA055312: "	"unprognostic (4.19e-2)"	"unprognostic (3.92e-2)"	"unprognostic (6.41e-2)"	"prognostic favourable (2.87e-4)"	"unprognostic (8.58e-2)"	"unprognostic (7.90e-3)"	"unprognostic (8.52e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.23e-1)"	"unprognostic (7.58e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.97e-3)"	"unprognostic (1.65e-1)"	93.5	40.5	34.2	73.0	60.5	177.2	57.2	14.2	38.9	49.2	56.5	24.6	143.2	82.2	43.9	51.9	56.9	36.8	80.6	81.5	53.7	27.7	79.2	116.1	163.6	67.3	31.9	22.2	26.5	32.3	19.3	74.4	185.7	100.2	51.0	49.9	39.3	110.6	173.3	14.4	25.4	65.5	23.5	100.8	108.6	64.5	25.6	27.1	23.0	102.7	41.1	60.6	52.4	29.6	7.3	19.0	206.1	136.4	1.8	13.2	34.6	7.8	15.9	4.0	6.3	34.5	14.1	11.0	11.5	19.4	2.8	6.7	7.5	23.2	13.1	21.2	2.7	11.9	2.1	71.3	10.5	4.3	9.7	6.3	6.9	63.5	44.4	6.1	6.1	29.2	54.5	22.3	109.8	23.6	2.6	11.6	8.3	7.4	4.4	27.6	2.7	7.3	3.8	2.6	15.6	91.3	16.2	1.1	1.1	11.8	26.9	22.7	4.1	1.3	8.8	23.5	1.1	14.0	5.6	4.9	1.1	2.9	14.0	3.6	4.4	25.8	42.0	26.9	4.1	110.5	2.6	7.3	4.9	3.3	19.0	4.7	2.9	3.3	206.1	1.8	136.4	9.4	13.2	34.6	34.2	60.5	14.2	38.9	53.7	27.7	31.9	22.2	100.2	27.1
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292453-121308694	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 143.5"	"Cell line enhanced"	"Detected in all"		"AF22: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"				"Nucleoplasm, Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA066283: , HPA070248: "	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavourable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"	10.9	15.3	16.9	5.5	18.4	2.7	23.3	10.4	26.9	9.4	9.4	17.8	24.5	17.4	6.8	30.1	19.5	7.2	7.4	9.4	18.7	19.6	19.7	143.5	10.1	5.5	20.8	17.8	7.8	8.9	17.5	14.7	6.3	40.8	40.3	8.6	8.2	9.5	24.0	3.9	7.7	13.4	7.6	43.4	4.1	8.8	9.7	16.0	3.7	10.4	8.2	8.1	14.0	14.6	6.0	9.8	7.5	6.3	6.8	10.0	3.8	7.1	3.6	53.9	11.5	21.0	18.2	7.6	8.0	15.1	5.4	9.6	22.5	26.6	6.7	25.4	8.7	26.7	16.8	20.3	5.3	3.3	22.9	10.0	23.5	17.9	17.1	6.3	3.4	14.9	16.7	17.1	17.6	8.2	6.5	9.8	24.9	7.4	2.5	8.2	16.8	11.4	3.5	13.6	5.7	38.0	32.0	14.2	8.0	18.4	4.2	10.5	16.8	10.9	15.5	5.2	8.4	9.2	3.7	1.8	3.1	9.0	2.0	13.9	9.0	7.5	4.8	1.2	5.0	6.3	8.5	6.0	6.8	6.0	8.5	6.0	10.0	9.5	0.4	6.8	4.5	9.8	6.9	3.8	16.9	18.4	10.4	26.9	18.7	19.6	20.8	17.8	40.8	16.0
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927229-53051703	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 168.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Peroxisomes		370000	370000	Peroxisomes		"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favourable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favourable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	29.1	26.2	21.8	19.9	21.2	14.0	30.3	12.0	19.7	24.4	51.9	15.9	28.1	49.2	19.0	28.8	32.2	18.1	32.1	29.3	20.0	20.0	54.2	168.3	21.8	14.0	25.6	17.8	22.8	24.6	16.7	24.1	17.1	21.9	25.5	40.5	18.9	21.8	23.3	22.0	18.8	80.1	20.6	27.1	20.9	33.9	16.7	19.4	23.0	28.2	28.6	17.6	22.3	20.5	36.4	57.1	67.8	50.7	40.8	49.2	61.2	25.9	14.3	19.3	35.3	63.3	54.1	20.9	31.0	46.6	20.4	29.6	12.8	28.2	24.7	33.6	45.4	18.3	13.2	29.0	31.2	36.0	19.2	26.6	20.5	26.3	42.2	38.3	44.9	43.9	39.6	24.2	12.1	57.7	23.6	12.9	41.2	15.0	42.5	33.3	21.1	28.1	22.4	33.9	33.8	56.5	44.2	16.0	19.2	27.1	55.0	25.9	28.1	43.8	44.6	27.8	14.4	48.4	24.7	21.6	27.4	28.9	36.0	38.1	25.7	55.4	48.7	67.8	49.2	50.7	39.9	36.4	39.2	48.6	57.1	29.8	33.2	47.1	7.5	40.8	46.8	37.1	47.1	61.2	21.8	21.2	12.0	19.7	20.0	20.0	25.6	17.8	21.9	19.4
SCYL1	"GKLP, HT019, MGC78454, NKTL, NTKL, P105, TAPK, TEIF, TRAP"	ENSG00000142186	"SCY1 like pseudokinase 1"	Q96KG9	11	65525077-65538704	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"ER-Golgi transport, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015015	Uncertain		Supported	Cytosol				Cytosol		"HPA015015: AB_1856643"	"unprognostic (5.56e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (6.49e-3)"	"unprognostic (4.27e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.29e-3)"	24.1	35.5	24.1	20.2	24.4	22.8	49.4	24.6	47.3	25.0	21.6	19.0	27.8	22.5	26.9	30.0	24.1	26.7	21.4	35.8	25.1	21.1	24.1	61.4	22.4	22.9	21.7	23.9	34.1	40.7	27.0	24.3	30.7	19.6	24.7	14.3	24.9	34.0	30.3	51.2	23.6	19.8	23.0	17.1	24.7	24.4	31.4	20.6	18.0	27.3	20.2	20.2	24.9	24.1	10.7	15.5	27.9	13.7	11.1	14.7	12.1	19.8	17.1	13.8	19.1	25.3	22.1	18.9	24.7	33.6	29.5	23.1	24.6	12.0	14.3	25.1	32.0	18.2	14.5	18.5	10.3	16.8	18.6	16.8	18.8	28.2	36.0	11.0	24.3	30.6	18.4	25.3	18.9	19.3	17.5	20.3	18.3	43.2	14.7	25.4	13.3	23.9	15.0	10.7	26.2	18.1	17.8	12.8	13.6	15.2	33.7	26.8	33.4	14.0	19.0	23.5	15.8	38.0	14.5	28.1	19.5	14.9	27.2	9.2	16.4	1.9	13.7	17.6	14.7	13.2	11.8	10.0	13.8	14.6	15.5	10.7	11.2	10.5	27.9	11.1	8.5	11.3	9.5	12.1	24.1	24.4	24.6	47.3	25.1	21.1	21.7	23.9	19.6	20.6
SDHB	"SDH, SDH1"	ENSG00000117118	"Succinate dehydrogenase complex iron sulfur subunit B"	P21912	1	17018722-17054170	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002868, CAB009822, CAB068233, CAB068234, CAB068235"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"	"Intracellular and membrane"			Mitochondria	"Nucleoplasm, Plasma membrane"	"CAB009822: AB_2183458, CAB068233: , CAB068234: , CAB068235: , HPA002868: AB_1079889"	"unprognostic (1.06e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.93e-2)"	"prognostic favourable (2.93e-7)"	"unprognostic (1.46e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.82e-2)"	17.8	25.6	19.8	16.6	21.7	17.0	26.4	18.0	29.1	13.9	30.8	12.3	15.1	34.0	14.2	15.7	19.8	13.6	15.1	86.9	18.2	16.4	51.0	75.1	16.8	24.6	20.1	18.9	10.5	30.7	20.0	11.3	15.6	16.7	13.0	31.5	11.7	15.9	19.5	96.2	13.2	31.4	21.3	16.5	17.2	21.7	18.7	15.7	14.2	15.5	52.2	18.0	15.4	17.1	22.2	45.9	48.5	48.7	18.9	26.7	25.0	25.5	25.4	14.5	18.5	28.2	28.1	16.5	22.4	28.8	51.4	46.5	35.7	30.8	35.1	28.0	30.2	30.2	57.7	44.7	58.0	20.6	47.3	31.6	26.4	27.4	34.6	49.4	23.6	28.8	29.5	44.4	75.3	36.3	26.4	40.7	35.7	21.1	32.8	28.2	12.0	51.1	23.6	27.9	43.5	47.3	14.5	27.3	15.0	30.4	38.1	63.9	22.3	27.9	18.0	19.8	22.3	36.3	29.5	17.0	20.9	35.9	30.3	75.3	21.8	16.6	38.4	37.4	18.3	48.7	18.3	22.2	21.2	19.5	45.9	18.3	19.3	19.5	48.5	18.9	42.2	21.5	26.7	25.0	19.8	21.7	18.0	29.1	18.2	16.4	20.1	18.9	16.7	15.7
SEC31A	"ABP125, ABP130, KIAA0905, SEC31L1"	ENSG00000138674	"SEC31 homolog A, COPII coat complex component"	O94979	4	82818661-82901166	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005457	Approved		Supported	Vesicles,Cytosol		22000	22000	"Vesicles, Cytosol"		"HPA005457: AB_1079896"	"unprognostic (3.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavourable (3.32e-4)"	"unprognostic (6.14e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (2.69e-4)"	41.3	40.6	22.5	28.0	29.2	30.6	34.5	27.4	30.6	46.4	36.0	26.4	39.2	35.7	53.6	50.2	37.7	34.8	36.1	42.8	23.7	23.8	47.3	57.8	33.9	26.6	25.3	25.3	67.1	79.1	42.7	62.7	54.1	36.0	37.2	38.1	32.6	47.8	46.0	38.7	34.1	51.4	46.2	24.5	28.4	35.9	23.3	23.3	35.7	50.0	31.0	39.5	47.1	37.6	29.4	34.6	34.8	36.0	40.5	40.0	30.5	24.8	11.3	32.7	23.1	58.3	72.7	23.8	46.4	52.0	26.1	32.4	19.5	32.0	32.3	20.4	92.5	11.9	32.2	30.7	36.2	32.9	12.8	19.7	19.4	51.1	58.0	21.0	25.1	69.5	39.0	39.9	45.9	42.3	29.9	32.1	46.4	21.8	27.7	17.0	22.4	10.3	20.7	17.7	23.9	42.1	14.4	21.1	23.5	18.4	32.1	29.9	25.0	23.8	43.2	34.4	17.9	30.1	29.0	24.1	10.3	44.4	34.4	25.4	39.5	34.8	31.1	23.3	32.6	34.8	40.0	29.4	29.2	31.8	34.6	24.4	29.3	28.0	9.5	40.5	36.0	28.9	24.0	30.5	22.5	29.2	27.4	30.6	23.7	23.8	25.3	25.3	36.0	23.3
SEC61A1		ENSG00000058262	"Sec61 translocon alpha 1 subunit"	P61619	3	128051641-128071683	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 178.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022076			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB022076: "	"unprognostic (1.84e-1)"	"unprognostic (8.00e-2)"	"unprognostic (8.21e-2)"	"prognostic favourable (7.82e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (1.07e-6)"	"unprognostic (2.84e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (6.84e-9)"	"unprognostic (2.73e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.51e-2)"	28.6	38.2	15.2	23.2	16.2	18.5	38.4	12.8	16.2	45.0	24.2	15.9	77.9	22.1	32.6	52.8	31.1	28.3	34.4	27.6	14.3	13.5	37.6	132.2	33.2	44.9	17.4	10.3	28.5	178.4	31.5	36.5	51.6	15.2	26.2	26.0	19.0	87.1	81.7	22.7	22.7	32.5	31.3	15.4	28.8	33.8	21.2	15.4	22.9	35.5	28.8	36.6	24.2	26.4	13.8	35.6	40.0	25.1	18.7	39.3	29.0	39.5	20.8	20.9	37.2	59.4	51.3	38.5	63.9	74.1	55.7	60.1	39.5	28.8	26.4	38.6	82.4	35.2	32.7	45.1	54.0	23.8	17.9	30.1	23.2	41.5	87.6	38.1	34.3	56.3	54.6	52.5	67.8	48.9	19.7	64.7	64.5	36.1	19.6	12.6	28.2	29.2	20.7	18.8	51.8	29.0	34.7	23.8	23.4	31.5	30.1	40.2	28.0	32.6	48.0	43.9	24.9	51.0	29.8	59.3	28.2	38.0	71.9	24.8	56.7	40.0	25.1	19.1	28.3	23.0	39.3	13.8	20.5	24.8	24.7	8.5	13.0	15.0	6.6	18.7	22.4	35.6	13.1	29.0	15.2	16.2	12.8	16.2	14.3	13.5	17.4	10.3	15.2	15.4
SEC63	"DNAJC23, ERdj2, PRO2507, SEC63L"	ENSG00000025796	"SEC63 homolog, protein translocation regulator"	Q9UGP8	6	107867756-107958189	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Transport"	Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053295, HPA060535"	Supported		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA053295: , HPA060535: "	"prognostic unfavourable (3.32e-4)"	"prognostic unfavourable (4.01e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.51e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (6.16e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.41e-2)"	19.9	26.0	22.2	14.4	20.0	20.2	17.4	17.3	19.2	22.8	17.6	13.9	21.9	11.5	22.4	21.5	16.3	18.6	15.4	19.5	18.4	14.5	14.2	35.2	17.6	10.6	19.2	17.9	30.5	45.8	24.9	32.3	27.9	16.8	20.0	13.3	14.0	46.6	27.2	15.3	14.6	12.6	20.2	20.0	13.7	18.5	21.6	21.5	16.7	36.2	9.3	11.7	24.2	21.4	6.1	9.6	6.3	12.0	9.2	11.1	4.9	11.2	6.8	18.9	23.5	19.8	23.5	17.0	23.9	26.5	11.5	16.3	12.2	14.0	20.9	20.5	21.5	16.5	13.1	15.4	17.7	25.1	14.5	22.6	10.8	12.5	31.0	25.7	13.4	18.3	25.5	18.3	40.6	15.9	18.8	33.8	23.4	8.9	8.0	11.6	14.9	7.4	25.7	22.4	17.0	13.9	14.8	16.7	18.9	13.2	20.0	23.9	14.2	38.1	17.1	17.3	10.8	17.3	18.5	12.9	9.5	20.8	19.1	22.6	19.8	6.3	7.3	6.3	7.0	6.3	11.1	6.1	5.9	5.7	7.4	6.1	6.6	5.1	2.5	9.2	12.0	9.6	3.1	4.9	22.2	20.0	17.3	19.2	18.4	14.5	19.2	17.9	16.8	21.5
SELENBP1	"hSBP, hSP56, LPSB"	ENSG00000143416	"Selenium binding protein 1"	Q13228	1	151364302-151372733	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 112.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 38.1;HEL: 28.3;HSkMC: 19.6;SK-BR-3: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 4.8"					"Low region specificity"	"Detected in all"			"HPA005741, CAB008366, HPA011731"	Enhanced		Supported	Nucleoli		57000000	57000000	Nucleoli		"CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663"	"unprognostic (1.51e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.25e-3)"	"unprognostic (6.28e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.86e-3)"	27.9	5.1	17.2	28.9	16.4	17.6	18.4	6.5	11.9	15.1	105.1	10.4	15.8	17.2	13.5	23.1	11.0	32.4	28.8	11.7	18.5	5.1	20.8	56.3	64.9	5.6	10.9	14.9	13.2	7.2	1.4	4.1	5.6	11.3	19.1	112.3	27.9	14.5	15.4	15.9	6.4	29.1	22.9	6.5	13.0	29.1	4.1	13.0	0.0	52.9	18.3	6.0	15.8	8.1	0.0	4.8	0.0	1.1	0.0	0.0	5.5	0.0	4.2	7.9	0.4	38.1	15.2	2.0	1.5	0.7	0.8	1.6	4.3	1.3	0.0	7.3	2.6	0.0	0.0	0.1	0.6	0.0	3.6	28.3	14.2	6.8	8.0	0.0	0.0	19.6	0.2	1.3	0.0	4.8	2.8	0.0	2.0	3.1	0.0	0.0	6.3	8.0	0.0	0.4	0.1	1.7	0.0	0.1	0.1	0.0	68.0	0.0	11.7	0.4	0.4	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	17.2	16.4	6.5	11.9	18.5	5.1	10.9	14.9	11.3	13.0
SELENOT	SELT	ENSG00000198843	"Selenoprotein T"	P62341	3	150602875-150630445	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039780	Approved									"HPA039780: AB_10805594"	"unprognostic (1.13e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-3)"	"unprognostic (4.91e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.41e-2)"	29.7	52.6	39.9	32.1	44.1	54.5	31.0	33.9	48.2	29.9	29.7	37.7	26.7	29.7	29.2	41.8	30.3	31.2	23.5	32.7	41.6	47.4	47.0	52.5	31.1	44.5	41.3	28.2	27.7	34.2	30.6	46.6	50.8	48.0	31.8	36.7	30.2	31.5	33.0	30.5	20.0	38.5	33.4	50.0	49.8	28.5	23.6	31.9	32.3	45.7	23.0	43.2	34.3	23.1	32.1	34.0	54.5	43.2	26.5	42.3	71.0	47.9	19.9	12.9	11.5	19.9	19.5	24.4	38.2	28.3	26.5	18.1	31.5	28.3	27.2	39.1	28.3	16.6	20.0	23.9	40.8	22.7	16.7	28.3	12.2	14.7	21.8	16.6	21.5	16.8	19.2	23.6	20.6	28.6	6.5	80.3	38.6	29.5	22.0	9.6	13.8	21.4	15.9	16.2	45.3	22.9	28.8	13.8	8.5	22.9	14.4	15.1	27.5	19.9	26.8	14.4	9.0	25.9	35.1	56.3	28.8	37.6	19.6	30.3	12.2	41.9	43.2	36.4	38.5	35.0	42.3	32.1	32.0	35.2	34.0	26.7	25.3	32.0	54.5	26.5	37.7	24.1	33.5	71.0	39.9	44.1	33.9	48.2	41.6	47.4	41.3	28.2	48.0	31.9
SEPSECS	"SLA, SLA/LP"	ENSG00000109618	"Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase"	Q9HD40	4	25120014-25160442	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"RNA-binding, Transferase, tRNA-binding"	"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 34.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070409			Approved	Vesicles				Vesicles		"HPA070409: "	"unprognostic (1.83e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.37e-3)"	"unprognostic (5.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.82e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.13e-3)"	7.0	6.1	3.8	8.5	6.4	11.8	7.4	5.4	6.0	5.3	13.5	7.8	8.9	11.8	6.7	9.6	5.3	6.5	8.9	5.6	4.8	3.6	10.5	34.2	9.4	9.7	7.2	4.9	8.5	11.3	7.3	5.1	4.4	5.4	4.7	7.8	5.2	6.2	9.2	5.5	10.9	15.3	3.7	7.0	7.5	7.4	8.9	6.8	12.3	7.7	4.8	8.0	6.8	5.5	5.7	5.9	3.2	4.0	3.4	5.5	2.2	2.9	1.6	6.3	3.3	5.7	8.0	5.5	3.1	4.1	3.4	3.4	1.3	7.3	5.4	3.0	3.5	3.6	4.9	3.6	3.8	2.7	1.6	6.7	5.6	2.6	6.4	5.9	8.8	7.5	5.8	2.5	5.7	3.6	10.5	5.5	2.7	1.7	9.4	16.5	2.9	6.2	4.8	7.4	4.8	4.7	3.1	4.7	4.4	2.8	2.2	5.2	4.2	5.7	3.7	5.2	2.7	1.7	2.9	8.7	9.7	6.0	3.2	9.7	3.2	2.4	4.0	2.2	3.6	3.4	3.5	3.4	4.5	4.9	3.4	5.7	4.6	5.5	3.2	3.4	2.4	5.9	2.6	2.2	3.8	6.4	5.4	6.0	4.8	3.6	7.2	4.9	5.4	6.8
SETD2	"FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A"	ENSG00000181555	"SET domain containing 2"	Q9BYW2	3	47016429-47163967	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042451	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA042451: AB_10806239"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (8.19e-4)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.84e-2)"	"prognostic favourable (7.99e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.43e-2)"	13.2	10.5	12.2	15.2	15.4	20.0	11.7	22.4	16.4	13.4	14.0	9.1	12.9	9.5	15.8	7.5	10.8	11.4	8.7	8.8	10.6	6.8	11.4	10.3	10.4	11.8	11.7	9.5	16.0	13.4	21.4	16.3	10.7	11.3	12.4	10.9	7.7	12.7	14.8	27.6	12.5	11.5	11.9	9.8	13.8	10.4	12.8	12.8	23.2	15.8	5.5	12.8	16.1	15.5	4.8	2.6	6.0	2.3	7.1	3.9	1.0	11.4	9.0	15.2	7.8	9.1	10.6	6.4	10.6	10.3	12.4	11.3	9.5	7.5	25.3	6.6	14.5	7.0	16.4	10.1	16.8	14.5	6.5	25.9	15.1	7.3	6.8	19.4	15.0	9.1	9.7	12.2	15.2	11.4	16.6	9.6	10.1	6.0	14.2	2.6	11.5	7.5	9.4	14.7	13.1	6.2	15.1	6.6	10.5	17.8	7.0	6.6	7.4	14.4	14.6	13.6	10.2	11.6	16.8	12.2	13.6	25.5	7.9	11.1	7.9	2.4	2.2	5.2	3.9	2.3	2.4	3.7	2.4	3.0	2.5	4.8	3.5	3.0	6.0	7.1	1.9	2.6	1.0	1.0	12.2	15.4	22.4	16.4	10.6	6.8	11.7	9.5	11.3	12.8
SFXN4	SLC56A4	ENSG00000183605	"Sideroflexin 4"	Q6P4A7	10	119140767-119165667	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020872	Approved									"HPA020872: AB_1856793"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.70e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.07e-3)"	8.7	26.8	10.7	15.8	21.4	11.8	12.9	16.3	18.6	9.2	17.1	15.6	18.2	15.7	8.9	15.1	13.5	11.7	13.5	25.4	11.5	12.0	21.2	25.7	9.3	10.8	17.0	14.4	12.8	30.2	13.4	14.7	7.5	14.2	12.6	20.7	12.8	22.6	11.1	34.2	7.9	14.0	17.8	12.8	14.6	12.0	10.0	13.7	5.1	20.0	16.7	14.8	11.8	9.8	11.1	17.3	2.0	15.7	5.4	10.8	9.0	11.1	13.0	4.1	21.5	4.9	8.9	16.0	7.1	8.3	9.1	9.4	18.9	18.9	24.8	7.2	6.5	20.6	25.5	15.2	11.2	13.4	27.6	11.6	8.1	24.7	16.8	20.7	12.2	9.4	14.7	9.9	28.5	10.6	17.7	9.0	6.4	13.0	21.9	32.5	5.6	13.9	22.7	12.6	20.1	13.5	8.4	11.0	8.1	4.9	19.0	27.0	11.6	13.6	5.1	4.4	10.0	8.5	15.6	20.9	23.6	22.8	7.0	30.8	4.0	2.0	14.6	1.4	5.7	15.7	9.4	11.1	6.9	6.1	17.3	5.9	10.8	8.5	1.7	5.4	12.6	8.7	4.9	9.0	10.7	21.4	16.3	18.6	11.5	12.0	17.0	14.4	14.2	13.7
SGPL1	SPL	ENSG00000166224	"Sphingosine-1-phosphate lyase 1"	O95470	10	70815961-70881173	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021125, HPA023086"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA021125: AB_1856803, HPA023086: AB_1856804"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.21e-2)"	"unprognostic (4.68e-3)"	9.6	11.2	12.0	20.2	11.4	4.9	24.4	10.8	10.6	16.2	17.1	16.0	21.9	13.3	15.5	16.8	26.7	13.5	13.4	8.3	11.3	9.8	18.2	27.1	10.4	20.1	11.9	9.5	10.0	34.6	15.4	10.2	11.3	10.4	16.1	15.6	7.6	15.0	19.5	7.6	28.6	32.5	12.1	15.7	22.9	10.3	15.3	11.0	14.7	17.6	12.8	18.0	21.4	26.8	5.6	9.7	8.9	24.8	10.9	11.5	6.6	10.5	14.1	13.6	15.5	3.7	4.9	9.0	6.2	6.7	6.8	8.9	15.3	23.4	9.5	7.4	6.3	17.8	11.7	12.5	9.7	15.2	6.2	0.9	7.2	18.2	14.2	4.1	8.6	9.2	21.2	9.1	24.0	4.2	2.8	8.3	9.6	11.7	5.0	2.8	6.1	7.8	6.5	10.4	3.5	10.8	44.8	9.3	11.3	12.4	19.1	11.3	9.9	3.0	8.1	6.1	16.2	4.7	11.9	3.4	4.7	4.4	6.1	7.7	4.3	0.6	11.5	7.9	11.5	20.3	10.4	4.7	7.5	9.4	9.7	5.6	5.7	9.0	8.9	10.9	24.8	5.4	6.8	6.6	12.0	11.4	10.8	10.4	11.3	9.8	11.9	9.5	10.4	11.0
SGSH	"HSS, MPS3A, SFMD"	ENSG00000181523	"N-sulfoglucosamine sulfohydrolase"	P51688	17	80206716-80220923	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023436, HPA023451"	Enhanced				"Intracellular and membrane"					"HPA023436: AB_1856806, HPA023451: AB_1856807"	"unprognostic (4.33e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.39e-3)"	"prognostic unfavourable (7.71e-4)"	"prognostic favourable (2.72e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.65e-1)"	"prognostic favourable (3.10e-4)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (2.66e-4)"	"unprognostic (1.42e-2)"	"prognostic unfavourable (5.37e-4)"	"unprognostic (7.50e-2)"	"unprognostic (3.68e-2)"	14.4	37.1	7.8	11.6	7.5	2.3	13.5	5.5	7.3	12.0	11.2	9.3	16.5	8.5	13.8	14.8	11.2	13.2	14.2	8.5	7.9	9.3	16.3	9.9	15.1	19.9	5.5	6.7	11.3	19.5	16.5	13.8	19.2	7.7	17.2	5.8	18.1	18.8	19.5	6.1	14.9	12.3	11.2	6.8	23.3	13.2	8.1	6.7	3.6	16.6	11.4	16.1	14.5	8.9	3.9	16.0	1.8	16.1	6.4	14.4	9.5	1.2	3.7	3.2	6.6	9.2	8.3	4.7	8.2	16.2	11.4	10.4	3.2	4.2	0.0	13.4	7.0	4.0	2.0	3.4	2.1	3.9	5.1	0.0	9.2	9.2	27.9	0.0	2.9	15.8	4.2	3.3	4.4	22.4	3.5	9.3	6.1	6.4	0.1	0.1	2.0	6.5	0.5	1.7	9.6	7.1	6.4	0.9	6.6	9.2	17.2	4.4	15.4	0.2	15.4	13.3	3.8	5.0	2.9	15.4	1.8	1.6	6.1	0.0	6.5	0.0	16.1	0.0	10.9	6.8	14.4	3.1	9.2	10.8	16.0	3.9	7.5	6.3	1.8	6.4	6.0	1.1	10.9	9.5	7.8	7.5	5.5	7.3	7.9	9.3	5.5	6.7	7.7	6.7
SHPK	"CARKL, SHK"	ENSG00000197417	Sedoheptulokinase	Q9UHJ6	17	3608262-3636322	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA024361, HPA064939"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles"		150000	150000	"Nucleoplasm, Nuclear speckles"		"HPA024361: AB_1846030, HPA064939: "	"unprognostic (1.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	8.9	12.9	7.6	6.2	10.6	5.9	8.9	17.3	12.3	8.8	14.1	14.9	8.8	18.5	10.7	6.1	11.6	7.6	5.3	5.9	7.0	5.5	14.3	26.7	6.3	5.3	12.0	4.5	10.2	13.7	11.8	6.2	8.6	9.8	7.4	8.6	12.3	8.9	9.4	7.5	12.1	22.8	5.1	6.7	6.1	9.7	5.2	13.0	7.7	7.7	4.0	7.6	7.5	9.6	5.2	7.1	5.1	4.8	6.4	7.5	5.4	5.2	10.7	11.5	7.3	4.8	4.8	6.4	3.5	3.2	6.9	4.2	18.5	4.9	6.2	7.9	6.8	10.3	15.2	11.5	5.1	10.0	14.8	6.8	9.2	13.2	5.7	5.9	9.7	8.1	5.5	7.6	5.2	13.0	9.0	8.0	6.7	9.4	7.5	4.6	5.8	7.2	10.4	6.0	9.9	9.8	6.8	3.3	8.8	12.9	12.0	3.6	10.7	3.5	9.3	10.6	5.1	10.2	8.5	2.7	3.4	4.1	11.5	5.3	5.4	3.3	4.7	5.1	4.6	4.8	4.7	5.2	4.2	3.7	6.5	4.0	7.5	4.7	0.9	6.4	4.1	7.1	3.6	5.4	7.6	10.6	17.3	12.3	7.0	5.5	12.0	4.5	9.8	13.0
SIAE	"CSE-C, LSE, MGC87009, YSG2"	ENSG00000110013	"Sialic acid acetylesterase"	Q9HAT2	11	124633113-124695707	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Serine esterase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 32.6;ASC TERT1: 33.9;HSkMC: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038052, HPA038053"	Approved				"Intracellular and membrane"	1800000	1800000			"HPA038052: AB_10671518, HPA038053: AB_10673039"	"unprognostic (9.97e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-3)"	"prognostic favourable (4.66e-5)"	"unprognostic (3.30e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.90e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.19e-2)"	"prognostic favourable (4.42e-11)"	"unprognostic (7.24e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.92e-2)"	9.0	12.3	9.0	6.7	13.4	1.9	8.2	8.2	16.8	7.0	46.7	15.7	7.3	16.8	5.9	17.8	10.2	9.9	8.4	23.0	10.3	17.6	42.5	28.3	10.7	2.8	18.2	8.1	5.1	11.2	32.4	13.1	7.8	31.4	10.7	51.7	9.9	15.9	8.3	17.3	6.7	25.5	5.4	19.9	7.9	9.3	5.6	8.1	1.9	46.1	11.1	7.0	9.8	4.7	2.7	4.1	8.6	5.8	1.2	4.3	3.2	3.1	4.9	2.9	12.5	32.6	33.9	7.6	6.0	8.5	1.5	0.9	3.7	21.7	1.9	8.8	7.5	6.1	4.5	6.6	1.5	9.0	1.4	3.0	1.5	3.9	15.4	0.5	2.7	36.3	9.0	4.1	6.2	10.8	2.4	13.5	5.2	5.7	0.2	1.4	1.8	10.2	1.1	0.1	3.3	18.6	4.4	1.0	1.9	16.3	6.7	2.8	13.1	2.9	12.0	8.7	1.6	9.6	1.4	3.6	2.6	0.4	3.1	1.6	3.5	8.6	5.6	0.3	1.9	4.2	2.2	2.4	3.1	2.0	4.1	2.7	4.3	3.4	1.2	1.2	5.8	2.5	2.2	3.2	9.0	13.4	8.2	16.8	10.3	17.6	18.2	8.1	31.4	8.1
SIK1	"msk, SNF1LK"	ENSG00000142178	"Salt inducible kinase 1"	P57059	21	43414483-43427189	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Cell cycle, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skin 1: 34.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 16.7;HeLa: 27.8;hTCEpi: 21.5;LHCN-M2: 21.6;U-266/84: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	10	"B-cells: 2.0;dendritic cells: 1.6"									"CAB023801, HPA038211, HPA078064"	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB023801: , HPA038211: , HPA078064: "	"unprognostic (4.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.35e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.82e-1)"	8.8	2.3	3.0	3.6	3.0	5.9	7.5	3.0	3.0	13.5	3.0	3.0	3.0	0.0	3.0	3.0	12.9	5.5	10.7	7.1	3.0	0.8	3.0	12.3	5.4	3.0	3.0	3.0	13.7	7.3	3.5	5.7	8.2	3.0	3.9	0.1	3.0	4.6	9.8	5.0	34.5	3.0	3.3	3.0	4.0	5.3	3.0	3.0	3.0	3.9	3.0	3.0	10.5	6.1	2.0	1.6	0.0	0.1	0.0	0.1	0.1	0.5	1.7	2.0	0.0	0.1	0.8	0.7	0.9	0.3	1.6	1.3	2.4	0.0	2.4	0.7	0.2	11.1	1.6	16.7	1.0	0.1	0.5	0.7	27.8	0.9	2.3	0.7	0.1	1.0	21.5	0.4	5.1	0.3	0.1	0.5	21.6	0.1	0.4	1.7	0.8	1.5	0.0	0.3	2.5	1.9	6.3	0.0	0.0	10.9	1.8	0.4	1.1	0.3	3.7	0.4	2.0	0.1	0.0	4.3	15.7	0.4	4.6	2.0	0.4	0.0	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.1	0.5	0.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	3.0	3.0	3.0	3.0	3.0	0.8	3.0	3.0	3.0	3.0
SLC11A2	"DCT1, DMT1, NRAMP2"	ENSG00000110911	"Solute carrier family 11 member 2"	P49281	12	50979401-51028566	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032139, HPA032140"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA032139: AB_10964213, HPA032140: AB_10962932"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.09e-1)"	"prognostic favourable (3.07e-6)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.24e-1)"	11.3	15.1	12.8	9.6	26.2	9.6	20.8	14.7	22.1	20.8	11.3	38.2	8.4	35.3	12.3	12.7	17.3	15.4	12.1	12.9	14.5	14.2	16.1	18.0	18.6	7.9	40.0	15.4	10.4	20.6	29.8	21.7	16.4	29.7	18.0	11.8	18.7	26.9	14.8	17.6	15.6	11.6	11.0	33.1	9.5	12.5	8.7	31.0	15.8	29.9	8.7	16.5	12.9	13.9	4.1	9.8	3.0	9.5	8.3	7.1	4.6	7.5	9.8	13.1	12.0	14.5	12.3	43.7	8.3	30.1	7.9	9.3	12.4	14.4	4.7	16.4	9.2	10.6	11.8	7.8	9.3	6.8	7.1	11.2	12.0	14.1	15.4	7.6	22.7	13.5	9.8	14.7	15.0	9.4	9.7	2.4	9.2	8.8	9.0	5.1	19.3	6.8	5.8	11.9	8.3	9.6	11.4	9.0	8.0	6.3	19.2	8.4	21.6	5.1	11.3	8.1	6.8	9.0	4.3	5.9	8.0	1.9	22.8	4.1	3.4	0.7	6.6	2.4	6.4	9.5	5.8	3.6	5.0	6.3	9.8	4.1	7.1	6.6	3.0	8.3	6.0	4.1	3.8	4.6	12.8	26.2	14.7	22.1	14.5	14.2	40.0	15.4	29.7	31.0
SLC12A6	"ACCPN, KCC3"	ENSG00000140199	"Solute carrier family 12 member 6"	Q9UHW9	15	34229996-34338060	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		Neuropathy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 9.4;neutrophil: 18.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 18.5"					"Low region specificity"	"Detected in all"			HPA034563	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA034563: AB_10603887"	"unprognostic (3.53e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.83e-1)"	"prognostic favourable (3.33e-6)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.41e-1)"	8.7	5.8	7.4	12.4	11.1	27.5	7.0	10.2	14.1	14.7	8.0	12.7	3.6	8.3	6.3	8.7	24.9	4.7	6.3	6.9	6.8	6.9	18.6	4.9	11.5	10.9	9.9	8.4	5.8	5.1	5.4	10.9	5.2	12.5	5.0	7.4	9.7	9.3	4.9	10.5	8.6	10.2	6.0	9.2	11.1	8.0	38.5	10.9	18.2	10.6	8.2	13.6	8.2	21.2	2.0	1.0	18.5	1.4	0.6	2.3	0.7	2.6	3.1	2.0	2.8	6.3	7.4	1.3	3.9	9.1	3.0	4.4	1.8	4.3	1.8	3.7	4.1	26.7	4.7	3.2	3.6	0.7	3.2	14.2	8.0	4.1	3.9	8.5	15.6	4.3	5.7	8.9	18.0	9.2	3.1	4.2	4.1	0.9	0.9	6.8	1.5	3.4	4.3	3.4	1.8	3.4	6.7	4.3	3.2	4.3	0.1	0.9	1.9	2.9	5.7	3.5	2.6	12.2	0.9	3.7	4.1	1.1	4.2	6.3	1.5	9.4	1.1	2.3	0.5	1.4	0.3	1.2	0.8	0.7	0.7	2.0	1.3	1.1	18.5	0.6	0.6	1.0	2.3	0.7	7.4	11.1	10.2	14.1	6.8	6.9	9.9	8.4	12.5	10.9
SLC12A8	CCC9	ENSG00000221955	"Solute carrier family 12 member 8"	A0AV02	3	125082636-125212864	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;thyroid gland: 20.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.9;HHSteC: 18.4;U-2197: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031123	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA031123: AB_2301872"	"unprognostic (4.74e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.35e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-2)"	"prognostic unfavourable (5.56e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-2)"	1.1	1.1	11.1	0.7	19.4	0.0	2.0	0.8	7.0	1.2	3.0	1.7	0.4	4.9	0.4	2.9	3.5	1.7	8.1	0.5	3.8	1.2	2.1	5.7	1.9	0.4	1.0	3.6	0.5	9.0	8.2	1.9	2.2	8.6	2.5	4.1	6.2	10.0	0.4	1.8	1.0	3.4	0.4	1.3	0.4	3.8	4.6	2.0	0.4	20.5	0.4	0.7	1.9	1.7	0.2	0.2	1.8	0.5	0.0	0.2	0.0	8.3	0.0	1.4	0.0	1.8	2.5	4.1	0.4	1.0	0.5	0.9	10.9	4.0	0.0	1.0	3.7	5.1	0.0	0.0	0.2	0.0	0.0	0.0	3.7	0.0	18.4	0.0	0.6	4.7	5.0	1.4	0.6	0.0	0.0	0.3	0.7	2.2	0.0	0.0	5.7	0.4	0.0	0.1	0.0	4.2	0.6	2.4	0.0	4.9	5.1	0.1	9.2	0.2	0.1	0.1	0.7	35.7	0.0	0.1	1.0	2.8	1.7	0.0	0.7	1.8	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	19.4	0.8	7.0	3.8	1.2	1.0	3.6	8.6	2.0
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684713-6713567	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	65	"liver: 150.4;salivary gland: 153.9"	"Cell line enriched"	"Detected in single"	61	"Hep G2: 35.0"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.2	0.8	1.0	0.1	1.9	0.1	0.2	0.6	2.3	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.3	0.9	0.1	0.1	0.9	0.7	0.4	150.4	0.1	0.2	0.8	1.2	0.3	0.2	0.1	0.2	0.1	0.6	0.1	0.1	0.0	153.9	0.1	0.1	0.1	0.1	0.1	0.2	0.9	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.9	0.6	2.3	0.9	0.7	0.8	1.2	0.6	0.0
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957013	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: "	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavourable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavourable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	11.6	7.2	17.4	8.7	19.5	3.1	4.4	10.0	24.0	4.6	23.4	12.7	3.3	18.4	19.3	15.1	10.4	8.7	8.3	39.0	19.5	12.3	6.5	26.9	3.2	5.8	19.2	6.5	6.0	1.9	5.6	3.7	18.8	16.6	8.3	18.1	22.8	2.5	6.5	31.4	7.5	9.5	20.0	16.1	4.8	14.5	17.9	22.5	4.9	5.4	17.7	6.2	9.6	6.2	3.0	5.9	0.6	3.2	2.0	11.4	2.4	19.9	4.7	14.4	12.3	10.0	8.5	47.4	10.8	8.2	8.5	13.7	15.8	11.6	21.9	15.1	9.7	19.1	20.1	20.1	16.1	13.7	20.4	18.0	12.8	18.3	17.7	22.9	1.9	11.9	24.6	12.6	24.7	20.5	22.7	14.6	9.5	3.9	13.5	11.5	46.6	15.0	12.0	22.8	15.1	10.5	0.3	16.0	8.4	20.9	0.6	16.0	0.9	8.7	13.8	8.2	14.5	16.1	15.9	7.7	6.7	22.1	23.8	14.5	10.1	0.6	3.2	0.0	4.1	2.6	6.3	3.0	4.1	4.4	5.9	2.1	4.4	3.8	0.3	2.0	0.7	1.0	11.4	2.4	17.4	19.5	10.0	24.0	19.5	12.3	19.2	6.5	16.6	22.5
SLC16A11	"FLJ90193, MCT11"	ENSG00000174326	"Solute carrier family 16 member 11"	Q8NCK7	17	7041630-7043923	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid metabolism, Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.7;NB-4: 1.6;U-266/84: 1.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 12.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"B-cells: 2.9;T-cells: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (4.65e-4)"	"unprognostic (9.40e-3)"	"unprognostic (6.10e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.97e-5)"	"unprognostic (5.22e-3)"	"prognostic favourable (2.56e-4)"	"unprognostic (2.22e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.58e-1)"	"prognostic favourable (1.45e-5)"	"unprognostic (1.30e-2)"	"prognostic favourable (3.19e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.83e-2)"	2.0	1.3	2.1	1.0	2.8	0.5	3.2	2.0	2.8	2.4	2.3	2.4	18.8	1.3	1.8	7.2	1.9	13.5	2.4	2.4	2.0	1.4	3.3	13.4	4.8	2.4	1.4	1.8	6.2	6.1	14.7	4.4	1.3	4.1	3.7	0.6	4.7	14.2	10.7	2.6	5.8	2.1	0.7	1.3	1.9	2.0	3.4	0.7	1.1	11.9	1.8	3.4	2.5	1.4	2.9	0.1	0.0	0.0	0.4	3.8	0.5	0.6	1.4	0.4	1.1	0.3	0.2	0.1	0.4	0.0	0.0	0.0	1.7	0.0	0.5	0.0	0.5	0.5	0.0	0.0	0.0	1.1	1.0	0.0	0.1	0.4	0.9	0.3	1.2	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.2	0.9	0.3	1.6	0.6	0.2	0.0	0.1	0.1	0.0	0.3	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.5	0.0	0.1	1.6	0.1	0.2	0.2	0.0	0.0	0.0	0.0	3.8	0.0	2.0	1.7	0.9	3.5	0.1	2.9	1.7	3.1	0.0	0.4	0.0	0.0	0.0	0.5	2.1	2.8	2.0	2.8	2.0	1.4	1.4	1.8	4.1	0.7
SLC16A13	MCT13	ENSG00000174327	"Solute carrier family 16 member 13"	Q7RTY0	17	7036075-7040121	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 55.9"	"Cell line enhanced"	"Detected in many"		"A549: 17.9;HaCaT: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065245			Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA065245: "	"unprognostic (5.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-1)"	"prognostic favourable (1.50e-4)"	"unprognostic (2.44e-2)"	"unprognostic (7.31e-3)"	"unprognostic (9.70e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-1)"	2.5	1.3	1.4	3.5	0.8	0.2	1.6	1.5	1.0	1.8	4.9	0.7	1.2	8.0	1.1	1.4	5.0	1.5	3.2	1.3	1.2	0.7	12.0	55.9	2.9	7.6	0.8	0.5	1.7	2.8	2.7	1.0	3.3	0.7	1.5	1.3	1.8	3.5	1.5	0.5	4.5	10.2	0.7	0.6	4.8	1.6	0.7	0.3	3.6	3.0	2.4	5.8	1.8	2.4	6.8	2.8	2.4	2.2	2.7	3.9	1.3	10.0	17.9	4.2	2.6	2.6	1.5	1.8	1.0	2.6	2.3	5.3	5.8	11.3	6.4	1.7	1.6	15.9	3.3	5.5	0.9	7.9	2.2	2.6	1.4	13.8	3.0	0.9	6.2	1.7	6.3	3.4	2.8	9.5	3.0	1.8	2.4	5.0	3.8	1.6	1.7	1.4	1.8	1.4	1.1	2.2	2.8	0.2	1.1	3.1	1.8	1.4	4.8	1.4	3.5	1.5	3.5	2.4	1.5	3.2	6.6	0.4	4.4	2.3	0.7	0.0	2.0	2.2	3.2	1.9	2.3	2.3	2.9	3.9	2.1	6.8	3.1	2.9	2.4	2.7	2.2	2.8	3.0	1.3	1.4	0.8	1.5	1.0	1.2	0.7	0.8	0.5	0.7	0.3
SLC16A2	"AHDS, DXS128, MCT7, MCT8, MRX22, XPCT"	ENSG00000147100	"Solute carrier family 16 member 2"	P36021	X	74421461-74533917	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.6"	"Cell line enhanced"	"Detected in many"		"BJ: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072719			Approved	"Plasma membrane"				"Plasma membrane"		"HPA072719: "	"prognostic unfavourable (8.88e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavourable (1.83e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavourable (3.16e-4)"	13.5	24.4	10.9	5.4	12.2	0.7	4.9	5.9	14.3	9.9	5.5	8.4	1.8	4.1	9.4	2.7	5.2	6.7	10.5	10.7	8.0	5.9	9.4	43.6	6.0	1.6	4.2	8.0	14.7	6.6	12.7	12.6	10.0	8.2	9.2	2.6	11.1	5.8	7.0	3.5	2.2	3.0	7.6	4.1	1.9	4.2	1.8	5.1	6.4	13.6	4.3	3.0	5.0	5.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.3	4.1	3.0	16.9	8.1	4.2	0.0	35.2	10.9	14.3	8.2	0.0	0.3	0.0	0.5	13.6	0.6	0.4	14.9	8.4	2.3	1.3	0.0	0.0	0.0	0.6	0.0	0.0	6.3	3.6	7.4	8.7	0.0	0.0	0.0	3.3	0.0	0.2	1.0	11.2	3.1	6.7	8.1	0.0	7.0	0.0	0.7	5.3	3.9	19.7	0.1	0.2	0.4	0.0	13.9	3.7	15.2	17.4	0.0	0.0	0.0	15.3	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	10.9	12.2	5.9	14.3	8.0	5.9	4.2	8.0	8.2	5.1
SLC17A8	"DFNA25, VGLUT3"	ENSG00000179520	"Solute carrier family 17 member 8"	Q8NDX2	12	100357079-100422059	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Hearing, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 10.7;intestine: 12.4;lymphoid tissue: 3.9"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;RPTEC TERT1: 1.3"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB079058		Supported								"CAB079058: "	"unprognostic (4.52e-3)"			"unprognostic (2.18e-1)"	"unprognostic (8.56e-2)"		"unprognostic (1.32e-3)"	"unprognostic (3.65e-1)"		"unprognostic (7.67e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.71e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.55e-1)"			0.1	0.3	2.0	0.1	3.7	0.1	0.1	0.0	10.7	0.1	1.1	0.0	0.0	1.8	0.4	0.2	0.1	1.0	0.1	0.1	6.9	2.2	0.3	1.2	0.2	0.1	0.8	1.0	0.2	0.2	0.1	0.4	1.0	3.6	0.1	1.0	1.7	0.1	0.1	0.1	0.1	12.4	0.1	0.5	0.1	0.2	0.4	0.1	3.9	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	2.0	3.7	0.0	10.7	6.9	2.2	0.8	1.0	3.6	0.1
SLC17A9	"C20orf59, FLJ23412, VNUT"	ENSG00000101194	"Solute carrier family 17 member 9"	Q9BYT1	20	62952647-62969585	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Exocytosis, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 42.7"	"Cell line enhanced"	"Detected in many"		"BJ: 15.7;CACO-2: 14.5;Hep G2: 30.1;NB-4: 16.2;RPMI-8226: 15.6;U-937: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA047470			Approved	Nucleoplasm				Nucleoplasm		"HPA047470: "	"unprognostic (2.65e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.33e-3)"	"unprognostic (5.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavourable (2.78e-15)"	"unprognostic (6.06e-3)"	"unprognostic (5.51e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	4.2	1.3	1.6	11.4	3.4	11.9	2.2	0.4	1.4	1.9	4.8	0.6	0.1	6.4	1.7	1.2	1.5	2.1	7.3	1.5	1.5	0.7	1.5	42.7	5.7	6.6	4.8	0.0	1.9	3.4	0.0	2.5	1.9	3.4	1.6	3.8	1.1	3.6	1.2	3.4	0.9	3.9	1.4	3.9	10.5	10.7	0.8	2.9	0.5	1.4	0.5	11.8	5.6	2.4	4.0	4.2	0.0	2.7	7.3	1.3	1.2	0.0	0.0	0.0	0.1	0.1	1.3	0.0	15.7	4.5	5.2	8.3	14.5	0.0	11.3	0.0	12.5	0.0	2.3	0.0	1.1	0.0	0.0	4.9	0.3	30.1	3.6	8.8	0.0	1.1	0.0	6.2	0.0	3.4	0.0	6.6	0.0	0.0	0.3	16.2	0.0	0.0	11.6	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	1.1	0.0	0.0	0.5	0.0	2.2	0.1	6.1	0.0	19.0	0.0	0.0	1.6	0.0	1.3	2.7	0.9	4.0	0.0	0.6	4.2	3.2	0.0	0.6	0.0	7.3	0.6	0.0	0.1	1.2	1.6	3.4	0.4	1.4	1.5	0.7	4.8	0.0	3.4	2.9
SLC18A3	VACHT	ENSG00000187714	"Solute carrier family 18 member A3"	Q16572	10	49610301-49612720	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.9"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 12.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"basal ganglia: 8.8;hypothalamus: 3.4;pons and medulla: 11.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	13	"basal ganglia: 17.7;pons and medulla: 20.9"	CAB079011		Supported								"CAB079011: "				"unprognostic (2.14e-4)"	"unprognostic (1.55e-1)"			"unprognostic (1.01e-1)"		"unprognostic (9.39e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-1)"		"unprognostic (5.85e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.16e-1)"		0.1	0.3	0.0	2.2	8.8	0.1	0.1	0.0	0.5	0.1	1.5	0.0	1.1	1.3	0.3	0.1	0.1	0.1	0.2	0.1	0.0	3.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.7	3.4	11.9	0.4	0.3	1.4	0.4	0.6	0.2	0.1	1.9	1.5	3.1	0.1	1.2	0.2	1.2	0.2	0.1	0.0	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	8.8	0.0	0.5	0.0	3.4	0.1	0.0	11.9	1.2
SLC19A2	"THTR1, TRMA"	ENSG00000117479	"Solute carrier family 19 member 2"	O60779	1	169463909-169486003	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006119, HPA016599"	Uncertain		Approved	Cytosol				Cytosol		"HPA006119: AB_1079996, HPA016599: AB_1857005"	"prognostic favourable (8.41e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.29e-3)"	"prognostic favourable (2.90e-4)"	"unprognostic (4.45e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (2.70e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-2)"	23.1	11.1	1.9	5.3	4.4	4.8	14.2	7.4	6.1	5.9	5.4	2.8	2.7	2.1	5.0	9.0	7.5	10.0	17.5	14.8	2.7	2.1	8.6	23.4	9.2	3.1	2.8	1.7	10.3	14.4	6.8	16.3	22.1	4.7	9.4	2.8	16.4	10.4	4.6	75.7	7.5	6.6	11.3	3.7	1.8	9.4	7.3	1.8	3.6	7.9	21.6	3.9	10.4	9.8	1.4	1.9	3.0	4.6	2.6	3.3	0.7	4.4	3.1	7.2	5.6	22.3	8.2	15.8	3.6	2.6	2.9	4.2	12.8	4.7	4.0	4.1	2.4	4.8	8.6	5.2	3.3	11.3	8.1	3.8	10.2	11.7	12.2	9.4	3.7	9.7	7.7	4.7	12.0	4.3	15.0	2.5	4.9	3.0	4.8	4.2	16.2	4.8	0.0	15.5	4.5	7.7	9.5	6.2	8.4	4.9	8.5	17.4	5.3	6.1	3.6	3.5	4.9	4.3	6.9	3.5	3.3	1.3	5.2	3.7	4.6	0.0	1.7	3.0	0.9	0.7	3.3	1.4	1.1	2.1	1.9	1.2	3.1	3.0	1.1	2.6	4.6	0.7	1.0	0.7	1.9	4.4	7.4	6.1	2.7	2.1	2.8	1.7	4.7	1.8
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718031	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 48.2;breast: 78.2;placenta: 27.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.1;BEWO: 7.2;CACO-2: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"	48.2	0.6	2.2	1.8	2.4	1.2	78.2	1.5	1.9	0.5	6.1	1.0	0.5	7.7	0.6	0.4	0.6	0.6	8.9	1.9	2.3	2.4	2.1	16.0	5.6	1.3	3.0	0.7	0.9	1.3	0.2	0.3	27.5	2.6	0.5	1.6	0.7	0.9	0.2	0.7	1.6	4.5	0.5	2.6	0.5	0.5	0.6	1.5	0.0	0.5	0.4	0.4	1.0	2.3	2.6	1.8	8.6	1.8	4.3	1.1	0.4	0.3	1.6	0.3	1.0	14.1	0.4	7.2	0.1	0.2	0.3	0.6	18.4	0.5	0.4	0.2	0.1	0.5	0.5	0.5	0.8	0.1	1.2	0.1	0.9	0.7	1.7	0.2	0.2	3.2	0.4	0.1	0.9	0.0	0.2	0.8	0.0	1.8	0.1	0.6	3.2	0.3	0.3	0.2	0.2	0.2	0.3	1.0	0.1	0.5	2.0	0.5	0.3	0.2	0.5	0.5	0.5	4.1	0.3	0.2	0.1	0.6	1.4	0.3	0.4	8.6	1.8	1.7	1.0	1.2	0.6	1.6	0.8	0.9	0.4	2.6	1.0	1.1	6.1	4.3	1.1	1.8	0.4	0.4	2.2	2.4	1.5	1.9	2.3	2.4	3.0	0.7	2.6	1.5
SLC1A1	"EAAC1, EAAT3"	ENSG00000106688	"Solute carrier family 1 member 1"	P43005	9	4490444-4587469	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.4;kidney: 31.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 13.6;HDLM-2: 30.9;HUVEC TERT2: 14.6;RPTEC TERT1: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	30	"T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015466, HPA020086"	Approved									"CAB015466: AB_1278942, HPA020086: AB_1849766"	"unprognostic (1.28e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.25e-2)"	"prognostic favourable (2.86e-8)"	"unprognostic (2.68e-1)"	"unprognostic (9.49e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.64e-1)"	3.3	1.4	8.6	3.4	10.2	0.3	2.9	4.7	12.4	4.0	17.9	2.7	0.5	21.0	4.0	28.8	1.7	1.9	16.3	2.0	10.0	10.2	31.2	29.1	12.8	1.8	8.6	5.8	0.7	1.8	0.4	5.2	5.1	6.7	4.3	6.6	1.9	3.1	2.4	2.2	1.2	40.4	5.6	5.3	0.5	3.4	0.8	4.4	0.0	25.0	1.8	5.0	3.5	1.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.9	0.7	4.3	11.3	13.6	3.8	4.6	9.6	1.4	1.4	7.6	0.2	6.0	0.3	2.4	0.0	1.6	2.5	1.3	30.9	2.0	0.0	6.4	0.0	0.3	0.4	0.0	0.9	0.1	5.5	0.0	14.6	0.0	0.0	1.0	0.1	0.0	0.1	1.9	0.8	0.0	0.0	0.0	30.4	2.7	1.0	0.9	0.3	1.7	0.0	0.6	0.2	7.8	2.2	0.1	4.3	1.3	0.0	0.0	0.0	10.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	8.6	10.2	4.7	11.7	10.0	10.2	8.6	5.8	6.7	4.4
SLC1A2	"EAAT2, GLT-1"	ENSG00000110436	"Solute carrier family 1 member 2"	P43004	11	35251205-35420063	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 160.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.4;BJ hTERT+: 4.8;fHDF/TERT166: 3.4;Hep G2: 5.6;NTERA-2: 6.2;SCLC-21H: 3.2"	"Cancer enriched"	"Detected in some"	5	"glioma: 28.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002574, HPA009172"	Enhanced									"CAB002574: AB_564087, HPA009172: AB_1849764"	"unprognostic (8.00e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.33e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.49e-2)"	1.7	4.1	65.1	1.9	79.4	1.8	3.7	7.2	160.9	2.0	1.7	9.8	0.0	1.8	2.1	1.8	1.7	1.7	1.7	2.1	47.6	11.7	1.7	20.5	1.9	2.5	15.2	43.1	1.6	4.2	1.6	0.4	2.1	27.6	1.7	1.7	0.0	3.9	1.7	1.7	2.3	1.6	1.8	17.2	1.8	2.6	2.4	16.3	0.0	1.7	0.0	2.4	1.7	0.3	1.1	0.7	3.9	0.7	1.2	0.9	0.4	0.0	0.2	1.1	0.1	0.5	4.4	0.0	1.0	4.8	0.2	0.2	0.2	0.0	0.1	0.1	3.4	0.3	0.0	0.0	0.4	0.0	0.0	0.4	0.5	5.6	0.2	0.6	0.2	0.9	0.0	0.4	0.0	0.0	0.0	0.4	0.1	2.1	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	2.3	0.0	1.1	0.0	0.6	0.2	0.2	0.5	0.1	0.6	0.0	0.0	1.1	0.0	0.3	3.9	0.7	0.8	0.5	0.3	0.3	0.4	0.5	0.4	0.7	1.1	0.9	0.7	2.1	1.2	0.4	0.6	0.4	0.4	65.1	79.4	7.2	64.9	47.6	11.7	15.2	43.1	27.6	16.3
SLC1A3	"EA6, EAAT1, GLAST"	ENSG00000079215	"Solute carrier family 1 member 3"	P43003	5	36606355-36688334	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 188.6"	"Cell line enhanced"	"Detected in many"		"AF22: 21.2;CACO-2: 34.1;HaCaT: 25.8"	"Cancer enriched"	"Detected in all"	21	"glioma: 168.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4"	"Group enriched"	"Detected in many"	39	"dendritic cells: 3.4;monocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002573, HPA037467, HPA037468"	Enhanced	Supported	Approved	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	17.3	10.3	76.1	5.9	70.6	3.1	6.3	45.8	188.6	6.9	3.2	26.3	0.0	2.1	2.8	2.3	7.2	5.4	5.9	12.0	57.9	27.3	3.1	3.6	4.7	8.6	32.7	39.6	8.6	4.0	2.6	3.7	12.7	28.5	3.3	2.6	1.9	3.0	4.4	7.6	5.5	2.3	4.1	29.4	5.8	2.9	2.7	33.6	0.0	2.6	0.7	4.5	4.8	1.2	0.0	3.4	0.0	4.3	0.0	0.0	0.8	0.4	0.1	21.2	1.8	2.1	5.9	13.5	0.0	0.0	0.8	1.8	34.1	1.7	0.0	10.3	0.3	25.8	6.2	2.8	0.9	0.3	12.7	0.0	0.1	0.0	0.4	0.4	0.1	10.9	12.8	5.2	2.1	0.0	0.0	0.1	3.6	0.0	0.0	0.0	2.5	2.1	0.0	0.1	0.0	0.0	1.3	1.8	0.0	2.1	6.2	0.3	0.0	1.0	0.0	1.9	3.1	0.0	7.5	0.0	0.0	0.0	8.6	14.3	4.8	0.0	4.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.8	76.1	70.6	45.8	57.8	57.9	27.3	32.7	39.6	28.5	33.6
SLC1A4	"ASCT1, SATT"	ENSG00000115902	"Solute carrier family 1 member 4"	P43007	2	64988477-65023865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 71.3;U-266/70: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034963, HPA034964"	Approved		Enhanced	Centrosome				Centrosome		"HPA034963: , HPA034964: AB_2674386"	"unprognostic (7.61e-2)"	"prognostic favourable (3.59e-4)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (4.23e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (6.37e-3)"	"unprognostic (4.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.98e-2)"	6.0	20.3	31.4	7.6	34.4	10.3	12.7	8.8	43.1	13.5	8.3	8.1	6.1	5.6	11.7	7.8	6.5	4.7	3.8	5.1	20.6	23.5	1.9	11.1	4.5	8.7	17.1	21.2	12.2	28.4	6.1	10.3	6.0	15.4	9.1	7.8	12.1	5.7	6.9	29.6	15.9	5.1	11.3	5.8	6.3	7.0	7.8	8.5	15.7	5.3	11.5	15.8	5.4	7.8	1.1	8.4	2.0	10.1	5.5	3.9	1.4	3.6	2.8	1.6	8.6	3.7	2.4	2.3	7.0	3.4	2.9	5.0	0.7	0.5	12.0	1.6	10.9	10.6	3.3	0.8	3.0	4.8	1.3	6.2	3.4	7.3	7.9	10.4	5.8	1.1	18.4	3.9	6.1	1.8	4.8	30.3	2.0	3.2	8.8	6.9	1.1	3.4	3.2	0.4	29.7	1.2	1.8	7.3	3.5	4.3	4.0	71.3	4.7	11.5	0.4	4.0	4.8	7.8	4.2	33.3	16.4	29.1	5.9	20.9	21.2	0.0	2.3	2.0	1.0	5.3	1.4	1.1	1.1	1.8	4.4	0.3	0.0	1.0	0.0	5.5	10.1	8.4	3.9	1.4	31.4	34.4	8.8	25.9	20.6	23.5	17.1	21.2	15.4	8.5
SLC20A2	"Glvr-2, GLVR2, MLVAR, PiT-2, Ram-1"	ENSG00000168575	"Solute carrier family 20 member 2"	Q08357	8	42416475-42541926	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Phosphate transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 90.6"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026540	Approved									"HPA026540: AB_1855408"	"prognostic unfavourable (7.67e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.43e-2)"	"prognostic favourable (1.01e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.95e-2)"	7.3	5.2	12.2	6.3	17.8	2.3	8.0	24.2	22.2	8.5	14.2	28.6	4.9	28.0	10.9	6.8	19.4	15.4	9.4	37.3	16.7	17.3	11.3	23.1	9.3	4.1	22.4	14.4	5.7	30.2	15.1	8.1	8.3	32.8	8.4	11.8	19.0	90.6	11.6	69.9	12.6	18.2	12.1	21.6	4.7	8.8	11.1	18.3	5.6	48.6	19.8	10.5	14.6	11.5	3.2	5.2	3.1	3.0	9.6	7.5	4.1	17.7	4.9	6.7	5.6	3.9	3.2	15.0	16.4	28.4	8.5	21.2	13.2	47.5	6.0	19.2	14.6	29.3	3.8	16.6	15.0	1.4	3.0	9.6	1.8	7.5	5.5	3.4	4.4	3.5	15.1	8.8	8.7	4.2	9.1	4.9	16.1	4.9	6.0	5.5	6.7	3.1	5.1	7.4	6.3	7.7	17.5	1.8	7.0	4.4	7.7	4.5	6.2	5.9	12.9	18.4	6.3	4.4	8.8	3.3	7.2	4.3	5.7	6.7	9.9	3.1	3.0	0.3	5.6	2.2	6.3	3.1	6.0	5.2	5.2	3.2	7.5	5.6	1.2	9.6	1.9	3.0	5.8	4.1	12.2	17.8	24.2	19.9	16.7	17.3	22.4	14.4	32.8	18.3
SLC22A18	"BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5"	ENSG00000110628	"Solute carrier family 22 member 18"	Q96BI1	11	2899721-2925246	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 71.4;liver: 44.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.3;Karpas-707: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA067812, HPA071461"	Enhanced									"HPA067812: , HPA071461: "	"unprognostic (1.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.80e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.35e-2)"	"unprognostic (8.60e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.51e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.82e-1)"	3.5	1.6	0.5	11.4	1.2	1.4	3.2	0.1	2.0	2.6	36.6	0.8	2.9	36.7	3.1	15.2	6.1	4.7	21.9	8.5	0.9	1.1	18.2	44.3	8.7	8.3	1.0	1.7	2.9	3.0	4.1	1.5	4.9	1.3	4.0	3.7	4.2	8.6	4.3	1.0	6.5	71.4	3.7	1.2	4.7	8.1	2.8	0.8	3.1	8.1	7.6	5.4	4.5	4.4	2.1	8.9	21.7	15.0	2.7	4.6	6.0	1.4	8.5	0.0	4.8	0.9	1.4	3.5	2.9	5.1	1.7	2.9	5.1	21.3	0.6	9.0	3.8	4.6	0.2	0.4	0.4	4.2	0.7	0.1	2.1	4.6	9.4	0.0	4.0	3.9	0.9	1.4	0.3	0.0	0.1	19.7	0.9	4.3	0.1	0.6	0.5	1.9	1.5	0.0	2.6	0.8	2.9	0.1	1.6	1.1	12.4	10.3	2.4	2.5	0.2	1.3	2.7	3.9	0.1	3.5	0.8	0.2	5.2	2.7	4.9	15.3	15.0	12.6	3.5	14.3	2.0	2.1	2.8	2.5	8.9	1.3	1.5	2.2	21.7	2.7	10.8	6.4	4.6	6.0	0.5	1.2	0.1	2.0	0.9	1.1	1.0	1.7	1.3	0.8
SLC22A5	"CDSP, OCTN2, SCD"	ENSG00000197375	"Solute carrier family 22 member 5"	O76082	5	132369752-132395614	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.3;skeletal muscle: 93.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 21.8;SiHa: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA063062			Approved	Mitochondria				Mitochondria		"HPA063062: "	"unprognostic (3.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.19e-2)"	"prognostic favourable (2.87e-5)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favourable (7.36e-4)"	"unprognostic (3.53e-2)"	"prognostic favourable (8.36e-4)"	"unprognostic (1.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.17e-2)"	3.0	4.7	4.0	1.9	4.9	0.6	4.4	9.0	4.2	4.4	10.6	3.6	15.0	11.8	3.6	12.6	2.5	7.4	5.2	7.2	3.8	3.8	42.3	4.5	2.3	1.5	3.5	3.2	3.9	5.2	17.9	8.5	8.1	3.9	8.2	8.3	5.9	4.2	21.8	93.6	3.5	19.6	2.9	3.8	1.7	4.4	2.5	2.7	1.0	5.0	3.2	2.4	3.9	3.2	1.4	6.4	0.4	4.1	1.5	4.0	2.1	3.5	8.5	0.5	6.9	2.7	1.3	11.8	1.6	1.7	2.7	3.8	6.3	7.3	1.7	3.7	1.5	8.6	5.6	4.2	3.2	2.1	6.9	0.9	21.8	2.8	4.6	1.4	1.5	1.3	7.9	1.8	9.7	0.7	3.9	1.1	2.6	6.0	2.0	1.4	0.6	3.7	0.8	0.0	9.2	8.2	8.9	3.0	2.0	22.5	17.6	4.4	8.2	1.8	0.4	0.4	2.4	5.7	2.0	3.7	7.2	0.1	1.8	3.5	1.6	0.0	4.1	0.0	2.6	2.2	2.8	1.4	2.4	3.1	6.4	1.4	2.6	3.0	0.4	1.5	0.7	0.6	4.0	2.1	4.0	4.9	9.0	4.2	3.8	3.8	3.5	3.2	3.9	2.7
SLC24A1	"CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX"	ENSG00000074621	"Solute carrier family 24 member 1"	O60721	15	65611366-65660995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision"		"Congenital stationary night blindness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"retina: 91.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039370	Enhanced		Approved	Microtubules				Microtubules		"HPA039370: AB_10960279"	"unprognostic (9.47e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.39e-3)"	"unprognostic (4.64e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.91e-2)"	"prognostic favourable (2.33e-6)"	"unprognostic (8.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.96e-2)"	6.2	5.3	4.5	7.7	5.0	2.6	9.3	7.0	3.4	8.9	5.0	5.6	7.5	3.7	10.6	12.2	4.2	9.0	6.2	4.1	4.7	4.1	7.9	4.7	12.0	6.0	5.3	2.6	9.7	6.6	6.5	6.1	8.9	4.0	6.0	4.1	91.1	6.4	8.3	3.8	8.5	4.5	5.0	6.8	7.8	4.2	10.8	3.2	6.9	9.0	4.6	4.8	6.0	5.3	3.8	2.6	4.7	1.5	2.3	1.8	0.4	1.5	3.1	3.4	3.1	5.1	8.7	4.2	4.0	4.3	3.9	2.6	1.4	6.8	2.2	13.3	3.8	4.4	4.1	4.3	2.3	2.2	2.9	4.7	2.4	6.9	7.4	3.1	6.5	7.3	6.3	2.2	13.2	6.7	5.0	7.4	6.3	6.5	2.0	2.9	4.4	1.2	2.1	1.1	1.4	6.0	6.2	1.6	2.4	1.1	3.0	8.2	6.3	4.3	9.6	4.0	4.1	1.5	2.7	3.0	5.4	2.5	4.2	6.7	3.4	4.7	1.5	2.1	1.4	1.3	1.8	1.4	1.5	1.2	1.1	3.8	1.1	1.5	1.7	2.3	0.6	2.6	0.3	0.4	4.5	5.0	7.0	3.4	4.7	4.1	5.3	2.6	4.0	3.2
SLC24A4	NCKX4	ENSG00000140090	"Solute carrier family 24 member 4"	Q8NFF2	14	92322581-92501483	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Olfaction, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.6;brain: 28.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.6;SCLC-21H: 5.1"	"Group enriched"	"Detected in some"	5	"glioma: 0.5;melanoma: 0.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 7.9;intermediate monocyte: 11.6;non-classical monocyte: 9.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 11.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.58e-2)"	1.8	1.0	4.9	3.8	6.0	8.6	0.6	1.1	11.7	0.8	0.9	9.6	6.3	0.9	0.6	0.7	0.8	0.8	1.9	0.9	4.7	3.2	0.5	0.7	2.3	2.7	10.8	4.7	1.0	0.6	0.5	1.8	1.2	28.1	0.7	1.0	4.6	0.7	1.2	2.4	0.8	1.2	1.4	14.2	5.0	0.9	2.9	5.7	0.0	0.6	0.0	1.4	1.5	0.8	0.1	2.3	1.3	11.6	0.2	0.2	2.0	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.6	2.6	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.7	0.3	0.4	0.2	0.0	0.2	0.3	0.0	0.2	0.3	0.0	0.0	0.1	0.6	0.0	0.4	0.0	0.3	1.1	0.3	0.1	0.1	0.3	0.0	0.3	5.1	0.0	0.2	0.2	0.5	0.3	1.1	0.6	0.2	1.5	0.3	0.1	0.4	0.1	0.1	0.2	0.3	0.3	0.2	7.9	0.0	0.0	11.6	0.2	0.0	0.0	0.0	2.3	0.1	0.0	0.0	1.3	0.2	9.4	0.4	0.0	2.0	4.9	6.0	1.1	7.3	4.7	3.2	10.8	4.7	28.1	5.7
SLC24A5	"JSX, OCA6"	ENSG00000188467	"Solute carrier family 24 member 5"	Q71RS6	15	48120972-48142672	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport"		Albinism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"retina: 71.9"	"Cell line enriched"	"Detected in single"	733	"SK-MEL-30: 73.2"	"Cancer enriched"	"Detected in single"	162	"melanoma: 8.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 3.3;pons and medulla: 4.4;thalamus: 1.7"	"Low region specificity"	"Detected in all"																		"unprognostic (3.47e-2)"				"unprognostic (1.80e-1)"	"unprognostic (1.35e-1)"			"unprognostic (1.92e-3)"					0.1	0.1	0.5	0.1	0.6	0.1	0.6	1.5	0.5	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.4	0.1	0.5	1.0	0.3	0.1	0.2	0.1	1.7	0.1	0.1	0.1	0.1	1.5	0.1	0.4	0.1	0.1	71.9	0.2	0.1	0.1	15.4	0.7	0.1	0.6	0.1	0.1	3.0	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.6	1.5	0.5	0.5	1.0	1.7	0.1	0.4	0.4
SLC25A1	"CTP, SLC20A3"	ENSG00000100075	"Solute carrier family 25 member 1"	P53007	22	19175575-19178830	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 38.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									19000	19000				"unprognostic (2.12e-1)"	"unprognostic (3.98e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.03e-2)"	42.5	23.6	11.6	16.1	12.8	5.5	59.1	9.1	12.2	14.9	33.8	14.6	17.6	50.1	12.9	16.4	20.2	12.4	25.1	9.2	14.0	17.6	26.2	60.2	12.2	18.8	15.6	9.1	20.7	25.1	14.8	12.7	15.1	18.0	19.1	15.4	13.6	19.3	16.3	4.8	14.0	53.9	13.8	16.6	12.0	16.1	14.5	13.8	9.9	20.1	13.0	13.7	14.7	15.2	14.2	5.6	38.5	9.2	4.9	8.4	4.0	24.5	25.2	20.0	16.6	49.5	24.6	20.5	19.4	22.2	15.3	20.8	30.2	17.2	15.0	9.2	24.8	20.5	18.8	31.0	8.7	14.9	37.0	7.6	21.4	59.9	34.9	14.4	24.1	34.3	19.0	17.4	13.6	14.3	40.6	14.0	16.9	62.3	8.9	17.2	13.3	15.3	15.8	10.0	6.6	45.1	30.1	12.3	15.8	18.7	36.3	10.4	27.6	37.5	13.9	18.5	16.6	14.1	11.9	18.2	8.8	7.6	19.1	6.9	9.3	3.6	6.2	38.5	7.3	7.2	4.7	13.4	8.4	7.9	5.6	14.2	7.5	6.3	3.3	4.9	9.2	4.4	7.7	4.0	11.6	12.8	9.1	12.2	14.0	17.6	15.6	9.1	18.0	13.8
SLC25A12	Aralar	ENSG00000115840	"Solute carrier family 25 member 12"	O75746	2	171784370-171999859	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035333, HPA035334"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA035333: AB_10603028, HPA035334: AB_2674577"	"unprognostic (3.24e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavourable (7.86e-4)"	"unprognostic (2.65e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.21e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (2.91e-8)"	"unprognostic (8.64e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	6.4	6.7	8.8	6.2	18.2	2.9	9.2	17.9	25.0	10.6	12.2	5.7	5.2	4.2	10.4	7.1	11.5	6.9	5.9	42.4	9.9	13.4	10.7	1.9	5.2	6.5	10.4	12.4	10.0	3.5	16.4	14.7	4.7	15.2	10.6	10.0	11.0	21.7	14.8	84.7	7.6	5.7	14.3	7.1	5.6	9.0	4.3	6.2	5.8	10.1	23.8	8.4	10.0	6.7	6.4	3.6	5.1	4.6	6.6	8.1	2.9	7.1	5.3	5.6	12.8	16.5	18.7	0.1	9.1	15.5	12.4	11.9	2.8	6.7	22.6	6.0	10.6	9.0	11.7	11.4	15.6	13.8	10.9	9.8	7.6	6.6	6.3	19.8	9.8	16.3	11.3	14.4	4.1	12.8	6.8	10.4	7.9	4.3	13.9	8.3	4.5	7.4	14.5	8.0	11.8	13.0	6.3	7.8	2.5	5.7	13.5	7.2	4.9	5.9	8.8	10.3	4.5	11.5	6.2	14.0	9.0	22.9	14.3	10.5	7.0	5.1	3.0	1.6	6.5	3.9	7.3	6.4	4.5	6.8	3.6	3.9	6.3	8.1	0.2	6.6	4.6	0.6	4.5	2.9	8.8	18.2	17.9	25.0	9.9	13.4	10.4	12.4	15.2	6.2
SLC25A13	"ARALAR2, CITRIN, CTLN2"	ENSG00000004864	"Solute carrier family 25 member 13"	Q9UJS0	7	96120220-96322147	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 79.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018997	Approved		Supported	Mitochondria				Mitochondria		"HPA018997: AB_1857023"	"unprognostic (3.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.99e-2)"	"prognostic favourable (9.14e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.32e-1)"	"unprognostic (7.09e-2)"	7.7	10.3	4.2	4.9	11.8	4.1	6.7	3.0	7.5	5.4	12.5	21.1	15.6	8.9	5.1	8.0	6.9	5.9	6.7	4.5	5.6	5.3	17.7	79.1	5.5	4.9	14.5	4.8	5.9	7.3	8.2	8.8	8.9	12.4	5.9	10.2	12.6	5.7	17.3	4.6	8.2	9.7	5.0	13.1	7.2	7.9	4.3	12.6	1.8	7.9	3.0	4.8	5.0	5.3	3.7	8.9	3.1	6.7	2.8	2.4	2.1	16.4	14.6	16.8	5.8	2.9	2.3	23.6	4.2	3.2	10.1	10.3	26.1	15.5	7.4	19.9	2.6	9.8	18.8	6.0	12.0	2.9	12.4	8.4	13.7	20.3	6.8	10.7	6.7	6.2	6.4	8.7	7.8	11.6	23.7	2.8	4.9	18.1	0.0	10.0	29.6	9.0	4.2	10.0	17.1	24.3	15.6	8.1	26.5	14.5	30.7	24.8	9.1	8.2	6.8	7.6	16.9	17.8	12.7	5.8	14.5	4.7	9.3	10.3	12.4	0.6	4.6	3.1	2.2	6.3	2.4	3.7	1.8	2.0	8.9	2.0	1.2	1.5	0.8	2.8	6.7	4.7	1.8	2.1	4.2	11.8	3.0	7.5	5.6	5.3	14.5	4.8	12.4	12.6
SLC25A15	"D13S327, HHH, ORC1, ORNT1"	ENSG00000102743	"Solute carrier family 25 member 15"	Q9Y619	13	40789412-40810111	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 26.0;liver: 66.4;pancreas: 24.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042146	Approved									"HPA042146: "	"unprognostic (4.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-1)"	"prognostic favourable (2.16e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-2)"	"prognostic favourable (1.74e-4)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (5.46e-4)"	1.0	1.1	1.4	4.7	1.7	1.6	2.6	1.0	2.0	1.3	13.2	1.0	0.2	16.3	1.6	1.5	1.8	1.2	3.1	1.9	1.3	1.6	4.0	66.4	1.6	2.0	1.6	0.9	1.8	24.9	0.8	1.0	1.8	1.5	1.0	2.6	0.9	1.4	1.6	2.5	1.3	26.0	1.5	1.4	1.5	2.0	3.8	1.0	2.7	8.0	2.9	3.8	1.2	1.1	1.7	3.4	0.0	3.1	2.4	5.0	1.6	5.0	9.9	9.8	13.5	3.6	4.8	12.5	3.7	1.9	4.2	2.7	10.5	9.7	32.0	4.3	6.2	8.2	15.4	10.2	3.7	7.6	7.7	24.2	4.9	13.6	6.9	8.6	3.1	5.2	4.5	5.3	13.0	6.5	12.4	5.1	6.5	16.3	6.4	3.8	21.2	5.1	15.8	8.1	6.9	5.1	4.6	5.5	13.6	6.9	10.9	5.9	9.1	12.8	6.2	5.3	8.5	8.1	10.7	5.8	5.5	18.8	5.6	7.0	10.6	0.0	1.3	0.0	4.3	3.1	2.7	1.6	2.9	2.8	3.4	1.7	3.0	5.0	0.0	2.4	1.0	0.7	1.8	1.6	1.4	1.7	1.0	2.0	1.3	1.6	1.6	0.9	1.5	1.0
SLC25A19	"DNC, MCPHA, MUP1, TPC"	ENSG00000125454	"Solute carrier family 25 member 19"	Q9HC21	17	75272981-75289510	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 35.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.28e-1)"	"unprognostic (7.05e-3)"	"unprognostic (8.21e-2)"	"prognostic unfavourable (8.72e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (1.21e-7)"	"unprognostic (6.71e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.13e-1)"	8.1	18.5	9.9	14.0	15.7	6.7	5.7	9.0	10.9	6.5	7.9	4.3	2.6	8.5	5.8	3.1	6.8	6.0	5.8	7.9	7.1	6.0	9.1	9.2	10.7	19.3	9.6	5.7	5.4	10.6	4.5	4.1	10.8	9.2	5.1	8.5	3.2	5.4	3.8	10.6	4.5	6.8	6.6	12.3	12.2	8.0	35.5	8.7	9.3	7.7	3.9	16.8	7.8	5.8	19.4	18.2	1.2	14.7	5.3	10.4	8.3	9.3	11.6	2.1	6.3	4.8	2.5	6.9	6.2	2.4	7.1	7.2	20.0	5.9	30.0	4.5	2.1	8.4	14.8	7.1	8.8	8.7	23.9	13.7	13.8	19.1	4.0	19.4	15.6	2.1	4.0	11.0	8.9	11.6	16.6	14.4	2.2	19.6	20.1	19.5	4.6	22.9	15.7	6.8	28.5	4.8	6.6	21.1	5.3	6.6	17.6	7.5	11.0	15.8	4.1	4.2	8.4	8.1	16.4	35.6	17.1	31.5	3.3	22.3	5.2	0.2	12.7	1.2	10.4	14.7	10.4	19.4	8.1	9.6	14.8	16.3	9.3	9.6	1.1	5.3	8.4	18.2	9.8	8.3	9.9	15.7	9.0	10.9	7.1	6.0	9.6	5.7	9.2	8.7
SLC25A20	"CAC, CACT"	ENSG00000178537	"Solute carrier family 25 member 20"	O43772	3	48856931-48898993	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 57.8;liver: 58.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 34.6;RPMI-8226: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016862, HPA029863"	Approved		Supported	Mitochondria,Cytosol		13000	13000	"Mitochondria, Cytosol"		"HPA016862: AB_1857028, HPA029863: AB_10602893"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (3.49e-2)"	11.9	13.7	6.7	5.6	7.3	3.4	10.2	3.0	5.6	3.3	19.7	4.7	5.2	25.0	4.7	3.1	3.3	5.0	9.9	37.1	7.3	4.6	16.8	58.3	6.6	4.9	8.5	5.1	2.7	16.8	5.9	5.1	3.3	5.8	5.0	9.1	5.4	7.4	3.7	27.4	4.0	32.2	5.7	5.5	8.8	7.5	4.4	6.6	9.1	5.5	5.5	5.9	4.5	9.8	9.4	33.3	57.8	29.0	17.3	28.4	24.7	1.4	4.4	3.5	4.9	11.3	4.3	0.7	7.8	4.2	5.5	5.7	5.5	6.8	6.5	5.5	12.3	1.4	8.7	3.5	4.1	16.4	4.1	9.0	6.9	6.9	5.1	9.4	17.4	5.5	4.0	7.4	1.2	7.0	8.0	34.6	7.2	3.7	10.3	4.7	1.8	9.9	3.7	2.1	47.7	5.9	3.4	1.4	5.0	7.2	0.0	4.0	11.0	4.4	5.7	6.2	1.1	9.1	5.7	12.9	8.9	7.5	9.0	6.7	8.2	13.8	29.0	57.8	28.4	21.0	18.1	9.4	16.1	20.8	27.0	7.8	12.7	21.3	13.5	17.3	21.4	33.3	16.1	24.7	6.7	7.3	3.0	5.6	7.3	4.6	8.5	5.1	5.8	6.6
SLC25A22	"EIEE3, FLJ13044, GC1, NET44"	ENSG00000177542	"Solute carrier family 25 member 22"	Q9H936	11	790475-798333	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.0;pancreas: 43.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014662	Approved		Approved	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA014662: AB_10600808"	"unprognostic (1.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (8.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.61e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	4.9	5.2	23.3	8.3	19.0	5.7	2.7	32.2	45.0	3.5	4.1	3.4	2.5	10.3	3.2	2.3	4.4	5.0	3.8	3.2	27.8	13.2	4.1	14.2	4.6	7.5	9.6	22.8	4.8	43.0	4.0	13.4	4.4	13.5	5.2	2.9	4.6	11.4	4.2	1.1	5.8	8.5	3.3	2.8	5.3	6.8	6.6	2.6	3.5	3.1	3.0	5.1	4.5	2.4	2.5	3.1	4.0	5.7	3.6	7.2	2.3	23.2	15.1	8.9	7.9	3.7	6.8	8.4	11.1	9.4	12.4	7.9	14.9	16.0	7.0	8.4	9.3	20.6	9.8	13.4	2.8	13.1	17.9	6.4	7.4	9.1	16.1	10.3	10.8	6.8	8.1	9.4	10.1	5.7	13.0	11.0	5.5	14.1	10.7	9.7	19.2	23.2	12.7	4.8	16.5	7.4	3.9	43.9	19.7	6.4	15.4	7.9	7.4	5.2	5.5	13.9	9.3	6.4	10.4	9.7	5.6	8.9	16.7	9.2	8.3	0.0	2.4	4.0	6.6	5.6	4.2	2.5	4.1	7.2	3.1	2.1	2.5	4.2	1.5	3.6	5.7	0.9	2.2	2.3	23.3	19.0	32.2	37.4	27.8	13.2	9.6	22.8	13.5	2.6
SLC25A26		ENSG00000144741	"Solute carrier family 25 member 26"	Q70HW3	3	66133610-66388116	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026887	Supported		Supported	Mitochondria				Mitochondria		"HPA026887: AB_2189921"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.43e-2)"	"prognostic favourable (1.73e-5)"	"unprognostic (4.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-1)"	11.8	12.9	20.2	8.5	14.8	13.3	16.5	7.9	27.2	10.3	12.6	15.8	9.2	9.7	11.1	12.9	14.3	13.1	10.1	19.5	16.9	12.8	15.7	22.7	10.0	15.2	17.6	11.8	20.0	21.2	16.2	11.6	11.9	14.6	10.8	13.4	12.6	16.1	12.6	29.8	16.5	11.0	16.8	14.3	11.4	12.7	18.3	12.6	12.0	19.0	14.2	12.9	13.4	10.8	12.0	12.2	3.6	7.1	10.5	14.4	9.1	6.3	6.1	3.8	7.7	8.4	8.7	8.0	5.3	10.1	7.2	6.8	8.1	8.5	6.5	3.2	9.7	4.7	4.4	9.9	7.4	6.7	10.3	9.8	4.9	11.7	10.2	13.8	8.4	11.9	19.6	5.7	13.7	5.3	4.3	8.7	8.6	7.9	5.7	15.8	11.1	3.6	6.0	6.9	11.0	5.9	4.7	2.9	8.9	7.7	6.7	12.6	5.6	10.9	6.0	7.6	7.2	9.5	9.3	12.9	16.7	8.4	10.4	13.2	8.2	1.3	6.8	3.6	10.9	7.1	9.9	12.0	12.1	11.1	12.2	10.2	14.4	12.3	0.4	10.5	4.1	11.6	11.1	9.1	20.2	14.8	7.9	27.2	16.9	12.8	17.6	11.8	14.6	12.6
SLC25A3	PHC	ENSG00000075415	"Solute carrier family 25 member 3"	Q00325	12	98593591-98606379	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 233.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045709			Supported	Mitochondria		5500000	5500000	Mitochondria		"HPA045709: AB_10965843"	"unprognostic (1.16e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.40e-2)"	"prognostic favourable (8.11e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.72e-2)"	35.7	71.2	23.6	38.3	27.2	24.6	48.9	25.1	50.2	29.8	69.6	22.4	33.8	53.9	38.5	35.9	54.6	30.1	55.1	233.5	22.9	25.3	60.2	72.6	47.0	75.5	27.8	26.0	39.6	59.7	55.5	29.1	34.2	31.6	33.8	53.3	30.9	53.5	33.5	190.6	33.8	76.0	46.7	19.6	35.6	51.4	16.9	15.1	42.0	41.5	125.8	44.4	38.5	31.9	46.8	82.3	33.4	78.5	43.3	56.6	76.3	75.6	59.1	78.4	64.9	71.4	118.8	101.1	66.4	88.5	86.1	72.0	106.1	39.8	103.4	39.5	80.4	65.2	79.5	89.7	90.8	38.9	63.4	61.6	43.6	70.3	88.0	72.1	49.0	112.3	80.3	62.5	90.0	121.5	66.4	30.7	102.6	56.4	66.9	80.5	72.6	97.1	76.5	81.7	114.7	111.3	76.0	40.3	54.0	79.5	71.5	109.6	96.6	78.9	81.6	48.0	45.3	52.6	66.4	52.0	61.1	72.3	37.8	42.6	61.7	24.4	59.5	33.4	40.1	77.2	47.4	46.8	45.7	44.3	82.3	33.3	47.9	45.3	26.4	43.3	78.5	50.3	56.6	76.3	23.6	27.2	25.1	50.2	22.9	25.3	27.8	26.0	31.6	15.1
SLC25A32	MFTC	ENSG00000164933	"Solute carrier family 25 member 32"	Q9H2D1	8	103398635-103415189	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024763, HPA047402"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA024763: , HPA047402: "	"unprognostic (2.45e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (2.06e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.22e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (9.47e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavourable (1.53e-6)"	"unprognostic (7.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.49e-2)"	24.1	14.9	11.1	19.6	17.0	21.6	21.6	22.1	21.9	16.3	14.7	15.4	8.8	11.0	19.4	13.0	13.1	18.8	19.6	16.4	12.6	16.5	15.2	29.6	16.1	23.9	16.4	11.6	21.0	13.4	17.3	30.1	16.5	24.2	14.9	14.2	15.7	13.0	13.1	17.8	13.9	14.1	18.5	14.1	25.1	14.4	15.3	13.6	17.2	14.9	11.7	19.8	18.3	14.2	8.9	5.0	1.8	4.6	5.7	9.3	6.5	14.9	5.4	7.3	8.9	10.1	11.7	4.9	12.7	18.0	14.3	14.9	6.5	9.2	32.5	12.1	13.7	9.6	10.5	10.7	22.2	19.8	7.5	24.0	4.6	8.3	17.5	11.7	10.9	11.5	8.9	16.1	24.0	14.8	14.8	12.8	14.2	6.0	19.9	9.6	8.8	10.8	15.0	7.8	22.4	9.7	6.9	20.5	9.0	6.2	10.2	21.3	9.1	8.4	10.2	17.8	11.8	20.4	16.3	9.1	8.6	33.9	15.1	17.2	13.1	0.7	3.9	1.8	7.7	4.4	9.3	8.9	8.3	8.8	5.0	6.5	8.6	8.7	1.1	5.7	4.6	4.3	6.5	6.5	11.1	17.0	22.1	21.9	12.6	16.5	16.4	11.6	24.2	13.6
SLC25A38	FLJ20551	ENSG00000144659	"Solute carrier family 25 member 38"	Q96DW6	3	39383324-39397351	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041027	Approved									"HPA041027: AB_10794403"	"unprognostic (3.82e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.54e-2)"	"prognostic favourable (1.58e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.06e-1)"	"prognostic favourable (7.29e-4)"	14.0	24.6	12.2	18.2	17.1	38.1	20.9	16.7	21.9	17.2	17.8	11.9	22.2	16.0	21.3	18.2	13.3	17.8	18.2	12.9	12.0	15.3	18.0	35.9	14.7	22.5	12.8	16.2	29.1	41.3	27.2	21.7	12.8	13.4	21.3	24.1	15.1	15.5	18.4	30.0	10.6	16.4	17.0	11.3	18.9	21.3	17.7	13.0	24.7	39.8	12.5	21.5	20.5	22.7	21.6	8.1	12.4	4.2	23.2	22.7	11.9	9.5	15.2	10.1	16.9	23.7	19.6	12.7	13.7	18.7	19.9	18.1	10.5	2.2	26.8	8.1	12.6	7.4	22.4	16.1	15.0	17.1	18.0	20.8	13.5	15.4	31.8	14.6	14.2	24.7	18.9	19.1	38.7	12.8	18.5	16.9	14.7	13.7	17.4	26.0	27.0	17.7	6.3	10.8	18.5	15.5	18.2	10.0	12.9	4.7	27.1	13.3	13.7	13.8	11.0	16.0	10.9	23.0	19.4	22.7	35.7	16.4	12.2	19.1	10.0	12.4	4.2	7.7	17.7	2.5	20.4	21.6	18.3	19.4	6.4	19.0	19.6	19.0	0.6	23.2	3.4	8.1	22.7	11.9	12.2	17.1	16.7	21.9	12.0	15.3	12.8	16.2	13.4	13.0
SLC25A46		ENSG00000164209	"Solute carrier family 25 member 46"	Q96AG3	5	110738136-110765161	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039601, HPA071582"	Approved		Supported	Mitochondria				Mitochondria		"HPA039601: , HPA071582: "	"unprognostic (1.86e-1)"	"unprognostic (3.29e-1)"	"prognostic favourable (8.41e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (2.52e-4)"	"unprognostic (1.98e-1)"	16.9	15.6	11.9	12.7	19.3	11.3	13.6	17.6	25.7	12.5	14.0	12.2	8.5	15.7	13.4	9.5	16.4	9.5	10.0	20.8	10.4	10.0	18.7	22.0	11.4	13.7	14.5	14.8	10.2	12.4	12.7	20.2	11.5	27.7	10.2	14.7	8.3	14.2	10.7	55.6	13.0	15.4	13.9	15.0	12.1	12.9	15.8	12.3	20.4	12.5	14.3	17.5	13.1	10.9	14.6	15.1	20.2	17.3	17.7	16.3	14.9	12.4	9.6	9.1	7.4	21.2	20.0	3.7	15.6	20.3	17.9	22.4	13.2	10.6	33.6	16.0	18.2	10.3	14.4	25.8	20.3	21.5	8.3	14.4	14.0	9.5	18.9	12.6	14.5	16.9	7.6	21.1	14.9	11.1	10.9	21.1	18.5	10.0	18.3	5.3	6.8	9.7	9.0	20.4	25.0	11.4	14.6	16.1	11.9	13.5	10.4	16.4	11.4	10.4	14.6	15.8	8.0	14.3	18.7	40.6	25.4	25.2	16.4	14.7	8.4	20.2	14.7	11.5	12.3	17.3	12.4	14.1	13.7	12.6	15.1	14.6	14.8	14.8	6.2	17.7	15.2	10.6	16.3	14.9	11.9	19.3	17.6	25.7	10.4	10.0	14.5	14.8	27.7	12.3
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 17.1;liver: 45.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 13.0;HMC-1: 8.9;T-47d: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041654	Uncertain		Approved	Microtubules				Microtubules		"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favourable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.1	6.5	1.4	1.7	1.7	1.5	1.6	4.6	2.7	1.3	7.4	1.1	1.1	6.5	1.4	1.9	1.1	1.1	2.6	1.1	1.4	1.5	17.1	45.4	1.1	1.7	1.1	1.1	1.6	4.0	0.0	2.1	1.1	1.1	1.8	0.0	1.1	4.2	1.1	1.5	3.1	10.5	1.1	1.1	2.4	4.0	1.1	1.1	1.1	2.0	1.1	1.1	1.1	1.1	0.4	0.3	7.0	0.6	1.1	1.8	0.7	1.3	2.2	0.0	1.7	0.2	0.4	4.1	1.9	0.1	0.0	0.0	4.4	2.5	0.7	2.2	0.0	1.3	0.1	0.0	0.0	2.5	0.9	3.3	3.0	13.0	0.2	2.1	8.9	0.6	0.2	0.1	0.0	0.3	3.4	0.0	0.3	2.8	1.3	3.5	1.0	7.0	7.1	0.0	0.3	0.7	5.0	0.2	1.3	0.5	0.2	1.2	9.0	1.4	2.1	4.7	0.9	4.7	1.3	6.8	3.1	1.2	1.6	4.3	2.1	7.0	0.6	0.4	0.4	0.3	0.8	0.4	1.2	0.9	0.2	0.1	0.8	1.8	0.0	1.1	0.3	0.3	1.6	0.7	1.4	1.7	4.6	1.6	1.4	1.5	1.1	1.1	1.1	1.1
SLC26A2	"DTD, DTDST"	ENSG00000155850	"Solute carrier family 26 member 2"	P50443	5	149960737-149993455	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 81.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 23.6;RPTEC TERT1: 54.3;TIME: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041957, HPA058090"	Enhanced		Approved	Vesicles				Vesicles		"HPA041957: AB_10795646, HPA058090: AB_2683602"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.03e-2)"	"prognostic favourable (7.29e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.06e-1)"	8.5	15.6	2.6	23.2	3.7	1.3	4.7	6.3	2.3	3.8	81.9	3.0	29.4	5.4	4.8	14.2	8.3	3.1	2.6	3.1	2.5	2.6	3.8	1.6	6.8	5.3	3.7	2.3	5.1	2.9	21.4	11.1	16.9	7.6	6.1	75.0	4.9	27.9	36.7	11.2	6.0	13.4	4.3	5.5	3.0	2.4	2.8	3.0	5.2	2.7	4.4	13.0	4.1	2.8	1.6	1.7	7.0	3.3	2.5	3.0	1.1	3.2	3.0	3.7	6.1	4.5	3.2	0.8	3.1	2.8	2.5	3.0	15.3	1.8	2.5	23.6	3.2	2.3	3.5	7.1	4.5	2.0	2.2	3.2	2.4	1.7	3.4	5.8	5.4	3.5	4.2	4.1	5.4	5.9	0.8	2.5	10.4	1.0	2.2	3.0	1.1	4.7	3.2	5.8	1.3	54.3	14.4	1.1	2.9	5.4	1.3	9.2	2.5	3.4	27.9	5.7	4.3	5.0	3.6	1.8	2.4	1.5	5.2	7.1	8.2	7.0	1.1	0.8	2.5	0.8	3.0	1.3	1.5	2.1	1.7	1.6	2.1	2.2	1.0	2.5	3.3	1.7	2.6	1.1	2.6	3.7	6.3	2.3	2.5	2.6	3.7	2.3	7.6	3.0
SLC26A3	"CLD, DRA"	ENSG00000091138	"Solute carrier family 26 member 3"	P40879	7	107765467-107803225	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 53.5;intestine: 110.1;lymphoid tissue: 42.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;CACO-2: 1.8;NB-4: 1.5;RPMI-8226: 7.5"	"Cancer enriched"	"Detected in many"	14	"colorectal cancer: 52.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA036055	Approved									"HPA036055: AB_10602401"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.58e-3)"	0.3	0.3	0.3	42.8	0.3	0.0	6.1	0.3	0.3	0.4	110.1	0.2	0.3	58.4	0.3	1.2	0.3	0.6	53.5	0.3	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.3	0.0	0.3	0.2	0.2	0.5	92.7	0.2	0.3	14.4	0.3	0.3	106.5	1.2	0.3	0.3	0.4	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.2	0.2
SLC26A4	"DFNB4, PDS"	ENSG00000091137	"Solute carrier family 26 member 4"	O43511	7	107660635-107717809	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"thyroid gland: 79.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.2;LHCN-M2: 5.5;U-251 MG: 3.3"	"Cancer enriched"	"Detected in some"	8	"thyroid cancer: 37.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"naive B-cell: 3.1"	"Lineage enriched"	"Detected in single"	5	"B-cells: 3.1"	"Region enriched"	"Detected in some"	4	"hippocampal formation: 10.6"	"Low region specificity"	"Detected in all"			HPA042860	Approved									"HPA042860: AB_10796680"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.39e-1)"	0.1	0.0	0.8	0.2	0.5	0.0	0.2	0.0	2.9	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.2	3.3	0.0	0.2	0.0	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.0	1.8	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	79.2	0.0	0.1	0.8	0.1	3.1	0.1	0.1	0.2	0.1	0.5	0.3	0.8	0.4	0.6	0.1	0.8	1.8	0.5	0.4	0.2	0.3	0.1	0.0	0.2	0.1	3.0	0.3	0.2	0.6	0.2	0.1	4.2	1.0	0.0	0.3	0.2	0.5	0.5	1.3	0.1	1.1	0.5	0.0	0.1	0.0	0.4	5.5	0.8	0.1	0.5	0.0	1.0	0.2	1.5	0.0	0.0	0.1	3.0	0.2	0.0	0.0	2.1	0.0	0.5	0.8	0.8	0.6	0.3	3.3	0.8	0.8	0.3	1.0	0.5	2.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	3.1	0.0	0.1	0.1	0.1	0.2	0.1	0.5	0.3	0.8	0.5	0.0	1.4	0.5	0.2	0.1	0.6	0.0	0.0
SLC26A5	"DFNB61, PRES"	ENSG00000170615	"Solute carrier family 26 member 5"	P58743	7	103352730-103446177	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell shape, Hearing"	"Motor protein"	"Deafness, Non-syndromic deafness"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 20.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.9;PC-3: 2.5;U-2197: 1.7"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	8	"cerebellum: 20.4"	"Cell type enriched"	"Detected in single"	8	"basophil: 2.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.7"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in some"	8	"basal ganglia: 9.5"												"unprognostic (3.86e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.56e-4)"	"unprognostic (4.21e-3)"	"unprognostic (8.92e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.67e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.69e-3)"	1.3	1.0	0.6	0.3	0.7	2.3	3.1	20.4	0.8	0.6	0.3	0.5	0.0	0.9	0.5	0.0	0.2	0.4	0.2	0.4	0.8	0.4	0.7	0.9	2.2	1.2	1.3	0.4	0.4	0.7	2.5	4.6	0.1	2.6	3.1	0.1	0.9	1.4	1.0	0.6	2.2	0.5	1.2	2.9	0.9	3.2	0.9	0.2	0.0	1.8	0.0	0.2	3.2	0.4	0.2	0.0	2.7	0.1	0.3	0.1	0.0	0.2	0.0	0.3	0.7	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	1.1	0.7	0.4	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.2	0.9	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.3	2.9	0.0	1.1	0.8	0.3	0.1	2.5	0.2	0.1	0.4	0.0	0.8	0.9	1.4	0.3	0.3	0.0	0.7	0.0	0.0	0.6	0.5	1.7	0.4	0.7	0.4	0.4	0.2	0.2	0.3	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.7	20.4	0.8	0.8	0.4	1.3	0.4	2.6	0.2
SLC26A8		ENSG00000112053	"Solute carrier family 26 member 8"	Q96RN1	6	35943514-36024868	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 65.2"	"Cell line enhanced"	"Detected in some"		"RT4: 2.8;T-47d: 1.0;THP-1: 2.2;TIME: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA038081	Enhanced									"HPA038081: AB_10670653"	"unprognostic (8.18e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.63e-6)"	"unprognostic (7.14e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.24e-8)"	0.3	0.2	1.3	0.5	2.2	3.7	0.3	4.2	1.8	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	2.1	0.2	0.2	0.2	1.1	0.7	1.7	0.2	0.3	0.2	0.1	0.2	1.9	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.6	0.9	0.2	65.2	0.1	0.1	0.4	0.0	0.2	0.2	0.0	0.0	0.2	5.4	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.7	0.2	0.0	0.4	0.0	0.0	0.8	2.8	0.8	0.0	0.0	0.0	0.1	1.0	2.2	1.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	1.3	2.2	4.2	1.8	0.8	2.1	0.7	1.7	1.9	0.1
SLC27A4	"ACSVL4, FATP4"	ENSG00000167114	"Solute carrier family 27 member 4"	Q6P1M0	9	128340646-128361470	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 56.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007293, CAB009771"	Approved		Supported	Vesicles				Vesicles		"CAB009771: AB_2270540, HPA007293: AB_1857062"	"unprognostic (7.25e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.07e-2)"	"prognostic favourable (2.61e-5)"	"unprognostic (7.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.45e-2)"	"unprognostic (8.01e-3)"	7.7	7.1	9.9	7.0	13.6	2.5	4.9	9.4	26.5	6.5	25.7	15.8	5.2	54.0	6.6	5.6	26.1	4.4	9.8	7.7	11.6	15.9	17.7	20.8	5.8	5.0	14.8	9.6	5.6	11.3	9.8	5.4	5.8	21.9	5.7	8.3	6.7	7.5	7.3	6.7	24.3	56.1	8.1	11.6	5.1	8.6	13.2	7.9	6.8	12.7	15.2	14.9	8.5	9.5	3.7	7.2	2.6	6.2	1.9	8.1	3.3	10.2	20.1	10.3	13.2	15.7	4.8	11.8	8.7	5.5	10.0	7.3	14.4	10.0	9.6	7.0	9.3	35.2	12.4	10.0	3.1	9.6	19.0	5.7	17.7	12.4	8.4	10.5	9.2	6.3	13.7	10.4	8.3	11.4	13.5	6.7	9.2	25.2	12.4	10.0	4.6	32.0	15.2	10.1	17.8	17.2	15.4	17.9	9.8	14.5	26.7	9.5	13.3	4.0	16.7	12.1	11.8	13.1	10.7	6.0	8.5	3.1	12.3	6.3	13.6	0.0	4.1	2.6	8.1	5.6	6.1	3.7	5.2	6.4	7.2	1.7	4.1	4.3	1.6	1.9	6.2	6.4	3.6	3.3	9.9	13.6	9.4	26.5	11.6	15.9	14.8	9.6	21.9	7.9
SLC29A3	"ENT3, FLJ11160"	ENSG00000198246	"Solute carrier family 29 member 3"	Q9BZD2	10	71319258-71381423	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.5;Hep G2: 21.7;RT4: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046085, HPA054976, HPA057905"	Approved		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA046085: , HPA054976: , HPA057905: "	"unprognostic (1.73e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (6.07e-6)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavourable (5.53e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.36e-1)"	"prognostic favourable (1.16e-4)"	"unprognostic (3.43e-3)"	11.3	4.0	6.4	6.6	8.3	1.9	6.8	3.2	12.6	8.3	6.1	11.3	2.4	4.1	12.1	4.6	3.5	9.4	7.4	3.6	8.0	5.5	3.9	12.5	11.1	10.5	9.8	6.5	15.8	7.4	7.1	2.8	24.6	6.7	8.3	6.0	4.6	7.5	5.4	2.1	3.7	4.9	8.9	8.0	9.4	8.9	4.9	7.7	9.3	6.7	1.3	6.2	18.4	10.0	3.6	19.3	2.8	12.9	5.7	4.0	5.6	1.2	7.3	1.0	4.6	4.2	3.3	19.5	1.3	1.4	0.4	0.2	8.0	5.2	4.2	3.9	2.7	11.6	3.3	1.8	0.0	3.3	3.3	1.2	0.6	21.7	2.0	1.0	2.7	3.2	8.0	0.1	0.3	1.9	3.9	4.1	0.5	11.3	2.7	2.1	2.5	2.6	3.3	0.4	3.4	1.6	17.3	5.5	5.8	3.9	12.7	1.0	1.9	2.3	3.0	0.1	2.4	1.3	0.0	1.1	1.8	2.3	5.1	14.3	0.8	2.8	12.9	1.4	4.0	10.1	3.4	3.6	3.2	3.6	19.3	1.5	2.6	3.6	1.0	5.7	6.3	13.6	3.4	5.6	6.4	8.3	3.2	12.6	8.0	5.5	9.8	6.5	6.7	7.7
SLC2A1	"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR"	ENSG00000117394	"Solute carrier family 2 member 1"	P11166	1	42925375-42959176	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 194.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.2;CACO-2: 71.8;Hep G2: 49.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB002759, HPA031345, HPA058494"	Enhanced	Supported	Enhanced	"Plasma membrane"		36000000	36000000	"Plasma membrane"		"CAB002759: , HPA031345: , HPA058494: "	"unprognostic (3.60e-2)"	"unprognostic (5.85e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (3.65e-8)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavourable (4.39e-5)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (4.55e-9)"	"unprognostic (1.11e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (4.05e-4)"	4.2	3.7	12.4	3.9	16.9	45.2	4.1	6.7	15.5	15.2	4.8	15.1	4.3	2.4	7.6	3.4	28.8	8.5	8.6	5.0	15.4	13.7	7.6	2.1	2.4	5.3	18.2	5.0	3.4	3.7	7.3	2.9	194.0	15.5	5.2	3.3	44.2	8.4	7.9	1.8	42.1	2.9	2.5	17.8	3.4	5.5	2.5	12.5	1.8	4.0	11.5	12.0	22.2	24.5	8.4	14.7	1.3	0.2	3.0	7.5	2.7	10.6	15.3	12.7	3.2	1.5	0.5	44.2	7.0	15.2	8.6	12.8	71.8	29.7	4.0	21.0	2.1	9.9	2.8	16.3	3.8	2.4	2.6	6.6	8.9	49.0	4.4	3.6	1.9	1.8	12.6	5.4	5.9	1.4	14.8	0.9	3.9	18.9	1.6	2.5	8.1	3.9	1.6	4.1	5.6	7.9	5.2	6.7	4.7	8.2	26.0	3.0	1.1	4.6	3.2	7.9	5.7	1.4	15.8	0.7	1.5	2.4	15.6	2.5	6.4	0.3	0.2	1.3	7.5	0.2	6.9	8.4	4.1	5.1	2.9	7.3	3.2	4.7	1.0	3.0	0.1	14.7	4.7	2.7	12.4	16.9	6.7	15.5	15.4	13.7	18.2	5.0	15.5	12.5
SLC2A10	GLUT10	ENSG00000197496	"Solute carrier family 2 member 10"	O95528	20	46709487-46736347	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 51.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.6;HSkMC: 24.2;SK-MEL-30: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	44	"basophil: 13.8"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041015	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA041015: "	"unprognostic (8.94e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.96e-2)"	4.7	4.6	2.6	4.3	3.3	0.1	8.7	2.1	3.1	11.4	6.7	2.7	6.7	2.6	5.4	6.6	4.8	5.6	10.2	6.7	3.3	1.4	2.6	51.5	4.8	3.4	2.2	2.0	7.1	22.9	15.0	4.2	8.3	3.8	18.0	8.8	9.8	11.5	11.0	2.1	2.4	3.0	9.7	2.3	1.9	12.4	3.4	1.0	0.8	18.1	4.5	4.6	7.1	5.7	0.0	0.0	13.8	0.0	0.3	0.0	0.0	0.0	0.0	4.7	4.8	19.6	16.7	14.4	9.1	12.5	4.3	5.1	0.3	16.0	0.0	6.9	16.5	0.1	0.0	0.4	2.0	0.0	0.1	1.3	0.0	7.6	13.8	0.0	0.0	24.2	0.4	2.6	0.0	1.7	0.1	0.0	7.2	16.6	0.0	0.4	1.8	1.2	0.0	0.7	0.0	0.0	4.3	0.0	0.7	1.8	3.0	24.8	2.3	3.7	1.0	9.2	4.0	7.2	1.1	0.1	0.0	0.0	0.0	0.0	1.9	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.6	3.3	2.1	3.1	3.3	1.4	2.2	2.0	3.8	1.0
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996348-171026750	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 77.4;liver: 172.8"	"Group enriched"	"Detected in some"	68	"CACO-2: 7.1;Hep G2: 23.7"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB010444: AB_641068, HPA028997: "			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favourable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	27.9	0.0	0.0	10.8	0.1	0.2	0.1	0.1	3.8	0.1	0.1	0.1	15.3	172.8	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	77.4	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	23.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SLC2A4	GLUT4	ENSG00000181856	"Solute carrier family 2 member 4"	P14672	17	7281667-7288257	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.2;skeletal muscle: 76.8;tongue: 33.5"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 10.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			CAB016544	Enhanced									"CAB016544: AB_629533"	"unprognostic (2.53e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.12e-4)"	"unprognostic (2.40e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.23e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.07e-2)"	9.9	1.4	0.6	1.8	0.7	1.1	6.4	0.0	0.6	4.7	13.9	0.2	4.0	1.0	4.2	7.0	11.8	3.2	2.9	37.2	0.3	0.1	0.7	1.2	0.5	0.7	0.8	0.1	1.9	0.4	2.9	1.2	0.8	0.5	6.3	1.4	6.4	4.6	3.8	76.8	0.9	3.3	23.5	0.2	0.2	3.8	1.5	0.0	0.0	1.2	33.5	1.6	18.6	1.6	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.8	1.5	0.7	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.1	1.2	0.2	0.0	0.8	0.3	0.2	0.1	0.0	1.8	0.0	0.3	10.6	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.6	0.2	0.0	0.4	0.0	0.2	0.7	0.1	2.4	0.6	0.8	0.0	0.1	0.0	1.0	0.0	1.3	0.0	0.8	0.1	0.0	0.0	1.5	0.0	0.2	0.6	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.7	0.0	0.6	0.3	0.1	0.8	0.1	0.5	0.0
SLC2A9	"Glut9, GLUTX, URATv1"	ENSG00000109667	"Solute carrier family 2 member 9"	Q9NRM0	4	9771153-10054936	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 43.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 29.0;Hep G2: 13.8;hTCEpi: 12.2;THP-1: 12.2;U-937: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 20.6;myeloid DC: 16.7"	"Group enriched"	"Detected in many"	31	"dendritic cells: 16.7;monocytes: 20.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA066229	Enhanced									"HPA066229: "	"unprognostic (3.21e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.56e-2)"	"unprognostic (8.94e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.23e-1)"	"prognostic favourable (1.32e-11)"	"unprognostic (1.01e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.20e-1)"	5.6	2.8	1.0	1.3	2.0	1.2	3.2	0.6	1.2	2.6	10.4	2.3	5.7	7.8	1.7	12.0	5.8	2.6	1.7	2.7	1.0	0.9	43.4	17.7	4.7	2.8	1.9	0.7	1.5	1.3	1.5	1.8	8.8	2.1	4.6	1.1	4.1	10.8	15.6	1.1	2.4	12.0	1.4	4.1	3.0	1.2	1.3	2.3	3.0	2.9	3.4	3.9	7.1	3.9	0.2	16.7	0.6	20.6	0.1	0.2	4.9	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.2	1.4	0.0	2.2	0.4	4.4	0.0	29.0	0.0	4.7	0.1	0.0	0.0	13.8	1.0	0.1	3.9	2.1	12.2	0.0	3.0	0.0	0.0	0.1	0.1	0.0	0.2	1.4	0.0	0.1	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	12.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	20.6	0.4	0.1	4.1	0.2	0.2	0.2	0.0	16.7	0.1	0.1	0.0	0.6	0.1	0.4	6.6	0.1	4.9	1.0	2.0	0.6	1.2	1.0	0.9	1.9	0.7	2.1	2.3
SLC30A10	"DKFZp547M236, ZnT-10, ZNT8, ZRC1"	ENSG00000196660	"Solute carrier family 30 member 10"	Q6XR72	1	219685427-219958647	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease mutation, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 33.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 4.3;HEL: 2.2;Hep G2: 4.2;K-562: 2.7"	"Cancer enriched"	"Detected in some"	14	"liver cancer: 7.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064547	Enhanced									"HPA064547: "	"unprognostic (7.88e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.47e-7)"	"unprognostic (3.16e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.19e-3)"	"unprognostic (5.72e-2)"	0.3	0.3	2.9	0.7	3.5	0.4	0.3	1.8	3.9	0.3	7.1	1.9	0.0	5.9	0.3	0.3	0.3	0.3	0.5	0.3	3.5	1.6	0.3	33.4	0.3	0.3	1.7	1.7	0.6	0.3	0.3	0.4	0.4	2.5	0.3	1.7	0.6	0.3	0.3	0.3	0.3	6.8	0.3	0.8	0.3	0.3	1.9	1.9	0.0	0.3	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.3	2.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.5	1.8	3.9	3.5	1.6	1.7	1.7	2.5	1.9
SLC30A2	ZNT2	ENSG00000158014	"Solute carrier family 30 member 2"	Q9BRI3	1	26037252-26046133	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 78.0;placenta: 20.0"	"Group enriched"	"Detected in some"	5	"BEWO: 4.6;RPTEC TERT1: 10.4;WM-115: 6.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 19.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 1.5"	"Low region specificity"	"Detected in some"			HPA017979			Approved	Vesicles				Vesicles		"HPA017979: AB_1857085"	"unprognostic (4.87e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.10e-1)"	"prognostic favourable (2.86e-6)"	"unprognostic (9.38e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.01e-2)"	0.1	0.7	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.0	1.3	1.1	0.1	0.1	4.0	2.2	0.1	0.1	10.4	0.1	0.2	0.1	0.1	0.1	0.1	78.0	0.1	0.1	20.0	0.1	0.3	0.0	2.0	1.0	1.4	1.7	0.4	0.6	0.1	0.1	0.1	0.1	0.4	0.1	0.1	12.8	0.2	0.1	0.5	0.1	1.5	1.1	3.1	1.0	1.5	0.9	0.4	0.2	0.2	0.2	0.9	0.3	0.1	4.6	0.4	0.1	0.1	0.1	0.9	1.0	0.2	0.9	0.1	0.8	0.2	0.3	0.1	0.6	0.3	0.6	0.7	0.1	0.1	0.6	0.7	0.0	0.2	0.1	0.1	0.0	0.6	1.4	0.0	0.7	0.5	0.9	0.7	0.2	0.3	0.7	0.6	10.4	0.4	0.9	0.5	0.6	1.1	0.4	0.7	0.5	0.5	0.7	1.1	0.6	0.3	1.0	0.5	0.7	0.5	0.6	6.3	3.1	1.0	0.4	0.9	0.4	0.5	0.7	0.6	0.8	0.2	1.5	0.6	0.8	3.1	1.5	0.5	1.1	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
SLC30A9	"C4orf1, GAC63, HUEL, ZNT9"	ENSG00000014824	"Solute carrier family 30 member 9"	Q6PML9	4	41990472-42090457	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transcription, Transcription regulation, Transport, Zinc transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA004014	Approved									"HPA004014: AB_1080005"	"unprognostic (4.26e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.99e-2)"	"prognostic favourable (2.86e-14)"	"unprognostic (4.67e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.39e-2)"	11.0	20.4	23.6	11.2	28.8	7.0	18.1	24.2	32.4	16.5	17.0	12.8	15.3	16.1	13.8	21.8	12.5	13.3	11.5	33.4	22.7	24.4	38.2	17.9	11.6	9.0	22.7	23.7	15.1	16.6	30.4	32.6	12.2	27.7	18.3	18.4	11.5	15.0	16.4	17.1	12.6	15.5	11.5	19.2	11.9	16.1	8.8	15.4	12.0	22.5	15.8	10.0	11.8	11.6	4.0	7.1	6.2	6.5	5.9	5.5	3.9	8.4	4.2	14.1	15.9	10.9	15.3	8.0	11.8	14.2	10.3	12.3	4.3	11.1	8.7	8.6	13.4	4.3	11.8	9.7	14.8	2.9	7.1	9.9	7.6	7.3	19.3	13.7	7.2	12.1	10.0	8.8	11.6	11.1	13.3	4.1	18.0	4.1	7.8	13.1	10.8	5.9	3.9	12.7	7.2	21.0	7.2	15.7	17.7	8.3	9.3	10.4	11.8	10.4	12.0	12.2	7.1	12.2	13.5	8.3	6.2	8.4	16.7	11.7	10.6	6.2	5.3	3.0	3.6	6.5	4.2	4.0	4.2	4.6	7.1	3.8	5.5	4.3	2.6	5.9	5.0	5.1	4.7	3.9	23.6	28.8	24.2	32.4	22.7	24.4	22.7	23.7	27.7	15.4
SLC33A1	"ACATN, AT-1, AT1, SPG42"	ENSG00000169359	"Solute carrier family 33 member 1"	O00400	3	155821024-155854456	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Cataract, Deafness, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042430, HPA060345"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA042430: AB_10806238, HPA060345: "	"unprognostic (5.12e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.73e-2)"	"unprognostic (5.74e-2)"	11.3	17.3	6.5	9.9	8.6	3.1	12.1	9.4	9.4	18.8	13.1	10.5	29.9	11.3	14.0	22.9	11.8	12.3	11.5	12.9	7.8	6.7	19.4	38.3	12.8	13.6	9.4	5.6	13.6	42.4	18.8	24.6	13.9	8.9	15.0	10.5	9.2	26.6	33.9	7.0	9.4	15.2	10.4	8.2	11.9	12.4	8.9	8.8	14.9	26.1	5.8	10.7	10.2	11.6	6.0	16.7	12.1	8.3	6.9	10.8	6.0	14.6	10.2	5.3	6.5	19.7	17.0	10.0	11.0	14.8	13.4	13.1	5.8	15.7	7.6	17.8	9.0	12.5	9.1	10.8	15.1	10.7	9.4	7.8	4.9	11.4	28.4	8.6	6.9	13.5	21.7	7.1	27.6	14.6	6.2	18.2	11.9	9.3	3.5	5.1	5.1	9.9	3.9	5.9	22.7	13.7	9.3	6.2	5.1	9.2	21.5	19.5	6.8	11.0	15.2	7.9	3.9	14.4	11.5	21.5	7.5	8.0	11.3	7.0	11.2	12.1	8.3	6.0	9.4	6.5	10.8	6.0	6.8	7.4	10.7	4.1	6.5	6.3	1.8	6.9	6.3	16.7	6.1	6.0	6.5	8.6	9.4	9.4	7.8	6.7	9.4	5.6	8.9	8.8
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"kidney: 94.5"	"Group enriched"	"Detected in some"	12	"HEL: 6.6;U-937: 4.3"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"				"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: , HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.2	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lung: 259.9;seminal vesicle: 69.1"	"Group enriched"	"Detected in some"	81	"BEWO: 12.3;EFO-21: 46.6;RPTEC TERT1: 33.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 585.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037989	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Golgi apparatus"	"HPA037989: AB_10670536"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	3.2	0.2	0.1	13.0	0.1	0.0	24.7	2.9	6.9	2.1	0.5	13.0	3.4	0.1	0.1	0.1	10.8	0.5	259.9	0.0	0.1	0.0	2.9	4.4	0.0	0.6	2.6	0.8	0.3	0.0	1.6	27.4	69.1	0.1	0.7	2.1	0.0	0.1	0.1	0.4	0.5	0.0	0.4	27.9	0.1	1.9	0.0	0.1	0.4	0.2	1.9	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	46.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.5	0.2	0.3	0.3	0.1	0.2	0.1	0.1	0.0	0.4	0.3	0.2	1.5	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.8	0.0
SLC34A3	"FLJ38680, NPTIIc"	ENSG00000198569	"Solute carrier family 34 member 3"	Q8N130	9	137230757-137236554	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 10.4;kidney: 14.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.9;HDLM-2: 3.6;HeLa: 3.9;MCF7: 9.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023776	Enhanced									"HPA023776: AB_1857102"	"unprognostic (2.69e-1)"	"unprognostic (4.16e-1)"	"unprognostic (9.08e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.20e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	3.6	0.5	0.2	0.2	0.2	0.0	14.8	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0	1.6	0.2	0.2	0.2	0.0	0.2	1.2	0.2	0.2	0.3	10.4	0.2	0.2	0.2	0.4	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.7	2.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	5.9	0.4	0.2	0.0	2.9	0.0	0.0	0.0	3.6	0.2	0.0	3.9	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	9.5	0.1	0.1	0.6	1.1	1.3	0.5	0.0	0.0	0.5	0.0	1.4	0.6	1.4	0.3	3.3	0.1	0.3	0.5	0.4	1.9	0.1	1.1	0.4	0.4	0.8	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SLC35A1	"CMPST, hCST"	ENSG00000164414	"Solute carrier family 35 member A1"	P78382	6	87470623-87512336	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.04e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.26e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavourable (2.70e-6)"	"unprognostic (2.85e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.04e-1)"	11.0	18.0	14.0	9.2	19.8	6.3	20.5	24.1	22.9	19.2	25.3	10.0	8.0	12.0	20.1	15.1	10.0	13.6	12.7	10.6	15.2	13.8	15.7	20.8	24.2	10.3	16.3	11.6	15.8	11.6	13.0	24.4	12.6	21.4	24.9	31.6	13.1	19.4	11.4	9.1	15.9	14.5	18.9	12.2	14.0	18.8	8.1	14.5	18.6	14.2	8.2	11.8	17.4	12.0	9.4	24.6	21.6	28.4	8.7	15.1	17.2	2.0	5.0	9.1	10.7	24.9	22.8	7.4	6.1	5.4	5.1	7.1	4.3	37.9	7.6	7.6	7.5	8.1	10.9	4.9	6.6	10.8	8.1	8.6	6.8	7.6	16.4	11.2	6.0	11.6	12.0	6.0	11.8	12.2	11.0	12.6	7.5	19.0	3.0	16.9	4.9	8.2	9.6	8.9	8.1	15.8	8.8	6.0	6.6	11.3	21.1	9.8	18.7	22.9	11.4	7.4	5.0	8.1	4.9	9.5	13.7	2.8	6.2	20.0	10.5	21.6	28.4	11.6	9.8	22.1	15.1	9.4	10.6	11.9	24.6	8.7	13.6	12.6	7.0	8.7	21.5	9.1	13.6	17.2	14.0	19.8	24.1	22.9	15.2	13.8	16.3	11.6	21.4	14.5
SLC35A2	"UGALT, UGAT, UGT, UGT1, UGT2, UGTL"	ENSG00000102100	"Solute carrier family 35 member A2"	P78381	X	48903180-48911958	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036087	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA036087: AB_10604093"	"prognostic unfavourable (3.16e-4)"	"unprognostic (3.34e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.15e-3)"	"unprognostic (4.25e-3)"	"prognostic unfavourable (9.64e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.16e-2)"	"prognostic favourable (8.23e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	11.4	17.2	10.5	9.7	12.2	10.9	21.9	5.9	18.4	16.2	22.7	20.5	13.4	13.5	11.5	24.2	17.2	23.1	14.3	12.8	10.3	10.9	18.8	43.6	14.5	18.9	12.0	9.7	10.6	30.6	18.8	16.2	29.8	12.7	14.1	23.1	10.3	16.9	14.7	12.9	15.9	13.0	9.0	13.8	12.1	19.8	8.8	10.3	8.8	13.3	12.5	13.0	11.3	11.4	7.5	18.5	24.2	15.7	7.8	10.9	6.9	20.4	23.7	8.0	11.5	17.3	14.1	11.9	21.1	20.6	21.2	25.6	25.5	36.2	7.7	10.0	23.2	29.5	21.7	16.3	17.6	10.1	14.7	8.5	14.9	19.9	20.2	16.1	18.4	15.0	27.5	18.6	17.7	12.4	16.1	12.8	15.6	19.5	7.9	13.3	16.8	28.8	8.5	14.4	23.5	19.2	16.8	9.4	15.2	22.0	23.9	12.0	35.2	12.7	8.9	12.8	13.1	23.0	11.9	19.9	13.5	8.4	15.5	13.3	15.7	11.4	14.4	24.2	10.2	15.7	10.9	7.5	9.2	9.6	17.5	7.3	5.8	10.6	15.9	7.8	10.6	18.5	8.8	6.9	10.5	12.2	5.9	18.4	10.3	10.9	12.0	9.7	12.7	10.3
SLC35A3		ENSG00000117620	"Solute carrier family 35 member A3"	Q9Y2D2	1	99969351-100035637	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015253	Uncertain									"HPA015253: AB_1857106"	"unprognostic (1.05e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.34e-2)"	10.7	9.4	6.5	16.7	6.8	5.9	16.2	7.4	8.9	12.4	31.4	5.5	16.2	29.1	10.5	10.8	14.9	9.5	12.5	7.1	5.4	4.8	13.2	21.9	18.0	10.9	7.0	6.3	7.9	13.8	12.8	8.6	12.2	9.6	14.4	32.7	6.0	22.3	21.9	7.5	10.0	41.0	15.3	7.6	6.3	19.9	5.1	5.6	24.7	15.3	7.9	8.1	13.9	13.0	4.3	9.0	6.4	3.7	7.7	5.2	3.2	17.1	4.7	4.2	4.5	9.6	8.5	17.0	15.3	9.3	6.1	8.8	3.0	9.3	9.2	19.3	8.9	10.0	8.0	6.9	14.0	11.4	5.8	8.3	6.6	7.2	6.1	13.3	1.0	4.5	7.8	7.3	14.3	7.0	13.8	13.8	12.2	4.2	8.7	7.0	5.2	15.6	2.7	13.0	5.8	11.1	10.0	5.5	3.1	10.6	20.6	8.1	12.5	10.2	8.1	9.3	8.3	20.4	8.2	8.2	9.6	6.9	14.8	8.3	3.8	6.4	3.6	2.0	4.2	3.7	4.7	4.3	4.2	4.9	3.1	3.4	5.2	4.4	1.2	7.7	2.9	9.0	4.8	3.2	6.5	6.8	7.4	8.9	5.4	4.8	7.0	6.3	9.6	5.6
SLC35C1	"FLJ11320, FUCT1"	ENSG00000181830	"Solute carrier family 35 member C1"	Q96A29	11	45804072-45813015	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064001	Enhanced		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA064001: "	"unprognostic (2.62e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (9.68e-4)"	"unprognostic (8.22e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.18e-1)"	"prognostic favourable (3.64e-4)"	"unprognostic (2.30e-2)"	14.9	4.8	5.1	7.2	4.5	1.5	14.3	4.4	7.3	7.0	13.8	4.4	4.9	17.4	7.1	3.2	22.5	6.1	8.8	5.3	5.4	3.9	6.0	74.7	7.1	7.1	3.9	3.6	4.9	11.4	4.9	7.8	10.5	5.6	6.0	9.8	3.6	15.5	7.0	8.5	3.4	17.4	6.8	5.0	6.5	13.4	7.4	4.8	5.6	5.2	7.0	10.9	9.4	8.6	4.7	8.3	9.9	10.5	4.3	16.7	8.6	5.3	13.8	3.1	8.0	10.2	10.4	10.6	11.6	10.1	6.8	7.5	6.2	8.7	5.0	5.5	13.2	14.1	6.6	6.8	3.2	13.0	7.9	2.8	11.0	11.2	22.5	5.5	8.8	12.3	8.3	5.2	5.6	8.8	6.4	7.5	7.1	11.5	2.8	4.3	14.0	19.5	3.8	5.3	11.8	7.6	13.3	3.1	4.5	8.6	8.3	4.8	7.4	2.9	13.4	14.2	8.3	24.9	8.3	5.5	12.9	2.5	10.2	7.3	7.7	5.0	10.2	9.9	10.2	10.5	11.1	4.7	16.7	13.4	8.3	3.6	8.5	7.4	1.6	4.3	6.9	7.2	10.8	8.6	5.1	4.5	4.4	7.3	5.4	3.9	3.9	3.6	5.6	4.8
SLC35D1	"KIAA0260, UGTREL7"	ENSG00000116704	"Solute carrier family 35 member D1"	Q9NTN3	1	66999332-67054099	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (6.91e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavourable (7.47e-4)"	"unprognostic (2.63e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (6.55e-4)"	"unprognostic (2.12e-3)"	"unprognostic (6.39e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.20e-1)"	4.0	6.3	5.1	7.5	7.0	4.7	4.7	6.6	5.5	6.2	16.2	7.5	4.8	9.9	5.4	3.8	5.3	4.4	4.4	3.8	4.7	3.8	8.1	50.4	3.8	5.7	7.4	4.0	6.4	7.2	6.4	8.7	6.0	5.4	5.6	17.3	7.1	3.9	4.0	6.9	6.2	14.3	5.4	4.0	4.0	8.0	4.1	5.6	11.1	5.1	4.0	6.4	5.8	6.5	2.3	1.8	9.7	2.4	5.1	4.3	1.4	4.9	2.8	8.8	7.4	9.2	10.7	10.5	11.2	14.8	8.1	5.7	6.1	1.2	15.4	4.9	8.8	7.7	6.1	7.1	10.3	15.3	2.8	11.4	6.0	12.1	7.7	13.0	7.6	10.3	15.9	9.6	6.9	3.1	6.9	8.2	19.7	1.6	8.0	4.0	3.7	3.9	6.2	18.2	1.7	3.7	9.5	1.1	3.9	16.9	5.2	7.1	4.3	9.7	3.4	15.2	3.6	9.3	10.7	17.2	8.9	8.6	10.8	2.0	6.4	9.7	1.5	4.0	3.4	1.1	4.2	2.3	2.6	2.7	1.8	1.7	3.7	3.3	0.3	5.1	2.4	1.0	4.3	1.4	5.1	7.0	6.6	5.5	4.7	3.8	7.4	4.0	5.4	5.6
SLC36A2	"PAT2, TRAMD1, tramdorin"	ENSG00000186335	"Solute carrier family 36 member 2"	Q495M3	5	151314978-151347590	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"kidney: 60.3;skeletal muscle: 36.8;tongue: 16.1"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.0"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 0.5"	"Region enhanced"	"Detected in single"		"midbrain: 1.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA044002, HPA062229"	Enhanced									"HPA044002: AB_10964214, HPA062229: "	"unprognostic (3.47e-1)"	"unprognostic (3.40e-1)"		"unprognostic (2.26e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.38e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.03e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.89e-2)"	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	2.6	0.5	0.1	0.0	0.2	0.1	0.1	60.3	0.1	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	1.1	2.0	0.0	36.8	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.0	0.0	0.1	16.1	1.4	0.1	0.1	2.1	1.5	4.3	0.8	1.5	0.9	0.3	0.1	0.3	0.4	0.7	0.3	0.1	1.0	0.4	0.0	0.1	0.0	0.6	0.3	0.8	0.3	0.2	0.4	0.0	0.7	0.0	1.4	1.5	0.3	0.8	0.3	0.0	1.8	0.5	0.1	0.1	0.0	0.0	0.5	0.1	1.4	0.2	0.3	0.4	2.0	1.1	0.2	0.5	0.3	0.2	0.2	0.1	0.4	0.4	0.1	1.2	0.0	0.3	0.3	0.5	0.2	0.2	1.2	0.2	0.5	0.2	0.4	0.3	0.3	0.1	3.2	0.8	0.9	0.7	0.6	0.6	1.1	0.6	0.6	0.2	2.1	0.7	0.9	4.3	1.5	0.6	1.5	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.4	0.0
SLC38A8		ENSG00000166558	"Solute carrier family 38 member 8"	A6NNN8	16	84009667-84042636	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 6.1;liver: 4.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.4;HMC-1: 2.1;SCLC-21H: 8.5;SK-MEL-30: 1.3"	"Cancer enriched"	"Detected in single"	14	"melanoma: 6.5"	"Group enriched"	"Detected in some"	5	"amygdala: 6.1;cerebral cortex: 2.6;hypothalamus: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"														"unprognostic (9.69e-2)"	"unprognostic (6.16e-2)"		"unprognostic (8.00e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.16e-2)"		"unprognostic (3.54e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-1)"			0.2	0.1	6.1	0.2	0.6	0.0	0.2	0.2	2.9	0.2	0.2	0.2	0.2	0.3	0.2	2.2	0.2	0.0	0.2	1.4	0.6	2.5	0.2	4.5	0.2	0.2	0.7	0.2	0.2	1.3	0.5	1.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	2.3	2.4	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.6	0.2	2.6	0.6	2.5	0.7	0.2	0.2	0.2
SLC39A13	FLJ25785	ENSG00000165915	"Solute carrier family 39 member 13"	Q96H72	11	47407132-47416501	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043971	Approved									"HPA043971: AB_10959744"	"unprognostic (7.84e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (2.60e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.56e-3)"	"unprognostic (3.81e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.40e-2)"	"prognostic unfavourable (2.73e-5)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-2)"	"prognostic favourable (1.96e-4)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.12e-1)"	17.0	19.2	14.1	19.7	17.0	6.3	15.1	25.6	21.8	17.8	18.6	18.8	12.4	12.1	32.1	20.2	17.1	18.5	19.0	35.5	16.1	10.3	39.9	17.6	23.2	14.8	18.5	15.0	21.3	20.7	19.0	21.0	34.5	15.5	20.5	6.3	23.8	20.0	24.9	19.8	27.1	12.0	22.8	10.6	15.3	16.1	25.9	16.4	9.8	18.7	9.3	10.4	19.5	15.7	5.8	5.0	6.5	14.4	6.7	13.2	5.2	7.4	6.5	7.7	8.6	18.9	26.5	2.2	29.6	22.0	16.6	18.9	2.5	5.1	2.9	8.1	22.2	12.5	2.3	19.9	4.6	8.3	8.7	1.5	15.6	5.2	28.4	2.5	3.7	22.0	14.3	10.5	8.6	17.7	1.4	6.4	17.8	6.5	5.4	3.6	3.6	9.8	6.6	11.3	2.9	28.1	3.5	6.8	12.4	8.9	15.9	8.3	10.6	3.7	24.7	25.4	11.7	28.9	13.5	5.0	1.6	1.2	28.1	3.5	18.4	2.0	3.6	3.0	13.2	13.7	8.8	4.5	8.7	9.3	4.6	5.8	8.3	6.8	6.5	6.7	14.4	5.0	4.5	5.2	14.1	17.0	25.6	21.8	16.1	10.3	18.5	15.0	15.5	16.4
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 77.8;liver: 38.2;pancreas: 101.1"	"Group enriched"	"Detected in some"	60	"CACO-2: 22.2;Hep G2: 32.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.9"	"Low region specificity"	"Detected in many"			HPA018423			Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favourable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.2	0.1	0.2	4.1	0.2	0.0	0.2	0.2	0.2	0.2	40.5	0.2	0.2	48.6	0.2	2.3	0.2	0.1	5.9	0.2	0.2	0.1	22.5	38.2	0.2	0.2	0.2	0.2	0.2	101.1	0.0	0.2	0.2	0.2	0.2	9.1	0.2	0.2	0.2	0.2	0.1	77.8	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	22.2	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	32.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
SLC39A8	BIGM103	ENSG00000138821	"Solute carrier family 39 member 8"	Q9C0K1	4	102251041-102431258	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 67.3;salivary gland: 54.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.6;HL-60: 32.5;Karpas-707: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038832, HPA038833"	Approved									"HPA038832: , HPA038833: AB_10670910"	"prognostic favourable (6.69e-4)"	"unprognostic (1.29e-2)"	"prognostic favourable (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.78e-2)"	"prognostic favourable (6.34e-6)"	"unprognostic (3.25e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.13e-3)"	22.0	2.0	3.7	11.4	5.5	10.3	6.1	2.8	4.3	31.4	18.1	2.2	1.1	2.1	3.9	7.3	1.7	7.2	2.6	17.8	4.3	3.5	6.2	18.4	67.3	8.6	5.1	1.6	5.4	42.1	25.7	6.7	44.8	5.9	5.7	14.9	4.3	54.6	2.3	1.8	5.1	3.4	3.0	8.8	6.5	2.5	2.3	3.2	7.5	4.9	2.3	5.6	5.8	6.0	3.1	2.7	1.0	1.5	11.5	10.5	3.4	5.4	5.4	1.2	0.0	4.5	10.4	2.8	0.6	44.6	1.6	2.7	0.2	20.2	5.3	5.9	0.1	0.3	3.8	1.2	0.9	9.1	11.0	13.8	11.4	0.1	1.8	32.5	4.7	5.5	1.4	0.8	2.6	0.6	13.8	48.4	8.6	3.6	11.7	15.2	3.6	5.3	3.0	0.0	17.3	9.4	2.0	1.6	4.0	15.2	0.2	1.4	3.7	12.1	3.1	5.4	2.0	11.0	8.6	21.7	9.0	25.1	8.9	21.2	4.9	0.0	1.5	1.0	5.6	1.0	9.8	1.3	10.5	9.0	2.7	3.1	7.9	5.4	0.1	11.5	0.3	1.0	3.9	3.4	3.7	5.5	2.8	4.3	4.3	3.5	5.1	1.6	5.9	3.2
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 66.0;kidney: 191.5;pancreas: 36.8"	"Cell line enriched"	"Detected in some"	17	"RPTEC TERT1: 48.7"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"				Mitochondria	"Nuclear bodies"	"HPA038360: , HPA071102: "	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favourable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.2	0.1	0.2	0.7	0.2	0.0	0.2	0.7	0.2	0.3	28.4	0.1	0.1	18.8	1.3	4.6	0.2	0.2	17.9	0.1	0.2	0.2	191.5	5.3	0.2	0.1	0.2	0.1	0.2	36.8	0.0	0.2	0.5	0.1	0.3	3.7	0.2	0.1	0.1	0.2	0.2	66.0	0.1	0.2	0.2	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	4.0	1.3	2.0	1.3	1.6	2.7	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.8	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.2	48.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.1	1.3	1.3	1.0	2.6	1.3	1.9	1.9	2.5	1.4	0.4	4.0	2.5	2.7	2.0	1.6	0.6	1.3	0.9	0.3	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.1	0.1	0.1
SLC40A1	"FPN1, HFE4, IREG1, MTP1, SLC11A3"	ENSG00000138449	"Solute carrier family 40 member 1"	Q9NP59	2	189560579-189583758	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 126.4;lymphoid tissue: 170.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 91.2;CACO-2: 20.8;HEL: 73.9;HMC-1: 19.5;T-47d: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 64.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065634	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA065634: "	"unprognostic (1.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.44e-2)"	"prognostic favourable (8.55e-5)"	"unprognostic (4.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.11e-2)"	18.2	126.4	3.9	10.1	5.5	3.9	47.4	1.8	3.5	20.0	25.7	3.7	13.9	34.4	24.7	24.3	6.3	25.9	25.2	37.1	4.1	4.3	14.4	42.1	45.9	170.2	5.1	1.9	50.9	24.0	4.6	9.8	51.3	6.4	18.4	15.8	11.6	10.2	16.6	12.3	4.9	44.7	13.6	5.8	76.4	11.3	16.2	3.5	17.0	20.8	6.4	8.8	11.1	20.4	0.1	22.7	64.7	20.8	0.8	17.3	20.1	0.0	1.2	0.1	0.0	91.2	0.6	4.4	0.0	1.1	0.3	0.5	20.8	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.3	73.9	0.3	7.6	0.3	0.2	19.5	6.4	0.0	0.2	0.0	2.2	7.5	0.2	1.1	0.0	3.0	4.8	0.2	0.3	0.0	0.8	0.4	0.9	3.0	0.1	0.9	0.1	6.1	0.0	36.0	1.0	0.0	0.1	2.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.3	20.8	32.9	0.4	4.7	0.6	0.0	11.3	1.0	22.7	0.1	17.3	3.7	64.7	0.8	0.4	3.7	1.0	20.1	3.9	5.5	1.8	3.5	4.1	4.3	5.1	1.9	6.4	3.5
SLC44A4	"C6orf29, CTL4, DFNA72, FLJ14491, NG22, TPPT"	ENSG00000204385	"Solute carrier family 44 member 4"	Q53GD3	6	31863192-31879046	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 34.6;intestine: 65.7"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 4.5;Hep G2: 4.2;RT4: 3.4;SK-BR-3: 1.9;TIME: 3.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 222.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA046977, HPA054176"	Enhanced									"HPA046977: , HPA054176: "	"unprognostic (5.84e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.75e-2)"	"prognostic favourable (3.54e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"prognostic favourable (1.06e-6)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.54e-2)"	"prognostic favourable (6.06e-4)"	0.3	2.4	0.2	11.2	0.3	0.2	2.1	0.2	0.3	5.9	43.6	0.3	7.6	23.7	2.9	3.0	0.6	10.9	34.6	0.2	0.2	0.0	20.4	0.3	9.1	0.6	0.2	0.2	4.9	7.3	0.0	5.0	5.1	0.5	25.7	8.6	0.3	12.0	4.4	0.2	0.1	65.7	1.2	0.2	0.6	23.7	0.8	0.2	0.4	0.5	0.7	4.2	6.3	1.9	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.3	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.0	0.8	0.0	3.4	0.0	0.3	0.0	1.9	0.0	0.7	0.5	3.4	0.0	0.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.0	0.2	0.2	0.5	0.2
SLC45A1	DNB5	ENSG00000162426	"Solute carrier family 45 member 1"	Q9Y2W3	1	8317826-8344167	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Symport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 5.8;HHSteC: 7.8;U-87 MG: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Group enriched"	"Detected in many"	7	"monocytes: 7.1;T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078818	Enhanced									"HPA078818: "	"unprognostic (1.77e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.32e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.18e-1)"	"unprognostic (5.67e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-3)"	5.0	6.6	8.5	2.4	15.3	1.1	2.6	13.8	24.0	6.0	4.4	5.4	2.1	2.5	6.8	3.6	3.9	5.2	4.3	3.1	6.0	7.9	4.3	1.1	2.0	2.1	6.1	12.4	4.4	4.1	4.1	8.1	1.9	13.1	4.9	2.2	3.2	1.5	7.7	4.0	1.7	2.8	4.3	4.6	4.4	2.6	3.8	4.6	0.0	2.4	0.8	1.5	3.6	3.3	0.6	0.2	0.0	7.1	0.0	1.8	0.7	0.0	2.6	0.5	1.1	5.8	3.8	0.1	0.2	1.2	0.4	0.8	0.0	0.4	0.0	0.2	0.8	0.0	0.1	0.3	0.1	2.2	0.0	0.0	0.2	0.0	7.8	0.0	2.1	2.0	0.2	0.9	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	1.2	1.7	0.0	1.1	0.0	0.0	0.0	2.0	2.8	0.0	0.0	0.0	0.2	0.0	2.5	0.1	0.5	2.3	0.4	0.0	0.0	0.0	10.0	0.0	0.1	0.0	0.2	0.0	1.3	1.3	1.8	0.6	0.9	0.9	0.2	0.1	0.6	0.6	0.0	0.0	7.1	0.0	0.6	0.7	8.5	15.3	13.8	24.0	6.0	7.9	6.1	12.4	13.1	4.6
SLC45A2	"AIM-1, MATP, OCA4"	ENSG00000164175	"Solute carrier family 45 member 2"	Q9UMX9	5	33944616-33984730	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Melanin biosynthesis, Sensory transduction, Vision"		"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 39.9"	"Cell line enriched"	"Detected in single"	40	"SK-MEL-30: 36.7"	"Cancer enriched"	"Detected in some"	18	"melanoma: 47.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (2.97e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (7.39e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.39e-1)"	0.2	0.0	0.3	0.2	0.4	0.0	0.2	0.7	0.4	0.2	1.1	0.2	0.2	0.0	0.5	0.2	0.2	0.4	0.3	1.5	0.4	0.6	0.8	3.1	0.2	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.8	1.2	39.9	0.2	0.2	0.4	4.5	0.2	0.3	0.4	0.2	0.6	2.8	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	36.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.4	0.4	0.6	0.3	0.2	0.2	0.2
SLC46A1	"HCP1, MGC9564, PCFT"	ENSG00000076351	"Solute carrier family 46 member 1"	Q96NT5	17	28394756-28407197	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.7"	"Cell line enriched"	"Detected in many"	5	"CACO-2: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011614	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB011614: AB_2270597"	"unprognostic (1.10e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavourable (5.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-1)"	3.1	17.8	4.6	2.5	7.0	1.3	5.1	13.2	5.2	2.9	43.8	5.2	9.4	45.4	2.2	4.5	1.8	6.7	3.0	2.2	4.4	6.0	3.8	17.9	3.2	4.9	4.0	4.0	4.4	5.0	8.1	7.8	5.0	5.0	3.7	2.7	6.1	5.7	5.8	2.0	2.0	52.7	2.6	4.6	4.9	2.3	2.2	4.2	2.2	4.0	0.4	1.2	2.4	2.4	2.7	2.6	7.1	5.9	2.9	1.7	0.8	1.7	7.3	2.4	4.0	2.0	0.4	7.6	2.0	1.5	1.7	1.9	66.1	2.1	0.2	1.2	1.1	5.6	2.7	4.6	1.4	4.2	6.4	0.0	4.5	5.6	0.7	0.0	3.3	0.9	8.5	1.8	5.3	0.1	2.8	0.4	0.3	2.3	0.0	0.2	1.4	0.9	0.1	2.0	0.8	1.3	3.8	6.5	3.4	14.2	6.6	0.9	5.1	1.1	0.2	0.2	2.9	0.4	2.1	3.0	3.4	0.1	0.4	0.4	1.5	7.1	1.6	1.1	0.8	5.9	1.4	2.7	0.9	0.7	2.6	1.7	1.0	1.7	2.3	2.9	4.3	1.1	1.6	0.8	4.6	7.0	13.2	5.2	4.4	6.0	4.0	4.0	5.0	4.2
SLC4A1	"AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR"	ENSG00000004939	"Solute carrier family 4 member 1 (Diego blood group)"	P02730	17	44248385-44268141	"Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"	"Blood group antigen"	"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 95.7;placenta: 32.7"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	91	"renal cancer: 16.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebellum: 0.4"	"Low region specificity"	"Detected in all"			"HPA015584, CAB034438, HPA063911"	Enhanced					160000000	160000000			"CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: "	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.13e-1)"	0.9	0.1	0.3	0.2	0.4	95.7	0.2	0.8	0.2	0.1	0.1	0.6	0.0	0.2	0.1	0.4	0.6	0.2	0.2	2.6	0.2	0.3	18.6	1.3	12.9	0.8	0.6	0.1	2.8	0.1	0.0	0.6	32.7	0.9	0.6	0.1	1.2	0.1	0.1	1.2	0.2	0.1	0.0	1.0	8.4	0.1	0.3	0.0	0.7	1.9	0.0	0.2	3.9	11.8	1.8	1.4	6.3	1.2	2.9	1.5	0.7	1.3	0.4	1.4	1.7	0.6	0.7	1.0	0.2	0.4	0.3	0.8	1.3	3.2	0.7	0.6	0.3	1.4	0.5	0.5	1.0	1.3	1.3	1.6	1.5	2.2	0.0	0.8	2.3	0.8	0.5	0.8	0.8	0.2	4.7	3.4	0.4	0.6	0.9	3.5	0.9	0.5	2.5	0.7	1.8	0.3	0.8	2.2	1.0	1.3	1.4	0.5	2.5	1.8	1.0	2.3	2.0	1.4	1.4	1.0	2.3	1.1	1.6	2.1	1.1	6.1	1.0	2.0	1.1	0.9	1.0	1.1	1.0	0.9	0.5	1.8	1.5	1.2	6.3	2.9	1.2	1.4	0.7	0.7	0.3	0.4	0.8	0.2	0.2	0.3	0.6	0.1	0.9	0.0
SLC4A11	"BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1"	ENSG00000088836	"Solute carrier family 4 member 11"	Q8NBS3	20	3227417-3239559	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Symport, Transport"		"Corneal dystrophy, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 34.4;thyroid gland: 42.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 35.2;Hep G2: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 1.4;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA018120, HPA058377"	Uncertain		Uncertain	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA018120: AB_1857186, HPA058377: "	"unprognostic (2.33e-1)"	"prognostic favourable (9.03e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.66e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.64e-1)"	"prognostic favourable (6.21e-6)"	"unprognostic (7.37e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-3)"	0.8	3.1	3.3	0.8	4.9	0.3	2.4	2.1	2.8	8.6	0.2	1.3	0.8	0.1	0.9	2.0	7.5	1.1	2.2	0.5	3.0	0.6	11.4	0.1	1.3	0.9	1.4	1.1	0.6	0.1	0.4	2.4	0.3	1.8	2.2	0.3	1.1	34.4	5.8	3.5	5.3	0.3	0.2	1.4	0.3	1.9	3.2	1.2	0.2	42.7	3.3	5.1	2.6	2.1	0.0	0.7	0.0	1.4	0.0	1.1	0.4	5.3	7.6	0.9	4.0	2.6	0.7	10.9	2.7	1.7	1.4	0.8	0.5	7.0	0.0	3.1	0.9	35.2	4.2	8.3	0.2	0.0	1.7	0.3	3.3	20.6	1.6	1.9	6.9	0.3	3.4	1.7	1.6	3.5	0.7	4.9	1.4	3.4	0.2	0.2	6.1	10.3	1.2	5.2	1.7	8.5	15.0	0.4	2.5	1.4	8.8	0.2	3.4	3.3	5.9	1.0	3.6	0.2	1.3	0.2	0.3	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7	0.0	0.3	0.0	0.0	0.0	1.4	0.0	1.1	0.4	3.3	4.9	2.1	2.8	3.0	0.6	1.4	1.1	1.8	1.2
SLC4A4	"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5"	ENSG00000080493	"Solute carrier family 4 member 4"	Q9Y6R1	4	71186757-71572087	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 47.4;pancreas: 113.8"	"Cell line enhanced"	"Detected in some"		"BJ: 13.7;fHDF/TERT166: 6.2;HBF TERT88: 5.7;RPTEC TERT1: 14.7;U-138 MG: 7.8;U-2197: 5.6"	"Group enriched"	"Detected in many"	5	"glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.8;memory CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022493, HPA035628, HPA035629"	Enhanced									"CAB022493: , HPA035628: , HPA035629: "	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"prognostic favourable (7.69e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (1.18e-4)"	"unprognostic (7.00e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.04e-1)"	2.4	0.9	14.3	4.3	19.9	0.7	1.1	18.1	15.2	5.8	17.2	4.5	0.1	22.4	0.8	0.7	1.1	1.0	24.9	2.9	13.1	8.1	47.4	9.4	5.8	0.6	9.7	11.2	1.0	113.8	10.0	4.1	1.6	18.1	14.6	17.1	11.1	1.5	1.1	1.3	0.7	10.4	1.3	21.6	0.9	8.3	0.7	8.0	0.0	9.5	0.0	0.6	2.6	0.9	0.0	0.1	0.0	0.0	0.5	2.8	0.3	0.0	3.5	1.0	0.0	0.0	0.0	0.1	13.7	1.8	2.3	1.8	0.0	0.1	0.0	0.1	6.2	0.0	0.2	0.0	5.7	0.0	1.7	0.9	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	4.6	0.2	0.1	0.0	0.0	0.0	0.9	14.7	4.1	1.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	7.8	0.7	5.6	0.6	0.0	0.0	0.0	5.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	1.4	0.0	0.8	2.4	0.1	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.3	14.3	19.9	18.1	12.4	13.1	8.1	9.7	11.2	18.1	8.0
SLC52A3	"bA371L19.1, C20orf54, hRFT2, RFVT3"	ENSG00000101276	"Solute carrier family 52 member 3"	Q9NQ40	20	760080-776015	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 27.0;RT4: 6.3;SK-BR-3: 9.9;T-47d: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049391, HPA059078"	Approved									"HPA049391: , HPA059078: "	"unprognostic (4.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.36e-2)"	"unprognostic (4.39e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.04e-3)"	"prognostic favourable (5.51e-6)"	"unprognostic (3.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	2.0	0.4	7.3	1.4	5.9	0.5	2.8	3.5	9.0	2.6	9.6	2.1	12.0	13.1	1.8	1.9	4.6	2.0	3.0	3.3	6.6	4.2	10.0	0.4	1.4	0.7	5.6	1.3	1.2	2.2	0.6	0.5	6.7	7.3	7.9	6.3	0.5	5.5	15.8	1.0	1.7	16.3	1.5	4.7	0.4	5.2	32.5	6.0	0.0	0.7	1.2	0.9	4.7	2.2	1.1	0.7	2.4	0.6	1.1	0.8	0.4	3.4	1.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.4	27.0	0.0	4.0	0.0	3.9	0.0	2.9	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	2.4	0.0	0.0	0.3	0.0	6.3	0.0	0.1	3.9	9.9	0.0	12.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.5	0.4	0.2	0.4	0.5	0.4	0.4	0.1	1.1	0.4	0.8	2.2	1.1	0.4	0.7	0.3	0.4	7.3	5.9	3.5	9.0	6.6	4.2	5.6	1.3	7.3	6.0
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043032-32113029	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 274.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.3;NB-4: 2.4;RPMI-8226: 4.8;SCLC-21H: 1.8;SH-SY5Y: 2.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	26	"cerebellum: 8.6"	"Low region specificity"	"Detected in all"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"CAB015467: , HPA051805: , HPA055106: "	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favourable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favourable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.2	0.0	0.2	1.3	0.2	0.0	1.5	0.2	0.2	2.2	181.5	0.2	2.9	95.5	0.3	0.8	1.9	0.0	14.1	24.5	0.2	0.0	1.0	0.9	0.3	0.2	0.2	0.2	0.2	0.4	0.0	1.0	0.2	0.2	0.8	1.6	0.2	5.7	3.5	0.2	4.6	274.9	0.2	0.2	0.7	1.2	0.8	0.2	0.2	0.2	3.5	1.5	0.2	2.0	0.3	0.1	0.6	0.8	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.6	0.0	0.0	0.0	0.0	6.3	1.3	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.0	2.4	0.1	0.0	0.0	0.0	4.8	0.0	0.1	1.8	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.6	0.3	0.8	0.1	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SLC5A5	NIS	ENSG00000105641	"Solute carrier family 5 member 5"	Q92911	19	17871973-17895174	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 31.5;salivary gland: 66.8;stomach 1: 32.7"	"Cell line enriched"	"Detected in some"	4	"BEWO: 15.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	12	"pons and medulla: 31.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB022364, HPA049055"	Enhanced									"CAB022364: , HPA049055: "	"unprognostic (2.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.51e-8)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-1)"	0.0	0.0	0.1	0.1	0.4	0.1	0.1	2.4	2.3	5.1	0.1	9.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.0	1.7	0.1	0.1	0.0	0.2	0.2	0.3	2.7	0.0	0.1	0.0	0.2	0.0	31.5	0.1	0.0	5.5	66.8	0.0	0.2	0.2	0.3	0.0	1.9	0.2	32.7	0.4	0.1	0.0	7.1	0.0	0.1	0.0	0.1	1.3	0.8	2.5	1.4	1.0	4.3	0.9	0.0	0.0	0.1	0.1	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.5	0.0	1.1	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	3.6	0.0	2.5	0.6	0.4	1.1	1.4	1.3	1.0	3.2	0.6	0.8	1.3	4.3	3.2	2.2	1.0	0.4	0.4	2.0	0.9	0.1	0.4	2.4	2.3	1.7	0.1	0.3	2.7	31.5	0.1
SLC5A7	"CHT1, hCHT"	ENSG00000115665	"Solute carrier family 5 member 7"	Q9GZV3	2	107986523-108013994	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport"		"Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"brain: 45.1"	"Group enriched"	"Detected in some"	22	"RT4: 8.7;SCLC-21H: 2.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Group enriched"	"Detected in some"	13	"basal ganglia: 13.8;pons and medulla: 45.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1"	"Group enriched"	"Detected in some"	15	"basal ganglia: 20.7;hippocampal formation: 7.2;pons and medulla: 26.3"	HPA046105			Approved	"Nuclear bodies,Cell Junctions,Intermediate filaments"				"Cell Junctions, Intermediate filaments"	"Nuclear bodies"	"HPA046105: "	"unprognostic (2.98e-1)"		"unprognostic (1.01e-1)"					"unprognostic (1.29e-3)"			"unprognostic (7.10e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.05e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.61e-2)"	0.3	2.4	0.1	1.6	13.8	0.0	0.3	0.1	0.4	3.3	5.2	0.1	0.3	2.3	1.6	0.7	1.0	0.2	0.5	1.2	0.2	2.2	0.9	0.2	0.9	0.0	0.3	0.5	0.8	0.5	0.0	0.1	0.0	45.1	0.8	2.5	1.0	0.9	4.2	0.1	0.1	2.5	3.1	10.0	0.1	1.7	0.3	0.8	0.0	4.0	0.3	0.1	4.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.8	0.1	0.4	0.2	2.2	0.3	0.5	45.1	0.8
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436622-116461458	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5"	"Group enriched"	"Detected in some"	4	"HeLa: 3.8;Hep G2: 8.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003193	Uncertain		Approved	Vesicles				Vesicles		"HPA003193: AB_2190122"	"unprognostic (3.06e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavourable (9.74e-4)"	"unprognostic (1.34e-2)"		"unprognostic (3.89e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	5.9	0.0	0.0	6.3	0.8	0.0	11.8	0.4	0.1	0.0	1.8	0.0	1.0	0.0	0.0		0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.2	0.5	0.3	0.0	26.3	5.8	0.0	1.1	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	23.5	1.2	1.0	1.0	0.4	0.2	1.1	0.4	0.3	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	3.8	8.2	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.2	0.0	1.4	0.5	0.0	0.0	0.1	0.0	1.1	0.4	0.5	0.4	0.1	0.3	0.4	0.2	0.2	0.1	0.4	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.0										
SLC6A17		ENSG00000197106	"Solute carrier family 6 member 17"	Q9H1V8	1	110150486-110202202	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 53.5"	"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 27.6"	"Cancer enriched"	"Detected in some"	9	"melanoma: 17.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007663, HPA008044"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA007663: AB_1857194, HPA008044: AB_1857192"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-3)"	"unprognostic (5.52e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.68e-3)"	1.4	7.8	9.3	1.2	18.3	1.1	1.3	21.8	53.5	1.0	1.1	2.3	0.0	1.0	1.0	2.1	1.3	1.0	1.1	1.0	11.2	14.9	2.1	0.9	1.0	0.9	6.0	16.2	1.0	2.6	1.0	12.4	1.8	19.5	1.0	1.0	2.6	1.2	1.0	1.0	7.6	1.1	1.1	1.8	1.0	1.8	2.4	0.7	0.0	1.3	0.0	0.9	1.0	0.1	0.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	4.2	0.4	1.6	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.6	4.7	1.4	27.6	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	5.6	0.0	2.5	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	9.3	18.3	21.8	37.3	11.2	14.9	6.0	16.2	19.5	0.7
SLC6A18	"FLJ31236, Xtrp2"	ENSG00000164363	"Solute carrier family 6 member 18"	Q96N87	5	1225355-1246189	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	32	"kidney: 14.1"	"Cell line enhanced"	"Detected in single"		"MCF7: 1.2"	"Cancer enriched"	"Detected in single"	44	"renal cancer: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011885	Enhanced									"HPA011885: AB_1857198"			"unprognostic (2.02e-1)"										"unprognostic (5.69e-3)"	"unprognostic (2.90e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.4	0.6	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC6A19		ENSG00000174358	"Solute carrier family 6 member 19"	Q695T7	5	1201595-1225117	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 167.3"	"Group enriched"	"Detected in some"	6	"BEWO: 14.2;HEL: 17.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.9;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037415, HPA043207"	Enhanced									"HPA037415: AB_10672346, HPA043207: AB_2678363"			"unprognostic (1.26e-1)"				"unprognostic (1.01e-3)"				"unprognostic (6.04e-2)"	"unprognostic (3.64e-1)"	"prognostic favourable (4.14e-6)"	"unprognostic (1.37e-1)"	"unprognostic (7.36e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	55.3	0.0	0.0	44.6	0.1	0.0	0.1	0.1	30.0	0.1	0.1	0.1	28.7	0.5	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.5	1.7	0.0	0.1	0.0	0.1	0.1	167.3	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SLC6A20	"XT3, Xtrp3"	ENSG00000163817	"Solute carrier family 6 member 20"	Q9NP91	3	45755450-45796535	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 14.3;intestine: 25.5;retina: 51.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 5.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029873	Uncertain									"HPA029873: AB_10602403"	"unprognostic (1.57e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.26e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.55e-5)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.09e-2)"	0.3	0.1	0.3	0.6	0.8	0.5	0.7	1.5	2.2	2.4	11.2	3.0	0.4	22.3	1.3	1.7	0.1	0.4	14.3	0.1	0.5	0.4	3.3	0.2	1.9	0.2	1.0	1.7	0.1	5.1	0.0	2.0	0.1	6.1	1.0	0.2	51.3	1.3	0.1	0.9	0.6	25.5	0.3	1.5	0.1	4.7	0.4	0.3	0.0	0.1	0.4	0.1	0.2	0.3	0.8	0.7	2.6	0.2	0.5	0.4	0.1	0.4	0.7	0.7	0.7	0.2	0.1	0.8	0.3	0.0	0.1	0.1	2.7	2.4	0.4	1.9	0.0	5.2	0.2	0.0	0.3	0.2	0.3	2.2	2.0	0.4	0.0	0.1	0.4	0.1	1.1	0.0	0.1	0.0	0.3	0.8	0.0	0.6	0.8	0.5	2.4	0.5	0.8	0.2	0.6	0.4	0.6	0.6	0.8	2.6	0.4	0.1	0.5	0.3	0.1	0.9	0.7	0.7	0.5	1.4	0.5	0.2	0.4	0.5	0.2	1.0	0.2	0.2	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.8	0.4	0.3	2.6	0.5	0.1	0.7	0.1	0.1	0.3	0.8	1.5	2.2	0.5	0.4	1.0	1.7	6.1	0.3
SLC6A5	"GLYT2, NET1"	ENSG00000165970	"Solute carrier family 6 member 5"	Q9Y345	11	20599400-20659285	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 21.3"	"Cell line enriched"	"Detected in single"	5	"SCLC-21H: 2.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"pons and medulla: 21.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	9	"pons and medulla: 51.6"	"Region enriched"	"Detected in some"	9	"pons and medulla: 33.2"	CAB079052		Supported								"CAB079052: "					"unprognostic (6.94e-2)"	"unprognostic (2.28e-1)"									"unprognostic (4.75e-2)"			0.0	0.1	0.1	0.1	0.0	0.0	0.0	3.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	5.1	0.1	0.1	0.0	0.0	0.0	0.0	2.2	0.0	21.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	6.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.4	0.3	0.1	0.1	0.0	21.3	0.0
SLC6A9	GLYT1	ENSG00000196517	"Solute carrier family 6 member 9"	P48067	1	43991500-44031467	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.2;skin 1: 38.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.5;hTCEpi: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013977	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA013977: AB_1849835"	"unprognostic (2.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (9.50e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (5.93e-4)"	"unprognostic (5.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.20e-2)"	2.9	22.8	8.8	4.6	18.3	8.6	5.4	5.5	14.3	6.0	7.9	38.1	2.6	2.5	6.2	1.5	16.5	9.6	4.9	1.3	9.9	10.0	2.0	4.9	5.6	1.4	29.5	4.5	4.0	7.8	2.1	1.0	1.7	26.8	2.6	6.2	24.0	7.9	6.1	1.3	38.2	5.6	8.9	42.2	1.1	3.5	1.2	26.3	0.0	4.9	7.2	4.3	6.6	10.9	0.2	0.0	0.2	0.1	0.0	1.4	0.2	7.2	5.4	2.7	6.9	4.3	1.4	6.1	5.8	15.6	9.4	11.7	1.8	2.8	0.1	0.6	15.9	23.5	4.1	4.6	1.9	0.0	0.7	6.4	12.8	2.1	19.8	1.4	0.3	4.4	41.1	4.6	11.0	0.2	4.9	18.5	0.4	4.0	1.0	0.0	2.0	7.2	0.8	0.0	8.2	0.9	0.8	1.7	1.6	2.9	13.4	2.6	3.5	3.8	0.1	1.0	4.4	0.9	3.0	20.4	14.0	1.6	3.5	0.0	1.4	0.0	0.0	0.2	0.4	0.1	0.2	0.2	0.4	0.0	0.0	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	0.2	8.8	18.3	5.5	9.4	9.9	10.0	29.5	4.5	26.8	26.3
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459584-170586074	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.4;pituitary gland: 14.5"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 7.0;SCLC-21H: 7.0"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: "	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	1.1	5.8	12.1	1.9	17.7	1.4	1.1	14.9	33.4	1.0	1.8	8.0	0.0	1.6	1.1	1.2	1.1	1.1	1.3	1.1	11.5	12.1	1.3	1.2	1.1	1.1	6.7	12.8	1.3	2.4	1.1	14.5	1.1	11.8	1.2	1.9	0.1	1.1	1.1	1.2	1.3	1.7	1.3	9.0	1.1	1.5	1.3	6.3	0.0	1.1	0.0	1.1	1.1	0.3	1.0	0.6	2.1	0.5	0.7	0.6	0.1	0.0	0.0	0.4	0.1	1.2	2.0	0.1	0.6	0.2	0.8	0.8	0.1	0.1	0.1	0.0	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	1.8	0.0	0.1	1.2	0.2	0.0	0.2	7.0	0.0	0.0	0.2	0.9	0.1	0.1	0.0	0.1	0.0	0.1	7.0	2.0	0.0	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	2.1	0.5	0.5	0.4	0.3	0.3	0.8	0.3	0.3	0.1	1.0	0.6	0.5	1.2	0.7	0.3	0.6	0.3	0.1	12.1	17.7	14.9	16.9	11.5	12.1	6.7	12.8	11.8	6.3
SLC7A9	CSNU3	ENSG00000021488	"Solute carrier family 7 member 9"	P82251	19	32830509-32869766	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 63.3;kidney: 26.4"	"Group enriched"	"Detected in some"	17	"BEWO: 4.8;CACO-2: 11.1;Hep G2: 10.7"	"Group enriched"	"Detected in some"	7	"liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042591	Enhanced									"HPA042591: AB_10962500"	"unprognostic (4.12e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.69e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (5.10e-5)"	0.1	0.0	0.1	0.3	0.2	0.0	0.1	0.3	0.2	0.2	20.1	0.1	0.1	30.5	0.1	1.1	0.1	0.2	0.1	0.1	0.1	0.1	26.4	11.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	63.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	4.8	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1
SLC9A1	"APNH, NHE1, PPP1R143"	ENSG00000090020	"Solute carrier family 9 member A1"	P19634	1	27098815-27166981	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"Deafness, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 60.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022371, HPA048532, HPA052891"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981"	"unprognostic (6.18e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavourable (7.47e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavourable (7.10e-4)"	"unprognostic (3.44e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-2)"	7.1	11.3	7.5	9.9	10.1	7.3	8.4	11.7	18.9	8.7	14.0	5.0	26.9	20.7	10.6	6.8	10.3	7.1	24.4	13.4	4.6	5.3	7.3	2.4	11.2	5.8	5.0	6.7	6.9	6.4	13.4	8.0	42.5	14.8	8.5	10.2	10.1	60.7	55.4	3.8	9.2	24.7	8.1	3.9	10.5	45.6	8.3	4.9	6.0	8.0	6.5	9.0	18.8	8.4	0.9	0.6	5.5	1.5	0.4	4.2	1.8	13.5	4.7	4.4	4.5	10.1	7.3	27.3	11.1	17.1	9.8	10.7	5.6	8.8	6.1	9.6	14.6	17.0	4.3	27.7	6.1	7.3	4.0	9.3	3.0	2.4	30.7	5.5	7.1	9.1	13.4	16.5	23.0	16.2	2.6	6.0	14.4	8.1	2.8	2.9	6.2	9.7	5.0	3.9	2.8	5.1	20.5	5.1	1.6	9.4	12.8	5.6	5.9	3.4	17.4	10.4	4.2	9.7	6.1	5.4	3.4	1.8	11.2	6.1	6.0	0.1	1.5	1.5	1.9	0.9	4.2	0.2	2.2	2.0	0.6	0.9	1.4	1.7	5.5	0.4	1.5	0.1	0.8	1.8	7.5	10.1	11.7	18.9	4.6	5.3	5.0	6.7	14.8	4.9
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470458-524332	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 65.8;intestine: 85.1;kidney: 43.6"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 27.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	14	"cerebellum: 4.6"	"Low region specificity"	"Detected in many"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavourable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	0.6	0.6	0.5	16.2	1.0	0.0	0.6	4.2	0.9	0.9	27.5	0.7	1.1	12.7	0.9	3.4	2.4	0.8	65.8	0.6	0.6	0.6	43.6	0.5	0.5	0.9	0.9	0.7	0.8	1.1	0.6	0.9	0.5	1.2	1.4	2.3	1.2	2.1	0.8	0.7	4.2	85.1	1.1	0.6	0.5	22.7	1.1	0.5	0.6	0.7	2.4	2.7	0.8	2.0	1.9	2.0	0.2	1.2	3.5	6.8	2.9	4.2	3.8	6.9	7.3	1.6	1.9	5.5	4.2	2.4	5.1	3.2	9.2	4.8	10.1	5.5	1.8	6.9	3.8	2.5	2.5	27.9	7.2	4.6	16.3	3.3	2.6	3.4	5.9	2.7	5.2	2.2	3.5	1.5	6.0	5.3	1.8	6.5	3.7	16.5	2.6	6.2	5.5	6.5	5.3	1.7	3.6	7.8	3.3	12.5	3.5	2.6	7.9	2.6	1.9	5.9	5.3	4.0	2.6	8.9	3.6	5.7	3.7	15.1	3.7	0.0	1.2	0.1	4.3	0.5	3.8	1.6	5.6	4.1	1.4	1.9	6.8	5.2	0.2	3.5	0.4	2.0	4.2	2.9	0.5	1.0	4.2	0.9	0.6	0.6	0.9	0.7	1.2	0.5
SLC9A3R1	"EBP50, NHERF, NHERF1"	ENSG00000109062	"SLC9A3 regulator 1"	O14745	17	74748652-74769353	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Wnt signaling pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 77.3;SK-BR-3: 63.1;T-47d: 122.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001962, HPA009672, HPA027247"	Enhanced		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		9600000	9600000	"Plasma membrane"	"Vesicles, Centriolar satellite"	"CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162"	"unprognostic (1.29e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (9.83e-5)"	"unprognostic (7.41e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.81e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.08e-2)"	5.4	33.3	19.8	9.9	23.3	22.6	15.2	21.9	15.1	12.5	30.6	15.2	35.9	57.6	5.4	12.0	74.3	20.5	30.8	5.6	14.2	8.8	36.1	64.9	8.6	13.5	14.3	14.0	5.0	26.5	12.5	4.9	8.3	12.8	10.1	13.4	22.9	41.8	23.3	1.5	11.2	73.3	3.1	12.1	13.8	14.8	5.4	14.1	18.4	5.6	24.3	30.3	7.1	20.3	9.8	14.3	72.7	24.8	45.1	70.4	44.3	13.7	11.3	5.6	5.8	3.4	2.5	25.5	3.3	3.1	8.5	8.3	35.4	8.2	3.0	3.4	7.0	19.7	9.7	6.4	4.0	3.6	9.3	22.6	30.6	47.1	7.0	14.7	15.3	2.0	3.6	6.7	2.9	7.0	7.1	16.2	13.0	77.3	34.7	33.1	5.0	6.7	3.8	6.3	13.6	11.7	9.8	4.9	6.4	3.4	63.1	7.1	122.1	11.8	2.3	2.6	7.7	6.1	5.4	28.2	12.7	5.5	4.3	19.7	1.5	72.7	14.1	65.3	70.4	20.6	46.6	9.8	43.2	59.3	13.7	8.6	25.5	45.2	50.3	45.1	24.8	14.3	47.0	44.3	19.8	23.3	21.9	15.1	14.2	8.8	14.3	14.0	12.8	14.1
SLC9A6	"KIAA0267, NHE6"	ENSG00000198689	"Solute carrier family 9 member A6"	Q92581	X	135973841-136047269	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059445, HPA059590"	Enhanced		Supported	Vesicles				Vesicles		"HPA059445: , HPA059590: "	"unprognostic (1.35e-1)"	"unprognostic (8.28e-3)"	"unprognostic (4.36e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.06e-2)"	4.3	5.7	16.4	4.7	27.6	4.0	3.1	15.3	35.1	5.2	5.2	7.8	1.6	7.5	5.7	3.2	5.6	5.2	4.8	7.2	19.1	24.3	6.2	3.9	5.7	4.7	15.0	15.6	7.4	3.3	9.3	8.6	4.0	22.3	3.6	5.5	4.6	3.3	4.6	5.5	4.1	6.5	6.5	9.5	4.8	5.2	5.1	4.0	3.6	5.9	1.7	5.8	4.7	3.2	5.3	6.8	3.2	8.4	5.9	13.9	6.0	13.0	6.9	7.3	2.7	10.4	10.1	13.1	10.5	11.3	9.1	19.3	6.0	10.5	9.7	24.1	12.1	7.8	9.4	9.4	13.2	7.6	8.6	2.6	11.0	3.5	5.5	7.6	9.2	5.6	8.4	15.0	7.5	7.7	4.8	14.0	10.0	5.8	10.0	2.2	4.1	9.4	6.8	10.9	9.9	6.5	6.6	6.5	4.9	7.6	0.8	6.1	3.2	5.9	10.9	11.3	8.1	16.8	13.6	6.7	14.9	8.6	6.9	13.0	6.3	2.2	6.0	3.2	8.1	8.4	13.9	5.3	9.5	7.9	6.8	4.0	10.6	7.9	2.6	5.9	6.6	4.3	8.0	6.0	16.4	27.6	15.3	25.9	19.1	24.3	15.0	15.6	22.3	4.0
SLC9A9	"FLJ35613, NHE9"	ENSG00000181804	"Solute carrier family 9 member A9"	Q8IVB4	3	143265222-143848531	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.3;ASC TERT1: 13.5;HSkMC: 9.4;Karpas-707: 32.7;RPMI-8226: 15.1;U-266/70: 15.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058234	Approved					41000	41000			"HPA058234: "	"unprognostic (8.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"prognostic favourable (8.18e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.35e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavourable (5.57e-7)"	"unprognostic (5.01e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.28e-2)"	17.4	8.4	16.8	11.4	25.9	2.7	7.7	4.5	17.2	10.6	9.6	17.2	2.0	4.5	6.2	5.7	18.0	9.2	13.4	8.2	14.7	11.7	3.7	9.9	8.3	17.5	23.0	7.4	11.8	2.2	1.9	6.5	21.3	18.3	12.9	8.6	4.6	7.1	12.8	3.5	10.3	9.3	12.1	27.5	16.9	7.3	2.9	24.1	10.7	5.7	7.1	17.8	17.3	10.8	4.4	8.7	0.7	10.8	3.9	9.3	4.7	0.3	0.3	0.4	0.5	10.3	13.5	0.1	0.5	3.4	0.2	1.6	0.0	0.1	1.5	0.1	1.5	0.4	0.5	1.0	0.4	6.6	0.1	0.8	0.2	0.0	1.1	0.4	0.6	9.4	2.7	0.3	0.5	0.1	0.0	32.7	2.2	0.0	0.7	0.0	0.1	0.2	1.3	0.1	15.1	0.0	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.3	0.0	1.2	0.3	1.4	0.7	15.3	0.0	0.0	2.2	0.2	0.6	0.1	6.6	0.7	5.2	10.8	4.5	3.7	5.5	8.1	8.7	4.4	3.1	4.6	0.5	3.9	9.2	0.6	9.3	4.7	16.8	25.9	4.5	17.2	14.7	11.7	23.0	7.4	18.3	24.1
SLCO1B1	"LST-1, OATP-C, OATP1B1, SLC21A6"	ENSG00000134538	"Solute carrier organic anion transporter family member 1B1"	Q9Y6L6	12	21131202-21239246	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	618	"liver: 121.0"	"Cell line enhanced"	"Detected in some"		"A-431: 2.6;A549: 2.1;HeLa: 3.3;NTERA-2: 3.0;RPMI-8226: 4.0"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 52.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA050892	Supported									"HPA050892: "			"unprognostic (5.45e-1)"			"unprognostic (1.82e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.96e-3)"		"unprognostic (1.80e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.82e-2)"		"unprognostic (5.63e-2)"	"unprognostic (3.86e-2)"		"unprognostic (3.49e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.7	0.0	0.8	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.4	0.0	0.9	0.0	0.0	1.2	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLCO1B3	"OATP1B3, OATP8, SLC21A8"	ENSG00000111700	"Solute carrier organic anion transporter family member 1B3"	Q9NPD5	12	20810702-20916911	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 88.1"	"Cell line enhanced"	"Detected in some"		"A-431: 35.2;A549: 9.7;CAPAN-2: 7.0;HeLa: 8.0;PC-3: 9.7;U-2 OS: 8.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004943, HPA050892"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"HPA004943: AB_1854758, HPA050892: "		"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.95e-2)"		"unprognostic (1.63e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.09e-2)"		"unprognostic (3.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.37e-2)"		"unprognostic (1.50e-1)"	"unprognostic (6.61e-3)"		"unprognostic (2.36e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	88.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLCO2A1	"MATR1, OATP2A1, PGT, SLC21A2"	ENSG00000174640	"Solute carrier organic anion transporter family member 2A1"	Q92959	3	133932696-134052184	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 112.9;seminal vesicle: 147.1"	"Cell line enriched"	"Detected in some"	4	"EFO-21: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA013742	Enhanced									"HPA013742: "	"unprognostic (4.39e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (9.69e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.32e-3)"	"prognostic favourable (9.24e-5)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.63e-3)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.07e-2)"	9.3	14.7	1.0	6.0	1.0	0.0	6.2	0.4	1.6	13.9	8.1	1.5	112.9	3.7	18.4	4.5	7.8	11.5	15.3	10.1	0.7	0.5	32.9	4.2	56.8	10.6	0.7	1.2	7.2	9.2	16.1	6.5	40.3	1.8	13.7	7.2	15.1	8.2	147.1	1.5	4.5	10.1	13.6	3.0	17.7	8.3	3.0	0.6	4.6	33.6	8.6	9.0	10.5	7.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	2.0	0.2	0.0	0.0	0.0	0.0	44.0	0.4	5.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	2.1	0.7	0.0	0.0	0.0	10.3	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.0	1.0	0.4	1.6	0.7	0.5	0.7	1.2	1.8	0.6
SLURP1	"ANUP, ARS, ArsB, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740944-142742411	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Cytokine	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 137.6;lymphoid tissue: 93.7;skin 1: 91.2;tongue: 107.5"	"Group enriched"	"Detected in some"	4	"HaCaT: 3.3;hTCEpi: 2.2;MCF7: 3.8;RT4: 2.6;T-47d: 6.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA050967	Approved				"Secreted in other tissues"	5400000	5400000			"HPA050967: "	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	2.5	0.1	0.1	17.3	0.1	0.1	0.1	0.1	1.1	0.1	137.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	7.7	0.1	0.4	91.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	107.5	93.7	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.8	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	3.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SMARCAD1	"DKFZP762K2015, ETL1, KIAA1122"	ENSG00000163104	"SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1"	Q9H4L7	4	94207611-94291292	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016737	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA016737: AB_1857271"	"unprognostic (5.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.41e-3)"	"unprognostic (9.08e-3)"	"prognostic unfavourable (3.22e-5)"	"unprognostic (2.45e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.20e-3)"	12.8	15.4	15.4	22.2	14.6	8.6	20.1	26.7	25.1	15.4	13.6	9.4	14.4	12.6	19.6	17.5	17.2	16.5	13.9	12.9	13.6	14.7	16.6	14.9	21.6	22.8	17.6	11.1	20.8	15.0	17.2	33.0	18.3	14.9	15.4	16.5	10.2	14.9	20.9	11.8	26.5	13.9	15.6	17.9	17.6	13.9	15.3	16.2	42.0	20.2	11.4	17.8	16.0	15.9	5.5	4.3	3.5	3.0	7.5	6.2	2.7	7.3	9.6	29.7	19.4	8.6	14.1	15.4	13.1	12.3	11.0	10.5	8.5	12.0	18.9	9.1	11.2	6.4	20.9	11.1	15.9	14.4	9.5	13.6	10.3	13.1	12.4	19.8	14.6	14.4	9.1	13.6	17.6	17.0	22.4	7.9	16.6	5.8	33.6	10.5	20.6	4.7	19.6	17.0	9.6	12.8	9.0	17.5	25.8	10.1	17.0	14.4	8.7	13.4	16.1	14.3	15.3	8.7	10.0	11.1	16.7	22.7	13.4	10.6	17.6	3.5	2.5	0.3	4.6	3.0	4.8	5.5	5.1	4.9	4.3	4.2	5.5	6.2	0.0	7.5	2.9	3.7	4.1	2.7	15.4	14.6	26.7	25.1	13.6	14.7	17.6	11.1	14.9	16.2
SMPD1	ASM	ENSG00000166311	"Sphingomyelin phosphodiesterase 1"	P17405	11	6390431-6394998	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Neurodegeneration, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.6;fHDF/TERT166: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	2000000	2000000				"unprognostic (8.76e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.28e-3)"	"prognostic unfavourable (7.72e-5)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.72e-1)"	"prognostic favourable (7.47e-4)"	"unprognostic (4.35e-2)"	"prognostic favourable (4.57e-6)"	"unprognostic (4.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.71e-1)"	14.7	21.4	12.4	10.9	18.7	5.4	10.7	17.2	32.4	14.5	17.4	30.6	15.7	14.3	12.2	15.0	11.6	7.9	18.5	26.8	14.5	13.2	47.1	77.5	17.1	10.7	17.4	15.9	12.9	19.9	35.4	23.8	23.1	21.6	17.6	12.9	23.3	21.5	18.5	20.9	19.7	15.8	14.9	17.8	11.7	13.3	7.4	14.1	18.8	20.2	10.3	11.8	12.5	11.4	3.2	1.8	3.4	2.7	6.8	11.4	3.1	4.6	3.7	2.8	7.6	41.6	21.7	5.1	17.6	27.3	8.0	9.7	6.4	3.3	1.2	8.2	41.0	1.9	2.4	3.6	3.8	5.9	2.8	1.4	6.0	1.7	18.6	1.0	11.0	28.6	6.9	7.4	5.0	17.6	2.5	8.8	17.1	4.8	0.0	1.8	1.1	6.6	0.3	1.6	1.9	6.9	1.7	4.9	2.8	7.9	5.5	10.8	2.1	1.9	15.3	29.9	3.2	17.3	4.2	11.3	12.1	1.0	27.7	3.0	13.4	1.8	2.7	3.4	6.9	2.1	5.6	1.6	5.9	5.5	1.4	3.2	11.3	11.4	2.7	6.8	0.6	1.8	4.8	3.1	12.4	18.7	17.2	32.4	14.5	13.2	17.4	15.9	21.6	14.1
SNCA	"NACP, PARK1, PARK4, PD1"	ENSG00000145335	"Synuclein alpha"	P37840	4	89724099-89838315	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Alzheimer disease, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 31.2;bone marrow: 91.0;brain: 121.3"	"Cell line enhanced"	"Detected in many"		"HEL: 43.3;HUVEC TERT2: 52.7;RT4: 27.8;SK-MEL-30: 51.7;TIME: 60.3"	"Cancer enriched"	"Detected in many"	8	"melanoma: 37.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 25.4;plasmacytoid DC: 31.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 31.2;granulocytes: 10.1;monocytes: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005459, CAB010877"	Enhanced				"Intracellular and membrane"	23000000	23000000			"CAB010877: AB_261518, HPA005459: "	"unprognostic (4.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-4)"	"unprognostic (7.48e-3)"	3.9	5.4	38.9	4.7	26.1	91.0	4.3	41.7	121.3	6.2	4.7	9.0	0.0	2.3	15.5	2.5	4.5	3.2	3.2	9.0	35.2	22.5	4.2	1.9	4.5	1.8	36.2	49.6	13.6	1.6	1.2	5.4	12.1	26.3	4.6	3.9	5.3	4.9	5.3	1.1	7.6	2.9	15.1	21.4	4.0	1.7	2.2	15.1	0.0	5.2	1.2	2.9	4.1	4.4	0.9	31.2	10.1	20.5	4.8	0.6	19.5	0.1	0.1	8.2	0.0	0.1	0.0	0.1	0.0	8.6	0.3	0.6	0.0	0.0	0.0	2.4	0.0	1.8	10.6	19.7	0.3	0.0	4.8	43.3	24.4	0.0	17.7	0.0	0.3	0.4	7.6	0.0	22.3	52.7	0.3	0.1	0.0	0.0	0.3	0.0	2.1	0.9	0.0	3.2	0.0	0.0	27.8	4.6	3.1	0.0	0.0	51.7	0.0	0.0	60.3	0.2	1.6	0.0	0.1	0.0	0.0	0.0	1.7	0.0	17.3	10.1	20.5	0.0	0.0	8.1	0.0	0.9	0.6	0.1	25.4	0.5	0.3	0.2	3.7	4.8	2.3	31.2	0.0	19.5	38.9	26.1	41.7	55.1	35.2	22.5	36.2	49.6	26.3	15.1
SNRNP200	"ASCC3L1, BRR2, HELIC2, KIAA0788, RP33, U5-200KD"	ENSG00000144028	"Small nuclear ribonucleoprotein U5 subunit 200"	O75643	2	96274336-96305515	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029321	Approved		Supported	Nucleoplasm		6600	6600	Nucleoplasm		"HPA029321: AB_10604096"	"unprognostic (2.63e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (3.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	26.6	25.2	18.4	28.4	21.9	32.0	26.1	37.2	25.8	24.4	23.6	23.7	20.6	18.4	34.7	22.6	23.4	26.5	22.0	22.0	19.7	12.3	19.0	25.8	22.7	25.1	16.6	18.9	39.3	22.7	49.4	25.2	33.7	18.9	21.3	22.0	25.5	28.3	23.0	39.7	25.3	27.6	28.3	15.8	25.2	23.4	34.3	19.5	57.3	25.3	21.3	31.2	33.7	24.0	8.5	7.7	15.3	7.5	9.1	12.6	6.0	23.1	26.3	35.3	26.5	16.5	14.6	33.2	16.0	19.6	29.3	28.1	47.8	17.0	40.3	25.4	20.4	18.4	64.8	21.8	30.4	21.8	34.2	51.6	41.9	25.9	10.7	39.5	22.7	15.1	13.6	33.3	28.4	23.8	45.1	27.2	16.9	20.2	37.0	11.8	46.0	25.5	43.7	34.3	25.3	11.4	34.2	39.2	37.4	26.0	22.3	16.6	21.2	24.7	20.6	24.5	29.7	24.8	23.0	25.3	29.8	50.3	16.5	26.4	26.1	15.3	5.6	7.5	10.1	7.0	12.2	7.8	7.8	12.6	7.3	8.5	7.6	9.3	6.2	9.1	7.5	7.7	8.5	6.0	18.4	21.9	37.2	25.8	19.7	12.3	16.6	18.9	18.9	19.5
SOD1	"ALS, ALS1, IPOA"	ENSG00000142168	"Superoxide dismutase 1"	P00441	21	31659622-31668931	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 282.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001401, CAB008670"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		91000000	91000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB008670: AB_1623312, HPA001401: AB_1080132"	"unprognostic (1.73e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.43e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.28e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.26e-2)"	39.2	86.5	71.1	29.1	74.3	24.6	108.6	35.6	74.9	26.8	37.7	19.1	35.4	62.5	24.6	42.2	25.8	36.0	46.8	96.5	77.8	73.1	84.0	282.6	23.0	26.8	80.2	67.0	53.9	27.2	27.1	30.4	29.7	96.1	35.1	32.6	19.3	19.7	39.3	83.9	20.5	45.5	45.2	88.2	19.2	25.8	22.2	43.8	12.3	30.1	34.7	25.6	25.4	124.0	57.6	32.3	24.9	57.2	29.6	95.6	55.6	55.6	48.7	34.2	34.2	45.8	31.9	28.4	47.0	28.1	32.0	24.2	63.1	35.4	66.7	49.5	43.3	20.2	49.0	34.6	26.4	49.2	60.9	107.6	63.9	90.2	30.3	47.5	40.3	33.1	26.4	44.8	24.9	35.9	74.2	85.3	38.5	90.4	51.0	47.9	51.4	52.0	43.9	69.0	103.7	62.5	34.2	37.4	31.4	87.1	46.1	45.2	53.0	42.0	42.0	24.9	55.1	33.6	34.6	65.2	141.0	79.0	50.8	69.3	33.0	22.1	21.9	24.9	45.0	30.2	51.6	57.6	73.1	56.9	28.6	40.9	76.2	59.3	5.1	29.6	57.2	32.3	95.6	55.6	71.1	74.3	35.6	74.9	77.8	73.1	80.2	67.0	96.1	43.8
SOD2		ENSG00000285441	"Superoxide dismutase 2"	P04179	6	159679119-159762529	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 3.2;bone marrow: 4.9;seminal vesicle: 3.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.0"									"Cell type enhanced"	"Detected in single"		"memory B-cell: 3.2"	"Low lineage specificity"	"Detected in single"																	140000000	140000000																					0.0	0.0	0.0	0.2	0.4	4.9	0.3	0.0	1.7	0.0	0.1	1.6	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0		0.3	1.0	0.6	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	1.6	0.5	0.2	1.0	0.1	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.4	0.9	0.4	0.2	0.8	0.2	0.0	0.3	0.4	0.4	1.4	1.3	0.5	0.1	2.0	0.8	1.4	0.5	0.2	0.1	0.4	0.4	0.3	1.0	1.8	0.5	0.2	0.0	0.2	0.4	0.7	0.6	0.1	0.1	1.0	1.4	1.6	0.0	0.1	0.2	0.6	0.4	0.0	0.7	0.1	0.1	0.0	0.5	0.3	0.4	0.4	0.0	0.7	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.3	0.0	0.6	0.6	0.2	0.2	0.2	0.1	0.6	0.4	0.4	0.7	0.2	0.1	3.2	0.6	0.4	0.4	0.9	0.8	0.4	0.9	0.2	0.4	0.2	0.5	0.2										
SON	"BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP"	ENSG00000159140	"SON DNA binding protein"	P18583	21	33542618-33577481	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023535, HPA031755, HPA031756"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: "	"unprognostic (1.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-1)"	40.0	41.1	33.3	32.7	42.8	87.7	40.8	46.2	42.3	38.7	36.1	41.3	34.1	27.8	51.9	41.6	39.3	44.8	27.7	37.5	32.9	25.6	32.0	38.0	41.3	44.8	40.0	32.6	52.9	40.4	92.1	70.3	42.4	41.2	41.3	37.6	37.6	40.7	36.3	64.1	39.2	41.6	34.6	47.6	47.0	41.2	29.6	41.4	59.0	42.1	27.3	46.4	43.0	47.3	20.1	27.1	26.8	15.5	15.2	17.2	9.0	27.2	13.7	35.6	20.1	31.5	28.5	25.6	19.1	25.6	20.3	19.2	22.8	19.8	44.3	11.2	31.8	20.3	41.3	31.9	32.3	18.3	20.2	57.4	18.8	30.2	23.4	54.1	26.4	30.2	37.2	23.9	36.8	30.8	43.2	44.7	29.1	27.5	28.9	30.5	38.8	16.0	28.4	38.0	32.7	31.3	24.4	20.5	20.2	32.0	27.4	22.1	25.0	31.8	30.5	21.7	20.2	16.3	20.7	42.0	34.4	52.9	23.3	46.4	21.1	18.6	14.4	18.7	15.4	12.6	15.3	19.9	17.1	16.0	10.9	20.1	17.2	16.7	26.8	15.2	15.5	27.1	14.5	9.0	33.3	42.8	46.2	42.3	32.9	25.6	40.0	32.6	41.2	41.4
SORT1	"Gp95, NT3"	ENSG00000134243	"Sortilin 1"	Q99523	1	109309568-109397951	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Osteogenesis, Transport"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.1;epididymis: 75.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 9.0;non-classical monocyte: 10.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006889, CAB011498"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB011498: AB_2192606, HPA006889: AB_1080056"	"unprognostic (2.10e-2)"	"unprognostic (7.46e-2)"	"prognostic favourable (7.74e-6)"	"unprognostic (4.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.23e-4)"	"unprognostic (3.34e-3)"	"unprognostic (4.27e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.95e-1)"	"unprognostic (4.46e-3)"	22.9	6.5	24.0	6.2	35.5	10.1	15.5	6.4	40.6	10.1	15.2	50.3	18.1	11.5	11.9	75.2	22.0	14.8	9.5	31.8	45.2	19.8	21.1	3.7	19.2	3.6	57.9	22.8	3.6	9.3	24.2	5.7	22.9	27.1	10.3	14.4	12.2	11.8	24.8	36.4	8.3	11.3	14.6	71.1	5.4	9.5	21.6	42.2	1.1	22.5	5.1	5.4	8.7	8.2	0.0	4.5	2.3	10.0	0.4	0.0	1.7	11.6	4.7	11.8	14.3	34.4	6.8	34.0	8.7	13.9	8.6	9.2	12.1	4.3	0.1	11.1	3.6	2.9	13.9	6.9	12.4	0.3	6.6	3.2	7.6	13.0	13.5	0.0	10.6	17.1	1.1	10.5	2.3	1.3	24.1	1.2	12.0	12.4	8.2	0.2	4.4	1.9	9.2	27.8	5.6	16.4	8.5	12.1	6.9	5.1	34.2	36.7	14.4	2.0	0.3	1.8	7.0	0.3	14.5	11.6	9.5	0.0	3.1	0.0	7.5	0.0	7.1	2.3	0.0	9.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.9	0.4	10.0	1.6	0.0	1.7	24.0	35.5	6.4	33.9	45.2	19.8	57.9	22.8	27.1	42.2
SPAST	"ADPSP, FSP2, KIAA1083, SPG4"	ENSG00000021574	Spastin	Q9UBP0	2	32063547-32157637	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis"	"Allosteric enzyme, Developmental protein, Isomerase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017311	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA017311: AB_1857415"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (3.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.13e-1)"	12.7	9.6	18.4	14.8	16.4	13.4	9.8	21.1	21.9	14.7	12.7	15.1	12.5	11.5	12.3	8.7	11.1	10.4	10.2	6.2	20.2	18.5	9.4	14.6	9.7	18.9	20.6	10.0	15.1	10.9	11.8	12.3	11.5	17.5	10.3	12.0	6.8	9.3	13.7	15.4	11.5	17.6	11.6	27.0	15.5	9.7	14.4	14.6	21.5	13.4	6.2	13.8	11.3	10.1	5.0	7.1	9.5	9.0	6.6	7.6	4.3	10.6	7.7	12.6	12.4	8.0	9.4	11.4	5.9	8.7	6.2	5.6	10.4	9.3	18.6	5.5	8.2	7.6	12.4	6.0	7.7	12.5	7.5	20.5	4.2	12.7	7.3	14.2	14.4	5.2	7.9	7.9	7.6	13.7	16.6	6.3	6.8	4.5	22.8	12.0	13.1	4.5	12.1	17.8	12.1	8.4	6.6	18.0	19.3	10.0	8.5	9.8	5.5	9.8	11.8	6.9	10.6	6.1	6.9	9.5	17.7	15.1	7.5	12.3	8.2	3.4	6.3	6.7	3.6	9.0	5.2	5.0	5.8	5.6	7.1	3.9	5.9	6.0	9.5	6.6	6.3	3.2	7.6	4.3	18.4	16.4	21.1	15.8	20.2	18.5	20.6	10.0	17.5	14.6
SPEG	"APEG1, BPEG, KIAA1297, MGC12676, SPEGalpha, SPEGbeta"	ENSG00000072195	"SPEG complex locus"	Q15772	2	219434846-219498287	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 88.7"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 14.7;U-2 OS: 15.0;U-251 MG: 13.7;U-87 MG: 16.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA018904	Enhanced		Approved	Vesicles				Vesicles		"HPA018904: AB_1844924"	"unprognostic (3.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.45e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.29e-2)"	"unprognostic (8.66e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.47e-9)"	"unprognostic (1.14e-1)"	"unprognostic (7.01e-2)"	"unprognostic (5.95e-4)"	"unprognostic (1.28e-3)"	7.7	7.1	10.1	9.1	7.7	1.2	4.2	10.4	9.8	19.2	45.1	4.1	10.5	5.7	31.6	14.1	13.5	19.0	17.4	17.8	8.7	5.3	2.0	1.4	3.0	1.7	4.0	8.0	7.0	2.9	4.7	10.5	4.8	5.5	16.7	4.5	6.7	7.8	23.0	88.7	2.2	9.2	45.2	9.1	1.9	16.1	3.0	3.9	0.0	2.0	16.8	1.6	22.5	12.6	0.0	0.3	0.0	0.0	0.0	0.5	0.7	4.0	0.3	2.1	3.5	1.1	3.2	1.4	8.7	5.8	5.8	4.4	3.1	1.4	0.0	3.2	6.4	5.1	1.7	2.0	2.3	0.5	1.3	0.4	3.7	0.2	1.5	0.0	0.7	9.3	3.1	5.3	1.3	0.0	3.0	0.0	4.2	1.1	0.1	12.4	4.4	1.6	2.1	4.7	0.7	5.7	0.0	2.3	10.9	0.6	0.0	0.1	0.3	0.1	0.1	14.7	15.0	1.7	13.7	0.5	0.0	0.1	16.6	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.7	10.1	7.7	10.4	9.8	8.7	5.3	4.0	8.0	5.5	3.9
SPG7	"CAR, CMAR, SPG5C"	ENSG00000197912	"SPG7, paraplegin matrix AAA peptidase subunit"	Q9UQ90	16	89490719-89557768	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.42e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.12e-2)"	"prognostic favourable (2.22e-4)"	"unprognostic (4.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.33e-1)"	"prognostic favourable (4.91e-4)"	"unprognostic (3.56e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.71e-1)"	"prognostic favourable (4.25e-4)"	14.6	23.6	15.6	11.7	19.9	14.5	17.5	25.2	33.2	14.2	14.9	19.1	19.5	18.0	18.3	16.1	14.2	13.9	15.9	34.3	15.6	15.6	22.3	24.5	14.1	16.2	13.9	23.7	21.6	22.1	17.9	21.0	10.2	19.3	15.9	14.0	16.5	17.4	18.1	75.6	27.9	17.7	17.8	16.9	17.8	16.5	24.1	12.9	13.3	28.4	18.4	16.1	16.6	13.4	6.6	5.0	7.9	4.9	7.2	6.4	2.0	5.4	14.9	7.7	13.8	14.8	9.1	6.1	14.6	10.2	8.5	5.1	11.8	11.4	8.6	15.7	9.0	14.6	10.5	10.9	9.3	4.9	13.2	4.1	7.4	21.3	6.5	3.4	5.5	5.1	7.6	5.3	6.2	11.9	9.4	3.7	8.1	10.7	7.4	12.6	13.7	10.8	13.8	13.6	5.2	8.2	8.4	8.3	5.5	21.4	3.7	4.4	12.1	8.9	18.5	6.7	9.4	4.7	6.8	6.1	9.6	7.4	8.7	9.9	8.0	7.9	4.9	7.4	5.6	4.7	5.4	3.3	3.5	2.8	5.0	6.6	6.4	4.3	7.2	7.2	3.3	4.9	3.6	2.0	15.6	19.9	25.2	33.2	15.6	15.6	13.9	23.7	19.3	12.9
SPR	SDR38C1	ENSG00000116096	"Sepiapterin reductase"	P35270	2	72887360-72892158	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 61.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 9.3;intermediate monocyte: 2.6;myeloid DC: 9.9"	"Group enriched"	"Detected in many"	13	"dendritic cells: 9.9;monocytes: 9.3"	"Low region specificity"	"Detected in all"							HPA039505	Uncertain		Supported	Nucleoplasm,Cytosol		52000	52000	"Nucleoplasm, Cytosol"		"HPA039505: AB_10795466"	"unprognostic (4.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.50e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.95e-1)"	13.3	22.6	6.3	6.1	8.2	0.0	36.2	2.0	6.4	6.0	17.1	3.1	8.9	11.4	5.7	19.1	13.4	13.2	11.4	16.1	6.4	6.0	20.3	43.5	7.2	5.3	7.9	5.0	8.7	61.7	16.7	5.5	3.9	7.9	17.3	16.2	4.5	20.9	8.8	16.0	3.3	15.1	9.5	4.9	4.7	15.4	4.9	7.2	1.0	31.7	6.2	3.6	9.5	41.4	0.0	9.9	0.7	9.3	0.0	0.4	2.5	13.9	39.2	0.2	6.1	16.1	5.8	9.8	6.6	9.6	4.9	4.6	24.9	14.5	10.2	7.9	7.8	13.2	17.5	10.5	4.1	2.9	13.6	15.3	9.7	25.5	6.0	2.4	4.2	5.2	11.8	5.4	6.1	12.9	15.7	2.0	6.4	29.4	0.9	9.1	3.3	37.5	0.0	25.5	6.0	26.0	21.9	2.4	4.6	12.1	27.3	8.9	12.3	2.9	15.8	5.4	13.2	9.4	11.5	2.2	4.9	0.7	7.7	5.2	9.3	0.0	9.3	0.7	0.4	2.6	0.4	0.0	0.2	0.1	9.9	0.0	0.2	0.4	0.0	0.0	1.0	0.9	0.0	2.5	6.3	8.2	2.0	6.4	6.4	6.0	7.9	5.0	7.9	7.2
SPTLC1	"hLCB1, HSAN1, HSN1, LCB1, SPTI"	ENSG00000090054	"Serine palmitoyltransferase long chain base subunit 1"	O15269	9	92000087-92115384	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010860, CAB018747, HPA063907"	Supported		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: "	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.37e-2)"	"prognostic favourable (1.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.49e-1)"	16.4	17.7	13.3	11.4	17.1	9.9	16.8	19.9	17.6	20.3	17.2	20.9	18.1	14.0	17.3	15.1	30.5	19.2	15.5	11.4	13.9	15.3	19.0	13.5	14.8	10.6	18.0	12.2	35.3	15.8	23.6	23.1	28.3	20.5	14.5	18.8	12.0	18.5	13.3	9.4	20.1	17.8	15.1	20.8	10.7	16.0	19.8	14.1	9.7	26.2	16.0	16.5	17.4	20.9	9.3	21.0	21.1	22.1	10.2	15.2	16.0	18.1	16.4	11.4	9.5	27.9	21.7	19.7	19.1	24.4	16.5	17.9	10.3	37.9	10.0	12.2	24.1	47.6	12.3	16.2	19.2	11.5	7.1	9.2	9.3	10.0	21.0	15.2	12.5	19.6	19.6	17.0	18.6	15.0	21.5	12.5	18.7	19.5	9.5	3.8	15.3	12.0	10.6	13.8	7.6	16.4	11.1	9.3	8.6	25.7	19.7	11.6	10.1	9.0	19.0	16.1	12.4	18.5	13.3	9.0	12.3	5.6	19.2	7.5	19.3	14.6	22.1	11.9	11.5	21.6	11.0	8.9	11.6	11.6	21.0	9.3	14.2	10.7	21.1	10.2	19.2	10.8	15.2	16.0	13.3	17.1	19.9	17.6	13.9	15.3	18.0	12.2	20.5	14.1
SPTLC2	"hLCB2a, KIAA0526, LCB2, LCB2A"	ENSG00000100596	"Serine palmitoyltransferase long chain base subunit 2"	O15270	14	77505997-77616773	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027552			Approved	Mitochondria				Mitochondria		"HPA027552: AB_10601717"	"unprognostic (3.16e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (3.62e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.51e-1)"	"prognostic favourable (6.69e-8)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.32e-1)"	30.0	12.8	15.4	11.4	27.0	27.3	25.6	6.9	18.5	15.3	17.0	32.4	8.5	13.4	10.2	7.6	22.8	13.7	11.1	7.8	20.8	14.1	17.1	7.2	12.2	17.5	33.1	13.3	10.2	7.6	12.8	9.8	18.8	21.2	8.2	18.8	6.0	16.6	9.6	5.5	11.3	15.8	11.0	47.6	23.5	18.8	4.7	34.9	10.0	10.3	8.8	12.0	13.2	17.1	4.8	18.2	15.1	18.2	10.0	4.2	6.9	11.9	7.9	6.1	6.6	6.3	7.9	10.3	17.8	13.2	12.3	12.9	10.0	26.7	12.0	4.5	18.1	14.8	16.1	10.0	18.7	5.2	4.7	33.9	6.1	5.9	5.3	3.4	11.3	5.1	4.9	8.0	8.9	17.3	6.6	5.8	7.0	10.3	9.0	11.7	3.9	7.1	9.7	6.2	4.1	14.2	26.9	5.9	7.4	6.4	21.5	6.7	26.4	6.3	10.8	11.3	8.1	4.1	4.1	3.3	5.4	8.1	7.5	12.2	6.4	8.8	18.2	15.1	3.8	13.8	3.5	4.1	3.2	4.2	18.2	4.8	2.2	3.6	11.2	10.0	16.7	6.5	3.3	6.9	15.4	27.0	6.9	18.5	20.8	14.1	33.1	13.3	21.2	34.9
SRD5A3	"FLJ13352, SRD5A2L, SRD5A2L1"	ENSG00000128039	"Steroid 5 alpha-reductase 3"	Q9H8P0	4	55346109-55373096	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Cataract, Congenital disorder of glycosylation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027006	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA027006: AB_1857469"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-2)"	"prognostic favourable (9.39e-4)"	"unprognostic (1.50e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavourable (1.80e-6)"	"unprognostic (9.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (4.85e-10)"	"unprognostic (4.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.52e-2)"	13.8	12.2	11.5	5.9	13.4	6.6	17.8	7.3	18.3	22.9	11.3	20.3	3.5	6.9	13.8	9.6	24.4	5.9	22.6	10.5	13.2	10.7	12.3	15.0	12.4	10.1	15.5	12.0	3.5	26.8	14.0	7.0	8.8	13.6	8.9	10.9	6.8	16.3	6.6	5.8	15.6	8.3	6.2	22.1	6.9	13.8	4.0	15.3	10.0	7.6	9.9	12.1	12.1	12.1	5.9	28.4	10.3	25.2	3.6	9.2	10.3	4.9	3.3	6.0	5.7	20.0	12.8	3.0	5.4	6.3	2.3	3.7	3.3	10.4	11.8	6.1	8.5	3.9	4.2	5.0	2.8	3.4	7.5	6.4	3.7	8.8	5.3	11.9	3.6	11.7	9.3	3.9	3.6	9.2	10.9	26.5	12.9	6.5	17.4	5.2	7.5	4.4	5.6	1.8	6.6	7.6	5.4	9.2	5.1	5.8	43.6	3.9	5.3	10.5	4.5	14.6	2.6	1.0	4.1	14.1	7.7	4.3	18.5	16.4	14.2	10.3	16.5	4.9	7.9	25.1	9.2	5.9	6.0	7.4	14.1	5.2	5.3	7.1	0.8	3.6	25.2	28.4	5.8	10.3	11.5	13.4	7.3	18.3	13.2	10.7	15.5	12.0	13.6	15.3
SRP72		ENSG00000174780	"Signal recognition particle 72"	O76094	4	56467336-56503681	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Ribonucleoprotein	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034621	Approved									"HPA034621: AB_10601593"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-2)"	"prognostic favourable (3.83e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.40e-2)"	"prognostic unfavourable (3.25e-6)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.35e-1)"	28.7	26.4	18.5	23.1	27.0	37.3	29.8	24.1	33.5	27.0	22.7	17.3	31.3	17.1	30.2	22.7	32.1	24.3	20.2	21.6	17.2	20.9	26.6	52.5	24.9	33.4	20.5	23.6	32.7	43.8	26.7	32.5	40.9	32.1	21.8	25.3	13.0	49.6	30.1	34.4	33.3	23.2	27.1	22.6	34.4	24.1	15.9	18.8	41.8	32.9	34.8	31.9	28.7	25.4	25.7	37.4	16.8	32.4	25.9	31.5	23.9	26.5	20.5	25.9	25.0	16.5	23.8	25.1	39.4	31.6	33.2	26.6	22.6	30.3	41.3	27.2	32.8	15.3	32.0	33.4	39.4	10.8	18.6	35.9	24.2	21.0	30.3	68.9	29.9	22.4	45.1	35.3	63.0	29.5	52.0	39.8	31.6	20.5	40.6	17.9	22.4	21.5	36.5	20.9	31.0	22.8	25.3	16.1	26.9	25.0	49.1	21.7	19.5	25.1	35.6	27.6	37.2	28.2	40.8	28.6	13.5	45.3	29.7	36.8	33.3	14.6	30.0	16.8	24.8	32.4	31.5	25.7	25.1	24.5	37.4	22.8	25.0	24.5	3.8	25.9	24.5	28.1	26.8	23.9	18.5	27.0	24.1	33.5	17.2	20.9	20.5	23.6	32.1	18.8
ST14	"HAI, MT-SP1, PRSS14, SNC19, TMPRSS14"	ENSG00000149418	"Suppression of tumorigenicity 14"	Q9Y5Y6	11	130159562-130210376	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 94.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 35.7;CAPAN-2: 72.1;HaCaT: 50.5;RPMI-8226: 47.3;SK-BR-3: 33.4;T-47d: 50.5;U-698: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 18.2"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 18.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA047014			Approved	Nucleoplasm,Vesicles		220000	220000	"Nucleoplasm, Vesicles"		"HPA047014: "	"unprognostic (1.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.25e-1)"	"prognostic favourable (5.03e-11)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.60e-2)"	10.1	1.8	0.7	21.9	1.8	0.5	5.5	0.8	1.4	8.9	48.6	0.5	23.8	33.8	2.8	16.9	38.9	9.7	32.4	1.1	0.5	0.5	30.5	3.2	9.5	7.5	1.8	0.6	3.6	34.3	8.4	9.5	12.7	1.5	12.1	15.4	0.7	25.1	15.8	0.7	17.8	94.1	1.2	1.8	4.0	16.7	2.1	1.5	5.2	24.0	20.1	28.4	8.3	14.9	3.8	18.2	2.3	2.7	0.0	0.1	0.8	26.2	0.0	0.0	0.1	0.0	0.0	14.3	0.0	0.0	0.0	0.0	35.7	72.1	26.0	2.7	0.0	50.5	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.1	0.2	0.1	0.0	0.0	47.3	4.7	21.5	2.9	0.0	0.2	33.4	0.0	50.5	5.1	0.0	0.0	0.4	0.1	0.1	0.0	0.0	34.4	0.0	8.0	0.0	0.0	2.7	2.3	0.0	1.5	0.1	3.8	0.0	0.0	4.5	2.3	0.0	0.0	0.3	0.0	0.2	18.2	0.0	0.8	0.7	1.8	0.8	1.4	0.5	0.5	1.8	0.6	1.5	1.5
ST3GAL3	"MRT12, SIAT6"	ENSG00000126091	"ST3 beta-galactoside alpha-2,3-sialyltransferase 3"	Q11203	1	43705824-43931165	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 71.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051102	Uncertain				"Intracellular and membrane"					"HPA051102: AB_2681344"	"unprognostic (8.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.01e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.60e-2)"	11.6	9.0	13.0	8.9	16.5	9.9	12.8	15.5	20.4	9.0	10.3	9.0	8.0	3.2	10.8	10.7	8.7	8.3	7.2	16.9	12.8	13.9	6.7	9.1	7.2	7.6	12.0	10.4	13.3	7.5	6.9	10.9	6.7	11.6	8.8	5.1	9.0	8.0	13.9	71.5	7.4	3.8	15.9	7.7	6.0	5.9	14.5	10.3	3.2	8.1	17.8	4.8	8.1	7.0	7.1	7.0	5.8	4.2	4.7	7.6	6.1	2.4	1.9	14.4	6.8	11.3	14.3	1.8	9.4	19.6	8.8	8.5	1.7	4.0	4.6	4.9	12.1	2.4	1.3	6.2	10.6	5.3	3.2	8.7	6.1	4.6	9.5	3.9	4.4	7.6	4.7	6.4	14.1	6.9	5.1	8.5	16.3	1.6	4.0	7.5	5.7	5.0	6.8	1.9	3.1	7.1	1.6	5.8	8.6	3.7	1.4	8.2	2.2	19.0	6.6	5.3	2.5	8.6	9.5	6.8	3.9	4.3	7.8	9.5	9.8	2.9	4.2	2.5	6.8	2.5	6.1	4.5	4.4	5.1	3.0	7.1	7.6	5.7	5.8	4.7	3.7	7.0	5.2	6.1	13.0	16.5	15.5	20.4	12.8	13.9	12.0	10.4	11.6	10.3
ST3GAL5	"SIAT9, SIATGM3S, ST3GalV"	ENSG00000115525	"ST3 beta-galactoside alpha-2,3-sialyltransferase 5"	Q9UNP4	2	85837120-85905199	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 40.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.6;RT4: 21.7;SK-MEL-30: 17.9;U-266/84: 18.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 41.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034708, HPA040425, HPA068928"	Uncertain		Approved	Vesicles				Vesicles		"HPA034708: AB_10601594, HPA040425: , HPA068928: "	"unprognostic (7.90e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-2)"	"unprognostic (5.03e-3)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (2.25e-7)"	"unprognostic (2.22e-1)"	"unprognostic (5.74e-2)"	"prognostic favourable (4.99e-4)"	"prognostic favourable (4.48e-4)"	8.0	40.1	15.3	7.2	18.5	4.1	4.2	9.9	34.9	3.3	3.8	18.8	0.0	2.7	8.0	2.9	2.9	4.9	11.8	2.1	14.8	12.0	2.4	7.0	18.0	11.5	14.0	13.4	7.2	2.9	1.5	7.4	24.1	18.1	4.8	5.0	18.7	4.8	2.2	9.5	5.0	3.4	6.2	18.0	11.1	4.1	9.0	13.4	5.5	36.7	0.4	6.9	30.9	7.8	2.5	1.1	1.3	6.1	1.4	1.8	0.5	0.1	12.5	1.1	25.6	10.6	5.7	3.8	2.7	8.4	2.7	2.4	0.2	9.1	0.3	0.0	4.6	0.4	1.6	2.9	3.3	0.1	1.5	0.2	0.5	0.4	8.5	0.1	3.7	3.2	0.4	1.0	0.4	6.4	0.3	14.2	8.6	0.8	0.8	1.4	0.1	0.0	1.6	8.1	5.0	1.4	21.7	1.8	1.8	0.1	0.0	17.9	0.1	0.5	2.1	0.0	1.3	0.0	0.2	14.3	18.9	0.2	2.0	2.6	12.9	0.9	1.8	0.1	1.4	6.1	1.8	2.5	0.8	0.9	1.1	1.5	0.7	0.8	1.3	1.4	5.1	0.4	0.3	0.5	15.3	18.5	9.9	21.9	14.8	12.0	14.0	13.4	18.1	13.4
STAMBP	AMSH	ENSG00000124356	"STAM binding protein"	O95630	2	73828916-73873659	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"LHCN-M2: 158.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035800, HPA035801"	Uncertain		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		11000	11000	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA035800: AB_10670591, HPA035801: "	"unprognostic (1.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (4.70e-5)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavourable (5.79e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	12.9	12.8	22.1	13.9	23.0	10.5	17.8	20.1	21.8	18.1	18.4	35.0	13.6	17.8	23.1	15.4	22.7	16.5	14.7	19.0	23.3	21.2	19.6	16.9	13.4	15.3	33.0	14.3	16.3	15.1	20.9	17.8	20.6	26.3	20.2	20.7	14.6	18.3	15.7	30.1	14.4	25.2	19.0	54.7	13.8	15.6	13.3	22.3	18.4	20.1	15.9	19.0	16.8	16.4	17.6	16.9	27.8	17.8	16.7	20.7	12.3	5.3	6.2	4.9	4.5	4.6	5.5	5.6	3.3	4.5	6.0	5.8	10.3	5.1	4.4	5.2	2.7	4.2	5.2	11.5	6.9	7.8	5.9	6.0	4.3	8.0	6.4	4.9	7.2	4.4	8.3	7.1	10.3	3.5	6.5	6.8	158.8	6.5	7.6	4.4	7.8	3.3	5.3	12.9	6.3	6.5	6.0	9.0	6.6	4.0	4.9	6.9	4.6	2.9	3.1	5.4	6.5	3.3	5.8	6.5	6.2	3.4	6.7	5.3	6.3	22.6	16.2	27.8	14.4	17.8	15.4	17.6	16.7	14.0	16.9	16.2	17.5	13.2	24.1	16.7	15.7	16.4	20.7	12.3	22.1	23.0	20.1	21.2	23.3	21.2	33.0	14.3	26.3	22.3
STIM1	"D11S4896E, GOK"	ENSG00000167323	"Stromal interaction molecule 1"	Q13586	11	3854527-4093210	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA011088, HPA012123, CAB037128, CAB037288"	Enhanced		Enhanced	"Endoplasmic reticulum"		4900000	4900000	"Endoplasmic reticulum"		"CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882"	"unprognostic (2.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	20.8	9.9	15.5	28.9	19.9	23.1	53.1	14.1	16.8	20.5	21.2	8.5	16.5	9.2	20.6	20.3	35.1	19.8	35.6	14.3	10.3	10.5	13.2	29.0	21.6	34.0	7.7	10.3	21.7	21.2	27.7	9.4	18.1	9.0	18.2	13.7	23.5	46.9	17.0	49.4	22.1	16.0	22.5	8.7	23.2	15.6	20.1	6.0	39.7	34.2	26.6	23.4	19.5	21.7	11.1	8.5	17.1	20.6	17.6	18.2	13.3	14.7	19.2	6.0	10.4	28.5	24.8	8.3	13.3	13.5	9.5	11.7	8.6	4.9	15.7	13.8	18.3	27.0	7.6	7.8	7.9	12.8	11.4	25.2	7.3	12.9	23.3	20.3	14.6	28.2	19.4	13.8	33.9	12.3	15.2	29.9	9.7	3.4	19.1	7.4	2.4	6.8	4.8	8.5	14.7	15.0	8.7	1.2	5.5	18.9	12.1	7.1	4.5	11.5	12.6	17.4	5.8	17.0	9.1	32.3	24.3	8.0	14.5	8.5	9.9	12.4	9.5	17.1	17.3	13.0	13.9	7.3	12.6	18.2	8.5	11.1	14.3	12.8	15.2	17.6	20.6	7.5	12.8	13.3	15.5	19.9	14.1	16.7	10.3	10.5	7.7	10.3	9.0	6.0
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042073-172188386	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Cell line enhanced"	"Detected in all"		"WM-115: 51.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 27.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		24000	24000	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: "	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favourable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	15.0	4.7	2.6	25.8	4.4	38.3	13.5	27.5	3.0	3.6	5.0	4.8	3.4	4.7	4.4	4.4	3.6	4.2	11.0	9.0	2.4	2.5	5.3	4.5	15.4	40.9	5.4	1.9	3.5	4.1	2.5	3.7	16.2	4.5	4.3	4.0	5.6	7.8	2.5	3.1	9.0	12.2	5.7	4.6	33.0	6.2	13.1	3.5	20.6	4.6	3.1	23.7	9.5	11.3	5.0	10.3	22.3	30.8	7.4	18.0	15.6	7.7	7.2	4.5	6.7	5.2	6.5	11.5	10.1	8.4	7.3	6.8	3.7	10.2	9.3	5.4	12.4	9.0	2.0	12.3	4.8	12.2	3.3	11.2	3.0	2.1	7.5	11.3	13.3	6.4	2.6	9.9	8.3	6.3	1.0	13.1	5.1	12.4	8.1	25.5	1.8	5.7	13.4	3.5	6.2	3.0	9.8	3.0	3.7	5.8	8.1	27.6	2.9	24.0	8.7	8.2	4.1	5.7	5.4	11.1	16.3	5.9	10.8	17.5	51.5	7.1	10.8	10.0	18.0	21.4	13.3	5.0	9.4	12.8	10.3	4.4	5.6	9.6	22.3	7.4	30.8	3.2	12.2	15.6	2.6	4.4	27.5	3.0	2.4	2.5	5.4	1.9	4.5	3.5
STK11	"LKB1, PJS"	ENSG00000118046	"Serine/threonine kinase 11"	Q15831	19	1177558-1228435	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Autophagy, Cell cycle, Differentiation, DNA damage, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016231, HPA017254, CAB022105, HPA067481"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB016231: AB_627890, CAB022105: , HPA017254: AB_1852924, HPA067481: "	"unprognostic (8.60e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.00e-2)"	"prognostic favourable (3.69e-5)"	"unprognostic (2.04e-2)"	"prognostic favourable (1.96e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.70e-3)"	"unprognostic (3.54e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.12e-3)"	13.4	13.7	13.5	11.8	12.4	19.3	16.7	17.8	16.0	12.2	16.1	8.3	19.8	18.1	10.8	8.7	15.1	10.0	11.8	15.3	12.6	9.8	10.7	22.1	9.4	12.5	9.7	10.4	11.0	16.8	10.7	11.6	12.2	9.9	12.2	5.3	11.9	16.0	12.2	49.2	16.8	18.0	7.7	7.6	16.9	15.5	59.8	7.5	11.8	12.4	14.5	19.0	11.4	9.8	2.7	1.9	11.7	6.3	1.9	1.8	0.5	21.1	10.2	7.8	14.7	7.4	6.7	16.5	10.3	10.8	9.7	10.4	8.3	14.8	13.9	11.5	10.8	13.7	7.6	15.9	3.0	25.9	18.7	14.2	0.6	10.5	15.9	14.2	23.8	12.2	11.6	7.5	11.1	9.7	26.5	19.1	5.5	15.8	13.7	14.4	14.9	12.6	21.7	8.3	15.5	8.8	15.5	18.1	13.0	0.0	7.7	11.1	12.1	23.4	13.1	10.1	11.4	19.7	16.4	37.6	15.8	10.4	10.0	19.0	10.3	2.0	4.2	4.5	0.6	6.0	0.4	2.7	1.0	1.8	1.9	1.0	1.0	0.9	11.7	1.9	6.3	1.0	0.7	0.5	13.5	12.4	17.8	16.0	12.6	9.8	9.7	10.4	9.9	7.5
STK4	"KRS2, MST1, YSK3"	ENSG00000101109	"Serine/threonine kinase 4"	Q13043	20	44966474-45079959	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004038, HPA015270"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB004038: AB_2144632, HPA015270: AB_1854150"	"unprognostic (2.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.83e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (8.04e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.18e-2)"	9.5	8.8	10.4	24.5	11.5	39.5	8.1	7.5	13.4	7.8	8.6	10.3	5.4	8.1	9.3	6.5	8.9	7.3	9.4	6.1	9.3	8.8	6.3	7.4	18.8	30.6	10.5	9.1	8.3	6.4	5.9	9.3	8.2	7.7	7.5	10.6	7.4	9.3	8.7	4.2	11.4	16.1	8.2	12.0	29.1	9.6	7.4	9.6	32.3	8.0	4.9	36.6	11.5	8.7	10.8	6.9	40.6	13.3	10.3	14.5	7.9	11.6	7.9	10.1	7.2	6.2	7.8	7.0	10.3	15.8	17.5	15.9	22.4	6.4	28.6	9.0	7.3	12.4	10.7	13.8	22.5	12.8	5.7	20.8	11.6	15.7	10.9	26.7	29.6	6.3	11.4	16.4	17.9	6.4	9.6	16.5	8.8	9.2	19.9	18.1	6.2	5.4	12.9	11.2	13.3	6.4	8.0	4.8	5.9	15.3	8.9	11.7	8.1	16.9	8.2	13.2	12.9	15.2	11.9	21.6	16.9	31.8	12.9	12.8	9.7	24.4	7.6	20.5	14.5	7.7	14.4	10.3	13.8	13.3	6.9	10.8	14.3	11.9	40.6	10.3	13.3	3.9	13.3	7.9	10.4	11.5	7.5	13.4	9.3	8.8	10.5	9.1	7.7	9.6
STRA6	FLJ12541	ENSG00000137868	"Stimulated by retinoic acid 6"	Q9BX79	15	74179466-74212267	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"cervix, uterine: 22.7;placenta: 88.6;retina: 42.8"	"Cell line enhanced"	"Detected in some"		"A549: 16.2;CAPAN-2: 46.0;SH-SY5Y: 28.6;WM-115: 69.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040839	Approved									"HPA040839: AB_10794881"	"unprognostic (1.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.89e-1)"	"unprognostic (7.91e-13)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.91e-1)"	0.2	1.6	0.2	0.5	0.3	0.0	1.1	0.2	0.5	22.7	0.1	0.3	1.6	0.0	6.9	2.8	1.0	5.0	0.7	0.3	0.4	0.2	7.3	0.0	0.3	1.1	0.1	0.3	0.6	0.2	0.0	5.3	88.6	0.7	5.0	0.0	42.8	0.6	2.6	0.1	0.4	0.2	0.3	1.5	0.3	0.1	2.8	0.1	0.9	0.2	1.4	1.9	1.8	2.3	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.2	16.2	0.9	0.0	0.0	0.0	2.7	0.5	0.1	0.0	0.0	5.6	46.0	0.0	11.1	0.0	1.6	0.9	0.0	0.0	0.0	0.0	1.4	0.6	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.9	0.2	1.4	0.0	0.2	0.0	0.0	0.0	1.5	8.7	28.6	0.0	1.6	0.0	0.1	0.0	0.0	0.1	3.8	0.3	0.7	0.0	0.1	0.0	0.3	0.0	69.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.4	0.4	0.2	0.1	0.3	0.7	0.1
STRADA	"LYK5, NY-BR-96, Stlk, STRAD"	ENSG00000266173	"STE20-related kinase adaptor alpha"	Q7RTN6	17	63682336-63741986	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031637	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA031637: AB_10601718"	"unprognostic (1.59e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.56e-5)"	"unprognostic (6.79e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"prognostic favourable (5.34e-5)"	"unprognostic (7.29e-2)"	"prognostic unfavourable (6.08e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"prognostic favourable (6.43e-4)"	13.3	17.7	19.4	14.6	23.7	17.5	13.0	25.0	28.4	15.2	13.2	27.1	8.7	9.5	16.1	20.6	14.3	20.9	14.5	15.1	18.9	20.2	14.7	13.0	13.9	19.6	20.9	21.7	18.5	12.5	21.9	17.5	14.4	26.0	13.8	13.1	22.2	12.6	16.7	10.3	20.1	12.0	19.1	19.4	20.7	12.6	55.4	21.4	16.2	13.3	8.9	21.3	12.9	12.8	11.2	16.2	18.6	10.0	15.6	11.7	7.5	7.2	21.7	18.9	19.0	18.6	13.9	7.4	13.8	12.7	19.9	17.8	5.6	8.4	11.0	8.6	11.7	6.0	12.5	13.3	19.8	12.2	12.1	21.8	15.2	13.4	13.2	20.6	15.7	14.5	11.5	22.6	13.0	22.0	13.9	11.8	18.8	13.4	24.2	14.1	9.4	12.3	15.8	30.1	13.5	17.8	14.3	20.7	23.2	9.4	15.5	15.1	11.4	15.0	17.6	19.0	13.5	15.3	11.4	11.8	12.5	13.9	14.1	12.5	14.9	18.6	9.5	8.6	10.5	7.1	9.7	11.2	9.7	11.7	16.2	9.0	9.6	8.5	11.4	15.6	10.0	13.7	7.2	7.5	19.4	23.7	25.0	28.4	18.9	20.2	20.9	21.7	26.0	21.4
STS	"ARSC, ARSC1"	ENSG00000101846	"Steroid sulfatase"	P08842	X	7219456-7354810	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Pregnancy, Steroid metabolism"	Hydrolase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"placenta: 258.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.9;RPMI-8226: 25.4;U-266/70: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.7"	"Low lineage specificity"	"Detected in many"											HPA002904	Enhanced									"HPA002904: AB_1080116"	"unprognostic (1.09e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavourable (3.47e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.34e-1)"	10.3	2.2	3.0	2.2	3.9	0.0	4.1	2.3	9.0	3.4	3.5	2.3	2.2	0.8	2.4	2.2	2.2	2.6	4.1	3.6	3.9	4.0	2.5	4.7	5.0	2.2	3.8	2.4	2.4	2.2	1.6	2.2	258.8	2.4	2.9	3.0	2.3	2.2	3.3	4.0	2.3	2.4	3.8	2.4	2.2	6.7	2.2	2.3	2.2	2.4	2.2	2.2	4.9	2.7	0.9	1.9	1.9	4.7	1.0	0.7	1.0	4.0	1.2	2.7	0.9	19.9	10.3	14.7	8.3	3.0	2.2	2.1	7.2	3.8	7.6	1.6	6.0	1.0	1.6	1.3	2.2	0.6	3.2	0.4	4.6	2.0	1.1	1.1	4.3	3.4	0.2	1.4	0.8	3.4	0.4	7.9	5.9	0.9	0.6	1.0	1.0	1.8	1.0	1.6	25.4	5.6	5.9	2.0	1.7	1.6	3.0	0.9	1.2	0.4	5.9	8.9	0.5	11.4	1.3	42.2	0.0	17.7	2.1	0.9	2.3	0.0	3.2	0.6	0.5	4.7	0.2	0.6	0.2	0.3	1.9	0.9	0.1	0.5	1.9	1.0	2.5	0.3	0.7	1.0	3.0	3.9	2.3	9.0	3.9	4.0	3.8	2.4	2.4	2.3
STT3A	"ITM1, MGC9042, STT3-A, TMC"	ENSG00000134910	"STT3A, catalytic subunit of the oligosaccharyltransferase complex"	P46977	11	125591712-125625215	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 202.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030735	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	Vesicles	"HPA030735: AB_10603342"	"unprognostic (8.25e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.02e-2)"	"prognostic favourable (1.32e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavourable (3.57e-4)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.82e-2)"	20.6	20.5	8.3	13.1	11.7	8.3	16.9	10.7	13.9	27.8	19.3	17.7	39.6	12.0	30.5	41.4	19.6	20.8	15.1	19.5	8.3	9.1	26.2	67.1	18.7	14.9	9.3	7.7	30.1	59.0	202.3	27.5	35.9	11.6	22.2	17.4	20.8	50.7	41.4	9.5	12.9	19.8	17.1	12.3	21.8	17.7	17.1	6.7	19.2	38.6	13.6	20.8	19.5	18.0	15.0	53.2	27.0	15.5	17.2	27.5	13.4	20.7	18.9	24.2	33.2	45.6	35.4	26.0	38.0	45.4	31.0	38.8	57.5	56.2	27.1	46.2	55.9	38.4	33.5	33.3	41.2	21.1	17.8	63.8	13.1	39.7	50.5	38.1	29.9	27.3	24.2	42.8	83.7	34.5	26.8	40.6	39.0	15.3	15.3	12.2	15.5	20.6	18.2	20.6	40.7	33.8	32.3	15.1	13.0	26.9	44.0	13.5	51.5	27.5	30.8	44.6	16.1	18.8	29.8	12.8	14.9	20.9	17.2	38.6	35.4	27.0	15.5	11.6	19.7	14.8	27.5	15.0	19.1	18.2	21.6	11.6	13.8	16.0	5.4	17.2	13.0	53.2	14.1	13.4	8.3	11.7	10.7	13.9	8.3	9.1	9.3	7.7	11.6	6.7
STT3B	"FLJ90106, SIMP, STT3-B"	ENSG00000163527	"STT3B, catalytic subunit of the oligosaccharyltransferase complex"	Q8TCJ2	3	31532638-31637622	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036448, HPA036646"	Approved		Supported	"Endoplasmic reticulum"		9300	9300	"Endoplasmic reticulum"		"HPA036448: , HPA036646: AB_10673472"	"unprognostic (2.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (7.91e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.02e-1)"	23.0	30.3	16.0	27.5	16.7	21.7	27.4	15.4	19.4	28.4	25.0	16.9	37.0	18.6	28.4	37.9	28.8	22.4	29.0	27.5	15.1	15.6	28.2	64.1	30.1	36.9	16.5	15.5	62.3	39.4	36.2	20.3	85.9	16.5	26.3	25.1	22.3	25.2	26.3	31.2	19.2	29.2	23.2	19.7	29.4	22.9	36.7	13.6	60.2	44.3	23.4	30.3	27.5	27.7	3.6	7.7	8.4	5.3	8.4	8.5	3.0	16.3	27.5	25.3	26.5	31.9	32.3	55.4	30.7	27.0	23.0	26.7	25.0	35.6	28.5	15.1	27.8	13.9	23.4	26.6	30.2	80.2	15.4	24.4	28.0	26.6	24.6	52.5	29.1	24.7	28.6	32.7	41.4	23.2	13.1	45.7	31.3	9.2	51.4	32.5	20.4	15.5	53.8	13.7	41.3	26.8	23.7	10.8	13.2	30.4	45.2	17.8	20.4	28.1	45.1	31.1	19.9	30.7	27.0	28.8	34.5	23.9	28.2	36.2	25.5	2.3	4.6	8.4	4.7	5.3	7.5	3.4	8.5	6.5	4.0	3.6	8.2	6.5	1.7	8.4	3.7	7.7	4.1	3.0	16.0	16.7	15.4	19.4	15.1	15.6	16.5	15.5	16.5	13.6
STUB1	"CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1"	ENSG00000103266	"STIP1 homology and U-box containing protein 1"	Q9UNE7	16	680224-682870	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037202, CAB037209, HPA041222, HPA043531"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533"	"unprognostic (5.70e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.77e-2)"	"prognostic favourable (6.49e-9)"	"unprognostic (9.67e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.30e-1)"	29.4	43.7	52.2	20.1	43.2	19.3	40.5	39.1	53.3	25.1	24.8	18.1	27.6	24.1	19.7	34.9	35.2	31.1	25.5	45.2	43.2	38.6	24.0	25.9	23.6	28.1	42.0	42.5	29.4	43.4	39.8	27.2	12.1	35.0	23.4	17.7	18.6	37.7	29.7	92.5	33.7	20.9	24.5	34.5	19.7	22.8	13.8	25.4	13.1	29.1	30.2	19.4	22.3	35.9	18.0	21.0	19.4	14.5	10.3	16.9	6.9	17.8	24.2	16.4	27.7	37.5	34.4	9.4	24.4	28.7	29.0	25.8	30.1	22.8	18.1	17.3	40.8	15.3	20.2	36.7	12.1	19.9	66.8	11.2	35.0	25.1	54.1	18.9	22.4	40.8	39.4	33.9	21.5	29.3	18.1	30.3	44.8	70.7	20.5	18.6	18.3	26.5	31.7	10.7	44.5	38.7	17.9	28.6	23.2	19.5	43.0	30.6	27.4	36.3	23.2	26.6	23.3	22.0	29.3	30.0	31.0	29.2	21.0	17.2	30.0	11.9	14.5	19.4	16.9	11.9	15.4	18.0	14.6	14.7	11.7	17.3	13.6	12.9	14.0	10.3	12.4	21.0	12.2	6.9	52.2	43.2	39.1	53.3	43.2	38.6	42.0	42.5	35.0	25.4
SUCLA2		ENSG00000136143	"Succinate-CoA ligase ADP-forming beta subunit"	Q9P2R7	13	47745736-48037968	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039435, HPA039536, HPA061528"	Enhanced	Supported	Enhanced	Mitochondria		6600	6600	Mitochondria		"HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553"	"unprognostic (5.66e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (7.59e-14)"	"unprognostic (3.53e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (1.22e-4)"	21.6	18.5	19.2	8.6	22.1	5.2	17.5	29.7	32.4	15.3	15.7	11.7	15.6	24.5	12.7	12.1	14.6	11.3	9.4	42.1	20.0	21.6	34.0	12.9	7.9	11.4	22.6	19.1	14.4	10.8	19.8	14.9	12.2	28.7	16.2	16.5	8.9	13.9	14.8	89.0	10.0	22.7	14.7	18.3	9.7	12.3	8.0	15.4	15.6	16.9	25.6	10.2	11.0	12.6	17.1	29.5	12.4	25.0	23.4	25.2	17.2	17.2	20.0	25.4	15.2	29.1	22.0	15.3	26.4	29.6	27.5	18.7	35.5	19.6	24.2	20.2	25.8	24.0	33.5	25.1	34.9	23.1	28.7	27.2	19.0	23.0	20.3	27.5	15.9	20.7	29.6	18.7	22.1	20.2	18.3	8.8	27.3	11.9	28.3	31.5	26.3	25.6	24.1	23.2	18.7	39.7	16.7	14.1	16.8	22.0	20.4	15.5	18.1	24.4	15.4	15.3	9.9	21.7	18.3	9.1	14.2	28.2	9.5	20.1	22.4	5.7	24.5	12.4	17.6	25.0	21.2	17.1	19.7	21.6	29.5	16.3	25.2	24.9	4.5	23.4	20.0	24.3	21.6	17.2	19.2	22.1	29.7	32.4	20.0	21.6	22.6	19.1	28.7	15.4
SUCLG1		ENSG00000163541	"Succinate-CoA ligase alpha subunit"	P53597	2	84423523-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 125.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Supported	"Plasma membrane,Mitochondria"	"Intracellular and membrane"	330000	330000	Mitochondria	"Plasma membrane"	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavourable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favourable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	26.1	23.3	18.0	15.0	18.9	10.6	23.8	18.9	19.5	14.1	50.1	17.7	23.2	53.9	13.9	19.6	25.0	13.5	14.0	57.7	17.4	17.3	125.6	44.1	12.8	13.3	19.2	17.0	12.7	33.9	36.2	16.3	13.8	17.3	17.1	39.4	16.9	39.3	24.9	57.6	15.6	71.6	26.5	17.1	12.1	21.9	13.3	16.0	16.9	28.8	42.8	15.2	24.3	16.3	26.6	43.5	31.6	40.3	35.2	39.1	46.8	23.5	25.9	20.5	25.0	38.6	26.0	35.5	26.9	23.0	34.6	25.3	59.3	19.5	32.4	18.6	32.1	34.4	42.1	31.6	41.2	31.3	38.3	28.1	22.4	33.7	32.6	28.6	23.0	30.9	26.0	29.1	39.8	30.8	28.5	26.7	31.5	36.0	40.6	26.2	10.7	46.4	25.8	47.5	35.5	46.4	28.6	24.9	13.9	21.4	44.5	42.7	27.1	22.6	24.8	27.2	26.3	33.3	32.9	23.5	33.3	28.0	31.7	39.7	23.9	31.6	34.4	28.7	31.4	40.3	34.6	26.6	29.2	35.1	43.5	20.2	32.4	34.2	18.5	35.2	40.0	23.7	39.1	46.8	18.0	18.9	18.9	19.5	17.4	17.3	19.2	17.0	17.3	16.0
SUGCT	"C7orf10, DERP13, FLJ11808, ORF19"	ENSG00000175600	"Succinyl-CoA:glutarate-CoA transferase"	Q9HAC7	7	40134977-40860763	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.1;liver: 27.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 27.5;LHCN-M2: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026698, HPA026704, HPA026705"	Enhanced									"HPA026698: AB_10600191, HPA026704: AB_10600230, HPA026705: AB_10601003"	"unprognostic (4.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.27e-3)"	"unprognostic (7.65e-2)"	"prognostic favourable (3.93e-7)"	"unprognostic (2.62e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.41e-3)"	"prognostic unfavourable (2.53e-4)"	2.7	13.5	3.2	5.1	4.6	0.7	4.0	1.1	3.1	4.4	5.0	1.1	0.7	1.4	9.6	2.9	3.2	2.7	4.5	6.9	4.3	2.4	42.1	27.6	1.2	3.9	2.8	2.4	5.7	3.8	3.8	3.5	1.2	4.8	3.4	2.9	5.4	2.4	4.3	11.3	1.6	5.6	13.9	5.0	1.3	1.8	4.1	4.1	0.0	2.4	6.3	1.5	2.9	3.5	1.4	0.2	1.1	0.2	0.0	4.6	0.7	0.5	0.0	3.0	2.3	3.3	7.6	1.2	1.5	2.9	2.2	2.5	1.2	0.6	2.0	0.7	2.2	0.1	1.0	27.5	3.4	0.0	1.3	1.7	0.2	4.4	4.1	0.2	0.2	9.6	6.2	2.3	1.4	0.6	2.3	0.3	16.5	0.0	0.1	0.3	5.2	2.3	1.9	0.3	0.0	4.7	0.0	0.2	1.7	2.5	1.1	3.5	0.1	0.4	2.3	9.4	2.7	0.1	0.6	0.2	0.0	0.1	1.8	0.8	2.1	0.0	0.1	0.3	0.7	0.0	1.2	1.4	2.0	1.0	0.1	1.2	4.6	2.7	1.1	0.0	0.2	0.2	0.0	0.7	3.2	4.6	1.1	3.1	4.3	2.4	2.8	2.4	4.8	4.1
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552075-48599425	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 91.8;lymphoid tissue: 78.6;tongue: 79.6"	"Cell line enhanced"	"Detected in some"		"A549: 7.1;CAPAN-2: 34.1;MCF7: 20.9;T-47d: 17.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB033013, HPA041724, HPA043539"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB033013: AB_661450, HPA041724: AB_2677638, HPA043539: AB_2678540"	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	4.0	0.1	0.2	28.7	0.8	0.0	9.2	2.9	2.2	5.2	91.8	0.3	2.3	0.0	0.1	0.1	2.5	0.1	6.5	0.0	0.2	0.0	0.1	0.2	0.8	0.1	11.4	0.0	6.9	0.0	0.0	12.4	6.9	0.2	45.7	13.4	0.0	0.1	0.0	0.7	0.2	0.0	0.5	1.1	79.6	78.6	0.6	32.0	0.7	1.5	2.5	1.0	1.1	3.1	0.9	5.6	7.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	34.1	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.0	0.0	3.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	20.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	2.9	0.1	17.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.5	0.8	0.4	2.1	0.9	3.1	0.4	1.8	1.4	0.7	0.7	0.6	1.2	1.4	1.1	1.0	1.5	1.1	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0
SUOX		ENSG00000139531	"Sulfite oxidase"	P51687	12	55997180-56006641	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038208, HPA038209"	Approved					26000	26000			"HPA038208: AB_2675892, HPA038209: AB_10672738"	"unprognostic (1.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.86e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.74e-2)"	"prognostic favourable (6.28e-4)"	"unprognostic (6.95e-2)"	"prognostic favourable (4.77e-7)"	"unprognostic (1.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.85e-2)"	"prognostic favourable (8.32e-5)"	12.2	25.4	11.9	6.4	13.3	7.5	11.9	9.7	21.3	12.4	11.8	18.8	15.4	12.8	14.5	22.2	14.1	16.0	13.6	18.9	10.5	9.8	26.8	43.4	10.5	7.0	14.2	15.8	16.1	13.5	45.6	11.9	7.6	15.2	17.5	11.7	17.5	17.4	25.0	25.9	7.0	10.4	12.9	11.6	9.6	13.4	5.5	14.4	3.2	15.1	13.4	11.4	16.5	9.6	1.6	10.0	17.6	11.8	9.2	4.6	7.1	4.6	13.8	8.8	14.2	14.9	6.5	20.2	5.5	6.1	7.9	5.5	13.4	10.2	0.5	9.6	6.6	6.2	6.9	6.9	4.4	20.8	4.6	7.1	8.3	16.1	5.8	0.1	13.4	10.2	2.9	6.6	4.8	18.5	12.7	9.7	8.2	11.4	0.2	4.7	4.0	10.0	6.3	3.6	9.9	8.7	9.2	4.5	5.8	9.8	21.2	7.9	34.5	8.7	9.5	4.1	5.2	5.0	3.7	11.2	9.6	0.6	7.0	4.3	6.0	5.9	8.1	17.6	0.1	11.8	0.0	1.6	0.7	0.0	10.0	0.2	0.5	0.2	3.2	9.2	9.4	0.2	4.6	7.1	11.9	13.3	9.7	21.3	10.5	9.8	14.2	15.8	15.2	14.4
SYNJ1	"INPP5G, PARK20"	ENSG00000159082	"Synaptojanin 1"	O43426	21	32628759-32728048	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, RNA-binding"	"Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011916	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA011916: AB_1857692"	"unprognostic (6.84e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (4.43e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.36e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.92e-1)"	5.5	6.8	13.6	5.0	25.9	20.6	4.2	19.5	39.0	4.8	4.8	6.5	0.8	3.9	4.6	5.3	3.9	4.0	5.2	5.2	18.3	18.2	7.4	5.5	6.5	5.7	16.6	18.4	4.6	4.5	10.6	10.9	9.3	33.5	3.6	5.5	7.0	3.8	4.0	4.4	5.0	4.6	5.0	7.3	6.0	4.2	9.0	5.7	3.2	6.8	1.5	4.8	4.7	3.3	0.4	3.1	11.5	6.0	0.5	3.0	1.1	5.5	2.8	5.1	5.6	8.9	7.2	10.3	11.5	6.6	7.0	5.9	6.3	2.6	2.0	3.9	6.9	5.2	9.1	6.7	8.4	6.5	8.7	13.8	9.0	3.5	4.8	5.7	12.3	4.0	5.0	12.2	6.2	10.9	10.3	11.9	9.0	5.6	5.3	4.7	3.6	6.3	5.8	11.1	7.2	7.4	4.0	5.8	4.5	14.1	9.0	5.5	7.8	7.4	12.1	10.9	5.4	8.7	6.3	6.2	7.2	4.3	8.2	10.8	8.6	3.7	3.4	7.9	1.6	6.0	2.7	0.2	2.4	2.6	3.1	0.4	2.9	2.8	11.5	0.5	5.3	1.6	3.0	1.1	13.6	25.9	19.5	28.7	18.3	18.2	16.6	18.4	33.5	5.7
SYP	MRX96	ENSG00000102003	Synaptophysin	P08247	X	49187804-49200259	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 179.2"	"Cell line enhanced"	"Detected in some"		"K-562: 8.5;SCLC-21H: 45.7;SH-SY5Y: 16.5"	"Group enriched"	"Detected in many"	6	"glioma: 12.8;pancreatic cancer: 5.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000076, HPA002858, CAB055505, CAB078999"	Enhanced	Supported								"CAB000076: AB_2315411, CAB055505: AB_564017, CAB078999: , HPA002858: AB_1080153"	"unprognostic (2.08e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.37e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.46e-5)"	"unprognostic (8.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.44e-3)"	"unprognostic (8.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.94e-1)"	2.7	21.4	34.5	3.2	42.5	1.9	1.9	53.8	179.2	2.0	3.6	7.2	0.0	7.4	2.2	2.6	2.2	2.0	2.0	2.3	44.4	45.3	2.7	1.8	2.8	2.0	25.5	39.0	2.1	5.2	1.9	17.4	2.0	46.7	2.1	3.5	11.5	2.0	2.1	2.4	2.3	8.1	2.5	15.5	2.4	3.9	2.0	4.0	0.0	2.1	0.0	1.9	1.8	0.2	1.3	1.6	5.3	0.8	0.5	0.7	0.1	0.4	1.7	1.3	2.6	1.4	0.2	0.2	0.1	0.0	0.3	0.3	1.5	0.9	1.3	0.2	0.0	1.3	1.3	0.1	0.3	2.7	1.5	2.1	0.5	0.5	0.0	0.2	4.7	0.2	0.0	0.2	0.3	0.1	8.5	3.3	0.3	0.5	0.7	0.1	4.2	0.3	0.3	0.2	0.6	0.1	0.2	45.7	16.5	0.5	0.2	0.6	0.8	0.8	0.2	0.3	1.4	0.4	0.2	0.2	2.8	0.3	0.7	0.5	1.4	1.7	0.8	0.4	0.2	0.7	0.4	0.7	0.5	0.7	0.4	1.3	0.5	0.5	5.3	0.5	0.4	1.6	0.3	0.1	34.5	42.5	53.8	84.8	44.4	45.3	25.5	39.0	46.7	4.0
SYT1	"P65, SVP65, SYT"	ENSG00000067715	"Synaptotagmin 1"	P21579	12	78863993-79452008	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 141.7"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.5;LHCN-M2: 18.0;SH-SY5Y: 17.4;WM-115: 16.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.3;memory B-cell: 3.3;naive B-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008394, HPA064788"	Enhanced	Supported								"HPA008394: AB_1857696, HPA064788: AB_2685351"	"unprognostic (1.02e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.77e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.68e-5)"	"unprognostic (2.78e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.05e-8)"	"unprognostic (2.89e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	1.3	11.5	23.9	2.1	31.8	1.3	1.4	44.3	141.7	1.8	2.3	1.8	0.0	1.8	5.6	1.4	1.4	1.4	1.7	1.1	32.4	22.9	2.0	2.0	1.5	1.2	23.1	38.6	3.6	1.2	1.1	1.4	2.3	28.9	4.3	2.5	2.7	1.2	3.8	1.1	1.2	2.6	12.9	2.5	2.2	1.8	1.4	3.6	0.0	1.2	0.0	1.2	1.3	0.7	3.4	0.9	0.0	2.3	0.0	0.0	0.1	0.0	10.5	7.9	0.0	0.8	2.3	0.0	0.7	0.9	0.6	0.6	0.5	0.3	0.0	1.6	0.1	0.3	0.1	1.2	0.9	0.1	0.4	0.6	0.2	0.0	2.0	0.0	0.1	0.6	0.8	2.9	22.5	7.5	0.4	1.2	18.0	1.6	1.0	0.0	5.8	3.0	0.0	8.2	0.0	0.0	3.0	10.5	17.4	0.0	1.3	0.2	3.9	0.0	3.0	1.1	0.4	0.0	3.3	1.9	4.2	0.0	2.6	0.0	16.2	0.0	2.3	0.0	0.0	0.2	0.0	3.3	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.9	31.8	44.3	74.8	32.4	22.9	23.1	38.6	28.9	3.6
TACR3	NK3R	ENSG00000169836	"Tachykinin receptor 3"	P29371	4	103586031-103719816	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 14.4;urinary bladder: 5.5"	"Cell line enriched"	"Detected in single"	13	"BEWO: 12.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 14.4;hypothalamus: 4.1;pons and medulla: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA009418	Uncertain									"HPA009418: AB_1857727"	"unprognostic (3.81e-2)"				"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"		"unprognostic (3.50e-1)"		"unprognostic (3.21e-1)"				"unprognostic (5.52e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	0.1	0.1	14.4	0.1	1.4	0.1	0.4	0.0	2.6	0.1	0.4	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.3	0.1	1.1	4.1	2.0	0.1	0.9	0.1	1.4	1.0	0.1	0.1	0.1	0.1	0.6	6.3	0.2	0.5	3.2	0.1	0.1	0.7	0.3	0.1	0.1	2.5	0.1	0.5	0.6	0.0	0.0	0.5	0.9	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	1.4	0.0	1.5	1.1	4.1	1.4	1.0	6.3	0.0
TAF1	"BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250"	ENSG00000147133	"TATA-box binding protein associated factor 1"	P21675	X	71366239-71532374	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Dystonia, Mental retardation, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA001075, CAB016283"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB016283: AB_671202, HPA001075: AB_1080179"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (6.54e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (6.03e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.56e-2)"	20.1	16.2	15.0	17.1	19.8	16.3	17.7	20.7	18.0	20.7	15.5	23.8	17.1	10.0	25.4	17.1	14.4	19.1	16.1	12.9	15.4	12.0	11.9	12.9	13.8	17.8	18.5	16.5	23.9	17.5	25.5	19.3	15.4	17.3	16.9	15.4	20.8	14.5	16.1	19.6	16.8	17.1	18.3	17.2	21.3	15.8	12.2	21.3	19.4	20.1	12.0	18.7	18.4	15.8	5.0	4.7	5.2	4.8	4.2	4.9	1.8	11.2	9.8	11.2	7.5	9.0	15.6	7.0	8.4	7.8	8.9	7.4	7.3	6.8	10.5	7.2	9.4	10.7	15.6	6.7	11.4	6.9	13.7	12.5	12.9	7.2	6.5	23.7	12.1	9.1	6.8	9.5	18.0	9.2	17.0	25.5	9.0	7.9	13.1	10.5	12.9	12.9	12.1	22.8	12.8	6.0	14.6	5.9	9.2	23.4	8.2	10.4	6.0	12.6	11.6	10.5	8.8	8.4	5.8	10.9	10.1	13.6	5.8	19.1	7.8	4.4	4.1	1.1	4.4	2.8	3.8	3.0	4.6	4.5	4.7	5.0	4.4	4.9	5.2	4.2	4.8	3.5	3.1	1.8	15.0	19.8	20.7	18.0	15.4	12.0	18.5	16.5	17.3	21.3
TALDO1		ENSG00000177156	"Transaldolase 1"	P37837	11	747329-765024	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pentose shunt"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 204.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 148.6;neutrophil: 204.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048089			Approved	Nucleoplasm,Cytosol		39000000	39000000	Nucleoplasm	Cytosol	"HPA048089: AB_2680260"	"unprognostic (5.29e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.16e-3)"	39.0	24.2	26.6	34.8	31.3	117.4	44.2	20.6	38.3	27.7	28.5	51.2	18.8	34.2	20.4	20.7	90.0	23.2	33.2	37.5	29.2	23.6	45.8	48.4	37.9	60.0	46.5	26.6	23.4	31.9	14.6	15.8	34.3	30.7	28.3	23.7	15.5	38.3	19.5	31.2	38.4	29.4	40.4	47.5	45.6	35.8	14.8	33.0	34.1	42.2	82.4	43.1	51.4	37.5	8.5	36.1	204.6	60.8	5.9	10.4	45.3	41.9	53.1	15.4	29.1	31.9	18.6	45.4	31.9	41.1	31.6	26.1	22.6	91.6	23.4	43.4	41.8	45.4	24.3	34.4	16.5	30.6	49.3	40.5	20.6	78.8	34.1	64.7	60.5	15.2	27.8	21.2	17.2	43.4	52.5	39.2	29.3	40.1	37.6	76.8	24.2	43.1	31.4	18.1	83.9	57.4	24.5	38.0	13.3	29.7	61.5	30.9	29.2	49.3	57.6	14.5	13.6	11.4	29.9	16.6	16.1	27.8	32.1	56.6	58.4	64.7	60.8	148.6	5.6	23.2	6.1	8.5	7.5	6.8	36.1	6.8	6.1	5.7	204.6	5.9	23.2	14.8	10.4	45.3	26.6	31.3	20.6	38.3	29.2	23.6	46.5	26.6	30.7	33.0
TAP1	"ABCB2, D6S114E, PSF1, RING4"	ENSG00000168394	"Transporter 1, ATP binding cassette subfamily B member"	Q03518	6	32845209-32853978	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009516, HPA072354"	Approved		Supported	"Endoplasmic reticulum,Centriolar satellite"		110000	110000	"Endoplasmic reticulum, Centriolar satellite"		"CAB009516: AB_2303048, HPA072354: "	"unprognostic (3.59e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (9.01e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.56e-2)"	"prognostic favourable (4.07e-4)"	"unprognostic (3.02e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavourable (6.58e-5)"	"unprognostic (2.07e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	10.7	7.9	3.8	20.4	5.2	6.1	8.7	3.1	4.9	6.5	12.6	4.5	1.9	9.1	8.2	3.9	10.5	6.4	9.6	6.5	3.5	3.3	6.5	6.4	17.6	26.9	6.4	3.6	5.0	4.4	3.0	3.6	8.7	6.0	9.0	5.4	6.6	9.4	4.4	7.5	15.3	19.5	5.7	5.2	24.2	12.6	5.8	4.9	20.8	13.1	8.9	20.3	6.6	7.6	22.7	8.8	45.3	10.9	14.4	25.3	21.0	2.8	1.8	0.0	1.7	0.9	1.2	16.6	1.5	3.4	6.9	9.4	0.1	3.0	5.9	3.9	1.1	5.5	1.1	2.4	0.4	10.1	1.5	6.6	1.3	2.3	4.3	0.0	2.4	1.3	2.1	1.9	1.2	1.7	0.4	5.6	0.8	1.7	1.1	13.1	0.0	1.9	5.9	1.2	3.9	8.9	0.5	0.0	0.3	1.6	4.2	5.7	3.8	11.8	0.9	2.6	1.0	6.3	0.0	7.5	10.4	1.7	1.7	4.0	1.8	27.7	10.6	44.2	15.5	10.9	16.3	22.7	17.5	16.4	8.8	20.9	25.3	19.4	45.3	14.4	10.5	7.2	21.7	21.0	3.8	5.2	3.1	4.9	3.5	3.3	6.4	3.6	6.0	4.9
TAP2	"ABCB3, D6S217E, PSF2, RING11"	ENSG00000204267	"Transporter 2, ATP binding cassette subfamily B member"	Q03519	6	32821833-32838780	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 28.3;U-251 MG: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA001312	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		14000	14000	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA001312: AB_1080206"	"unprognostic (2.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavourable (1.51e-4)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (5.22e-8)"	"unprognostic (5.32e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.71e-2)"	12.8	8.4	6.5	22.5	6.9	14.7	9.5	6.3	7.3	8.8	15.0	7.6	3.3	15.3	9.6	5.9	17.4	7.9	11.5	7.7	5.2	6.0	10.8	19.0	18.0	14.0	7.1	6.3	9.7	6.1	2.6	5.8	5.7	7.9	8.2	11.9	7.9	12.1	5.2	5.8	9.6	28.0	7.0	6.1	24.9	7.7	3.3	6.9	25.9	14.7	7.1	20.1	23.6	10.7	0.9	2.8	4.9	5.4	2.9	4.1	1.9	7.8	0.0	0.0	2.3	2.2	3.0	0.0	0.5	1.6	6.2	8.4	2.1	16.1	15.4	3.0	3.9	8.2	7.1	28.3	2.4	10.4	0.9	1.8	6.0	0.7	1.0	0.0	12.2	0.3	0.4	8.4	13.0	4.0	8.5	5.2	0.0	0.6	2.0	1.0	0.3	3.9	8.4	0.0	5.9	5.2	0.1	0.1	0.0	7.6	16.2	1.6	0.8	0.0	2.3	8.7	2.0	2.3	28.0	8.0	13.3	14.4	8.0	10.8	1.5	1.7	2.0	1.8	4.1	5.4	2.0	0.9	1.2	2.7	2.0	0.6	1.0	0.6	4.9	2.9	4.1	2.8	1.9	1.9	6.5	6.9	6.3	7.3	5.2	6.0	7.1	6.3	7.9	6.9
TARS2	"FLJ12528, TARSL1"	ENSG00000143374	"Threonyl-tRNA synthetase 2, mitochondrial"	Q9BW92	1	150487364-150507609	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028626	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"				"Nucleoplasm, Cytosol"	"Intermediate filaments"	"HPA028626: AB_10601719"	"unprognostic (2.48e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.55e-2)"	10.7	21.1	16.5	10.5	17.8	9.2	11.3	17.5	21.4	10.2	10.9	14.8	12.9	9.4	10.5	14.7	15.7	13.0	11.8	20.9	18.1	12.3	15.6	26.8	9.1	14.0	15.0	19.7	13.3	11.5	20.4	12.2	9.4	16.5	9.8	12.5	13.3	11.3	10.9	36.0	13.3	10.5	10.9	13.8	15.1	12.4	10.7	16.6	10.6	12.3	12.2	15.7	12.5	10.8	21.5	17.4	20.4	18.6	21.5	20.9	12.2	17.0	14.3	9.7	14.5	10.9	10.0	18.4	8.3	9.1	16.5	16.7	11.6	16.0	24.8	18.4	6.2	17.8	23.4	19.3	12.7	14.9	20.3	11.7	13.5	11.7	10.8	16.1	18.0	8.8	16.2	12.5	17.1	10.6	20.3	17.4	11.5	20.7	13.6	13.2	11.9	21.3	14.1	12.3	30.6	11.2	8.1	13.7	16.0	12.6	27.9	19.6	22.5	25.3	6.2	9.7	10.3	7.9	14.0	16.8	19.8	18.7	14.4	18.8	9.3	15.1	11.0	20.4	15.7	18.3	15.6	21.5	15.4	15.5	17.4	18.6	15.1	15.8	1.7	21.5	18.6	11.7	20.9	12.2	16.5	17.8	17.5	21.4	18.1	12.3	15.0	19.7	16.5	16.6
TAT		ENSG00000198650	"Tyrosine aminotransferase"	P17735	16	71565660-71577130	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Aminotransferase, Transferase"	"Disease mutation, Mental retardation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 387.0"	"Group enriched"	"Detected in some"	5	"Daudi: 2.3;Hep G2: 7.1"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 152.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (3.66e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic favourable (6.51e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	387.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.9	2.6	1.5	0.4	0.2	0.5	0.2	0.1	0.2	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.2	7.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.2	0.4	0.1	0.0	0.7	0.9	0.0	0.1	0.3	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.5	0.2	0.5	0.0	0.3	0.2	1.5	0.4	0.2	0.3	0.1	0.4	1.2	0.5	0.4	0.2	1.9	0.5	0.5	1.5	0.2	0.1	2.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
TBC1D4	"AS160, DKFZp779C0666, KIAA0603"	ENSG00000136111	"TBC1 domain family member 4"	O60343	13	75284665-75482114	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"GTPase activation"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 36.9;HUVEC TERT2: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 17.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.2;T-cells: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040145, HPA059885"	Approved		Supported	Cytosol				Cytosol		"HPA040145: , HPA059885: "	"unprognostic (5.44e-3)"	"unprognostic (5.23e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.54e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.64e-1)"	"prognostic favourable (1.07e-11)"	"unprognostic (6.40e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.88e-2)"	"unprognostic (3.45e-1)"	12.0	43.9	6.7	6.7	7.0	1.2	17.5	9.3	10.7	6.9	5.7	4.6	4.2	1.9	5.4	10.1	6.1	5.9	8.5	25.5	8.0	4.1	15.6	5.3	8.5	14.9	5.4	7.0	22.5	8.5	9.5	4.2	9.5	11.1	7.4	4.9	2.0	20.8	2.4	40.1	10.8	6.3	4.7	4.8	9.6	6.1	3.3	4.4	1.1	17.7	17.3	14.8	4.7	8.7	0.5	7.2	2.6	0.3	0.3	17.4	1.8	5.5	6.5	4.1	0.2	9.7	10.5	5.3	4.8	2.5	3.9	4.3	36.9	6.8	1.1	1.1	6.8	5.2	10.4	4.8	4.1	18.3	10.5	18.0	8.8	11.1	2.4	8.5	0.2	11.4	8.9	4.3	10.2	27.3	5.0	0.6	4.4	2.6	12.4	1.5	5.8	3.9	11.2	3.9	6.5	3.8	4.0	7.6	2.3	2.1	6.5	3.5	2.2	0.2	11.4	4.4	5.5	2.3	5.6	0.3	0.0	0.1	7.9	8.0	6.5	2.6	0.3	0.0	0.5	0.1	0.0	0.5	8.6	1.8	0.4	0.4	8.0	3.7	0.3	0.3	0.1	7.2	17.4	1.8	6.7	7.0	9.3	10.7	8.0	4.1	5.4	7.0	11.1	4.4
TBCK	"HSPC302, MGC16169"	ENSG00000145348	"TBC1 domain containing kinase"	Q8TEA7	4	106041599-106321495	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 24.8;BJ hTERT+ SV40 Large T+ RasG12V: 43.6;HBF TERT88: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039951, HPA051611"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA039951: AB_10795300, HPA051611: "	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.81e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (3.20e-4)"	"unprognostic (8.17e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-1)"	12.8	19.0	14.2	7.6	15.2	3.4	10.0	16.3	15.2	13.5	8.3	10.0	11.0	4.4	10.9	14.9	10.6	13.0	13.2	9.3	12.1	11.1	17.8	10.5	9.6	6.9	15.0	8.5	17.5	8.2	12.6	24.2	13.7	12.1	11.9	9.1	9.0	9.1	14.6	4.2	8.5	7.2	13.3	10.3	8.5	8.1	12.0	13.8	18.5	13.9	4.6	8.9	14.5	10.7	10.7	6.3	11.9	6.8	5.9	8.4	4.2	0.9	2.5	5.1	1.9	19.2	12.0	0.9	3.8	6.2	24.8	43.6	4.4	3.8	1.7	5.8	13.0	2.2	3.4	4.7	29.8	2.3	1.0	5.3	2.0	4.6	5.0	2.2	3.1	11.2	3.9	2.3	3.9	6.4	4.1	2.1	7.5	3.3	2.8	2.0	1.2	1.7	2.1	3.2	3.5	6.5	4.4	2.7	2.2	3.4	2.4	3.3	3.3	4.8	3.7	4.4	2.2	1.0	1.9	1.0	2.8	3.7	6.0	3.2	2.3	11.9	6.4	6.3	6.2	6.8	7.2	6.2	6.8	8.4	6.3	10.7	7.4	6.7	0.5	5.9	4.6	6.1	6.7	4.2	14.2	15.2	16.3	15.2	12.1	11.1	15.0	8.5	12.1	13.8
TBK1	NAK	ENSG00000183735	"TANK binding kinase 1"	Q9UHD2	12	64451880-64502108	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045797, HPA060211"	Uncertain		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA045797: , HPA060211: "	"unprognostic (4.73e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (3.30e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (3.48e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (4.20e-6)"	"unprognostic (4.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.56e-3)"	19.1	23.3	13.7	16.8	17.1	32.3	19.1	17.8	20.5	14.9	18.3	10.0	14.1	18.0	17.0	15.1	15.3	13.8	15.6	11.7	14.7	15.6	15.4	20.8	17.8	18.3	20.2	13.6	15.6	11.1	13.1	27.2	40.6	21.1	16.3	12.9	10.1	15.0	18.3	24.8	12.1	21.4	17.2	18.8	24.6	14.5	27.9	16.9	3.4	13.3	12.6	16.7	18.4	19.6	9.7	8.2	22.5	11.9	16.3	11.8	5.9	13.4	15.5	8.8	12.9	15.8	16.0	19.5	14.8	21.5	13.9	13.3	8.7	8.2	18.9	12.9	16.0	12.7	11.4	12.4	16.5	17.3	10.8	20.2	11.2	12.0	17.4	20.6	25.3	12.0	11.4	13.9	13.4	18.5	15.5	27.5	17.9	16.5	0.6	16.2	17.7	9.1	9.6	9.8	18.2	15.2	24.5	7.4	10.7	19.5	20.0	14.3	20.5	15.0	17.1	12.6	12.2	10.1	14.4	17.4	30.3	18.4	15.9	11.4	16.2	22.5	7.3	16.6	11.0	11.9	11.8	9.7	8.0	11.0	8.2	7.6	2.8	7.1	15.1	16.3	10.6	1.9	9.5	5.9	13.7	17.1	17.8	20.5	14.7	15.6	20.2	13.6	21.1	16.9
TDO2	"TDO, TPH2"	ENSG00000151790	"Tryptophan 2,3-dioxygenase"	P48775	4	155854738-155920406	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"liver: 187.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 8.4;HDLM-2: 16.4;U-87 MG: 9.6"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 35.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebellum: 7.0;hippocampal formation: 5.9"	"Not detected"	"Not detected"			HPA039611	Uncertain		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA039611: "	"unprognostic (1.10e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-8)"	"unprognostic (7.99e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-2)"	0.2	0.5	0.2	2.5	0.5	0.0	0.1	0.1	2.0	0.1	0.2	0.0	0.1	0.6	0.1	0.2	0.2	0.1	0.3	0.1	1.5	0.2	0.2	187.9	0.8	2.9	0.2	0.7	0.1	0.1	0.0	5.8	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	1.1	0.4	0.2	1.5	0.3	0.1	0.0	0.0	0.1	0.0	0.4	1.2	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	8.4	0.0	0.0	0.1	0.0	0.0	16.4	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.1	0.3	0.4	0.0	2.6	0.0	0.0	9.6	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	2.0	1.5	0.2	0.2	0.7	0.1	0.0
TDRD9	"C14orf75, DKFZp434N0820, FLJ36164, NET54"	ENSG00000156414	"Tudor domain containing 9"	Q8NDG6	14	103928462-104052667	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"parathyroid gland: 19.9;testis: 48.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.8;HeLa: 9.5;HMC-1: 44.1;RPTEC TERT1: 12.0;SK-MEL-30: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"classical monocyte: 4.6"	"Lineage enriched"	"Detected in single"	5	"monocytes: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (3.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-4)"	"unprognostic (1.60e-2)"	"unprognostic (4.57e-3)"	"unprognostic (8.97e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (2.41e-2)"	0.4	0.4	0.7	0.4	1.5	1.2	0.5	1.5	1.5	0.3	0.3	0.8	0.6	0.1	0.3	0.3	0.2	0.7	2.1	0.6	0.8	0.7	1.8	0.5	1.0	0.3	0.8	1.3	0.3	0.7	19.9	0.9	0.4	3.4	0.3	0.1	1.8	0.9	1.0	0.1	0.1	0.3	0.4	1.6	2.8	0.6	48.0	0.5	0.2	4.2	0.0	0.8	0.4	0.2	0.0	0.8	0.0	4.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	9.5	0.0	0.0	0.0	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	4.0	0.0	0.0	0.3	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	1.5	1.5	1.5	0.8	0.7	0.8	1.3	3.4	0.5
TECR	"GPSN2, MRT14, SC2, TER"	ENSG00000099797	"Trans-2,3-enoyl-CoA reductase"	Q9NZ01	19	14517085-14565980	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029780, HPA056488"	Supported		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA029780: AB_10603348, HPA056488: AB_2683149"	"unprognostic (9.73e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavourable (2.60e-4)"	32.8	43.2	45.0	15.0	43.7	23.0	26.2	51.7	70.8	34.9	26.1	64.5	40.1	37.8	16.5	38.2	89.6	32.4	19.0	22.3	42.9	38.3	29.0	45.9	20.7	17.8	45.6	34.7	25.0	37.0	95.0	20.9	68.5	50.4	23.9	21.7	34.5	69.8	42.0	121.4	89.5	34.8	13.8	53.3	20.0	24.5	59.6	40.2	29.8	33.5	40.7	49.5	18.3	43.8	21.7	30.2	10.7	22.8	34.3	60.6	32.7	38.8	29.0	27.7	31.2	40.5	18.5	29.3	11.3	32.2	36.6	45.6	38.5	45.0	20.9	23.9	23.8	60.6	29.2	46.2	14.8	34.2	25.1	35.5	43.5	42.4	24.4	25.1	27.1	27.4	37.0	32.2	17.7	17.2	22.7	72.1	18.7	48.9	29.5	43.8	29.0	31.4	27.5	18.1	92.4	49.7	21.0	34.6	21.2	19.0	51.2	24.3	27.5	49.8	10.0	29.4	12.7	25.5	38.2	22.1	21.1	21.5	30.2	37.9	29.3	9.2	16.0	10.7	32.0	22.8	34.7	21.7	42.0	36.6	27.3	21.0	49.2	38.8	7.2	34.3	17.1	30.2	60.6	32.7	45.0	43.7	51.7	70.8	42.9	38.3	45.6	34.7	50.4	40.2
TERT	"EST2, hEST2, TCS1, TP2, TRT"	ENSG00000164362	"Telomerase reverse transcriptase"	O14746	5	1253147-1295069	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase"	"Cancer-related genes, Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.4;lymphoid tissue: 12.0;testis: 5.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 61.2;fHDF/TERT166: 58.1;HBEC3-KT: 118.1;hTEC/SVTERT24-B: 74.6;LHCN-M2: 33.7;TIME: 96.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA054641, HPA065897"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA054641: , HPA065897: "	"unprognostic (1.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.16e-4)"	"unprognostic (8.84e-11)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"		"unprognostic (3.35e-1)"	0.0	0.0	0.0	7.1	0.9	3.4	0.0	0.0	0.2	0.1	1.1	0.0	0.0	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	1.0	0.4	5.0	0.0	12.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	30.6	61.2	0.5	0.0	23.3	4.2	7.9	0.1	0.1	0.7	0.0	58.1	0.0	0.2	118.1	5.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.2	0.0	3.0	74.6	0.8	0.2	0.6	0.1	33.7	0.0	0.2	1.6	0.4	0.2	0.8	0.0	0.8	3.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	96.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0
TET1	"bA119F7.1, CXXC6, KIAA1676, LCX"	ENSG00000138336	"Tet methylcytosine dioxygenase 1"	Q8NFU7	10	68560656-68694482	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 15.1;HAP1: 17.2;K-562: 9.6;NTERA-2: 10.1"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 10.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019032, HPA057273"			Supported	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"HPA019032: AB_1847363, HPA057273: "	"unprognostic (1.60e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.52e-3)"	4.4	1.6	3.3	4.3	2.6	1.6	3.1	4.4	4.3	5.1	2.4	5.8	3.2	1.2	6.0	3.4	2.4	2.9	3.5	2.4	3.5	2.3	1.8	1.5	1.6	1.7	2.5	2.6	6.1	1.6	7.4	2.2	5.8	2.9	3.2	2.0	8.1	15.9	4.8	4.0	2.2	1.8	6.5	3.6	1.7	2.2	1.4	5.9	1.2	3.2	3.2	1.8	5.1	5.4	1.3	1.1	1.0	0.0	0.9	2.3	0.2	0.6	0.7	6.8	7.7	0.7	0.6	15.1	0.3	0.8	0.6	1.1	4.6	0.2	0.0	0.2	0.7	0.0	17.2	0.0	0.7	0.2	2.7	1.8	0.0	4.0	1.0	1.5	0.9	0.9	0.1	0.4	0.0	0.1	9.6	1.2	0.6	0.5	2.7	1.2	10.1	0.9	2.6	2.2	0.2	0.3	0.7	1.9	3.0	0.3	0.4	1.4	0.9	1.2	0.2	0.6	1.4	0.0	0.5	0.5	0.5	2.7	0.1	0.0	0.1	0.0	0.0	1.0	1.5	0.0	2.0	1.3	0.8	1.3	0.2	0.5	1.4	1.1	0.0	0.9	0.0	1.1	2.3	0.2	3.3	2.6	4.4	2.6	3.5	2.3	2.5	2.6	2.9	5.9
TET2	"FLJ20032, KIAA1546"	ENSG00000168769	"Tet methylcytosine dioxygenase 2"	Q6N021	4	105145875-105279816	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043135	Supported		Approved	Nucleoplasm				Nucleoplasm		"HPA043135: AB_10794177"	"unprognostic (6.83e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.15e-2)"	"unprognostic (7.84e-2)"	9.9	6.1	8.7	11.9	11.4	26.3	8.0	4.1	10.0	9.6	7.4	10.1	5.8	8.2	10.1	7.4	16.2	9.2	6.6	6.8	9.0	4.2	6.7	5.5	9.9	9.8	13.7	5.7	8.5	7.0	7.4	29.0	12.4	9.1	6.5	8.0	4.7	13.5	8.2	9.8	16.0	10.2	7.8	15.5	12.9	6.8	3.2	14.6	9.3	7.2	6.9	8.7	9.8	12.3	2.8	5.1	29.0	7.0	2.6	2.1	1.4	4.7	3.1	10.4	10.6	1.9	4.3	4.3	3.4	4.6	4.9	4.8	3.1	6.4	0.5	3.9	4.3	4.6	10.1	6.0	5.6	6.2	2.7	6.6	5.9	1.1	5.3	15.1	11.1	3.6	8.1	4.7	6.1	6.5	7.1	12.5	4.2	3.6	2.5	4.1	2.3	1.9	7.8	5.2	0.9	4.5	10.0	7.4	6.1	3.8	9.8	0.6	4.4	10.9	8.4	7.5	6.8	2.1	5.8	8.4	6.0	6.3	4.6	3.7	7.3	10.8	7.0	7.2	2.1	5.5	0.8	2.6	1.2	1.2	5.1	2.8	1.0	1.6	29.0	2.6	6.4	4.5	1.5	1.4	8.7	11.4	4.1	10.0	9.0	4.2	13.7	5.7	9.1	14.6
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 52.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.9;Karpas-707: 11.6;MCF7: 4.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA030620: AB_10601598, HPA077020: "	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.2	0.1	0.3	1.5	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.5	0.2	0.0	52.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.2	0.1	0.0	0.2	2.5	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.2	0.0	0.0	0.3	0.0	0.2	8.9	1.3	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.0	0.1	11.6	0.0	4.7	0.4	0.1	0.6	0.1	0.5	0.4	1.7	0.0	0.1	1.4	0.2	0.0	0.0	0.6	0.4	0.1	0.0	0.1	0.3	0.0	0.0	2.0	0.5	1.1	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.8	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.9	0.2	0.3	0.2	0.2	0.1	0.4	0.1
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 112.6"	"Group enriched"	"Detected in some"	11	"HEL: 27.8;HMC-1: 38.6;K-562: 25.7"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	46	"basophil: 5.5;eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011937, CAB016255"	Enhanced									"CAB016255: AB_628395, HPA011937: AB_1858243"	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favourable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	0.1	0.0	0.1	0.1	0.1	5.3	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.1	112.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	2.8	0.0	0.6	38.6	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082189	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	14000000	14000000	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavourable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (2.96e-4)"	"unprognostic (2.62e-2)"	24.3	11.9	11.9	20.6	11.3	73.8	7.6	9.6	17.8	11.8	25.0	9.5	3.8	11.9	12.1	7.5	18.5	11.7	11.4	18.7	9.5	8.3	15.3	13.6	28.1	8.1	7.4	9.5	50.0	7.8	18.0	6.9	110.0	26.5	7.2	19.4	8.5	8.3	5.0	25.6	9.9	37.4	10.9	13.2	7.9	10.0	8.3	6.1	14.3	7.0	10.5	12.9	11.2	8.0	5.7	7.5	2.2	12.4	1.8	6.5	2.1	21.9	20.0	9.2	18.6	20.4	11.8	57.5	31.4	23.9	22.1	36.7	48.7	20.2	22.5	59.6	11.6	33.9	31.5	10.4	27.1	107.6	10.7	85.3	17.0	22.6	16.1	69.9	17.3	13.3	10.3	19.0	17.2	7.3	35.5	21.6	17.2	20.3	22.9	14.8	28.0	41.0	12.2	13.7	27.0	19.8	55.6	21.0	8.7	30.3	79.7	7.1	77.4	14.6	9.4	26.3	21.4	23.0	47.0	6.1	47.5	35.2	30.8	19.0	15.9	0.0	1.6	2.2	2.5	7.9	1.7	5.7	2.7	1.7	3.7	3.2	2.5	1.9	0.3	1.8	12.4	7.5	6.5	2.1	11.9	11.3	9.6	17.8	9.5	8.3	7.4	9.5	26.5	6.1
TGDS	"SDR2E1, TDPGD"	ENSG00000088451	"TDP-glucose 4,6-dehydratase"	O95455	13	94574051-94596257	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039927, HPA040857"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA039927: AB_10795238, HPA040857: AB_10794867"	"unprognostic (4.07e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (5.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.09e-1)"	11.1	12.2	7.9	11.4	11.8	5.8	13.4	8.0	7.8	11.9	9.0	9.0	13.4	11.1	13.7	13.2	10.3	10.5	8.7	7.7	7.0	7.0	11.8	31.9	7.8	12.5	11.8	6.8	13.9	14.1	6.2	24.3	10.8	10.1	10.5	10.6	15.4	12.5	12.7	7.6	7.9	11.1	10.3	12.6	11.9	9.8	7.2	12.6	27.1	15.8	8.9	12.5	10.9	9.2	9.9	8.0	10.5	7.0	10.4	17.4	6.7	7.2	3.0	5.1	4.6	7.6	6.1	6.4	6.6	6.4	6.3	6.1	8.4	7.1	11.2	6.7	4.6	4.6	9.0	5.2	6.5	8.9	3.6	9.0	3.6	7.8	9.6	30.8	6.2	7.1	4.2	3.5	10.1	5.8	8.8	3.9	5.6	4.4	8.4	15.9	6.7	3.9	7.2	5.2	6.6	7.9	3.2	7.3	4.0	5.0	10.5	18.6	4.7	16.7	5.3	2.5	6.6	3.9	5.5	8.9	4.8	41.2	6.9	11.4	6.8	10.5	5.3	9.6	9.6	6.2	14.5	9.9	11.3	10.5	8.0	7.3	17.4	12.4	1.5	10.4	7.0	7.1	12.5	6.7	7.9	11.8	8.0	7.8	7.0	7.0	11.8	6.8	10.1	12.6
TGFBR1	"ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI"	ENSG00000106799	"Transforming growth factor beta receptor 1"	P36897	9	99104038-99154192	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 67.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002441, CAB031481, HPA056473"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: "	"unprognostic (2.58e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-2)"	11.1	6.9	10.3	11.5	14.6	20.0	15.4	12.6	11.3	14.4	20.0	11.0	5.5	7.4	18.8	8.0	13.2	10.9	14.9	9.7	7.8	7.5	16.0	9.8	19.2	18.9	15.8	4.3	13.3	8.8	6.5	13.5	50.9	14.1	12.3	9.2	10.4	10.2	12.2	8.4	6.6	11.0	28.6	17.9	13.9	25.5	11.4	12.4	10.8	7.7	8.1	11.5	13.0	10.2	1.6	2.0	13.1	2.4	4.0	8.3	1.9	3.3	5.0	30.8	9.5	7.2	5.3	4.6	11.5	12.6	10.7	12.1	5.1	2.4	7.5	3.6	9.0	8.0	10.4	8.9	14.6	19.5	3.2	11.2	5.6	4.5	11.9	6.9	27.3	11.0	9.6	16.8	7.9	1.9	15.5	3.2	14.7	5.2	1.0	7.8	6.5	3.0	2.8	67.2	3.2	2.6	0.8	8.3	9.7	8.9	39.9	11.9	7.4	9.4	3.5	8.0	6.9	34.3	7.0	3.2	3.2	5.1	16.8	11.9	6.9	13.1	2.4	9.1	8.3	1.6	7.2	1.6	3.6	6.1	2.0	1.3	3.5	6.7	4.9	4.0	1.9	1.4	2.2	1.9	10.3	14.6	12.6	11.3	7.8	7.5	15.8	4.3	14.1	12.4
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	"Transforming growth factor beta receptor 2"	P37173	3	30606502-30694142	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 53.4;ASC TERT1: 80.5;HSkMC: 69.5;LHCN-M2: 65.8;TIME: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB073537			Supported	"Plasma membrane"		560000	560000	"Plasma membrane"		"CAB073537: "	"unprognostic (1.74e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.81e-2)"	"unprognostic (8.02e-2)"	91.8	24.6	6.7	24.6	10.3	7.3	88.3	3.6	7.3	36.5	42.6	9.8	18.6	13.2	42.6	23.3	36.2	28.4	42.6	73.5	6.9	5.2	32.6	21.9	52.6	75.7	12.6	3.7	22.2	26.0	17.4	10.3	24.2	9.9	35.2	17.5	27.9	22.5	19.5	34.9	17.0	31.3	37.2	12.0	68.7	26.8	15.4	8.2	19.3	40.9	16.8	26.9	48.0	82.0	5.3	6.8	20.0	6.6	1.4	19.7	3.9	2.4	14.4	0.9	0.0	53.4	80.5	2.4	12.5	17.6	4.3	4.3	3.2	13.3	0.3	45.3	16.8	5.0	0.6	18.3	7.2	1.0	1.3	1.4	1.6	16.2	22.8	2.2	11.8	69.5	16.3	18.6	18.0	46.7	0.2	0.0	65.8	0.2	2.3	1.6	0.4	5.8	2.0	5.8	0.3	23.2	5.8	0.0	0.9	3.7	1.0	3.5	0.0	2.4	60.3	21.2	5.2	9.6	4.7	0.4	0.0	2.0	12.7	2.5	8.5	6.9	2.9	20.0	3.5	3.0	3.2	4.0	5.4	4.2	2.6	5.3	19.7	9.1	12.6	1.4	6.6	6.8	1.2	3.9	6.7	10.3	3.6	7.3	6.9	5.2	12.6	3.7	9.9	8.2
TGM1	"ICR2, LI, LI1, TGASE, TGK"	ENSG00000092295	"Transglutaminase 1"	P22735	14	24249114-24264432	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 106.0;lymphoid tissue: 70.0;tongue: 86.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 12.8;HaCaT: 17.6;HeLa: 11.5;MCF7: 12.6;SK-BR-3: 15.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 78.3"	"Region enriched"	"Detected in single"	11	"cerebellum: 3.0"	"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015159, HPA040171"	Enhanced					430000	430000			"CAB015159: AB_2202870, HPA040171: "	"unprognostic (2.95e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.94e-7)"	"unprognostic (7.11e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.86e-2)"	2.9	0.2	0.2	0.4	0.2	0.2	0.7	3.0	0.3	10.1	1.0	0.2	0.2	0.3	0.5	2.0	106.0	1.3	0.2	0.6	0.2	0.0	0.6	0.3	0.9	0.4	0.2	0.2	0.7	1.3	0.2	0.2	0.9	0.2	0.5	0.3	0.4	12.8	1.4	0.7	9.3	0.3	0.2	0.2	0.4	0.2	0.4	0.2	0.5	0.4	86.8	70.0	0.4	17.2	0.4	0.5	0.0	0.5	0.0	1.1	0.2	0.8	1.5	0.8	0.7	0.0	0.6	12.8	0.3	0.2	0.7	1.2	0.9	1.3	0.7	1.7	0.9	17.6	2.1	1.4	0.5	1.4	2.4	1.0	11.5	4.0	0.6	0.6	1.1	1.1	7.0	0.4	1.5	0.5	0.7	0.7	0.5	12.6	0.5	1.3	0.2	1.6	0.8	0.1	0.8	0.5	1.5	0.9	1.1	0.2	15.7	0.0	1.1	0.8	0.6	0.8	3.7	1.5	0.6	1.1	1.2	0.2	0.3	1.5	0.9	0.0	0.5	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.2	0.2	3.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2
TGM3	TGE	ENSG00000125780	"Transglutaminase 3"	Q08188	20	2296001-2341078	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 195.0;lymphoid tissue: 152.6;tongue: 206.5"	"Cell line enriched"	"Detected in some"	6	"EFO-21: 11.6"	"Cancer enriched"	"Detected in many"	9	"head and neck cancer: 81.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	205	"neutrophil: 20.4"	"Lineage enriched"	"Detected in single"	205	"granulocytes: 20.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA004728	Enhanced					14000000	14000000			"HPA004728: AB_1080360"	"unprognostic (7.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.23e-3)"	"unprognostic (4.27e-2)"	"unprognostic (4.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.78e-8)"	"unprognostic (1.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.67e-2)"	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.1	0.1	195.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	24.5	0.0	0.1	7.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	206.5	152.6	0.0	2.8	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TGM5	TGX	ENSG00000104055	"Transglutaminase 5"	O43548	15	43232595-43266857	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 9.7;lymphoid tissue: 10.4;skin 1: 24.3;tongue: 13.1"	"Cell line enriched"	"Detected in some"	7	"HEL: 19.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"cerebellum: 2.9"	"Not detected"	"Not detected"														"unprognostic (3.17e-2)"	"unprognostic (1.03e-2)"		"unprognostic (5.92e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-2)"		"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.44e-15)"	"unprognostic (1.94e-1)"	"unprognostic (3.14e-1)"	"unprognostic (7.22e-3)"	"unprognostic (5.71e-2)"	0.3	0.0	0.1	0.1	0.1	0.2	2.1	0.1	0.1	2.6	0.1	0.1	0.1	0.0	0.7	0.1	9.7	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.6	0.0	0.1	2.8	3.4	0.1	24.3	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	13.1	10.4	0.8	4.7	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.4	0.0	0.7	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TGM6	"dJ734P14.3, SCA35, TGM3L, TGY"	ENSG00000166948	"Transglutaminase 6"	O95932	20	2380908-2432753	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	34	"lymphoid tissue: 5.7;skin 1: 3.3;tongue: 4.2"	"Cell line enriched"	"Detected in single"	12	"SCLC-21H: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	34	"cerebellum: 1.8"	HPA059196	Uncertain									"HPA059196: "						"unprognostic (1.18e-1)"						"unprognostic (2.84e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	5.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TK2	SCA31	ENSG00000166548	"Thymidine kinase 2, mitochondrial"	O00142	16	66508003-66552544	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA synthesis"	"Kinase, Transferase"	"Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041162	Uncertain									"HPA041162: AB_10961178"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.27e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.85e-1)"	"prognostic favourable (2.18e-6)"	"unprognostic (3.05e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.05e-2)"	34.0	25.4	18.5	9.0	18.9	6.2	25.5	13.1	22.4	19.8	10.9	17.2	18.5	9.5	15.2	29.0	11.0	17.4	18.3	15.2	19.2	15.5	20.9	27.8	16.5	11.5	18.2	18.5	23.7	21.6	50.2	18.0	12.9	27.9	14.9	11.5	13.7	18.1	18.8	20.8	10.0	10.5	17.0	28.2	17.4	12.0	29.4	15.5	6.5	23.4	9.0	8.7	15.5	18.6	1.4	12.6	10.3	15.6	4.4	4.3	3.3	4.7	9.4	5.1	5.3	28.1	23.1	0.3	8.2	10.0	6.6	7.7	2.8	10.5	0.1	9.1	25.6	4.1	2.5	6.8	4.3	3.1	2.3	0.8	6.0	5.2	20.0	1.3	3.6	17.2	6.5	7.6	10.5	9.8	2.8	11.1	15.5	1.6	2.5	6.2	2.5	5.6	2.8	9.2	10.9	20.3	4.0	1.9	3.3	24.8	2.5	10.7	3.8	6.8	10.4	12.8	6.6	10.3	3.0	12.5	5.2	5.6	15.4	2.5	7.5	4.7	15.6	10.3	4.3	13.3	3.3	0.9	2.9	3.0	12.6	1.4	1.4	2.3	8.2	4.4	9.8	5.2	2.8	3.3	18.5	18.9	13.1	22.4	19.2	15.5	18.2	18.5	27.9	15.5
TKT		ENSG00000163931	Transketolase	P29401	3	53224707-53256052	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 216.3"	"Cell line enhanced"	"Detected in all"		"A549: 161.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 63.0;eosinophil: 41.5;intermediate monocyte: 31.0;myeloid DC: 32.5;neutrophil: 60.1;non-classical monocyte: 35.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 32.5;granulocytes: 60.1;monocytes: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029480, HPA029481"	Enhanced		Enhanced	Nucleoplasm		190000000	190000000	Nucleoplasm		"HPA029480: AB_10599307, HPA029481: AB_10601895"	"unprognostic (5.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (7.21e-6)"	"unprognostic (6.78e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.90e-3)"	53.6	37.0	21.2	24.1	26.0	216.3	70.1	18.1	24.3	19.0	24.3	21.1	9.9	31.8	16.9	9.5	60.4	21.8	36.5	15.3	19.4	23.0	51.9	27.4	50.1	45.6	33.4	16.0	35.2	69.9	22.5	16.9	29.8	28.7	25.2	19.6	17.5	21.0	21.6	5.2	16.8	22.5	34.5	28.2	45.6	24.5	10.8	23.3	44.8	67.7	37.9	25.1	58.2	57.3	6.8	32.5	60.1	63.0	4.7	5.7	37.6	31.8	161.2	23.1	25.6	51.5	63.0	47.1	21.6	37.5	37.4	35.8	44.5	82.0	40.1	10.4	31.5	46.2	40.0	81.3	11.1	13.3	22.2	26.7	112.8	66.8	63.0	32.6	18.1	45.5	46.8	44.8	23.1	47.1	19.0	17.5	15.2	38.9	34.0	36.5	78.3	38.9	20.6	10.5	74.5	58.5	54.2	15.0	11.1	40.2	64.4	38.8	20.0	45.2	35.2	11.6	17.9	34.1	41.2	10.1	18.9	24.0	25.3	33.0	21.5	7.0	63.0	41.5	3.0	31.0	3.8	6.8	4.4	3.4	32.5	3.5	4.6	3.4	60.1	4.7	35.5	5.5	5.7	37.6	21.2	26.0	18.1	24.3	19.4	23.0	33.4	16.0	28.7	23.3
TLL1		ENSG00000038295	"Tolloid like 1"	O43897	4	165873258-166103895	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"Atrial septal defect, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6"	"Group enriched"	"Detected in some"	4	"HeLa: 8.5;Karpas-707: 13.3;PC-3: 4.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 40.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"cerebellum: 132.6"	HPA060767			Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA060767: "	"unprognostic (2.17e-1)"	"unprognostic (6.45e-4)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.37e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.21e-5)"	10.1	1.3	1.2	2.6	2.8	0.0	7.9	40.6	2.9	5.0	5.4	0.2	4.2	1.4	3.0	2.7	2.5	2.4	5.4	2.4	2.2	1.7	3.3	0.5	3.1	3.0	1.1	0.6	1.6	4.6	1.1	2.2	13.8	8.5	3.1	2.2	3.3	1.9	1.9	1.6	2.7	4.4	3.3	0.9	0.4	1.7	1.5	0.1	0.0	3.2	1.4	1.6	3.6	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.0	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.5	1.5	0.0	1.8	1.4	0.0	13.3	0.0	0.0	0.0	0.2	1.2	4.8	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.8	40.6	2.9	2.2	1.7	1.1	0.6	8.5	0.1
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362156-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	86	"intestine: 147.8"	"Cell line enhanced"	"Detected in some"		"A549: 7.1;RPMI-8226: 4.4"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"		"HPA051838: , HPA063184: , HPA065531: "	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	46.5	0.0	0.0	73.5	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.1	0.1	147.8	0.2	0.1	0.1	0.1	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.1	1.2	1.1	0.5	1.7	0.7	0.0	0.1	7.1	0.2	0.1	0.0	0.0	1.3	0.8	0.1	0.0	0.0	1.3	0.5	0.2	0.1	0.4	0.2	0.0	0.0	0.1	0.1	0.4	0.0	1.3	0.2	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.8	0.3	0.0	0.1	1.6	0.3	0.1	0.4	0.1	4.4	0.1	0.3	0.6	1.7	1.0	0.1	0.0	0.3	0.1	0.3	0.6	0.3	1.9	0.2	0.5	0.3	0.4	0.2	0.2	0.2	0.8	0.5	0.1	0.7	0.3	0.3	0.7	0.4	0.4	0.0	1.1	0.7	0.5	1.1	1.7	0.1	1.2	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0
TMC1	"DFNA36, DFNB11, DFNB7"	ENSG00000165091	"Transmembrane channel like 1"	Q8TDI8	9	72521608-72838230	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Hearing, Ion transport, Transport"	"Ion channel"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 3.0"	"Group enriched"	"Detected in some"	4	"BEWO: 3.3;HAP1: 10.3;NTERA-2: 4.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.97e-1)"	"unprognostic (5.67e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-1)"	0.2	0.0	0.9	0.0	0.7	0.0	0.2	0.2	1.1	3.0	0.0			0.0	0.2	1.3	0.7	0.7	0.2	0.0	0.7	0.5	1.4	0.0	0.0	0.0	1.0		0.2	0.0	0.0	0.0	1.1		0.7	0.0		0.0	0.3	0.2	0.0	0.0	0.0	1.5	0.0	0.0	1.1			0.0		0.3	1.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	10.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0										
TMC6	"EVER1, EVIN1, LAK-4P"	ENSG00000141524	"Transmembrane channel like 6"	Q7Z403	17	78110458-78132407	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.6;brain: 43.1;lymphoid tissue: 41.4"	"Cell line enhanced"	"Detected in many"		"K-562: 33.7;SK-BR-3: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051430	Uncertain									"HPA051430: "	"unprognostic (6.34e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.16e-2)"	"prognostic favourable (1.82e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-2)"	"prognostic favourable (3.20e-4)"	10.5	3.5	7.5	26.1	25.5	39.6	8.3	2.1	12.8	4.1	8.8	33.5	5.6	13.5	3.1	1.7	9.5	5.6	6.5	8.1	12.5	8.1	6.9	3.7	14.4	39.2	43.1	4.6	1.7	6.4	1.8	2.4	6.6	20.3	7.5	4.7	3.6	12.7	7.2	2.3	6.5	17.5	2.7	31.4	41.4	9.1	1.6	31.2	12.1	5.0	2.7	24.8	7.3	6.5	13.5	8.3	9.8	26.7	15.6	27.2	13.2	5.4	4.3	2.4	1.9	0.0	0.0	4.9	0.0	0.0	0.0	0.0	7.8	6.2	6.2	7.7	0.0	9.7	0.3	1.8	0.0	0.6	3.5	12.8	1.1	9.6	0.6	11.7	21.9	0.3	5.2	0.0	0.4	4.7	33.7	23.4	0.0	11.0	5.7	20.0	1.9	1.6	2.6	0.2	18.1	3.6	20.3	0.6	1.5	1.8	38.5	10.4	21.9	17.8	1.6	0.0	3.0	0.0	0.1	18.5	8.1	3.9	0.0	19.0	0.3	6.4	4.9	9.8	27.2	16.9	23.7	13.5	20.1	21.9	8.3	10.2	18.1	18.7	6.9	15.6	26.7	2.5	17.0	13.2	7.5	25.5	2.1	12.8	12.5	8.1	43.1	4.6	20.3	31.2
TMC8	"EVER2, EVIN2"	ENSG00000167895	"Transmembrane channel like 8"	Q8IU68	17	78130770-78142968	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.6;intestine: 23.2;lymphoid tissue: 52.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.4;HL-60: 20.4;HMC-1: 41.5;Karpas-707: 35.2;RPMI-8226: 21.8;U-266/70: 17.1;U-937: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047387, HPA054429"	Uncertain		Uncertain	"Golgi apparatus"				"Golgi apparatus"		"HPA047387: , HPA054429: "	"unprognostic (8.54e-3)"	"prognostic favourable (8.45e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.59e-1)"	"prognostic favourable (4.19e-5)"	"unprognostic (6.38e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavourable (1.96e-7)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	3.6	1.6	2.3	30.1	4.6	33.6	1.9	0.7	2.3	1.7	4.4	3.5	0.1	4.2	2.5	2.1	2.5	2.1	6.2	1.5	2.3	1.7	3.4	3.1	10.7	38.7	4.0	0.8	0.9	1.2	0.1	1.3	1.5	2.8	2.4	1.9	2.6	10.2	1.0	0.6	1.7	23.2	1.0	5.1	52.9	4.1	0.7	3.7	49.7	3.1	1.8	36.6	3.9	2.5	5.0	2.1	5.5	6.6	6.7	13.1	4.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	15.4	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	20.4	41.5	0.0	0.0	0.0	0.0	0.0	1.3	35.2	0.0	0.4	7.0	0.9	0.0	0.1	0.4	0.1	21.8	0.0	0.0	0.0	0.0	0.0	0.7	0.2	2.3	4.2	0.0	0.0	0.0	0.0	0.0	17.1	0.7	1.5	0.0	17.3	0.0	2.3	1.8	5.5	13.1	3.1	9.4	5.0	10.5	12.9	2.1	5.0	9.4	8.4	3.0	6.7	6.6	1.9	5.7	4.2	2.3	4.6	0.7	2.3	2.3	1.7	4.0	0.8	2.8	3.7
TMCO1	"HP10122, TMCC4"	ENSG00000143183	"Transmembrane and coiled-coil domains 1"	Q9UM00	1	165724293-165827755	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, Glaucoma, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054768			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA054768: "	"unprognostic (1.22e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavourable (5.17e-7)"	"prognostic unfavourable (3.21e-4)"	"unprognostic (5.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.80e-2)"	28.8	48.5	28.1	18.7	29.8	17.2	34.1	21.5	28.7	30.2	47.4	26.9	37.6	43.0	28.4	43.3	34.3	24.9	30.6	25.9	23.8	26.8	62.6	89.8	24.9	23.6	27.2	21.0	30.6	37.3	32.6	50.1	47.0	31.1	30.7	48.8	29.9	43.5	38.5	20.2	20.9	70.9	23.7	31.4	29.4	29.9	34.4	22.4	36.3	53.7	24.1	31.1	29.4	25.2	46.0	76.6	52.5	57.6	45.1	61.7	78.0	29.6	33.6	25.7	15.5	47.4	22.5	25.1	51.0	36.2	30.1	31.4	47.9	45.0	18.9	53.1	36.9	42.3	33.4	26.8	32.8	48.1	30.9	23.9	39.0	29.5	38.3	40.7	31.5	30.6	31.2	34.9	28.2	21.8	62.0	37.2	42.1	23.0	32.1	30.9	32.8	38.1	23.7	28.8	47.8	36.5	39.2	26.5	46.4	39.1	41.6	31.0	54.5	51.7	23.9	27.7	23.1	24.3	47.2	71.2	96.2	66.6	22.2	26.6	36.7	52.5	55.6	51.2	53.0	50.8	55.6	46.0	56.5	56.5	41.8	39.8	46.0	53.2	43.1	45.1	57.6	76.6	61.7	78.0	28.1	29.8	21.5	28.7	23.8	26.8	27.2	21.0	31.1	22.4
TMEM106B	"FLJ11273, MGC33727"	ENSG00000106460	"Transmembrane protein 106B"	Q9NUM4	7	12211241-12243367	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Amyotrophic lateral sclerosis, Disease mutation, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058342	Approved		Supported	Endosomes,Lysosomes				"Endosomes, Lysosomes"		"HPA058342: "	"unprognostic (5.29e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.52e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-1)"	17.1	48.3	16.2	11.4	23.7	6.2	17.0	18.5	29.0	26.0	20.3	19.4	13.5	16.1	24.9	19.7	18.5	19.9	18.0	20.8	15.7	16.2	30.9	33.0	12.9	11.7	20.5	21.2	22.1	18.3	17.5	31.3	35.3	26.8	27.2	22.6	15.2	23.2	24.3	23.9	15.5	18.1	24.8	24.8	13.5	15.5	12.0	21.3	14.7	30.7	14.9	12.4	21.4	17.9	7.6	2.8	8.8	6.3	14.1	19.4	7.3	9.8	23.4	9.5	25.3	22.2	21.6	10.1	14.6	33.4	10.3	13.3	5.7	38.9	3.9	16.5	19.4	11.4	8.2	9.6	14.1	5.7	7.5	4.8	10.9	6.7	17.9	12.7	6.9	17.3	12.4	7.6	18.0	15.8	11.5	11.8	15.4	4.2	2.8	7.2	15.3	9.5	7.1	8.2	7.7	25.5	9.9	12.2	17.3	15.6	14.2	13.4	12.9	9.1	15.6	14.9	18.0	12.8	12.5	10.9	19.7	4.6	18.6	5.2	34.1	8.8	4.2	4.8	9.4	4.9	13.5	6.3	11.6	11.1	2.8	7.6	19.4	13.5	2.5	14.1	6.3	0.9	9.7	7.3	16.2	23.7	18.5	29.0	15.7	16.2	20.5	21.2	26.8	21.3
TMEM165	"GDT1, TMPT27, TPARL"	ENSG00000134851	"Transmembrane protein 165"	Q9HC07	4	55395957-55453397	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038299, HPA062424"	Supported		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA038299: AB_10675793, HPA062424: "	"unprognostic (2.53e-2)"	"unprognostic (1.08e-3)"	"unprognostic (3.46e-3)"	"unprognostic (7.07e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.84e-2)"	"prognostic unfavourable (2.08e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (1.18e-8)"	"unprognostic (9.05e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-2)"	28.5	37.6	19.4	25.6	49.0	6.0	27.3	11.3	26.1	31.1	20.0	54.4	17.6	19.8	22.4	20.7	33.0	19.1	29.4	23.9	29.1	20.0	26.7	11.9	30.4	22.3	65.8	16.2	14.0	23.6	22.9	14.9	37.6	33.1	24.9	21.6	15.7	25.5	20.8	9.9	16.2	16.0	25.0	50.5	22.6	23.8	8.4	49.4	14.4	24.3	16.5	25.5	34.0	23.2	11.3	22.8	17.6	24.8	11.3	11.8	17.8	18.5	7.8	12.4	13.0	38.5	28.4	13.1	35.6	55.0	25.8	28.3	8.7	27.9	19.4	25.9	21.9	13.8	12.9	14.6	26.2	10.9	12.0	16.5	13.9	16.7	23.9	22.8	19.7	29.2	19.1	14.6	9.9	29.2	27.8	12.4	30.2	13.6	17.9	19.1	13.4	18.3	13.0	9.2	10.5	38.7	17.9	12.7	17.0	17.9	67.9	21.2	10.7	16.5	25.1	22.0	13.1	9.6	25.8	11.6	9.4	11.9	26.1	19.5	17.5	12.7	24.8	15.5	9.9	20.9	11.3	11.3	9.6	11.8	22.8	7.8	8.2	9.8	17.6	11.3	20.5	17.5	10.8	17.8	19.4	49.0	11.3	26.1	29.1	20.0	65.8	16.2	33.1	49.4
TMEM175	MGC4618	ENSG00000127419	"Transmembrane protein 175"	Q9BSA9	4	932387-958656	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057160	Approved		Approved	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA057160: "	"unprognostic (3.84e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.50e-2)"	"prognostic favourable (9.85e-5)"	"unprognostic (4.71e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.51e-3)"	17.2	22.9	20.5	13.5	24.0	17.8	12.2	29.0	27.6	17.4	10.8	23.5	16.8	13.6	13.4	14.9	13.4	12.9	16.0	13.3	18.4	19.8	11.7	24.2	14.1	21.9	16.9	25.4	9.3	26.3	18.7	26.4	11.8	20.4	15.0	6.2	17.1	26.8	16.8	14.5	25.8	12.4	10.4	17.2	18.7	14.8	11.8	17.9	13.0	19.7	9.2	12.0	16.2	9.6	13.8	29.3	16.9	23.4	9.5	13.6	11.8	3.3	6.0	3.5	4.8	16.7	8.8	8.1	8.1	5.9	5.0	7.4	2.8	13.2	2.5	5.1	8.5	5.5	3.2	6.4	2.2	6.2	7.4	5.1	8.8	2.8	9.7	2.7	9.6	12.4	7.8	4.4	3.0	3.1	5.2	20.7	4.3	10.8	6.8	11.1	2.2	17.0	4.8	2.1	7.1	4.7	3.1	9.5	8.4	5.7	3.6	5.4	15.8	7.4	4.0	9.2	2.1	10.6	6.2	14.1	3.7	4.8	8.9	5.9	7.4	16.9	19.8	15.5	13.6	23.4	9.1	12.5	11.7	10.1	17.2	13.8	8.4	11.9	16.4	9.5	21.6	29.3	11.0	11.8	20.5	24.0	29.0	27.6	18.4	19.8	16.9	25.4	20.4	17.9
TMEM199	"C17orf32, MGC45714, VMA12, VPH2"	ENSG00000244045	"Transmembrane protein 199"	Q8N511	17	28357581-28363683	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027051	Uncertain									"HPA027051: AB_10600915"	"unprognostic (3.01e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavourable (5.55e-4)"	"unprognostic (9.98e-2)"	"unprognostic (4.60e-2)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (1.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.38e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.51e-3)"	"unprognostic (5.95e-2)"	14.5	20.7	16.0	18.3	17.9	21.7	16.7	19.7	23.7	13.2	14.2	19.7	17.9	13.9	17.0	19.1	17.5	13.2	15.7	15.9	16.4	18.2	22.3	23.4	14.5	21.4	17.0	20.1	14.4	15.4	23.9	23.0	23.4	17.1	17.3	15.4	15.9	16.0	15.7	14.3	18.7	14.5	12.1	19.0	23.2	14.4	19.3	13.9	24.8	20.5	15.0	20.2	14.9	14.4	17.1	19.7	22.2	24.0	14.4	17.7	17.0	7.0	12.4	11.8	10.1	4.9	4.2	10.1	8.7	5.6	12.3	11.2	28.6	5.7	10.2	9.1	6.5	12.2	12.9	8.2	10.8	18.9	11.7	7.5	10.6	13.8	9.8	10.5	13.3	6.1	7.5	11.7	7.9	6.1	12.2	13.0	9.1	14.0	12.0	14.7	9.8	8.3	10.0	14.7	9.4	9.4	11.9	15.1	15.8	10.6	27.3	15.3	17.2	9.7	8.3	10.6	8.3	9.1	14.6	17.7	21.6	9.5	13.1	6.6	13.2	22.2	24.0	18.8	15.9	23.9	17.3	17.1	14.0	13.9	19.7	16.1	17.7	15.4	18.6	14.4	21.0	13.7	14.1	17.0	16.0	17.9	19.7	23.7	16.4	18.2	17.0	20.1	17.1	13.9
TMEM38B	"bA219P18.1, C9orf87, D4Ertd89e, FLJ10493, TRIC-B"	ENSG00000095209	"Transmembrane protein 38B"	Q9NVV0	9	105694544-105776612	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018465	Uncertain									"HPA018465: AB_1858116"	"unprognostic (3.34e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.80e-2)"	"prognostic favourable (7.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.89e-3)"	"unprognostic (9.98e-2)"	8.8	10.0	6.0	4.0	7.4	10.4	17.4	4.1	5.7	6.8	7.4	10.4	2.8	4.0	5.5	11.0	4.8	4.5	4.2	28.3	6.6	6.1	18.6	11.7	5.7	8.1	12.5	3.4	11.7	4.1	5.3	16.6	2.9	7.9	5.1	7.3	9.2	4.2	4.4	43.9	4.0	6.4	5.2	10.4	3.6	4.3	21.1	9.0	3.3	17.9	15.6	3.0	7.5	8.2	26.3	24.2	24.5	13.3	12.0	20.2	11.3	5.8	9.2	7.1	11.3	41.5	9.2	15.2	8.7	5.5	8.3	8.6	14.2	8.1	13.6	4.3	3.0	4.3	10.2	4.8	9.1	10.2	13.9	5.6	6.4	8.7	5.8	16.8	12.0	8.6	4.3	5.7	8.1	3.3	29.2	12.2	5.1	16.2	11.6	5.1	5.5	10.0	7.8	22.5	6.5	3.8	4.9	12.5	3.0	8.7	14.3	6.2	17.9	11.9	1.7	7.6	7.6	28.8	8.7	14.9	37.0	6.7	14.1	18.5	15.0	5.8	9.7	24.5	6.7	13.3	8.7	26.3	9.2	7.9	10.8	24.7	20.2	12.5	1.4	12.0	11.5	24.2	7.8	11.3	6.0	7.4	4.1	5.7	6.6	6.1	12.5	3.4	7.9	9.0
TMEM67	"JBTS6, MGC26979, MKS3, NPHP11"	ENSG00000164953	"Transmembrane protein 67"	Q5HYA8	8	93754844-93819234	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Deafness, Disease mutation, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.57e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.25e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.43e-2)"	"prognostic unfavourable (7.62e-4)"	"unprognostic (8.41e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	4.1	4.9	8.3	2.5	12.3	2.3	6.2	6.8	7.6	6.7	3.7	4.9	10.1	2.7	9.8	11.2	3.3	22.4	5.0	8.4	6.8	8.3	5.6	2.3	9.3	4.0	2.9	6.4	8.6	6.2	9.3	21.3	3.7	19.1	5.2	4.0	7.0	3.8	8.9	2.1	6.2	2.6	8.2	3.3	3.3	3.7	22.5	3.7	3.4	10.3	1.8	3.2	5.1	4.4	3.9	2.9	2.9	1.5	4.8	4.0	1.2	6.3	4.1	5.8	4.4	5.2	8.5	3.6	3.6	6.1	4.3	8.6	2.0	14.4	1.6	7.9	3.9	6.6	2.1	3.7	6.4	1.3	4.9	3.8	6.0	2.0	4.7	2.9	1.7	4.9	3.4	7.7	3.4	4.5	2.6	1.0	4.5	1.5	4.9	2.2	4.7	3.8	1.8	1.9	0.0	5.4	2.8	3.8	6.5	3.7	1.0	6.2	7.5	1.6	2.3	4.7	2.0	6.5	3.3	2.1	5.6	1.5	8.4	0.8	4.4	2.9	1.5	0.5	3.6	0.7	3.1	1.8	3.4	3.2	2.3	3.9	4.0	3.9	1.5	4.8	0.5	2.9	0.7	1.2	8.3	12.3	6.8	7.6	6.8	8.3	2.9	6.4	19.1	3.7
TMEM70	FLJ20533	ENSG00000175606	"Transmembrane protein 70"	Q9BUB7	8	73972437-73982783	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.1"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023187, CAB034226"	Uncertain		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"CAB034226: AB_2205189, HPA023187: "	"unprognostic (2.26e-3)"	"unprognostic (4.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.65e-3)"	"unprognostic (6.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.70e-2)"	9.5	12.3	7.6	7.4	8.0	7.0	9.4	7.1	12.8	6.0	7.4	3.6	3.9	4.8	6.1	9.0	6.2	9.1	7.4	13.3	9.3	7.9	9.7	38.8	6.2	9.6	6.8	7.3	7.3	17.0	5.1	6.3	8.1	10.0	6.3	8.0	3.8	7.1	5.3	81.1	4.8	6.9	7.7	6.3	9.9	10.6	10.9	5.1	8.5	6.5	13.4	7.9	6.7	5.9	18.4	12.3	7.5	11.0	6.2	12.7	12.7	11.0	8.8	7.1	7.4	8.4	7.2	7.3	9.4	8.6	10.6	8.6	8.3	6.4	15.0	8.2	6.4	10.1	13.6	9.1	12.0	9.7	9.3	15.0	5.8	11.0	8.4	8.1	8.0	6.7	8.4	6.7	3.6	8.9	11.2	7.4	11.2	8.2	18.5	15.4	6.6	11.0	13.1	7.0	12.7	11.2	10.5	16.2	7.2	5.8	42.5	11.9	8.8	7.5	5.6	6.2	7.5	11.2	8.9	11.0	9.4	14.7	9.0	6.4	6.8	6.3	10.8	7.0	9.5	11.0	10.9	18.4	10.9	10.8	10.5	10.8	12.7	11.8	7.5	6.2	8.1	12.3	8.6	12.7	7.6	8.0	7.1	12.8	9.3	7.9	6.8	7.3	10.0	5.1
TMIE	DFNB6	ENSG00000181585	"Transmembrane inner ear"	Q8NEW7	3	46694528-46710886	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 11.7;brain: 11.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.3;EFO-21: 5.6;hTCEpi: 3.8;SH-SY5Y: 4.8"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038298	Uncertain		Uncertain	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA038298: AB_10675792"	"unprognostic (6.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.78e-2)"	1.2	11.7	6.7	0.7	2.9	0.0	0.5	2.7	7.0	0.8	0.9	2.3	0.4	0.6	0.8	1.2	2.2	1.0	0.4	1.0	5.9	11.4	1.4	0.9	1.8	1.2	5.8	4.8	2.8	0.4	0.0	8.1	0.7	3.8	0.9	0.6	1.1	0.8	1.8	5.8	1.3	0.6	0.7	5.2	1.2	0.3	1.6	1.0	0.4	0.8	1.7	1.3	0.8	0.4	0.0	0.3	0.0	0.1	0.0	6.1	1.2	2.0	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.2	0.0	6.3	0.0	5.6	0.0	0.2	0.4	0.5	0.0	0.0	0.0	1.6	0.1	0.0	1.8	0.0	0.0	0.0	3.8	0.0	2.5	1.0	0.0	0.5	0.0	0.3	0.1	0.0	0.4	0.3	2.4	0.0	0.5	0.2	0.1	0.7	4.8	0.7	0.8	0.1	0.2	1.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.2	0.0	1.8	1.0	0.3	0.0	6.1	0.9	0.0	0.0	0.0	0.0	1.0	1.2	6.7	2.9	2.7	7.0	5.9	11.4	5.8	4.8	3.8	1.0
TMLHE	"BBOX2, FLJ10727, TMLH, XAP130"	ENSG00000185973	"Trimethyllysine hydroxylase, epsilon"	Q9NVH6	X	155490115-155669944	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"	"Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034589, HPA040331"	Approved		Supported	Mitochondria				Mitochondria		"HPA034589: AB_10670571, HPA040331: "	"unprognostic (1.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.97e-2)"	"prognostic favourable (3.68e-6)"	"unprognostic (1.69e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.75e-2)"	10.1	15.0	8.5	6.7	10.5	6.7	10.4	17.1	13.5	11.3	10.5	10.0	9.1	10.7	10.9	10.1	9.5	9.5	7.4	22.3	10.3	7.5	15.8	16.9	6.9	14.6	12.5	7.4	12.4	10.7	18.4	17.5	7.6	11.5	7.7	11.6	10.6	16.2	9.6	28.1	7.8	10.0	13.8	13.7	9.2	9.8	3.1	11.2	12.2	10.5	5.3	8.7	10.2	9.1	9.1	10.3	14.7	15.7	4.3	5.6	4.5	15.2	7.5	6.2	18.1	7.7	11.9	0.0	6.2	9.1	7.8	20.4	5.3	8.6	0.0	25.0	10.8	8.3	13.2	6.0	8.9	6.2	9.1	6.8	12.2	6.2	10.8	6.4	4.9	12.6	12.7	8.7	13.2	12.3	9.5	5.6	12.9	5.7	7.7	7.2	1.9	0.1	7.7	9.9	5.8	9.4	5.2	5.9	8.9	5.8	0.3	6.7	6.7	7.3	10.3	6.6	6.3	13.0	7.6	7.0	7.5	5.9	8.0	10.0	6.0	1.9	10.1	11.3	3.9	11.4	2.9	6.2	4.3	3.3	10.3	9.1	5.6	4.9	14.7	4.3	15.7	4.7	4.2	4.5	8.5	10.5	17.1	13.5	10.3	7.5	12.5	7.4	11.5	11.2
TMPRSS15	"ENTK, MGC133046, PRSS7"	ENSG00000154646	"Transmembrane serine protease 15"	P98073	21	18269116-18485879	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	67	"intestine: 154.6"	"Group enriched"	"Detected in some"	20	"U-138 MG: 19.8;U-87 MG: 55.3"	"Group enriched"	"Detected in some"	12	"liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"olfactory region: 9.3"	"HPA015611, HPA034857, HPA072934"	Enhanced		Approved	"Nucleoli,Plasma membrane"				"Plasma membrane"	Nucleoli	"HPA015611: AB_1855791, HPA034857: , HPA072934: "					"unprognostic (9.26e-2)"	"unprognostic (4.14e-1)"		"unprognostic (3.52e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.70e-2)"		"unprognostic (6.35e-2)"	"unprognostic (5.92e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	80.5	0.0	0.0	154.6	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	42.4	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.5	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.1	0.0	0.3	0.0	0.0	55.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
TMPRSS3	"DFNB10, DFNB8"	ENSG00000160183	"Transmembrane serine protease 3"	P57727	21	42371837-42396846	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.7"	"Group enriched"	"Detected in some"	5	"HEL: 18.3;U-266/84: 73.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 6.3"	"Lineage enriched"	"Detected in single"	7	"T-cells: 6.3"	"Region enriched"	"Detected in single"	7	"cerebellum: 0.9"	"Not detected"	"Not detected"														"unprognostic (8.47e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (3.64e-4)"	"unprognostic (2.85e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.17e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (8.24e-4)"	"unprognostic (2.66e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.33e-1)"	1.8	0.7	8.6	0.3	7.7	0.3	9.4	0.3	7.1	6.8	0.4	0.0	0.0	1.7	0.9	0.4	0.4	24.7	8.6	0.2	1.8	1.6	3.5	3.5	3.7	0.6	3.7	2.0	2.8	7.4	0.2	5.8	5.7	3.3	0.8	0.4	2.4	12.3	0.6	0.3	0.6	1.3	0.2	0.2	0.6	15.9	0.2	0.8	0.0	9.8	0.2	0.6	1.9	0.0	0.0	0.1	0.7	0.8	0.0	6.3	1.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.0	0.0	18.3	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.4	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.4	0.0	0.0	9.5	0.4	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.2	73.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	6.3	0.0	3.5	3.6	0.1	0.0	0.7	1.8	0.7	0.0	0.8	0.0	1.6	1.0	8.6	7.7	0.3	7.1	1.8	1.6	3.7	2.0	3.3	0.8
TMPRSS5	"MGC141886, MGC148044"	ENSG00000166682	"Transmembrane serine protease 5"	Q9H3S3	11	113687546-113706373	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 24.0;salivary gland: 15.0;skeletal muscle: 6.0"	"Cell line enhanced"	"Detected in some"		"AF22: 4.4;CAPAN-2: 7.1;WM-115: 5.8"	"Cancer enhanced"	"Detected in some"		"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010992			Approved	Nucleoplasm				Nucleoplasm		"HPA010992: AB_1858152"	"unprognostic (1.53e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.19e-3)"	"unprognostic (8.49e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.04e-3)"	2.1	1.7	10.8	1.0	24.0	3.2	2.2	2.1	14.8	1.2	1.0	21.6	0.0	1.0	1.2	0.9	1.8	1.1	2.2	1.2	11.5	5.7	0.9	0.9	0.9	1.1	11.6	12.7	1.4	1.2	0.6	1.5	1.2	16.5	1.2	1.3	0.9	15.0	1.4	6.0	2.7	0.7	1.2	16.9	1.1	2.4	2.3	8.8	0.0	1.1	0.4	1.3	0.9	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.8	4.4	2.5	0.5	0.4	0.6	1.2	0.5	0.6	0.9	2.5	7.1	0.3	3.2	0.5	0.8	0.4	0.4	0.3	0.5	1.3	1.0	0.6	0.0	0.3	1.0	0.8	0.6	0.6	0.6	1.2	0.8	0.8	0.5	0.9	0.0	0.8	1.2	0.5	0.2	0.9	0.5	0.0	0.7	0.4	0.6	1.0	0.5	0.1	3.5	0.5	0.6	0.5	0.9	1.7	0.6	0.7	0.5	0.2	0.1	0.4	0.9	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	24.0	2.1	12.3	11.5	5.7	11.6	12.7	16.5	8.8
TMPRSS6	FLJ30744	ENSG00000187045	"Transmembrane serine protease 6"	Q8IU80	22	37065436-37109563	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 59.3"	"Group enriched"	"Detected in some"	4	"Hep G2: 7.5;SCLC-21H: 12.9"	"Group enriched"	"Detected in many"	14	"liver cancer: 51.3;thyroid cancer: 14.1"	"Region enriched"	"Detected in single"	10	"basal ganglia: 1.8"	"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 2.2"												"unprognostic (3.93e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.29e-5)"	"unprognostic (7.95e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (8.16e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-7)"	"unprognostic (2.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.86e-5)"	0.1	0.0	0.1	0.1	1.8	0.0	0.8	0.1	0.1	0.1	0.3	0.1	0.1	1.1	0.1	0.4	0.1	0.2	0.4	0.1	0.1	0.0	0.1	59.3	1.9	0.1	0.1	0.1	0.5	0.9	0.0	5.3	0.6	0.1	0.2	0.2	0.1	0.1	0.1	0.1	1.1	0.6	0.1	0.1	0.1	2.3	2.6	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.0	0.1	0.0	1.3	0.0	0.2	0.8	0.2	0.4	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.8	2.3	0.3	0.1	7.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.3	0.0	0.0	0.3	0.1	0.4	0.2	0.3	0.0	0.0	12.9	0.4	0.2	1.0	0.0	0.1	0.0	0.6	0.5	1.6	0.1	0.0	1.5	0.4	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.5	0.2	1.3	0.1	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TMTC3	"FLJ90492, SMILE"	ENSG00000139324	"Transmembrane and tetratricopeptide repeat containing 3"	Q6ZXV5	12	88142296-88199887	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Transferase	"Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038550	Approved									"HPA038550: AB_10672715"	"unprognostic (1.05e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.56e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	12.4	7.8	9.9	6.3	9.4	2.8	14.0	15.1	12.0	13.8	9.6	5.7	10.7	8.5	12.0	9.2	18.4	8.1	9.8	7.4	8.3	9.5	14.0	18.1	8.8	4.6	8.3	7.9	9.7	6.6	12.6	18.3	18.5	10.1	13.0	8.3	8.3	11.0	11.4	5.1	20.4	10.5	15.3	9.5	6.6	8.2	7.4	7.7	6.1	10.7	10.5	7.4	13.2	12.2	4.1	1.7	9.5	2.7	2.2	4.8	1.4	7.2	7.8	7.2	6.8	16.9	15.0	12.8	15.2	14.7	9.1	9.8	11.3	5.1	2.2	2.9	14.1	16.2	7.6	12.5	15.3	1.3	5.7	2.2	5.8	5.1	8.8	2.3	1.4	12.7	6.8	17.5	6.9	14.0	4.8	0.8	10.0	4.3	1.6	3.0	5.5	4.1	1.4	15.6	2.2	7.9	11.8	6.1	6.1	12.8	9.0	4.0	14.6	2.3	14.7	12.6	7.0	11.1	7.5	2.6	3.3	2.6	3.9	2.7	9.3	9.5	2.5	4.0	3.6	2.2	4.4	4.1	4.1	2.8	1.7	3.7	4.8	3.9	2.4	2.2	2.7	1.7	3.0	1.4	9.9	9.4	15.1	12.0	8.3	9.5	8.3	7.9	10.1	7.7
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867188-137883312	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Ubl conjugation pathway"	"DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 48.4;REH: 42.0;U-266/84: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA002116, HPA067479"	Approved		Supported	Vesicles				Vesicles		"HPA002116: AB_1858162, HPA067479: "	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	27.4	6.0	1.5	58.6	1.8	112.4	17.2	0.4	1.5	7.7	15.7	3.2	2.6	5.1	9.7	7.3	12.7	12.1	17.0	11.7	2.1	1.3	6.8	8.1	45.1	38.8	2.1	2.6	37.5	7.2	2.1	3.7	14.5	4.6	13.8	6.3	7.2	8.2	3.5	10.7	20.5	17.2	8.2	3.8	25.9	8.0	9.3	2.1	38.6	5.7	9.2	31.4	23.3	9.5	7.1	18.6	10.0	9.7	7.5	20.5	9.0	8.9	1.5	0.5	0.8	3.0	5.1	2.1	5.1	20.0	1.4	1.8	9.9	3.0	2.0	13.2	5.9	6.8	0.3	14.8	2.6	14.6	0.5	2.0	5.2	5.8	3.3	2.7	3.7	4.7	2.1	16.9	16.1	0.8	4.1	48.4	2.4	0.5	14.7	11.5	0.3	0.4	42.0	10.4	1.4	4.4	4.3	0.2	0.0	1.0	1.5	4.4	1.0	3.4	4.0	14.5	1.7	12.9	2.9	15.6	36.1	4.1	5.3	3.5	1.8	5.6	9.7	5.5	14.8	7.1	20.5	6.2	15.1	13.3	10.3	7.1	10.0	7.4	10.0	7.5	3.7	18.6	14.7	9.0	1.5	1.8	0.4	1.5	2.1	1.3	2.1	2.6	4.6	2.1
TNIK	KIAA0551	ENSG00000154310	"TRAF2 and NCK interacting kinase"	Q9UKE5	3	171061339-171460408	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.9"	"Cell line enhanced"	"Detected in many"		"AF22: 19.6;HEL: 26.6;HMC-1: 30.3;HUVEC TERT2: 19.5;WM-115: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"basophil: 4.4;eosinophil: 10.5;gdT-cell: 4.2;MAIT T-cell: 5.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.7;naive CD4 T-cell: 6.7;naive CD8 T-cell: 3.8;NK-cell: 2.7;T-reg: 5.3"	"Group enriched"	"Detected in many"	29	"granulocytes: 10.5;NK-cells: 2.7;T-cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012128, HPA012297"	Approved		Supported	Nucleoplasm,Cytosol		9100	9100	Nucleoplasm	Cytosol	"HPA012128: AB_1858226, HPA012297: AB_1858225"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.97e-2)"	2.2	5.4	29.0	7.4	30.9	4.9	3.6	21.1	26.1	1.9	10.9	12.2	4.1	25.8	4.3	2.1	5.6	4.3	7.1	11.2	30.9	14.8	5.6	4.6	11.3	7.9	11.4	18.3	2.6	5.2	0.7	9.0	3.1	13.6	5.6	9.5	3.5	2.9	7.3	23.2	1.6	25.6	6.0	14.5	5.8	9.2	10.7	21.1	3.7	7.1	2.2	6.9	6.4	2.6	0.2	0.0	10.5	0.1	2.7	6.7	1.1	0.3	0.5	19.6	2.0	0.3	0.0	4.6	4.1	1.1	3.2	2.2	17.5	7.3	0.0	1.4	3.7	6.0	2.8	1.1	3.5	0.1	4.3	26.6	1.5	0.0	9.4	5.2	30.3	2.8	2.9	1.9	0.4	19.5	9.6	0.0	0.5	0.4	1.6	6.7	8.0	7.6	0.0	5.0	7.0	6.3	0.0	0.9	1.0	2.5	0.2	4.3	8.8	1.3	0.2	0.0	3.4	8.9	3.0	0.0	0.0	0.0	0.9	5.9	22.7	4.4	0.1	10.5	4.2	0.0	5.2	0.0	5.0	3.7	0.0	0.2	6.7	3.8	0.1	2.7	0.1	0.0	5.3	1.1	29.0	30.9	21.1	22.2	30.9	14.8	11.4	18.3	13.6	21.1
TNNI3K	CARK	ENSG00000116783	"TNNI3 interacting kinase"	Q59H18	1	74235401-74544428	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 44.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.9;HSkMC: 2.7;RPTEC TERT1: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.3;plasmacytoid DC: 1.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.9;monocytes: 2.3;T-cells: 1.0"																				"unprognostic (1.04e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.66e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.77e-2)"	0.7	0.6	1.1	0.5	1.5	0.0	1.0	6.0	1.7	0.5	0.5	0.5	0.5	0.2	0.5	1.7	0.5	0.7	0.5	44.6	1.1	1.3	2.2	0.5	0.5	0.5	0.6	0.5	0.7	0.5	0.3	0.6	0.5	0.9	0.5	0.3	0.5	0.5	1.2	0.5	0.9	0.5	0.6	0.5	0.5	0.1	1.8	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.3	1.9	0.0	2.3	0.0	1.0	0.1	0.0	0.6	0.7	0.0	0.5	1.6	0.0	0.0	1.3	0.3	1.0	0.0	3.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.5	2.7	1.6	0.2	0.0	0.5	0.0	0.8	1.1	0.0	0.2	0.2	1.1	0.0	0.2	0.0	0.0	2.6	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.8	1.3	0.0	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.1	2.3	0.0	0.1	0.3	1.0	0.1	0.3	0.2	0.4	0.0	0.0	0.2	1.9	0.0	0.1	1.1	1.5	6.0	1.7	1.1	1.3	0.6	0.5	0.9	0.5
TOPORS	"LUN, RP31, TP53BPL"	ENSG00000197579	"TOP1 binding arginine/serine rich protein"	Q9NS56	9	32540544-32552553	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060640, HPA065661"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA060640: , HPA065661: "	"unprognostic (1.75e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.94e-2)"	"prognostic favourable (7.07e-4)"	"unprognostic (2.70e-1)"	"unprognostic (3.61e-1)"	"prognostic favourable (6.64e-6)"	"unprognostic (1.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.92e-1)"	16.0	12.5	12.7	8.5	16.0	22.9	13.7	18.6	15.1	14.0	12.2	9.6	9.5	8.8	12.9	11.4	13.1	10.5	11.7	9.3	15.9	9.6	14.6	17.4	10.6	10.0	20.1	5.2	17.5	13.2	19.6	19.5	17.9	14.8	13.1	10.3	9.2	11.0	10.8	10.9	10.2	16.8	12.3	17.8	12.4	10.7	18.9	15.0	15.5	15.6	9.8	10.5	16.3	16.0	5.2	4.9	33.4	5.9	7.1	7.4	3.4	8.0	7.5	10.3	9.0	12.6	11.4	6.5	10.3	9.7	8.6	10.0	4.6	4.1	13.1	5.9	10.2	5.4	12.1	11.7	12.1	10.9	6.6	44.2	13.0	5.8	7.8	12.5	12.2	9.2	13.1	12.4	8.8	10.4	7.6	6.8	13.9	4.3	11.2	23.1	13.7	7.6	11.6	9.2	5.9	11.4	8.5	5.1	8.2	10.3	5.6	6.7	5.7	7.2	10.9	9.4	9.6	4.9	7.6	4.8	7.7	14.2	8.7	7.2	4.2	14.6	4.9	10.0	5.0	4.6	5.4	4.6	5.4	5.8	4.9	5.2	7.4	7.2	33.4	7.1	5.9	4.0	6.3	3.4	12.7	16.0	18.6	15.1	15.9	9.6	20.1	5.2	14.8	15.0
TP53	"LFS1, p53"	ENSG00000141510	"Tumor protein p53"	P04637	17	7661779-7687550	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 102.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: , HPA051244: , HPA063532: "	"unprognostic (2.29e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.26e-2)"	"prognostic favourable (1.35e-4)"	"unprognostic (9.95e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (5.01e-4)"	"unprognostic (1.86e-3)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.08e-1)"	18.5	11.1	6.0	28.6	6.8	9.0	17.5	2.5	7.3	18.5	14.6	6.8	8.3	9.7	20.3	15.0	25.3	16.7	22.6	8.1	5.0	3.8	10.6	20.8	11.2	26.0	6.6	3.1	33.8	13.8	4.9	6.0	22.8	6.9	16.5	14.5	9.9	15.3	16.1	12.5	24.6	14.0	12.8	6.2	24.2	12.0	14.1	6.9	102.6	13.2	23.5	31.2	16.9	15.0	15.2	19.6	2.2	14.1	11.0	11.3	8.2	19.2	35.6	19.4	14.0	9.1	10.8	20.6	6.9	15.6	19.2	24.3	1.0	9.9	45.3	31.5	13.6	42.5	28.2	19.1	18.0	10.1	18.9	18.3	20.0	16.9	27.4	0.4	9.5	13.7	22.2	9.3	25.7	18.8	0.9	1.7	9.8	34.2	30.7	22.4	19.6	0.7	59.7	13.7	15.7	14.3	21.3	11.6	20.0	22.8	15.4	5.9	26.7	1.7	24.3	23.0	7.6	0.3	11.6	11.9	8.7	19.5	6.0	2.3	19.4	0.8	13.3	2.2	9.1	14.1	11.1	15.2	9.4	10.2	19.6	14.5	9.9	10.8	1.7	11.0	11.9	17.9	11.3	8.2	6.0	6.8	2.5	6.4	5.0	3.8	6.6	3.1	6.9	6.9
TP53RK	"BUD32, C20orf64, dJ101A2.2, Nori-2p, prpk"	ENSG00000172315	"TP53 regulating kinase"	Q96S44	20	46684365-46689779	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB004688, HPA015837"	Approved									"CAB004688: AB_426116, HPA015837: AB_1855776"	"unprognostic (9.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (9.76e-2)"	"prognostic unfavourable (6.70e-5)"	"unprognostic (4.41e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavourable (6.27e-5)"	"unprognostic (9.16e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.74e-2)"	11.2	14.5	12.7	12.6	15.3	9.6	16.8	8.1	20.3	14.1	11.7	13.7	5.3	8.8	14.8	8.9	16.9	12.2	12.6	9.9	12.1	11.3	12.7	13.6	10.6	18.2	13.1	12.8	15.3	10.1	11.8	15.7	14.9	12.1	15.5	11.4	12.6	13.8	12.2	12.4	16.8	11.2	12.7	10.6	13.2	13.3	26.4	11.8	21.9	16.6	13.1	21.1	14.3	12.7	14.7	19.1	21.7	12.4	16.2	18.5	12.2	3.9	2.7	5.8	5.1	6.1	5.1	5.2	5.5	5.2	7.4	5.4	7.7	2.5	9.5	8.4	4.6	6.2	7.4	6.4	6.4	2.3	3.7	9.6	2.7	6.9	8.1	6.2	69.0	6.7	7.8	5.1	5.0	4.8	6.4	4.2	6.2	5.8	9.3	10.3	4.7	9.2	5.4	5.2	5.6	4.9	4.3	6.9	3.6	6.7	13.6	27.0	4.9	6.8	4.9	8.6	5.0	5.6	6.1	4.6	5.7	7.6	5.0	4.7	4.0	21.7	12.4	20.6	13.7	11.5	15.8	14.7	14.8	15.6	12.6	14.2	16.4	14.0	2.0	16.2	10.2	19.1	18.5	12.2	12.7	15.3	8.1	20.3	12.1	11.3	13.1	12.8	12.1	11.8
TPI1		ENSG00000111669	"Triosephosphate isomerase 1"	P60174	12	6867119-6870948	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Glycolysis"	"Isomerase, Lyase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 234.8;skeletal muscle: 211.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050924, HPA053568"	Uncertain		Approved	Nucleoplasm,Vesicles		270000000	270000000	Nucleoplasm	Vesicles	"HPA050924: AB_2681276, HPA053568: AB_2682193"	"unprognostic (2.85e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (1.04e-5)"	"unprognostic (4.14e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (6.54e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	20.2	41.2	41.2	24.3	46.9	27.4	83.4	93.2	196.1	27.1	39.1	12.8	18.6	40.1	17.2	22.6	51.0	22.1	33.3	94.9	36.7	33.1	43.1	40.8	48.8	140.2	34.0	34.6	19.9	87.0	32.1	16.8	27.1	70.7	19.0	43.5	21.1	26.0	28.7	211.0	25.8	37.8	29.4	20.8	20.1	21.6	15.7	19.4	14.2	20.2	38.4	38.0	23.0	28.0	55.4	170.3	145.5	148.2	81.2	67.1	234.8	119.2	106.9	56.6	87.6	55.5	58.6	100.1	86.3	95.3	163.1	197.9	110.3	65.6	70.0	17.4	85.1	59.4	134.6	144.2	181.0	92.3	100.3	90.7	78.3	72.7	41.4	103.2	74.5	63.6	60.2	125.8	108.4	99.1	46.9	26.9	125.2	87.8	54.2	87.2	139.7	68.1	31.9	93.2	71.8	102.1	85.1	40.3	67.1	75.3	78.4	41.8	17.9	77.6	61.2	87.5	75.0	56.6	126.5	52.6	21.6	104.6	175.6	64.2	62.7	87.7	146.1	145.5	56.1	148.2	57.0	55.4	56.5	54.5	170.3	44.3	39.9	49.3	61.1	81.2	127.8	30.7	67.1	234.8	41.2	46.9	93.2	196.1	36.7	33.1	34.0	34.6	70.7	19.4
TPP1	"CLN2, SCAR7"	ENSG00000166340	"Tripeptidyl peptidase 1"	O14773	11	6612763-6619485	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037709, HPA044868"	Enhanced				"Intracellular and membrane"	13000000	13000000			"HPA037709: AB_10672913, HPA044868: AB_2679122"	"unprognostic (8.27e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (4.31e-4)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavourable (4.46e-4)"	"unprognostic (3.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-2)"	37.4	64.6	32.2	28.8	36.2	43.0	23.1	15.1	33.3	24.0	26.8	41.7	13.2	28.0	32.0	22.3	20.3	18.0	26.9	25.6	24.5	25.1	36.0	45.1	35.9	42.3	31.0	29.3	22.0	14.8	35.1	30.0	56.4	25.4	19.4	28.2	43.4	18.4	29.1	15.4	15.5	31.4	42.4	32.8	69.0	19.8	17.9	24.7	21.7	24.0	9.1	26.9	25.6	29.4	9.4	43.5	12.8	38.9	7.0	15.3	26.2	4.9	10.1	5.1	9.6	59.4	32.9	3.9	9.8	46.5	7.6	13.3	4.2	21.3	7.2	6.5	24.7	14.9	10.0	13.7	11.6	7.1	5.7	5.8	5.2	11.2	44.9	8.3	35.3	49.3	22.4	8.9	19.8	32.5	11.0	21.6	22.2	6.1	2.6	10.3	3.6	12.2	6.5	4.3	14.0	13.5	7.8	0.6	3.9	10.5	7.8	18.3	5.2	15.9	37.1	22.0	6.3	19.8	3.5	18.3	17.9	2.5	28.0	19.6	11.5	12.8	37.7	8.9	10.7	38.9	8.7	9.4	8.5	11.0	43.5	8.5	5.8	7.6	6.9	7.0	26.4	24.2	15.3	26.2	32.2	36.2	15.1	33.3	24.5	25.1	31.0	29.3	25.4	24.7
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"				"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favourable (4.71e-4)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	21.5	17.3	14.3	26.7	21.3	21.6	19.0	24.4	17.1	21.7	24.2	7.3	27.1	12.9	20.8	23.5	18.5	16.9	16.8	28.3	13.8	10.5	18.7	20.6	17.9	20.4	14.1	16.6	24.7	17.8	44.2	29.1	29.7	15.1	22.2	17.7	9.1	20.2	30.1	33.1	20.5	21.1	21.2	16.4	26.1	18.8	35.0	17.8	39.5	21.7	19.7	21.4	25.1	19.1	19.1	19.8	50.3	15.2	10.7	16.9	5.2	22.0	19.1	28.7	16.6	23.0	20.6	30.2	25.4	17.0	18.0	16.8	28.7	18.9	25.9	19.7	17.2	29.0	21.6	17.4	22.2	19.4	23.6	34.5	30.9	20.1	12.4	36.8	22.6	15.7	10.6	27.1	21.1	21.2	41.5	23.4	19.1	19.1	18.2	9.8	31.6	6.7	21.7	22.5	22.4	14.7	26.6	15.6	24.8	29.6	19.7	15.9	21.9	23.5	29.7	18.0	17.1	19.8	30.7	25.7	30.0	23.7	11.5	18.8	16.1	29.5	12.0	21.9	15.8	10.0	13.3	15.2	13.8	12.7	6.8	19.1	16.9	11.7	50.3	10.7	15.2	19.8	15.3	5.2	14.3	21.3	24.4	17.1	13.8	10.5	14.1	16.6	15.1	17.8
TRAF3	"CAP-1, CD40bp, CRAF1, LAP1, RNF118"	ENSG00000131323	"TNF receptor associated factor 3"	Q13114	14	102777476-102911500	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Immunity, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002933	Uncertain									"HPA002933: AB_1080352"	"unprognostic (4.06e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.49e-3)"	"unprognostic (5.25e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (1.31e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (2.42e-5)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.12e-1)"	7.6	5.3	13.6	23.3	9.1	18.8	7.7	12.5	16.0	4.2	8.9	8.8	5.8	8.4	7.5	3.9	7.5	8.9	7.1	7.3	16.6	12.7	6.7	7.0	8.1	26.0	11.5	8.0	4.8	5.1	10.0	10.3	6.8	8.5	6.1	8.0	7.9	5.7	8.0	5.5	7.9	11.8	7.8	9.8	14.2	7.1	12.2	6.6	10.5	7.5	4.1	25.4	11.1	9.3	12.0	6.7	4.3	5.7	2.4	5.1	4.9	11.9	13.6	7.6	4.7	4.4	6.3	11.5	9.4	10.3	10.1	8.5	6.6	17.8	9.5	11.7	10.0	7.3	10.8	10.3	10.4	23.7	7.0	8.9	6.0	4.9	7.2	10.1	26.7	6.3	7.8	7.0	10.1	7.3	9.1	28.4	6.4	12.1	21.6	5.9	4.0	10.3	11.9	10.5	4.8	9.0	14.7	20.2	7.2	10.2	7.1	6.6	6.8	11.5	15.5	9.6	7.4	24.9	13.3	20.6	23.5	17.4	10.4	5.2	11.3	2.6	5.7	1.7	3.7	4.6	3.0	12.0	5.1	3.3	4.1	11.5	3.7	2.6	4.3	2.4	2.8	6.7	4.4	4.9	13.6	9.1	12.5	16.0	16.6	12.7	11.5	8.0	8.5	6.6
TRAIP	"RNF206, TRIP"	ENSG00000183763	"TRAF interacting protein"	Q9BWF2	3	49828599-49856574	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036261, HPA036262"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA036261: AB_10673348, HPA036262: AB_2675029"	"unprognostic (5.30e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.68e-3)"	"prognostic unfavourable (8.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.01e-5)"	"unprognostic (5.84e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	4.8	1.6	3.4	6.0	10.7	9.5	3.0	7.4	3.0	3.5	3.7	2.0	3.2	2.3	3.8	2.4	4.5	3.0	2.9	1.5	2.7	2.7	1.6	1.2	1.3	8.1	2.0	2.8	3.4	1.6	1.6	2.0	2.5	3.0	2.9	4.8	2.7	3.1	1.7	2.8	6.7	3.4	3.4	5.1	3.7	1.9	25.0	3.4	11.5	2.2	3.1	6.8	1.9	3.0	5.1	1.6	0.6	3.0	2.7	4.9	1.6	6.4	7.9	11.3	11.3	1.0	1.6	9.3	7.8	3.7	16.5	15.8	9.5	7.4	15.9	5.5	4.5	8.5	11.8	8.9	12.4	9.1	7.8	11.9	9.6	8.5	0.4	9.7	10.0	1.1	1.3	13.2	7.0	4.3	8.6	11.5	7.3	9.3	16.1	12.4	9.0	13.0	8.9	7.6	9.2	3.0	9.0	5.5	9.4	8.6	7.3	5.5	6.6	13.9	3.3	10.6	12.6	14.5	15.2	8.5	20.2	17.0	5.3	13.2	9.4	0.0	1.5	0.6	2.3	0.8	2.0	5.1	1.3	4.9	1.3	3.8	1.7	2.6	0.3	2.7	3.0	1.6	0.8	1.6	3.4	10.7	7.4	3.0	2.7	2.7	2.0	2.8	3.0	3.4
TRDN		ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.5;K-562: 1.8;MCF7: 6.0;SCLC-21H: 1.2;SK-BR-3: 1.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 2.9"	"Region enriched"	"Detected in single"	10	"olfactory region: 13.6"					"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: "	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	3.8	0.4	0.4	0.0	0.5	0.0	0.3	0.2	0.2	0.3	0.1	0.0	0.7	0.1	0.3	9.2	3.0	1.9	0.1	52.8	1.6	1.3	0.1	0.1	0.1	0.1	1.6	0.1	1.5	0.1	0.0	3.2	0.1	1.3	1.9	0.1	1.3	2.0	0.2	215.5	0.1	0.1	0.2	3.4	0.1	0.1	0.7	0.5	0.0	1.2	80.1	1.6	0.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	6.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	1.6	1.3	1.6	0.1	1.3	0.5
TREH	"MGC129621, TRE, TREA"	ENSG00000118094	Trehalase	O43280	11	118657316-118679690	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 51.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.3;Hep G2: 2.1;RPMI-8226: 1.9;SiHa: 1.8;U-2 OS: 2.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039913, HPA042045"	Enhanced				"Intracellular and membrane"	12000000	12000000			"HPA039913: AB_10674988, HPA042045: AB_2677817"	"unprognostic (1.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.22e-4)"	"unprognostic (2.52e-1)"	"unprognostic (9.83e-2)"	"prognostic favourable (3.76e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-2)"	"prognostic favourable (2.33e-6)"	"unprognostic (2.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-1)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	24.1	0.0	0.0	28.9	0.1	3.3	0.6	0.1	3.7	0.1	0.1	0.1	6.1	2.6	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.1	0.1	51.8	0.0	0.1	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.3	5.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	1.9	0.0	0.0	0.2	0.9	1.8	0.2	1.4	0.7	0.0	0.8	0.1	2.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.0
TREX1	"AGS1, DRN3"	ENSG00000213689	"Three prime repair exonuclease 1"	Q9NSU2	3	48465811-48467645	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Exonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease mutation, Neurodegeneration, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 31.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035437, HPA046721"	Supported		Supported	Cytosol				Cytosol		"HPA035437: AB_10672092, HPA046721: "																		14.2	14.3	16.7	14.6	10.6	20.7	17.2	13.0	16.9	13.4	11.0	12.8	17.5	10.3	8.1	14.9	16.6	14.5	12.3	9.8	14.4	14.2	11.6	12.7	12.5	26.2	14.6	17.4	7.3	13.0	6.8	31.2	11.6	11.2	15.4	9.3	10.8	32.2	19.3	10.8	22.9	10.9	8.2	12.6	25.5	12.4	4.6	10.1	18.5	7.4	18.3	21.7	13.3	10.6	24.9	35.5	23.3	41.8	8.6	13.1	20.1	8.0	7.4	6.2	4.4	7.7	7.9	0.0	2.6	13.1	22.0	31.0	0.1	9.6	9.5	5.4	11.1	9.4	0.4	11.8	3.1	8.0	0.7	5.5	26.6	0.4	9.7	5.0	3.9	6.9	1.1	11.1	4.4	9.3	0.0	14.6	9.3	0.1	7.0	3.6	0.0	4.6	5.8	1.6	18.6	5.8	1.6	0.0	3.7	9.6	13.0	6.3	0.4	8.4	9.8	4.1	3.9	8.7	6.1	11.8	6.8	4.0	9.1	10.7	3.3	2.1	41.8	3.0	9.8	32.5	5.6	24.6	13.1	9.4	35.5	24.9	12.4	10.3	23.3	8.6	24.3	28.0	11.6	20.1	16.7	10.6	13.0	16.9	14.4	14.2	14.6	17.4	11.2	10.1
TRIM2	"CMT2R, KIAA0517, RNF86"	ENSG00000109654	"Tripartite motif containing 2"	Q9C040	4	153152342-153339320	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.0"	"Cell line enhanced"	"Detected in many"		"AF22: 28.1;NTERA-2: 23.1;RPTEC TERT1: 26.3;SK-MEL-30: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 5.4"	"Group enriched"	"Detected in many"	4	"B-cells: 1.9;T-cells: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035853, HPA035854"	Enhanced		Approved	Centrosome				Centrosome		"HPA035853: AB_10669533, HPA035854: AB_10669659"	"unprognostic (8.94e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.30e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.42e-2)"	"prognostic favourable (6.58e-14)"	"unprognostic (5.89e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.13e-2)"	4.2	9.9	28.4	4.4	35.7	0.6	12.2	28.9	56.9	19.6	17.8	67.0	5.9	13.5	9.7	15.1	8.5	12.9	10.3	6.2	38.9	25.3	22.1	6.4	5.9	2.3	39.4	34.6	10.9	8.2	1.0	10.9	2.5	45.3	11.5	19.2	4.6	30.1	11.8	1.8	3.8	14.4	6.6	44.2	8.8	23.5	1.9	44.7	0.0	38.9	0.6	4.3	7.6	5.5	1.9	0.8	0.3	0.6	0.3	5.4	0.7	4.7	0.2	28.1	12.3	10.6	12.2	0.4	6.3	8.6	1.8	2.6	2.7	0.3	0.2	4.0	10.9	4.3	13.1	2.4	1.8	0.1	4.9	0.2	2.9	0.6	12.4	0.2	0.1	7.9	1.4	3.6	2.3	1.6	0.2	0.1	2.2	0.4	1.3	0.0	23.1	5.6	0.8	5.1	0.0	26.3	6.2	9.1	17.9	3.0	11.4	25.2	1.2	0.2	2.4	7.9	2.3	6.1	3.0	0.1	0.0	0.1	11.8	0.1	9.7	0.3	0.6	0.1	0.1	0.0	0.0	1.6	5.4	0.1	0.8	1.9	1.6	1.0	0.2	0.3	0.0	0.1	2.6	0.7	28.4	35.7	28.9	41.1	38.9	25.3	39.4	34.6	45.3	44.7
TRIM24	"hTIF1, RNF82, TIF1, Tif1a"	ENSG00000122779	"Tripartite motif containing 24"	O15164	7	138460334-138589993	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 42.7;HMC-1: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043495, HPA061717"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA043495: AB_10962915, HPA061717: AB_2684592"	"unprognostic (2.40e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (9.94e-4)"	"prognostic favourable (6.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.54e-2)"	"unprognostic (6.34e-2)"	10.3	31.4	10.4	11.2	10.6	8.8	8.8	8.5	10.7	9.4	9.2	14.6	5.7	9.4	9.0	8.5	11.3	7.0	10.3	9.7	8.4	8.5	9.6	21.5	10.7	8.5	10.5	8.0	29.9	11.6	20.7	7.3	13.5	8.4	13.6	9.1	7.5	10.1	7.1	16.0	9.8	14.1	9.4	8.0	8.5	10.8	24.1	11.3	34.8	8.8	9.2	8.9	11.3	11.2	1.3	1.9	3.7	2.5	2.2	2.7	0.8	4.1	5.1	42.7	12.3	2.9	2.6	3.3	3.9	4.1	3.0	3.0	8.1	3.9	8.0	3.9	3.7	2.2	20.7	3.2	4.5	6.1	5.1	17.7	3.8	24.9	3.9	13.7	57.8	2.3	3.4	2.5	4.1	7.2	20.0	4.9	3.6	8.1	23.4	12.5	16.3	4.6	18.6	5.0	6.8	6.8	12.5	8.9	20.2	7.3	6.5	2.1	4.5	9.1	3.0	3.5	2.9	6.2	5.3	4.6	4.9	13.7	5.9	9.1	5.2	1.1	2.3	3.6	2.2	2.5	0.4	0.9	1.9	1.2	1.9	1.3	1.8	2.0	3.7	2.2	1.1	1.4	2.7	0.8	10.4	10.6	8.5	9.7	8.4	8.5	10.5	8.0	8.4	11.3
TRIM27	"RFP, RNF76"	ENSG00000204713	"Tripartite motif containing 27"	P14373	6	28903002-28923989	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048684, HPA053408"	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA048684: , HPA053408: "	"unprognostic (1.57e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavourable (3.50e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"prognostic favourable (2.71e-4)"	11.5	10.6	8.8	25.5	9.7	7.9	9.3	10.1	12.2	11.2	10.2	8.7	20.2	23.8	12.1	13.2	7.8	12.1	11.4	8.1	8.2	9.6	10.1	22.5	10.4	17.4	12.6	8.3	14.7	31.0	7.4	13.9	13.7	10.6	13.7	4.6	7.7	17.0	25.2	12.2	9.7	19.4	9.2	8.4	18.6	18.5	9.2	9.2	16.7	12.5	7.9	12.1	9.9	11.8	12.5	12.5	13.8	13.9	11.2	15.9	13.8	3.3	2.3	0.9	6.0	0.8	1.7	0.6	4.6	1.1	1.4	1.7	1.7	1.4	7.7	7.9	1.3	7.4	1.1	2.7	0.1	3.0	12.9	10.8	0.5	2.3	1.3	4.5	1.7	1.3	1.6	1.2	0.5	1.2	10.5	3.3	0.4	1.3	6.3	2.4	0.0	7.3	9.0	6.9	14.2	1.1	1.1	3.2	12.9	5.5	3.4	7.3	3.3	3.5	3.9	3.4	7.1	6.2	2.7	12.0	14.4	12.0	1.8	11.5	5.2	12.6	13.8	8.8	12.7	13.9	15.9	12.5	12.6	14.4	12.5	10.5	11.8	12.1	13.8	11.2	12.1	9.8	10.4	13.8	8.8	9.7	10.1	12.2	8.2	9.6	12.6	8.3	10.6	9.2
TRIM32	"BBS11, HT2A, LGMD2H, TATIP"	ENSG00000119401	"Tripartite motif containing 32"	Q13049	9	116687302-116701300	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Limb-girdle muscular dystrophy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050060	Approved		Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA050060: "	"unprognostic (2.47e-2)"	"unprognostic (7.06e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavourable (4.53e-4)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.03e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.64e-3)"	"unprognostic (9.77e-2)"	9.5	9.1	6.6	5.8	11.5	0.8	8.0	23.2	17.1	12.8	7.9	7.2	6.2	6.7	17.0	8.0	8.8	15.9	8.2	8.9	5.7	7.3	6.2	5.0	6.3	8.4	5.7	9.8	12.6	12.5	12.2	7.7	7.0	9.1	10.3	7.4	10.4	10.9	9.2	23.9	6.6	8.9	12.9	5.3	6.9	6.8	6.5	2.2	9.4	8.4	6.2	8.3	11.1	8.8	6.1	3.5	0.2	2.6	5.6	16.0	4.7	6.4	14.9	8.8	9.7	17.9	12.9	6.7	12.1	13.3	13.8	11.6	9.9	7.1	6.7	5.4	18.5	13.9	10.7	13.6	12.6	5.9	5.2	3.6	9.6	6.0	9.3	2.4	11.9	11.0	12.3	13.0	7.7	8.9	5.0	5.7	16.1	8.3	6.4	0.0	8.0	9.0	7.6	23.7	4.4	5.6	15.2	8.8	4.5	9.5	6.6	6.9	18.4	2.4	11.0	12.8	10.3	9.4	9.1	9.4	2.5	10.5	10.7	1.6	12.5	0.0	1.3	0.0	9.3	2.6	7.2	6.1	8.2	7.4	1.8	4.4	8.3	8.4	0.2	5.6	2.1	3.5	16.0	4.7	6.6	11.5	23.2	17.1	5.7	7.3	5.7	9.8	9.1	2.2
TRIM33	"FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA"	ENSG00000197323	"Tripartite motif containing 33"	Q9UPN9	1	114392777-114511160	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004345	Supported		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA004345: AB_1858287"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"prognostic favourable (6.20e-4)"	"unprognostic (1.09e-2)"	"unprognostic (8.42e-3)"	"prognostic favourable (8.93e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	15.2	12.8	16.9	18.4	19.9	27.1	17.1	38.3	21.8	16.9	14.3	11.0	21.9	10.9	19.8	38.3	16.4	15.0	15.6	10.8	18.1	12.5	17.3	15.0	14.3	15.2	12.1	18.0	19.8	15.7	21.8	22.4	27.2	15.2	16.5	13.0	10.7	16.4	19.1	14.3	19.5	14.8	20.2	12.9	14.9	14.1	29.0	16.3	20.5	17.9	9.8	16.6	17.9	28.7	3.4	4.0	12.2	2.8	4.7	4.4	1.0	12.9	7.0	13.2	9.9	5.6	5.9	22.5	6.6	7.0	9.2	9.8	7.9	5.5	13.8	6.8	7.7	7.5	12.0	7.7	12.7	10.4	7.1	13.3	9.2	9.1	6.2	16.8	11.1	5.6	5.7	10.9	11.2	7.7	16.6	9.8	8.8	48.5	16.9	7.1	17.8	7.1	14.6	20.2	4.5	6.6	20.4	9.2	9.7	12.5	15.1	11.9	6.9	9.2	8.6	6.4	10.5	14.8	9.2	6.9	6.4	14.5	9.1	9.8	18.2	12.2	1.6	7.4	3.5	1.8	3.1	3.4	3.7	3.7	2.0	2.2	2.9	4.4	4.8	4.7	2.8	4.0	2.0	1.0	16.9	19.9	38.3	21.8	18.1	12.5	12.1	18.0	15.2	16.3
TRIM36	"HAPRIN, RBCC728, RNF98"	ENSG00000152503	"Tripartite motif containing 36"	Q9NQ86	5	115124762-115180546	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 88.8"	"Cell line enhanced"	"Detected in many"		"RH-30: 17.8;SCLC-21H: 19.9;SH-SY5Y: 14.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 7.5;non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	43	"dendritic cells: 7.5;granulocytes: 4.2;monocytes: 7.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061321			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA061321: "	"unprognostic (6.36e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.33e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.82e-13)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.80e-3)"	1.0	1.4	6.8	1.4	7.6	0.8	3.2	0.6	11.7	1.4	4.8	7.7	0.0	8.2	1.1	1.0	0.8	1.9	1.0	0.7	10.1	7.2	0.9	0.9	1.6	0.8	7.1	8.6	3.5	1.5	0.7	8.2	1.3	18.3	5.7	4.8	5.1	1.0	1.0	0.7	1.0	7.9	1.1	8.7	0.9	2.0	88.8	4.7	0.0	0.8	0.0	0.9	0.8	1.0	0.1	7.5	4.2	7.7	0.0	0.0	0.8	2.4	0.7	1.2	6.2	0.1	0.1	1.5	0.5	2.1	1.1	1.3	0.9	1.2	0.0	1.0	0.1	0.6	5.8	1.1	0.8	0.4	1.9	4.3	2.5	1.2	0.2	4.2	3.6	0.1	1.1	0.5	1.5	0.0	0.1	5.9	1.7	3.3	1.1	3.8	4.9	2.8	0.9	17.8	1.4	0.6	0.0	19.9	14.5	3.8	0.4	2.3	4.2	5.3	0.5	1.7	1.3	1.3	1.9	0.9	0.5	0.0	1.9	2.4	0.8	0.0	1.7	4.2	0.0	1.6	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.3	0.0	7.7	1.6	0.0	0.8	6.8	7.6	0.6	11.7	10.1	7.2	7.1	8.6	18.3	4.7
TRIM37	"KIAA0898, MUL, POB1, TEF3"	ENSG00000108395	"Tripartite motif containing 37"	O94972	17	58982638-59106921	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"	"Repressor, Transferase"	"Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.1"	"Cell line enriched"	"Detected in all"	4	"MCF7: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 20.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021911	Uncertain									"HPA021911: AB_10964487"	"unprognostic (4.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (4.99e-6)"	"unprognostic (7.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.46e-1)"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-2)"	6.7	10.3	17.4	7.1	24.4	5.1	7.1	33.4	33.9	7.2	5.9	7.9	4.9	5.2	7.4	9.2	7.1	8.2	7.5	9.1	19.0	19.5	6.5	6.5	7.4	6.8	17.7	18.1	5.5	6.5	6.1	8.9	7.7	32.4	8.1	6.2	5.8	4.4	8.1	7.9	6.1	4.6	8.9	8.7	6.4	5.3	46.1	7.4	6.8	11.1	2.1	6.7	6.8	4.4	3.8	3.4	20.0	3.1	2.9	6.5	2.5	6.8	10.0	6.9	9.1	6.8	6.2	11.1	7.5	11.7	8.2	13.5	6.1	4.7	6.4	11.5	7.8	5.9	10.0	5.6	13.1	12.7	9.7	9.9	9.5	8.4	12.0	5.1	5.3	5.0	5.4	10.2	13.3	10.5	7.7	9.5	8.1	75.3	10.3	3.0	10.1	6.7	4.6	18.2	4.5	7.8	8.8	16.8	9.9	7.8	3.3	7.3	9.7	2.4	8.1	12.9	15.4	11.7	8.5	9.6	14.1	5.7	8.8	5.5	6.0	20.0	3.1	3.6	6.3	2.4	5.9	3.2	4.1	4.1	3.4	3.8	3.7	4.7	4.5	2.9	2.3	2.6	6.5	2.5	17.4	24.4	33.4	33.9	19.0	19.5	17.7	18.1	32.4	7.4
TRIO	ARHGEF23	ENSG00000038382	"Trio Rho guanine nucleotide exchange factor"	O75962	5	14143702-14532128	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008157, HPA064664"	Supported		Approved	Vesicles,Cytosol				Cytosol	Vesicles	"HPA008157: AB_1858327, HPA064664: "	"unprognostic (6.65e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (9.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (3.11e-5)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.23e-1)"	29.7	13.7	27.6	15.8	18.9	5.8	30.3	32.6	29.7	13.7	18.5	11.3	9.2	8.3	23.1	19.3	10.4	12.2	25.2	15.1	18.9	15.0	11.7	12.6	15.8	10.9	11.0	17.7	28.9	11.5	17.2	19.6	13.7	12.3	16.3	16.5	23.3	10.5	14.0	19.8	16.0	15.6	22.7	11.6	24.2	13.7	11.3	11.5	7.4	10.0	11.9	12.3	15.6	16.9	3.8	2.7	0.3	1.9	4.3	0.6	0.4	12.2	4.4	10.6	5.0	22.7	29.8	12.1	11.3	13.5	9.1	10.5	2.8	4.8	2.8	8.5	15.4	3.7	1.7	5.3	18.9	7.8	2.5	1.5	11.8	3.5	11.8	3.7	4.2	13.9	5.6	32.2	10.3	8.0	0.3	1.9	22.0	2.3	0.0	2.6	2.6	4.0	2.8	6.4	9.4	8.9	5.5	4.8	19.5	9.6	2.5	5.0	1.5	0.5	18.6	17.6	11.2	12.7	13.3	0.0	0.6	3.6	62.5	2.4	4.1	0.3	1.5	0.0	0.1	1.9	0.3	2.0	0.0	0.0	1.4	3.8	0.0	0.0	0.0	4.3	1.4	2.7	0.6	0.4	27.6	18.9	32.6	29.7	18.9	15.0	11.0	17.7	12.3	11.5
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564032	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"				"Nucleoli, Actin filaments"	"Nucleoplasm, Cytosol"	"HPA047601: , HPA058241: "	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavourable (2.14e-4)"	"unprognostic (1.68e-2)"	7.0	8.9	6.5	7.5	8.9	3.3	13.1	6.1	8.7	4.6	6.0	9.3	7.5	7.3	5.5	7.2	9.2	10.1	6.1	5.0	7.9	6.7	9.1	16.8	4.9	7.4	9.2	6.1	6.6	12.4	6.7	12.2	10.0	9.7	7.4	6.9	2.5	7.3	4.7	9.3	6.5	10.4	5.1	10.5	7.0	7.6	16.7	10.1	10.7	10.8	5.1	8.0	7.2	10.8	8.8	10.0	9.2	7.6	5.8	7.1	4.0	6.6	4.7	9.2	4.7	5.5	7.7	6.7	8.1	3.1	5.7	4.3	3.9	8.3	9.2	3.1	4.8	3.9	10.7	5.1	8.8	11.7	4.7	6.3	4.1	6.4	5.2	16.0	6.8	4.9	13.2	5.7	12.5	5.8	14.6	8.3	4.8	7.7	13.5	3.3	5.5	4.6	7.8	8.8	5.9	7.7	5.5	5.8	5.0	4.4	24.6	8.1	8.0	6.9	4.2	5.8	6.0	4.7	9.2	5.8	9.7	8.4	4.4	9.4	4.1	4.0	7.6	3.7	3.8	7.1	3.1	6.3	6.5	6.4	10.0	8.8	6.7	6.2	9.2	5.8	6.2	5.6	7.1	4.0	6.5	8.9	6.1	8.7	7.9	6.7	9.2	6.1	9.7	10.1
TRMT10C	"FLJ20432, MRPP1, RG9MTD1"	ENSG00000174173	"TRNA methyltransferase 10C, mitochondrial RNase P subunit"	Q7L0Y3	3	101561862-101566446	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036671	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA036671: AB_10602085"	"unprognostic (7.42e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.08e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.55e-2)"	"prognostic unfavourable (6.56e-5)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.28e-2)"	"prognostic favourable (3.32e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	18.0	21.2	13.1	13.6	14.1	14.4	19.7	16.4	19.1	16.1	15.3	5.5	12.9	11.6	14.6	13.1	20.9	15.0	10.7	20.4	13.0	13.4	26.6	34.6	10.0	19.3	12.5	16.7	18.8	12.1	9.9	19.9	18.2	18.5	16.2	14.2	5.5	14.5	13.0	35.2	15.2	16.5	15.3	14.3	19.6	15.6	14.7	10.6	23.0	16.6	30.5	18.5	15.6	11.3	21.6	15.4	27.4	14.8	12.2	23.1	11.8	20.8	10.2	13.6	13.7	12.5	10.7	12.7	12.4	12.2	16.3	18.2	15.5	14.1	43.4	16.3	7.7	21.1	26.2	19.0	22.4	15.5	12.9	29.1	8.1	11.2	9.6	25.5	12.4	12.5	19.8	14.2	13.3	15.8	24.6	9.7	17.5	14.3	20.4	18.7	25.2	22.1	15.2	11.1	19.4	20.8	17.7	33.9	19.4	9.7	20.7	27.4	27.3	28.2	10.4	8.9	16.8	5.9	13.1	11.3	20.6	41.6	15.0	18.4	13.3	27.4	11.2	7.3	13.6	14.4	18.8	21.6	16.8	15.8	13.5	20.4	23.1	21.1	4.9	12.2	14.8	15.4	15.0	11.8	13.1	14.1	16.4	19.1	13.0	13.4	12.5	16.7	18.5	10.6
TRMT5	"KIAA1393, TRM5"	ENSG00000126814	"TRNA methyltransferase 5"	Q32P41	14	60971451-60981358	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000943	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA000943: AB_1080388"	"unprognostic (1.58e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.82e-3)"	"unprognostic (4.50e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	15.8	10.1	7.9	13.8	12.1	5.4	12.9	9.3	11.8	10.9	8.6	5.7	11.9	7.5	12.0	10.9	11.1	10.0	6.7	6.8	7.7	7.1	12.5	13.9	6.6	7.3	6.7	8.3	17.1	11.1	15.9	13.1	10.8	9.0	10.6	8.1	4.8	11.5	9.9	14.8	9.7	7.4	9.2	6.3	8.6	8.1	24.9	5.9	12.4	10.4	12.1	7.2	13.3	9.0	7.2	7.4	0.9	7.5	2.0	6.0	3.7	28.3	7.3	10.7	14.9	9.4	14.2	11.7	10.7	8.2	11.5	9.1	5.3	17.0	14.6	11.9	7.7	13.1	13.4	15.4	15.1	14.4	6.8	10.7	4.9	5.9	15.4	18.9	6.0	11.2	15.0	10.4	15.4	10.0	13.9	5.2	16.8	10.7	9.7	9.5	9.8	12.0	3.1	24.8	12.3	9.7	9.6	13.1	13.0	11.9	11.9	9.4	19.9	11.4	9.4	13.3	16.1	9.4	10.1	3.2	6.0	6.9	9.3	4.1	12.4	0.1	4.6	0.9	3.5	7.5	5.0	7.2	5.2	5.2	4.2	4.9	5.6	5.1	0.4	2.0	7.5	7.4	6.0	3.7	7.9	12.1	9.3	11.8	7.7	7.1	6.7	8.3	9.0	5.9
TRMU	"FLJ10140, MTO2, TRMT"	ENSG00000100416	"TRNA 5-methylaminomethyl-2-thiouridylate methyltransferase"	O75648	22	46330875-46357340	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"RNA-binding, Transferase, tRNA-binding"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000824, HPA035273, HPA043300"	Uncertain		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA000824: , HPA035273: AB_10602901, HPA043300: "	"unprognostic (2.96e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.52e-3)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (4.72e-2)"	"unprognostic (7.14e-2)"	"unprognostic (7.89e-2)"	"prognostic favourable (6.86e-4)"	"unprognostic (4.74e-3)"	"prognostic unfavourable (5.63e-6)"	"unprognostic (7.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.44e-3)"	8.5	16.1	11.5	9.9	16.0	6.4	7.5	17.8	16.0	9.7	8.7	11.5	10.2	10.9	12.1	18.0	10.9	6.2	7.3	16.8	11.3	11.9	20.5	18.8	7.1	10.2	15.7	11.8	8.0	22.7	20.0	13.6	9.7	11.2	8.7	10.2	9.0	12.5	15.5	17.8	9.8	7.6	9.4	11.4	8.7	9.2	8.3	13.9	6.5	9.6	8.3	9.8	7.1	9.1	6.2	7.6	3.9	9.6	7.5	11.3	6.3	10.8	9.9	4.3	9.6	8.0	5.7	10.7	11.3	8.0	16.1	12.5	14.0	2.7	7.1	8.0	10.1	9.7	18.1	10.1	13.8	4.6	24.4	8.4	15.2	16.5	6.9	16.1	5.8	5.4	11.4	16.6	5.3	10.3	11.7	1.7	9.7	11.4	6.2	13.2	16.1	17.5	7.4	9.2	13.1	8.0	7.5	10.2	12.3	10.0	11.8	18.9	6.7	6.7	7.5	7.2	12.8	10.1	12.6	4.2	4.5	7.6	10.1	11.7	14.4	0.0	6.8	3.9	11.1	9.4	9.4	5.7	9.4	10.0	7.6	6.2	8.6	8.0	1.4	7.5	9.6	6.0	11.3	6.3	11.5	16.0	17.8	16.0	11.3	11.9	15.7	11.8	11.2	13.9
TRNT1	"CCA1, CGI-47, MtCCA"	ENSG00000072756	"TRNA nucleotidyl transferase 1"	Q96Q11	3	3126916-3150879	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036938	Uncertain		Supported	Mitochondria				Mitochondria		"HPA036938: AB_10670566"	"unprognostic (6.39e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-1)"	15.2	16.9	17.5	17.8	20.7	8.7	18.2	14.5	22.7	12.9	13.2	13.2	17.4	11.1	18.4	14.7	15.9	12.2	15.6	13.9	17.1	16.0	21.1	16.1	13.7	19.0	17.5	15.6	14.6	13.9	14.3	31.0	19.0	21.3	23.9	16.4	10.1	13.2	13.1	14.8	15.3	12.5	15.3	19.3	20.5	15.5	13.5	15.1	22.1	20.9	10.6	19.8	17.8	13.0	15.1	10.5	29.0	12.0	15.1	16.6	7.4	11.9	17.3	13.4	7.6	16.0	13.7	14.3	13.7	11.4	13.7	14.2	16.0	14.7	21.8	9.1	13.2	8.6	17.7	12.4	17.5	16.2	8.5	20.3	18.4	16.0	21.4	21.4	16.5	12.8	17.5	14.1	4.8	13.5	15.7	9.2	23.6	22.3	13.8	19.4	10.6	12.6	13.2	18.1	21.2	18.3	17.8	7.7	11.0	19.8	14.4	11.4	13.3	12.2	11.0	15.5	13.5	16.0	17.5	9.4	18.8	27.5	11.6	19.3	17.2	29.0	8.8	22.5	12.1	11.8	11.9	15.1	15.0	12.7	10.5	9.5	16.6	14.3	11.7	15.1	12.0	9.6	11.1	7.4	17.5	20.7	14.5	22.7	17.1	16.0	17.5	15.6	21.3	15.1
TRPC3		ENSG00000138741	"Transient receptor potential cation channel subfamily C member 3"	Q13507	4	121879027-121951754	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 9.3;pituitary gland: 12.0;smooth muscle: 9.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.7;HEL: 5.5;Karpas-707: 5.8;U-2 OS: 3.7;U-251 MG: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.12e-3)"	"unprognostic (9.80e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.42e-3)"	1.4	0.4	1.8	0.7	9.3	0.3	0.5	5.8	7.4	3.3	0.8	1.7	0.8	0.8	1.6	1.2	0.6	1.1	7.3	0.5	1.8	2.3	0.7	0.5	2.9	0.5	2.3	1.9	0.8	0.2	0.6	12.0	4.2	7.3	1.1	0.8	0.3	0.8	2.5	0.6	0.5	1.2	9.4	1.1	1.0	0.9	1.6	3.6	0.0	0.6	0.0	0.4	3.6	2.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.3	1.0	1.5	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.1	0.0	3.7	5.5	0.1	0.0	0.2	1.5	0.5	0.6	0.0	0.1	0.0	0.0	0.0	5.8	1.2	0.0	1.6	0.0	1.0	0.5	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.7	0.0	3.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	9.3	5.8	7.4	1.8	2.3	2.3	1.9	7.3	3.6
TRPC6	"FSGS2, TRP6"	ENSG00000137672	"Transient receptor potential cation channel subfamily C member 6"	Q9Y210	11	101451564-101872562	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 35.3;placenta: 20.6"	"Cell line enhanced"	"Detected in some"		"A549: 4.6;ASC diff: 8.6;BJ hTERT+: 4.6;HEL: 4.3;RPTEC TERT1: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"eosinophil: 5.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 7.1;hippocampal formation: 12.5;midbrain: 9.6"	HPA045098	Approved					140000	140000			"HPA045098: AB_10959600"	"unprognostic (1.45e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.71e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-4)"	"unprognostic (1.99e-3)"	"unprognostic (4.88e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.32e-2)"	6.0	0.5	1.5	0.6	2.4	0.1	9.7	0.8	2.0	7.6	3.9	1.1	7.5	1.1	6.6	7.0	10.8	5.3	3.2	1.1	2.0	1.5	1.6	0.4	35.3	0.9	2.2	3.4	2.2	1.0	1.0	0.6	20.6	2.9	2.3	1.6	0.3	3.3	7.2	0.8	3.0	1.9	3.9	0.7	2.0	1.5	1.0	0.1	0.1	9.6	2.7	1.1	1.6	3.8	0.0	1.0	5.5	0.5	0.0	0.0	0.3	0.0	4.6	0.2	0.0	8.6	2.1	0.0	3.0	4.6	0.7	0.1	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	4.3	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.3	1.5	2.4	0.8	2.0	2.0	1.5	2.2	3.4	2.9	0.1
TRPM1	"CSNB1C, LTRPC1, MLSN1"	ENSG00000134160	"Transient receptor potential cation channel subfamily M member 1"	Q7Z4N2	15	31001061-31161273	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 99.0"	"Cell line enriched"	"Detected in single"	122	"SK-MEL-30: 15.9"	"Cancer enriched"	"Detected in single"	179	"melanoma: 14.6"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014779, HPA071139"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Centriolar satellite"				"Centriolar satellite"	"Golgi apparatus, Plasma membrane"	"HPA014779: , HPA071139: "	"unprognostic (5.28e-2)"	"unprognostic (1.35e-1)"		"unprognostic (9.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.84e-2)"	"unprognostic (6.20e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.63e-2)"	0.1	0.0	0.4	0.0	0.6	0.0	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.3	0.1	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	99.0	0.4	0.0	0.2	10.4	0.0	0.1	1.9	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.1	0.3	0.7	0.2	1.6	0.0	0.3	0.1
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 32.5;SK-BR-3: 21.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 5.4;granulocytes: 4.9;monocytes: 6.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		6500	6500	"Nucleoplasm, Plasma membrane"		"HPA041169: "	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favourable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favourable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	6.7	3.8	3.5	13.7	3.7	4.3	8.5	3.0	6.8	8.2	25.2	4.5	8.6	20.6	7.9	9.1	7.7	5.4	24.8	9.3	2.7	2.2	14.2	23.6	9.4	3.5	2.6	5.7	2.7	17.4	3.4	3.3	5.0	6.9	20.2	11.4	10.6	16.2	13.2	16.4	16.1	26.8	9.4	2.5	3.4	18.3	4.2	2.2	0.4	10.1	11.5	6.8	9.9	8.6	1.1	5.4	4.9	6.8	1.0	0.7	2.1	6.0	4.5	1.1	5.1	3.8	3.6	3.6	5.1	3.0	1.4	1.9	3.3	9.5	0.2	1.3	3.4	8.0	0.7	1.5	0.6	0.1	1.6	1.0	1.9	2.0	3.4	0.1	6.6	4.3	7.0	2.6	1.2	2.4	2.4	1.2	3.5	9.1	0.4	0.5	0.6	6.9	2.2	1.0	0.3	2.4	32.5	0.4	1.1	2.1	21.4	1.1	11.6	2.0	6.1	7.6	4.3	4.2	0.1	2.2	2.2	0.2	4.3	4.0	2.8	2.7	6.8	1.1	0.6	4.0	0.5	0.8	0.5	0.4	5.4	1.1	0.6	0.7	4.9	1.0	1.5	4.9	0.3	2.1	3.5	3.7	3.0	6.8	2.7	2.2	2.6	5.7	6.9	2.2
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.1;intestine: 19.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;HeLa: 4.4;Karpas-707: 2.5;RT4: 7.2;U-266/70: 2.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 16.1;neutrophil: 6.6"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 16.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (3.95e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.80e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.72e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.10e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-2)"	2.9	0.0	1.3	0.5	1.2	2.5	1.1	1.3	1.2	0.8	13.3	0.2	1.0	7.2	0.4	0.2	0.6	0.4	1.0	0.5	1.9	1.2	3.1	0.2	1.5	0.2	2.6	0.0	0.4	0.2	3.8	4.9	0.2	1.6	1.7	17.5	0.4	1.1	0.0	1.6	0.8	19.5	0.7	5.0	3.9	0.2	1.7	0.5	1.6	0.3	1.1	2.1	0.5	0.6	0.3	0.3	16.1	0.1	0.5	0.1	0.0	0.0	1.6	0.2	0.2	0.0	0.0	7.5	0.1	0.0	0.0	0.1	2.1	0.2	0.6	0.0	0.1	0.3	0.5	0.5	0.0	0.1	0.2	0.2	4.4	0.3	0.1	0.1	0.2	0.3	0.2	0.0	0.0	0.2	0.0	2.5	0.1	0.9	0.0	0.1	0.6	0.2	0.0	0.0	0.3	0.0	7.2	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	1.1	0.2	0.0	2.7	0.0	0.2	0.1	0.1	0.3	16.1	0.1	1.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	6.6	0.5	0.1	0.3	0.0	0.0	1.3	1.2	1.3	1.2	1.9	1.2	2.6	0.0	1.6	0.5
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686815	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 91.8"	"Cell line enhanced"	"Detected in all"		"U-2197: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: "	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	13.3	10.8	6.6	14.7	9.0	12.8	12.1	19.5	9.3	11.8	11.7	8.1	9.7	9.9	16.5	10.7	9.4	11.0	8.2	19.1	5.5	4.9	16.0	20.0	10.8	10.6	12.4	5.2	16.6	11.6	91.8	14.6	14.3	10.2	9.7	10.3	28.6	11.5	13.5	10.8	11.7	12.8	12.8	9.8	11.1	10.3	6.9	10.0	14.5	12.6	6.9	12.6	12.9	12.3	7.0	4.7	4.4	3.4	5.7	7.6	2.0	8.3	8.3	7.0	7.7	20.2	15.2	8.5	10.6	14.7	6.7	8.9	11.4	4.6	18.2	5.2	12.2	14.1	9.3	7.8	9.7	10.1	5.6	14.5	12.8	6.0	18.4	15.0	11.3	14.1	9.2	7.6	14.4	5.4	16.4	14.0	12.2	13.1	9.6	7.3	5.3	5.1	10.6	9.7	8.9	9.4	19.8	5.8	7.4	7.3	11.6	14.2	7.3	16.3	8.2	10.7	5.1	49.9	12.1	9.5	21.0	17.5	11.7	30.7	9.9	3.8	3.4	3.9	6.6	3.2	7.6	5.6	4.8	4.4	3.7	7.0	4.4	5.2	4.4	5.7	3.2	4.7	4.8	2.0	6.6	9.0	19.5	9.3	5.5	4.9	12.4	5.2	10.2	10.0
TRPV4	"CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC"	ENSG00000111199	"Transient receptor potential cation channel subfamily V member 4"	Q9HBA0	12	109783085-109833401	"Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Charcot-Marie-Tooth disease, Disease mutation, Dwarfism, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 32.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 8.9;BJ hTERT+: 9.1;EFO-21: 8.0;HaCaT: 14.5;HUVEC TERT2: 8.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	11	"pons and medulla: 15.0"	"Cell type enriched"	"Detected in single"	7	"classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA007150	Uncertain									"HPA007150: AB_1080393"	"unprognostic (2.98e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.20e-3)"	"unprognostic (6.25e-3)"	"unprognostic (1.09e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"prognostic favourable (4.12e-5)"	"unprognostic (1.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	1.3	0.9	0.3	0.9	0.4	0.1	3.3	0.2	0.6	2.3	0.4	3.2	0.0	0.6	0.8	3.7	9.5	5.6	5.2	1.6	1.3	0.2	11.6	7.8	2.6	1.8	0.2	0.0	0.6	7.1	0.1	4.3	11.1	15.0	6.2	0.3	12.6	32.6	1.4	0.2	6.5	0.3	0.9	0.3	3.5	0.9	0.7	0.1	0.2	0.9	2.6	8.7	2.6	1.7	0.0	0.4	0.0	3.0	0.0	0.0	0.4	2.5	0.1	0.0	0.0	1.9	1.8	8.9	4.2	9.1	1.2	0.5	0.0	6.3	0.0	8.0	5.4	14.5	1.1	0.0	0.3	0.0	2.1	0.0	0.0	3.6	0.7	0.0	0.0	3.3	2.0	3.3	0.0	8.3	0.8	0.0	0.4	5.3	0.0	0.0	1.6	0.2	0.0	0.5	0.0	0.0	5.1	0.0	0.0	0.3	0.6	2.5	1.2	0.4	5.1	0.0	3.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.8	0.0	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.2	0.6	1.3	0.2	0.2	0.0	15.0	0.1
TSEN2	"MGC2776, SEN2, SEN2L"	ENSG00000154743	"TRNA splicing endonuclease subunit 2"	Q8NCE0	3	12484432-12539623	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027120, HPA027125, HPA027268"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347"	"unprognostic (5.58e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (1.13e-5)"	"unprognostic (1.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.06e-2)"	"prognostic favourable (3.49e-4)"	8.8	10.6	9.7	8.8	19.1	6.7	10.9	16.5	14.0	10.4	9.8	12.7	8.4	5.8	14.0	9.9	7.9	12.8	10.3	14.3	10.5	12.3	9.8	7.3	7.3	10.9	11.5	7.6	18.0	11.9	14.3	15.3	4.9	10.2	10.5	10.9	13.5	7.2	13.1	16.7	15.3	6.1	12.3	12.3	6.1	8.5	11.3	9.1	9.9	12.5	9.6	8.1	8.6	8.3	8.5	7.1	2.6	4.2	5.0	13.7	5.6	8.0	14.0	7.5	9.9	12.8	13.6	17.4	7.6	6.7	8.1	5.9	7.9	8.6	9.7	5.3	6.2	7.5	12.5	13.0	9.3	7.6	15.6	10.6	18.8	8.1	9.9	16.6	4.1	11.7	15.1	14.8	18.2	6.5	15.6	5.3	9.4	15.1	12.6	7.6	10.6	16.9	9.6	5.2	19.3	12.2	8.2	4.9	8.6	7.0	6.3	5.9	11.4	11.6	5.8	5.2	5.1	7.1	11.7	5.0	12.7	12.0	7.0	16.7	6.5	2.4	4.2	0.3	6.4	4.2	10.9	8.5	9.8	7.4	5.9	8.3	13.7	11.7	2.6	5.0	3.6	7.1	3.5	5.6	9.7	19.1	16.5	14.0	10.5	12.3	11.5	7.6	10.2	9.1
TSEN34	"LENG5, SEN34, SEN34L"	ENSG00000170892	"TRNA splicing endonuclease subunit 34"	Q9BSV6	19	54189938-54194536	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Disease mutation, Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 24.8;monocytes: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041111, HPA048208"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA041111: AB_10794263, HPA048208: "	"unprognostic (3.24e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavourable (1.44e-7)"	"unprognostic (2.38e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.12e-1)"	12.3	28.0	10.4	10.8	10.2	8.2	15.4	4.0	12.8	19.8	19.5	9.4	19.2	3.0	17.3	23.4	20.2	25.3	18.1	20.0	8.8	9.8	15.4	20.0	13.4	18.2	8.7	8.9	31.8	27.3	19.2	14.3	22.0	8.7	23.2	12.3	15.7	17.8	29.5	15.7	14.7	9.8	18.6	7.8	18.0	13.0	27.3	7.7	12.9	28.5	19.6	14.9	19.8	15.5	1.4	2.6	24.8	8.1	0.8	2.4	1.5	28.9	4.2	11.8	16.8	7.0	14.3	12.8	3.6	7.3	8.8	8.2	2.1	4.2	2.2	1.0	5.6	20.4	16.0	21.3	6.4	7.5	24.4	2.6	0.8	2.3	6.7	0.7	3.6	22.9	9.8	6.0	7.1	17.9	5.8	1.3	18.6	3.5	1.5	0.0	2.7	3.1	7.3	8.0	1.0	25.2	2.5	0.6	6.8	0.8	21.6	8.0	17.1	2.1	1.2	0.0	12.2	12.6	22.2	8.2	7.9	2.0	21.1	1.3	13.4	4.1	8.1	17.8	0.9	3.3	1.8	1.0	1.3	2.4	2.3	1.4	2.3	0.9	24.8	0.8	5.2	2.6	0.7	1.5	10.4	10.2	4.0	12.8	8.8	9.8	8.7	8.9	8.7	7.7
TSPAN12	"NET-2, TM4SF12"	ENSG00000106025	"Tetraspanin 12"	O95859	7	120787320-120858402	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 20.8;HUVEC TERT2: 23.2;RH-30: 21.3;RPTEC TERT1: 34.0;RT4: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051570, HPA058244"	Uncertain		Approved	Vesicles,Microtubules				Microtubules	Vesicles	"HPA051570: , HPA058244: AB_2683652"	"unprognostic (2.40e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.43e-1)"	6.8	40.9	3.1	4.3	3.9	0.0	4.5	2.2	3.3	8.1	19.3	2.1	36.8	13.5	6.1	8.7	3.6	3.7	13.6	22.2	3.2	2.7	40.7	12.6	16.9	1.6	2.7	2.3	2.5	12.8	1.1	10.3	9.9	3.3	7.9	7.1	2.9	33.7	15.1	2.3	1.2	31.0	4.1	1.8	18.4	7.6	3.0	2.2	0.5	18.7	3.5	3.2	10.4	3.3	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	6.1	0.1	1.3	0.4	5.9	0.1	0.2	0.5	2.0	0.9	1.5	0.0	4.2	0.1	0.1	3.1	0.6	0.7	0.0	20.8	1.1	6.1	0.8	3.3	0.0	1.0	0.1	0.0	0.1	0.1	23.2	0.2	0.7	2.7	0.7	0.0	0.1	9.7	3.7	0.0	21.3	0.7	34.0	25.9	5.0	2.9	0.2	0.5	0.0	3.1	0.7	1.0	5.0	1.5	0.0	2.5	6.4	0.0	0.0	0.7	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.9	2.2	3.3	3.2	2.7	2.7	2.3	3.3	2.2
TSPAN7	"A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2"	ENSG00000156298	"Tetraspanin 7"	P41732	X	38561370-38688920	"CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 131.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.3;Hep G2: 10.6;MOLT-4: 55.3;SCLC-21H: 31.0;U-266/70: 20.5"	"Cancer enhanced"	"Detected in all"		"glioma: 71.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.9"	"Low lineage specificity"	"Detected in single"											"HPA003140, CAB062566, CAB068245"	Enhanced									"CAB062566: , CAB068245: , HPA003140: AB_1078454"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (3.40e-4)"	"unprognostic (5.06e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-2)"	"prognostic favourable (1.70e-4)"	"unprognostic (1.54e-1)"	"prognostic favourable (5.48e-7)"	"unprognostic (5.65e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-3)"	15.2	28.7	39.6	3.5	83.0	0.8	7.3	83.8	131.1	12.4	18.5	11.5	2.3	7.9	11.6	9.2	7.9	10.5	5.8	17.1	34.5	30.7	15.8	12.0	16.2	8.8	19.4	37.7	5.2	4.4	4.1	11.4	6.6	23.8	5.6	17.3	8.1	3.3	7.4	17.9	4.9	7.8	14.5	11.9	21.3	4.6	1.7	9.5	0.0	11.8	5.4	8.2	8.2	4.2	0.9	0.5	0.3	0.2	0.3	2.9	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.9	0.3	0.0	13.3	2.5	0.0	0.0	10.6	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	55.3	0.0	2.9	0.0	2.7	1.1	0.0	1.4	0.2	31.0	3.2	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.7	0.0	0.2	20.5	5.8	0.0	1.3	0.1	0.4	0.2	0.1	0.0	0.6	0.2	0.7	0.4	1.1	2.9	0.1	0.9	2.1	1.8	0.3	0.3	0.0	0.5	0.0	0.1	39.6	83.0	83.8	86.3	34.5	30.7	19.4	37.7	23.8	9.5
TTBK2	"KIAA0847, SCA11"	ENSG00000128881	"Tau tubulin kinase 2"	Q6IQ55	15	42738734-42920809	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018113, HPA049866"	Approved		Uncertain	"Intermediate filaments"				"Intermediate filaments"		"HPA018113: AB_1858421, HPA049866: "	"unprognostic (2.15e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.30e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.26e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.78e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	6.7	7.3	8.7	5.1	14.0	8.0	6.0	17.8	22.0	7.0	7.2	10.9	3.8	3.3	8.5	6.2	4.2	7.8	6.2	10.7	9.4	11.5	6.1	4.3	6.1	5.5	11.1	14.8	11.5	3.3	9.0	13.9	8.8	24.7	8.2	5.6	7.6	4.8	6.5	11.6	6.3	4.6	8.4	10.9	7.1	4.9	41.8	10.8	3.6	6.7	1.9	5.4	6.8	8.7	2.5	1.4	1.3	3.0	2.1	3.1	0.7	6.1	3.4	9.2	4.9	6.3	6.6	1.9	5.1	7.2	4.4	6.6	4.6	1.4	4.0	6.4	4.8	4.1	8.1	6.0	6.7	12.9	5.7	4.9	7.6	1.9	4.9	7.0	8.6	5.2	6.2	3.9	20.8	5.5	7.4	6.5	4.1	0.8	4.7	5.0	2.6	3.8	7.9	8.7	1.9	5.5	3.8	6.9	7.8	12.4	0.9	2.6	3.2	8.7	6.7	5.7	5.7	7.0	7.0	7.5	10.0	5.9	4.2	5.5	3.6	0.4	3.0	1.2	1.7	1.4	3.1	1.5	1.6	1.3	0.8	2.5	2.1	1.5	1.3	2.1	1.5	1.4	0.5	0.7	8.7	14.0	17.8	22.0	9.4	11.5	11.1	14.8	24.7	10.8
TTN	"CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD"	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 136.5;skeletal muscle: 713.8;tongue: 227.0"	"Cell line enhanced"	"Detected in many"		"RH-30: 4.8"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA007042, CAB022682, HPA030048"	Enhanced					25000000	25000000			"CAB022682: , HPA007042: AB_1080292, HPA030048: "	"unprognostic (1.00e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.49e-4)"	"unprognostic (1.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-2)"	23.7	0.3	0.2	0.3	0.3	0.9	0.3	0.2	0.4	0.2	0.2	0.0	0.0	0.2	0.2	21.3	8.3	0.2	0.3	136.5	0.2	0.2	0.2	0.2	0.4	0.4	0.2	0.0	0.3	0.4	0.2	0.3	0.3	0.0	0.7	0.2	0.0	11.6	0.2	713.8	0.3	0.2	0.2	0.3	0.3	0.2	0.4	0.0	0.0	5.6	227.0	15.8	0.3	0.2	7.0	0.3	1.9	0.3	5.0	7.3	0.1	0.7	0.3	1.9	1.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	1.8	0.3	2.4	0.6	0.0	1.7	0.0	0.0	0.0	2.3	2.0	3.7	2.6	1.0	0.0	0.3	0.8	2.4	0.0	0.0	0.0	1.4	2.1	1.2	0.4	0.4	1.6	2.5	0.4	1.8	1.3	4.8	1.3	0.0	0.6	1.0	1.7	0.4	1.3	0.0	0.7	2.4	1.6	0.0	0.0	0.9	0.4	3.5	0.4	3.5	0.1	1.1	0.9	1.9	0.3	0.7	0.5	0.2	0.2	6.9	1.2	0.9	0.2	7.0	2.7	3.5	1.3	5.0	0.2	0.3	7.3	0.1	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TUSC3	"MGC13453, MRT7, N33, OST3A"	ENSG00000104723	"Tumor suppressor candidate 3"	Q13454	8	15417215-15766649	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 127.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049851, HPA049974"	Approved									"HPA049851: , HPA049974: "	"unprognostic (3.31e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.81e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	"prognostic favourable (7.86e-4)"	"unprognostic (1.55e-1)"	10.5	35.3	10.5	4.0	23.0	0.1	19.7	21.5	19.8	12.1	6.2	5.4	5.1	4.5	16.0	50.5	6.1	27.0	8.1	16.1	10.4	21.4	11.6	3.2	8.5	3.3	6.0	15.6	35.5	15.8	24.8	50.6	127.8	13.4	23.9	7.1	11.6	5.7	14.1	2.8	3.8	4.1	14.4	4.3	3.6	5.2	10.2	3.3	2.9	4.7	3.6	2.4	15.0	9.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	13.1	9.5	26.4	24.5	30.8	35.7	0.0	18.7	40.2	20.7	34.7	0.0	0.0	0.1	6.6	24.9	10.1	9.2	18.0	30.1	0.0	12.6	0.0	7.8	1.5	13.3	0.0	1.3	28.3	5.7	29.0	10.8	1.7	17.4	4.0	31.4	9.5	4.8	0.1	13.1	8.3	5.9	21.9	0.1	28.6	32.8	10.5	20.2	0.0	10.7	14.6	12.5	0.0	8.1	19.1	18.9	7.9	9.3	0.0	2.3	0.0	0.3	0.0	26.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.5	23.0	21.5	19.8	10.4	21.4	6.0	15.6	13.4	3.3
TWNK	"C10orf2, FLJ21832, IOSCA, PEO, PEO1, TWINKLE, TWINL"	ENSG00000107815	"Twinkle mtDNA helicase"	Q96RR1	10	100987367-100994401	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	"Helicase, Hydrolase"	"Deafness, Disease mutation, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002532	Uncertain									"HPA002532: AB_1078311"	"unprognostic (8.10e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.82e-3)"	"unprognostic (7.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.95e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.46e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.45e-1)"	8.5	12.1	8.4	11.1	9.9	4.2	12.6	8.7	10.4	6.1	7.3	6.0	2.6	5.4	9.1	9.0	10.1	11.4	6.6	8.4	8.7	5.1	8.4	10.8	4.4	9.6	10.6	7.4	9.8	14.7	9.5	11.1	6.4	9.4	7.7	8.3	3.9	6.8	5.9	32.5	9.6	6.8	7.4	12.2	10.4	7.0	15.0	10.9	12.6	8.9	9.8	13.1	6.6	14.1	5.4	2.4	1.1	1.5	4.7	7.8	2.5	6.4	13.6	5.4	17.2	5.0	3.4	6.5	4.7	6.4	7.7	7.6	22.4	5.7	23.3	9.3	2.9	10.8	22.7	11.8	9.7	10.8	13.4	17.6	8.0	17.2	8.4	22.5	7.3	6.7	13.6	11.2	35.2	4.7	18.9	6.5	5.3	8.8	15.3	8.2	15.6	11.4	14.9	12.0	14.2	5.0	6.6	8.8	17.0	5.1	7.0	17.0	9.1	7.7	5.3	3.8	7.8	4.7	13.9	12.2	12.6	19.9	4.6	20.7	4.2	1.1	1.1	0.1	2.6	0.9	7.8	5.4	3.8	5.0	2.1	4.0	4.1	4.5	0.0	4.7	1.5	2.4	1.0	2.5	8.4	9.9	8.7	10.4	8.7	5.1	10.6	7.4	9.4	10.9
TYK2	JTK1	ENSG00000105397	"Tyrosine kinase 2"	P29597	19	10350529-10380676	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005157	Uncertain		Approved	Cytosol				Cytosol		"HPA005157: AB_1858480"	"unprognostic (1.60e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.67e-2)"	"prognostic favourable (9.62e-4)"	"unprognostic (7.61e-2)"	"prognostic favourable (1.05e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.90e-2)"	"prognostic favourable (1.02e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (2.10e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-1)"	"prognostic favourable (4.16e-4)"	16.8	19.0	22.9	36.0	22.6	49.4	17.5	24.4	23.9	17.8	19.4	26.7	13.9	20.0	19.3	20.2	15.0	16.8	21.8	17.0	18.3	14.0	24.0	34.4	27.5	31.5	24.7	17.4	20.0	21.3	19.0	24.8	13.9	19.1	21.1	18.6	21.6	24.4	15.4	15.6	24.4	23.8	16.7	17.9	47.9	18.5	6.4	22.8	33.9	20.9	13.5	34.7	16.7	15.1	5.8	15.8	22.9	13.4	5.3	9.1	7.3	8.5	12.5	7.5	11.7	10.0	14.1	7.2	11.7	12.0	14.9	16.4	9.6	5.7	13.0	13.8	13.1	8.6	9.0	13.8	7.9	22.9	14.0	24.0	24.9	23.5	15.6	10.1	27.7	13.6	9.8	16.9	10.0	14.4	10.1	36.4	13.1	26.9	14.8	62.3	2.4	21.9	14.8	6.4	13.3	12.1	27.6	7.0	8.7	11.5	12.1	8.4	6.7	17.2	12.2	20.1	7.2	23.1	13.7	30.0	23.3	11.9	10.0	21.1	11.2	6.6	13.4	17.0	9.1	10.2	5.9	5.6	5.5	8.1	15.8	5.8	3.8	5.1	22.9	5.3	9.7	9.0	6.8	7.3	22.9	22.6	24.4	23.9	18.3	14.0	24.7	17.4	19.1	22.8
UBA1	"A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X"	ENSG00000130985	"Ubiquitin like modifier activating enzyme 1"	P22314	X	47190861-47215128	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase	"Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000289, HPA001506, CAB019435, CAB073410"	Approved		Enhanced	Nucleoplasm		16000000	16000000	Nucleoplasm		"CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305"	"unprognostic (7.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (6.10e-5)"	"unprognostic (7.22e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.38e-2)"	"prognostic favourable (1.78e-4)"	"unprognostic (1.21e-2)"	45.6	63.0	56.0	47.2	50.6	42.0	38.3	58.1	75.7	48.0	39.3	55.9	44.9	36.3	52.9	34.1	59.4	56.0	39.9	48.7	49.5	39.9	51.1	60.0	42.0	48.2	47.7	62.3	57.6	34.9	78.8	55.5	39.1	47.6	40.2	35.5	41.0	47.5	45.7	77.7	56.1	37.9	59.4	35.5	53.4	38.7	36.0	48.6	52.7	65.0	43.9	54.0	39.2	52.7	28.9	30.6	32.6	36.0	25.6	29.0	24.1	45.8	47.6	54.5	82.8	37.3	34.0	24.1	30.5	32.5	43.9	35.8	37.8	35.0	34.2	20.3	61.0	44.3	68.3	64.9	32.3	28.3	69.4	21.4	52.8	30.3	26.3	36.0	46.2	31.9	34.0	63.8	49.8	57.5	23.2	30.8	43.5	58.1	33.9	31.9	58.0	74.4	39.5	38.0	58.2	35.1	49.4	35.3	26.5	90.9	44.2	20.2	61.5	22.5	42.0	33.0	38.3	47.5	28.4	21.1	21.9	48.8	33.9	25.8	39.4	17.4	27.0	27.4	29.0	36.0	25.4	28.9	24.0	25.9	30.6	22.0	19.1	23.4	32.6	25.6	32.8	20.8	28.2	24.1	56.0	50.6	58.1	75.7	49.5	39.9	47.7	62.3	47.6	48.6
UBE2A	"HHR6A, RAD6A, UBC2"	ENSG00000077721	"Ubiquitin conjugating enzyme E2 A"	P49459	X	119574467-119591083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: , HPA051765: , HPA065898: "	"unprognostic (2.27e-3)"	"prognostic favourable (2.16e-4)"	"unprognostic (1.12e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (9.07e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (2.20e-6)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.92e-2)"	24.8	20.6	26.7	23.1	24.6	16.8	32.5	20.2	24.2	23.7	32.8	23.9	20.2	21.7	23.8	26.7	37.2	20.3	21.2	42.2	23.6	22.1	32.2	26.6	22.8	26.3	26.8	19.7	18.7	17.2	24.3	18.2	112.4	24.7	20.4	30.2	20.0	21.0	22.6	46.8	23.6	29.2	27.9	29.1	25.1	20.4	17.0	19.5	36.3	23.2	32.8	31.5	26.7	24.0	21.0	29.0	34.1	36.3	12.8	21.2	17.4	32.5	27.5	17.3	14.6	30.3	37.4	16.2	33.8	30.2	40.3	38.3	14.2	22.4	25.8	34.4	37.2	23.5	24.7	17.9	38.9	35.8	14.6	11.4	22.0	12.7	27.8	28.5	19.6	25.5	25.6	38.6	16.8	27.9	14.0	23.1	45.6	34.5	43.9	26.9	28.8	31.1	22.4	18.4	24.0	32.5	21.4	13.3	13.7	45.0	20.7	24.6	18.0	24.9	27.2	25.9	11.6	51.1	38.1	22.4	36.4	25.3	27.5	36.1	20.2	16.5	22.7	34.1	18.1	35.4	14.3	21.0	15.7	15.8	29.0	18.8	10.0	14.3	30.1	12.8	36.3	23.0	21.2	17.4	26.7	24.6	20.2	24.2	23.6	22.1	26.8	19.7	24.7	19.5
UBE2QL1	FLJ25076	ENSG00000215218	"Ubiquitin conjugating enzyme E2 Q family like 1"	A1L167	5	6448623-6494909	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 28.1;heart muscle: 11.3;retina: 8.2;seminal vesicle: 8.6;skeletal muscle: 21.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 17.8;PC-3: 14.9;SCLC-21H: 13.9;U-266/70: 33.3;U-266/84: 29.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057414			Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA057414: "	"unprognostic (1.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.41e-2)"	"prognostic favourable (6.81e-8)"	"unprognostic (3.18e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.41e-2)"	0.6	2.3	8.6	0.8	4.2	0.3	0.9	20.7	28.1	1.0	1.8	1.0	0.5	0.7	1.4	1.8	1.0	0.5	0.8	11.3	12.6	8.2	2.6	1.1	0.4	0.7	5.2	4.6	3.6	0.8	0.3	1.3	0.3	8.7	3.1	0.8	8.2	1.0	8.6	21.3	2.4	1.0	1.3	1.4	0.4	2.2	0.9	0.0	0.0	1.9	2.0	0.5	0.5	0.9	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.8	0.0	3.0	0.0	0.0	0.2	14.9	0.1	0.0	6.6	0.0	0.0	13.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	33.3	29.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	4.2	20.7	19.4	12.6	8.2	5.2	4.6	8.7	0.0
UBE2T	"FANCT, HSPC150"	ENSG00000077152	"Ubiquitin conjugating enzyme E2 T"	Q9NPD8	1	202331657-202341980	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002831			Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA002831: AB_1080445"	"unprognostic (2.38e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.27e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavourable (4.79e-6)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"prognostic favourable (6.90e-6)"	"unprognostic (6.28e-3)"	"unprognostic (2.85e-2)"	"prognostic unfavourable (2.22e-16)"	"unprognostic (5.37e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	1.9	4.2	9.6	8.5	12.2	20.8	3.9	4.4	13.5	3.5	11.2	0.7	17.2	7.5	4.3	4.1	10.3	2.9	3.0	8.8	8.8	11.2	4.5	2.8	3.1	15.2	8.7	8.2	1.3	0.9	2.4	3.1	8.7	8.2	2.2	13.9	1.9	2.8	7.0	13.1	4.5	6.9	8.1	3.4	6.7	4.0	16.0	1.8	46.8	2.6	12.8	15.3	6.3	4.5	9.0	3.6	1.7	8.6	1.1	11.1	2.9	30.3	29.0	43.2	20.4	4.0	7.4	24.7	33.2	18.6	38.0	26.8	20.6	37.3	35.4	13.2	12.1	24.8	39.9	19.5	34.3	32.1	22.8	21.6	15.8	23.5	1.8	25.9	26.4	2.6	4.7	29.9	12.4	22.0	27.3	29.3	29.7	28.3	46.3	33.0	16.7	14.8	35.9	46.0	30.8	14.5	14.6	34.0	34.7	23.2	28.6	11.1	30.1	16.4	10.8	17.1	27.4	29.9	39.4	14.9	29.0	45.1	17.0	27.0	35.5	0.0	0.8	1.7	3.7	2.4	2.8	9.0	5.0	3.9	1.7	6.3	7.3	8.0	0.0	1.1	8.6	3.6	11.1	2.9	9.6	12.2	4.4	13.5	8.8	11.2	8.7	8.2	8.2	1.8
UBE3A	"ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A"	ENSG00000114062	"Ubiquitin protein ligase E3A"	Q05086	15	25333728-25439056	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009723, HPA039410, HPA040380"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952"	"unprognostic (7.95e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.17e-2)"	19.3	19.4	20.3	23.1	25.0	17.8	20.2	30.0	25.1	21.7	19.9	14.3	19.8	14.1	21.0	22.1	19.8	18.5	17.2	24.0	22.2	20.8	20.2	24.6	19.7	23.1	19.1	19.5	23.0	17.2	26.1	24.6	20.1	20.9	20.6	17.9	13.3	19.3	21.5	70.2	18.4	18.8	21.2	19.9	18.8	16.9	26.4	16.4	36.4	25.0	26.6	19.5	19.9	26.6	15.6	11.9	11.6	14.8	21.1	16.0	5.7	19.3	10.9	27.6	16.4	16.1	19.2	13.6	29.8	18.7	21.1	19.2	25.3	9.7	34.7	22.6	22.2	17.9	34.9	21.0	25.8	17.9	11.7	28.8	18.4	14.9	24.2	34.7	21.3	22.6	19.8	19.9	25.5	16.5	29.0	24.8	33.1	10.5	28.7	10.1	17.9	15.9	29.5	41.2	15.3	19.1	30.4	28.3	21.4	24.1	26.2	34.2	21.4	19.6	21.2	37.0	30.6	17.7	21.7	28.4	33.5	46.8	21.2	18.9	19.2	8.6	8.7	11.6	13.3	7.6	15.2	12.0	14.0	15.9	11.9	15.6	16.0	14.2	2.0	21.1	14.8	11.1	10.1	5.7	20.3	25.0	30.0	25.1	22.2	20.8	19.1	19.5	20.9	16.4
UBE3B		ENSG00000151148	"Ubiquitin protein ligase E3B"	Q7Z3V4	12	109477402-109536705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041012	Approved		Approved	"Nuclear speckles,Mitochondria"				"Nuclear speckles"	Mitochondria	"HPA041012: AB_10964435"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.23e-1)"	"prognostic favourable (2.49e-5)"	"unprognostic (3.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	14.5	19.3	17.2	12.9	21.2	9.2	15.3	19.7	27.8	14.4	17.3	23.3	14.0	14.6	17.4	16.2	20.1	19.3	13.9	28.6	14.6	11.6	19.8	16.4	15.5	13.1	18.6	13.9	18.4	20.3	25.5	15.1	16.8	15.8	17.5	21.2	20.7	15.7	17.4	34.0	21.6	16.3	18.6	15.2	17.0	17.3	24.5	18.3	18.2	21.1	17.6	15.9	19.5	19.6	15.9	14.5	22.4	16.7	14.3	18.2	11.4	10.4	16.6	13.0	9.4	22.2	17.9	11.4	13.8	15.9	16.8	11.3	17.3	10.8	6.5	10.3	22.6	13.5	13.2	17.7	16.3	14.3	9.3	12.5	10.8	15.6	14.3	10.1	10.5	20.3	16.6	16.3	19.6	18.1	13.6	6.2	19.1	16.4	6.9	14.8	13.3	20.0	11.5	12.3	12.8	14.4	18.9	12.1	22.4	16.1	22.0	10.8	22.4	10.8	16.5	20.9	6.0	10.6	9.8	13.9	11.5	11.5	20.8	8.5	17.3	22.4	15.3	14.3	15.9	16.7	15.7	15.9	15.3	11.2	14.5	12.9	12.9	17.1	19.5	14.3	13.6	13.5	18.2	11.4	17.2	21.2	19.7	27.8	14.6	11.6	18.6	13.9	15.8	18.3
UBR1		ENSG00000159459	"Ubiquitin protein ligase E3 component n-recognin 1"	Q8IWV7	15	42942897-43106113	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038838	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA038838: AB_10673120"	"unprognostic (1.07e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.89e-1)"	16.7	13.2	13.7	18.3	16.7	28.4	18.8	21.8	18.1	18.2	16.2	14.8	10.5	11.3	21.0	12.9	10.8	15.9	14.2	19.7	10.0	15.4	14.4	10.6	16.6	14.9	11.8	10.5	16.3	16.4	26.3	25.6	16.2	18.9	15.3	12.9	12.5	11.8	16.8	23.6	11.0	14.4	18.2	12.1	14.7	13.8	13.7	14.7	23.2	18.8	9.7	14.3	17.3	19.7	4.6	5.0	5.5	4.2	6.2	7.2	1.8	4.9	7.2	8.3	6.7	13.2	10.2	7.9	12.1	13.4	10.7	13.9	9.1	3.9	5.8	7.2	12.4	8.6	11.9	10.6	12.8	11.9	5.8	22.9	14.4	4.4	9.2	16.1	11.0	11.0	6.0	13.1	10.7	12.0	13.0	8.8	13.3	2.8	8.7	4.8	4.7	7.4	11.4	11.4	5.0	10.8	11.7	8.4	7.5	15.9	8.4	5.6	8.1	8.4	16.5	13.2	8.2	11.7	12.2	10.4	17.6	16.7	9.0	10.2	11.9	4.4	3.0	5.2	5.7	4.2	6.5	4.1	5.9	6.9	2.9	4.6	5.9	7.2	5.5	6.2	3.4	5.0	4.1	1.8	13.7	16.7	21.8	18.1	10.0	15.4	11.8	10.5	18.9	14.7
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 225.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 97.1;SCLC-21H: 96.9;U-251 MG: 88.7;U-266/84: 85.5;U-87 MG: 94.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 3.6"	"Lineage enriched"	"Detected in single"	37	"B-cells: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		440000	440000	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavourable (1.93e-4)"	8.2	40.2	52.4	8.9	65.1	2.0	3.1	17.5	225.8	4.5	6.3	11.5	0.0	5.5	6.0	1.8	2.7	5.7	6.5	5.4	53.4	97.4	14.0	2.0	2.7	6.5	62.0	57.1	15.4	6.3	1.8	30.5	2.7	100.6	5.3	4.7	6.0	3.0	4.4	7.5	2.7	8.6	5.2	38.6	2.3	2.8	8.0	8.3	0.0	3.9	0.0	4.5	5.6	2.8	3.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	55.0	11.4	0.0	1.5	1.9	0.0	57.6	29.7	20.4	20.6	11.1	0.0	0.0	97.1	29.3	0.1	21.0	0.0	8.3	0.1	8.6	0.0	0.3	0.0	44.0	0.0	0.0	10.6	0.2	16.3	0.0	0.1	0.0	0.2	10.8	0.0	0.0	0.9	32.9	62.2	0.0	24.4	0.0	30.8	0.0	96.9	60.9	0.3	0.2	0.1	0.0	0.4	0.3	1.3	0.4	0.0	88.7	45.5	85.5	0.2	94.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	52.4	65.1	17.5	92.6	53.4	97.4	62.0	57.1	100.6	8.3
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000281-74009435	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 99.6"	"Cell line enriched"	"Detected in many"	4	"HDLM-2: 17.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010771: AB_261839, HPA072225: "	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	0.9	0.2	0.2	0.3	0.2	0.6	0.2	1.1	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.5	0.9	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	1.0	0.2	99.6	0.3	0.2	0.2	0.2	0.5	0.1	0.6	0.2	0.2	0.6	6.4	0.8	0.2	0.2	0.8	0.1	0.7	0.3	0.2	2.1	0.4	0.2	2.0	2.0	1.7	0.8	0.4	0.4	0.5	0.5	0.5	0.3	0.5	0.4	1.0	0.3	0.4	2.2	0.8	0.4	0.8	17.8	0.7	0.4	2.4	0.2	0.6	1.2	1.7	0.5	1.4	1.3	0.1	0.6	0.5	1.4	0.7	1.2	0.8	1.6	1.0	1.4	1.6	4.2	0.6	1.1	0.6	1.2	1.2	0.5	0.9	0.7	0.2	1.1	0.4	0.3	1.4	0.6	1.2	1.6	1.7	0.8	0.3	1.1	0.6	0.0	0.3	0.7	2.1	0.1	0.9	0.0	1.5	1.8	0.0	0.8	0.6	1.2	0.1	0.2	0.0	0.1	0.4	0.4	0.2	0.2	1.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2
UFSP2	"C4orf20, FLJ11200"	ENSG00000109775	"UFM1 specific peptidase 2"	Q9NUQ7	4	185399540-185425985	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039985, HPA043298"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA039985: AB_10794206, HPA043298: AB_10795037"	"unprognostic (8.87e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.56e-1)"	"prognostic favourable (1.07e-8)"	"unprognostic (1.92e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.36e-3)"	"unprognostic (6.70e-3)"	15.8	20.3	12.5	10.3	14.9	4.1	18.7	11.3	20.3	17.3	17.4	16.3	17.0	11.0	19.4	17.4	20.1	17.3	13.5	24.2	11.4	11.7	28.1	19.2	13.2	11.6	14.6	11.3	30.5	20.1	18.3	22.8	12.3	17.0	18.4	12.6	13.7	14.4	20.3	40.8	16.6	13.6	16.9	20.2	14.2	17.3	23.7	14.6	15.8	23.5	19.2	12.2	20.8	13.3	15.6	13.0	5.5	7.9	13.9	17.9	8.2	12.0	7.4	20.8	15.0	18.8	19.6	11.5	12.5	12.7	15.0	14.2	12.4	15.5	12.2	5.8	15.1	9.6	16.1	20.3	15.6	13.0	9.4	6.4	7.2	11.2	20.8	9.7	8.0	11.5	15.9	13.1	13.6	24.0	16.3	24.6	19.4	7.3	13.0	7.3	5.4	10.7	12.9	8.2	14.6	14.4	7.0	12.4	11.6	7.8	12.7	15.2	9.8	6.9	13.9	6.3	11.1	4.3	9.7	22.4	8.6	5.8	20.3	6.1	15.9	5.5	7.9	5.4	16.3	6.8	17.1	15.6	16.5	17.6	9.8	11.0	17.8	17.9	0.4	13.9	6.6	13.0	14.0	8.2	12.5	14.9	11.3	20.3	11.4	11.7	14.6	11.3	17.0	14.6
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760248-233773299	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 48.6;liver: 120.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.2;HaCaT: 11.0;PC-3: 5.0;RT4: 26.1"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"																				"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.2	35.6	0.1	0.1	48.6	0.1	0.1	4.3	0.0	0.3	0.1	0.1	0.0	4.5	120.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.4	0.1	0.7	0.1	0.1	0.9	48.2	0.5	0.1	0.1	1.3	0.2	0.1	0.1	0.2	0.1	0.1	5.2	0.8	1.0	0.4	4.7	0.4	1.1	0.5	0.2	0.2	0.8	0.1	0.2	0.1	0.1	0.5	0.0	0.0	0.0	0.0	4.2	0.3	0.1	2.0	0.0	11.0	0.0	0.2	0.0	0.2	0.1	0.1	0.4	1.1	0.0	0.4	0.1	0.2	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.1	0.2	0.4	5.0	0.1	0.1	0.4	0.0	26.1	0.2	0.3	2.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.6	0.3	0.2	2.1	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.3	0.1	1.0	0.4	0.5	4.7	1.1	0.4	0.4	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
UGT1A4	"HUG-BR2, UGT1D"	ENSG00000244474	"UDP glucuronosyltransferase family 1 member A4"	P22310	2	233718778-233773299	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"liver: 99.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.6;HL-60: 1.3;RH-30: 2.2"	"Cancer enriched"	"Detected in single"	487	"liver cancer: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"unprognostic (9.89e-3)"						"unprognostic (6.77e-5)"	"unprognostic (2.59e-1)"			"unprognostic (3.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	99.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 75.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 62.6;REH: 142.1"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 8.2;T-cells: 4.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavourable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	0.7	0.0	0.7	8.2	3.7	16.5	0.7	0.3	4.2	0.3	1.5	1.6	0.0	2.1	0.3	0.2	2.0	0.0	1.0	0.9	1.2		0.1	0.1	0.3	10.0	4.3	0.7	0.3	0.6	0.0	0.0	1.0	1.4	0.0	1.4	0.0	0.0	0.0	0.3	1.9	2.2	0.8	0.7	2.2	1.9	3.1	4.0	75.6	0.0	4.0	6.6	1.1	0.0	0.4	8.2	1.5	0.4	0.9	4.2	0.9	15.6	11.3	17.2	12.2	0.5	2.0	2.7	12.7	6.1	13.3	12.9	13.5	7.9	8.9	3.1	5.6	7.8	11.8	6.9	9.4	14.4	13.4	7.7	10.6	14.4	0.2	18.9	11.7	0.9	0.5	7.2	1.8	3.9	11.0	10.3	7.9	12.2	62.6	11.6	7.7	12.3	142.1	38.3	6.5	3.6	11.5	12.7	10.1	10.0	5.5	1.7	9.9	18.1	4.9	14.1	11.5	18.2	15.3	4.4	4.5	26.2	8.1	18.4	17.9	0.6	0.4	0.2	1.1	0.1	0.1	0.3	1.5	1.9	2.2	0.4	0.4	1.5	1.5	0.9	0.3	8.2	4.2	0.9										
UHRF2	"MGC33463, NIRF, RNF107, TDRD23, URF2"	ENSG00000147854	"Ubiquitin like with PHD and ring finger domains 2"	Q96PU4	9	6413151-6507054	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026633, HPA026697"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA026633: AB_1858610, HPA026697: AB_1858611"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.21e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.50e-1)"	14.1	12.9	10.6	25.4	12.2	49.1	19.0	24.8	11.8	18.6	15.6	12.7	17.6	7.9	17.5	15.1	13.3	12.0	11.9	11.3	10.2	10.6	10.1	9.8	13.5	19.3	12.3	10.5	18.9	14.5	12.7	12.7	14.6	11.4	19.3	12.0	10.7	13.0	16.4	15.7	11.0	12.0	17.1	12.2	14.1	11.6	10.6	14.8	40.3	15.2	10.2	19.8	18.7	18.2	5.1	2.5	7.5	1.4	1.2	3.6	1.2	6.6	7.5	10.9	4.6	9.0	12.9	8.0	15.3	9.4	9.6	16.9	4.8	4.8	10.2	3.3	7.6	4.3	10.0	8.9	14.8	18.3	4.7	17.7	14.7	7.6	7.4	8.2	6.0	5.8	5.8	7.5	18.4	37.5	1.7	9.9	22.7	2.3	13.8	32.1	4.2	5.6	15.8	5.0	3.6	7.2	4.6	9.9	3.8	6.6	4.4	9.6	5.5	16.6	31.7	10.3	3.8	4.3	12.8	2.6	7.9	11.9	5.0	7.2	4.1	7.5	1.1	4.3	2.3	0.9	1.7	3.5	3.6	1.8	0.7	5.1	2.3	3.0	1.3	1.2	1.4	2.5	3.5	1.2	10.6	12.2	24.8	11.8	10.2	10.6	12.3	10.5	11.4	14.8
ULK4	"FAM7C1, FLJ20574, REC01035"	ENSG00000168038	"Unc-51 like kinase 4"	Q96C45	3	41246599-41962430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017930	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria, Cytosol"		"HPA017930: AB_1858615"	"unprognostic (3.16e-2)"	"unprognostic (2.98e-3)"	"unprognostic (9.72e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.12e-2)"	4.3	4.8	5.1	4.7	8.3	10.3	4.2	4.3	5.4	11.9	2.8	5.9	6.0	2.1	10.7	10.9	2.8	12.3	3.1	13.1	5.2	3.0	5.4	3.4	5.5	4.2	3.1	4.2	4.5	3.6	13.5	19.7	9.0	5.8	4.4	2.8	6.7	4.2	4.5	1.4	3.5	3.3	5.1	5.7	4.4	3.4	27.5	3.4	6.3	7.1	1.7	8.4	4.0	6.0	6.4	5.1	10.7	6.3	2.6	10.3	5.2	7.2	1.7	2.6	3.0	1.1	1.7	4.5	2.5	2.6	3.0	2.6	0.9	2.1	8.4	1.4	5.7	3.7	3.2	1.9	2.8	1.1	0.9	1.6	5.3	2.8	3.9	5.5	1.7	1.6	2.2	14.7	3.0	2.1	1.8	7.0	2.2	5.8	6.9	4.4	3.2	3.0	1.5	8.4	3.7	6.4	7.0	1.3	9.7	2.5	1.2	2.0	2.9	1.8	6.1	1.9	2.2	13.0	2.0	4.2	7.9	3.5	10.8	5.8	2.3	5.7	5.8	5.8	8.0	6.3	6.5	5.6	8.6	7.2	5.1	6.4	6.5	9.2	10.7	2.6	3.2	4.6	10.3	5.2	5.1	8.3	4.3	5.4	5.2	3.0	3.1	4.2	5.8	3.4
UMPS		ENSG00000114491	"Uridine monophosphate synthetase"	P11172	3	124730366-124749273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036178, HPA036179"	Uncertain		Supported	Cytosol				Cytosol		"HPA036178: AB_10673002, HPA036179: AB_10673615"	"unprognostic (6.41e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.51e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavourable (9.20e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	8.4	12.2	4.9	6.8	6.8	4.8	8.0	9.3	7.6	5.9	9.1	8.5	5.2	8.4	6.8	6.7	13.2	8.2	6.6	3.6	4.0	3.9	9.6	20.7	5.2	10.1	7.3	3.6	8.9	19.0	9.5	9.3	11.6	4.7	6.4	7.1	6.4	8.9	4.0	10.9	9.5	8.5	5.5	5.9	9.8	8.3	6.8	6.2	10.6	7.4	12.0	9.3	7.8	6.4	16.6	13.1	4.6	9.8	10.2	13.0	7.9	1.4	4.3	5.0	2.0	3.0	3.4	5.2	7.4	2.3	3.1	2.6	3.7	2.0	3.8	8.2	2.9	8.3	7.0	2.4	5.0	4.3	4.0	7.7	2.8	2.6	2.6	8.0	5.9	3.8	2.3	1.9	3.9	1.4	3.5	1.8	2.3	3.3	9.9	1.5	10.9	2.8	6.5	5.9	3.1	2.5	2.4	4.0	2.6	11.1	4.0	4.1	4.0	3.0	14.2	2.5	5.0	6.8	2.9	7.4	10.1	10.3	2.8	3.3	2.5	4.5	9.0	4.6	12.5	9.8	12.1	13.7	8.9	11.3	13.1	16.6	13.0	10.4	0.6	10.2	8.0	9.7	10.3	7.9	4.9	6.8	9.3	5.7	4.0	3.9	7.3	3.6	4.7	6.2
UNC93B1	UNC93	ENSG00000110057	"Unc-93 homolog B1, TLR signaling regulator"	Q9H1C4	11	67991104-68004982	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.6"	"Group enriched"	"Detected in many"	4	"CAPAN-2: 30.6;RPMI-8226: 85.2;SK-BR-3: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038716, HPA038717, HPA042803"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA038716: , HPA038717: AB_10674836, HPA042803: "	"unprognostic (3.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (4.76e-2)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.05e-3)"	"unprognostic (5.23e-3)"	8.0	2.7	5.7	9.7	7.4	9.2	5.0	6.2	7.0	4.7	11.9	5.3	6.9	11.8	2.3	5.7	5.5	4.1	13.9	4.6	8.7	6.0	5.9	7.1	13.4	20.8	3.6	0.4	3.0	5.2	0.8	3.3	6.7	2.7	5.3	1.2	5.0	12.3	9.0	6.1	3.7	16.9	2.7	3.5	28.6	10.7	4.1	2.2	2.6	5.3	2.4	13.3	5.9	2.8	2.5	13.6	5.7	6.6	1.8	0.2	0.9	4.4	8.0	0.6	3.3	1.8	0.6	7.0	2.0	1.8	3.1	2.9	0.6	30.6	9.8	7.7	0.9	10.7	0.2	1.6	0.1	3.4	2.3	0.9	2.5	1.4	2.7	6.9	5.5	1.5	1.8	0.9	0.3	0.6	0.7	4.6	0.4	4.3	0.0	5.5	1.5	4.3	5.8	0.0	85.2	2.8	2.5	0.9	1.4	3.3	22.9	4.4	8.5	9.1	2.1	2.1	3.0	3.0	0.2	3.3	4.3	1.6	3.9	7.2	2.5	0.1	3.6	5.7	0.1	6.6	0.2	2.4	0.2	0.2	4.7	2.5	0.0	0.0	3.1	1.8	6.6	13.6	0.0	0.9	5.7	7.4	6.2	7.0	8.7	6.0	3.6	0.4	2.7	2.2
UNG	"DGU, HIGM4, UDG, UNG1, UNG2"	ENSG00000076248	"Uracil DNA glycosylase"	P13051	12	109097574-109110992	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB011605	Uncertain		Approved	Cytosol				Cytosol		"CAB011605: AB_778737"	"unprognostic (4.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.64e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavourable (6.40e-4)"	"unprognostic (5.68e-3)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (4.66e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.57e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.89e-2)"	16.3	44.1	17.0	19.4	17.0	10.0	22.8	10.5	14.4	13.5	20.3	10.2	21.4	12.6	11.8	10.8	22.5	11.8	11.0	15.4	13.5	13.1	20.4	23.3	7.1	12.1	19.6	12.2	12.3	12.7	17.3	8.9	18.6	12.0	12.9	22.1	10.7	16.6	19.7	29.1	22.5	13.5	11.0	19.7	13.2	12.3	35.6	9.8	35.1	25.1	19.8	19.0	11.5	14.4	9.8	3.9	5.8	3.0	8.7	19.5	7.9	20.0	20.6	19.8	18.0	33.1	9.5	19.0	11.9	8.1	18.8	14.4	16.3	13.8	26.3	17.9	10.6	12.7	21.9	12.3	18.3	22.3	40.7	25.7	11.9	27.6	4.9	38.2	15.9	8.5	11.3	9.0	5.0	13.5	20.8	8.8	12.6	25.0	35.1	45.1	35.3	31.8	32.3	29.9	22.4	11.7	25.3	28.3	15.7	21.3	18.4	10.3	34.2	17.9	6.9	16.3	14.6	10.7	16.4	17.2	37.0	50.0	12.4	25.7	19.8	5.8	1.5	2.7	13.4	3.0	19.5	9.8	15.9	15.5	3.9	9.2	10.3	11.5	0.0	8.7	3.0	2.8	14.0	7.9	17.0	17.0	10.5	14.4	13.5	13.1	19.6	12.2	12.0	9.8
UPB1	BUP1	ENSG00000100024	"Beta-ureidopropionase 1"	Q9UBR1	22	24494107-24528390	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 85.7"	"Group enriched"	"Detected in some"	5	"CACO-2: 10.9;NB-4: 4.5;THP-1: 6.0;U-937: 6.8"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 25.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"basophil: 11.4;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	43	"granulocytes: 11.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA000728	Enhanced					790000	790000			"HPA000728: AB_1080471"	"unprognostic (7.27e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.09e-4)"	"prognostic favourable (2.30e-7)"	"unprognostic (8.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.89e-6)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.63e-3)"	0.1	0.0	0.1	0.1	0.2	1.0	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.6	0.1	0.5	0.1	0.0	0.1	0.5	0.1	0.0	13.5	85.7	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0.2	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	11.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	10.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.2	0.0	0.3	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.4	0.3	0.1	0.0	0.2	1.1	1.3	0.3	0.0	0.0	6.0	0.5	0.1	0.1	0.0	0.0	1.1	0.0	1.3	1.3	6.8	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	3.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
UPK3A	UPK3	ENSG00000100373	"Uroplakin 3A"	O75631	22	45284982-45295874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.7;skeletal muscle: 24.5;urinary bladder: 45.5"	"Group enriched"	"Detected in some"	5	"Hep G2: 18.3;RT4: 30.6"	"Group enriched"	"Detected in many"	6	"prostate cancer: 35.3;urothelial cancer: 78.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	11	"classical monocyte: 8.5;intermediate monocyte: 9.6;myeloid DC: 33.7;non-classical monocyte: 11.3;plasmacytoid DC: 13.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 33.7;monocytes: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018407, HPA018415"	Enhanced		Uncertain	"Nuclear membrane,Nuclear bodies"				"Nuclear membrane"	"Nuclear bodies"	"HPA018407: AB_1858641, HPA018415: AB_1858640"	"unprognostic (1.27e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.98e-5)"	"unprognostic (1.69e-2)"	"unprognostic (4.82e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.05e-3)"	0.2	0.1	0.3	1.6	0.4	0.9	0.3	0.2	0.5	0.4	0.7	0.0	0.0	0.0	0.2	2.3	0.2	0.2	0.6	0.2	0.3	0.3	0.2	0.2	0.2	1.0	0.4	0.1	0.2	0.2	6.4	0.5	0.0	0.7	17.9	0.5	0.6	12.9	1.8	24.5	0.2	1.8	13.0	0.3	0.7	0.2	0.2	0.0	1.3	4.6	1.7	0.6	45.5	2.7	0.3	33.7	1.4	11.3	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	30.6	0.1	0.0	0.1	0.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	9.6	0.0	0.3	0.0	0.0	33.7	0.2	0.0	0.0	1.4	0.1	11.3	13.0	0.0	2.8	0.3	0.4	0.2	0.5	0.3	0.3	0.4	0.1	0.7	0.0
UQCRC2	"QCR2, UQCR2"	ENSG00000140740	"Ubiquinol-cytochrome c reductase core protein 2"	P22695	16	21952660-21983660	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007998, HPA019146"	Enhanced		Enhanced	Mitochondria		4000000	4000000	Mitochondria		"HPA007998: AB_1858648, HPA019146: AB_1858649"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.43e-2)"	"prognostic favourable (6.58e-9)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-3)"	"unprognostic (4.67e-3)"	"unprognostic (7.36e-2)"	22.7	26.8	20.6	17.1	32.7	20.5	21.3	29.2	33.7	17.7	38.4	17.4	19.5	45.0	20.8	18.6	28.7	20.0	19.1	94.9	19.8	19.3	35.1	35.8	15.9	23.6	20.9	28.5	21.9	20.8	36.6	20.2	17.8	29.6	17.7	40.5	18.5	22.1	20.2	103.9	22.2	42.0	30.4	16.5	16.5	29.3	10.3	19.2	25.2	21.4	70.0	22.9	27.9	20.0	20.0	30.6	14.3	29.3	18.7	25.7	27.4	18.9	20.9	12.9	8.6	14.4	20.2	18.3	18.4	15.0	16.9	17.2	33.7	18.8	37.7	16.6	15.8	34.7	20.9	18.5	19.5	17.2	19.4	21.3	18.4	47.6	15.3	27.1	54.0	23.6	23.2	13.2	18.2	22.1	23.0	19.7	18.3	25.2	28.1	17.6	14.1	16.1	32.9	29.9	41.2	25.3	22.4	17.8	13.0	26.1	33.0	19.8	37.8	28.8	19.5	12.0	11.3	11.7	16.4	14.3	10.3	33.4	19.6	28.8	13.7	14.3	24.7	12.8	16.9	29.3	21.9	20.0	20.5	18.6	30.6	15.8	22.8	20.8	9.1	18.7	27.6	13.2	25.7	27.4	20.6	32.7	29.2	33.7	19.8	19.3	20.9	28.5	29.6	19.2
UROC1	"FLJ31300, HMFN0320"	ENSG00000159650	"Urocanate hydratase 1"	Q96N76	3	126481281-126517773	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"liver: 50.7"	"Cell line enriched"	"Detected in some"	8	"NB-4: 9.3"	"Cancer enriched"	"Detected in single"	100	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069863	Enhanced					510000	510000			"HPA069863: "	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.71e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.65e-5)"	"unprognostic (3.97e-2)"	"unprognostic (2.66e-1)"		"unprognostic (5.52e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	50.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UROD		ENSG00000126088	"Uroporphyrinogen decarboxylase"	P06132	1	45012147-45015575	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027468, HPA028668, HPA030350"	Uncertain		Supported	Nucleoplasm,Cytosol		5200000	5200000	"Nucleoplasm, Cytosol"		"HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: "	"unprognostic (5.90e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.73e-2)"	"unprognostic (8.12e-2)"	20.7	50.2	23.1	12.2	26.2	67.5	20.7	14.2	28.6	17.7	24.2	16.5	25.9	11.2	27.8	22.6	17.8	20.8	17.4	34.0	21.1	20.3	29.6	58.1	14.3	14.8	21.6	22.9	27.4	18.4	35.9	17.6	25.8	16.2	19.2	12.3	24.3	45.6	19.2	28.8	12.1	13.2	22.9	18.9	16.6	15.0	16.3	11.5	17.2	26.3	23.6	16.0	15.0	13.0	25.7	48.6	20.6	36.3	26.0	27.4	35.6	12.5	8.2	13.2	17.3	22.8	21.5	6.4	15.3	39.6	32.3	24.9	11.8	6.6	8.9	16.2	23.2	6.5	25.1	29.9	22.5	7.9	26.4	46.0	19.0	39.1	26.6	14.0	8.6	22.3	19.0	30.8	25.0	41.4	79.8	9.8	30.8	10.5	9.5	12.1	20.5	29.1	14.4	19.6	12.9	28.1	10.6	14.1	11.1	16.8	12.6	25.9	9.9	14.7	26.8	18.4	14.4	6.3	24.7	10.2	10.9	7.5	28.8	21.3	9.2	17.6	36.3	20.6	19.7	25.8	20.0	25.7	23.8	19.2	48.6	23.7	22.3	20.3	6.6	26.0	15.5	32.4	27.4	35.6	23.1	26.2	14.2	28.6	21.1	20.3	21.6	22.9	16.2	11.5
UROS		ENSG00000188690	"Uroporphyrinogen III synthase"	P10746	10	125784980-125823248	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044038	Approved		Approved	Nucleoplasm,Cytosol		15000	15000	Nucleoplasm	Cytosol	"HPA044038: AB_10966692"	"unprognostic (8.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavourable (6.27e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-1)"	13.8	16.1	48.6	9.0	46.6	33.2	13.9	12.8	35.3	8.9	11.4	15.7	12.8	13.2	9.3	41.2	10.5	11.3	11.5	31.4	36.9	20.4	22.6	25.5	10.0	16.8	22.7	23.4	14.5	14.1	14.4	12.0	7.9	20.0	12.9	12.4	14.0	18.1	14.0	45.6	9.8	12.0	13.0	12.5	11.7	12.5	13.8	13.8	10.8	16.4	14.4	12.7	9.4	6.3	17.3	27.1	2.4	15.6	24.7	21.3	17.8	17.4	18.9	13.8	30.7	18.5	18.8	18.6	22.6	39.1	15.9	15.9	8.2	21.3	24.4	10.6	28.0	10.0	8.0	16.1	15.0	30.1	15.2	51.8	10.7	13.5	26.1	21.8	12.2	23.5	9.2	11.1	29.8	14.5	8.9	23.2	26.5	20.8	19.1	24.6	15.0	19.8	13.5	15.3	14.5	20.8	10.9	10.8	18.6	22.6	17.4	30.7	15.6	20.8	14.4	21.1	7.9	16.2	19.1	21.4	15.5	16.6	29.4	8.9	10.0	2.4	15.6	2.2	16.1	15.4	18.5	15.7	16.0	20.4	27.1	17.3	21.3	16.3	1.2	24.7	14.6	12.9	14.2	17.8	48.6	46.6	12.8	35.3	36.9	20.4	22.7	23.4	20.0	13.8
USP16	Ubp-M	ENSG00000156256	"Ubiquitin specific peptidase 16"	Q9Y5T5	21	29024629-29054488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021140	Supported		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021140: AB_1858668"	"unprognostic (6.06e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.65e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	25.4	21.7	24.4	27.4	24.2	20.4	22.8	32.4	23.1	24.2	24.3	13.5	23.6	20.4	22.6	28.2	27.1	19.4	17.0	23.8	23.8	22.6	28.4	34.0	16.8	20.7	25.8	19.5	27.3	23.6	31.6	41.6	45.9	25.3	26.0	22.3	13.3	20.6	28.8	35.8	16.1	33.2	26.2	28.6	29.1	20.8	20.1	25.3	37.6	28.4	25.6	25.5	30.8	17.1	30.9	23.5	21.2	20.5	19.9	26.2	10.1	21.8	8.7	13.9	12.5	9.9	16.3	13.1	21.3	14.2	14.8	14.1	10.9	14.2	22.3	6.5	20.4	10.0	17.2	15.5	19.4	21.3	18.3	29.7	10.6	12.1	14.7	29.1	16.5	13.9	16.4	19.3	17.8	14.2	24.4	39.4	17.1	10.0	17.9	10.6	14.8	11.3	12.0	34.3	25.5	12.2	15.8	15.1	16.1	13.8	22.1	18.7	15.2	20.0	14.2	17.3	21.6	15.9	21.9	33.7	46.2	23.4	18.1	21.2	17.2	21.2	16.2	20.9	25.4	16.1	19.8	26.4	23.9	22.8	14.9	30.9	26.2	24.8	15.5	19.9	20.5	23.5	24.5	10.1	24.4	24.2	32.4	23.1	23.8	22.6	25.8	19.5	25.3	25.3
USP18		ENSG00000184979	"Ubiquitin specific peptidase 18"	Q9UMW8	22	18149899-18177397	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 48.0;BJ hTERT+ SV40 Large T+ RasG12V: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA044768	Uncertain		Approved	Cytosol				Cytosol		"HPA044768: AB_10963697"	"unprognostic (2.06e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (5.42e-2)"	"unprognostic (3.29e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.38e-2)"	20.4	6.4	4.8	13.0	4.8	6.3	15.4	1.9	5.5	5.3	6.3	5.6	3.2	5.2	6.1	9.5	6.0	6.5	7.1	5.4	4.4	4.6	8.8	20.9	14.0	15.9	4.3	4.8	4.9	4.2	3.8	7.8	7.6	4.7	4.8	3.9	5.7	11.7	2.3	9.7	4.2	15.5	4.5	4.1	10.6	6.4	10.6	4.0	22.4	10.6	2.9	7.7	4.3	6.9	4.1	2.9	6.6	8.8	11.0	11.0	4.8	3.7	3.7	1.1	4.8	4.9	3.6	4.9	1.9	4.5	48.0	52.3	0.6	5.2	0.0	2.9	1.0	1.3	5.6	1.6	1.6	16.4	7.8	7.2	0.5	6.8	0.5	1.7	6.9	1.6	0.6	3.4	0.0	10.6	0.3	0.4	0.4	6.3	8.3	4.2	3.4	2.9	3.3	7.5	0.0	0.9	3.1	4.0	3.2	2.3	3.9	17.8	2.6	1.7	17.4	0.3	0.9	1.1	1.9	0.9	11.2	0.0	4.3	4.3	2.7	2.7	3.2	6.6	7.8	8.8	10.0	4.1	6.7	10.1	1.6	2.7	7.9	8.8	0.5	11.0	6.6	2.9	11.0	4.8	4.8	4.8	1.9	4.0	4.4	4.6	4.3	4.8	4.7	4.0
USP27X	USP27	ENSG00000273820	"Ubiquitin specific peptidase 27, X-linked"	A6NNY8	X	49879948-49882565	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077264			Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA077264: "	"unprognostic (4.12e-2)"	"unprognostic (9.58e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (6.14e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.31e-2)"	"prognostic favourable (9.31e-4)"	"unprognostic (5.37e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.58e-1)"	1.8	3.3	1.8	5.9	2.9	0.3	7.7	1.7	7.4	3.9	5.9	4.8	2.2	1.1	12.7	4.1	3.1	4.7	3.8	3.9	2.2		3.5	3.5	6.1	1.9	1.3	3.2	8.8	3.2	4.1	0.8	15.5	2.8	4.1	1.7	4.1	5.2	3.9	7.5	2.6	4.7	3.9	1.3	2.0	1.9	3.8	1.9	2.8	3.2	3.6	2.2	3.7	3.1	1.7	1.0	0.7	0.7	0.3	1.3	0.4	2.1	5.6	6.5	7.5	6.2	5.0	5.4	2.4	4.1	2.8	2.3	10.0	2.5	1.4	2.3	6.4	3.6	9.3	6.2	4.1	2.9	4.3	2.3	1.6	9.2	4.2	0.7	5.1	7.0	4.2	4.0	4.0	3.9	4.6	2.4	4.5	5.3	3.5	2.0	7.0	3.9	3.7	5.6	0.5	4.6	2.1	1.7	4.9	4.8	4.5	5.8	5.2	1.7	2.9	3.3	6.4	5.7	0.9	2.2	0.5	1.0	3.8	2.0	3.6	0.7	0.4	0.1	0.6	0.4	0.8	0.6	0.5	0.3	1.0	1.7	0.8	0.6	0.7	0.3	0.7	0.4	1.3	0.4										
USP6	"HRP1, Tre-2, TRE17, Tre2, TRESMCR"	ENSG00000129204	"Ubiquitin specific peptidase 6"	P35125	17	5116438-5175034	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Calmodulin-binding, Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"skeletal muscle: 18.2;testis: 29.0"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	14	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA046969			Uncertain	Vesicles				Vesicles		"HPA046969: "	"unprognostic (3.89e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.91e-4)"	"unprognostic (6.28e-3)"	"unprognostic (3.24e-4)"	"unprognostic (3.75e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.09e-4)"	0.3	0.3	0.3	0.3	0.6	0.2	0.4	0.5	0.5	0.3	0.5	0.3	1.2	0.0	0.6	0.6	0.3	0.5	0.4	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.3	0.3	2.6	0.3	0.0	0.4	0.4	0.3	0.4	0.1	0.3	0.3	0.3	18.2	0.6	0.7	0.9	0.3	0.3	0.0	29.0	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.9	1.2	1.9	1.0	0.2	0.4	0.1	2.2	1.0	2.2	1.7	0.4	0.2	2.3	1.9	0.1	0.6	0.4	0.8	1.1	2.2	1.7	1.3	1.0	0.7	0.8	0.5	1.6	1.3	1.7	1.3	0.9	1.2	0.5	2.9	1.1	0.5	0.1	0.2	0.3	0.5	0.3	0.5	2.5	1.9	0.7	1.6	0.1	1.4	2.0	0.2	0.5	0.7	0.9	2.2	1.0	0.1	3.3	2.2	2.2	1.2	1.0	3.3	2.1	1.4	2.0	1.7	1.5	0.0	0.1	2.7	0.1	0.4	0.9	0.4	0.3	0.2	0.6	0.3	0.3	0.3	0.9	0.3	0.4	1.9	0.2	1.0	1.2	0.1	0.1	0.3	0.6	0.5	0.3	0.3	0.1	0.3	0.3	0.3	0.3
USP8	"HumORF8, KIAA0055, SPG59, UBPY"	ENSG00000138592	"Ubiquitin specific peptidase 8"	P40818	15	50424380-50514419	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050215	Approved		Supported	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA050215: "	"unprognostic (5.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.99e-2)"	"prognostic favourable (1.29e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.58e-1)"	19.4	21.9	21.0	20.6	20.6	21.6	18.1	27.3	21.6	21.4	23.9	13.8	19.5	20.2	22.1	17.4	22.3	17.4	15.5	17.4	19.7	18.2	28.2	26.4	17.0	25.4	21.8	15.2	21.9	16.7	42.6	43.2	29.1	29.7	16.7	18.9	10.7	19.9	17.9	24.3	17.8	32.1	19.2	29.3	30.3	17.7	27.5	26.1	28.9	24.1	12.7	20.9	22.3	18.4	16.7	10.6	38.1	15.1	9.5	11.9	6.9	11.0	15.9	8.9	15.7	16.3	18.3	12.4	15.9	18.9	15.5	18.4	10.6	7.3	11.7	12.3	18.2	21.5	12.2	11.9	18.4	10.2	8.1	21.6	14.8	10.9	16.8	14.4	14.6	14.2	14.3	13.7	23.3	15.0	12.3	14.2	14.5	22.7	9.2	5.7	10.2	7.3	8.4	16.6	17.5	14.7	26.1	11.4	10.4	16.8	25.1	20.8	13.7	17.7	17.0	16.1	9.1	49.6	21.0	11.1	23.1	12.9	12.9	29.2	15.5	38.1	13.3	22.4	11.1	12.4	10.7	16.5	11.4	11.1	10.6	16.7	11.9	10.7	22.7	9.5	15.1	9.9	8.5	6.9	21.0	20.6	27.3	21.6	19.7	18.2	21.8	15.2	29.7	26.1
USP9X	"DFFRX, FAF, MRX99"	ENSG00000124486	"Ubiquitin specific peptidase 9, X-linked"	Q93008	X	41085635-41236579	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Chromosome partition, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011618, HPA047417, CAB070164"	Approved		Uncertain	Vesicles				Vesicles		"CAB011618: AB_470860, CAB070164: AB_10011071, HPA047417: "	"unprognostic (5.42e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.99e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.33e-1)"	18.0	21.8	17.7	14.0	15.9	15.5	16.8	16.6	16.7	18.4	20.6	11.4	25.4	13.2	19.6	19.0	17.3	17.0	17.1	20.9	14.2	14.2	18.5	34.2	16.7	23.1	15.2	15.4	15.7	16.5	45.8	17.0	41.1	12.9	13.4	14.4	13.9	14.2	25.2	42.8	14.8	22.0	17.3	14.0	16.7	16.9	16.9	14.0	21.1	20.3	17.6	16.5	20.3	19.9	6.4	5.5	13.0	5.0	4.9	7.8	3.1	19.0	22.6	20.1	20.5	16.9	17.7	4.6	11.0	14.8	12.5	14.6	10.4	8.9	12.8	6.2	25.0	12.9	34.5	20.0	21.1	16.1	24.8	14.9	21.9	9.3	14.3	12.9	10.9	15.3	9.0	30.0	28.5	19.3	18.0	10.5	19.3	14.0	9.2	5.1	21.2	12.5	10.1	27.5	8.3	11.9	15.8	11.4	10.7	46.2	12.8	12.6	12.4	7.2	20.6	19.2	14.8	18.1	11.8	9.6	11.2	16.4	13.7	5.8	9.5	3.3	4.7	6.0	5.6	4.2	7.8	6.4	6.6	6.2	5.5	4.7	6.7	6.0	13.0	4.9	5.0	4.2	5.6	3.1	17.7	15.9	16.6	16.7	14.2	14.2	15.2	15.4	12.9	14.0
USP9Y	DFFRY	ENSG00000114374	"Ubiquitin specific peptidase 9, Y-linked"	O00507	Y	12701231-12860839	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 16.0;RT4: 8.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.7"					"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.4;dendritic cells: 2.0;T-cells: 2.7"	"Not detected"	"Not detected"							HPA057687			Uncertain	Vesicles				Vesicles		"HPA057687: "			"unprognostic (2.63e-1)"		"unprognostic (8.97e-2)"	"unprognostic (1.10e-5)"	"unprognostic (8.46e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.42e-1)"	1.2	2.2	1.4	0.9	3.1	1.7	1.1	9.6	4.0	0.0	1.6			1.4	0.0	8.6	4.4	0.0	3.8	2.4	1.8	3.4	2.9	2.2	2.2	1.4	2.1		0.0	2.7	0.0	4.8	1.7		9.3	4.8		2.3	7.6	2.8	2.0	1.8	0.0	1.5	2.2	1.5	2.9			2.8		4.5	3.2	0.0	2.4	2.0	0.1	0.2	0.5	2.7	0.2	0.0	2.2	0.0	0.0	0.0	0.0	2.4	7.1	7.1	3.6	3.9	0.0	0.0	4.0	0.0	5.9	0.0	0.0	0.0	3.2	2.2	0.0	2.5	0.0	7.0	4.0	0.0	0.0	5.9	5.2	0.0	0.0	0.0	0.0	0.0	6.4	0.0	4.0	0.0	1.5	0.0	0.0	2.0	0.8	16.0	8.6	2.8	0.0	0.0	0.0	2.1	0.0	0.0	5.5	4.4	0.0	0.0	3.2	0.0	3.7	7.0	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.2	2.7	1.2	2.2	1.5	0.3	2.4	2.2	1.3	0.1	0.5	0.0	2.0	1.6	0.2										
VAPB	"ALS8, VAP-B, VAP-C"	ENSG00000124164	"VAMP associated protein B and C"	O95292	20	58389122-58451101	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Unfolded protein response"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013144, CAB013722"	Supported		Enhanced	"Endoplasmic reticulum"		220000	220000	"Endoplasmic reticulum"		"CAB013722: , HPA013144: AB_1858717"	"unprognostic (3.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favourable (1.08e-8)"	"unprognostic (1.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.99e-2)"	17.4	31.1	21.8	12.6	24.3	4.8	13.2	16.5	31.8	11.7	16.1	17.0	13.3	22.5	13.0	13.1	14.8	13.7	12.7	24.5	21.4	22.1	21.8	23.5	13.6	10.4	23.2	25.1	17.7	15.5	28.5	16.3	11.1	31.6	15.0	12.1	11.4	17.9	15.7	46.8	15.3	20.6	15.2	24.9	11.4	14.7	9.4	15.8	6.7	26.7	18.8	9.4	11.6	18.5	5.6	4.3	6.8	5.2	6.6	9.5	4.6	10.7	10.8	12.2	6.5	11.3	4.7	10.8	9.7	4.0	15.0	7.4	43.6	10.4	9.5	13.9	6.5	20.6	9.7	13.9	9.0	4.4	7.3	5.7	12.0	13.7	11.3	5.4	7.3	10.7	16.2	8.3	6.9	7.4	13.5	5.4	7.2	33.9	8.4	10.7	6.4	14.4	8.4	11.4	6.2	11.4	14.5	17.2	11.9	16.0	42.6	16.6	17.4	8.1	10.2	24.3	11.8	12.1	12.9	7.3	7.8	11.0	20.5	5.9	12.2	3.9	4.4	5.2	7.8	4.4	9.1	5.6	9.0	6.2	4.3	4.7	6.7	9.5	6.8	6.6	5.2	4.3	5.0	4.6	21.8	24.3	16.5	31.8	21.4	22.1	23.2	25.1	31.6	15.8
VARS2	"DKFZP434L1435, G7a, KIAA1885, VARS2L, VARSL"	ENSG00000137411	"Valyl-tRNA synthetase 2, mitochondrial"	Q5ST30	6	30908242-30926459	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062449, HPA070267"	Approved		Approved	Mitochondria				Mitochondria		"HPA062449: , HPA070267: "	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.50e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.43e-2)"	7.2	7.8	6.3	12.5	8.6	6.9	6.8	21.4	11.4	4.2	6.5	8.9	6.2	6.2	8.8	6.2	20.6	6.3	7.4	4.9	7.4	6.4	12.0	13.5	7.3	12.9	5.6	9.3	8.8	12.5	8.5	9.7	5.1	7.9	6.0	8.1	4.6	8.2	10.5	9.4	11.0	7.4	4.4	6.3	7.8	8.6	8.3	3.4	13.4	8.2	4.6	10.0	4.8	6.1	1.8	1.3	0.1	0.9	0.2	1.8	0.5	8.5	6.9	3.7	14.8	3.1	2.3	0.1	1.2	0.8	1.2	1.1	6.0	4.9	6.5	5.1	0.9	0.0	10.3	0.0	1.9	3.3	8.9	7.8	5.8	0.6	2.7	1.6	0.0	1.8	2.6	3.7	0.8	0.9	0.0	7.4	3.0	0.0	2.5	0.0	0.9	0.9	6.1	0.0	6.3	4.9	0.0	4.5	0.1	0.0	3.3	3.7	10.1	4.1	1.6	9.2	0.6	0.5	0.1	6.8	10.5	13.4	0.0	0.3	6.1	0.0	0.2	0.0	1.1	0.9	1.8	1.8	1.0	1.6	1.0	0.7	0.6	0.3	0.1	0.2	0.6	1.3	1.2	0.5	6.3	8.6	21.4	11.4	7.4	6.4	5.6	9.3	7.9	3.4
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35056064-35073249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		110000000	110000000	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favourable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favourable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	33.7	43.6	19.6	30.3	21.8	30.8	31.4	19.4	31.0	32.2	25.7	22.7	32.9	22.2	30.5	34.0	40.0	24.7	33.8	69.6	20.0	23.4	30.1	63.4	27.6	42.7	23.1	21.1	25.0	34.9	44.5	29.0	46.3	26.3	33.4	26.5	21.2	30.7	34.1	80.4	29.2	26.3	29.2	23.0	37.8	28.9	25.6	18.2	43.3	32.1	42.2	35.7	31.5	26.5	25.9	29.4	43.4	30.6	23.0	32.1	34.4	36.0	41.2	28.4	15.3	34.3	24.2	21.7	33.6	38.1	50.3	37.2	27.5	14.9	28.6	29.5	41.7	17.4	42.3	40.1	43.6	30.7	24.5	19.9	38.9	37.6	26.6	22.3	26.6	27.6	27.0	43.5	19.5	54.3	20.6	20.8	40.1	25.4	21.8	53.7	37.0	39.4	19.4	22.1	17.7	39.3	25.8	15.5	19.5	20.3	23.0	10.2	18.5	15.9	44.4	20.2	26.1	17.9	29.4	10.6	22.4	24.5	33.1	16.1	25.8	43.4	24.5	31.9	24.7	27.2	23.8	25.9	23.6	24.8	29.4	21.1	17.7	18.5	28.4	23.0	30.6	18.9	32.1	34.4	19.6	21.8	19.4	31.0	20.0	23.4	23.1	21.1	26.3	18.2
VEGFC	VRP	ENSG00000150630	"Vascular endothelial growth factor C"	P49767	4	176683538-176792727	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 20.1"	"Cell line enhanced"	"Detected in many"		"BJ: 41.2;HBF TERT88: 33.5;hTEC/SVTERT24-B: 33.7;LHCN-M2: 37.2"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	50000	50000				"unprognostic (4.18e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (7.88e-5)"	"unprognostic (4.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (1.17e-4)"	"unprognostic (1.89e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.22e-1)"	8.9	2.0	0.5	1.9	2.0	0.0	20.1	1.5	1.9	4.8	4.5	0.7	2.9	0.8	6.2	1.5	5.5	5.1	7.7	5.9	0.8		1.5	1.7	16.0	3.5	0.0	0.1	3.9	0.5	0.6	0.0	11.6	1.6	4.8	1.6	3.4	4.3	2.7	6.2	0.2	1.6	3.8	1.7	2.6	0.4	2.4	0.4	0.3	17.7	3.4	2.3	6.8	9.2	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.5	0.8	0.5	0.0	7.5	7.5	0.0	41.2	24.9	23.0	18.3	0.0	0.2	0.0	0.0	23.2	1.2	0.3	15.5	33.5	0.0	0.8	0.0	1.1	0.0	4.1	0.0	0.0	8.0	0.7	33.7	23.5	14.1	0.0	0.0	37.2	0.6	0.0	0.0	0.3	13.5	0.0	2.4	0.0	0.0	0.9	0.0	0.0	0.6	0.9	0.0	0.2	0.0	6.8	24.4	2.6	6.0	11.6	0.0	0.0	0.0	10.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1										
VRK1		ENSG00000100749	"Vaccinia related kinase 1"	Q99986	14	96797304-96931722	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	6.0	4.4	7.1	9.8	17.1	39.0	8.7	8.6	10.2	6.1	7.8	4.4	4.1	5.2	5.9	5.7	9.4	6.9	3.3	6.0	7.4	6.5	6.2	4.3	4.5	18.3	6.9	6.1	5.9	3.7	3.8	5.1	7.1	6.7	5.3	9.1	4.1	4.8	4.1	4.3	6.4	6.9	5.4	6.1	15.7	6.7	33.3	6.9	33.0	4.9	6.1	18.4	5.9	5.7	20.8	13.5	20.1	9.5	28.5	22.3	12.5	15.7	9.1	22.5	10.0	2.7	5.0	14.0	11.9	9.3	19.1	19.0	10.8	15.6	40.1	8.1	7.0	17.5	21.0	15.5	26.3	22.8	11.3	25.0	6.0	11.1	2.9	48.0	15.7	2.7	2.8	14.4	10.6	13.2	21.2	25.4	16.4	18.0	38.1	20.7	14.4	17.3	35.7	39.4	13.6	8.7	16.2	15.9	9.0	10.5	10.8	8.0	12.3	19.0	7.1	8.7	7.8	15.0	11.9	13.3	15.7	38.8	13.6	21.0	10.3	20.1	7.6	14.5	15.1	9.3	18.4	20.3	17.6	18.5	9.9	20.8	19.1	19.3	4.5	28.5	9.5	13.5	22.3	12.5	7.1	17.1	8.6	10.2	7.4	6.5	6.9	6.1	6.7	6.9
WARS	"IFI53, IFP53"	ENSG00000140105	"Tryptophanyl-tRNA synthetase"	P23381	14	100333788-100376805	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 142.8;thyroid gland: 157.0"	"Cell line enhanced"	"Detected in all"		"HHSteC: 116.6;SK-MEL-30: 140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"intermediate monocyte: 131.2;non-classical monocyte: 142.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol		53000000	53000000	Cytosol		"HPA005573: , HPA018944: "	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favourable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	42.5	23.3	14.5	53.9	20.1	17.0	20.6	10.7	25.4	11.1	19.1	13.3	7.1	12.7	16.5	20.5	17.8	14.5	13.7	32.0	17.8	18.7	24.6	17.9	68.5	35.3	16.9	14.8	12.1	15.6	9.4	23.5	89.6	28.2	16.4	21.0	23.5	15.7	11.7	22.3	9.3	19.8	21.0	15.7	51.6	19.8	23.7	9.4	20.9	157.0	19.2	22.7	24.0	13.8	5.6	27.7	51.8	142.8	3.3	3.4	46.4	10.9	10.4	6.8	39.9	9.9	14.1	11.0	14.1	27.3	30.5	38.4	6.8	9.8	11.9	13.2	33.7	18.6	19.9	16.1	19.6	18.8	5.7	7.6	7.9	8.3	116.6	21.8	12.6	16.0	23.2	17.7	36.8	27.2	24.0	31.5	13.0	20.9	7.5	10.2	6.9	18.9	6.2	10.8	7.6	14.8	9.6	18.4	10.7	8.4	7.3	140.8	18.8	27.6	18.0	3.3	7.3	33.3	7.4	61.5	31.2	22.1	36.7	16.9	29.7	6.1	39.5	51.8	3.4	131.2	3.1	5.6	2.8	3.1	27.7	4.1	2.0	2.4	14.1	3.3	142.8	4.2	3.3	46.4	14.5	20.1	10.7	25.4	17.8	18.7	16.9	14.8	28.2	9.4
WARS2	TrpRS	ENSG00000116874	"Tryptophanyl tRNA synthetase 2, mitochondrial"	Q9UGM6	1	119031216-119140671	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069692	Enhanced		Supported	"Plasma membrane,Mitochondria"				Mitochondria	"Plasma membrane"	"HPA069692: "	"unprognostic (1.00e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.05e-2)"	"unprognostic (7.73e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.76e-3)"	"prognostic favourable (1.45e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.88e-3)"	"unprognostic (4.71e-2)"	17.3	16.7	6.8	11.7	8.3	2.8	14.6	7.5	8.7	12.9	11.2	7.7	7.6	12.3	13.5	10.4	13.4	14.9	8.8	12.1	6.2	6.1	15.3	14.9	9.2	12.4	6.4	6.1	14.7	17.8	15.1	12.3	14.9	8.3	14.1	12.7	11.3	10.5	10.4	12.2	10.0	13.1	9.0	5.4	9.9	11.2	6.9	6.1	11.6	12.8	13.2	14.2	14.3	10.4	7.2	9.0	0.5	6.9	5.3	7.4	4.9	10.2	4.5	6.0	6.3	7.7	17.4	6.5	5.8	8.2	6.1	7.3	11.2	4.7	15.1	9.4	9.2	6.9	10.8	9.8	9.3	8.1	14.1	7.1	12.0	10.7	15.7	11.5	4.1	13.3	7.6	8.8	16.1	9.0	11.1	11.0	11.2	11.9	6.8	6.7	8.1	9.2	5.0	20.0	7.6	16.5	14.3	8.9	5.4	9.0	12.6	13.0	5.6	9.0	6.9	6.6	8.0	12.4	10.9	5.3	3.6	6.7	8.1	9.7	12.2	0.0	6.9	0.5	5.1	4.9	7.4	6.6	5.4	6.7	9.0	7.2	6.5	6.2	0.3	5.3	3.0	4.5	6.0	4.9	6.8	8.3	7.5	8.7	6.2	6.1	6.4	6.1	8.3	6.1
WFS1	"DFNA14, DFNA38, DFNA6, DIDMOAD, WFS"	ENSG00000109501	"Wolframin ER transmembrane glycoprotein"	O76024	4	6269849-6303265	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029128	Approved									"HPA029128: AB_10603460"	"unprognostic (4.27e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.58e-1)"	"prognostic favourable (1.13e-6)"	"unprognostic (7.35e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (3.64e-2)"	28.5	13.3	17.9	7.0	52.5	1.5	16.5	9.4	24.2	22.3	15.5	13.2	21.9	12.0	31.2	15.1	12.1	28.9	24.0	27.8	19.4	12.2	7.1	7.6	30.2	7.4	13.5	16.5	51.0	12.4	8.8	20.7	25.4	13.6	22.6	4.5	16.6	12.1	39.0	10.3	10.0	11.1	28.1	14.2	16.9	12.5	18.3	14.9	1.3	23.4	4.4	3.2	24.2	12.2	4.4	0.6	0.0	1.6	2.5	6.9	2.4	5.3	10.9	3.7	13.3	15.2	4.0	40.1	9.5	12.5	6.5	5.7	9.4	14.6	2.4	14.0	10.2	2.4	2.7	5.3	2.7	2.1	5.5	0.0	4.8	29.0	13.6	0.0	0.4	13.5	7.5	5.6	5.3	10.0	0.1	9.8	3.8	9.9	0.4	0.1	5.2	15.5	1.2	3.7	2.7	2.6	23.2	2.3	6.2	5.5	6.8	5.1	11.9	0.1	8.2	7.5	9.7	7.3	5.7	10.8	3.5	0.0	9.5	0.0	7.5	0.0	1.0	0.0	4.9	1.6	6.9	4.4	2.6	3.5	0.3	2.3	2.3	2.8	0.0	2.5	1.6	0.6	1.3	2.4	17.9	52.5	9.4	24.2	19.4	12.2	13.5	16.5	13.6	14.9
WNK1	"HSAN2, HSN2, PPP1R167, PRKWNK1"	ENSG00000060237	"WNK lysine deficient protein kinase 1"	Q9H4A3	12	752593-911452	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046541, HPA059157"	Enhanced		Supported	Cytosol				Cytosol		"HPA046541: , HPA059157: "	"unprognostic (1.40e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (9.67e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.30e-2)"	30.0	12.4	49.3	19.1	47.5	28.9	45.4	22.5	36.7	21.2	12.6	42.6	10.6	8.5	15.9	19.4	45.5	16.9	16.5	38.5	53.7	36.4	45.6	18.0	33.0	34.3	62.3	27.1	18.5	11.3	29.1	12.7	20.3	41.4	17.1	14.3	12.0	15.4	20.3	43.4	31.3	10.3	22.3	82.8	16.9	15.7	23.8	38.8	23.9	16.7	17.4	24.5	18.9	26.5	3.7	2.6	10.9	7.1	2.1	5.2	1.9	14.2	27.0	35.7	3.3	25.8	24.8	13.6	14.2	17.1	15.4	14.4	15.2	16.3	20.1	5.0	30.5	10.8	24.1	16.4	21.7	34.8	14.4	44.9	35.9	13.1	18.9	24.2	19.6	19.2	25.0	25.5	45.8	20.8	20.4	48.6	23.3	13.1	43.5	4.1	29.1	6.5	20.8	39.6	5.4	22.2	30.9	10.4	12.2	33.2	21.5	9.6	23.7	24.9	23.0	19.1	22.2	26.8	20.9	7.4	12.3	30.5	18.2	12.8	15.5	0.9	2.7	2.6	3.8	4.0	5.2	3.0	4.3	3.6	2.6	3.7	2.3	4.1	10.9	2.1	7.1	1.7	4.9	1.9	49.3	47.5	22.5	36.7	53.7	36.4	62.3	27.1	41.4	38.8
WNK4	PRKWNK4	ENSG00000126562	"WNK lysine deficient protein kinase 4"	Q96J92	17	42780678-42796936	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.1;ovary: 14.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 19.4;K-562: 21.7;TIME: 21.0;WM-115: 14.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016500	Approved									"HPA016500: AB_10962984"	"unprognostic (6.34e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.08e-3)"	"unprognostic (4.33e-3)"	"unprognostic (7.70e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.99e-2)"	1.1	0.0	0.8	5.8	0.2	0.0	2.6	0.6	0.3	0.7	12.9	0.4	0.4	2.1	0.2	2.8	8.7	0.5	1.0	0.2	2.6	0.0	28.1	0.2	0.4	0.1	0.1	0.3	14.6	1.0	0.0	2.4	0.0	1.7	11.1	11.7	12.2	1.4	1.2	0.0	0.5	3.3	0.4	0.8	0.1	2.6	0.4	0.2	0.0	0.0	0.2	2.0	0.3	0.4	0.4	0.0	0.0	0.3	0.0	1.0	0.0	1.2	0.6	0.2	0.0	0.2	0.1	2.9	7.2	2.8	2.7	0.8	0.4	0.5	0.2	4.3	19.4	0.0	0.1	0.2	4.7	0.4	0.9	0.0	0.0	2.8	4.6	0.0	0.4	2.5	0.4	3.9	1.2	0.2	21.7	0.7	0.0	0.6	0.0	0.5	0.2	4.9	0.3	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.9	1.4	1.5	21.0	0.2	1.9	0.2	0.1	3.5	3.0	0.6	0.0	1.2	14.1	0.0	0.3	0.0	0.0	0.0	0.7	0.4	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.6	0.3	2.6	0.0	0.1	0.3	1.7	0.2
WRN	"RECQ3, RECQL2"	ENSG00000165392	"Werner syndrome RecQ like helicase"	Q14191	8	31033801-31173769	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028661	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA028661: AB_10602255"	"unprognostic (8.73e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.66e-1)"	10.1	9.2	5.6	8.5	6.6	15.6	11.1	10.7	7.3	14.2	8.0	7.7	7.7	5.5	24.4	8.8	7.6	9.7	6.9	7.0	5.9	4.0	5.1	7.7	7.2	6.7	8.2	5.3	12.0	9.9	7.8	28.1	8.5	7.0	8.6	7.8	8.3	10.8	7.8	7.7	10.2	7.0	12.1	14.9	8.9	8.3	10.4	7.3	11.8	7.9	6.3	9.3	10.8	8.7	3.9	2.7	1.3	1.9	2.9	6.2	1.6	6.4	6.3	13.1	8.3	7.8	12.5	8.3	7.3	7.1	8.9	9.3	4.0	3.9	15.1	6.7	7.3	3.3	8.1	5.2	13.4	4.2	6.9	15.4	6.0	3.3	9.8	9.1	5.7	9.1	5.8	8.5	10.2	8.6	24.3	9.6	8.2	4.1	18.9	4.4	11.2	4.6	10.9	9.9	6.0	3.7	7.0	2.8	7.5	8.8	5.0	6.9	3.5	4.5	13.7	9.7	6.0	5.0	6.1	2.5	2.7	19.0	7.2	7.2	6.6	1.2	1.9	1.3	3.3	1.9	6.2	3.9	3.8	3.3	2.7	3.5	2.5	3.2	0.5	2.9	0.8	2.0	2.8	1.6	5.6	6.6	10.7	7.3	5.9	4.0	8.2	5.3	7.0	7.3
XK	"Kx, NA, NAC, X1k, XKR1"	ENSG00000047597	"X-linked Kx blood group"	P51811	X	37685756-37732130	"Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"	"Blood group antigen"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.6"	"Cell line enhanced"	"Detected in many"		"HEL: 24.7;HL-60: 12.7;K-562: 15.9;NB-4: 11.7;RPMI-8226: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	40	"basophil: 9.4;eosinophil: 6.8"	"Lineage enriched"	"Detected in single"	94	"granulocytes: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019036	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria				Mitochondria	"Nucleoplasm, Vesicles"	"HPA019036: AB_1846286"	"unprognostic (2.37e-2)"	"unprognostic (7.13e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"unprognostic (4.56e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.90e-2)"	"unprognostic (4.44e-8)"	"unprognostic (1.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	0.6	2.9	4.9	3.0	5.1	14.0	1.1	10.2	8.3	1.8	16.5	1.2	0.0	12.9	1.2	0.8	2.7	4.8	2.0	8.1	4.7	6.6	1.4	2.1	1.5	0.7	3.0	5.9	1.2	7.9	2.2	3.8	1.4	4.4	2.1	13.8	1.0	8.6	1.5	5.9	1.2	23.6	3.2	1.6	1.2	13.3	3.5	0.2	0.1	1.4	5.9	0.8	2.9	2.5	0.0	0.0	9.4	0.0	0.0	0.0	0.7	9.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	8.2	0.1	0.0	1.5	8.8	0.0	0.0	0.0	2.4	24.7	1.4	0.0	0.0	12.7	2.0	0.0	0.4	0.0	0.0	0.0	15.9	6.3	0.0	0.9	0.1	11.7	3.1	3.2	0.0	0.0	11.2	0.0	0.6	2.3	0.0	0.4	0.8	0.0	1.2	3.1	0.0	0.0	0.4	0.0	1.3	5.4	8.9	0.0	0.1	6.8	0.0	9.4	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	4.9	5.1	10.2	8.3	4.7	6.6	3.0	5.9	4.4	0.2
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738974-129769538	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"intestine: 145.6;kidney: 49.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 6.2;ASC TERT1: 32.6;HSkMC: 16.5"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.3;liver cancer: 18.3;stomach cancer: 3.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 7.3;intermediate monocyte: 2.1;MAIT T-cell: 2.2;memory CD4 T-cell: 2.4;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.6;non-classical monocyte: 4.4;T-reg: 2.2"	"Group enriched"	"Detected in many"	7	"monocytes: 4.4;T-cells: 7.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	8900000	8900000	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	4.7	0.5	0.0	1.1	0.1	0.0	3.2	0.0	0.1	1.7	57.4	0.1	0.8	37.0	1.2	1.7	4.2	3.4	1.3	2.6	0.0	0.0	49.7	8.0	1.0	1.2	0.0	0.0	3.5	0.9	0.0	0.0	0.6	0.1	3.6	2.0	0.7	0.7	0.3	1.6	2.1	145.6	2.5	0.1	0.2	1.7	1.2	0.0	0.1	0.9	1.4	0.3	4.0	10.7	0.4	0.8	0.2	4.4	0.0	7.3	1.3	0.0	0.0	0.4	0.0	6.2	32.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	7.3	2.1	2.2	0.0	2.4	4.8	0.3	0.4	0.7	3.6	0.2	0.0	4.4	0.8	2.2	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
XPNPEP3	"APP3, ICP55, NPHPL1"	ENSG00000196236	"X-prolyl aminopeptidase 3"	Q9NQH7	22	40857077-40932815	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA000527	Approved									"HPA000527: AB_1079266"	"prognostic unfavourable (8.19e-4)"	"unprognostic (6.77e-2)"	"unprognostic (3.22e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (6.10e-4)"	"unprognostic (1.24e-1)"	8.2	13.6	7.5	5.8	9.2	4.7	9.7	5.2	7.8	7.3	6.1	10.8	11.6	32.3	10.7	12.3	7.2	9.4	10.5	11.2	7.6	7.1	9.8	19.0	6.6	10.6	7.9	6.1	10.7	10.5	8.0	15.0	6.1	10.7	7.3	6.2	9.3	8.5	13.6	12.0	11.5	20.9	7.1	9.3	7.7	6.8	18.9	8.2	11.5	9.1	7.3	8.8	12.6	8.2	5.9	6.0	6.4	10.0	1.2	4.4	4.0	3.2	4.7	3.2	7.0	9.0	6.0	2.2	4.1	3.1	2.3	2.3	3.9	2.1	6.5	2.3	7.9	7.6	6.0	3.2	3.4	3.9	12.4	4.2	9.3	7.3	4.1	7.3	0.7	5.2	5.0	7.2	4.3	4.0	3.5	5.9	4.8	5.0	3.5	3.9	1.9	9.6	4.9	4.3	3.7	6.4	4.4	2.8	2.5	4.0	6.1	3.8	7.1	3.3	4.0	4.7	4.1	4.3	2.4	5.5	4.2	7.9	7.2	9.6	3.2	4.0	4.4	4.4	3.4	3.9	1.8	5.9	2.1	2.2	3.1	3.7	4.4	3.3	6.4	1.2	10.0	6.0	3.0	4.0	7.5	9.2	5.2	7.8	7.6	7.1	7.9	6.1	10.7	8.2
XYLT1	"PXYLT1, XT-I"	ENSG00000103489	"Xylosyltransferase 1"	Q86Y38	16	17101769-17470881	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 18.8;U-2197: 19.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007478, HPA007966"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to blood"	30000	30000	"Plasma membrane"	"Endoplasmic reticulum"	"HPA007478: AB_1080616, HPA007966: AB_1080618"	"unprognostic (1.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	5.7	5.9	6.3	21.6	3.1	5.9	7.0	3.8	6.7	8.0	7.4	1.4	0.9	3.9	7.4	3.0	4.9	3.2	4.4	3.8	6.3	4.2	1.9	0.9	2.9	7.5	4.3	2.2	5.5	2.6	0.2	1.8	5.4	2.6	4.4	4.9	3.4	2.6	4.3	1.3	4.1	4.7	5.1	3.9	6.3	3.2	3.0	2.1	4.6	2.7	6.7	6.6	4.7	4.2	1.2	0.8	1.2	3.6	0.9	0.7	0.5	0.0	0.1	2.6	0.0	18.8	11.7	3.2	8.4	4.3	0.9	0.4	0.1	0.2	2.0	0.0	10.1	0.2	0.0	1.7	1.5	4.0	0.2	2.5	0.0	0.0	0.2	3.6	3.4	4.3	0.2	5.4	0.8	0.0	0.3	7.9	0.9	0.3	0.0	3.9	2.8	0.0	1.2	0.0	0.4	0.0	3.8	0.7	5.1	0.6	2.6	0.5	0.6	2.3	0.0	8.8	1.0	19.3	0.0	8.8	0.5	3.8	9.8	4.1	7.4	0.6	0.6	1.2	0.6	2.5	0.7	1.2	0.5	0.3	0.8	1.2	0.5	0.4	0.3	0.9	3.6	0.2	0.7	0.5	6.3	3.1	3.8	5.3	6.3	4.2	4.3	2.2	2.6	2.1
XYLT2	"PXYLT2, XT-II"	ENSG00000015532	"Xylosyltransferase 2"	Q9H1B5	17	50346092-50363138	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 53.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016456			Approved	"Nuclear bodies,Cytosol"	"Secreted to blood"	990000	990000	"Nuclear bodies"	Cytosol	"HPA016456: AB_1858907"	"unprognostic (1.52e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.68e-2)"	6.9	8.5	5.8	11.3	10.6	4.1	7.4	10.3	10.9	10.7	9.2	5.4	15.8	10.0	9.6	12.2	8.5	10.4	14.9	9.4	5.3	4.8	9.2	6.1	6.1	10.2	4.7	8.8	11.8	13.5	9.1	5.8	9.0	5.4	12.1	3.9	13.1	12.7	11.7	7.9	15.6	6.9	17.0	3.8	8.4	53.4	5.8	3.7	10.2	9.5	6.7	10.4	11.7	9.0	5.3	4.9	6.6	4.0	7.8	7.8	4.3	9.7	12.5	3.4	2.8	4.8	4.7	8.9	9.1	8.4	8.2	9.3	13.2	7.4	5.1	23.2	8.2	7.5	1.1	12.8	1.7	25.2	8.9	11.4	3.8	5.7	6.6	3.6	6.2	6.4	7.9	6.6	3.1	7.0	2.0	4.3	5.4	12.7	6.6	4.9	3.1	8.8	3.3	10.0	4.2	4.6	5.1	1.8	4.3	6.1	5.8	9.6	27.6	3.5	8.2	18.8	9.6	10.2	8.1	23.4	10.7	1.7	19.8	5.8	5.1	6.6	4.0	3.2	5.9	2.8	6.3	2.9	5.9	7.8	4.9	5.3	6.0	5.3	4.7	7.8	2.5	3.4	5.2	4.3	5.8	10.6	10.3	10.9	5.3	4.8	4.7	8.8	5.4	3.7
YARS	"tyrRS, YRS, YTS"	ENSG00000134684	"Tyrosyl-tRNA synthetase"	P54577	1	32775237-32818153	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017936, HPA018950, HPA018954"	Enhanced		Enhanced	Cytosol		230000	230000	Cytosol		"HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915"	"unprognostic (4.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.38e-3)"	"prognostic unfavourable (6.97e-11)"	"unprognostic (5.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavourable (1.02e-11)"	"unprognostic (3.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavourable (6.57e-4)"	16.6	36.3	22.8	22.8	40.6	17.4	13.9	26.6	43.1	14.6	17.5	16.3	22.4	17.1	14.2	15.5	24.1	14.4	11.2	15.5	24.9	28.3	14.1	29.6	21.3	23.2	24.9	27.4	21.2	54.8	19.3	13.9	17.5	26.7	12.7	21.9	11.2	23.5	25.7	27.3	16.5	14.9	22.7	22.7	14.6	25.9	20.9	26.0	15.2	30.0	16.8	29.6	17.0	28.0	9.9	17.8	20.9	13.4	36.5	24.3	17.1	28.3	14.8	15.7	37.7	19.5	22.5	16.7	29.4	24.3	24.1	30.8	17.6	19.6	51.7	11.7	30.5	16.7	47.7	34.6	38.2	21.7	18.9	47.3	22.5	16.6	64.2	37.3	28.7	22.2	43.0	38.1	97.1	24.4	52.2	54.8	20.7	14.7	41.8	20.5	28.5	20.6	36.7	15.0	43.5	17.3	14.2	30.3	18.6	16.0	18.8	54.1	18.8	40.7	19.8	14.7	26.2	29.8	24.2	44.3	47.1	48.3	36.7	52.1	40.3	20.9	12.7	6.6	24.3	13.4	23.9	9.9	14.5	22.3	17.8	8.1	10.8	16.5	3.0	36.5	12.4	10.2	15.6	17.1	22.8	40.6	26.6	43.1	24.9	28.3	24.9	27.4	26.7	26.0
YARS2	"CGI-04, FLJ13995, mt-TyrRS"	ENSG00000139131	"Tyrosyl-tRNA synthetase 2"	Q9Y2Z4	12	32727490-32755902	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038721, HPA057610, HPA074097"	Uncertain		Supported	"Nuclear bodies,Mitochondria"				Mitochondria	"Nuclear bodies"	"HPA038721: AB_10674837, HPA057610: , HPA074097: "	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.99e-3)"	"prognostic unfavourable (3.19e-5)"	"unprognostic (1.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.39e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.09e-1)"	12.6	15.8	11.0	12.6	15.3	13.9	13.8	11.6	14.9	13.1	11.8	11.5	18.4	9.8	13.3	12.9	17.5	11.3	9.1	12.1	11.9	9.7	12.4	16.3	9.2	15.5	10.8	11.7	13.3	21.0	11.0	16.6	15.9	13.5	12.9	13.7	11.3	17.4	10.0	15.9	12.0	10.8	11.1	12.6	13.3	12.3	12.5	12.6	17.5	12.3	16.0	16.4	13.3	11.8	11.8	9.5	9.4	9.9	12.9	12.7	5.2	9.5	11.5	6.7	8.0	7.4	8.7	21.3	7.3	7.5	9.1	8.9	28.8	12.3	17.3	12.0	7.4	12.4	13.4	19.3	10.3	7.5	20.9	11.4	8.7	16.0	10.7	12.1	6.7	8.1	12.4	8.5	15.6	14.3	16.1	8.0	9.6	7.8	9.0	14.7	37.1	14.2	10.2	14.4	10.2	11.5	13.7	10.4	5.0	11.2	9.8	7.2	18.3	11.0	9.6	8.6	9.2	14.0	12.3	4.8	5.1	18.0	8.0	9.1	7.1	9.4	7.0	4.1	10.1	8.9	10.6	8.8	10.7	10.4	9.5	11.8	11.2	12.7	1.4	12.9	9.9	9.3	9.3	5.2	11.0	15.3	11.6	14.9	11.9	9.7	10.8	11.7	13.5	12.6
YME1L1		ENSG00000136758	"YME1 like 1 ATPase"	Q96TA2	10	27110112-27155266	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066953	Approved		Supported	"Nuclear bodies,Mitochondria"				Mitochondria	"Nuclear bodies"	"HPA066953: "	"unprognostic (2.28e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (8.25e-6)"	"unprognostic (7.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.09e-2)"	27.8	37.3	22.7	25.0	26.2	41.4	39.2	27.8	27.5	27.6	24.3	15.7	29.8	22.3	29.9	35.9	34.5	25.3	24.4	34.1	23.4	21.5	26.8	45.4	26.9	38.7	19.3	25.5	32.5	33.8	27.8	28.6	33.4	22.0	25.9	26.3	23.3	28.1	31.3	79.0	26.8	25.3	34.6	20.2	26.5	24.7	24.7	20.9	41.7	30.9	32.0	28.9	36.4	28.9	55.6	79.2	73.9	53.0	45.5	56.0	45.9	40.0	30.1	36.1	17.8	35.4	38.1	29.5	39.6	23.2	40.7	46.7	40.7	49.4	42.8	26.4	43.7	38.8	43.3	35.0	45.0	38.8	26.0	40.6	26.9	28.5	38.9	27.7	33.4	31.2	41.4	35.5	36.0	42.5	47.1	43.6	44.9	27.1	51.2	16.0	28.6	14.1	44.3	57.9	39.5	33.2	19.1	27.8	35.6	39.6	30.8	39.7	29.5	34.8	41.6	24.7	34.5	41.4	35.5	21.9	32.1	54.7	35.1	51.5	18.8	53.0	53.0	55.2	55.3	44.8	56.0	51.4	53.8	51.2	42.6	55.6	49.7	51.9	73.9	45.5	47.3	79.2	52.6	45.9	22.7	26.2	27.8	27.5	23.4	21.5	19.3	25.5	22.0	20.9
ZAP70	"SRK, STD, ZAP-70"	ENSG00000115085	"Zeta chain of T cell receptor associated protein kinase 70"	P43403	2	97713560-97739862	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 37.4;lymphoid tissue: 107.1"	"Cell line enriched"	"Detected in some"	13	"MOLT-4: 61.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	41	"gdT-cell: 37.4;MAIT T-cell: 25.4;memory CD4 T-cell: 19.6;memory CD8 T-cell: 29.2;naive CD4 T-cell: 14.3;naive CD8 T-cell: 21.9;NK-cell: 26.4;T-reg: 19.9"	"Group enriched"	"Detected in many"	53	"NK-cells: 26.4;T-cells: 37.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002625, HPA003134"	Enhanced									"CAB002625: , HPA003134: AB_1080629"	"unprognostic (4.11e-3)"	"prognostic favourable (6.89e-5)"	"unprognostic (3.82e-3)"	"prognostic favourable (9.66e-8)"	"unprognostic (5.78e-2)"	"prognostic favourable (3.93e-6)"	"unprognostic (2.30e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (3.02e-8)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.83e-3)"	2.2	0.5	0.3	18.1	0.6	11.2	1.5	0.7	0.6	1.2	3.7	0.7	0.3	2.9	1.2	1.1	1.7	1.5	2.8	0.9	0.4	0.8	2.2	2.3	5.8	28.1	0.8	0.6	0.9	1.3	0.0	0.7	0.9	0.6	2.1	0.6	1.0	5.5	1.0	0.7	1.0	12.3	0.7	0.7	24.8	3.2	1.4	0.6	107.1	2.5	1.1	20.8	3.0	1.7	0.4	0.2	0.5	0.2	26.4	37.4	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	61.5	0.1	0.0	0.0	2.4	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.1	37.4	0.1	25.4	0.0	19.6	29.2	0.0	0.4	14.3	21.9	0.5	26.4	0.2	0.2	19.9	14.3	0.3	0.6	0.7	0.6	0.4	0.8	0.8	0.6	0.6	0.6
ZDHHC15	"DHHC15, FLJ31812, MRX91"	ENSG00000102383	"Zinc finger DHHC-type containing 15"	Q96MV8	X	75368427-75523502	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 5.6;K-562: 3.5;LHCN-M2: 3.9;MOLT-4: 4.1;NTERA-2: 3.7;RH-30: 5.7;RPTEC TERT1: 3.1;SH-SY5Y: 4.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003618	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA003618: AB_2217686"	"unprognostic (8.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.62e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.19e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.78e-13)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.67e-4)"	3.0	5.4	4.9	1.5	6.8	1.1	5.3	6.2	9.9	5.8	3.4	3.9	2.4	1.3	6.5	3.7	3.2	4.5	3.3	5.4	5.9	8.7	5.3	1.2	4.1	1.6	4.8	5.3	8.5	4.7	5.0	8.7	0.7	7.0	4.0	2.3	5.4	12.7	6.9	1.6	2.8	1.8	5.2	6.4	2.9	2.1	2.6	3.1	2.0	6.6	2.1	1.5	2.6	3.1	0.3	0.4	0.7	0.2	0.5	1.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	3.9	0.0	4.1	0.1	3.7	0.0	0.0	5.7	0.0	3.1	0.0	1.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.0	0.0	0.7	2.8	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.0	0.1	0.3	0.6	0.0	0.0	0.2	1.6	1.1	0.7	0.5	0.1	0.4	0.0	0.3	4.9	6.8	6.2	9.6	5.9	8.7	4.8	5.3	7.0	3.1
ZDHHC9	"CGI-89, CXorf11, ZDHHC10, ZNF379, ZNF380"	ENSG00000188706	"Zinc finger DHHC-type containing 9"	Q9Y397	X	129803288-129843909	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031814	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"				"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA031814: AB_10610700"	"prognostic unfavourable (9.77e-5)"	"prognostic unfavourable (4.64e-5)"	"unprognostic (2.83e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (4.01e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.11e-2)"	18.2	7.3	16.7	6.7	24.7	3.2	14.2	7.8	33.9	14.1	14.7	78.3	5.1	21.1	8.4	8.4	9.8	7.9	10.4	7.4	24.1	15.2	25.4	27.0	15.6	3.0	24.9	13.9	8.0	17.4	19.6	7.1	11.5	28.4	13.4	17.3	3.8	13.2	8.3	7.4	19.7	22.2	10.4	32.7	2.4	12.8	2.8	25.3	1.2	9.6	5.7	4.3	10.8	9.4	4.6	7.8	2.6	6.8	3.4	7.6	3.3	15.2	8.0	11.5	23.2	39.9	31.4	9.4	15.1	17.3	7.2	9.1	12.6	19.9	0.5	25.8	16.0	10.3	13.0	15.1	10.5	0.8	8.1	3.0	8.4	16.6	15.8	2.0	5.5	34.1	24.7	11.8	17.6	13.6	3.3	6.1	11.7	13.3	2.9	3.8	6.2	13.9	2.7	7.4	9.0	10.5	8.5	9.1	7.7	4.3	22.3	7.0	9.5	3.4	11.1	7.4	2.5	17.3	12.1	5.7	4.1	1.8	13.3	8.4	3.7	0.0	3.3	2.6	4.8	2.9	6.1	4.6	5.8	4.7	3.7	2.7	7.6	4.3	0.0	3.4	6.8	7.8	2.5	3.3	16.7	24.7	7.8	33.9	24.1	15.2	24.9	13.9	28.4	25.3
ZMPSTE24	"FACE-1, HGPS, PRO1, STE24, Ste24p"	ENSG00000084073	"Zinc metallopeptidase STE24"	O75844	1	40258107-40294184	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006988	Approved		Approved	"Golgi apparatus,Cytosol"		13000	13000	Cytosol	"Golgi apparatus"	"HPA006988: AB_1080659"	"unprognostic (6.32e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (5.73e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.78e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (6.34e-4)"	"unprognostic (2.71e-2)"	21.6	24.2	17.6	15.4	19.6	6.5	18.6	10.7	21.3	20.9	20.6	14.9	27.0	17.9	29.7	19.7	21.4	19.9	20.7	20.8	17.1	16.9	34.2	48.7	16.2	23.1	21.9	17.0	16.0	20.4	39.8	17.0	23.0	23.5	21.7	23.3	15.6	18.9	19.0	19.1	14.7	20.9	25.2	19.2	17.7	19.0	10.7	17.9	20.9	20.6	14.7	18.4	19.1	16.7	15.1	25.8	15.1	23.9	24.2	22.5	20.3	20.7	13.9	10.8	8.1	28.7	23.0	21.0	21.8	18.2	24.6	22.5	15.1	36.0	17.9	15.1	26.6	21.6	22.0	20.0	28.4	16.8	14.1	17.3	14.8	13.8	16.4	27.8	21.7	16.6	20.6	21.0	9.1	17.3	18.3	18.0	23.3	9.7	16.8	8.3	20.7	14.5	14.6	19.2	22.2	21.8	20.1	11.3	13.3	20.1	44.9	27.0	16.5	76.8	17.1	22.3	16.3	20.7	26.4	11.1	29.6	15.6	24.4	19.5	23.6	15.1	20.0	13.6	17.9	23.9	21.5	15.1	19.1	18.9	25.8	11.6	17.0	22.5	11.8	24.2	22.7	16.9	22.3	20.3	17.6	19.6	10.7	21.3	17.1	16.9	21.9	17.0	23.5	17.9
